PGSC0003DMC200054361	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMC200054361	K00517	ko00626	Naphthalene and anthracene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMC200054361	K00517	ko00903	Limonene and pinene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMC200054361	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMC200054361	K00517	ko01110	Biosynthesis of secondary metabolites	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMC200054362	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMC200054362	K00517	ko00626	Naphthalene and anthracene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMC200054362	K00517	ko00903	Limonene and pinene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMC200054362	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMC200054362	K00517	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMC200054368	K00558	ko00270	Cysteine and methionine metabolism	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMC200054368	K00558	ko01100	Metabolic pathways	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMC200054372	K12929	ko00904	Diterpenoid biosynthesis	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMC200054372	K12929	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMC200054373	K12929	ko00904	Diterpenoid biosynthesis	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMC200054373	K12929	ko01110	Biosynthesis of secondary metabolites	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMC200054387	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.3e-09	0.36	0.52	0.60
PGSC0003DMC200054388	K11294	ko05130	Pathogenic Escherichia coli infection	399	3.6e-16	0.28	0.50	0.85
PGSC0003DMC200053624	K01692	ko00071	Fatty acid metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00280	Valine, leucine and isoleucine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00281	Geraniol degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00310	Lysine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00380	Tryptophan metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00410	beta-Alanine metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00632	Benzoate degradation via CoA ligation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00640	Propanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00650	Butanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00903	Limonene and pinene degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko00930	Caprolactam degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko01100	Metabolic pathways	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053624	K01692	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMC200053625	K01692	ko00071	Fatty acid metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00280	Valine, leucine and isoleucine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00281	Geraniol degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00310	Lysine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00380	Tryptophan metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00410	beta-Alanine metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00632	Benzoate degradation via CoA ligation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00640	Propanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00650	Butanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00903	Limonene and pinene degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko00930	Caprolactam degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko01100	Metabolic pathways	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053625	K01692	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMC200053626	K01692	ko00071	Fatty acid metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00280	Valine, leucine and isoleucine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00281	Geraniol degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00310	Lysine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00380	Tryptophan metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00410	beta-Alanine metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00632	Benzoate degradation via CoA ligation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00640	Propanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00650	Butanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00903	Limonene and pinene degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko00930	Caprolactam degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko01100	Metabolic pathways	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053626	K01692	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMC200053627	K00472	ko00330	Arginine and proline metabolism	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMC200053627	K00472	ko01100	Metabolic pathways	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMC200041735	K03108	ko03060	Protein export	412	1.0e-16	0.90	0.97	0.67
PGSC0003DMC200041737	K11778	ko00900	Terpenoid backbone biosynthesis	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMC200041737	K11778	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMC200041739	K04120	ko00904	Diterpenoid biosynthesis	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMC200041739	K04120	ko01100	Metabolic pathways	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMC200041739	K04120	ko01110	Biosynthesis of secondary metabolites	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMC200041740	K13065	ko00940	Phenylpropanoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMC200041740	K13065	ko00941	Flavonoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMC200041740	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMC200041740	K13065	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMC200041741	K13065	ko00940	Phenylpropanoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMC200041741	K13065	ko00941	Flavonoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMC200041741	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMC200041741	K13065	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMC200041742	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMC200041743	K11866	ko04144	Endocytosis	601	8.0e-27	0.30	0.46	0.91
PGSC0003DMC200041744	K11866	ko04144	Endocytosis	600	9.2e-27	0.30	0.46	0.91
PGSC0003DMC200041745	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMC200041753	K04121	ko00904	Diterpenoid biosynthesis	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMC200041753	K04121	ko01100	Metabolic pathways	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMC200041753	K04121	ko01110	Biosynthesis of secondary metabolites	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMC200041754	K01177	ko00500	Starch and sucrose metabolism	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMC200041754	K01177	ko01100	Metabolic pathways	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMC200041756	K04733	ko04210	Apoptosis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMC200041756	K04733	ko04620	Toll-like receptor signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMC200041756	K04733	ko04722	Neurotrophin signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMC200041756	K04733	ko05140	Leishmaniasis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMC200041756	K04733	ko05142	Chagas disease	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMC200049782	K00826	ko00280	Valine, leucine and isoleucine degradation	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMC200049782	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMC200049782	K00826	ko00770	Pantothenate and CoA biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMC200049782	K00826	ko01100	Metabolic pathways	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMC200049782	K00826	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMC200049783	K00826	ko00280	Valine, leucine and isoleucine degradation	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMC200049783	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMC200049783	K00826	ko00770	Pantothenate and CoA biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMC200049783	K00826	ko01100	Metabolic pathways	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMC200049783	K00826	ko01110	Biosynthesis of secondary metabolites	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMC200049786	K10601	ko04120	Ubiquitin mediated proteolysis	313	2.0e-11	0.28	0.42	0.63
PGSC0003DMC200049787	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMC200049788	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMC200049795	K00869	ko00900	Terpenoid backbone biosynthesis	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMC200049795	K00869	ko01100	Metabolic pathways	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMC200049795	K00869	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMC200049795	K00869	ko04146	Peroxisome	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMC200049796	K00869	ko00900	Terpenoid backbone biosynthesis	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMC200049796	K00869	ko01100	Metabolic pathways	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMC200049796	K00869	ko01110	Biosynthesis of secondary metabolites	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMC200049796	K00869	ko04146	Peroxisome	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMC200049800	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3380	1.4e-180	0.87	0.95	1.00
PGSC0003DMC200031382	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMC200031382	K00517	ko00626	Naphthalene and anthracene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMC200031382	K00517	ko00903	Limonene and pinene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMC200031382	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMC200031382	K00517	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMC200031383	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMC200031383	K00517	ko00626	Naphthalene and anthracene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMC200031383	K00517	ko00903	Limonene and pinene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMC200031383	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMC200031383	K00517	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMC200066470	K02703	ko00195	Photosynthesis	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMC200066470	K02703	ko01100	Metabolic pathways	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMC200025571	K11816	ko00380	Tryptophan metabolism	2400	1.5e-126	0.69	0.81	0.99
PGSC0003DMC200025578	K00558	ko00270	Cysteine and methionine metabolism	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMC200025578	K00558	ko01100	Metabolic pathways	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMC200025579	K00558	ko00270	Cysteine and methionine metabolism	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMC200025579	K00558	ko01100	Metabolic pathways	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMC200025585	K01899	ko00020	Citrate cycle (TCA cycle)	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMC200025585	K01899	ko00640	Propanoate metabolism	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMC200025585	K01899	ko01100	Metabolic pathways	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMC200025585	K01899	ko01110	Biosynthesis of secondary metabolites	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMC200025586	K01899	ko00020	Citrate cycle (TCA cycle)	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMC200025586	K01899	ko00640	Propanoate metabolism	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMC200025586	K01899	ko01100	Metabolic pathways	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMC200025586	K01899	ko01110	Biosynthesis of secondary metabolites	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMC200018573	K10879	ko03440	Homologous recombination	215	5.0e-06	0.44	0.65	0.52
PGSC0003DMC200018577	K10879	ko03440	Homologous recombination	510	2.7e-22	0.49	0.60	0.82
PGSC0003DMC200018592	K06062	ko04330	Notch signaling pathway	1349	1.4e-68	0.70	0.79	0.89
PGSC0003DMC200018593	K06062	ko04330	Notch signaling pathway	1211	5.9e-61	0.84	0.90	0.75
PGSC0003DMC200018594	K06062	ko04330	Notch signaling pathway	3448	2.4e-184	0.79	0.88	1.00
PGSC0003DMC200018595	K06062	ko04330	Notch signaling pathway	1277	1.3e-64	0.72	0.82	0.97
PGSC0003DMC200018596	K06062	ko04330	Notch signaling pathway	3429	2.7e-183	0.79	0.87	1.00
PGSC0003DMC200039243	K05757	ko04666	Fc gamma R-mediated phagocytosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMC200039243	K05757	ko04810	Regulation of actin cytoskeleton	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMC200039243	K05757	ko05100	Bacterial invasion of epithelial cells	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMC200039243	K05757	ko05130	Pathogenic Escherichia coli infection	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMC200039243	K05757	ko05131	Shigellosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMC200039244	K05757	ko04666	Fc gamma R-mediated phagocytosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMC200039244	K05757	ko04810	Regulation of actin cytoskeleton	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMC200039244	K05757	ko05100	Bacterial invasion of epithelial cells	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMC200039244	K05757	ko05130	Pathogenic Escherichia coli infection	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMC200039244	K05757	ko05131	Shigellosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMC200039245	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039245	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039245	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039245	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039245	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039246	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039246	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039246	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039246	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039246	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMC200039247	K04512	ko04310	Wnt signaling pathway	630	1.3e-28	0.27	0.48	0.77
PGSC0003DMC200039249	K12131	ko04712	Circadian rhythm - plant	302	8.8e-11	0.31	0.51	0.90
PGSC0003DMC200039250	K08243	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMC200039250	K08243	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMC200039251	K08243	ko00941	Flavonoid biosynthesis	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMC200039251	K08243	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMC200039262	K03354	ko04110	Cell cycle	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039262	K03354	ko04111	Cell cycle - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039262	K03354	ko04113	Meiosis - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039262	K03354	ko04114	Oocyte meiosis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039262	K03354	ko04120	Ubiquitin mediated proteolysis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039262	K03354	ko04914	Progesterone-mediated oocyte maturation	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMC200039267	K01046	ko00561	Glycerolipid metabolism	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMC200039267	K01046	ko01100	Metabolic pathways	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMC200039269	K10144	ko04115	p53 signaling pathway	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMC200039269	K10144	ko04120	Ubiquitin mediated proteolysis	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMC200039270	K10144	ko04115	p53 signaling pathway	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMC200039270	K10144	ko04120	Ubiquitin mediated proteolysis	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMC200058784	K00021	ko00900	Terpenoid backbone biosynthesis	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMC200058784	K00021	ko01100	Metabolic pathways	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMC200058784	K00021	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMC200056638	K11644	ko05016	Huntington's disease	422	1.8e-16	0.32	0.48	0.73
PGSC0003DMC200033991	K01501	ko00380	Tryptophan metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033991	K01501	ko00460	Cyanoamino acid metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033991	K01501	ko00632	Benzoate degradation via CoA ligation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033991	K01501	ko00643	Styrene degradation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033991	K01501	ko00910	Nitrogen metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033991	K01501	ko01100	Metabolic pathways	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMC200033997	K01255	ko00480	Glutathione metabolism	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMC200033997	K01255	ko01100	Metabolic pathways	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMC200034002	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMC200034002	K01602	ko00710	Carbon fixation in photosynthetic organisms	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMC200034002	K01602	ko01100	Metabolic pathways	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMC200034004	K12655	ko04622	RIG-I-like receptor signaling pathway	222	6.5e-06	0.31	0.45	0.87
PGSC0003DMC200034006	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034006	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034006	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034007	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034007	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034007	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMC200034008	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034008	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034008	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034009	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034009	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034009	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMC200034010	K12886	ko03040	Spliceosome	402	2.4e-16	0.29	0.43	0.55
PGSC0003DMC200034012	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMC200034013	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMC200051368	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMC200051369	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051369	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051369	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051369	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051369	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051369	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMC200051371	K00100	ko00051	Fructose and mannose metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051371	K00100	ko00363	Bisphenol A degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051371	K00100	ko00591	Linoleic acid metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051371	K00100	ko00625	Tetrachloroethene degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051371	K00100	ko00650	Butanoate metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051371	K00100	ko01100	Metabolic pathways	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMC200051373	K12356	ko00940	Phenylpropanoid biosynthesis	745	3.0e-35	0.50	0.62	0.51
PGSC0003DMC200051374	K12356	ko00940	Phenylpropanoid biosynthesis	538	7.7e-24	0.31	0.52	0.94
PGSC0003DMC200051375	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.46	0.59	0.77
PGSC0003DMC200051377	K13228	ko00402	Benzoxazinoid biosynthesis	230	8.0e-11	0.35	0.54	0.70
PGSC0003DMC200051380	K12356	ko00940	Phenylpropanoid biosynthesis	285	8.7e-10	0.33	0.53	0.86
PGSC0003DMC200051382	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.53	0.93
PGSC0003DMC200051387	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMC200051387	K01078	ko00740	Riboflavin metabolism	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMC200051388	K04498	ko04110	Cell cycle	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04310	Wnt signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04330	Notch signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04350	TGF-beta signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04520	Adherens junction	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04630	Jak-STAT signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04720	Long-term potentiation	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko04916	Melanogenesis	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko05016	Huntington's disease	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko05200	Pathways in cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko05211	Renal cell carcinoma	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200051388	K04498	ko05215	Prostate cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMC200001536	K11091	ko03040	Spliceosome	269	3.7e-08	0.41	0.49	0.08
PGSC0003DMC200001551	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001551	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200001552	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMC200064727	K10643	ko03018	RNA degradation	264	1.1e-06	0.27	0.44	0.92
PGSC0003DMC200064735	K10591	ko04120	Ubiquitin mediated proteolysis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMC200064735	K10591	ko04144	Endocytosis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMC200027577	K00799	ko00480	Glutathione metabolism	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMC200027577	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMC200027577	K00799	ko00982	Drug metabolism - cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMC200027579	K00117	ko00030	Pentose phosphate pathway	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMC200027579	K00117	ko01100	Metabolic pathways	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMC200027579	K00117	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMC200027580	K00117	ko00030	Pentose phosphate pathway	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMC200027580	K00117	ko01100	Metabolic pathways	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMC200027580	K00117	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMC200027581	K00117	ko00030	Pentose phosphate pathway	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMC200027581	K00117	ko01100	Metabolic pathways	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMC200027581	K00117	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMC200027584	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMC200027584	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMC200027585	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMC200027585	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMC200027587	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMC200027587	K00430	ko00680	Methane metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMC200027587	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMC200027587	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMC200027587	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMC200027588	K07199	ko04910	Insulin signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMC200027588	K07199	ko04920	Adipocytokine signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMC200027588	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMC200027589	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027589	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027589	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027590	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027590	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027590	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMC200027593	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMC200027594	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMC200010448	K12581	ko03018	RNA degradation	1253	2.8e-63	0.59	0.76	0.99
PGSC0003DMC200010461	K03012	ko00230	Purine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMC200010461	K03012	ko00240	Pyrimidine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMC200010461	K03012	ko01100	Metabolic pathways	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMC200010461	K03012	ko03020	RNA polymerase	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMC200010461	K03012	ko05016	Huntington's disease	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMC200010462	K03012	ko00230	Purine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMC200010462	K03012	ko00240	Pyrimidine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMC200010462	K03012	ko01100	Metabolic pathways	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMC200010462	K03012	ko03020	RNA polymerase	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMC200010462	K03012	ko05016	Huntington's disease	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMC200010464	K02183	ko04020	Calcium signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04070	Phosphatidylinositol signaling system	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04114	Oocyte meiosis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04270	Vascular smooth muscle contraction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04626	Plant-pathogen interaction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04720	Long-term potentiation	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04722	Neurotrophin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04740	Olfactory transduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04744	Phototransduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04745	Phototransduction - fly	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04910	Insulin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04912	GnRH signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04916	Melanogenesis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04970	Salivary secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko04971	Gastric acid secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko05010	Alzheimer's disease	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010464	K02183	ko05214	Glioma	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMC200010470	K02949	ko03010	Ribosome	1197	3.5e-60	0.91	0.93	0.84
PGSC0003DMC200005191	K07297	ko04920	Adipocytokine signaling pathway	1729	1.6e-89	0.61	0.77	0.98
PGSC0003DMC200005192	K07297	ko04920	Adipocytokine signaling pathway	1213	4.5e-61	0.67	0.82	0.94
PGSC0003DMC200005212	K06653	ko04111	Cell cycle - yeast	324	3.9e-11	0.30	0.48	0.93
PGSC0003DMC200005213	K00510	ko00860	Porphyrin and chlorophyll metabolism	1655	1.9e-85	0.85	0.92	0.99
PGSC0003DMC200005219	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMC200005219	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMC200005220	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMC200005220	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMC200022562	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMC200022562	K00766	ko01100	Metabolic pathways	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMC200022562	K00766	ko01110	Biosynthesis of secondary metabolites	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMC200022569	K10245	ko01040	Biosynthesis of unsaturated fatty acids	419	2.8e-17	0.38	0.56	0.69
PGSC0003DMC200022586	K04514	ko04062	Chemokine signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04270	Vascular smooth muscle contraction	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04310	Wnt signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04350	TGF-beta signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04360	Axon guidance	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04510	Focal adhesion	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04670	Leukocyte transendothelial migration	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko04810	Regulation of actin cytoskeleton	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko05130	Pathogenic Escherichia coli infection	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022586	K04514	ko05131	Shigellosis	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMC200022588	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMC200022588	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMC200022589	K10352	ko04530	Tight junction	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMC200022589	K10352	ko05416	Viral myocarditis	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMC200014554	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200014554	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200014555	K08912	ko00196	Photosynthesis - antenna proteins	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMC200014555	K08912	ko01100	Metabolic pathways	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMC200014556	K08912	ko00196	Photosynthesis - antenna proteins	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMC200014556	K08912	ko01100	Metabolic pathways	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMC200014557	K08912	ko00196	Photosynthesis - antenna proteins	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMC200014557	K08912	ko01100	Metabolic pathways	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMC200014558	K08912	ko00196	Photosynthesis - antenna proteins	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMC200014558	K08912	ko01100	Metabolic pathways	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMC200014565	K02084	ko04115	p53 signaling pathway	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko04210	Apoptosis	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko05010	Alzheimer's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko05012	Parkinson's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko05016	Huntington's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014565	K02084	ko05222	Small cell lung cancer	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMC200014567	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMC200014569	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMC200014570	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMC200014571	K00356	ko00190	Oxidative phosphorylation	305	5.5e-11	0.37	0.50	0.55
PGSC0003DMC200014572	K00356	ko00190	Oxidative phosphorylation	303	7.1e-11	0.37	0.51	0.55
PGSC0003DMC200014573	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMC200014574	K02541	ko03030	DNA replication	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMC200014574	K02541	ko04110	Cell cycle	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMC200014574	K02541	ko04111	Cell cycle - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMC200014574	K02541	ko04113	Meiosis - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMC200014575	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014575	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014575	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014575	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014576	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014576	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014576	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014576	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMC200014577	K08912	ko00196	Photosynthesis - antenna proteins	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMC200014577	K08912	ko01100	Metabolic pathways	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMC200014578	K03015	ko00230	Purine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMC200014578	K03015	ko00240	Pyrimidine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMC200014578	K03015	ko01100	Metabolic pathways	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMC200014578	K03015	ko03020	RNA polymerase	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMC200014578	K03015	ko05016	Huntington's disease	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMC200014579	K09458	ko00061	Fatty acid biosynthesis	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMC200014579	K09458	ko01100	Metabolic pathways	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMC200040447	K02639	ko00195	Photosynthesis	849	5.4e-41	0.68	0.81	0.99
PGSC0003DMC200040448	K11099	ko03040	Spliceosome	604	1.8e-27	0.90	0.96	0.99
PGSC0003DMC200040450	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMC200040451	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMC200040452	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMC200040456	K03885	ko00190	Oxidative phosphorylation	367	2.1e-14	0.28	0.47	0.96
PGSC0003DMC200040457	K03885	ko00190	Oxidative phosphorylation	318	1.1e-11	0.28	0.46	0.88
PGSC0003DMC200040458	K12198	ko04144	Endocytosis	1583	1.8e-81	0.84	0.94	0.96
PGSC0003DMC200040459	K12198	ko04144	Endocytosis	900	8.3e-44	0.84	0.91	0.99
PGSC0003DMC200040460	K12198	ko04144	Endocytosis	1699	7.1e-88	0.84	0.94	1.00
PGSC0003DMC200040461	K12198	ko04144	Endocytosis	784	2.1e-37	0.84	0.91	0.92
PGSC0003DMC200057579	K00430	ko00360	Phenylalanine metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMC200057579	K00430	ko00680	Methane metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMC200057579	K00430	ko00940	Phenylpropanoid biosynthesis	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMC200057579	K00430	ko01100	Metabolic pathways	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMC200057579	K00430	ko01110	Biosynthesis of secondary metabolites	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMC200057584	K03469	ko03030	DNA replication	268	6.0e-09	0.52	0.70	0.63
PGSC0003DMC200057595	K00058	ko00260	Glycine, serine and threonine metabolism	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMC200057595	K00058	ko01100	Metabolic pathways	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMC200057596	K01184	ko00040	Pentose and glucuronate interconversions	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMC200057596	K01184	ko00500	Starch and sucrose metabolism	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMC200057596	K01184	ko01100	Metabolic pathways	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMC200052561	K05658	ko02010	ABC transporters	3516	4.3e-188	0.38	0.58	0.96
PGSC0003DMC200052562	K05658	ko02010	ABC transporters	3583	8.7e-192	0.38	0.59	0.96
PGSC0003DMC200052563	K02918	ko03010	Ribosome	922	5.1e-45	0.93	0.98	0.99
PGSC0003DMC200052565	K12830	ko03040	Spliceosome	9560	0.	0.91	0.97	1.00
PGSC0003DMC200052567	K01051	ko00040	Pentose and glucuronate interconversions	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMC200052567	K01051	ko00500	Starch and sucrose metabolism	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMC200052567	K01051	ko01100	Metabolic pathways	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMC200052569	K00412	ko00190	Oxidative phosphorylation	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052569	K00412	ko01100	Metabolic pathways	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052569	K00412	ko04260	Cardiac muscle contraction	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052569	K00412	ko05010	Alzheimer's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052569	K00412	ko05012	Parkinson's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052569	K00412	ko05016	Huntington's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMC200052574	K02006	ko02010	ABC transporters	746	2.6e-35	0.46	0.65	0.81
PGSC0003DMC200052575	K02006	ko02010	ABC transporters	357	7.4e-14	0.40	0.59	0.70
PGSC0003DMC200052576	K02006	ko02010	ABC transporters	745	3.0e-35	0.46	0.65	0.81
PGSC0003DMC200052577	K02006	ko02010	ABC transporters	416	4.1e-17	0.46	0.62	0.88
PGSC0003DMC200052588	K00889	ko00562	Inositol phosphate metabolism	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200052588	K00889	ko01100	Metabolic pathways	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200052588	K00889	ko04070	Phosphatidylinositol signaling system	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200052588	K00889	ko04144	Endocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200052588	K00889	ko04666	Fc gamma R-mediated phagocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200052588	K00889	ko04810	Regulation of actin cytoskeleton	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMC200035197	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035197	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035197	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035197	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035197	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035198	K00430	ko00360	Phenylalanine metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMC200035198	K00430	ko00680	Methane metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMC200035198	K00430	ko00940	Phenylpropanoid biosynthesis	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMC200035198	K00430	ko01100	Metabolic pathways	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMC200035198	K00430	ko01110	Biosynthesis of secondary metabolites	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMC200035199	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035199	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035199	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035199	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035199	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMC200035200	K10808	ko00230	Purine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMC200035200	K10808	ko00240	Pyrimidine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMC200035200	K10808	ko00480	Glutathione metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMC200035200	K10808	ko01100	Metabolic pathways	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMC200035200	K10808	ko04115	p53 signaling pathway	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMC200035209	K01046	ko00561	Glycerolipid metabolism	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMC200035209	K01046	ko01100	Metabolic pathways	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMC200035212	K02183	ko04020	Calcium signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04070	Phosphatidylinositol signaling system	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04114	Oocyte meiosis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04270	Vascular smooth muscle contraction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04626	Plant-pathogen interaction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04720	Long-term potentiation	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04722	Neurotrophin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04740	Olfactory transduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04744	Phototransduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04745	Phototransduction - fly	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04910	Insulin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04912	GnRH signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04916	Melanogenesis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04970	Salivary secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko04971	Gastric acid secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko05010	Alzheimer's disease	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200035212	K02183	ko05214	Glioma	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMC200044552	K07203	ko04012	ErbB signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko04150	mTOR signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko04910	Insulin signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko04920	Adipocytokine signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko04930	Type II diabetes mellitus	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko05200	Pathways in cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko05214	Glioma	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko05215	Prostate cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044552	K07203	ko05221	Acute myeloid leukemia	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMC200044553	K07203	ko04012	ErbB signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko04150	mTOR signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko04910	Insulin signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko04920	Adipocytokine signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko04930	Type II diabetes mellitus	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko05200	Pathways in cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko05214	Glioma	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko05215	Prostate cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044553	K07203	ko05221	Acute myeloid leukemia	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMC200044554	K07203	ko04012	ErbB signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko04150	mTOR signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko04910	Insulin signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko04920	Adipocytokine signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko04930	Type II diabetes mellitus	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko05200	Pathways in cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko05214	Glioma	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko05215	Prostate cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044554	K07203	ko05221	Acute myeloid leukemia	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMC200044555	K00873	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko00230	Purine metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko00620	Pyruvate metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko00710	Carbon fixation in photosynthetic organisms	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko01100	Metabolic pathways	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044555	K00873	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMC200044556	K00873	ko00010	Glycolysis / Gluconeogenesis	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko00230	Purine metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko00620	Pyruvate metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko00710	Carbon fixation in photosynthetic organisms	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko01100	Metabolic pathways	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044556	K00873	ko04930	Type II diabetes mellitus	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMC200044557	K00873	ko00010	Glycolysis / Gluconeogenesis	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko00230	Purine metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko00620	Pyruvate metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko01100	Metabolic pathways	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko01110	Biosynthesis of secondary metabolites	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044557	K00873	ko04930	Type II diabetes mellitus	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMC200044576	K12478	ko04144	Endocytosis	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMC200044576	K12478	ko04145	Phagosome	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMC200028772	K01759	ko00620	Pyruvate metabolism	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMC200028772	K01759	ko04011	MAPK signaling pathway - yeast	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMC200028780	K00430	ko00360	Phenylalanine metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMC200028780	K00430	ko00680	Methane metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMC200028780	K00430	ko00940	Phenylpropanoid biosynthesis	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMC200028780	K00430	ko01100	Metabolic pathways	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMC200028780	K00430	ko01110	Biosynthesis of secondary metabolites	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMC200009248	K01184	ko00040	Pentose and glucuronate interconversions	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMC200009248	K01184	ko00500	Starch and sucrose metabolism	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMC200009248	K01184	ko01100	Metabolic pathways	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMC200009250	K01051	ko00040	Pentose and glucuronate interconversions	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMC200009250	K01051	ko00500	Starch and sucrose metabolism	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMC200009250	K01051	ko01100	Metabolic pathways	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMC200009251	K01051	ko00040	Pentose and glucuronate interconversions	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMC200009251	K01051	ko00500	Starch and sucrose metabolism	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMC200009251	K01051	ko01100	Metabolic pathways	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMC200009252	K01051	ko00040	Pentose and glucuronate interconversions	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMC200009252	K01051	ko00500	Starch and sucrose metabolism	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMC200009252	K01051	ko01100	Metabolic pathways	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMC200009254	K13065	ko00940	Phenylpropanoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMC200009254	K13065	ko00941	Flavonoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMC200009254	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMC200009254	K13065	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMC200009255	K01051	ko00040	Pentose and glucuronate interconversions	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMC200009255	K01051	ko00500	Starch and sucrose metabolism	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMC200009255	K01051	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMC200009266	K06573	ko04966	Collecting duct acid secretion	701	7.9e-33	0.29	0.44	0.82
PGSC0003DMC200009267	K06573	ko04966	Collecting duct acid secretion	736	9.3e-35	0.29	0.44	0.83
PGSC0003DMC200009270	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMC200026629	K08066	ko04612	Antigen processing and presentation	472	3.4e-20	0.41	0.63	0.66
PGSC0003DMC200026631	K08066	ko04612	Antigen processing and presentation	452	4.3e-19	0.51	0.76	0.46
PGSC0003DMC200026632	K08066	ko04612	Antigen processing and presentation	456	2.6e-19	0.37	0.58	0.56
PGSC0003DMC200021363	K01823	ko00900	Terpenoid backbone biosynthesis	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMC200021363	K01823	ko01100	Metabolic pathways	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMC200021363	K01823	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMC200021368	K12879	ko03040	Spliceosome	408	2.0e-15	0.32	0.62	0.77
PGSC0003DMC200021375	K04507	ko04310	Wnt signaling pathway	1384	1.7e-70	0.76	0.88	0.97
PGSC0003DMC200021380	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.51	0.66	0.89
PGSC0003DMC200021384	K02917	ko03010	Ribosome	895	1.6e-43	0.90	0.95	0.99
PGSC0003DMC200021385	K05741	ko04810	Regulation of actin cytoskeleton	340	4.1e-11	0.26	0.42	0.87
PGSC0003DMC200003995	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMC200003995	K02367	ko01100	Metabolic pathways	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMC200003998	K12813	ko03040	Spliceosome	5131	3.6e-277	0.73	0.83	0.99
PGSC0003DMC200004015	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMC200004016	K11294	ko05130	Pathogenic Escherichia coli infection	272	3.7e-06	0.32	0.48	0.27
PGSC0003DMC200004017	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMC200004018	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMC200004019	K12489	ko04144	Endocytosis	5103	1.3e-275	0.78	0.87	0.96
PGSC0003DMC200004020	K12489	ko04144	Endocytosis	5539	1.1e-299	0.80	0.89	1.00
PGSC0003DMC200000331	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMC200000331	K00517	ko00626	Naphthalene and anthracene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMC200000331	K00517	ko00903	Limonene and pinene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMC200000331	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMC200000331	K00517	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMC200000332	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000332	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000332	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000332	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000332	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000334	K09480	ko00561	Glycerolipid metabolism	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMC200000334	K09480	ko01100	Metabolic pathways	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMC200000335	K09480	ko00561	Glycerolipid metabolism	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMC200000335	K09480	ko01100	Metabolic pathways	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMC200000336	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMC200000336	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMC200000337	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMC200000337	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMC200000338	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMC200000338	K01491	ko00670	One carbon pool by folate	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMC200000338	K01491	ko01100	Metabolic pathways	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMC200000353	K05765	ko04360	Axon guidance	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMC200000353	K05765	ko04666	Fc gamma R-mediated phagocytosis	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMC200000353	K05765	ko04810	Regulation of actin cytoskeleton	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMC200000359	K12604	ko03018	RNA degradation	782	3.8e-36	0.48	0.63	0.94
PGSC0003DMC200000360	K11752	ko00740	Riboflavin metabolism	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMC200000360	K11752	ko01100	Metabolic pathways	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMC200055562	K13228	ko00402	Benzoxazinoid biosynthesis	294	2.2e-10	0.33	0.51	0.73
PGSC0003DMC200055565	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	232	5.8e-07	0.44	0.52	0.97
PGSC0003DMC200055567	K01046	ko00561	Glycerolipid metabolism	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMC200055567	K01046	ko01100	Metabolic pathways	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMC200055574	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMC200055574	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMC200055574	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMC200055575	K00799	ko00480	Glutathione metabolism	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMC200055575	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMC200055575	K00799	ko00982	Drug metabolism - cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMC200055576	K00799	ko00480	Glutathione metabolism	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMC200055576	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMC200055576	K00799	ko00982	Drug metabolism - cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMC200055577	K02717	ko00195	Photosynthesis	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMC200055577	K02717	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMC200055581	K12816	ko03040	Spliceosome	688	4.1e-32	0.34	0.55	0.70
PGSC0003DMC200055582	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055582	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055583	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055584	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMC200055585	K00817	ko00340	Histidine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko00350	Tyrosine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko00360	Phenylalanine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko00401	Novobiocin biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko01100	Metabolic pathways	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055585	K00817	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMC200055590	K12859	ko03040	Spliceosome	1208	8.6e-61	0.96	1.00	0.99
PGSC0003DMC200030185	K01087	ko00500	Starch and sucrose metabolism	4897	2.9e-264	0.76	0.89	0.98
PGSC0003DMC200030186	K01087	ko00500	Starch and sucrose metabolism	5427	1.7e-293	0.75	0.89	0.98
PGSC0003DMC200030191	K07424	ko00140	Steroid hormone biosynthesis	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00591	Linoleic acid metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00830	Retinol metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00982	Drug metabolism - cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko00983	Drug metabolism - other enzymes	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030191	K07424	ko01100	Metabolic pathways	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMC200030192	K07424	ko00140	Steroid hormone biosynthesis	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00591	Linoleic acid metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00830	Retinol metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00982	Drug metabolism - cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko00983	Drug metabolism - other enzymes	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030192	K07424	ko01100	Metabolic pathways	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMC200030194	K06685	ko04111	Cell cycle - yeast	424	4.1e-15	0.30	0.46	0.65
PGSC0003DMC200030201	K01757	ko00901	Indole alkaloid biosynthesis	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMC200030201	K01757	ko01100	Metabolic pathways	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMC200030201	K01757	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMC200048571	K04733	ko04210	Apoptosis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMC200048571	K04733	ko04620	Toll-like receptor signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMC200048571	K04733	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMC200048571	K04733	ko05140	Leishmaniasis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMC200048571	K04733	ko05142	Chagas disease	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMC200048574	K10949	ko05110	Vibrio cholerae infection	426	1.2e-17	0.35	0.61	0.75
PGSC0003DMC200048575	K10949	ko05110	Vibrio cholerae infection	518	9.8e-23	0.36	0.59	0.77
PGSC0003DMC200048576	K10949	ko05110	Vibrio cholerae infection	399	3.6e-16	0.34	0.55	0.95
PGSC0003DMC200048583	K06628	ko04110	Cell cycle	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMC200048583	K06628	ko04111	Cell cycle - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMC200048583	K06628	ko04113	Meiosis - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMC200048589	K00754	ko00051	Fructose and mannose metabolism	797	4.0e-38	0.36	0.46	0.74
PGSC0003DMC200048590	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.54
PGSC0003DMC200048591	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMC200048592	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMC200048596	K02154	ko00190	Oxidative phosphorylation	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko01100	Metabolic pathways	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko04142	Lysosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko04145	Phagosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko04966	Collecting duct acid secretion	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko05110	Vibrio cholerae infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048596	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMC200048597	K02154	ko00190	Oxidative phosphorylation	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko01100	Metabolic pathways	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko04142	Lysosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko04145	Phagosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko04966	Collecting duct acid secretion	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko05110	Vibrio cholerae infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200048597	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMC200024367	K12356	ko00940	Phenylpropanoid biosynthesis	354	1.1e-13	0.36	0.51	0.96
PGSC0003DMC200024368	K00485	ko00982	Drug metabolism - cytochrome P450	1248	5.3e-63	0.59	0.73	0.93
PGSC0003DMC200024369	K00485	ko00982	Drug metabolism - cytochrome P450	1357	5.2e-69	0.59	0.72	0.98
PGSC0003DMC200024370	K00485	ko00982	Drug metabolism - cytochrome P450	1727	2.0e-89	0.61	0.74	0.98
PGSC0003DMC200024371	K00485	ko00982	Drug metabolism - cytochrome P450	811	6.8e-39	0.55	0.68	0.84
PGSC0003DMC200024372	K00485	ko00982	Drug metabolism - cytochrome P450	2294	1.1e-120	0.60	0.74	0.98
PGSC0003DMC200024373	K00485	ko00982	Drug metabolism - cytochrome P450	2009	5.7e-105	0.62	0.75	0.98
PGSC0003DMC200024374	K01087	ko00500	Starch and sucrose metabolism	1454	2.3e-74	0.60	0.75	0.88
PGSC0003DMC200024375	K01087	ko00500	Starch and sucrose metabolism	1134	1.0e-56	0.49	0.65	0.95
PGSC0003DMC200024386	K00287	ko00670	One carbon pool by folate	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMC200024386	K00287	ko00790	Folate biosynthesis	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMC200024386	K00287	ko01100	Metabolic pathways	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMC200024387	K00287	ko00670	One carbon pool by folate	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMC200024387	K00287	ko00790	Folate biosynthesis	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMC200024387	K00287	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMC200023621	K13066	ko00940	Phenylpropanoid biosynthesis	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMC200023621	K13066	ko01110	Biosynthesis of secondary metabolites	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMC200023622	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMC200023622	K01870	ko00970	Aminoacyl-tRNA biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMC200023623	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMC200023623	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMC200023624	K03138	ko03022	Basal transcription factors	2460	7.6e-130	0.75	0.85	0.99
PGSC0003DMC200023625	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMC200023626	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMC200023627	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMC200023628	K03955	ko00190	Oxidative phosphorylation	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMC200023628	K03955	ko01100	Metabolic pathways	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMC200023628	K03955	ko05010	Alzheimer's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMC200023628	K03955	ko05012	Parkinson's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMC200023628	K03955	ko05016	Huntington's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMC200023629	K03020	ko00230	Purine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMC200023629	K03020	ko00240	Pyrimidine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMC200023629	K03020	ko01100	Metabolic pathways	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMC200023629	K03020	ko03020	RNA polymerase	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMC200023629	K03020	ko04623	Cytosolic DNA-sensing pathway	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMC200023631	K12462	ko04722	Neurotrophin signaling pathway	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMC200023631	K12462	ko04962	Vasopressin-regulated water reabsorption	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMC200023635	K10591	ko04120	Ubiquitin mediated proteolysis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMC200023635	K10591	ko04144	Endocytosis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMC200011740	K09561	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.72	0.86	0.82
PGSC0003DMC200011741	K09561	ko04120	Ubiquitin mediated proteolysis	1069	4.0e-53	0.67	0.81	0.86
PGSC0003DMC200011742	K09561	ko04120	Ubiquitin mediated proteolysis	597	4.3e-27	0.58	0.72	0.76
PGSC0003DMC200011751	K00962	ko00230	Purine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMC200011751	K00962	ko00240	Pyrimidine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMC200011751	K00962	ko03018	RNA degradation	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMC200011752	K08905	ko00195	Photosynthesis	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMC200011752	K08905	ko01100	Metabolic pathways	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMC200019783	K13065	ko00940	Phenylpropanoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMC200019783	K13065	ko00941	Flavonoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMC200019783	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMC200019783	K13065	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMC200019784	K13065	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMC200019784	K13065	ko00941	Flavonoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMC200019784	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMC200019784	K13065	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMC200019788	K03260	ko05416	Viral myocarditis	1004	1.5e-49	0.51	0.74	0.92
PGSC0003DMC200019789	K03260	ko05416	Viral myocarditis	781	3.1e-37	0.53	0.73	0.80
PGSC0003DMC200019790	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.84
PGSC0003DMC200019791	K03260	ko05416	Viral myocarditis	1072	2.7e-53	0.53	0.74	0.72
PGSC0003DMC200019792	K03260	ko05416	Viral myocarditis	1070	3.5e-53	0.51	0.72	0.84
PGSC0003DMC200019793	K03260	ko05416	Viral myocarditis	1049	5.1e-52	0.52	0.74	0.85
PGSC0003DMC200019794	K03260	ko05416	Viral myocarditis	1040	1.6e-51	0.52	0.73	0.93
PGSC0003DMC200019795	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.93
PGSC0003DMC200019798	K02943	ko03010	Ribosome	600	2.9e-27	0.71	0.81	0.98
PGSC0003DMC200019800	K03260	ko05416	Viral myocarditis	2356	4.1e-124	0.48	0.63	0.88
PGSC0003DMC200002654	K02924	ko03010	Ribosome	445	1.0e-18	0.96	0.98	0.98
PGSC0003DMC200002661	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMC200002663	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMC200002667	K04733	ko04210	Apoptosis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMC200002667	K04733	ko04620	Toll-like receptor signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMC200002667	K04733	ko04722	Neurotrophin signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMC200002667	K04733	ko05140	Leishmaniasis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMC200002667	K04733	ko05142	Chagas disease	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMC200065467	K12356	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.42	0.61	0.90
PGSC0003DMC200065477	K00033	ko00030	Pentose phosphate pathway	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMC200065477	K00033	ko00480	Glutathione metabolism	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMC200065477	K00033	ko01100	Metabolic pathways	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMC200065477	K00033	ko01110	Biosynthesis of secondary metabolites	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMC200062072	K05282	ko00904	Diterpenoid biosynthesis	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMC200062072	K05282	ko01100	Metabolic pathways	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMC200062072	K05282	ko01110	Biosynthesis of secondary metabolites	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMC200062081	K10760	ko00908	Zeatin biosynthesis	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMC200062081	K10760	ko01100	Metabolic pathways	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMC200062081	K10760	ko01110	Biosynthesis of secondary metabolites	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMC200062094	K05282	ko00904	Diterpenoid biosynthesis	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMC200062094	K05282	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMC200062094	K05282	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMC200065931	K09658	ko00510	N-Glycan biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMC200065931	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMC200065931	K09658	ko01100	Metabolic pathways	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMC200065940	K04733	ko04210	Apoptosis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMC200065940	K04733	ko04620	Toll-like receptor signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMC200065940	K04733	ko04722	Neurotrophin signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMC200065940	K04733	ko05140	Leishmaniasis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMC200065940	K04733	ko05142	Chagas disease	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMC200002731	K08739	ko03430	Mismatch repair	1887	3.0e-98	0.38	0.52	0.99
PGSC0003DMC200002732	K08739	ko03430	Mismatch repair	338	6.5e-12	0.82	0.92	0.82
PGSC0003DMC200002747	K11778	ko00900	Terpenoid backbone biosynthesis	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMC200002747	K11778	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMC200002752	K05868	ko04110	Cell cycle	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMC200002752	K05868	ko04115	p53 signaling pathway	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMC200002752	K05868	ko04914	Progesterone-mediated oocyte maturation	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMC200002753	K00831	ko00260	Glycine, serine and threonine metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMC200002753	K00831	ko00750	Vitamin B6 metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMC200002753	K00831	ko01100	Metabolic pathways	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMC200002754	K00030	ko00020	Citrate cycle (TCA cycle)	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMC200002754	K00030	ko01100	Metabolic pathways	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMC200002754	K00030	ko01110	Biosynthesis of secondary metabolites	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMC200002757	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1185	1.6e-59	0.57	0.72	0.89
PGSC0003DMC200002758	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1294	1.6e-65	0.64	0.75	0.89
PGSC0003DMC200024217	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMC200024217	K00517	ko00626	Naphthalene and anthracene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMC200024217	K00517	ko00903	Limonene and pinene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMC200024217	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMC200024217	K00517	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMC200024219	K12598	ko03018	RNA degradation	6159	0.	0.86	0.93	0.99
PGSC0003DMC200024220	K12598	ko03018	RNA degradation	7232	0.	0.85	0.93	1.00
PGSC0003DMC200024224	K03678	ko03018	RNA degradation	2544	1.8e-134	0.68	0.81	1.00
PGSC0003DMC200024226	K03678	ko03018	RNA degradation	2594	3.1e-137	0.68	0.80	1.00
PGSC0003DMC200024228	K01840	ko00051	Fructose and mannose metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMC200024228	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMC200024228	K01840	ko01100	Metabolic pathways	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMC200024228	K01840	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMC200024229	K01840	ko00051	Fructose and mannose metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMC200024229	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMC200024229	K01840	ko01100	Metabolic pathways	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMC200024229	K01840	ko01110	Biosynthesis of secondary metabolites	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMC200024230	K01840	ko00051	Fructose and mannose metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMC200024230	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMC200024230	K01840	ko01100	Metabolic pathways	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMC200024230	K01840	ko01110	Biosynthesis of secondary metabolites	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMC200024231	K00967	ko00440	Phosphonate and phosphinate metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMC200024231	K00967	ko00564	Glycerophospholipid metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMC200024231	K00967	ko01100	Metabolic pathways	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMC200024232	K00967	ko00440	Phosphonate and phosphinate metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMC200024232	K00967	ko00564	Glycerophospholipid metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMC200024232	K00967	ko01100	Metabolic pathways	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMC200024236	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMC200024236	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMC200024236	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMC200024236	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMC200024236	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMC200024237	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200024237	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200024237	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200024237	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200024237	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200013352	K01046	ko00561	Glycerolipid metabolism	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMC200013352	K01046	ko01100	Metabolic pathways	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMC200013353	K01046	ko00561	Glycerolipid metabolism	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMC200013353	K01046	ko01100	Metabolic pathways	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMC200013366	K11866	ko04144	Endocytosis	861	1.2e-41	0.53	0.66	0.96
PGSC0003DMC200013367	K11866	ko04144	Endocytosis	2621	1.0e-138	0.66	0.74	1.00
PGSC0003DMC200013377	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013377	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013377	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013377	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013377	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013377	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200013378	K09843	ko00906	Carotenoid biosynthesis	1012	5.5e-50	0.34	0.53	0.98
PGSC0003DMC200007802	K04733	ko04210	Apoptosis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMC200007802	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMC200007802	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMC200007802	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMC200007802	K04733	ko05142	Chagas disease	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMC200007812	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.3e-12	0.32	0.49	0.42
PGSC0003DMC200007828	K03514	ko03018	RNA degradation	274	5.7e-06	0.29	0.48	0.24
PGSC0003DMC200023761	K00599	ko00340	Histidine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMC200023761	K00599	ko00350	Tyrosine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMC200023761	K00599	ko00450	Selenoamino acid metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMC200023761	K00599	ko00626	Naphthalene and anthracene degradation	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMC200023762	K00599	ko00340	Histidine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMC200023762	K00599	ko00350	Tyrosine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMC200023762	K00599	ko00450	Selenoamino acid metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMC200023762	K00599	ko00626	Naphthalene and anthracene degradation	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMC200023763	K01052	ko00100	Steroid biosynthesis	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMC200023763	K01052	ko04142	Lysosome	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMC200023765	K02183	ko04020	Calcium signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04070	Phosphatidylinositol signaling system	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04114	Oocyte meiosis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04270	Vascular smooth muscle contraction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04626	Plant-pathogen interaction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04720	Long-term potentiation	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04722	Neurotrophin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04740	Olfactory transduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04744	Phototransduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04745	Phototransduction - fly	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04910	Insulin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04912	GnRH signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04916	Melanogenesis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04970	Salivary secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko04971	Gastric acid secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko05010	Alzheimer's disease	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023765	K02183	ko05214	Glioma	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMC200023767	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023767	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023767	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023768	K00231	ko00860	Porphyrin and chlorophyll metabolism	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMC200023768	K00231	ko01100	Metabolic pathways	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMC200023768	K00231	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMC200023769	K00231	ko00860	Porphyrin and chlorophyll metabolism	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMC200023769	K00231	ko01100	Metabolic pathways	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMC200023769	K00231	ko01110	Biosynthesis of secondary metabolites	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMC200023770	K00231	ko00860	Porphyrin and chlorophyll metabolism	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMC200023770	K00231	ko01100	Metabolic pathways	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMC200023770	K00231	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMC200023771	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023771	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023771	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMC200023772	K00231	ko00860	Porphyrin and chlorophyll metabolism	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMC200023772	K00231	ko01100	Metabolic pathways	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMC200023772	K00231	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMC200023775	K12386	ko04142	Lysosome	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMC200023776	K00276	ko00260	Glycine, serine and threonine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko00350	Tyrosine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko00360	Phenylalanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko00410	beta-Alanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko00950	Isoquinoline alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko01100	Metabolic pathways	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023776	K00276	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMC200023780	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.91	0.92	0.99
PGSC0003DMC200023781	K00958	ko00230	Purine metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMC200023781	K00958	ko00450	Selenoamino acid metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMC200023781	K00958	ko00920	Sulfur metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMC200023781	K00958	ko01100	Metabolic pathways	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMC200023782	K00958	ko00230	Purine metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMC200023782	K00958	ko00450	Selenoamino acid metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMC200023782	K00958	ko00920	Sulfur metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMC200023782	K00958	ko01100	Metabolic pathways	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMC200023785	K05748	ko04520	Adherens junction	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMC200023785	K05748	ko04666	Fc gamma R-mediated phagocytosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMC200023785	K05748	ko04810	Regulation of actin cytoskeleton	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMC200023785	K05748	ko05100	Bacterial invasion of epithelial cells	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMC200023785	K05748	ko05131	Shigellosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMC200023788	K00660	ko00941	Flavonoid biosynthesis	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMC200023788	K00660	ko01100	Metabolic pathways	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMC200023788	K00660	ko01110	Biosynthesis of secondary metabolites	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMC200023788	K00660	ko04712	Circadian rhythm - plant	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMC200023789	K00660	ko00941	Flavonoid biosynthesis	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMC200023789	K00660	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMC200023789	K00660	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMC200023789	K00660	ko04712	Circadian rhythm - plant	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMC200011643	K12869	ko03040	Spliceosome	1216	3.1e-61	0.34	0.47	0.98
PGSC0003DMC200011647	K00873	ko00010	Glycolysis / Gluconeogenesis	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko00230	Purine metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko00620	Pyruvate metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko00710	Carbon fixation in photosynthetic organisms	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko01100	Metabolic pathways	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko01110	Biosynthesis of secondary metabolites	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011647	K00873	ko04930	Type II diabetes mellitus	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMC200011648	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1762	2.4e-91	0.68	0.83	0.97
PGSC0003DMC200011652	K05666	ko02010	ABC transporters	2670	2.0e-141	0.33	0.52	0.97
PGSC0003DMC200011653	K05673	ko02010	ABC transporters	290	4.0e-09	0.49	0.71	0.83
PGSC0003DMC200011656	K10595	ko04120	Ubiquitin mediated proteolysis	275	1.2e-07	0.40	0.55	0.98
PGSC0003DMC200042152	K13065	ko00940	Phenylpropanoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMC200042152	K13065	ko00941	Flavonoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMC200042152	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMC200042152	K13065	ko01110	Biosynthesis of secondary metabolites	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMC200042159	K04725	ko04120	Ubiquitin mediated proteolysis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042159	K04725	ko04210	Apoptosis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042159	K04725	ko04510	Focal adhesion	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042159	K04725	ko04621	NOD-like receptor signaling pathway	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042159	K04725	ko05200	Pathways in cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042159	K04725	ko05222	Small cell lung cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMC200042160	K04725	ko04120	Ubiquitin mediated proteolysis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200042160	K04725	ko04210	Apoptosis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200042160	K04725	ko04510	Focal adhesion	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200042160	K04725	ko04621	NOD-like receptor signaling pathway	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200042160	K04725	ko05200	Pathways in cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200042160	K04725	ko05222	Small cell lung cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMC200036607	K01054	ko00561	Glycerolipid metabolism	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMC200036607	K01054	ko01100	Metabolic pathways	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMC200036609	K04506	ko04115	p53 signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMC200036609	K04506	ko04120	Ubiquitin mediated proteolysis	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMC200036609	K04506	ko04310	Wnt signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMC200036610	K04506	ko04115	p53 signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMC200036610	K04506	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMC200036610	K04506	ko04310	Wnt signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMC200036611	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.41	0.58	0.85
PGSC0003DMC200036612	K08064	ko04612	Antigen processing and presentation	455	2.9e-19	0.58	0.75	0.81
PGSC0003DMC200036627	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMC200036627	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMC200036628	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMC200036628	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMC200055412	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2743	1.9e-145	0.78	0.89	0.99
PGSC0003DMC200055418	K00454	ko00591	Linoleic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMC200055418	K00454	ko00592	alpha-Linolenic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMC200055418	K00454	ko01100	Metabolic pathways	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMC200055419	K00454	ko00591	Linoleic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMC200055419	K00454	ko00592	alpha-Linolenic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMC200055419	K00454	ko01100	Metabolic pathways	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMC200055422	K00423	ko00053	Ascorbate and aldarate metabolism	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMC200055422	K00423	ko01100	Metabolic pathways	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMC200055427	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	760	4.4e-36	0.38	0.45	0.89
PGSC0003DMC200055428	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	909	2.7e-44	0.36	0.44	0.93
PGSC0003DMC200055438	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMC200055438	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMC200055439	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMC200055439	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMC200055440	K00547	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMC200055440	K00547	ko01100	Metabolic pathways	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMC200055440	K00547	ko01110	Biosynthesis of secondary metabolites	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMC200063066	K12356	ko00940	Phenylpropanoid biosynthesis	373	9.7e-15	0.39	0.49	0.61
PGSC0003DMC200063074	K10760	ko00908	Zeatin biosynthesis	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMC200063074	K10760	ko01100	Metabolic pathways	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMC200063074	K10760	ko01110	Biosynthesis of secondary metabolites	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMC200009337	K02134	ko00190	Oxidative phosphorylation	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMC200009337	K02134	ko01100	Metabolic pathways	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMC200009337	K02134	ko05010	Alzheimer's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMC200009337	K02134	ko05012	Parkinson's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMC200009337	K02134	ko05016	Huntington's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMC200009338	K03363	ko04110	Cell cycle	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMC200009338	K03363	ko04111	Cell cycle - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMC200009338	K03363	ko04113	Meiosis - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMC200009338	K03363	ko04114	Oocyte meiosis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMC200009338	K03363	ko04120	Ubiquitin mediated proteolysis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMC200009343	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009343	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009343	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009344	K10717	ko00908	Zeatin biosynthesis	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMC200009344	K10717	ko01100	Metabolic pathways	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMC200009344	K10717	ko01110	Biosynthesis of secondary metabolites	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMC200009345	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009345	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009345	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMC200009346	K10717	ko00908	Zeatin biosynthesis	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMC200009346	K10717	ko01100	Metabolic pathways	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMC200009346	K10717	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMC200009357	K03950	ko00190	Oxidative phosphorylation	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMC200009357	K03950	ko01100	Metabolic pathways	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMC200009357	K03950	ko05010	Alzheimer's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMC200009357	K03950	ko05012	Parkinson's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMC200009357	K03950	ko05016	Huntington's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMC200009358	K00430	ko00360	Phenylalanine metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMC200009358	K00430	ko00680	Methane metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMC200009358	K00430	ko00940	Phenylpropanoid biosynthesis	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMC200009358	K00430	ko01100	Metabolic pathways	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMC200009358	K00430	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMC200009359	K00430	ko00360	Phenylalanine metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMC200009359	K00430	ko00680	Methane metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMC200009359	K00430	ko00940	Phenylpropanoid biosynthesis	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMC200009359	K00430	ko01100	Metabolic pathways	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMC200009359	K00430	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMC200009360	K00430	ko00360	Phenylalanine metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMC200009360	K00430	ko00680	Methane metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMC200009360	K00430	ko00940	Phenylpropanoid biosynthesis	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMC200009360	K00430	ko01100	Metabolic pathways	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMC200009360	K00430	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMC200016035	K01087	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.53	0.73	0.95
PGSC0003DMC200026761	K03010	ko00230	Purine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMC200026761	K03010	ko00240	Pyrimidine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMC200026761	K03010	ko01100	Metabolic pathways	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMC200026761	K03010	ko03020	RNA polymerase	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMC200026761	K03010	ko05016	Huntington's disease	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMC200026762	K03010	ko00230	Purine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMC200026762	K03010	ko00240	Pyrimidine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMC200026762	K03010	ko01100	Metabolic pathways	7907	0.	0.76	0.87	1.00
PGSC0003DMC200026762	K03010	ko03020	RNA polymerase	7907	0.	0.76	0.87	1.00
PGSC0003DMC200026762	K03010	ko05016	Huntington's disease	7907	0.	0.76	0.87	1.00
PGSC0003DMC200026764	K08066	ko04612	Antigen processing and presentation	685	6.0e-32	0.44	0.56	0.87
PGSC0003DMC200026765	K08066	ko04612	Antigen processing and presentation	420	2.5e-17	0.44	0.64	0.79
PGSC0003DMC200026772	K01114	ko00562	Inositol phosphate metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMC200026772	K01114	ko00564	Glycerophospholipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMC200026772	K01114	ko00565	Ether lipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMC200026772	K01114	ko01100	Metabolic pathways	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMC200026773	K01114	ko00562	Inositol phosphate metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMC200026773	K01114	ko00564	Glycerophospholipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMC200026773	K01114	ko00565	Ether lipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMC200026773	K01114	ko01100	Metabolic pathways	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMC200026777	K10684	ko04120	Ubiquitin mediated proteolysis	2068	3.2e-108	0.75	0.88	0.98
PGSC0003DMC200026780	K05681	ko02010	ABC transporters	1119	7.0e-56	0.34	0.51	0.92
PGSC0003DMC200026781	K02998	ko03010	Ribosome	1850	3.3e-96	0.73	0.79	1.00
PGSC0003DMC200026783	K07407	ko00052	Galactose metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMC200026783	K07407	ko00561	Glycerolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMC200026783	K07407	ko00600	Sphingolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMC200026783	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMC200026784	K07407	ko00052	Galactose metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMC200026784	K07407	ko00561	Glycerolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMC200026784	K07407	ko00600	Sphingolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMC200026784	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMC200021222	K02433	ko00970	Aminoacyl-tRNA biosynthesis	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMC200021222	K02433	ko01100	Metabolic pathways	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMC200021223	K02433	ko00970	Aminoacyl-tRNA biosynthesis	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMC200021223	K02433	ko01100	Metabolic pathways	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMC200021224	K02433	ko00970	Aminoacyl-tRNA biosynthesis	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMC200021224	K02433	ko01100	Metabolic pathways	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMC200021225	K02433	ko00970	Aminoacyl-tRNA biosynthesis	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMC200021225	K02433	ko01100	Metabolic pathways	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMC200021226	K02433	ko00970	Aminoacyl-tRNA biosynthesis	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMC200021226	K02433	ko01100	Metabolic pathways	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMC200021228	K04077	ko03018	RNA degradation	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMC200021228	K04077	ko04940	Type I diabetes mellitus	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMC200021233	K05681	ko02010	ABC transporters	573	9.1e-26	0.35	0.54	0.77
PGSC0003DMC200021234	K05681	ko02010	ABC transporters	651	4.5e-30	0.31	0.51	0.87
PGSC0003DMC200021235	K05681	ko02010	ABC transporters	676	1.9e-31	0.31	0.51	0.82
PGSC0003DMC200021236	K05683	ko02010	ABC transporters	739	6.3e-35	0.31	0.52	0.83
PGSC0003DMC200021237	K05683	ko02010	ABC transporters	838	2.2e-40	0.31	0.51	0.83
PGSC0003DMC200021238	K05683	ko02010	ABC transporters	638	2.4e-29	0.37	0.57	0.71
PGSC0003DMC200032595	K13065	ko00940	Phenylpropanoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMC200032595	K13065	ko00941	Flavonoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMC200032595	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMC200032595	K13065	ko01110	Biosynthesis of secondary metabolites	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMC200032596	K13065	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMC200032596	K13065	ko00941	Flavonoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMC200032596	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMC200032596	K13065	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMC200032597	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMC200032597	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMC200032597	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMC200032597	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMC200032598	K02908	ko03010	Ribosome	920	6.6e-45	0.96	1.00	0.99
PGSC0003DMC200032602	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.90
PGSC0003DMC200032603	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.92
PGSC0003DMC200032607	K01426	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032607	K01426	ko00360	Phenylalanine metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032607	K01426	ko00380	Tryptophan metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032607	K01426	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032607	K01426	ko00632	Benzoate degradation via CoA ligation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032607	K01426	ko00643	Styrene degradation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMC200032608	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032608	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032608	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032608	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032608	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032608	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200032609	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMC200040538	K00249	ko00071	Fatty acid metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko00280	Valine, leucine and isoleucine degradation	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko00410	beta-Alanine metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko00640	Propanoate metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko01100	Metabolic pathways	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko01110	Biosynthesis of secondary metabolites	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040538	K00249	ko03320	PPAR signaling pathway	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMC200040539	K00249	ko00071	Fatty acid metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko00280	Valine, leucine and isoleucine degradation	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko00410	beta-Alanine metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko00640	Propanoate metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko01100	Metabolic pathways	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko01110	Biosynthesis of secondary metabolites	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040539	K00249	ko03320	PPAR signaling pathway	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMC200040540	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMC200040540	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMC200040540	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMC200040549	K10594	ko04120	Ubiquitin mediated proteolysis	367	1.0e-12	0.40	0.56	0.46
PGSC0003DMC200040550	K10615	ko04120	Ubiquitin mediated proteolysis	681	1.8e-31	0.33	0.52	0.89
PGSC0003DMC200040551	K10615	ko04120	Ubiquitin mediated proteolysis	545	1.2e-23	0.35	0.54	0.84
PGSC0003DMC200040552	K10615	ko04120	Ubiquitin mediated proteolysis	674	4.7e-31	0.33	0.52	0.89
PGSC0003DMC200040553	K10615	ko04120	Ubiquitin mediated proteolysis	483	3.9e-20	0.35	0.54	0.80
PGSC0003DMC200047231	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMC200047231	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMC200047231	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMC200047231	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMC200047232	K13065	ko00940	Phenylpropanoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMC200047232	K13065	ko00941	Flavonoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMC200047232	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMC200047232	K13065	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMC200047243	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMC200047244	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMC200047245	K02917	ko03010	Ribosome	901	7.4e-44	0.91	0.95	0.99
PGSC0003DMC200052417	K00681	ko00430	Taurine and hypotaurine metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052417	K00681	ko00450	Selenoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052417	K00681	ko00460	Cyanoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052417	K00681	ko00480	Glutathione metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052417	K00681	ko00590	Arachidonic acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052417	K00681	ko01100	Metabolic pathways	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMC200052418	K00681	ko00430	Taurine and hypotaurine metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052418	K00681	ko00450	Selenoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052418	K00681	ko00460	Cyanoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052418	K00681	ko00480	Glutathione metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052418	K00681	ko00590	Arachidonic acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052418	K00681	ko01100	Metabolic pathways	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMC200052436	K03013	ko00230	Purine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMC200052436	K03013	ko00240	Pyrimidine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMC200052436	K03013	ko01100	Metabolic pathways	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMC200052436	K03013	ko03020	RNA polymerase	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMC200052436	K03013	ko05016	Huntington's disease	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMC200017222	K03660	ko03410	Base excision repair	270	2.6e-08	0.41	0.55	0.71
PGSC0003DMC200017225	K12192	ko04144	Endocytosis	1157	5.6e-58	0.74	0.89	0.85
PGSC0003DMC200017226	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMC200017227	K12192	ko04144	Endocytosis	886	4.9e-43	0.72	0.87	0.99
PGSC0003DMC200017228	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMC200017230	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMC200017230	K00517	ko00626	Naphthalene and anthracene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMC200017230	K00517	ko00903	Limonene and pinene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMC200017230	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMC200017230	K00517	ko01110	Biosynthesis of secondary metabolites	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMC200017231	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMC200017231	K00517	ko00626	Naphthalene and anthracene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMC200017231	K00517	ko00903	Limonene and pinene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMC200017231	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMC200017231	K00517	ko01110	Biosynthesis of secondary metabolites	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMC200017232	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMC200017232	K00517	ko00626	Naphthalene and anthracene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMC200017232	K00517	ko00903	Limonene and pinene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMC200017232	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMC200017232	K00517	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMC200017233	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMC200017233	K00517	ko00626	Naphthalene and anthracene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMC200017233	K00517	ko00903	Limonene and pinene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMC200017233	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMC200017233	K00517	ko01110	Biosynthesis of secondary metabolites	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMC200017234	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMC200017234	K00517	ko00626	Naphthalene and anthracene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMC200017234	K00517	ko00903	Limonene and pinene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMC200017234	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMC200017234	K00517	ko01110	Biosynthesis of secondary metabolites	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMC200017235	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMC200017235	K00517	ko00626	Naphthalene and anthracene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMC200017235	K00517	ko00903	Limonene and pinene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMC200017235	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMC200017235	K00517	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMC200017241	K00558	ko00270	Cysteine and methionine metabolism	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMC200017241	K00558	ko01100	Metabolic pathways	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMC200017249	K12606	ko03018	RNA degradation	273	3.2e-09	0.62	0.71	0.80
PGSC0003DMC200017250	K12606	ko03018	RNA degradation	187	6.3e-13	0.56	0.66	0.83
PGSC0003DMC200010538	K05864	ko04020	Calcium signaling pathway	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMC200010538	K05864	ko05012	Parkinson's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMC200010538	K05864	ko05016	Huntington's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMC200010541	K01188	ko00460	Cyanoamino acid metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMC200010541	K01188	ko00500	Starch and sucrose metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMC200010541	K01188	ko00940	Phenylpropanoid biosynthesis	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMC200010541	K01188	ko01110	Biosynthesis of secondary metabolites	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMC200010542	K01188	ko00460	Cyanoamino acid metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMC200010542	K01188	ko00500	Starch and sucrose metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMC200010542	K01188	ko00940	Phenylpropanoid biosynthesis	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMC200010542	K01188	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMC200010543	K01188	ko00460	Cyanoamino acid metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMC200010543	K01188	ko00500	Starch and sucrose metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMC200010543	K01188	ko00940	Phenylpropanoid biosynthesis	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMC200010543	K01188	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMC200010544	K01188	ko00460	Cyanoamino acid metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMC200010544	K01188	ko00500	Starch and sucrose metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMC200010544	K01188	ko00940	Phenylpropanoid biosynthesis	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMC200010544	K01188	ko01110	Biosynthesis of secondary metabolites	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMC200010545	K01188	ko00460	Cyanoamino acid metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMC200010545	K01188	ko00500	Starch and sucrose metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMC200010545	K01188	ko00940	Phenylpropanoid biosynthesis	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMC200010545	K01188	ko01110	Biosynthesis of secondary metabolites	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMC200010546	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.57	0.89
PGSC0003DMC200010551	K03361	ko04111	Cell cycle - yeast	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMC200010551	K03361	ko04120	Ubiquitin mediated proteolysis	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMC200010554	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010554	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010554	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010555	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010555	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010555	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMC200010556	K05868	ko04110	Cell cycle	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMC200010556	K05868	ko04115	p53 signaling pathway	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMC200010556	K05868	ko04914	Progesterone-mediated oocyte maturation	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMC200022412	K10839	ko03420	Nucleotide excision repair	2396	2.6e-126	0.76	0.85	1.00
PGSC0003DMC200022413	K10839	ko03420	Nucleotide excision repair	1128	2.2e-56	0.71	0.84	0.95
PGSC0003DMC200022414	K10839	ko03420	Nucleotide excision repair	2464	4.6e-130	0.77	0.86	1.00
PGSC0003DMC200022417	K10615	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.49	0.96
PGSC0003DMC200022419	K10579	ko04120	Ubiquitin mediated proteolysis	1200	2.4e-60	0.72	0.83	0.73
PGSC0003DMC200022420	K10579	ko04120	Ubiquitin mediated proteolysis	1219	2.1e-61	0.77	0.85	0.99
PGSC0003DMC200022421	K12356	ko00940	Phenylpropanoid biosynthesis	1238	1.9e-62	0.57	0.72	0.96
PGSC0003DMC200022422	K12356	ko00940	Phenylpropanoid biosynthesis	1953	7.0e-102	0.51	0.71	0.98
PGSC0003DMC200022423	K04427	ko04010	MAPK signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04310	Wnt signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04520	Adherens junction	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04620	Toll-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04621	NOD-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04622	RIG-I-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko04660	T cell receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022423	K04427	ko05140	Leishmaniasis	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMC200022432	K01939	ko00230	Purine metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMC200022432	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMC200022432	K01939	ko01100	Metabolic pathways	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMC200022435	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022435	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022435	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022436	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022436	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022436	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022437	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMC200022437	K01602	ko00710	Carbon fixation in photosynthetic organisms	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMC200022437	K01602	ko01100	Metabolic pathways	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMC200022438	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022438	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022438	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMC200022439	K00430	ko00360	Phenylalanine metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMC200022439	K00430	ko00680	Methane metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMC200022439	K00430	ko00940	Phenylpropanoid biosynthesis	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMC200022439	K00430	ko01100	Metabolic pathways	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMC200022439	K00430	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMC200022440	K00430	ko00360	Phenylalanine metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMC200022440	K00430	ko00680	Methane metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMC200022440	K00430	ko00940	Phenylpropanoid biosynthesis	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMC200022440	K00430	ko01100	Metabolic pathways	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMC200022440	K00430	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMC200068856	K10760	ko00908	Zeatin biosynthesis	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMC200068856	K10760	ko01100	Metabolic pathways	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMC200068856	K10760	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMC200068875	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2561	2.0e-135	0.72	0.84	0.99
PGSC0003DMC200064262	K05282	ko00904	Diterpenoid biosynthesis	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMC200064262	K05282	ko01100	Metabolic pathways	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMC200064262	K05282	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMC200064272	K13248	ko00750	Vitamin B6 metabolism	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMC200064272	K13248	ko01100	Metabolic pathways	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMC200001441	K05280	ko00941	Flavonoid biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMC200001441	K05280	ko00944	Flavone and flavonol biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMC200001441	K05280	ko01100	Metabolic pathways	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMC200001441	K05280	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMC200001442	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMC200001442	K00517	ko00626	Naphthalene and anthracene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMC200001442	K00517	ko00903	Limonene and pinene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMC200001442	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMC200001442	K00517	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMC200001443	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMC200001443	K00517	ko00626	Naphthalene and anthracene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMC200001443	K00517	ko00903	Limonene and pinene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMC200001443	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMC200001443	K00517	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMC200001444	K05280	ko00941	Flavonoid biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMC200001444	K05280	ko00944	Flavone and flavonol biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMC200001444	K05280	ko01100	Metabolic pathways	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMC200001444	K05280	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMC200001445	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMC200001445	K00517	ko00626	Naphthalene and anthracene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMC200001445	K00517	ko00903	Limonene and pinene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMC200001445	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMC200001445	K00517	ko01110	Biosynthesis of secondary metabolites	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMC200001446	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMC200001446	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMC200001446	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMC200001446	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMC200001446	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMC200001447	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMC200001447	K00517	ko00626	Naphthalene and anthracene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMC200001447	K00517	ko00903	Limonene and pinene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMC200001447	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMC200001447	K00517	ko01110	Biosynthesis of secondary metabolites	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMC200001449	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMC200001449	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMC200001449	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMC200001449	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMC200001449	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMC200001453	K11228	ko04011	MAPK signaling pathway - yeast	960	4.1e-47	0.34	0.49	0.79
PGSC0003DMC200001454	K11228	ko04011	MAPK signaling pathway - yeast	956	6.8e-47	0.35	0.49	0.79
PGSC0003DMC200001455	K01834	ko00010	Glycolysis / Gluconeogenesis	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMC200001455	K01834	ko01100	Metabolic pathways	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMC200001455	K01834	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMC200001456	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001456	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001456	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001457	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001457	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001457	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMC200001458	K01834	ko00010	Glycolysis / Gluconeogenesis	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMC200001458	K01834	ko01100	Metabolic pathways	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMC200001458	K01834	ko01110	Biosynthesis of secondary metabolites	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMC200001459	K01834	ko00010	Glycolysis / Gluconeogenesis	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMC200001459	K01834	ko01100	Metabolic pathways	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMC200001459	K01834	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMC200001462	K08233	ko00901	Indole alkaloid biosynthesis	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMC200001462	K08233	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMC200001463	K08233	ko00901	Indole alkaloid biosynthesis	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMC200001463	K08233	ko01110	Biosynthesis of secondary metabolites	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMC200001464	K08233	ko00901	Indole alkaloid biosynthesis	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMC200001464	K08233	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMC200001465	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMC200001465	K00517	ko00626	Naphthalene and anthracene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMC200001465	K00517	ko00903	Limonene and pinene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMC200001465	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMC200001465	K00517	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMC200001466	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMC200001466	K00517	ko00626	Naphthalene and anthracene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMC200001466	K00517	ko00903	Limonene and pinene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMC200001466	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMC200001466	K00517	ko01110	Biosynthesis of secondary metabolites	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMC200001467	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMC200001467	K00517	ko00626	Naphthalene and anthracene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMC200001467	K00517	ko00903	Limonene and pinene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMC200001467	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMC200001467	K00517	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMC200001468	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMC200001468	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMC200001468	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMC200001468	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMC200001468	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMC200046022	K10781	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMC200046022	K10781	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMC200046029	K08916	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMC200046029	K08916	ko01100	Metabolic pathways	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMC200046033	K02145	ko00190	Oxidative phosphorylation	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046033	K02145	ko01100	Metabolic pathways	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046033	K02145	ko04145	Phagosome	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046033	K02145	ko04966	Collecting duct acid secretion	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046033	K02145	ko05110	Vibrio cholerae infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046033	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMC200046039	K01230	ko00510	N-Glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMC200046039	K01230	ko00513	High-mannose type N-glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMC200046039	K01230	ko01100	Metabolic pathways	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMC200046040	K01230	ko00510	N-Glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMC200046040	K01230	ko00513	High-mannose type N-glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMC200046040	K01230	ko01100	Metabolic pathways	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMC200046041	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046041	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046041	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046042	K01230	ko00510	N-Glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMC200046042	K01230	ko00513	High-mannose type N-glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMC200046042	K01230	ko01100	Metabolic pathways	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMC200046043	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046043	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046043	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMC200046048	K02135	ko00190	Oxidative phosphorylation	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMC200046048	K02135	ko01100	Metabolic pathways	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMC200046048	K02135	ko05010	Alzheimer's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMC200046048	K02135	ko05012	Parkinson's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMC200046048	K02135	ko05016	Huntington's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMC200039343	K02183	ko04020	Calcium signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04070	Phosphatidylinositol signaling system	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04114	Oocyte meiosis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04270	Vascular smooth muscle contraction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04626	Plant-pathogen interaction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04720	Long-term potentiation	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04722	Neurotrophin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04740	Olfactory transduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04744	Phototransduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04745	Phototransduction - fly	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04910	Insulin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04912	GnRH signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04916	Melanogenesis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04970	Salivary secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko04971	Gastric acid secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko05010	Alzheimer's disease	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039343	K02183	ko05214	Glioma	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMC200039344	K08101	ko00860	Porphyrin and chlorophyll metabolism	1562	2.6e-80	0.56	0.72	0.97
PGSC0003DMC200039345	K08101	ko00860	Porphyrin and chlorophyll metabolism	655	2.7e-30	0.49	0.64	0.90
PGSC0003DMC200039346	K08101	ko00860	Porphyrin and chlorophyll metabolism	910	2.3e-44	0.66	0.83	0.93
PGSC0003DMC200039347	K08101	ko00860	Porphyrin and chlorophyll metabolism	1472	2.4e-75	0.64	0.81	0.94
PGSC0003DMC200039354	K12796	ko04621	NOD-like receptor signaling pathway	422	1.3e-13	0.29	0.47	0.33
PGSC0003DMC200039359	K05868	ko04110	Cell cycle	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMC200039359	K05868	ko04115	p53 signaling pathway	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMC200039359	K05868	ko04914	Progesterone-mediated oocyte maturation	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMC200056775	K09757	ko00940	Phenylpropanoid biosynthesis	252	4.6e-08	0.65	0.77	0.57
PGSC0003DMC200056776	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.40	0.56	0.56
PGSC0003DMC200051213	K05298	ko00710	Carbon fixation in photosynthetic organisms	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMC200051213	K05298	ko01100	Metabolic pathways	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMC200051216	K03781	ko00380	Tryptophan metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMC200051216	K03781	ko00680	Methane metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMC200051216	K03781	ko01100	Metabolic pathways	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMC200051216	K03781	ko04146	Peroxisome	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMC200051216	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMC200051217	K08332	ko04140	Regulation of autophagy	326	1.4e-09	0.29	0.51	0.42
PGSC0003DMC200051220	K00121	ko00010	Glycolysis / Gluconeogenesis	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00071	Fatty acid metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00350	Tyrosine metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00641	3-Chloroacrylic acid degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00680	Methane metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00830	Retinol metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko00982	Drug metabolism - cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko01100	Metabolic pathways	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051220	K00121	ko01110	Biosynthesis of secondary metabolites	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMC200051221	K00121	ko00010	Glycolysis / Gluconeogenesis	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00071	Fatty acid metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00350	Tyrosine metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00641	3-Chloroacrylic acid degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00680	Methane metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00830	Retinol metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko00982	Drug metabolism - cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko01100	Metabolic pathways	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051221	K00121	ko01110	Biosynthesis of secondary metabolites	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMC200051222	K00121	ko00010	Glycolysis / Gluconeogenesis	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00071	Fatty acid metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00350	Tyrosine metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00641	3-Chloroacrylic acid degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00680	Methane metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00830	Retinol metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko00982	Drug metabolism - cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko01100	Metabolic pathways	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051222	K00121	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMC200051224	K00423	ko00053	Ascorbate and aldarate metabolism	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMC200051224	K00423	ko01100	Metabolic pathways	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMC200051225	K06685	ko04111	Cell cycle - yeast	350	2.2e-10	0.31	0.48	0.42
PGSC0003DMC200051226	K06685	ko04111	Cell cycle - yeast	350	6.8e-10	0.31	0.48	0.28
PGSC0003DMC200051227	K00799	ko00480	Glutathione metabolism	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMC200051227	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMC200051227	K00799	ko00982	Drug metabolism - cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMC200051228	K00799	ko00480	Glutathione metabolism	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMC200051228	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMC200051228	K00799	ko00982	Drug metabolism - cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMC200051238	K12619	ko03018	RNA degradation	6012	0.	0.67	0.76	0.98
PGSC0003DMC200051239	K12619	ko03018	RNA degradation	5999	0.	0.67	0.76	0.98
PGSC0003DMC200025414	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMC200025415	K12188	ko04144	Endocytosis	1076	1.6e-53	0.83	0.95	0.96
PGSC0003DMC200025416	K12188	ko04144	Endocytosis	1892	1.6e-98	0.88	0.96	0.99
PGSC0003DMC200025426	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	0.99
PGSC0003DMC200025427	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	1.00
PGSC0003DMC200025428	K08770	ko03320	PPAR signaling pathway	4360	1.2e-234	1.00	1.00	1.00
PGSC0003DMC200025434	K08770	ko03320	PPAR signaling pathway	331	2.0e-12	0.76	0.88	0.95
PGSC0003DMC200006601	K04371	ko04010	MAPK signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04012	ErbB signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04013	MAPK signaling pathway - fly	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04062	Chemokine signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04114	Oocyte meiosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04150	mTOR signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04270	Vascular smooth muscle contraction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04320	Dorso-ventral axis formation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04350	TGF-beta signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04360	Axon guidance	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04370	VEGF signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04510	Focal adhesion	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04520	Adherens junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04540	Gap junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04620	Toll-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04621	NOD-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04650	Natural killer cell mediated cytotoxicity	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04660	T cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04662	B cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04664	Fc epsilon RI signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04666	Fc gamma R-mediated phagocytosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04720	Long-term potentiation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04722	Neurotrophin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04730	Long-term depression	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04810	Regulation of actin cytoskeleton	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04910	Insulin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04912	GnRH signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04914	Progesterone-mediated oocyte maturation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04916	Melanogenesis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04930	Type II diabetes mellitus	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko04960	Aldosterone-regulated sodium reabsorption	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05010	Alzheimer's disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05020	Prion diseases	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05131	Shigellosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05140	Leishmaniasis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05142	Chagas disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05200	Pathways in cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05210	Colorectal cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05211	Renal cell carcinoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05212	Pancreatic cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05213	Endometrial cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05214	Glioma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05215	Prostate cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05216	Thyroid cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05218	Melanoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05219	Bladder cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05220	Chronic myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05221	Acute myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006601	K04371	ko05223	Non-small cell lung cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMC200006602	K04371	ko04010	MAPK signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04012	ErbB signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04013	MAPK signaling pathway - fly	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04062	Chemokine signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04114	Oocyte meiosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04150	mTOR signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04270	Vascular smooth muscle contraction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04320	Dorso-ventral axis formation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04360	Axon guidance	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04370	VEGF signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04510	Focal adhesion	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04520	Adherens junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04540	Gap junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04620	Toll-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04621	NOD-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04650	Natural killer cell mediated cytotoxicity	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04660	T cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04662	B cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04664	Fc epsilon RI signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04666	Fc gamma R-mediated phagocytosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04720	Long-term potentiation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04722	Neurotrophin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04730	Long-term depression	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04810	Regulation of actin cytoskeleton	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04910	Insulin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04912	GnRH signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04914	Progesterone-mediated oocyte maturation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04916	Melanogenesis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04930	Type II diabetes mellitus	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko04960	Aldosterone-regulated sodium reabsorption	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05010	Alzheimer's disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05020	Prion diseases	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05131	Shigellosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05140	Leishmaniasis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05142	Chagas disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05200	Pathways in cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05210	Colorectal cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05211	Renal cell carcinoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05212	Pancreatic cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05213	Endometrial cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05214	Glioma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05215	Prostate cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05216	Thyroid cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05218	Melanoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05219	Bladder cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05220	Chronic myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05221	Acute myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006602	K04371	ko05223	Non-small cell lung cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMC200006604	K01190	ko00052	Galactose metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMC200006604	K01190	ko00511	Other glycan degradation	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMC200006604	K01190	ko00600	Sphingolipid metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMC200006604	K01190	ko01100	Metabolic pathways	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMC200006605	K01338	ko04112	Cell cycle - Caulobacter	805	1.4e-38	0.51	0.68	0.74
PGSC0003DMC200006626	K04618	ko00052	Galactose metabolism	468	6.4e-20	0.29	0.44	0.81
PGSC0003DMC200006627	K04618	ko00052	Galactose metabolism	437	4.6e-18	0.29	0.44	0.81
PGSC0003DMC200006628	K04618	ko00052	Galactose metabolism	470	4.8e-20	0.29	0.46	0.81
PGSC0003DMC200012151	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMC200012157	K04457	ko04010	MAPK signaling pathway	558	3.6e-24	0.35	0.51	0.24
PGSC0003DMC200012161	K01184	ko00040	Pentose and glucuronate interconversions	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMC200012161	K01184	ko00500	Starch and sucrose metabolism	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMC200012161	K01184	ko01100	Metabolic pathways	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMC200012163	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.52	0.67	0.65
PGSC0003DMC200012164	K08064	ko04612	Antigen processing and presentation	591	9.2e-27	0.40	0.55	0.75
PGSC0003DMC200012170	K02137	ko00190	Oxidative phosphorylation	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMC200012170	K02137	ko01100	Metabolic pathways	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMC200012170	K02137	ko05010	Alzheimer's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMC200012170	K02137	ko05012	Parkinson's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMC200012170	K02137	ko05016	Huntington's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMC200060875	K01955	ko00240	Pyrimidine metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMC200060875	K01955	ko00250	Alanine, aspartate and glutamate metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMC200060875	K01955	ko01100	Metabolic pathways	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMC200037803	K01087	ko00500	Starch and sucrose metabolism	1309	2.3e-66	0.69	0.81	0.98
PGSC0003DMC200037805	K05658	ko02010	ABC transporters	342	4.7e-12	0.57	0.77	0.95
PGSC0003DMC200037806	K05658	ko02010	ABC transporters	324	4.7e-11	0.55	0.71	0.99
PGSC0003DMC200037807	K05658	ko02010	ABC transporters	544	2.3e-23	0.54	0.73	0.97
PGSC0003DMC200037819	K01858	ko00521	Streptomycin biosynthesis	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMC200037819	K01858	ko00562	Inositol phosphate metabolism	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMC200037819	K01858	ko01100	Metabolic pathways	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMC200037819	K01858	ko01110	Biosynthesis of secondary metabolites	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMC200043360	K10151	ko04110	Cell cycle	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMC200043360	K10151	ko04115	p53 signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMC200043360	K10151	ko04310	Wnt signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMC200043360	K10151	ko04510	Focal adhesion	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMC200043360	K10151	ko04630	Jak-STAT signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMC200043361	K01110	ko00562	Inositol phosphate metabolism	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko04070	Phosphatidylinositol signaling system	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko04115	p53 signaling pathway	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko04510	Focal adhesion	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko04530	Tight junction	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05200	Pathways in cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05213	Endometrial cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05214	Glioma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05215	Prostate cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05218	Melanoma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043361	K01110	ko05222	Small cell lung cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMC200043362	K01110	ko00562	Inositol phosphate metabolism	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko04070	Phosphatidylinositol signaling system	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko04115	p53 signaling pathway	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko04510	Focal adhesion	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko04530	Tight junction	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05200	Pathways in cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05213	Endometrial cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05214	Glioma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05215	Prostate cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05218	Melanoma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043362	K01110	ko05222	Small cell lung cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMC200043363	K01110	ko00562	Inositol phosphate metabolism	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko04070	Phosphatidylinositol signaling system	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko04115	p53 signaling pathway	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko04510	Focal adhesion	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko04530	Tight junction	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05200	Pathways in cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05213	Endometrial cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05214	Glioma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05215	Prostate cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05218	Melanoma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043363	K01110	ko05222	Small cell lung cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMC200043371	K05849	ko04020	Calcium signaling pathway	413	1.6e-16	0.35	0.52	0.51
PGSC0003DMC200043374	K00851	ko00030	Pentose phosphate pathway	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMC200043374	K00851	ko01100	Metabolic pathways	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMC200043374	K00851	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMC200043375	K00851	ko00030	Pentose phosphate pathway	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMC200043375	K00851	ko01100	Metabolic pathways	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMC200043375	K00851	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMC200054211	K00963	ko00040	Pentose and glucuronate interconversions	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054211	K00963	ko00052	Galactose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054211	K00963	ko00500	Starch and sucrose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054211	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054211	K00963	ko01100	Metabolic pathways	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054211	K00963	ko01110	Biosynthesis of secondary metabolites	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMC200054212	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054212	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054212	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054212	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054212	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054212	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054213	K00963	ko00040	Pentose and glucuronate interconversions	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054213	K00963	ko00052	Galactose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054213	K00963	ko00500	Starch and sucrose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054213	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054213	K00963	ko01100	Metabolic pathways	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054213	K00963	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMC200054214	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054214	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054214	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054214	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054214	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054214	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMC200054227	K12373	ko00511	Other glycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko00531	Glycosaminoglycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko01100	Metabolic pathways	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054227	K12373	ko04142	Lysosome	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMC200054228	K12373	ko00511	Other glycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko00531	Glycosaminoglycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko01100	Metabolic pathways	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054228	K12373	ko04142	Lysosome	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMC200054230	K04382	ko04111	Cell cycle - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04113	Meiosis - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04114	Oocyte meiosis	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04310	Wnt signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04350	TGF-beta signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04530	Tight junction	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko04730	Long-term depression	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054230	K04382	ko05142	Chagas disease	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMC200054231	K04382	ko04111	Cell cycle - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04113	Meiosis - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04114	Oocyte meiosis	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04310	Wnt signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04350	TGF-beta signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04530	Tight junction	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko04730	Long-term depression	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200054231	K04382	ko05142	Chagas disease	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMC200053767	K06685	ko04111	Cell cycle - yeast	1620	1.6e-83	0.96	0.98	0.99
PGSC0003DMC200053768	K06685	ko04111	Cell cycle - yeast	1816	2.5e-94	0.97	0.99	1.00
PGSC0003DMC200053769	K11422	ko00310	Lysine degradation	288	1.3e-06	0.30	0.41	0.63
PGSC0003DMC200053770	K04512	ko04310	Wnt signaling pathway	833	4.1e-40	0.33	0.57	0.97
PGSC0003DMC200053771	K08762	ko03320	PPAR signaling pathway	606	1.4e-27	0.82	0.91	0.97
PGSC0003DMC200053772	K02873	ko03010	Ribosome	1563	2.3e-80	0.88	0.95	1.00
PGSC0003DMC200053773	K02948	ko03010	Ribosome	795	5.2e-38	0.61	0.77	0.99
PGSC0003DMC200053774	K02948	ko03010	Ribosome	854	2.9e-41	0.50	0.66	0.97
PGSC0003DMC200053780	K02895	ko03010	Ribosome	424	1.5e-17	0.53	0.72	0.61
PGSC0003DMC200053789	K03010	ko00230	Purine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMC200053789	K03010	ko00240	Pyrimidine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMC200053789	K03010	ko01100	Metabolic pathways	7637	0.	0.72	0.83	0.99
PGSC0003DMC200053789	K03010	ko03020	RNA polymerase	7637	0.	0.72	0.83	0.99
PGSC0003DMC200053789	K03010	ko05016	Huntington's disease	7637	0.	0.72	0.83	0.99
PGSC0003DMC200053790	K03010	ko00230	Purine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMC200053790	K03010	ko00240	Pyrimidine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMC200053790	K03010	ko01100	Metabolic pathways	6880	0.	0.79	0.89	1.00
PGSC0003DMC200053790	K03010	ko03020	RNA polymerase	6880	0.	0.79	0.89	1.00
PGSC0003DMC200053790	K03010	ko05016	Huntington's disease	6880	0.	0.79	0.89	1.00
PGSC0003DMC200041645	K12669	ko00510	N-Glycan biosynthesis	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMC200041645	K12669	ko01100	Metabolic pathways	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMC200041656	K02917	ko03010	Ribosome	838	2.2e-40	0.85	0.90	0.99
PGSC0003DMC200042274	K03039	ko03050	Proteasome	2881	4.6e-153	0.89	0.96	1.00
PGSC0003DMC200042275	K00059	ko00061	Fatty acid biosynthesis	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMC200042275	K00059	ko01040	Biosynthesis of unsaturated fatty acids	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMC200042275	K00059	ko01100	Metabolic pathways	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMC200042276	K01581	ko00330	Arginine and proline metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMC200042276	K01581	ko00480	Glutathione metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMC200042276	K01581	ko01100	Metabolic pathways	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMC200042276	K01581	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMC200042281	K00100	ko00051	Fructose and mannose metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042281	K00100	ko00363	Bisphenol A degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042281	K00100	ko00591	Linoleic acid metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042281	K00100	ko00625	Tetrachloroethene degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042281	K00100	ko00650	Butanoate metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042281	K00100	ko01100	Metabolic pathways	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMC200042282	K00117	ko00030	Pentose phosphate pathway	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMC200042282	K00117	ko01100	Metabolic pathways	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMC200042282	K00117	ko01110	Biosynthesis of secondary metabolites	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMC200042288	K10418	ko04962	Vasopressin-regulated water reabsorption	337	9.4e-13	0.52	0.66	0.32
PGSC0003DMC200042289	K12126	ko04712	Circadian rhythm - plant	274	5.1e-09	0.35	0.48	0.61
PGSC0003DMC200042291	K12126	ko04712	Circadian rhythm - plant	302	1.1e-10	0.34	0.52	0.62
PGSC0003DMC200042299	K12843	ko03040	Spliceosome	1429	5.6e-73	0.35	0.56	0.91
PGSC0003DMC200042300	K10643	ko03018	RNA degradation	266	1.3e-08	0.46	0.73	0.15
PGSC0003DMC200037081	K12850	ko03040	Spliceosome	349	2.1e-13	0.24	0.48	0.98
PGSC0003DMC200037089	K10352	ko04530	Tight junction	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMC200037089	K10352	ko05416	Viral myocarditis	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMC200037094	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMC200037096	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMC200061973	K04121	ko00904	Diterpenoid biosynthesis	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMC200061973	K04121	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMC200061973	K04121	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMC200002507	K04371	ko04010	MAPK signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04012	ErbB signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04013	MAPK signaling pathway - fly	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04062	Chemokine signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04114	Oocyte meiosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04150	mTOR signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04270	Vascular smooth muscle contraction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04320	Dorso-ventral axis formation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04350	TGF-beta signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04360	Axon guidance	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04370	VEGF signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04510	Focal adhesion	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04520	Adherens junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04540	Gap junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04620	Toll-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04621	NOD-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04650	Natural killer cell mediated cytotoxicity	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04660	T cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04662	B cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04664	Fc epsilon RI signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04666	Fc gamma R-mediated phagocytosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04720	Long-term potentiation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04722	Neurotrophin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04730	Long-term depression	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04810	Regulation of actin cytoskeleton	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04910	Insulin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04912	GnRH signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04914	Progesterone-mediated oocyte maturation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04916	Melanogenesis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04930	Type II diabetes mellitus	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko04960	Aldosterone-regulated sodium reabsorption	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05010	Alzheimer's disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05020	Prion diseases	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05131	Shigellosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05140	Leishmaniasis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05142	Chagas disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05200	Pathways in cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05210	Colorectal cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05211	Renal cell carcinoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05212	Pancreatic cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05213	Endometrial cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05214	Glioma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05215	Prostate cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05216	Thyroid cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05218	Melanoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05219	Bladder cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05220	Chronic myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05221	Acute myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002507	K04371	ko05223	Non-small cell lung cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMC200002508	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMC200002509	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMC200013479	K01187	ko00052	Galactose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMC200013479	K01187	ko00500	Starch and sucrose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMC200013479	K01187	ko01100	Metabolic pathways	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMC200013480	K01187	ko00052	Galactose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMC200013480	K01187	ko00500	Starch and sucrose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMC200013480	K01187	ko01100	Metabolic pathways	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMC200013483	K02890	ko03010	Ribosome	387	1.6e-15	0.44	0.66	0.47
PGSC0003DMC200013484	K12872	ko03040	Spliceosome	3548	7.4e-190	0.83	0.91	0.99
PGSC0003DMC200013488	K01633	ko00790	Folate biosynthesis	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMC200013488	K01633	ko01100	Metabolic pathways	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMC200013493	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMC200013493	K03860	ko01100	Metabolic pathways	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMC200013494	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMC200013494	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMC200013495	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMC200013495	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMC200013499	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200013499	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200013499	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200013500	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200013500	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200013500	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMC200008281	K05185	ko04080	Neuroactive ligand-receptor interaction	908	3.0e-44	0.30	0.33	0.96
PGSC0003DMC200008282	K05185	ko04080	Neuroactive ligand-receptor interaction	841	1.5e-40	0.31	0.34	0.85
PGSC0003DMC200008283	K01081	ko00230	Purine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMC200008283	K01081	ko00240	Pyrimidine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMC200008283	K01081	ko00760	Nicotinate and nicotinamide metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMC200008283	K01081	ko01100	Metabolic pathways	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMC200008283	K01081	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMC200008291	K05658	ko02010	ABC transporters	6786	0.	0.64	0.80	1.00
PGSC0003DMC200008292	K02881	ko03010	Ribosome	1026	9.4e-51	0.77	0.86	0.98
PGSC0003DMC200008295	K01139	ko00230	Purine metabolism	797	4.0e-38	0.38	0.56	0.80
PGSC0003DMC200008296	K01139	ko00230	Purine metabolism	853	3.3e-41	0.39	0.57	0.65
PGSC0003DMC200008299	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMC200008300	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMC200008303	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008303	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008303	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008303	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008304	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008304	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008304	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200008304	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMC200023523	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMC200023523	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMC200023523	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMC200023524	K07199	ko04910	Insulin signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMC200023524	K07199	ko04920	Adipocytokine signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMC200023524	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMC200023529	K08065	ko04612	Antigen processing and presentation	451	4.9e-19	0.54	0.73	0.79
PGSC0003DMC200023533	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023533	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023534	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMC200023536	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMC200023536	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMC200023537	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMC200023537	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMC200023543	K06678	ko04111	Cell cycle - yeast	3346	1.0e-178	0.63	0.78	1.00
PGSC0003DMC200023546	K03934	ko00190	Oxidative phosphorylation	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMC200023546	K03934	ko01100	Metabolic pathways	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMC200023546	K03934	ko05010	Alzheimer's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMC200023546	K03934	ko05012	Parkinson's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMC200023546	K03934	ko05016	Huntington's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMC200023547	K03934	ko00190	Oxidative phosphorylation	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMC200023547	K03934	ko01100	Metabolic pathways	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMC200023547	K03934	ko05010	Alzheimer's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMC200023547	K03934	ko05012	Parkinson's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMC200023547	K03934	ko05016	Huntington's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMC200023548	K06171	ko04330	Notch signaling pathway	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMC200023548	K06171	ko05010	Alzheimer's disease	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMC200023549	K06171	ko04330	Notch signaling pathway	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMC200023549	K06171	ko05010	Alzheimer's disease	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMC200023550	K06171	ko04330	Notch signaling pathway	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMC200023550	K06171	ko05010	Alzheimer's disease	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMC200032717	K10872	ko04113	Meiosis - yeast	256	9.8e-08	0.30	0.45	0.87
PGSC0003DMC200032718	K10872	ko04113	Meiosis - yeast	252	1.7e-07	0.35	0.56	0.67
PGSC0003DMC200032719	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.86
PGSC0003DMC200032720	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.76
PGSC0003DMC200032722	K05894	ko00592	alpha-Linolenic acid metabolism	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMC200032722	K05894	ko01100	Metabolic pathways	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMC200032723	K05894	ko00592	alpha-Linolenic acid metabolism	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMC200032723	K05894	ko01100	Metabolic pathways	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMC200032724	K05894	ko00592	alpha-Linolenic acid metabolism	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMC200032724	K05894	ko01100	Metabolic pathways	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMC200032725	K05894	ko00592	alpha-Linolenic acid metabolism	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMC200032725	K05894	ko01100	Metabolic pathways	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMC200032726	K05894	ko00592	alpha-Linolenic acid metabolism	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMC200032726	K05894	ko01100	Metabolic pathways	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMC200040298	K12347	ko04142	Lysosome	2945	1.3e-156	0.72	0.86	0.93
PGSC0003DMC200040306	K11294	ko05130	Pathogenic Escherichia coli infection	308	4.0e-08	0.28	0.48	0.30
PGSC0003DMC200040308	K00001	ko00010	Glycolysis / Gluconeogenesis	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00071	Fatty acid metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00350	Tyrosine metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00641	3-Chloroacrylic acid degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00830	Retinol metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko00982	Drug metabolism - cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko01100	Metabolic pathways	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040308	K00001	ko01110	Biosynthesis of secondary metabolites	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMC200040309	K00001	ko00010	Glycolysis / Gluconeogenesis	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00071	Fatty acid metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00350	Tyrosine metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00641	3-Chloroacrylic acid degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00830	Retinol metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko00982	Drug metabolism - cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko01100	Metabolic pathways	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040309	K00001	ko01110	Biosynthesis of secondary metabolites	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMC200040313	K01082	ko00920	Sulfur metabolism	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMC200040313	K01082	ko01100	Metabolic pathways	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMC200040314	K01082	ko00920	Sulfur metabolism	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMC200040314	K01082	ko01100	Metabolic pathways	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMC200040315	K12843	ko03040	Spliceosome	1417	2.5e-72	0.39	0.60	0.81
PGSC0003DMC200040320	K00901	ko00561	Glycerolipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMC200040320	K00901	ko00564	Glycerophospholipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMC200040320	K00901	ko01100	Metabolic pathways	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMC200040320	K00901	ko04070	Phosphatidylinositol signaling system	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMC200046862	K02900	ko03010	Ribosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200046863	K00276	ko00260	Glycine, serine and threonine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko00350	Tyrosine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko00360	Phenylalanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko00410	beta-Alanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko00950	Isoquinoline alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko01100	Metabolic pathways	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046863	K00276	ko01110	Biosynthesis of secondary metabolites	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMC200046864	K06067	ko04110	Cell cycle	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMC200046864	K06067	ko04330	Notch signaling pathway	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMC200046864	K06067	ko05016	Huntington's disease	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMC200046864	K06067	ko05200	Pathways in cancer	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMC200046864	K06067	ko05220	Chronic myeloid leukemia	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMC200046865	K06067	ko04110	Cell cycle	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMC200046865	K06067	ko04330	Notch signaling pathway	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMC200046865	K06067	ko05016	Huntington's disease	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMC200046865	K06067	ko05200	Pathways in cancer	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMC200046865	K06067	ko05220	Chronic myeloid leukemia	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMC200046867	K12393	ko04142	Lysosome	1001	2.2e-49	0.89	0.95	0.98
PGSC0003DMC200046869	K12854	ko03040	Spliceosome	1505	8.2e-77	0.54	0.69	1.00
PGSC0003DMC200046873	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMC200046873	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMC200046873	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMC200046874	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMC200046874	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMC200046874	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMC200046875	K03143	ko03022	Basal transcription factors	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMC200046875	K03143	ko03420	Nucleotide excision repair	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMC200046876	K03143	ko03022	Basal transcription factors	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMC200046876	K03143	ko03420	Nucleotide excision repair	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMC200046877	K04424	ko04010	MAPK signaling pathway	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMC200046877	K04424	ko04530	Tight junction	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMC200046880	K05278	ko00941	Flavonoid biosynthesis	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMC200046880	K05278	ko01100	Metabolic pathways	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMC200046880	K05278	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMC200046885	K02604	ko04110	Cell cycle	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMC200046885	K02604	ko04111	Cell cycle - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMC200046885	K02604	ko04113	Meiosis - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMC200046886	K02604	ko04110	Cell cycle	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMC200046886	K02604	ko04111	Cell cycle - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMC200046886	K02604	ko04113	Meiosis - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMC200035350	K12343	ko00140	Steroid hormone biosynthesis	1649	4.1e-85	0.71	0.83	0.99
PGSC0003DMC200035352	K00368	ko00910	Nitrogen metabolism	1577	3.8e-81	0.41	0.56	0.95
PGSC0003DMC200035353	K00368	ko00910	Nitrogen metabolism	1640	1.3e-84	0.43	0.57	0.89
PGSC0003DMC200035354	K08769	ko03320	PPAR signaling pathway	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMC200035354	K08769	ko05016	Huntington's disease	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMC200035355	K08769	ko03320	PPAR signaling pathway	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMC200035355	K08769	ko05016	Huntington's disease	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMC200035367	K00847	ko00051	Fructose and mannose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMC200035367	K00847	ko00500	Starch and sucrose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMC200035367	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMC200035367	K00847	ko01100	Metabolic pathways	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMC200035369	K03841	ko00010	Glycolysis / Gluconeogenesis	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko00030	Pentose phosphate pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko00051	Fructose and mannose metabolism	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko00710	Carbon fixation in photosynthetic organisms	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko01100	Metabolic pathways	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko01110	Biosynthesis of secondary metabolites	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200035369	K03841	ko04910	Insulin signaling pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMC200063429	K12837	ko03040	Spliceosome	362	1.9e-13	0.25	0.53	0.99
PGSC0003DMC200063434	K10592	ko04120	Ubiquitin mediated proteolysis	397	1.1e-14	0.28	0.46	0.95
PGSC0003DMC200063436	K03469	ko03030	DNA replication	270	1.7e-08	0.35	0.59	0.65
PGSC0003DMC200063450	K00368	ko00910	Nitrogen metabolism	1684	4.8e-87	0.44	0.57	0.91
PGSC0003DMC200009092	K00026	ko00020	Citrate cycle (TCA cycle)	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009092	K00026	ko00620	Pyruvate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009092	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009092	K00026	ko00710	Carbon fixation in photosynthetic organisms	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009092	K00026	ko01100	Metabolic pathways	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009092	K00026	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMC200009100	K12489	ko04144	Endocytosis	772	9.6e-37	0.55	0.69	0.90
PGSC0003DMC200009111	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMC200009112	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMC200009113	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMC200009114	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2036	1.8e-106	0.84	0.91	0.97
PGSC0003DMC200009115	K01876	ko00970	Aminoacyl-tRNA biosynthesis	3232	2.0e-172	0.76	0.85	0.99
PGSC0003DMC200009116	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2785	9.0e-148	0.86	0.93	0.99
PGSC0003DMC200009120	K01199	ko00500	Starch and sucrose metabolism	834	3.6e-40	0.38	0.55	0.76
PGSC0003DMC200015678	K03850	ko00510	N-Glycan biosynthesis	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMC200015678	K03850	ko01100	Metabolic pathways	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMC200015679	K03850	ko00510	N-Glycan biosynthesis	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMC200015679	K03850	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMC200015680	K03850	ko00510	N-Glycan biosynthesis	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMC200015680	K03850	ko01100	Metabolic pathways	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMC200015681	K03850	ko00510	N-Glycan biosynthesis	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMC200015681	K03850	ko01100	Metabolic pathways	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMC200015682	K03850	ko00510	N-Glycan biosynthesis	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMC200015682	K03850	ko01100	Metabolic pathways	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMC200015687	K06053	ko04330	Notch signaling pathway	233	2.6e-06	0.31	0.43	0.65
PGSC0003DMC200015689	K09392	ko04110	Cell cycle	600	2.9e-27	0.42	0.61	0.72
PGSC0003DMC200015690	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMC200015690	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMC200026522	K00430	ko00360	Phenylalanine metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMC200026522	K00430	ko00680	Methane metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMC200026522	K00430	ko00940	Phenylpropanoid biosynthesis	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMC200026522	K00430	ko01100	Metabolic pathways	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMC200026522	K00430	ko01110	Biosynthesis of secondary metabolites	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMC200026523	K00430	ko00360	Phenylalanine metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMC200026523	K00430	ko00680	Methane metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMC200026523	K00430	ko00940	Phenylpropanoid biosynthesis	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMC200026523	K00430	ko01100	Metabolic pathways	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMC200026523	K00430	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMC200026524	K00430	ko00360	Phenylalanine metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMC200026524	K00430	ko00680	Methane metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMC200026524	K00430	ko00940	Phenylpropanoid biosynthesis	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMC200026524	K00430	ko01100	Metabolic pathways	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMC200026524	K00430	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMC200026525	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMC200026525	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMC200026525	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMC200026525	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMC200026525	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMC200026528	K05745	ko04810	Regulation of actin cytoskeleton	334	1.1e-11	0.40	0.55	0.54
PGSC0003DMC200026533	K09561	ko04120	Ubiquitin mediated proteolysis	224	2.7e-06	0.36	0.56	0.22
PGSC0003DMC200004141	K05933	ko00270	Cysteine and methionine metabolism	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMC200004141	K05933	ko01110	Biosynthesis of secondary metabolites	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMC200004154	K01053	ko00030	Pentose phosphate pathway	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMC200004154	K01053	ko00053	Ascorbate and aldarate metabolism	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMC200004154	K01053	ko00930	Caprolactam degradation	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMC200004154	K01053	ko01100	Metabolic pathways	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMC200004154	K01053	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMC200004155	K01053	ko00030	Pentose phosphate pathway	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMC200004155	K01053	ko00053	Ascorbate and aldarate metabolism	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMC200004155	K01053	ko00930	Caprolactam degradation	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMC200004155	K01053	ko01100	Metabolic pathways	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMC200004155	K01053	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMC200004156	K01053	ko00030	Pentose phosphate pathway	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMC200004156	K01053	ko00053	Ascorbate and aldarate metabolism	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMC200004156	K01053	ko00930	Caprolactam degradation	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMC200004156	K01053	ko01100	Metabolic pathways	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMC200004156	K01053	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMC200004162	K13229	ko00402	Benzoxazinoid biosynthesis	480	1.2e-20	0.41	0.58	0.81
PGSC0003DMC200004165	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004165	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004165	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004165	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004165	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004165	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMC200004166	K00100	ko00051	Fructose and mannose metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004166	K00100	ko00363	Bisphenol A degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004166	K00100	ko00591	Linoleic acid metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004166	K00100	ko00625	Tetrachloroethene degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004166	K00100	ko00650	Butanoate metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004166	K00100	ko01100	Metabolic pathways	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMC200004167	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004167	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004167	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004167	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004167	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004167	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMC200004170	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMC200045667	K12456	ko04110	Cell cycle	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMC200045667	K12456	ko04114	Oocyte meiosis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMC200045667	K12456	ko04120	Ubiquitin mediated proteolysis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMC200045667	K12456	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMC200045668	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMC200045668	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMC200045669	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMC200045669	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMC200045670	K00648	ko00061	Fatty acid biosynthesis	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMC200045670	K00648	ko01100	Metabolic pathways	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMC200045674	K12128	ko04712	Circadian rhythm - plant	219	6.0e-06	0.52	0.67	0.57
PGSC0003DMC200045675	K12135	ko04712	Circadian rhythm - plant	598	3.8e-27	0.38	0.62	0.54
PGSC0003DMC200045689	K12896	ko03040	Spliceosome	1435	2.6e-73	0.89	0.95	0.99
PGSC0003DMC200045690	K00301	ko00260	Glycine, serine and threonine metabolism	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMC200045690	K00301	ko01100	Metabolic pathways	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMC200039091	K08492	ko04130	SNARE interactions in vesicular transport	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMC200039091	K08492	ko04145	Phagosome	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMC200039092	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMC200039092	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMC200039093	K08492	ko04130	SNARE interactions in vesicular transport	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMC200039093	K08492	ko04145	Phagosome	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMC200039098	K12897	ko03040	Spliceosome	301	9.1e-11	0.50	0.54	0.81
PGSC0003DMC200039109	K06689	ko04120	Ubiquitin mediated proteolysis	1176	5.0e-59	0.88	0.97	0.99
PGSC0003DMC200039115	K03029	ko03050	Proteasome	1884	4.5e-98	0.65	0.79	0.86
PGSC0003DMC200039116	K03029	ko03050	Proteasome	2069	2.8e-108	0.65	0.79	0.99
PGSC0003DMC200039117	K03029	ko03050	Proteasome	2020	1.4e-105	0.62	0.75	1.00
PGSC0003DMC200039120	K10772	ko03410	Base excision repair	2944	1.5e-156	0.59	0.70	0.99
PGSC0003DMC200056548	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMC200056548	K01657	ko01100	Metabolic pathways	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMC200056548	K01657	ko01110	Biosynthesis of secondary metabolites	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMC200034143	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMC200034143	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMC200034144	K03135	ko03022	Basal transcription factors	573	9.1e-26	0.54	0.70	0.98
PGSC0003DMC200034145	K03135	ko03022	Basal transcription factors	1070	3.5e-53	0.62	0.77	1.00
PGSC0003DMC200034152	K01246	ko03410	Base excision repair	576	6.2e-26	0.43	0.46	0.78
PGSC0003DMC200034153	K01246	ko03410	Base excision repair	689	3.6e-32	0.80	0.92	0.98
PGSC0003DMC200034154	K12356	ko00940	Phenylpropanoid biosynthesis	692	2.5e-32	0.33	0.50	0.97
PGSC0003DMC200034157	K12126	ko04712	Circadian rhythm - plant	277	3.4e-09	0.37	0.52	0.54
PGSC0003DMC200034158	K12126	ko04712	Circadian rhythm - plant	311	3.8e-09	0.28	0.45	0.72
PGSC0003DMC200034159	K12126	ko04712	Circadian rhythm - plant	307	6.7e-09	0.27	0.44	0.70
PGSC0003DMC200034162	K05683	ko02010	ABC transporters	825	1.1e-39	0.29	0.50	0.84
PGSC0003DMC200034164	K06685	ko04111	Cell cycle - yeast	440	8.5e-15	0.27	0.40	0.85
PGSC0003DMC200016875	K04733	ko04210	Apoptosis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMC200016875	K04733	ko04620	Toll-like receptor signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMC200016875	K04733	ko04722	Neurotrophin signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMC200016875	K04733	ko05140	Leishmaniasis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMC200016875	K04733	ko05142	Chagas disease	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMC200010291	K02701	ko00195	Photosynthesis	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMC200010291	K02701	ko01100	Metabolic pathways	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMC200010292	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMC200010292	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMC200010292	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMC200010292	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMC200010293	K01840	ko00051	Fructose and mannose metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMC200010293	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMC200010293	K01840	ko01100	Metabolic pathways	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMC200010293	K01840	ko01110	Biosynthesis of secondary metabolites	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMC200010294	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010294	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010294	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010294	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010295	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010295	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010295	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010295	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMC200010298	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMC200010298	K08680	ko01100	Metabolic pathways	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMC200010298	K08680	ko01110	Biosynthesis of secondary metabolites	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMC200010302	K01838	ko00500	Starch and sucrose metabolism	509	3.1e-22	0.45	0.64	0.95
PGSC0003DMC200010303	K01838	ko00500	Starch and sucrose metabolism	307	4.3e-11	0.47	0.59	0.94
PGSC0003DMC200010304	K01838	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.43	0.64	0.67
PGSC0003DMC200010305	K01838	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.43	0.62	0.77
PGSC0003DMC200010306	K12356	ko00940	Phenylpropanoid biosynthesis	716	1.2e-33	0.32	0.51	0.90
PGSC0003DMC200010314	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010314	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010314	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010315	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010315	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010315	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMC200010316	K09587	ko00905	Brassinosteroid biosynthesis	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMC200010316	K09587	ko01100	Metabolic pathways	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMC200010316	K09587	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMC200010319	K12235	ko00260	Glycine, serine and threonine metabolism	2022	1.1e-105	0.72	0.85	0.99
PGSC0003DMC200010320	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMC200005353	K06685	ko04111	Cell cycle - yeast	464	3.9e-16	0.25	0.41	0.86
PGSC0003DMC200005368	K01757	ko00901	Indole alkaloid biosynthesis	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMC200005368	K01757	ko01100	Metabolic pathways	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMC200005368	K01757	ko01110	Biosynthesis of secondary metabolites	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMC200068389	K10760	ko00908	Zeatin biosynthesis	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMC200068389	K10760	ko01100	Metabolic pathways	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMC200068389	K10760	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMC200064641	K00993	ko00440	Phosphonate and phosphinate metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMC200064641	K00993	ko00564	Glycerophospholipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMC200064641	K00993	ko00565	Ether lipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMC200064641	K00993	ko01100	Metabolic pathways	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMC200064645	K01051	ko00040	Pentose and glucuronate interconversions	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMC200064645	K01051	ko00500	Starch and sucrose metabolism	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMC200064645	K01051	ko01100	Metabolic pathways	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMC200038291	K05692	ko04145	Phagosome	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04510	Focal adhesion	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04520	Adherens junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04530	Tight junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04670	Leukocyte transendothelial migration	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04745	Phototransduction - fly	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko04810	Regulation of actin cytoskeleton	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05100	Bacterial invasion of epithelial cells	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05110	Vibrio cholerae infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05130	Pathogenic Escherichia coli infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05131	Shigellosis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05414	Dilated cardiomyopathy	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038291	K05692	ko05416	Viral myocarditis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMC200038295	K12880	ko03040	Spliceosome	2486	2.8e-131	0.90	0.96	1.00
PGSC0003DMC200038296	K12880	ko03040	Spliceosome	1245	7.8e-63	0.93	0.97	0.91
PGSC0003DMC200038297	K06699	ko03050	Proteasome	5875	0.	0.74	0.86	1.00
PGSC0003DMC200038298	K06699	ko03050	Proteasome	5243	2.4e-283	0.74	0.86	1.00
PGSC0003DMC200038299	K06699	ko03050	Proteasome	8480	0.	0.74	0.86	1.00
PGSC0003DMC200038300	K06699	ko03050	Proteasome	5997	0.	0.75	0.86	0.99
PGSC0003DMC200038301	K06699	ko03050	Proteasome	346	4.4e-12	0.49	0.67	0.81
PGSC0003DMC200043472	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMC200043472	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMC200043472	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMC200043473	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMC200043473	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMC200043473	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMC200043474	K01099	ko00562	Inositol phosphate metabolism	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMC200043474	K01099	ko01100	Metabolic pathways	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMC200043474	K01099	ko04070	Phosphatidylinositol signaling system	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMC200043478	K01528	ko04144	Endocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMC200043478	K01528	ko04666	Fc gamma R-mediated phagocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMC200043478	K01528	ko05100	Bacterial invasion of epithelial cells	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMC200043480	K01834	ko00010	Glycolysis / Gluconeogenesis	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMC200043480	K01834	ko01100	Metabolic pathways	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMC200043480	K01834	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMC200043481	K01834	ko00010	Glycolysis / Gluconeogenesis	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMC200043481	K01834	ko01100	Metabolic pathways	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMC200043481	K01834	ko01110	Biosynthesis of secondary metabolites	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMC200043485	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1519	6.0e-78	0.66	0.75	0.98
PGSC0003DMC200043486	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	886	4.9e-43	0.70	0.81	0.99
PGSC0003DMC200043487	K12124	ko04712	Circadian rhythm - plant	7647	0.	0.79	0.86	1.00
PGSC0003DMC200043488	K12124	ko04712	Circadian rhythm - plant	6348	0.	0.79	0.87	0.99
PGSC0003DMC200043492	K09841	ko00906	Carotenoid biosynthesis	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMC200043492	K09841	ko01100	Metabolic pathways	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMC200043492	K09841	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMC200043493	K09841	ko00906	Carotenoid biosynthesis	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMC200043493	K09841	ko01100	Metabolic pathways	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMC200043493	K09841	ko01110	Biosynthesis of secondary metabolites	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMC200043494	K09841	ko00906	Carotenoid biosynthesis	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMC200043494	K09841	ko01100	Metabolic pathways	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMC200043494	K09841	ko01110	Biosynthesis of secondary metabolites	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMC200053521	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMC200053521	K03183	ko01100	Metabolic pathways	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMC200053521	K03183	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMC200053522	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMC200053522	K03183	ko01100	Metabolic pathways	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMC200053522	K03183	ko01110	Biosynthesis of secondary metabolites	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMC200053523	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMC200053523	K03183	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMC200053523	K03183	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMC200053524	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMC200053524	K03183	ko01100	Metabolic pathways	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMC200053524	K03183	ko01110	Biosynthesis of secondary metabolites	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMC200053525	K00485	ko00982	Drug metabolism - cytochrome P450	443	1.3e-18	0.34	0.49	0.75
PGSC0003DMC200053532	K12852	ko03040	Spliceosome	7668	0.	0.90	0.96	1.00
PGSC0003DMC200007090	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007090	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007090	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007091	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007091	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007091	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007092	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007092	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007092	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMC200007097	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMC200007098	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMC200007109	K12622	ko03018	RNA degradation	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMC200007109	K12622	ko03040	Spliceosome	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMC200012279	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMC200012280	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMC200012282	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMC200012282	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMC200012283	K01728	ko00040	Pentose and glucuronate interconversions	1615	3.1e-83	0.53	0.69	0.92
PGSC0003DMC200012284	K01728	ko00040	Pentose and glucuronate interconversions	1819	1.7e-94	0.58	0.70	0.86
PGSC0003DMC200012298	K01184	ko00040	Pentose and glucuronate interconversions	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMC200012298	K01184	ko00500	Starch and sucrose metabolism	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMC200012298	K01184	ko01100	Metabolic pathways	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMC200065986	K11251	ko05322	Systemic lupus erythematosus	471	3.8e-20	0.66	0.82	0.77
PGSC0003DMC200025321	K12741	ko03040	Spliceosome	1355	6.7e-69	0.44	0.56	0.98
PGSC0003DMC200025322	K12741	ko03040	Spliceosome	874	2.3e-42	0.39	0.52	0.93
PGSC0003DMC200025323	K02995	ko03010	Ribosome	1624	9.8e-84	0.87	0.93	0.99
PGSC0003DMC200025333	K12606	ko03018	RNA degradation	258	2.1e-08	0.60	0.68	0.80
PGSC0003DMC200025334	K08908	ko00196	Photosynthesis - antenna proteins	1319	6.5e-67	0.95	0.98	0.99
PGSC0003DMC200025345	K01696	ko00260	Glycine, serine and threonine metabolism	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMC200025345	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMC200025345	K01696	ko01100	Metabolic pathways	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMC200025345	K01696	ko01110	Biosynthesis of secondary metabolites	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMC200019053	K05658	ko02010	ABC transporters	3916	3.7e-210	0.44	0.64	0.99
PGSC0003DMC200019066	K03841	ko00010	Glycolysis / Gluconeogenesis	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko00030	Pentose phosphate pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko00051	Fructose and mannose metabolism	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko00710	Carbon fixation in photosynthetic organisms	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko01100	Metabolic pathways	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019066	K03841	ko04910	Insulin signaling pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMC200019067	K03841	ko00010	Glycolysis / Gluconeogenesis	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko00030	Pentose phosphate pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko00051	Fructose and mannose metabolism	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko00710	Carbon fixation in photosynthetic organisms	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko01100	Metabolic pathways	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019067	K03841	ko04910	Insulin signaling pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMC200019071	K03364	ko04110	Cell cycle	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMC200019071	K03364	ko04111	Cell cycle - yeast	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMC200019071	K03364	ko04120	Ubiquitin mediated proteolysis	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMC200019071	K03364	ko04914	Progesterone-mediated oocyte maturation	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMC200019079	K03801	ko00785	Lipoic acid metabolism	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMC200019079	K03801	ko01100	Metabolic pathways	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMC200054142	K00975	ko00500	Starch and sucrose metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMC200054142	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMC200054142	K00975	ko01100	Metabolic pathways	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMC200041492	K05712	ko00360	Phenylalanine metabolism	289	5.5e-10	0.33	0.46	0.74
PGSC0003DMC200041495	K05712	ko00360	Phenylalanine metabolism	254	6.5e-08	0.31	0.45	0.74
PGSC0003DMC200041497	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.87
PGSC0003DMC200041498	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.88
PGSC0003DMC200041508	K00104	ko00630	Glyoxylate and dicarboxylate metabolism	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMC200041508	K00104	ko01100	Metabolic pathways	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMC200041520	K04077	ko03018	RNA degradation	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMC200041520	K04077	ko04940	Type I diabetes mellitus	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMC200031502	K10712	ko00430	Taurine and hypotaurine metabolism	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMC200031502	K10712	ko01100	Metabolic pathways	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMC200031504	K10573	ko04120	Ubiquitin mediated proteolysis	1318	7.4e-67	0.97	0.99	0.99
PGSC0003DMC200031505	K05645	ko02010	ABC transporters	986	1.4e-47	0.38	0.57	0.96
PGSC0003DMC200031511	K05645	ko02010	ABC transporters	980	3.1e-47	0.38	0.58	0.96
PGSC0003DMC200031513	K01785	ko00010	Glycolysis / Gluconeogenesis	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMC200031513	K01785	ko01110	Biosynthesis of secondary metabolites	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMC200031528	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMC200001298	K01895	ko00010	Glycolysis / Gluconeogenesis	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001298	K01895	ko00620	Pyruvate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001298	K01895	ko00640	Propanoate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001298	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001298	K01895	ko01100	Metabolic pathways	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001298	K01895	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMC200001299	K01895	ko00010	Glycolysis / Gluconeogenesis	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001299	K01895	ko00620	Pyruvate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001299	K01895	ko00640	Propanoate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001299	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001299	K01895	ko01100	Metabolic pathways	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001299	K01895	ko01110	Biosynthesis of secondary metabolites	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMC200001300	K01895	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001300	K01895	ko00620	Pyruvate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001300	K01895	ko00640	Propanoate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001300	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001300	K01895	ko01100	Metabolic pathways	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001300	K01895	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMC200001306	K04459	ko04010	MAPK signaling pathway	1564	2.0e-80	0.73	0.86	0.94
PGSC0003DMC200001307	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMC200001308	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMC200001313	K00799	ko00480	Glutathione metabolism	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMC200001313	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMC200001313	K00799	ko00982	Drug metabolism - cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMC200001314	K00799	ko00480	Glutathione metabolism	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMC200001314	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMC200001314	K00799	ko00982	Drug metabolism - cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMC200001315	K01179	ko00500	Starch and sucrose metabolism	1757	4.5e-91	0.48	0.63	0.96
PGSC0003DMC200001319	K00895	ko00051	Fructose and mannose metabolism	3818	9.5e-205	0.81	0.89	1.00
PGSC0003DMC200028057	K05280	ko00941	Flavonoid biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMC200028057	K05280	ko00944	Flavone and flavonol biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMC200028057	K05280	ko01100	Metabolic pathways	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMC200028057	K05280	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMC200028058	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMC200028058	K00517	ko00626	Naphthalene and anthracene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMC200028058	K00517	ko00903	Limonene and pinene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMC200028058	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMC200028058	K00517	ko01110	Biosynthesis of secondary metabolites	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMC200028068	K12356	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.45	0.95
PGSC0003DMC200017314	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMC200017314	K00517	ko00626	Naphthalene and anthracene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMC200017314	K00517	ko00903	Limonene and pinene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMC200017314	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMC200017314	K00517	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMC200017315	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMC200017315	K00517	ko00626	Naphthalene and anthracene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMC200017315	K00517	ko00903	Limonene and pinene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMC200017315	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMC200017315	K00517	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMC200017316	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMC200017316	K00517	ko00626	Naphthalene and anthracene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMC200017316	K00517	ko00903	Limonene and pinene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMC200017316	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMC200017316	K00517	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMC200017317	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMC200017317	K00517	ko00626	Naphthalene and anthracene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMC200017317	K00517	ko00903	Limonene and pinene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMC200017317	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMC200017317	K00517	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMC200017336	K09755	ko00940	Phenylpropanoid biosynthesis	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMC200017336	K09755	ko01100	Metabolic pathways	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMC200017336	K09755	ko01110	Biosynthesis of secondary metabolites	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMC200017337	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMC200017337	K00517	ko00626	Naphthalene and anthracene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMC200017337	K00517	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMC200017337	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMC200017337	K00517	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMC200017339	K09755	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMC200017339	K09755	ko01100	Metabolic pathways	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMC200017339	K09755	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMC200017340	K02997	ko03010	Ribosome	1593	5.0e-82	0.94	0.99	0.99
PGSC0003DMC200004853	K08232	ko00053	Ascorbate and aldarate metabolism	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMC200004853	K08232	ko01100	Metabolic pathways	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMC200004854	K08232	ko00053	Ascorbate and aldarate metabolism	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMC200004854	K08232	ko01100	Metabolic pathways	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMC200004858	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMC200022330	K04424	ko04010	MAPK signaling pathway	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMC200022330	K04424	ko04530	Tight junction	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMC200014671	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMC200014671	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMC200014672	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMC200014672	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMC200014673	K03842	ko00510	N-Glycan biosynthesis	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMC200014673	K03842	ko01100	Metabolic pathways	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMC200014680	K00059	ko00061	Fatty acid biosynthesis	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMC200014680	K00059	ko01040	Biosynthesis of unsaturated fatty acids	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMC200014680	K00059	ko01100	Metabolic pathways	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMC200014681	K00059	ko00061	Fatty acid biosynthesis	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMC200014681	K00059	ko01040	Biosynthesis of unsaturated fatty acids	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMC200014681	K00059	ko01100	Metabolic pathways	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMC200014682	K00059	ko00061	Fatty acid biosynthesis	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMC200014682	K00059	ko01040	Biosynthesis of unsaturated fatty acids	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMC200014682	K00059	ko01100	Metabolic pathways	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMC200014683	K02896	ko03010	Ribosome	312	2.3e-11	0.78	0.88	0.59
PGSC0003DMC200014684	K02896	ko03010	Ribosome	361	4.5e-14	0.82	0.89	0.98
PGSC0003DMC200014685	K02896	ko03010	Ribosome	1239	1.7e-62	0.90	0.93	0.80
PGSC0003DMC200014686	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMC200014687	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMC200014691	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.34	0.55	0.72
PGSC0003DMC200014692	K01199	ko00500	Starch and sucrose metabolism	618	3.0e-28	0.34	0.55	0.92
PGSC0003DMC200014693	K00889	ko00562	Inositol phosphate metabolism	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014693	K00889	ko01100	Metabolic pathways	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014693	K00889	ko04070	Phosphatidylinositol signaling system	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014693	K00889	ko04144	Endocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014693	K00889	ko04666	Fc gamma R-mediated phagocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014693	K00889	ko04810	Regulation of actin cytoskeleton	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMC200014695	K12625	ko03018	RNA degradation	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMC200014695	K12625	ko03040	Spliceosome	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMC200014698	K04683	ko04110	Cell cycle	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMC200014698	K04683	ko04350	TGF-beta signaling pathway	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMC200014699	K04683	ko04110	Cell cycle	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMC200014699	K04683	ko04350	TGF-beta signaling pathway	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMC200014700	K13034	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMC200014700	K13034	ko00450	Selenoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMC200014700	K13034	ko00460	Cyanoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMC200014700	K13034	ko00920	Sulfur metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMC200014700	K13034	ko01100	Metabolic pathways	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMC200046119	K00791	ko00908	Zeatin biosynthesis	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMC200046119	K00791	ko01100	Metabolic pathways	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMC200046119	K00791	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMC200046120	K00791	ko00908	Zeatin biosynthesis	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMC200046120	K00791	ko01100	Metabolic pathways	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMC200046120	K00791	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMC200046121	K00791	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMC200046121	K00791	ko01100	Metabolic pathways	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMC200046121	K00791	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMC200046122	K00791	ko00908	Zeatin biosynthesis	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMC200046122	K00791	ko01100	Metabolic pathways	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMC200046122	K00791	ko01110	Biosynthesis of secondary metabolites	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMC200046126	K12873	ko03040	Spliceosome	1148	1.8e-57	0.86	0.92	0.99
PGSC0003DMC200059263	K12796	ko04621	NOD-like receptor signaling pathway	326	9.8e-09	0.32	0.49	0.32
PGSC0003DMC200059270	K10760	ko00908	Zeatin biosynthesis	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMC200059270	K10760	ko01100	Metabolic pathways	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMC200059270	K10760	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMC200033631	K01968	ko00280	Valine, leucine and isoleucine degradation	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMC200033631	K01968	ko01100	Metabolic pathways	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMC200033632	K01968	ko00280	Valine, leucine and isoleucine degradation	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMC200033632	K01968	ko01100	Metabolic pathways	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMC200033641	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMC200033643	K12817	ko03040	Spliceosome	2608	5.2e-138	0.77	0.87	1.00
PGSC0003DMC200033655	K02291	ko00906	Carotenoid biosynthesis	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMC200033655	K02291	ko01100	Metabolic pathways	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMC200033655	K02291	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMC200051121	K01184	ko00040	Pentose and glucuronate interconversions	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMC200051121	K01184	ko00500	Starch and sucrose metabolism	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMC200051121	K01184	ko01100	Metabolic pathways	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMC200051122	K01184	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMC200051122	K01184	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMC200051122	K01184	ko01100	Metabolic pathways	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMC200051123	K01184	ko00040	Pentose and glucuronate interconversions	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMC200051123	K01184	ko00500	Starch and sucrose metabolism	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMC200051123	K01184	ko01100	Metabolic pathways	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMC200051126	K01099	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMC200051126	K01099	ko01100	Metabolic pathways	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMC200051126	K01099	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMC200051127	K01099	ko00562	Inositol phosphate metabolism	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMC200051127	K01099	ko01100	Metabolic pathways	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMC200051127	K01099	ko04070	Phosphatidylinositol signaling system	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMC200051128	K12195	ko04144	Endocytosis	1518	6.8e-78	0.82	0.91	1.00
PGSC0003DMC200051129	K01239	ko00230	Purine metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMC200051129	K01239	ko00760	Nicotinate and nicotinamide metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMC200051129	K01239	ko01100	Metabolic pathways	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMC200051130	K01239	ko00230	Purine metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMC200051130	K01239	ko00760	Nicotinate and nicotinamide metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMC200051130	K01239	ko01100	Metabolic pathways	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMC200051131	K01239	ko00230	Purine metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMC200051131	K01239	ko00760	Nicotinate and nicotinamide metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMC200051131	K01239	ko01100	Metabolic pathways	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMC200051141	K01516	ko00230	Purine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMC200051141	K01516	ko00730	Thiamine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMC200051141	K01516	ko01100	Metabolic pathways	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMC200051142	K01516	ko00230	Purine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMC200051142	K01516	ko00730	Thiamine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMC200051142	K01516	ko01100	Metabolic pathways	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMC200051144	K12135	ko04712	Circadian rhythm - plant	588	1.3e-26	0.35	0.55	0.95
PGSC0003DMC200051145	K12135	ko04712	Circadian rhythm - plant	584	2.2e-26	0.40	0.60	0.54
PGSC0003DMC200051150	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMC200051150	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMC200051150	K00734	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMC200029252	K00695	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMC200029252	K00695	ko01100	Metabolic pathways	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMC200029253	K00695	ko00500	Starch and sucrose metabolism	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMC200029253	K00695	ko01100	Metabolic pathways	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMC200029254	K02876	ko03010	Ribosome	592	8.1e-27	0.41	0.55	0.78
PGSC0003DMC200029261	K09658	ko00510	N-Glycan biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMC200029261	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMC200029261	K09658	ko01100	Metabolic pathways	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMC200029277	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMC200029277	K08081	ko01100	Metabolic pathways	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMC200029277	K08081	ko01110	Biosynthesis of secondary metabolites	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMC200029278	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMC200029278	K08081	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMC200029278	K08081	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMC200029280	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMC200029280	K08081	ko01100	Metabolic pathways	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMC200029280	K08081	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMC200016111	K00889	ko00562	Inositol phosphate metabolism	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016111	K00889	ko01100	Metabolic pathways	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016111	K00889	ko04070	Phosphatidylinositol signaling system	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016111	K00889	ko04144	Endocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016111	K00889	ko04666	Fc gamma R-mediated phagocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016111	K00889	ko04810	Regulation of actin cytoskeleton	9580	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko00562	Inositol phosphate metabolism	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko01100	Metabolic pathways	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko04070	Phosphatidylinositol signaling system	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko04144	Endocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko04666	Fc gamma R-mediated phagocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016112	K00889	ko04810	Regulation of actin cytoskeleton	9591	0.	0.65	0.76	1.00
PGSC0003DMC200016113	K00889	ko00562	Inositol phosphate metabolism	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016113	K00889	ko01100	Metabolic pathways	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016113	K00889	ko04070	Phosphatidylinositol signaling system	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016113	K00889	ko04144	Endocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016113	K00889	ko04666	Fc gamma R-mediated phagocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016113	K00889	ko04810	Regulation of actin cytoskeleton	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMC200016121	K04554	ko04120	Ubiquitin mediated proteolysis	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMC200016121	K04554	ko05012	Parkinson's disease	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMC200016122	K04554	ko04120	Ubiquitin mediated proteolysis	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMC200016122	K04554	ko05012	Parkinson's disease	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMC200016123	K04554	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMC200016123	K04554	ko05012	Parkinson's disease	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMC200016124	K04554	ko04120	Ubiquitin mediated proteolysis	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMC200016124	K04554	ko05012	Parkinson's disease	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMC200016132	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.98	1.00
PGSC0003DMC200016133	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.64
PGSC0003DMC200016139	K02293	ko00906	Carotenoid biosynthesis	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMC200016139	K02293	ko01100	Metabolic pathways	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMC200016139	K02293	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMC200016140	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200016140	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200016140	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200021125	K02084	ko04115	p53 signaling pathway	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko04210	Apoptosis	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko05010	Alzheimer's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko05012	Parkinson's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko05016	Huntington's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021125	K02084	ko05222	Small cell lung cancer	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMC200021128	K00475	ko00941	Flavonoid biosynthesis	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMC200021128	K00475	ko01100	Metabolic pathways	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMC200021128	K00475	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMC200021129	K05277	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMC200021129	K05277	ko01100	Metabolic pathways	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMC200021129	K05277	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMC200021130	K05278	ko00941	Flavonoid biosynthesis	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMC200021130	K05278	ko01100	Metabolic pathways	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMC200021130	K05278	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMC200021131	K05278	ko00941	Flavonoid biosynthesis	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMC200021131	K05278	ko01100	Metabolic pathways	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMC200021131	K05278	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMC200021142	K12356	ko00940	Phenylpropanoid biosynthesis	721	6.2e-34	0.34	0.51	0.83
PGSC0003DMC200021144	K05857	ko00562	Inositol phosphate metabolism	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMC200021144	K05857	ko01100	Metabolic pathways	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMC200021144	K05857	ko04020	Calcium signaling pathway	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMC200021144	K05857	ko04070	Phosphatidylinositol signaling system	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMC200021145	K05857	ko00562	Inositol phosphate metabolism	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMC200021145	K05857	ko01100	Metabolic pathways	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMC200021145	K05857	ko04020	Calcium signaling pathway	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMC200021145	K05857	ko04070	Phosphatidylinositol signaling system	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMC200021146	K05857	ko00562	Inositol phosphate metabolism	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMC200021146	K05857	ko01100	Metabolic pathways	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMC200021146	K05857	ko04020	Calcium signaling pathway	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMC200021146	K05857	ko04070	Phosphatidylinositol signaling system	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMC200021149	K01190	ko00052	Galactose metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMC200021149	K01190	ko00511	Other glycan degradation	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMC200021149	K01190	ko00600	Sphingolipid metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMC200021149	K01190	ko01100	Metabolic pathways	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMC200003649	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00270	Cysteine and methionine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00350	Tyrosine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00360	Phenylalanine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00401	Novobiocin biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko01100	Metabolic pathways	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003649	K00815	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMC200003654	K01610	ko00010	Glycolysis / Gluconeogenesis	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003654	K01610	ko00020	Citrate cycle (TCA cycle)	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003654	K01610	ko00620	Pyruvate metabolism	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003654	K01610	ko00710	Carbon fixation in photosynthetic organisms	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003654	K01610	ko01100	Metabolic pathways	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003654	K01610	ko01110	Biosynthesis of secondary metabolites	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMC200003655	K01610	ko00010	Glycolysis / Gluconeogenesis	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200003655	K01610	ko00020	Citrate cycle (TCA cycle)	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200003655	K01610	ko00620	Pyruvate metabolism	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200003655	K01610	ko00710	Carbon fixation in photosynthetic organisms	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200003655	K01610	ko01100	Metabolic pathways	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200003655	K01610	ko01110	Biosynthesis of secondary metabolites	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMC200047313	K00754	ko00051	Fructose and mannose metabolism	1841	1.0e-95	0.49	0.70	0.83
PGSC0003DMC200047314	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMC200047315	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMC200047316	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMC200047320	K00914	ko00562	Inositol phosphate metabolism	6073	0.	0.86	0.92	1.00
PGSC0003DMC200047320	K00914	ko01100	Metabolic pathways	6073	0.	0.86	0.92	1.00
PGSC0003DMC200047320	K00914	ko04070	Phosphatidylinositol signaling system	6073	0.	0.86	0.92	1.00
PGSC0003DMC200047320	K00914	ko04140	Regulation of autophagy	6073	0.	0.86	0.92	1.00
PGSC0003DMC200047320	K00914	ko04145	Phagosome	6073	0.	0.86	0.92	1.00
PGSC0003DMC200047321	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047321	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047321	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047321	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047321	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047322	K00914	ko00562	Inositol phosphate metabolism	6138	0.	0.89	0.94	1.00
PGSC0003DMC200047322	K00914	ko01100	Metabolic pathways	6138	0.	0.89	0.94	1.00
PGSC0003DMC200047322	K00914	ko04070	Phosphatidylinositol signaling system	6138	0.	0.89	0.94	1.00
PGSC0003DMC200047322	K00914	ko04140	Regulation of autophagy	6138	0.	0.89	0.94	1.00
PGSC0003DMC200047322	K00914	ko04145	Phagosome	6138	0.	0.89	0.94	1.00
PGSC0003DMC200047323	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047323	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047323	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047323	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047323	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMC200047327	K04733	ko04210	Apoptosis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMC200047327	K04733	ko04620	Toll-like receptor signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMC200047327	K04733	ko04722	Neurotrophin signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMC200047327	K04733	ko05140	Leishmaniasis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMC200047327	K04733	ko05142	Chagas disease	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMC200047330	K03405	ko00860	Porphyrin and chlorophyll metabolism	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMC200047330	K03405	ko01100	Metabolic pathways	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMC200047330	K03405	ko01110	Biosynthesis of secondary metabolites	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMC200047331	K03405	ko00860	Porphyrin and chlorophyll metabolism	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMC200047331	K03405	ko01100	Metabolic pathways	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMC200047331	K03405	ko01110	Biosynthesis of secondary metabolites	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMC200047338	K01184	ko00040	Pentose and glucuronate interconversions	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMC200047338	K01184	ko00500	Starch and sucrose metabolism	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMC200047338	K01184	ko01100	Metabolic pathways	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMC200047339	K01184	ko00040	Pentose and glucuronate interconversions	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMC200047339	K01184	ko00500	Starch and sucrose metabolism	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMC200047339	K01184	ko01100	Metabolic pathways	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMC200047340	K01188	ko00460	Cyanoamino acid metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMC200047340	K01188	ko00500	Starch and sucrose metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMC200047340	K01188	ko00940	Phenylpropanoid biosynthesis	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMC200047340	K01188	ko01110	Biosynthesis of secondary metabolites	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMC200058078	K01307	ko00790	Folate biosynthesis	1800	1.9e-93	0.63	0.78	0.98
PGSC0003DMC200052322	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.97
PGSC0003DMC200052323	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.93
PGSC0003DMC200052338	K02960	ko03010	Ribosome	1151	1.2e-57	0.91	0.94	0.99
PGSC0003DMC200052344	K04371	ko04010	MAPK signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04012	ErbB signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04013	MAPK signaling pathway - fly	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04062	Chemokine signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04114	Oocyte meiosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04270	Vascular smooth muscle contraction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04320	Dorso-ventral axis formation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04350	TGF-beta signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04360	Axon guidance	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04370	VEGF signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04520	Adherens junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04540	Gap junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04620	Toll-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04621	NOD-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04650	Natural killer cell mediated cytotoxicity	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04660	T cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04662	B cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04664	Fc epsilon RI signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04666	Fc gamma R-mediated phagocytosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04720	Long-term potentiation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04722	Neurotrophin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04730	Long-term depression	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04810	Regulation of actin cytoskeleton	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04912	GnRH signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04914	Progesterone-mediated oocyte maturation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04916	Melanogenesis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04930	Type II diabetes mellitus	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05010	Alzheimer's disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05020	Prion diseases	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05131	Shigellosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05140	Leishmaniasis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05142	Chagas disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05200	Pathways in cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05210	Colorectal cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05211	Renal cell carcinoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05212	Pancreatic cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05214	Glioma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05216	Thyroid cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05218	Melanoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05219	Bladder cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05220	Chronic myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05221	Acute myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052344	K04371	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMC200052345	K04371	ko04010	MAPK signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04012	ErbB signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04013	MAPK signaling pathway - fly	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04062	Chemokine signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04114	Oocyte meiosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04150	mTOR signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04270	Vascular smooth muscle contraction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04320	Dorso-ventral axis formation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04350	TGF-beta signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04360	Axon guidance	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04370	VEGF signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04510	Focal adhesion	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04520	Adherens junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04540	Gap junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04620	Toll-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04621	NOD-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04650	Natural killer cell mediated cytotoxicity	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04660	T cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04662	B cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04664	Fc epsilon RI signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04666	Fc gamma R-mediated phagocytosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04720	Long-term potentiation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04722	Neurotrophin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04730	Long-term depression	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04810	Regulation of actin cytoskeleton	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04910	Insulin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04912	GnRH signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04914	Progesterone-mediated oocyte maturation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04916	Melanogenesis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04930	Type II diabetes mellitus	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05010	Alzheimer's disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05020	Prion diseases	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05131	Shigellosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05140	Leishmaniasis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05142	Chagas disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05200	Pathways in cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05210	Colorectal cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05211	Renal cell carcinoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05212	Pancreatic cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05213	Endometrial cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05214	Glioma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05215	Prostate cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05216	Thyroid cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05218	Melanoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05219	Bladder cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05220	Chronic myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05221	Acute myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052345	K04371	ko05223	Non-small cell lung cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMC200052346	K10643	ko03018	RNA degradation	1364	2.1e-69	0.39	0.56	0.95
PGSC0003DMC200052347	K10643	ko03018	RNA degradation	1160	3.8e-58	0.38	0.54	0.94
PGSC0003DMC200052348	K10643	ko03018	RNA degradation	2747	1.1e-145	0.46	0.61	0.99
PGSC0003DMC200052349	K10643	ko03018	RNA degradation	4216	1.1e-226	0.53	0.67	1.00
PGSC0003DMC200034839	K03062	ko03050	Proteasome	3588	4.6e-192	0.97	0.98	1.00
PGSC0003DMC200034847	K03024	ko00230	Purine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMC200034847	K03024	ko00240	Pyrimidine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMC200034847	K03024	ko01100	Metabolic pathways	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMC200034847	K03024	ko03020	RNA polymerase	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMC200034847	K03024	ko04623	Cytosolic DNA-sensing pathway	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMC200034848	K03024	ko00230	Purine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMC200034848	K03024	ko00240	Pyrimidine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMC200034848	K03024	ko01100	Metabolic pathways	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMC200034848	K03024	ko03020	RNA polymerase	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMC200034848	K03024	ko04623	Cytosolic DNA-sensing pathway	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMC200034850	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMC200034850	K08081	ko01100	Metabolic pathways	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMC200034850	K08081	ko01110	Biosynthesis of secondary metabolites	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMC200034851	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMC200034851	K08081	ko01100	Metabolic pathways	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMC200034851	K08081	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMC200034852	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034852	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034852	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034853	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034853	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034853	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034854	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMC200034854	K08081	ko01100	Metabolic pathways	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMC200034854	K08081	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMC200034855	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMC200034855	K08081	ko01100	Metabolic pathways	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMC200034855	K08081	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMC200034856	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMC200034856	K08081	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMC200034856	K08081	ko01110	Biosynthesis of secondary metabolites	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMC200034857	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034857	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034857	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMC200034858	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMC200034858	K08081	ko01100	Metabolic pathways	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMC200034858	K08081	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMC200034859	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMC200034859	K08081	ko01100	Metabolic pathways	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMC200034859	K08081	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMC200034860	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMC200034860	K08081	ko01100	Metabolic pathways	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMC200034860	K08081	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMC200044676	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044676	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044676	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044677	K01528	ko04144	Endocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMC200044677	K01528	ko04666	Fc gamma R-mediated phagocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMC200044677	K01528	ko05100	Bacterial invasion of epithelial cells	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMC200044679	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044679	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044679	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMC200044683	K01528	ko04144	Endocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMC200044683	K01528	ko04666	Fc gamma R-mediated phagocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMC200044683	K01528	ko05100	Bacterial invasion of epithelial cells	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMC200044692	K00753	ko00510	N-Glycan biosynthesis	1682	6.2e-87	0.76	0.91	0.99
PGSC0003DMC200044693	K00753	ko00510	N-Glycan biosynthesis	2269	2.6e-119	0.78	0.89	0.97
PGSC0003DMC200044694	K00753	ko00510	N-Glycan biosynthesis	2996	2.1e-159	0.69	0.83	0.99
PGSC0003DMC200044695	K00753	ko00510	N-Glycan biosynthesis	2380	2.0e-125	0.79	0.90	1.00
PGSC0003DMC200024126	K00384	ko00240	Pyrimidine metabolism	2442	7.4e-129	0.79	0.88	0.99
PGSC0003DMC200024128	K12741	ko03040	Spliceosome	318	1.1e-11	0.43	0.60	0.34
PGSC0003DMC200024135	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	412	2.6e-16	0.36	0.51	0.45
PGSC0003DMC200024148	K08139	ko04113	Meiosis - yeast	611	5.5e-53	0.38	0.59	0.60
PGSC0003DMC200011491	K10577	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.92	0.96	0.99
PGSC0003DMC200011498	K13065	ko00940	Phenylpropanoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMC200011498	K13065	ko00941	Flavonoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMC200011498	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMC200011498	K13065	ko01110	Biosynthesis of secondary metabolites	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMC200011502	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	549	3.6e-24	0.35	0.50	0.88
PGSC0003DMC200011503	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	498	3.3e-21	0.34	0.47	0.99
PGSC0003DMC200011504	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMC200011504	K12567	ko05414	Dilated cardiomyopathy	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMC200011505	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMC200011505	K12567	ko05414	Dilated cardiomyopathy	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMC200011506	K02903	ko03010	Ribosome	971	1.0e-47	0.83	0.92	0.99
PGSC0003DMC200011510	K02957	ko03010	Ribosome	835	3.2e-40	0.72	0.90	0.99
PGSC0003DMC200011518	K01178	ko00500	Starch and sucrose metabolism	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMC200011518	K01178	ko01100	Metabolic pathways	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMC200020262	K00208	ko00061	Fatty acid biosynthesis	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMC200020262	K00208	ko01100	Metabolic pathways	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMC200020272	K03021	ko00230	Purine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMC200020272	K03021	ko00240	Pyrimidine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMC200020272	K03021	ko01100	Metabolic pathways	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMC200020272	K03021	ko03020	RNA polymerase	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMC200020272	K03021	ko04623	Cytosolic DNA-sensing pathway	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMC200020273	K03021	ko00230	Purine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMC200020273	K03021	ko00240	Pyrimidine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMC200020273	K03021	ko01100	Metabolic pathways	8032	0.	0.82	0.91	0.98
PGSC0003DMC200020273	K03021	ko03020	RNA polymerase	8032	0.	0.82	0.91	0.98
PGSC0003DMC200020273	K03021	ko04623	Cytosolic DNA-sensing pathway	8032	0.	0.82	0.91	0.98
PGSC0003DMC200020274	K03021	ko00230	Purine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMC200020274	K03021	ko00240	Pyrimidine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMC200020274	K03021	ko01100	Metabolic pathways	7627	0.	0.79	0.89	0.98
PGSC0003DMC200020274	K03021	ko03020	RNA polymerase	7627	0.	0.79	0.89	0.98
PGSC0003DMC200020274	K03021	ko04623	Cytosolic DNA-sensing pathway	7627	0.	0.79	0.89	0.98
PGSC0003DMC200020279	K12603	ko03018	RNA degradation	4537	2.1e-244	0.87	0.94	1.00
PGSC0003DMC200020280	K02889	ko03010	Ribosome	1223	1.3e-61	0.85	0.92	0.99
PGSC0003DMC200065830	K00799	ko00480	Glutathione metabolism	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMC200065830	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMC200065830	K00799	ko00982	Drug metabolism - cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMC200067186	K10591	ko04120	Ubiquitin mediated proteolysis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMC200067186	K10591	ko04144	Endocytosis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMC200067193	K00901	ko00561	Glycerolipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMC200067193	K00901	ko00564	Glycerophospholipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMC200067193	K00901	ko01100	Metabolic pathways	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMC200067193	K00901	ko04070	Phosphatidylinositol signaling system	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMC200067199	K07385	ko00902	Monoterpenoid biosynthesis	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMC200067199	K07385	ko01100	Metabolic pathways	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMC200055323	K00008	ko00051	Fructose and mannose metabolism	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMC200055323	K00008	ko01100	Metabolic pathways	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMC200055324	K00008	ko00051	Fructose and mannose metabolism	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMC200055324	K00008	ko01100	Metabolic pathways	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMC200055325	K00454	ko00591	Linoleic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMC200055325	K00454	ko00592	alpha-Linolenic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMC200055325	K00454	ko01100	Metabolic pathways	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMC200055326	K00454	ko00591	Linoleic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMC200055326	K00454	ko00592	alpha-Linolenic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMC200055326	K00454	ko01100	Metabolic pathways	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMC200055332	K10418	ko04962	Vasopressin-regulated water reabsorption	307	4.3e-11	0.46	0.62	0.66
PGSC0003DMC200030301	K04460	ko04010	MAPK signaling pathway	3733	4.6e-200	0.89	0.95	1.00
PGSC0003DMC200030302	K00754	ko00051	Fructose and mannose metabolism	779	3.9e-37	0.34	0.53	0.72
PGSC0003DMC200030303	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMC200030304	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMC200030305	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMC200030306	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMC200030313	K00948	ko00030	Pentose phosphate pathway	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMC200030313	K00948	ko00230	Purine metabolism	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMC200030313	K00948	ko01100	Metabolic pathways	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMC200030313	K00948	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMC200030316	K10955	ko05110	Vibrio cholerae infection	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMC200030316	K10955	ko05146	Amoebiasis	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMC200030317	K01213	ko00040	Pentose and glucuronate interconversions	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMC200030317	K01213	ko00500	Starch and sucrose metabolism	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMC200030317	K01213	ko01100	Metabolic pathways	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMC200030323	K12639	ko00905	Brassinosteroid biosynthesis	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMC200030323	K12639	ko01100	Metabolic pathways	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMC200030323	K12639	ko01110	Biosynthesis of secondary metabolites	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMC200030330	K01835	ko00010	Glycolysis / Gluconeogenesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00030	Pentose phosphate pathway	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00052	Galactose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00230	Purine metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00500	Starch and sucrose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko00521	Streptomycin biosynthesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko01100	Metabolic pathways	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200030330	K01835	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMC200049051	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMC200049051	K08081	ko01100	Metabolic pathways	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMC200049051	K08081	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMC200049052	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMC200049052	K08081	ko01100	Metabolic pathways	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMC200049052	K08081	ko01110	Biosynthesis of secondary metabolites	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMC200049053	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMC200049053	K08081	ko01100	Metabolic pathways	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMC200049053	K08081	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMC200049054	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMC200049054	K08081	ko01100	Metabolic pathways	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMC200049054	K08081	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMC200049059	K09835	ko00906	Carotenoid biosynthesis	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMC200049059	K09835	ko01100	Metabolic pathways	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMC200049059	K09835	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMC200049060	K09835	ko00906	Carotenoid biosynthesis	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMC200049060	K09835	ko01100	Metabolic pathways	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMC200049060	K09835	ko01110	Biosynthesis of secondary metabolites	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMC200049061	K09835	ko00906	Carotenoid biosynthesis	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMC200049061	K09835	ko01100	Metabolic pathways	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMC200049061	K09835	ko01110	Biosynthesis of secondary metabolites	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMC200049062	K09835	ko00906	Carotenoid biosynthesis	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMC200049062	K09835	ko01100	Metabolic pathways	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMC200049062	K09835	ko01110	Biosynthesis of secondary metabolites	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMC200049070	K03504	ko00230	Purine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko00240	Pyrimidine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko01100	Metabolic pathways	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko03030	DNA replication	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko03410	Base excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko03420	Nucleotide excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko03430	Mismatch repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049070	K03504	ko03440	Homologous recombination	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMC200049076	K09480	ko00561	Glycerolipid metabolism	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMC200049076	K09480	ko01100	Metabolic pathways	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMC200049079	K09480	ko00561	Glycerolipid metabolism	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMC200049079	K09480	ko01100	Metabolic pathways	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMC200049080	K09480	ko00561	Glycerolipid metabolism	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMC200049080	K09480	ko01100	Metabolic pathways	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMC200041018	K04506	ko04115	p53 signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMC200041018	K04506	ko04120	Ubiquitin mediated proteolysis	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMC200041018	K04506	ko04310	Wnt signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMC200041019	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041019	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041019	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041020	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041020	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041020	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041021	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041021	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041021	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041022	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041022	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041022	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMC200041023	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041023	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041023	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMC200041024	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMC200041025	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMC200041026	K03652	ko03410	Base excision repair	1514	1.1e-77	0.69	0.77	0.99
PGSC0003DMC200041028	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041028	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041029	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMC200041036	K04124	ko00904	Diterpenoid biosynthesis	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMC200041036	K04124	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMC200041037	K13082	ko00941	Flavonoid biosynthesis	839	1.9e-40	0.38	0.57	0.98
PGSC0003DMC200041038	K02999	ko00230	Purine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMC200041038	K02999	ko00240	Pyrimidine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMC200041038	K02999	ko01100	Metabolic pathways	8494	0.	0.62	0.77	1.00
PGSC0003DMC200041038	K02999	ko03020	RNA polymerase	8494	0.	0.62	0.77	1.00
PGSC0003DMC200034622	K12599	ko03018	RNA degradation	4266	1.9e-229	0.68	0.78	0.98
PGSC0003DMC200034623	K12599	ko03018	RNA degradation	3887	1.5e-208	0.68	0.79	0.97
PGSC0003DMC200034624	K12599	ko03018	RNA degradation	4529	5.8e-244	0.70	0.80	0.99
PGSC0003DMC200034625	K12599	ko03018	RNA degradation	4112	5.8e-221	0.69	0.79	0.99
PGSC0003DMC200034626	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMC200034626	K01657	ko01100	Metabolic pathways	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMC200034626	K01657	ko01110	Biosynthesis of secondary metabolites	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMC200034631	K04733	ko04210	Apoptosis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMC200034631	K04733	ko04620	Toll-like receptor signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMC200034631	K04733	ko04722	Neurotrophin signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMC200034631	K04733	ko05140	Leishmaniasis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMC200034631	K04733	ko05142	Chagas disease	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMC200034632	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMC200034632	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMC200034632	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMC200053131	K04733	ko04210	Apoptosis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMC200053131	K04733	ko04620	Toll-like receptor signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMC200053131	K04733	ko04722	Neurotrophin signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMC200053131	K04733	ko05140	Leishmaniasis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMC200053131	K04733	ko05142	Chagas disease	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMC200053132	K04733	ko04210	Apoptosis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMC200053132	K04733	ko04620	Toll-like receptor signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMC200053132	K04733	ko04722	Neurotrophin signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMC200053132	K04733	ko05140	Leishmaniasis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMC200053132	K04733	ko05142	Chagas disease	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMC200053134	K04733	ko04210	Apoptosis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMC200053134	K04733	ko04620	Toll-like receptor signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMC200053134	K04733	ko04722	Neurotrophin signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMC200053134	K04733	ko05140	Leishmaniasis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMC200053134	K04733	ko05142	Chagas disease	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMC200053136	K04733	ko04210	Apoptosis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMC200053136	K04733	ko04620	Toll-like receptor signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMC200053136	K04733	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMC200053136	K04733	ko05140	Leishmaniasis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMC200053136	K04733	ko05142	Chagas disease	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMC200053138	K04733	ko04210	Apoptosis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMC200053138	K04733	ko04620	Toll-like receptor signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMC200053138	K04733	ko04722	Neurotrophin signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMC200053138	K04733	ko05140	Leishmaniasis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMC200053138	K04733	ko05142	Chagas disease	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMC200053139	K04733	ko04210	Apoptosis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMC200053139	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMC200053139	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMC200053139	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMC200053139	K04733	ko05142	Chagas disease	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMC200053140	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMC200053140	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMC200053140	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMC200053140	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMC200053140	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMC200053141	K04733	ko04210	Apoptosis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMC200053141	K04733	ko04620	Toll-like receptor signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMC200053141	K04733	ko04722	Neurotrophin signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMC200053141	K04733	ko05140	Leishmaniasis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMC200053141	K04733	ko05142	Chagas disease	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMC200053142	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMC200053142	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMC200053142	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMC200053142	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMC200053142	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMC200053143	K04733	ko04210	Apoptosis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMC200053143	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMC200053143	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMC200053143	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMC200053143	K04733	ko05142	Chagas disease	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMC200053144	K04733	ko04210	Apoptosis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMC200053144	K04733	ko04620	Toll-like receptor signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMC200053144	K04733	ko04722	Neurotrophin signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMC200053144	K04733	ko05140	Leishmaniasis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMC200053144	K04733	ko05142	Chagas disease	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMC200053145	K04733	ko04210	Apoptosis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMC200053145	K04733	ko04620	Toll-like receptor signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMC200053145	K04733	ko04722	Neurotrophin signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMC200053145	K04733	ko05140	Leishmaniasis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMC200053145	K04733	ko05142	Chagas disease	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMC200053146	K04733	ko04210	Apoptosis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMC200053146	K04733	ko04620	Toll-like receptor signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMC200053146	K04733	ko04722	Neurotrophin signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMC200053146	K04733	ko05140	Leishmaniasis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMC200053146	K04733	ko05142	Chagas disease	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMC200053149	K04733	ko04210	Apoptosis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMC200053149	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMC200053149	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMC200053149	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMC200053149	K04733	ko05142	Chagas disease	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMC200053151	K04733	ko04210	Apoptosis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMC200053151	K04733	ko04620	Toll-like receptor signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMC200053151	K04733	ko04722	Neurotrophin signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMC200053151	K04733	ko05140	Leishmaniasis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMC200053151	K04733	ko05142	Chagas disease	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMC200053153	K04733	ko04210	Apoptosis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMC200053153	K04733	ko04620	Toll-like receptor signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMC200053153	K04733	ko04722	Neurotrophin signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMC200053153	K04733	ko05140	Leishmaniasis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMC200053153	K04733	ko05142	Chagas disease	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMC200053154	K02910	ko03010	Ribosome	717	1.0e-33	0.92	0.97	0.92
PGSC0003DMC200053155	K02910	ko03010	Ribosome	940	5.2e-46	0.93	0.97	0.99
PGSC0003DMC200038371	K01692	ko00071	Fatty acid metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00280	Valine, leucine and isoleucine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00281	Geraniol degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00310	Lysine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00380	Tryptophan metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00410	beta-Alanine metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00632	Benzoate degradation via CoA ligation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00640	Propanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00650	Butanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00903	Limonene and pinene degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko00930	Caprolactam degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko01100	Metabolic pathways	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038371	K01692	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMC200038372	K01692	ko00071	Fatty acid metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00280	Valine, leucine and isoleucine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00281	Geraniol degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00310	Lysine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00380	Tryptophan metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00410	beta-Alanine metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00632	Benzoate degradation via CoA ligation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00640	Propanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00650	Butanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00903	Limonene and pinene degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko00930	Caprolactam degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko01100	Metabolic pathways	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038372	K01692	ko01110	Biosynthesis of secondary metabolites	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMC200038387	K00640	ko00270	Cysteine and methionine metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMC200038387	K00640	ko00920	Sulfur metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMC200038387	K00640	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMC200038391	K05665	ko02010	ABC transporters	3210	3.3e-171	0.38	0.58	0.95
PGSC0003DMC200000965	K01673	ko00910	Nitrogen metabolism	1970	8.0e-103	0.74	0.84	1.00
PGSC0003DMC200000968	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMC200000968	K00122	ko00680	Methane metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMC200000968	K00122	ko01100	Metabolic pathways	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMC200000975	K04733	ko04210	Apoptosis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMC200000975	K04733	ko04620	Toll-like receptor signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMC200000975	K04733	ko04722	Neurotrophin signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMC200000975	K04733	ko05140	Leishmaniasis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMC200000975	K04733	ko05142	Chagas disease	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMC200069097	K12831	ko03040	Spliceosome	370	3.5e-28	0.66	0.83	0.82
PGSC0003DMC200069108	K01051	ko00040	Pentose and glucuronate interconversions	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMC200069108	K01051	ko00500	Starch and sucrose metabolism	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMC200069108	K01051	ko01100	Metabolic pathways	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMC200069111	K11644	ko05016	Huntington's disease	777	1.4e-36	0.44	0.58	0.56
PGSC0003DMC200009814	K03965	ko00190	Oxidative phosphorylation	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMC200009814	K03965	ko01100	Metabolic pathways	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMC200009814	K03965	ko05010	Alzheimer's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMC200009814	K03965	ko05012	Parkinson's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMC200009814	K03965	ko05016	Huntington's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMC200009815	K03965	ko00190	Oxidative phosphorylation	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMC200009815	K03965	ko01100	Metabolic pathways	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMC200009815	K03965	ko05010	Alzheimer's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMC200009815	K03965	ko05012	Parkinson's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMC200009815	K03965	ko05016	Huntington's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMC200009819	K04079	ko04612	Antigen processing and presentation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009819	K04079	ko04621	NOD-like receptor signaling pathway	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009819	K04079	ko04626	Plant-pathogen interaction	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009819	K04079	ko04914	Progesterone-mediated oocyte maturation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009819	K04079	ko05200	Pathways in cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009819	K04079	ko05215	Prostate cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMC200009820	K04079	ko04612	Antigen processing and presentation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009820	K04079	ko04621	NOD-like receptor signaling pathway	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009820	K04079	ko04626	Plant-pathogen interaction	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009820	K04079	ko04914	Progesterone-mediated oocyte maturation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009820	K04079	ko05200	Pathways in cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009820	K04079	ko05215	Prostate cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMC200009833	K05280	ko00941	Flavonoid biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMC200009833	K05280	ko00944	Flavone and flavonol biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMC200009833	K05280	ko01100	Metabolic pathways	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMC200009833	K05280	ko01110	Biosynthesis of secondary metabolites	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMC200009834	K09754	ko00360	Phenylalanine metabolism	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009834	K09754	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009834	K09754	ko00941	Flavonoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009834	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009834	K09754	ko01100	Metabolic pathways	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009834	K09754	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMC200009835	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMC200009835	K00517	ko00626	Naphthalene and anthracene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMC200009835	K00517	ko00903	Limonene and pinene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMC200009835	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMC200009835	K00517	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMC200028214	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMC200028216	K10352	ko04530	Tight junction	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMC200028216	K10352	ko05416	Viral myocarditis	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMC200028223	K00599	ko00340	Histidine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMC200028223	K00599	ko00350	Tyrosine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMC200028223	K00599	ko00450	Selenoamino acid metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMC200028223	K00599	ko00626	Naphthalene and anthracene degradation	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMC200028224	K00599	ko00340	Histidine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMC200028224	K00599	ko00350	Tyrosine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMC200028224	K00599	ko00450	Selenoamino acid metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMC200028224	K00599	ko00626	Naphthalene and anthracene degradation	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMC200028225	K00599	ko00340	Histidine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMC200028225	K00599	ko00350	Tyrosine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMC200028225	K00599	ko00450	Selenoamino acid metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMC200028225	K00599	ko00626	Naphthalene and anthracene degradation	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMC200003421	K12126	ko04712	Circadian rhythm - plant	342	7.2e-12	0.26	0.43	0.76
PGSC0003DMC200003422	K12126	ko04712	Circadian rhythm - plant	251	2.2e-07	0.33	0.50	0.49
PGSC0003DMC200003426	K03469	ko03030	DNA replication	370	1.4e-14	0.43	0.63	0.34
PGSC0003DMC200003429	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.48	0.97
PGSC0003DMC200003430	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.49	0.79
PGSC0003DMC200003438	K00161	ko00010	Glycolysis / Gluconeogenesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko00020	Citrate cycle (TCA cycle)	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko00620	Pyruvate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko00650	Butanoate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko01100	Metabolic pathways	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003438	K00161	ko01110	Biosynthesis of secondary metabolites	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMC200003440	K04382	ko04111	Cell cycle - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04113	Meiosis - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04114	Oocyte meiosis	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04310	Wnt signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04350	TGF-beta signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04530	Tight junction	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko04730	Long-term depression	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003440	K04382	ko05142	Chagas disease	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMC200003441	K04382	ko04111	Cell cycle - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04113	Meiosis - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04114	Oocyte meiosis	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04310	Wnt signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04350	TGF-beta signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04530	Tight junction	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko04730	Long-term depression	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003441	K04382	ko05142	Chagas disease	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMC200003442	K12126	ko04712	Circadian rhythm - plant	298	2.0e-10	0.34	0.54	0.80
PGSC0003DMC200003444	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003444	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003444	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003444	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003445	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003445	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003445	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003445	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003446	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003446	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003446	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003446	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMC200003447	K00558	ko00270	Cysteine and methionine metabolism	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMC200003447	K00558	ko01100	Metabolic pathways	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMC200003448	K00558	ko00270	Cysteine and methionine metabolism	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMC200003448	K00558	ko01100	Metabolic pathways	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMC200003449	K00558	ko00270	Cysteine and methionine metabolism	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMC200003449	K00558	ko01100	Metabolic pathways	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMC200021935	K12893	ko03040	Spliceosome	305	1.3e-10	0.33	0.47	0.40
PGSC0003DMC200021936	K12893	ko03040	Spliceosome	305	1.2e-10	0.33	0.47	0.41
PGSC0003DMC200021946	K00074	ko00632	Benzoate degradation via CoA ligation	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMC200021946	K00074	ko00650	Butanoate metabolism	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMC200021949	K09880	ko00270	Cysteine and methionine metabolism	3448	2.4e-184	0.78	0.88	1.00
PGSC0003DMC200021951	K09880	ko00270	Cysteine and methionine metabolism	226	1.7e-10	0.78	0.90	0.43
PGSC0003DMC200021953	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021953	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021953	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021954	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021954	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021954	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMC200021955	K02435	ko00970	Aminoacyl-tRNA biosynthesis	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMC200021955	K02435	ko01100	Metabolic pathways	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMC200021959	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMC200021959	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMC200021960	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMC200021960	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMC200056133	K05673	ko02010	ABC transporters	1594	4.4e-82	0.32	0.50	0.80
PGSC0003DMC200056134	K05673	ko02010	ABC transporters	1655	1.9e-85	0.32	0.50	0.81
PGSC0003DMC200056135	K05666	ko02010	ABC transporters	2909	1.3e-154	0.34	0.55	0.92
PGSC0003DMC200056136	K00059	ko00061	Fatty acid biosynthesis	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMC200056136	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMC200056136	K00059	ko01100	Metabolic pathways	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMC200056137	K00059	ko00061	Fatty acid biosynthesis	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMC200056137	K00059	ko01040	Biosynthesis of unsaturated fatty acids	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMC200056137	K00059	ko01100	Metabolic pathways	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMC200056145	K01190	ko00052	Galactose metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMC200056145	K01190	ko00511	Other glycan degradation	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMC200056145	K01190	ko00600	Sphingolipid metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMC200056145	K01190	ko01100	Metabolic pathways	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMC200056146	K01190	ko00052	Galactose metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMC200056146	K01190	ko00511	Other glycan degradation	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMC200056146	K01190	ko00600	Sphingolipid metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMC200056146	K01190	ko01100	Metabolic pathways	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMC200056147	K01190	ko00052	Galactose metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMC200056147	K01190	ko00511	Other glycan degradation	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMC200056147	K01190	ko00600	Sphingolipid metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMC200056147	K01190	ko01100	Metabolic pathways	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMC200056149	K00558	ko00270	Cysteine and methionine metabolism	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMC200056149	K00558	ko01100	Metabolic pathways	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMC200056150	K06130	ko00564	Glycerophospholipid metabolism	213	6.5e-06	0.38	0.49	0.75
PGSC0003DMC200056151	K06130	ko00564	Glycerophospholipid metabolism	551	1.5e-24	0.37	0.55	0.85
PGSC0003DMC200048001	K01599	ko00860	Porphyrin and chlorophyll metabolism	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMC200048001	K01599	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMC200048006	K03283	ko03040	Spliceosome	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMC200048006	K03283	ko04010	MAPK signaling pathway	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMC200048006	K03283	ko04144	Endocytosis	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMC200048006	K03283	ko04612	Antigen processing and presentation	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMC200048009	K00430	ko00360	Phenylalanine metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMC200048009	K00430	ko00680	Methane metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMC200048009	K00430	ko00940	Phenylpropanoid biosynthesis	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMC200048009	K00430	ko01100	Metabolic pathways	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMC200048009	K00430	ko01110	Biosynthesis of secondary metabolites	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMC200048015	K00654	ko00600	Sphingolipid metabolism	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMC200048015	K00654	ko01100	Metabolic pathways	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMC200048024	K01933	ko00230	Purine metabolism	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMC200048024	K01933	ko01100	Metabolic pathways	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMC200048024	K01933	ko01110	Biosynthesis of secondary metabolites	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMC200048026	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMC200048026	K00015	ko01100	Metabolic pathways	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMC200048027	K00058	ko00260	Glycine, serine and threonine metabolism	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMC200048027	K00058	ko01100	Metabolic pathways	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMC200048028	K00058	ko00260	Glycine, serine and threonine metabolism	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMC200048028	K00058	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMC200048029	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMC200048029	K00015	ko01100	Metabolic pathways	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMC200030763	K07199	ko04910	Insulin signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMC200030763	K07199	ko04920	Adipocytokine signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMC200030763	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMC200068295	K04508	ko04310	Wnt signaling pathway	422	1.9e-17	0.42	0.52	0.71
PGSC0003DMC200024931	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMC200024932	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024932	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024932	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024933	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024933	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024933	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMC200024956	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMC200024957	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMC200024958	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMC200024959	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMC200017795	K12135	ko04712	Circadian rhythm - plant	330	2.3e-12	0.39	0.55	0.75
PGSC0003DMC200017796	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMC200017797	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMC200017798	K12135	ko04712	Circadian rhythm - plant	959	4.6e-47	0.47	0.60	0.91
PGSC0003DMC200017799	K12135	ko04712	Circadian rhythm - plant	922	5.1e-45	0.46	0.61	0.71
PGSC0003DMC200017800	K12135	ko04712	Circadian rhythm - plant	327	3.4e-12	0.40	0.55	0.48
PGSC0003DMC200017809	K05864	ko04020	Calcium signaling pathway	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMC200017809	K05864	ko05012	Parkinson's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMC200017809	K05864	ko05016	Huntington's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMC200017810	K05864	ko04020	Calcium signaling pathway	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMC200017810	K05864	ko05012	Parkinson's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMC200017810	K05864	ko05016	Huntington's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMC200017811	K00430	ko00360	Phenylalanine metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMC200017811	K00430	ko00680	Methane metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMC200017811	K00430	ko00940	Phenylpropanoid biosynthesis	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMC200017811	K00430	ko01100	Metabolic pathways	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMC200017811	K00430	ko01110	Biosynthesis of secondary metabolites	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMC200017812	K00430	ko00360	Phenylalanine metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMC200017812	K00430	ko00680	Methane metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMC200017812	K00430	ko00940	Phenylpropanoid biosynthesis	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMC200017812	K00430	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMC200017812	K00430	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMC200017814	K00430	ko00360	Phenylalanine metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMC200017814	K00430	ko00680	Methane metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMC200017814	K00430	ko00940	Phenylpropanoid biosynthesis	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMC200017814	K00430	ko01100	Metabolic pathways	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMC200017814	K00430	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMC200017815	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMC200017816	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMC200017817	K02897	ko03010	Ribosome	1277	1.3e-64	0.63	0.78	1.00
PGSC0003DMC200017818	K02897	ko03010	Ribosome	1300	7.2e-66	0.65	0.81	1.00
PGSC0003DMC200019209	K02918	ko03010	Ribosome	719	8.0e-34	0.89	0.96	0.44
PGSC0003DMC200019210	K02918	ko03010	Ribosome	913	1.6e-44	0.92	0.96	0.99
PGSC0003DMC200019211	K07195	ko04910	Insulin signaling pathway	2086	3.2e-109	0.47	0.67	0.94
PGSC0003DMC200019220	K04123	ko00904	Diterpenoid biosynthesis	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMC200019220	K04123	ko01100	Metabolic pathways	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMC200019220	K04123	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMC200054933	K01718	ko00240	Pyrimidine metabolism	778	4.5e-37	0.41	0.58	0.99
PGSC0003DMC200054935	K01718	ko00240	Pyrimidine metabolism	1059	1.4e-52	0.41	0.58	0.91
PGSC0003DMC200054944	K00648	ko00061	Fatty acid biosynthesis	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMC200054944	K00648	ko01100	Metabolic pathways	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMC200054957	K07466	ko03030	DNA replication	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMC200054957	K07466	ko03420	Nucleotide excision repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMC200054957	K07466	ko03430	Mismatch repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMC200054957	K07466	ko03440	Homologous recombination	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMC200047791	K04731	ko04210	Apoptosis	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMC200047791	K04731	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMC200047804	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	318	2.2e-09	0.28	0.44	0.63
PGSC0003DMC200047806	K12190	ko04144	Endocytosis	1875	1.4e-97	0.70	0.82	0.87
PGSC0003DMC200047807	K12190	ko04144	Endocytosis	2563	1.6e-135	0.70	0.82	1.00
PGSC0003DMC200047808	K12190	ko04144	Endocytosis	735	1.1e-34	0.72	0.89	0.87
PGSC0003DMC200031963	K04852	ko04010	MAPK signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMC200031963	K04852	ko04020	Calcium signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMC200031963	K04852	ko04930	Type II diabetes mellitus	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMC200049201	K07424	ko00140	Steroid hormone biosynthesis	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00591	Linoleic acid metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00830	Retinol metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00982	Drug metabolism - cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko00983	Drug metabolism - other enzymes	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049201	K07424	ko01100	Metabolic pathways	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMC200049202	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049202	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049204	K07424	ko00140	Steroid hormone biosynthesis	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00591	Linoleic acid metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00830	Retinol metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00982	Drug metabolism - cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko00983	Drug metabolism - other enzymes	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049204	K07424	ko01100	Metabolic pathways	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMC200049205	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049205	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMC200049206	K07424	ko00140	Steroid hormone biosynthesis	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00591	Linoleic acid metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00830	Retinol metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00982	Drug metabolism - cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko00983	Drug metabolism - other enzymes	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049206	K07424	ko01100	Metabolic pathways	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMC200049213	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	368	1.8e-14	0.38	0.62	0.93
PGSC0003DMC200049214	K00847	ko00051	Fructose and mannose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMC200049214	K00847	ko00500	Starch and sucrose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMC200049214	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMC200049214	K00847	ko01100	Metabolic pathways	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMC200049215	K00847	ko00051	Fructose and mannose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMC200049215	K00847	ko00500	Starch and sucrose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMC200049215	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMC200049215	K00847	ko01100	Metabolic pathways	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMC200049228	K01940	ko00250	Alanine, aspartate and glutamate metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMC200049228	K01940	ko00330	Arginine and proline metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMC200049228	K01940	ko01100	Metabolic pathways	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMC200049228	K01940	ko01110	Biosynthesis of secondary metabolites	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMC200026141	K02516	ko04111	Cell cycle - yeast	273	1.0e-08	0.49	0.60	0.95
PGSC0003DMC200026143	K02516	ko04111	Cell cycle - yeast	4430	1.7e-238	0.78	0.87	1.00
PGSC0003DMC200026144	K00999	ko00562	Inositol phosphate metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMC200026144	K00999	ko00564	Glycerophospholipid metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMC200026144	K00999	ko01100	Metabolic pathways	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMC200026144	K00999	ko04070	Phosphatidylinositol signaling system	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMC200026147	K00999	ko00562	Inositol phosphate metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMC200026147	K00999	ko00564	Glycerophospholipid metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMC200026147	K00999	ko01100	Metabolic pathways	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMC200026147	K00999	ko04070	Phosphatidylinositol signaling system	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMC200026148	K00999	ko00562	Inositol phosphate metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMC200026148	K00999	ko00564	Glycerophospholipid metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMC200026148	K00999	ko01100	Metabolic pathways	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMC200026148	K00999	ko04070	Phosphatidylinositol signaling system	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMC200026149	K00999	ko00562	Inositol phosphate metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMC200026149	K00999	ko00564	Glycerophospholipid metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMC200026149	K00999	ko01100	Metabolic pathways	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMC200026149	K00999	ko04070	Phosphatidylinositol signaling system	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMC200026152	K06675	ko04111	Cell cycle - yeast	280	1.4e-06	0.25	0.47	0.84
PGSC0003DMC200026153	K06675	ko04111	Cell cycle - yeast	285	5.3e-07	0.26	0.49	0.83
PGSC0003DMC200026154	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200026154	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200026154	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200026157	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMC200026157	K02366	ko01100	Metabolic pathways	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMC200018002	K01924	ko00471	D-Glutamine and D-glutamate metabolism	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMC200018002	K01924	ko00550	Peptidoglycan biosynthesis	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMC200018002	K01924	ko01100	Metabolic pathways	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMC200018003	K01924	ko00471	D-Glutamine and D-glutamate metabolism	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMC200018003	K01924	ko00550	Peptidoglycan biosynthesis	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMC200018003	K01924	ko01100	Metabolic pathways	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMC200018004	K01924	ko00471	D-Glutamine and D-glutamate metabolism	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMC200018004	K01924	ko00550	Peptidoglycan biosynthesis	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMC200018004	K01924	ko01100	Metabolic pathways	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMC200018005	K02294	ko00906	Carotenoid biosynthesis	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMC200018005	K02294	ko01100	Metabolic pathways	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMC200018005	K02294	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMC200058207	K08967	ko00270	Cysteine and methionine metabolism	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMC200058207	K08967	ko01100	Metabolic pathways	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMC200058222	K02896	ko03010	Ribosome	333	1.6e-12	0.56	0.71	0.96
PGSC0003DMC200058228	K11251	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.54	0.68	0.92
PGSC0003DMC200039815	K01046	ko00561	Glycerolipid metabolism	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMC200039815	K01046	ko01100	Metabolic pathways	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMC200039834	K01500	ko00791	Atrazine degradation	385	2.1e-15	0.36	0.45	0.72
PGSC0003DMC200039835	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMC200039836	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMC200039837	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMC200039838	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMC200039839	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMC200051933	K06268	ko04010	MAPK signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04020	Calcium signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04114	Oocyte meiosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04210	Apoptosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04310	Wnt signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04360	Axon guidance	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04370	VEGF signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04650	Natural killer cell mediated cytotoxicity	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04660	T cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04662	B cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko04720	Long-term potentiation	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko05010	Alzheimer's disease	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051933	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMC200051954	K07466	ko03030	DNA replication	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMC200051954	K07466	ko03420	Nucleotide excision repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMC200051954	K07466	ko03430	Mismatch repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMC200051954	K07466	ko03440	Homologous recombination	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMC200051955	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051955	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051955	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051955	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051956	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051956	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051956	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051956	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051958	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051958	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051958	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200051958	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMC200033442	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMC200033443	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMC200033444	K10418	ko04962	Vasopressin-regulated water reabsorption	389	1.3e-15	0.56	0.73	0.73
PGSC0003DMC200033445	K08914	ko00196	Photosynthesis - antenna proteins	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMC200033445	K08914	ko01100	Metabolic pathways	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMC200033446	K08914	ko00196	Photosynthesis - antenna proteins	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMC200033446	K08914	ko01100	Metabolic pathways	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMC200011021	K00588	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011021	K00588	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011021	K00588	ko00941	Flavonoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011021	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011021	K00588	ko01100	Metabolic pathways	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011021	K00588	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMC200011022	K00588	ko00360	Phenylalanine metabolism	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011022	K00588	ko00940	Phenylpropanoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011022	K00588	ko00941	Flavonoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011022	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011022	K00588	ko01100	Metabolic pathways	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011022	K00588	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMC200011025	K05402	ko04620	Toll-like receptor signaling pathway	262	1.3e-08	0.29	0.41	0.93
PGSC0003DMC200011026	K00933	ko00330	Arginine and proline metabolism	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMC200011026	K00933	ko01100	Metabolic pathways	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMC200011027	K12869	ko03040	Spliceosome	1106	3.6e-55	0.43	0.59	0.93
PGSC0003DMC200011030	K02184	ko04320	Dorso-ventral axis formation	979	2.3e-47	0.43	0.50	0.99
PGSC0003DMC200011034	K00753	ko00510	N-Glycan biosynthesis	1316	9.5e-67	0.62	0.74	0.89
PGSC0003DMC200011035	K00753	ko00510	N-Glycan biosynthesis	1405	1.2e-71	0.73	0.88	0.93
PGSC0003DMC200011036	K00753	ko00510	N-Glycan biosynthesis	2979	1.8e-158	0.68	0.81	0.97
PGSC0003DMC200011037	K00753	ko00510	N-Glycan biosynthesis	2247	4.2e-118	0.77	0.89	0.85
PGSC0003DMC200027001	K02926	ko03010	Ribosome	1940	3.6e-101	0.78	0.84	1.00
PGSC0003DMC200027002	K02926	ko03010	Ribosome	1963	2.0e-102	0.80	0.86	1.00
PGSC0003DMC200027007	K01046	ko00561	Glycerolipid metabolism	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMC200027007	K01046	ko01100	Metabolic pathways	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMC200027008	K01046	ko00561	Glycerolipid metabolism	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMC200027008	K01046	ko01100	Metabolic pathways	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMC200027018	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMC200027018	K00517	ko00626	Naphthalene and anthracene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMC200027018	K00517	ko00903	Limonene and pinene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMC200027018	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMC200027018	K00517	ko01110	Biosynthesis of secondary metabolites	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMC200027019	K12815	ko03040	Spliceosome	5735	0.	0.73	0.83	0.94
PGSC0003DMC200027020	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMC200027021	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMC200027022	K10579	ko04120	Ubiquitin mediated proteolysis	1427	7.2e-73	0.87	0.96	0.99
PGSC0003DMC200027025	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMC200027026	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMC200023133	K02906	ko03010	Ribosome	751	1.4e-35	0.72	0.84	0.65
PGSC0003DMC200023134	K02906	ko03010	Ribosome	272	3.6e-09	0.51	0.66	0.83
PGSC0003DMC200023135	K02906	ko03010	Ribosome	947	2.1e-46	0.50	0.59	0.75
PGSC0003DMC200023136	K02906	ko03010	Ribosome	1542	3.2e-79	0.71	0.83	0.81
PGSC0003DMC200023138	K01051	ko00040	Pentose and glucuronate interconversions	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMC200023138	K01051	ko00500	Starch and sucrose metabolism	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMC200023138	K01051	ko01100	Metabolic pathways	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMC200023139	K01051	ko00040	Pentose and glucuronate interconversions	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMC200023139	K01051	ko00500	Starch and sucrose metabolism	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMC200023139	K01051	ko01100	Metabolic pathways	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMC200023148	K01046	ko00561	Glycerolipid metabolism	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMC200023148	K01046	ko01100	Metabolic pathways	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMC200023156	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMC200023156	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMC200023157	K01046	ko00561	Glycerolipid metabolism	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMC200023157	K01046	ko01100	Metabolic pathways	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMC200004621	K01190	ko00052	Galactose metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMC200004621	K01190	ko00511	Other glycan degradation	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMC200004621	K01190	ko00600	Sphingolipid metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMC200004621	K01190	ko01100	Metabolic pathways	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMC200004622	K01190	ko00052	Galactose metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMC200004622	K01190	ko00511	Other glycan degradation	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMC200004622	K01190	ko00600	Sphingolipid metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMC200004622	K01190	ko01100	Metabolic pathways	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMC200004626	K01115	ko00564	Glycerophospholipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004626	K01115	ko00565	Ether lipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004626	K01115	ko01100	Metabolic pathways	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004626	K01115	ko04144	Endocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004626	K01115	ko04666	Fc gamma R-mediated phagocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004626	K01115	ko04912	GnRH signaling pathway	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMC200004627	K00558	ko00270	Cysteine and methionine metabolism	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMC200004627	K00558	ko01100	Metabolic pathways	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMC200004628	K01112	ko00051	Fructose and mannose metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMC200004628	K01112	ko00730	Thiamine metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMC200004628	K01112	ko00740	Riboflavin metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMC200004628	K01112	ko01100	Metabolic pathways	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMC200004629	K01112	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMC200004629	K01112	ko00730	Thiamine metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMC200004629	K01112	ko00740	Riboflavin metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMC200004629	K01112	ko01100	Metabolic pathways	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMC200004630	K01112	ko00051	Fructose and mannose metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMC200004630	K01112	ko00730	Thiamine metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMC200004630	K01112	ko00740	Riboflavin metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMC200004630	K01112	ko01100	Metabolic pathways	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMC200004631	K01112	ko00051	Fructose and mannose metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMC200004631	K01112	ko00730	Thiamine metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMC200004631	K01112	ko00740	Riboflavin metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMC200004631	K01112	ko01100	Metabolic pathways	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMC200004632	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004632	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004632	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004632	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004633	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004633	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004633	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004633	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMC200004634	K01112	ko00051	Fructose and mannose metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMC200004634	K01112	ko00730	Thiamine metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMC200004634	K01112	ko00740	Riboflavin metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMC200004634	K01112	ko01100	Metabolic pathways	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMC200004635	K13248	ko00750	Vitamin B6 metabolism	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMC200004635	K13248	ko01100	Metabolic pathways	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMC200004636	K01112	ko00051	Fructose and mannose metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMC200004636	K01112	ko00730	Thiamine metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMC200004636	K01112	ko00740	Riboflavin metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMC200004636	K01112	ko01100	Metabolic pathways	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMC200004638	K12197	ko04144	Endocytosis	1509	2.1e-77	0.91	0.97	1.00
PGSC0003DMC200004639	K02903	ko03010	Ribosome	980	3.2e-48	0.84	0.91	0.99
PGSC0003DMC200004649	K04733	ko04210	Apoptosis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMC200004649	K04733	ko04620	Toll-like receptor signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMC200004649	K04733	ko04722	Neurotrophin signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMC200004649	K04733	ko05140	Leishmaniasis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMC200004649	K04733	ko05142	Chagas disease	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMC200008395	K01051	ko00040	Pentose and glucuronate interconversions	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMC200008395	K01051	ko00500	Starch and sucrose metabolism	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMC200008395	K01051	ko01100	Metabolic pathways	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMC200008399	K01369	ko04142	Lysosome	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMC200008399	K01369	ko04612	Antigen processing and presentation	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMC200062720	K03006	ko00230	Purine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMC200062720	K03006	ko00240	Pyrimidine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMC200062720	K03006	ko01100	Metabolic pathways	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMC200062720	K03006	ko03020	RNA polymerase	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMC200062720	K03006	ko05016	Huntington's disease	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMC200062723	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMC200062723	K00517	ko00626	Naphthalene and anthracene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMC200062723	K00517	ko00903	Limonene and pinene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMC200062723	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMC200062723	K00517	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMC200002161	K01066	ko00623	2,4-Dichlorobenzoate degradation	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMC200002161	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMC200002168	K00754	ko00051	Fructose and mannose metabolism	310	5.0e-11	0.30	0.50	0.67
PGSC0003DMC200002176	K11294	ko05130	Pathogenic Escherichia coli infection	2615	2.1e-138	0.54	0.64	1.00
PGSC0003DMC200002179	K01051	ko00040	Pentose and glucuronate interconversions	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMC200002179	K01051	ko00500	Starch and sucrose metabolism	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMC200002179	K01051	ko01100	Metabolic pathways	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMC200002011	K00748	ko00540	Lipopolysaccharide biosynthesis	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMC200002011	K00748	ko01100	Metabolic pathways	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMC200002012	K00748	ko00540	Lipopolysaccharide biosynthesis	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMC200002012	K00748	ko01100	Metabolic pathways	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMC200002013	K00748	ko00540	Lipopolysaccharide biosynthesis	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMC200002013	K00748	ko01100	Metabolic pathways	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMC200002017	K02153	ko00190	Oxidative phosphorylation	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002017	K02153	ko01100	Metabolic pathways	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002017	K02153	ko04145	Phagosome	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002017	K02153	ko04966	Collecting duct acid secretion	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002017	K02153	ko05110	Vibrio cholerae infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002017	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMC200002021	K12606	ko03018	RNA degradation	547	2.5e-24	0.48	0.68	0.82
PGSC0003DMC200002022	K12606	ko03018	RNA degradation	606	1.4e-27	0.36	0.49	0.66
PGSC0003DMC200002031	K12356	ko00940	Phenylpropanoid biosynthesis	633	4.4e-29	0.31	0.46	0.93
PGSC0003DMC200020406	K02084	ko04115	p53 signaling pathway	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko04210	Apoptosis	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko05010	Alzheimer's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko05012	Parkinson's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko05016	Huntington's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020406	K02084	ko05222	Small cell lung cancer	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMC200020408	K02084	ko04115	p53 signaling pathway	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko04210	Apoptosis	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko05010	Alzheimer's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko05012	Parkinson's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko05016	Huntington's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020408	K02084	ko05222	Small cell lung cancer	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMC200020411	K02084	ko04115	p53 signaling pathway	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko04210	Apoptosis	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko05010	Alzheimer's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko05012	Parkinson's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko05016	Huntington's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020411	K02084	ko05222	Small cell lung cancer	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMC200020414	K05298	ko00710	Carbon fixation in photosynthetic organisms	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMC200020414	K05298	ko01100	Metabolic pathways	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMC200020415	K12855	ko03040	Spliceosome	236	2.4e-06	0.28	0.48	0.97
PGSC0003DMC200020416	K12869	ko03040	Spliceosome	306	4.2e-08	0.25	0.44	0.70
PGSC0003DMC200011166	K12891	ko03040	Spliceosome	218	3.4e-06	0.43	0.66	0.53
PGSC0003DMC200011167	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMC200011168	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMC200011169	K12900	ko03040	Spliceosome	415	4.7e-17	0.45	0.58	0.80
PGSC0003DMC200011170	K12900	ko03040	Spliceosome	570	1.3e-25	0.43	0.53	0.87
PGSC0003DMC200011171	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMC200011184	K05663	ko02010	ABC transporters	839	1.9e-40	0.52	0.65	0.98
PGSC0003DMC200011185	K05663	ko02010	ABC transporters	2998	1.6e-159	0.73	0.83	0.96
PGSC0003DMC200016608	K03028	ko03050	Proteasome	6579	0.	0.88	0.95	0.99
PGSC0003DMC200016609	K09561	ko04120	Ubiquitin mediated proteolysis	318	5.5e-11	0.32	0.46	0.68
PGSC0003DMC200016610	K12581	ko03018	RNA degradation	408	2.7e-14	0.29	0.44	0.75
PGSC0003DMC200016611	K12581	ko03018	RNA degradation	297	1.2e-07	0.30	0.45	0.59
PGSC0003DMC200016612	K12581	ko03018	RNA degradation	341	3.8e-10	0.29	0.44	0.71
PGSC0003DMC200023050	K06685	ko04111	Cell cycle - yeast	1629	5.2e-84	0.87	0.94	0.99
PGSC0003DMC200023051	K06685	ko04111	Cell cycle - yeast	959	4.6e-47	0.86	0.94	0.98
PGSC0003DMC200023052	K06685	ko04111	Cell cycle - yeast	919	7.5e-45	0.83	0.92	0.79
PGSC0003DMC200023054	K01213	ko00040	Pentose and glucuronate interconversions	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMC200023054	K01213	ko00500	Starch and sucrose metabolism	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMC200023054	K01213	ko01100	Metabolic pathways	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMC200023060	K03097	ko04310	Wnt signaling pathway	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMC200023060	K03097	ko04520	Adherens junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMC200023060	K03097	ko04530	Tight junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMC200023060	K03097	ko04712	Circadian rhythm - plant	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMC200023061	K03097	ko04310	Wnt signaling pathway	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMC200023061	K03097	ko04520	Adherens junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMC200023061	K03097	ko04530	Tight junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMC200023061	K03097	ko04712	Circadian rhythm - plant	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMC200023065	K12857	ko03040	Spliceosome	261	1.5e-08	0.28	0.48	0.58
PGSC0003DMC200023066	K10140	ko03420	Nucleotide excision repair	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMC200023066	K10140	ko04115	p53 signaling pathway	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMC200023066	K10140	ko04120	Ubiquitin mediated proteolysis	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMC200023067	K12857	ko03040	Spliceosome	216	4.4e-06	0.28	0.47	0.81
PGSC0003DMC200023068	K12857	ko03040	Spliceosome	261	6.9e-08	0.28	0.48	0.33
PGSC0003DMC200023069	K12857	ko03040	Spliceosome	261	5.2e-08	0.28	0.48	0.38
PGSC0003DMC200023070	K01066	ko00623	2,4-Dichlorobenzoate degradation	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMC200023070	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMC200000121	K12604	ko03018	RNA degradation	812	6.1e-38	0.51	0.70	1.00
PGSC0003DMC200000122	K12604	ko03018	RNA degradation	572	1.4e-24	0.51	0.70	0.94
PGSC0003DMC200000123	K12604	ko03018	RNA degradation	493	4.3e-20	0.50	0.67	0.84
PGSC0003DMC200000124	K12604	ko03018	RNA degradation	379	9.1e-14	0.55	0.74	0.59
PGSC0003DMC200000143	K04371	ko04010	MAPK signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04012	ErbB signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04013	MAPK signaling pathway - fly	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04062	Chemokine signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04114	Oocyte meiosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04150	mTOR signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04270	Vascular smooth muscle contraction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04320	Dorso-ventral axis formation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04350	TGF-beta signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04360	Axon guidance	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04370	VEGF signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04510	Focal adhesion	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04520	Adherens junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04540	Gap junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04620	Toll-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04621	NOD-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04650	Natural killer cell mediated cytotoxicity	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04660	T cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04662	B cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04664	Fc epsilon RI signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04666	Fc gamma R-mediated phagocytosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04720	Long-term potentiation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04722	Neurotrophin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04730	Long-term depression	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04810	Regulation of actin cytoskeleton	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04910	Insulin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04912	GnRH signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04914	Progesterone-mediated oocyte maturation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04916	Melanogenesis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04930	Type II diabetes mellitus	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05010	Alzheimer's disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05020	Prion diseases	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05131	Shigellosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05140	Leishmaniasis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05142	Chagas disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05200	Pathways in cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05210	Colorectal cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05211	Renal cell carcinoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05212	Pancreatic cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05213	Endometrial cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05214	Glioma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05215	Prostate cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05216	Thyroid cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05218	Melanoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05219	Bladder cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05220	Chronic myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05221	Acute myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000143	K04371	ko05223	Non-small cell lung cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMC200000144	K04371	ko04010	MAPK signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04012	ErbB signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04013	MAPK signaling pathway - fly	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04062	Chemokine signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04114	Oocyte meiosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04150	mTOR signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04270	Vascular smooth muscle contraction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04320	Dorso-ventral axis formation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04350	TGF-beta signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04360	Axon guidance	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04370	VEGF signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04510	Focal adhesion	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04520	Adherens junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04540	Gap junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04620	Toll-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04621	NOD-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04650	Natural killer cell mediated cytotoxicity	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04660	T cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04662	B cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04664	Fc epsilon RI signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04666	Fc gamma R-mediated phagocytosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04720	Long-term potentiation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04722	Neurotrophin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04730	Long-term depression	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04810	Regulation of actin cytoskeleton	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04910	Insulin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04912	GnRH signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04914	Progesterone-mediated oocyte maturation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04916	Melanogenesis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04930	Type II diabetes mellitus	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05010	Alzheimer's disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05020	Prion diseases	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05131	Shigellosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05140	Leishmaniasis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05142	Chagas disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05200	Pathways in cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05210	Colorectal cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05211	Renal cell carcinoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05212	Pancreatic cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05213	Endometrial cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05214	Glioma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05215	Prostate cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05216	Thyroid cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05218	Melanoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05219	Bladder cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05220	Chronic myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05221	Acute myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000144	K04371	ko05223	Non-small cell lung cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMC200000148	K12356	ko00940	Phenylpropanoid biosynthesis	557	6.9e-25	0.30	0.47	0.90
PGSC0003DMC200039966	K00901	ko00561	Glycerolipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMC200039966	K00901	ko00564	Glycerophospholipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMC200039966	K00901	ko01100	Metabolic pathways	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMC200039966	K00901	ko04070	Phosphatidylinositol signaling system	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMC200039968	K03111	ko03030	DNA replication	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMC200039968	K03111	ko03430	Mismatch repair	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMC200039968	K03111	ko03440	Homologous recombination	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMC200039969	K03111	ko03030	DNA replication	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMC200039969	K03111	ko03430	Mismatch repair	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMC200039969	K03111	ko03440	Homologous recombination	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMC200039981	K06100	ko04530	Tight junction	4555	2.1e-245	0.53	0.67	0.98
PGSC0003DMC200039982	K06100	ko04530	Tight junction	5034	8.1e-272	0.53	0.67	0.99
PGSC0003DMC200045401	K01177	ko00500	Starch and sucrose metabolism	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMC200045401	K01177	ko01100	Metabolic pathways	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMC200045407	K06654	ko04111	Cell cycle - yeast	295	2.0e-10	0.35	0.49	0.69
PGSC0003DMC200051855	K02925	ko03010	Ribosome	3182	1.1e-169	0.94	0.98	1.00
PGSC0003DMC200051860	K13289	ko04142	Lysosome	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMC200051860	K13289	ko04614	Renin-angiotensin system	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMC200060304	K02992	ko03010	Ribosome	1060	1.2e-52	0.98	0.98	0.99
PGSC0003DMC200060313	K05282	ko00904	Diterpenoid biosynthesis	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMC200060313	K05282	ko01100	Metabolic pathways	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMC200060313	K05282	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMC200060321	K12356	ko00940	Phenylpropanoid biosynthesis	648	6.6e-30	0.30	0.48	0.98
PGSC0003DMC200012781	K12486	ko04144	Endocytosis	466	1.1e-19	0.27	0.41	0.69
PGSC0003DMC200012782	K05870	ko04612	Antigen processing and presentation	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMC200012782	K05870	ko04916	Melanogenesis	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMC200012782	K05870	ko04962	Vasopressin-regulated water reabsorption	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMC200012782	K05870	ko05016	Huntington's disease	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMC200012782	K05870	ko05215	Prostate cancer	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMC200012793	K01046	ko00561	Glycerolipid metabolism	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMC200012793	K01046	ko01100	Metabolic pathways	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMC200012805	K00697	ko00500	Starch and sucrose metabolism	5931	0.	0.78	0.87	0.97
PGSC0003DMC200005972	K01762	ko00270	Cysteine and methionine metabolism	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMC200005972	K01762	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMC200005975	K03040	ko00230	Purine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMC200005975	K03040	ko00240	Pyrimidine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMC200005975	K03040	ko01100	Metabolic pathways	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMC200005975	K03040	ko03020	RNA polymerase	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMC200005984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMC200005984	K00517	ko00626	Naphthalene and anthracene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMC200005984	K00517	ko00903	Limonene and pinene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMC200005984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMC200005984	K00517	ko01110	Biosynthesis of secondary metabolites	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMC200005985	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMC200005985	K00517	ko00626	Naphthalene and anthracene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMC200005985	K00517	ko00903	Limonene and pinene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMC200005985	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMC200005985	K00517	ko01110	Biosynthesis of secondary metabolites	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMC200005986	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMC200005986	K00517	ko00626	Naphthalene and anthracene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMC200005986	K00517	ko00903	Limonene and pinene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMC200005986	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMC200005986	K00517	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMC200005994	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMC200005994	K00517	ko00626	Naphthalene and anthracene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMC200005994	K00517	ko00903	Limonene and pinene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMC200005994	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMC200005994	K00517	ko01110	Biosynthesis of secondary metabolites	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMC200005995	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMC200005995	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMC200005995	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMC200005995	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMC200005995	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMC200005996	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMC200005996	K00517	ko00626	Naphthalene and anthracene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMC200005996	K00517	ko00903	Limonene and pinene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMC200005996	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMC200005996	K00517	ko01110	Biosynthesis of secondary metabolites	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMC200005997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMC200005997	K00517	ko00626	Naphthalene and anthracene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMC200005997	K00517	ko00903	Limonene and pinene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMC200005997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMC200005997	K00517	ko01110	Biosynthesis of secondary metabolites	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMC200005998	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMC200005998	K00517	ko00626	Naphthalene and anthracene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMC200005998	K00517	ko00903	Limonene and pinene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMC200005998	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMC200005998	K00517	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMC200026041	K00630	ko00561	Glycerolipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMC200026041	K00630	ko00564	Glycerophospholipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMC200026041	K00630	ko01100	Metabolic pathways	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMC200026044	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026044	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026045	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026046	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMC200026049	K08488	ko04130	SNARE interactions in vesicular transport	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMC200026049	K08488	ko04145	Phagosome	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMC200026052	K02830	ko04111	Cell cycle - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMC200026052	K02830	ko04113	Meiosis - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMC200026053	K02830	ko04111	Cell cycle - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMC200026053	K02830	ko04113	Meiosis - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMC200026063	K11229	ko04011	MAPK signaling pathway - yeast	532	1.4e-22	0.35	0.52	0.95
PGSC0003DMC200026067	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMC200026067	K07541	ko01100	Metabolic pathways	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMC200026068	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMC200026068	K07541	ko01100	Metabolic pathways	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMC200029401	K09680	ko00770	Pantothenate and CoA biosynthesis	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMC200029401	K09680	ko01100	Metabolic pathways	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMC200029402	K09680	ko00770	Pantothenate and CoA biosynthesis	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMC200029402	K09680	ko01100	Metabolic pathways	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMC200029406	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.67
PGSC0003DMC200029407	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.64
PGSC0003DMC200029408	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.63
PGSC0003DMC200029409	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.61
PGSC0003DMC200029416	K11816	ko00380	Tryptophan metabolism	676	1.9e-31	0.47	0.64	0.96
PGSC0003DMC200029417	K11816	ko00380	Tryptophan metabolism	355	9.6e-14	0.44	0.70	0.98
PGSC0003DMC200029418	K11816	ko00380	Tryptophan metabolism	652	4.0e-30	0.47	0.65	0.96
PGSC0003DMC200029419	K11816	ko00380	Tryptophan metabolism	412	6.9e-17	0.60	0.79	0.94
PGSC0003DMC200029420	K11816	ko00380	Tryptophan metabolism	649	5.8e-30	0.49	0.72	0.98
PGSC0003DMC200029428	K08769	ko03320	PPAR signaling pathway	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMC200029428	K08769	ko05016	Huntington's disease	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMC200054843	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054843	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054843	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054844	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMC200054844	K00517	ko00626	Naphthalene and anthracene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMC200054844	K00517	ko00903	Limonene and pinene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMC200054844	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMC200054844	K00517	ko01110	Biosynthesis of secondary metabolites	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMC200054845	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054845	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054845	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMC200054846	K11818	ko00380	Tryptophan metabolism	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMC200054846	K11818	ko00966	Glucosinolate biosynthesis	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMC200054846	K11818	ko01110	Biosynthesis of secondary metabolites	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMC200054847	K11818	ko00380	Tryptophan metabolism	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMC200054847	K11818	ko00966	Glucosinolate biosynthesis	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMC200054847	K11818	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMC200054848	K11818	ko00380	Tryptophan metabolism	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMC200054848	K11818	ko00966	Glucosinolate biosynthesis	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMC200054848	K11818	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMC200054849	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMC200054849	K00517	ko00626	Naphthalene and anthracene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMC200054849	K00517	ko00903	Limonene and pinene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMC200054849	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMC200054849	K00517	ko01110	Biosynthesis of secondary metabolites	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMC200054850	K11818	ko00380	Tryptophan metabolism	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMC200054850	K11818	ko00966	Glucosinolate biosynthesis	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMC200054850	K11818	ko01110	Biosynthesis of secondary metabolites	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMC200054851	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMC200054851	K00517	ko00626	Naphthalene and anthracene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMC200054851	K00517	ko00903	Limonene and pinene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMC200054851	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMC200054851	K00517	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMC200054852	K11818	ko00380	Tryptophan metabolism	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMC200054852	K11818	ko00966	Glucosinolate biosynthesis	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMC200054852	K11818	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMC200054853	K11818	ko00380	Tryptophan metabolism	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMC200054853	K11818	ko00966	Glucosinolate biosynthesis	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMC200054853	K11818	ko01110	Biosynthesis of secondary metabolites	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMC200054854	K11818	ko00380	Tryptophan metabolism	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMC200054854	K11818	ko00966	Glucosinolate biosynthesis	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMC200054854	K11818	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMC200054855	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMC200054855	K00517	ko00626	Naphthalene and anthracene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMC200054855	K00517	ko00903	Limonene and pinene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMC200054855	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMC200054855	K00517	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMC200054856	K11818	ko00380	Tryptophan metabolism	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMC200054856	K11818	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMC200054856	K11818	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMC200054857	K11818	ko00380	Tryptophan metabolism	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMC200054857	K11818	ko00966	Glucosinolate biosynthesis	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMC200054857	K11818	ko01110	Biosynthesis of secondary metabolites	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMC200054858	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054858	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054859	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMC200054865	K12823	ko03040	Spliceosome	253	1.0e-07	0.59	0.62	0.75
PGSC0003DMC200043982	K03018	ko00230	Purine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMC200043982	K03018	ko00240	Pyrimidine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMC200043982	K03018	ko01100	Metabolic pathways	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMC200043982	K03018	ko03020	RNA polymerase	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMC200043982	K03018	ko04623	Cytosolic DNA-sensing pathway	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMC200043983	K03018	ko00230	Purine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMC200043983	K03018	ko00240	Pyrimidine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMC200043983	K03018	ko01100	Metabolic pathways	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMC200043983	K03018	ko03020	RNA polymerase	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMC200043983	K03018	ko04623	Cytosolic DNA-sensing pathway	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMC200043984	K03018	ko00230	Purine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMC200043984	K03018	ko00240	Pyrimidine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMC200043984	K03018	ko01100	Metabolic pathways	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMC200043984	K03018	ko03020	RNA polymerase	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMC200043984	K03018	ko04623	Cytosolic DNA-sensing pathway	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMC200043987	K07512	ko00062	Fatty acid elongation in mitochondria	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMC200043987	K07512	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMC200043988	K07512	ko00062	Fatty acid elongation in mitochondria	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMC200043988	K07512	ko01100	Metabolic pathways	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMC200043989	K07512	ko00062	Fatty acid elongation in mitochondria	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMC200043989	K07512	ko01100	Metabolic pathways	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMC200043990	K07512	ko00062	Fatty acid elongation in mitochondria	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMC200043990	K07512	ko01100	Metabolic pathways	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMC200043996	K01627	ko00540	Lipopolysaccharide biosynthesis	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMC200043996	K01627	ko01100	Metabolic pathways	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMC200043997	K01627	ko00540	Lipopolysaccharide biosynthesis	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMC200043997	K01627	ko01100	Metabolic pathways	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMC200043998	K01627	ko00540	Lipopolysaccharide biosynthesis	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMC200043998	K01627	ko01100	Metabolic pathways	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMC200043999	K01627	ko00540	Lipopolysaccharide biosynthesis	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMC200043999	K01627	ko01100	Metabolic pathways	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMC200044003	K04371	ko04010	MAPK signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04012	ErbB signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04013	MAPK signaling pathway - fly	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04062	Chemokine signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04114	Oocyte meiosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04150	mTOR signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04270	Vascular smooth muscle contraction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04320	Dorso-ventral axis formation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04350	TGF-beta signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04360	Axon guidance	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04370	VEGF signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04510	Focal adhesion	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04520	Adherens junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04540	Gap junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04620	Toll-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04621	NOD-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04650	Natural killer cell mediated cytotoxicity	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04660	T cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04662	B cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04664	Fc epsilon RI signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04666	Fc gamma R-mediated phagocytosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04720	Long-term potentiation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04722	Neurotrophin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04730	Long-term depression	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04810	Regulation of actin cytoskeleton	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04910	Insulin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04912	GnRH signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04914	Progesterone-mediated oocyte maturation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04916	Melanogenesis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04930	Type II diabetes mellitus	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05010	Alzheimer's disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05020	Prion diseases	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05131	Shigellosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05140	Leishmaniasis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05142	Chagas disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05200	Pathways in cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05210	Colorectal cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05211	Renal cell carcinoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05212	Pancreatic cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05213	Endometrial cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05214	Glioma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05215	Prostate cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05216	Thyroid cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05218	Melanoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05219	Bladder cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05220	Chronic myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05221	Acute myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044003	K04371	ko05223	Non-small cell lung cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMC200044007	K10352	ko04530	Tight junction	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMC200044007	K10352	ko05416	Viral myocarditis	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMC200044008	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMC200044008	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMC200044009	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMC200044009	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMC200044010	K10352	ko04530	Tight junction	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMC200044010	K10352	ko05416	Viral myocarditis	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMC200037171	K00860	ko00230	Purine metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMC200037171	K00860	ko00450	Selenoamino acid metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMC200037171	K00860	ko00920	Sulfur metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMC200037171	K00860	ko01100	Metabolic pathways	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMC200037174	K05862	ko04020	Calcium signaling pathway	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMC200037174	K05862	ko05012	Parkinson's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMC200037174	K05862	ko05016	Huntington's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMC200037175	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.76
PGSC0003DMC200037176	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.66
PGSC0003DMC200037187	K12134	ko04712	Circadian rhythm - plant	656	2.4e-30	0.38	0.52	0.63
PGSC0003DMC200037190	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.71
PGSC0003DMC200037191	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.43
PGSC0003DMC200037192	K06027	ko04962	Vasopressin-regulated water reabsorption	345	1.1e-12	0.40	0.60	0.53
PGSC0003DMC200037193	K01578	ko00410	beta-Alanine metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMC200037193	K01578	ko00640	Propanoate metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMC200037193	K01578	ko01100	Metabolic pathways	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMC200037193	K01578	ko04146	Peroxisome	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMC200037194	K01578	ko00410	beta-Alanine metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMC200037194	K01578	ko00640	Propanoate metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMC200037194	K01578	ko01100	Metabolic pathways	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMC200037194	K01578	ko04146	Peroxisome	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMC200037195	K01578	ko00410	beta-Alanine metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMC200037195	K01578	ko00640	Propanoate metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMC200037195	K01578	ko01100	Metabolic pathways	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMC200037195	K01578	ko04146	Peroxisome	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMC200037196	K01578	ko00410	beta-Alanine metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMC200037196	K01578	ko00640	Propanoate metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMC200037196	K01578	ko01100	Metabolic pathways	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMC200037196	K01578	ko04146	Peroxisome	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMC200037197	K01578	ko00410	beta-Alanine metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMC200037197	K01578	ko00640	Propanoate metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMC200037197	K01578	ko01100	Metabolic pathways	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMC200037197	K01578	ko04146	Peroxisome	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMC200037198	K01578	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMC200037198	K01578	ko00640	Propanoate metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMC200037198	K01578	ko01100	Metabolic pathways	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMC200037198	K01578	ko04146	Peroxisome	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMC200037199	K01578	ko00410	beta-Alanine metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMC200037199	K01578	ko00640	Propanoate metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMC200037199	K01578	ko01100	Metabolic pathways	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMC200037199	K01578	ko04146	Peroxisome	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMC200035822	K00235	ko00020	Citrate cycle (TCA cycle)	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko00190	Oxidative phosphorylation	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko01100	Metabolic pathways	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko05010	Alzheimer's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko05012	Parkinson's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035822	K00235	ko05016	Huntington's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMC200035831	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMC200035831	K08081	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMC200035831	K08081	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMC200035832	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMC200035832	K08081	ko01100	Metabolic pathways	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMC200035832	K08081	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMC200035833	K01087	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.76	0.86	0.79
PGSC0003DMC200035834	K01087	ko00500	Starch and sucrose metabolism	1903	4.0e-99	0.78	0.86	0.82
PGSC0003DMC200035835	K01087	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.77	0.86	0.78
PGSC0003DMC200035836	K00232	ko00071	Fatty acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035836	K00232	ko00592	alpha-Linolenic acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035836	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035836	K00232	ko01100	Metabolic pathways	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035836	K00232	ko03320	PPAR signaling pathway	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035836	K00232	ko04146	Peroxisome	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMC200035845	K01099	ko00562	Inositol phosphate metabolism	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMC200035845	K01099	ko01100	Metabolic pathways	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMC200035845	K01099	ko04070	Phosphatidylinositol signaling system	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMC200035846	K01834	ko00010	Glycolysis / Gluconeogenesis	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMC200035846	K01834	ko01100	Metabolic pathways	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMC200035846	K01834	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMC200035847	K01834	ko00010	Glycolysis / Gluconeogenesis	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMC200035847	K01834	ko01100	Metabolic pathways	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMC200035847	K01834	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMC200007171	K09838	ko00906	Carotenoid biosynthesis	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMC200007171	K09838	ko01100	Metabolic pathways	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMC200007171	K09838	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMC200007172	K09838	ko00906	Carotenoid biosynthesis	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMC200007172	K09838	ko01100	Metabolic pathways	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMC200007172	K09838	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMC200007173	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3188	5.3e-170	0.78	0.85	0.99
PGSC0003DMC200007174	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3551	5.1e-190	0.84	0.91	0.99
PGSC0003DMC200007177	K10840	ko03420	Nucleotide excision repair	784	2.1e-37	0.56	0.85	0.92
PGSC0003DMC200007187	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMC200007187	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMC200007187	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMC200007187	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMC200007188	K03360	ko04111	Cell cycle - yeast	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMC200007188	K03360	ko04120	Ubiquitin mediated proteolysis	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMC200007189	K00588	ko00360	Phenylalanine metabolism	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007189	K00588	ko00940	Phenylpropanoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007189	K00588	ko00941	Flavonoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007189	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007189	K00588	ko01100	Metabolic pathways	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007189	K00588	ko01110	Biosynthesis of secondary metabolites	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMC200007190	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007190	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007190	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007190	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007190	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007190	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko00360	Phenylalanine metabolism	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko00940	Phenylpropanoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko00941	Flavonoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko01100	Metabolic pathways	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007191	K00588	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007192	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007193	K00588	ko00360	Phenylalanine metabolism	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007193	K00588	ko00940	Phenylpropanoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007193	K00588	ko00941	Flavonoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007193	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007193	K00588	ko01100	Metabolic pathways	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007193	K00588	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMC200007194	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007194	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007194	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007194	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007194	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007194	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007195	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko00360	Phenylalanine metabolism	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko00940	Phenylpropanoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko00941	Flavonoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko01100	Metabolic pathways	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007196	K00588	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMC200007197	K02320	ko00230	Purine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMC200007197	K02320	ko00240	Pyrimidine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMC200007197	K02320	ko01100	Metabolic pathways	8469	0.	0.66	0.79	1.00
PGSC0003DMC200007197	K02320	ko03030	DNA replication	8469	0.	0.66	0.79	1.00
PGSC0003DMC200013981	K10577	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.87	0.94	0.99
PGSC0003DMC200013983	K13065	ko00940	Phenylpropanoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMC200013983	K13065	ko00941	Flavonoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMC200013983	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMC200013983	K13065	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMC200013989	K12126	ko04712	Circadian rhythm - plant	422	1.9e-17	0.52	0.65	0.59
PGSC0003DMC200013990	K12126	ko04712	Circadian rhythm - plant	467	6.4e-20	0.40	0.55	0.71
PGSC0003DMC200013991	K12126	ko04712	Circadian rhythm - plant	485	6.5e-21	0.40	0.54	0.70
PGSC0003DMC200014009	K01046	ko00561	Glycerolipid metabolism	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMC200014009	K01046	ko01100	Metabolic pathways	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMC200014010	K01046	ko00561	Glycerolipid metabolism	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMC200014010	K01046	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMC200024845	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3749	6.1e-201	0.84	0.93	0.98
PGSC0003DMC200024860	K00864	ko00561	Glycerolipid metabolism	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMC200024860	K00864	ko01100	Metabolic pathways	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMC200024860	K00864	ko03320	PPAR signaling pathway	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMC200024860	K00864	ko04626	Plant-pathogen interaction	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMC200024862	K10563	ko03410	Base excision repair	1000	2.5e-49	0.84	0.96	0.98
PGSC0003DMC200024863	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMC200024864	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMC200024865	K10563	ko03410	Base excision repair	1843	8.1e-96	0.82	0.95	0.98
PGSC0003DMC200024866	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMC200024867	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMC200024868	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMC200024869	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMC200005823	K12126	ko04712	Circadian rhythm - plant	293	3.9e-10	0.35	0.56	0.74
PGSC0003DMC200005829	K00029	ko00620	Pyruvate metabolism	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMC200005829	K00029	ko00710	Carbon fixation in photosynthetic organisms	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMC200005829	K00029	ko01100	Metabolic pathways	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMC200005830	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005830	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005830	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005832	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005832	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005832	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMC200005840	K09756	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.43	0.60	0.98
PGSC0003DMC200005844	K09489	ko04612	Antigen processing and presentation	423	5.5e-17	0.66	0.81	0.51
PGSC0003DMC200005845	K09489	ko04612	Antigen processing and presentation	474	6.5e-20	0.72	0.84	0.86
PGSC0003DMC200061511	K01051	ko00040	Pentose and glucuronate interconversions	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMC200061511	K01051	ko00500	Starch and sucrose metabolism	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMC200061511	K01051	ko01100	Metabolic pathways	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMC200056049	K07385	ko00902	Monoterpenoid biosynthesis	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMC200056049	K07385	ko01100	Metabolic pathways	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMC200056050	K07385	ko00902	Monoterpenoid biosynthesis	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMC200056050	K07385	ko01100	Metabolic pathways	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMC200056051	K07385	ko00902	Monoterpenoid biosynthesis	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMC200056051	K07385	ko01100	Metabolic pathways	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMC200056052	K07385	ko00902	Monoterpenoid biosynthesis	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMC200056052	K07385	ko01100	Metabolic pathways	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMC200056053	K07385	ko00902	Monoterpenoid biosynthesis	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMC200056053	K07385	ko01100	Metabolic pathways	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMC200056054	K07385	ko00902	Monoterpenoid biosynthesis	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMC200056054	K07385	ko01100	Metabolic pathways	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMC200056055	K07385	ko00902	Monoterpenoid biosynthesis	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMC200056055	K07385	ko01100	Metabolic pathways	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMC200056056	K07385	ko00902	Monoterpenoid biosynthesis	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMC200056056	K07385	ko01100	Metabolic pathways	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMC200056057	K07385	ko00902	Monoterpenoid biosynthesis	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMC200056057	K07385	ko01100	Metabolic pathways	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMC200056058	K07385	ko00902	Monoterpenoid biosynthesis	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMC200056058	K07385	ko01100	Metabolic pathways	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMC200056067	K12127	ko04712	Circadian rhythm - plant	250	2.8e-07	0.39	0.58	0.29
PGSC0003DMC200056068	K12127	ko04712	Circadian rhythm - plant	250	1.4e-07	0.39	0.58	0.33
PGSC0003DMC200035972	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035972	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035972	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035973	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035973	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035973	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMC200035974	K00849	ko00052	Galactose metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMC200035974	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMC200035974	K00849	ko01100	Metabolic pathways	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMC200035975	K00849	ko00052	Galactose metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMC200035975	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMC200035975	K00849	ko01100	Metabolic pathways	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMC200035976	K00849	ko00052	Galactose metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMC200035976	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMC200035976	K00849	ko01100	Metabolic pathways	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMC200035979	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	312	2.3e-11	0.60	0.77	0.92
PGSC0003DMC200035986	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMC200035986	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMC200035987	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMC200035987	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMC200035992	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	297	1.5e-10	0.60	0.71	0.62
PGSC0003DMC200035993	K12836	ko03040	Spliceosome	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMC200035993	K12836	ko05131	Shigellosis	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMC200035996	K12836	ko03040	Spliceosome	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMC200035996	K12836	ko05131	Shigellosis	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMC200035999	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMC200036000	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMC200042781	K09490	ko03060	Protein export	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMC200042781	K09490	ko05020	Prion diseases	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMC200042785	K01358	ko04112	Cell cycle - Caulobacter	824	1.3e-39	0.48	0.70	0.67
PGSC0003DMC200042788	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMC200042788	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMC200042788	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMC200042788	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMC200042788	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMC200042789	K00680	ko00350	Tyrosine metabolism	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMC200042789	K00680	ko00624	1- and 2-Methylnaphthalene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMC200042789	K00680	ko00632	Benzoate degradation via CoA ligation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMC200042789	K00680	ko00642	Ethylbenzene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMC200042789	K00680	ko00903	Limonene and pinene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMC200042790	K00680	ko00350	Tyrosine metabolism	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMC200042790	K00680	ko00624	1- and 2-Methylnaphthalene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMC200042790	K00680	ko00632	Benzoate degradation via CoA ligation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMC200042790	K00680	ko00642	Ethylbenzene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMC200042790	K00680	ko00903	Limonene and pinene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMC200042796	K10532	ko00531	Glycosaminoglycan degradation	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMC200042796	K10532	ko01100	Metabolic pathways	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMC200042796	K10532	ko04142	Lysosome	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMC200042797	K12623	ko03018	RNA degradation	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMC200042797	K12623	ko03040	Spliceosome	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMC200042798	K03065	ko03050	Proteasome	3408	3.9e-182	0.96	0.99	1.00
PGSC0003DMC200042806	K02891	ko03010	Ribosome	897	1.2e-43	0.84	0.94	0.99
PGSC0003DMC200015391	K07203	ko04012	ErbB signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko04150	mTOR signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko04910	Insulin signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko04920	Adipocytokine signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko04930	Type II diabetes mellitus	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko05200	Pathways in cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko05214	Glioma	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko05215	Prostate cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015391	K07203	ko05221	Acute myeloid leukemia	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMC200015393	K12478	ko04144	Endocytosis	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMC200015393	K12478	ko04145	Phagosome	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMC200015395	K02921	ko03010	Ribosome	631	5.7e-29	0.88	0.94	0.99
PGSC0003DMC200015412	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015412	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015412	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015412	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015412	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015412	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200015413	K10747	ko03030	DNA replication	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMC200015413	K10747	ko03410	Base excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMC200015413	K10747	ko03420	Nucleotide excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMC200015413	K10747	ko03430	Mismatch repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMC200009964	K12861	ko03040	Spliceosome	1593	5.0e-82	0.75	0.87	0.99
PGSC0003DMC200009976	K03211	ko04013	MAPK signaling pathway - fly	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMC200009976	K03211	ko04320	Dorso-ventral axis formation	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMC200009977	K02563	ko00550	Peptidoglycan biosynthesis	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMC200009977	K02563	ko01100	Metabolic pathways	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMC200009977	K02563	ko04112	Cell cycle - Caulobacter	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMC200009978	K02563	ko00550	Peptidoglycan biosynthesis	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMC200009978	K02563	ko01100	Metabolic pathways	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMC200009978	K02563	ko04112	Cell cycle - Caulobacter	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMC200009981	K03821	ko00650	Butanoate metabolism	281	1.3e-09	0.24	0.41	0.87
PGSC0003DMC200021853	K00432	ko00480	Glutathione metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMC200021853	K00432	ko00590	Arachidonic acid metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMC200021855	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMC200021855	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMC200021856	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMC200021856	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMC200063640	K12606	ko03018	RNA degradation	618	3.0e-28	0.43	0.65	0.94
PGSC0003DMC200000819	K04565	ko04146	Peroxisome	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMC200000819	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMC200000819	K04565	ko05016	Huntington's disease	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMC200000819	K04565	ko05020	Prion diseases	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMC200000820	K04565	ko04146	Peroxisome	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMC200000820	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMC200000820	K04565	ko05016	Huntington's disease	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMC200000820	K04565	ko05020	Prion diseases	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMC200000823	K11252	ko05322	Systemic lupus erythematosus	1034	3.4e-51	0.89	0.94	0.99
PGSC0003DMC200000835	K13083	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMC200000835	K13083	ko00944	Flavone and flavonol biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMC200000835	K13083	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMC200000836	K13083	ko00941	Flavonoid biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMC200000836	K13083	ko00944	Flavone and flavonol biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMC200000836	K13083	ko01110	Biosynthesis of secondary metabolites	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMC200050401	K08008	ko04145	Phagosome	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMC200050401	K08008	ko04670	Leukocyte transendothelial migration	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMC200050402	K08008	ko04145	Phagosome	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMC200050402	K08008	ko04670	Leukocyte transendothelial migration	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMC200050403	K08008	ko04145	Phagosome	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMC200050403	K08008	ko04670	Leukocyte transendothelial migration	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMC200050404	K08008	ko04145	Phagosome	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMC200050404	K08008	ko04670	Leukocyte transendothelial migration	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMC200050405	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMC200050405	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMC200050416	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMC200050416	K01904	ko00360	Phenylalanine metabolism	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMC200050416	K01904	ko00940	Phenylpropanoid biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMC200050416	K01904	ko01100	Metabolic pathways	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMC200050416	K01904	ko01110	Biosynthesis of secondary metabolites	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMC200050421	K08054	ko04145	Phagosome	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMC200050421	K08054	ko04612	Antigen processing and presentation	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMC200050422	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMC200050422	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMC200050423	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMC200050423	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMC200050424	K02978	ko03010	Ribosome	588	1.3e-26	0.82	0.89	0.85
PGSC0003DMC200046594	K01199	ko00500	Starch and sucrose metabolism	736	9.3e-35	0.32	0.56	0.85
PGSC0003DMC200046598	K05759	ko04810	Regulation of actin cytoskeleton	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMC200046598	K05759	ko05131	Shigellosis	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMC200041166	K10245	ko01040	Biosynthesis of unsaturated fatty acids	479	1.4e-20	0.35	0.49	0.87
PGSC0003DMC200041171	K00889	ko00562	Inositol phosphate metabolism	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041171	K00889	ko01100	Metabolic pathways	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041171	K00889	ko04070	Phosphatidylinositol signaling system	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041171	K00889	ko04144	Endocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041171	K00889	ko04666	Fc gamma R-mediated phagocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041171	K00889	ko04810	Regulation of actin cytoskeleton	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMC200041172	K00889	ko00562	Inositol phosphate metabolism	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041172	K00889	ko01100	Metabolic pathways	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041172	K00889	ko04070	Phosphatidylinositol signaling system	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041172	K00889	ko04144	Endocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041172	K00889	ko04666	Fc gamma R-mediated phagocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041172	K00889	ko04810	Regulation of actin cytoskeleton	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMC200041180	K00600	ko00260	Glycine, serine and threonine metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041180	K00600	ko00460	Cyanoamino acid metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041180	K00600	ko00670	One carbon pool by folate	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041180	K00600	ko00680	Methane metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041180	K00600	ko01100	Metabolic pathways	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041180	K00600	ko01110	Biosynthesis of secondary metabolites	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMC200041186	K10901	ko03440	Homologous recombination	1531	1.3e-78	0.63	0.81	0.98
PGSC0003DMC200053048	K08311	ko03018	RNA degradation	554	1.0e-24	0.46	0.65	0.83
PGSC0003DMC200053051	K03655	ko03440	Homologous recombination	334	1.3e-11	0.57	0.71	0.91
PGSC0003DMC200053052	K03655	ko03440	Homologous recombination	2856	1.1e-151	0.77	0.88	0.94
PGSC0003DMC200053053	K03655	ko03440	Homologous recombination	3680	3.9e-197	0.62	0.73	1.00
PGSC0003DMC200053054	K03655	ko03440	Homologous recombination	5420	4.2e-293	0.67	0.77	1.00
PGSC0003DMC200053055	K03655	ko03440	Homologous recombination	1562	2.6e-80	0.85	0.92	1.00
PGSC0003DMC200053067	K00767	ko00760	Nicotinate and nicotinamide metabolism	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMC200053067	K00767	ko01100	Metabolic pathways	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMC200053068	K00889	ko00562	Inositol phosphate metabolism	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053068	K00889	ko01100	Metabolic pathways	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053068	K00889	ko04070	Phosphatidylinositol signaling system	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053068	K00889	ko04144	Endocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053068	K00889	ko04666	Fc gamma R-mediated phagocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053068	K00889	ko04810	Regulation of actin cytoskeleton	8412	0.	0.60	0.74	1.00
PGSC0003DMC200053069	K00889	ko00562	Inositol phosphate metabolism	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200053069	K00889	ko01100	Metabolic pathways	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200053069	K00889	ko04070	Phosphatidylinositol signaling system	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200053069	K00889	ko04144	Endocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200053069	K00889	ko04666	Fc gamma R-mediated phagocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200053069	K00889	ko04810	Regulation of actin cytoskeleton	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMC200039721	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMC200039721	K11517	ko01100	Metabolic pathways	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMC200039721	K11517	ko04146	Peroxisome	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMC200039722	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMC200039722	K11517	ko01100	Metabolic pathways	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMC200039722	K11517	ko04146	Peroxisome	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMC200039723	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMC200039723	K11517	ko01100	Metabolic pathways	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMC200039723	K11517	ko04146	Peroxisome	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMC200039724	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMC200039724	K11517	ko01100	Metabolic pathways	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMC200039724	K11517	ko04146	Peroxisome	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMC200039727	K08517	ko04130	SNARE interactions in vesicular transport	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMC200039727	K08517	ko04145	Phagosome	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMC200039728	K08517	ko04130	SNARE interactions in vesicular transport	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMC200039728	K08517	ko04145	Phagosome	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMC200039733	K05658	ko02010	ABC transporters	3808	3.4e-204	0.43	0.62	0.80
PGSC0003DMC200039734	K12893	ko03040	Spliceosome	310	2.9e-08	0.28	0.42	0.55
PGSC0003DMC200039738	K08233	ko00901	Indole alkaloid biosynthesis	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMC200039738	K08233	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMC200039740	K10260	ko04120	Ubiquitin mediated proteolysis	402	2.4e-16	0.28	0.45	0.68
PGSC0003DMC200039746	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMC200039746	K00224	ko00364	Fluorobenzoate degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMC200039746	K00224	ko00628	Fluorene degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMC200039746	K00224	ko00640	Propanoate metabolism	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMC200039748	K08233	ko00901	Indole alkaloid biosynthesis	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMC200039748	K08233	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMC200039749	K08233	ko00901	Indole alkaloid biosynthesis	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMC200039749	K08233	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMC200039750	K08233	ko00901	Indole alkaloid biosynthesis	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMC200039750	K08233	ko01110	Biosynthesis of secondary metabolites	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMC200045032	K01051	ko00040	Pentose and glucuronate interconversions	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMC200045032	K01051	ko00500	Starch and sucrose metabolism	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMC200045032	K01051	ko01100	Metabolic pathways	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMC200045033	K08495	ko04130	SNARE interactions in vesicular transport	1720	4.9e-89	0.89	0.95	0.98
PGSC0003DMC200045038	K06096	ko04530	Tight junction	411	7.8e-17	0.34	0.54	0.94
PGSC0003DMC200045048	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.76
PGSC0003DMC200045049	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.80
PGSC0003DMC200045056	K01692	ko00071	Fatty acid metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00280	Valine, leucine and isoleucine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00281	Geraniol degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00310	Lysine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00380	Tryptophan metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00410	beta-Alanine metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00632	Benzoate degradation via CoA ligation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00640	Propanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00650	Butanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko00930	Caprolactam degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko01100	Metabolic pathways	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045056	K01692	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMC200045059	K01509	ko00230	Purine metabolism	948	3.9e-46	0.42	0.59	0.90
PGSC0003DMC200033514	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033514	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033514	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033514	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033514	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033515	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033515	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033515	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033515	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033515	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMC200033516	K01758	ko00260	Glycine, serine and threonine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMC200033516	K01758	ko00270	Cysteine and methionine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMC200033516	K01758	ko00450	Selenoamino acid metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMC200033516	K01758	ko00910	Nitrogen metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMC200033516	K01758	ko01100	Metabolic pathways	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMC200033525	K05681	ko02010	ABC transporters	1336	7.5e-68	0.37	0.55	0.97
PGSC0003DMC200033529	K00008	ko00051	Fructose and mannose metabolism	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMC200033529	K00008	ko01100	Metabolic pathways	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMC200033530	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMC200033530	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMC200033531	K00008	ko00051	Fructose and mannose metabolism	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMC200033531	K00008	ko01100	Metabolic pathways	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMC200033532	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMC200033532	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMC200033534	K03943	ko00190	Oxidative phosphorylation	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMC200033534	K03943	ko01100	Metabolic pathways	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMC200033534	K03943	ko05010	Alzheimer's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMC200033534	K03943	ko05012	Parkinson's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMC200033534	K03943	ko05016	Huntington's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMC200033536	K00648	ko00061	Fatty acid biosynthesis	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMC200033536	K00648	ko01100	Metabolic pathways	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMC200033537	K11251	ko05322	Systemic lupus erythematosus	1025	1.1e-50	0.91	0.96	0.99
PGSC0003DMC200033539	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMC200033539	K12502	ko01100	Metabolic pathways	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMC200033539	K12502	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMC200033540	K01047	ko00564	Glycerophospholipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko00565	Ether lipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko00590	Arachidonic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko00591	Linoleic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko00592	alpha-Linolenic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko01100	Metabolic pathways	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04010	MAPK signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04270	Vascular smooth muscle contraction	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04370	VEGF signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04664	Fc epsilon RI signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04730	Long-term depression	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200033540	K01047	ko04912	GnRH signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMC200065191	K10601	ko04120	Ubiquitin mediated proteolysis	261	4.2e-08	0.31	0.41	0.93
PGSC0003DMC200065215	K00472	ko00330	Arginine and proline metabolism	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMC200065215	K00472	ko01100	Metabolic pathways	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMC200020883	K09526	ko04144	Endocytosis	327	1.8e-11	0.40	0.59	0.64
PGSC0003DMC200020885	K00858	ko00760	Nicotinate and nicotinamide metabolism	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMC200020885	K00858	ko01100	Metabolic pathways	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMC200020886	K00858	ko00760	Nicotinate and nicotinamide metabolism	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMC200020886	K00858	ko01100	Metabolic pathways	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMC200020887	K00858	ko00760	Nicotinate and nicotinamide metabolism	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMC200020887	K00858	ko01100	Metabolic pathways	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMC200020888	K00858	ko00760	Nicotinate and nicotinamide metabolism	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMC200020888	K00858	ko01100	Metabolic pathways	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMC200020890	K12929	ko00904	Diterpenoid biosynthesis	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMC200020890	K12929	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMC200020891	K04506	ko04115	p53 signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMC200020891	K04506	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMC200020891	K04506	ko04310	Wnt signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMC200020898	K05863	ko04020	Calcium signaling pathway	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMC200020898	K05863	ko05012	Parkinson's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMC200020898	K05863	ko05016	Huntington's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMC200010924	K00943	ko00240	Pyrimidine metabolism	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMC200010924	K00943	ko01100	Metabolic pathways	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMC200010925	K00943	ko00240	Pyrimidine metabolism	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMC200010925	K00943	ko01100	Metabolic pathways	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMC200010937	K03033	ko03050	Proteasome	3555	3.0e-190	0.87	0.92	1.00
PGSC0003DMC200010938	K03033	ko03050	Proteasome	2690	1.6e-142	0.73	0.84	0.92
PGSC0003DMC200010939	K03033	ko03050	Proteasome	3578	1.6e-191	0.88	0.93	1.00
PGSC0003DMC200010940	K10581	ko04120	Ubiquitin mediated proteolysis	5128	3.2e-279	0.63	0.74	0.94
PGSC0003DMC200010941	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMC200010942	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMC200010950	K01190	ko00052	Galactose metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMC200010950	K01190	ko00511	Other glycan degradation	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMC200010950	K01190	ko00600	Sphingolipid metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMC200010950	K01190	ko01100	Metabolic pathways	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMC200016239	K12876	ko03040	Spliceosome	1160	3.8e-58	0.74	0.84	0.78
PGSC0003DMC200016240	K12876	ko03040	Spliceosome	1290	2.6e-65	0.76	0.86	0.99
PGSC0003DMC200016241	K13065	ko00940	Phenylpropanoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMC200016241	K13065	ko00941	Flavonoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMC200016241	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMC200016241	K13065	ko01110	Biosynthesis of secondary metabolites	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMC200016256	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	238	2.7e-07	0.30	0.42	0.70
PGSC0003DMC200016257	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1028	7.3e-51	0.42	0.56	0.89
PGSC0003DMC200016258	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	374	8.6e-15	0.32	0.50	0.81
PGSC0003DMC200016259	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	327	3.4e-12	0.52	0.69	0.99
PGSC0003DMC200004711	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMC200004711	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMC200004712	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMC200004712	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMC200004714	K06664	ko04146	Peroxisome	902	6.5e-44	0.47	0.53	0.71
PGSC0003DMC200004715	K06664	ko04146	Peroxisome	411	7.8e-17	0.81	0.84	0.57
PGSC0003DMC200004716	K06664	ko04146	Peroxisome	746	2.6e-35	0.77	0.85	0.86
PGSC0003DMC200004730	K03843	ko00510	N-Glycan biosynthesis	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMC200004730	K03843	ko01100	Metabolic pathways	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMC200044110	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044110	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044110	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044110	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044110	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044110	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200044111	K07195	ko04910	Insulin signaling pathway	464	9.3e-20	0.71	0.84	0.66
PGSC0003DMC200044125	K13229	ko00402	Benzoxazinoid biosynthesis	1271	2.9e-64	0.45	0.65	0.98
PGSC0003DMC200044126	K13229	ko00402	Benzoxazinoid biosynthesis	1249	4.7e-63	0.45	0.64	0.99
PGSC0003DMC200044127	K13229	ko00402	Benzoxazinoid biosynthesis	1063	8.5e-53	0.47	0.66	0.95
PGSC0003DMC200044128	K13229	ko00402	Benzoxazinoid biosynthesis	1066	5.8e-53	0.48	0.66	0.96
PGSC0003DMC200037653	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037653	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037654	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037654	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037655	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037655	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMC200037656	K07385	ko00902	Monoterpenoid biosynthesis	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMC200037656	K07385	ko01100	Metabolic pathways	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMC200037659	K08901	ko00195	Photosynthesis	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMC200037659	K08901	ko01100	Metabolic pathways	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMC200037664	K04733	ko04210	Apoptosis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMC200037664	K04733	ko04620	Toll-like receptor signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMC200037664	K04733	ko04722	Neurotrophin signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMC200037664	K04733	ko05140	Leishmaniasis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMC200037664	K04733	ko05142	Chagas disease	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMC200037668	K04733	ko04210	Apoptosis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMC200037668	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMC200037668	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMC200037668	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMC200037668	K04733	ko05142	Chagas disease	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMC200037669	K04733	ko04210	Apoptosis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMC200037669	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMC200037669	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMC200037669	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMC200037669	K04733	ko05142	Chagas disease	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMC200037671	K04733	ko04210	Apoptosis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMC200037671	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMC200037671	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMC200037671	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMC200037671	K04733	ko05142	Chagas disease	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMC200037672	K00558	ko00270	Cysteine and methionine metabolism	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMC200037672	K00558	ko01100	Metabolic pathways	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMC200037677	K05933	ko00270	Cysteine and methionine metabolism	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMC200037677	K05933	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMC200037678	K05278	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMC200037678	K05278	ko01100	Metabolic pathways	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMC200037678	K05278	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMC200037680	K11820	ko00380	Tryptophan metabolism	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMC200037680	K11820	ko00966	Glucosinolate biosynthesis	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMC200037680	K11820	ko01110	Biosynthesis of secondary metabolites	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMC200035461	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMC200035461	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMC200035462	K04424	ko04010	MAPK signaling pathway	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMC200035462	K04424	ko04530	Tight junction	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMC200035463	K04424	ko04010	MAPK signaling pathway	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMC200035463	K04424	ko04530	Tight junction	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMC200035464	K04424	ko04010	MAPK signaling pathway	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMC200035464	K04424	ko04530	Tight junction	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMC200035466	K05741	ko04810	Regulation of actin cytoskeleton	280	3.4e-07	0.32	0.45	0.63
PGSC0003DMC200035467	K01595	ko00620	Pyruvate metabolism	7500	0.	0.91	0.97	1.00
PGSC0003DMC200035467	K01595	ko00710	Carbon fixation in photosynthetic organisms	7500	0.	0.91	0.97	1.00
PGSC0003DMC200035467	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7500	0.	0.91	0.97	1.00
PGSC0003DMC200035467	K01595	ko01100	Metabolic pathways	7500	0.	0.91	0.97	1.00
PGSC0003DMC200035468	K01595	ko00620	Pyruvate metabolism	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMC200035468	K01595	ko00710	Carbon fixation in photosynthetic organisms	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMC200035468	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMC200035468	K01595	ko01100	Metabolic pathways	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMC200035469	K01595	ko00620	Pyruvate metabolism	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMC200035469	K01595	ko00710	Carbon fixation in photosynthetic organisms	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMC200035469	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMC200035469	K01595	ko01100	Metabolic pathways	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMC200035476	K06630	ko04110	Cell cycle	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMC200035476	K06630	ko04114	Oocyte meiosis	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMC200035476	K06630	ko04722	Neurotrophin signaling pathway	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMC200035477	K00861	ko00740	Riboflavin metabolism	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMC200035477	K00861	ko01100	Metabolic pathways	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMC200035478	K00861	ko00740	Riboflavin metabolism	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMC200035478	K00861	ko01100	Metabolic pathways	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMC200047959	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047959	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047960	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMC200047960	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMC200047961	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047961	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047962	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047962	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047963	K04564	ko04146	Peroxisome	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMC200047963	K04564	ko05016	Huntington's disease	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMC200047964	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047964	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMC200047965	K04564	ko04146	Peroxisome	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMC200047965	K04564	ko05016	Huntington's disease	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMC200047966	K04564	ko04146	Peroxisome	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMC200047966	K04564	ko05016	Huntington's disease	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMC200047967	K03348	ko04110	Cell cycle	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047967	K03348	ko04111	Cell cycle - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047967	K03348	ko04113	Meiosis - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047967	K03348	ko04114	Oocyte meiosis	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047967	K03348	ko04120	Ubiquitin mediated proteolysis	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047967	K03348	ko04914	Progesterone-mediated oocyte maturation	8324	0.	0.69	0.80	0.99
PGSC0003DMC200047968	K03348	ko04110	Cell cycle	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047968	K03348	ko04111	Cell cycle - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047968	K03348	ko04113	Meiosis - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047968	K03348	ko04114	Oocyte meiosis	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047968	K03348	ko04120	Ubiquitin mediated proteolysis	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047968	K03348	ko04914	Progesterone-mediated oocyte maturation	10013	0.	0.66	0.78	1.00
PGSC0003DMC200047969	K03348	ko04110	Cell cycle	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200047969	K03348	ko04111	Cell cycle - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200047969	K03348	ko04113	Meiosis - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200047969	K03348	ko04114	Oocyte meiosis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200047969	K03348	ko04120	Ubiquitin mediated proteolysis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200047969	K03348	ko04914	Progesterone-mediated oocyte maturation	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMC200060203	K05282	ko00904	Diterpenoid biosynthesis	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMC200060203	K05282	ko01100	Metabolic pathways	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMC200060203	K05282	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMC200060205	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.9e-10	0.34	0.51	0.82
PGSC0003DMC200012918	K00901	ko00561	Glycerolipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMC200012918	K00901	ko00564	Glycerophospholipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMC200012918	K00901	ko01100	Metabolic pathways	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMC200012918	K00901	ko04070	Phosphatidylinositol signaling system	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMC200012919	K00901	ko00561	Glycerolipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMC200012919	K00901	ko00564	Glycerophospholipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMC200012919	K00901	ko01100	Metabolic pathways	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMC200012919	K00901	ko04070	Phosphatidylinositol signaling system	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMC200012920	K05658	ko02010	ABC transporters	7400	0.	0.62	0.76	0.98
PGSC0003DMC200012921	K05658	ko02010	ABC transporters	8550	0.	0.79	0.89	1.00
PGSC0003DMC200012927	K04733	ko04210	Apoptosis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMC200012927	K04733	ko04620	Toll-like receptor signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMC200012927	K04733	ko04722	Neurotrophin signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMC200012927	K04733	ko05140	Leishmaniasis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMC200012927	K04733	ko05142	Chagas disease	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMC200012930	K04371	ko04010	MAPK signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04012	ErbB signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04013	MAPK signaling pathway - fly	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04062	Chemokine signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04114	Oocyte meiosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04150	mTOR signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04270	Vascular smooth muscle contraction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04320	Dorso-ventral axis formation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04350	TGF-beta signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04360	Axon guidance	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04370	VEGF signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04510	Focal adhesion	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04520	Adherens junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04540	Gap junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04620	Toll-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04621	NOD-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04650	Natural killer cell mediated cytotoxicity	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04660	T cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04662	B cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04664	Fc epsilon RI signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04666	Fc gamma R-mediated phagocytosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04720	Long-term potentiation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04722	Neurotrophin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04730	Long-term depression	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04810	Regulation of actin cytoskeleton	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04910	Insulin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04912	GnRH signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04914	Progesterone-mediated oocyte maturation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04916	Melanogenesis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04930	Type II diabetes mellitus	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko04960	Aldosterone-regulated sodium reabsorption	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05010	Alzheimer's disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05020	Prion diseases	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05131	Shigellosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05140	Leishmaniasis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05142	Chagas disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05200	Pathways in cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05210	Colorectal cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05211	Renal cell carcinoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05212	Pancreatic cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05213	Endometrial cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05214	Glioma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05215	Prostate cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05216	Thyroid cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05218	Melanoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05219	Bladder cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05220	Chronic myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05221	Acute myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200012930	K04371	ko05223	Non-small cell lung cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMC200006456	K00754	ko00051	Fructose and mannose metabolism	281	3.2e-08	0.30	0.48	0.55
PGSC0003DMC200006457	K10688	ko04120	Ubiquitin mediated proteolysis	1349	1.4e-68	0.93	0.97	0.99
PGSC0003DMC200006464	K00128	ko00010	Glycolysis / Gluconeogenesis	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00053	Ascorbate and aldarate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00071	Fatty acid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00280	Valine, leucine and isoleucine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00310	Lysine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00330	Arginine and proline metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00340	Histidine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00380	Tryptophan metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00410	beta-Alanine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00561	Glycerolipid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00620	Pyruvate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00631	1,2-Dichloroethane degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00640	Propanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00641	3-Chloroacrylic acid degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00650	Butanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko01100	Metabolic pathways	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006464	K00128	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMC200006465	K00128	ko00010	Glycolysis / Gluconeogenesis	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00053	Ascorbate and aldarate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00071	Fatty acid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00280	Valine, leucine and isoleucine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00310	Lysine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00330	Arginine and proline metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00340	Histidine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00380	Tryptophan metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00410	beta-Alanine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00561	Glycerolipid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00620	Pyruvate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00631	1,2-Dichloroethane degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00640	Propanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00641	3-Chloroacrylic acid degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00650	Butanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko00903	Limonene and pinene degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko01100	Metabolic pathways	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006465	K00128	ko01110	Biosynthesis of secondary metabolites	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMC200006466	K00128	ko00010	Glycolysis / Gluconeogenesis	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00053	Ascorbate and aldarate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00071	Fatty acid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00280	Valine, leucine and isoleucine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00310	Lysine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00330	Arginine and proline metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00340	Histidine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00380	Tryptophan metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00410	beta-Alanine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00561	Glycerolipid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00620	Pyruvate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00631	1,2-Dichloroethane degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00640	Propanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00641	3-Chloroacrylic acid degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00650	Butanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko00903	Limonene and pinene degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko01100	Metabolic pathways	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006466	K00128	ko01110	Biosynthesis of secondary metabolites	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMC200006467	K00128	ko00010	Glycolysis / Gluconeogenesis	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00053	Ascorbate and aldarate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00071	Fatty acid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00280	Valine, leucine and isoleucine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00310	Lysine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00330	Arginine and proline metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00340	Histidine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00380	Tryptophan metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00410	beta-Alanine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00561	Glycerolipid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00620	Pyruvate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00631	1,2-Dichloroethane degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00640	Propanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00641	3-Chloroacrylic acid degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00650	Butanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko00903	Limonene and pinene degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko01100	Metabolic pathways	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006467	K00128	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMC200006476	K01051	ko00040	Pentose and glucuronate interconversions	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMC200006476	K01051	ko00500	Starch and sucrose metabolism	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMC200006476	K01051	ko01100	Metabolic pathways	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMC200029881	K00001	ko00010	Glycolysis / Gluconeogenesis	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00071	Fatty acid metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00350	Tyrosine metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00641	3-Chloroacrylic acid degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00830	Retinol metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko00982	Drug metabolism - cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko01100	Metabolic pathways	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029881	K00001	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMC200029882	K00001	ko00010	Glycolysis / Gluconeogenesis	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00071	Fatty acid metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00350	Tyrosine metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00641	3-Chloroacrylic acid degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00830	Retinol metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko00982	Drug metabolism - cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko01100	Metabolic pathways	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029882	K00001	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMC200029884	K00826	ko00280	Valine, leucine and isoleucine degradation	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMC200029884	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMC200029884	K00826	ko00770	Pantothenate and CoA biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMC200029884	K00826	ko01100	Metabolic pathways	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMC200029884	K00826	ko01110	Biosynthesis of secondary metabolites	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMC200029885	K00826	ko00280	Valine, leucine and isoleucine degradation	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMC200029885	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMC200029885	K00826	ko00770	Pantothenate and CoA biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMC200029885	K00826	ko01100	Metabolic pathways	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMC200029885	K00826	ko01110	Biosynthesis of secondary metabolites	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMC200029886	K10606	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.49	0.64	0.99
PGSC0003DMC200029887	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMC200029888	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMC200029889	K10606	ko04120	Ubiquitin mediated proteolysis	219	3.0e-06	0.55	0.67	0.94
PGSC0003DMC200029901	K12606	ko03018	RNA degradation	676	1.9e-31	0.44	0.61	0.86
PGSC0003DMC200036451	K00454	ko00591	Linoleic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMC200036451	K00454	ko00592	alpha-Linolenic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMC200036451	K00454	ko01100	Metabolic pathways	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMC200036454	K12877	ko03040	Spliceosome	1044	9.5e-52	0.90	0.96	0.58
PGSC0003DMC200036455	K12877	ko03040	Spliceosome	1194	5.1e-60	0.92	0.97	0.97
PGSC0003DMC200036457	K11420	ko00310	Lysine degradation	698	4.1e-32	0.38	0.52	0.34
PGSC0003DMC200036458	K11420	ko00310	Lysine degradation	710	8.5e-33	0.38	0.52	0.34
PGSC0003DMC200036459	K11421	ko00310	Lysine degradation	485	1.1e-34	0.34	0.50	0.68
PGSC0003DMC200036463	K00020	ko00280	Valine, leucine and isoleucine degradation	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMC200036463	K00020	ko01100	Metabolic pathways	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMC200036464	K00020	ko00280	Valine, leucine and isoleucine degradation	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMC200036464	K00020	ko01100	Metabolic pathways	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMC200036471	K01583	ko00330	Arginine and proline metabolism	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMC200036471	K01583	ko01100	Metabolic pathways	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMC200036472	K01583	ko00330	Arginine and proline metabolism	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMC200036472	K01583	ko01100	Metabolic pathways	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMC200036473	K01583	ko00330	Arginine and proline metabolism	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMC200036473	K01583	ko01100	Metabolic pathways	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMC200042901	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMC200042916	K01051	ko00040	Pentose and glucuronate interconversions	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMC200042916	K01051	ko00500	Starch and sucrose metabolism	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMC200042916	K01051	ko01100	Metabolic pathways	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMC200042917	K01051	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMC200042917	K01051	ko00500	Starch and sucrose metabolism	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMC200042917	K01051	ko01100	Metabolic pathways	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMC200042918	K01051	ko00040	Pentose and glucuronate interconversions	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMC200042918	K01051	ko00500	Starch and sucrose metabolism	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMC200042918	K01051	ko01100	Metabolic pathways	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMC200059895	K03094	ko04110	Cell cycle	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04111	Cell cycle - yeast	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04114	Oocyte meiosis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04120	Ubiquitin mediated proteolysis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04310	Wnt signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04350	TGF-beta signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200059895	K03094	ko04710	Circadian rhythm - mammal	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMC200007654	K08913	ko00196	Photosynthesis - antenna proteins	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMC200007654	K08913	ko01100	Metabolic pathways	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMC200007657	K09828	ko00100	Steroid biosynthesis	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMC200007657	K09828	ko01100	Metabolic pathways	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMC200007657	K09828	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMC200007658	K12478	ko04144	Endocytosis	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMC200007658	K12478	ko04145	Phagosome	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMC200007662	K12590	ko03018	RNA degradation	935	9.8e-46	0.59	0.67	0.85
PGSC0003DMC200007663	K12590	ko03018	RNA degradation	1612	4.5e-83	0.78	0.91	1.00
PGSC0003DMC200007664	K12590	ko03018	RNA degradation	844	1.0e-40	0.83	0.93	0.86
PGSC0003DMC200007665	K12590	ko03018	RNA degradation	799	3.1e-38	0.84	0.93	0.87
PGSC0003DMC200014101	K09756	ko00940	Phenylpropanoid biosynthesis	1781	2.1e-92	0.47	0.67	0.99
PGSC0003DMC200014118	K03030	ko03050	Proteasome	2584	1.1e-136	0.97	0.99	1.00
PGSC0003DMC200005462	K05592	ko03018	RNA degradation	786	1.6e-37	0.31	0.52	0.78
PGSC0003DMC200005481	K10755	ko03030	DNA replication	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMC200005481	K10755	ko03420	Nucleotide excision repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMC200005481	K10755	ko03430	Mismatch repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMC200005482	K10755	ko03030	DNA replication	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMC200005482	K10755	ko03420	Nucleotide excision repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMC200005482	K10755	ko03430	Mismatch repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMC200005483	K10755	ko03030	DNA replication	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMC200005483	K10755	ko03420	Nucleotide excision repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMC200005483	K10755	ko03430	Mismatch repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMC200005486	K01784	ko00052	Galactose metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMC200005486	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMC200005486	K01784	ko01100	Metabolic pathways	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMC200005487	K01784	ko00052	Galactose metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMC200005487	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMC200005487	K01784	ko01100	Metabolic pathways	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMC200017945	K00020	ko00280	Valine, leucine and isoleucine degradation	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMC200017945	K00020	ko01100	Metabolic pathways	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMC200017963	K07151	ko00510	N-Glycan biosynthesis	5704	0.	0.92	0.95	1.00
PGSC0003DMC200017963	K07151	ko01100	Metabolic pathways	5704	0.	0.92	0.95	1.00
PGSC0003DMC200017964	K07151	ko00510	N-Glycan biosynthesis	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMC200017964	K07151	ko01100	Metabolic pathways	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMC200017965	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMC200017966	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMC200017970	K11097	ko03040	Spliceosome	687	4.7e-32	0.98	0.98	0.91
PGSC0003DMC200061400	K01213	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMC200061400	K01213	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMC200061400	K01213	ko01100	Metabolic pathways	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMC200061403	K12126	ko04712	Circadian rhythm - plant	322	7.2e-12	0.29	0.47	0.82
PGSC0003DMC200050886	K12872	ko03040	Spliceosome	422	1.9e-17	0.83	0.88	0.55
PGSC0003DMC200050887	K12356	ko00940	Phenylpropanoid biosynthesis	404	1.9e-16	0.59	0.65	0.90
PGSC0003DMC200050891	K08241	ko00592	alpha-Linolenic acid metabolism	609	9.4e-28	0.34	0.53	0.92
PGSC0003DMC200050907	K13230	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.42	0.58	0.97
PGSC0003DMC200050908	K13230	ko00402	Benzoxazinoid biosynthesis	362	3.9e-14	0.47	0.66	0.74
PGSC0003DMC200046231	K01392	ko04614	Renin-angiotensin system	3227	3.8e-172	0.55	0.76	0.99
PGSC0003DMC200046232	K01392	ko04614	Renin-angiotensin system	3298	4.6e-176	0.57	0.79	0.99
PGSC0003DMC200046237	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMC200046237	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMC200046237	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMC200046237	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMC200046237	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMC200046241	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMC200046241	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMC200046242	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMC200046242	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMC200046243	K08233	ko00901	Indole alkaloid biosynthesis	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMC200046243	K08233	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMC200040921	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMC200040921	K00517	ko00626	Naphthalene and anthracene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMC200040921	K00517	ko00903	Limonene and pinene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMC200040921	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMC200040921	K00517	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMC200040922	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMC200040922	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMC200040922	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMC200040922	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMC200040922	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMC200040923	K00889	ko00562	Inositol phosphate metabolism	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040923	K00889	ko01100	Metabolic pathways	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040923	K00889	ko04070	Phosphatidylinositol signaling system	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040923	K00889	ko04144	Endocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040923	K00889	ko04666	Fc gamma R-mediated phagocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040923	K00889	ko04810	Regulation of actin cytoskeleton	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMC200040933	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3596	1.7e-192	0.74	0.84	0.99
PGSC0003DMC200040935	K00860	ko00230	Purine metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMC200040935	K00860	ko00450	Selenoamino acid metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMC200040935	K00860	ko00920	Sulfur metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMC200040935	K00860	ko01100	Metabolic pathways	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMC200040936	K00860	ko00230	Purine metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMC200040936	K00860	ko00450	Selenoamino acid metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMC200040936	K00860	ko00920	Sulfur metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMC200040936	K00860	ko01100	Metabolic pathways	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMC200040937	K03259	ko04150	mTOR signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMC200040937	K03259	ko04910	Insulin signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMC200040938	K12830	ko03040	Spliceosome	733	1.6e-31	0.25	0.41	0.95
PGSC0003DMC200040939	K12830	ko03040	Spliceosome	627	2.1e-25	0.24	0.40	0.94
PGSC0003DMC200040941	K02889	ko03010	Ribosome	1211	5.9e-61	0.84	0.92	0.99
PGSC0003DMC200034717	K04733	ko04210	Apoptosis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMC200034717	K04733	ko04620	Toll-like receptor signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMC200034717	K04733	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMC200034717	K04733	ko05140	Leishmaniasis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMC200034717	K04733	ko05142	Chagas disease	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMC200034720	K01199	ko00500	Starch and sucrose metabolism	1076	1.6e-53	0.41	0.57	0.94
PGSC0003DMC200034721	K01199	ko00500	Starch and sucrose metabolism	634	3.9e-29	0.45	0.69	0.91
PGSC0003DMC200034722	K01199	ko00500	Starch and sucrose metabolism	531	1.9e-23	0.45	0.67	0.93
PGSC0003DMC200034724	K04733	ko04210	Apoptosis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMC200034724	K04733	ko04620	Toll-like receptor signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMC200034724	K04733	ko04722	Neurotrophin signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMC200034724	K04733	ko05140	Leishmaniasis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMC200034724	K04733	ko05142	Chagas disease	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMC200034728	K04733	ko04210	Apoptosis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMC200034728	K04733	ko04620	Toll-like receptor signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMC200034728	K04733	ko04722	Neurotrophin signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMC200034728	K04733	ko05140	Leishmaniasis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMC200034728	K04733	ko05142	Chagas disease	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMC200034731	K02738	ko03050	Proteasome	468	5.6e-20	0.72	0.82	0.61
PGSC0003DMC200034739	K01853	ko00100	Steroid biosynthesis	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMC200034739	K01853	ko01100	Metabolic pathways	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMC200034739	K01853	ko01110	Biosynthesis of secondary metabolites	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMC200034740	K01853	ko00100	Steroid biosynthesis	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMC200034740	K01853	ko01100	Metabolic pathways	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMC200034740	K01853	ko01110	Biosynthesis of secondary metabolites	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMC200015031	K01069	ko00620	Pyruvate metabolism	657	2.1e-30	0.55	0.67	0.94
PGSC0003DMC200015032	K01069	ko00620	Pyruvate metabolism	861	1.2e-41	0.56	0.69	0.95
PGSC0003DMC200015033	K01069	ko00620	Pyruvate metabolism	987	1.3e-48	0.53	0.68	0.98
PGSC0003DMC200015035	K08914	ko00196	Photosynthesis - antenna proteins	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMC200015035	K08914	ko01100	Metabolic pathways	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMC200015036	K11252	ko05322	Systemic lupus erythematosus	892	2.3e-43	0.84	0.88	0.40
PGSC0003DMC200015037	K11252	ko05322	Systemic lupus erythematosus	1043	1.1e-51	0.89	0.93	0.99
PGSC0003DMC200015044	K01082	ko00920	Sulfur metabolism	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMC200015044	K01082	ko01100	Metabolic pathways	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMC200015055	K12484	ko04144	Endocytosis	280	2.2e-07	0.26	0.42	0.98
PGSC0003DMC200015056	K12484	ko04144	Endocytosis	272	1.7e-06	0.25	0.42	0.69
PGSC0003DMC200015058	K12484	ko04144	Endocytosis	272	1.3e-06	0.25	0.42	0.78
PGSC0003DMC200015060	K11252	ko05322	Systemic lupus erythematosus	1062	9.7e-53	0.89	0.91	0.99
PGSC0003DMC200009722	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMC200009722	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMC200009723	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMC200009723	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMC200009724	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMC200009724	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMC200009725	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMC200009725	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMC200009732	K01728	ko00040	Pentose and glucuronate interconversions	1570	9.3e-81	0.55	0.68	0.92
PGSC0003DMC200009733	K01728	ko00040	Pentose and glucuronate interconversions	1831	3.7e-95	0.59	0.71	0.84
PGSC0003DMC200009739	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMC200009739	K00517	ko00626	Naphthalene and anthracene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMC200009739	K00517	ko00903	Limonene and pinene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMC200009739	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMC200009739	K00517	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMC200003518	K12741	ko03040	Spliceosome	312	4.5e-11	0.36	0.45	0.32
PGSC0003DMC200003519	K09843	ko00906	Carotenoid biosynthesis	3082	3.7e-164	0.78	0.88	0.99
PGSC0003DMC200003520	K09843	ko00906	Carotenoid biosynthesis	1301	6.4e-66	0.75	0.86	0.99
PGSC0003DMC200003521	K09843	ko00906	Carotenoid biosynthesis	1713	1.2e-88	0.81	0.91	0.94
PGSC0003DMC200003528	K02886	ko03010	Ribosome	681	1.0e-31	0.48	0.64	0.96
PGSC0003DMC200003529	K06066	ko04330	Notch signaling pathway	697	1.3e-32	0.29	0.44	0.85
PGSC0003DMC200003530	K05681	ko02010	ABC transporters	1011	6.3e-50	0.41	0.59	0.91
PGSC0003DMC200003531	K05681	ko02010	ABC transporters	1391	6.9e-71	0.38	0.57	0.96
PGSC0003DMC200003533	K09840	ko00906	Carotenoid biosynthesis	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMC200003533	K09840	ko01100	Metabolic pathways	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMC200003533	K09840	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMC200003534	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003534	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003534	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003535	K09840	ko00906	Carotenoid biosynthesis	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMC200003535	K09840	ko01100	Metabolic pathways	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMC200003535	K09840	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMC200003536	K09840	ko00906	Carotenoid biosynthesis	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMC200003536	K09840	ko01100	Metabolic pathways	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMC200003536	K09840	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMC200003537	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003537	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003537	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMC200003538	K09840	ko00906	Carotenoid biosynthesis	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMC200003538	K09840	ko01100	Metabolic pathways	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMC200003538	K09840	ko01110	Biosynthesis of secondary metabolites	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMC200003539	K09840	ko00906	Carotenoid biosynthesis	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMC200003539	K09840	ko01100	Metabolic pathways	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMC200003539	K09840	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMC200069266	K12194	ko04144	Endocytosis	331	2.0e-12	0.50	0.71	0.33
PGSC0003DMC200000727	K06063	ko03040	Spliceosome	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMC200000727	K06063	ko04330	Notch signaling pathway	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMC200000729	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMC200000729	K02367	ko01100	Metabolic pathways	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMC200000730	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMC200000730	K02367	ko01100	Metabolic pathways	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMC200000731	K08139	ko04113	Meiosis - yeast	846	7.9e-41	0.35	0.56	0.87
PGSC0003DMC200000749	K10527	ko00592	alpha-Linolenic acid metabolism	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMC200000749	K10527	ko01100	Metabolic pathways	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMC200000750	K10527	ko00592	alpha-Linolenic acid metabolism	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMC200000750	K10527	ko01100	Metabolic pathways	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMC200069335	K10591	ko04120	Ubiquitin mediated proteolysis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMC200069335	K10591	ko04144	Endocytosis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMC200069337	K02183	ko04020	Calcium signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04070	Phosphatidylinositol signaling system	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04114	Oocyte meiosis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04270	Vascular smooth muscle contraction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04626	Plant-pathogen interaction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04720	Long-term potentiation	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04722	Neurotrophin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04740	Olfactory transduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04744	Phototransduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04745	Phototransduction - fly	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04910	Insulin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04912	GnRH signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04916	Melanogenesis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04970	Salivary secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko04971	Gastric acid secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko05010	Alzheimer's disease	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069337	K02183	ko05214	Glioma	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMC200069358	K12132	ko04712	Circadian rhythm - plant	1051	3.9e-52	0.51	0.67	0.77
PGSC0003DMC200015541	K00620	ko00330	Arginine and proline metabolism	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMC200015541	K00620	ko01100	Metabolic pathways	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMC200015541	K00620	ko01110	Biosynthesis of secondary metabolites	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMC200015560	K12611	ko03018	RNA degradation	452	4.3e-19	0.34	0.55	0.90
PGSC0003DMC200015561	K12611	ko03018	RNA degradation	543	4.1e-24	0.29	0.49	0.94
PGSC0003DMC200015562	K12611	ko03018	RNA degradation	526	3.5e-23	0.30	0.49	0.87
PGSC0003DMC200015563	K12611	ko03018	RNA degradation	281	1.2e-09	0.28	0.45	0.90
PGSC0003DMC200015564	K05746	ko04810	Regulation of actin cytoskeleton	237	1.7e-06	0.36	0.45	0.63
PGSC0003DMC200015568	K12733	ko03040	Spliceosome	1300	7.2e-66	0.90	0.96	0.99
PGSC0003DMC200028689	K00558	ko00270	Cysteine and methionine metabolism	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMC200028689	K00558	ko01100	Metabolic pathways	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMC200028710	K01252	ko01053	Biosynthesis of siderophore group nonribosomal peptides	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMC200028710	K01252	ko01110	Biosynthesis of secondary metabolites	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMC200003061	K10742	ko03030	DNA replication	4201	7.1e-226	0.70	0.82	0.98
PGSC0003DMC200003062	K10742	ko03030	DNA replication	3430	2.4e-183	0.68	0.81	1.00
PGSC0003DMC200003070	K10601	ko04120	Ubiquitin mediated proteolysis	233	1.4e-06	0.38	0.59	0.46
PGSC0003DMC200003071	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMC200003071	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMC200003072	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMC200003072	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMC200003075	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMC200003075	K03861	ko01100	Metabolic pathways	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMC200003080	K01528	ko04144	Endocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMC200003080	K01528	ko04666	Fc gamma R-mediated phagocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMC200003080	K01528	ko05100	Bacterial invasion of epithelial cells	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMC200003087	K03849	ko00510	N-Glycan biosynthesis	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMC200003087	K03849	ko01100	Metabolic pathways	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMC200021699	K03031	ko03050	Proteasome	1854	2.0e-96	0.82	0.90	1.00
PGSC0003DMC200021700	K03031	ko03050	Proteasome	1867	3.9e-97	0.83	0.91	1.00
PGSC0003DMC200021709	K09458	ko00061	Fatty acid biosynthesis	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMC200021709	K09458	ko01100	Metabolic pathways	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMC200021710	K09458	ko00061	Fatty acid biosynthesis	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMC200021710	K09458	ko01100	Metabolic pathways	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMC200057494	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMC200057494	K00517	ko00626	Naphthalene and anthracene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMC200057494	K00517	ko00903	Limonene and pinene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMC200057494	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMC200057494	K00517	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMC200046754	K08488	ko04130	SNARE interactions in vesicular transport	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMC200046754	K08488	ko04145	Phagosome	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMC200046756	K13056	ko04114	Oocyte meiosis	259	1.9e-08	0.29	0.43	0.60
PGSC0003DMC200046757	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMC200046758	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMC200046764	K00071	ko00140	Steroid hormone biosynthesis	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMC200046764	K00071	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMC200046764	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMC200046765	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	411	3.2e-16	0.30	0.44	0.98
PGSC0003DMC200046770	K00162	ko00010	Glycolysis / Gluconeogenesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko00020	Citrate cycle (TCA cycle)	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko00620	Pyruvate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko00650	Butanoate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko01100	Metabolic pathways	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200046770	K00162	ko01110	Biosynthesis of secondary metabolites	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMC200034271	K00308	ko04146	Peroxisome	288	1.2e-09	0.45	0.66	0.66
PGSC0003DMC200034273	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMC200034273	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMC200034273	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMC200034273	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMC200034273	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMC200034274	K04733	ko04210	Apoptosis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMC200034274	K04733	ko04620	Toll-like receptor signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMC200034274	K04733	ko04722	Neurotrophin signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMC200034274	K04733	ko05140	Leishmaniasis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMC200034274	K04733	ko05142	Chagas disease	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMC200034279	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200034279	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200034279	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200034279	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200034282	K04733	ko04210	Apoptosis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMC200034282	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMC200034282	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMC200034282	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMC200034282	K04733	ko05142	Chagas disease	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMC200034283	K04733	ko04210	Apoptosis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMC200034283	K04733	ko04620	Toll-like receptor signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMC200034283	K04733	ko04722	Neurotrophin signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMC200034283	K04733	ko05140	Leishmaniasis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMC200034283	K04733	ko05142	Chagas disease	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMC200034285	K00799	ko00480	Glutathione metabolism	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMC200034285	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMC200034285	K00799	ko00982	Drug metabolism - cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMC200034286	K12864	ko03040	Spliceosome	3476	6.9e-186	0.78	0.88	1.00
PGSC0003DMC200034287	K12864	ko03040	Spliceosome	2287	2.6e-120	0.72	0.80	0.99
PGSC0003DMC200052894	K02866	ko03010	Ribosome	1779	2.8e-92	0.93	0.97	0.99
PGSC0003DMC200052898	K08008	ko04145	Phagosome	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMC200052898	K08008	ko04670	Leukocyte transendothelial migration	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMC200052901	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.48	0.65	0.99
PGSC0003DMC200052902	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.98	0.99
PGSC0003DMC200052909	K03946	ko00190	Oxidative phosphorylation	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMC200052909	K03946	ko01100	Metabolic pathways	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMC200052909	K03946	ko05010	Alzheimer's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMC200052909	K03946	ko05012	Parkinson's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMC200052909	K03946	ko05016	Huntington's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMC200052910	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200052911	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200052912	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200052913	K11254	ko05322	Systemic lupus erythematosus	513	1.8e-22	1.00	1.00	0.94
PGSC0003DMC200052917	K03283	ko03040	Spliceosome	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMC200052917	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMC200052917	K03283	ko04144	Endocytosis	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMC200052917	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMC200052919	K08332	ko04140	Regulation of autophagy	310	5.5e-11	0.30	0.52	0.77
PGSC0003DMC200052920	K08332	ko04140	Regulation of autophagy	310	1.4e-08	0.30	0.52	0.39
PGSC0003DMC200038851	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMC200038851	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMC200038852	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMC200038852	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMC200038859	K02183	ko04020	Calcium signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04070	Phosphatidylinositol signaling system	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04114	Oocyte meiosis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04270	Vascular smooth muscle contraction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04626	Plant-pathogen interaction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04720	Long-term potentiation	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04740	Olfactory transduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04744	Phototransduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04745	Phototransduction - fly	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04910	Insulin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04912	GnRH signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04916	Melanogenesis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04970	Salivary secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko04971	Gastric acid secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko05010	Alzheimer's disease	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038859	K02183	ko05214	Glioma	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMC200038860	K02183	ko04020	Calcium signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04070	Phosphatidylinositol signaling system	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04114	Oocyte meiosis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04270	Vascular smooth muscle contraction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04626	Plant-pathogen interaction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04720	Long-term potentiation	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04722	Neurotrophin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04740	Olfactory transduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04744	Phototransduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04745	Phototransduction - fly	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04910	Insulin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04912	GnRH signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04916	Melanogenesis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04970	Salivary secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko04971	Gastric acid secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko05010	Alzheimer's disease	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038860	K02183	ko05214	Glioma	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMC200038861	K02183	ko04020	Calcium signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04070	Phosphatidylinositol signaling system	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04114	Oocyte meiosis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04270	Vascular smooth muscle contraction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04626	Plant-pathogen interaction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04720	Long-term potentiation	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04740	Olfactory transduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04744	Phototransduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04745	Phototransduction - fly	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04910	Insulin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04912	GnRH signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04916	Melanogenesis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04970	Salivary secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko04971	Gastric acid secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko05010	Alzheimer's disease	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200038861	K02183	ko05214	Glioma	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMC200067811	K02893	ko03010	Ribosome	483	8.3e-21	0.84	0.87	0.92
PGSC0003DMC200024703	K10702	ko00642	Ethylbenzene degradation	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMC200024703	K10702	ko01100	Metabolic pathways	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMC200024705	K00951	ko00230	Purine metabolism	1234	3.2e-62	0.40	0.57	0.67
PGSC0003DMC200024706	K00951	ko00230	Purine metabolism	940	5.2e-46	0.43	0.65	0.59
PGSC0003DMC200024707	K00951	ko00230	Purine metabolism	1219	2.1e-61	0.45	0.64	0.61
PGSC0003DMC200024708	K00430	ko00360	Phenylalanine metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMC200024708	K00430	ko00680	Methane metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMC200024708	K00430	ko00940	Phenylpropanoid biosynthesis	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMC200024708	K00430	ko01100	Metabolic pathways	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMC200024708	K00430	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMC200024709	K00430	ko00360	Phenylalanine metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMC200024709	K00430	ko00680	Methane metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMC200024709	K00430	ko00940	Phenylpropanoid biosynthesis	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMC200024709	K00430	ko01100	Metabolic pathways	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMC200024709	K00430	ko01110	Biosynthesis of secondary metabolites	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMC200024710	K00430	ko00360	Phenylalanine metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMC200024710	K00430	ko00680	Methane metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMC200024710	K00430	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMC200024710	K00430	ko01100	Metabolic pathways	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMC200024710	K00430	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMC200024711	K00430	ko00360	Phenylalanine metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMC200024711	K00430	ko00680	Methane metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMC200024711	K00430	ko00940	Phenylpropanoid biosynthesis	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMC200024711	K00430	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMC200024711	K00430	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMC200024713	K03217	ko03060	Protein export	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMC200024713	K03217	ko03070	Bacterial secretion system	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMC200024720	K05849	ko04020	Calcium signaling pathway	323	2.2e-11	0.34	0.52	0.65
PGSC0003DMC200005928	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMC200005928	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMC200005928	K12366	ko05131	Shigellosis	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMC200005933	K12885	ko03040	Spliceosome	434	4.2e-18	0.33	0.42	0.87
PGSC0003DMC200005934	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMC200005934	K00517	ko00626	Naphthalene and anthracene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMC200005934	K00517	ko00903	Limonene and pinene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMC200005934	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMC200005934	K00517	ko01110	Biosynthesis of secondary metabolites	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMC200005935	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMC200005935	K00517	ko00626	Naphthalene and anthracene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMC200005935	K00517	ko00903	Limonene and pinene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMC200005935	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMC200005935	K00517	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMC200005936	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMC200005936	K00517	ko00626	Naphthalene and anthracene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMC200005936	K00517	ko00903	Limonene and pinene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMC200005936	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMC200005936	K00517	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMC200005937	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMC200005937	K00517	ko00626	Naphthalene and anthracene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMC200005937	K00517	ko00903	Limonene and pinene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMC200005937	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMC200005937	K00517	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMC200005938	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMC200005938	K00517	ko00626	Naphthalene and anthracene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMC200005938	K00517	ko00903	Limonene and pinene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMC200005938	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMC200005938	K00517	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMC200005939	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMC200005939	K00517	ko00626	Naphthalene and anthracene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMC200005939	K00517	ko00903	Limonene and pinene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMC200005939	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMC200005939	K00517	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMC200005940	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMC200005940	K00517	ko00626	Naphthalene and anthracene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMC200005940	K00517	ko00903	Limonene and pinene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMC200005940	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMC200005940	K00517	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMC200017437	K01115	ko00564	Glycerophospholipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017437	K01115	ko00565	Ether lipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017437	K01115	ko01100	Metabolic pathways	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017437	K01115	ko04144	Endocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017437	K01115	ko04666	Fc gamma R-mediated phagocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017437	K01115	ko04912	GnRH signaling pathway	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMC200017438	K01115	ko00564	Glycerophospholipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017438	K01115	ko00565	Ether lipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017438	K01115	ko01100	Metabolic pathways	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017438	K01115	ko04144	Endocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017438	K01115	ko04666	Fc gamma R-mediated phagocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017438	K01115	ko04912	GnRH signaling pathway	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMC200017439	K01115	ko00564	Glycerophospholipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017439	K01115	ko00565	Ether lipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017439	K01115	ko01100	Metabolic pathways	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017439	K01115	ko04144	Endocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017439	K01115	ko04666	Fc gamma R-mediated phagocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017439	K01115	ko04912	GnRH signaling pathway	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMC200017445	K01176	ko00500	Starch and sucrose metabolism	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMC200017445	K01176	ko01100	Metabolic pathways	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMC200017447	K01176	ko00500	Starch and sucrose metabolism	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMC200017447	K01176	ko01100	Metabolic pathways	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMC200017448	K01176	ko00500	Starch and sucrose metabolism	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMC200017448	K01176	ko01100	Metabolic pathways	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMC200017453	K07466	ko03030	DNA replication	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMC200017453	K07466	ko03420	Nucleotide excision repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMC200017453	K07466	ko03430	Mismatch repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMC200017453	K07466	ko03440	Homologous recombination	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMC200017459	K00121	ko00010	Glycolysis / Gluconeogenesis	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00071	Fatty acid metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00350	Tyrosine metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00641	3-Chloroacrylic acid degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00680	Methane metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00830	Retinol metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko00982	Drug metabolism - cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko01100	Metabolic pathways	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200017459	K00121	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMC200019694	K06268	ko04010	MAPK signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04020	Calcium signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04114	Oocyte meiosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04210	Apoptosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04310	Wnt signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04360	Axon guidance	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04370	VEGF signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04650	Natural killer cell mediated cytotoxicity	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04660	T cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04662	B cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko04720	Long-term potentiation	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko05010	Alzheimer's disease	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019694	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMC200019704	K07297	ko04920	Adipocytokine signaling pathway	1710	1.8e-88	0.56	0.73	0.99
PGSC0003DMC200019705	K07297	ko04920	Adipocytokine signaling pathway	1087	4.1e-54	0.68	0.81	0.95
PGSC0003DMC200019706	K11424	ko00310	Lysine degradation	1074	2.1e-53	0.38	0.52	0.39
PGSC0003DMC200019707	K04514	ko04062	Chemokine signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04270	Vascular smooth muscle contraction	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04310	Wnt signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04350	TGF-beta signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04360	Axon guidance	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04510	Focal adhesion	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04670	Leukocyte transendothelial migration	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko04810	Regulation of actin cytoskeleton	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019707	K04514	ko05131	Shigellosis	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMC200019708	K04514	ko04062	Chemokine signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04270	Vascular smooth muscle contraction	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04310	Wnt signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04350	TGF-beta signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04360	Axon guidance	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04510	Focal adhesion	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04670	Leukocyte transendothelial migration	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko04810	Regulation of actin cytoskeleton	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019708	K04514	ko05131	Shigellosis	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMC200019709	K11424	ko00310	Lysine degradation	859	1.5e-41	0.51	0.68	0.83
PGSC0003DMC200019710	K11424	ko00310	Lysine degradation	602	2.3e-27	0.52	0.67	0.77
PGSC0003DMC200055892	K10760	ko00908	Zeatin biosynthesis	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMC200055892	K10760	ko01100	Metabolic pathways	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMC200055892	K10760	ko01110	Biosynthesis of secondary metabolites	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMC200055898	K12524	ko00260	Glycine, serine and threonine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMC200055898	K12524	ko00270	Cysteine and methionine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMC200055898	K12524	ko00300	Lysine biosynthesis	5788	0.	0.75	0.86	1.00
PGSC0003DMC200055898	K12524	ko01100	Metabolic pathways	5788	0.	0.75	0.86	1.00
PGSC0003DMC200055898	K12524	ko01110	Biosynthesis of secondary metabolites	5788	0.	0.75	0.86	1.00
PGSC0003DMC200055904	K02084	ko04115	p53 signaling pathway	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko04210	Apoptosis	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko05010	Alzheimer's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko05012	Parkinson's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko05016	Huntington's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055904	K02084	ko05222	Small cell lung cancer	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMC200055906	K03544	ko04112	Cell cycle - Caulobacter	3973	2.7e-213	0.74	0.81	0.98
PGSC0003DMC200055907	K03544	ko04112	Cell cycle - Caulobacter	3866	2.1e-207	0.75	0.82	0.97
PGSC0003DMC200055916	K02936	ko03010	Ribosome	1691	2.0e-87	0.86	0.94	0.92
PGSC0003DMC200055917	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMC200055918	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMC200055919	K02936	ko03010	Ribosome	405	1.7e-16	0.87	0.98	0.98
PGSC0003DMC200055920	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMC200055920	K02367	ko01100	Metabolic pathways	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMC200048493	K01366	ko04142	Lysosome	581	3.3e-26	0.57	0.69	0.90
PGSC0003DMC200048494	K01366	ko04142	Lysosome	2092	1.5e-109	0.71	0.82	0.99
PGSC0003DMC200048504	K05849	ko04020	Calcium signaling pathway	436	3.1e-15	0.34	0.55	0.18
PGSC0003DMC200025894	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMC200025902	K02875	ko03010	Ribosome	1015	3.8e-50	0.90	0.96	0.99
PGSC0003DMC200025903	K12192	ko04144	Endocytosis	1153	9.3e-58	0.77	0.91	0.95
PGSC0003DMC200025910	K12126	ko04712	Circadian rhythm - plant	745	3.0e-35	0.37	0.49	0.77
PGSC0003DMC200025911	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.72
PGSC0003DMC200025912	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.73
PGSC0003DMC200025916	K11816	ko00380	Tryptophan metabolism	2517	5.4e-133	0.72	0.86	0.97
PGSC0003DMC200025917	K03869	ko04120	Ubiquitin mediated proteolysis	437	6.3e-18	0.33	0.54	0.95
PGSC0003DMC200018497	K04733	ko04210	Apoptosis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMC200018497	K04733	ko04620	Toll-like receptor signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMC200018497	K04733	ko04722	Neurotrophin signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMC200018497	K04733	ko05140	Leishmaniasis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMC200018497	K04733	ko05142	Chagas disease	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMC200018508	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMC200018508	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMC200018508	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMC200018508	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMC200018508	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMC200018509	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMC200018509	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMC200018509	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMC200018509	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMC200018509	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMC200066604	K01213	ko00040	Pentose and glucuronate interconversions	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMC200066604	K01213	ko00500	Starch and sucrose metabolism	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMC200066604	K01213	ko01100	Metabolic pathways	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMC200066623	K02893	ko03010	Ribosome	1066	5.8e-53	0.85	0.90	0.99
PGSC0003DMC200054691	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMC200054691	K12448	ko01100	Metabolic pathways	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMC200054696	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMC200054696	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMC200054697	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko04210	Apoptosis	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko05016	Huntington's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054697	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMC200054698	K02084	ko04115	p53 signaling pathway	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko04210	Apoptosis	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko05010	Alzheimer's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko05012	Parkinson's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko05016	Huntington's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054698	K02084	ko05222	Small cell lung cancer	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMC200054711	K00279	ko00908	Zeatin biosynthesis	453	3.8e-19	0.58	0.74	0.96
PGSC0003DMC200054712	K00279	ko00908	Zeatin biosynthesis	1140	4.8e-57	0.61	0.72	0.95
PGSC0003DMC200054713	K00279	ko00908	Zeatin biosynthesis	2560	2.3e-135	0.60	0.74	0.99
PGSC0003DMC200054714	K00279	ko00908	Zeatin biosynthesis	2652	1.9e-140	0.62	0.77	0.92
PGSC0003DMC200054718	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMC200054718	K00517	ko00626	Naphthalene and anthracene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMC200054718	K00517	ko00903	Limonene and pinene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMC200054718	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMC200054718	K00517	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMC200054719	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMC200054719	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMC200054719	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMC200054719	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMC200054719	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMC200047432	K00889	ko00562	Inositol phosphate metabolism	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047432	K00889	ko01100	Metabolic pathways	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047432	K00889	ko04070	Phosphatidylinositol signaling system	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047432	K00889	ko04144	Endocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047432	K00889	ko04666	Fc gamma R-mediated phagocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047432	K00889	ko04810	Regulation of actin cytoskeleton	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMC200047435	K05279	ko00944	Flavone and flavonol biosynthesis	1066	5.8e-53	0.51	0.70	0.99
PGSC0003DMC200047436	K13066	ko00940	Phenylpropanoid biosynthesis	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMC200047436	K13066	ko01110	Biosynthesis of secondary metabolites	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMC200047446	K03403	ko00860	Porphyrin and chlorophyll metabolism	9108	0.	0.85	0.93	0.91
PGSC0003DMC200047446	K03403	ko01100	Metabolic pathways	9108	0.	0.85	0.93	0.91
PGSC0003DMC200047446	K03403	ko01110	Biosynthesis of secondary metabolites	9108	0.	0.85	0.93	0.91
PGSC0003DMC200047451	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMC200047451	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMC200047452	K09756	ko00940	Phenylpropanoid biosynthesis	1094	1.7e-54	0.45	0.69	0.89
PGSC0003DMC200047453	K09756	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.52	0.73	0.87
PGSC0003DMC200047454	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMC200047454	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMC200032078	K01510	ko00230	Purine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMC200032078	K01510	ko00240	Pyrimidine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMC200032079	K01510	ko00230	Purine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMC200032079	K01510	ko00240	Pyrimidine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMC200032083	K13030	ko00460	Cyanoamino acid metabolism	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMC200032083	K13030	ko01110	Biosynthesis of secondary metabolites	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMC200032084	K13030	ko00460	Cyanoamino acid metabolism	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMC200032084	K13030	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMC200032094	K08243	ko00941	Flavonoid biosynthesis	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMC200032094	K08243	ko01110	Biosynthesis of secondary metabolites	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMC200032095	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032095	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032095	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032095	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032095	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032095	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMC200032096	K08243	ko00941	Flavonoid biosynthesis	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMC200032096	K08243	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMC200032097	K02881	ko03010	Ribosome	289	4.2e-10	0.43	0.61	0.60
PGSC0003DMC200032098	K02881	ko03010	Ribosome	352	1.4e-13	0.39	0.54	0.85
PGSC0003DMC200049685	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.57
PGSC0003DMC200049686	K01507	ko00190	Oxidative phosphorylation	2272	1.8e-119	0.96	0.99	1.00
PGSC0003DMC200049687	K01507	ko00190	Oxidative phosphorylation	228	5.0e-06	0.64	0.87	0.68
PGSC0003DMC200049691	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMC200049691	K01563	ko00626	Naphthalene and anthracene degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMC200049691	K01563	ko00631	1,2-Dichloroethane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMC200049691	K01563	ko00641	3-Chloroacrylic acid degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMC200049691	K01563	ko01100	Metabolic pathways	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMC200049698	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	271	2.3e-08	0.34	0.45	0.97
PGSC0003DMC200049699	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	340	4.4e-12	0.29	0.45	0.91
PGSC0003DMC200049709	K01115	ko00564	Glycerophospholipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049709	K01115	ko00565	Ether lipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049709	K01115	ko01100	Metabolic pathways	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049709	K01115	ko04144	Endocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049709	K01115	ko04666	Fc gamma R-mediated phagocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049709	K01115	ko04912	GnRH signaling pathway	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMC200049710	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049710	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049710	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049710	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049710	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049710	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMC200000212	K04427	ko04010	MAPK signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04310	Wnt signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04520	Adherens junction	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04620	Toll-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04621	NOD-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04622	RIG-I-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko04660	T cell receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000212	K04427	ko05140	Leishmaniasis	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMC200000235	K12356	ko00940	Phenylpropanoid biosynthesis	690	3.2e-32	0.31	0.50	0.94
PGSC0003DMC200016747	K01834	ko00010	Glycolysis / Gluconeogenesis	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMC200016747	K01834	ko01100	Metabolic pathways	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMC200016747	K01834	ko01110	Biosynthesis of secondary metabolites	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMC200016748	K01834	ko00010	Glycolysis / Gluconeogenesis	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMC200016748	K01834	ko01100	Metabolic pathways	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMC200016748	K01834	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMC200016750	K06634	ko03420	Nucleotide excision repair	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMC200016750	K06634	ko04110	Cell cycle	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMC200016751	K06634	ko03420	Nucleotide excision repair	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMC200016751	K06634	ko04110	Cell cycle	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMC200016752	K06634	ko03420	Nucleotide excision repair	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMC200016752	K06634	ko04110	Cell cycle	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMC200016753	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016753	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016754	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016754	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016755	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016755	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMC200016756	K06634	ko03420	Nucleotide excision repair	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMC200016756	K06634	ko04110	Cell cycle	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMC200016764	K01087	ko00500	Starch and sucrose metabolism	1865	5.0e-97	0.73	0.84	0.82
PGSC0003DMC200027484	K01768	ko00230	Purine metabolism	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMC200027484	K01768	ko04113	Meiosis - yeast	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMC200027506	K12881	ko03040	Spliceosome	1485	4.5e-76	0.68	0.79	1.00
PGSC0003DMC200027507	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMC200027508	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMC200027509	K12881	ko03040	Spliceosome	814	4.6e-39	0.65	0.78	0.99
PGSC0003DMC200027510	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMC200022903	K01213	ko00040	Pentose and glucuronate interconversions	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMC200022903	K01213	ko00500	Starch and sucrose metabolism	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMC200022903	K01213	ko01100	Metabolic pathways	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMC200022913	K12815	ko03040	Spliceosome	415	4.4e-16	0.27	0.45	0.93
PGSC0003DMC200022914	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.35	0.55	0.70
PGSC0003DMC200022915	K01199	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.38	0.58	0.53
PGSC0003DMC200022916	K00889	ko00562	Inositol phosphate metabolism	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200022916	K00889	ko01100	Metabolic pathways	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200022916	K00889	ko04070	Phosphatidylinositol signaling system	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200022916	K00889	ko04144	Endocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200022916	K00889	ko04666	Fc gamma R-mediated phagocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200022916	K00889	ko04810	Regulation of actin cytoskeleton	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMC200004271	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMC200004273	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMC200004273	K05928	ko01100	Metabolic pathways	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMC200004273	K05928	ko01110	Biosynthesis of secondary metabolites	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMC200004274	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMC200004274	K05928	ko01100	Metabolic pathways	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMC200004274	K05928	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMC200004275	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMC200004275	K05928	ko01100	Metabolic pathways	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMC200004275	K05928	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMC200004278	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMC200004278	K00517	ko00626	Naphthalene and anthracene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMC200004278	K00517	ko00903	Limonene and pinene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMC200004278	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMC200004278	K00517	ko01110	Biosynthesis of secondary metabolites	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMC200004281	K02866	ko03010	Ribosome	1450	3.9e-74	0.92	0.95	0.99
PGSC0003DMC200004284	K03063	ko03050	Proteasome	2698	5.7e-143	0.98	0.99	1.00
PGSC0003DMC200004285	K03063	ko03050	Proteasome	366	2.4e-14	0.67	0.79	0.99
PGSC0003DMC200008866	K01598	ko00770	Pantothenate and CoA biosynthesis	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMC200008866	K01598	ko01100	Metabolic pathways	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMC200008868	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMC200008868	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMC200008868	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMC200008869	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMC200008869	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMC200008869	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMC200008870	K00432	ko00480	Glutathione metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMC200008870	K00432	ko00590	Arachidonic acid metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMC200008871	K00432	ko00480	Glutathione metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMC200008871	K00432	ko00590	Arachidonic acid metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMC200008872	K00432	ko00480	Glutathione metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMC200008872	K00432	ko00590	Arachidonic acid metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMC200008873	K00432	ko00480	Glutathione metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMC200008873	K00432	ko00590	Arachidonic acid metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMC200008874	K00432	ko00480	Glutathione metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMC200008874	K00432	ko00590	Arachidonic acid metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMC200008875	K00432	ko00480	Glutathione metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMC200008875	K00432	ko00590	Arachidonic acid metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMC200062583	K10760	ko00908	Zeatin biosynthesis	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMC200062583	K10760	ko01100	Metabolic pathways	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMC200062583	K10760	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMC200001921	K02112	ko00190	Oxidative phosphorylation	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMC200001921	K02112	ko00195	Photosynthesis	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMC200001921	K02112	ko01100	Metabolic pathways	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMC200001922	K01112	ko00051	Fructose and mannose metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMC200001922	K01112	ko00730	Thiamine metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMC200001922	K01112	ko00740	Riboflavin metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMC200001922	K01112	ko01100	Metabolic pathways	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMC200001923	K01112	ko00051	Fructose and mannose metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMC200001923	K01112	ko00730	Thiamine metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMC200001923	K01112	ko00740	Riboflavin metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMC200001923	K01112	ko01100	Metabolic pathways	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMC200001935	K05746	ko04810	Regulation of actin cytoskeleton	371	4.1e-14	0.36	0.42	0.55
PGSC0003DMC200001948	K00600	ko00260	Glycine, serine and threonine metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200001948	K00600	ko00460	Cyanoamino acid metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200001948	K00600	ko00670	One carbon pool by folate	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200001948	K00600	ko00680	Methane metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200001948	K00600	ko01100	Metabolic pathways	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200001948	K00600	ko01110	Biosynthesis of secondary metabolites	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMC200058683	K03122	ko03022	Basal transcription factors	321	7.2e-12	0.31	0.55	0.84
PGSC0003DMC200045554	K00030	ko00020	Citrate cycle (TCA cycle)	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMC200045554	K00030	ko01100	Metabolic pathways	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMC200045554	K00030	ko01110	Biosynthesis of secondary metabolites	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMC200045555	K11419	ko00310	Lysine degradation	655	6.0e-30	0.39	0.54	0.25
PGSC0003DMC200045561	K02214	ko04110	Cell cycle	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMC200045561	K02214	ko04111	Cell cycle - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMC200045561	K02214	ko04113	Meiosis - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMC200045562	K02214	ko04110	Cell cycle	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMC200045562	K02214	ko04111	Cell cycle - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMC200045562	K02214	ko04113	Meiosis - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMC200045563	K02214	ko04110	Cell cycle	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMC200045563	K02214	ko04111	Cell cycle - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMC200045563	K02214	ko04113	Meiosis - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMC200045565	K06096	ko04530	Tight junction	297	1.5e-10	0.34	0.51	0.81
PGSC0003DMC200045566	K02884	ko03010	Ribosome	380	4.0e-15	0.43	0.68	0.50
PGSC0003DMC200051693	K03364	ko04110	Cell cycle	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMC200051693	K03364	ko04111	Cell cycle - yeast	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMC200051693	K03364	ko04120	Ubiquitin mediated proteolysis	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMC200051693	K03364	ko04914	Progesterone-mediated oocyte maturation	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMC200051694	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051694	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051694	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051694	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051695	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051695	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051695	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051695	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMC200051696	K05350	ko00460	Cyanoamino acid metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMC200051696	K05350	ko00500	Starch and sucrose metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMC200051696	K05350	ko00940	Phenylpropanoid biosynthesis	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMC200051696	K05350	ko01110	Biosynthesis of secondary metabolites	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMC200051697	K05350	ko00460	Cyanoamino acid metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMC200051697	K05350	ko00500	Starch and sucrose metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMC200051697	K05350	ko00940	Phenylpropanoid biosynthesis	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMC200051697	K05350	ko01110	Biosynthesis of secondary metabolites	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMC200051704	K10591	ko04120	Ubiquitin mediated proteolysis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMC200051704	K10591	ko04144	Endocytosis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMC200051708	K12397	ko04142	Lysosome	3043	5.3e-162	0.60	0.75	1.00
PGSC0003DMC200051709	K12397	ko04142	Lysosome	6116	0.	0.67	0.79	1.00
PGSC0003DMC200051710	K12397	ko04142	Lysosome	1204	1.4e-60	0.66	0.77	0.98
PGSC0003DMC200051711	K12397	ko04142	Lysosome	1599	2.3e-82	0.55	0.73	0.91
PGSC0003DMC200051715	K03127	ko03022	Basal transcription factors	929	2.1e-45	0.86	0.97	0.98
PGSC0003DMC200033074	K01915	ko00250	Alanine, aspartate and glutamate metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMC200033074	K01915	ko00330	Arginine and proline metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMC200033074	K01915	ko00910	Nitrogen metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMC200033074	K01915	ko01100	Metabolic pathways	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMC200033074	K01915	ko02020	Two-component system	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMC200033079	K12126	ko04712	Circadian rhythm - plant	244	2.9e-07	0.37	0.56	0.35
PGSC0003DMC200033083	K02918	ko03010	Ribosome	566	2.2e-25	0.89	0.95	0.80
PGSC0003DMC200033085	K12828	ko03040	Spliceosome	2880	5.2e-153	0.90	0.94	0.99
PGSC0003DMC200033086	K00901	ko00561	Glycerolipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMC200033086	K00901	ko00564	Glycerophospholipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMC200033086	K00901	ko01100	Metabolic pathways	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMC200033086	K00901	ko04070	Phosphatidylinositol signaling system	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMC200033087	K03014	ko00230	Purine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMC200033087	K03014	ko00240	Pyrimidine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMC200033087	K03014	ko01100	Metabolic pathways	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMC200033087	K03014	ko03020	RNA polymerase	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMC200033087	K03014	ko05016	Huntington's disease	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMC200033089	K05391	ko04626	Plant-pathogen interaction	3502	2.6e-187	0.65	0.77	0.92
PGSC0003DMC200043291	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043291	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043291	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043291	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043291	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043292	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043292	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043292	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043292	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043292	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMC200043293	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMC200043293	K00517	ko00626	Naphthalene and anthracene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMC200043293	K00517	ko00903	Limonene and pinene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMC200043293	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMC200043293	K00517	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMC200043294	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMC200043294	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMC200043294	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMC200043294	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMC200043294	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMC200037862	K03028	ko03050	Proteasome	2079	7.8e-109	0.73	0.84	0.92
PGSC0003DMC200037863	K03028	ko03050	Proteasome	5725	0.	0.78	0.88	0.99
PGSC0003DMC200037864	K03028	ko03050	Proteasome	3223	6.2e-172	0.81	0.90	0.99
PGSC0003DMC200037865	K03028	ko03050	Proteasome	3400	1.1e-181	0.81	0.91	1.00
PGSC0003DMC200037866	K03028	ko03050	Proteasome	1064	7.5e-53	0.79	0.85	0.94
PGSC0003DMC200037868	K05863	ko04020	Calcium signaling pathway	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMC200037868	K05863	ko05012	Parkinson's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMC200037868	K05863	ko05016	Huntington's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMC200037869	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037869	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037870	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMC200037875	K07466	ko03030	DNA replication	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMC200037875	K07466	ko03420	Nucleotide excision repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMC200037875	K07466	ko03430	Mismatch repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMC200037875	K07466	ko03440	Homologous recombination	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMC200037876	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00270	Cysteine and methionine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00350	Tyrosine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00360	Phenylalanine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00401	Novobiocin biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko01100	Metabolic pathways	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037876	K00815	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMC200037877	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00270	Cysteine and methionine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00350	Tyrosine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00360	Phenylalanine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00401	Novobiocin biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko01100	Metabolic pathways	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037877	K00815	ko01110	Biosynthesis of secondary metabolites	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMC200037880	K12929	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMC200037880	K12929	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMC200037883	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMC200037883	K00517	ko00626	Naphthalene and anthracene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMC200037883	K00517	ko00903	Limonene and pinene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMC200037883	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMC200037883	K00517	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMC200037884	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMC200037884	K00517	ko00626	Naphthalene and anthracene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMC200037884	K00517	ko00903	Limonene and pinene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMC200037884	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMC200037884	K00517	ko01110	Biosynthesis of secondary metabolites	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMC200037885	K11818	ko00380	Tryptophan metabolism	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMC200037885	K11818	ko00966	Glucosinolate biosynthesis	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMC200037885	K11818	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMC200037886	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMC200037886	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMC200037886	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMC200037886	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMC200037886	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMC200037887	K11818	ko00380	Tryptophan metabolism	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMC200037887	K11818	ko00966	Glucosinolate biosynthesis	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMC200037887	K11818	ko01110	Biosynthesis of secondary metabolites	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMC200037888	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMC200037888	K00517	ko00626	Naphthalene and anthracene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMC200037888	K00517	ko00903	Limonene and pinene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMC200037888	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMC200037888	K00517	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMC200037889	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMC200037889	K00517	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMC200037889	K00517	ko00903	Limonene and pinene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMC200037889	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMC200037889	K00517	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMC200053707	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMC200053709	K00434	ko00053	Ascorbate and aldarate metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMC200053709	K00434	ko00480	Glutathione metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMC200053710	K00434	ko00053	Ascorbate and aldarate metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMC200053710	K00434	ko00480	Glutathione metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMC200053725	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.30	0.48	0.67
PGSC0003DMC200050342	K05666	ko02010	ABC transporters	3169	5.9e-169	0.36	0.56	0.88
PGSC0003DMC200050346	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMC200050346	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMC200050347	K12134	ko04712	Circadian rhythm - plant	468	5.6e-20	0.54	0.68	0.33
PGSC0003DMC200050348	K02294	ko00906	Carotenoid biosynthesis	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMC200050348	K02294	ko01100	Metabolic pathways	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMC200050348	K02294	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMC200050351	K03127	ko03022	Basal transcription factors	501	8.7e-22	0.52	0.67	0.18
PGSC0003DMC200050352	K03127	ko03022	Basal transcription factors	771	1.1e-36	0.73	0.88	0.96
PGSC0003DMC200050362	K12795	ko04621	NOD-like receptor signaling pathway	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMC200050362	K12795	ko04626	Plant-pathogen interaction	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMC200050363	K12795	ko04621	NOD-like receptor signaling pathway	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMC200050363	K12795	ko04626	Plant-pathogen interaction	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMC200050364	K12795	ko04621	NOD-like receptor signaling pathway	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMC200050364	K12795	ko04626	Plant-pathogen interaction	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMC200050365	K03949	ko00190	Oxidative phosphorylation	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMC200050365	K03949	ko01100	Metabolic pathways	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMC200050365	K03949	ko05010	Alzheimer's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMC200050365	K03949	ko05012	Parkinson's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMC200050365	K03949	ko05016	Huntington's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMC200012091	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012091	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012091	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012092	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012092	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012092	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012093	K09842	ko00906	Carotenoid biosynthesis	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMC200012093	K09842	ko01100	Metabolic pathways	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMC200012093	K09842	ko01110	Biosynthesis of secondary metabolites	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMC200012094	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012094	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012094	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMC200012095	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMC200012096	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMC200012097	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMC200012098	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMC200012109	K01759	ko00620	Pyruvate metabolism	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMC200012109	K01759	ko04011	MAPK signaling pathway - yeast	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMC200012115	K00658	ko00020	Citrate cycle (TCA cycle)	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMC200012115	K00658	ko00310	Lysine degradation	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMC200012115	K00658	ko01100	Metabolic pathways	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMC200012115	K00658	ko01110	Biosynthesis of secondary metabolites	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMC200006673	K00088	ko00230	Purine metabolism	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMC200006673	K00088	ko00983	Drug metabolism - other enzymes	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMC200006673	K00088	ko01100	Metabolic pathways	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMC200006673	K00088	ko01110	Biosynthesis of secondary metabolites	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMC200006676	K02725	ko03050	Proteasome	1981	2.0e-103	0.85	0.90	1.00
PGSC0003DMC200006677	K00611	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMC200006677	K00611	ko01100	Metabolic pathways	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMC200006677	K00611	ko01110	Biosynthesis of secondary metabolites	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMC200006678	K00611	ko00330	Arginine and proline metabolism	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMC200006678	K00611	ko01100	Metabolic pathways	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMC200006678	K00611	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMC200006679	K00611	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMC200006679	K00611	ko01100	Metabolic pathways	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMC200006679	K00611	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMC200006681	K08241	ko00592	alpha-Linolenic acid metabolism	1558	4.3e-80	0.52	0.66	0.99
PGSC0003DMC200006682	K10610	ko03420	Nucleotide excision repair	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMC200006682	K10610	ko04120	Ubiquitin mediated proteolysis	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMC200006690	K13065	ko00940	Phenylpropanoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMC200006690	K13065	ko00941	Flavonoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMC200006690	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMC200006690	K13065	ko01110	Biosynthesis of secondary metabolites	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMC200019149	K00680	ko00350	Tyrosine metabolism	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMC200019149	K00680	ko00624	1- and 2-Methylnaphthalene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMC200019149	K00680	ko00632	Benzoate degradation via CoA ligation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMC200019149	K00680	ko00642	Ethylbenzene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMC200019149	K00680	ko00903	Limonene and pinene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMC200019153	K00600	ko00260	Glycine, serine and threonine metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019153	K00600	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019153	K00600	ko00670	One carbon pool by folate	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019153	K00600	ko00680	Methane metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019153	K00600	ko01100	Metabolic pathways	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019153	K00600	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMC200019154	K11090	ko05322	Systemic lupus erythematosus	2332	8.7e-123	0.62	0.78	0.99
PGSC0003DMC200019155	K01590	ko00340	Histidine metabolism	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMC200019155	K01590	ko01100	Metabolic pathways	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMC200019155	K01590	ko01110	Biosynthesis of secondary metabolites	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMC200019156	K01590	ko00340	Histidine metabolism	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMC200019156	K01590	ko01100	Metabolic pathways	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMC200019156	K01590	ko01110	Biosynthesis of secondary metabolites	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMC200019157	K00813	ko00250	Alanine, aspartate and glutamate metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00270	Cysteine and methionine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00330	Arginine and proline metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00350	Tyrosine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00360	Phenylalanine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00401	Novobiocin biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00710	Carbon fixation in photosynthetic organisms	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00950	Isoquinoline alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko01100	Metabolic pathways	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019157	K00813	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMC200019158	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00270	Cysteine and methionine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00330	Arginine and proline metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00350	Tyrosine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00360	Phenylalanine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00401	Novobiocin biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00710	Carbon fixation in photosynthetic organisms	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko01100	Metabolic pathways	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200019158	K00813	ko01110	Biosynthesis of secondary metabolites	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMC200039271	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.30	0.48	0.99
PGSC0003DMC200046086	K12836	ko03040	Spliceosome	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMC200046086	K12836	ko05131	Shigellosis	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMC200046087	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMC200046087	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMC200046088	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMC200046088	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMC200046092	K08488	ko04130	SNARE interactions in vesicular transport	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMC200046092	K08488	ko04145	Phagosome	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMC200046098	K06067	ko04110	Cell cycle	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMC200046098	K06067	ko04330	Notch signaling pathway	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMC200046098	K06067	ko05016	Huntington's disease	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMC200046098	K06067	ko05200	Pathways in cancer	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMC200046098	K06067	ko05220	Chronic myeloid leukemia	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMC200046099	K06067	ko04110	Cell cycle	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMC200046099	K06067	ko04330	Notch signaling pathway	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMC200046099	K06067	ko05016	Huntington's disease	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMC200046099	K06067	ko05200	Pathways in cancer	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMC200046099	K06067	ko05220	Chronic myeloid leukemia	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMC200046100	K01193	ko00052	Galactose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMC200046100	K01193	ko00500	Starch and sucrose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMC200046100	K01193	ko01100	Metabolic pathways	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMC200046101	K01193	ko00052	Galactose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMC200046101	K01193	ko00500	Starch and sucrose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMC200046101	K01193	ko01100	Metabolic pathways	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMC200046110	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMC200046110	K04518	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMC200059354	K00789	ko00270	Cysteine and methionine metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMC200059354	K00789	ko00450	Selenoamino acid metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMC200059354	K00789	ko01100	Metabolic pathways	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMC200059354	K00789	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMC200059369	K03094	ko04110	Cell cycle	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04111	Cell cycle - yeast	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04114	Oocyte meiosis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04310	Wnt signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04350	TGF-beta signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200059369	K03094	ko04710	Circadian rhythm - mammal	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMC200056701	K00128	ko00010	Glycolysis / Gluconeogenesis	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00053	Ascorbate and aldarate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00071	Fatty acid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00280	Valine, leucine and isoleucine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00310	Lysine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00330	Arginine and proline metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00340	Histidine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00380	Tryptophan metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00410	beta-Alanine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00561	Glycerolipid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00620	Pyruvate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00631	1,2-Dichloroethane degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00640	Propanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00641	3-Chloroacrylic acid degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00650	Butanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko00903	Limonene and pinene degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko01100	Metabolic pathways	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056701	K00128	ko01110	Biosynthesis of secondary metabolites	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMC200056706	K10760	ko00908	Zeatin biosynthesis	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMC200056706	K10760	ko01100	Metabolic pathways	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMC200056706	K10760	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMC200056713	K09866	ko04962	Vasopressin-regulated water reabsorption	298	1.3e-10	0.30	0.45	0.98
PGSC0003DMC200056716	K08059	ko04612	Antigen processing and presentation	457	2.3e-19	0.54	0.69	0.91
PGSC0003DMC200028143	K00002	ko00010	Glycolysis / Gluconeogenesis	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMC200028143	K00002	ko00561	Glycerolipid metabolism	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMC200028143	K00002	ko00930	Caprolactam degradation	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMC200028143	K00002	ko01100	Metabolic pathways	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMC200028143	K00002	ko01110	Biosynthesis of secondary metabolites	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMC200028151	K12857	ko03040	Spliceosome	224	1.6e-06	0.28	0.44	0.92
PGSC0003DMC200028153	K12857	ko03040	Spliceosome	223	1.8e-06	0.29	0.48	0.82
PGSC0003DMC200028159	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMC200028159	K02366	ko01100	Metabolic pathways	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMC200028160	K01662	ko00900	Terpenoid backbone biosynthesis	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMC200028160	K01662	ko01100	Metabolic pathways	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMC200028160	K01662	ko01110	Biosynthesis of secondary metabolites	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMC200028161	K01662	ko00900	Terpenoid backbone biosynthesis	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMC200028161	K01662	ko01100	Metabolic pathways	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMC200028161	K01662	ko01110	Biosynthesis of secondary metabolites	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMC200028162	K12356	ko00940	Phenylpropanoid biosynthesis	671	3.6e-31	0.32	0.49	0.93
PGSC0003DMC200028163	K12356	ko00940	Phenylpropanoid biosynthesis	654	3.1e-30	0.33	0.47	0.93
PGSC0003DMC200028164	K12356	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.38	0.54	0.84
PGSC0003DMC200028170	K00558	ko00270	Cysteine and methionine metabolism	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMC200028170	K00558	ko01100	Metabolic pathways	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMC200010471	K02949	ko03010	Ribosome	1231	4.6e-62	0.91	0.93	0.99
PGSC0003DMC200010472	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMC200010473	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMC200010474	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMC200010475	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMC200010476	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200010477	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMC200010478	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMC200010479	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMC200010480	K06669	ko04110	Cell cycle	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMC200010480	K06669	ko04111	Cell cycle - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMC200010480	K06669	ko04113	Meiosis - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMC200010480	K06669	ko04114	Oocyte meiosis	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMC200010481	K06669	ko04110	Cell cycle	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMC200010481	K06669	ko04111	Cell cycle - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMC200010481	K06669	ko04113	Meiosis - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMC200010481	K06669	ko04114	Oocyte meiosis	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMC200010482	K06669	ko04110	Cell cycle	7897	0.	0.79	0.90	1.00
PGSC0003DMC200010482	K06669	ko04111	Cell cycle - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMC200010482	K06669	ko04113	Meiosis - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMC200010482	K06669	ko04114	Oocyte meiosis	7897	0.	0.79	0.90	1.00
PGSC0003DMC200010483	K06669	ko04110	Cell cycle	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMC200010483	K06669	ko04111	Cell cycle - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMC200010483	K06669	ko04113	Meiosis - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMC200010483	K06669	ko04114	Oocyte meiosis	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMC200010484	K06669	ko04110	Cell cycle	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMC200010484	K06669	ko04111	Cell cycle - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMC200010484	K06669	ko04113	Meiosis - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMC200010484	K06669	ko04114	Oocyte meiosis	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMC200010491	K12627	ko03018	RNA degradation	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMC200010491	K12627	ko03040	Spliceosome	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMC200010492	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMC200010492	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMC200010493	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMC200010493	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMC200017283	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMC200017283	K00517	ko00626	Naphthalene and anthracene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMC200017283	K00517	ko00903	Limonene and pinene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMC200017283	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMC200017283	K00517	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMC200017284	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMC200017284	K00517	ko00626	Naphthalene and anthracene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMC200017284	K00517	ko00903	Limonene and pinene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMC200017284	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMC200017284	K00517	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMC200017285	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMC200017285	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMC200017285	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMC200017285	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMC200017285	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMC200017286	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMC200017286	K00517	ko00626	Naphthalene and anthracene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMC200017286	K00517	ko00903	Limonene and pinene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMC200017286	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMC200017286	K00517	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMC200017287	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMC200017287	K00517	ko00626	Naphthalene and anthracene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMC200017287	K00517	ko00903	Limonene and pinene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMC200017287	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMC200017287	K00517	ko01110	Biosynthesis of secondary metabolites	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMC200017288	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMC200017288	K00517	ko00626	Naphthalene and anthracene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMC200017288	K00517	ko00903	Limonene and pinene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMC200017288	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMC200017288	K00517	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMC200017294	K06674	ko04111	Cell cycle - yeast	271	4.9e-06	0.29	0.47	0.78
PGSC0003DMC200017296	K05663	ko02010	ABC transporters	1305	3.8e-66	0.82	0.92	0.88
PGSC0003DMC200068814	K10760	ko00908	Zeatin biosynthesis	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMC200068814	K10760	ko01100	Metabolic pathways	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMC200068814	K10760	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMC200064207	K03094	ko04110	Cell cycle	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04111	Cell cycle - yeast	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04114	Oocyte meiosis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04120	Ubiquitin mediated proteolysis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04310	Wnt signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04350	TGF-beta signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064207	K03094	ko04710	Circadian rhythm - mammal	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMC200064226	K03403	ko00860	Porphyrin and chlorophyll metabolism	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMC200064226	K03403	ko01100	Metabolic pathways	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMC200064226	K03403	ko01110	Biosynthesis of secondary metabolites	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMC200032521	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMC200032522	K00485	ko00982	Drug metabolism - cytochrome P450	442	1.5e-18	0.31	0.47	0.96
PGSC0003DMC200032523	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMC200032532	K00384	ko00240	Pyrimidine metabolism	2354	5.3e-124	0.83	0.93	1.00
PGSC0003DMC200032533	K08139	ko04113	Meiosis - yeast	578	3.1e-51	0.36	0.59	0.62
PGSC0003DMC200032549	K05868	ko04110	Cell cycle	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMC200032549	K05868	ko04115	p53 signaling pathway	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMC200032549	K05868	ko04914	Progesterone-mediated oocyte maturation	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMC200032550	K05868	ko04110	Cell cycle	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMC200032550	K05868	ko04115	p53 signaling pathway	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMC200032550	K05868	ko04914	Progesterone-mediated oocyte maturation	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMC200047286	K04125	ko00904	Diterpenoid biosynthesis	1058	1.6e-52	0.45	0.61	0.93
PGSC0003DMC200047293	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMC200047294	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMC200047295	K12121	ko04712	Circadian rhythm - plant	2256	1.4e-118	0.72	0.85	0.98
PGSC0003DMC200047296	K12121	ko04712	Circadian rhythm - plant	7381	0.	0.78	0.87	0.99
PGSC0003DMC200047297	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047297	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047297	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047297	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047298	K01648	ko00020	Citrate cycle (TCA cycle)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMC200047298	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMC200047298	K01648	ko01100	Metabolic pathways	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMC200047298	K01648	ko01110	Biosynthesis of secondary metabolites	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMC200047299	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047299	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047299	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047299	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMC200047300	K03017	ko00230	Purine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMC200047300	K03017	ko00240	Pyrimidine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMC200047300	K03017	ko01100	Metabolic pathways	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMC200047300	K03017	ko03020	RNA polymerase	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMC200047300	K03017	ko05016	Huntington's disease	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMC200047303	K00382	ko00010	Glycolysis / Gluconeogenesis	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko00020	Citrate cycle (TCA cycle)	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko00260	Glycine, serine and threonine metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko00620	Pyruvate metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko01100	Metabolic pathways	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047303	K00382	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMC200047305	K00878	ko00730	Thiamine metabolism	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMC200047305	K00878	ko01100	Metabolic pathways	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMC200047306	K03013	ko00230	Purine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMC200047306	K03013	ko00240	Pyrimidine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMC200047306	K03013	ko01100	Metabolic pathways	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMC200047306	K03013	ko03020	RNA polymerase	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMC200047306	K03013	ko05016	Huntington's disease	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMC200040477	K06269	ko04113	Meiosis - yeast	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04114	Oocyte meiosis	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04270	Vascular smooth muscle contraction	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04510	Focal adhesion	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04720	Long-term potentiation	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04810	Regulation of actin cytoskeleton	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040477	K06269	ko04910	Insulin signaling pathway	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMC200040478	K06269	ko04113	Meiosis - yeast	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04114	Oocyte meiosis	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04270	Vascular smooth muscle contraction	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04510	Focal adhesion	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04720	Long-term potentiation	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04810	Regulation of actin cytoskeleton	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040478	K06269	ko04910	Insulin signaling pathway	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMC200040484	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMC200040485	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMC200040486	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMC200040500	K03075	ko03060	Protein export	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMC200040500	K03075	ko03070	Bacterial secretion system	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMC200058156	K02183	ko04020	Calcium signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04070	Phosphatidylinositol signaling system	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04114	Oocyte meiosis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04270	Vascular smooth muscle contraction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04626	Plant-pathogen interaction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04720	Long-term potentiation	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04722	Neurotrophin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04740	Olfactory transduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04744	Phototransduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04745	Phototransduction - fly	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04910	Insulin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04912	GnRH signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04916	Melanogenesis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04970	Salivary secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko04971	Gastric acid secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko05010	Alzheimer's disease	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058156	K02183	ko05214	Glioma	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMC200058162	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMC200058162	K00517	ko00626	Naphthalene and anthracene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMC200058162	K00517	ko00903	Limonene and pinene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMC200058162	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMC200058162	K00517	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMC200063015	K11093	ko03040	Spliceosome	248	7.6e-08	0.29	0.49	0.83
PGSC0003DMC200063017	K03006	ko00230	Purine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMC200063017	K03006	ko00240	Pyrimidine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMC200063017	K03006	ko01100	Metabolic pathways	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMC200063017	K03006	ko03020	RNA polymerase	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMC200063017	K03006	ko05016	Huntington's disease	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMC200029343	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029343	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029343	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029343	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029344	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029344	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029344	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029344	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMC200029345	K00599	ko00340	Histidine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMC200029345	K00599	ko00350	Tyrosine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMC200029345	K00599	ko00450	Selenoamino acid metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMC200029345	K00599	ko00626	Naphthalene and anthracene degradation	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMC200029346	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029346	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029346	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029346	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029347	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029347	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029347	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029347	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMC200029348	K05681	ko02010	ABC transporters	1091	2.4e-54	0.35	0.53	0.80
PGSC0003DMC200029358	K05681	ko02010	ABC transporters	1154	8.2e-58	0.34	0.54	0.78
PGSC0003DMC200029359	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMC200029360	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMC200029365	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMC200029366	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMC200029367	K12796	ko04621	NOD-like receptor signaling pathway	434	3.7e-15	0.32	0.47	0.63
PGSC0003DMC200016110	K00889	ko00562	Inositol phosphate metabolism	8174	0.	0.63	0.74	1.00
PGSC0003DMC200016110	K00889	ko01100	Metabolic pathways	8174	0.	0.63	0.74	1.00
PGSC0003DMC200016110	K00889	ko04070	Phosphatidylinositol signaling system	8174	0.	0.63	0.74	1.00
PGSC0003DMC200016110	K00889	ko04144	Endocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMC200016110	K00889	ko04666	Fc gamma R-mediated phagocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMC200016110	K00889	ko04810	Regulation of actin cytoskeleton	8174	0.	0.63	0.74	1.00
PGSC0003DMC200009271	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMC200009272	K02874	ko03010	Ribosome	847	7.0e-41	0.86	0.94	0.99
PGSC0003DMC200009279	K03921	ko00061	Fatty acid biosynthesis	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMC200009279	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMC200009280	K03921	ko00061	Fatty acid biosynthesis	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMC200009280	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMC200009281	K03921	ko00061	Fatty acid biosynthesis	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMC200009281	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMC200009282	K03921	ko00061	Fatty acid biosynthesis	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMC200009282	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMC200009283	K03921	ko00061	Fatty acid biosynthesis	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMC200009283	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMC200009291	K00599	ko00340	Histidine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMC200009291	K00599	ko00350	Tyrosine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMC200009291	K00599	ko00450	Selenoamino acid metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMC200009291	K00599	ko00626	Naphthalene and anthracene degradation	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMC200009298	K01564	ko00791	Atrazine degradation	1060	1.2e-52	0.38	0.57	0.96
PGSC0003DMC200009299	K01564	ko00791	Atrazine degradation	927	2.7e-45	0.38	0.56	0.92
PGSC0003DMC200026701	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMC200026701	K00517	ko00626	Naphthalene and anthracene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMC200026701	K00517	ko00903	Limonene and pinene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMC200026701	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMC200026701	K00517	ko01110	Biosynthesis of secondary metabolites	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMC200026711	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMC200026711	K00517	ko00626	Naphthalene and anthracene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMC200026711	K00517	ko00903	Limonene and pinene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMC200026711	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMC200026711	K00517	ko01110	Biosynthesis of secondary metabolites	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMC200026712	K01728	ko00040	Pentose and glucuronate interconversions	2622	8.8e-139	0.74	0.85	0.98
PGSC0003DMC200026724	K02495	ko00860	Porphyrin and chlorophyll metabolism	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMC200026724	K02495	ko01100	Metabolic pathways	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMC200026724	K02495	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMC200036663	K08507	ko04130	SNARE interactions in vesicular transport	216	4.4e-06	0.29	0.49	0.90
PGSC0003DMC200036680	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	609	9.4e-28	0.34	0.50	0.45
PGSC0003DMC200036682	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	606	1.4e-27	0.34	0.50	0.84
PGSC0003DMC200036683	K09832	ko00100	Steroid biosynthesis	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMC200036683	K09832	ko01110	Biosynthesis of secondary metabolites	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMC200036684	K02955	ko03010	Ribosome	1205	1.3e-60	0.95	0.98	0.99
PGSC0003DMC200036685	K01000	ko00550	Peptidoglycan biosynthesis	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMC200036685	K01000	ko01100	Metabolic pathways	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMC200036686	K01000	ko00550	Peptidoglycan biosynthesis	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMC200036686	K01000	ko01100	Metabolic pathways	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMC200036688	K11090	ko05322	Systemic lupus erythematosus	400	3.2e-16	0.31	0.52	0.70
PGSC0003DMC200036689	K11090	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.33	0.54	0.68
PGSC0003DMC200042096	K00430	ko00360	Phenylalanine metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMC200042096	K00430	ko00680	Methane metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMC200042096	K00430	ko00940	Phenylpropanoid biosynthesis	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMC200042096	K00430	ko01100	Metabolic pathways	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMC200042096	K00430	ko01110	Biosynthesis of secondary metabolites	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMC200042097	K00430	ko00360	Phenylalanine metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMC200042097	K00430	ko00680	Methane metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMC200042097	K00430	ko00940	Phenylpropanoid biosynthesis	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMC200042097	K00430	ko01100	Metabolic pathways	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMC200042097	K00430	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMC200042098	K00430	ko00360	Phenylalanine metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMC200042098	K00430	ko00680	Methane metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMC200042098	K00430	ko00940	Phenylpropanoid biosynthesis	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMC200042098	K00430	ko01100	Metabolic pathways	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMC200042098	K00430	ko01110	Biosynthesis of secondary metabolites	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMC200042107	K00430	ko00360	Phenylalanine metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMC200042107	K00430	ko00680	Methane metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMC200042107	K00430	ko00940	Phenylpropanoid biosynthesis	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMC200042107	K00430	ko01100	Metabolic pathways	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMC200042107	K00430	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMC200042108	K00430	ko00360	Phenylalanine metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMC200042108	K00430	ko00680	Methane metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMC200042108	K00430	ko00940	Phenylpropanoid biosynthesis	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMC200042108	K00430	ko01100	Metabolic pathways	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMC200042108	K00430	ko01110	Biosynthesis of secondary metabolites	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMC200042119	K08266	ko04150	mTOR signaling pathway	2614	2.4e-138	0.94	0.98	0.99
PGSC0003DMC200049144	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMC200049144	K00517	ko00626	Naphthalene and anthracene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMC200049144	K00517	ko00903	Limonene and pinene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMC200049144	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMC200049144	K00517	ko01110	Biosynthesis of secondary metabolites	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMC200049145	K05280	ko00941	Flavonoid biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMC200049145	K05280	ko00944	Flavone and flavonol biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMC200049145	K05280	ko01100	Metabolic pathways	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMC200049145	K05280	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMC200049146	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMC200049146	K00517	ko00626	Naphthalene and anthracene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMC200049146	K00517	ko00903	Limonene and pinene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMC200049146	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMC200049146	K00517	ko01110	Biosynthesis of secondary metabolites	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMC200049147	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMC200049147	K00517	ko00626	Naphthalene and anthracene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMC200049147	K00517	ko00903	Limonene and pinene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMC200049147	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMC200049147	K00517	ko01110	Biosynthesis of secondary metabolites	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMC200049148	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMC200049148	K00517	ko00626	Naphthalene and anthracene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMC200049148	K00517	ko00903	Limonene and pinene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMC200049148	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMC200049148	K00517	ko01110	Biosynthesis of secondary metabolites	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMC200049149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMC200049149	K00517	ko00626	Naphthalene and anthracene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMC200049149	K00517	ko00903	Limonene and pinene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMC200049149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMC200049149	K00517	ko01110	Biosynthesis of secondary metabolites	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMC200049150	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMC200049150	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMC200049150	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMC200049150	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMC200049150	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMC200049151	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMC200049151	K00517	ko00626	Naphthalene and anthracene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMC200049151	K00517	ko00903	Limonene and pinene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMC200049151	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMC200049151	K00517	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMC200049152	K12869	ko03040	Spliceosome	4679	3.1e-252	0.80	0.88	1.00
PGSC0003DMC200049153	K02896	ko03010	Ribosome	1255	2.2e-63	0.91	0.94	0.99
PGSC0003DMC200049154	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMC200049154	K02366	ko01100	Metabolic pathways	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMC200049155	K01754	ko00260	Glycine, serine and threonine metabolism	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMC200049155	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMC200049155	K01754	ko01100	Metabolic pathways	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMC200049155	K01754	ko01110	Biosynthesis of secondary metabolites	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMC200049156	K01754	ko00260	Glycine, serine and threonine metabolism	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMC200049156	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMC200049156	K01754	ko01100	Metabolic pathways	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMC200049156	K01754	ko01110	Biosynthesis of secondary metabolites	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMC200049159	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMC200049159	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMC200049159	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMC200049159	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMC200049159	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMC200049160	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMC200049160	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMC200049160	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMC200049160	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMC200049160	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMC200049161	K01915	ko00250	Alanine, aspartate and glutamate metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMC200049161	K01915	ko00330	Arginine and proline metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMC200049161	K01915	ko00910	Nitrogen metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMC200049161	K01915	ko01100	Metabolic pathways	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMC200049161	K01915	ko02020	Two-component system	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMC200049162	K01915	ko00250	Alanine, aspartate and glutamate metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMC200049162	K01915	ko00330	Arginine and proline metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMC200049162	K01915	ko00910	Nitrogen metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMC200049162	K01915	ko01100	Metabolic pathways	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMC200049162	K01915	ko02020	Two-component system	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMC200049166	K01674	ko00910	Nitrogen metabolism	1406	1.0e-71	0.66	0.78	0.93
PGSC0003DMC200049167	K01674	ko00910	Nitrogen metabolism	1307	3.0e-66	0.69	0.82	0.96
PGSC0003DMC200049168	K01674	ko00910	Nitrogen metabolism	1501	5.9e-77	0.66	0.79	0.97
PGSC0003DMC200049169	K01674	ko00910	Nitrogen metabolism	1487	3.5e-76	0.66	0.79	0.97
PGSC0003DMC200002694	K11294	ko05130	Pathogenic Escherichia coli infection	420	2.5e-17	0.32	0.51	0.54
PGSC0003DMC200002695	K11294	ko05130	Pathogenic Escherichia coli infection	244	4.6e-07	0.36	0.48	0.87
PGSC0003DMC200002696	K12890	ko03040	Spliceosome	232	1.1e-06	0.37	0.51	0.28
PGSC0003DMC200002699	K08737	ko03430	Mismatch repair	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMC200002699	K08737	ko05200	Pathways in cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMC200002699	K08737	ko05210	Colorectal cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMC200002700	K08737	ko03430	Mismatch repair	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMC200002700	K08737	ko05200	Pathways in cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMC200002700	K08737	ko05210	Colorectal cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMC200062131	K10760	ko00908	Zeatin biosynthesis	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMC200062131	K10760	ko01100	Metabolic pathways	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMC200062131	K10760	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMC200062135	K03094	ko04110	Cell cycle	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04111	Cell cycle - yeast	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04114	Oocyte meiosis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04310	Wnt signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04350	TGF-beta signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062135	K03094	ko04710	Circadian rhythm - mammal	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMC200062157	K11228	ko04011	MAPK signaling pathway - yeast	328	1.6e-11	0.37	0.49	0.93
PGSC0003DMC200007862	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007862	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007863	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007864	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007865	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007866	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007867	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007868	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007869	K00754	ko00051	Fructose and mannose metabolism	1355	6.7e-69	0.42	0.60	0.98
PGSC0003DMC200007874	K01159	ko03440	Homologous recombination	238	2.7e-07	0.30	0.48	0.53
PGSC0003DMC200007881	K01803	ko00010	Glycolysis / Gluconeogenesis	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007881	K01803	ko00051	Fructose and mannose metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007881	K01803	ko00562	Inositol phosphate metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007881	K01803	ko00710	Carbon fixation in photosynthetic organisms	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007881	K01803	ko01100	Metabolic pathways	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007881	K01803	ko01110	Biosynthesis of secondary metabolites	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMC200007882	K10949	ko05110	Vibrio cholerae infection	535	1.1e-23	0.36	0.58	0.82
PGSC0003DMC200013294	K12586	ko03018	RNA degradation	1996	3.0e-104	0.81	0.90	1.00
PGSC0003DMC200013295	K12586	ko03018	RNA degradation	1942	2.8e-101	0.82	0.91	1.00
PGSC0003DMC200013301	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013301	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013301	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013302	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMC200013302	K11517	ko01100	Metabolic pathways	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMC200013302	K11517	ko04146	Peroxisome	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMC200013303	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMC200013303	K11517	ko01100	Metabolic pathways	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMC200013303	K11517	ko04146	Peroxisome	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMC200013304	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013304	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013304	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMC200013305	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMC200013305	K11517	ko01100	Metabolic pathways	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMC200013305	K11517	ko04146	Peroxisome	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMC200013306	K00993	ko00440	Phosphonate and phosphinate metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMC200013306	K00993	ko00564	Glycerophospholipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMC200013306	K00993	ko00565	Ether lipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMC200013306	K00993	ko01100	Metabolic pathways	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMC200013314	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200013314	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200013314	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200013315	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200013315	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200013315	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMC200023704	K07192	ko04910	Insulin signaling pathway	1311	1.8e-66	0.39	0.60	0.97
PGSC0003DMC200023705	K07192	ko04910	Insulin signaling pathway	990	9.1e-49	0.44	0.66	0.93
PGSC0003DMC200020355	K10581	ko04120	Ubiquitin mediated proteolysis	534	5.7e-23	0.29	0.42	0.72
PGSC0003DMC200020358	K01620	ko00260	Glycine, serine and threonine metabolism	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMC200020358	K01620	ko01100	Metabolic pathways	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMC200020358	K01620	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMC200020359	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020359	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020359	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020360	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020360	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020360	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020361	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020361	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020361	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMC200020362	K12860	ko03040	Spliceosome	651	8.0e-30	0.45	0.60	0.78
PGSC0003DMC200020363	K12860	ko03040	Spliceosome	5879	0.	0.73	0.84	1.00
PGSC0003DMC200024301	K08486	ko04130	SNARE interactions in vesicular transport	1883	5.1e-98	0.77	0.87	0.96
PGSC0003DMC200024308	K02636	ko00195	Photosynthesis	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMC200024308	K02636	ko01100	Metabolic pathways	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMC200024313	K03006	ko00230	Purine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMC200024313	K03006	ko00240	Pyrimidine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMC200024313	K03006	ko01100	Metabolic pathways	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMC200024313	K03006	ko03020	RNA polymerase	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMC200024313	K03006	ko05016	Huntington's disease	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMC200008314	K10581	ko04120	Ubiquitin mediated proteolysis	980	3.2e-48	0.48	0.65	0.82
PGSC0003DMC200008315	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMC200008315	K04424	ko04530	Tight junction	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMC200008316	K04424	ko04010	MAPK signaling pathway	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMC200008316	K04424	ko04530	Tight junction	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMC200008317	K01648	ko00020	Citrate cycle (TCA cycle)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMC200008317	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMC200008317	K01648	ko01100	Metabolic pathways	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMC200008317	K01648	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMC200008318	K01648	ko00020	Citrate cycle (TCA cycle)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMC200008318	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMC200008318	K01648	ko01100	Metabolic pathways	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMC200008318	K01648	ko01110	Biosynthesis of secondary metabolites	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMC200008323	K00128	ko00010	Glycolysis / Gluconeogenesis	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00053	Ascorbate and aldarate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00071	Fatty acid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00280	Valine, leucine and isoleucine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00310	Lysine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00330	Arginine and proline metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00340	Histidine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00380	Tryptophan metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00410	beta-Alanine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00561	Glycerolipid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00620	Pyruvate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00631	1,2-Dichloroethane degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00640	Propanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00641	3-Chloroacrylic acid degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00650	Butanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko00903	Limonene and pinene degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko01100	Metabolic pathways	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008323	K00128	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMC200008324	K00128	ko00010	Glycolysis / Gluconeogenesis	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00053	Ascorbate and aldarate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00071	Fatty acid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00280	Valine, leucine and isoleucine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00310	Lysine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00330	Arginine and proline metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00340	Histidine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00380	Tryptophan metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00410	beta-Alanine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00561	Glycerolipid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00620	Pyruvate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00631	1,2-Dichloroethane degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00640	Propanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00641	3-Chloroacrylic acid degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00650	Butanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko01100	Metabolic pathways	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008324	K00128	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMC200008325	K00128	ko00010	Glycolysis / Gluconeogenesis	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00053	Ascorbate and aldarate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00071	Fatty acid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00280	Valine, leucine and isoleucine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00310	Lysine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00330	Arginine and proline metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00340	Histidine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00380	Tryptophan metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00410	beta-Alanine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00561	Glycerolipid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00620	Pyruvate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00631	1,2-Dichloroethane degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00640	Propanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00641	3-Chloroacrylic acid degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00650	Butanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko00903	Limonene and pinene degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko01100	Metabolic pathways	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008325	K00128	ko01110	Biosynthesis of secondary metabolites	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMC200008326	K10578	ko04120	Ubiquitin mediated proteolysis	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMC200008326	K10578	ko05012	Parkinson's disease	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMC200008331	K02905	ko03010	Ribosome	461	1.4e-19	0.91	0.96	0.95
PGSC0003DMC200011688	K02206	ko04110	Cell cycle	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko04114	Oocyte meiosis	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko04115	p53 signaling pathway	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko04914	Progesterone-mediated oocyte maturation	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko05200	Pathways in cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko05215	Prostate cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011688	K02206	ko05222	Small cell lung cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMC200011690	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011690	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011691	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMC200011696	K12857	ko03040	Spliceosome	238	1.4e-06	0.34	0.50	0.53
PGSC0003DMC200019831	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019831	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019831	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019831	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019831	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019831	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019832	K02144	ko00190	Oxidative phosphorylation	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019832	K02144	ko01100	Metabolic pathways	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019832	K02144	ko04142	Lysosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019832	K02144	ko04145	Phagosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019832	K02144	ko05110	Vibrio cholerae infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019832	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMC200019841	K02916	ko03010	Ribosome	272	3.6e-09	0.53	0.69	0.41
PGSC0003DMC200019851	K07424	ko00140	Steroid hormone biosynthesis	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00591	Linoleic acid metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00830	Retinol metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00982	Drug metabolism - cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko00983	Drug metabolism - other enzymes	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019851	K07424	ko01100	Metabolic pathways	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMC200019858	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMC200019858	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMC200019858	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMC200019860	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMC200019860	K05286	ko01100	Metabolic pathways	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMC200062048	K01184	ko00040	Pentose and glucuronate interconversions	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMC200062048	K01184	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMC200062048	K01184	ko01100	Metabolic pathways	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMC200062062	K01051	ko00040	Pentose and glucuronate interconversions	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMC200062062	K01051	ko00500	Starch and sucrose metabolism	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMC200062062	K01051	ko01100	Metabolic pathways	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMC200065422	K01516	ko00230	Purine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMC200065422	K01516	ko00730	Thiamine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMC200065422	K01516	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMC200067598	K05279	ko00944	Flavone and flavonol biosynthesis	738	7.2e-35	0.36	0.55	0.78
PGSC0003DMC200037112	K00619	ko00330	Arginine and proline metabolism	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMC200037112	K00619	ko01100	Metabolic pathways	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMC200037112	K00619	ko01110	Biosynthesis of secondary metabolites	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMC200037113	K00619	ko00330	Arginine and proline metabolism	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMC200037113	K00619	ko01100	Metabolic pathways	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMC200037113	K00619	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMC200037125	K02898	ko03010	Ribosome	1123	4.2e-56	0.89	0.99	0.99
PGSC0003DMC200037127	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037127	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037127	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037127	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037127	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037128	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037128	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037128	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037128	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037128	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMC200037129	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMC200037129	K00517	ko00626	Naphthalene and anthracene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMC200037129	K00517	ko00903	Limonene and pinene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMC200037129	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMC200037129	K00517	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMC200037134	K00826	ko00280	Valine, leucine and isoleucine degradation	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMC200037134	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMC200037134	K00826	ko00770	Pantothenate and CoA biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMC200037134	K00826	ko01100	Metabolic pathways	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMC200037134	K00826	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMC200037135	K01762	ko00270	Cysteine and methionine metabolism	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMC200037135	K01762	ko01110	Biosynthesis of secondary metabolites	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMC200055504	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMC200055504	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMC200055504	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMC200055504	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMC200055504	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMC200055510	K09754	ko00360	Phenylalanine metabolism	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055510	K09754	ko00940	Phenylpropanoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055510	K09754	ko00941	Flavonoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055510	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055510	K09754	ko01100	Metabolic pathways	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055510	K09754	ko01110	Biosynthesis of secondary metabolites	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMC200055518	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMC200055519	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMC200055521	K03108	ko03060	Protein export	2925	1.7e-155	0.75	0.87	0.99
PGSC0003DMC200048639	K03139	ko03022	Basal transcription factors	1519	6.0e-78	0.62	0.70	1.00
PGSC0003DMC200048640	K03139	ko03022	Basal transcription factors	1813	3.7e-94	0.80	0.89	1.00
PGSC0003DMC200048641	K03139	ko03022	Basal transcription factors	1447	5.6e-74	0.86	0.91	0.99
PGSC0003DMC200048642	K11594	ko04622	RIG-I-like receptor signaling pathway	1440	1.4e-73	0.42	0.55	0.92
PGSC0003DMC200030121	K13229	ko00402	Benzoxazinoid biosynthesis	1084	5.9e-54	0.43	0.58	0.93
PGSC0003DMC200030122	K13229	ko00402	Benzoxazinoid biosynthesis	1077	1.4e-53	0.43	0.58	0.98
PGSC0003DMC200030123	K13229	ko00402	Benzoxazinoid biosynthesis	281	1.2e-09	0.43	0.62	0.84
PGSC0003DMC200030124	K13229	ko00402	Benzoxazinoid biosynthesis	880	1.1e-42	0.39	0.54	0.98
PGSC0003DMC200030125	K13229	ko00402	Benzoxazinoid biosynthesis	426	1.2e-17	0.38	0.56	0.96
PGSC0003DMC200030126	K13229	ko00402	Benzoxazinoid biosynthesis	1047	6.5e-52	0.41	0.59	0.98
PGSC0003DMC200030127	K13229	ko00402	Benzoxazinoid biosynthesis	1020	2.0e-50	0.40	0.58	0.98
PGSC0003DMC200030128	K13229	ko00402	Benzoxazinoid biosynthesis	1038	2.0e-51	0.41	0.58	0.98
PGSC0003DMC200030129	K13229	ko00402	Benzoxazinoid biosynthesis	1036	2.6e-51	0.41	0.58	0.98
PGSC0003DMC200030130	K13229	ko00402	Benzoxazinoid biosynthesis	985	1.7e-48	0.41	0.57	0.98
PGSC0003DMC200030131	K13229	ko00402	Benzoxazinoid biosynthesis	868	4.9e-42	0.42	0.58	0.89
PGSC0003DMC200030132	K13229	ko00402	Benzoxazinoid biosynthesis	1111	1.9e-55	0.44	0.59	0.96
PGSC0003DMC200030133	K13229	ko00402	Benzoxazinoid biosynthesis	288	4.8e-10	0.33	0.52	0.97
PGSC0003DMC200030134	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.37	0.53	0.77
PGSC0003DMC200030135	K13229	ko00402	Benzoxazinoid biosynthesis	1094	1.7e-54	0.44	0.58	0.98
PGSC0003DMC200030136	K13229	ko00402	Benzoxazinoid biosynthesis	1200	2.4e-60	0.45	0.63	0.96
PGSC0003DMC200030137	K13229	ko00402	Benzoxazinoid biosynthesis	340	6.4e-13	0.41	0.57	0.88
PGSC0003DMC200030138	K13229	ko00402	Benzoxazinoid biosynthesis	833	4.1e-40	0.33	0.48	0.97
PGSC0003DMC200030139	K13229	ko00402	Benzoxazinoid biosynthesis	540	6.0e-24	0.29	0.42	0.96
PGSC0003DMC200030140	K13229	ko00402	Benzoxazinoid biosynthesis	995	4.8e-49	0.40	0.54	0.97
PGSC0003DMC200030141	K13229	ko00402	Benzoxazinoid biosynthesis	400	3.2e-16	0.55	0.69	0.68
PGSC0003DMC200030142	K13229	ko00402	Benzoxazinoid biosynthesis	1223	1.3e-61	0.45	0.63	0.93
PGSC0003DMC200030143	K13229	ko00402	Benzoxazinoid biosynthesis	1209	7.6e-61	0.44	0.63	0.92
PGSC0003DMC200030144	K13229	ko00402	Benzoxazinoid biosynthesis	1219	2.1e-61	0.46	0.62	0.94
PGSC0003DMC200030145	K13229	ko00402	Benzoxazinoid biosynthesis	963	2.8e-47	0.46	0.63	0.87
PGSC0003DMC200030146	K13229	ko00402	Benzoxazinoid biosynthesis	989	1.0e-48	0.46	0.64	0.92
PGSC0003DMC200030147	K13229	ko00402	Benzoxazinoid biosynthesis	1128	2.2e-56	0.43	0.60	0.99
PGSC0003DMC200030148	K13229	ko00402	Benzoxazinoid biosynthesis	1216	3.1e-61	0.45	0.62	0.99
PGSC0003DMC200030149	K13229	ko00402	Benzoxazinoid biosynthesis	1161	3.4e-58	0.43	0.61	0.97
PGSC0003DMC200028843	K02866	ko03010	Ribosome	642	1.4e-29	0.41	0.59	0.96
PGSC0003DMC200028844	K02866	ko03010	Ribosome	685	6.0e-32	0.41	0.55	0.95
PGSC0003DMC200028845	K02866	ko03010	Ribosome	687	4.7e-32	0.40	0.56	0.95
PGSC0003DMC200028846	K02866	ko03010	Ribosome	674	2.4e-31	0.40	0.54	0.95
PGSC0003DMC200028847	K05759	ko04810	Regulation of actin cytoskeleton	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMC200028847	K05759	ko05131	Shigellosis	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMC200028857	K06664	ko04146	Peroxisome	1976	3.8e-103	0.85	0.92	0.99
PGSC0003DMC200028858	K06664	ko04146	Peroxisome	2401	1.4e-126	0.79	0.89	1.00
PGSC0003DMC200004055	K02912	ko03010	Ribosome	1028	7.3e-51	0.89	0.95	0.99
PGSC0003DMC200004060	K06685	ko04111	Cell cycle - yeast	400	6.5e-13	0.25	0.42	0.89
PGSC0003DMC200004067	K03115	ko04310	Wnt signaling pathway	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMC200004067	K03115	ko04520	Adherens junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMC200004067	K03115	ko04530	Tight junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMC200004067	K03115	ko04712	Circadian rhythm - plant	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMC200004068	K03115	ko04310	Wnt signaling pathway	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMC200004068	K03115	ko04520	Adherens junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMC200004068	K03115	ko04530	Tight junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMC200004068	K03115	ko04712	Circadian rhythm - plant	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMC200004069	K03115	ko04310	Wnt signaling pathway	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMC200004069	K03115	ko04520	Adherens junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMC200004069	K03115	ko04530	Tight junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMC200004069	K03115	ko04712	Circadian rhythm - plant	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMC200021306	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	578	4.8e-26	0.75	0.82	0.95
PGSC0003DMC200021314	K00273	ko00260	Glycine, serine and threonine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021314	K00273	ko00311	Penicillin and cephalosporin biosynthesis	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021314	K00273	ko00330	Arginine and proline metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021314	K00273	ko00472	D-Arginine and D-ornithine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021314	K00273	ko01100	Metabolic pathways	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021314	K00273	ko04146	Peroxisome	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMC200021330	K12796	ko04621	NOD-like receptor signaling pathway	261	3.9e-08	0.31	0.46	0.96
PGSC0003DMC200000278	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMC200000292	K01115	ko00564	Glycerophospholipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000292	K01115	ko00565	Ether lipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000292	K01115	ko01100	Metabolic pathways	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000292	K01115	ko04144	Endocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000292	K01115	ko04666	Fc gamma R-mediated phagocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000292	K01115	ko04912	GnRH signaling pathway	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMC200000293	K01115	ko00564	Glycerophospholipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000293	K01115	ko00565	Ether lipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000293	K01115	ko01100	Metabolic pathways	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000293	K01115	ko04144	Endocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000293	K01115	ko04666	Fc gamma R-mediated phagocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000293	K01115	ko04912	GnRH signaling pathway	6363	0.	0.67	0.78	1.00
PGSC0003DMC200000298	K00100	ko00051	Fructose and mannose metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000298	K00100	ko00363	Bisphenol A degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000298	K00100	ko00591	Linoleic acid metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000298	K00100	ko00625	Tetrachloroethene degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000298	K00100	ko00650	Butanoate metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000298	K00100	ko01100	Metabolic pathways	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMC200000299	K00100	ko00051	Fructose and mannose metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000299	K00100	ko00363	Bisphenol A degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000299	K00100	ko00591	Linoleic acid metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000299	K00100	ko00625	Tetrachloroethene degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000299	K00100	ko00650	Butanoate metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000299	K00100	ko01100	Metabolic pathways	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMC200000300	K00100	ko00051	Fructose and mannose metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200000300	K00100	ko00363	Bisphenol A degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200000300	K00100	ko00591	Linoleic acid metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200000300	K00100	ko00625	Tetrachloroethene degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200000300	K00100	ko00650	Butanoate metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200000300	K00100	ko01100	Metabolic pathways	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMC200057634	K10760	ko00908	Zeatin biosynthesis	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMC200057634	K10760	ko01100	Metabolic pathways	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMC200057634	K10760	ko01110	Biosynthesis of secondary metabolites	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMC200057659	K03980	ko00550	Peptidoglycan biosynthesis	336	5.6e-12	0.39	0.43	0.92
PGSC0003DMC200035257	K03046	ko00230	Purine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMC200035257	K03046	ko00240	Pyrimidine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMC200035257	K03046	ko01100	Metabolic pathways	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMC200035257	K03046	ko03020	RNA polymerase	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMC200035258	K03046	ko00230	Purine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMC200035258	K03046	ko00240	Pyrimidine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMC200035258	K03046	ko01100	Metabolic pathways	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMC200035258	K03046	ko03020	RNA polymerase	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMC200035259	K03046	ko00230	Purine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMC200035259	K03046	ko00240	Pyrimidine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMC200035259	K03046	ko01100	Metabolic pathways	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMC200035259	K03046	ko03020	RNA polymerase	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMC200035260	K00088	ko00230	Purine metabolism	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMC200035260	K00088	ko00983	Drug metabolism - other enzymes	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMC200035260	K00088	ko01100	Metabolic pathways	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMC200035260	K00088	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMC200035261	K00042	ko00630	Glyoxylate and dicarboxylate metabolism	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMC200035261	K00042	ko01100	Metabolic pathways	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMC200035264	K09526	ko04144	Endocytosis	329	1.4e-11	0.46	0.65	0.94
PGSC0003DMC200035270	K02932	ko03010	Ribosome	1688	2.9e-87	0.85	0.95	1.00
PGSC0003DMC200035271	K02932	ko03010	Ribosome	2239	1.2e-117	0.86	0.94	1.00
PGSC0003DMC200035272	K02956	ko03010	Ribosome	508	3.5e-22	0.73	0.84	0.99
PGSC0003DMC200035273	K01142	ko03410	Base excision repair	297	1.5e-10	0.32	0.44	0.71
PGSC0003DMC200035280	K06119	ko00561	Glycerolipid metabolism	2888	1.9e-153	0.77	0.90	0.99
PGSC0003DMC200052521	K02882	ko03010	Ribosome	1444	8.3e-74	0.92	0.98	0.99
PGSC0003DMC200052530	K09458	ko00061	Fatty acid biosynthesis	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMC200052530	K09458	ko01100	Metabolic pathways	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMC200044491	K02915	ko03010	Ribosome	651	4.5e-30	0.90	0.93	0.99
PGSC0003DMC200044492	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMC200044492	K00517	ko00626	Naphthalene and anthracene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMC200044492	K00517	ko00903	Limonene and pinene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMC200044492	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMC200044492	K00517	ko01110	Biosynthesis of secondary metabolites	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMC200044493	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMC200044493	K00517	ko00626	Naphthalene and anthracene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMC200044493	K00517	ko00903	Limonene and pinene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMC200044493	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMC200044493	K00517	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMC200044494	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMC200044494	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMC200044494	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMC200044494	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMC200044494	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMC200044496	K13230	ko00402	Benzoxazinoid biosynthesis	636	3.0e-29	0.38	0.54	0.96
PGSC0003DMC200044497	K13230	ko00402	Benzoxazinoid biosynthesis	1046	7.4e-52	0.41	0.58	0.98
PGSC0003DMC200044498	K13230	ko00402	Benzoxazinoid biosynthesis	1053	3.0e-52	0.42	0.58	0.97
PGSC0003DMC200044499	K13230	ko00402	Benzoxazinoid biosynthesis	1028	7.3e-51	0.41	0.58	0.97
PGSC0003DMC200044504	K00852	ko00030	Pentose phosphate pathway	292	2.9e-10	0.28	0.45	0.95
PGSC0003DMC200044508	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMC200044509	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMC200001471	K00423	ko00053	Ascorbate and aldarate metabolism	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMC200001471	K00423	ko01100	Metabolic pathways	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMC200001472	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMC200001472	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMC200001473	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMC200001473	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMC200001476	K01955	ko00240	Pyrimidine metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMC200001476	K01955	ko00250	Alanine, aspartate and glutamate metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMC200001476	K01955	ko01100	Metabolic pathways	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMC200001477	K01955	ko00240	Pyrimidine metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMC200001477	K01955	ko00250	Alanine, aspartate and glutamate metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMC200001477	K01955	ko01100	Metabolic pathways	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMC200001480	K00100	ko00051	Fructose and mannose metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001480	K00100	ko00363	Bisphenol A degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001480	K00100	ko00591	Linoleic acid metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001480	K00100	ko00625	Tetrachloroethene degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001480	K00100	ko00650	Butanoate metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001480	K00100	ko01100	Metabolic pathways	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMC200001484	K01853	ko00100	Steroid biosynthesis	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMC200001484	K01853	ko01100	Metabolic pathways	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMC200001484	K01853	ko01110	Biosynthesis of secondary metabolites	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMC200001485	K01853	ko00100	Steroid biosynthesis	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMC200001485	K01853	ko01100	Metabolic pathways	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMC200001485	K01853	ko01110	Biosynthesis of secondary metabolites	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMC200001487	K11091	ko03040	Spliceosome	215	5.0e-06	0.31	0.51	0.51
PGSC0003DMC200001494	K05753	ko04520	Adherens junction	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMC200001494	K05753	ko04666	Fc gamma R-mediated phagocytosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMC200001494	K05753	ko04810	Regulation of actin cytoskeleton	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMC200001494	K05753	ko05100	Bacterial invasion of epithelial cells	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMC200001494	K05753	ko05131	Shigellosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMC200001495	K10955	ko05110	Vibrio cholerae infection	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMC200001495	K10955	ko05146	Amoebiasis	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMC200001499	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMC200001499	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMC200001499	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMC200001500	K01590	ko00340	Histidine metabolism	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMC200001500	K01590	ko01100	Metabolic pathways	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMC200001500	K01590	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMC200027631	K10866	ko03440	Homologous recombination	6622	0.	0.75	0.86	1.00
PGSC0003DMC200027631	K10866	ko03450	Non-homologous end-joining	6622	0.	0.75	0.86	1.00
PGSC0003DMC200027632	K10866	ko03440	Homologous recombination	8512	0.	0.78	0.88	1.00
PGSC0003DMC200027632	K10866	ko03450	Non-homologous end-joining	8512	0.	0.78	0.88	1.00
PGSC0003DMC200027641	K02872	ko03010	Ribosome	1610	5.8e-83	0.91	0.97	1.00
PGSC0003DMC200027643	K03032	ko03050	Proteasome	7019	0.	0.85	0.92	1.00
PGSC0003DMC200027644	K03032	ko03050	Proteasome	6080	0.	0.85	0.92	1.00
PGSC0003DMC200027649	K12120	ko04712	Circadian rhythm - plant	7050	0.	0.76	0.84	1.00
PGSC0003DMC200027650	K12120	ko04712	Circadian rhythm - plant	7809	0.	0.82	0.91	1.00
PGSC0003DMC200022506	K02913	ko03010	Ribosome	334	1.4e-12	0.70	0.77	0.98
PGSC0003DMC200022509	K01199	ko00500	Starch and sucrose metabolism	1464	6.5e-75	0.56	0.72	0.95
PGSC0003DMC200022510	K12662	ko03040	Spliceosome	3811	2.3e-204	0.78	0.87	0.99
PGSC0003DMC200022515	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.48	0.59	0.94
PGSC0003DMC200022516	K12356	ko00940	Phenylpropanoid biosynthesis	801	2.4e-38	0.36	0.50	0.98
PGSC0003DMC200022522	K00057	ko00564	Glycerophospholipid metabolism	362	3.9e-14	0.27	0.46	0.77
PGSC0003DMC200005255	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMC200005255	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMC200005255	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMC200005255	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMC200005257	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMC200005257	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMC200005257	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMC200005257	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMC200005262	K00161	ko00010	Glycolysis / Gluconeogenesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko00020	Citrate cycle (TCA cycle)	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko00620	Pyruvate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko00650	Butanoate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko01100	Metabolic pathways	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005262	K00161	ko01110	Biosynthesis of secondary metabolites	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMC200005263	K02961	ko03010	Ribosome	332	1.8e-12	0.70	0.75	0.98
PGSC0003DMC200005264	K02961	ko03010	Ribosome	660	1.4e-30	0.68	0.80	0.99
PGSC0003DMC200005266	K02961	ko03010	Ribosome	264	1.0e-08	0.50	0.56	0.91
PGSC0003DMC200005268	K04424	ko04010	MAPK signaling pathway	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMC200005268	K04424	ko04530	Tight junction	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMC200005273	K09458	ko00061	Fatty acid biosynthesis	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMC200005273	K09458	ko01100	Metabolic pathways	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMC200005274	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMC200005274	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMC200005275	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMC200005275	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMC200014494	K00366	ko00910	Nitrogen metabolism	4175	1.9e-224	0.82	0.91	1.00
PGSC0003DMC200014501	K07424	ko00140	Steroid hormone biosynthesis	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00591	Linoleic acid metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00830	Retinol metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00982	Drug metabolism - cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko00983	Drug metabolism - other enzymes	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014501	K07424	ko01100	Metabolic pathways	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMC200014505	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	367	1.9e-11	0.27	0.41	0.60
PGSC0003DMC200014507	K12580	ko03018	RNA degradation	312	4.6e-09	0.29	0.39	0.47
PGSC0003DMC200014508	K12580	ko03018	RNA degradation	306	1.1e-08	0.30	0.40	0.45
PGSC0003DMC200014509	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	374	7.4e-12	0.27	0.41	0.61
PGSC0003DMC200014510	K12580	ko03018	RNA degradation	306	1.5e-08	0.28	0.38	0.50
PGSC0003DMC200058844	K08243	ko00941	Flavonoid biosynthesis	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMC200058844	K08243	ko01110	Biosynthesis of secondary metabolites	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMC200051301	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMC200051301	K01078	ko00740	Riboflavin metabolism	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMC200051302	K01184	ko00040	Pentose and glucuronate interconversions	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMC200051302	K01184	ko00500	Starch and sucrose metabolism	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMC200051302	K01184	ko01100	Metabolic pathways	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMC200051303	K01184	ko00040	Pentose and glucuronate interconversions	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMC200051303	K01184	ko00500	Starch and sucrose metabolism	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMC200051303	K01184	ko01100	Metabolic pathways	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMC200051304	K01184	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMC200051304	K01184	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMC200051304	K01184	ko01100	Metabolic pathways	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMC200034059	K00873	ko00010	Glycolysis / Gluconeogenesis	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko00230	Purine metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko00620	Pyruvate metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko00710	Carbon fixation in photosynthetic organisms	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko01100	Metabolic pathways	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko01110	Biosynthesis of secondary metabolites	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034059	K00873	ko04930	Type II diabetes mellitus	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMC200034060	K00873	ko00010	Glycolysis / Gluconeogenesis	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko00230	Purine metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko00620	Pyruvate metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko00710	Carbon fixation in photosynthetic organisms	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko01100	Metabolic pathways	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko01110	Biosynthesis of secondary metabolites	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034060	K00873	ko04930	Type II diabetes mellitus	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMC200034062	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.80
PGSC0003DMC200034063	K11091	ko03040	Spliceosome	216	4.4e-06	0.36	0.51	0.61
PGSC0003DMC200034064	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.61
PGSC0003DMC200034068	K09490	ko03060	Protein export	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMC200034068	K09490	ko05020	Prion diseases	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMC200034072	K01051	ko00040	Pentose and glucuronate interconversions	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMC200034072	K01051	ko00500	Starch and sucrose metabolism	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMC200034072	K01051	ko01100	Metabolic pathways	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMC200034073	K01051	ko00040	Pentose and glucuronate interconversions	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMC200034073	K01051	ko00500	Starch and sucrose metabolism	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMC200034073	K01051	ko01100	Metabolic pathways	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMC200034074	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMC200034075	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMC200060866	K10601	ko04120	Ubiquitin mediated proteolysis	225	4.7e-06	0.31	0.51	0.67
PGSC0003DMC200066399	K05747	ko04062	Chemokine signaling pathway	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko04520	Adherens junction	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko04666	Fc gamma R-mediated phagocytosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko04810	Regulation of actin cytoskeleton	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko05100	Bacterial invasion of epithelial cells	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko05130	Pathogenic Escherichia coli infection	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066399	K05747	ko05131	Shigellosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMC200066420	K03094	ko04110	Cell cycle	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04111	Cell cycle - yeast	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04114	Oocyte meiosis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04120	Ubiquitin mediated proteolysis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04310	Wnt signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04350	TGF-beta signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200066420	K03094	ko04710	Circadian rhythm - mammal	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMC200025522	K12486	ko04144	Endocytosis	386	7.1e-14	0.26	0.42	0.98
PGSC0003DMC200025523	K12486	ko04144	Endocytosis	387	9.0e-14	0.26	0.41	0.93
PGSC0003DMC200025524	K12486	ko04144	Endocytosis	404	9.0e-15	0.25	0.40	0.94
PGSC0003DMC200025528	K02879	ko03010	Ribosome	1254	2.5e-63	0.91	0.96	0.98
PGSC0003DMC200025529	K10144	ko04115	p53 signaling pathway	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMC200025529	K10144	ko04120	Ubiquitin mediated proteolysis	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMC200025530	K10144	ko04115	p53 signaling pathway	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMC200025530	K10144	ko04120	Ubiquitin mediated proteolysis	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMC200007113	K08300	ko03018	RNA degradation	369	1.1e-13	0.35	0.48	0.94
PGSC0003DMC200007124	K08269	ko04140	Regulation of autophagy	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMC200007124	K08269	ko04150	mTOR signaling pathway	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMC200007126	K08269	ko04140	Regulation of autophagy	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMC200007126	K08269	ko04150	mTOR signaling pathway	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMC200007127	K08269	ko04140	Regulation of autophagy	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMC200007127	K08269	ko04150	mTOR signaling pathway	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMC200007128	K08269	ko04140	Regulation of autophagy	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMC200007128	K08269	ko04150	mTOR signaling pathway	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMC200007129	K08269	ko04140	Regulation of autophagy	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMC200007129	K08269	ko04150	mTOR signaling pathway	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMC200018633	K07424	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00591	Linoleic acid metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00830	Retinol metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00982	Drug metabolism - cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko00983	Drug metabolism - other enzymes	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018633	K07424	ko01100	Metabolic pathways	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMC200018634	K07424	ko00140	Steroid hormone biosynthesis	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00591	Linoleic acid metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00830	Retinol metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00982	Drug metabolism - cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko00983	Drug metabolism - other enzymes	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018634	K07424	ko01100	Metabolic pathways	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMC200018635	K07424	ko00140	Steroid hormone biosynthesis	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00591	Linoleic acid metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00830	Retinol metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00982	Drug metabolism - cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko00983	Drug metabolism - other enzymes	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018635	K07424	ko01100	Metabolic pathways	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMC200018636	K07424	ko00140	Steroid hormone biosynthesis	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00591	Linoleic acid metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00830	Retinol metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00982	Drug metabolism - cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko00983	Drug metabolism - other enzymes	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018636	K07424	ko01100	Metabolic pathways	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMC200018638	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMC200018638	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMC200018639	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMC200018639	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMC200018644	K02726	ko03050	Proteasome	1643	8.7e-85	0.87	0.89	1.00
PGSC0003DMC200018645	K02726	ko03050	Proteasome	1856	1.6e-96	0.96	0.97	1.00
PGSC0003DMC200018646	K00599	ko00340	Histidine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMC200018646	K00599	ko00350	Tyrosine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMC200018646	K00599	ko00450	Selenoamino acid metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMC200018646	K00599	ko00626	Naphthalene and anthracene degradation	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMC200018647	K00599	ko00340	Histidine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMC200018647	K00599	ko00350	Tyrosine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMC200018647	K00599	ko00450	Selenoamino acid metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMC200018647	K00599	ko00626	Naphthalene and anthracene degradation	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMC200018650	K12669	ko00510	N-Glycan biosynthesis	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMC200018650	K12669	ko01100	Metabolic pathways	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMC200018652	K00232	ko00071	Fatty acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018652	K00232	ko00592	alpha-Linolenic acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018652	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018652	K00232	ko01100	Metabolic pathways	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018652	K00232	ko03320	PPAR signaling pathway	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018652	K00232	ko04146	Peroxisome	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMC200018653	K00232	ko00071	Fatty acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018653	K00232	ko00592	alpha-Linolenic acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018653	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018653	K00232	ko01100	Metabolic pathways	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018653	K00232	ko03320	PPAR signaling pathway	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018653	K00232	ko04146	Peroxisome	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMC200018654	K05279	ko00944	Flavone and flavonol biosynthesis	465	8.2e-20	0.36	0.54	0.96
PGSC0003DMC200038314	K04079	ko04612	Antigen processing and presentation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038314	K04079	ko04621	NOD-like receptor signaling pathway	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038314	K04079	ko04626	Plant-pathogen interaction	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038314	K04079	ko04914	Progesterone-mediated oocyte maturation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038314	K04079	ko05200	Pathways in cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038314	K04079	ko05215	Prostate cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMC200038315	K12863	ko03040	Spliceosome	1614	3.5e-83	0.80	0.89	1.00
PGSC0003DMC200038316	K12863	ko03040	Spliceosome	1637	1.9e-84	0.83	0.92	1.00
PGSC0003DMC200054303	K03847	ko00510	N-Glycan biosynthesis	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMC200054303	K03847	ko01100	Metabolic pathways	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMC200054306	K03847	ko00510	N-Glycan biosynthesis	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMC200054306	K03847	ko01100	Metabolic pathways	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMC200054307	K03847	ko00510	N-Glycan biosynthesis	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMC200054307	K03847	ko01100	Metabolic pathways	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMC200054308	K03847	ko00510	N-Glycan biosynthesis	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMC200054308	K03847	ko01100	Metabolic pathways	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMC200054309	K03847	ko00510	N-Glycan biosynthesis	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMC200054309	K03847	ko01100	Metabolic pathways	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMC200054310	K03847	ko00510	N-Glycan biosynthesis	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMC200054310	K03847	ko01100	Metabolic pathways	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMC200054311	K03847	ko00510	N-Glycan biosynthesis	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMC200054311	K03847	ko01100	Metabolic pathways	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMC200054312	K07192	ko04910	Insulin signaling pathway	1265	6.2e-64	0.38	0.55	0.97
PGSC0003DMC200054318	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMC200054318	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMC200054318	K12366	ko05131	Shigellosis	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMC200031329	K02183	ko04020	Calcium signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04070	Phosphatidylinositol signaling system	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04114	Oocyte meiosis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04270	Vascular smooth muscle contraction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04626	Plant-pathogen interaction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04720	Long-term potentiation	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04722	Neurotrophin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04740	Olfactory transduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04744	Phototransduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04745	Phototransduction - fly	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04910	Insulin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04912	GnRH signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04916	Melanogenesis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04970	Salivary secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko04971	Gastric acid secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko05010	Alzheimer's disease	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031329	K02183	ko05214	Glioma	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMC200031337	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMC200031338	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMC200031339	K08332	ko04140	Regulation of autophagy	392	1.8e-13	0.31	0.53	0.38
PGSC0003DMC200031348	K10352	ko04530	Tight junction	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMC200031348	K10352	ko05416	Viral myocarditis	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMC200049837	K01423	ko00310	Lysine degradation	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMC200049837	K01423	ko00780	Biotin metabolism	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMC200049837	K01423	ko01100	Metabolic pathways	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMC200042242	K00167	ko00280	Valine, leucine and isoleucine degradation	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMC200042242	K00167	ko01100	Metabolic pathways	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMC200042242	K00167	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMC200042243	K03120	ko03022	Basal transcription factors	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMC200042243	K03120	ko05016	Huntington's disease	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMC200042244	K03120	ko03022	Basal transcription factors	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMC200042244	K03120	ko05016	Huntington's disease	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMC200042246	K00558	ko00270	Cysteine and methionine metabolism	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMC200042246	K00558	ko01100	Metabolic pathways	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMC200042247	K00558	ko00270	Cysteine and methionine metabolism	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMC200042247	K00558	ko01100	Metabolic pathways	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMC200042250	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042250	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042251	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042252	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042253	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMC200042254	K02084	ko04115	p53 signaling pathway	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko04210	Apoptosis	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko05010	Alzheimer's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko05012	Parkinson's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko05016	Huntington's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042254	K02084	ko05222	Small cell lung cancer	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMC200042256	K07195	ko04910	Insulin signaling pathway	422	1.9e-17	0.83	0.93	0.86
PGSC0003DMC200042258	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200042258	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200042258	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200042263	K12929	ko00904	Diterpenoid biosynthesis	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMC200042263	K12929	ko01110	Biosynthesis of secondary metabolites	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMC200042264	K12929	ko00904	Diterpenoid biosynthesis	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMC200042264	K12929	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMC200042265	K12929	ko00904	Diterpenoid biosynthesis	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMC200042265	K12929	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMC200042266	K12467	ko00902	Monoterpenoid biosynthesis	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMC200042266	K12467	ko01110	Biosynthesis of secondary metabolites	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMC200042268	K12929	ko00904	Diterpenoid biosynthesis	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMC200042268	K12929	ko01110	Biosynthesis of secondary metabolites	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMC200055389	K02942	ko03010	Ribosome	714	1.5e-33	0.80	0.85	0.99
PGSC0003DMC200055394	K04506	ko04115	p53 signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMC200055394	K04506	ko04120	Ubiquitin mediated proteolysis	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMC200055394	K04506	ko04310	Wnt signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMC200055395	K04506	ko04115	p53 signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMC200055395	K04506	ko04120	Ubiquitin mediated proteolysis	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMC200055395	K04506	ko04310	Wnt signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMC200055396	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055396	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055396	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055397	K04506	ko04115	p53 signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMC200055397	K04506	ko04120	Ubiquitin mediated proteolysis	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMC200055397	K04506	ko04310	Wnt signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMC200055398	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055398	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055398	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMC200055404	K00430	ko00360	Phenylalanine metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMC200055404	K00430	ko00680	Methane metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMC200055404	K00430	ko00940	Phenylpropanoid biosynthesis	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMC200055404	K00430	ko01100	Metabolic pathways	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMC200055404	K00430	ko01110	Biosynthesis of secondary metabolites	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMC200048997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMC200048997	K00517	ko00626	Naphthalene and anthracene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMC200048997	K00517	ko00903	Limonene and pinene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMC200048997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMC200048997	K00517	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMC200048998	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMC200048998	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMC200048998	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMC200048998	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMC200048998	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMC200049005	K07375	ko04145	Phagosome	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMC200049005	K07375	ko04540	Gap junction	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMC200049005	K07375	ko05130	Pathogenic Escherichia coli infection	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMC200049006	K07375	ko04145	Phagosome	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMC200049006	K07375	ko04540	Gap junction	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMC200049006	K07375	ko05130	Pathogenic Escherichia coli infection	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMC200049017	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1351	1.1e-68	0.35	0.52	0.90
PGSC0003DMC200049019	K02183	ko04020	Calcium signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04070	Phosphatidylinositol signaling system	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04114	Oocyte meiosis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04270	Vascular smooth muscle contraction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04626	Plant-pathogen interaction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04720	Long-term potentiation	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04722	Neurotrophin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04740	Olfactory transduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04744	Phototransduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04745	Phototransduction - fly	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04910	Insulin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04912	GnRH signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04916	Melanogenesis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04970	Salivary secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko04971	Gastric acid secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko05010	Alzheimer's disease	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049019	K02183	ko05214	Glioma	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMC200049020	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049020	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200030367	K01178	ko00500	Starch and sucrose metabolism	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMC200030367	K01178	ko01100	Metabolic pathways	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMC200030368	K01178	ko00500	Starch and sucrose metabolism	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMC200030368	K01178	ko01100	Metabolic pathways	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMC200030369	K01178	ko00500	Starch and sucrose metabolism	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMC200030369	K01178	ko01100	Metabolic pathways	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMC200030375	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMC200030375	K02366	ko01100	Metabolic pathways	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMC200030382	K00036	ko00030	Pentose phosphate pathway	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMC200030382	K00036	ko00480	Glutathione metabolism	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMC200030382	K00036	ko01100	Metabolic pathways	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMC200030382	K00036	ko01110	Biosynthesis of secondary metabolites	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMC200030383	K00036	ko00030	Pentose phosphate pathway	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMC200030383	K00036	ko00480	Glutathione metabolism	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMC200030383	K00036	ko01100	Metabolic pathways	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMC200030383	K00036	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMC200030385	K12121	ko04712	Circadian rhythm - plant	5599	0.	0.60	0.78	0.99
PGSC0003DMC200030386	K00736	ko00510	N-Glycan biosynthesis	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMC200030386	K00736	ko01100	Metabolic pathways	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMC200030387	K07199	ko04910	Insulin signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMC200030387	K07199	ko04920	Adipocytokine signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMC200030387	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMC200030388	K07199	ko04910	Insulin signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMC200030388	K07199	ko04920	Adipocytokine signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMC200030388	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMC200030389	K07199	ko04910	Insulin signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMC200030389	K07199	ko04920	Adipocytokine signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMC200030389	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMC200030390	K07199	ko04910	Insulin signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMC200030390	K07199	ko04920	Adipocytokine signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMC200030390	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMC200024181	K12585	ko03018	RNA degradation	6422	0.	0.81	0.90	1.00
PGSC0003DMC200024186	K10840	ko03420	Nucleotide excision repair	716	1.2e-33	0.57	0.82	0.89
PGSC0003DMC200024187	K10840	ko03420	Nucleotide excision repair	798	3.5e-38	0.58	0.81	0.91
PGSC0003DMC200024188	K00948	ko00030	Pentose phosphate pathway	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMC200024188	K00948	ko00230	Purine metabolism	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMC200024188	K00948	ko01100	Metabolic pathways	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMC200024188	K00948	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMC200024189	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024189	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024189	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024189	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024190	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024190	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024190	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024190	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMC200024196	K01051	ko00040	Pentose and glucuronate interconversions	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMC200024196	K01051	ko00500	Starch and sucrose metabolism	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMC200024196	K01051	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMC200024197	K01051	ko00040	Pentose and glucuronate interconversions	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMC200024197	K01051	ko00500	Starch and sucrose metabolism	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMC200024197	K01051	ko01100	Metabolic pathways	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMC200024198	K01853	ko00100	Steroid biosynthesis	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMC200024198	K01853	ko01100	Metabolic pathways	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMC200024198	K01853	ko01110	Biosynthesis of secondary metabolites	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMC200024202	K00487	ko00360	Phenylalanine metabolism	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024202	K00487	ko00940	Phenylpropanoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024202	K00487	ko00941	Flavonoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024202	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024202	K00487	ko01100	Metabolic pathways	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024202	K00487	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMC200024203	K02738	ko03050	Proteasome	1682	6.2e-87	0.86	0.94	0.97
PGSC0003DMC200024210	K12667	ko00510	N-Glycan biosynthesis	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMC200024210	K12667	ko01100	Metabolic pathways	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMC200013442	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMC200013443	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMC200013469	K03025	ko00230	Purine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMC200013469	K03025	ko00240	Pyrimidine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMC200013469	K03025	ko01100	Metabolic pathways	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMC200013469	K03025	ko03020	RNA polymerase	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMC200013469	K03025	ko04623	Cytosolic DNA-sensing pathway	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMC200011559	K02084	ko04115	p53 signaling pathway	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko04210	Apoptosis	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko05010	Alzheimer's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko05012	Parkinson's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko05016	Huntington's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011559	K02084	ko05222	Small cell lung cancer	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMC200011569	K05282	ko00904	Diterpenoid biosynthesis	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMC200011569	K05282	ko01100	Metabolic pathways	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMC200011569	K05282	ko01110	Biosynthesis of secondary metabolites	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMC200011570	K01875	ko00970	Aminoacyl-tRNA biosynthesis	875	2.0e-42	0.82	0.92	0.96
PGSC0003DMC200020195	K01188	ko00460	Cyanoamino acid metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMC200020195	K01188	ko00500	Starch and sucrose metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMC200020195	K01188	ko00940	Phenylpropanoid biosynthesis	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMC200020195	K01188	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMC200020196	K01188	ko00460	Cyanoamino acid metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMC200020196	K01188	ko00500	Starch and sucrose metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMC200020196	K01188	ko00940	Phenylpropanoid biosynthesis	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMC200020196	K01188	ko01110	Biosynthesis of secondary metabolites	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMC200020197	K01188	ko00460	Cyanoamino acid metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMC200020197	K01188	ko00500	Starch and sucrose metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMC200020197	K01188	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMC200020197	K01188	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMC200020199	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020199	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020199	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020199	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020200	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020200	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020200	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020200	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020201	K01188	ko00460	Cyanoamino acid metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMC200020201	K01188	ko00500	Starch and sucrose metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMC200020201	K01188	ko00940	Phenylpropanoid biosynthesis	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMC200020201	K01188	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMC200020202	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020202	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020202	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020202	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMC200020203	K01188	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMC200020203	K01188	ko00500	Starch and sucrose metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMC200020203	K01188	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMC200020203	K01188	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMC200020204	K05350	ko00460	Cyanoamino acid metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMC200020204	K05350	ko00500	Starch and sucrose metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMC200020204	K05350	ko00940	Phenylpropanoid biosynthesis	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMC200020204	K05350	ko01110	Biosynthesis of secondary metabolites	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMC200020207	K12890	ko03040	Spliceosome	1966	1.3e-102	0.78	0.85	0.97
PGSC0003DMC200020208	K12890	ko03040	Spliceosome	783	2.4e-37	0.73	0.80	0.95
PGSC0003DMC200020209	K12890	ko03040	Spliceosome	1111	1.9e-55	0.85	0.91	0.96
PGSC0003DMC200020210	K11096	ko03040	Spliceosome	838	2.2e-40	0.94	0.96	0.99
PGSC0003DMC200067258	K03412	ko02020	Two-component system	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMC200067258	K03412	ko02030	Bacterial chemotaxis	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMC200032612	K09842	ko00906	Carotenoid biosynthesis	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMC200032612	K09842	ko01100	Metabolic pathways	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMC200032612	K09842	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMC200032613	K09842	ko00906	Carotenoid biosynthesis	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMC200032613	K09842	ko01100	Metabolic pathways	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMC200032613	K09842	ko01110	Biosynthesis of secondary metabolites	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMC200032614	K11817	ko00380	Tryptophan metabolism	6653	0.	0.60	0.77	1.00
PGSC0003DMC200032615	K09842	ko00906	Carotenoid biosynthesis	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMC200032615	K09842	ko01100	Metabolic pathways	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMC200032615	K09842	ko01110	Biosynthesis of secondary metabolites	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMC200032616	K09842	ko00906	Carotenoid biosynthesis	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMC200032616	K09842	ko01100	Metabolic pathways	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMC200032616	K09842	ko01110	Biosynthesis of secondary metabolites	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMC200032617	K09842	ko00906	Carotenoid biosynthesis	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMC200032617	K09842	ko01100	Metabolic pathways	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMC200032617	K09842	ko01110	Biosynthesis of secondary metabolites	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMC200032618	K09842	ko00906	Carotenoid biosynthesis	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMC200032618	K09842	ko01100	Metabolic pathways	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMC200032618	K09842	ko01110	Biosynthesis of secondary metabolites	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMC200032619	K09842	ko00906	Carotenoid biosynthesis	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMC200032619	K09842	ko01100	Metabolic pathways	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMC200032619	K09842	ko01110	Biosynthesis of secondary metabolites	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMC200032620	K09842	ko00906	Carotenoid biosynthesis	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMC200032620	K09842	ko01100	Metabolic pathways	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMC200032620	K09842	ko01110	Biosynthesis of secondary metabolites	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMC200032621	K09842	ko00906	Carotenoid biosynthesis	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMC200032621	K09842	ko01100	Metabolic pathways	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMC200032621	K09842	ko01110	Biosynthesis of secondary metabolites	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMC200032622	K11817	ko00380	Tryptophan metabolism	588	8.9e-26	0.64	0.78	0.99
PGSC0003DMC200032623	K11817	ko00380	Tryptophan metabolism	6084	0.	0.56	0.73	0.99
PGSC0003DMC200032624	K11817	ko00380	Tryptophan metabolism	6464	0.	0.58	0.76	0.99
PGSC0003DMC200032628	K00079	ko00590	Arachidonic acid metabolism	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMC200032628	K00079	ko01100	Metabolic pathways	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMC200032629	K00079	ko00590	Arachidonic acid metabolism	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMC200032629	K00079	ko01100	Metabolic pathways	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMC200032631	K02935	ko03010	Ribosome	367	2.1e-14	0.43	0.63	0.65
PGSC0003DMC200032632	K00606	ko00770	Pantothenate and CoA biosynthesis	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMC200032632	K00606	ko01100	Metabolic pathways	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMC200032632	K00606	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMC200057997	K12800	ko04621	NOD-like receptor signaling pathway	321	5.4e-09	0.30	0.50	0.50
PGSC0003DMC200058009	K02183	ko04020	Calcium signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04070	Phosphatidylinositol signaling system	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04114	Oocyte meiosis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04270	Vascular smooth muscle contraction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04626	Plant-pathogen interaction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04720	Long-term potentiation	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04722	Neurotrophin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04740	Olfactory transduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04744	Phototransduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04745	Phototransduction - fly	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04910	Insulin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04912	GnRH signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04916	Melanogenesis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04970	Salivary secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko04971	Gastric acid secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko05010	Alzheimer's disease	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058009	K02183	ko05214	Glioma	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMC200058012	K10760	ko00908	Zeatin biosynthesis	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMC200058012	K10760	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMC200058012	K10760	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMC200034781	K00551	ko00564	Glycerophospholipid metabolism	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMC200034781	K00551	ko01100	Metabolic pathways	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMC200034782	K00551	ko00564	Glycerophospholipid metabolism	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMC200034782	K00551	ko01100	Metabolic pathways	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMC200034792	K10352	ko04530	Tight junction	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMC200034792	K10352	ko05416	Viral myocarditis	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMC200034796	K01955	ko00240	Pyrimidine metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMC200034796	K01955	ko00250	Alanine, aspartate and glutamate metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMC200034796	K01955	ko01100	Metabolic pathways	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMC200034797	K05278	ko00941	Flavonoid biosynthesis	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMC200034797	K05278	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMC200034797	K05278	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMC200034799	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMC200034800	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMC200052382	K03787	ko00230	Purine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMC200052382	K03787	ko00240	Pyrimidine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMC200052382	K03787	ko00760	Nicotinate and nicotinamide metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMC200052382	K03787	ko01100	Metabolic pathways	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMC200052382	K03787	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMC200052383	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052383	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052383	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052383	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052383	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052384	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052384	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052384	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052384	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052384	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052385	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052385	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052385	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052385	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052385	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMC200052386	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052386	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052386	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052386	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052386	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052387	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052387	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052387	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052387	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052387	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMC200052390	K00276	ko00260	Glycine, serine and threonine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko00350	Tyrosine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko00410	beta-Alanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko01100	Metabolic pathways	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052390	K00276	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMC200052391	K00276	ko00260	Glycine, serine and threonine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko00350	Tyrosine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko00360	Phenylalanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko00410	beta-Alanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko01100	Metabolic pathways	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052391	K00276	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMC200052395	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052395	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052395	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052396	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052396	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052396	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMC200052399	K12132	ko04712	Circadian rhythm - plant	1254	2.5e-63	0.48	0.63	0.99
PGSC0003DMC200052400	K12132	ko04712	Circadian rhythm - plant	2032	3.1e-106	0.53	0.65	1.00
PGSC0003DMC200052401	K12132	ko04712	Circadian rhythm - plant	2679	6.3e-142	0.57	0.69	0.99
PGSC0003DMC200052402	K12132	ko04712	Circadian rhythm - plant	3548	7.4e-190	0.62	0.73	1.00
PGSC0003DMC200052403	K12132	ko04712	Circadian rhythm - plant	3126	1.4e-166	0.60	0.71	1.00
PGSC0003DMC200052405	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052405	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052405	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052405	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052406	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052406	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052406	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200052406	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMC200044731	K05864	ko04020	Calcium signaling pathway	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMC200044731	K05864	ko05012	Parkinson's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMC200044731	K05864	ko05016	Huntington's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMC200044749	K01046	ko00561	Glycerolipid metabolism	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMC200044749	K01046	ko01100	Metabolic pathways	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMC200044750	K01066	ko00623	2,4-Dichlorobenzoate degradation	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMC200044750	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMC200044751	K01046	ko00561	Glycerolipid metabolism	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMC200044751	K01046	ko01100	Metabolic pathways	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMC200044755	K01046	ko00561	Glycerolipid metabolism	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMC200044755	K01046	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMC200029192	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029192	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029192	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029192	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029192	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029193	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029193	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029193	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029193	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029193	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMC200029194	K10775	ko00360	Phenylalanine metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMC200029194	K10775	ko00910	Nitrogen metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMC200029194	K10775	ko00940	Phenylpropanoid biosynthesis	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMC200029194	K10775	ko01100	Metabolic pathways	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMC200029194	K10775	ko01110	Biosynthesis of secondary metabolites	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMC200029195	K10775	ko00360	Phenylalanine metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMC200029195	K10775	ko00910	Nitrogen metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMC200029195	K10775	ko00940	Phenylpropanoid biosynthesis	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMC200029195	K10775	ko01100	Metabolic pathways	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMC200029195	K10775	ko01110	Biosynthesis of secondary metabolites	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMC200029196	K04506	ko04115	p53 signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMC200029196	K04506	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMC200029196	K04506	ko04310	Wnt signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMC200029198	K04506	ko04115	p53 signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMC200029198	K04506	ko04120	Ubiquitin mediated proteolysis	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMC200029198	K04506	ko04310	Wnt signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMC200029199	K04506	ko04115	p53 signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMC200029199	K04506	ko04120	Ubiquitin mediated proteolysis	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMC200029199	K04506	ko04310	Wnt signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMC200029202	K08912	ko00196	Photosynthesis - antenna proteins	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMC200029202	K08912	ko01100	Metabolic pathways	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMC200029216	K13229	ko00402	Benzoxazinoid biosynthesis	298	1.3e-10	0.49	0.65	0.90
PGSC0003DMC200003571	K01081	ko00230	Purine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMC200003571	K01081	ko00240	Pyrimidine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMC200003571	K01081	ko00760	Nicotinate and nicotinamide metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMC200003571	K01081	ko01100	Metabolic pathways	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMC200003571	K01081	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMC200003572	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003572	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003572	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003572	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003572	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003573	K01081	ko00230	Purine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMC200003573	K01081	ko00240	Pyrimidine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMC200003573	K01081	ko00760	Nicotinate and nicotinamide metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMC200003573	K01081	ko01100	Metabolic pathways	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMC200003573	K01081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMC200003577	K02084	ko04115	p53 signaling pathway	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko04210	Apoptosis	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko05010	Alzheimer's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko05012	Parkinson's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko05016	Huntington's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003577	K02084	ko05222	Small cell lung cancer	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMC200003581	K07195	ko04910	Insulin signaling pathway	3859	5.2e-207	0.72	0.86	0.97
PGSC0003DMC200003583	K11818	ko00380	Tryptophan metabolism	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMC200003583	K11818	ko00966	Glucosinolate biosynthesis	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMC200003583	K11818	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMC200003584	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003584	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003584	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003584	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003584	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003585	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003585	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003585	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003585	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003585	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003586	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003586	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003586	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003586	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003586	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMC200003587	K11818	ko00380	Tryptophan metabolism	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMC200003587	K11818	ko00966	Glucosinolate biosynthesis	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMC200003587	K11818	ko01110	Biosynthesis of secondary metabolites	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMC200003599	K02703	ko00195	Photosynthesis	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMC200003599	K02703	ko01100	Metabolic pathways	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMC200021183	K08139	ko04113	Meiosis - yeast	915	1.2e-44	0.34	0.55	0.92
PGSC0003DMC200021184	K08139	ko04113	Meiosis - yeast	694	1.9e-32	0.36	0.59	0.94
PGSC0003DMC200021185	K08139	ko04113	Meiosis - yeast	1048	5.7e-52	0.36	0.58	0.89
PGSC0003DMC200021192	K12356	ko00940	Phenylpropanoid biosynthesis	780	3.5e-37	0.43	0.59	0.90
PGSC0003DMC200021204	K06627	ko04110	Cell cycle	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMC200021204	K06627	ko04914	Progesterone-mediated oocyte maturation	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMC200021205	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMC200021206	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMC200059210	K10760	ko00908	Zeatin biosynthesis	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMC200059210	K10760	ko01100	Metabolic pathways	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMC200059210	K10760	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMC200051181	K00600	ko00260	Glycine, serine and threonine metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051181	K00600	ko00460	Cyanoamino acid metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051181	K00600	ko00670	One carbon pool by folate	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051181	K00600	ko00680	Methane metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051181	K00600	ko01100	Metabolic pathways	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051181	K00600	ko01110	Biosynthesis of secondary metabolites	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMC200051182	K01369	ko04142	Lysosome	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMC200051182	K01369	ko04612	Antigen processing and presentation	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMC200051183	K00970	ko03018	RNA degradation	1893	1.4e-98	0.64	0.80	0.82
PGSC0003DMC200051184	K00970	ko03018	RNA degradation	3077	7.1e-164	0.67	0.82	0.87
PGSC0003DMC200051185	K11481	ko04114	Oocyte meiosis	431	6.2e-18	0.79	0.93	0.97
PGSC0003DMC200051186	K11481	ko04114	Oocyte meiosis	2309	1.6e-121	0.89	0.97	1.00
PGSC0003DMC200051187	K01867	ko00380	Tryptophan metabolism	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMC200051187	K01867	ko00970	Aminoacyl-tRNA biosynthesis	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMC200051188	K01867	ko00380	Tryptophan metabolism	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMC200051188	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMC200051189	K01867	ko00380	Tryptophan metabolism	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMC200051189	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMC200033589	K03111	ko03030	DNA replication	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMC200033589	K03111	ko03430	Mismatch repair	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMC200033589	K03111	ko03440	Homologous recombination	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMC200033590	K12126	ko04712	Circadian rhythm - plant	294	3.4e-10	0.47	0.81	0.24
PGSC0003DMC200033592	K12183	ko04144	Endocytosis	725	3.7e-34	0.35	0.53	0.92
PGSC0003DMC200068942	K01955	ko00240	Pyrimidine metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMC200068942	K01955	ko00250	Alanine, aspartate and glutamate metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMC200068942	K01955	ko01100	Metabolic pathways	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMC200068955	K01066	ko00623	2,4-Dichlorobenzoate degradation	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMC200068955	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMC200001352	K01199	ko00500	Starch and sucrose metabolism	872	2.9e-42	0.38	0.58	0.72
PGSC0003DMC200001359	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMC200001360	K08139	ko04113	Meiosis - yeast	446	9.2e-19	0.37	0.55	0.89
PGSC0003DMC200001362	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMC200001363	K08139	ko04113	Meiosis - yeast	491	3.0e-21	0.39	0.62	0.97
PGSC0003DMC200001366	K08139	ko04113	Meiosis - yeast	530	2.1e-23	0.42	0.64	0.65
PGSC0003DMC200001367	K00430	ko00360	Phenylalanine metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMC200001367	K00430	ko00680	Methane metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMC200001367	K00430	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMC200001367	K00430	ko01100	Metabolic pathways	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMC200001367	K00430	ko01110	Biosynthesis of secondary metabolites	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMC200001368	K00430	ko00360	Phenylalanine metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMC200001368	K00430	ko00680	Methane metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMC200001368	K00430	ko00940	Phenylpropanoid biosynthesis	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMC200001368	K00430	ko01100	Metabolic pathways	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMC200001368	K00430	ko01110	Biosynthesis of secondary metabolites	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMC200001369	K11584	ko04113	Meiosis - yeast	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMC200001369	K11584	ko04114	Oocyte meiosis	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMC200001369	K11584	ko04310	Wnt signaling pathway	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMC200001375	K00558	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMC200001375	K00558	ko01100	Metabolic pathways	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMC200001376	K00558	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMC200001376	K00558	ko01100	Metabolic pathways	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMC200028000	K02966	ko03010	Ribosome	1079	1.1e-53	0.87	0.93	0.99
PGSC0003DMC200028002	K02942	ko03010	Ribosome	685	6.0e-32	0.75	0.83	0.99
PGSC0003DMC200028005	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028005	K00261	ko00330	Arginine and proline metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028005	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028005	K00261	ko00910	Nitrogen metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028005	K00261	ko01100	Metabolic pathways	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028005	K00261	ko04964	Proximal tubule bicarbonate reclamation	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMC200028013	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028013	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028013	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028014	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028014	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028014	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMC200028017	K02183	ko04020	Calcium signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04070	Phosphatidylinositol signaling system	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04114	Oocyte meiosis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04270	Vascular smooth muscle contraction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04626	Plant-pathogen interaction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04720	Long-term potentiation	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04722	Neurotrophin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04740	Olfactory transduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04744	Phototransduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04745	Phototransduction - fly	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04910	Insulin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04912	GnRH signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04916	Melanogenesis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04970	Salivary secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko04971	Gastric acid secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko05010	Alzheimer's disease	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028017	K02183	ko05214	Glioma	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMC200028018	K00558	ko00270	Cysteine and methionine metabolism	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMC200028018	K00558	ko01100	Metabolic pathways	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMC200028019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMC200028019	K00517	ko00626	Naphthalene and anthracene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMC200028019	K00517	ko00903	Limonene and pinene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMC200028019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMC200028019	K00517	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMC200028020	K01597	ko00900	Terpenoid backbone biosynthesis	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMC200028020	K01597	ko01100	Metabolic pathways	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMC200028020	K01597	ko01110	Biosynthesis of secondary metabolites	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMC200022384	K03980	ko00550	Peptidoglycan biosynthesis	492	1.6e-25	0.34	0.49	0.62
PGSC0003DMC200022385	K03980	ko00550	Peptidoglycan biosynthesis	534	1.3e-23	0.41	0.62	0.92
PGSC0003DMC200022386	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMC200022386	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMC200022387	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMC200022387	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMC200022394	K01728	ko00040	Pentose and glucuronate interconversions	2728	1.3e-144	0.76	0.87	0.99
PGSC0003DMC200022397	K00100	ko00051	Fructose and mannose metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022397	K00100	ko00363	Bisphenol A degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022397	K00100	ko00591	Linoleic acid metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022397	K00100	ko00625	Tetrachloroethene degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022397	K00100	ko00650	Butanoate metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022397	K00100	ko01100	Metabolic pathways	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMC200022398	K10251	ko01040	Biosynthesis of unsaturated fatty acids	856	2.2e-41	0.41	0.61	0.93
PGSC0003DMC200022405	K01814	ko00340	Histidine metabolism	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMC200022405	K01814	ko01100	Metabolic pathways	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMC200022405	K01814	ko01110	Biosynthesis of secondary metabolites	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMC200022406	K01814	ko00340	Histidine metabolism	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMC200022406	K01814	ko01100	Metabolic pathways	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMC200022406	K01814	ko01110	Biosynthesis of secondary metabolites	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMC200004772	K10865	ko03440	Homologous recombination	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMC200004772	K10865	ko03450	Non-homologous end-joining	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMC200004773	K10865	ko03440	Homologous recombination	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMC200004773	K10865	ko03450	Non-homologous end-joining	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMC200004777	K10865	ko03440	Homologous recombination	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMC200004777	K10865	ko03450	Non-homologous end-joining	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMC200004779	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMC200004781	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMC200004783	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMC200004784	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMC200004786	K01623	ko00010	Glycolysis / Gluconeogenesis	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004786	K01623	ko00030	Pentose phosphate pathway	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004786	K01623	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004786	K01623	ko00710	Carbon fixation in photosynthetic organisms	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004786	K01623	ko01100	Metabolic pathways	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004786	K01623	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMC200004787	K01623	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004787	K01623	ko00030	Pentose phosphate pathway	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004787	K01623	ko00051	Fructose and mannose metabolism	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004787	K01623	ko00710	Carbon fixation in photosynthetic organisms	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004787	K01623	ko01100	Metabolic pathways	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004787	K01623	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMC200004793	K09540	ko03060	Protein export	4426	2.8e-238	0.76	0.87	1.00
PGSC0003DMC200004794	K09540	ko03060	Protein export	1560	3.3e-80	0.70	0.83	0.97
PGSC0003DMC200014736	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMC200014736	K02366	ko01100	Metabolic pathways	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMC200014752	K04733	ko04210	Apoptosis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMC200014752	K04733	ko04620	Toll-like receptor signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMC200014752	K04733	ko04722	Neurotrophin signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMC200014752	K04733	ko05140	Leishmaniasis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMC200014752	K04733	ko05142	Chagas disease	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMC200014753	K04733	ko04210	Apoptosis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMC200014753	K04733	ko04620	Toll-like receptor signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMC200014753	K04733	ko04722	Neurotrophin signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMC200014753	K04733	ko05140	Leishmaniasis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMC200014753	K04733	ko05142	Chagas disease	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMC200014754	K04733	ko04210	Apoptosis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMC200014754	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMC200014754	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMC200014754	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMC200014754	K04733	ko05142	Chagas disease	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMC200014757	K02087	ko04110	Cell cycle	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMC200014757	K02087	ko04114	Oocyte meiosis	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMC200014757	K02087	ko04115	p53 signaling pathway	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMC200014757	K02087	ko04540	Gap junction	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMC200014757	K02087	ko04914	Progesterone-mediated oocyte maturation	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMC200043446	K00979	ko00540	Lipopolysaccharide biosynthesis	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMC200043446	K00979	ko01100	Metabolic pathways	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMC200043447	K03514	ko03018	RNA degradation	454	3.3e-19	0.66	0.78	0.62
PGSC0003DMC200043448	K03514	ko03018	RNA degradation	998	3.3e-49	0.69	0.81	0.76
PGSC0003DMC200043449	K03514	ko03018	RNA degradation	2644	5.4e-140	0.69	0.80	0.90
PGSC0003DMC200043450	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.49
PGSC0003DMC200043452	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.53
PGSC0003DMC200043454	K02260	ko00190	Oxidative phosphorylation	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMC200043454	K02260	ko01100	Metabolic pathways	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMC200043457	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMC200043457	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMC200043457	K00771	ko01100	Metabolic pathways	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMC200043458	K09880	ko00270	Cysteine and methionine metabolism	2120	4.3e-111	0.56	0.62	0.99
PGSC0003DMC200043459	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMC200043459	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMC200043460	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMC200043460	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMC200043470	K00760	ko00230	Purine metabolism	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMC200043470	K00760	ko00983	Drug metabolism - other enzymes	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMC200043470	K00760	ko01100	Metabolic pathways	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMC200043470	K00760	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMC200054191	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMC200054191	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMC200054192	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMC200054192	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMC200054210	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMC200054210	K06127	ko01100	Metabolic pathways	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMC200054210	K06127	ko01110	Biosynthesis of secondary metabolites	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMC200041555	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	216	8.7e-06	0.40	0.54	0.82
PGSC0003DMC200041563	K02885	ko03010	Ribosome	764	2.6e-36	0.99	0.99	0.57
PGSC0003DMC200041564	K02885	ko03010	Ribosome	1005	1.3e-49	0.98	0.99	0.99
PGSC0003DMC200041569	K10532	ko00531	Glycosaminoglycan degradation	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMC200041569	K10532	ko01100	Metabolic pathways	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMC200041569	K10532	ko04142	Lysosome	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMC200041570	K10532	ko00531	Glycosaminoglycan degradation	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMC200041570	K10532	ko01100	Metabolic pathways	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMC200041570	K10532	ko04142	Lysosome	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMC200041571	K10532	ko00531	Glycosaminoglycan degradation	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMC200041571	K10532	ko01100	Metabolic pathways	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMC200041571	K10532	ko04142	Lysosome	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMC200041573	K10532	ko00531	Glycosaminoglycan degradation	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMC200041573	K10532	ko01100	Metabolic pathways	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMC200041573	K10532	ko04142	Lysosome	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMC200041575	K10532	ko00531	Glycosaminoglycan degradation	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMC200041575	K10532	ko01100	Metabolic pathways	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMC200041575	K10532	ko04142	Lysosome	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMC200041576	K02986	ko03010	Ribosome	1292	2.0e-65	0.87	0.92	0.99
PGSC0003DMC200031576	K07385	ko00902	Monoterpenoid biosynthesis	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMC200031576	K07385	ko01100	Metabolic pathways	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMC200031577	K12467	ko00902	Monoterpenoid biosynthesis	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMC200031577	K12467	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMC200031578	K12467	ko00902	Monoterpenoid biosynthesis	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMC200031578	K12467	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMC200031579	K07385	ko00902	Monoterpenoid biosynthesis	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMC200031579	K07385	ko01100	Metabolic pathways	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMC200031580	K07385	ko00902	Monoterpenoid biosynthesis	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMC200031580	K07385	ko01100	Metabolic pathways	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMC200031581	K07385	ko00902	Monoterpenoid biosynthesis	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMC200031581	K07385	ko01100	Metabolic pathways	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMC200031582	K07385	ko00902	Monoterpenoid biosynthesis	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMC200031582	K07385	ko01100	Metabolic pathways	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMC200031583	K07385	ko00902	Monoterpenoid biosynthesis	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMC200031583	K07385	ko01100	Metabolic pathways	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMC200050196	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMC200050197	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMC200050198	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMC200050204	K12741	ko03040	Spliceosome	358	6.5e-14	0.39	0.54	0.72
PGSC0003DMC200050208	K00857	ko00240	Pyrimidine metabolism	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMC200050208	K00857	ko00983	Drug metabolism - other enzymes	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMC200050208	K00857	ko01100	Metabolic pathways	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMC200025385	K03131	ko03022	Basal transcription factors	1421	1.5e-72	0.64	0.75	1.00
PGSC0003DMC200025386	K03131	ko03022	Basal transcription factors	3169	5.9e-169	0.70	0.82	1.00
PGSC0003DMC200025387	K12476	ko04144	Endocytosis	1873	1.8e-97	0.53	0.68	0.84
PGSC0003DMC200025388	K12476	ko04144	Endocytosis	1872	2.0e-97	0.53	0.68	0.84
PGSC0003DMC200025394	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025395	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025396	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMC200025397	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMC200025398	K12606	ko03018	RNA degradation	2230	3.7e-117	0.86	0.89	1.00
PGSC0003DMC200025399	K12606	ko03018	RNA degradation	1102	6.0e-55	0.83	0.88	0.98
PGSC0003DMC200025400	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025401	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025402	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025403	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025404	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025405	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025406	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMC200025407	K12606	ko03018	RNA degradation	1353	8.6e-69	0.58	0.64	0.99
PGSC0003DMC200025408	K12606	ko03018	RNA degradation	897	1.2e-43	0.84	0.90	0.98
PGSC0003DMC200012257	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMC200012257	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMC200012258	K01046	ko00561	Glycerolipid metabolism	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMC200012258	K01046	ko01100	Metabolic pathways	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMC200012259	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMC200012259	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMC200019001	K10594	ko04120	Ubiquitin mediated proteolysis	544	1.6e-22	0.32	0.49	0.89
PGSC0003DMC200019002	K10595	ko04120	Ubiquitin mediated proteolysis	606	6.1e-26	0.32	0.48	0.96
PGSC0003DMC200019003	K10615	ko04120	Ubiquitin mediated proteolysis	535	4.3e-23	0.32	0.51	0.85
PGSC0003DMC200019004	K03217	ko03060	Protein export	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMC200019004	K03217	ko03070	Bacterial secretion system	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMC200019005	K03217	ko03060	Protein export	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMC200019005	K03217	ko03070	Bacterial secretion system	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMC200019006	K03217	ko03060	Protein export	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMC200019006	K03217	ko03070	Bacterial secretion system	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMC200019008	K10251	ko01040	Biosynthesis of unsaturated fatty acids	831	5.3e-40	0.39	0.62	0.95
PGSC0003DMC200012338	K00006	ko00564	Glycerophospholipid metabolism	2140	3.4e-112	0.84	0.92	0.99
PGSC0003DMC200012339	K00006	ko00564	Glycerophospholipid metabolism	2621	1.0e-138	0.84	0.92	1.00
PGSC0003DMC200012348	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.56
PGSC0003DMC200012349	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.57
PGSC0003DMC200012350	K10652	ko04622	RIG-I-like receptor signaling pathway	265	3.9e-08	0.35	0.47	0.56
PGSC0003DMC200012351	K10652	ko04622	RIG-I-like receptor signaling pathway	260	4.1e-06	0.32	0.44	0.57
PGSC0003DMC200012353	K11584	ko04113	Meiosis - yeast	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMC200012353	K11584	ko04114	Oocyte meiosis	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMC200012353	K11584	ko04310	Wnt signaling pathway	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMC200007023	K10352	ko04530	Tight junction	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMC200007023	K10352	ko05416	Viral myocarditis	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMC200007033	K01358	ko04112	Cell cycle - Caulobacter	1751	9.6e-91	0.70	0.86	1.00
PGSC0003DMC200007035	K10845	ko03420	Nucleotide excision repair	457	2.3e-19	0.75	0.90	0.97
PGSC0003DMC200007046	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko00362	Benzoate degradation via hydroxylation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko00632	Benzoate degradation via CoA ligation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko00903	Limonene and pinene degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko00930	Caprolactam degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko01100	Metabolic pathways	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007046	K01559	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMC200007048	K08679	ko00500	Starch and sucrose metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMC200007048	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMC200007048	K08679	ko01100	Metabolic pathways	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMC200007049	K08679	ko00500	Starch and sucrose metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMC200007049	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMC200007049	K08679	ko01100	Metabolic pathways	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMC200007050	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMC200007050	K00517	ko00626	Naphthalene and anthracene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMC200007050	K00517	ko00903	Limonene and pinene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMC200007050	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMC200007050	K00517	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMC200060694	K03094	ko04110	Cell cycle	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04111	Cell cycle - yeast	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04114	Oocyte meiosis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04120	Ubiquitin mediated proteolysis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04310	Wnt signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04350	TGF-beta signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200060694	K03094	ko04710	Circadian rhythm - mammal	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMC200066555	K09490	ko03060	Protein export	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMC200066555	K09490	ko05020	Prion diseases	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMC200066557	K10760	ko00908	Zeatin biosynthesis	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMC200066557	K10760	ko01100	Metabolic pathways	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMC200066557	K10760	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMC200043531	K05280	ko00941	Flavonoid biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMC200043531	K05280	ko00944	Flavone and flavonol biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMC200043531	K05280	ko01100	Metabolic pathways	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMC200043531	K05280	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMC200043532	K05280	ko00941	Flavonoid biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMC200043532	K05280	ko00944	Flavone and flavonol biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMC200043532	K05280	ko01100	Metabolic pathways	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMC200043532	K05280	ko01110	Biosynthesis of secondary metabolites	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMC200043540	K09835	ko00906	Carotenoid biosynthesis	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMC200043540	K09835	ko01100	Metabolic pathways	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMC200043540	K09835	ko01110	Biosynthesis of secondary metabolites	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMC200043541	K09835	ko00906	Carotenoid biosynthesis	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMC200043541	K09835	ko01100	Metabolic pathways	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMC200043541	K09835	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMC200043542	K09835	ko00906	Carotenoid biosynthesis	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMC200043542	K09835	ko01100	Metabolic pathways	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMC200043542	K09835	ko01110	Biosynthesis of secondary metabolites	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMC200043543	K09835	ko00906	Carotenoid biosynthesis	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMC200043543	K09835	ko01100	Metabolic pathways	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMC200043543	K09835	ko01110	Biosynthesis of secondary metabolites	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMC200043551	K00558	ko00270	Cysteine and methionine metabolism	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMC200043551	K00558	ko01100	Metabolic pathways	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMC200043552	K00558	ko00270	Cysteine and methionine metabolism	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMC200043552	K00558	ko01100	Metabolic pathways	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMC200043553	K01500	ko00791	Atrazine degradation	596	4.9e-27	0.49	0.64	0.83
PGSC0003DMC200043554	K01500	ko00791	Atrazine degradation	610	4.4e-27	0.49	0.63	0.13
PGSC0003DMC200043557	K01423	ko00310	Lysine degradation	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMC200043557	K01423	ko00780	Biotin metabolism	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMC200043557	K01423	ko01100	Metabolic pathways	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMC200043558	K01423	ko00310	Lysine degradation	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMC200043558	K01423	ko00780	Biotin metabolism	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMC200043558	K01423	ko01100	Metabolic pathways	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMC200043559	K01066	ko00623	2,4-Dichlorobenzoate degradation	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMC200043559	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMC200043560	K01432	ko00380	Tryptophan metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMC200043560	K01432	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMC200043560	K01432	ko01100	Metabolic pathways	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMC200038226	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMC200038226	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMC200038227	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMC200038227	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMC200038228	K13237	ko04146	Peroxisome	1261	1.0e-63	0.86	0.92	0.99
PGSC0003DMC200038229	K00927	ko00010	Glycolysis / Gluconeogenesis	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMC200038229	K00927	ko00710	Carbon fixation in photosynthetic organisms	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMC200038229	K00927	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMC200038229	K00927	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMC200038230	K00927	ko00010	Glycolysis / Gluconeogenesis	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMC200038230	K00927	ko00710	Carbon fixation in photosynthetic organisms	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMC200038230	K00927	ko01100	Metabolic pathways	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMC200038230	K00927	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMC200038231	K00927	ko00010	Glycolysis / Gluconeogenesis	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMC200038231	K00927	ko00710	Carbon fixation in photosynthetic organisms	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMC200038231	K00927	ko01100	Metabolic pathways	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMC200038231	K00927	ko01110	Biosynthesis of secondary metabolites	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMC200038240	K09561	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.30	0.52	0.71
PGSC0003DMC200038248	K01749	ko00860	Porphyrin and chlorophyll metabolism	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMC200038248	K01749	ko01100	Metabolic pathways	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMC200038248	K01749	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMC200053587	K06061	ko04330	Notch signaling pathway	299	6.5e-13	0.28	0.39	0.60
PGSC0003DMC200053590	K04498	ko04110	Cell cycle	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04310	Wnt signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04330	Notch signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04350	TGF-beta signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04520	Adherens junction	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04630	Jak-STAT signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04720	Long-term potentiation	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko04916	Melanogenesis	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko05016	Huntington's disease	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko05200	Pathways in cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko05211	Renal cell carcinoma	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053590	K04498	ko05215	Prostate cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMC200053596	K00001	ko00010	Glycolysis / Gluconeogenesis	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00071	Fatty acid metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00350	Tyrosine metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00624	1- and 2-Methylnaphthalene degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00641	3-Chloroacrylic acid degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00830	Retinol metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko00982	Drug metabolism - cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko01100	Metabolic pathways	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053596	K00001	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMC200053597	K00001	ko00010	Glycolysis / Gluconeogenesis	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00071	Fatty acid metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00350	Tyrosine metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00641	3-Chloroacrylic acid degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00830	Retinol metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko00982	Drug metabolism - cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko01100	Metabolic pathways	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053597	K00001	ko01110	Biosynthesis of secondary metabolites	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMC200053598	K03921	ko00061	Fatty acid biosynthesis	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMC200053598	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMC200053599	K03921	ko00061	Fatty acid biosynthesis	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMC200053599	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMC200053600	K03921	ko00061	Fatty acid biosynthesis	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMC200053600	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMC200053601	K03921	ko00061	Fatty acid biosynthesis	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMC200053601	K03921	ko01040	Biosynthesis of unsaturated fatty acids	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMC200053602	K03921	ko00061	Fatty acid biosynthesis	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMC200053602	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMC200053603	K03921	ko00061	Fatty acid biosynthesis	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMC200053603	K03921	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMC200053604	K03921	ko00061	Fatty acid biosynthesis	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMC200053604	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMC200031418	K13065	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMC200031418	K13065	ko00941	Flavonoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMC200031418	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMC200031418	K13065	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMC200031435	K00430	ko00360	Phenylalanine metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMC200031435	K00430	ko00680	Methane metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMC200031435	K00430	ko00940	Phenylpropanoid biosynthesis	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMC200031435	K00430	ko01100	Metabolic pathways	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMC200031435	K00430	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMC200010353	K01897	ko00071	Fatty acid metabolism	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMC200010353	K01897	ko01100	Metabolic pathways	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMC200010353	K01897	ko03320	PPAR signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMC200010353	K01897	ko04146	Peroxisome	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMC200010353	K01897	ko04920	Adipocytokine signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMC200010354	K03217	ko03060	Protein export	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMC200010354	K03217	ko03070	Bacterial secretion system	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMC200010355	K03217	ko03060	Protein export	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMC200010355	K03217	ko03070	Bacterial secretion system	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMC200010356	K03217	ko03060	Protein export	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMC200010356	K03217	ko03070	Bacterial secretion system	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMC200010357	K06268	ko04010	MAPK signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04020	Calcium signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04114	Oocyte meiosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04210	Apoptosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04310	Wnt signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04360	Axon guidance	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04370	VEGF signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04660	T cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko04720	Long-term potentiation	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko05010	Alzheimer's disease	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010357	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMC200010358	K06268	ko04010	MAPK signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04020	Calcium signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04114	Oocyte meiosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04210	Apoptosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04310	Wnt signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04360	Axon guidance	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04370	VEGF signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04650	Natural killer cell mediated cytotoxicity	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04660	T cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04662	B cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko04720	Long-term potentiation	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko05010	Alzheimer's disease	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010358	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMC200010365	K00059	ko00061	Fatty acid biosynthesis	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMC200010365	K00059	ko01040	Biosynthesis of unsaturated fatty acids	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMC200010365	K00059	ko01100	Metabolic pathways	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMC200010377	K12660	ko00051	Fructose and mannose metabolism	570	1.3e-25	0.36	0.57	0.71
PGSC0003DMC200016807	K02294	ko00906	Carotenoid biosynthesis	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMC200016807	K02294	ko01100	Metabolic pathways	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMC200016807	K02294	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMC200016814	K12869	ko03040	Spliceosome	4223	4.4e-227	0.74	0.82	0.99
PGSC0003DMC200016818	K04079	ko04612	Antigen processing and presentation	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016818	K04079	ko04621	NOD-like receptor signaling pathway	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016818	K04079	ko04626	Plant-pathogen interaction	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016818	K04079	ko04914	Progesterone-mediated oocyte maturation	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016818	K04079	ko05200	Pathways in cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016818	K04079	ko05215	Prostate cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMC200016819	K01213	ko00040	Pentose and glucuronate interconversions	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMC200016819	K01213	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMC200016819	K01213	ko01100	Metabolic pathways	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMC200014641	K02084	ko04115	p53 signaling pathway	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko04210	Apoptosis	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko05010	Alzheimer's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko05012	Parkinson's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko05016	Huntington's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014641	K02084	ko05222	Small cell lung cancer	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMC200014649	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMC200014650	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMC200014651	K02989	ko03010	Ribosome	1260	1.2e-63	0.97	0.99	0.99
PGSC0003DMC200014664	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014664	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014664	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014664	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014664	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014664	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200014665	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMC200068447	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200068447	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200068447	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200068449	K02872	ko03010	Ribosome	1509	2.1e-77	0.89	0.95	0.98
PGSC0003DMC200068456	K00791	ko00908	Zeatin biosynthesis	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMC200068456	K00791	ko01100	Metabolic pathways	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMC200068456	K00791	ko01110	Biosynthesis of secondary metabolites	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMC200064697	K02707	ko00195	Photosynthesis	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMC200064697	K02707	ko01100	Metabolic pathways	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMC200064701	K04508	ko04310	Wnt signaling pathway	2837	1.2e-150	0.66	0.80	0.99
PGSC0003DMC200039156	K00117	ko00030	Pentose phosphate pathway	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMC200039156	K00117	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMC200039156	K00117	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMC200039157	K00117	ko00030	Pentose phosphate pathway	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMC200039157	K00117	ko01100	Metabolic pathways	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMC200039157	K00117	ko01110	Biosynthesis of secondary metabolites	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMC200039158	K00100	ko00051	Fructose and mannose metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039158	K00100	ko00363	Bisphenol A degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039158	K00100	ko00591	Linoleic acid metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039158	K00100	ko00625	Tetrachloroethene degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039158	K00100	ko00650	Butanoate metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039158	K00100	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMC200039161	K12126	ko04712	Circadian rhythm - plant	337	9.4e-13	0.40	0.60	0.58
PGSC0003DMC200039162	K12126	ko04712	Circadian rhythm - plant	363	3.5e-14	0.37	0.53	0.70
PGSC0003DMC200039173	K04382	ko04111	Cell cycle - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04113	Meiosis - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04114	Oocyte meiosis	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04310	Wnt signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04350	TGF-beta signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04530	Tight junction	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko04730	Long-term depression	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039173	K04382	ko05142	Chagas disease	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMC200039175	K11644	ko05016	Huntington's disease	4257	5.8e-229	0.60	0.72	1.00
PGSC0003DMC200039176	K11644	ko05016	Huntington's disease	6612	0.	0.59	0.72	0.99
PGSC0003DMC200039177	K11644	ko05016	Huntington's disease	6616	0.	0.59	0.72	0.99
PGSC0003DMC200039178	K00161	ko00010	Glycolysis / Gluconeogenesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko00020	Citrate cycle (TCA cycle)	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko00620	Pyruvate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko00650	Butanoate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko01100	Metabolic pathways	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039178	K00161	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200039179	K00754	ko00051	Fructose and mannose metabolism	366	2.4e-14	0.27	0.47	0.81
PGSC0003DMC200045605	K00588	ko00360	Phenylalanine metabolism	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045605	K00588	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045605	K00588	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045605	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045605	K00588	ko01100	Metabolic pathways	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045605	K00588	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMC200045606	K00588	ko00360	Phenylalanine metabolism	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045606	K00588	ko00940	Phenylpropanoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045606	K00588	ko00941	Flavonoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045606	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045606	K00588	ko01100	Metabolic pathways	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045606	K00588	ko01110	Biosynthesis of secondary metabolites	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMC200045607	K00588	ko00360	Phenylalanine metabolism	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045607	K00588	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045607	K00588	ko00941	Flavonoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045607	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045607	K00588	ko01100	Metabolic pathways	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045607	K00588	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMC200045608	K00588	ko00360	Phenylalanine metabolism	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045608	K00588	ko00940	Phenylpropanoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045608	K00588	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045608	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045608	K00588	ko01100	Metabolic pathways	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045608	K00588	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMC200045612	K13230	ko00402	Benzoxazinoid biosynthesis	851	4.2e-41	0.36	0.53	0.99
PGSC0003DMC200045613	K13230	ko00402	Benzoxazinoid biosynthesis	332	1.8e-12	0.40	0.59	0.99
PGSC0003DMC200045615	K05277	ko00941	Flavonoid biosynthesis	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMC200045615	K05277	ko01100	Metabolic pathways	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMC200045615	K05277	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMC200045616	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMC200045616	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMC200045616	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMC200045617	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMC200045617	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMC200045617	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMC200045619	K05277	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMC200045619	K05277	ko01100	Metabolic pathways	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMC200045619	K05277	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMC200045620	K05277	ko00941	Flavonoid biosynthesis	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMC200045620	K05277	ko01100	Metabolic pathways	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMC200045620	K05277	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMC200045622	K07385	ko00902	Monoterpenoid biosynthesis	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMC200045622	K07385	ko01100	Metabolic pathways	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMC200045623	K01590	ko00340	Histidine metabolism	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMC200045623	K01590	ko01100	Metabolic pathways	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMC200045623	K01590	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMC200045624	K01590	ko00340	Histidine metabolism	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMC200045624	K01590	ko01100	Metabolic pathways	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMC200045624	K01590	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMC200045625	K00432	ko00480	Glutathione metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMC200045625	K00432	ko00590	Arachidonic acid metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMC200045630	K01613	ko00564	Glycerophospholipid metabolism	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMC200045630	K01613	ko01100	Metabolic pathways	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMC200056583	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMC200056583	K00517	ko00626	Naphthalene and anthracene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMC200056583	K00517	ko00903	Limonene and pinene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMC200056583	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMC200056583	K00517	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMC200056591	K12818	ko03040	Spliceosome	6479	0.	0.94	0.98	1.00
PGSC0003DMC200056593	K01507	ko00190	Oxidative phosphorylation	456	2.6e-19	0.90	0.94	0.95
PGSC0003DMC200063492	K10760	ko00908	Zeatin biosynthesis	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMC200063492	K10760	ko01100	Metabolic pathways	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMC200063492	K10760	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMC200063499	K00791	ko00908	Zeatin biosynthesis	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMC200063499	K00791	ko01100	Metabolic pathways	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMC200063499	K00791	ko01110	Biosynthesis of secondary metabolites	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMC200063505	K10760	ko00908	Zeatin biosynthesis	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMC200063505	K10760	ko01100	Metabolic pathways	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMC200063505	K10760	ko01110	Biosynthesis of secondary metabolites	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMC200015613	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMC200015613	K00517	ko00626	Naphthalene and anthracene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMC200015613	K00517	ko00903	Limonene and pinene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMC200015613	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMC200015613	K00517	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMC200015616	K08269	ko04140	Regulation of autophagy	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMC200015616	K08269	ko04150	mTOR signaling pathway	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMC200015617	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMC200015617	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMC200015618	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMC200015618	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMC200015619	K08269	ko04140	Regulation of autophagy	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMC200015619	K08269	ko04150	mTOR signaling pathway	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMC200015620	K08269	ko04140	Regulation of autophagy	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMC200015620	K08269	ko04150	mTOR signaling pathway	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMC200015621	K00761	ko00240	Pyrimidine metabolism	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMC200015621	K00761	ko01100	Metabolic pathways	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMC200015628	K00002	ko00010	Glycolysis / Gluconeogenesis	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMC200015628	K00002	ko00561	Glycerolipid metabolism	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMC200015628	K00002	ko00930	Caprolactam degradation	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMC200015628	K00002	ko01100	Metabolic pathways	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMC200015628	K00002	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMC200015629	K00002	ko00010	Glycolysis / Gluconeogenesis	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMC200015629	K00002	ko00561	Glycerolipid metabolism	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMC200015629	K00002	ko00930	Caprolactam degradation	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMC200015629	K00002	ko01100	Metabolic pathways	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMC200015629	K00002	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMC200015630	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015630	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015630	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015630	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015630	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200009151	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.34	0.52	0.84
PGSC0003DMC200009152	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	416	7.0e-17	0.37	0.54	0.89
PGSC0003DMC200009159	K01520	ko00240	Pyrimidine metabolism	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMC200009159	K01520	ko01100	Metabolic pathways	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMC200009160	K01520	ko00240	Pyrimidine metabolism	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMC200009160	K01520	ko01100	Metabolic pathways	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMC200009176	K02084	ko04115	p53 signaling pathway	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko04210	Apoptosis	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko05010	Alzheimer's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko05012	Parkinson's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko05016	Huntington's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009176	K02084	ko05222	Small cell lung cancer	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMC200009180	K02084	ko04115	p53 signaling pathway	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko04210	Apoptosis	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko05010	Alzheimer's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko05012	Parkinson's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko05016	Huntington's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200009180	K02084	ko05222	Small cell lung cancer	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMC200026583	K01609	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMC200026583	K01609	ko01100	Metabolic pathways	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMC200026583	K01609	ko01110	Biosynthesis of secondary metabolites	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMC200026584	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMC200026585	K06611	ko00052	Galactose metabolism	877	1.5e-42	0.41	0.61	0.89
PGSC0003DMC200026586	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMC200026587	K06611	ko00052	Galactose metabolism	756	7.3e-36	0.40	0.58	0.98
PGSC0003DMC200026588	K06611	ko00052	Galactose metabolism	2107	2.2e-110	0.40	0.58	0.97
PGSC0003DMC200026589	K11294	ko05130	Pathogenic Escherichia coli infection	492	2.7e-21	0.36	0.56	0.77
PGSC0003DMC200026599	K02343	ko00230	Purine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026599	K02343	ko00240	Pyrimidine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026599	K02343	ko01100	Metabolic pathways	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026599	K02343	ko03030	DNA replication	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026599	K02343	ko03430	Mismatch repair	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026599	K02343	ko03440	Homologous recombination	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMC200026606	K01838	ko00500	Starch and sucrose metabolism	538	7.7e-24	0.39	0.56	0.69
PGSC0003DMC200032776	K09841	ko00906	Carotenoid biosynthesis	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMC200032776	K09841	ko01100	Metabolic pathways	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMC200032776	K09841	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMC200032777	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032777	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032777	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032778	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032778	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032778	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMC200032779	K09841	ko00906	Carotenoid biosynthesis	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMC200032779	K09841	ko01100	Metabolic pathways	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMC200032779	K09841	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMC200032780	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMC200032780	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMC200032780	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMC200032781	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032781	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032781	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032782	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032782	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032782	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMC200032783	K09841	ko00906	Carotenoid biosynthesis	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMC200032783	K09841	ko01100	Metabolic pathways	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMC200032783	K09841	ko01110	Biosynthesis of secondary metabolites	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMC200046814	K02998	ko03010	Ribosome	1911	1.4e-99	0.77	0.80	1.00
PGSC0003DMC200046815	K02998	ko03010	Ribosome	1912	1.3e-99	0.76	0.80	1.00
PGSC0003DMC200046816	K02998	ko03010	Ribosome	610	8.3e-28	0.97	1.00	0.85
PGSC0003DMC200046817	K05681	ko02010	ABC transporters	1018	2.6e-50	0.33	0.49	0.90
PGSC0003DMC200046818	K05680	ko02010	ABC transporters	311	6.6e-11	0.27	0.50	0.89
PGSC0003DMC200046819	K10684	ko04120	Ubiquitin mediated proteolysis	2010	5.0e-105	0.75	0.87	0.98
PGSC0003DMC200046824	K00940	ko00230	Purine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMC200046824	K00940	ko00240	Pyrimidine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMC200046824	K00940	ko01100	Metabolic pathways	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMC200046824	K00940	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMC200046825	K13065	ko00940	Phenylpropanoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMC200046825	K13065	ko00941	Flavonoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMC200046825	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMC200046825	K13065	ko01110	Biosynthesis of secondary metabolites	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMC200046827	K00134	ko00010	Glycolysis / Gluconeogenesis	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMC200046827	K00134	ko01100	Metabolic pathways	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMC200046827	K00134	ko01110	Biosynthesis of secondary metabolites	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMC200046827	K00134	ko05010	Alzheimer's disease	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMC200040353	K12613	ko03018	RNA degradation	2239	1.2e-117	0.80	0.90	1.00
PGSC0003DMC200040356	K08907	ko00196	Photosynthesis - antenna proteins	1801	1.7e-93	0.84	0.91	0.99
PGSC0003DMC200040379	K13228	ko00402	Benzoxazinoid biosynthesis	601	2.6e-27	0.38	0.61	0.82
PGSC0003DMC200040380	K13068	ko00940	Phenylpropanoid biosynthesis	811	6.8e-39	0.30	0.51	0.99
PGSC0003DMC200044641	K00083	ko00940	Phenylpropanoid biosynthesis	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMC200044641	K00083	ko01100	Metabolic pathways	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMC200044641	K00083	ko01110	Biosynthesis of secondary metabolites	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMC200044647	K03544	ko04112	Cell cycle - Caulobacter	413	8.3e-17	0.49	0.57	0.41
PGSC0003DMC200044665	K04733	ko04210	Apoptosis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMC200044665	K04733	ko04620	Toll-like receptor signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMC200044665	K04733	ko04722	Neurotrophin signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMC200044665	K04733	ko05140	Leishmaniasis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMC200044665	K04733	ko05142	Chagas disease	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMC200044666	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044666	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044666	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044666	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044666	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044667	K04733	ko04210	Apoptosis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMC200044667	K04733	ko04620	Toll-like receptor signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMC200044667	K04733	ko04722	Neurotrophin signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMC200044667	K04733	ko05140	Leishmaniasis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMC200044667	K04733	ko05142	Chagas disease	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMC200044668	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044668	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044668	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044668	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200044668	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMC200002560	K05658	ko02010	ABC transporters	1964	1.7e-102	0.60	0.80	0.99
PGSC0003DMC200002561	K05658	ko02010	ABC transporters	3845	3.1e-206	0.48	0.68	1.00
PGSC0003DMC200002562	K05658	ko02010	ABC transporters	4788	3.0e-258	0.48	0.68	1.00
PGSC0003DMC200002563	K02915	ko03010	Ribosome	967	1.7e-47	0.96	0.98	0.99
PGSC0003DMC200002571	K01535	ko00190	Oxidative phosphorylation	3351	5.4e-179	0.51	0.64	0.98
PGSC0003DMC200061895	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMC200061895	K00517	ko00626	Naphthalene and anthracene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMC200061895	K00517	ko00903	Limonene and pinene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMC200061895	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMC200061895	K00517	ko01110	Biosynthesis of secondary metabolites	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMC200067747	K11644	ko05016	Huntington's disease	270	5.4e-08	0.29	0.48	0.76
PGSC0003DMC200067749	K03094	ko04110	Cell cycle	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04111	Cell cycle - yeast	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04114	Oocyte meiosis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04120	Ubiquitin mediated proteolysis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04310	Wnt signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04350	TGF-beta signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200067749	K03094	ko04710	Circadian rhythm - mammal	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMC200008221	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMC200008221	K00517	ko00626	Naphthalene and anthracene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMC200008221	K00517	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMC200008221	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMC200008221	K00517	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMC200008222	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMC200008222	K00517	ko00626	Naphthalene and anthracene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMC200008222	K00517	ko00903	Limonene and pinene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMC200008222	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMC200008222	K00517	ko01110	Biosynthesis of secondary metabolites	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMC200008223	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMC200008223	K00517	ko00626	Naphthalene and anthracene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMC200008223	K00517	ko00903	Limonene and pinene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMC200008223	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMC200008223	K00517	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMC200008234	K13290	ko00250	Alanine, aspartate and glutamate metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMC200008234	K13290	ko00260	Glycine, serine and threonine metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMC200008234	K13290	ko01100	Metabolic pathways	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMC200008234	K13290	ko01110	Biosynthesis of secondary metabolites	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMC200008235	K13290	ko00250	Alanine, aspartate and glutamate metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMC200008235	K13290	ko00260	Glycine, serine and threonine metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMC200008235	K13290	ko01100	Metabolic pathways	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMC200008235	K13290	ko01110	Biosynthesis of secondary metabolites	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMC200008242	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMC200008242	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMC200008242	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMC200008248	K08679	ko00500	Starch and sucrose metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMC200008248	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMC200008248	K08679	ko01100	Metabolic pathways	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMC200008249	K00600	ko00260	Glycine, serine and threonine metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200008249	K00600	ko00460	Cyanoamino acid metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200008249	K00600	ko00670	One carbon pool by folate	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200008249	K00600	ko00680	Methane metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200008249	K00600	ko01100	Metabolic pathways	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200008249	K00600	ko01110	Biosynthesis of secondary metabolites	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMC200013538	K08233	ko00901	Indole alkaloid biosynthesis	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMC200013538	K08233	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMC200013540	K01516	ko00230	Purine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMC200013540	K01516	ko00730	Thiamine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMC200013540	K01516	ko01100	Metabolic pathways	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMC200013541	K01516	ko00230	Purine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMC200013541	K01516	ko00730	Thiamine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMC200013541	K01516	ko01100	Metabolic pathways	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMC200013545	K01874	ko00450	Selenoamino acid metabolism	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMC200013545	K01874	ko00970	Aminoacyl-tRNA biosynthesis	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMC200013546	K01874	ko00450	Selenoamino acid metabolism	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMC200013546	K01874	ko00970	Aminoacyl-tRNA biosynthesis	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMC200013550	K09753	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMC200013550	K09753	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMC200013550	K09753	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMC200013551	K09753	ko00940	Phenylpropanoid biosynthesis	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMC200013551	K09753	ko01100	Metabolic pathways	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMC200013551	K09753	ko01110	Biosynthesis of secondary metabolites	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMC200023594	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023594	K01580	ko00410	beta-Alanine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023594	K01580	ko00430	Taurine and hypotaurine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023594	K01580	ko00650	Butanoate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023594	K01580	ko01100	Metabolic pathways	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023594	K01580	ko04940	Type I diabetes mellitus	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMC200023595	K00031	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023595	K00031	ko00480	Glutathione metabolism	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023595	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023595	K00031	ko01100	Metabolic pathways	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023595	K00031	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023595	K00031	ko04146	Peroxisome	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMC200023597	K00031	ko00020	Citrate cycle (TCA cycle)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023597	K00031	ko00480	Glutathione metabolism	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023597	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023597	K00031	ko01100	Metabolic pathways	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023597	K00031	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023597	K00031	ko04146	Peroxisome	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMC200023598	K00031	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023598	K00031	ko00480	Glutathione metabolism	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023598	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023598	K00031	ko01100	Metabolic pathways	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023598	K00031	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023598	K00031	ko04146	Peroxisome	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMC200023599	K00031	ko00020	Citrate cycle (TCA cycle)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023599	K00031	ko00480	Glutathione metabolism	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023599	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023599	K00031	ko01100	Metabolic pathways	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023599	K00031	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023599	K00031	ko04146	Peroxisome	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMC200023600	K00963	ko00040	Pentose and glucuronate interconversions	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023600	K00963	ko00052	Galactose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023600	K00963	ko00500	Starch and sucrose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023600	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023600	K00963	ko01100	Metabolic pathways	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023600	K00963	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMC200023605	K10143	ko04115	p53 signaling pathway	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMC200023605	K10143	ko04120	Ubiquitin mediated proteolysis	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMC200023606	K10143	ko04115	p53 signaling pathway	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMC200023606	K10143	ko04120	Ubiquitin mediated proteolysis	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMC200023607	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMC200023607	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMC200023608	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMC200023608	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMC200023609	K10143	ko04115	p53 signaling pathway	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMC200023609	K10143	ko04120	Ubiquitin mediated proteolysis	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMC200037030	K00645	ko00061	Fatty acid biosynthesis	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMC200037030	K00645	ko01100	Metabolic pathways	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMC200037033	K11294	ko05130	Pathogenic Escherichia coli infection	432	5.4e-18	0.30	0.50	0.71
PGSC0003DMC200037034	K08064	ko04612	Antigen processing and presentation	422	1.9e-17	0.37	0.49	0.75
PGSC0003DMC200037040	K11422	ko00310	Lysine degradation	2670	2.0e-141	0.35	0.48	0.99
PGSC0003DMC200037041	K11422	ko00310	Lysine degradation	2340	3.1e-123	0.35	0.48	0.99
PGSC0003DMC200037042	K11422	ko00310	Lysine degradation	1812	4.2e-94	0.35	0.51	0.98
PGSC0003DMC200037043	K11422	ko00310	Lysine degradation	3215	1.7e-171	0.38	0.52	0.99
PGSC0003DMC200037044	K11422	ko00310	Lysine degradation	3093	9.2e-165	0.36	0.50	1.00
PGSC0003DMC200042331	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042331	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042332	K02183	ko04020	Calcium signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04070	Phosphatidylinositol signaling system	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04114	Oocyte meiosis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04270	Vascular smooth muscle contraction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04626	Plant-pathogen interaction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04720	Long-term potentiation	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04722	Neurotrophin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04740	Olfactory transduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04744	Phototransduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04745	Phototransduction - fly	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04910	Insulin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04912	GnRH signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04916	Melanogenesis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04970	Salivary secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko04971	Gastric acid secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko05010	Alzheimer's disease	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042332	K02183	ko05214	Glioma	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMC200042333	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042333	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMC200042336	K02183	ko04020	Calcium signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04070	Phosphatidylinositol signaling system	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04114	Oocyte meiosis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04270	Vascular smooth muscle contraction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04626	Plant-pathogen interaction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04720	Long-term potentiation	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04722	Neurotrophin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04740	Olfactory transduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04744	Phototransduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04745	Phototransduction - fly	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04910	Insulin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04912	GnRH signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04916	Melanogenesis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04970	Salivary secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko04971	Gastric acid secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko05010	Alzheimer's disease	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042336	K02183	ko05214	Glioma	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMC200042337	K02183	ko04020	Calcium signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04070	Phosphatidylinositol signaling system	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04114	Oocyte meiosis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04270	Vascular smooth muscle contraction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04626	Plant-pathogen interaction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04720	Long-term potentiation	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04722	Neurotrophin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04740	Olfactory transduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04744	Phototransduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04745	Phototransduction - fly	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04910	Insulin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04912	GnRH signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04916	Melanogenesis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04970	Salivary secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko04971	Gastric acid secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko05010	Alzheimer's disease	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042337	K02183	ko05214	Glioma	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMC200042353	K00128	ko00010	Glycolysis / Gluconeogenesis	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00053	Ascorbate and aldarate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00071	Fatty acid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00280	Valine, leucine and isoleucine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00310	Lysine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00330	Arginine and proline metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00340	Histidine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00380	Tryptophan metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00410	beta-Alanine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00561	Glycerolipid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00620	Pyruvate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00631	1,2-Dichloroethane degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00640	Propanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00641	3-Chloroacrylic acid degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00650	Butanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko00903	Limonene and pinene degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko01100	Metabolic pathways	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042353	K00128	ko01110	Biosynthesis of secondary metabolites	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMC200042355	K10881	ko03050	Proteasome	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMC200042355	K10881	ko03440	Homologous recombination	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMC200030211	K04424	ko04010	MAPK signaling pathway	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMC200030211	K04424	ko04530	Tight junction	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMC200030212	K04424	ko04010	MAPK signaling pathway	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMC200030212	K04424	ko04530	Tight junction	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMC200030213	K04424	ko04010	MAPK signaling pathway	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMC200030213	K04424	ko04530	Tight junction	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMC200030214	K04424	ko04010	MAPK signaling pathway	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMC200030214	K04424	ko04530	Tight junction	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMC200030222	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.38	0.59	0.97
PGSC0003DMC200030235	K04042	ko00520	Amino sugar and nucleotide sugar metabolism	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMC200030235	K04042	ko01100	Metabolic pathways	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMC200050462	K00423	ko00053	Ascorbate and aldarate metabolism	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMC200050462	K00423	ko01100	Metabolic pathways	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMC200050463	K00423	ko00053	Ascorbate and aldarate metabolism	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMC200050463	K00423	ko01100	Metabolic pathways	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMC200050464	K00423	ko00053	Ascorbate and aldarate metabolism	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMC200050464	K00423	ko01100	Metabolic pathways	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMC200050465	K00423	ko00053	Ascorbate and aldarate metabolism	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMC200050465	K00423	ko01100	Metabolic pathways	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMC200050466	K00423	ko00053	Ascorbate and aldarate metabolism	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMC200050466	K00423	ko01100	Metabolic pathways	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMC200050467	K00423	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMC200050467	K00423	ko01100	Metabolic pathways	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMC200050470	K00071	ko00140	Steroid hormone biosynthesis	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMC200050470	K00071	ko01100	Metabolic pathways	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMC200050470	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMC200050471	K00071	ko00140	Steroid hormone biosynthesis	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMC200050471	K00071	ko01100	Metabolic pathways	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMC200050471	K00071	ko04960	Aldosterone-regulated sodium reabsorption	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMC200050472	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMC200050472	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMC200050472	K00734	ko01100	Metabolic pathways	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMC200050473	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMC200050473	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMC200050473	K00734	ko01100	Metabolic pathways	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMC200041104	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMC200041104	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMC200041105	K11157	ko00830	Retinol metabolism	383	2.7e-15	0.33	0.49	0.56
PGSC0003DMC200046651	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMC200046651	K01657	ko01100	Metabolic pathways	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMC200046651	K01657	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMC200046652	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMC200046652	K01657	ko01100	Metabolic pathways	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMC200046652	K01657	ko01110	Biosynthesis of secondary metabolites	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMC200046653	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMC200046653	K00517	ko00626	Naphthalene and anthracene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMC200046653	K00517	ko00903	Limonene and pinene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMC200046653	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMC200046653	K00517	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMC200046654	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMC200046654	K00517	ko00626	Naphthalene and anthracene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMC200046654	K00517	ko00903	Limonene and pinene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMC200046654	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMC200046654	K00517	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMC200046655	K12832	ko03040	Spliceosome	739	6.3e-35	0.97	0.98	0.99
PGSC0003DMC200046667	K03821	ko00650	Butanoate metabolism	279	3.5e-09	0.31	0.48	0.43
PGSC0003DMC200046671	K04123	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMC200046671	K04123	ko01100	Metabolic pathways	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMC200046671	K04123	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMC200046672	K04123	ko00904	Diterpenoid biosynthesis	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMC200046672	K04123	ko01100	Metabolic pathways	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMC200046672	K04123	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMC200038959	K00514	ko00906	Carotenoid biosynthesis	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMC200038959	K00514	ko01100	Metabolic pathways	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMC200038959	K00514	ko01110	Biosynthesis of secondary metabolites	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMC200009918	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.31
PGSC0003DMC200009919	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.35
PGSC0003DMC200009927	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMC200009930	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMC200015454	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1868	3.4e-97	0.67	0.76	1.00
PGSC0003DMC200015455	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1425	9.2e-73	0.60	0.71	1.00
PGSC0003DMC200015464	K08912	ko00196	Photosynthesis - antenna proteins	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMC200015464	K08912	ko01100	Metabolic pathways	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMC200015465	K08912	ko00196	Photosynthesis - antenna proteins	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMC200015465	K08912	ko01100	Metabolic pathways	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMC200015466	K08912	ko00196	Photosynthesis - antenna proteins	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMC200015466	K08912	ko01100	Metabolic pathways	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMC200015470	K12126	ko04712	Circadian rhythm - plant	305	1.0e-08	0.30	0.46	0.60
PGSC0003DMC200015471	K04410	ko04010	MAPK signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko04012	ErbB signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko04360	Axon guidance	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko04510	Focal adhesion	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko04660	T cell receptor signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko04810	Regulation of actin cytoskeleton	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015471	K04410	ko05211	Renal cell carcinoma	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMC200015476	K01581	ko00330	Arginine and proline metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMC200015476	K01581	ko00480	Glutathione metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMC200015476	K01581	ko01100	Metabolic pathways	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMC200015476	K01581	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMC200028711	K01899	ko00020	Citrate cycle (TCA cycle)	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMC200028711	K01899	ko00640	Propanoate metabolism	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMC200028711	K01899	ko01100	Metabolic pathways	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMC200028711	K01899	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMC200028712	K08139	ko04113	Meiosis - yeast	467	6.4e-20	0.40	0.64	0.75
PGSC0003DMC200028724	K06620	ko04110	Cell cycle	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05200	Pathways in cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05212	Pancreatic cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05214	Glioma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05215	Prostate cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05218	Melanoma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05219	Bladder cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05220	Chronic myeloid leukemia	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05222	Small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028724	K06620	ko05223	Non-small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMC200028726	K06620	ko04110	Cell cycle	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05200	Pathways in cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05212	Pancreatic cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05214	Glioma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05215	Prostate cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05218	Melanoma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05219	Bladder cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05220	Chronic myeloid leukemia	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05222	Small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028726	K06620	ko05223	Non-small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMC200028727	K06620	ko04110	Cell cycle	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05200	Pathways in cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05212	Pancreatic cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05214	Glioma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05215	Prostate cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05218	Melanoma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05219	Bladder cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05220	Chronic myeloid leukemia	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05222	Small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028727	K06620	ko05223	Non-small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMC200028728	K06620	ko04110	Cell cycle	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05200	Pathways in cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05212	Pancreatic cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05214	Glioma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05215	Prostate cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05218	Melanoma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05219	Bladder cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05220	Chronic myeloid leukemia	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05222	Small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200028728	K06620	ko05223	Non-small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMC200063596	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMC200063596	K00517	ko00626	Naphthalene and anthracene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMC200063596	K00517	ko00903	Limonene and pinene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMC200063596	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMC200063596	K00517	ko01110	Biosynthesis of secondary metabolites	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMC200042721	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMC200042721	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMC200042721	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMC200042722	K00454	ko00591	Linoleic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMC200042722	K00454	ko00592	alpha-Linolenic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMC200042722	K00454	ko01100	Metabolic pathways	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMC200042723	K00454	ko00591	Linoleic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMC200042723	K00454	ko00592	alpha-Linolenic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMC200042723	K00454	ko01100	Metabolic pathways	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMC200042724	K00454	ko00591	Linoleic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMC200042724	K00454	ko00592	alpha-Linolenic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMC200042724	K00454	ko01100	Metabolic pathways	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMC200042725	K00454	ko00591	Linoleic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMC200042725	K00454	ko00592	alpha-Linolenic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMC200042725	K00454	ko01100	Metabolic pathways	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMC200042726	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMC200042726	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMC200042726	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMC200042727	K00454	ko00591	Linoleic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMC200042727	K00454	ko00592	alpha-Linolenic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMC200042727	K00454	ko01100	Metabolic pathways	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMC200042728	K00454	ko00591	Linoleic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMC200042728	K00454	ko00592	alpha-Linolenic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMC200042728	K00454	ko01100	Metabolic pathways	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMC200042729	K00454	ko00591	Linoleic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMC200042729	K00454	ko00592	alpha-Linolenic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMC200042729	K00454	ko01100	Metabolic pathways	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMC200042730	K02350	ko01100	Metabolic pathways	7592	0.	0.55	0.67	1.00
PGSC0003DMC200042731	K12893	ko03040	Spliceosome	254	1.7e-06	0.30	0.43	0.34
PGSC0003DMC200042732	K00020	ko00280	Valine, leucine and isoleucine degradation	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMC200042732	K00020	ko01100	Metabolic pathways	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMC200042733	K00020	ko00280	Valine, leucine and isoleucine degradation	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMC200042733	K00020	ko01100	Metabolic pathways	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMC200042738	K06634	ko03420	Nucleotide excision repair	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMC200042738	K06634	ko04110	Cell cycle	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMC200042739	K06634	ko03420	Nucleotide excision repair	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMC200042739	K06634	ko04110	Cell cycle	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMC200042740	K06634	ko03420	Nucleotide excision repair	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMC200042740	K06634	ko04110	Cell cycle	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMC200042741	K06634	ko03420	Nucleotide excision repair	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMC200042741	K06634	ko04110	Cell cycle	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMC200042742	K06634	ko03420	Nucleotide excision repair	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMC200042742	K06634	ko04110	Cell cycle	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMC200042743	K06634	ko03420	Nucleotide excision repair	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMC200042743	K06634	ko04110	Cell cycle	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMC200036037	K08247	ko00450	Selenoamino acid metabolism	6265	0.	0.70	0.84	0.99
PGSC0003DMC200036055	K02084	ko04115	p53 signaling pathway	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko04210	Apoptosis	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko05010	Alzheimer's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko05012	Parkinson's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko05016	Huntington's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036055	K02084	ko05222	Small cell lung cancer	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMC200036057	K02084	ko04115	p53 signaling pathway	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko04210	Apoptosis	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko05010	Alzheimer's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko05012	Parkinson's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko05016	Huntington's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200036057	K02084	ko05222	Small cell lung cancer	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMC200048513	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMC200048513	K00517	ko00626	Naphthalene and anthracene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMC200048513	K00517	ko00903	Limonene and pinene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMC200048513	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMC200048513	K00517	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMC200048515	K10878	ko04113	Meiosis - yeast	2979	1.8e-158	0.85	0.91	1.00
PGSC0003DMC200048518	K02930	ko03010	Ribosome	2898	5.3e-154	0.84	0.91	1.00
PGSC0003DMC200048529	K00939	ko00230	Purine metabolism	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMC200048529	K00939	ko01100	Metabolic pathways	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMC200048529	K00939	ko01110	Biosynthesis of secondary metabolites	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMC200048538	K03142	ko03022	Basal transcription factors	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMC200048538	K03142	ko03420	Nucleotide excision repair	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMC200048540	K00423	ko00053	Ascorbate and aldarate metabolism	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMC200048540	K00423	ko01100	Metabolic pathways	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMC200013930	K02184	ko04320	Dorso-ventral axis formation	710	2.3e-32	0.34	0.39	0.82
PGSC0003DMC200013931	K02184	ko04320	Dorso-ventral axis formation	901	5.4e-43	0.29	0.42	0.77
PGSC0003DMC200013932	K04512	ko04310	Wnt signaling pathway	230	4.1e-06	0.29	0.52	0.98
PGSC0003DMC200013933	K05740	ko04510	Focal adhesion	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMC200013933	K05740	ko04810	Regulation of actin cytoskeleton	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMC200013933	K05740	ko05131	Shigellosis	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMC200013934	K01246	ko03410	Base excision repair	296	1.7e-10	0.62	0.76	0.98
PGSC0003DMC200013935	K01246	ko03410	Base excision repair	2155	5.0e-113	0.72	0.80	1.00
PGSC0003DMC200013936	K05391	ko04626	Plant-pathogen interaction	4312	5.4e-232	0.76	0.85	0.99
PGSC0003DMC200013937	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMC200013938	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMC200013939	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMC200013941	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMC200013941	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMC200013942	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMC200013942	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMC200013944	K03260	ko05416	Viral myocarditis	2329	1.3e-122	0.47	0.63	0.89
PGSC0003DMC200013945	K03260	ko05416	Viral myocarditis	1019	2.3e-50	0.44	0.58	0.93
PGSC0003DMC200013946	K12356	ko00940	Phenylpropanoid biosynthesis	243	2.6e-07	0.50	0.65	0.22
PGSC0003DMC200013947	K12356	ko00940	Phenylpropanoid biosynthesis	379	4.5e-15	0.41	0.63	0.92
PGSC0003DMC200007232	K03456	ko04111	Cell cycle - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04113	Meiosis - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04114	Oocyte meiosis	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04310	Wnt signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04350	TGF-beta signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04530	Tight junction	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko04730	Long-term depression	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007232	K03456	ko05142	Chagas disease	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMC200007253	K05863	ko04020	Calcium signaling pathway	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMC200007253	K05863	ko05012	Parkinson's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMC200007253	K05863	ko05016	Huntington's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMC200007254	K05863	ko04020	Calcium signaling pathway	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMC200007254	K05863	ko05012	Parkinson's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMC200007254	K05863	ko05016	Huntington's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMC200007255	K05748	ko04520	Adherens junction	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMC200007255	K05748	ko04666	Fc gamma R-mediated phagocytosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMC200007255	K05748	ko04810	Regulation of actin cytoskeleton	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMC200007255	K05748	ko05100	Bacterial invasion of epithelial cells	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMC200007255	K05748	ko05131	Shigellosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMC200007260	K01126	ko00564	Glycerophospholipid metabolism	2616	1.9e-138	0.76	0.87	0.99
PGSC0003DMC200005886	K10591	ko04120	Ubiquitin mediated proteolysis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMC200005886	K10591	ko04144	Endocytosis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMC200005887	K10591	ko04120	Ubiquitin mediated proteolysis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMC200005887	K10591	ko04144	Endocytosis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMC200005888	K10591	ko04120	Ubiquitin mediated proteolysis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMC200005888	K10591	ko04144	Endocytosis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMC200005902	K09754	ko00360	Phenylalanine metabolism	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005902	K09754	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005902	K09754	ko00941	Flavonoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005902	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005902	K09754	ko01100	Metabolic pathways	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005902	K09754	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMC200005905	K02969	ko03010	Ribosome	985	1.7e-48	0.97	0.98	0.98
PGSC0003DMC200005906	K12878	ko03040	Spliceosome	3260	5.7e-174	0.66	0.75	1.00
PGSC0003DMC200005907	K12878	ko03040	Spliceosome	4122	1.6e-221	0.79	0.89	1.00
PGSC0003DMC200019711	K02377	ko00051	Fructose and mannose metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMC200019711	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMC200019711	K02377	ko01100	Metabolic pathways	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMC200019712	K01951	ko00230	Purine metabolism	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMC200019712	K01951	ko00983	Drug metabolism - other enzymes	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMC200019712	K01951	ko01100	Metabolic pathways	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMC200019733	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMC200019733	K02367	ko01100	Metabolic pathways	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMC200019734	K03022	ko00230	Purine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMC200019734	K03022	ko00240	Pyrimidine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMC200019734	K03022	ko01100	Metabolic pathways	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMC200019734	K03022	ko03020	RNA polymerase	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMC200019734	K03022	ko04623	Cytosolic DNA-sensing pathway	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMC200019735	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019735	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019735	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019735	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019735	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019736	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019736	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019736	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019736	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019736	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMC200019739	K02267	ko00190	Oxidative phosphorylation	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019739	K02267	ko01100	Metabolic pathways	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019739	K02267	ko04260	Cardiac muscle contraction	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019739	K02267	ko05010	Alzheimer's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019739	K02267	ko05012	Parkinson's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019739	K02267	ko05016	Huntington's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMC200019740	K02267	ko00190	Oxidative phosphorylation	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200019740	K02267	ko01100	Metabolic pathways	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200019740	K02267	ko04260	Cardiac muscle contraction	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200019740	K02267	ko05010	Alzheimer's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200019740	K02267	ko05012	Parkinson's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200019740	K02267	ko05016	Huntington's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMC200061561	K10760	ko00908	Zeatin biosynthesis	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMC200061561	K10760	ko01100	Metabolic pathways	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMC200061561	K10760	ko01110	Biosynthesis of secondary metabolites	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMC200037232	K08339	ko04140	Regulation of autophagy	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMC200037232	K08339	ko04622	RIG-I-like receptor signaling pathway	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMC200037232	K08339	ko05131	Shigellosis	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMC200037233	K08339	ko04140	Regulation of autophagy	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMC200037233	K08339	ko04622	RIG-I-like receptor signaling pathway	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMC200037233	K08339	ko05131	Shigellosis	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMC200037234	K08339	ko04140	Regulation of autophagy	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMC200037234	K08339	ko04622	RIG-I-like receptor signaling pathway	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMC200037234	K08339	ko05131	Shigellosis	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMC200037235	K05933	ko00270	Cysteine and methionine metabolism	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMC200037235	K05933	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMC200037236	K05933	ko00270	Cysteine and methionine metabolism	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMC200037236	K05933	ko01110	Biosynthesis of secondary metabolites	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMC200037259	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMC200037259	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMC200037260	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMC200037260	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMC200043927	K05584	ko00190	Oxidative phosphorylation	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMC200043927	K05584	ko01100	Metabolic pathways	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMC200043929	K00799	ko00480	Glutathione metabolism	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMC200043929	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMC200043929	K00799	ko00982	Drug metabolism - cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMC200043930	K00368	ko00910	Nitrogen metabolism	514	1.6e-22	0.39	0.56	0.74
PGSC0003DMC200043931	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMC200043932	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMC200043933	K02957	ko03010	Ribosome	453	3.8e-19	0.95	0.96	0.89
PGSC0003DMC200043938	K01535	ko00190	Oxidative phosphorylation	7328	0.	0.88	0.93	1.00
PGSC0003DMC200043939	K01535	ko00190	Oxidative phosphorylation	2737	4.0e-145	0.92	0.97	0.92
PGSC0003DMC200043940	K01535	ko00190	Oxidative phosphorylation	7398	0.	0.91	0.97	1.00
PGSC0003DMC200043946	K09841	ko00906	Carotenoid biosynthesis	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMC200043946	K09841	ko01100	Metabolic pathways	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMC200043946	K09841	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMC200035894	K02932	ko03010	Ribosome	2184	1.3e-114	0.84	0.93	0.99
PGSC0003DMC200049711	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049711	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049711	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049711	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049711	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049711	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049712	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMC200049717	K01184	ko00040	Pentose and glucuronate interconversions	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMC200049717	K01184	ko00500	Starch and sucrose metabolism	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMC200049717	K01184	ko01100	Metabolic pathways	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMC200049718	K02160	ko00061	Fatty acid biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049718	K02160	ko00253	Tetracycline biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049718	K02160	ko00620	Pyruvate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049718	K02160	ko00640	Propanoate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049718	K02160	ko01100	Metabolic pathways	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049718	K02160	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMC200049723	K06130	ko00564	Glycerophospholipid metabolism	623	1.6e-28	0.37	0.56	0.88
PGSC0003DMC200049724	K02265	ko00190	Oxidative phosphorylation	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049724	K02265	ko01100	Metabolic pathways	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049724	K02265	ko04260	Cardiac muscle contraction	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049724	K02265	ko05010	Alzheimer's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049724	K02265	ko05012	Parkinson's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049724	K02265	ko05016	Huntington's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMC200049727	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049727	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049727	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049727	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049727	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049727	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMC200049733	K01044	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMC200049733	K01044	ko00983	Drug metabolism - other enzymes	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMC200049733	K01044	ko01100	Metabolic pathways	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMC200049733	K01044	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMC200060362	K04428	ko04010	MAPK signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMC200060362	K04428	ko04912	GnRH signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMC200060384	K12604	ko03018	RNA degradation	316	3.5e-10	0.26	0.47	0.99
PGSC0003DMC200006053	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMC200006053	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMC200006054	K04713	ko00600	Sphingolipid metabolism	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMC200006054	K04713	ko01100	Metabolic pathways	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMC200006055	K02608	ko04110	Cell cycle	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMC200006055	K02608	ko04111	Cell cycle - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMC200006055	K02608	ko04113	Meiosis - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMC200012728	K09754	ko00360	Phenylalanine metabolism	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012728	K09754	ko00940	Phenylpropanoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012728	K09754	ko00941	Flavonoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012728	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012728	K09754	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012728	K09754	ko01110	Biosynthesis of secondary metabolites	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMC200012729	K09754	ko00360	Phenylalanine metabolism	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012729	K09754	ko00940	Phenylpropanoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012729	K09754	ko00941	Flavonoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012729	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012729	K09754	ko01100	Metabolic pathways	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012729	K09754	ko01110	Biosynthesis of secondary metabolites	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMC200012730	K09754	ko00360	Phenylalanine metabolism	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012730	K09754	ko00940	Phenylpropanoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012730	K09754	ko00941	Flavonoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012730	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012730	K09754	ko01100	Metabolic pathways	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012730	K09754	ko01110	Biosynthesis of secondary metabolites	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMC200012731	K09754	ko00360	Phenylalanine metabolism	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012731	K09754	ko00940	Phenylpropanoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012731	K09754	ko00941	Flavonoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012731	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012731	K09754	ko01100	Metabolic pathways	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012731	K09754	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMC200012733	K00558	ko00270	Cysteine and methionine metabolism	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMC200012733	K00558	ko01100	Metabolic pathways	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMC200012734	K00558	ko00270	Cysteine and methionine metabolism	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMC200012734	K00558	ko01100	Metabolic pathways	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMC200012737	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMC200012738	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMC200012739	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMC200012744	K04035	ko00860	Porphyrin and chlorophyll metabolism	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMC200012744	K04035	ko01100	Metabolic pathways	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMC200012744	K04035	ko01110	Biosynthesis of secondary metabolites	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMC200012745	K02727	ko03050	Proteasome	626	1.1e-28	0.97	0.99	0.67
PGSC0003DMC200012746	K02727	ko03050	Proteasome	2017	2.1e-105	0.94	0.99	1.00
PGSC0003DMC200012747	K02727	ko03050	Proteasome	529	2.4e-23	0.92	1.00	0.99
PGSC0003DMC200018520	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMC200018526	K10604	ko04120	Ubiquitin mediated proteolysis	615	4.4e-28	0.37	0.53	0.91
PGSC0003DMC200018528	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMC200018529	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMC200018533	K00430	ko00360	Phenylalanine metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMC200018533	K00430	ko00680	Methane metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMC200018533	K00430	ko00940	Phenylpropanoid biosynthesis	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMC200018533	K00430	ko01100	Metabolic pathways	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMC200018533	K00430	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMC200018534	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMC200018534	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMC200018534	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMC200018534	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMC200018534	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMC200018535	K08506	ko04130	SNARE interactions in vesicular transport	1750	1.1e-90	0.78	0.90	0.99
PGSC0003DMC200018538	K01199	ko00500	Starch and sucrose metabolism	1216	3.1e-61	0.49	0.69	0.88
PGSC0003DMC200018539	K01199	ko00500	Starch and sucrose metabolism	1087	4.1e-54	0.49	0.69	0.98
PGSC0003DMC200018540	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018540	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018540	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018540	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018540	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200029476	K00660	ko00941	Flavonoid biosynthesis	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMC200029476	K00660	ko01100	Metabolic pathways	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMC200029476	K00660	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMC200029476	K00660	ko04712	Circadian rhythm - plant	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMC200029477	K00660	ko00941	Flavonoid biosynthesis	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMC200029477	K00660	ko01100	Metabolic pathways	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMC200029477	K00660	ko01110	Biosynthesis of secondary metabolites	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMC200029477	K00660	ko04712	Circadian rhythm - plant	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMC200029479	K08515	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.87	0.96	0.29
PGSC0003DMC200029484	K00660	ko00941	Flavonoid biosynthesis	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMC200029484	K00660	ko01100	Metabolic pathways	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMC200029484	K00660	ko01110	Biosynthesis of secondary metabolites	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMC200029484	K00660	ko04712	Circadian rhythm - plant	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMC200029487	K00469	ko00053	Ascorbate and aldarate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMC200029487	K00469	ko00562	Inositol phosphate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMC200029490	K01404	ko05140	Leishmaniasis	5188	2.6e-280	0.72	0.82	0.95
PGSC0003DMC200045453	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMC200045454	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMC200045458	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMC200045459	K12866	ko03040	Spliceosome	247	3.0e-07	0.40	0.48	0.85
PGSC0003DMC200045462	K12866	ko03040	Spliceosome	240	7.6e-07	0.38	0.46	0.72
PGSC0003DMC200045464	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	282	1.8e-07	0.29	0.43	0.94
PGSC0003DMC200045467	K05740	ko04510	Focal adhesion	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMC200045467	K05740	ko04810	Regulation of actin cytoskeleton	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMC200045467	K05740	ko05131	Shigellosis	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMC200045472	K01177	ko00500	Starch and sucrose metabolism	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMC200045472	K01177	ko01100	Metabolic pathways	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMC200045473	K01177	ko00500	Starch and sucrose metabolism	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMC200045473	K01177	ko01100	Metabolic pathways	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMC200045474	K01177	ko00500	Starch and sucrose metabolism	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMC200045474	K01177	ko01100	Metabolic pathways	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMC200045475	K01177	ko00500	Starch and sucrose metabolism	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMC200045475	K01177	ko01100	Metabolic pathways	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMC200039901	K01509	ko00230	Purine metabolism	1521	4.7e-78	0.42	0.57	0.58
PGSC0003DMC200039902	K02957	ko03010	Ribosome	712	2.0e-33	0.87	0.90	0.64
PGSC0003DMC200039904	K02957	ko03010	Ribosome	366	2.4e-14	0.85	0.91	0.42
PGSC0003DMC200039905	K00368	ko00910	Nitrogen metabolism	437	2.9e-18	0.35	0.55	0.76
PGSC0003DMC200039906	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMC200039906	K12447	ko01100	Metabolic pathways	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMC200039907	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMC200039907	K12447	ko01100	Metabolic pathways	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMC200039910	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039910	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039911	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMC200039912	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04744	Phototransduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04916	Melanogenesis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04970	Salivary secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039912	K02183	ko05214	Glioma	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMC200039917	K01933	ko00230	Purine metabolism	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMC200039917	K01933	ko01100	Metabolic pathways	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMC200039917	K01933	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMC200064783	K01593	ko00340	Histidine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00350	Tyrosine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00360	Phenylalanine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00380	Tryptophan metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00901	Indole alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00950	Isoquinoline alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko00965	Betalain biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko01100	Metabolic pathways	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064783	K01593	ko01110	Biosynthesis of secondary metabolites	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMC200064796	K12493	ko04144	Endocytosis	924	4.0e-45	0.54	0.72	0.72
PGSC0003DMC200062639	K09481	ko03060	Protein export	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMC200062639	K09481	ko04145	Phagosome	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMC200062639	K09481	ko05110	Vibrio cholerae infection	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMC200000184	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1648	4.6e-85	0.66	0.78	0.95
PGSC0003DMC200000185	K03260	ko05416	Viral myocarditis	293	7.6e-07	0.26	0.38	0.80
PGSC0003DMC200000204	K06689	ko04120	Ubiquitin mediated proteolysis	1103	5.3e-55	0.95	0.96	0.86
PGSC0003DMC200000205	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMC200000206	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMC200020469	K07374	ko04145	Phagosome	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMC200020469	K07374	ko04540	Gap junction	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMC200020469	K07374	ko05130	Pathogenic Escherichia coli infection	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMC200020476	K00826	ko00280	Valine, leucine and isoleucine degradation	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMC200020476	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMC200020476	K00826	ko00770	Pantothenate and CoA biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMC200020476	K00826	ko01100	Metabolic pathways	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMC200020476	K00826	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMC200020477	K00826	ko00280	Valine, leucine and isoleucine degradation	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMC200020477	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMC200020477	K00826	ko00770	Pantothenate and CoA biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMC200020477	K00826	ko01100	Metabolic pathways	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMC200020477	K00826	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMC200020478	K00826	ko00280	Valine, leucine and isoleucine degradation	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMC200020478	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMC200020478	K00826	ko00770	Pantothenate and CoA biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMC200020478	K00826	ko01100	Metabolic pathways	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMC200020478	K00826	ko01110	Biosynthesis of secondary metabolites	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMC200020481	K09756	ko00940	Phenylpropanoid biosynthesis	1104	4.7e-55	0.58	0.73	0.50
PGSC0003DMC200020482	K09756	ko00940	Phenylpropanoid biosynthesis	1475	3.1e-80	0.45	0.61	0.94
PGSC0003DMC200020483	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMC200020484	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMC200020485	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMC200020486	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMC200020487	K09757	ko00940	Phenylpropanoid biosynthesis	851	4.2e-41	0.48	0.64	1.00
PGSC0003DMC200020488	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMC200020489	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMC200016651	K02151	ko00190	Oxidative phosphorylation	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016651	K02151	ko01100	Metabolic pathways	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016651	K02151	ko04145	Phagosome	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016651	K02151	ko04966	Collecting duct acid secretion	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016651	K02151	ko05110	Vibrio cholerae infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016651	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMC200016652	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016652	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016652	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016652	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016652	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016652	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016653	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016654	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMC200016658	K11160	ko00561	Glycerolipid metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMC200016658	K11160	ko00830	Retinol metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMC200016658	K11160	ko01100	Metabolic pathways	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMC200016659	K11160	ko00561	Glycerolipid metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMC200016659	K11160	ko00830	Retinol metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMC200016659	K11160	ko01100	Metabolic pathways	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMC200016660	K11160	ko00561	Glycerolipid metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMC200016660	K11160	ko00830	Retinol metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMC200016660	K11160	ko01100	Metabolic pathways	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMC200016673	K01719	ko00860	Porphyrin and chlorophyll metabolism	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMC200016673	K01719	ko01100	Metabolic pathways	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMC200016673	K01719	ko01110	Biosynthesis of secondary metabolites	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMC200011112	K04103	ko00380	Tryptophan metabolism	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMC200011112	K04103	ko01100	Metabolic pathways	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMC200027511	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMC200008954	K12667	ko00510	N-Glycan biosynthesis	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMC200008954	K12667	ko01100	Metabolic pathways	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMC200008956	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.78
PGSC0003DMC200008957	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.82
PGSC0003DMC200008959	K10717	ko00908	Zeatin biosynthesis	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMC200008959	K10717	ko01100	Metabolic pathways	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMC200008959	K10717	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMC200008965	K04121	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMC200008965	K04121	ko01100	Metabolic pathways	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMC200008965	K04121	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMC200008966	K01054	ko00561	Glycerolipid metabolism	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMC200008966	K01054	ko01100	Metabolic pathways	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMC200020915	K09828	ko00100	Steroid biosynthesis	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMC200020915	K09828	ko01100	Metabolic pathways	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMC200020915	K09828	ko01110	Biosynthesis of secondary metabolites	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMC200020925	K08064	ko04612	Antigen processing and presentation	305	5.5e-11	0.49	0.64	0.50
PGSC0003DMC200020926	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.53	0.69	0.59
PGSC0003DMC200020928	K12486	ko04144	Endocytosis	527	3.1e-23	0.37	0.55	0.64
PGSC0003DMC200027063	K04420	ko04010	MAPK signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMC200027063	K04420	ko04540	Gap junction	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMC200027063	K04420	ko04912	GnRH signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMC200027064	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.78
PGSC0003DMC200027065	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.77
PGSC0003DMC200027066	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.84
PGSC0003DMC200027070	K10260	ko04120	Ubiquitin mediated proteolysis	394	6.8e-16	0.31	0.45	0.78
PGSC0003DMC200027088	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMC200027089	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMC200004685	K01179	ko00500	Starch and sucrose metabolism	320	8.2e-12	0.67	0.78	0.58
PGSC0003DMC200004695	K00058	ko00260	Glycine, serine and threonine metabolism	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMC200004695	K00058	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMC200004696	K00100	ko00051	Fructose and mannose metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004696	K00100	ko00363	Bisphenol A degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004696	K00100	ko00591	Linoleic acid metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004696	K00100	ko00625	Tetrachloroethene degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004696	K00100	ko00650	Butanoate metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004696	K00100	ko01100	Metabolic pathways	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMC200004697	K00058	ko00260	Glycine, serine and threonine metabolism	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMC200004697	K00058	ko01100	Metabolic pathways	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMC200004698	K00058	ko00260	Glycine, serine and threonine metabolism	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMC200004698	K00058	ko01100	Metabolic pathways	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMC200004699	K02695	ko00195	Photosynthesis	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMC200004699	K02695	ko01100	Metabolic pathways	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMC200023071	K01066	ko00623	2,4-Dichlorobenzoate degradation	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMC200023071	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMC200023072	K00472	ko00330	Arginine and proline metabolism	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMC200023072	K00472	ko01100	Metabolic pathways	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMC200023073	K00472	ko00330	Arginine and proline metabolism	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMC200023073	K00472	ko01100	Metabolic pathways	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMC200023085	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023085	K01652	ko00650	Butanoate metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023085	K01652	ko00660	C5-Branched dibasic acid metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023085	K01652	ko00770	Pantothenate and CoA biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023085	K01652	ko01100	Metabolic pathways	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023085	K01652	ko01110	Biosynthesis of secondary metabolites	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMC200023086	K00166	ko00280	Valine, leucine and isoleucine degradation	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMC200023086	K00166	ko01100	Metabolic pathways	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMC200023086	K00166	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMC200023087	K00166	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMC200023087	K00166	ko01100	Metabolic pathways	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMC200023087	K00166	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMC200023088	K00166	ko00280	Valine, leucine and isoleucine degradation	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMC200023088	K00166	ko01100	Metabolic pathways	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMC200023088	K00166	ko01110	Biosynthesis of secondary metabolites	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMC200023089	K00166	ko00280	Valine, leucine and isoleucine degradation	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMC200023089	K00166	ko01100	Metabolic pathways	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMC200023089	K00166	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMC200023090	K00166	ko00280	Valine, leucine and isoleucine degradation	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMC200023090	K00166	ko01100	Metabolic pathways	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMC200023090	K00166	ko01110	Biosynthesis of secondary metabolites	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMC200023094	K12929	ko00904	Diterpenoid biosynthesis	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMC200023094	K12929	ko01110	Biosynthesis of secondary metabolites	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMC200023095	K12929	ko00904	Diterpenoid biosynthesis	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMC200023095	K12929	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMC200023096	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMC200023097	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMC200008432	K02084	ko04115	p53 signaling pathway	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko04210	Apoptosis	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko05010	Alzheimer's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko05012	Parkinson's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko05016	Huntington's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008432	K02084	ko05222	Small cell lung cancer	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMC200008438	K01051	ko00040	Pentose and glucuronate interconversions	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMC200008438	K01051	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMC200008438	K01051	ko01100	Metabolic pathways	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMC200008439	K01051	ko00040	Pentose and glucuronate interconversions	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMC200008439	K01051	ko00500	Starch and sucrose metabolism	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMC200008439	K01051	ko01100	Metabolic pathways	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMC200002106	K12393	ko04142	Lysosome	1644	7.7e-85	0.94	0.98	0.79
PGSC0003DMC200002107	K12393	ko04142	Lysosome	1749	1.2e-90	0.92	0.97	0.99
PGSC0003DMC200002108	K12393	ko04142	Lysosome	3398	1.4e-181	0.93	0.97	1.00
PGSC0003DMC200002115	K05280	ko00941	Flavonoid biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMC200002115	K05280	ko00944	Flavone and flavonol biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMC200002115	K05280	ko01100	Metabolic pathways	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMC200002115	K05280	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMC200002116	K05280	ko00941	Flavonoid biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMC200002116	K05280	ko00944	Flavone and flavonol biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMC200002116	K05280	ko01100	Metabolic pathways	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMC200002116	K05280	ko01110	Biosynthesis of secondary metabolites	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMC200002118	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002118	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002118	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002119	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002119	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002119	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002120	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002120	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002120	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMC200002124	K04077	ko03018	RNA degradation	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMC200002124	K04077	ko04940	Type I diabetes mellitus	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMC200002125	K01723	ko00592	alpha-Linolenic acid metabolism	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMC200002125	K01723	ko01100	Metabolic pathways	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMC200002128	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMC200002129	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMC200002130	K09590	ko00905	Brassinosteroid biosynthesis	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMC200002130	K09590	ko01100	Metabolic pathways	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMC200002130	K09590	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMC200058274	K02639	ko00195	Photosynthesis	650	5.1e-30	0.78	0.87	0.99
PGSC0003DMC200058278	K08243	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMC200058278	K08243	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMC200058281	K12132	ko04712	Circadian rhythm - plant	1043	1.1e-51	0.49	0.67	0.89
PGSC0003DMC200033484	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.33	0.53	0.80
PGSC0003DMC200033485	K02938	ko03010	Ribosome	2216	2.2e-116	0.97	0.99	1.00
PGSC0003DMC200033509	K12486	ko04144	Endocytosis	2659	8.0e-141	0.67	0.79	1.00
PGSC0003DMC200051891	K02377	ko00051	Fructose and mannose metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMC200051891	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMC200051891	K02377	ko01100	Metabolic pathways	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMC200051894	K04079	ko04612	Antigen processing and presentation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051894	K04079	ko04621	NOD-like receptor signaling pathway	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051894	K04079	ko04626	Plant-pathogen interaction	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051894	K04079	ko04914	Progesterone-mediated oocyte maturation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051894	K04079	ko05200	Pathways in cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051894	K04079	ko05215	Prostate cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMC200051895	K00795	ko00900	Terpenoid backbone biosynthesis	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMC200051895	K00795	ko01100	Metabolic pathways	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMC200051895	K00795	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMC200051898	K03027	ko00230	Purine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMC200051898	K03027	ko00240	Pyrimidine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMC200051898	K03027	ko01100	Metabolic pathways	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMC200051898	K03027	ko03020	RNA polymerase	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMC200051898	K03027	ko04623	Cytosolic DNA-sensing pathway	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMC200006548	K00472	ko00330	Arginine and proline metabolism	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMC200006548	K00472	ko01100	Metabolic pathways	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMC200006565	K01081	ko00230	Purine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMC200006565	K01081	ko00240	Pyrimidine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMC200006565	K01081	ko00760	Nicotinate and nicotinamide metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMC200006565	K01081	ko01100	Metabolic pathways	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMC200006565	K01081	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMC200006568	K01247	ko03410	Base excision repair	1046	7.4e-52	0.60	0.72	0.95
PGSC0003DMC200006569	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMC200006570	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMC200026071	K03094	ko04110	Cell cycle	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04111	Cell cycle - yeast	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04114	Oocyte meiosis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04120	Ubiquitin mediated proteolysis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04310	Wnt signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04350	TGF-beta signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026071	K03094	ko04710	Circadian rhythm - mammal	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMC200026082	K06674	ko04111	Cell cycle - yeast	7527	0.	0.77	0.86	1.00
PGSC0003DMC200026083	K06674	ko04111	Cell cycle - yeast	7634	0.	0.80	0.90	1.00
PGSC0003DMC200026084	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMC200026084	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMC200026084	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMC200026084	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMC200026084	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMC200018067	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMC200018067	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMC200018068	K01066	ko00623	2,4-Dichlorobenzoate degradation	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMC200018068	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMC200018069	K01046	ko00561	Glycerolipid metabolism	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMC200018069	K01046	ko01100	Metabolic pathways	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMC200018070	K01046	ko00561	Glycerolipid metabolism	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMC200018070	K01046	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMC200018071	K01046	ko00561	Glycerolipid metabolism	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMC200018071	K01046	ko01100	Metabolic pathways	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMC200018072	K01046	ko00561	Glycerolipid metabolism	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMC200018072	K01046	ko01100	Metabolic pathways	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMC200018080	K01046	ko00561	Glycerolipid metabolism	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMC200018080	K01046	ko01100	Metabolic pathways	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMC200029914	K05280	ko00941	Flavonoid biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMC200029914	K05280	ko00944	Flavone and flavonol biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMC200029914	K05280	ko01100	Metabolic pathways	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMC200029914	K05280	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMC200029915	K05280	ko00941	Flavonoid biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMC200029915	K05280	ko00944	Flavone and flavonol biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMC200029915	K05280	ko01100	Metabolic pathways	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMC200029915	K05280	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMC200029916	K05280	ko00941	Flavonoid biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMC200029916	K05280	ko00944	Flavone and flavonol biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMC200029916	K05280	ko01100	Metabolic pathways	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMC200029916	K05280	ko01110	Biosynthesis of secondary metabolites	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMC200029917	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMC200029917	K00517	ko00626	Naphthalene and anthracene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMC200029917	K00517	ko00903	Limonene and pinene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMC200029917	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMC200029917	K00517	ko01110	Biosynthesis of secondary metabolites	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMC200029926	K10589	ko04120	Ubiquitin mediated proteolysis	4751	3.3e-256	0.79	0.88	0.97
PGSC0003DMC200029927	K10589	ko04120	Ubiquitin mediated proteolysis	5308	6.3e-287	0.76	0.86	0.96
PGSC0003DMC200029931	K12153	ko00966	Glucosinolate biosynthesis	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMC200029931	K12153	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMC200029932	K11812	ko00380	Tryptophan metabolism	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMC200029932	K11812	ko00966	Glucosinolate biosynthesis	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMC200029936	K02084	ko04115	p53 signaling pathway	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko04210	Apoptosis	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko05010	Alzheimer's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko05012	Parkinson's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko05016	Huntington's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029936	K02084	ko05222	Small cell lung cancer	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMC200029937	K02084	ko04115	p53 signaling pathway	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko04210	Apoptosis	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko05010	Alzheimer's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko05012	Parkinson's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko05016	Huntington's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029937	K02084	ko05222	Small cell lung cancer	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMC200029938	K04124	ko00904	Diterpenoid biosynthesis	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMC200029938	K04124	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMC200060227	K10760	ko00908	Zeatin biosynthesis	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMC200060227	K10760	ko01100	Metabolic pathways	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMC200060227	K10760	ko01110	Biosynthesis of secondary metabolites	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMC200060233	K11818	ko00380	Tryptophan metabolism	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMC200060233	K11818	ko00966	Glucosinolate biosynthesis	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMC200060233	K11818	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMC200060239	K01528	ko04144	Endocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMC200060239	K01528	ko04666	Fc gamma R-mediated phagocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMC200060239	K01528	ko05100	Bacterial invasion of epithelial cells	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMC200054895	K00599	ko00340	Histidine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMC200054895	K00599	ko00350	Tyrosine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMC200054895	K00599	ko00450	Selenoamino acid metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMC200054895	K00599	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMC200054896	K00599	ko00340	Histidine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMC200054896	K00599	ko00350	Tyrosine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMC200054896	K00599	ko00450	Selenoamino acid metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMC200054896	K00599	ko00626	Naphthalene and anthracene degradation	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMC200054897	K00599	ko00340	Histidine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMC200054897	K00599	ko00350	Tyrosine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMC200054897	K00599	ko00450	Selenoamino acid metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMC200054897	K00599	ko00626	Naphthalene and anthracene degradation	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMC200037741	K13030	ko00460	Cyanoamino acid metabolism	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMC200037741	K13030	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMC200037742	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMC200037742	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMC200037746	K13030	ko00460	Cyanoamino acid metabolism	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMC200037746	K13030	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMC200037747	K13030	ko00460	Cyanoamino acid metabolism	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMC200037747	K13030	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMC200037752	K08139	ko04113	Meiosis - yeast	324	7.2e-12	0.41	0.60	0.62
PGSC0003DMC200037753	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.44	0.58	0.88
PGSC0003DMC200037754	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.45	0.59	0.77
PGSC0003DMC200037767	K00430	ko00360	Phenylalanine metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMC200037767	K00430	ko00680	Methane metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMC200037767	K00430	ko00940	Phenylpropanoid biosynthesis	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMC200037767	K00430	ko01100	Metabolic pathways	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMC200037767	K00430	ko01110	Biosynthesis of secondary metabolites	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMC200047864	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3901	2.5e-209	0.82	0.90	1.00
PGSC0003DMC200047867	K08387	ko04080	Neuroactive ligand-receptor interaction	842	1.3e-40	0.48	0.69	0.78
PGSC0003DMC200047868	K08387	ko04080	Neuroactive ligand-receptor interaction	568	1.7e-25	0.43	0.66	0.83
PGSC0003DMC200047869	K08387	ko04080	Neuroactive ligand-receptor interaction	1101	6.8e-55	0.44	0.66	0.89
PGSC0003DMC200047873	K12875	ko03040	Spliceosome	633	4.4e-29	0.26	0.44	0.94
PGSC0003DMC200047874	K12875	ko03040	Spliceosome	670	4.0e-31	0.27	0.45	0.93
PGSC0003DMC200047875	K12875	ko03040	Spliceosome	650	5.1e-30	0.27	0.44	0.94
PGSC0003DMC200047876	K12875	ko03040	Spliceosome	679	1.3e-31	0.29	0.44	0.77
PGSC0003DMC200047877	K12875	ko03040	Spliceosome	395	6.0e-16	0.35	0.49	0.99
PGSC0003DMC200047878	K02908	ko03010	Ribosome	867	5.5e-42	0.91	0.97	0.99
PGSC0003DMC200049266	K12356	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.32	0.48	0.93
PGSC0003DMC200049270	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMC200049270	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMC200049271	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMC200049271	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMC200049272	K02180	ko04110	Cell cycle	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMC200049272	K02180	ko04111	Cell cycle - yeast	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMC200049280	K02084	ko04115	p53 signaling pathway	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko04210	Apoptosis	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko05010	Alzheimer's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko05012	Parkinson's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko05016	Huntington's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049280	K02084	ko05222	Small cell lung cancer	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMC200049282	K10744	ko03030	DNA replication	1148	1.8e-57	0.58	0.74	0.42
PGSC0003DMC200049284	K10744	ko03030	DNA replication	1270	3.3e-64	0.57	0.72	0.83
PGSC0003DMC200049285	K10744	ko03030	DNA replication	1272	2.5e-64	0.58	0.73	0.83
PGSC0003DMC200049286	K11821	ko00380	Tryptophan metabolism	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMC200049286	K11821	ko00966	Glucosinolate biosynthesis	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMC200049286	K11821	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMC200049287	K11821	ko00380	Tryptophan metabolism	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMC200049287	K11821	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMC200049287	K11821	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMC200049289	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMC200049290	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMC200031892	K01648	ko00020	Citrate cycle (TCA cycle)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMC200031892	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMC200031892	K01648	ko01100	Metabolic pathways	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMC200031892	K01648	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMC200031893	K01648	ko00020	Citrate cycle (TCA cycle)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMC200031893	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMC200031893	K01648	ko01100	Metabolic pathways	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMC200031893	K01648	ko01110	Biosynthesis of secondary metabolites	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMC200031900	K10581	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.45	0.61	0.85
PGSC0003DMC200031908	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMC200031908	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMC200031909	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMC200031909	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMC200031911	K12855	ko03040	Spliceosome	7156	0.	0.83	0.91	1.00
PGSC0003DMC200061422	K01369	ko04142	Lysosome	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMC200061422	K01369	ko04612	Antigen processing and presentation	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMC200061429	K10577	ko04120	Ubiquitin mediated proteolysis	325	4.3e-12	0.50	0.53	0.94
PGSC0003DMC200068250	K05282	ko00904	Diterpenoid biosynthesis	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMC200068250	K05282	ko01100	Metabolic pathways	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMC200068250	K05282	ko01110	Biosynthesis of secondary metabolites	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMC200007742	K02008	ko02010	ABC transporters	458	2.0e-19	0.41	0.62	0.82
PGSC0003DMC200007743	K02008	ko02010	ABC transporters	681	1.0e-31	0.38	0.60	0.65
PGSC0003DMC200007746	K01915	ko00250	Alanine, aspartate and glutamate metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMC200007746	K01915	ko00330	Arginine and proline metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMC200007746	K01915	ko00910	Nitrogen metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMC200007746	K01915	ko01100	Metabolic pathways	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMC200007746	K01915	ko02020	Two-component system	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMC200007751	K01066	ko00623	2,4-Dichlorobenzoate degradation	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMC200007751	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMC200007752	K01066	ko00623	2,4-Dichlorobenzoate degradation	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMC200007752	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMC200007753	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMC200007753	K01061	ko00364	Fluorobenzoate degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMC200007753	K01061	ko00627	1,4-Dichlorobenzene degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMC200007753	K01061	ko01100	Metabolic pathways	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMC200007754	K01066	ko00623	2,4-Dichlorobenzoate degradation	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMC200007754	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMC200007759	K00940	ko00230	Purine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMC200007759	K00940	ko00240	Pyrimidine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMC200007759	K00940	ko01100	Metabolic pathways	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMC200007759	K00940	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMC200007760	K12620	ko03018	RNA degradation	247	8.7e-08	0.83	0.92	0.09
PGSC0003DMC200024875	K05674	ko02010	ABC transporters	2119	4.9e-111	0.41	0.56	0.99
PGSC0003DMC200024876	K05674	ko02010	ABC transporters	1962	2.2e-102	0.41	0.55	0.99
PGSC0003DMC200024877	K05674	ko02010	ABC transporters	3478	5.4e-186	0.36	0.53	1.00
PGSC0003DMC200024878	K05674	ko02010	ABC transporters	2702	3.4e-143	0.41	0.56	0.99
PGSC0003DMC200024879	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMC200024880	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMC200024883	K13065	ko00940	Phenylpropanoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMC200024883	K13065	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMC200024883	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMC200024883	K13065	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMC200024885	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMC200024885	K05287	ko01100	Metabolic pathways	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMC200024886	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMC200024886	K05287	ko01100	Metabolic pathways	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMC200024888	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024888	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024888	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024888	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024888	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024888	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMC200024889	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024889	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024889	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024889	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024889	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024889	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMC200024890	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024890	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024890	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024890	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024890	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024890	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMC200024891	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200024891	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200024891	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200024891	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200024891	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200024891	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMC200017854	K01354	ko05142	Chagas disease	710	2.5e-33	0.42	0.60	0.96
PGSC0003DMC200017855	K01354	ko05142	Chagas disease	1278	1.2e-64	0.32	0.50	0.94
PGSC0003DMC200017860	K04631	ko04744	Phototransduction	668	5.9e-31	0.35	0.52	0.39
PGSC0003DMC200017863	K00908	ko01100	Metabolic pathways	420	3.5e-17	0.27	0.45	0.77
PGSC0003DMC200019261	K00626	ko00071	Fatty acid metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00072	Synthesis and degradation of ketone bodies	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00280	Valine, leucine and isoleucine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00310	Lysine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00380	Tryptophan metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00620	Pyruvate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00632	Benzoate degradation via CoA ligation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00640	Propanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00650	Butanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko00900	Terpenoid backbone biosynthesis	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko01100	Metabolic pathways	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019261	K00626	ko02020	Two-component system	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMC200019262	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019262	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019263	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMC200019275	K00873	ko00010	Glycolysis / Gluconeogenesis	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko00230	Purine metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko00620	Pyruvate metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko00710	Carbon fixation in photosynthetic organisms	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko01100	Metabolic pathways	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko01110	Biosynthesis of secondary metabolites	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019275	K00873	ko04930	Type II diabetes mellitus	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMC200019289	K12488	ko04144	Endocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMC200019289	K12488	ko04666	Fc gamma R-mediated phagocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMC200056079	K03841	ko00010	Glycolysis / Gluconeogenesis	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko00030	Pentose phosphate pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko00051	Fructose and mannose metabolism	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko00710	Carbon fixation in photosynthetic organisms	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko01100	Metabolic pathways	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056079	K03841	ko04910	Insulin signaling pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMC200056082	K03110	ko03060	Protein export	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMC200056082	K03110	ko03070	Bacterial secretion system	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMC200056083	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMC200056083	K12567	ko05414	Dilated cardiomyopathy	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMC200056084	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMC200056084	K12567	ko05414	Dilated cardiomyopathy	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMC200056085	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMC200056085	K12567	ko05414	Dilated cardiomyopathy	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMC200056100	K13027	ko00460	Cyanoamino acid metabolism	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMC200056100	K13027	ko00966	Glucosinolate biosynthesis	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMC200056100	K13027	ko01100	Metabolic pathways	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMC200056100	K13027	ko01110	Biosynthesis of secondary metabolites	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMC200036546	K10676	ko00627	1,4-Dichlorobenzene degradation	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMC200036546	K10676	ko01100	Metabolic pathways	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMC200036547	K10676	ko00627	1,4-Dichlorobenzene degradation	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMC200036547	K10676	ko01100	Metabolic pathways	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMC200036556	K04125	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.58	0.74	0.89
PGSC0003DMC200036558	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMC200036558	K07819	ko01100	Metabolic pathways	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMC200036563	K02084	ko04115	p53 signaling pathway	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko04210	Apoptosis	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko05010	Alzheimer's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko05012	Parkinson's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko05016	Huntington's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036563	K02084	ko05222	Small cell lung cancer	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMC200036567	K02912	ko03010	Ribosome	545	3.2e-24	0.83	0.93	0.96
PGSC0003DMC200030691	K00128	ko00010	Glycolysis / Gluconeogenesis	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00053	Ascorbate and aldarate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00071	Fatty acid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00280	Valine, leucine and isoleucine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00310	Lysine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00330	Arginine and proline metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00340	Histidine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00380	Tryptophan metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00410	beta-Alanine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00561	Glycerolipid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00620	Pyruvate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00631	1,2-Dichloroethane degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00640	Propanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00641	3-Chloroacrylic acid degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00650	Butanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko00903	Limonene and pinene degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko01100	Metabolic pathways	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030691	K00128	ko01110	Biosynthesis of secondary metabolites	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMC200030694	K03862	ko00623	2,4-Dichlorobenzoate degradation	243	1.4e-07	0.44	0.61	0.24
PGSC0003DMC200030696	K03862	ko00623	2,4-Dichlorobenzoate degradation	450	5.5e-19	0.32	0.46	0.53
PGSC0003DMC200030700	K02877	ko03010	Ribosome	1697	9.2e-88	0.94	0.97	1.00
PGSC0003DMC200030701	K01881	ko00970	Aminoacyl-tRNA biosynthesis	363	8.2e-14	0.35	0.57	0.51
PGSC0003DMC200030711	K11294	ko05130	Pathogenic Escherichia coli infection	471	3.8e-20	0.37	0.56	0.71
PGSC0003DMC200030716	K10604	ko04120	Ubiquitin mediated proteolysis	586	1.7e-26	0.36	0.56	0.72
PGSC0003DMC200048062	K04734	ko04062	Chemokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04210	Apoptosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04620	Toll-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04621	NOD-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04622	RIG-I-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04623	Cytosolic DNA-sensing pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04660	T cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04662	B cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko04920	Adipocytokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05120	Epithelial cell signaling in Helicobacter pylori infection	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05131	Shigellosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05140	Leishmaniasis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05142	Chagas disease	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05200	Pathways in cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05215	Prostate cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05220	Chronic myeloid leukemia	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048062	K04734	ko05222	Small cell lung cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMC200048072	K08803	ko05200	Pathways in cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMC200048072	K08803	ko05219	Bladder cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMC200048079	K04125	ko00904	Diterpenoid biosynthesis	435	3.7e-18	0.67	0.81	0.94
PGSC0003DMC200048080	K04125	ko00904	Diterpenoid biosynthesis	1469	3.5e-75	0.52	0.67	0.99
PGSC0003DMC200048084	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200048084	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200048085	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200048085	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200048086	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200048086	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMC200059923	K10591	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMC200059923	K10591	ko04144	Endocytosis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMC200000901	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMC200000904	K02219	ko04111	Cell cycle - yeast	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMC200000904	K02219	ko05200	Pathways in cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMC200000904	K02219	ko05222	Small cell lung cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMC200000905	K10603	ko04120	Ubiquitin mediated proteolysis	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMC200000905	K10603	ko05340	Primary immunodeficiency	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMC200000917	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.36	0.54	0.87
PGSC0003DMC200000918	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.37	0.52	0.86
PGSC0003DMC200000919	K00679	ko00561	Glycerolipid metabolism	966	1.9e-47	0.41	0.59	0.65
PGSC0003DMC200000926	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMC200000926	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMC200000927	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMC200000927	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMC200028261	K06670	ko04110	Cell cycle	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMC200028261	K06670	ko04111	Cell cycle - yeast	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMC200028264	K03921	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMC200028264	K03921	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMC200028271	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	2331	9.9e-123	0.79	0.86	0.99
PGSC0003DMC200028286	K12356	ko00940	Phenylpropanoid biosynthesis	625	1.6e-30	0.31	0.48	0.94
PGSC0003DMC200028289	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.32	0.48	0.93
PGSC0003DMC200021881	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMC200021882	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMC200021883	K06672	ko04111	Cell cycle - yeast	2528	1.3e-133	0.66	0.78	1.00
PGSC0003DMC200021884	K06672	ko04111	Cell cycle - yeast	9601	0.	0.61	0.73	1.00
PGSC0003DMC200021888	K07195	ko04910	Insulin signaling pathway	2269	2.6e-119	0.47	0.66	0.98
PGSC0003DMC200021890	K07424	ko00140	Steroid hormone biosynthesis	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00591	Linoleic acid metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00830	Retinol metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00982	Drug metabolism - cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko00983	Drug metabolism - other enzymes	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021890	K07424	ko01100	Metabolic pathways	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMC200021891	K07424	ko00140	Steroid hormone biosynthesis	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00591	Linoleic acid metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00830	Retinol metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00982	Drug metabolism - cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko00983	Drug metabolism - other enzymes	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021891	K07424	ko01100	Metabolic pathways	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMC200021892	K07424	ko00140	Steroid hormone biosynthesis	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00591	Linoleic acid metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00830	Retinol metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00982	Drug metabolism - cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko00983	Drug metabolism - other enzymes	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021892	K07424	ko01100	Metabolic pathways	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMC200021893	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021893	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021894	K07424	ko00140	Steroid hormone biosynthesis	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00591	Linoleic acid metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00830	Retinol metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00982	Drug metabolism - cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko00983	Drug metabolism - other enzymes	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021894	K07424	ko01100	Metabolic pathways	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMC200021895	K07424	ko00140	Steroid hormone biosynthesis	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00591	Linoleic acid metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00830	Retinol metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00982	Drug metabolism - cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko00983	Drug metabolism - other enzymes	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021895	K07424	ko01100	Metabolic pathways	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMC200021896	K07424	ko00140	Steroid hormone biosynthesis	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00591	Linoleic acid metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00830	Retinol metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00982	Drug metabolism - cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko00983	Drug metabolism - other enzymes	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021896	K07424	ko01100	Metabolic pathways	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMC200021897	K07424	ko00140	Steroid hormone biosynthesis	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00591	Linoleic acid metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00830	Retinol metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00982	Drug metabolism - cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko00983	Drug metabolism - other enzymes	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021897	K07424	ko01100	Metabolic pathways	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMC200021898	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021898	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMC200021899	K01595	ko00620	Pyruvate metabolism	7238	0.	0.87	0.95	1.00
PGSC0003DMC200021899	K01595	ko00710	Carbon fixation in photosynthetic organisms	7238	0.	0.87	0.95	1.00
PGSC0003DMC200021899	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7238	0.	0.87	0.95	1.00
PGSC0003DMC200021899	K01595	ko01100	Metabolic pathways	7238	0.	0.87	0.95	1.00
PGSC0003DMC200021900	K03846	ko00510	N-Glycan biosynthesis	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMC200021900	K03846	ko01100	Metabolic pathways	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMC200003481	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMC200003481	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMC200003481	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMC200003482	K04120	ko00904	Diterpenoid biosynthesis	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMC200003482	K04120	ko01100	Metabolic pathways	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMC200003482	K04120	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMC200003483	K04120	ko00904	Diterpenoid biosynthesis	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMC200003483	K04120	ko01100	Metabolic pathways	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMC200003483	K04120	ko01110	Biosynthesis of secondary metabolites	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMC200003484	K04120	ko00904	Diterpenoid biosynthesis	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMC200003484	K04120	ko01100	Metabolic pathways	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMC200003484	K04120	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMC200003488	K00108	ko00260	Glycine, serine and threonine metabolism	662	1.1e-30	0.28	0.48	0.73
PGSC0003DMC200003489	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMC200003490	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMC200003491	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMC200003492	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMC200003493	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.65
PGSC0003DMC200003494	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.87
PGSC0003DMC200003500	K12400	ko04142	Lysosome	4000	8.7e-215	0.87	0.95	0.97
PGSC0003DMC200003501	K12400	ko04142	Lysosome	6108	0.	0.77	0.86	1.00
PGSC0003DMC200003502	K12400	ko04142	Lysosome	1944	2.2e-101	0.61	0.73	1.00
PGSC0003DMC200003503	K12400	ko04142	Lysosome	1552	9.1e-80	0.58	0.70	1.00
PGSC0003DMC200050911	K09754	ko00360	Phenylalanine metabolism	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050911	K09754	ko00940	Phenylpropanoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050911	K09754	ko00941	Flavonoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050911	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050911	K09754	ko01100	Metabolic pathways	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050911	K09754	ko01110	Biosynthesis of secondary metabolites	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMC200050921	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.69
PGSC0003DMC200050922	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.68
PGSC0003DMC200050932	K12127	ko04712	Circadian rhythm - plant	282	1.1e-07	0.33	0.52	0.34
PGSC0003DMC200050934	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMC200050934	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMC200050934	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMC200050934	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMC200050937	K07512	ko00062	Fatty acid elongation in mitochondria	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMC200050937	K07512	ko01100	Metabolic pathways	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMC200050938	K07512	ko00062	Fatty acid elongation in mitochondria	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMC200050938	K07512	ko01100	Metabolic pathways	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMC200050939	K13065	ko00940	Phenylpropanoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMC200050939	K13065	ko00941	Flavonoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMC200050939	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMC200050939	K13065	ko01110	Biosynthesis of secondary metabolites	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMC200050940	K07512	ko00062	Fatty acid elongation in mitochondria	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMC200050940	K07512	ko01100	Metabolic pathways	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMC200053075	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.84
PGSC0003DMC200053076	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.82
PGSC0003DMC200053078	K01807	ko00030	Pentose phosphate pathway	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMC200053078	K01807	ko00710	Carbon fixation in photosynthetic organisms	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMC200053078	K01807	ko01100	Metabolic pathways	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMC200053078	K01807	ko01110	Biosynthesis of secondary metabolites	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMC200053096	K02606	ko04110	Cell cycle	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMC200053096	K02606	ko04111	Cell cycle - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMC200053096	K02606	ko04113	Meiosis - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMC200034683	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034683	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034683	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034683	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034683	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034684	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034684	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034684	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034684	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034684	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMC200034693	K00128	ko00010	Glycolysis / Gluconeogenesis	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00053	Ascorbate and aldarate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00071	Fatty acid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00310	Lysine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00330	Arginine and proline metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00340	Histidine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00380	Tryptophan metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00410	beta-Alanine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00561	Glycerolipid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00620	Pyruvate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00631	1,2-Dichloroethane degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00640	Propanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00641	3-Chloroacrylic acid degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00650	Butanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko00903	Limonene and pinene degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko01100	Metabolic pathways	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034693	K00128	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMC200034694	K00128	ko00010	Glycolysis / Gluconeogenesis	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00053	Ascorbate and aldarate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00071	Fatty acid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00280	Valine, leucine and isoleucine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00310	Lysine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00330	Arginine and proline metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00340	Histidine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00380	Tryptophan metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00410	beta-Alanine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00561	Glycerolipid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00620	Pyruvate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00631	1,2-Dichloroethane degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00640	Propanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00641	3-Chloroacrylic acid degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00650	Butanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko00903	Limonene and pinene degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034694	K00128	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMC200034695	K00128	ko00010	Glycolysis / Gluconeogenesis	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00053	Ascorbate and aldarate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00071	Fatty acid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00280	Valine, leucine and isoleucine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00310	Lysine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00330	Arginine and proline metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00340	Histidine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00380	Tryptophan metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00410	beta-Alanine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00561	Glycerolipid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00620	Pyruvate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00631	1,2-Dichloroethane degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00640	Propanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00641	3-Chloroacrylic acid degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00650	Butanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko00903	Limonene and pinene degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko01100	Metabolic pathways	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200034695	K00128	ko01110	Biosynthesis of secondary metabolites	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMC200038431	K03531	ko04112	Cell cycle - Caulobacter	2809	4.3e-149	0.83	0.91	1.00
PGSC0003DMC200038433	K05399	ko04620	Toll-like receptor signaling pathway	985	1.7e-48	0.50	0.69	0.69
PGSC0003DMC200038434	K05399	ko04620	Toll-like receptor signaling pathway	1269	3.7e-64	0.47	0.66	0.78
PGSC0003DMC200038435	K05399	ko04620	Toll-like receptor signaling pathway	233	5.1e-07	0.61	0.75	0.31
PGSC0003DMC200038436	K05399	ko04620	Toll-like receptor signaling pathway	756	7.3e-36	0.47	0.67	0.97
PGSC0003DMC200038439	K08241	ko00592	alpha-Linolenic acid metabolism	820	2.2e-39	0.38	0.52	0.88
PGSC0003DMC200038441	K00981	ko00564	Glycerophospholipid metabolism	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMC200038441	K00981	ko01100	Metabolic pathways	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMC200038441	K00981	ko04070	Phosphatidylinositol signaling system	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMC200038445	K01179	ko00500	Starch and sucrose metabolism	1376	4.7e-70	0.43	0.62	0.98
PGSC0003DMC200038451	K04426	ko04010	MAPK signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMC200038451	K04426	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMC200038451	K04426	ko05014	Amyotrophic lateral sclerosis (ALS)	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMC200038452	K02501	ko00340	Histidine metabolism	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMC200038452	K02501	ko01100	Metabolic pathways	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMC200038452	K02501	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMC200038453	K02501	ko00340	Histidine metabolism	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMC200038453	K02501	ko01100	Metabolic pathways	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMC200038453	K02501	ko01110	Biosynthesis of secondary metabolites	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMC200038454	K02501	ko00340	Histidine metabolism	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMC200038454	K02501	ko01100	Metabolic pathways	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMC200038454	K02501	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMC200038459	K00795	ko00900	Terpenoid backbone biosynthesis	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMC200038459	K00795	ko01100	Metabolic pathways	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMC200038459	K00795	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMC200058634	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMC200058634	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMC200058634	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMC200058640	K10717	ko00908	Zeatin biosynthesis	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMC200058640	K10717	ko01100	Metabolic pathways	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMC200058640	K10717	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMC200058642	K12831	ko03040	Spliceosome	326	3.8e-12	0.51	0.61	0.72
PGSC0003DMC200033005	K01853	ko00100	Steroid biosynthesis	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMC200033005	K01853	ko01100	Metabolic pathways	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMC200033005	K01853	ko01110	Biosynthesis of secondary metabolites	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMC200033006	K01853	ko00100	Steroid biosynthesis	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMC200033006	K01853	ko01100	Metabolic pathways	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMC200033006	K01853	ko01110	Biosynthesis of secondary metabolites	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMC200033007	K01853	ko00100	Steroid biosynthesis	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMC200033007	K01853	ko01100	Metabolic pathways	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMC200033007	K01853	ko01110	Biosynthesis of secondary metabolites	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMC200033008	K01853	ko00100	Steroid biosynthesis	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMC200033008	K01853	ko01100	Metabolic pathways	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMC200033008	K01853	ko01110	Biosynthesis of secondary metabolites	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMC200033009	K13280	ko03060	Protein export	1250	4.1e-63	0.96	0.99	0.36
PGSC0003DMC200033010	K13280	ko03060	Protein export	1275	1.7e-64	0.90	0.93	0.80
PGSC0003DMC200033011	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMC200033012	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMC200033013	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMC200033018	K12929	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMC200033018	K12929	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMC200051773	K03010	ko00230	Purine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMC200051773	K03010	ko00240	Pyrimidine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMC200051773	K03010	ko01100	Metabolic pathways	9859	0.	0.96	0.98	1.00
PGSC0003DMC200051773	K03010	ko03020	RNA polymerase	9859	0.	0.96	0.98	1.00
PGSC0003DMC200051773	K03010	ko05016	Huntington's disease	9859	0.	0.96	0.98	1.00
PGSC0003DMC200051774	K03010	ko00230	Purine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMC200051774	K03010	ko00240	Pyrimidine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMC200051774	K03010	ko01100	Metabolic pathways	6353	0.	0.69	0.70	1.00
PGSC0003DMC200051774	K03010	ko03020	RNA polymerase	6353	0.	0.69	0.70	1.00
PGSC0003DMC200051774	K03010	ko05016	Huntington's disease	6353	0.	0.69	0.70	1.00
PGSC0003DMC200051776	K01834	ko00010	Glycolysis / Gluconeogenesis	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMC200051776	K01834	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMC200051776	K01834	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMC200051777	K01834	ko00010	Glycolysis / Gluconeogenesis	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMC200051777	K01834	ko01100	Metabolic pathways	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMC200051777	K01834	ko01110	Biosynthesis of secondary metabolites	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMC200051779	K10581	ko04120	Ubiquitin mediated proteolysis	2564	1.4e-135	0.40	0.57	0.95
PGSC0003DMC200004201	K01930	ko00790	Folate biosynthesis	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMC200004201	K01930	ko01100	Metabolic pathways	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMC200004202	K01930	ko00790	Folate biosynthesis	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMC200004202	K01930	ko01100	Metabolic pathways	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMC200004203	K01930	ko00790	Folate biosynthesis	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMC200004203	K01930	ko01100	Metabolic pathways	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMC200004212	K07195	ko04910	Insulin signaling pathway	2209	5.3e-116	0.48	0.67	0.97
PGSC0003DMC200022955	K12819	ko03040	Spliceosome	268	5.4e-06	0.30	0.49	0.34
PGSC0003DMC200022957	K12819	ko03040	Spliceosome	268	3.5e-08	0.30	0.49	0.72
PGSC0003DMC200022967	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMC200022967	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMC200022971	K00627	ko00010	Glycolysis / Gluconeogenesis	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMC200022971	K00627	ko00020	Citrate cycle (TCA cycle)	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMC200022971	K00627	ko00620	Pyruvate metabolism	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMC200022971	K00627	ko01100	Metabolic pathways	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMC200022971	K00627	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMC200022975	K03456	ko04111	Cell cycle - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04113	Meiosis - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04114	Oocyte meiosis	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04310	Wnt signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04350	TGF-beta signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04530	Tight junction	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko04730	Long-term depression	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200022975	K03456	ko05142	Chagas disease	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMC200008791	K09756	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.61	0.78	0.86
PGSC0003DMC200001984	K11251	ko05322	Systemic lupus erythematosus	1000	2.5e-49	0.93	0.95	0.99
PGSC0003DMC200001989	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001989	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001989	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001990	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001990	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001990	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001991	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001991	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001991	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001992	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001992	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001992	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001993	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001993	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001993	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001994	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001994	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001994	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001995	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001995	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001995	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001996	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001996	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001996	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMC200001997	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001997	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001997	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001998	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001998	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001998	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMC200001999	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMC200001999	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMC200002000	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMC200002000	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMC200002002	K02184	ko04320	Dorso-ventral axis formation	1292	2.0e-65	0.42	0.47	0.44
PGSC0003DMC200002005	K13065	ko00940	Phenylpropanoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMC200002005	K13065	ko00941	Flavonoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMC200002005	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMC200002005	K13065	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMC200002006	K13065	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMC200002006	K13065	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMC200002006	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMC200002006	K13065	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMC200002007	K06676	ko04111	Cell cycle - yeast	3594	2.2e-192	0.67	0.78	0.99
PGSC0003DMC200002008	K10528	ko00592	alpha-Linolenic acid metabolism	1870	2.6e-97	0.49	0.69	0.96
PGSC0003DMC200002009	K00748	ko00540	Lipopolysaccharide biosynthesis	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMC200002009	K00748	ko01100	Metabolic pathways	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMC200002010	K00748	ko00540	Lipopolysaccharide biosynthesis	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMC200002010	K00748	ko01100	Metabolic pathways	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMC200054757	K12356	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.30	0.45	0.85
PGSC0003DMC200054760	K10775	ko00360	Phenylalanine metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMC200054760	K10775	ko00910	Nitrogen metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMC200054760	K10775	ko00940	Phenylpropanoid biosynthesis	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMC200054760	K10775	ko01100	Metabolic pathways	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMC200054760	K10775	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMC200054762	K10571	ko04120	Ubiquitin mediated proteolysis	1876	1.2e-97	0.82	0.90	0.89
PGSC0003DMC200054763	K10571	ko04120	Ubiquitin mediated proteolysis	3824	4.4e-205	0.84	0.92	1.00
PGSC0003DMC200054764	K10571	ko04120	Ubiquitin mediated proteolysis	1303	4.9e-66	0.85	0.94	0.99
PGSC0003DMC200054765	K02894	ko03010	Ribosome	792	7.6e-38	0.92	0.95	0.42
PGSC0003DMC200044013	K09753	ko00940	Phenylpropanoid biosynthesis	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMC200044013	K09753	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMC200044013	K09753	ko01110	Biosynthesis of secondary metabolites	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMC200044014	K09753	ko00940	Phenylpropanoid biosynthesis	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMC200044014	K09753	ko01100	Metabolic pathways	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMC200044014	K09753	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMC200044015	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMC200044015	K04518	ko01100	Metabolic pathways	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMC200044016	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMC200044016	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMC200044017	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMC200044017	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMC200044018	K02154	ko00190	Oxidative phosphorylation	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko01100	Metabolic pathways	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko04142	Lysosome	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko04145	Phagosome	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko04966	Collecting duct acid secretion	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko05110	Vibrio cholerae infection	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044018	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	6059	0.	0.86	0.93	1.00
PGSC0003DMC200044021	K05915	ko00363	Bisphenol A degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMC200044021	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMC200044021	K05915	ko01100	Metabolic pathways	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMC200044022	K10643	ko03018	RNA degradation	4110	7.5e-221	0.51	0.64	1.00
PGSC0003DMC200044023	K10643	ko03018	RNA degradation	4123	1.4e-221	0.52	0.64	1.00
PGSC0003DMC200044024	K10643	ko03018	RNA degradation	4121	1.8e-221	0.51	0.64	1.00
PGSC0003DMC200044029	K01955	ko00240	Pyrimidine metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMC200044029	K01955	ko00250	Alanine, aspartate and glutamate metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMC200044029	K01955	ko01100	Metabolic pathways	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMC200044039	K10869	ko03440	Homologous recombination	1180	3.0e-59	0.67	0.84	0.97
PGSC0003DMC200044040	K10869	ko03440	Homologous recombination	787	1.4e-37	0.64	0.79	0.77
PGSC0003DMC200047371	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMC200047372	K01408	ko05010	Alzheimer's disease	1154	8.2e-58	0.69	0.79	0.89
PGSC0003DMC200047373	K01408	ko05010	Alzheimer's disease	1773	5.9e-92	0.60	0.80	0.98
PGSC0003DMC200047374	K01408	ko05010	Alzheimer's disease	407	6.0e-16	0.57	0.80	0.81
PGSC0003DMC200047378	K05768	ko04666	Fc gamma R-mediated phagocytosis	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMC200047378	K05768	ko04810	Regulation of actin cytoskeleton	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMC200047379	K05768	ko04666	Fc gamma R-mediated phagocytosis	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMC200047379	K05768	ko04810	Regulation of actin cytoskeleton	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMC200047390	K05643	ko02010	ABC transporters	2969	6.4e-158	0.33	0.48	0.99
PGSC0003DMC200047391	K05643	ko02010	ABC transporters	3229	1.1e-178	0.34	0.51	0.97
PGSC0003DMC200047394	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMC200047395	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMC200047396	K00384	ko00240	Pyrimidine metabolism	3414	1.8e-182	0.76	0.87	0.97
PGSC0003DMC200047397	K00384	ko00240	Pyrimidine metabolism	1648	4.6e-85	0.83	0.92	1.00
PGSC0003DMC200049621	K05277	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMC200049621	K05277	ko01100	Metabolic pathways	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMC200049621	K05277	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMC200049622	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049622	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049622	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049649	K00413	ko00190	Oxidative phosphorylation	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200049649	K00413	ko01100	Metabolic pathways	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200049649	K00413	ko04260	Cardiac muscle contraction	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200049649	K00413	ko05010	Alzheimer's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200049649	K00413	ko05012	Parkinson's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200049649	K00413	ko05016	Huntington's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMC200032145	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032145	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032145	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032145	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032145	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032146	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032146	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032146	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032146	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032146	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMC200032152	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.74
PGSC0003DMC200032153	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.65
PGSC0003DMC200032156	K06685	ko04111	Cell cycle - yeast	368	1.0e-10	0.26	0.42	0.75
PGSC0003DMC200032157	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032157	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032158	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032158	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko04115	p53 signaling pathway	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko04210	Apoptosis	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko05010	Alzheimer's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko05012	Parkinson's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko05016	Huntington's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032159	K02084	ko05222	Small cell lung cancer	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMC200032160	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032160	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200012816	K04124	ko00904	Diterpenoid biosynthesis	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMC200012816	K04124	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMC200012817	K04124	ko00904	Diterpenoid biosynthesis	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMC200012817	K04124	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMC200012819	K04124	ko00904	Diterpenoid biosynthesis	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMC200012819	K04124	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMC200012820	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012820	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012820	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012821	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012821	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012821	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMC200012827	K05278	ko00941	Flavonoid biosynthesis	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMC200012827	K05278	ko01100	Metabolic pathways	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMC200012827	K05278	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMC200012828	K01046	ko00561	Glycerolipid metabolism	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMC200012828	K01046	ko01100	Metabolic pathways	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMC200012830	K06316	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.90	0.95	0.98
PGSC0003DMC200012831	K06316	ko00510	N-Glycan biosynthesis	568	1.7e-25	0.68	0.82	0.99
PGSC0003DMC200012832	K06316	ko00510	N-Glycan biosynthesis	1872	2.0e-97	0.79	0.88	1.00
PGSC0003DMC200012833	K03026	ko00230	Purine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMC200012833	K03026	ko00240	Pyrimidine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMC200012833	K03026	ko01100	Metabolic pathways	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMC200012833	K03026	ko03020	RNA polymerase	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMC200012833	K03026	ko04623	Cytosolic DNA-sensing pathway	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMC200012834	K03026	ko00230	Purine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMC200012834	K03026	ko00240	Pyrimidine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMC200012834	K03026	ko01100	Metabolic pathways	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMC200012834	K03026	ko03020	RNA polymerase	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMC200012834	K03026	ko04623	Cytosolic DNA-sensing pathway	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMC200025952	K09561	ko04120	Ubiquitin mediated proteolysis	239	3.7e-07	0.49	0.67	0.15
PGSC0003DMC200025953	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025953	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025953	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025953	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025953	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025953	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025954	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025955	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025956	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMC200025957	K12611	ko03018	RNA degradation	555	8.9e-25	0.31	0.49	0.95
PGSC0003DMC200025972	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.39	0.58	0.96
PGSC0003DMC200025973	K09843	ko00906	Carotenoid biosynthesis	1015	3.8e-50	0.36	0.54	0.93
PGSC0003DMC200025974	K00615	ko00030	Pentose phosphate pathway	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMC200025974	K00615	ko00710	Carbon fixation in photosynthetic organisms	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMC200025974	K00615	ko01051	Biosynthesis of ansamycins	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMC200025974	K00615	ko01100	Metabolic pathways	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMC200025974	K00615	ko01110	Biosynthesis of secondary metabolites	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMC200025975	K01955	ko00240	Pyrimidine metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMC200025975	K01955	ko00250	Alanine, aspartate and glutamate metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMC200025975	K01955	ko01100	Metabolic pathways	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMC200025978	K09843	ko00906	Carotenoid biosynthesis	438	2.5e-18	0.39	0.60	0.84
PGSC0003DMC200018424	K04077	ko03018	RNA degradation	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMC200018424	K04077	ko04940	Type I diabetes mellitus	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMC200018425	K04077	ko03018	RNA degradation	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMC200018425	K04077	ko04940	Type I diabetes mellitus	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMC200018426	K04077	ko03018	RNA degradation	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMC200018426	K04077	ko04940	Type I diabetes mellitus	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMC200018427	K05750	ko04810	Regulation of actin cytoskeleton	6846	0.	0.87	0.94	0.99
PGSC0003DMC200018428	K05750	ko04810	Regulation of actin cytoskeleton	4758	1.4e-256	0.77	0.89	1.00
PGSC0003DMC200018429	K05750	ko04810	Regulation of actin cytoskeleton	8187	0.	0.83	0.92	1.00
PGSC0003DMC200018430	K05750	ko04810	Regulation of actin cytoskeleton	4147	6.8e-223	0.75	0.88	0.99
PGSC0003DMC200066661	K00368	ko00910	Nitrogen metabolism	633	4.4e-29	0.32	0.48	0.83
PGSC0003DMC200066672	K12412	ko04111	Cell cycle - yeast	247	8.7e-08	0.34	0.50	0.89
PGSC0003DMC200066684	K08065	ko04612	Antigen processing and presentation	611	7.3e-28	0.65	0.80	0.61
PGSC0003DMC200055956	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMC200055956	K00517	ko00626	Naphthalene and anthracene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMC200055956	K00517	ko00903	Limonene and pinene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMC200055956	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMC200055956	K00517	ko01110	Biosynthesis of secondary metabolites	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMC200055962	K05745	ko04810	Regulation of actin cytoskeleton	310	2.5e-10	0.44	0.57	0.63
PGSC0003DMC200055970	K03350	ko04110	Cell cycle	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055970	K03350	ko04111	Cell cycle - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055970	K03350	ko04113	Meiosis - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055970	K03350	ko04114	Oocyte meiosis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055970	K03350	ko04120	Ubiquitin mediated proteolysis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055970	K03350	ko04914	Progesterone-mediated oocyte maturation	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMC200055976	K06685	ko04111	Cell cycle - yeast	308	5.6e-09	0.34	0.52	0.56
PGSC0003DMC200055977	K06685	ko04111	Cell cycle - yeast	367	1.1e-11	0.33	0.50	0.55
PGSC0003DMC200055978	K06685	ko04111	Cell cycle - yeast	377	1.7e-11	0.27	0.42	0.78
PGSC0003DMC200055979	K06685	ko04111	Cell cycle - yeast	377	2.2e-11	0.27	0.42	0.70
PGSC0003DMC200042811	K02883	ko03010	Ribosome	1389	8.9e-71	0.87	0.95	0.99
PGSC0003DMC200042812	K01115	ko00564	Glycerophospholipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042812	K01115	ko00565	Ether lipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042812	K01115	ko01100	Metabolic pathways	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042812	K01115	ko04144	Endocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042812	K01115	ko04666	Fc gamma R-mediated phagocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042812	K01115	ko04912	GnRH signaling pathway	5784	0.	0.64	0.76	0.99
PGSC0003DMC200042813	K01115	ko00564	Glycerophospholipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042813	K01115	ko00565	Ether lipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042813	K01115	ko01100	Metabolic pathways	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042813	K01115	ko04144	Endocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042813	K01115	ko04666	Fc gamma R-mediated phagocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042813	K01115	ko04912	GnRH signaling pathway	6322	0.	0.68	0.82	0.99
PGSC0003DMC200042814	K01115	ko00564	Glycerophospholipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042814	K01115	ko00565	Ether lipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042814	K01115	ko01100	Metabolic pathways	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042814	K01115	ko04144	Endocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042814	K01115	ko04666	Fc gamma R-mediated phagocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042814	K01115	ko04912	GnRH signaling pathway	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMC200042815	K01115	ko00564	Glycerophospholipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042815	K01115	ko00565	Ether lipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042815	K01115	ko01100	Metabolic pathways	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042815	K01115	ko04144	Endocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042815	K01115	ko04666	Fc gamma R-mediated phagocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042815	K01115	ko04912	GnRH signaling pathway	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMC200042816	K01520	ko00240	Pyrimidine metabolism	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMC200042816	K01520	ko01100	Metabolic pathways	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMC200042818	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMC200042819	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMC200042820	K12849	ko03040	Spliceosome	2653	1.7e-140	0.80	0.87	1.00
PGSC0003DMC200042821	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMC200042821	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMC200042821	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMC200042822	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMC200042822	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMC200042822	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMC200042824	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.7e-20	0.30	0.45	0.56
PGSC0003DMC200042825	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.6e-20	0.30	0.45	0.57
PGSC0003DMC200042826	K08489	ko04130	SNARE interactions in vesicular transport	445	1.0e-18	0.77	0.84	0.93
PGSC0003DMC200042827	K08489	ko04130	SNARE interactions in vesicular transport	1075	1.9e-53	0.80	0.90	0.90
PGSC0003DMC200042828	K08489	ko04130	SNARE interactions in vesicular transport	2110	1.5e-110	0.74	0.81	0.99
PGSC0003DMC200042829	K08489	ko04130	SNARE interactions in vesicular transport	2205	8.8e-116	0.84	0.92	0.99
PGSC0003DMC200042830	K08489	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.92	0.99	0.93
PGSC0003DMC200042839	K01514	ko00230	Purine metabolism	829	6.9e-40	0.35	0.54	0.94
PGSC0003DMC200042840	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMC200030931	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMC200030931	K01491	ko00670	One carbon pool by folate	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMC200030931	K01491	ko01100	Metabolic pathways	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMC200030932	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMC200030932	K01491	ko00670	One carbon pool by folate	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMC200030932	K01491	ko01100	Metabolic pathways	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMC200030933	K01915	ko00250	Alanine, aspartate and glutamate metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMC200030933	K01915	ko00330	Arginine and proline metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMC200030933	K01915	ko00910	Nitrogen metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMC200030933	K01915	ko01100	Metabolic pathways	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMC200030933	K01915	ko02020	Two-component system	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMC200030935	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMC200030935	K02366	ko01100	Metabolic pathways	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMC200030936	K12617	ko03018	RNA degradation	4657	5.0e-251	0.69	0.81	1.00
PGSC0003DMC200030938	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMC200030938	K00457	ko00350	Tyrosine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMC200030938	K00457	ko00360	Phenylalanine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMC200030938	K00457	ko01100	Metabolic pathways	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMC200030943	K02969	ko03010	Ribosome	360	5.1e-14	0.48	0.56	0.99
PGSC0003DMC200030950	K03660	ko03410	Base excision repair	1107	3.2e-55	0.40	0.56	0.86
PGSC0003DMC200030951	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMC200030952	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMC200030953	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMC200030954	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMC200030956	K03660	ko03410	Base excision repair	798	3.5e-38	0.48	0.67	0.92
PGSC0003DMC200030957	K03660	ko03410	Base excision repair	962	3.2e-47	0.44	0.60	0.96
PGSC0003DMC200030958	K12891	ko03040	Spliceosome	1785	1.3e-92	0.80	0.88	1.00
PGSC0003DMC200048425	K10579	ko04120	Ubiquitin mediated proteolysis	1215	3.5e-61	0.92	0.97	0.66
PGSC0003DMC200048426	K10579	ko04120	Ubiquitin mediated proteolysis	1477	1.3e-75	0.91	0.96	0.99
PGSC0003DMC200048427	K03006	ko00230	Purine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMC200048427	K03006	ko00240	Pyrimidine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMC200048427	K03006	ko01100	Metabolic pathways	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMC200048427	K03006	ko03020	RNA polymerase	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMC200048427	K03006	ko05016	Huntington's disease	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMC200048431	K12356	ko00940	Phenylpropanoid biosynthesis	1696	1.0e-87	0.48	0.66	0.97
PGSC0003DMC200048432	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMC200048432	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMC200048432	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMC200048433	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMC200048433	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMC200048433	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMC200048439	K00795	ko00900	Terpenoid backbone biosynthesis	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMC200048439	K00795	ko01100	Metabolic pathways	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMC200048439	K00795	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMC200048440	K01246	ko03410	Base excision repair	1537	6.1e-79	0.57	0.72	0.98
PGSC0003DMC200067865	K02960	ko03010	Ribosome	648	6.6e-30	0.95	0.99	0.99
PGSC0003DMC200014011	K01046	ko00561	Glycerolipid metabolism	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMC200014011	K01046	ko01100	Metabolic pathways	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMC200014026	K09843	ko00906	Carotenoid biosynthesis	2668	2.6e-141	0.71	0.83	0.93
PGSC0003DMC200014027	K08764	ko00120	Primary bile acid biosynthesis	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMC200014027	K08764	ko01100	Metabolic pathways	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMC200014027	K08764	ko03320	PPAR signaling pathway	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMC200014027	K08764	ko04146	Peroxisome	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMC200014028	K01176	ko00500	Starch and sucrose metabolism	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMC200014028	K01176	ko01100	Metabolic pathways	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMC200014029	K01176	ko00500	Starch and sucrose metabolism	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMC200014029	K01176	ko01100	Metabolic pathways	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMC200014032	K11820	ko00380	Tryptophan metabolism	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMC200014032	K11820	ko00966	Glucosinolate biosynthesis	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMC200014032	K11820	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMC200014035	K12356	ko00940	Phenylpropanoid biosynthesis	394	6.8e-16	0.29	0.44	0.88
PGSC0003DMC200014036	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.30	0.46	0.91
PGSC0003DMC200014037	K12356	ko00940	Phenylpropanoid biosynthesis	349	2.1e-13	0.29	0.43	0.98
PGSC0003DMC200024754	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMC200024754	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMC200024754	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMC200024754	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMC200024758	K02537	ko04110	Cell cycle	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMC200024758	K02537	ko04111	Cell cycle - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMC200024758	K02537	ko04113	Meiosis - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMC200024758	K02537	ko04114	Oocyte meiosis	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMC200024758	K02537	ko04914	Progesterone-mediated oocyte maturation	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMC200024760	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024760	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024760	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024760	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024760	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024761	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024761	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024761	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024761	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024761	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMC200024763	K10884	ko03450	Non-homologous end-joining	1956	4.8e-102	0.80	0.89	0.99
PGSC0003DMC200024764	K10884	ko03450	Non-homologous end-joining	3237	1.1e-172	0.75	0.90	0.97
PGSC0003DMC200024765	K10884	ko03450	Non-homologous end-joining	4063	2.9e-218	0.76	0.89	1.00
PGSC0003DMC200024768	K05282	ko00904	Diterpenoid biosynthesis	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMC200024768	K05282	ko01100	Metabolic pathways	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMC200024768	K05282	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMC200024770	K12811	ko03040	Spliceosome	431	3.4e-17	0.30	0.61	0.90
PGSC0003DMC200024772	K02948	ko03010	Ribosome	806	1.3e-38	0.92	0.93	0.99
PGSC0003DMC200024773	K03040	ko00230	Purine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMC200024773	K03040	ko00240	Pyrimidine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMC200024773	K03040	ko01100	Metabolic pathways	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMC200024773	K03040	ko03020	RNA polymerase	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMC200024774	K02874	ko03010	Ribosome	779	3.9e-37	0.93	0.96	0.92
PGSC0003DMC200017381	K00844	ko00010	Glycolysis / Gluconeogenesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00051	Fructose and mannose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00052	Galactose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00500	Starch and sucrose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00521	Streptomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko00524	Butirosin and neomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko01100	Metabolic pathways	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko01110	Biosynthesis of secondary metabolites	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko04910	Insulin signaling pathway	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017381	K00844	ko04930	Type II diabetes mellitus	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMC200017382	K00844	ko00010	Glycolysis / Gluconeogenesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00051	Fructose and mannose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00052	Galactose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00500	Starch and sucrose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00521	Streptomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko00524	Butirosin and neomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko01100	Metabolic pathways	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko04910	Insulin signaling pathway	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017382	K00844	ko04930	Type II diabetes mellitus	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMC200017383	K00844	ko00010	Glycolysis / Gluconeogenesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00051	Fructose and mannose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00052	Galactose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00500	Starch and sucrose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00521	Streptomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko00524	Butirosin and neomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko01100	Metabolic pathways	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko01110	Biosynthesis of secondary metabolites	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko04910	Insulin signaling pathway	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017383	K00844	ko04930	Type II diabetes mellitus	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMC200017384	K11827	ko04144	Endocytosis	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMC200017384	K11827	ko05016	Huntington's disease	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMC200017394	K00423	ko00053	Ascorbate and aldarate metabolism	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMC200017394	K00423	ko01100	Metabolic pathways	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMC200019623	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMC200019625	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMC200057435	K11816	ko00380	Tryptophan metabolism	636	3.0e-29	0.38	0.60	0.90
PGSC0003DMC200057441	K02898	ko03010	Ribosome	1122	4.8e-56	0.90	0.98	0.99
PGSC0003DMC200052953	K00430	ko00360	Phenylalanine metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMC200052953	K00430	ko00680	Methane metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMC200052953	K00430	ko00940	Phenylpropanoid biosynthesis	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMC200052953	K00430	ko01100	Metabolic pathways	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMC200052953	K00430	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMC200052954	K07375	ko04145	Phagosome	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMC200052954	K07375	ko04540	Gap junction	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMC200052954	K07375	ko05130	Pathogenic Escherichia coli infection	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMC200052955	K04802	ko03030	DNA replication	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMC200052955	K04802	ko03410	Base excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMC200052955	K04802	ko03420	Nucleotide excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMC200052955	K04802	ko03430	Mismatch repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMC200052955	K04802	ko04110	Cell cycle	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMC200052970	K01188	ko00460	Cyanoamino acid metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMC200052970	K01188	ko00500	Starch and sucrose metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMC200052970	K01188	ko00940	Phenylpropanoid biosynthesis	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMC200052970	K01188	ko01110	Biosynthesis of secondary metabolites	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMC200052974	K02941	ko03010	Ribosome	2057	1.3e-107	0.78	0.89	1.00
PGSC0003DMC200052976	K11778	ko00900	Terpenoid backbone biosynthesis	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMC200052976	K11778	ko01110	Biosynthesis of secondary metabolites	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMC200052977	K11778	ko00900	Terpenoid backbone biosynthesis	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMC200052977	K11778	ko01110	Biosynthesis of secondary metabolites	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMC200052978	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMC200052978	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMC200034225	K10807	ko00230	Purine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMC200034225	K10807	ko00240	Pyrimidine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMC200034225	K10807	ko00480	Glutathione metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMC200034225	K10807	ko01100	Metabolic pathways	6338	0.	0.91	0.97	1.00
PGSC0003DMC200038800	K01466	ko00230	Purine metabolism	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMC200038800	K01466	ko01100	Metabolic pathways	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMC200038801	K01466	ko00230	Purine metabolism	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMC200038801	K01466	ko01100	Metabolic pathways	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMC200038802	K07456	ko03430	Mismatch repair	2409	4.9e-127	0.69	0.82	0.92
PGSC0003DMC200038803	K07456	ko03430	Mismatch repair	3429	2.7e-183	0.62	0.79	1.00
PGSC0003DMC200038819	K10145	ko04115	p53 signaling pathway	281	1.2e-09	0.32	0.48	0.66
PGSC0003DMC200069273	K03876	ko04120	Ubiquitin mediated proteolysis	251	5.2e-08	0.31	0.52	0.79
PGSC0003DMC200000783	K03283	ko03040	Spliceosome	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMC200000783	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMC200000783	K03283	ko04144	Endocytosis	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMC200000783	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMC200000787	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMC200000787	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMC200000788	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMC200000788	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMC200000791	K01710	ko00521	Streptomycin biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMC200000791	K01710	ko00523	Polyketide sugar unit biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMC200000791	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMC200000791	K01710	ko01100	Metabolic pathways	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMC200000791	K01710	ko01110	Biosynthesis of secondary metabolites	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMC200000792	K11254	ko05322	Systemic lupus erythematosus	856	2.2e-41	1.00	1.00	0.99
PGSC0003DMC200000806	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMC200000806	K02366	ko01100	Metabolic pathways	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMC200028622	K12581	ko03018	RNA degradation	1047	6.5e-52	0.51	0.67	0.98
PGSC0003DMC200028634	K08488	ko04130	SNARE interactions in vesicular transport	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMC200028634	K08488	ko04145	Phagosome	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMC200028636	K12833	ko03040	Spliceosome	977	4.7e-48	0.92	0.96	0.99
PGSC0003DMC200028637	K02884	ko03010	Ribosome	245	1.1e-07	0.37	0.53	0.33
PGSC0003DMC200028639	K02884	ko03010	Ribosome	326	3.8e-12	0.53	0.74	0.91
PGSC0003DMC200028640	K02884	ko03010	Ribosome	370	1.4e-14	0.44	0.71	0.41
PGSC0003DMC200028641	K01961	ko00061	Fatty acid biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028641	K01961	ko00253	Tetracycline biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028641	K01961	ko00620	Pyruvate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028641	K01961	ko00640	Propanoate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028641	K01961	ko01100	Metabolic pathways	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028641	K01961	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMC200028642	K01066	ko00623	2,4-Dichlorobenzoate degradation	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMC200028642	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMC200028644	K01066	ko00623	2,4-Dichlorobenzoate degradation	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMC200028644	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMC200028646	K00254	ko00240	Pyrimidine metabolism	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMC200028646	K00254	ko01100	Metabolic pathways	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMC200021752	K02684	ko00230	Purine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMC200021752	K02684	ko00240	Pyrimidine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMC200021752	K02684	ko01100	Metabolic pathways	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMC200021752	K02684	ko03030	DNA replication	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMC200021773	K04424	ko04010	MAPK signaling pathway	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMC200021773	K04424	ko04530	Tight junction	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMC200021775	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMC200021779	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMC200021779	K01687	ko00770	Pantothenate and CoA biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMC200021779	K01687	ko01100	Metabolic pathways	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMC200021779	K01687	ko01110	Biosynthesis of secondary metabolites	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMC200003007	K07750	ko00100	Steroid biosynthesis	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMC200003007	K07750	ko01100	Metabolic pathways	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMC200003008	K07750	ko00100	Steroid biosynthesis	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMC200003008	K07750	ko01100	Metabolic pathways	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMC200003009	K07750	ko00100	Steroid biosynthesis	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMC200003009	K07750	ko01100	Metabolic pathways	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMC200003010	K03358	ko04110	Cell cycle	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003010	K03358	ko04111	Cell cycle - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003010	K03358	ko04113	Meiosis - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003010	K03358	ko04114	Oocyte meiosis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003010	K03358	ko04120	Ubiquitin mediated proteolysis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003010	K03358	ko04914	Progesterone-mediated oocyte maturation	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMC200003011	K12823	ko03040	Spliceosome	242	4.7e-07	0.56	0.75	0.51
PGSC0003DMC200003012	K12823	ko03040	Spliceosome	250	1.6e-07	0.75	0.88	0.54
PGSC0003DMC200003016	K02881	ko03010	Ribosome	229	8.5e-07	0.34	0.56	0.64
PGSC0003DMC200003018	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMC200003018	K03861	ko01100	Metabolic pathways	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMC200003019	K01528	ko04144	Endocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMC200003019	K01528	ko04666	Fc gamma R-mediated phagocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMC200003019	K01528	ko05100	Bacterial invasion of epithelial cells	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMC200003020	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMC200003020	K03861	ko01100	Metabolic pathways	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMC200003021	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMC200003021	K03861	ko01100	Metabolic pathways	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMC200003024	K03955	ko00190	Oxidative phosphorylation	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMC200003024	K03955	ko01100	Metabolic pathways	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMC200003024	K03955	ko05010	Alzheimer's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMC200003024	K03955	ko05012	Parkinson's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMC200003024	K03955	ko05016	Huntington's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMC200009781	K01178	ko00500	Starch and sucrose metabolism	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMC200009781	K01178	ko01100	Metabolic pathways	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMC200009796	K00660	ko00941	Flavonoid biosynthesis	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMC200009796	K00660	ko01100	Metabolic pathways	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMC200009796	K00660	ko01110	Biosynthesis of secondary metabolites	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMC200009796	K00660	ko04712	Circadian rhythm - plant	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMC200014988	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMC200014988	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMC200064080	K01142	ko03410	Base excision repair	245	1.8e-07	0.45	0.56	0.64
PGSC0003DMC200050821	K10755	ko03030	DNA replication	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMC200050821	K10755	ko03420	Nucleotide excision repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMC200050821	K10755	ko03430	Mismatch repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMC200050837	K00522	ko00860	Porphyrin and chlorophyll metabolism	827	8.9e-40	0.59	0.76	0.71
PGSC0003DMC200050840	K12929	ko00904	Diterpenoid biosynthesis	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMC200050840	K12929	ko01110	Biosynthesis of secondary metabolites	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMC200050841	K12929	ko00904	Diterpenoid biosynthesis	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMC200050841	K12929	ko01110	Biosynthesis of secondary metabolites	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMC200050843	K12929	ko00904	Diterpenoid biosynthesis	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMC200050843	K12929	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMC200050844	K12929	ko00904	Diterpenoid biosynthesis	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMC200050844	K12929	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMC200050845	K12929	ko00904	Diterpenoid biosynthesis	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMC200050845	K12929	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMC200050846	K12929	ko00904	Diterpenoid biosynthesis	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMC200050846	K12929	ko01110	Biosynthesis of secondary metabolites	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMC200050848	K12929	ko00904	Diterpenoid biosynthesis	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMC200050848	K12929	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMC200050850	K12929	ko00904	Diterpenoid biosynthesis	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMC200050850	K12929	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMC200040983	K05768	ko04666	Fc gamma R-mediated phagocytosis	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMC200040983	K05768	ko04810	Regulation of actin cytoskeleton	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMC200040984	K05768	ko04666	Fc gamma R-mediated phagocytosis	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMC200040984	K05768	ko04810	Regulation of actin cytoskeleton	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMC200040985	K05768	ko04666	Fc gamma R-mediated phagocytosis	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMC200040985	K05768	ko04810	Regulation of actin cytoskeleton	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMC200040987	K00384	ko00240	Pyrimidine metabolism	3477	6.1e-186	0.77	0.88	0.98
PGSC0003DMC200040988	K00384	ko00240	Pyrimidine metabolism	1613	3.9e-83	0.66	0.79	0.93
PGSC0003DMC200040991	K03124	ko03022	Basal transcription factors	771	1.1e-36	0.76	0.87	0.99
PGSC0003DMC200040992	K03124	ko03022	Basal transcription factors	2044	6.7e-107	0.76	0.89	0.99
PGSC0003DMC200040993	K03124	ko03022	Basal transcription factors	1760	3.1e-91	0.75	0.89	0.98
PGSC0003DMC200040994	K03124	ko03022	Basal transcription factors	471	3.8e-20	0.75	0.90	0.74
PGSC0003DMC200040995	K03124	ko03022	Basal transcription factors	950	1.5e-46	0.74	0.91	0.84
PGSC0003DMC200040996	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMC200040996	K00517	ko00626	Naphthalene and anthracene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMC200040996	K00517	ko00903	Limonene and pinene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMC200040996	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMC200040996	K00517	ko01110	Biosynthesis of secondary metabolites	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMC200046173	K12382	ko04142	Lysosome	337	9.4e-13	0.31	0.50	0.77
PGSC0003DMC200046177	K00430	ko00360	Phenylalanine metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMC200046177	K00430	ko00680	Methane metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMC200046177	K00430	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMC200046177	K00430	ko01100	Metabolic pathways	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMC200046177	K00430	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMC200046178	K00430	ko00360	Phenylalanine metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMC200046178	K00430	ko00680	Methane metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMC200046178	K00430	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMC200046178	K00430	ko01100	Metabolic pathways	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMC200046178	K00430	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMC200046185	K11420	ko00310	Lysine degradation	681	4.7e-34	0.31	0.42	0.87
PGSC0003DMC200046186	K11420	ko00310	Lysine degradation	681	1.3e-29	0.31	0.42	0.60
PGSC0003DMC200046187	K06268	ko04010	MAPK signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04020	Calcium signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04114	Oocyte meiosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04210	Apoptosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04310	Wnt signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04360	Axon guidance	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04370	VEGF signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04650	Natural killer cell mediated cytotoxicity	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04660	T cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04662	B cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko04720	Long-term potentiation	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko05010	Alzheimer's disease	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046187	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMC200046188	K00430	ko00360	Phenylalanine metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMC200046188	K00430	ko00680	Methane metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMC200046188	K00430	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMC200046188	K00430	ko01100	Metabolic pathways	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMC200046188	K00430	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMC200046191	K03115	ko04310	Wnt signaling pathway	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMC200046191	K03115	ko04520	Adherens junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMC200046191	K03115	ko04530	Tight junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMC200046191	K03115	ko04712	Circadian rhythm - plant	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMC200046192	K03115	ko04310	Wnt signaling pathway	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMC200046192	K03115	ko04520	Adherens junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMC200046192	K03115	ko04530	Tight junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMC200046192	K03115	ko04712	Circadian rhythm - plant	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMC200046193	K03115	ko04310	Wnt signaling pathway	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMC200046193	K03115	ko04520	Adherens junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMC200046193	K03115	ko04530	Tight junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMC200046193	K03115	ko04712	Circadian rhythm - plant	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMC200046194	K03115	ko04310	Wnt signaling pathway	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMC200046194	K03115	ko04520	Adherens junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMC200046194	K03115	ko04530	Tight junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMC200046194	K03115	ko04712	Circadian rhythm - plant	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMC200014162	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014162	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014162	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014163	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014163	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014163	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMC200014185	K08681	ko00750	Vitamin B6 metabolism	1492	1.9e-76	0.72	0.83	1.00
PGSC0003DMC200014186	K08681	ko00750	Vitamin B6 metabolism	1156	6.3e-58	0.77	0.90	0.95
PGSC0003DMC200014188	K02006	ko02010	ABC transporters	910	2.3e-44	0.55	0.69	0.95
PGSC0003DMC200014189	K02006	ko02010	ABC transporters	566	2.2e-25	0.54	0.70	0.91
PGSC0003DMC200007594	K00423	ko00053	Ascorbate and aldarate metabolism	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMC200007594	K00423	ko01100	Metabolic pathways	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMC200007595	K07374	ko04145	Phagosome	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMC200007595	K07374	ko04540	Gap junction	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMC200007595	K07374	ko05130	Pathogenic Escherichia coli infection	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMC200007596	K07374	ko04145	Phagosome	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMC200007596	K07374	ko04540	Gap junction	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMC200007596	K07374	ko05130	Pathogenic Escherichia coli infection	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMC200007597	K12900	ko03040	Spliceosome	622	1.8e-28	0.40	0.54	0.86
PGSC0003DMC200007598	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMC200007599	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMC200007600	K01895	ko00010	Glycolysis / Gluconeogenesis	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007600	K01895	ko00620	Pyruvate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007600	K01895	ko00640	Propanoate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007600	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007600	K01895	ko01100	Metabolic pathways	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007600	K01895	ko01110	Biosynthesis of secondary metabolites	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMC200007601	K01895	ko00010	Glycolysis / Gluconeogenesis	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007601	K01895	ko00620	Pyruvate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007601	K01895	ko00640	Propanoate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007601	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007601	K01895	ko01100	Metabolic pathways	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007601	K01895	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMC200007602	K01895	ko00010	Glycolysis / Gluconeogenesis	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007602	K01895	ko00620	Pyruvate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007602	K01895	ko00640	Propanoate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007602	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007602	K01895	ko01100	Metabolic pathways	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007602	K01895	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMC200007603	K05277	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMC200007603	K05277	ko01100	Metabolic pathways	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMC200007603	K05277	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMC200007604	K03950	ko00190	Oxidative phosphorylation	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMC200007604	K03950	ko01100	Metabolic pathways	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMC200007604	K03950	ko05010	Alzheimer's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMC200007604	K03950	ko05012	Parkinson's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMC200007604	K03950	ko05016	Huntington's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMC200007605	K03950	ko00190	Oxidative phosphorylation	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMC200007605	K03950	ko01100	Metabolic pathways	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMC200007605	K03950	ko05010	Alzheimer's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMC200007605	K03950	ko05012	Parkinson's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMC200007605	K03950	ko05016	Huntington's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMC200007606	K03950	ko00190	Oxidative phosphorylation	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMC200007606	K03950	ko01100	Metabolic pathways	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMC200007606	K03950	ko05010	Alzheimer's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMC200007606	K03950	ko05012	Parkinson's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMC200007606	K03950	ko05016	Huntington's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMC200007607	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMC200007608	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMC200007609	K11594	ko04622	RIG-I-like receptor signaling pathway	546	2.8e-24	0.77	0.83	0.99
PGSC0003DMC200005401	K10576	ko04120	Ubiquitin mediated proteolysis	1299	8.2e-66	0.84	0.92	0.99
PGSC0003DMC200005402	K10576	ko04120	Ubiquitin mediated proteolysis	585	2.0e-26	0.75	0.88	0.99
PGSC0003DMC200005403	K10576	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.83	0.92	0.99
PGSC0003DMC200005404	K10576	ko04120	Ubiquitin mediated proteolysis	733	1.4e-34	0.93	0.97	0.81
PGSC0003DMC200005415	K01046	ko00561	Glycerolipid metabolism	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMC200005415	K01046	ko01100	Metabolic pathways	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMC200005424	K01188	ko00460	Cyanoamino acid metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMC200005424	K01188	ko00500	Starch and sucrose metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMC200005424	K01188	ko00940	Phenylpropanoid biosynthesis	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMC200005424	K01188	ko01110	Biosynthesis of secondary metabolites	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMC200005425	K01188	ko00460	Cyanoamino acid metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMC200005425	K01188	ko00500	Starch and sucrose metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMC200005425	K01188	ko00940	Phenylpropanoid biosynthesis	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMC200005425	K01188	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMC200005426	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005426	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005426	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005426	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005427	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005427	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005427	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005427	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMC200005429	K12929	ko00904	Diterpenoid biosynthesis	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMC200005429	K12929	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMC200005430	K08008	ko04145	Phagosome	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMC200005430	K08008	ko04670	Leukocyte transendothelial migration	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMC200061325	K13229	ko00402	Benzoxazinoid biosynthesis	403	2.2e-16	0.52	0.68	0.82
PGSC0003DMC200042961	K02183	ko04020	Calcium signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04070	Phosphatidylinositol signaling system	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04114	Oocyte meiosis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04270	Vascular smooth muscle contraction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04626	Plant-pathogen interaction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04720	Long-term potentiation	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04722	Neurotrophin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04740	Olfactory transduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04744	Phototransduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04745	Phototransduction - fly	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04910	Insulin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04912	GnRH signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04916	Melanogenesis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04970	Salivary secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko04971	Gastric acid secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko05010	Alzheimer's disease	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042961	K02183	ko05214	Glioma	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMC200042962	K02183	ko04020	Calcium signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04070	Phosphatidylinositol signaling system	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04114	Oocyte meiosis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04270	Vascular smooth muscle contraction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04626	Plant-pathogen interaction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04720	Long-term potentiation	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04722	Neurotrophin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04740	Olfactory transduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04744	Phototransduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04745	Phototransduction - fly	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04910	Insulin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04912	GnRH signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04916	Melanogenesis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04970	Salivary secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko04971	Gastric acid secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko05010	Alzheimer's disease	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042962	K02183	ko05214	Glioma	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMC200042978	K13289	ko04142	Lysosome	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMC200042978	K13289	ko04614	Renin-angiotensin system	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMC200042979	K13289	ko04142	Lysosome	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMC200042979	K13289	ko04614	Renin-angiotensin system	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMC200042981	K13289	ko04142	Lysosome	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMC200042981	K13289	ko04614	Renin-angiotensin system	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMC200036394	K12929	ko00904	Diterpenoid biosynthesis	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMC200036394	K12929	ko01110	Biosynthesis of secondary metabolites	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMC200036406	K00599	ko00340	Histidine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMC200036406	K00599	ko00350	Tyrosine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMC200036406	K00599	ko00450	Selenoamino acid metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMC200036406	K00599	ko00626	Naphthalene and anthracene degradation	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMC200036407	K00599	ko00340	Histidine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMC200036407	K00599	ko00350	Tyrosine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMC200036407	K00599	ko00450	Selenoamino acid metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMC200036407	K00599	ko00626	Naphthalene and anthracene degradation	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMC200036409	K00430	ko00360	Phenylalanine metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMC200036409	K00430	ko00680	Methane metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMC200036409	K00430	ko00940	Phenylpropanoid biosynthesis	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMC200036409	K00430	ko01100	Metabolic pathways	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMC200036409	K00430	ko01110	Biosynthesis of secondary metabolites	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMC200030842	K04733	ko04210	Apoptosis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMC200030842	K04733	ko04620	Toll-like receptor signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMC200030842	K04733	ko04722	Neurotrophin signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMC200030842	K04733	ko05140	Leishmaniasis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMC200030842	K04733	ko05142	Chagas disease	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMC200030862	K03043	ko00230	Purine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMC200030862	K03043	ko00240	Pyrimidine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMC200030862	K03043	ko01100	Metabolic pathways	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMC200030862	K03043	ko03020	RNA polymerase	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMC200030863	K03046	ko00230	Purine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMC200030863	K03046	ko00240	Pyrimidine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMC200030863	K03046	ko01100	Metabolic pathways	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMC200030863	K03046	ko03020	RNA polymerase	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMC200030864	K02967	ko03010	Ribosome	798	3.5e-38	0.93	0.95	0.56
PGSC0003DMC200030865	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030865	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030865	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030865	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030866	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030866	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030866	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030866	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMC200030867	K03046	ko00230	Purine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMC200030867	K03046	ko00240	Pyrimidine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMC200030867	K03046	ko01100	Metabolic pathways	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMC200030867	K03046	ko03020	RNA polymerase	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMC200059833	K00059	ko00061	Fatty acid biosynthesis	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMC200059833	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMC200059833	K00059	ko01100	Metabolic pathways	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMC200059841	K04371	ko04010	MAPK signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04012	ErbB signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04013	MAPK signaling pathway - fly	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04062	Chemokine signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04114	Oocyte meiosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04150	mTOR signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04320	Dorso-ventral axis formation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04350	TGF-beta signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04360	Axon guidance	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04370	VEGF signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04510	Focal adhesion	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04520	Adherens junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04540	Gap junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04620	Toll-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04621	NOD-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04650	Natural killer cell mediated cytotoxicity	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04660	T cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04662	B cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04664	Fc epsilon RI signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04666	Fc gamma R-mediated phagocytosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04720	Long-term potentiation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04730	Long-term depression	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04810	Regulation of actin cytoskeleton	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04910	Insulin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04912	GnRH signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04914	Progesterone-mediated oocyte maturation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04916	Melanogenesis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04930	Type II diabetes mellitus	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko04960	Aldosterone-regulated sodium reabsorption	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05010	Alzheimer's disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05020	Prion diseases	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05131	Shigellosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05140	Leishmaniasis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05142	Chagas disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05200	Pathways in cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05210	Colorectal cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05211	Renal cell carcinoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05212	Pancreatic cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05213	Endometrial cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05214	Glioma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05215	Prostate cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05216	Thyroid cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05218	Melanoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05219	Bladder cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05220	Chronic myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05221	Acute myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200059841	K04371	ko05223	Non-small cell lung cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMC200060131	K06261	ko04512	ECM-receptor interaction	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMC200060131	K06261	ko04640	Hematopoietic cell lineage	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMC200060138	K13229	ko00402	Benzoxazinoid biosynthesis	937	7.6e-46	0.45	0.62	0.91
PGSC0003DMC200006395	K01735	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMC200006395	K01735	ko01100	Metabolic pathways	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMC200006395	K01735	ko01110	Biosynthesis of secondary metabolites	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMC200006397	K06689	ko04120	Ubiquitin mediated proteolysis	841	1.5e-40	0.69	0.73	0.98
PGSC0003DMC200006398	K06689	ko04120	Ubiquitin mediated proteolysis	1195	4.5e-60	0.90	0.97	0.99
PGSC0003DMC200006400	K00889	ko00562	Inositol phosphate metabolism	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006400	K00889	ko01100	Metabolic pathways	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006400	K00889	ko04070	Phosphatidylinositol signaling system	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006400	K00889	ko04144	Endocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006400	K00889	ko04666	Fc gamma R-mediated phagocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006400	K00889	ko04810	Regulation of actin cytoskeleton	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMC200006411	K03006	ko00230	Purine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMC200006411	K03006	ko00240	Pyrimidine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMC200006411	K03006	ko01100	Metabolic pathways	14720	0.	0.91	0.96	1.00
PGSC0003DMC200006411	K03006	ko03020	RNA polymerase	14720	0.	0.91	0.96	1.00
PGSC0003DMC200006411	K03006	ko05016	Huntington's disease	14720	0.	0.91	0.96	1.00
PGSC0003DMC200006412	K01115	ko00564	Glycerophospholipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006412	K01115	ko00565	Ether lipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006412	K01115	ko01100	Metabolic pathways	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006412	K01115	ko04144	Endocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006412	K01115	ko04666	Fc gamma R-mediated phagocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006412	K01115	ko04912	GnRH signaling pathway	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMC200006413	K01115	ko00564	Glycerophospholipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006413	K01115	ko00565	Ether lipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006413	K01115	ko01100	Metabolic pathways	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006413	K01115	ko04144	Endocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006413	K01115	ko04666	Fc gamma R-mediated phagocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006413	K01115	ko04912	GnRH signaling pathway	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMC200006414	K01115	ko00564	Glycerophospholipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006414	K01115	ko00565	Ether lipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006414	K01115	ko01100	Metabolic pathways	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006414	K01115	ko04144	Endocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006414	K01115	ko04666	Fc gamma R-mediated phagocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006414	K01115	ko04912	GnRH signaling pathway	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMC200006415	K12897	ko03040	Spliceosome	336	1.1e-12	0.43	0.49	0.97
PGSC0003DMC200012965	K12825	ko03040	Spliceosome	1405	1.2e-71	0.75	0.86	1.00
PGSC0003DMC200012966	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMC200012967	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMC200012979	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMC200012979	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMC200012979	K00771	ko01100	Metabolic pathways	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMC200012980	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMC200012980	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMC200012980	K00771	ko01100	Metabolic pathways	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMC200012990	K01516	ko00230	Purine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMC200012990	K01516	ko00730	Thiamine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMC200012990	K01516	ko01100	Metabolic pathways	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMC200029828	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029828	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029828	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029829	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029829	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029829	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029830	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029830	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029830	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029831	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029831	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200029831	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMC200037604	K13030	ko00460	Cyanoamino acid metabolism	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMC200037604	K13030	ko01110	Biosynthesis of secondary metabolites	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMC200037609	K13228	ko00402	Benzoxazinoid biosynthesis	760	4.4e-36	0.32	0.48	0.85
PGSC0003DMC200037610	K13228	ko00402	Benzoxazinoid biosynthesis	624	1.4e-28	0.43	0.60	0.96
PGSC0003DMC200037619	K13228	ko00402	Benzoxazinoid biosynthesis	1123	4.2e-56	0.39	0.59	0.98
PGSC0003DMC200037620	K13228	ko00402	Benzoxazinoid biosynthesis	506	4.5e-22	0.52	0.72	0.87
PGSC0003DMC200044172	K01379	ko04142	Lysosome	290	1.7e-09	0.27	0.43	0.83
PGSC0003DMC200044175	K11229	ko04011	MAPK signaling pathway - yeast	611	5.0e-27	0.37	0.56	0.73
PGSC0003DMC200044181	K00430	ko00360	Phenylalanine metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMC200044181	K00430	ko00680	Methane metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMC200044181	K00430	ko00940	Phenylpropanoid biosynthesis	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMC200044181	K00430	ko01100	Metabolic pathways	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMC200044181	K00430	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMC200035402	K07466	ko03030	DNA replication	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMC200035402	K07466	ko03420	Nucleotide excision repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMC200035402	K07466	ko03430	Mismatch repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMC200035402	K07466	ko03440	Homologous recombination	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMC200035406	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMC200035406	K06127	ko01100	Metabolic pathways	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMC200035406	K06127	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMC200035407	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMC200035407	K06127	ko01100	Metabolic pathways	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMC200035407	K06127	ko01110	Biosynthesis of secondary metabolites	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMC200035408	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMC200035408	K06127	ko01100	Metabolic pathways	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMC200035408	K06127	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMC200035409	K11090	ko05322	Systemic lupus erythematosus	328	3.0e-12	0.34	0.55	0.56
PGSC0003DMC200035410	K11090	ko05322	Systemic lupus erythematosus	359	5.8e-14	0.30	0.46	0.59
PGSC0003DMC200035420	K00430	ko00360	Phenylalanine metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMC200035420	K00430	ko00680	Methane metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMC200035420	K00430	ko00940	Phenylpropanoid biosynthesis	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMC200035420	K00430	ko01100	Metabolic pathways	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMC200035420	K00430	ko01110	Biosynthesis of secondary metabolites	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMC200035421	K12598	ko03018	RNA degradation	4700	2.1e-253	0.82	0.90	0.97
PGSC0003DMC200035422	K12598	ko03018	RNA degradation	3393	2.6e-181	0.78	0.86	0.98
PGSC0003DMC200035423	K12598	ko03018	RNA degradation	6837	0.	0.82	0.91	1.00
PGSC0003DMC200035424	K12598	ko03018	RNA degradation	5237	5.2e-283	0.82	0.90	1.00
PGSC0003DMC200035425	K12598	ko03018	RNA degradation	1602	1.6e-82	0.82	0.94	0.92
PGSC0003DMC200035430	K01184	ko00040	Pentose and glucuronate interconversions	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMC200035430	K01184	ko00500	Starch and sucrose metabolism	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMC200035430	K01184	ko01100	Metabolic pathways	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMC200032050	K00876	ko00240	Pyrimidine metabolism	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMC200032050	K00876	ko00983	Drug metabolism - other enzymes	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMC200032050	K00876	ko01100	Metabolic pathways	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMC200032051	K00876	ko00240	Pyrimidine metabolism	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMC200032051	K00876	ko00983	Drug metabolism - other enzymes	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMC200032051	K00876	ko01100	Metabolic pathways	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMC200032052	K00876	ko00240	Pyrimidine metabolism	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMC200032052	K00876	ko00983	Drug metabolism - other enzymes	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMC200032052	K00876	ko01100	Metabolic pathways	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMC200032065	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200032065	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200032065	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200032066	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200032066	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200032066	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMC200065266	K12493	ko04144	Endocytosis	581	1.4e-25	0.46	0.60	0.74
PGSC0003DMC200020825	K01051	ko00040	Pentose and glucuronate interconversions	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMC200020825	K01051	ko00500	Starch and sucrose metabolism	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMC200020825	K01051	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMC200020826	K01051	ko00040	Pentose and glucuronate interconversions	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMC200020826	K01051	ko00500	Starch and sucrose metabolism	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMC200020826	K01051	ko01100	Metabolic pathways	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMC200020829	K13228	ko00402	Benzoxazinoid biosynthesis	679	1.3e-31	0.31	0.48	0.97
PGSC0003DMC200020830	K07424	ko00140	Steroid hormone biosynthesis	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00591	Linoleic acid metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00830	Retinol metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00982	Drug metabolism - cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko00983	Drug metabolism - other enzymes	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020830	K07424	ko01100	Metabolic pathways	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMC200020831	K07424	ko00140	Steroid hormone biosynthesis	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00591	Linoleic acid metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00830	Retinol metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00982	Drug metabolism - cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko00983	Drug metabolism - other enzymes	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020831	K07424	ko01100	Metabolic pathways	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMC200020832	K07424	ko00140	Steroid hormone biosynthesis	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00591	Linoleic acid metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00830	Retinol metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00982	Drug metabolism - cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko00983	Drug metabolism - other enzymes	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020832	K07424	ko01100	Metabolic pathways	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMC200020833	K07424	ko00140	Steroid hormone biosynthesis	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00591	Linoleic acid metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00830	Retinol metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00982	Drug metabolism - cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko00983	Drug metabolism - other enzymes	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020833	K07424	ko01100	Metabolic pathways	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMC200020834	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020834	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020834	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020835	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020835	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020835	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMC200020837	K10352	ko04530	Tight junction	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMC200020837	K10352	ko05416	Viral myocarditis	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMC200020841	K01962	ko00061	Fatty acid biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200020841	K01962	ko00253	Tetracycline biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200020841	K01962	ko00620	Pyruvate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200020841	K01962	ko00640	Propanoate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200020841	K01962	ko01100	Metabolic pathways	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200020841	K01962	ko01110	Biosynthesis of secondary metabolites	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMC200016173	K10773	ko03410	Base excision repair	1556	5.5e-80	0.36	0.49	0.46
PGSC0003DMC200016177	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMC200016177	K00814	ko00710	Carbon fixation in photosynthetic organisms	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMC200016177	K00814	ko01100	Metabolic pathways	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMC200016178	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMC200016178	K00814	ko00710	Carbon fixation in photosynthetic organisms	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMC200016178	K00814	ko01100	Metabolic pathways	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMC200016179	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMC200016179	K00814	ko00710	Carbon fixation in photosynthetic organisms	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMC200016179	K00814	ko01100	Metabolic pathways	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMC200016180	K01051	ko00040	Pentose and glucuronate interconversions	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMC200016180	K01051	ko00500	Starch and sucrose metabolism	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMC200016180	K01051	ko01100	Metabolic pathways	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMC200016181	K01051	ko00040	Pentose and glucuronate interconversions	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMC200016181	K01051	ko00500	Starch and sucrose metabolism	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMC200016181	K01051	ko01100	Metabolic pathways	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMC200016182	K01051	ko00040	Pentose and glucuronate interconversions	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMC200016182	K01051	ko00500	Starch and sucrose metabolism	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMC200016182	K01051	ko01100	Metabolic pathways	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMC200016183	K01051	ko00040	Pentose and glucuronate interconversions	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMC200016183	K01051	ko00500	Starch and sucrose metabolism	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMC200016183	K01051	ko01100	Metabolic pathways	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMC200016192	K04368	ko04010	MAPK signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04012	ErbB signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04013	MAPK signaling pathway - fly	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04062	Chemokine signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04114	Oocyte meiosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04270	Vascular smooth muscle contraction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04320	Dorso-ventral axis formation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04370	VEGF signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04510	Focal adhesion	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04540	Gap junction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04620	Toll-like receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04626	Plant-pathogen interaction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04650	Natural killer cell mediated cytotoxicity	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04660	T cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04662	B cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04664	Fc epsilon RI signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04666	Fc gamma R-mediated phagocytosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04720	Long-term potentiation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04730	Long-term depression	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04810	Regulation of actin cytoskeleton	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04910	Insulin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04912	GnRH signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04914	Progesterone-mediated oocyte maturation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko04916	Melanogenesis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05020	Prion diseases	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05200	Pathways in cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05210	Colorectal cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05211	Renal cell carcinoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05212	Pancreatic cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05213	Endometrial cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05214	Glioma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05215	Prostate cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05216	Thyroid cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05218	Melanoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05219	Bladder cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05220	Chronic myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05221	Acute myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200016192	K04368	ko05223	Non-small cell lung cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMC200010981	K10590	ko04120	Ubiquitin mediated proteolysis	12254	0.	0.79	0.88	0.99
PGSC0003DMC200010982	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMC200010983	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMC200010984	K02731	ko03050	Proteasome	1990	6.3e-104	0.96	0.99	1.00
PGSC0003DMC200010998	K05765	ko04360	Axon guidance	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMC200010998	K05765	ko04666	Fc gamma R-mediated phagocytosis	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMC200010998	K05765	ko04810	Regulation of actin cytoskeleton	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMC200011006	K02936	ko03010	Ribosome	880	1.1e-42	0.77	0.82	0.99
PGSC0003DMC200044972	K08233	ko00901	Indole alkaloid biosynthesis	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMC200044972	K08233	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMC200044973	K08233	ko00901	Indole alkaloid biosynthesis	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMC200044973	K08233	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMC200044985	K02184	ko04320	Dorso-ventral axis formation	1074	7.4e-53	0.38	0.46	0.43
PGSC0003DMC200044995	K04631	ko04744	Phototransduction	534	1.3e-23	0.33	0.53	0.80
PGSC0003DMC200044997	K10260	ko04120	Ubiquitin mediated proteolysis	297	1.5e-10	0.34	0.49	0.47
PGSC0003DMC200044998	K10260	ko04120	Ubiquitin mediated proteolysis	354	1.5e-16	0.31	0.47	0.64
PGSC0003DMC200039788	K13229	ko00402	Benzoxazinoid biosynthesis	289	4.2e-10	0.39	0.52	0.94
PGSC0003DMC200039792	K02878	ko03010	Ribosome	246	9.8e-08	0.61	0.73	0.94
PGSC0003DMC200039802	K04103	ko00380	Tryptophan metabolism	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMC200039802	K04103	ko01100	Metabolic pathways	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMC200039803	K04103	ko00380	Tryptophan metabolism	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMC200039803	K04103	ko01100	Metabolic pathways	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMC200039806	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200039806	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200039806	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200039806	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200039806	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200062353	K05278	ko00941	Flavonoid biosynthesis	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMC200062353	K05278	ko01100	Metabolic pathways	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMC200062353	K05278	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMC200062364	K01199	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.54	0.71	0.92
PGSC0003DMC200062365	K10760	ko00908	Zeatin biosynthesis	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMC200062365	K10760	ko01100	Metabolic pathways	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMC200062365	K10760	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMC200067303	K10760	ko00908	Zeatin biosynthesis	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMC200067303	K10760	ko01100	Metabolic pathways	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMC200067303	K10760	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMC200065720	K01051	ko00040	Pentose and glucuronate interconversions	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMC200065720	K01051	ko00500	Starch and sucrose metabolism	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMC200065720	K01051	ko01100	Metabolic pathways	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMC200024003	K04424	ko04010	MAPK signaling pathway	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMC200024003	K04424	ko04530	Tight junction	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMC200024018	K09843	ko00906	Carotenoid biosynthesis	1009	8.1e-50	0.36	0.53	0.96
PGSC0003DMC200008017	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMC200008017	K00430	ko00680	Methane metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMC200008017	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMC200008017	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMC200008017	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMC200008037	K04733	ko04210	Apoptosis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMC200008037	K04733	ko04620	Toll-like receptor signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMC200008037	K04733	ko04722	Neurotrophin signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMC200008037	K04733	ko05140	Leishmaniasis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMC200008037	K04733	ko05142	Chagas disease	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMC200008038	K04733	ko04210	Apoptosis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMC200008038	K04733	ko04620	Toll-like receptor signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMC200008038	K04733	ko04722	Neurotrophin signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMC200008038	K04733	ko05140	Leishmaniasis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMC200008038	K04733	ko05142	Chagas disease	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMC200008039	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008039	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200008040	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMC200020135	K00949	ko00730	Thiamine metabolism	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMC200020135	K00949	ko01100	Metabolic pathways	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMC200020136	K00949	ko00730	Thiamine metabolism	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMC200020136	K00949	ko01100	Metabolic pathways	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMC200020137	K00949	ko00730	Thiamine metabolism	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMC200020137	K00949	ko01100	Metabolic pathways	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMC200020139	K10858	ko03430	Mismatch repair	3978	1.4e-213	0.56	0.71	0.99
PGSC0003DMC200020140	K05666	ko02010	ABC transporters	3402	8.4e-182	0.35	0.55	0.94
PGSC0003DMC200020141	K05666	ko02010	ABC transporters	3424	5.1e-183	0.35	0.55	0.97
PGSC0003DMC200020146	K01710	ko00521	Streptomycin biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMC200020146	K01710	ko00523	Polyketide sugar unit biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMC200020146	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMC200020146	K01710	ko01100	Metabolic pathways	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMC200020146	K01710	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMC200020147	K01710	ko00521	Streptomycin biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMC200020147	K01710	ko00523	Polyketide sugar unit biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMC200020147	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMC200020147	K01710	ko01100	Metabolic pathways	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMC200020147	K01710	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMC200020148	K01710	ko00521	Streptomycin biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMC200020148	K01710	ko00523	Polyketide sugar unit biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMC200020148	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMC200020148	K01710	ko01100	Metabolic pathways	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMC200020148	K01710	ko01110	Biosynthesis of secondary metabolites	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMC200020149	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.29
PGSC0003DMC200020150	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.40
PGSC0003DMC200020158	K08852	ko05010	Alzheimer's disease	246	1.5e-07	0.45	0.57	0.31
PGSC0003DMC200011372	K01046	ko00561	Glycerolipid metabolism	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMC200011372	K01046	ko01100	Metabolic pathways	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMC200011373	K01046	ko00561	Glycerolipid metabolism	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMC200011373	K01046	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMC200011378	K06630	ko04110	Cell cycle	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMC200011378	K06630	ko04114	Oocyte meiosis	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMC200011378	K06630	ko04722	Neurotrophin signaling pathway	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMC200011390	K05933	ko00270	Cysteine and methionine metabolism	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMC200011390	K05933	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMC200011391	K05933	ko00270	Cysteine and methionine metabolism	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMC200011391	K05933	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMC200011392	K05933	ko00270	Cysteine and methionine metabolism	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMC200011392	K05933	ko01110	Biosynthesis of secondary metabolites	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMC200011393	K05933	ko00270	Cysteine and methionine metabolism	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMC200011393	K05933	ko01110	Biosynthesis of secondary metabolites	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMC200011394	K05933	ko00270	Cysteine and methionine metabolism	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMC200011394	K05933	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMC200011395	K09458	ko00061	Fatty acid biosynthesis	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMC200011395	K09458	ko01100	Metabolic pathways	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMC200011396	K09458	ko00061	Fatty acid biosynthesis	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMC200011396	K09458	ko01100	Metabolic pathways	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMC200011397	K09458	ko00061	Fatty acid biosynthesis	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMC200011397	K09458	ko01100	Metabolic pathways	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMC200011398	K09458	ko00061	Fatty acid biosynthesis	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMC200011398	K09458	ko01100	Metabolic pathways	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMC200011399	K09458	ko00061	Fatty acid biosynthesis	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMC200011399	K09458	ko01100	Metabolic pathways	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMC200036811	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036811	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036811	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036812	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036812	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036812	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMC200036826	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMC200036827	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMC200036828	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMC200036830	K01307	ko00790	Folate biosynthesis	1944	2.2e-101	0.73	0.84	0.95
PGSC0003DMC200036831	K03504	ko00230	Purine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko00240	Pyrimidine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko01100	Metabolic pathways	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko03030	DNA replication	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko03410	Base excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko03420	Nucleotide excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko03430	Mismatch repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036831	K03504	ko03440	Homologous recombination	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMC200036832	K03504	ko00230	Purine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko00240	Pyrimidine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko01100	Metabolic pathways	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko03030	DNA replication	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko03410	Base excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko03420	Nucleotide excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko03430	Mismatch repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036832	K03504	ko03440	Homologous recombination	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko00230	Purine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko00240	Pyrimidine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko01100	Metabolic pathways	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko03030	DNA replication	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko03410	Base excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko03420	Nucleotide excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko03430	Mismatch repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036833	K03504	ko03440	Homologous recombination	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMC200036834	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200036834	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200036834	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200036835	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200036835	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200036835	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMC200055204	K00472	ko00330	Arginine and proline metabolism	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMC200055204	K00472	ko01100	Metabolic pathways	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMC200055209	K01006	ko00620	Pyruvate metabolism	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMC200055209	K01006	ko00710	Carbon fixation in photosynthetic organisms	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMC200055209	K01006	ko01100	Metabolic pathways	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMC200055210	K01006	ko00620	Pyruvate metabolism	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMC200055210	K01006	ko00710	Carbon fixation in photosynthetic organisms	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMC200055210	K01006	ko01100	Metabolic pathways	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMC200055211	K01006	ko00620	Pyruvate metabolism	6272	0.	0.87	0.95	1.00
PGSC0003DMC200055211	K01006	ko00710	Carbon fixation in photosynthetic organisms	6272	0.	0.87	0.95	1.00
PGSC0003DMC200055211	K01006	ko01100	Metabolic pathways	6272	0.	0.87	0.95	1.00
PGSC0003DMC200055218	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200055222	K01611	ko00270	Cysteine and methionine metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMC200055222	K01611	ko00330	Arginine and proline metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMC200055222	K01611	ko01100	Metabolic pathways	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMC200030421	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMC200030423	K12741	ko03040	Spliceosome	953	1.0e-46	0.52	0.65	1.00
PGSC0003DMC200030424	K12741	ko03040	Spliceosome	755	8.3e-36	0.63	0.88	0.76
PGSC0003DMC200030426	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMC200030427	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMC200030428	K10601	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.32	0.52	0.74
PGSC0003DMC200030430	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMC200030431	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMC200030433	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.30
PGSC0003DMC200030437	K00850	ko00010	Glycolysis / Gluconeogenesis	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030437	K00850	ko00030	Pentose phosphate pathway	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030437	K00850	ko00051	Fructose and mannose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030437	K00850	ko00052	Galactose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030437	K00850	ko01100	Metabolic pathways	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030437	K00850	ko01110	Biosynthesis of secondary metabolites	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMC200030444	K02084	ko04115	p53 signaling pathway	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko04210	Apoptosis	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko05010	Alzheimer's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko05012	Parkinson's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko05016	Huntington's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030444	K02084	ko05222	Small cell lung cancer	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMC200030446	K02084	ko04115	p53 signaling pathway	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko04210	Apoptosis	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko05010	Alzheimer's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko05012	Parkinson's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko05016	Huntington's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200030446	K02084	ko05222	Small cell lung cancer	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMC200048949	K03531	ko04112	Cell cycle - Caulobacter	3206	5.4e-171	0.81	0.89	1.00
PGSC0003DMC200048953	K01915	ko00250	Alanine, aspartate and glutamate metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMC200048953	K01915	ko00330	Arginine and proline metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMC200048953	K01915	ko00910	Nitrogen metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMC200048953	K01915	ko01100	Metabolic pathways	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMC200048953	K01915	ko02020	Two-component system	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMC200048958	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMC200048958	K00517	ko00626	Naphthalene and anthracene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMC200048958	K00517	ko00903	Limonene and pinene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMC200048958	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMC200048958	K00517	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMC200048959	K02527	ko00540	Lipopolysaccharide biosynthesis	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMC200048959	K02527	ko01100	Metabolic pathways	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMC200048960	K02527	ko00540	Lipopolysaccharide biosynthesis	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMC200048960	K02527	ko01100	Metabolic pathways	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMC200029153	K01426	ko00330	Arginine and proline metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029153	K01426	ko00360	Phenylalanine metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029153	K01426	ko00380	Tryptophan metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029153	K01426	ko00460	Cyanoamino acid metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029153	K01426	ko00632	Benzoate degradation via CoA ligation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029153	K01426	ko00643	Styrene degradation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMC200029154	K01426	ko00330	Arginine and proline metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029154	K01426	ko00360	Phenylalanine metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029154	K01426	ko00380	Tryptophan metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029154	K01426	ko00460	Cyanoamino acid metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029154	K01426	ko00632	Benzoate degradation via CoA ligation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029154	K01426	ko00643	Styrene degradation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMC200029160	K01692	ko00071	Fatty acid metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00280	Valine, leucine and isoleucine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00281	Geraniol degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00310	Lysine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00380	Tryptophan metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00410	beta-Alanine metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00632	Benzoate degradation via CoA ligation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00640	Propanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00650	Butanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00903	Limonene and pinene degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko00930	Caprolactam degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko01100	Metabolic pathways	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200029160	K01692	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMC200021001	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMC200021002	K02924	ko03010	Ribosome	310	2.9e-11	0.92	0.97	0.63
PGSC0003DMC200021003	K02924	ko03010	Ribosome	439	2.2e-18	0.94	0.98	0.98
PGSC0003DMC200021004	K06237	ko04510	Focal adhesion	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMC200021004	K06237	ko04512	ECM-receptor interaction	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMC200021004	K06237	ko05146	Amoebiasis	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMC200021004	K06237	ko05200	Pathways in cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMC200021004	K06237	ko05222	Small cell lung cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMC200021005	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.36	0.52	0.92
PGSC0003DMC200021006	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	462	1.2e-19	0.31	0.49	0.65
PGSC0003DMC200021008	K01053	ko00030	Pentose phosphate pathway	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMC200021008	K01053	ko00053	Ascorbate and aldarate metabolism	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMC200021008	K01053	ko00930	Caprolactam degradation	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMC200021008	K01053	ko01100	Metabolic pathways	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMC200021008	K01053	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMC200003762	K11826	ko04144	Endocytosis	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMC200003762	K11826	ko05016	Huntington's disease	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMC200003763	K11826	ko04144	Endocytosis	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMC200003763	K11826	ko05016	Huntington's disease	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMC200057939	K10760	ko00908	Zeatin biosynthesis	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMC200057939	K10760	ko01100	Metabolic pathways	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMC200057939	K10760	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMC200052201	K12667	ko00510	N-Glycan biosynthesis	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMC200052201	K12667	ko01100	Metabolic pathways	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMC200052213	K01047	ko00564	Glycerophospholipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko00565	Ether lipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko00590	Arachidonic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko00591	Linoleic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko00592	alpha-Linolenic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko01100	Metabolic pathways	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04010	MAPK signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04270	Vascular smooth muscle contraction	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04370	VEGF signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04664	Fc epsilon RI signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04730	Long-term depression	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052213	K01047	ko04912	GnRH signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMC200052217	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMC200052217	K00517	ko00626	Naphthalene and anthracene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMC200052217	K00517	ko00903	Limonene and pinene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMC200052217	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMC200052217	K00517	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMC200052218	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMC200052218	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMC200052218	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMC200052218	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMC200052218	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMC200052223	K01834	ko00010	Glycolysis / Gluconeogenesis	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMC200052223	K01834	ko01100	Metabolic pathways	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMC200052223	K01834	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMC200052224	K05350	ko00460	Cyanoamino acid metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMC200052224	K05350	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMC200052224	K05350	ko00940	Phenylpropanoid biosynthesis	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMC200052224	K05350	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMC200052225	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMC200052225	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMC200052225	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMC200052225	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMC200052229	K01354	ko05142	Chagas disease	416	8.0e-17	0.57	0.72	0.65
PGSC0003DMC200052230	K01354	ko05142	Chagas disease	2254	1.7e-118	0.74	0.86	0.99
PGSC0003DMC200034952	K02721	ko00195	Photosynthesis	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMC200034952	K02721	ko01100	Metabolic pathways	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMC200034960	K10955	ko05110	Vibrio cholerae infection	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMC200034960	K10955	ko05146	Amoebiasis	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMC200034964	K06636	ko04110	Cell cycle	7300	0.	0.69	0.81	1.00
PGSC0003DMC200034964	K06636	ko04111	Cell cycle - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMC200034964	K06636	ko04113	Meiosis - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMC200034964	K06636	ko04114	Oocyte meiosis	7300	0.	0.69	0.81	1.00
PGSC0003DMC200034965	K06636	ko04110	Cell cycle	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMC200034965	K06636	ko04111	Cell cycle - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMC200034965	K06636	ko04113	Meiosis - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMC200034965	K06636	ko04114	Oocyte meiosis	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMC200034967	K02875	ko03010	Ribosome	1011	6.3e-50	0.90	0.95	0.99
PGSC0003DMC200034968	K01900	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMC200034968	K01900	ko00640	Propanoate metabolism	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMC200034968	K01900	ko01100	Metabolic pathways	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMC200034968	K01900	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMC200034969	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMC200034970	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.62
PGSC0003DMC200034971	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.48
PGSC0003DMC200034972	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMC200034973	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMC200034978	K02693	ko00195	Photosynthesis	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMC200034978	K02693	ko01100	Metabolic pathways	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMC200034980	K01728	ko00040	Pentose and glucuronate interconversions	2857	9.6e-152	0.80	0.89	0.87
PGSC0003DMC200027934	K10572	ko00562	Inositol phosphate metabolism	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMC200027934	K10572	ko01100	Metabolic pathways	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMC200027934	K10572	ko04070	Phosphatidylinositol signaling system	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMC200027936	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027936	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027936	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027937	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027937	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027937	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMC200027938	K00975	ko00500	Starch and sucrose metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMC200027938	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMC200027938	K00975	ko01100	Metabolic pathways	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMC200027951	K02689	ko00195	Photosynthesis	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMC200027951	K02689	ko01100	Metabolic pathways	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMC200027952	K04618	ko00052	Galactose metabolism	341	3.2e-10	0.27	0.41	0.78
PGSC0003DMC200027954	K12821	ko03040	Spliceosome	3869	1.5e-207	0.62	0.72	0.99
PGSC0003DMC200027955	K12821	ko03040	Spliceosome	3769	4.8e-202	0.69	0.82	1.00
PGSC0003DMC200027956	K12821	ko03040	Spliceosome	5200	5.7e-281	0.61	0.72	1.00
PGSC0003DMC200014812	K07199	ko04910	Insulin signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMC200014812	K07199	ko04920	Adipocytokine signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMC200014812	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMC200014813	K07199	ko04910	Insulin signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMC200014813	K07199	ko04920	Adipocytokine signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMC200014813	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMC200014814	K07199	ko04910	Insulin signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMC200014814	K07199	ko04920	Adipocytokine signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMC200014814	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMC200014819	K08300	ko03018	RNA degradation	238	2.4e-06	0.40	0.47	0.86
PGSC0003DMC200014820	K08300	ko03018	RNA degradation	241	1.6e-06	0.41	0.47	0.90
PGSC0003DMC200004968	K01358	ko04112	Cell cycle - Caulobacter	1882	5.7e-98	0.90	0.94	0.44
PGSC0003DMC200004969	K01358	ko04112	Cell cycle - Caulobacter	1964	1.7e-102	0.80	0.87	0.98
PGSC0003DMC200004976	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200004976	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200022201	K05681	ko02010	ABC transporters	1047	6.5e-52	0.32	0.52	0.88
PGSC0003DMC200022202	K05681	ko02010	ABC transporters	450	5.5e-19	0.48	0.69	0.74
PGSC0003DMC200022203	K05681	ko02010	ABC transporters	367	4.6e-14	0.29	0.49	0.83
PGSC0003DMC200022204	K05681	ko02010	ABC transporters	1132	1.3e-56	0.33	0.54	0.89
PGSC0003DMC200022205	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMC200022206	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMC200022207	K05681	ko02010	ABC transporters	1123	4.2e-56	0.34	0.55	0.87
PGSC0003DMC200022208	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMC200022208	K01626	ko01100	Metabolic pathways	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMC200022208	K01626	ko01110	Biosynthesis of secondary metabolites	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMC200022209	K02371	ko00061	Fatty acid biosynthesis	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMC200022209	K02371	ko01100	Metabolic pathways	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMC200022210	K02371	ko00061	Fatty acid biosynthesis	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMC200022210	K02371	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMC200022211	K13030	ko00460	Cyanoamino acid metabolism	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMC200022211	K13030	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMC200022212	K13030	ko00460	Cyanoamino acid metabolism	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMC200022212	K13030	ko01110	Biosynthesis of secondary metabolites	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMC200022230	K12891	ko03040	Spliceosome	1647	5.3e-85	0.76	0.84	0.99
PGSC0003DMC200001172	K00475	ko00941	Flavonoid biosynthesis	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMC200001172	K00475	ko01100	Metabolic pathways	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMC200001172	K00475	ko01110	Biosynthesis of secondary metabolites	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMC200001175	K12130	ko04712	Circadian rhythm - plant	1781	2.1e-92	0.42	0.54	1.00
PGSC0003DMC200001176	K12130	ko04712	Circadian rhythm - plant	1585	1.4e-81	0.40	0.52	0.95
PGSC0003DMC200001189	K05933	ko00270	Cysteine and methionine metabolism	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMC200001189	K05933	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMC200001191	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMC200001192	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMC200001193	K05278	ko00941	Flavonoid biosynthesis	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMC200001193	K05278	ko01100	Metabolic pathways	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMC200001193	K05278	ko01110	Biosynthesis of secondary metabolites	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMC200001194	K05282	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMC200001194	K05282	ko01100	Metabolic pathways	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMC200001194	K05282	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMC200001195	K05933	ko00270	Cysteine and methionine metabolism	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMC200001195	K05933	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMC200001196	K05933	ko00270	Cysteine and methionine metabolism	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMC200001196	K05933	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMC200001197	K05933	ko00270	Cysteine and methionine metabolism	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMC200001197	K05933	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMC200001199	K05933	ko00270	Cysteine and methionine metabolism	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMC200001199	K05933	ko01110	Biosynthesis of secondary metabolites	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMC200001200	K05933	ko00270	Cysteine and methionine metabolism	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMC200001200	K05933	ko01110	Biosynthesis of secondary metabolites	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMC200059147	K03007	ko00230	Purine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMC200059147	K03007	ko00240	Pyrimidine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMC200059147	K03007	ko01100	Metabolic pathways	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMC200059147	K03007	ko03020	RNA polymerase	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMC200059147	K03007	ko05016	Huntington's disease	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMC200059148	K00059	ko00061	Fatty acid biosynthesis	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMC200059148	K00059	ko01040	Biosynthesis of unsaturated fatty acids	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMC200059148	K00059	ko01100	Metabolic pathways	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMC200033759	K12843	ko03040	Spliceosome	1782	1.9e-92	0.37	0.52	0.94
PGSC0003DMC200033766	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.31
PGSC0003DMC200033767	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.33
PGSC0003DMC200033768	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.61	0.70	0.32
PGSC0003DMC200033774	K03006	ko00230	Purine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMC200033774	K03006	ko00240	Pyrimidine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMC200033774	K03006	ko01100	Metabolic pathways	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMC200033774	K03006	ko03020	RNA polymerase	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMC200033774	K03006	ko05016	Huntington's disease	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMC200051005	K06685	ko04111	Cell cycle - yeast	1669	3.0e-88	0.82	0.85	0.87
PGSC0003DMC200051006	K06685	ko04111	Cell cycle - yeast	1795	3.6e-93	0.95	0.99	1.00
PGSC0003DMC200051007	K06685	ko04111	Cell cycle - yeast	1739	4.4e-90	0.95	0.99	0.96
PGSC0003DMC200051022	K12125	ko04712	Circadian rhythm - plant	1607	8.4e-83	0.40	0.53	0.99
PGSC0003DMC200051023	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.40	0.51	0.84
PGSC0003DMC200051024	K12125	ko04712	Circadian rhythm - plant	819	2.5e-39	0.40	0.50	0.93
PGSC0003DMC200051025	K00850	ko00010	Glycolysis / Gluconeogenesis	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051025	K00850	ko00030	Pentose phosphate pathway	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051025	K00850	ko00051	Fructose and mannose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051025	K00850	ko00052	Galactose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051025	K00850	ko01100	Metabolic pathways	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051025	K00850	ko01110	Biosynthesis of secondary metabolites	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMC200051026	K02087	ko04110	Cell cycle	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMC200051026	K02087	ko04114	Oocyte meiosis	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMC200051026	K02087	ko04115	p53 signaling pathway	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMC200051026	K02087	ko04540	Gap junction	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMC200051026	K02087	ko04914	Progesterone-mediated oocyte maturation	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMC200025201	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMC200025202	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMC200025203	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMC200025204	K05658	ko02010	ABC transporters	1051	1.1e-55	0.43	0.61	0.94
PGSC0003DMC200025230	K08094	ko00040	Pentose and glucuronate interconversions	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMC200025230	K08094	ko00680	Methane metabolism	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMC200006811	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMC200006812	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.40
PGSC0003DMC200006813	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.37
PGSC0003DMC200006814	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMC200006815	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMC200006818	K02922	ko03010	Ribosome	465	8.2e-20	0.64	0.69	0.97
PGSC0003DMC200006821	K10143	ko04115	p53 signaling pathway	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMC200006821	K10143	ko04120	Ubiquitin mediated proteolysis	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMC200006825	K12621	ko03018	RNA degradation	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMC200006825	K12621	ko03040	Spliceosome	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMC200006827	K02358	ko04626	Plant-pathogen interaction	3395	2.0e-181	0.90	0.93	1.00
PGSC0003DMC200006833	K00754	ko00051	Fructose and mannose metabolism	335	1.6e-12	0.30	0.50	0.53
PGSC0003DMC200006838	K03025	ko00230	Purine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMC200006838	K03025	ko00240	Pyrimidine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMC200006838	K03025	ko01100	Metabolic pathways	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMC200006838	K03025	ko03020	RNA polymerase	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMC200006838	K03025	ko04623	Cytosolic DNA-sensing pathway	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMC200018931	K12275	ko03060	Protein export	2026	6.6e-106	0.79	0.87	0.92
PGSC0003DMC200018932	K12275	ko03060	Protein export	2034	2.4e-106	0.79	0.87	0.92
PGSC0003DMC200018933	K12275	ko03060	Protein export	2163	1.8e-113	0.72	0.83	0.99
PGSC0003DMC200018941	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMC200018941	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMC200018941	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMC200018941	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMC200018941	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMC200018942	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018942	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018942	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018942	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018942	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018944	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMC200018944	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMC200018944	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMC200018944	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMC200018944	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMC200018945	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018945	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018945	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018945	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018945	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMC200018951	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200018951	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200018951	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200018951	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200018951	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMC200018952	K00430	ko00360	Phenylalanine metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMC200018952	K00430	ko00680	Methane metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMC200018952	K00430	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMC200018952	K00430	ko01100	Metabolic pathways	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMC200018952	K00430	ko01110	Biosynthesis of secondary metabolites	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMC200061155	K11251	ko05322	Systemic lupus erythematosus	763	3.0e-36	0.73	0.84	0.94
PGSC0003DMC200061158	K03094	ko04110	Cell cycle	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04111	Cell cycle - yeast	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04114	Oocyte meiosis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04120	Ubiquitin mediated proteolysis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04310	Wnt signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04350	TGF-beta signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200061158	K03094	ko04710	Circadian rhythm - mammal	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMC200066093	K11644	ko05016	Huntington's disease	286	2.8e-06	0.24	0.42	0.53
PGSC0003DMC200066096	K11251	ko05322	Systemic lupus erythematosus	536	1.0e-23	0.71	0.85	0.72
PGSC0003DMC200066098	K03133	ko03022	Basal transcription factors	231	6.6e-07	0.55	0.70	0.33
PGSC0003DMC200066113	K01955	ko00240	Pyrimidine metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMC200066113	K01955	ko00250	Alanine, aspartate and glutamate metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMC200066113	K01955	ko01100	Metabolic pathways	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMC200038015	K02894	ko03010	Ribosome	179	2.6e-06	0.91	0.97	0.19
PGSC0003DMC200038023	K06110	ko04530	Tight junction	765	2.3e-36	0.28	0.44	0.83
PGSC0003DMC200038024	K06110	ko04530	Tight junction	788	1.3e-37	0.28	0.44	0.84
PGSC0003DMC200038025	K00368	ko00910	Nitrogen metabolism	878	1.4e-42	0.40	0.57	0.86
PGSC0003DMC200038026	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.88
PGSC0003DMC200038027	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.95
PGSC0003DMC200038039	K13229	ko00402	Benzoxazinoid biosynthesis	343	4.4e-13	0.42	0.57	0.91
PGSC0003DMC200038040	K13229	ko00402	Benzoxazinoid biosynthesis	649	5.8e-30	0.42	0.58	0.99
PGSC0003DMC200054020	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMC200054020	K00517	ko00626	Naphthalene and anthracene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMC200054020	K00517	ko00903	Limonene and pinene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMC200054020	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMC200054020	K00517	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMC200054021	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMC200054021	K00517	ko00626	Naphthalene and anthracene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMC200054021	K00517	ko00903	Limonene and pinene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMC200054021	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMC200054021	K00517	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMC200054022	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMC200054022	K00517	ko00626	Naphthalene and anthracene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMC200054022	K00517	ko00903	Limonene and pinene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMC200054022	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMC200054022	K00517	ko01110	Biosynthesis of secondary metabolites	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMC200054023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMC200054023	K00517	ko00626	Naphthalene and anthracene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMC200054023	K00517	ko00903	Limonene and pinene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMC200054023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMC200054023	K00517	ko01110	Biosynthesis of secondary metabolites	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMC200054024	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMC200054024	K00517	ko00626	Naphthalene and anthracene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMC200054024	K00517	ko00903	Limonene and pinene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMC200054024	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMC200054024	K00517	ko01110	Biosynthesis of secondary metabolites	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMC200050131	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMC200050131	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMC200050132	K04424	ko04010	MAPK signaling pathway	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMC200050132	K04424	ko04530	Tight junction	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMC200050133	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMC200050133	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMC200050142	K13289	ko04142	Lysosome	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMC200050142	K13289	ko04614	Renin-angiotensin system	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMC200050143	K13289	ko04142	Lysosome	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMC200050143	K13289	ko04614	Renin-angiotensin system	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMC200031621	K09680	ko00770	Pantothenate and CoA biosynthesis	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMC200031621	K09680	ko01100	Metabolic pathways	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMC200031622	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMC200031622	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMC200031623	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMC200031623	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMC200031650	K10573	ko04120	Ubiquitin mediated proteolysis	1333	1.1e-67	0.98	1.00	0.99
PGSC0003DMC200041383	K01955	ko00240	Pyrimidine metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMC200041383	K01955	ko00250	Alanine, aspartate and glutamate metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMC200041383	K01955	ko01100	Metabolic pathways	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMC200041393	K01227	ko00511	Other glycan degradation	434	6.6e-18	0.29	0.46	0.96
PGSC0003DMC200041394	K01227	ko00511	Other glycan degradation	1350	1.3e-68	0.36	0.52	0.97
PGSC0003DMC200041395	K01227	ko00511	Other glycan degradation	897	1.2e-43	0.31	0.45	0.96
PGSC0003DMC200053401	K01613	ko00564	Glycerophospholipid metabolism	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMC200053401	K01613	ko01100	Metabolic pathways	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMC200053403	K04733	ko04210	Apoptosis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMC200053403	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMC200053403	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMC200053403	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMC200053403	K04733	ko05142	Chagas disease	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMC200053407	K05349	ko00460	Cyanoamino acid metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMC200053407	K05349	ko00500	Starch and sucrose metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMC200053407	K05349	ko00940	Phenylpropanoid biosynthesis	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMC200053407	K05349	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMC200053408	K05349	ko00460	Cyanoamino acid metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMC200053408	K05349	ko00500	Starch and sucrose metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMC200053408	K05349	ko00940	Phenylpropanoid biosynthesis	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMC200053408	K05349	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMC200053414	K09880	ko00270	Cysteine and methionine metabolism	742	6.5e-35	0.27	0.44	0.93
PGSC0003DMC200038164	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMC200038164	K00517	ko00626	Naphthalene and anthracene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMC200038164	K00517	ko00903	Limonene and pinene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMC200038164	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMC200038164	K00517	ko01110	Biosynthesis of secondary metabolites	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMC200038165	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMC200038165	K00517	ko00626	Naphthalene and anthracene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMC200038165	K00517	ko00903	Limonene and pinene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMC200038165	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMC200038165	K00517	ko01110	Biosynthesis of secondary metabolites	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMC200038169	K10140	ko03420	Nucleotide excision repair	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMC200038169	K10140	ko04115	p53 signaling pathway	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMC200038169	K10140	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMC200038170	K10140	ko03420	Nucleotide excision repair	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMC200038170	K10140	ko04115	p53 signaling pathway	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMC200038170	K10140	ko04120	Ubiquitin mediated proteolysis	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMC200038174	K01582	ko00310	Lysine degradation	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMC200038174	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMC200038174	K01582	ko01100	Metabolic pathways	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMC200038174	K01582	ko01110	Biosynthesis of secondary metabolites	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMC200038175	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038175	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038175	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038175	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038175	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038175	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038176	K00106	ko00230	Purine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038176	K00106	ko00232	Caffeine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038176	K00106	ko00983	Drug metabolism - other enzymes	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038176	K00106	ko01100	Metabolic pathways	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038176	K00106	ko01110	Biosynthesis of secondary metabolites	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038176	K00106	ko04146	Peroxisome	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMC200038177	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038177	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038177	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038177	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038177	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038177	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038178	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMC200038179	K00106	ko00230	Purine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038179	K00106	ko00232	Caffeine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038179	K00106	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038179	K00106	ko01100	Metabolic pathways	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038179	K00106	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038179	K00106	ko04146	Peroxisome	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMC200038185	K00615	ko00030	Pentose phosphate pathway	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMC200038185	K00615	ko00710	Carbon fixation in photosynthetic organisms	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMC200038185	K00615	ko01051	Biosynthesis of ansamycins	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMC200038185	K00615	ko01100	Metabolic pathways	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMC200038185	K00615	ko01110	Biosynthesis of secondary metabolites	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMC200043591	K03011	ko00230	Purine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMC200043591	K03011	ko00240	Pyrimidine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMC200043591	K03011	ko01100	Metabolic pathways	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMC200043591	K03011	ko03020	RNA polymerase	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMC200043591	K03011	ko05016	Huntington's disease	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMC200043592	K03011	ko00230	Purine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMC200043592	K03011	ko00240	Pyrimidine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMC200043592	K03011	ko01100	Metabolic pathways	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMC200043592	K03011	ko03020	RNA polymerase	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMC200043592	K03011	ko05016	Huntington's disease	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMC200043596	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043596	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043596	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043596	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043597	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043597	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043597	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043597	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMC200043598	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMC200043598	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMC200043599	K04077	ko03018	RNA degradation	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMC200043599	K04077	ko04940	Type I diabetes mellitus	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMC200043600	K04077	ko03018	RNA degradation	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMC200043600	K04077	ko04940	Type I diabetes mellitus	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMC200043601	K04077	ko03018	RNA degradation	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMC200043601	K04077	ko04940	Type I diabetes mellitus	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMC200043602	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMC200043602	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMC200043614	K02183	ko04020	Calcium signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04070	Phosphatidylinositol signaling system	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04114	Oocyte meiosis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04270	Vascular smooth muscle contraction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04626	Plant-pathogen interaction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04720	Long-term potentiation	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04722	Neurotrophin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04740	Olfactory transduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04744	Phototransduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04745	Phototransduction - fly	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04910	Insulin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04912	GnRH signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04916	Melanogenesis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04970	Salivary secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko04971	Gastric acid secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko05010	Alzheimer's disease	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043614	K02183	ko05214	Glioma	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMC200043619	K01739	ko00270	Cysteine and methionine metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMC200043619	K01739	ko00450	Selenoamino acid metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMC200043619	K01739	ko00920	Sulfur metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMC200043619	K01739	ko01100	Metabolic pathways	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMC200043619	K01739	ko01110	Biosynthesis of secondary metabolites	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMC200043620	K06653	ko04111	Cell cycle - yeast	309	2.1e-10	0.30	0.46	0.98
PGSC0003DMC200050054	K12856	ko03040	Spliceosome	19338	0.	0.94	0.96	0.99
PGSC0003DMC200050055	K12856	ko03040	Spliceosome	19795	0.	0.95	0.97	1.00
PGSC0003DMC200006968	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	664	8.7e-31	0.45	0.56	0.68
PGSC0003DMC200006970	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	628	8.4e-29	0.44	0.55	0.98
PGSC0003DMC200006974	K01762	ko00270	Cysteine and methionine metabolism	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMC200006974	K01762	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMC200006990	K07750	ko00100	Steroid biosynthesis	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMC200006990	K07750	ko01100	Metabolic pathways	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMC200012392	K00430	ko00360	Phenylalanine metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMC200012392	K00430	ko00680	Methane metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMC200012392	K00430	ko00940	Phenylpropanoid biosynthesis	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMC200012392	K00430	ko01100	Metabolic pathways	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMC200012392	K00430	ko01110	Biosynthesis of secondary metabolites	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMC200012393	K00430	ko00360	Phenylalanine metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMC200012393	K00430	ko00680	Methane metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMC200012393	K00430	ko00940	Phenylpropanoid biosynthesis	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMC200012393	K00430	ko01100	Metabolic pathways	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMC200012393	K00430	ko01110	Biosynthesis of secondary metabolites	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMC200012394	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012394	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012394	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012395	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012395	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012395	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012396	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012396	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012396	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012397	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012397	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012397	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012398	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012398	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012398	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMC200012401	K13065	ko00940	Phenylpropanoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMC200012401	K13065	ko00941	Flavonoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMC200012401	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMC200012401	K13065	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMC200012402	K02183	ko04020	Calcium signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04070	Phosphatidylinositol signaling system	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04114	Oocyte meiosis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04270	Vascular smooth muscle contraction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04626	Plant-pathogen interaction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04720	Long-term potentiation	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04722	Neurotrophin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04740	Olfactory transduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04744	Phototransduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04745	Phototransduction - fly	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04910	Insulin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04912	GnRH signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04916	Melanogenesis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04970	Salivary secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko04971	Gastric acid secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko05010	Alzheimer's disease	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012402	K02183	ko05214	Glioma	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMC200012406	K06129	ko00564	Glycerophospholipid metabolism	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMC200012406	K06129	ko04142	Lysosome	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMC200012407	K03115	ko04310	Wnt signaling pathway	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMC200012407	K03115	ko04520	Adherens junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMC200012407	K03115	ko04530	Tight junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMC200012407	K03115	ko04712	Circadian rhythm - plant	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMC200012408	K03115	ko04310	Wnt signaling pathway	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMC200012408	K03115	ko04520	Adherens junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMC200012408	K03115	ko04530	Tight junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMC200012408	K03115	ko04712	Circadian rhythm - plant	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMC200012415	K02113	ko00190	Oxidative phosphorylation	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMC200012415	K02113	ko00195	Photosynthesis	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMC200012415	K02113	ko01100	Metabolic pathways	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMC200012416	K00275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMC200012416	K00275	ko01100	Metabolic pathways	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMC200018841	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMC200018841	K03785	ko01100	Metabolic pathways	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMC200018841	K03785	ko01110	Biosynthesis of secondary metabolites	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMC200018842	K04565	ko04146	Peroxisome	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMC200018842	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMC200018842	K04565	ko05016	Huntington's disease	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMC200018842	K04565	ko05020	Prion diseases	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMC200018848	K01177	ko00500	Starch and sucrose metabolism	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMC200018848	K01177	ko01100	Metabolic pathways	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMC200018849	K01177	ko00500	Starch and sucrose metabolism	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMC200018849	K01177	ko01100	Metabolic pathways	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMC200018866	K00140	ko00280	Valine, leucine and isoleucine degradation	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMC200018866	K00140	ko00562	Inositol phosphate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMC200018866	K00140	ko00640	Propanoate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMC200018866	K00140	ko01100	Metabolic pathways	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMC200018867	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018867	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018867	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018867	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018868	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018868	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018868	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018868	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMC200018869	K00140	ko00280	Valine, leucine and isoleucine degradation	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMC200018869	K00140	ko00562	Inositol phosphate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMC200018869	K00140	ko00640	Propanoate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMC200018869	K00140	ko01100	Metabolic pathways	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMC200018870	K01951	ko00230	Purine metabolism	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMC200018870	K01951	ko00983	Drug metabolism - other enzymes	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMC200018870	K01951	ko01100	Metabolic pathways	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMC200045799	K04733	ko04210	Apoptosis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMC200045799	K04733	ko04620	Toll-like receptor signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMC200045799	K04733	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMC200045799	K04733	ko05140	Leishmaniasis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMC200045799	K04733	ko05142	Chagas disease	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMC200045800	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMC200045800	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMC200045800	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMC200045800	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMC200045800	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMC200045801	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMC200045801	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMC200045801	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMC200045801	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMC200045801	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMC200038973	K03013	ko00230	Purine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMC200038973	K03013	ko00240	Pyrimidine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMC200038973	K03013	ko01100	Metabolic pathways	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMC200038973	K03013	ko03020	RNA polymerase	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMC200038973	K03013	ko05016	Huntington's disease	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMC200038974	K03013	ko00230	Purine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMC200038974	K03013	ko00240	Pyrimidine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMC200038974	K03013	ko01100	Metabolic pathways	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMC200038974	K03013	ko03020	RNA polymerase	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMC200038974	K03013	ko05016	Huntington's disease	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMC200038994	K01066	ko00623	2,4-Dichlorobenzoate degradation	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMC200038994	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMC200038995	K01066	ko00623	2,4-Dichlorobenzoate degradation	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMC200038995	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMC200038996	K03006	ko00230	Purine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMC200038996	K03006	ko00240	Pyrimidine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMC200038996	K03006	ko01100	Metabolic pathways	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMC200038996	K03006	ko03020	RNA polymerase	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMC200038996	K03006	ko05016	Huntington's disease	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMC200059050	K10760	ko00908	Zeatin biosynthesis	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMC200059050	K10760	ko01100	Metabolic pathways	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMC200059050	K10760	ko01110	Biosynthesis of secondary metabolites	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMC200059055	K10760	ko00908	Zeatin biosynthesis	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMC200059055	K10760	ko01100	Metabolic pathways	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMC200059055	K10760	ko01110	Biosynthesis of secondary metabolites	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMC200059070	K00012	ko00040	Pentose and glucuronate interconversions	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200059070	K00012	ko00053	Ascorbate and aldarate metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200059070	K00012	ko00500	Starch and sucrose metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200059070	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200059070	K00012	ko01100	Metabolic pathways	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200059070	K00012	ko01110	Biosynthesis of secondary metabolites	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMC200056402	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMC200056403	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMC200064505	K10760	ko00908	Zeatin biosynthesis	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMC200064505	K10760	ko01100	Metabolic pathways	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMC200064505	K10760	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMC200064529	K09880	ko00270	Cysteine and methionine metabolism	244	6.4e-07	0.28	0.50	0.78
PGSC0003DMC200068505	K12581	ko03018	RNA degradation	927	2.7e-45	0.51	0.67	0.94
PGSC0003DMC200027842	K07253	ko00350	Tyrosine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMC200027842	K07253	ko00360	Phenylalanine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMC200027852	K12869	ko03040	Spliceosome	828	7.8e-40	0.57	0.71	0.83
PGSC0003DMC200027858	K05583	ko00190	Oxidative phosphorylation	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMC200027858	K05583	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMC200027859	K06671	ko04110	Cell cycle	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMC200027859	K06671	ko04111	Cell cycle - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMC200027859	K06671	ko04113	Meiosis - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMC200027860	K06671	ko04110	Cell cycle	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMC200027860	K06671	ko04111	Cell cycle - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMC200027860	K06671	ko04113	Meiosis - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMC200027861	K06671	ko04110	Cell cycle	6343	0.	0.68	0.84	1.00
PGSC0003DMC200027861	K06671	ko04111	Cell cycle - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMC200027861	K06671	ko04113	Meiosis - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMC200027862	K01840	ko00051	Fructose and mannose metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMC200027862	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMC200027862	K01840	ko01100	Metabolic pathways	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMC200027862	K01840	ko01110	Biosynthesis of secondary metabolites	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMC200027868	K00908	ko01100	Metabolic pathways	268	2.2e-08	0.33	0.49	0.98
PGSC0003DMC200016989	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMC200016989	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMC200016989	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMC200016989	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMC200016989	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMC200016990	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMC200016990	K00517	ko00626	Naphthalene and anthracene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMC200016990	K00517	ko00903	Limonene and pinene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMC200016990	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMC200016990	K00517	ko01110	Biosynthesis of secondary metabolites	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMC200016991	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMC200016991	K00517	ko00626	Naphthalene and anthracene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMC200016991	K00517	ko00903	Limonene and pinene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMC200016991	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMC200016991	K00517	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMC200016992	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMC200016992	K00517	ko00626	Naphthalene and anthracene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMC200016992	K00517	ko00903	Limonene and pinene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMC200016992	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMC200016992	K00517	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMC200016993	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMC200016993	K00517	ko00626	Naphthalene and anthracene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMC200016993	K00517	ko00903	Limonene and pinene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMC200016993	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMC200016993	K00517	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMC200016996	K09755	ko00940	Phenylpropanoid biosynthesis	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMC200016996	K09755	ko01100	Metabolic pathways	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMC200016996	K09755	ko01110	Biosynthesis of secondary metabolites	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMC200016997	K09755	ko00940	Phenylpropanoid biosynthesis	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMC200016997	K09755	ko01100	Metabolic pathways	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMC200016997	K09755	ko01110	Biosynthesis of secondary metabolites	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMC200017000	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMC200017000	K00517	ko00626	Naphthalene and anthracene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMC200017000	K00517	ko00903	Limonene and pinene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMC200017000	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMC200017000	K00517	ko01110	Biosynthesis of secondary metabolites	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMC200010172	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMC200010172	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMC200010173	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMC200010173	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMC200010177	K04424	ko04010	MAPK signaling pathway	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMC200010177	K04424	ko04530	Tight junction	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMC200010178	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMC200010178	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMC200010180	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMC200010180	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMC200010183	K10746	ko03430	Mismatch repair	2459	8.6e-130	0.59	0.74	0.87
PGSC0003DMC200010184	K10746	ko03430	Mismatch repair	1046	7.4e-52	0.62	0.79	0.86
PGSC0003DMC200010185	K10529	ko00592	alpha-Linolenic acid metabolism	2785	9.0e-148	0.62	0.80	0.99
PGSC0003DMC200010186	K10529	ko00592	alpha-Linolenic acid metabolism	3217	1.3e-171	0.60	0.77	0.99
PGSC0003DMC200010187	K10529	ko00592	alpha-Linolenic acid metabolism	2288	2.3e-120	0.57	0.74	0.96
PGSC0003DMC200010188	K10529	ko00592	alpha-Linolenic acid metabolism	1982	1.8e-103	0.58	0.74	0.96
PGSC0003DMC200040171	K01771	ko00562	Inositol phosphate metabolism	271	4.1e-09	0.35	0.57	0.35
PGSC0003DMC200040187	K01590	ko00340	Histidine metabolism	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMC200040187	K01590	ko01100	Metabolic pathways	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMC200040187	K01590	ko01110	Biosynthesis of secondary metabolites	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMC200040188	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMC200040188	K01649	ko00620	Pyruvate metabolism	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMC200040188	K01649	ko01100	Metabolic pathways	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMC200040188	K01649	ko01110	Biosynthesis of secondary metabolites	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMC200046987	K12871	ko03040	Spliceosome	840	1.7e-40	0.64	0.81	0.99
PGSC0003DMC200046988	K00001	ko00010	Glycolysis / Gluconeogenesis	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00071	Fatty acid metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00350	Tyrosine metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00641	3-Chloroacrylic acid degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00830	Retinol metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko00982	Drug metabolism - cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko01100	Metabolic pathways	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046988	K00001	ko01110	Biosynthesis of secondary metabolites	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMC200046989	K00001	ko00010	Glycolysis / Gluconeogenesis	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00071	Fatty acid metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00350	Tyrosine metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00641	3-Chloroacrylic acid degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00830	Retinol metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko00982	Drug metabolism - cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko01100	Metabolic pathways	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046989	K00001	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMC200046990	K00121	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00071	Fatty acid metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00350	Tyrosine metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00624	1- and 2-Methylnaphthalene degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00641	3-Chloroacrylic acid degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00680	Methane metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00830	Retinol metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko00982	Drug metabolism - cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko01100	Metabolic pathways	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200046990	K00121	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMC200047003	K07342	ko03060	Protein export	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMC200047003	K07342	ko04145	Phagosome	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMC200047003	K07342	ko05110	Vibrio cholerae infection	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMC200057842	K00942	ko00230	Purine metabolism	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMC200057842	K00942	ko01100	Metabolic pathways	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMC200032835	K08496	ko04130	SNARE interactions in vesicular transport	1230	5.3e-62	0.63	0.81	0.96
PGSC0003DMC200032841	K02866	ko03010	Ribosome	727	2.9e-34	0.44	0.60	0.80
PGSC0003DMC200032844	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMC200029041	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMC200029041	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMC200029041	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMC200029041	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMC200029041	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMC200029043	K11818	ko00380	Tryptophan metabolism	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMC200029043	K11818	ko00966	Glucosinolate biosynthesis	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMC200029043	K11818	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMC200029044	K11818	ko00380	Tryptophan metabolism	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMC200029044	K11818	ko00966	Glucosinolate biosynthesis	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMC200029044	K11818	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMC200029045	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMC200029045	K00517	ko00626	Naphthalene and anthracene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMC200029045	K00517	ko00903	Limonene and pinene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMC200029045	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMC200029045	K00517	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMC200029046	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMC200029046	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMC200029046	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMC200029046	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMC200029046	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMC200029047	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMC200029047	K00517	ko00626	Naphthalene and anthracene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMC200029047	K00517	ko00903	Limonene and pinene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMC200029047	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMC200029047	K00517	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMC200029048	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMC200029048	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMC200029048	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMC200029048	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMC200029048	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMC200029049	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMC200029049	K00517	ko00626	Naphthalene and anthracene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMC200029049	K00517	ko00903	Limonene and pinene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMC200029049	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMC200029049	K00517	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMC200029050	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMC200029050	K00517	ko00626	Naphthalene and anthracene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMC200029050	K00517	ko00903	Limonene and pinene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMC200029050	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMC200029050	K00517	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMC200029051	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMC200029051	K00517	ko00626	Naphthalene and anthracene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMC200029051	K00517	ko00903	Limonene and pinene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMC200029051	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMC200029051	K00517	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMC200029052	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMC200029052	K00517	ko00626	Naphthalene and anthracene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMC200029052	K00517	ko00903	Limonene and pinene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMC200029052	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMC200029052	K00517	ko01110	Biosynthesis of secondary metabolites	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMC200029053	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMC200029053	K00517	ko00626	Naphthalene and anthracene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMC200029053	K00517	ko00903	Limonene and pinene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMC200029053	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMC200029053	K00517	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMC200029054	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMC200029054	K00517	ko00626	Naphthalene and anthracene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMC200029054	K00517	ko00903	Limonene and pinene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMC200029054	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMC200029054	K00517	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMC200029055	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029055	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029055	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029055	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029055	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029055	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMC200029056	K00100	ko00051	Fructose and mannose metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029056	K00100	ko00363	Bisphenol A degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029056	K00100	ko00591	Linoleic acid metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029056	K00100	ko00625	Tetrachloroethene degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029056	K00100	ko00650	Butanoate metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029056	K00100	ko01100	Metabolic pathways	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMC200029057	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMC200029057	K00517	ko00626	Naphthalene and anthracene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMC200029057	K00517	ko00903	Limonene and pinene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMC200029057	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMC200029057	K00517	ko01110	Biosynthesis of secondary metabolites	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMC200029058	K00100	ko00051	Fructose and mannose metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029058	K00100	ko00363	Bisphenol A degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029058	K00100	ko00591	Linoleic acid metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029058	K00100	ko00625	Tetrachloroethene degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029058	K00100	ko00650	Butanoate metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029058	K00100	ko01100	Metabolic pathways	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMC200029059	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029059	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029059	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029059	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029059	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029059	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029060	K00100	ko00051	Fructose and mannose metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029060	K00100	ko00363	Bisphenol A degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029060	K00100	ko00591	Linoleic acid metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029060	K00100	ko00625	Tetrachloroethene degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029060	K00100	ko00650	Butanoate metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029060	K00100	ko01100	Metabolic pathways	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMC200029061	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029061	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029061	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029061	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029061	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029061	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMC200029062	K00100	ko00051	Fructose and mannose metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029062	K00100	ko00363	Bisphenol A degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029062	K00100	ko00591	Linoleic acid metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029062	K00100	ko00625	Tetrachloroethene degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029062	K00100	ko00650	Butanoate metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029062	K00100	ko01100	Metabolic pathways	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMC200029063	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMC200029063	K00517	ko00626	Naphthalene and anthracene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMC200029063	K00517	ko00903	Limonene and pinene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMC200029063	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMC200029063	K00517	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMC200029064	K05275	ko00750	Vitamin B6 metabolism	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMC200029064	K05275	ko01100	Metabolic pathways	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMC200029065	K00100	ko00051	Fructose and mannose metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029065	K00100	ko00363	Bisphenol A degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029065	K00100	ko00591	Linoleic acid metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029065	K00100	ko00625	Tetrachloroethene degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029065	K00100	ko00650	Butanoate metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029065	K00100	ko01100	Metabolic pathways	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMC200029066	K00100	ko00051	Fructose and mannose metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029066	K00100	ko00363	Bisphenol A degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029066	K00100	ko00591	Linoleic acid metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029066	K00100	ko00625	Tetrachloroethene degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029066	K00100	ko00650	Butanoate metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029066	K00100	ko01100	Metabolic pathways	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMC200029067	K00100	ko00051	Fructose and mannose metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029067	K00100	ko00363	Bisphenol A degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029067	K00100	ko00591	Linoleic acid metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029067	K00100	ko00625	Tetrachloroethene degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029067	K00100	ko00650	Butanoate metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029067	K00100	ko01100	Metabolic pathways	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMC200029068	K00100	ko00051	Fructose and mannose metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029068	K00100	ko00363	Bisphenol A degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029068	K00100	ko00591	Linoleic acid metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029068	K00100	ko00625	Tetrachloroethene degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029068	K00100	ko00650	Butanoate metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029068	K00100	ko01100	Metabolic pathways	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMC200029069	K00100	ko00051	Fructose and mannose metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029069	K00100	ko00363	Bisphenol A degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029069	K00100	ko00591	Linoleic acid metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029069	K00100	ko00625	Tetrachloroethene degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029069	K00100	ko00650	Butanoate metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029069	K00100	ko01100	Metabolic pathways	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMC200029070	K00100	ko00051	Fructose and mannose metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200029070	K00100	ko00363	Bisphenol A degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200029070	K00100	ko00591	Linoleic acid metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200029070	K00100	ko00625	Tetrachloroethene degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200029070	K00100	ko00650	Butanoate metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200029070	K00100	ko01100	Metabolic pathways	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMC200008972	K12486	ko04144	Endocytosis	469	4.9e-20	0.30	0.45	0.98
PGSC0003DMC200008973	K12486	ko04144	Endocytosis	1334	9.6e-68	0.42	0.56	1.00
PGSC0003DMC200008974	K12486	ko04144	Endocytosis	1324	3.4e-67	0.42	0.56	1.00
PGSC0003DMC200008975	K12486	ko04144	Endocytosis	1324	3.4e-67	0.43	0.57	1.00
PGSC0003DMC200008976	K12486	ko04144	Endocytosis	229	1.6e-06	0.36	0.50	0.93
PGSC0003DMC200008981	K08139	ko04113	Meiosis - yeast	910	2.3e-44	0.36	0.56	0.85
PGSC0003DMC200008983	K06627	ko04110	Cell cycle	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMC200008983	K06627	ko04914	Progesterone-mediated oocyte maturation	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMC200008994	K02536	ko00540	Lipopolysaccharide biosynthesis	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMC200008994	K02536	ko01100	Metabolic pathways	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMC200008995	K02536	ko00540	Lipopolysaccharide biosynthesis	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMC200008995	K02536	ko01100	Metabolic pathways	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMC200008997	K02536	ko00540	Lipopolysaccharide biosynthesis	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMC200008997	K02536	ko01100	Metabolic pathways	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMC200008998	K09755	ko00940	Phenylpropanoid biosynthesis	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMC200008998	K09755	ko01100	Metabolic pathways	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMC200008998	K09755	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMC200009000	K02084	ko04115	p53 signaling pathway	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko04210	Apoptosis	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko05010	Alzheimer's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko05012	Parkinson's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko05016	Huntington's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200009000	K02084	ko05222	Small cell lung cancer	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMC200015793	K01193	ko00052	Galactose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMC200015793	K01193	ko00500	Starch and sucrose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMC200015793	K01193	ko01100	Metabolic pathways	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMC200015794	K00680	ko00350	Tyrosine metabolism	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMC200015794	K00680	ko00624	1- and 2-Methylnaphthalene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMC200015794	K00680	ko00632	Benzoate degradation via CoA ligation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMC200015794	K00680	ko00642	Ethylbenzene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMC200015794	K00680	ko00903	Limonene and pinene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMC200015807	K01953	ko00250	Alanine, aspartate and glutamate metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMC200015807	K01953	ko00910	Nitrogen metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMC200015807	K01953	ko01100	Metabolic pathways	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMC200015807	K01953	ko01110	Biosynthesis of secondary metabolites	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMC200015808	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMC200015809	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.76
PGSC0003DMC200015810	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMC200026413	K04428	ko04010	MAPK signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMC200026413	K04428	ko04912	GnRH signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMC200026414	K11230	ko04011	MAPK signaling pathway - yeast	698	5.8e-32	0.39	0.58	0.76
PGSC0003DMC200026415	K04428	ko04010	MAPK signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMC200026415	K04428	ko04912	GnRH signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMC200026416	K12929	ko00904	Diterpenoid biosynthesis	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMC200026416	K12929	ko01110	Biosynthesis of secondary metabolites	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMC200026417	K12929	ko00904	Diterpenoid biosynthesis	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMC200026417	K12929	ko01110	Biosynthesis of secondary metabolites	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMC200026418	K12929	ko00904	Diterpenoid biosynthesis	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMC200026418	K12929	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMC200026430	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMC200026430	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMC200026430	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMC200026430	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMC200026430	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMC200063307	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.32	0.48	0.96
PGSC0003DMC200063314	K13030	ko00460	Cyanoamino acid metabolism	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMC200063314	K13030	ko01110	Biosynthesis of secondary metabolites	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMC200042392	K01895	ko00010	Glycolysis / Gluconeogenesis	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042392	K01895	ko00620	Pyruvate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042392	K01895	ko00640	Propanoate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042392	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042392	K01895	ko01100	Metabolic pathways	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042392	K01895	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMC200042393	K01895	ko00010	Glycolysis / Gluconeogenesis	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042393	K01895	ko00620	Pyruvate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042393	K01895	ko00640	Propanoate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042393	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042393	K01895	ko01100	Metabolic pathways	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042393	K01895	ko01110	Biosynthesis of secondary metabolites	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMC200042394	K01895	ko00010	Glycolysis / Gluconeogenesis	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042394	K01895	ko00620	Pyruvate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042394	K01895	ko00640	Propanoate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042394	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042394	K01895	ko01100	Metabolic pathways	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042394	K01895	ko01110	Biosynthesis of secondary metabolites	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMC200042396	K01689	ko00010	Glycolysis / Gluconeogenesis	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMC200042396	K01689	ko01100	Metabolic pathways	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMC200042396	K01689	ko01110	Biosynthesis of secondary metabolites	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMC200042396	K01689	ko03018	RNA degradation	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMC200042397	K01689	ko00010	Glycolysis / Gluconeogenesis	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMC200042397	K01689	ko01100	Metabolic pathways	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMC200042397	K01689	ko01110	Biosynthesis of secondary metabolites	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMC200042397	K01689	ko03018	RNA degradation	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMC200036965	K08486	ko04130	SNARE interactions in vesicular transport	1108	2.8e-55	0.73	0.84	0.92
PGSC0003DMC200036966	K08486	ko04130	SNARE interactions in vesicular transport	1887	3.0e-98	0.75	0.88	1.00
PGSC0003DMC200036982	K12811	ko03040	Spliceosome	318	5.6e-09	0.25	0.43	0.92
PGSC0003DMC200036989	K05681	ko02010	ABC transporters	1249	4.7e-63	0.36	0.54	0.81
PGSC0003DMC200048845	K02327	ko00230	Purine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko00240	Pyrimidine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko01100	Metabolic pathways	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko03030	DNA replication	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko03410	Base excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko03420	Nucleotide excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko03430	Mismatch repair	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048845	K02327	ko03440	Homologous recombination	7941	0.	0.85	0.92	1.00
PGSC0003DMC200048846	K02327	ko00230	Purine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko00240	Pyrimidine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko01100	Metabolic pathways	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko03030	DNA replication	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko03410	Base excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko03420	Nucleotide excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko03430	Mismatch repair	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048846	K02327	ko03440	Homologous recombination	8040	0.	0.86	0.93	1.00
PGSC0003DMC200048848	K01625	ko00030	Pentose phosphate pathway	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMC200048848	K01625	ko00040	Pentose and glucuronate interconversions	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMC200048848	K01625	ko00330	Arginine and proline metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMC200048848	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMC200048848	K01625	ko01100	Metabolic pathways	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMC200048849	K01625	ko00030	Pentose phosphate pathway	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMC200048849	K01625	ko00040	Pentose and glucuronate interconversions	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMC200048849	K01625	ko00330	Arginine and proline metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMC200048849	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMC200048849	K01625	ko01100	Metabolic pathways	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMC200048850	K01625	ko00030	Pentose phosphate pathway	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMC200048850	K01625	ko00040	Pentose and glucuronate interconversions	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMC200048850	K01625	ko00330	Arginine and proline metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMC200048850	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMC200048850	K01625	ko01100	Metabolic pathways	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMC200048856	K09054	ko05010	Alzheimer's disease	253	1.5e-06	0.28	0.46	0.66
PGSC0003DMC200048858	K11098	ko03040	Spliceosome	644	1.1e-29	0.85	0.95	0.99
PGSC0003DMC200048864	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMC200048864	K01563	ko00626	Naphthalene and anthracene degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMC200048864	K01563	ko00631	1,2-Dichloroethane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMC200048864	K01563	ko00641	3-Chloroacrylic acid degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMC200048864	K01563	ko01100	Metabolic pathways	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMC200048869	K00549	ko00270	Cysteine and methionine metabolism	5729	0.	0.88	0.94	1.00
PGSC0003DMC200048869	K00549	ko01100	Metabolic pathways	5729	0.	0.88	0.94	1.00
PGSC0003DMC200048869	K00549	ko01110	Biosynthesis of secondary metabolites	5729	0.	0.88	0.94	1.00
PGSC0003DMC200048870	K08486	ko04130	SNARE interactions in vesicular transport	2080	6.9e-109	0.82	0.90	1.00
PGSC0003DMC200013591	K13065	ko00940	Phenylpropanoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMC200013591	K13065	ko00941	Flavonoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMC200013591	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMC200013591	K13065	ko01110	Biosynthesis of secondary metabolites	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMC200013601	K10589	ko04120	Ubiquitin mediated proteolysis	674	3.4e-34	0.35	0.52	0.86
PGSC0003DMC200013602	K10589	ko04120	Ubiquitin mediated proteolysis	589	1.8e-29	0.36	0.55	0.79
PGSC0003DMC200013606	K02872	ko03010	Ribosome	1619	1.8e-83	0.92	0.97	1.00
PGSC0003DMC200013618	K00799	ko00480	Glutathione metabolism	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMC200013618	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMC200013618	K00799	ko00982	Drug metabolism - cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMC200008163	K13289	ko04142	Lysosome	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMC200008163	K13289	ko04614	Renin-angiotensin system	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMC200008165	K00970	ko03018	RNA degradation	1185	1.6e-59	0.37	0.56	0.86
PGSC0003DMC200008166	K00970	ko03018	RNA degradation	257	5.8e-08	0.29	0.49	0.93
PGSC0003DMC200008172	K01051	ko00040	Pentose and glucuronate interconversions	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMC200008172	K01051	ko00500	Starch and sucrose metabolism	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMC200008172	K01051	ko01100	Metabolic pathways	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMC200008173	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMC200008173	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMC200008173	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMC200008185	K01051	ko00040	Pentose and glucuronate interconversions	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMC200008185	K01051	ko00500	Starch and sucrose metabolism	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMC200008185	K01051	ko01100	Metabolic pathways	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMC200020052	K11818	ko00380	Tryptophan metabolism	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMC200020052	K11818	ko00966	Glucosinolate biosynthesis	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMC200020052	K11818	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMC200020054	K01557	ko00350	Tyrosine metabolism	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMC200020054	K01557	ko01100	Metabolic pathways	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMC200020058	K09699	ko00280	Valine, leucine and isoleucine degradation	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMC200020058	K09699	ko01100	Metabolic pathways	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMC200020058	K09699	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMC200020059	K09699	ko00280	Valine, leucine and isoleucine degradation	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMC200020059	K09699	ko01100	Metabolic pathways	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMC200020059	K09699	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMC200020060	K09699	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMC200020060	K09699	ko01100	Metabolic pathways	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMC200020060	K09699	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMC200020061	K10418	ko04962	Vasopressin-regulated water reabsorption	706	4.2e-33	0.74	0.82	0.98
PGSC0003DMC200020066	K01710	ko00521	Streptomycin biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMC200020066	K01710	ko00523	Polyketide sugar unit biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMC200020066	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMC200020066	K01710	ko01100	Metabolic pathways	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMC200020066	K01710	ko01110	Biosynthesis of secondary metabolites	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMC200020067	K01710	ko00521	Streptomycin biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMC200020067	K01710	ko00523	Polyketide sugar unit biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMC200020067	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMC200020067	K01710	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMC200020067	K01710	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMC200020069	K10599	ko03040	Spliceosome	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMC200020069	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMC200061834	K11644	ko05016	Huntington's disease	687	1.9e-31	0.59	0.71	0.55
PGSC0003DMC200061856	K07195	ko04910	Insulin signaling pathway	3008	4.5e-160	0.59	0.72	0.99
PGSC0003DMC200061859	K11816	ko00380	Tryptophan metabolism	803	1.9e-38	0.46	0.65	0.95
PGSC0003DMC200002371	K03869	ko04120	Ubiquitin mediated proteolysis	5513	3.1e-298	0.88	0.95	1.00
PGSC0003DMC200002372	K03869	ko04120	Ubiquitin mediated proteolysis	4903	1.4e-264	0.88	0.95	1.00
PGSC0003DMC200002380	K06675	ko04111	Cell cycle - yeast	5148	4.2e-278	0.77	0.89	0.98
PGSC0003DMC200002381	K06675	ko04111	Cell cycle - yeast	7990	0.	0.78	0.89	0.99
PGSC0003DMC200002383	K00703	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMC200002383	K00703	ko01100	Metabolic pathways	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMC200002384	K00703	ko00500	Starch and sucrose metabolism	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMC200002384	K00703	ko01100	Metabolic pathways	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMC200002390	K02183	ko04020	Calcium signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04070	Phosphatidylinositol signaling system	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04114	Oocyte meiosis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04270	Vascular smooth muscle contraction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04626	Plant-pathogen interaction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04720	Long-term potentiation	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04722	Neurotrophin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04740	Olfactory transduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04744	Phototransduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04745	Phototransduction - fly	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04910	Insulin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04912	GnRH signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04916	Melanogenesis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04970	Salivary secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko04971	Gastric acid secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko05010	Alzheimer's disease	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002390	K02183	ko05214	Glioma	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMC200002400	K06653	ko04111	Cell cycle - yeast	296	1.1e-09	0.31	0.49	0.77
PGSC0003DMC200061001	K00368	ko00910	Nitrogen metabolism	712	2.0e-33	0.37	0.52	0.89
PGSC0003DMC200061005	K10760	ko00908	Zeatin biosynthesis	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMC200061005	K10760	ko01100	Metabolic pathways	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMC200061005	K10760	ko01110	Biosynthesis of secondary metabolites	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMC200066256	K12356	ko00940	Phenylpropanoid biosynthesis	764	2.6e-36	0.35	0.50	0.92
PGSC0003DMC200066260	K00799	ko00480	Glutathione metabolism	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMC200066260	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMC200066260	K00799	ko00982	Drug metabolism - cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMC200006727	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006727	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006731	K04618	ko00052	Galactose metabolism	482	9.5e-21	0.29	0.45	0.87
PGSC0003DMC200006732	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMC200006737	K12383	ko04142	Lysosome	219	3.0e-06	0.35	0.45	0.43
PGSC0003DMC200006739	K01179	ko00500	Starch and sucrose metabolism	372	1.1e-14	0.50	0.72	0.86
PGSC0003DMC200006740	K01179	ko00500	Starch and sucrose metabolism	1583	1.8e-81	0.43	0.63	0.91
PGSC0003DMC200006741	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.42	0.61	0.92
PGSC0003DMC200006747	K09389	ko04110	Cell cycle	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05200	Pathways in cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05212	Pancreatic cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05214	Glioma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05215	Prostate cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05218	Melanoma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05219	Bladder cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05220	Chronic myeloid leukemia	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05222	Small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006747	K09389	ko05223	Non-small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMC200006748	K06620	ko04110	Cell cycle	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05200	Pathways in cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05212	Pancreatic cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05214	Glioma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05215	Prostate cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05218	Melanoma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05219	Bladder cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05220	Chronic myeloid leukemia	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05222	Small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006748	K06620	ko05223	Non-small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMC200006749	K06620	ko04110	Cell cycle	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05200	Pathways in cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05212	Pancreatic cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05214	Glioma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05215	Prostate cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05218	Melanoma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05219	Bladder cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05220	Chronic myeloid leukemia	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05222	Small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200006749	K06620	ko05223	Non-small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMC200012057	K05863	ko04020	Calcium signaling pathway	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMC200012057	K05863	ko05012	Parkinson's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMC200012057	K05863	ko05016	Huntington's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMC200053885	K02878	ko03010	Ribosome	525	4.0e-23	0.52	0.65	0.95
PGSC0003DMC200053888	K00558	ko00270	Cysteine and methionine metabolism	9011	0.	0.73	0.84	1.00
PGSC0003DMC200053888	K00558	ko01100	Metabolic pathways	9011	0.	0.73	0.84	1.00
PGSC0003DMC200053890	K03935	ko00190	Oxidative phosphorylation	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMC200053890	K03935	ko01100	Metabolic pathways	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMC200053890	K03935	ko05010	Alzheimer's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMC200053890	K03935	ko05012	Parkinson's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMC200053890	K03935	ko05016	Huntington's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMC200053892	K04371	ko04010	MAPK signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04012	ErbB signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04013	MAPK signaling pathway - fly	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04062	Chemokine signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04114	Oocyte meiosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04150	mTOR signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04270	Vascular smooth muscle contraction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04320	Dorso-ventral axis formation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04350	TGF-beta signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04360	Axon guidance	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04370	VEGF signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04510	Focal adhesion	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04520	Adherens junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04540	Gap junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04621	NOD-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04650	Natural killer cell mediated cytotoxicity	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04660	T cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04662	B cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04664	Fc epsilon RI signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04666	Fc gamma R-mediated phagocytosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04720	Long-term potentiation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04730	Long-term depression	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04810	Regulation of actin cytoskeleton	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04910	Insulin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04912	GnRH signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04916	Melanogenesis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04930	Type II diabetes mellitus	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko04960	Aldosterone-regulated sodium reabsorption	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05010	Alzheimer's disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05020	Prion diseases	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05131	Shigellosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05140	Leishmaniasis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05142	Chagas disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05200	Pathways in cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05210	Colorectal cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05211	Renal cell carcinoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05212	Pancreatic cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05213	Endometrial cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05214	Glioma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05215	Prostate cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05216	Thyroid cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05218	Melanoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05219	Bladder cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05220	Chronic myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05221	Acute myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053892	K04371	ko05223	Non-small cell lung cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMC200053900	K01092	ko00521	Streptomycin biosynthesis	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMC200053900	K01092	ko00562	Inositol phosphate metabolism	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMC200053900	K01092	ko01100	Metabolic pathways	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMC200053900	K01092	ko01110	Biosynthesis of secondary metabolites	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMC200053900	K01092	ko04070	Phosphatidylinositol signaling system	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMC200053901	K10685	ko04120	Ubiquitin mediated proteolysis	4207	3.3e-226	0.78	0.86	1.00
PGSC0003DMC200053902	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMC200053903	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMC200053904	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.68
PGSC0003DMC200053905	K11294	ko05130	Pathogenic Escherichia coli infection	254	4.3e-08	0.33	0.56	0.62
PGSC0003DMC200053909	K01190	ko00052	Galactose metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMC200053909	K01190	ko00511	Other glycan degradation	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMC200053909	K01190	ko00600	Sphingolipid metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMC200053909	K01190	ko01100	Metabolic pathways	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMC200053910	K01190	ko00052	Galactose metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMC200053910	K01190	ko00511	Other glycan degradation	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMC200053910	K01190	ko00600	Sphingolipid metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMC200053910	K01190	ko01100	Metabolic pathways	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMC200037938	K01076	ko00632	Benzoate degradation via CoA ligation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMC200037938	K01076	ko00903	Limonene and pinene degradation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMC200037938	K01076	ko01040	Biosynthesis of unsaturated fatty acids	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMC200037939	K01076	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMC200037939	K01076	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMC200037939	K01076	ko01040	Biosynthesis of unsaturated fatty acids	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMC200037948	K05740	ko04510	Focal adhesion	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMC200037948	K05740	ko04810	Regulation of actin cytoskeleton	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMC200037948	K05740	ko05131	Shigellosis	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMC200043241	K00765	ko00340	Histidine metabolism	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMC200043241	K00765	ko01100	Metabolic pathways	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMC200043241	K00765	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMC200043246	K02951	ko03010	Ribosome	1014	4.3e-50	0.84	0.92	0.99
PGSC0003DMC200031713	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMC200031713	K00517	ko00626	Naphthalene and anthracene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMC200031713	K00517	ko00903	Limonene and pinene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMC200031713	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMC200031713	K00517	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMC200031714	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMC200031714	K00517	ko00626	Naphthalene and anthracene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMC200031714	K00517	ko00903	Limonene and pinene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMC200031714	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMC200031714	K00517	ko01110	Biosynthesis of secondary metabolites	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMC200031715	K07466	ko03030	DNA replication	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMC200031715	K07466	ko03420	Nucleotide excision repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMC200031715	K07466	ko03430	Mismatch repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMC200031715	K07466	ko03440	Homologous recombination	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMC200031716	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMC200031716	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMC200031716	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMC200031716	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMC200031716	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMC200031728	K00991	ko00900	Terpenoid backbone biosynthesis	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMC200031728	K00991	ko01100	Metabolic pathways	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMC200031729	K00991	ko00900	Terpenoid backbone biosynthesis	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMC200031729	K00991	ko01100	Metabolic pathways	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMC200031730	K00991	ko00900	Terpenoid backbone biosynthesis	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMC200031730	K00991	ko01100	Metabolic pathways	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMC200031731	K00991	ko00900	Terpenoid backbone biosynthesis	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMC200031731	K00991	ko01100	Metabolic pathways	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMC200031733	K09753	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMC200031733	K09753	ko01100	Metabolic pathways	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMC200031733	K09753	ko01110	Biosynthesis of secondary metabolites	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMC200031735	K09753	ko00940	Phenylpropanoid biosynthesis	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMC200031735	K09753	ko01100	Metabolic pathways	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMC200031735	K09753	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMC200031736	K09753	ko00940	Phenylpropanoid biosynthesis	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMC200031736	K09753	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMC200031736	K09753	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMC200064389	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200064389	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200064389	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200064398	K01762	ko00270	Cysteine and methionine metabolism	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMC200064398	K01762	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMC200064401	K05278	ko00941	Flavonoid biosynthesis	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMC200064401	K05278	ko01100	Metabolic pathways	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMC200064401	K05278	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMC200068731	K10760	ko00908	Zeatin biosynthesis	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMC200068731	K10760	ko01100	Metabolic pathways	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMC200068731	K10760	ko01110	Biosynthesis of secondary metabolites	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMC200068745	K01051	ko00040	Pentose and glucuronate interconversions	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMC200068745	K01051	ko00500	Starch and sucrose metabolism	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMC200068745	K01051	ko01100	Metabolic pathways	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMC200017117	K04733	ko04210	Apoptosis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMC200017117	K04733	ko04620	Toll-like receptor signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMC200017117	K04733	ko04722	Neurotrophin signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMC200017117	K04733	ko05140	Leishmaniasis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMC200017117	K04733	ko05142	Chagas disease	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMC200017123	K00284	ko00910	Nitrogen metabolism	11627	0.	0.85	0.91	1.00
PGSC0003DMC200017124	K00284	ko00910	Nitrogen metabolism	11939	0.	0.86	0.93	1.00
PGSC0003DMC200017125	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMC200017125	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMC200017126	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMC200017126	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMC200010653	K12126	ko04712	Circadian rhythm - plant	319	1.1e-11	0.47	0.71	0.43
PGSC0003DMC200010669	K06685	ko04111	Cell cycle - yeast	411	2.7e-13	0.28	0.44	0.43
PGSC0003DMC200010670	K06685	ko04111	Cell cycle - yeast	425	6.4e-14	0.27	0.43	0.44
PGSC0003DMC200014960	K01426	ko00330	Arginine and proline metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014960	K01426	ko00360	Phenylalanine metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014960	K01426	ko00380	Tryptophan metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014960	K01426	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014960	K01426	ko00632	Benzoate degradation via CoA ligation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014960	K01426	ko00643	Styrene degradation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMC200014968	K00558	ko00270	Cysteine and methionine metabolism	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMC200014968	K00558	ko01100	Metabolic pathways	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMC200039465	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039465	K01580	ko00410	beta-Alanine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039465	K01580	ko00430	Taurine and hypotaurine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039465	K01580	ko00650	Butanoate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039465	K01580	ko01100	Metabolic pathways	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039465	K01580	ko04940	Type I diabetes mellitus	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMC200039476	K09659	ko00510	N-Glycan biosynthesis	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMC200039476	K09659	ko01100	Metabolic pathways	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMC200039477	K09659	ko00510	N-Glycan biosynthesis	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMC200039477	K09659	ko01100	Metabolic pathways	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMC200056892	K03094	ko04110	Cell cycle	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04111	Cell cycle - yeast	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04114	Oocyte meiosis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04120	Ubiquitin mediated proteolysis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04310	Wnt signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04350	TGF-beta signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200056892	K03094	ko04710	Circadian rhythm - mammal	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMC200009470	K01509	ko00230	Purine metabolism	824	1.4e-39	0.49	0.67	0.96
PGSC0003DMC200009471	K01509	ko00230	Purine metabolism	1483	5.8e-76	0.47	0.66	0.84
PGSC0003DMC200009472	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMC200009473	K01509	ko00230	Purine metabolism	1564	2.0e-80	0.34	0.53	0.84
PGSC0003DMC200009474	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMC200015903	K02210	ko03030	DNA replication	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMC200015903	K02210	ko04110	Cell cycle	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMC200015903	K02210	ko04111	Cell cycle - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMC200015903	K02210	ko04113	Meiosis - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMC200015929	K01897	ko00071	Fatty acid metabolism	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMC200015929	K01897	ko01100	Metabolic pathways	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMC200015929	K01897	ko03320	PPAR signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMC200015929	K01897	ko04146	Peroxisome	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMC200015929	K01897	ko04920	Adipocytokine signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMC200015930	K01897	ko00071	Fatty acid metabolism	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMC200015930	K01897	ko01100	Metabolic pathways	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMC200015930	K01897	ko03320	PPAR signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMC200015930	K01897	ko04146	Peroxisome	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMC200015930	K01897	ko04920	Adipocytokine signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMC200026896	K06636	ko04110	Cell cycle	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMC200026896	K06636	ko04111	Cell cycle - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMC200026896	K06636	ko04113	Meiosis - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMC200026896	K06636	ko04114	Oocyte meiosis	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMC200026899	K01810	ko00010	Glycolysis / Gluconeogenesis	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026899	K01810	ko00030	Pentose phosphate pathway	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026899	K01810	ko00500	Starch and sucrose metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026899	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026899	K01810	ko01100	Metabolic pathways	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026899	K01810	ko01110	Biosynthesis of secondary metabolites	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMC200026904	K05681	ko02010	ABC transporters	1201	2.1e-60	0.36	0.55	0.99
PGSC0003DMC200026905	K05681	ko02010	ABC transporters	1307	3.0e-66	0.36	0.55	0.96
PGSC0003DMC200026908	K00492	ko00340	Histidine metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00363	Bisphenol A degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00622	Toluene and xylene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00624	1- and 2-Methylnaphthalene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00626	Naphthalene and anthracene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00627	1,4-Dichlorobenzene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00680	Methane metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko00903	Limonene and pinene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko01100	Metabolic pathways	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026908	K00492	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMC200026910	K00492	ko00340	Histidine metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00363	Bisphenol A degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00622	Toluene and xylene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00624	1- and 2-Methylnaphthalene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00626	Naphthalene and anthracene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00627	1,4-Dichlorobenzene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00680	Methane metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko00903	Limonene and pinene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko01100	Metabolic pathways	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200026910	K00492	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMC200063201	K05282	ko00904	Diterpenoid biosynthesis	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMC200063201	K05282	ko01100	Metabolic pathways	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMC200063201	K05282	ko01110	Biosynthesis of secondary metabolites	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMC200063204	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMC200063204	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMC200063204	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMC200063204	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMC200063204	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMC200063208	K03133	ko03022	Basal transcription factors	315	1.5e-11	0.58	0.73	0.90
PGSC0003DMC200040661	K00430	ko00360	Phenylalanine metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMC200040661	K00430	ko00680	Methane metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMC200040661	K00430	ko00940	Phenylpropanoid biosynthesis	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMC200040661	K00430	ko01100	Metabolic pathways	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMC200040661	K00430	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMC200040678	K11717	ko00450	Selenoamino acid metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMC200040678	K11717	ko00730	Thiamine metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMC200040678	K11717	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMC200040679	K11717	ko00450	Selenoamino acid metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMC200040679	K11717	ko00730	Thiamine metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMC200040679	K11717	ko01100	Metabolic pathways	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMC200047102	K00522	ko00860	Porphyrin and chlorophyll metabolism	538	7.7e-24	0.67	0.78	0.51
PGSC0003DMC200047103	K00522	ko00860	Porphyrin and chlorophyll metabolism	823	1.5e-39	0.60	0.75	0.66
PGSC0003DMC200047104	K03103	ko00562	Inositol phosphate metabolism	401	2.8e-16	0.29	0.45	0.93
PGSC0003DMC200047105	K03103	ko00562	Inositol phosphate metabolism	566	2.2e-25	0.28	0.49	0.81
PGSC0003DMC200047106	K03103	ko00562	Inositol phosphate metabolism	562	3.7e-25	0.28	0.49	0.81
PGSC0003DMC200047107	K03103	ko00562	Inositol phosphate metabolism	530	2.1e-23	0.27	0.46	0.82
PGSC0003DMC200047117	K01100	ko00710	Carbon fixation in photosynthetic organisms	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMC200047117	K01100	ko01100	Metabolic pathways	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMC200047118	K01100	ko00710	Carbon fixation in photosynthetic organisms	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMC200047118	K01100	ko01100	Metabolic pathways	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMC200047121	K13065	ko00940	Phenylpropanoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMC200047121	K13065	ko00941	Flavonoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMC200047121	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMC200047121	K13065	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMC200047126	K05857	ko00562	Inositol phosphate metabolism	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMC200047126	K05857	ko01100	Metabolic pathways	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMC200047126	K05857	ko04020	Calcium signaling pathway	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMC200047126	K05857	ko04070	Phosphatidylinositol signaling system	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMC200047127	K05857	ko00562	Inositol phosphate metabolism	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMC200047127	K05857	ko01100	Metabolic pathways	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMC200047127	K05857	ko04020	Calcium signaling pathway	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMC200047127	K05857	ko04070	Phosphatidylinositol signaling system	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMC200032461	K04733	ko04210	Apoptosis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMC200032461	K04733	ko04620	Toll-like receptor signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMC200032461	K04733	ko04722	Neurotrophin signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMC200032461	K04733	ko05140	Leishmaniasis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMC200032461	K04733	ko05142	Chagas disease	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMC200032462	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMC200032462	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMC200032462	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMC200032462	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMC200032462	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMC200032463	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6180	0.	0.75	0.84	0.81
PGSC0003DMC200032464	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6350	0.	0.77	0.86	0.99
PGSC0003DMC200032467	K00655	ko00561	Glycerolipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMC200032467	K00655	ko00564	Glycerophospholipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMC200032467	K00655	ko01100	Metabolic pathways	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMC200032468	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032468	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032468	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032469	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032469	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032469	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMC200032477	K08242	ko00100	Steroid biosynthesis	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMC200032477	K08242	ko01110	Biosynthesis of secondary metabolites	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMC200032483	K06640	ko04110	Cell cycle	11655	0.	0.68	0.82	1.00
PGSC0003DMC200032483	K06640	ko04115	p53 signaling pathway	11655	0.	0.68	0.82	1.00
PGSC0003DMC200032485	K06640	ko04110	Cell cycle	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMC200032485	K06640	ko04115	p53 signaling pathway	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMC200032486	K04424	ko04010	MAPK signaling pathway	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMC200032486	K04424	ko04530	Tight junction	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMC200032487	K04424	ko04010	MAPK signaling pathway	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMC200032487	K04424	ko04530	Tight junction	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMC200044945	K00145	ko00330	Arginine and proline metabolism	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMC200044945	K00145	ko01100	Metabolic pathways	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMC200044945	K00145	ko01110	Biosynthesis of secondary metabolites	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMC200044947	K00145	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMC200044947	K00145	ko01100	Metabolic pathways	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMC200044947	K00145	ko01110	Biosynthesis of secondary metabolites	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMC200044949	K08233	ko00901	Indole alkaloid biosynthesis	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMC200044949	K08233	ko01110	Biosynthesis of secondary metabolites	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMC200044950	K08233	ko00901	Indole alkaloid biosynthesis	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMC200044950	K08233	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMC200044951	K08233	ko00901	Indole alkaloid biosynthesis	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMC200044951	K08233	ko01110	Biosynthesis of secondary metabolites	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMC200044952	K08233	ko00901	Indole alkaloid biosynthesis	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMC200044952	K08233	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMC200044953	K08233	ko00901	Indole alkaloid biosynthesis	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMC200044953	K08233	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMC200044954	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMC200044954	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMC200044955	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMC200044955	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMC200044956	K08233	ko00901	Indole alkaloid biosynthesis	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMC200044956	K08233	ko01110	Biosynthesis of secondary metabolites	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMC200044957	K08233	ko00901	Indole alkaloid biosynthesis	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMC200044957	K08233	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMC200044958	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMC200044958	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMC200044959	K08233	ko00901	Indole alkaloid biosynthesis	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMC200044959	K08233	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMC200044960	K08233	ko00901	Indole alkaloid biosynthesis	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMC200044960	K08233	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMC200044961	K08233	ko00901	Indole alkaloid biosynthesis	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMC200044961	K08233	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMC200044962	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMC200044962	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMC200044963	K08233	ko00901	Indole alkaloid biosynthesis	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMC200044963	K08233	ko01110	Biosynthesis of secondary metabolites	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMC200044965	K08233	ko00901	Indole alkaloid biosynthesis	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMC200044965	K08233	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMC200044966	K08233	ko00901	Indole alkaloid biosynthesis	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMC200044966	K08233	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMC200044967	K08233	ko00901	Indole alkaloid biosynthesis	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMC200044967	K08233	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMC200044968	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMC200044968	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMC200044969	K08233	ko00901	Indole alkaloid biosynthesis	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMC200044969	K08233	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMC200044970	K08233	ko00901	Indole alkaloid biosynthesis	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMC200044970	K08233	ko01110	Biosynthesis of secondary metabolites	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMC200023881	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMC200023882	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMC200023883	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMC200023895	K09680	ko00770	Pantothenate and CoA biosynthesis	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMC200023895	K09680	ko01100	Metabolic pathways	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMC200023896	K09680	ko00770	Pantothenate and CoA biosynthesis	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMC200023896	K09680	ko01100	Metabolic pathways	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMC200023897	K09680	ko00770	Pantothenate and CoA biosynthesis	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMC200023897	K09680	ko01100	Metabolic pathways	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMC200023903	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMC200023903	K01661	ko01100	Metabolic pathways	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMC200023903	K01661	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMC200023904	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMC200023904	K01661	ko01100	Metabolic pathways	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMC200023904	K01661	ko01110	Biosynthesis of secondary metabolites	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMC200023905	K01184	ko00040	Pentose and glucuronate interconversions	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMC200023905	K01184	ko00500	Starch and sucrose metabolism	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMC200023905	K01184	ko01100	Metabolic pathways	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMC200023906	K01184	ko00040	Pentose and glucuronate interconversions	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMC200023906	K01184	ko00500	Starch and sucrose metabolism	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMC200023906	K01184	ko01100	Metabolic pathways	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMC200023907	K01184	ko00040	Pentose and glucuronate interconversions	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMC200023907	K01184	ko00500	Starch and sucrose metabolism	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMC200023907	K01184	ko01100	Metabolic pathways	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMC200023908	K01184	ko00040	Pentose and glucuronate interconversions	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMC200023908	K01184	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMC200023908	K01184	ko01100	Metabolic pathways	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMC200013235	K05681	ko02010	ABC transporters	898	1.1e-43	0.42	0.68	0.70
PGSC0003DMC200013237	K05681	ko02010	ABC transporters	931	1.6e-45	0.36	0.59	0.80
PGSC0003DMC200013238	K01595	ko00620	Pyruvate metabolism	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMC200013238	K01595	ko00710	Carbon fixation in photosynthetic organisms	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMC200013238	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMC200013238	K01595	ko01100	Metabolic pathways	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMC200013239	K01595	ko00620	Pyruvate metabolism	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMC200013239	K01595	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMC200013239	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMC200013239	K01595	ko01100	Metabolic pathways	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMC200013240	K01595	ko00620	Pyruvate metabolism	7179	0.	0.80	0.89	1.00
PGSC0003DMC200013240	K01595	ko00710	Carbon fixation in photosynthetic organisms	7179	0.	0.80	0.89	1.00
PGSC0003DMC200013240	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7179	0.	0.80	0.89	1.00
PGSC0003DMC200013240	K01595	ko01100	Metabolic pathways	7179	0.	0.80	0.89	1.00
PGSC0003DMC200013241	K01595	ko00620	Pyruvate metabolism	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMC200013241	K01595	ko00710	Carbon fixation in photosynthetic organisms	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMC200013241	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMC200013241	K01595	ko01100	Metabolic pathways	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMC200013260	K00162	ko00010	Glycolysis / Gluconeogenesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko00020	Citrate cycle (TCA cycle)	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko00620	Pyruvate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko00650	Butanoate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko01100	Metabolic pathways	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200013260	K00162	ko01110	Biosynthesis of secondary metabolites	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMC200007926	K01193	ko00052	Galactose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMC200007926	K01193	ko00500	Starch and sucrose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMC200007926	K01193	ko01100	Metabolic pathways	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMC200007927	K01193	ko00052	Galactose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMC200007927	K01193	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMC200007927	K01193	ko01100	Metabolic pathways	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMC200007939	K13065	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMC200007939	K13065	ko00941	Flavonoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMC200007939	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMC200007939	K13065	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMC200007940	K13065	ko00940	Phenylpropanoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMC200007940	K13065	ko00941	Flavonoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMC200007940	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMC200007940	K13065	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMC200062193	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200062193	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200062193	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200062198	K12929	ko00904	Diterpenoid biosynthesis	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMC200062198	K12929	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMC200062203	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMC200062203	K00517	ko00626	Naphthalene and anthracene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMC200062203	K00517	ko00903	Limonene and pinene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMC200062203	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMC200062203	K00517	ko01110	Biosynthesis of secondary metabolites	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMC200067450	K00799	ko00480	Glutathione metabolism	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMC200067450	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMC200067450	K00799	ko00982	Drug metabolism - cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMC200002851	K00640	ko00270	Cysteine and methionine metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMC200002851	K00640	ko00920	Sulfur metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMC200002851	K00640	ko01100	Metabolic pathways	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMC200002852	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMC200002852	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMC200002852	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMC200002853	K01053	ko00030	Pentose phosphate pathway	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMC200002853	K01053	ko00053	Ascorbate and aldarate metabolism	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMC200002853	K01053	ko00930	Caprolactam degradation	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMC200002853	K01053	ko01100	Metabolic pathways	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMC200002853	K01053	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMC200002856	K06636	ko04110	Cell cycle	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMC200002856	K06636	ko04111	Cell cycle - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMC200002856	K06636	ko04113	Meiosis - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMC200002856	K06636	ko04114	Oocyte meiosis	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMC200002868	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMC200002868	K05284	ko01100	Metabolic pathways	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMC200002869	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMC200002869	K05284	ko01100	Metabolic pathways	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMC200002870	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMC200002870	K05284	ko01100	Metabolic pathways	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMC200002871	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMC200002871	K05284	ko01100	Metabolic pathways	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMC200002872	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMC200002872	K05284	ko01100	Metabolic pathways	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMC200042043	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMC200042043	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMC200042044	K04424	ko04010	MAPK signaling pathway	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMC200042044	K04424	ko04530	Tight junction	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMC200042045	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMC200042045	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMC200036724	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMC200036724	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMC200036724	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMC200036725	K12182	ko04144	Endocytosis	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMC200036725	K12182	ko04145	Phagosome	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMC200036732	K04733	ko04210	Apoptosis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMC200036732	K04733	ko04620	Toll-like receptor signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMC200036732	K04733	ko04722	Neurotrophin signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMC200036732	K04733	ko05140	Leishmaniasis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMC200036732	K04733	ko05142	Chagas disease	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMC200036735	K01897	ko00071	Fatty acid metabolism	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMC200036735	K01897	ko01100	Metabolic pathways	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMC200036735	K01897	ko03320	PPAR signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMC200036735	K01897	ko04146	Peroxisome	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMC200036735	K01897	ko04920	Adipocytokine signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMC200036736	K01897	ko00071	Fatty acid metabolism	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMC200036736	K01897	ko01100	Metabolic pathways	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMC200036736	K01897	ko03320	PPAR signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMC200036736	K01897	ko04146	Peroxisome	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMC200036736	K01897	ko04920	Adipocytokine signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMC200036737	K01897	ko00071	Fatty acid metabolism	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMC200036737	K01897	ko01100	Metabolic pathways	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMC200036737	K01897	ko03320	PPAR signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMC200036737	K01897	ko04146	Peroxisome	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMC200036737	K01897	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMC200036738	K02975	ko03010	Ribosome	850	4.8e-41	0.93	0.98	0.99
PGSC0003DMC200036739	K02887	ko03010	Ribosome	931	1.6e-45	0.83	0.97	0.99
PGSC0003DMC200036740	K12840	ko03040	Spliceosome	2254	1.7e-118	0.70	0.79	1.00
PGSC0003DMC200036747	K12192	ko04144	Endocytosis	1090	2.8e-54	0.64	0.81	0.95
PGSC0003DMC200030511	K03165	ko03440	Homologous recombination	2868	2.4e-152	0.75	0.82	0.94
PGSC0003DMC200030512	K03165	ko03440	Homologous recombination	2314	8.5e-122	0.72	0.84	1.00
PGSC0003DMC200030513	K00454	ko00591	Linoleic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMC200030513	K00454	ko00592	alpha-Linolenic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMC200030513	K00454	ko01100	Metabolic pathways	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMC200030514	K00454	ko00591	Linoleic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMC200030514	K00454	ko00592	alpha-Linolenic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMC200030514	K00454	ko01100	Metabolic pathways	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMC200030515	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030515	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030515	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030516	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030516	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030516	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030517	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030517	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030517	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMC200030518	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030518	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030518	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMC200030519	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200030519	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200030519	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200030520	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200030520	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200030520	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMC200042541	K00275	ko00750	Vitamin B6 metabolism	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMC200042541	K00275	ko01100	Metabolic pathways	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMC200042544	K00275	ko00750	Vitamin B6 metabolism	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMC200042544	K00275	ko01100	Metabolic pathways	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMC200042545	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMC200042545	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMC200042546	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMC200042546	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMC200042547	K00971	ko00051	Fructose and mannose metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMC200042547	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMC200042547	K00971	ko01100	Metabolic pathways	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMC200042547	K00971	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMC200042548	K00966	ko00051	Fructose and mannose metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMC200042548	K00966	ko00520	Amino sugar and nucleotide sugar metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMC200042548	K00966	ko01100	Metabolic pathways	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMC200042548	K00966	ko01110	Biosynthesis of secondary metabolites	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMC200042549	K00130	ko00260	Glycine, serine and threonine metabolism	3144	1.4e-167	0.72	0.85	0.99
PGSC0003DMC200042551	K01205	ko00531	Glycosaminoglycan degradation	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMC200042551	K01205	ko01100	Metabolic pathways	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMC200042551	K01205	ko04142	Lysosome	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMC200042559	K04392	ko04010	MAPK signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04062	Chemokine signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04145	Phagosome	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04310	Wnt signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04360	Axon guidance	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04370	VEGF signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04510	Focal adhesion	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04520	Adherens junction	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04650	Natural killer cell mediated cytotoxicity	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04662	B cell receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04664	Fc epsilon RI signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04666	Fc gamma R-mediated phagocytosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04670	Leukocyte transendothelial migration	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko04810	Regulation of actin cytoskeleton	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05100	Bacterial invasion of epithelial cells	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05131	Shigellosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05200	Pathways in cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05210	Colorectal cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05211	Renal cell carcinoma	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05212	Pancreatic cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042559	K04392	ko05416	Viral myocarditis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMC200042560	K04392	ko04010	MAPK signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04062	Chemokine signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04145	Phagosome	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04310	Wnt signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04360	Axon guidance	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04370	VEGF signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04510	Focal adhesion	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04520	Adherens junction	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04620	Toll-like receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04650	Natural killer cell mediated cytotoxicity	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04662	B cell receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04664	Fc epsilon RI signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04666	Fc gamma R-mediated phagocytosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04670	Leukocyte transendothelial migration	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04722	Neurotrophin signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko04810	Regulation of actin cytoskeleton	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05100	Bacterial invasion of epithelial cells	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05131	Shigellosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05200	Pathways in cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05210	Colorectal cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05211	Renal cell carcinoma	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05212	Pancreatic cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042560	K04392	ko05416	Viral myocarditis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMC200042561	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042561	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042562	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMC200042563	K05391	ko04626	Plant-pathogen interaction	1374	6.0e-70	0.69	0.79	0.97
PGSC0003DMC200042564	K05391	ko04626	Plant-pathogen interaction	3594	2.2e-192	0.62	0.75	0.99
PGSC0003DMC200042568	K12356	ko00940	Phenylpropanoid biosynthesis	797	4.0e-38	0.34	0.51	0.97
PGSC0003DMC200042569	K12356	ko00940	Phenylpropanoid biosynthesis	785	1.8e-37	0.34	0.50	0.99
PGSC0003DMC200055685	K00635	ko00561	Glycerolipid metabolism	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMC200055685	K00635	ko01100	Metabolic pathways	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMC200055686	K00635	ko00561	Glycerolipid metabolism	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMC200055686	K00635	ko01100	Metabolic pathways	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMC200055690	K02218	ko04340	Hedgehog signaling pathway	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMC200055690	K02218	ko04711	Circadian rhythm - fly	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMC200055701	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMC200055701	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMC200055701	K00734	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMC200030068	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMC200030068	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMC200030068	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMC200030068	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMC200030069	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030069	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030069	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030069	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030070	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030070	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030070	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030070	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMC200030079	K02218	ko04340	Hedgehog signaling pathway	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMC200030079	K02218	ko04711	Circadian rhythm - fly	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMC200048691	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048691	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048691	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048692	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMC200048692	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMC200048692	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMC200048693	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMC200048693	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMC200048693	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMC200048694	K09841	ko00906	Carotenoid biosynthesis	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMC200048694	K09841	ko01100	Metabolic pathways	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMC200048694	K09841	ko01110	Biosynthesis of secondary metabolites	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMC200048695	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048695	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048695	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMC200048697	K09841	ko00906	Carotenoid biosynthesis	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMC200048697	K09841	ko01100	Metabolic pathways	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMC200048697	K09841	ko01110	Biosynthesis of secondary metabolites	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMC200048698	K09841	ko00906	Carotenoid biosynthesis	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMC200048698	K09841	ko01100	Metabolic pathways	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMC200048698	K09841	ko01110	Biosynthesis of secondary metabolites	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMC200048711	K00616	ko00030	Pentose phosphate pathway	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMC200048711	K00616	ko01100	Metabolic pathways	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMC200048711	K00616	ko01110	Biosynthesis of secondary metabolites	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMC200048712	K00616	ko00030	Pentose phosphate pathway	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMC200048712	K00616	ko01100	Metabolic pathways	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMC200048712	K00616	ko01110	Biosynthesis of secondary metabolites	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMC200048717	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMC200048717	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMC200048718	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMC200048718	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMC200048719	K00218	ko00860	Porphyrin and chlorophyll metabolism	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMC200048719	K00218	ko01100	Metabolic pathways	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMC200048719	K00218	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMC200067555	K10760	ko00908	Zeatin biosynthesis	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMC200067555	K10760	ko01100	Metabolic pathways	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMC200067555	K10760	ko01110	Biosynthesis of secondary metabolites	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMC200067558	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMC200024484	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMC200024484	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMC200024484	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMC200024484	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMC200024484	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMC200024488	K04733	ko04210	Apoptosis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMC200024488	K04733	ko04620	Toll-like receptor signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMC200024488	K04733	ko04722	Neurotrophin signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMC200024488	K04733	ko05140	Leishmaniasis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMC200024488	K04733	ko05142	Chagas disease	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMC200024494	K10840	ko03420	Nucleotide excision repair	212	7.4e-06	0.34	0.61	0.76
PGSC0003DMC200024507	K10143	ko04115	p53 signaling pathway	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMC200024507	K10143	ko04120	Ubiquitin mediated proteolysis	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMC200024508	K10143	ko04115	p53 signaling pathway	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMC200024508	K10143	ko04120	Ubiquitin mediated proteolysis	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMC200024509	K10143	ko04115	p53 signaling pathway	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMC200024509	K10143	ko04120	Ubiquitin mediated proteolysis	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMC200024510	K05933	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMC200024510	K05933	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMC200013752	K13065	ko00940	Phenylpropanoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMC200013752	K13065	ko00941	Flavonoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMC200013752	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMC200013752	K13065	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMC200013753	K13065	ko00940	Phenylpropanoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMC200013753	K13065	ko00941	Flavonoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMC200013753	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMC200013753	K13065	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMC200013764	K06630	ko04110	Cell cycle	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMC200013764	K06630	ko04114	Oocyte meiosis	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMC200013764	K06630	ko04722	Neurotrophin signaling pathway	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMC200013765	K06630	ko04110	Cell cycle	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMC200013765	K06630	ko04114	Oocyte meiosis	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMC200013765	K06630	ko04722	Neurotrophin signaling pathway	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMC200019895	K08770	ko03320	PPAR signaling pathway	1014	4.3e-50	0.81	0.89	0.99
PGSC0003DMC200019897	K12882	ko03040	Spliceosome	3663	3.4e-196	0.77	0.88	0.96
PGSC0003DMC200019898	K12882	ko03040	Spliceosome	2196	2.8e-115	0.78	0.89	0.96
PGSC0003DMC200019899	K12882	ko03040	Spliceosome	5680	0.	0.77	0.88	1.00
PGSC0003DMC200019901	K00134	ko00010	Glycolysis / Gluconeogenesis	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMC200019901	K00134	ko01100	Metabolic pathways	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMC200019901	K00134	ko01110	Biosynthesis of secondary metabolites	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMC200019901	K00134	ko05010	Alzheimer's disease	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMC200019915	K04733	ko04210	Apoptosis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMC200019915	K04733	ko04620	Toll-like receptor signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMC200019915	K04733	ko04722	Neurotrophin signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMC200019915	K04733	ko05140	Leishmaniasis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMC200019915	K04733	ko05142	Chagas disease	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMC200019916	K07385	ko00902	Monoterpenoid biosynthesis	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMC200019916	K07385	ko01100	Metabolic pathways	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMC200019917	K07385	ko00902	Monoterpenoid biosynthesis	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMC200019917	K07385	ko01100	Metabolic pathways	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMC200019918	K12742	ko00900	Terpenoid backbone biosynthesis	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMC200019918	K12742	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMC200019919	K05282	ko00904	Diterpenoid biosynthesis	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMC200019919	K05282	ko01100	Metabolic pathways	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMC200019919	K05282	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMC200011863	K01066	ko00623	2,4-Dichlorobenzoate degradation	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMC200011863	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMC200011864	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMC200011864	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMC200011865	K12598	ko03018	RNA degradation	600	9.2e-27	0.75	0.80	0.93
PGSC0003DMC200011866	K12598	ko03018	RNA degradation	823	1.5e-39	0.83	0.93	0.81
PGSC0003DMC200011867	K11778	ko00900	Terpenoid backbone biosynthesis	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMC200011867	K11778	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMC200011868	K12929	ko00904	Diterpenoid biosynthesis	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMC200011868	K12929	ko01110	Biosynthesis of secondary metabolites	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMC200011870	K04123	ko00904	Diterpenoid biosynthesis	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMC200011870	K04123	ko01100	Metabolic pathways	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMC200011870	K04123	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMC200011871	K04123	ko00904	Diterpenoid biosynthesis	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMC200011871	K04123	ko01100	Metabolic pathways	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMC200011871	K04123	ko01110	Biosynthesis of secondary metabolites	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMC200011872	K04123	ko00904	Diterpenoid biosynthesis	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMC200011872	K04123	ko01100	Metabolic pathways	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMC200011872	K04123	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMC200011873	K04123	ko00904	Diterpenoid biosynthesis	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMC200011873	K04123	ko01100	Metabolic pathways	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMC200011873	K04123	ko01110	Biosynthesis of secondary metabolites	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMC200011874	K04123	ko00904	Diterpenoid biosynthesis	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMC200011874	K04123	ko01100	Metabolic pathways	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMC200011874	K04123	ko01110	Biosynthesis of secondary metabolites	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMC200011875	K04123	ko00904	Diterpenoid biosynthesis	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMC200011875	K04123	ko01100	Metabolic pathways	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMC200011875	K04123	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMC200011876	K04123	ko00904	Diterpenoid biosynthesis	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMC200011876	K04123	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMC200011876	K04123	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMC200057706	K03413	ko02020	Two-component system	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMC200057706	K03413	ko02030	Bacterial chemotaxis	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMC200032913	K02894	ko03010	Ribosome	346	3.0e-13	0.93	1.00	0.50
PGSC0003DMC200032917	K01757	ko00901	Indole alkaloid biosynthesis	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMC200032917	K01757	ko01100	Metabolic pathways	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMC200032917	K01757	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMC200032918	K01757	ko00901	Indole alkaloid biosynthesis	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMC200032918	K01757	ko01100	Metabolic pathways	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMC200032918	K01757	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMC200032935	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032935	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032936	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMC200032940	K02084	ko04115	p53 signaling pathway	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko04210	Apoptosis	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko05010	Alzheimer's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko05012	Parkinson's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko05016	Huntington's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200032940	K02084	ko05222	Small cell lung cancer	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMC200044433	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMC200044433	K03785	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMC200044433	K03785	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMC200044437	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044437	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044437	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044437	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044439	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMC200044439	K01061	ko00364	Fluorobenzoate degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMC200044439	K01061	ko00627	1,4-Dichlorobenzene degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMC200044439	K01061	ko01100	Metabolic pathways	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMC200044440	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044440	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044440	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044440	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044441	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044441	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044441	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044441	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMC200044459	K12600	ko03018	RNA degradation	2894	8.7e-154	0.51	0.68	0.96
PGSC0003DMC200044460	K12600	ko03018	RNA degradation	2646	4.2e-140	0.55	0.74	0.97
PGSC0003DMC200052686	K12356	ko00940	Phenylpropanoid biosynthesis	703	6.1e-33	0.36	0.56	0.94
PGSC0003DMC200052703	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMC200052704	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMC200052708	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1846	5.6e-96	0.67	0.81	1.00
PGSC0003DMC200035087	K00387	ko00920	Sulfur metabolism	2676	9.2e-142	0.76	0.87	1.00
PGSC0003DMC200035088	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMC200035088	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMC200035088	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMC200035088	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMC200035088	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMC200000455	K11253	ko05322	Systemic lupus erythematosus	660	1.4e-30	0.69	0.81	0.60
PGSC0003DMC200000456	K11253	ko05322	Systemic lupus erythematosus	863	9.2e-42	0.68	0.80	0.99
PGSC0003DMC200000465	K01897	ko00071	Fatty acid metabolism	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMC200000465	K01897	ko01100	Metabolic pathways	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMC200000465	K01897	ko03320	PPAR signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMC200000465	K01897	ko04146	Peroxisome	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMC200000465	K01897	ko04920	Adipocytokine signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMC200000466	K05391	ko04626	Plant-pathogen interaction	1959	3.3e-102	0.76	0.88	1.00
PGSC0003DMC200000473	K11422	ko00310	Lysine degradation	644	2.3e-29	0.39	0.54	0.26
PGSC0003DMC200000475	K11422	ko00310	Lysine degradation	644	2.6e-29	0.39	0.54	0.26
PGSC0003DMC200000480	K01528	ko04144	Endocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMC200000480	K01528	ko04666	Fc gamma R-mediated phagocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMC200000480	K01528	ko05100	Bacterial invasion of epithelial cells	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMC200028894	K00844	ko00010	Glycolysis / Gluconeogenesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00051	Fructose and mannose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00052	Galactose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00500	Starch and sucrose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00521	Streptomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko00524	Butirosin and neomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko01100	Metabolic pathways	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko01110	Biosynthesis of secondary metabolites	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko04910	Insulin signaling pathway	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028894	K00844	ko04930	Type II diabetes mellitus	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMC200028895	K00844	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00051	Fructose and mannose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00052	Galactose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00500	Starch and sucrose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00521	Streptomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko00524	Butirosin and neomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko01100	Metabolic pathways	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko04910	Insulin signaling pathway	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028895	K00844	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMC200028896	K00844	ko00010	Glycolysis / Gluconeogenesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00051	Fructose and mannose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00052	Galactose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00521	Streptomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko00524	Butirosin and neomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko01100	Metabolic pathways	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko04910	Insulin signaling pathway	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028896	K00844	ko04930	Type II diabetes mellitus	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMC200028897	K00844	ko00010	Glycolysis / Gluconeogenesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00051	Fructose and mannose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00052	Galactose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00500	Starch and sucrose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00521	Streptomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko00524	Butirosin and neomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko01100	Metabolic pathways	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko01110	Biosynthesis of secondary metabolites	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko04910	Insulin signaling pathway	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028897	K00844	ko04930	Type II diabetes mellitus	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMC200028898	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMC200028899	K00970	ko03018	RNA degradation	336	2.0e-12	0.39	0.61	0.44
PGSC0003DMC200028900	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMC200028913	K08139	ko04113	Meiosis - yeast	359	5.8e-14	0.37	0.61	0.68
PGSC0003DMC200021481	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200021481	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200021481	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200021489	K10143	ko04115	p53 signaling pathway	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMC200021489	K10143	ko04120	Ubiquitin mediated proteolysis	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMC200021490	K10143	ko04115	p53 signaling pathway	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMC200021490	K10143	ko04120	Ubiquitin mediated proteolysis	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMC200021491	K10143	ko04115	p53 signaling pathway	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMC200021491	K10143	ko04120	Ubiquitin mediated proteolysis	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMC200021492	K10143	ko04115	p53 signaling pathway	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMC200021492	K10143	ko04120	Ubiquitin mediated proteolysis	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMC200021493	K10143	ko04115	p53 signaling pathway	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMC200021493	K10143	ko04120	Ubiquitin mediated proteolysis	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMC200021496	K02150	ko00190	Oxidative phosphorylation	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021496	K02150	ko01100	Metabolic pathways	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021496	K02150	ko04145	Phagosome	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021496	K02150	ko04966	Collecting duct acid secretion	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021496	K02150	ko05110	Vibrio cholerae infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021496	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMC200021497	K02150	ko00190	Oxidative phosphorylation	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021497	K02150	ko01100	Metabolic pathways	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021497	K02150	ko04145	Phagosome	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021497	K02150	ko04966	Collecting duct acid secretion	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021497	K02150	ko05110	Vibrio cholerae infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021497	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMC200021500	K05666	ko02010	ABC transporters	1596	3.4e-82	0.29	0.49	0.96
PGSC0003DMC200021501	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMC200021502	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMC200003872	K00799	ko00480	Glutathione metabolism	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMC200003872	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMC200003872	K00799	ko00982	Drug metabolism - cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMC200003874	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMC200003874	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMC200003874	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMC200003875	K00799	ko00480	Glutathione metabolism	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMC200003875	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMC200003875	K00799	ko00982	Drug metabolism - cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMC200003876	K00799	ko00480	Glutathione metabolism	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMC200003876	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMC200003876	K00799	ko00982	Drug metabolism - cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMC200003877	K00799	ko00480	Glutathione metabolism	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMC200003877	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMC200003877	K00799	ko00982	Drug metabolism - cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMC200003878	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMC200003878	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMC200003878	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMC200003882	K00799	ko00480	Glutathione metabolism	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMC200003882	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMC200003882	K00799	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMC200003883	K00799	ko00480	Glutathione metabolism	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMC200003883	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMC200003883	K00799	ko00982	Drug metabolism - cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMC200003884	K00799	ko00480	Glutathione metabolism	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMC200003884	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMC200003884	K00799	ko00982	Drug metabolism - cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMC200003886	K00799	ko00480	Glutathione metabolism	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMC200003886	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMC200003886	K00799	ko00982	Drug metabolism - cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMC200003887	K00799	ko00480	Glutathione metabolism	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMC200003887	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMC200003887	K00799	ko00982	Drug metabolism - cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMC200003891	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003891	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003891	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003892	K00799	ko00480	Glutathione metabolism	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMC200003892	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMC200003892	K00799	ko00982	Drug metabolism - cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMC200003893	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003893	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003893	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMC200003894	K00799	ko00480	Glutathione metabolism	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMC200003894	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMC200003894	K00799	ko00982	Drug metabolism - cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMC200003895	K00799	ko00480	Glutathione metabolism	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMC200003895	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMC200003895	K00799	ko00982	Drug metabolism - cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMC200003897	K11808	ko00230	Purine metabolism	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMC200003897	K11808	ko01100	Metabolic pathways	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMC200003897	K11808	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMC200003898	K10532	ko00531	Glycosaminoglycan degradation	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMC200003898	K10532	ko01100	Metabolic pathways	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMC200003898	K10532	ko04142	Lysosome	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMC200033873	K12356	ko00940	Phenylpropanoid biosynthesis	620	2.3e-28	0.34	0.46	0.89
PGSC0003DMC200033878	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMC200033879	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMC200033880	K00430	ko00360	Phenylalanine metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMC200033880	K00430	ko00680	Methane metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMC200033880	K00430	ko00940	Phenylpropanoid biosynthesis	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMC200033880	K00430	ko01100	Metabolic pathways	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMC200033880	K00430	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMC200033881	K00430	ko00360	Phenylalanine metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMC200033881	K00430	ko00680	Methane metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMC200033881	K00430	ko00940	Phenylpropanoid biosynthesis	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMC200033881	K00430	ko01100	Metabolic pathways	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMC200033881	K00430	ko01110	Biosynthesis of secondary metabolites	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMC200033882	K00430	ko00360	Phenylalanine metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMC200033882	K00430	ko00680	Methane metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMC200033882	K00430	ko00940	Phenylpropanoid biosynthesis	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMC200033882	K00430	ko01100	Metabolic pathways	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMC200033882	K00430	ko01110	Biosynthesis of secondary metabolites	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMC200033885	K01193	ko00052	Galactose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMC200033885	K01193	ko00500	Starch and sucrose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMC200033885	K01193	ko01100	Metabolic pathways	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMC200033886	K01193	ko00052	Galactose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMC200033886	K01193	ko00500	Starch and sucrose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMC200033886	K01193	ko01100	Metabolic pathways	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMC200033887	K01193	ko00052	Galactose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMC200033887	K01193	ko00500	Starch and sucrose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMC200033887	K01193	ko01100	Metabolic pathways	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMC200033891	K12356	ko00940	Phenylpropanoid biosynthesis	258	9.1e-11	0.29	0.46	0.94
PGSC0003DMC200033894	K08493	ko04130	SNARE interactions in vesicular transport	1175	5.7e-59	0.78	0.89	0.99
PGSC0003DMC200033895	K08493	ko04130	SNARE interactions in vesicular transport	1512	1.5e-77	0.82	0.93	1.00
PGSC0003DMC200051484	K01867	ko00380	Tryptophan metabolism	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMC200051484	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMC200051485	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMC200051485	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMC200051486	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMC200051486	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMC200051496	K01868	ko00970	Aminoacyl-tRNA biosynthesis	1271	2.9e-64	0.74	0.87	0.98
PGSC0003DMC200051497	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4821	4.5e-260	0.82	0.91	0.99
PGSC0003DMC200051502	K00422	ko00350	Tyrosine metabolism	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMC200051502	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMC200051502	K00422	ko01100	Metabolic pathways	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMC200051502	K00422	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMC200051503	K00422	ko00350	Tyrosine metabolism	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMC200051503	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMC200051503	K00422	ko01100	Metabolic pathways	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMC200051503	K00422	ko01110	Biosynthesis of secondary metabolites	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMC200051508	K08300	ko03018	RNA degradation	346	2.0e-12	0.25	0.45	0.96
PGSC0003DMC200027694	K00472	ko00330	Arginine and proline metabolism	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMC200027694	K00472	ko01100	Metabolic pathways	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMC200027695	K00472	ko00330	Arginine and proline metabolism	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMC200027695	K00472	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMC200027696	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMC200027696	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMC200027697	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMC200027697	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMC200027709	K00100	ko00051	Fructose and mannose metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027709	K00100	ko00363	Bisphenol A degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027709	K00100	ko00591	Linoleic acid metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027709	K00100	ko00625	Tetrachloroethene degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027709	K00100	ko00650	Butanoate metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027709	K00100	ko01100	Metabolic pathways	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMC200027712	K11778	ko00900	Terpenoid backbone biosynthesis	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMC200027712	K11778	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMC200027713	K02920	ko03010	Ribosome	828	7.8e-40	0.92	0.96	0.99
PGSC0003DMC200027718	K10352	ko04530	Tight junction	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMC200027718	K10352	ko05416	Viral myocarditis	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMC200027720	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027720	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200014435	K00599	ko00340	Histidine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMC200014435	K00599	ko00350	Tyrosine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMC200014435	K00599	ko00450	Selenoamino acid metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMC200014435	K00599	ko00626	Naphthalene and anthracene degradation	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMC200014436	K00599	ko00340	Histidine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMC200014436	K00599	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMC200014436	K00599	ko00450	Selenoamino acid metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMC200014436	K00599	ko00626	Naphthalene and anthracene degradation	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMC200014437	K00599	ko00340	Histidine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMC200014437	K00599	ko00350	Tyrosine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMC200014437	K00599	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMC200014437	K00599	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMC200014456	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMC200014456	K00517	ko00626	Naphthalene and anthracene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMC200014456	K00517	ko00903	Limonene and pinene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMC200014456	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMC200014456	K00517	ko01110	Biosynthesis of secondary metabolites	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMC200005075	K12848	ko03040	Spliceosome	1422	1.4e-72	0.84	0.93	0.97
PGSC0003DMC200005080	K10901	ko03440	Homologous recombination	2561	2.0e-135	0.77	0.85	0.86
PGSC0003DMC200005081	K10901	ko03440	Homologous recombination	2035	2.1e-106	0.82	0.91	0.99
PGSC0003DMC200005082	K10901	ko03440	Homologous recombination	800	2.7e-38	0.74	0.88	0.87
PGSC0003DMC200005083	K10901	ko03440	Homologous recombination	632	5.0e-29	0.51	0.67	0.80
PGSC0003DMC200022686	K02603	ko04110	Cell cycle	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMC200022686	K02603	ko04111	Cell cycle - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMC200022686	K02603	ko04113	Meiosis - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMC200022687	K02603	ko04110	Cell cycle	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMC200022687	K02603	ko04111	Cell cycle - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMC200022687	K02603	ko04113	Meiosis - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMC200022688	K02603	ko04110	Cell cycle	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMC200022688	K02603	ko04111	Cell cycle - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMC200022688	K02603	ko04113	Meiosis - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMC200022689	K02603	ko04110	Cell cycle	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMC200022689	K02603	ko04111	Cell cycle - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMC200022689	K02603	ko04113	Meiosis - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMC200022690	K04424	ko04010	MAPK signaling pathway	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMC200022690	K04424	ko04530	Tight junction	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMC200001653	K05280	ko00941	Flavonoid biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMC200001653	K05280	ko00944	Flavone and flavonol biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMC200001653	K05280	ko01100	Metabolic pathways	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMC200001653	K05280	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMC200001663	K02911	ko03010	Ribosome	367	2.1e-14	0.85	0.88	0.93
PGSC0003DMC200001673	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMC200001673	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMC200001673	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMC200001678	K03876	ko04120	Ubiquitin mediated proteolysis	292	2.9e-10	0.31	0.49	0.67
PGSC0003DMC200068665	K03094	ko04110	Cell cycle	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04111	Cell cycle - yeast	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04114	Oocyte meiosis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04120	Ubiquitin mediated proteolysis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04310	Wnt signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04350	TGF-beta signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200068665	K03094	ko04710	Circadian rhythm - mammal	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMC200043757	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMC200043757	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMC200043757	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMC200043757	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMC200043758	K04371	ko04010	MAPK signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04012	ErbB signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04013	MAPK signaling pathway - fly	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04062	Chemokine signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04114	Oocyte meiosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04150	mTOR signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04270	Vascular smooth muscle contraction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04320	Dorso-ventral axis formation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04350	TGF-beta signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04360	Axon guidance	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04370	VEGF signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04510	Focal adhesion	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04520	Adherens junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04540	Gap junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04620	Toll-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04621	NOD-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04650	Natural killer cell mediated cytotoxicity	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04660	T cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04662	B cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04664	Fc epsilon RI signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04666	Fc gamma R-mediated phagocytosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04720	Long-term potentiation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04722	Neurotrophin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04730	Long-term depression	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04810	Regulation of actin cytoskeleton	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04910	Insulin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04912	GnRH signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04914	Progesterone-mediated oocyte maturation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04916	Melanogenesis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04930	Type II diabetes mellitus	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05010	Alzheimer's disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05020	Prion diseases	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05131	Shigellosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05140	Leishmaniasis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05142	Chagas disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05200	Pathways in cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05210	Colorectal cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05211	Renal cell carcinoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05212	Pancreatic cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05213	Endometrial cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05214	Glioma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05215	Prostate cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05216	Thyroid cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05218	Melanoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05219	Bladder cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05220	Chronic myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05221	Acute myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043758	K04371	ko05223	Non-small cell lung cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMC200043759	K05740	ko04510	Focal adhesion	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMC200043759	K05740	ko04810	Regulation of actin cytoskeleton	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMC200043759	K05740	ko05131	Shigellosis	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMC200043760	K04512	ko04310	Wnt signaling pathway	304	7.6e-08	0.32	0.52	0.35
PGSC0003DMC200043761	K05849	ko04020	Calcium signaling pathway	297	6.5e-10	0.37	0.56	0.33
PGSC0003DMC200043765	K02940	ko03010	Ribosome	1466	5.1e-75	0.91	0.96	0.99
PGSC0003DMC200043766	K01184	ko00040	Pentose and glucuronate interconversions	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMC200043766	K01184	ko00500	Starch and sucrose metabolism	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMC200043766	K01184	ko01100	Metabolic pathways	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMC200043767	K01184	ko00040	Pentose and glucuronate interconversions	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMC200043767	K01184	ko00500	Starch and sucrose metabolism	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMC200043767	K01184	ko01100	Metabolic pathways	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMC200043768	K08803	ko05200	Pathways in cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMC200043768	K08803	ko05219	Bladder cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMC200054497	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200054497	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200054497	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMC200054508	K02183	ko04020	Calcium signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04070	Phosphatidylinositol signaling system	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04114	Oocyte meiosis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04270	Vascular smooth muscle contraction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04626	Plant-pathogen interaction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04720	Long-term potentiation	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04722	Neurotrophin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04740	Olfactory transduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04744	Phototransduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04745	Phototransduction - fly	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04910	Insulin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04912	GnRH signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04916	Melanogenesis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04970	Salivary secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko04971	Gastric acid secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko05010	Alzheimer's disease	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200054508	K02183	ko05214	Glioma	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMC200049891	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMC200049891	K01687	ko00770	Pantothenate and CoA biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMC200049891	K01687	ko01100	Metabolic pathways	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMC200049891	K01687	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMC200049892	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMC200049892	K01687	ko00770	Pantothenate and CoA biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMC200049892	K01687	ko01100	Metabolic pathways	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMC200049892	K01687	ko01110	Biosynthesis of secondary metabolites	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMC200049898	K00413	ko00190	Oxidative phosphorylation	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049898	K00413	ko01100	Metabolic pathways	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049898	K00413	ko04260	Cardiac muscle contraction	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049898	K00413	ko05010	Alzheimer's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049898	K00413	ko05012	Parkinson's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049898	K00413	ko05016	Huntington's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMC200049899	K00413	ko00190	Oxidative phosphorylation	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049899	K00413	ko01100	Metabolic pathways	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049899	K00413	ko04260	Cardiac muscle contraction	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049899	K00413	ko05010	Alzheimer's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049899	K00413	ko05012	Parkinson's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049899	K00413	ko05016	Huntington's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMC200049914	K11152	ko00830	Retinol metabolism	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMC200049914	K11152	ko01100	Metabolic pathways	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMC200049918	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2360	2.5e-124	0.69	0.83	0.99
PGSC0003DMC200049919	K10256	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.78	0.90	0.98
PGSC0003DMC200049920	K13083	ko00941	Flavonoid biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMC200049920	K13083	ko00944	Flavone and flavonol biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMC200049920	K13083	ko01110	Biosynthesis of secondary metabolites	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMC200031262	K12929	ko00904	Diterpenoid biosynthesis	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMC200031262	K12929	ko01110	Biosynthesis of secondary metabolites	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMC200031263	K12929	ko00904	Diterpenoid biosynthesis	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMC200031263	K12929	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMC200031264	K12929	ko00904	Diterpenoid biosynthesis	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMC200031264	K12929	ko01110	Biosynthesis of secondary metabolites	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMC200031269	K01051	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMC200031269	K01051	ko00500	Starch and sucrose metabolism	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMC200031269	K01051	ko01100	Metabolic pathways	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMC200031270	K01051	ko00040	Pentose and glucuronate interconversions	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMC200031270	K01051	ko00500	Starch and sucrose metabolism	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMC200031270	K01051	ko01100	Metabolic pathways	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMC200031271	K10527	ko00592	alpha-Linolenic acid metabolism	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMC200031271	K10527	ko01100	Metabolic pathways	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMC200031272	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMC200031272	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMC200031273	K10527	ko00592	alpha-Linolenic acid metabolism	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMC200031273	K10527	ko01100	Metabolic pathways	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMC200031274	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMC200031274	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMC200031277	K02885	ko03010	Ribosome	1654	2.2e-85	0.93	0.96	1.00
PGSC0003DMC200031278	K01213	ko00040	Pentose and glucuronate interconversions	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMC200031278	K01213	ko00500	Starch and sucrose metabolism	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMC200031278	K01213	ko01100	Metabolic pathways	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMC200031279	K01051	ko00040	Pentose and glucuronate interconversions	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMC200031279	K01051	ko00500	Starch and sucrose metabolism	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMC200031279	K01051	ko01100	Metabolic pathways	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMC200031280	K01051	ko00040	Pentose and glucuronate interconversions	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMC200031280	K01051	ko00500	Starch and sucrose metabolism	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMC200031280	K01051	ko01100	Metabolic pathways	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMC200031283	K05849	ko04020	Calcium signaling pathway	1488	3.1e-76	0.81	0.92	0.99
PGSC0003DMC200031284	K05849	ko04020	Calcium signaling pathway	2887	2.1e-153	0.53	0.60	0.97
PGSC0003DMC200041871	K03037	ko03050	Proteasome	459	1.8e-19	0.61	0.81	0.61
PGSC0003DMC200041872	K03037	ko03050	Proteasome	2100	5.4e-110	0.93	0.97	0.99
PGSC0003DMC200041873	K03037	ko03050	Proteasome	2784	1.0e-147	0.87	0.94	1.00
PGSC0003DMC200041875	K00945	ko00240	Pyrimidine metabolism	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMC200041875	K00945	ko01100	Metabolic pathways	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMC200041876	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200041876	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200041877	K00945	ko00240	Pyrimidine metabolism	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMC200041877	K00945	ko01100	Metabolic pathways	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMC200041878	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200041878	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200041879	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200041879	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMC200025687	K00287	ko00670	One carbon pool by folate	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMC200025687	K00287	ko00790	Folate biosynthesis	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMC200025687	K00287	ko01100	Metabolic pathways	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMC200025689	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMC200025689	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMC200025689	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMC200025697	K02183	ko04020	Calcium signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04070	Phosphatidylinositol signaling system	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04114	Oocyte meiosis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04270	Vascular smooth muscle contraction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04626	Plant-pathogen interaction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04720	Long-term potentiation	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04722	Neurotrophin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04740	Olfactory transduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04744	Phototransduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04745	Phototransduction - fly	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04910	Insulin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04912	GnRH signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04916	Melanogenesis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04970	Salivary secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko04971	Gastric acid secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko05010	Alzheimer's disease	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025697	K02183	ko05214	Glioma	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMC200025701	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMC200025701	K01915	ko00330	Arginine and proline metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMC200025701	K01915	ko00910	Nitrogen metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMC200025701	K01915	ko01100	Metabolic pathways	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMC200025701	K01915	ko02020	Two-component system	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMC200025706	K04503	ko04110	Cell cycle	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko04115	p53 signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko04310	Wnt signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko04510	Focal adhesion	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko04630	Jak-STAT signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05200	Pathways in cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05210	Colorectal cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05212	Pancreatic cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05213	Endometrial cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05214	Glioma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05215	Prostate cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05216	Thyroid cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05218	Melanoma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05219	Bladder cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05220	Chronic myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05221	Acute myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05222	Small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05223	Non-small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200025706	K04503	ko05416	Viral myocarditis	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMC200012541	K07424	ko00140	Steroid hormone biosynthesis	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00591	Linoleic acid metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00830	Retinol metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00982	Drug metabolism - cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko00983	Drug metabolism - other enzymes	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012541	K07424	ko01100	Metabolic pathways	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMC200012542	K07424	ko00140	Steroid hormone biosynthesis	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00591	Linoleic acid metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00830	Retinol metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00982	Drug metabolism - cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko00983	Drug metabolism - other enzymes	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012542	K07424	ko01100	Metabolic pathways	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMC200012543	K07424	ko00140	Steroid hormone biosynthesis	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00591	Linoleic acid metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00830	Retinol metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00982	Drug metabolism - cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko00983	Drug metabolism - other enzymes	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012543	K07424	ko01100	Metabolic pathways	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMC200012544	K07424	ko00140	Steroid hormone biosynthesis	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00591	Linoleic acid metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00830	Retinol metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00982	Drug metabolism - cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko00983	Drug metabolism - other enzymes	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012544	K07424	ko01100	Metabolic pathways	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMC200012545	K07424	ko00140	Steroid hormone biosynthesis	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00591	Linoleic acid metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00830	Retinol metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko00983	Drug metabolism - other enzymes	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012545	K07424	ko01100	Metabolic pathways	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMC200012546	K07424	ko00140	Steroid hormone biosynthesis	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00591	Linoleic acid metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00830	Retinol metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00982	Drug metabolism - cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko00983	Drug metabolism - other enzymes	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012546	K07424	ko01100	Metabolic pathways	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMC200012547	K07424	ko00140	Steroid hormone biosynthesis	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00591	Linoleic acid metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00830	Retinol metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00982	Drug metabolism - cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko00983	Drug metabolism - other enzymes	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012547	K07424	ko01100	Metabolic pathways	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMC200012548	K07424	ko00140	Steroid hormone biosynthesis	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00591	Linoleic acid metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00830	Retinol metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00982	Drug metabolism - cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko00983	Drug metabolism - other enzymes	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012548	K07424	ko01100	Metabolic pathways	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMC200012549	K07424	ko00140	Steroid hormone biosynthesis	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00591	Linoleic acid metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00830	Retinol metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00982	Drug metabolism - cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko00983	Drug metabolism - other enzymes	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012549	K07424	ko01100	Metabolic pathways	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMC200012550	K07424	ko00140	Steroid hormone biosynthesis	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00591	Linoleic acid metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00830	Retinol metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00982	Drug metabolism - cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko00983	Drug metabolism - other enzymes	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012550	K07424	ko01100	Metabolic pathways	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMC200012552	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012552	K01652	ko00650	Butanoate metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012552	K01652	ko00660	C5-Branched dibasic acid metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012552	K01652	ko00770	Pantothenate and CoA biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012552	K01652	ko01100	Metabolic pathways	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012552	K01652	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMC200012553	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012553	K01652	ko00650	Butanoate metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012553	K01652	ko00660	C5-Branched dibasic acid metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012553	K01652	ko00770	Pantothenate and CoA biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012553	K01652	ko01100	Metabolic pathways	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012553	K01652	ko01110	Biosynthesis of secondary metabolites	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMC200012556	K09647	ko03060	Protein export	757	6.4e-36	0.72	0.84	0.99
PGSC0003DMC200012558	K02523	ko00900	Terpenoid backbone biosynthesis	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMC200012558	K02523	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMC200012559	K02523	ko00900	Terpenoid backbone biosynthesis	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMC200012559	K02523	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMC200012570	K00697	ko00500	Starch and sucrose metabolism	541	1.3e-23	0.64	0.77	0.96
PGSC0003DMC200018691	K08332	ko04140	Regulation of autophagy	235	1.2e-06	0.29	0.51	0.64
PGSC0003DMC200018696	K08065	ko04612	Antigen processing and presentation	614	5.0e-28	0.54	0.71	0.92
PGSC0003DMC200018697	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMC200018698	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMC200018699	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMC200018702	K12831	ko03040	Spliceosome	368	1.9e-13	0.38	0.44	0.12
PGSC0003DMC200018703	K04733	ko04210	Apoptosis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMC200018703	K04733	ko04620	Toll-like receptor signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMC200018703	K04733	ko04722	Neurotrophin signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMC200018703	K04733	ko05140	Leishmaniasis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMC200018703	K04733	ko05142	Chagas disease	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMC200018704	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMC200018704	K00517	ko00626	Naphthalene and anthracene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMC200018704	K00517	ko00903	Limonene and pinene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMC200018704	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMC200018704	K00517	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMC200018708	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMC200018709	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMC200018716	K12929	ko00904	Diterpenoid biosynthesis	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMC200018716	K12929	ko01110	Biosynthesis of secondary metabolites	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMC200018717	K12929	ko00904	Diterpenoid biosynthesis	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMC200018717	K12929	ko01110	Biosynthesis of secondary metabolites	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMC200018718	K12868	ko03040	Spliceosome	1866	4.4e-97	0.73	0.82	1.00
PGSC0003DMC200018719	K12868	ko03040	Spliceosome	742	4.3e-35	0.44	0.51	0.99
PGSC0003DMC200062462	K03715	ko00561	Glycerolipid metabolism	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMC200062462	K03715	ko01100	Metabolic pathways	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMC200001804	K00967	ko00440	Phosphonate and phosphinate metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMC200001804	K00967	ko00564	Glycerophospholipid metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMC200001804	K00967	ko01100	Metabolic pathways	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMC200001807	K00432	ko00480	Glutathione metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMC200001807	K00432	ko00590	Arachidonic acid metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMC200001808	K00432	ko00480	Glutathione metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMC200001808	K00432	ko00590	Arachidonic acid metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMC200001825	K10760	ko00908	Zeatin biosynthesis	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMC200001825	K10760	ko01100	Metabolic pathways	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMC200001825	K10760	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMC200027368	K11422	ko00310	Lysine degradation	384	1.2e-16	0.46	0.59	0.15
PGSC0003DMC200020611	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	407	5.1e-16	0.30	0.43	0.93
PGSC0003DMC200020612	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMC200020612	K12567	ko05414	Dilated cardiomyopathy	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMC200020617	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMC200020617	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMC200020617	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMC200020617	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMC200020617	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMC200020640	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMC200020640	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMC200020640	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMC200020640	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMC200020640	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMC200008735	K04371	ko04010	MAPK signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04012	ErbB signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04013	MAPK signaling pathway - fly	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04062	Chemokine signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04114	Oocyte meiosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04150	mTOR signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04270	Vascular smooth muscle contraction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04320	Dorso-ventral axis formation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04350	TGF-beta signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04360	Axon guidance	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04370	VEGF signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04510	Focal adhesion	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04520	Adherens junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04540	Gap junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04620	Toll-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04621	NOD-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04650	Natural killer cell mediated cytotoxicity	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04660	T cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04662	B cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04664	Fc epsilon RI signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04666	Fc gamma R-mediated phagocytosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04720	Long-term potentiation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04722	Neurotrophin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04730	Long-term depression	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04810	Regulation of actin cytoskeleton	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04910	Insulin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04912	GnRH signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04914	Progesterone-mediated oocyte maturation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04916	Melanogenesis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04930	Type II diabetes mellitus	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko04960	Aldosterone-regulated sodium reabsorption	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05010	Alzheimer's disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05020	Prion diseases	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05131	Shigellosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05140	Leishmaniasis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05142	Chagas disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05200	Pathways in cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05210	Colorectal cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05211	Renal cell carcinoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05212	Pancreatic cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05213	Endometrial cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05214	Glioma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05215	Prostate cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05216	Thyroid cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05218	Melanoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05219	Bladder cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05220	Chronic myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05221	Acute myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008735	K04371	ko05223	Non-small cell lung cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMC200008745	K12741	ko03040	Spliceosome	1048	5.7e-52	0.44	0.58	0.96
PGSC0003DMC200008749	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.85
PGSC0003DMC200008750	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMC200008751	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMC200008752	K00511	ko00100	Steroid biosynthesis	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMC200008752	K00511	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMC200008752	K00511	ko01110	Biosynthesis of secondary metabolites	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMC200008753	K00511	ko00100	Steroid biosynthesis	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMC200008753	K00511	ko01100	Metabolic pathways	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMC200008753	K00511	ko01110	Biosynthesis of secondary metabolites	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMC200008754	K00511	ko00100	Steroid biosynthesis	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMC200008754	K00511	ko01100	Metabolic pathways	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMC200008754	K00511	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMC200008756	K01762	ko00270	Cysteine and methionine metabolism	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMC200008756	K01762	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMC200022777	K12476	ko04144	Endocytosis	1866	4.4e-97	0.54	0.72	0.77
PGSC0003DMC200022780	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.73
PGSC0003DMC200022781	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMC200022782	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.72
PGSC0003DMC200022783	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMC200022784	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMC200022785	K08770	ko03320	PPAR signaling pathway	376	6.7e-15	0.36	0.55	0.93
PGSC0003DMC200022787	K12606	ko03018	RNA degradation	1090	2.8e-54	0.57	0.60	0.99
PGSC0003DMC200022788	K12606	ko03018	RNA degradation	2198	2.1e-115	0.94	0.97	1.00
PGSC0003DMC200022790	K00995	ko00564	Glycerophospholipid metabolism	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMC200022790	K00995	ko01100	Metabolic pathways	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMC200004386	K00679	ko00561	Glycerolipid metabolism	1312	1.6e-66	0.36	0.51	0.90
PGSC0003DMC200004387	K00679	ko00561	Glycerolipid metabolism	226	3.0e-06	0.53	0.71	0.31
PGSC0003DMC200004388	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.61	0.78	0.54
PGSC0003DMC200004389	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMC200004390	K08064	ko04612	Antigen processing and presentation	440	2.0e-18	0.40	0.61	0.91
PGSC0003DMC200004391	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMC200004392	K08064	ko04612	Antigen processing and presentation	582	2.9e-26	0.58	0.76	0.57
PGSC0003DMC200004393	K08064	ko04612	Antigen processing and presentation	483	8.3e-21	0.65	0.78	0.52
PGSC0003DMC200004397	K01733	ko00260	Glycine, serine and threonine metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMC200004397	K01733	ko00750	Vitamin B6 metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMC200004397	K01733	ko01100	Metabolic pathways	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMC200051575	K03046	ko00230	Purine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMC200051575	K03046	ko00240	Pyrimidine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMC200051575	K03046	ko01100	Metabolic pathways	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMC200051575	K03046	ko03020	RNA polymerase	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMC200051580	K01519	ko00230	Purine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMC200051580	K01519	ko00240	Pyrimidine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMC200051580	K01519	ko00983	Drug metabolism - other enzymes	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMC200051580	K01519	ko01100	Metabolic pathways	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMC200051581	K01519	ko00230	Purine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMC200051581	K01519	ko00240	Pyrimidine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMC200051581	K01519	ko00983	Drug metabolism - other enzymes	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMC200051581	K01519	ko01100	Metabolic pathways	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMC200051582	K03505	ko00230	Purine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko00240	Pyrimidine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko01100	Metabolic pathways	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko03030	DNA replication	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko03410	Base excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko03420	Nucleotide excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko03430	Mismatch repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051582	K03505	ko03440	Homologous recombination	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMC200051583	K04424	ko04010	MAPK signaling pathway	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMC200051583	K04424	ko04530	Tight junction	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMC200051584	K04424	ko04010	MAPK signaling pathway	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMC200051584	K04424	ko04530	Tight junction	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMC200051585	K04423	ko04010	MAPK signaling pathway	492	6.2e-21	0.42	0.57	0.88
PGSC0003DMC200051586	K00632	ko00071	Fatty acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko00280	Valine, leucine and isoleucine degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko00281	Geraniol degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko00362	Benzoate degradation via hydroxylation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko00592	alpha-Linolenic acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko00642	Ethylbenzene degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko01100	Metabolic pathways	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051586	K00632	ko01110	Biosynthesis of secondary metabolites	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMC200051588	K00660	ko00941	Flavonoid biosynthesis	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMC200051588	K00660	ko01100	Metabolic pathways	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMC200051588	K00660	ko01110	Biosynthesis of secondary metabolites	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMC200051588	K00660	ko04712	Circadian rhythm - plant	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMC200051589	K00660	ko00941	Flavonoid biosynthesis	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMC200051589	K00660	ko01100	Metabolic pathways	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMC200051589	K00660	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMC200051589	K00660	ko04712	Circadian rhythm - plant	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMC200051590	K02941	ko03010	Ribosome	1877	1.1e-97	0.81	0.90	0.99
PGSC0003DMC200051591	K08241	ko00592	alpha-Linolenic acid metabolism	655	1.0e-34	0.45	0.63	0.98
PGSC0003DMC200051592	K08241	ko00592	alpha-Linolenic acid metabolism	1168	1.4e-58	0.44	0.59	0.99
PGSC0003DMC200051593	K08241	ko00592	alpha-Linolenic acid metabolism	547	2.5e-24	0.49	0.60	0.99
PGSC0003DMC200051594	K08241	ko00592	alpha-Linolenic acid metabolism	471	3.8e-20	0.45	0.65	0.86
PGSC0003DMC200051596	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMC200051596	K06126	ko01100	Metabolic pathways	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMC200051596	K06126	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMC200051597	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051597	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051597	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051598	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051598	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051598	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMC200051599	K12741	ko03040	Spliceosome	463	1.1e-19	0.43	0.53	0.51
PGSC0003DMC200033181	K10845	ko03420	Nucleotide excision repair	449	6.3e-19	0.74	0.88	0.97
PGSC0003DMC200033185	K05350	ko00460	Cyanoamino acid metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMC200033185	K05350	ko00500	Starch and sucrose metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMC200033185	K05350	ko00940	Phenylpropanoid biosynthesis	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMC200033185	K05350	ko01110	Biosynthesis of secondary metabolites	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMC200033186	K05350	ko00460	Cyanoamino acid metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMC200033186	K05350	ko00500	Starch and sucrose metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMC200033186	K05350	ko00940	Phenylpropanoid biosynthesis	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMC200033186	K05350	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMC200033191	K10879	ko03440	Homologous recombination	603	2.0e-27	0.64	0.79	0.84
PGSC0003DMC200033203	K03505	ko00230	Purine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko00240	Pyrimidine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko01100	Metabolic pathways	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko03030	DNA replication	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko03410	Base excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko03420	Nucleotide excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko03430	Mismatch repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033203	K03505	ko03440	Homologous recombination	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMC200033204	K00660	ko00941	Flavonoid biosynthesis	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMC200033204	K00660	ko01100	Metabolic pathways	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMC200033204	K00660	ko01110	Biosynthesis of secondary metabolites	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMC200033204	K00660	ko04712	Circadian rhythm - plant	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMC200033205	K08241	ko00592	alpha-Linolenic acid metabolism	1074	2.1e-53	0.42	0.60	0.99
PGSC0003DMC200033208	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200033208	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200033209	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200033209	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200033210	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200033210	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMC200060524	K11816	ko00380	Tryptophan metabolism	304	4.6e-18	0.46	0.63	0.94
PGSC0003DMC200060526	K10760	ko00908	Zeatin biosynthesis	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMC200060526	K10760	ko01100	Metabolic pathways	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMC200060526	K10760	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMC200060538	K05282	ko00904	Diterpenoid biosynthesis	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMC200060538	K05282	ko01100	Metabolic pathways	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMC200060538	K05282	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMC200006245	K01103	ko00051	Fructose and mannose metabolism	393	8.9e-13	0.31	0.51	0.52
PGSC0003DMC200006246	K01103	ko00051	Fructose and mannose metabolism	385	4.5e-14	0.31	0.51	0.58
PGSC0003DMC200006247	K01103	ko00051	Fructose and mannose metabolism	393	1.5e-12	0.31	0.51	0.49
PGSC0003DMC200006248	K01103	ko00051	Fructose and mannose metabolism	393	5.8e-13	0.25	0.43	0.84
PGSC0003DMC200006252	K10702	ko00642	Ethylbenzene degradation	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMC200006252	K10702	ko01100	Metabolic pathways	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMC200006259	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMC200006260	K00368	ko00910	Nitrogen metabolism	1761	2.7e-91	0.45	0.61	0.92
PGSC0003DMC200006261	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMC200006262	K00368	ko00910	Nitrogen metabolism	1747	1.6e-90	0.46	0.62	0.88
PGSC0003DMC200006264	K01507	ko00190	Oxidative phosphorylation	1637	1.9e-84	0.90	0.94	0.99
PGSC0003DMC200006265	K01507	ko00190	Oxidative phosphorylation	1341	4.0e-68	0.90	0.94	0.88
PGSC0003DMC200006266	K00680	ko00350	Tyrosine metabolism	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMC200006266	K00680	ko00624	1- and 2-Methylnaphthalene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMC200006266	K00680	ko00632	Benzoate degradation via CoA ligation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMC200006266	K00680	ko00642	Ethylbenzene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMC200006266	K00680	ko00903	Limonene and pinene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMC200025774	K00454	ko00591	Linoleic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMC200025774	K00454	ko00592	alpha-Linolenic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMC200025774	K00454	ko01100	Metabolic pathways	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMC200025775	K00454	ko00591	Linoleic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMC200025775	K00454	ko00592	alpha-Linolenic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMC200025775	K00454	ko01100	Metabolic pathways	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMC200025776	K00454	ko00591	Linoleic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMC200025776	K00454	ko00592	alpha-Linolenic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMC200025776	K00454	ko01100	Metabolic pathways	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMC200025777	K00454	ko00591	Linoleic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMC200025777	K00454	ko00592	alpha-Linolenic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMC200025777	K00454	ko01100	Metabolic pathways	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMC200025778	K00454	ko00591	Linoleic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMC200025778	K00454	ko00592	alpha-Linolenic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMC200025778	K00454	ko01100	Metabolic pathways	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMC200025779	K00454	ko00591	Linoleic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMC200025779	K00454	ko00592	alpha-Linolenic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMC200025779	K00454	ko01100	Metabolic pathways	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMC200025780	K00454	ko00591	Linoleic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMC200025780	K00454	ko00592	alpha-Linolenic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMC200025780	K00454	ko01100	Metabolic pathways	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMC200025788	K00754	ko00051	Fructose and mannose metabolism	342	6.3e-13	0.27	0.44	0.89
PGSC0003DMC200025791	K10844	ko03420	Nucleotide excision repair	557	6.9e-25	0.86	0.93	0.90
PGSC0003DMC200025792	K10844	ko03420	Nucleotide excision repair	4707	8.8e-254	0.81	0.91	0.99
PGSC0003DMC200025793	K10844	ko03420	Nucleotide excision repair	4507	9.5e-243	0.81	0.91	0.99
PGSC0003DMC200025796	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.48	0.63	0.92
PGSC0003DMC200025799	K12890	ko03040	Spliceosome	1669	3.2e-86	0.81	0.87	0.83
PGSC0003DMC200029622	K00368	ko00910	Nitrogen metabolism	1047	6.5e-52	0.35	0.47	0.90
PGSC0003DMC200029626	K01922	ko00770	Pantothenate and CoA biosynthesis	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMC200029626	K01922	ko01100	Metabolic pathways	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMC200029628	K01922	ko00770	Pantothenate and CoA biosynthesis	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMC200029628	K01922	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMC200029629	K01922	ko00770	Pantothenate and CoA biosynthesis	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMC200029629	K01922	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMC200029630	K01922	ko00770	Pantothenate and CoA biosynthesis	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMC200029630	K01922	ko01100	Metabolic pathways	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMC200029632	K02113	ko00190	Oxidative phosphorylation	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMC200029632	K02113	ko00195	Photosynthesis	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMC200029632	K02113	ko01100	Metabolic pathways	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMC200029633	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMC200029633	K00517	ko00626	Naphthalene and anthracene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMC200029633	K00517	ko00903	Limonene and pinene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMC200029633	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMC200029633	K00517	ko01110	Biosynthesis of secondary metabolites	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMC200029634	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	444	1.2e-18	0.38	0.51	0.65
PGSC0003DMC200029640	K01179	ko00500	Starch and sucrose metabolism	291	1.6e-07	0.26	0.41	0.67
PGSC0003DMC200018361	K00026	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018361	K00026	ko00620	Pyruvate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018361	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018361	K00026	ko00710	Carbon fixation in photosynthetic organisms	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018361	K00026	ko01100	Metabolic pathways	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018361	K00026	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko00020	Citrate cycle (TCA cycle)	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko00620	Pyruvate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko00710	Carbon fixation in photosynthetic organisms	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko01100	Metabolic pathways	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018362	K00026	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMC200018363	K00026	ko00020	Citrate cycle (TCA cycle)	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018363	K00026	ko00620	Pyruvate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018363	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018363	K00026	ko00710	Carbon fixation in photosynthetic organisms	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018363	K00026	ko01100	Metabolic pathways	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018363	K00026	ko01110	Biosynthesis of secondary metabolites	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMC200018372	K10591	ko04120	Ubiquitin mediated proteolysis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMC200018372	K10591	ko04144	Endocytosis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMC200018373	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMC200018373	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMC200018374	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMC200018374	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMC200018375	K10591	ko04120	Ubiquitin mediated proteolysis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMC200018375	K10591	ko04144	Endocytosis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMC200018376	K02183	ko04020	Calcium signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04070	Phosphatidylinositol signaling system	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04114	Oocyte meiosis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04270	Vascular smooth muscle contraction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04626	Plant-pathogen interaction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04720	Long-term potentiation	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04722	Neurotrophin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04740	Olfactory transduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04744	Phototransduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04745	Phototransduction - fly	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04910	Insulin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04912	GnRH signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04916	Melanogenesis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04970	Salivary secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko04971	Gastric acid secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko05010	Alzheimer's disease	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018376	K02183	ko05214	Glioma	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMC200018384	K01809	ko00051	Fructose and mannose metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMC200018384	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMC200018384	K01809	ko01100	Metabolic pathways	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMC200018384	K01809	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMC200054583	K10609	ko03420	Nucleotide excision repair	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMC200054583	K10609	ko04120	Ubiquitin mediated proteolysis	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMC200054584	K10609	ko03420	Nucleotide excision repair	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMC200054584	K10609	ko04120	Ubiquitin mediated proteolysis	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMC200054585	K10609	ko03420	Nucleotide excision repair	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMC200054585	K10609	ko04120	Ubiquitin mediated proteolysis	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMC200054586	K10609	ko03420	Nucleotide excision repair	5917	0.	0.89	0.93	0.95
PGSC0003DMC200054586	K10609	ko04120	Ubiquitin mediated proteolysis	5917	0.	0.89	0.93	0.95
PGSC0003DMC200054592	K13034	ko00270	Cysteine and methionine metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMC200054592	K13034	ko00450	Selenoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMC200054592	K13034	ko00460	Cyanoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMC200054592	K13034	ko00920	Sulfur metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMC200054592	K13034	ko01100	Metabolic pathways	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMC200054598	K01051	ko00040	Pentose and glucuronate interconversions	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMC200054598	K01051	ko00500	Starch and sucrose metabolism	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMC200054598	K01051	ko01100	Metabolic pathways	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMC200054599	K01051	ko00040	Pentose and glucuronate interconversions	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMC200054599	K01051	ko00500	Starch and sucrose metabolism	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMC200054599	K01051	ko01100	Metabolic pathways	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMC200054600	K02964	ko03010	Ribosome	1229	6.0e-62	0.94	0.98	0.99
PGSC0003DMC200037442	K02866	ko03010	Ribosome	710	2.5e-33	0.43	0.60	0.84
PGSC0003DMC200037450	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	754	9.4e-36	0.39	0.57	0.76
PGSC0003DMC200037459	K04536	ko04062	Chemokine signaling pathway	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMC200037459	K04536	ko04742	Taste transduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMC200037459	K04536	ko04744	Phototransduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMC200037462	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMC200037463	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMC200032196	K05681	ko02010	ABC transporters	995	4.8e-49	0.36	0.56	0.99
PGSC0003DMC200032197	K05681	ko02010	ABC transporters	1415	3.3e-72	0.37	0.57	0.94
PGSC0003DMC200032198	K05681	ko02010	ABC transporters	1409	7.0e-72	0.37	0.57	0.94
PGSC0003DMC200032199	K09840	ko00906	Carotenoid biosynthesis	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMC200032199	K09840	ko01100	Metabolic pathways	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMC200032199	K09840	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMC200032200	K09840	ko00906	Carotenoid biosynthesis	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMC200032200	K09840	ko01100	Metabolic pathways	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMC200032200	K09840	ko01110	Biosynthesis of secondary metabolites	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMC200032213	K11984	ko03040	Spliceosome	370	9.6e-14	0.30	0.46	0.68
PGSC0003DMC200032215	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032215	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200032216	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMC200049581	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMC200049582	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMC200049583	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.70
PGSC0003DMC200047561	K00627	ko00010	Glycolysis / Gluconeogenesis	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMC200047561	K00627	ko00020	Citrate cycle (TCA cycle)	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMC200047561	K00627	ko00620	Pyruvate metabolism	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMC200047561	K00627	ko01100	Metabolic pathways	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMC200047561	K00627	ko01110	Biosynthesis of secondary metabolites	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMC200047562	K00627	ko00010	Glycolysis / Gluconeogenesis	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMC200047562	K00627	ko00020	Citrate cycle (TCA cycle)	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMC200047562	K00627	ko00620	Pyruvate metabolism	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMC200047562	K00627	ko01100	Metabolic pathways	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMC200047562	K00627	ko01110	Biosynthesis of secondary metabolites	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMC200047563	K00627	ko00010	Glycolysis / Gluconeogenesis	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMC200047563	K00627	ko00020	Citrate cycle (TCA cycle)	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMC200047563	K00627	ko00620	Pyruvate metabolism	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMC200047563	K00627	ko01100	Metabolic pathways	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMC200047563	K00627	ko01110	Biosynthesis of secondary metabolites	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMC200047564	K01243	ko00270	Cysteine and methionine metabolism	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMC200047564	K01243	ko01100	Metabolic pathways	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMC200047565	K01243	ko00270	Cysteine and methionine metabolism	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMC200047565	K01243	ko01100	Metabolic pathways	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMC200047567	K06276	ko03320	PPAR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko04150	mTOR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko04510	Focal adhesion	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko04910	Insulin signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko04960	Aldosterone-regulated sodium reabsorption	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko05213	Endometrial cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko05215	Prostate cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047567	K06276	ko05223	Non-small cell lung cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMC200047568	K06276	ko03320	PPAR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko04150	mTOR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko04510	Focal adhesion	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko04910	Insulin signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko05213	Endometrial cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko05215	Prostate cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047568	K06276	ko05223	Non-small cell lung cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMC200047569	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMC200047569	K02367	ko01100	Metabolic pathways	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMC200047571	K01099	ko00562	Inositol phosphate metabolism	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMC200047571	K01099	ko01100	Metabolic pathways	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMC200047571	K01099	ko04070	Phosphatidylinositol signaling system	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMC200007443	K01188	ko00460	Cyanoamino acid metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMC200007443	K01188	ko00500	Starch and sucrose metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMC200007443	K01188	ko00940	Phenylpropanoid biosynthesis	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMC200007443	K01188	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMC200007444	K01188	ko00460	Cyanoamino acid metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMC200007444	K01188	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMC200007444	K01188	ko00940	Phenylpropanoid biosynthesis	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMC200007444	K01188	ko01110	Biosynthesis of secondary metabolites	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMC200007445	K01188	ko00460	Cyanoamino acid metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMC200007445	K01188	ko00500	Starch and sucrose metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMC200007445	K01188	ko00940	Phenylpropanoid biosynthesis	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMC200007445	K01188	ko01110	Biosynthesis of secondary metabolites	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMC200007446	K01188	ko00460	Cyanoamino acid metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMC200007446	K01188	ko00500	Starch and sucrose metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMC200007446	K01188	ko00940	Phenylpropanoid biosynthesis	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMC200007446	K01188	ko01110	Biosynthesis of secondary metabolites	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMC200007450	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMC200007451	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMC200007452	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMC200007453	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2431	3.0e-128	0.72	0.86	0.97
PGSC0003DMC200007456	K03885	ko00190	Oxidative phosphorylation	3040	7.7e-162	0.72	0.84	1.00
PGSC0003DMC200007457	K03885	ko00190	Oxidative phosphorylation	2752	5.9e-146	0.72	0.83	0.92
PGSC0003DMC200007458	K03885	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.88	0.89
PGSC0003DMC200007459	K03885	ko00190	Oxidative phosphorylation	1627	6.7e-84	0.69	0.80	0.99
PGSC0003DMC200007460	K03885	ko00190	Oxidative phosphorylation	1899	6.6e-99	0.81	0.89	0.95
PGSC0003DMC200007461	K03885	ko00190	Oxidative phosphorylation	3095	7.2e-165	0.73	0.85	1.00
PGSC0003DMC200007463	K01953	ko00250	Alanine, aspartate and glutamate metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMC200007463	K01953	ko00910	Nitrogen metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMC200007463	K01953	ko01100	Metabolic pathways	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMC200007463	K01953	ko01110	Biosynthesis of secondary metabolites	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMC200007464	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMC200007464	K01953	ko00910	Nitrogen metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMC200007464	K01953	ko01100	Metabolic pathways	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMC200007464	K01953	ko01110	Biosynthesis of secondary metabolites	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMC200019561	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200019561	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200019561	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200019563	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.38	0.58	0.88
PGSC0003DMC200019582	K07375	ko04145	Phagosome	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMC200019582	K07375	ko04540	Gap junction	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMC200019582	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMC200019586	K06119	ko00561	Glycerolipid metabolism	1051	3.9e-52	0.80	0.89	0.97
PGSC0003DMC200019587	K06119	ko00561	Glycerolipid metabolism	2951	6.3e-157	0.83	0.92	0.95
PGSC0003DMC200019588	K06119	ko00561	Glycerolipid metabolism	1412	4.8e-72	0.78	0.90	0.98
PGSC0003DMC200017551	K07375	ko04145	Phagosome	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMC200017551	K07375	ko04540	Gap junction	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMC200017551	K07375	ko05130	Pathogenic Escherichia coli infection	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMC200017553	K09487	ko04621	NOD-like receptor signaling pathway	5765	0.	0.85	0.92	1.00
PGSC0003DMC200017553	K09487	ko04626	Plant-pathogen interaction	5765	0.	0.85	0.92	1.00
PGSC0003DMC200017553	K09487	ko05200	Pathways in cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMC200017553	K09487	ko05215	Prostate cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMC200017554	K09487	ko04621	NOD-like receptor signaling pathway	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMC200017554	K09487	ko04626	Plant-pathogen interaction	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMC200017554	K09487	ko05200	Pathways in cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMC200017554	K09487	ko05215	Prostate cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMC200017559	K05868	ko04110	Cell cycle	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMC200017559	K05868	ko04115	p53 signaling pathway	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMC200017559	K05868	ko04914	Progesterone-mediated oocyte maturation	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMC200017567	K03260	ko05416	Viral myocarditis	340	1.1e-09	0.28	0.38	0.63
PGSC0003DMC200017568	K03260	ko05416	Viral myocarditis	340	9.2e-12	0.28	0.38	0.79
PGSC0003DMC200017570	K00430	ko00360	Phenylalanine metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMC200017570	K00430	ko00680	Methane metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMC200017570	K00430	ko00940	Phenylpropanoid biosynthesis	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMC200017570	K00430	ko01100	Metabolic pathways	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMC200017570	K00430	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMC200017575	K00472	ko00330	Arginine and proline metabolism	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMC200017575	K00472	ko01100	Metabolic pathways	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMC200061740	K08066	ko04612	Antigen processing and presentation	404	1.9e-16	0.45	0.66	0.81
PGSC0003DMC200067943	K09487	ko04621	NOD-like receptor signaling pathway	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMC200067943	K09487	ko04626	Plant-pathogen interaction	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMC200067943	K09487	ko05200	Pathways in cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMC200067943	K09487	ko05215	Prostate cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMC200055772	K01535	ko00190	Oxidative phosphorylation	7433	0.	0.92	0.97	1.00
PGSC0003DMC200055773	K01535	ko00190	Oxidative phosphorylation	286	3.9e-09	0.73	0.86	0.96
PGSC0003DMC200055786	K05748	ko04520	Adherens junction	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMC200055786	K05748	ko04666	Fc gamma R-mediated phagocytosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMC200055786	K05748	ko04810	Regulation of actin cytoskeleton	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMC200055786	K05748	ko05100	Bacterial invasion of epithelial cells	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMC200055786	K05748	ko05131	Shigellosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMC200055787	K01601	ko00630	Glyoxylate and dicarboxylate metabolism	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMC200055787	K01601	ko00710	Carbon fixation in photosynthetic organisms	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMC200055787	K01601	ko01100	Metabolic pathways	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMC200055788	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMC200055788	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMC200055788	K02552	ko01100	Metabolic pathways	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMC200055788	K02552	ko01110	Biosynthesis of secondary metabolites	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMC200055789	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMC200055789	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMC200055789	K02552	ko01100	Metabolic pathways	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMC200055789	K02552	ko01110	Biosynthesis of secondary metabolites	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMC200055790	K10573	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.99	1.00	0.99
PGSC0003DMC200055791	K05648	ko02010	ABC transporters	286	8.5e-09	0.33	0.56	0.97
PGSC0003DMC200055792	K05643	ko02010	ABC transporters	1094	4.4e-54	0.34	0.52	0.74
PGSC0003DMC200036243	K05849	ko04020	Calcium signaling pathway	239	1.2e-06	0.41	0.54	0.90
PGSC0003DMC200036247	K06677	ko04111	Cell cycle - yeast	455	2.5e-18	0.56	0.69	0.95
PGSC0003DMC200036249	K07192	ko04910	Insulin signaling pathway	612	6.4e-28	0.49	0.67	0.98
PGSC0003DMC200036250	K07192	ko04910	Insulin signaling pathway	344	3.9e-13	0.39	0.59	0.84
PGSC0003DMC200036252	K06677	ko04111	Cell cycle - yeast	403	1.9e-15	0.62	0.74	0.81
PGSC0003DMC200036266	K12272	ko03060	Protein export	775	6.5e-37	0.49	0.60	0.97
PGSC0003DMC200036267	K02084	ko04115	p53 signaling pathway	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko04210	Apoptosis	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko05010	Alzheimer's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko05012	Parkinson's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko05016	Huntington's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036267	K02084	ko05222	Small cell lung cancer	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMC200036268	K00700	ko00500	Starch and sucrose metabolism	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMC200036268	K00700	ko01100	Metabolic pathways	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMC200036270	K02084	ko04115	p53 signaling pathway	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko04210	Apoptosis	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko05010	Alzheimer's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko05012	Parkinson's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko05016	Huntington's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200036270	K02084	ko05222	Small cell lung cancer	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMC200048364	K04733	ko04210	Apoptosis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMC200048364	K04733	ko04620	Toll-like receptor signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMC200048364	K04733	ko04722	Neurotrophin signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMC200048364	K04733	ko05140	Leishmaniasis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMC200048364	K04733	ko05142	Chagas disease	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMC200048385	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048385	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048385	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048385	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048385	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048386	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048386	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048386	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048386	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200048386	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMC200031002	K10867	ko03440	Homologous recombination	339	5.2e-10	0.25	0.42	0.86
PGSC0003DMC200031003	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031004	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031005	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031006	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031007	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031008	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMC200031013	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMC200031013	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMC200031014	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMC200031014	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMC200031019	K13030	ko00460	Cyanoamino acid metabolism	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMC200031019	K13030	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMC200031020	K13030	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMC200031020	K13030	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMC200028568	K01069	ko00620	Pyruvate metabolism	992	7.0e-49	0.48	0.64	0.80
PGSC0003DMC200028578	K03038	ko03050	Proteasome	2432	2.7e-128	0.93	0.98	1.00
PGSC0003DMC200028579	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3814	1.6e-204	0.76	0.86	1.00
PGSC0003DMC200028580	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.77	0.87	1.00
PGSC0003DMC200028581	K13065	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMC200028581	K13065	ko00941	Flavonoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMC200028581	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMC200028581	K13065	ko01110	Biosynthesis of secondary metabolites	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMC200028583	K08139	ko04113	Meiosis - yeast	1037	2.3e-51	0.33	0.51	0.90
PGSC0003DMC200003184	K10604	ko04120	Ubiquitin mediated proteolysis	603	2.0e-27	0.35	0.52	0.81
PGSC0003DMC200003198	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003198	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003198	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003198	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003198	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003199	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003199	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003199	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003199	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003199	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMC200003205	K10756	ko03030	DNA replication	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMC200003205	K10756	ko03420	Nucleotide excision repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMC200003205	K10756	ko03430	Mismatch repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMC200021575	K01951	ko00230	Purine metabolism	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMC200021575	K01951	ko00983	Drug metabolism - other enzymes	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMC200021575	K01951	ko01100	Metabolic pathways	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMC200021576	K01951	ko00230	Purine metabolism	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMC200021576	K01951	ko00983	Drug metabolism - other enzymes	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMC200021576	K01951	ko01100	Metabolic pathways	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMC200021586	K01838	ko00500	Starch and sucrose metabolism	355	9.6e-14	0.33	0.49	0.54
PGSC0003DMC200021587	K01919	ko00480	Glutathione metabolism	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMC200021587	K01919	ko01100	Metabolic pathways	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMC200021588	K01919	ko00480	Glutathione metabolism	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMC200021588	K01919	ko01100	Metabolic pathways	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMC200021597	K12298	ko00100	Steroid biosynthesis	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMC200021597	K12298	ko00561	Glycerolipid metabolism	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMC200021597	K12298	ko01100	Metabolic pathways	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMC200021599	K12298	ko00100	Steroid biosynthesis	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMC200021599	K12298	ko00561	Glycerolipid metabolism	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMC200021599	K12298	ko01100	Metabolic pathways	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMC200021600	K12298	ko00100	Steroid biosynthesis	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMC200021600	K12298	ko00561	Glycerolipid metabolism	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMC200021600	K12298	ko01100	Metabolic pathways	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMC200000602	K01759	ko00620	Pyruvate metabolism	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMC200000602	K01759	ko04011	MAPK signaling pathway - yeast	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMC200000604	K04392	ko04010	MAPK signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04062	Chemokine signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04145	Phagosome	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04310	Wnt signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04360	Axon guidance	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04370	VEGF signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04510	Focal adhesion	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04520	Adherens junction	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04620	Toll-like receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04650	Natural killer cell mediated cytotoxicity	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04662	B cell receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04664	Fc epsilon RI signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04666	Fc gamma R-mediated phagocytosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04670	Leukocyte transendothelial migration	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04722	Neurotrophin signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko04810	Regulation of actin cytoskeleton	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05100	Bacterial invasion of epithelial cells	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05131	Shigellosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05200	Pathways in cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05210	Colorectal cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05211	Renal cell carcinoma	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05212	Pancreatic cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000604	K04392	ko05416	Viral myocarditis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04010	MAPK signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04062	Chemokine signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04145	Phagosome	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04310	Wnt signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04360	Axon guidance	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04370	VEGF signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04510	Focal adhesion	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04520	Adherens junction	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04620	Toll-like receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04650	Natural killer cell mediated cytotoxicity	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04662	B cell receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04664	Fc epsilon RI signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04666	Fc gamma R-mediated phagocytosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04670	Leukocyte transendothelial migration	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04722	Neurotrophin signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko04810	Regulation of actin cytoskeleton	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05100	Bacterial invasion of epithelial cells	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05131	Shigellosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05200	Pathways in cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05210	Colorectal cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05211	Renal cell carcinoma	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05212	Pancreatic cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000605	K04392	ko05416	Viral myocarditis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMC200000606	K04392	ko04010	MAPK signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04062	Chemokine signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04145	Phagosome	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04310	Wnt signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04360	Axon guidance	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04370	VEGF signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04510	Focal adhesion	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04520	Adherens junction	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04620	Toll-like receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04650	Natural killer cell mediated cytotoxicity	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04662	B cell receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04664	Fc epsilon RI signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04666	Fc gamma R-mediated phagocytosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04670	Leukocyte transendothelial migration	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04722	Neurotrophin signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko04810	Regulation of actin cytoskeleton	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05100	Bacterial invasion of epithelial cells	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05131	Shigellosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05200	Pathways in cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05210	Colorectal cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05211	Renal cell carcinoma	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05212	Pancreatic cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000606	K04392	ko05416	Viral myocarditis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMC200000607	K04392	ko04010	MAPK signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04062	Chemokine signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04145	Phagosome	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04310	Wnt signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04360	Axon guidance	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04370	VEGF signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04510	Focal adhesion	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04520	Adherens junction	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04620	Toll-like receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04650	Natural killer cell mediated cytotoxicity	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04662	B cell receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04664	Fc epsilon RI signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04666	Fc gamma R-mediated phagocytosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04670	Leukocyte transendothelial migration	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04722	Neurotrophin signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko04810	Regulation of actin cytoskeleton	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05100	Bacterial invasion of epithelial cells	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05131	Shigellosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05200	Pathways in cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05210	Colorectal cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05211	Renal cell carcinoma	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05212	Pancreatic cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000607	K04392	ko05416	Viral myocarditis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMC200000630	K12355	ko00940	Phenylpropanoid biosynthesis	2055	1.6e-107	0.75	0.86	0.98
PGSC0003DMC200050613	K01590	ko00340	Histidine metabolism	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMC200050613	K01590	ko01100	Metabolic pathways	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMC200050613	K01590	ko01110	Biosynthesis of secondary metabolites	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMC200050614	K09834	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMC200050614	K09834	ko01100	Metabolic pathways	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMC200050614	K09834	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMC200050615	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMC200050615	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMC200050615	K10157	ko01100	Metabolic pathways	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMC200050621	K00970	ko03018	RNA degradation	1228	6.8e-62	0.41	0.59	0.83
PGSC0003DMC200050622	K00970	ko03018	RNA degradation	1093	1.9e-54	0.41	0.59	0.90
PGSC0003DMC200050628	K04124	ko00904	Diterpenoid biosynthesis	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMC200050628	K04124	ko01110	Biosynthesis of secondary metabolites	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMC200050634	K12338	ko00942	Anthocyanin biosynthesis	523	5.2e-23	0.53	0.66	0.89
PGSC0003DMC200038731	K06096	ko04530	Tight junction	223	1.8e-06	0.32	0.54	0.55
PGSC0003DMC200038732	K06236	ko04510	Focal adhesion	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMC200038732	K06236	ko04512	ECM-receptor interaction	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMC200038732	K06236	ko05146	Amoebiasis	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMC200038740	K12888	ko03040	Spliceosome	800	2.7e-38	0.31	0.49	0.68
PGSC0003DMC200038741	K12888	ko03040	Spliceosome	841	1.5e-40	0.31	0.49	0.76
PGSC0003DMC200038746	K03351	ko04110	Cell cycle	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038746	K03351	ko04111	Cell cycle - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038746	K03351	ko04113	Meiosis - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038746	K03351	ko04114	Oocyte meiosis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038746	K03351	ko04120	Ubiquitin mediated proteolysis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038746	K03351	ko04914	Progesterone-mediated oocyte maturation	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMC200038747	K04718	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMC200038747	K04718	ko01100	Metabolic pathways	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMC200038747	K04718	ko04020	Calcium signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMC200038747	K04718	ko04370	VEGF signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMC200038747	K04718	ko04666	Fc gamma R-mediated phagocytosis	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMC200038748	K04718	ko00600	Sphingolipid metabolism	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMC200038748	K04718	ko01100	Metabolic pathways	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMC200038748	K04718	ko04020	Calcium signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMC200038748	K04718	ko04370	VEGF signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMC200038748	K04718	ko04666	Fc gamma R-mediated phagocytosis	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMC200038758	K12816	ko03040	Spliceosome	4257	5.8e-229	0.82	0.90	1.00
PGSC0003DMC200038759	K01190	ko00052	Galactose metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMC200038759	K01190	ko00511	Other glycan degradation	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMC200038759	K01190	ko00600	Sphingolipid metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMC200038759	K01190	ko01100	Metabolic pathways	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMC200034388	K04733	ko04210	Apoptosis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMC200034388	K04733	ko04620	Toll-like receptor signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMC200034388	K04733	ko04722	Neurotrophin signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMC200034388	K04733	ko05140	Leishmaniasis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMC200034388	K04733	ko05142	Chagas disease	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMC200034407	K01634	ko00600	Sphingolipid metabolism	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMC200034407	K01634	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMC200034408	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMC200034408	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMC200034409	K01634	ko00600	Sphingolipid metabolism	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMC200034409	K01634	ko01100	Metabolic pathways	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMC200034410	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMC200034410	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMC200052796	K03872	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMC200052796	K03872	ko05200	Pathways in cancer	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMC200052796	K03872	ko05211	Renal cell carcinoma	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMC200057220	K10760	ko00908	Zeatin biosynthesis	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMC200057220	K10760	ko01100	Metabolic pathways	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMC200057220	K10760	ko01110	Biosynthesis of secondary metabolites	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMC200057232	K03133	ko03022	Basal transcription factors	348	2.3e-13	0.62	0.75	0.63
PGSC0003DMC200057234	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200057234	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMC200046353	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMC200046354	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMC200046355	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMC200046355	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMC200046356	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMC200046356	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMC200046363	K06668	ko04111	Cell cycle - yeast	297	1.2e-09	0.35	0.52	0.93
PGSC0003DMC200046370	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMC200046370	K00517	ko00626	Naphthalene and anthracene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMC200046370	K00517	ko00903	Limonene and pinene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMC200046370	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMC200046370	K00517	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMC200046371	K06627	ko04110	Cell cycle	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMC200046371	K06627	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMC200046373	K06626	ko04110	Cell cycle	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046373	K06626	ko04114	Oocyte meiosis	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046373	K06626	ko04115	p53 signaling pathway	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046373	K06626	ko05200	Pathways in cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046373	K06626	ko05215	Prostate cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046373	K06626	ko05222	Small cell lung cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMC200046377	K12130	ko04712	Circadian rhythm - plant	228	3.5e-06	0.37	0.55	0.38
PGSC0003DMC200040801	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1463	7.4e-75	0.77	0.87	1.00
PGSC0003DMC200040802	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMC200040803	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1516	8.8e-78	0.79	0.90	1.00
PGSC0003DMC200040804	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMC200040806	K12831	ko03040	Spliceosome	330	2.3e-12	0.51	0.61	0.73
PGSC0003DMC200040807	K12831	ko03040	Spliceosome	287	6.5e-10	0.51	0.60	0.69
PGSC0003DMC200040809	K12831	ko03040	Spliceosome	315	1.5e-11	0.51	0.60	0.70
PGSC0003DMC200040814	K04733	ko04210	Apoptosis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMC200040814	K04733	ko04620	Toll-like receptor signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMC200040814	K04733	ko04722	Neurotrophin signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMC200040814	K04733	ko05140	Leishmaniasis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMC200040814	K04733	ko05142	Chagas disease	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMC200040817	K04733	ko04210	Apoptosis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMC200040817	K04733	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMC200040817	K04733	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMC200040817	K04733	ko05140	Leishmaniasis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMC200040817	K04733	ko05142	Chagas disease	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMC200040820	K08333	ko04140	Regulation of autophagy	676	1.3e-30	0.86	0.92	0.97
PGSC0003DMC200040821	K08333	ko04140	Regulation of autophagy	9877	0.	0.75	0.85	1.00
PGSC0003DMC200040822	K08333	ko04140	Regulation of autophagy	9220	0.	0.75	0.85	1.00
PGSC0003DMC200040823	K06630	ko04110	Cell cycle	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMC200040823	K06630	ko04114	Oocyte meiosis	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMC200040823	K06630	ko04722	Neurotrophin signaling pathway	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMC200040826	K10807	ko00230	Purine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMC200040826	K10807	ko00240	Pyrimidine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMC200040826	K10807	ko00480	Glutathione metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMC200040826	K10807	ko01100	Metabolic pathways	6309	0.	0.90	0.96	1.00
PGSC0003DMC200040828	K13065	ko00940	Phenylpropanoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMC200040828	K13065	ko00941	Flavonoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMC200040828	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMC200040828	K13065	ko01110	Biosynthesis of secondary metabolites	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMC200040829	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMC200040829	K00517	ko00626	Naphthalene and anthracene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMC200040829	K00517	ko00903	Limonene and pinene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMC200040829	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMC200040829	K00517	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMC200040830	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMC200040830	K00517	ko00626	Naphthalene and anthracene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMC200040830	K00517	ko00903	Limonene and pinene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMC200040830	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMC200040830	K00517	ko01110	Biosynthesis of secondary metabolites	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMC200050763	K05656	ko02010	ABC transporters	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMC200050763	K05656	ko04142	Lysosome	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMC200050764	K05656	ko02010	ABC transporters	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMC200050764	K05656	ko04142	Lysosome	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMC200050765	K05656	ko02010	ABC transporters	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMC200050765	K05656	ko04142	Lysosome	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMC200050766	K05656	ko02010	ABC transporters	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMC200050766	K05656	ko04142	Lysosome	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMC200050767	K05656	ko02010	ABC transporters	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMC200050767	K05656	ko04142	Lysosome	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMC200050768	K09756	ko00940	Phenylpropanoid biosynthesis	1721	4.4e-89	0.47	0.66	0.95
PGSC0003DMC200050769	K09756	ko00940	Phenylpropanoid biosynthesis	1227	7.7e-62	0.47	0.65	0.93
PGSC0003DMC200050770	K09756	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.49	0.68	0.94
PGSC0003DMC200050771	K09756	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.48	0.67	0.95
PGSC0003DMC200050773	K10609	ko03420	Nucleotide excision repair	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMC200050773	K10609	ko04120	Ubiquitin mediated proteolysis	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMC200050786	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMC200050787	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMC200050788	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMC200050789	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.92	0.99
PGSC0003DMC200050790	K11252	ko05322	Systemic lupus erythematosus	718	9.1e-34	0.82	0.88	0.79
PGSC0003DMC200038641	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.73
PGSC0003DMC200038642	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.84
PGSC0003DMC200038649	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMC200038649	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMC200038650	K00700	ko00500	Starch and sucrose metabolism	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMC200038650	K00700	ko01100	Metabolic pathways	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMC200038651	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMC200038651	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMC200038652	K00658	ko00020	Citrate cycle (TCA cycle)	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMC200038652	K00658	ko00310	Lysine degradation	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMC200038652	K00658	ko01100	Metabolic pathways	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMC200038652	K00658	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMC200038653	K00658	ko00020	Citrate cycle (TCA cycle)	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMC200038653	K00658	ko00310	Lysine degradation	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMC200038653	K00658	ko01100	Metabolic pathways	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMC200038653	K00658	ko01110	Biosynthesis of secondary metabolites	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMC200038654	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038654	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038654	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038654	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038655	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038655	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038655	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038655	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMC200038658	K12741	ko03040	Spliceosome	258	2.1e-08	0.48	0.52	0.72
PGSC0003DMC200038665	K00912	ko00540	Lipopolysaccharide biosynthesis	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMC200038665	K00912	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMC200038667	K00912	ko00540	Lipopolysaccharide biosynthesis	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMC200038667	K00912	ko01100	Metabolic pathways	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMC200038668	K00912	ko00540	Lipopolysaccharide biosynthesis	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMC200038668	K00912	ko01100	Metabolic pathways	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMC200038670	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMC200063871	K02358	ko04626	Plant-pathogen interaction	3382	1.1e-180	0.84	0.90	0.99
PGSC0003DMC200015166	K12796	ko04621	NOD-like receptor signaling pathway	330	2.6e-09	0.30	0.48	0.33
PGSC0003DMC200015167	K12796	ko04621	NOD-like receptor signaling pathway	330	3.1e-09	0.30	0.48	0.29
PGSC0003DMC200015172	K00799	ko00480	Glutathione metabolism	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMC200015172	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMC200015172	K00799	ko00982	Drug metabolism - cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMC200015173	K00660	ko00941	Flavonoid biosynthesis	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMC200015173	K00660	ko01100	Metabolic pathways	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMC200015173	K00660	ko01110	Biosynthesis of secondary metabolites	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMC200015173	K00660	ko04712	Circadian rhythm - plant	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMC200015174	K00660	ko00941	Flavonoid biosynthesis	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMC200015174	K00660	ko01100	Metabolic pathways	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMC200015174	K00660	ko01110	Biosynthesis of secondary metabolites	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMC200015174	K00660	ko04712	Circadian rhythm - plant	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMC200015175	K00660	ko00941	Flavonoid biosynthesis	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMC200015175	K00660	ko01100	Metabolic pathways	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMC200015175	K00660	ko01110	Biosynthesis of secondary metabolites	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMC200015175	K00660	ko04712	Circadian rhythm - plant	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMC200015176	K00660	ko00941	Flavonoid biosynthesis	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMC200015176	K00660	ko01100	Metabolic pathways	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMC200015176	K00660	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMC200015176	K00660	ko04712	Circadian rhythm - plant	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMC200009611	K01593	ko00340	Histidine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00350	Tyrosine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00360	Phenylalanine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00380	Tryptophan metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00901	Indole alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00950	Isoquinoline alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko00965	Betalain biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko01100	Metabolic pathways	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009611	K01593	ko01110	Biosynthesis of secondary metabolites	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMC200009612	K01593	ko00340	Histidine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00350	Tyrosine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00360	Phenylalanine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00380	Tryptophan metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00901	Indole alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko00965	Betalain biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko01100	Metabolic pathways	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009612	K01593	ko01110	Biosynthesis of secondary metabolites	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMC200009613	K05277	ko00941	Flavonoid biosynthesis	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMC200009613	K05277	ko01100	Metabolic pathways	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMC200009613	K05277	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMC200009614	K08233	ko00901	Indole alkaloid biosynthesis	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMC200009614	K08233	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMC200009617	K05277	ko00941	Flavonoid biosynthesis	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMC200009617	K05277	ko01100	Metabolic pathways	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMC200009617	K05277	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMC200009618	K05277	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMC200009618	K05277	ko01100	Metabolic pathways	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMC200009618	K05277	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMC200009619	K05277	ko00941	Flavonoid biosynthesis	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMC200009619	K05277	ko01100	Metabolic pathways	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMC200009619	K05277	ko01110	Biosynthesis of secondary metabolites	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMC200009620	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMC200009620	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMC200009621	K05933	ko00270	Cysteine and methionine metabolism	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMC200009621	K05933	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMC200028421	K08099	ko00860	Porphyrin and chlorophyll metabolism	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMC200028421	K08099	ko01100	Metabolic pathways	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMC200028421	K08099	ko01110	Biosynthesis of secondary metabolites	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMC200028422	K08099	ko00860	Porphyrin and chlorophyll metabolism	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMC200028422	K08099	ko01100	Metabolic pathways	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMC200028422	K08099	ko01110	Biosynthesis of secondary metabolites	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMC200028433	K00648	ko00061	Fatty acid biosynthesis	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMC200028433	K00648	ko01100	Metabolic pathways	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMC200036335	K12591	ko03018	RNA degradation	3520	2.6e-188	0.51	0.64	1.00
PGSC0003DMC200036337	K12126	ko04712	Circadian rhythm - plant	328	1.5e-10	0.28	0.40	0.71
PGSC0003DMC200036351	K12338	ko00942	Anthocyanin biosynthesis	519	8.6e-23	0.49	0.67	0.85
PGSC0003DMC200036352	K12929	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMC200036352	K12929	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMC200036353	K12929	ko00904	Diterpenoid biosynthesis	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMC200036353	K12929	ko01110	Biosynthesis of secondary metabolites	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMC200036354	K12929	ko00904	Diterpenoid biosynthesis	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMC200036354	K12929	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMC200036355	K12338	ko00942	Anthocyanin biosynthesis	325	4.3e-12	0.48	0.69	0.98
PGSC0003DMC200036356	K12338	ko00942	Anthocyanin biosynthesis	1883	5.1e-98	0.51	0.69	0.98
PGSC0003DMC200036357	K12338	ko00942	Anthocyanin biosynthesis	502	7.5e-22	0.54	0.72	0.97
PGSC0003DMC200036358	K12338	ko00942	Anthocyanin biosynthesis	1177	4.4e-59	0.50	0.69	0.95
PGSC0003DMC200036359	K12338	ko00942	Anthocyanin biosynthesis	264	1.2e-08	0.37	0.54	0.71
PGSC0003DMC200043026	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.76
PGSC0003DMC200043027	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.87
PGSC0003DMC200043049	K02981	ko03010	Ribosome	2040	1.1e-106	0.88	0.92	1.00
PGSC0003DMC200059761	K05282	ko00904	Diterpenoid biosynthesis	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMC200059761	K05282	ko01100	Metabolic pathways	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMC200059761	K05282	ko01110	Biosynthesis of secondary metabolites	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMC200059773	K05759	ko04810	Regulation of actin cytoskeleton	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMC200059773	K05759	ko05131	Shigellosis	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMC200059782	K02894	ko03010	Ribosome	550	1.7e-24	0.93	0.94	0.99
PGSC0003DMC200048218	K04646	ko04142	Lysosome	10758	0.	0.78	0.82	1.00
PGSC0003DMC200048218	K04646	ko04144	Endocytosis	10758	0.	0.78	0.82	1.00
PGSC0003DMC200048218	K04646	ko05016	Huntington's disease	10758	0.	0.78	0.82	1.00
PGSC0003DMC200048218	K04646	ko05100	Bacterial invasion of epithelial cells	10758	0.	0.78	0.82	1.00
PGSC0003DMC200048219	K04646	ko04142	Lysosome	13479	0.	0.93	0.97	1.00
PGSC0003DMC200048219	K04646	ko04144	Endocytosis	13479	0.	0.93	0.97	1.00
PGSC0003DMC200048219	K04646	ko05016	Huntington's disease	13479	0.	0.93	0.97	1.00
PGSC0003DMC200048219	K04646	ko05100	Bacterial invasion of epithelial cells	13479	0.	0.93	0.97	1.00
PGSC0003DMC200048229	K10575	ko04120	Ubiquitin mediated proteolysis	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMC200048229	K10575	ko05012	Parkinson's disease	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMC200048231	K01710	ko00521	Streptomycin biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMC200048231	K01710	ko00523	Polyketide sugar unit biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMC200048231	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMC200048231	K01710	ko01100	Metabolic pathways	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMC200048231	K01710	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMC200048232	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200048236	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048236	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048236	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048236	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048236	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048237	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048237	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048237	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048237	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048237	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMC200048239	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMC200048239	K00517	ko00626	Naphthalene and anthracene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMC200048239	K00517	ko00903	Limonene and pinene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMC200048239	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMC200048239	K00517	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMC200005581	K01507	ko00190	Oxidative phosphorylation	2043	7.6e-107	0.81	0.86	1.00
PGSC0003DMC200005583	K02492	ko00860	Porphyrin and chlorophyll metabolism	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMC200005583	K02492	ko01100	Metabolic pathways	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMC200005583	K02492	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMC200005584	K02492	ko00860	Porphyrin and chlorophyll metabolism	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMC200005584	K02492	ko01100	Metabolic pathways	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMC200005584	K02492	ko01110	Biosynthesis of secondary metabolites	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMC200005585	K02492	ko00860	Porphyrin and chlorophyll metabolism	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMC200005585	K02492	ko01100	Metabolic pathways	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMC200005585	K02492	ko01110	Biosynthesis of secondary metabolites	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMC200005591	K12135	ko04712	Circadian rhythm - plant	319	9.3e-12	0.47	0.57	0.64
PGSC0003DMC200005593	K12135	ko04712	Circadian rhythm - plant	340	6.4e-13	0.33	0.46	0.85
PGSC0003DMC200005596	K11247	ko04144	Endocytosis	864	8.1e-42	0.64	0.79	0.95
PGSC0003DMC200005597	K11247	ko04144	Endocytosis	1464	6.5e-75	0.57	0.74	0.99
PGSC0003DMC200005598	K11247	ko04144	Endocytosis	1674	1.7e-86	0.57	0.75	0.99
PGSC0003DMC200014233	K05391	ko04626	Plant-pathogen interaction	2025	7.4e-106	0.78	0.84	0.98
PGSC0003DMC200014234	K05391	ko04626	Plant-pathogen interaction	4387	3.9e-236	0.74	0.83	0.99
PGSC0003DMC200014243	K01674	ko00910	Nitrogen metabolism	1444	8.3e-74	0.62	0.80	0.95
PGSC0003DMC200014244	K03008	ko00230	Purine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMC200014244	K03008	ko00240	Pyrimidine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMC200014244	K03008	ko01100	Metabolic pathways	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMC200014244	K03008	ko03020	RNA polymerase	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMC200014244	K03008	ko05016	Huntington's disease	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMC200019414	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMC200019414	K00517	ko00626	Naphthalene and anthracene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMC200019414	K00517	ko00903	Limonene and pinene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMC200019414	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMC200019414	K00517	ko01110	Biosynthesis of secondary metabolites	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMC200019415	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMC200019415	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMC200019415	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMC200019415	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMC200019415	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMC200019416	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMC200019416	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMC200019416	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMC200019416	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMC200019416	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMC200019417	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMC200019417	K00517	ko00626	Naphthalene and anthracene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMC200019417	K00517	ko00903	Limonene and pinene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMC200019417	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMC200019417	K00517	ko01110	Biosynthesis of secondary metabolites	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMC200019418	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMC200019418	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMC200019418	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMC200019418	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMC200019418	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMC200019419	K09755	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMC200019419	K09755	ko01100	Metabolic pathways	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMC200019419	K09755	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMC200019420	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMC200019420	K00517	ko00626	Naphthalene and anthracene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMC200019420	K00517	ko00903	Limonene and pinene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMC200019420	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMC200019420	K00517	ko01110	Biosynthesis of secondary metabolites	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMC200019421	K02308	ko04010	MAPK signaling pathway	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMC200019421	K02308	ko05014	Amyotrophic lateral sclerosis (ALS)	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMC200019422	K00680	ko00350	Tyrosine metabolism	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMC200019422	K00680	ko00624	1- and 2-Methylnaphthalene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMC200019422	K00680	ko00632	Benzoate degradation via CoA ligation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMC200019422	K00680	ko00642	Ethylbenzene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMC200019422	K00680	ko00903	Limonene and pinene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMC200019423	K05765	ko04360	Axon guidance	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMC200019423	K05765	ko04666	Fc gamma R-mediated phagocytosis	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMC200019423	K05765	ko04810	Regulation of actin cytoskeleton	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMC200019426	K12492	ko04144	Endocytosis	2717	5.1e-144	0.70	0.81	1.00
PGSC0003DMC200019427	K12492	ko04144	Endocytosis	838	2.2e-40	0.64	0.77	0.99
PGSC0003DMC200019429	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.28
PGSC0003DMC200035593	K13065	ko00940	Phenylpropanoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMC200035593	K13065	ko00941	Flavonoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMC200035593	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMC200035593	K13065	ko01110	Biosynthesis of secondary metabolites	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMC200035599	K06268	ko04010	MAPK signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04020	Calcium signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04114	Oocyte meiosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04210	Apoptosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04310	Wnt signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04360	Axon guidance	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04370	VEGF signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04650	Natural killer cell mediated cytotoxicity	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04660	T cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04662	B cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko04720	Long-term potentiation	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko05010	Alzheimer's disease	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035599	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMC200035600	K06268	ko04010	MAPK signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04020	Calcium signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04114	Oocyte meiosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04210	Apoptosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04310	Wnt signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04360	Axon guidance	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04370	VEGF signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04650	Natural killer cell mediated cytotoxicity	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04660	T cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04662	B cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko04720	Long-term potentiation	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko05010	Alzheimer's disease	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035600	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMC200035601	K06268	ko04010	MAPK signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04020	Calcium signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04114	Oocyte meiosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04210	Apoptosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04310	Wnt signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04360	Axon guidance	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04370	VEGF signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04650	Natural killer cell mediated cytotoxicity	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04660	T cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04662	B cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko04720	Long-term potentiation	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko05010	Alzheimer's disease	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035601	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMC200035602	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMC200035602	K00430	ko00680	Methane metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMC200035602	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMC200035602	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMC200035602	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMC200035603	K00430	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMC200035603	K00430	ko00680	Methane metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMC200035603	K00430	ko00940	Phenylpropanoid biosynthesis	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMC200035603	K00430	ko01100	Metabolic pathways	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMC200035603	K00430	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMC200035607	K01099	ko00562	Inositol phosphate metabolism	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMC200035607	K01099	ko01100	Metabolic pathways	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMC200035607	K01099	ko04070	Phosphatidylinositol signaling system	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMC200035608	K01099	ko00562	Inositol phosphate metabolism	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMC200035608	K01099	ko01100	Metabolic pathways	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMC200035608	K01099	ko04070	Phosphatidylinositol signaling system	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMC200035609	K01099	ko00562	Inositol phosphate metabolism	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMC200035609	K01099	ko01100	Metabolic pathways	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMC200035609	K01099	ko04070	Phosphatidylinositol signaling system	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMC200035610	K01099	ko00562	Inositol phosphate metabolism	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMC200035610	K01099	ko01100	Metabolic pathways	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMC200035610	K01099	ko04070	Phosphatidylinositol signaling system	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMC200044238	K03660	ko03410	Base excision repair	279	8.0e-09	0.42	0.56	0.62
PGSC0003DMC200044239	K03660	ko03410	Base excision repair	279	8.0e-09	0.45	0.59	0.53
PGSC0003DMC200037531	K11086	ko03040	Spliceosome	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMC200037531	K11086	ko05322	Systemic lupus erythematosus	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMC200037532	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMC200037532	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMC200037533	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMC200037533	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMC200037535	K04371	ko04010	MAPK signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04012	ErbB signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04013	MAPK signaling pathway - fly	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04062	Chemokine signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04114	Oocyte meiosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04150	mTOR signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04270	Vascular smooth muscle contraction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04320	Dorso-ventral axis formation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04350	TGF-beta signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04360	Axon guidance	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04370	VEGF signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04510	Focal adhesion	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04520	Adherens junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04540	Gap junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04620	Toll-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04621	NOD-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04650	Natural killer cell mediated cytotoxicity	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04660	T cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04662	B cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04664	Fc epsilon RI signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04666	Fc gamma R-mediated phagocytosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04720	Long-term potentiation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04722	Neurotrophin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04730	Long-term depression	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04810	Regulation of actin cytoskeleton	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04910	Insulin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04912	GnRH signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04914	Progesterone-mediated oocyte maturation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04916	Melanogenesis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04930	Type II diabetes mellitus	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05010	Alzheimer's disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05020	Prion diseases	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05131	Shigellosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05140	Leishmaniasis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05142	Chagas disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05200	Pathways in cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05210	Colorectal cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05211	Renal cell carcinoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05212	Pancreatic cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05213	Endometrial cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05214	Glioma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05215	Prostate cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05216	Thyroid cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05218	Melanoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05219	Bladder cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05220	Chronic myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05221	Acute myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037535	K04371	ko05223	Non-small cell lung cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMC200037537	K01762	ko00270	Cysteine and methionine metabolism	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMC200037537	K01762	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMC200037548	K12614	ko03018	RNA degradation	3586	5.9e-192	0.87	0.92	1.00
PGSC0003DMC200037552	K01213	ko00040	Pentose and glucuronate interconversions	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMC200037552	K01213	ko00500	Starch and sucrose metabolism	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMC200037552	K01213	ko01100	Metabolic pathways	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMC200037553	K01213	ko00040	Pentose and glucuronate interconversions	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMC200037553	K01213	ko00500	Starch and sucrose metabolism	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMC200037553	K01213	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMC200037559	K08486	ko04130	SNARE interactions in vesicular transport	1841	1.0e-95	0.76	0.86	0.96
PGSC0003DMC200049425	K00013	ko00340	Histidine metabolism	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMC200049425	K00013	ko01100	Metabolic pathways	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMC200049425	K00013	ko01110	Biosynthesis of secondary metabolites	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMC200049426	K00013	ko00340	Histidine metabolism	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMC200049426	K00013	ko01100	Metabolic pathways	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMC200049426	K00013	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMC200049430	K11093	ko03040	Spliceosome	225	1.4e-06	0.37	0.46	0.69
PGSC0003DMC200049439	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200049439	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200049440	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200049440	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200013021	K05665	ko02010	ABC transporters	1289	2.9e-65	0.35	0.54	0.91
PGSC0003DMC200013026	K00857	ko00240	Pyrimidine metabolism	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMC200013026	K00857	ko00983	Drug metabolism - other enzymes	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMC200013026	K00857	ko01100	Metabolic pathways	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMC200013039	K08139	ko04113	Meiosis - yeast	897	1.2e-43	0.33	0.52	0.96
PGSC0003DMC200013040	K00106	ko00230	Purine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013040	K00106	ko00232	Caffeine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013040	K00106	ko00983	Drug metabolism - other enzymes	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013040	K00106	ko01100	Metabolic pathways	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013040	K00106	ko01110	Biosynthesis of secondary metabolites	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013040	K00106	ko04146	Peroxisome	6366	0.	0.61	0.72	1.00
PGSC0003DMC200013041	K00106	ko00230	Purine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013041	K00106	ko00232	Caffeine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013041	K00106	ko00983	Drug metabolism - other enzymes	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013041	K00106	ko01100	Metabolic pathways	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013041	K00106	ko01110	Biosynthesis of secondary metabolites	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013041	K00106	ko04146	Peroxisome	8662	0.	0.74	0.86	1.00
PGSC0003DMC200013042	K00106	ko00230	Purine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013042	K00106	ko00232	Caffeine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013042	K00106	ko00983	Drug metabolism - other enzymes	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013042	K00106	ko01100	Metabolic pathways	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013042	K00106	ko01110	Biosynthesis of secondary metabolites	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013042	K00106	ko04146	Peroxisome	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMC200013043	K00106	ko00230	Purine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013043	K00106	ko00232	Caffeine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013043	K00106	ko00983	Drug metabolism - other enzymes	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013043	K00106	ko01100	Metabolic pathways	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013043	K00106	ko01110	Biosynthesis of secondary metabolites	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013043	K00106	ko04146	Peroxisome	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMC200013049	K00680	ko00350	Tyrosine metabolism	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMC200013049	K00680	ko00624	1- and 2-Methylnaphthalene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMC200013049	K00680	ko00632	Benzoate degradation via CoA ligation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMC200013049	K00680	ko00642	Ethylbenzene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMC200013049	K00680	ko00903	Limonene and pinene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMC200013050	K12183	ko04144	Endocytosis	231	2.0e-06	0.32	0.45	0.57
PGSC0003DMC200006333	K01623	ko00010	Glycolysis / Gluconeogenesis	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006333	K01623	ko00030	Pentose phosphate pathway	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006333	K01623	ko00051	Fructose and mannose metabolism	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006333	K01623	ko00710	Carbon fixation in photosynthetic organisms	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006333	K01623	ko01100	Metabolic pathways	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006333	K01623	ko01110	Biosynthesis of secondary metabolites	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMC200006334	K01623	ko00010	Glycolysis / Gluconeogenesis	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006334	K01623	ko00030	Pentose phosphate pathway	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006334	K01623	ko00051	Fructose and mannose metabolism	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006334	K01623	ko00710	Carbon fixation in photosynthetic organisms	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006334	K01623	ko01100	Metabolic pathways	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006334	K01623	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMC200006351	K11088	ko03040	Spliceosome	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMC200006351	K11088	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMC200006358	K00475	ko00941	Flavonoid biosynthesis	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMC200006358	K00475	ko01100	Metabolic pathways	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMC200006358	K00475	ko01110	Biosynthesis of secondary metabolites	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMC200006359	K00475	ko00941	Flavonoid biosynthesis	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMC200006359	K00475	ko01100	Metabolic pathways	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMC200006359	K00475	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMC200006360	K00475	ko00941	Flavonoid biosynthesis	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMC200006360	K00475	ko01100	Metabolic pathways	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMC200006360	K00475	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMC200029761	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029761	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029761	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029762	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029762	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029762	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029763	K06671	ko04110	Cell cycle	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMC200029763	K06671	ko04111	Cell cycle - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMC200029763	K06671	ko04113	Meiosis - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMC200029764	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMC200029765	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029765	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029765	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029766	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029766	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029766	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029767	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMC200029774	K07204	ko04150	mTOR signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMC200029774	K07204	ko04910	Insulin signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMC200029775	K07204	ko04150	mTOR signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMC200029775	K07204	ko04910	Insulin signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMC200029776	K07204	ko04150	mTOR signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMC200029776	K07204	ko04910	Insulin signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMC200029780	K01762	ko00270	Cysteine and methionine metabolism	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMC200029780	K01762	ko01110	Biosynthesis of secondary metabolites	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMC200018220	K12608	ko03018	RNA degradation	1844	7.2e-96	0.78	0.89	0.98
PGSC0003DMC200018221	K12608	ko03018	RNA degradation	1109	2.5e-55	0.79	0.90	0.89
PGSC0003DMC200018224	K08332	ko04140	Regulation of autophagy	390	1.0e-13	0.31	0.53	0.47
PGSC0003DMC200018225	K08332	ko04140	Regulation of autophagy	390	2.3e-13	0.31	0.53	0.38
PGSC0003DMC200018228	K09647	ko03060	Protein export	230	7.5e-07	0.33	0.49	0.59
PGSC0003DMC200018229	K09647	ko03060	Protein export	232	5.8e-07	0.34	0.50	0.59
PGSC0003DMC200018235	K12819	ko03040	Spliceosome	3985	5.9e-214	0.85	0.93	1.00
PGSC0003DMC200018240	K13065	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMC200018240	K13065	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMC200018240	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMC200018240	K13065	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMC200060073	K10591	ko04120	Ubiquitin mediated proteolysis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMC200060073	K10591	ko04144	Endocytosis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMC200060080	K08243	ko00941	Flavonoid biosynthesis	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMC200060080	K08243	ko01110	Biosynthesis of secondary metabolites	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMC200058428	K11821	ko00380	Tryptophan metabolism	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMC200058428	K11821	ko00966	Glucosinolate biosynthesis	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMC200058428	K11821	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMC200039610	K00430	ko00360	Phenylalanine metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMC200039610	K00430	ko00680	Methane metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMC200039610	K00430	ko00940	Phenylpropanoid biosynthesis	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMC200039610	K00430	ko01100	Metabolic pathways	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMC200039610	K00430	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMC200039611	K00430	ko00360	Phenylalanine metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMC200039611	K00430	ko00680	Methane metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMC200039611	K00430	ko00940	Phenylpropanoid biosynthesis	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMC200039611	K00430	ko01100	Metabolic pathways	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMC200039611	K00430	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMC200039612	K00430	ko00360	Phenylalanine metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMC200039612	K00430	ko00680	Methane metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMC200039612	K00430	ko00940	Phenylpropanoid biosynthesis	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMC200039612	K00430	ko01100	Metabolic pathways	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMC200039612	K00430	ko01110	Biosynthesis of secondary metabolites	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMC200039613	K00430	ko00360	Phenylalanine metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMC200039613	K00430	ko00680	Methane metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMC200039613	K00430	ko00940	Phenylpropanoid biosynthesis	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMC200039613	K00430	ko01100	Metabolic pathways	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMC200039613	K00430	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMC200039614	K00430	ko00360	Phenylalanine metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMC200039614	K00430	ko00680	Methane metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMC200039614	K00430	ko00940	Phenylpropanoid biosynthesis	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMC200039614	K00430	ko01100	Metabolic pathways	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMC200039614	K00430	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMC200039624	K11095	ko03040	Spliceosome	932	1.4e-45	0.61	0.68	0.92
PGSC0003DMC200039625	K01662	ko00900	Terpenoid backbone biosynthesis	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMC200039625	K01662	ko01100	Metabolic pathways	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMC200039625	K01662	ko01110	Biosynthesis of secondary metabolites	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMC200039626	K01662	ko00900	Terpenoid backbone biosynthesis	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMC200039626	K01662	ko01100	Metabolic pathways	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMC200039626	K01662	ko01110	Biosynthesis of secondary metabolites	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMC200045151	K12604	ko03018	RNA degradation	8425	0.	0.50	0.60	1.00
PGSC0003DMC200045158	K00026	ko00020	Citrate cycle (TCA cycle)	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045158	K00026	ko00620	Pyruvate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045158	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045158	K00026	ko00710	Carbon fixation in photosynthetic organisms	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045158	K00026	ko01100	Metabolic pathways	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045158	K00026	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMC200045159	K00026	ko00020	Citrate cycle (TCA cycle)	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045159	K00026	ko00620	Pyruvate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045159	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045159	K00026	ko00710	Carbon fixation in photosynthetic organisms	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045159	K00026	ko01100	Metabolic pathways	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045159	K00026	ko01110	Biosynthesis of secondary metabolites	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMC200045177	K05754	ko04666	Fc gamma R-mediated phagocytosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMC200045177	K05754	ko04810	Regulation of actin cytoskeleton	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMC200045177	K05754	ko05100	Bacterial invasion of epithelial cells	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMC200045177	K05754	ko05130	Pathogenic Escherichia coli infection	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMC200045177	K05754	ko05131	Shigellosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMC200045178	K05754	ko04666	Fc gamma R-mediated phagocytosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMC200045178	K05754	ko04810	Regulation of actin cytoskeleton	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMC200045178	K05754	ko05100	Bacterial invasion of epithelial cells	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMC200045178	K05754	ko05130	Pathogenic Escherichia coli infection	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMC200045178	K05754	ko05131	Shigellosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMC200045179	K02084	ko04115	p53 signaling pathway	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko04210	Apoptosis	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko05010	Alzheimer's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko05012	Parkinson's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko05016	Huntington's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200045179	K02084	ko05222	Small cell lung cancer	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMC200010802	K12126	ko04712	Circadian rhythm - plant	315	1.9e-11	0.49	0.85	0.24
PGSC0003DMC200010820	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010820	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010820	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010820	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010821	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010821	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010821	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010821	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMC200010823	K10773	ko03410	Base excision repair	275	2.5e-09	0.64	0.71	0.85
PGSC0003DMC200010824	K10773	ko03410	Base excision repair	312	2.3e-11	0.70	0.94	0.53
PGSC0003DMC200010825	K10773	ko03410	Base excision repair	1564	2.0e-80	0.59	0.71	0.99
PGSC0003DMC200010826	K10773	ko03410	Base excision repair	1153	9.3e-58	0.56	0.71	0.88
PGSC0003DMC200010830	K00660	ko00941	Flavonoid biosynthesis	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMC200010830	K00660	ko01100	Metabolic pathways	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMC200010830	K00660	ko01110	Biosynthesis of secondary metabolites	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMC200010830	K00660	ko04712	Circadian rhythm - plant	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMC200016354	K13065	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMC200016354	K13065	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMC200016354	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMC200016354	K13065	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMC200016360	K00893	ko00230	Purine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMC200016360	K00893	ko00240	Pyrimidine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMC200016361	K00599	ko00340	Histidine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMC200016361	K00599	ko00350	Tyrosine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMC200016361	K00599	ko00450	Selenoamino acid metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMC200016361	K00599	ko00626	Naphthalene and anthracene degradation	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMC200016362	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016362	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016362	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016362	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016363	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016363	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016363	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016363	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016364	K00599	ko00340	Histidine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMC200016364	K00599	ko00350	Tyrosine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMC200016364	K00599	ko00450	Selenoamino acid metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMC200016364	K00599	ko00626	Naphthalene and anthracene degradation	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMC200016365	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016365	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016365	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016365	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016366	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016366	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016366	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016366	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016367	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016367	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016367	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016367	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016368	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016368	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016368	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016368	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMC200016369	K00599	ko00340	Histidine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMC200016369	K00599	ko00350	Tyrosine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMC200016369	K00599	ko00450	Selenoamino acid metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMC200016369	K00599	ko00626	Naphthalene and anthracene degradation	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMC200027211	K12605	ko03018	RNA degradation	746	2.6e-35	0.77	0.92	0.93
PGSC0003DMC200027213	K03946	ko00190	Oxidative phosphorylation	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMC200027213	K03946	ko01100	Metabolic pathways	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMC200027213	K03946	ko05010	Alzheimer's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMC200027213	K03946	ko05012	Parkinson's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMC200027213	K03946	ko05016	Huntington's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMC200027226	K10703	ko01040	Biosynthesis of unsaturated fatty acids	614	5.0e-28	0.66	0.81	0.54
PGSC0003DMC200027227	K10703	ko01040	Biosynthesis of unsaturated fatty acids	421	2.2e-17	0.52	0.64	0.98
PGSC0003DMC200027228	K10703	ko01040	Biosynthesis of unsaturated fatty acids	530	2.1e-23	0.58	0.70	0.98
PGSC0003DMC200027229	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1070	3.5e-53	0.60	0.74	0.99
PGSC0003DMC200027230	K10703	ko01040	Biosynthesis of unsaturated fatty acids	373	9.7e-15	0.61	0.76	0.44
PGSC0003DMC200027233	K02858	ko00740	Riboflavin metabolism	2657	1.0e-140	0.84	0.92	0.94
PGSC0003DMC200027234	K02858	ko00740	Riboflavin metabolism	2618	1.5e-138	0.71	0.80	0.96
PGSC0003DMC200027235	K02858	ko00740	Riboflavin metabolism	3110	1.1e-165	0.73	0.82	0.95
PGSC0003DMC200020762	K02865	ko03010	Ribosome	1259	1.3e-63	0.89	0.92	0.44
PGSC0003DMC200020763	K02865	ko03010	Ribosome	1643	8.7e-85	0.92	0.95	1.00
PGSC0003DMC200020780	K10352	ko04530	Tight junction	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMC200020780	K10352	ko05416	Viral myocarditis	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMC200020789	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMC200020789	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMC200020789	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMC200020789	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMC200020790	K07407	ko00052	Galactose metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMC200020790	K07407	ko00561	Glycerolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMC200020790	K07407	ko00600	Sphingolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMC200020790	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMC200008641	K04554	ko04120	Ubiquitin mediated proteolysis	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMC200008641	K04554	ko05012	Parkinson's disease	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMC200008647	K03061	ko03050	Proteasome	888	3.8e-43	0.91	0.96	0.94
PGSC0003DMC200008648	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.99	1.00
PGSC0003DMC200008649	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.82
PGSC0003DMC200008650	K03061	ko03050	Proteasome	837	2.5e-40	0.87	0.91	0.97
PGSC0003DMC200008668	K00469	ko00053	Ascorbate and aldarate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMC200008668	K00469	ko00562	Inositol phosphate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMC200065075	K01051	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMC200065075	K01051	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMC200065075	K01051	ko01100	Metabolic pathways	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMC200065079	K13065	ko00940	Phenylpropanoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMC200065079	K13065	ko00941	Flavonoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMC200065079	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMC200065079	K13065	ko01110	Biosynthesis of secondary metabolites	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMC200065091	K00799	ko00480	Glutathione metabolism	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMC200065091	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMC200065091	K00799	ko00982	Drug metabolism - cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMC200065094	K03094	ko04110	Cell cycle	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04111	Cell cycle - yeast	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04114	Oocyte meiosis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04120	Ubiquitin mediated proteolysis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04310	Wnt signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04350	TGF-beta signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200065094	K03094	ko04710	Circadian rhythm - mammal	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMC200063756	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2321	3.5e-122	0.66	0.80	0.99
PGSC0003DMC200063760	K12836	ko03040	Spliceosome	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMC200063760	K12836	ko05131	Shigellosis	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMC200015278	K00795	ko00900	Terpenoid backbone biosynthesis	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMC200015278	K00795	ko01100	Metabolic pathways	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMC200015278	K00795	ko01110	Biosynthesis of secondary metabolites	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMC200015279	K00795	ko00900	Terpenoid backbone biosynthesis	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMC200015279	K00795	ko01100	Metabolic pathways	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMC200015279	K00795	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMC200015280	K00795	ko00900	Terpenoid backbone biosynthesis	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMC200015280	K00795	ko01100	Metabolic pathways	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMC200015280	K00795	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMC200015282	K12042	ko04020	Calcium signaling pathway	296	1.7e-10	0.37	0.52	0.68
PGSC0003DMC200015288	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200015292	K03283	ko03040	Spliceosome	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMC200015292	K03283	ko04010	MAPK signaling pathway	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMC200015292	K03283	ko04144	Endocytosis	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMC200015292	K03283	ko04612	Antigen processing and presentation	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMC200010083	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010083	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010085	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010085	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010086	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010086	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010087	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010087	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMC200010092	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMC200010092	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMC200010095	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMC200010095	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMC200010096	K12603	ko03018	RNA degradation	496	1.6e-21	0.35	0.57	0.56
PGSC0003DMC200010097	K12603	ko03018	RNA degradation	301	1.8e-10	0.31	0.43	0.95
PGSC0003DMC200010098	K12603	ko03018	RNA degradation	346	4.5e-13	0.36	0.50	0.69
PGSC0003DMC200010107	K10260	ko04120	Ubiquitin mediated proteolysis	558	3.3e-24	0.32	0.51	0.24
PGSC0003DMC200010108	K10260	ko04120	Ubiquitin mediated proteolysis	558	6.1e-25	0.32	0.51	0.51
PGSC0003DMC200046490	K12489	ko04144	Endocytosis	3267	2.3e-174	0.70	0.84	0.99
PGSC0003DMC200046491	K12489	ko04144	Endocytosis	634	3.9e-29	0.60	0.75	0.99
PGSC0003DMC200046492	K12489	ko04144	Endocytosis	957	6.0e-47	0.61	0.79	0.88
PGSC0003DMC200046493	K05282	ko00904	Diterpenoid biosynthesis	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMC200046493	K05282	ko01100	Metabolic pathways	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMC200046493	K05282	ko01110	Biosynthesis of secondary metabolites	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMC200041287	K00889	ko00562	Inositol phosphate metabolism	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041287	K00889	ko01100	Metabolic pathways	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041287	K00889	ko04070	Phosphatidylinositol signaling system	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041287	K00889	ko04144	Endocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041287	K00889	ko04666	Fc gamma R-mediated phagocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041287	K00889	ko04810	Regulation of actin cytoskeleton	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMC200041288	K00889	ko00562	Inositol phosphate metabolism	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041288	K00889	ko01100	Metabolic pathways	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041288	K00889	ko04070	Phosphatidylinositol signaling system	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041288	K00889	ko04144	Endocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041288	K00889	ko04666	Fc gamma R-mediated phagocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041288	K00889	ko04810	Regulation of actin cytoskeleton	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMC200041289	K02901	ko03010	Ribosome	766	2.1e-36	0.71	0.81	0.99
PGSC0003DMC200041301	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMC200041301	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMC200041301	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMC200041301	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMC200041301	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMC200050521	K01423	ko00310	Lysine degradation	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMC200050521	K01423	ko00780	Biotin metabolism	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMC200050521	K01423	ko01100	Metabolic pathways	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMC200050523	K01254	ko00590	Arachidonic acid metabolism	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMC200050523	K01254	ko01100	Metabolic pathways	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMC200050534	K02291	ko00906	Carotenoid biosynthesis	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMC200050534	K02291	ko01100	Metabolic pathways	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMC200050534	K02291	ko01110	Biosynthesis of secondary metabolites	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMC200050537	K05577	ko00190	Oxidative phosphorylation	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMC200050537	K05577	ko01100	Metabolic pathways	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMC200061626	K00002	ko00010	Glycolysis / Gluconeogenesis	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMC200061626	K00002	ko00561	Glycerolipid metabolism	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMC200061626	K00002	ko00930	Caprolactam degradation	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMC200061626	K00002	ko01100	Metabolic pathways	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMC200061626	K00002	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMC200061636	K02183	ko04020	Calcium signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04070	Phosphatidylinositol signaling system	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04114	Oocyte meiosis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04270	Vascular smooth muscle contraction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04626	Plant-pathogen interaction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04720	Long-term potentiation	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04722	Neurotrophin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04740	Olfactory transduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04744	Phototransduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04745	Phototransduction - fly	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04910	Insulin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04912	GnRH signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04916	Melanogenesis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04970	Salivary secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko04971	Gastric acid secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko05010	Alzheimer's disease	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061636	K02183	ko05214	Glioma	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMC200061639	K01051	ko00040	Pentose and glucuronate interconversions	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMC200061639	K01051	ko00500	Starch and sucrose metabolism	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMC200061639	K01051	ko01100	Metabolic pathways	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMC200005703	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMC200005703	K01904	ko00360	Phenylalanine metabolism	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMC200005703	K01904	ko00940	Phenylpropanoid biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMC200005703	K01904	ko01100	Metabolic pathways	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMC200005703	K01904	ko01110	Biosynthesis of secondary metabolites	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMC200005707	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMC200005707	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMC200005708	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMC200005708	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMC200005718	K10352	ko04530	Tight junction	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMC200005718	K10352	ko05416	Viral myocarditis	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMC200005722	K10610	ko03420	Nucleotide excision repair	8587	0.	0.93	0.97	1.00
PGSC0003DMC200005722	K10610	ko04120	Ubiquitin mediated proteolysis	8587	0.	0.93	0.97	1.00
PGSC0003DMC200005723	K10610	ko03420	Nucleotide excision repair	8568	0.	0.92	0.97	1.00
PGSC0003DMC200005723	K10610	ko04120	Ubiquitin mediated proteolysis	8568	0.	0.92	0.97	1.00
PGSC0003DMC200005725	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMC200005726	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMC200005728	K03259	ko04150	mTOR signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMC200005728	K03259	ko04910	Insulin signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMC200007306	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMC200007307	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMC200007309	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMC200007309	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMC200007309	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMC200007309	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMC200007309	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMC200007314	K10777	ko03450	Non-homologous end-joining	3820	7.4e-205	0.58	0.73	0.99
PGSC0003DMC200007315	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMC200007316	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMC200007317	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMC200007318	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMC200007319	K10777	ko03450	Non-homologous end-joining	747	2.3e-35	0.82	0.88	0.82
PGSC0003DMC200007320	K10777	ko03450	Non-homologous end-joining	2277	9.4e-120	0.83	0.92	0.94
PGSC0003DMC200013864	K02084	ko04115	p53 signaling pathway	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko04210	Apoptosis	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko05010	Alzheimer's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko05012	Parkinson's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko05016	Huntington's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013864	K02084	ko05222	Small cell lung cancer	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMC200013867	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013867	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMC200013868	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013868	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMC200013872	K02084	ko04115	p53 signaling pathway	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko04210	Apoptosis	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko05010	Alzheimer's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko05012	Parkinson's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko05016	Huntington's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013872	K02084	ko05222	Small cell lung cancer	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMC200013873	K02084	ko04115	p53 signaling pathway	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko04210	Apoptosis	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko05010	Alzheimer's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko05012	Parkinson's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko05016	Huntington's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013873	K02084	ko05222	Small cell lung cancer	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMC200013881	K03010	ko00230	Purine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMC200013881	K03010	ko00240	Pyrimidine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMC200013881	K03010	ko01100	Metabolic pathways	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMC200013881	K03010	ko03020	RNA polymerase	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMC200013881	K03010	ko05016	Huntington's disease	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMC200036105	K04706	ko04120	Ubiquitin mediated proteolysis	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMC200036105	K04706	ko04630	Jak-STAT signaling pathway	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMC200036105	K04706	ko05200	Pathways in cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMC200036105	K04706	ko05222	Small cell lung cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMC200036107	K04706	ko04120	Ubiquitin mediated proteolysis	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMC200036107	K04706	ko04630	Jak-STAT signaling pathway	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMC200036107	K04706	ko05200	Pathways in cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMC200036107	K04706	ko05222	Small cell lung cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMC200036117	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMC200036118	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMC200036119	K12812	ko03040	Spliceosome	1363	2.4e-69	0.96	0.99	0.88
PGSC0003DMC200036120	K12812	ko03040	Spliceosome	2834	1.8e-150	0.97	0.99	1.00
PGSC0003DMC200042663	K12813	ko03040	Spliceosome	657	4.6e-30	0.57	0.75	0.99
PGSC0003DMC200042664	K12813	ko03040	Spliceosome	983	2.2e-48	0.86	0.95	0.98
PGSC0003DMC200042665	K12813	ko03040	Spliceosome	2692	1.2e-142	0.92	0.96	0.99
PGSC0003DMC200042666	K12813	ko03040	Spliceosome	6693	0.	0.86	0.94	1.00
PGSC0003DMC200042667	K12813	ko03040	Spliceosome	7348	0.	0.82	0.92	1.00
PGSC0003DMC200042673	K07964	ko00531	Glycosaminoglycan degradation	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMC200042673	K07964	ko01100	Metabolic pathways	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMC200042674	K07964	ko00531	Glycosaminoglycan degradation	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMC200042674	K07964	ko01100	Metabolic pathways	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMC200042675	K07964	ko00531	Glycosaminoglycan degradation	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMC200042675	K07964	ko01100	Metabolic pathways	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMC200042684	K10849	ko03420	Nucleotide excision repair	402	2.4e-16	0.52	0.62	0.91
PGSC0003DMC200042685	K10849	ko03420	Nucleotide excision repair	557	6.9e-25	0.59	0.67	0.94
PGSC0003DMC200042686	K10849	ko03420	Nucleotide excision repair	1204	1.4e-60	0.70	0.80	0.94
PGSC0003DMC200042687	K10849	ko03420	Nucleotide excision repair	2219	1.5e-116	0.70	0.79	0.97
PGSC0003DMC200059528	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMC200059528	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMC200059548	K01051	ko00040	Pentose and glucuronate interconversions	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMC200059548	K01051	ko00500	Starch and sucrose metabolism	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMC200059548	K01051	ko01100	Metabolic pathways	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMC200031153	K08488	ko04130	SNARE interactions in vesicular transport	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMC200031153	K08488	ko04145	Phagosome	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMC200031162	K09753	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMC200031162	K09753	ko01100	Metabolic pathways	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMC200031162	K09753	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMC200031163	K13082	ko00941	Flavonoid biosynthesis	254	3.6e-08	0.32	0.55	0.95
PGSC0003DMC200031170	K02703	ko00195	Photosynthesis	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMC200031170	K02703	ko01100	Metabolic pathways	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMC200012668	K01834	ko00010	Glycolysis / Gluconeogenesis	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMC200012668	K01834	ko01100	Metabolic pathways	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMC200012668	K01834	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMC200012670	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMC200012670	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMC200012670	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMC200012671	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMC200012671	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMC200012671	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMC200012672	K01834	ko00010	Glycolysis / Gluconeogenesis	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMC200012672	K01834	ko01100	Metabolic pathways	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMC200012672	K01834	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMC200012673	K01834	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMC200012673	K01834	ko01100	Metabolic pathways	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMC200012673	K01834	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMC200012674	K01834	ko00010	Glycolysis / Gluconeogenesis	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMC200012674	K01834	ko01100	Metabolic pathways	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMC200012674	K01834	ko01110	Biosynthesis of secondary metabolites	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMC200012675	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.52
PGSC0003DMC200012676	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.70
PGSC0003DMC200012680	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.43
PGSC0003DMC200012681	K11824	ko04144	Endocytosis	7439	0.	0.86	0.91	1.00
PGSC0003DMC200012681	K11824	ko05016	Huntington's disease	7439	0.	0.86	0.91	1.00
PGSC0003DMC200012682	K11824	ko04144	Endocytosis	7490	0.	0.88	0.93	1.00
PGSC0003DMC200012682	K11824	ko05016	Huntington's disease	7490	0.	0.88	0.93	1.00
PGSC0003DMC200012683	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMC200012683	K12449	ko01100	Metabolic pathways	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMC200006091	K10643	ko03018	RNA degradation	2173	5.1e-114	0.38	0.53	1.00
PGSC0003DMC200006094	K11584	ko04113	Meiosis - yeast	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMC200006094	K11584	ko04114	Oocyte meiosis	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMC200006094	K11584	ko04310	Wnt signaling pathway	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMC200006101	K02147	ko00190	Oxidative phosphorylation	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006101	K02147	ko01100	Metabolic pathways	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006101	K02147	ko04145	Phagosome	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006101	K02147	ko04966	Collecting duct acid secretion	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006101	K02147	ko05110	Vibrio cholerae infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006101	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMC200006102	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006102	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006102	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006102	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006102	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006102	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006103	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMC200006108	K12741	ko03040	Spliceosome	334	1.4e-12	0.41	0.48	0.62
PGSC0003DMC200006109	K12741	ko03040	Spliceosome	320	8.2e-12	0.34	0.45	0.92
PGSC0003DMC200006110	K12741	ko03040	Spliceosome	318	1.1e-11	0.34	0.45	0.92
PGSC0003DMC200029541	K12929	ko00904	Diterpenoid biosynthesis	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMC200029541	K12929	ko01110	Biosynthesis of secondary metabolites	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMC200029542	K04371	ko04010	MAPK signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04012	ErbB signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04013	MAPK signaling pathway - fly	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04062	Chemokine signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04114	Oocyte meiosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04150	mTOR signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04270	Vascular smooth muscle contraction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04320	Dorso-ventral axis formation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04350	TGF-beta signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04360	Axon guidance	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04370	VEGF signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04510	Focal adhesion	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04520	Adherens junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04540	Gap junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04621	NOD-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04650	Natural killer cell mediated cytotoxicity	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04660	T cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04662	B cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04664	Fc epsilon RI signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04666	Fc gamma R-mediated phagocytosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04720	Long-term potentiation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04730	Long-term depression	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04810	Regulation of actin cytoskeleton	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04910	Insulin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04912	GnRH signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04914	Progesterone-mediated oocyte maturation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04916	Melanogenesis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04930	Type II diabetes mellitus	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko04960	Aldosterone-regulated sodium reabsorption	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05010	Alzheimer's disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05020	Prion diseases	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05131	Shigellosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05140	Leishmaniasis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05142	Chagas disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05200	Pathways in cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05210	Colorectal cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05211	Renal cell carcinoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05212	Pancreatic cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05213	Endometrial cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05214	Glioma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05215	Prostate cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05216	Thyroid cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05218	Melanoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05219	Bladder cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05220	Chronic myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05221	Acute myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200029542	K04371	ko05223	Non-small cell lung cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMC200060435	K04508	ko04310	Wnt signaling pathway	2773	4.1e-147	0.64	0.78	1.00
PGSC0003DMC200060440	K10760	ko00908	Zeatin biosynthesis	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMC200060440	K10760	ko01100	Metabolic pathways	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMC200060440	K10760	ko01110	Biosynthesis of secondary metabolites	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMC200060445	K10760	ko00908	Zeatin biosynthesis	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMC200060445	K10760	ko01100	Metabolic pathways	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMC200060445	K10760	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMC200066834	K03921	ko00061	Fatty acid biosynthesis	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMC200066834	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMC200035703	K02987	ko03010	Ribosome	1939	4.1e-101	0.92	0.98	0.98
PGSC0003DMC200035704	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMC200035705	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMC200035706	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMC200035707	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMC200035708	K02987	ko03010	Ribosome	1303	4.9e-66	0.85	0.94	0.96
PGSC0003DMC200035725	K03178	ko04120	Ubiquitin mediated proteolysis	7555	0.	0.81	0.90	1.00
PGSC0003DMC200035725	K03178	ko05012	Parkinson's disease	7555	0.	0.81	0.90	1.00
PGSC0003DMC200035726	K08059	ko04612	Antigen processing and presentation	798	3.5e-38	0.53	0.68	0.89
PGSC0003DMC200035727	K08059	ko04612	Antigen processing and presentation	974	6.9e-48	0.64	0.77	0.69
PGSC0003DMC200043861	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMC200043861	K00517	ko00626	Naphthalene and anthracene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMC200043861	K00517	ko00903	Limonene and pinene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMC200043861	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMC200043861	K00517	ko01110	Biosynthesis of secondary metabolites	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMC200043870	K08248	ko00460	Cyanoamino acid metabolism	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMC200043870	K08248	ko01100	Metabolic pathways	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMC200043871	K00008	ko00051	Fructose and mannose metabolism	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMC200043871	K00008	ko01100	Metabolic pathways	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMC200037292	K13239	ko00071	Fatty acid metabolism	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMC200037292	K13239	ko04146	Peroxisome	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMC200037309	K06627	ko04110	Cell cycle	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMC200037309	K06627	ko04914	Progesterone-mediated oocyte maturation	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMC200037310	K04503	ko04110	Cell cycle	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko04115	p53 signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko04310	Wnt signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko04510	Focal adhesion	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko04630	Jak-STAT signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05200	Pathways in cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05210	Colorectal cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05212	Pancreatic cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05213	Endometrial cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05214	Glioma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05215	Prostate cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05216	Thyroid cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05218	Melanoma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05219	Bladder cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05220	Chronic myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05221	Acute myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05222	Small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05223	Non-small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037310	K04503	ko05416	Viral myocarditis	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMC200037318	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMC200037319	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMC200037320	K12126	ko04712	Circadian rhythm - plant	289	6.7e-10	0.31	0.46	0.75
PGSC0003DMC200032346	K00001	ko00010	Glycolysis / Gluconeogenesis	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00071	Fatty acid metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00350	Tyrosine metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00641	3-Chloroacrylic acid degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00830	Retinol metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko00982	Drug metabolism - cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko01100	Metabolic pathways	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032346	K00001	ko01110	Biosynthesis of secondary metabolites	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMC200032347	K00121	ko00010	Glycolysis / Gluconeogenesis	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00071	Fatty acid metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00350	Tyrosine metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00641	3-Chloroacrylic acid degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00680	Methane metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00830	Retinol metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko00982	Drug metabolism - cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko01100	Metabolic pathways	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032347	K00121	ko01110	Biosynthesis of secondary metabolites	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMC200032348	K00121	ko00010	Glycolysis / Gluconeogenesis	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00071	Fatty acid metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00350	Tyrosine metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00624	1- and 2-Methylnaphthalene degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00641	3-Chloroacrylic acid degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00680	Methane metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00830	Retinol metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko00982	Drug metabolism - cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko01100	Metabolic pathways	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032348	K00121	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMC200032349	K02899	ko03010	Ribosome	1023	1.4e-50	0.82	0.90	0.98
PGSC0003DMC200011285	K02872	ko03010	Ribosome	279	1.5e-09	0.79	0.85	0.83
PGSC0003DMC200011295	K05280	ko00941	Flavonoid biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMC200011295	K05280	ko00944	Flavone and flavonol biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMC200011295	K05280	ko01100	Metabolic pathways	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMC200011295	K05280	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMC200011296	K05280	ko00941	Flavonoid biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMC200011296	K05280	ko00944	Flavone and flavonol biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMC200011296	K05280	ko01100	Metabolic pathways	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMC200011296	K05280	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMC200011302	K08492	ko04130	SNARE interactions in vesicular transport	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMC200011302	K08492	ko04145	Phagosome	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMC200011303	K08492	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMC200011303	K08492	ko04145	Phagosome	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMC200011304	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMC200011304	K08492	ko04145	Phagosome	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMC200011305	K01934	ko00670	One carbon pool by folate	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMC200011305	K01934	ko01100	Metabolic pathways	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMC200011306	K01934	ko00670	One carbon pool by folate	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMC200011306	K01934	ko01100	Metabolic pathways	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMC200011310	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200011310	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200011310	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200016479	K10592	ko04120	Ubiquitin mediated proteolysis	21015	0.	0.71	0.83	0.98
PGSC0003DMC200016480	K10592	ko04120	Ubiquitin mediated proteolysis	21346	0.	0.72	0.84	0.99
PGSC0003DMC200016489	K04424	ko04010	MAPK signaling pathway	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMC200016489	K04424	ko04530	Tight junction	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMC200016490	K04424	ko04010	MAPK signaling pathway	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMC200016490	K04424	ko04530	Tight junction	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMC200016491	K04424	ko04010	MAPK signaling pathway	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMC200016491	K04424	ko04530	Tight junction	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMC200020526	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMC200020526	K00517	ko00626	Naphthalene and anthracene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMC200020526	K00517	ko00903	Limonene and pinene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMC200020526	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMC200020526	K00517	ko01110	Biosynthesis of secondary metabolites	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMC200020527	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMC200020527	K00517	ko00626	Naphthalene and anthracene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMC200020527	K00517	ko00903	Limonene and pinene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMC200020527	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMC200020527	K00517	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMC200020529	K06627	ko04110	Cell cycle	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMC200020529	K06627	ko04914	Progesterone-mediated oocyte maturation	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMC200020544	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020544	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020544	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020544	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020544	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020544	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020545	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMC200020547	K11816	ko00380	Tryptophan metabolism	2536	4.9e-134	0.71	0.86	0.97
PGSC0003DMC200000004	K10610	ko03420	Nucleotide excision repair	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMC200000004	K10610	ko04120	Ubiquitin mediated proteolysis	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMC200000005	K10610	ko03420	Nucleotide excision repair	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMC200000005	K10610	ko04120	Ubiquitin mediated proteolysis	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMC200000006	K12307	ko04142	Lysosome	263	3.3e-06	0.24	0.43	0.59
PGSC0003DMC200000007	K12307	ko04142	Lysosome	348	2.7e-11	0.24	0.43	0.70
PGSC0003DMC200000008	K12307	ko04142	Lysosome	316	2.7e-09	0.24	0.43	0.68
PGSC0003DMC200000009	K12307	ko04142	Lysosome	344	1.9e-11	0.24	0.43	0.91
PGSC0003DMC200000021	K00680	ko00350	Tyrosine metabolism	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMC200000021	K00680	ko00624	1- and 2-Methylnaphthalene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMC200000021	K00680	ko00632	Benzoate degradation via CoA ligation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMC200000021	K00680	ko00642	Ethylbenzene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMC200000021	K00680	ko00903	Limonene and pinene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMC200000022	K00680	ko00350	Tyrosine metabolism	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMC200000022	K00680	ko00624	1- and 2-Methylnaphthalene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMC200000022	K00680	ko00632	Benzoate degradation via CoA ligation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMC200000022	K00680	ko00642	Ethylbenzene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMC200000022	K00680	ko00903	Limonene and pinene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMC200040098	K00558	ko00270	Cysteine and methionine metabolism	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMC200040098	K00558	ko01100	Metabolic pathways	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMC200040099	K00558	ko00270	Cysteine and methionine metabolism	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMC200040099	K00558	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMC200040105	K04124	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMC200040105	K04124	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMC200045271	K04428	ko04010	MAPK signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMC200045271	K04428	ko04912	GnRH signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMC200045272	K02216	ko04110	Cell cycle	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMC200045272	K02216	ko04111	Cell cycle - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMC200045272	K02216	ko04113	Meiosis - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMC200045272	K02216	ko04115	p53 signaling pathway	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMC200045273	K06627	ko04110	Cell cycle	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMC200045273	K06627	ko04914	Progesterone-mediated oocyte maturation	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMC200045274	K06627	ko04110	Cell cycle	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMC200045274	K06627	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMC200045275	K03130	ko03022	Basal transcription factors	4519	2.1e-243	0.79	0.88	1.00
PGSC0003DMC200045280	K08495	ko04130	SNARE interactions in vesicular transport	1456	1.8e-74	0.80	0.90	1.00
PGSC0003DMC200045282	K11228	ko04011	MAPK signaling pathway - yeast	325	2.3e-11	0.36	0.54	0.64
PGSC0003DMC200052062	K11821	ko00380	Tryptophan metabolism	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMC200052062	K11821	ko00966	Glucosinolate biosynthesis	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMC200052062	K11821	ko01110	Biosynthesis of secondary metabolites	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMC200052063	K04733	ko04210	Apoptosis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMC200052063	K04733	ko04620	Toll-like receptor signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMC200052063	K04733	ko04722	Neurotrophin signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMC200052063	K04733	ko05140	Leishmaniasis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMC200052063	K04733	ko05142	Chagas disease	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMC200052072	K00696	ko00500	Starch and sucrose metabolism	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMC200052072	K00696	ko01100	Metabolic pathways	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMC200052073	K00696	ko00500	Starch and sucrose metabolism	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMC200052073	K00696	ko01100	Metabolic pathways	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMC200052076	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMC200052076	K00517	ko00626	Naphthalene and anthracene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMC200052076	K00517	ko00903	Limonene and pinene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMC200052076	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMC200052076	K00517	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMC200052077	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200052077	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200052077	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200052077	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200052077	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMC200052079	K12489	ko04144	Endocytosis	578	4.8e-26	0.78	0.92	0.64
PGSC0003DMC200052080	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052080	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200033310	K00232	ko00071	Fatty acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033310	K00232	ko00592	alpha-Linolenic acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033310	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033310	K00232	ko01100	Metabolic pathways	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033310	K00232	ko03320	PPAR signaling pathway	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033310	K00232	ko04146	Peroxisome	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMC200033311	K04567	ko00970	Aminoacyl-tRNA biosynthesis	717	1.0e-33	0.78	0.87	0.99
PGSC0003DMC200033312	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3430	2.4e-183	0.66	0.83	1.00
PGSC0003DMC200033316	K05857	ko00562	Inositol phosphate metabolism	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMC200033316	K05857	ko01100	Metabolic pathways	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMC200033316	K05857	ko04020	Calcium signaling pathway	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMC200033316	K05857	ko04070	Phosphatidylinositol signaling system	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMC200033317	K05857	ko00562	Inositol phosphate metabolism	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMC200033317	K05857	ko01100	Metabolic pathways	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMC200033317	K05857	ko04020	Calcium signaling pathway	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMC200033317	K05857	ko04070	Phosphatidylinositol signaling system	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMC200033318	K05857	ko00562	Inositol phosphate metabolism	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMC200033318	K05857	ko01100	Metabolic pathways	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMC200033318	K05857	ko04020	Calcium signaling pathway	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMC200033318	K05857	ko04070	Phosphatidylinositol signaling system	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMC200033319	K05857	ko00562	Inositol phosphate metabolism	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMC200033319	K05857	ko01100	Metabolic pathways	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMC200033319	K05857	ko04020	Calcium signaling pathway	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMC200033319	K05857	ko04070	Phosphatidylinositol signaling system	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMC200033327	K03844	ko00510	N-Glycan biosynthesis	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMC200033327	K03844	ko01100	Metabolic pathways	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMC200033328	K03844	ko00510	N-Glycan biosynthesis	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMC200033328	K03844	ko01100	Metabolic pathways	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMC200033329	K03844	ko00510	N-Glycan biosynthesis	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMC200033329	K03844	ko01100	Metabolic pathways	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMC200062833	K04733	ko04210	Apoptosis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMC200062833	K04733	ko04620	Toll-like receptor signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMC200062833	K04733	ko04722	Neurotrophin signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMC200062833	K04733	ko05140	Leishmaniasis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMC200062833	K04733	ko05142	Chagas disease	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMC200062836	K07466	ko03030	DNA replication	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMC200062836	K07466	ko03420	Nucleotide excision repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMC200062836	K07466	ko03430	Mismatch repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMC200062836	K07466	ko03440	Homologous recombination	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMC200002288	K12135	ko04712	Circadian rhythm - plant	254	3.6e-08	0.45	0.56	0.17
PGSC0003DMC200002308	K05279	ko00944	Flavone and flavonol biosynthesis	411	7.8e-17	0.34	0.47	0.96
PGSC0003DMC200027121	K00558	ko00270	Cysteine and methionine metabolism	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMC200027121	K00558	ko01100	Metabolic pathways	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMC200027124	K01247	ko03410	Base excision repair	1708	2.3e-88	0.59	0.72	1.00
PGSC0003DMC200027130	K12126	ko04712	Circadian rhythm - plant	306	6.6e-11	0.32	0.47	0.63
PGSC0003DMC200027131	K03357	ko04110	Cell cycle	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027131	K03357	ko04111	Cell cycle - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027131	K03357	ko04113	Meiosis - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027131	K03357	ko04114	Oocyte meiosis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027131	K03357	ko04120	Ubiquitin mediated proteolysis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027131	K03357	ko04914	Progesterone-mediated oocyte maturation	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMC200027132	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027132	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027132	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027132	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027132	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027132	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027133	K03357	ko04110	Cell cycle	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027133	K03357	ko04111	Cell cycle - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027133	K03357	ko04113	Meiosis - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027133	K03357	ko04114	Oocyte meiosis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027133	K03357	ko04120	Ubiquitin mediated proteolysis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027133	K03357	ko04914	Progesterone-mediated oocyte maturation	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMC200027134	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027134	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027134	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027134	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027134	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027134	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027135	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMC200027136	K03357	ko04110	Cell cycle	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027136	K03357	ko04111	Cell cycle - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027136	K03357	ko04113	Meiosis - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027136	K03357	ko04114	Oocyte meiosis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027136	K03357	ko04120	Ubiquitin mediated proteolysis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027136	K03357	ko04914	Progesterone-mediated oocyte maturation	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMC200027137	K00368	ko00910	Nitrogen metabolism	1750	1.1e-90	0.45	0.61	0.91
PGSC0003DMC200027138	K00368	ko00910	Nitrogen metabolism	1132	1.3e-56	0.42	0.56	0.96
PGSC0003DMC200027139	K13034	ko00270	Cysteine and methionine metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMC200027139	K13034	ko00450	Selenoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMC200027139	K13034	ko00460	Cyanoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMC200027139	K13034	ko00920	Sulfur metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMC200027139	K13034	ko01100	Metabolic pathways	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMC200027141	K12883	ko03040	Spliceosome	1881	6.5e-98	0.82	0.92	0.99
PGSC0003DMC200027142	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMC200027143	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMC200027145	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027145	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027145	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027145	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027145	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027146	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027146	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027146	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027146	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200027146	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMC200008492	K00423	ko00053	Ascorbate and aldarate metabolism	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMC200008492	K00423	ko01100	Metabolic pathways	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMC200008493	K01193	ko00052	Galactose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMC200008493	K01193	ko00500	Starch and sucrose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMC200008493	K01193	ko01100	Metabolic pathways	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMC200008494	K00616	ko00030	Pentose phosphate pathway	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMC200008494	K00616	ko01100	Metabolic pathways	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMC200008494	K00616	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMC200008495	K01087	ko00500	Starch and sucrose metabolism	1444	8.3e-74	0.58	0.75	0.81
PGSC0003DMC200008505	K00016	ko00010	Glycolysis / Gluconeogenesis	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008505	K00016	ko00270	Cysteine and methionine metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008505	K00016	ko00620	Pyruvate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008505	K00016	ko00640	Propanoate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008505	K00016	ko01100	Metabolic pathways	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008505	K00016	ko01110	Biosynthesis of secondary metabolites	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMC200008510	K08341	ko04140	Regulation of autophagy	937	7.6e-46	0.95	0.97	0.95
PGSC0003DMC200008511	K08341	ko04140	Regulation of autophagy	700	9.0e-33	0.97	0.99	0.91
PGSC0003DMC200023252	K01188	ko00460	Cyanoamino acid metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMC200023252	K01188	ko00500	Starch and sucrose metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMC200023252	K01188	ko00940	Phenylpropanoid biosynthesis	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMC200023252	K01188	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMC200023253	K01188	ko00460	Cyanoamino acid metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMC200023253	K01188	ko00500	Starch and sucrose metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMC200023253	K01188	ko00940	Phenylpropanoid biosynthesis	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMC200023253	K01188	ko01110	Biosynthesis of secondary metabolites	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMC200004505	K00430	ko00360	Phenylalanine metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMC200004505	K00430	ko00680	Methane metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMC200004505	K00430	ko00940	Phenylpropanoid biosynthesis	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMC200004505	K00430	ko01100	Metabolic pathways	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMC200004505	K00430	ko01110	Biosynthesis of secondary metabolites	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMC200004507	K02922	ko03010	Ribosome	783	2.4e-37	0.93	0.98	0.99
PGSC0003DMC200004510	K00558	ko00270	Cysteine and methionine metabolism	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMC200004510	K00558	ko01100	Metabolic pathways	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMC200004511	K00558	ko00270	Cysteine and methionine metabolism	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMC200004511	K00558	ko01100	Metabolic pathways	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMC200004512	K07897	ko04144	Endocytosis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMC200004512	K07897	ko04145	Phagosome	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMC200004512	K07897	ko05146	Amoebiasis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMC200004520	K10418	ko04962	Vasopressin-regulated water reabsorption	325	4.3e-12	0.48	0.65	0.94
PGSC0003DMC200004525	K02961	ko03010	Ribosome	895	1.6e-43	0.71	0.84	0.98
PGSC0003DMC200055051	K06061	ko04330	Notch signaling pathway	837	6.5e-37	0.27	0.38	0.49
PGSC0003DMC200055052	K06061	ko04330	Notch signaling pathway	830	1.7e-36	0.26	0.38	0.49
PGSC0003DMC200055053	K06061	ko04330	Notch signaling pathway	830	2.7e-39	0.26	0.38	0.82
PGSC0003DMC200055054	K00454	ko00591	Linoleic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMC200055054	K00454	ko00592	alpha-Linolenic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMC200055054	K00454	ko01100	Metabolic pathways	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMC200055055	K00454	ko00591	Linoleic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMC200055055	K00454	ko00592	alpha-Linolenic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMC200055055	K00454	ko01100	Metabolic pathways	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMC200055056	K01054	ko00561	Glycerolipid metabolism	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMC200055056	K01054	ko01100	Metabolic pathways	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMC200055057	K01054	ko00561	Glycerolipid metabolism	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMC200055057	K01054	ko01100	Metabolic pathways	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMC200055066	K11094	ko03040	Spliceosome	528	2.8e-23	0.60	0.78	0.82
PGSC0003DMC200055067	K11094	ko03040	Spliceosome	1165	2.0e-58	0.60	0.79	0.92
PGSC0003DMC200055069	K01051	ko00040	Pentose and glucuronate interconversions	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMC200055069	K01051	ko00500	Starch and sucrose metabolism	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMC200055069	K01051	ko01100	Metabolic pathways	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMC200055070	K01139	ko00230	Purine metabolism	820	2.2e-39	0.37	0.54	0.93
PGSC0003DMC200055072	K01139	ko00230	Purine metabolism	1236	2.5e-62	0.37	0.55	0.91
PGSC0003DMC200055074	K01139	ko00230	Purine metabolism	1941	3.2e-101	0.42	0.59	0.80
PGSC0003DMC200055075	K01139	ko00230	Purine metabolism	799	3.1e-38	0.52	0.65	0.58
PGSC0003DMC200044311	K04713	ko00600	Sphingolipid metabolism	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMC200044311	K04713	ko01100	Metabolic pathways	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMC200044312	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMC200044312	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMC200044313	K04713	ko00600	Sphingolipid metabolism	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMC200044313	K04713	ko01100	Metabolic pathways	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMC200044314	K04713	ko00600	Sphingolipid metabolism	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMC200044314	K04713	ko01100	Metabolic pathways	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMC200044315	K04713	ko00600	Sphingolipid metabolism	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMC200044315	K04713	ko01100	Metabolic pathways	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMC200044317	K02964	ko03010	Ribosome	1231	4.6e-62	0.94	0.98	0.99
PGSC0003DMC200044319	K03950	ko00190	Oxidative phosphorylation	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMC200044319	K03950	ko01100	Metabolic pathways	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMC200044319	K03950	ko05010	Alzheimer's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMC200044319	K03950	ko05012	Parkinson's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMC200044319	K03950	ko05016	Huntington's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMC200044331	K01692	ko00071	Fatty acid metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00280	Valine, leucine and isoleucine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00281	Geraniol degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00310	Lysine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00380	Tryptophan metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00410	beta-Alanine metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00632	Benzoate degradation via CoA ligation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00640	Propanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00650	Butanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00903	Limonene and pinene degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko00930	Caprolactam degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko01100	Metabolic pathways	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044331	K01692	ko01110	Biosynthesis of secondary metabolites	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMC200044334	K00079	ko00590	Arachidonic acid metabolism	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMC200044334	K00079	ko01100	Metabolic pathways	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMC200031837	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMC200031837	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMC200031838	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMC200031838	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMC200031846	K04799	ko03030	DNA replication	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMC200031846	K04799	ko03410	Base excision repair	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMC200031846	K04799	ko03450	Non-homologous end-joining	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMC200031849	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMC200031850	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMC200031851	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031851	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031851	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031851	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031851	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031851	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200031852	K03358	ko04110	Cell cycle	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031852	K03358	ko04111	Cell cycle - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031852	K03358	ko04113	Meiosis - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031852	K03358	ko04114	Oocyte meiosis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031852	K03358	ko04120	Ubiquitin mediated proteolysis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031852	K03358	ko04914	Progesterone-mediated oocyte maturation	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMC200031853	K03358	ko04110	Cell cycle	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031853	K03358	ko04111	Cell cycle - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031853	K03358	ko04113	Meiosis - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031853	K03358	ko04114	Oocyte meiosis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031853	K03358	ko04120	Ubiquitin mediated proteolysis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031853	K03358	ko04914	Progesterone-mediated oocyte maturation	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMC200031857	K12929	ko00904	Diterpenoid biosynthesis	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMC200031857	K12929	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMC200031858	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200031858	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200031859	K12929	ko00904	Diterpenoid biosynthesis	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMC200031859	K12929	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMC200031860	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200031860	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200049321	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049321	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049321	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049324	K04406	ko04010	MAPK signaling pathway	516	7.2e-22	0.41	0.57	0.52
PGSC0003DMC200049325	K04411	ko04010	MAPK signaling pathway	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMC200049325	K04411	ko05200	Pathways in cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMC200049325	K04411	ko05223	Non-small cell lung cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMC200049326	K04406	ko04010	MAPK signaling pathway	369	1.3e-13	0.38	0.53	0.47
PGSC0003DMC200049331	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMC200049331	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMC200049332	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMC200049332	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMC200049334	K06027	ko04962	Vasopressin-regulated water reabsorption	2015	2.7e-105	0.47	0.65	0.89
PGSC0003DMC200049335	K06027	ko04962	Vasopressin-regulated water reabsorption	1282	7.1e-65	0.52	0.71	0.80
PGSC0003DMC200047676	K06685	ko04111	Cell cycle - yeast	433	2.4e-14	0.26	0.41	0.76
PGSC0003DMC200047679	K12890	ko03040	Spliceosome	493	2.7e-21	0.35	0.46	0.43
PGSC0003DMC200047680	K12890	ko03040	Spliceosome	407	1.3e-16	0.35	0.44	0.79
PGSC0003DMC200047683	K03364	ko04110	Cell cycle	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMC200047683	K03364	ko04111	Cell cycle - yeast	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMC200047683	K03364	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMC200047683	K03364	ko04914	Progesterone-mediated oocyte maturation	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMC200047684	K12893	ko03040	Spliceosome	445	1.0e-18	0.33	0.47	0.61
PGSC0003DMC200047699	K01768	ko00230	Purine metabolism	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMC200047699	K01768	ko04113	Meiosis - yeast	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMC200047700	K08139	ko04113	Meiosis - yeast	917	9.6e-45	0.34	0.53	0.89
PGSC0003DMC200066963	K01188	ko00460	Cyanoamino acid metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMC200066963	K01188	ko00500	Starch and sucrose metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMC200066963	K01188	ko00940	Phenylpropanoid biosynthesis	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMC200066963	K01188	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMC200066989	K07466	ko03030	DNA replication	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMC200066989	K07466	ko03420	Nucleotide excision repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMC200066989	K07466	ko03430	Mismatch repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMC200066989	K07466	ko03440	Homologous recombination	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMC200013111	K12196	ko04144	Endocytosis	1229	6.0e-62	0.92	0.96	0.90
PGSC0003DMC200013119	K01897	ko00071	Fatty acid metabolism	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMC200013119	K01897	ko01100	Metabolic pathways	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMC200013119	K01897	ko03320	PPAR signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMC200013119	K01897	ko04146	Peroxisome	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMC200013119	K01897	ko04920	Adipocytokine signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMC200013123	K00100	ko00051	Fructose and mannose metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013123	K00100	ko00363	Bisphenol A degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013123	K00100	ko00591	Linoleic acid metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013123	K00100	ko00625	Tetrachloroethene degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013123	K00100	ko00650	Butanoate metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013123	K00100	ko01100	Metabolic pathways	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMC200013124	K00100	ko00051	Fructose and mannose metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013124	K00100	ko00363	Bisphenol A degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013124	K00100	ko00591	Linoleic acid metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013124	K00100	ko00625	Tetrachloroethene degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013124	K00100	ko00650	Butanoate metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013124	K00100	ko01100	Metabolic pathways	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMC200013127	K02943	ko03010	Ribosome	749	1.8e-35	0.83	0.88	0.99
PGSC0003DMC200013129	K05658	ko02010	ABC transporters	5887	0.	0.51	0.70	0.91
PGSC0003DMC200013130	K05658	ko02010	ABC transporters	1034	3.4e-51	0.70	0.85	0.99
PGSC0003DMC200013138	K02324	ko00230	Purine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMC200013138	K02324	ko00240	Pyrimidine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMC200013138	K02324	ko01100	Metabolic pathways	14930	0.	0.78	0.88	1.00
PGSC0003DMC200013138	K02324	ko03030	DNA replication	14930	0.	0.78	0.88	1.00
PGSC0003DMC200013138	K02324	ko03410	Base excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMC200013138	K02324	ko03420	Nucleotide excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMC200026253	K12818	ko03040	Spliceosome	1489	2.7e-76	0.48	0.66	0.98
PGSC0003DMC200026254	K12818	ko03040	Spliceosome	486	2.0e-20	0.59	0.81	0.87
PGSC0003DMC200026256	K02987	ko03010	Ribosome	448	7.1e-19	0.72	0.83	0.29
PGSC0003DMC200026261	K07375	ko04145	Phagosome	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMC200026261	K07375	ko04540	Gap junction	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMC200026261	K07375	ko05130	Pathogenic Escherichia coli infection	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMC200026269	K02935	ko03010	Ribosome	397	4.6e-16	0.48	0.64	0.62
PGSC0003DMC200026270	K12356	ko00940	Phenylpropanoid biosynthesis	676	1.9e-31	0.30	0.51	0.95
PGSC0003DMC200018127	K01255	ko00480	Glutathione metabolism	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMC200018127	K01255	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMC200018136	K08271	ko04150	mTOR signaling pathway	343	4.4e-13	0.29	0.45	0.93
PGSC0003DMC200018139	K00754	ko00051	Fructose and mannose metabolism	1984	1.4e-103	0.49	0.68	0.79
PGSC0003DMC200018140	K00754	ko00051	Fructose and mannose metabolism	403	2.2e-16	0.59	0.74	0.97
PGSC0003DMC200018141	K00079	ko00590	Arachidonic acid metabolism	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMC200018141	K00079	ko01100	Metabolic pathways	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMC200018142	K00079	ko00590	Arachidonic acid metabolism	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMC200018142	K00079	ko01100	Metabolic pathways	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMC200018143	K05765	ko04360	Axon guidance	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMC200018143	K05765	ko04666	Fc gamma R-mediated phagocytosis	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMC200018143	K05765	ko04810	Regulation of actin cytoskeleton	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMC200018146	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMC200018146	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMC200018146	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMC200018146	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMC200018146	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMC200056254	K06689	ko04120	Ubiquitin mediated proteolysis	1277	1.3e-64	0.97	0.98	0.99
PGSC0003DMC200056255	K06689	ko04120	Ubiquitin mediated proteolysis	897	1.2e-43	0.98	0.99	0.75
PGSC0003DMC200056271	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1614	3.5e-83	0.68	0.81	0.92
PGSC0003DMC200056274	K01762	ko00270	Cysteine and methionine metabolism	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMC200056274	K01762	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMC200056278	K05681	ko02010	ABC transporters	883	7.2e-43	0.32	0.54	0.47
PGSC0003DMC200043115	K08738	ko04115	p53 signaling pathway	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko04210	Apoptosis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05010	Alzheimer's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05012	Parkinson's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05016	Huntington's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05200	Pathways in cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05210	Colorectal cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05222	Small cell lung cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043115	K08738	ko05416	Viral myocarditis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMC200043140	K03083	ko04012	ErbB signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04062	Chemokine signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04110	Cell cycle	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04310	Wnt signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04340	Hedgehog signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04360	Axon guidance	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04510	Focal adhesion	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04660	T cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04662	B cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04711	Circadian rhythm - fly	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04722	Neurotrophin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04910	Insulin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko04916	Melanogenesis	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05010	Alzheimer's disease	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05200	Pathways in cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05210	Colorectal cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05213	Endometrial cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05215	Prostate cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200043140	K03083	ko05217	Basal cell carcinoma	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMC200048121	K02699	ko00195	Photosynthesis	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMC200048121	K02699	ko01100	Metabolic pathways	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMC200048124	K02879	ko03010	Ribosome	1260	1.2e-63	0.77	0.87	0.99
PGSC0003DMC200048125	K02879	ko03010	Ribosome	1271	2.9e-64	0.77	0.87	0.99
PGSC0003DMC200048130	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	1558	4.3e-80	0.91	0.96	0.99
PGSC0003DMC200048131	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2325	2.1e-122	0.86	0.93	1.00
PGSC0003DMC200048142	K01824	ko00100	Steroid biosynthesis	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMC200048142	K01824	ko01100	Metabolic pathways	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMC200048142	K01824	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMC200048147	K02183	ko04020	Calcium signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04070	Phosphatidylinositol signaling system	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04114	Oocyte meiosis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04270	Vascular smooth muscle contraction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04626	Plant-pathogen interaction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04720	Long-term potentiation	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04722	Neurotrophin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04740	Olfactory transduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04744	Phototransduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04745	Phototransduction - fly	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04910	Insulin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04912	GnRH signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04916	Melanogenesis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04970	Salivary secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko04971	Gastric acid secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko05010	Alzheimer's disease	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048147	K02183	ko05214	Glioma	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMC200048149	K13289	ko04142	Lysosome	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMC200048149	K13289	ko04614	Renin-angiotensin system	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMC200048150	K13289	ko04142	Lysosome	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMC200048150	K13289	ko04614	Renin-angiotensin system	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMC200030632	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMC200030632	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMC200030633	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMC200030633	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMC200030635	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMC200030635	K05283	ko01100	Metabolic pathways	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMC200030637	K09753	ko00940	Phenylpropanoid biosynthesis	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMC200030637	K09753	ko01100	Metabolic pathways	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMC200030637	K09753	ko01110	Biosynthesis of secondary metabolites	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMC200030638	K09753	ko00940	Phenylpropanoid biosynthesis	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMC200030638	K09753	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMC200030638	K09753	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMC200030639	K09753	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMC200030639	K09753	ko01100	Metabolic pathways	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMC200030639	K09753	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMC200030640	K09753	ko00940	Phenylpropanoid biosynthesis	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMC200030640	K09753	ko01100	Metabolic pathways	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMC200030640	K09753	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMC200030644	K00697	ko00500	Starch and sucrose metabolism	441	4.4e-18	0.65	0.77	0.92
PGSC0003DMC200030645	K00697	ko00500	Starch and sucrose metabolism	435	1.2e-17	0.79	0.88	0.84
PGSC0003DMC200030646	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMC200030647	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMC200030648	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMC200030653	K13066	ko00940	Phenylpropanoid biosynthesis	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMC200030653	K13066	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMC200030654	K13066	ko00940	Phenylpropanoid biosynthesis	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMC200030654	K13066	ko01110	Biosynthesis of secondary metabolites	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMC200030657	K00434	ko00053	Ascorbate and aldarate metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMC200030657	K00434	ko00480	Glutathione metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMC200014311	K03124	ko03022	Basal transcription factors	2346	1.5e-123	0.88	0.95	0.99
PGSC0003DMC200014314	K12356	ko00940	Phenylpropanoid biosynthesis	707	3.7e-33	0.33	0.49	0.96
PGSC0003DMC200014315	K12356	ko00940	Phenylpropanoid biosynthesis	655	2.7e-30	0.45	0.62	0.42
PGSC0003DMC200014318	K12356	ko00940	Phenylpropanoid biosynthesis	749	1.8e-35	0.33	0.49	0.90
PGSC0003DMC200014322	K03553	ko03440	Homologous recombination	1253	2.8e-63	0.48	0.68	0.98
PGSC0003DMC200014329	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMC200014330	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMC200014333	K08064	ko04612	Antigen processing and presentation	243	1.4e-07	0.56	0.68	0.63
PGSC0003DMC200014334	K08064	ko04612	Antigen processing and presentation	514	1.6e-22	0.42	0.58	0.82
PGSC0003DMC200014339	K00655	ko00561	Glycerolipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMC200014339	K00655	ko00564	Glycerophospholipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMC200014339	K00655	ko01100	Metabolic pathways	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMC200014340	K00655	ko00561	Glycerolipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMC200014340	K00655	ko00564	Glycerophospholipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMC200014340	K00655	ko01100	Metabolic pathways	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMC200025059	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMC200025059	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMC200025060	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMC200025060	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMC200025062	K08054	ko04145	Phagosome	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMC200025062	K08054	ko04612	Antigen processing and presentation	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMC200025071	K00079	ko00590	Arachidonic acid metabolism	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMC200025071	K00079	ko01100	Metabolic pathways	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMC200025073	K01880	ko00970	Aminoacyl-tRNA biosynthesis	4676	4.5e-252	0.88	0.94	0.99
PGSC0003DMC200025074	K01880	ko00970	Aminoacyl-tRNA biosynthesis	2858	8.5e-152	0.91	0.96	0.97
PGSC0003DMC200019343	K04733	ko04210	Apoptosis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMC200019343	K04733	ko04620	Toll-like receptor signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMC200019343	K04733	ko04722	Neurotrophin signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMC200019343	K04733	ko05140	Leishmaniasis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMC200019343	K04733	ko05142	Chagas disease	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMC200019349	K02084	ko04115	p53 signaling pathway	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko04210	Apoptosis	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko05010	Alzheimer's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko05012	Parkinson's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko05016	Huntington's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200019349	K02084	ko05222	Small cell lung cancer	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMC200017671	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017671	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017671	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017672	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017672	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017672	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMC200017673	K09753	ko00940	Phenylpropanoid biosynthesis	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMC200017673	K09753	ko01100	Metabolic pathways	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMC200017673	K09753	ko01110	Biosynthesis of secondary metabolites	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMC200017681	K11820	ko00380	Tryptophan metabolism	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMC200017681	K11820	ko00966	Glucosinolate biosynthesis	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMC200017681	K11820	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMC200017682	K11820	ko00380	Tryptophan metabolism	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMC200017682	K11820	ko00966	Glucosinolate biosynthesis	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMC200017682	K11820	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMC200017683	K11820	ko00380	Tryptophan metabolism	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMC200017683	K11820	ko00966	Glucosinolate biosynthesis	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMC200017683	K11820	ko01110	Biosynthesis of secondary metabolites	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMC200017686	K00895	ko00051	Fructose and mannose metabolism	2052	2.4e-107	0.85	0.90	0.89
PGSC0003DMC200017687	K00895	ko00051	Fructose and mannose metabolism	2936	4.2e-156	0.85	0.92	0.99
PGSC0003DMC200017688	K00895	ko00051	Fructose and mannose metabolism	4395	1.4e-236	0.84	0.92	0.99
PGSC0003DMC200017690	K02178	ko04110	Cell cycle	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMC200017690	K02178	ko04111	Cell cycle - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMC200017690	K02178	ko04113	Meiosis - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMC200017690	K02178	ko04114	Oocyte meiosis	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMC200017690	K02178	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMC200038491	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMC200038491	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMC200038491	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMC200038511	K02132	ko00190	Oxidative phosphorylation	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMC200038511	K02132	ko01100	Metabolic pathways	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMC200038511	K02132	ko05010	Alzheimer's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMC200038511	K02132	ko05012	Parkinson's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMC200038511	K02132	ko05016	Huntington's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMC200038514	K03541	ko00195	Photosynthesis	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMC200038514	K03541	ko01100	Metabolic pathways	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMC200034503	K00430	ko00360	Phenylalanine metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMC200034503	K00430	ko00680	Methane metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMC200034503	K00430	ko00940	Phenylpropanoid biosynthesis	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMC200034503	K00430	ko01100	Metabolic pathways	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMC200034503	K00430	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMC200034509	K01046	ko00561	Glycerolipid metabolism	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMC200034509	K01046	ko01100	Metabolic pathways	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMC200034521	K08695	ko00941	Flavonoid biosynthesis	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMC200034521	K08695	ko01110	Biosynthesis of secondary metabolites	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMC200034522	K08695	ko00941	Flavonoid biosynthesis	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMC200034522	K08695	ko01110	Biosynthesis of secondary metabolites	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMC200034523	K08695	ko00941	Flavonoid biosynthesis	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMC200034523	K08695	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMC200034525	K00499	ko00260	Glycine, serine and threonine metabolism	2264	4.9e-119	0.67	0.79	0.96
PGSC0003DMC200034526	K00499	ko00260	Glycine, serine and threonine metabolism	1396	3.7e-71	0.70	0.81	0.99
PGSC0003DMC200034527	K00499	ko00260	Glycine, serine and threonine metabolism	341	5.7e-13	0.58	0.73	0.97
PGSC0003DMC200034530	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200034530	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200034530	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200053251	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053251	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053251	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053251	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053251	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053251	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053252	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMC200053255	K08066	ko04612	Antigen processing and presentation	463	1.1e-19	0.30	0.48	0.70
PGSC0003DMC200053263	K08066	ko04612	Antigen processing and presentation	427	1.0e-17	0.34	0.48	0.89
PGSC0003DMC200053264	K08066	ko04612	Antigen processing and presentation	481	1.1e-20	0.33	0.46	0.71
PGSC0003DMC200053266	K08066	ko04612	Antigen processing and presentation	439	2.2e-18	0.37	0.53	0.58
PGSC0003DMC200053267	K08066	ko04612	Antigen processing and presentation	465	8.2e-20	0.31	0.48	0.63
PGSC0003DMC200053272	K08066	ko04612	Antigen processing and presentation	293	2.5e-10	0.28	0.43	0.84
PGSC0003DMC200053275	K02133	ko00190	Oxidative phosphorylation	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMC200053275	K02133	ko01100	Metabolic pathways	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMC200053275	K02133	ko05010	Alzheimer's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMC200053275	K02133	ko05012	Parkinson's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMC200053275	K02133	ko05016	Huntington's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMC200053276	K02133	ko00190	Oxidative phosphorylation	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMC200053276	K02133	ko01100	Metabolic pathways	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMC200053276	K02133	ko05010	Alzheimer's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMC200053276	K02133	ko05012	Parkinson's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMC200053276	K02133	ko05016	Huntington's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMC200053277	K06272	ko03320	PPAR signaling pathway	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMC200053277	K06272	ko04510	Focal adhesion	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMC200053277	K06272	ko05100	Bacterial invasion of epithelial cells	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMC200053277	K06272	ko05213	Endometrial cancer	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMC200053278	K06272	ko03320	PPAR signaling pathway	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMC200053278	K06272	ko04510	Focal adhesion	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMC200053278	K06272	ko05100	Bacterial invasion of epithelial cells	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMC200053278	K06272	ko05213	Endometrial cancer	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMC200028322	K05933	ko00270	Cysteine and methionine metabolism	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMC200028322	K05933	ko01110	Biosynthesis of secondary metabolites	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMC200028323	K05278	ko00941	Flavonoid biosynthesis	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMC200028323	K05278	ko01100	Metabolic pathways	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMC200028323	K05278	ko01110	Biosynthesis of secondary metabolites	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMC200028327	K01210	ko00500	Starch and sucrose metabolism	2022	1.1e-105	0.52	0.68	0.89
PGSC0003DMC200028329	K12818	ko03040	Spliceosome	1665	5.3e-86	0.38	0.57	0.40
PGSC0003DMC200028330	K02858	ko00740	Riboflavin metabolism	1798	2.5e-93	0.89	0.95	0.93
PGSC0003DMC200028331	K02858	ko00740	Riboflavin metabolism	3265	3.0e-174	0.76	0.84	0.95
PGSC0003DMC200028334	K06630	ko04110	Cell cycle	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMC200028334	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMC200028334	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMC200028336	K00430	ko00360	Phenylalanine metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMC200028336	K00430	ko00680	Methane metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMC200028336	K00430	ko00940	Phenylpropanoid biosynthesis	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMC200028336	K00430	ko01100	Metabolic pathways	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMC200028336	K00430	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMC200028338	K05681	ko02010	ABC transporters	1085	5.2e-54	0.32	0.54	0.96
PGSC0003DMC200028339	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMC200028339	K01626	ko01100	Metabolic pathways	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMC200028339	K01626	ko01110	Biosynthesis of secondary metabolites	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMC200028340	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMC200028340	K01626	ko01100	Metabolic pathways	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMC200028340	K01626	ko01110	Biosynthesis of secondary metabolites	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMC200028345	K01259	ko00330	Arginine and proline metabolism	312	2.3e-11	0.30	0.48	0.77
PGSC0003DMC200003306	K01528	ko04144	Endocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMC200003306	K01528	ko04666	Fc gamma R-mediated phagocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMC200003306	K01528	ko05100	Bacterial invasion of epithelial cells	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMC200003310	K02921	ko03010	Ribosome	776	5.8e-37	0.99	1.00	0.92
PGSC0003DMC200003311	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMC200003312	K03260	ko05416	Viral myocarditis	3612	2.2e-193	0.56	0.69	0.99
PGSC0003DMC200003313	K10875	ko03440	Homologous recombination	472	1.8e-17	0.27	0.45	0.43
PGSC0003DMC200003314	K10875	ko03440	Homologous recombination	770	1.2e-36	0.31	0.51	0.47
PGSC0003DMC200003315	K10875	ko03440	Homologous recombination	596	2.2e-26	0.28	0.46	0.50
PGSC0003DMC200003321	K01177	ko00500	Starch and sucrose metabolism	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMC200003321	K01177	ko01100	Metabolic pathways	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMC200003323	K08014	ko04670	Leukocyte transendothelial migration	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMC200003323	K08014	ko04720	Long-term potentiation	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMC200022073	K06096	ko04530	Tight junction	364	3.1e-14	0.34	0.53	0.85
PGSC0003DMC200022074	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMC200022075	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMC200022076	K00016	ko00010	Glycolysis / Gluconeogenesis	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022076	K00016	ko00270	Cysteine and methionine metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022076	K00016	ko00620	Pyruvate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022076	K00016	ko00640	Propanoate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022076	K00016	ko01100	Metabolic pathways	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022076	K00016	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMC200022077	K00016	ko00010	Glycolysis / Gluconeogenesis	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022077	K00016	ko00270	Cysteine and methionine metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022077	K00016	ko00620	Pyruvate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022077	K00016	ko00640	Propanoate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022077	K00016	ko01100	Metabolic pathways	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022077	K00016	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMC200022079	K09553	ko05020	Prion diseases	3725	1.3e-199	0.64	0.78	0.99
PGSC0003DMC200001081	K00951	ko00230	Purine metabolism	964	5.8e-55	0.36	0.52	0.78
PGSC0003DMC200001082	K00951	ko00230	Purine metabolism	973	1.9e-55	0.35	0.51	0.70
PGSC0003DMC200001083	K00951	ko00230	Purine metabolism	629	7.4e-29	0.48	0.65	0.48
PGSC0003DMC200001084	K00951	ko00230	Purine metabolism	768	1.6e-36	0.40	0.51	0.65
PGSC0003DMC200001085	K00951	ko00230	Purine metabolism	750	1.6e-35	0.38	0.52	0.67
PGSC0003DMC200001087	K06228	ko04340	Hedgehog signaling pathway	5770	0.	0.56	0.72	1.00
PGSC0003DMC200001087	K06228	ko05200	Pathways in cancer	5770	0.	0.56	0.72	1.00
PGSC0003DMC200001087	K06228	ko05217	Basal cell carcinoma	5770	0.	0.56	0.72	1.00
PGSC0003DMC200001088	K06228	ko04340	Hedgehog signaling pathway	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMC200001088	K06228	ko05200	Pathways in cancer	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMC200001088	K06228	ko05217	Basal cell carcinoma	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMC200001091	K03363	ko04110	Cell cycle	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMC200001091	K03363	ko04111	Cell cycle - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMC200001091	K03363	ko04113	Meiosis - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMC200001091	K03363	ko04114	Oocyte meiosis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMC200001091	K03363	ko04120	Ubiquitin mediated proteolysis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMC200001108	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001108	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001108	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001108	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001108	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001109	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001109	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001109	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001109	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200001109	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMC200068995	K00975	ko00500	Starch and sucrose metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMC200068995	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMC200068995	K00975	ko01100	Metabolic pathways	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMC200023462	K12483	ko04144	Endocytosis	1298	9.3e-66	0.56	0.74	0.97
PGSC0003DMC200023463	K11147	ko00830	Retinol metabolism	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMC200023463	K11147	ko01100	Metabolic pathways	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMC200023463	K11147	ko04146	Peroxisome	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMC200023464	K04424	ko04010	MAPK signaling pathway	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMC200023464	K04424	ko04530	Tight junction	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMC200023467	K00601	ko00230	Purine metabolism	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMC200023467	K00601	ko00670	One carbon pool by folate	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMC200023467	K00601	ko01100	Metabolic pathways	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMC200023467	K00601	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMC200023468	K02934	ko03010	Ribosome	1598	2.6e-82	0.81	0.89	1.00
PGSC0003DMC200023471	K01555	ko00350	Tyrosine metabolism	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMC200023471	K01555	ko00643	Styrene degradation	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMC200023471	K01555	ko01100	Metabolic pathways	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMC200023472	K01555	ko00350	Tyrosine metabolism	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMC200023472	K01555	ko00643	Styrene degradation	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMC200023472	K01555	ko01100	Metabolic pathways	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMC200023473	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023473	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023473	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023474	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023474	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023474	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023475	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023475	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023475	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMC200023487	K02705	ko00195	Photosynthesis	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMC200023487	K02705	ko01100	Metabolic pathways	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMC200024511	K05933	ko00270	Cysteine and methionine metabolism	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMC200024511	K05933	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMC200024518	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMC200024519	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMC200024520	K04459	ko04010	MAPK signaling pathway	1699	7.1e-88	0.74	0.84	0.99
PGSC0003DMC200024527	K12356	ko00940	Phenylpropanoid biosynthesis	512	2.1e-22	0.35	0.51	0.89
PGSC0003DMC200024528	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200024528	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200024528	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200024529	K10591	ko04120	Ubiquitin mediated proteolysis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMC200024529	K10591	ko04144	Endocytosis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMC200008106	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008106	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008106	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008107	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008107	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008107	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMC200008108	K12811	ko03040	Spliceosome	6963	0.	0.72	0.84	1.00
PGSC0003DMC200008113	K12471	ko04144	Endocytosis	640	2.4e-29	0.29	0.42	0.62
PGSC0003DMC200008114	K12471	ko04144	Endocytosis	810	7.7e-39	0.31	0.45	0.65
PGSC0003DMC200008115	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.84
PGSC0003DMC200008116	K05185	ko04080	Neuroactive ligand-receptor interaction	611	9.4e-28	0.36	0.38	0.47
PGSC0003DMC200008118	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.50
PGSC0003DMC200008119	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	764	2.6e-36	0.40	0.58	0.75
PGSC0003DMC200008122	K05658	ko02010	ABC transporters	1111	1.9e-55	0.75	0.86	0.98
PGSC0003DMC200008127	K03260	ko05416	Viral myocarditis	358	6.7e-13	0.42	0.55	0.96
PGSC0003DMC200013657	K03110	ko03060	Protein export	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMC200013657	K03110	ko03070	Bacterial secretion system	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMC200013669	K12135	ko04712	Circadian rhythm - plant	308	6.6e-11	0.33	0.47	0.34
PGSC0003DMC200013670	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.33	0.47	0.44
PGSC0003DMC200013676	K01489	ko00240	Pyrimidine metabolism	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMC200013676	K01489	ko00983	Drug metabolism - other enzymes	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMC200013676	K01489	ko01100	Metabolic pathways	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMC200011948	K01255	ko00480	Glutathione metabolism	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMC200011948	K01255	ko01100	Metabolic pathways	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMC200011954	K00279	ko00908	Zeatin biosynthesis	2766	1.0e-146	0.62	0.78	0.97
PGSC0003DMC200011955	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.77
PGSC0003DMC200011956	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.74
PGSC0003DMC200011957	K00057	ko00564	Glycerophospholipid metabolism	368	1.8e-14	0.31	0.45	0.88
PGSC0003DMC200011968	K06685	ko04111	Cell cycle - yeast	421	7.0e-14	0.26	0.41	0.83
PGSC0003DMC200011969	K06685	ko04111	Cell cycle - yeast	421	8.8e-14	0.26	0.41	0.75
PGSC0003DMC200002453	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002453	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002454	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002454	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002455	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002455	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMC200002459	K08233	ko00901	Indole alkaloid biosynthesis	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMC200002459	K08233	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMC200061771	K01516	ko00230	Purine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMC200061771	K01516	ko00730	Thiamine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMC200061771	K01516	ko01100	Metabolic pathways	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMC200061783	K04371	ko04010	MAPK signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04012	ErbB signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04013	MAPK signaling pathway - fly	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04062	Chemokine signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04114	Oocyte meiosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04150	mTOR signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04270	Vascular smooth muscle contraction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04320	Dorso-ventral axis formation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04350	TGF-beta signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04360	Axon guidance	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04370	VEGF signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04510	Focal adhesion	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04520	Adherens junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04540	Gap junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04620	Toll-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04621	NOD-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04650	Natural killer cell mediated cytotoxicity	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04660	T cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04662	B cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04664	Fc epsilon RI signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04666	Fc gamma R-mediated phagocytosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04720	Long-term potentiation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04722	Neurotrophin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04730	Long-term depression	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04810	Regulation of actin cytoskeleton	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04910	Insulin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04912	GnRH signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04914	Progesterone-mediated oocyte maturation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04916	Melanogenesis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04930	Type II diabetes mellitus	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko04960	Aldosterone-regulated sodium reabsorption	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05010	Alzheimer's disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05020	Prion diseases	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05131	Shigellosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05140	Leishmaniasis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05142	Chagas disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05200	Pathways in cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05210	Colorectal cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05211	Renal cell carcinoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05212	Pancreatic cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05213	Endometrial cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05214	Glioma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05215	Prostate cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05216	Thyroid cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05218	Melanoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05219	Bladder cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05220	Chronic myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05221	Acute myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061783	K04371	ko05223	Non-small cell lung cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMC200061789	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMC200061789	K00517	ko00626	Naphthalene and anthracene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMC200061789	K00517	ko00903	Limonene and pinene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMC200061789	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMC200061789	K00517	ko01110	Biosynthesis of secondary metabolites	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMC200065616	K09843	ko00906	Carotenoid biosynthesis	835	3.2e-40	0.39	0.56	0.98
PGSC0003DMC200065632	K00791	ko00908	Zeatin biosynthesis	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMC200065632	K00791	ko01100	Metabolic pathways	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMC200065632	K00791	ko01110	Biosynthesis of secondary metabolites	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMC200036930	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMC200036930	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMC200036930	K00734	ko01100	Metabolic pathways	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMC200042458	K07195	ko04910	Insulin signaling pathway	1887	3.0e-98	0.43	0.63	0.99
PGSC0003DMC200042462	K04458	ko04010	MAPK signaling pathway	359	5.8e-14	0.48	0.64	0.56
PGSC0003DMC200042471	K02966	ko03010	Ribosome	1065	6.6e-53	0.86	0.92	0.99
PGSC0003DMC200042472	K00901	ko00561	Glycerolipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMC200042472	K00901	ko00564	Glycerophospholipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMC200042472	K00901	ko01100	Metabolic pathways	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMC200042472	K00901	ko04070	Phosphatidylinositol signaling system	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMC200042473	K00901	ko00561	Glycerolipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMC200042473	K00901	ko00564	Glycerophospholipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMC200042473	K00901	ko01100	Metabolic pathways	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMC200042473	K00901	ko04070	Phosphatidylinositol signaling system	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMC200055711	K05894	ko00592	alpha-Linolenic acid metabolism	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMC200055711	K05894	ko01100	Metabolic pathways	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMC200055713	K10841	ko03420	Nucleotide excision repair	1276	1.5e-64	0.32	0.52	0.85
PGSC0003DMC200055728	K05863	ko04020	Calcium signaling pathway	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMC200055728	K05863	ko05012	Parkinson's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMC200055728	K05863	ko05016	Huntington's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMC200055729	K02178	ko04110	Cell cycle	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMC200055729	K02178	ko04111	Cell cycle - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMC200055729	K02178	ko04113	Meiosis - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMC200055729	K02178	ko04114	Oocyte meiosis	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMC200055729	K02178	ko04914	Progesterone-mediated oocyte maturation	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMC200055730	K02178	ko04110	Cell cycle	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMC200055730	K02178	ko04111	Cell cycle - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMC200055730	K02178	ko04113	Meiosis - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMC200055730	K02178	ko04114	Oocyte meiosis	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMC200055730	K02178	ko04914	Progesterone-mediated oocyte maturation	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMC200055731	K02178	ko04110	Cell cycle	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMC200055731	K02178	ko04111	Cell cycle - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMC200055731	K02178	ko04113	Meiosis - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMC200055731	K02178	ko04114	Oocyte meiosis	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMC200055731	K02178	ko04914	Progesterone-mediated oocyte maturation	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMC200055732	K02178	ko04110	Cell cycle	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMC200055732	K02178	ko04111	Cell cycle - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMC200055732	K02178	ko04113	Meiosis - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMC200055732	K02178	ko04114	Oocyte meiosis	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMC200055732	K02178	ko04914	Progesterone-mediated oocyte maturation	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMC200015724	K01179	ko00500	Starch and sucrose metabolism	2383	1.3e-125	0.60	0.74	0.95
PGSC0003DMC200015732	K01193	ko00052	Galactose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMC200015732	K01193	ko00500	Starch and sucrose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMC200015732	K01193	ko01100	Metabolic pathways	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMC200015733	K01193	ko00052	Galactose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMC200015733	K01193	ko00500	Starch and sucrose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMC200015733	K01193	ko01100	Metabolic pathways	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMC200015734	K01193	ko00052	Galactose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMC200015734	K01193	ko00500	Starch and sucrose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMC200015734	K01193	ko01100	Metabolic pathways	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMC200015737	K13229	ko00402	Benzoxazinoid biosynthesis	479	1.4e-20	0.34	0.54	0.96
PGSC0003DMC200015738	K13229	ko00402	Benzoxazinoid biosynthesis	1119	7.0e-56	0.42	0.60	0.95
PGSC0003DMC200015739	K13229	ko00402	Benzoxazinoid biosynthesis	482	9.5e-21	0.40	0.59	0.82
PGSC0003DMC200015740	K13229	ko00402	Benzoxazinoid biosynthesis	912	1.8e-44	0.43	0.62	0.88
PGSC0003DMC200015741	K13229	ko00402	Benzoxazinoid biosynthesis	1192	6.5e-60	0.43	0.62	0.98
PGSC0003DMC200015742	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMC200015743	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMC200015744	K13229	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.46	0.65	0.98
PGSC0003DMC200015745	K13229	ko00402	Benzoxazinoid biosynthesis	1308	2.6e-66	0.46	0.64	0.99
PGSC0003DMC200015746	K03869	ko04120	Ubiquitin mediated proteolysis	1396	3.7e-71	0.36	0.57	0.99
PGSC0003DMC200015747	K10609	ko03420	Nucleotide excision repair	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMC200015747	K10609	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMC200009038	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMC200009039	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMC200009045	K03016	ko00230	Purine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMC200009045	K03016	ko00240	Pyrimidine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMC200009045	K03016	ko01100	Metabolic pathways	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMC200009045	K03016	ko03020	RNA polymerase	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMC200009045	K03016	ko05016	Huntington's disease	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMC200009046	K03016	ko00230	Purine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMC200009046	K03016	ko00240	Pyrimidine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMC200009046	K03016	ko01100	Metabolic pathways	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMC200009046	K03016	ko03020	RNA polymerase	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMC200009046	K03016	ko05016	Huntington's disease	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMC200009049	K05350	ko00460	Cyanoamino acid metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMC200009049	K05350	ko00500	Starch and sucrose metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMC200009049	K05350	ko00940	Phenylpropanoid biosynthesis	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMC200009049	K05350	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMC200009059	K02981	ko03010	Ribosome	519	8.6e-23	0.74	0.80	0.79
PGSC0003DMC200021534	K01179	ko00500	Starch and sucrose metabolism	1950	1.0e-101	0.48	0.67	0.95
PGSC0003DMC200021535	K01179	ko00500	Starch and sucrose metabolism	467	6.4e-20	0.53	0.73	0.85
PGSC0003DMC200021536	K10878	ko04113	Meiosis - yeast	279	1.5e-09	0.33	0.53	0.77
PGSC0003DMC200021537	K01770	ko00900	Terpenoid backbone biosynthesis	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMC200021537	K01770	ko01100	Metabolic pathways	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMC200021537	K01770	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMC200021538	K01762	ko00270	Cysteine and methionine metabolism	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMC200021538	K01762	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMC200063373	K09843	ko00906	Carotenoid biosynthesis	852	3.7e-41	0.32	0.51	0.98
PGSC0003DMC200063381	K04371	ko04010	MAPK signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04012	ErbB signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04013	MAPK signaling pathway - fly	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04062	Chemokine signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04114	Oocyte meiosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04150	mTOR signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04270	Vascular smooth muscle contraction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04320	Dorso-ventral axis formation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04350	TGF-beta signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04360	Axon guidance	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04370	VEGF signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04510	Focal adhesion	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04520	Adherens junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04540	Gap junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04620	Toll-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04621	NOD-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04650	Natural killer cell mediated cytotoxicity	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04660	T cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04662	B cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04664	Fc epsilon RI signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04666	Fc gamma R-mediated phagocytosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04720	Long-term potentiation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04722	Neurotrophin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04730	Long-term depression	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04810	Regulation of actin cytoskeleton	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04910	Insulin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04912	GnRH signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04914	Progesterone-mediated oocyte maturation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04916	Melanogenesis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04930	Type II diabetes mellitus	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko04960	Aldosterone-regulated sodium reabsorption	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05010	Alzheimer's disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05020	Prion diseases	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05131	Shigellosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05140	Leishmaniasis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05142	Chagas disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05200	Pathways in cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05210	Colorectal cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05211	Renal cell carcinoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05212	Pancreatic cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05213	Endometrial cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05214	Glioma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05215	Prostate cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05216	Thyroid cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05218	Melanoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05219	Bladder cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05220	Chronic myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05221	Acute myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200063381	K04371	ko05223	Non-small cell lung cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMC200000543	K05279	ko00944	Flavone and flavonol biosynthesis	686	5.3e-32	0.41	0.59	0.92
PGSC0003DMC200000545	K08064	ko04612	Antigen processing and presentation	418	3.2e-17	0.40	0.53	0.63
PGSC0003DMC200000546	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMC200000547	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMC200000548	K08064	ko04612	Antigen processing and presentation	501	8.5e-22	0.57	0.73	0.75
PGSC0003DMC200000549	K04368	ko04010	MAPK signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04012	ErbB signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04013	MAPK signaling pathway - fly	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04062	Chemokine signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04114	Oocyte meiosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04270	Vascular smooth muscle contraction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04320	Dorso-ventral axis formation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04370	VEGF signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04510	Focal adhesion	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04540	Gap junction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04620	Toll-like receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04626	Plant-pathogen interaction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04650	Natural killer cell mediated cytotoxicity	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04660	T cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04662	B cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04664	Fc epsilon RI signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04666	Fc gamma R-mediated phagocytosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04720	Long-term potentiation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04722	Neurotrophin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04730	Long-term depression	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04810	Regulation of actin cytoskeleton	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04910	Insulin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04912	GnRH signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04914	Progesterone-mediated oocyte maturation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko04916	Melanogenesis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05020	Prion diseases	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05200	Pathways in cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05210	Colorectal cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05211	Renal cell carcinoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05212	Pancreatic cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05213	Endometrial cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05214	Glioma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05215	Prostate cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05216	Thyroid cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05218	Melanoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05219	Bladder cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05220	Chronic myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05221	Acute myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000549	K04368	ko05223	Non-small cell lung cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMC200000550	K04368	ko04010	MAPK signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04012	ErbB signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04013	MAPK signaling pathway - fly	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04062	Chemokine signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04114	Oocyte meiosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04270	Vascular smooth muscle contraction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04320	Dorso-ventral axis formation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04370	VEGF signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04510	Focal adhesion	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04540	Gap junction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04620	Toll-like receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04626	Plant-pathogen interaction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04650	Natural killer cell mediated cytotoxicity	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04660	T cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04662	B cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04664	Fc epsilon RI signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04666	Fc gamma R-mediated phagocytosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04720	Long-term potentiation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04722	Neurotrophin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04730	Long-term depression	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04810	Regulation of actin cytoskeleton	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04910	Insulin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04912	GnRH signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04914	Progesterone-mediated oocyte maturation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko04916	Melanogenesis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05020	Prion diseases	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05200	Pathways in cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05210	Colorectal cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05211	Renal cell carcinoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05212	Pancreatic cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05213	Endometrial cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05214	Glioma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05215	Prostate cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05216	Thyroid cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05218	Melanoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05219	Bladder cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05220	Chronic myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05221	Acute myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000550	K04368	ko05223	Non-small cell lung cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMC200000551	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMC200000551	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMC200000552	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMC200000552	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMC200000556	K00279	ko00908	Zeatin biosynthesis	2211	4.1e-116	0.56	0.75	0.96
PGSC0003DMC200000565	K00640	ko00270	Cysteine and methionine metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMC200000565	K00640	ko00920	Sulfur metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMC200000565	K00640	ko01100	Metabolic pathways	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMC200000566	K00640	ko00270	Cysteine and methionine metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMC200000566	K00640	ko00920	Sulfur metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMC200000566	K00640	ko01100	Metabolic pathways	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMC200000567	K00968	ko00440	Phosphonate and phosphinate metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMC200000567	K00968	ko00564	Glycerophospholipid metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMC200000567	K00968	ko01100	Metabolic pathways	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMC200000568	K00968	ko00440	Phosphonate and phosphinate metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMC200000568	K00968	ko00564	Glycerophospholipid metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMC200000568	K00968	ko01100	Metabolic pathways	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMC200000570	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200000570	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200000570	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200046927	K05658	ko02010	ABC transporters	3425	4.5e-183	0.40	0.60	0.98
PGSC0003DMC200046937	K03363	ko04110	Cell cycle	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMC200046937	K03363	ko04111	Cell cycle - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMC200046937	K03363	ko04113	Meiosis - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMC200046937	K03363	ko04114	Oocyte meiosis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMC200046937	K03363	ko04120	Ubiquitin mediated proteolysis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMC200046938	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046938	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046938	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046938	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046938	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046939	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046939	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046939	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046939	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046939	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMC200046944	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMC200046945	K10601	ko04120	Ubiquitin mediated proteolysis	2868	2.4e-152	0.67	0.77	0.97
PGSC0003DMC200046946	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMC200040238	K00058	ko00260	Glycine, serine and threonine metabolism	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMC200040238	K00058	ko01100	Metabolic pathways	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMC200040250	K02084	ko04115	p53 signaling pathway	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko04210	Apoptosis	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko05010	Alzheimer's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko05012	Parkinson's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko05016	Huntington's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040250	K02084	ko05222	Small cell lung cancer	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMC200040254	K02901	ko03010	Ribosome	490	3.4e-21	0.82	0.89	0.61
PGSC0003DMC200032892	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMC200032893	K12893	ko03040	Spliceosome	440	2.0e-18	0.35	0.51	0.93
PGSC0003DMC200032895	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMC200032896	K05280	ko00941	Flavonoid biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMC200032896	K05280	ko00944	Flavone and flavonol biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMC200032896	K05280	ko01100	Metabolic pathways	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMC200032896	K05280	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMC200032898	K04506	ko04115	p53 signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMC200032898	K04506	ko04120	Ubiquitin mediated proteolysis	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMC200032898	K04506	ko04310	Wnt signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMC200032899	K04506	ko04115	p53 signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMC200032899	K04506	ko04120	Ubiquitin mediated proteolysis	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMC200032899	K04506	ko04310	Wnt signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMC200032903	K02934	ko03010	Ribosome	227	1.1e-06	0.49	0.61	0.52
PGSC0003DMC200032906	K12132	ko04712	Circadian rhythm - plant	645	9.7e-30	0.44	0.60	0.46
PGSC0003DMC200052721	K04733	ko04210	Apoptosis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMC200052721	K04733	ko04620	Toll-like receptor signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMC200052721	K04733	ko04722	Neurotrophin signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMC200052721	K04733	ko05140	Leishmaniasis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMC200052721	K04733	ko05142	Chagas disease	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMC200052724	K04733	ko04210	Apoptosis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMC200052724	K04733	ko04620	Toll-like receptor signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMC200052724	K04733	ko04722	Neurotrophin signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMC200052724	K04733	ko05140	Leishmaniasis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMC200052724	K04733	ko05142	Chagas disease	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMC200052725	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052725	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052725	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052725	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052725	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052726	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052726	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052726	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052726	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052726	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMC200052734	K01853	ko00100	Steroid biosynthesis	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMC200052734	K01853	ko01100	Metabolic pathways	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMC200052734	K01853	ko01110	Biosynthesis of secondary metabolites	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMC200052739	K12605	ko03018	RNA degradation	4162	1.0e-223	0.74	0.82	0.97
PGSC0003DMC200052740	K12605	ko03018	RNA degradation	2793	3.3e-148	0.78	0.88	0.91
PGSC0003DMC200001744	K00889	ko00562	Inositol phosphate metabolism	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001744	K00889	ko01100	Metabolic pathways	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001744	K00889	ko04070	Phosphatidylinositol signaling system	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001744	K00889	ko04144	Endocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001744	K00889	ko04666	Fc gamma R-mediated phagocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001744	K00889	ko04810	Regulation of actin cytoskeleton	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMC200001745	K00889	ko00562	Inositol phosphate metabolism	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001745	K00889	ko01100	Metabolic pathways	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001745	K00889	ko04070	Phosphatidylinositol signaling system	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001745	K00889	ko04144	Endocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001745	K00889	ko04666	Fc gamma R-mediated phagocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001745	K00889	ko04810	Regulation of actin cytoskeleton	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMC200001760	K02717	ko00195	Photosynthesis	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMC200001760	K02717	ko01100	Metabolic pathways	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMC200001761	K02717	ko00195	Photosynthesis	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMC200001761	K02717	ko01100	Metabolic pathways	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMC200001769	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMC200001769	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMC200001769	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMC200064574	K03413	ko02020	Two-component system	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMC200064574	K03413	ko02030	Bacterial chemotaxis	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMC200068580	K10747	ko03030	DNA replication	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMC200068580	K10747	ko03410	Base excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMC200068580	K10747	ko03420	Nucleotide excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMC200068580	K10747	ko03430	Mismatch repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMC200010237	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMC200010237	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMC200010238	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMC200010238	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMC200010239	K04424	ko04010	MAPK signaling pathway	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMC200010239	K04424	ko04530	Tight junction	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMC200010240	K04424	ko04010	MAPK signaling pathway	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMC200010240	K04424	ko04530	Tight junction	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMC200010244	K02945	ko03010	Ribosome	315	8.5e-11	0.33	0.56	0.17
PGSC0003DMC200010245	K12478	ko04144	Endocytosis	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMC200010245	K12478	ko04145	Phagosome	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMC200010254	K04079	ko04612	Antigen processing and presentation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010254	K04079	ko04621	NOD-like receptor signaling pathway	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010254	K04079	ko04626	Plant-pathogen interaction	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010254	K04079	ko04914	Progesterone-mediated oocyte maturation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010254	K04079	ko05200	Pathways in cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010254	K04079	ko05215	Prostate cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMC200010256	K06689	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.97	0.99	0.99
PGSC0003DMC200016922	K00558	ko00270	Cysteine and methionine metabolism	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMC200016922	K00558	ko01100	Metabolic pathways	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMC200016929	K00888	ko00562	Inositol phosphate metabolism	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMC200016929	K00888	ko01100	Metabolic pathways	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMC200016929	K00888	ko04070	Phosphatidylinositol signaling system	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMC200016930	K00888	ko00562	Inositol phosphate metabolism	7866	0.	0.81	0.89	1.00
PGSC0003DMC200016930	K00888	ko01100	Metabolic pathways	7866	0.	0.81	0.89	1.00
PGSC0003DMC200016930	K00888	ko04070	Phosphatidylinositol signaling system	7866	0.	0.81	0.89	1.00
PGSC0003DMC200016931	K00888	ko00562	Inositol phosphate metabolism	12335	0.	0.74	0.84	1.00
PGSC0003DMC200016931	K00888	ko01100	Metabolic pathways	12335	0.	0.74	0.84	1.00
PGSC0003DMC200016931	K00888	ko04070	Phosphatidylinositol signaling system	12335	0.	0.74	0.84	1.00
PGSC0003DMC200016936	K03094	ko04110	Cell cycle	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04111	Cell cycle - yeast	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04120	Ubiquitin mediated proteolysis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04310	Wnt signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04350	TGF-beta signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016936	K03094	ko04710	Circadian rhythm - mammal	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMC200016939	K00854	ko00040	Pentose and glucuronate interconversions	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMC200016939	K00854	ko01100	Metabolic pathways	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMC200016940	K00854	ko00040	Pentose and glucuronate interconversions	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMC200016940	K00854	ko01100	Metabolic pathways	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMC200016941	K00854	ko00040	Pentose and glucuronate interconversions	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMC200016941	K00854	ko01100	Metabolic pathways	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMC200016942	K00854	ko00040	Pentose and glucuronate interconversions	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMC200016942	K00854	ko01100	Metabolic pathways	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMC200016945	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMC200016949	K08679	ko00500	Starch and sucrose metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMC200016949	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMC200016949	K08679	ko01100	Metabolic pathways	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMC200022740	K03531	ko04112	Cell cycle - Caulobacter	2289	2.0e-120	0.69	0.77	1.00
PGSC0003DMC200039031	K02936	ko03010	Ribosome	1892	1.6e-98	0.85	0.95	1.00
PGSC0003DMC200039034	K03006	ko00230	Purine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMC200039034	K03006	ko00240	Pyrimidine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMC200039034	K03006	ko01100	Metabolic pathways	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMC200039034	K03006	ko03020	RNA polymerase	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMC200039034	K03006	ko05016	Huntington's disease	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMC200039036	K03006	ko00230	Purine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMC200039036	K03006	ko00240	Pyrimidine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMC200039036	K03006	ko01100	Metabolic pathways	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMC200039036	K03006	ko03020	RNA polymerase	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMC200039036	K03006	ko05016	Huntington's disease	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMC200039037	K03006	ko00230	Purine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMC200039037	K03006	ko00240	Pyrimidine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMC200039037	K03006	ko01100	Metabolic pathways	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMC200039037	K03006	ko03020	RNA polymerase	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMC200039037	K03006	ko05016	Huntington's disease	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMC200039038	K03006	ko00230	Purine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMC200039038	K03006	ko00240	Pyrimidine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMC200039038	K03006	ko01100	Metabolic pathways	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMC200039038	K03006	ko03020	RNA polymerase	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMC200039038	K03006	ko05016	Huntington's disease	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMC200039043	K00472	ko00330	Arginine and proline metabolism	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMC200039043	K00472	ko01100	Metabolic pathways	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMC200045728	K00419	ko00190	Oxidative phosphorylation	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045728	K00419	ko01100	Metabolic pathways	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045728	K00419	ko04260	Cardiac muscle contraction	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045728	K00419	ko05010	Alzheimer's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045728	K00419	ko05012	Parkinson's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045728	K00419	ko05016	Huntington's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMC200045729	K00419	ko00190	Oxidative phosphorylation	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045729	K00419	ko01100	Metabolic pathways	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045729	K00419	ko04260	Cardiac muscle contraction	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045729	K00419	ko05010	Alzheimer's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045729	K00419	ko05012	Parkinson's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045729	K00419	ko05016	Huntington's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMC200045732	K10352	ko04530	Tight junction	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMC200045732	K10352	ko05416	Viral myocarditis	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMC200045734	K01768	ko00230	Purine metabolism	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMC200045734	K01768	ko04113	Meiosis - yeast	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMC200045736	K12655	ko04622	RIG-I-like receptor signaling pathway	411	7.8e-17	0.38	0.59	0.70
PGSC0003DMC200045737	K12655	ko04622	RIG-I-like receptor signaling pathway	559	2.0e-27	0.33	0.53	0.69
PGSC0003DMC200045738	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMC200045739	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMC200045740	K12655	ko04622	RIG-I-like receptor signaling pathway	320	8.2e-12	0.54	0.74	0.85
PGSC0003DMC200045744	K05758	ko04666	Fc gamma R-mediated phagocytosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMC200045744	K05758	ko04810	Regulation of actin cytoskeleton	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMC200045744	K05758	ko05100	Bacterial invasion of epithelial cells	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMC200045744	K05758	ko05130	Pathogenic Escherichia coli infection	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMC200045744	K05758	ko05131	Shigellosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMC200051511	K12832	ko03040	Spliceosome	603	2.0e-27	0.94	1.00	0.31
PGSC0003DMC200051512	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMC200051514	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051514	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051514	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051514	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051514	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051515	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051515	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051515	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051515	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051515	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMC200051524	K12356	ko00940	Phenylpropanoid biosynthesis	327	3.4e-12	0.43	0.56	0.84
PGSC0003DMC200051537	K12886	ko03040	Spliceosome	411	7.8e-17	0.29	0.44	0.81
PGSC0003DMC200051540	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMC200051540	K03434	ko01100	Metabolic pathways	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMC200060574	K10760	ko00908	Zeatin biosynthesis	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMC200060574	K10760	ko01100	Metabolic pathways	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMC200060574	K10760	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMC200012453	K09756	ko00940	Phenylpropanoid biosynthesis	1003	1.7e-49	0.51	0.70	0.79
PGSC0003DMC200012454	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMC200012455	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMC200012456	K09756	ko00940	Phenylpropanoid biosynthesis	1632	3.5e-84	0.48	0.67	0.86
PGSC0003DMC200012457	K13289	ko04142	Lysosome	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMC200012457	K13289	ko04614	Renin-angiotensin system	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMC200012458	K02084	ko04115	p53 signaling pathway	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko04210	Apoptosis	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko05010	Alzheimer's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko05012	Parkinson's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko05016	Huntington's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012458	K02084	ko05222	Small cell lung cancer	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMC200012478	K00368	ko00910	Nitrogen metabolism	658	1.9e-30	0.40	0.54	0.86
PGSC0003DMC200012479	K00368	ko00910	Nitrogen metabolism	1486	4.0e-76	0.43	0.58	0.91
PGSC0003DMC200006901	K00927	ko00010	Glycolysis / Gluconeogenesis	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMC200006901	K00927	ko00710	Carbon fixation in photosynthetic organisms	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMC200006901	K00927	ko01100	Metabolic pathways	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMC200006901	K00927	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMC200006902	K00927	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMC200006902	K00927	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMC200006902	K00927	ko01100	Metabolic pathways	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMC200006902	K00927	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMC200006909	K01512	ko00620	Pyruvate metabolism	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMC200006909	K01512	ko00632	Benzoate degradation via CoA ligation	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMC200006910	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMC200006910	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMC200006911	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMC200006911	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMC200006912	K01512	ko00620	Pyruvate metabolism	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMC200006912	K01512	ko00632	Benzoate degradation via CoA ligation	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMC200006917	K05658	ko02010	ABC transporters	4475	5.5e-241	0.47	0.68	0.94
PGSC0003DMC200006921	K00953	ko00740	Riboflavin metabolism	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMC200006921	K00953	ko01100	Metabolic pathways	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMC200006928	K10532	ko00531	Glycosaminoglycan degradation	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMC200006928	K10532	ko01100	Metabolic pathways	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMC200006928	K10532	ko04142	Lysosome	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMC200006929	K11584	ko04113	Meiosis - yeast	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMC200006929	K11584	ko04114	Oocyte meiosis	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMC200006929	K11584	ko04310	Wnt signaling pathway	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMC200053463	K04424	ko04010	MAPK signaling pathway	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMC200053463	K04424	ko04530	Tight junction	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMC200053464	K04424	ko04010	MAPK signaling pathway	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMC200053464	K04424	ko04530	Tight junction	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMC200053479	K04733	ko04210	Apoptosis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMC200053479	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMC200053479	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMC200053479	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMC200053479	K04733	ko05142	Chagas disease	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMC200043656	K13030	ko00460	Cyanoamino acid metabolism	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMC200043656	K13030	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMC200043657	K01176	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMC200043657	K01176	ko01100	Metabolic pathways	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMC200043658	K01176	ko00500	Starch and sucrose metabolism	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMC200043658	K01176	ko01100	Metabolic pathways	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMC200043659	K01176	ko00500	Starch and sucrose metabolism	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMC200043659	K01176	ko01100	Metabolic pathways	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMC200043663	K02965	ko03010	Ribosome	325	4.3e-12	0.45	0.67	0.85
PGSC0003DMC200043669	K01723	ko00592	alpha-Linolenic acid metabolism	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMC200043669	K01723	ko01100	Metabolic pathways	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMC200043670	K01723	ko00592	alpha-Linolenic acid metabolism	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMC200043670	K01723	ko01100	Metabolic pathways	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMC200043671	K01723	ko00592	alpha-Linolenic acid metabolism	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMC200043671	K01723	ko01100	Metabolic pathways	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMC200043678	K03527	ko00900	Terpenoid backbone biosynthesis	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMC200043678	K03527	ko01100	Metabolic pathways	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMC200043678	K03527	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMC200043679	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2697	6.4e-143	0.80	0.90	0.96
PGSC0003DMC200043680	K00680	ko00350	Tyrosine metabolism	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMC200043680	K00680	ko00624	1- and 2-Methylnaphthalene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMC200043680	K00680	ko00632	Benzoate degradation via CoA ligation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMC200043680	K00680	ko00642	Ethylbenzene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMC200043680	K00680	ko00903	Limonene and pinene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMC200038109	K03000	ko00230	Purine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMC200038109	K03000	ko00240	Pyrimidine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMC200038109	K03000	ko01100	Metabolic pathways	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMC200038109	K03000	ko03020	RNA polymerase	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMC200038110	K03000	ko00230	Purine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMC200038110	K03000	ko00240	Pyrimidine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMC200038110	K03000	ko01100	Metabolic pathways	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMC200038110	K03000	ko03020	RNA polymerase	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMC200038129	K12818	ko03040	Spliceosome	8022	0.	0.82	0.89	0.99
PGSC0003DMC200054520	K10949	ko05110	Vibrio cholerae infection	1624	9.8e-84	0.85	0.94	1.00
PGSC0003DMC200054535	K02261	ko00190	Oxidative phosphorylation	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054535	K02261	ko01100	Metabolic pathways	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054535	K02261	ko04260	Cardiac muscle contraction	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054535	K02261	ko05010	Alzheimer's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054535	K02261	ko05012	Parkinson's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054535	K02261	ko05016	Huntington's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMC200054538	K11420	ko00310	Lysine degradation	400	2.5e-15	0.39	0.54	0.33
PGSC0003DMC200054539	K11421	ko00310	Lysine degradation	311	2.9e-10	0.43	0.55	0.85
PGSC0003DMC200054540	K11420	ko00310	Lysine degradation	706	1.4e-32	0.38	0.52	0.32
PGSC0003DMC200041942	K00847	ko00051	Fructose and mannose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMC200041942	K00847	ko00500	Starch and sucrose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMC200041942	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMC200041942	K00847	ko01100	Metabolic pathways	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMC200041943	K00847	ko00051	Fructose and mannose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMC200041943	K00847	ko00500	Starch and sucrose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMC200041943	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMC200041943	K00847	ko01100	Metabolic pathways	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMC200041944	K00847	ko00051	Fructose and mannose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMC200041944	K00847	ko00500	Starch and sucrose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMC200041944	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMC200041944	K00847	ko01100	Metabolic pathways	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMC200041945	K00847	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMC200041945	K00847	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMC200041945	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMC200041945	K00847	ko01100	Metabolic pathways	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMC200041949	K05282	ko00904	Diterpenoid biosynthesis	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMC200041949	K05282	ko01100	Metabolic pathways	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMC200041949	K05282	ko01110	Biosynthesis of secondary metabolites	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMC200041950	K01835	ko00010	Glycolysis / Gluconeogenesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00030	Pentose phosphate pathway	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00052	Galactose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00230	Purine metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko00521	Streptomycin biosynthesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko01100	Metabolic pathways	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041950	K01835	ko01110	Biosynthesis of secondary metabolites	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMC200041951	K01835	ko00010	Glycolysis / Gluconeogenesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00030	Pentose phosphate pathway	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00052	Galactose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00230	Purine metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko00521	Streptomycin biosynthesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko01100	Metabolic pathways	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041951	K01835	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMC200041959	K00430	ko00360	Phenylalanine metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMC200041959	K00430	ko00680	Methane metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMC200041959	K00430	ko00940	Phenylpropanoid biosynthesis	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMC200041959	K00430	ko01100	Metabolic pathways	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMC200041959	K00430	ko01110	Biosynthesis of secondary metabolites	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMC200053911	K01190	ko00052	Galactose metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMC200053911	K01190	ko00511	Other glycan degradation	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMC200053911	K01190	ko00600	Sphingolipid metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMC200053911	K01190	ko01100	Metabolic pathways	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMC200053917	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.41
PGSC0003DMC200053918	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.49
PGSC0003DMC200053920	K03064	ko03050	Proteasome	506	4.5e-22	0.97	0.98	0.95
PGSC0003DMC200053921	K03064	ko03050	Proteasome	3154	4.0e-168	0.95	0.98	1.00
PGSC0003DMC200053932	K02154	ko00190	Oxidative phosphorylation	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko01100	Metabolic pathways	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko04142	Lysosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko04145	Phagosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko04966	Collecting duct acid secretion	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko05110	Vibrio cholerae infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053932	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMC200053933	K02212	ko03030	DNA replication	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMC200053933	K02212	ko04110	Cell cycle	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMC200053933	K02212	ko04111	Cell cycle - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMC200053933	K02212	ko04113	Meiosis - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMC200053934	K02212	ko03030	DNA replication	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMC200053934	K02212	ko04110	Cell cycle	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMC200053934	K02212	ko04111	Cell cycle - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMC200053934	K02212	ko04113	Meiosis - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMC200053935	K02212	ko03030	DNA replication	6005	0.	0.86	0.92	1.00
PGSC0003DMC200053935	K02212	ko04110	Cell cycle	6005	0.	0.86	0.92	1.00
PGSC0003DMC200053935	K02212	ko04111	Cell cycle - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMC200053935	K02212	ko04113	Meiosis - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMC200054061	K01505	ko00640	Propanoate metabolism	1280	9.2e-65	0.44	0.62	0.94
PGSC0003DMC200054062	K01505	ko00640	Propanoate metabolism	1252	3.2e-63	0.43	0.61	0.94
PGSC0003DMC200054063	K01505	ko00640	Propanoate metabolism	1253	2.8e-63	0.43	0.61	0.94
PGSC0003DMC200054064	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054064	K01580	ko00410	beta-Alanine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054064	K01580	ko00430	Taurine and hypotaurine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054064	K01580	ko00650	Butanoate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054064	K01580	ko01100	Metabolic pathways	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054064	K01580	ko04940	Type I diabetes mellitus	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMC200054065	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054065	K01580	ko00410	beta-Alanine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054065	K01580	ko00430	Taurine and hypotaurine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054065	K01580	ko00650	Butanoate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054065	K01580	ko01100	Metabolic pathways	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054065	K01580	ko04940	Type I diabetes mellitus	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMC200054066	K01580	ko00250	Alanine, aspartate and glutamate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054066	K01580	ko00410	beta-Alanine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054066	K01580	ko00430	Taurine and hypotaurine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054066	K01580	ko00650	Butanoate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054066	K01580	ko01100	Metabolic pathways	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054066	K01580	ko04940	Type I diabetes mellitus	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMC200054067	K02325	ko00230	Purine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054067	K02325	ko00240	Pyrimidine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054067	K02325	ko01100	Metabolic pathways	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054067	K02325	ko03030	DNA replication	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054067	K02325	ko03410	Base excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054067	K02325	ko03420	Nucleotide excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMC200054068	K02325	ko00230	Purine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054068	K02325	ko00240	Pyrimidine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054068	K02325	ko01100	Metabolic pathways	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054068	K02325	ko03030	DNA replication	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054068	K02325	ko03410	Base excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054068	K02325	ko03420	Nucleotide excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMC200054069	K02325	ko00230	Purine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054069	K02325	ko00240	Pyrimidine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054069	K02325	ko01100	Metabolic pathways	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054069	K02325	ko03030	DNA replication	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054069	K02325	ko03410	Base excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054069	K02325	ko03420	Nucleotide excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMC200054070	K02325	ko00230	Purine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054070	K02325	ko00240	Pyrimidine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054070	K02325	ko01100	Metabolic pathways	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054070	K02325	ko03030	DNA replication	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054070	K02325	ko03410	Base excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054070	K02325	ko03420	Nucleotide excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMC200054071	K02325	ko00230	Purine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054071	K02325	ko00240	Pyrimidine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054071	K02325	ko01100	Metabolic pathways	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054071	K02325	ko03030	DNA replication	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054071	K02325	ko03410	Base excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054071	K02325	ko03420	Nucleotide excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMC200054076	K00695	ko00500	Starch and sucrose metabolism	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMC200054076	K00695	ko01100	Metabolic pathways	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMC200054077	K01581	ko00330	Arginine and proline metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMC200054077	K01581	ko00480	Glutathione metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMC200054077	K01581	ko01100	Metabolic pathways	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMC200054077	K01581	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMC200031683	K06067	ko04110	Cell cycle	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMC200031683	K06067	ko04330	Notch signaling pathway	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMC200031683	K06067	ko05016	Huntington's disease	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMC200031683	K06067	ko05200	Pathways in cancer	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMC200031683	K06067	ko05220	Chronic myeloid leukemia	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMC200031685	K02900	ko03010	Ribosome	1132	1.3e-56	0.87	0.93	0.99
PGSC0003DMC200031686	K12823	ko03040	Spliceosome	3245	3.8e-173	0.59	0.69	0.99
PGSC0003DMC200031687	K12823	ko03040	Spliceosome	3488	1.5e-186	0.67	0.78	0.99
PGSC0003DMC200031688	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMC200031689	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMC200031700	K02358	ko04626	Plant-pathogen interaction	3409	3.4e-182	0.84	0.90	1.00
PGSC0003DMC200031701	K12132	ko04712	Circadian rhythm - plant	2130	1.2e-111	0.47	0.59	0.99
PGSC0003DMC200031703	K12132	ko04712	Circadian rhythm - plant	2133	8.2e-112	0.46	0.59	0.99
PGSC0003DMC200031704	K12132	ko04712	Circadian rhythm - plant	2157	3.9e-113	0.46	0.59	0.95
PGSC0003DMC200031707	K03517	ko00760	Nicotinate and nicotinamide metabolism	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMC200031707	K03517	ko01100	Metabolic pathways	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMC200050075	K02535	ko00540	Lipopolysaccharide biosynthesis	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMC200050075	K02535	ko01100	Metabolic pathways	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMC200050076	K02535	ko00540	Lipopolysaccharide biosynthesis	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMC200050076	K02535	ko01100	Metabolic pathways	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMC200050083	K01874	ko00450	Selenoamino acid metabolism	5739	0.	0.82	0.90	1.00
PGSC0003DMC200050083	K01874	ko00970	Aminoacyl-tRNA biosynthesis	5739	0.	0.82	0.90	1.00
PGSC0003DMC200041438	K00990	ko02020	Two-component system	230	5.3e-06	0.29	0.45	0.73
PGSC0003DMC200041440	K02259	ko00190	Oxidative phosphorylation	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMC200041440	K02259	ko00860	Porphyrin and chlorophyll metabolism	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMC200041440	K02259	ko01100	Metabolic pathways	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMC200041440	K02259	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMC200041440	K02259	ko02020	Two-component system	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMC200041444	K01597	ko00900	Terpenoid backbone biosynthesis	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMC200041444	K01597	ko01100	Metabolic pathways	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMC200041444	K01597	ko01110	Biosynthesis of secondary metabolites	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMC200041449	K11099	ko03040	Spliceosome	604	1.8e-27	0.88	0.95	0.99
PGSC0003DMC200041456	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMC200041457	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMC200025261	K08736	ko03430	Mismatch repair	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMC200025261	K08736	ko05200	Pathways in cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMC200025261	K08736	ko05210	Colorectal cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMC200025262	K08517	ko04130	SNARE interactions in vesicular transport	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMC200025262	K08517	ko04145	Phagosome	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMC200025271	K05765	ko04360	Axon guidance	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMC200025271	K05765	ko04666	Fc gamma R-mediated phagocytosis	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMC200025271	K05765	ko04810	Regulation of actin cytoskeleton	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMC200025279	K01199	ko00500	Starch and sucrose metabolism	1126	2.9e-56	0.48	0.65	0.91
PGSC0003DMC200018871	K01528	ko04144	Endocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMC200018871	K01528	ko04666	Fc gamma R-mediated phagocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMC200018871	K01528	ko05100	Bacterial invasion of epithelial cells	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMC200018872	K01528	ko04144	Endocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMC200018872	K01528	ko04666	Fc gamma R-mediated phagocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMC200018872	K01528	ko05100	Bacterial invasion of epithelial cells	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMC200018876	K04043	ko03018	RNA degradation	1298	9.3e-66	0.83	0.93	0.99
PGSC0003DMC200018877	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMC200018878	K04043	ko03018	RNA degradation	5026	2.2e-271	0.89	0.95	1.00
PGSC0003DMC200018879	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMC200018887	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMC200018887	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMC200018888	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMC200018888	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMC200018889	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMC200018889	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMC200018890	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMC200018890	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMC200018894	K12131	ko04712	Circadian rhythm - plant	222	4.7e-06	0.42	0.59	0.38
PGSC0003DMC200066160	K00472	ko00330	Arginine and proline metabolism	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMC200066160	K00472	ko01100	Metabolic pathways	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMC200039543	K05747	ko04062	Chemokine signaling pathway	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko04520	Adherens junction	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko04666	Fc gamma R-mediated phagocytosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko04810	Regulation of actin cytoskeleton	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko05100	Bacterial invasion of epithelial cells	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko05130	Pathogenic Escherichia coli infection	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039543	K05747	ko05131	Shigellosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMC200039566	K12356	ko00940	Phenylpropanoid biosynthesis	408	1.1e-16	0.34	0.48	0.80
PGSC0003DMC200039567	K12356	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.29	0.42	0.98
PGSC0003DMC200059094	K03006	ko00230	Purine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMC200059094	K03006	ko00240	Pyrimidine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMC200059094	K03006	ko01100	Metabolic pathways	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMC200059094	K03006	ko03020	RNA polymerase	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMC200059094	K03006	ko05016	Huntington's disease	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMC200051061	K12405	ko00120	Primary bile acid biosynthesis	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMC200051061	K12405	ko01100	Metabolic pathways	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMC200051061	K12405	ko04146	Peroxisome	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMC200051062	K12405	ko00120	Primary bile acid biosynthesis	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMC200051062	K12405	ko01100	Metabolic pathways	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMC200051062	K12405	ko04146	Peroxisome	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMC200051070	K00480	ko00624	1- and 2-Methylnaphthalene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMC200051070	K00480	ko00626	Naphthalene and anthracene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMC200051070	K00480	ko00628	Fluorene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMC200051070	K00480	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMC200051071	K00480	ko00624	1- and 2-Methylnaphthalene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMC200051071	K00480	ko00626	Naphthalene and anthracene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMC200051071	K00480	ko00628	Fluorene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMC200051071	K00480	ko01100	Metabolic pathways	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMC200051073	K00430	ko00360	Phenylalanine metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMC200051073	K00430	ko00680	Methane metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMC200051073	K00430	ko00940	Phenylpropanoid biosynthesis	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMC200051073	K00430	ko01100	Metabolic pathways	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMC200051073	K00430	ko01110	Biosynthesis of secondary metabolites	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMC200051074	K00430	ko00360	Phenylalanine metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMC200051074	K00430	ko00680	Methane metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMC200051074	K00430	ko00940	Phenylpropanoid biosynthesis	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMC200051074	K00430	ko01100	Metabolic pathways	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMC200051074	K00430	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMC200051079	K10591	ko04120	Ubiquitin mediated proteolysis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMC200051079	K10591	ko04144	Endocytosis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMC200051081	K07375	ko04145	Phagosome	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMC200051081	K07375	ko04540	Gap junction	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMC200051081	K07375	ko05130	Pathogenic Escherichia coli infection	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMC200051087	K10599	ko03040	Spliceosome	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMC200051087	K10599	ko04120	Ubiquitin mediated proteolysis	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMC200051088	K10599	ko03040	Spliceosome	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMC200051088	K10599	ko04120	Ubiquitin mediated proteolysis	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMC200051089	K10599	ko03040	Spliceosome	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMC200051089	K10599	ko04120	Ubiquitin mediated proteolysis	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMC200033691	K10576	ko04120	Ubiquitin mediated proteolysis	1405	1.2e-71	0.90	0.96	0.99
PGSC0003DMC200033692	K10576	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.88	0.94	0.99
PGSC0003DMC200033697	K06689	ko04120	Ubiquitin mediated proteolysis	1288	3.3e-65	0.98	0.98	0.99
PGSC0003DMC200033698	K06689	ko04120	Ubiquitin mediated proteolysis	972	8.9e-48	0.98	0.98	0.99
PGSC0003DMC200027873	K01880	ko00970	Aminoacyl-tRNA biosynthesis	5018	6.2e-271	0.86	0.93	0.99
PGSC0003DMC200027874	K00411	ko00190	Oxidative phosphorylation	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027874	K00411	ko01100	Metabolic pathways	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027874	K00411	ko04260	Cardiac muscle contraction	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027874	K00411	ko05010	Alzheimer's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027874	K00411	ko05012	Parkinson's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027874	K00411	ko05016	Huntington's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMC200027878	K01199	ko00500	Starch and sucrose metabolism	391	9.9e-16	0.31	0.51	0.92
PGSC0003DMC200027882	K13065	ko00940	Phenylpropanoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMC200027882	K13065	ko00941	Flavonoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMC200027882	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMC200027882	K13065	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMC200027888	K01692	ko00071	Fatty acid metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00280	Valine, leucine and isoleucine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00281	Geraniol degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00310	Lysine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00380	Tryptophan metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00410	beta-Alanine metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00632	Benzoate degradation via CoA ligation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00640	Propanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00650	Butanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00903	Limonene and pinene degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko00930	Caprolactam degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko01100	Metabolic pathways	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027888	K01692	ko01110	Biosynthesis of secondary metabolites	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMC200027896	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMC200027897	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMC200027899	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMC200027899	K12448	ko01100	Metabolic pathways	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMC200027900	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMC200027900	K12448	ko01100	Metabolic pathways	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMC200010741	K03070	ko03060	Protein export	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMC200010741	K03070	ko03070	Bacterial secretion system	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMC200010742	K03070	ko03060	Protein export	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMC200010742	K03070	ko03070	Bacterial secretion system	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMC200010748	K00858	ko00760	Nicotinate and nicotinamide metabolism	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMC200010748	K00858	ko01100	Metabolic pathways	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMC200010749	K00858	ko00760	Nicotinate and nicotinamide metabolism	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMC200010749	K00858	ko01100	Metabolic pathways	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMC200010750	K12865	ko03040	Spliceosome	2263	5.6e-119	0.60	0.74	0.84
PGSC0003DMC200010761	K00472	ko00330	Arginine and proline metabolism	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMC200010761	K00472	ko01100	Metabolic pathways	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMC200010762	K00472	ko00330	Arginine and proline metabolism	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMC200010762	K00472	ko01100	Metabolic pathways	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMC200014857	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2918	4.1e-155	0.76	0.83	0.99
PGSC0003DMC200014863	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMC200014863	K01817	ko01100	Metabolic pathways	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMC200014863	K01817	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMC200014865	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014865	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014865	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014866	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014866	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014866	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMC200014867	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMC200014867	K01817	ko01100	Metabolic pathways	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMC200014867	K01817	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMC200014868	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMC200014868	K01817	ko01100	Metabolic pathways	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMC200014868	K01817	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMC200014872	K02111	ko00190	Oxidative phosphorylation	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMC200014872	K02111	ko00195	Photosynthesis	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMC200014872	K02111	ko01100	Metabolic pathways	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMC200014873	K01739	ko00270	Cysteine and methionine metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMC200014873	K01739	ko00450	Selenoamino acid metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMC200014873	K01739	ko00920	Sulfur metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMC200014873	K01739	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMC200014873	K01739	ko01110	Biosynthesis of secondary metabolites	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMC200014880	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMC200014880	K03857	ko01100	Metabolic pathways	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMC200022267	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMC200022267	K02548	ko01100	Metabolic pathways	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMC200022267	K02548	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMC200022268	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMC200022268	K02548	ko01100	Metabolic pathways	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMC200022268	K02548	ko01110	Biosynthesis of secondary metabolites	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMC200022269	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMC200022269	K02548	ko01100	Metabolic pathways	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMC200022269	K02548	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMC200022270	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMC200022270	K02548	ko01100	Metabolic pathways	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMC200022270	K02548	ko01110	Biosynthesis of secondary metabolites	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMC200022273	K13030	ko00460	Cyanoamino acid metabolism	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMC200022273	K13030	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMC200022274	K13030	ko00460	Cyanoamino acid metabolism	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMC200022274	K13030	ko01110	Biosynthesis of secondary metabolites	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMC200004892	K01689	ko00010	Glycolysis / Gluconeogenesis	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMC200004892	K01689	ko01100	Metabolic pathways	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMC200004892	K01689	ko01110	Biosynthesis of secondary metabolites	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMC200004892	K01689	ko03018	RNA degradation	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMC200004893	K01689	ko00010	Glycolysis / Gluconeogenesis	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMC200004893	K01689	ko01100	Metabolic pathways	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMC200004893	K01689	ko01110	Biosynthesis of secondary metabolites	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMC200004893	K01689	ko03018	RNA degradation	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMC200004901	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMC200004901	K00517	ko00626	Naphthalene and anthracene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMC200004901	K00517	ko00903	Limonene and pinene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMC200004901	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMC200004901	K00517	ko01110	Biosynthesis of secondary metabolites	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMC200004902	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMC200004902	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMC200004902	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMC200004902	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMC200004902	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMC200004903	K09903	ko00240	Pyrimidine metabolism	1201	2.1e-60	0.61	0.76	0.46
PGSC0003DMC200004905	K02896	ko03010	Ribosome	1252	3.2e-63	0.91	0.95	0.99
PGSC0003DMC200004917	K05280	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMC200004917	K05280	ko00944	Flavone and flavonol biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMC200004917	K05280	ko01100	Metabolic pathways	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMC200004917	K05280	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMC200001242	K03106	ko03060	Protein export	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMC200001242	K03106	ko03070	Bacterial secretion system	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMC200001243	K03106	ko03060	Protein export	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMC200001243	K03106	ko03070	Bacterial secretion system	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMC200001253	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMC200001254	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMC200040741	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMC200040742	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMC200040747	K12128	ko04712	Circadian rhythm - plant	409	1.4e-16	0.26	0.45	0.63
PGSC0003DMC200040748	K12129	ko04712	Circadian rhythm - plant	426	2.7e-17	0.36	0.54	0.73
PGSC0003DMC200057872	K01052	ko00100	Steroid biosynthesis	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMC200057872	K01052	ko04142	Lysosome	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMC200057873	K09755	ko00940	Phenylpropanoid biosynthesis	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMC200057873	K09755	ko01100	Metabolic pathways	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMC200057873	K09755	ko01110	Biosynthesis of secondary metabolites	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMC200057882	K11423	ko00310	Lysine degradation	512	3.6e-21	0.37	0.53	0.83
PGSC0003DMC200057886	K13229	ko00402	Benzoxazinoid biosynthesis	247	8.7e-08	0.27	0.41	0.99
PGSC0003DMC200057896	K03469	ko03030	DNA replication	233	8.0e-07	0.34	0.53	0.27
PGSC0003DMC200044861	K00899	ko00270	Cysteine and methionine metabolism	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMC200044861	K00899	ko01100	Metabolic pathways	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMC200044862	K13068	ko00940	Phenylpropanoid biosynthesis	1950	1.0e-101	0.51	0.70	0.96
PGSC0003DMC200044871	K10151	ko04110	Cell cycle	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMC200044871	K10151	ko04115	p53 signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMC200044871	K10151	ko04310	Wnt signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMC200044871	K10151	ko04510	Focal adhesion	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMC200044871	K10151	ko04630	Jak-STAT signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMC200044873	K05402	ko04620	Toll-like receptor signaling pathway	296	1.7e-10	0.31	0.39	0.87
PGSC0003DMC200044874	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044874	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044875	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMC200044876	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044876	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044877	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMC200044878	K01110	ko00562	Inositol phosphate metabolism	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko04070	Phosphatidylinositol signaling system	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko04115	p53 signaling pathway	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko04510	Focal adhesion	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko04530	Tight junction	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05200	Pathways in cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05213	Endometrial cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05214	Glioma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05215	Prostate cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05218	Melanoma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044878	K01110	ko05222	Small cell lung cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMC200044880	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMC200034903	K13289	ko04142	Lysosome	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMC200034903	K13289	ko04614	Renin-angiotensin system	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMC200052261	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMC200052261	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMC200052274	K12200	ko04144	Endocytosis	259	1.1e-07	0.38	0.43	0.75
PGSC0003DMC200052281	K01107	ko00562	Inositol phosphate metabolism	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMC200052281	K01107	ko01100	Metabolic pathways	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMC200052281	K01107	ko04070	Phosphatidylinositol signaling system	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMC200063225	K03469	ko03030	DNA replication	223	8.1e-06	0.31	0.56	0.53
PGSC0003DMC200063236	K13066	ko00940	Phenylpropanoid biosynthesis	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMC200063236	K13066	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMC200029071	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMC200029071	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMC200029072	K05275	ko00750	Vitamin B6 metabolism	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMC200029072	K05275	ko01100	Metabolic pathways	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMC200029073	K05275	ko00750	Vitamin B6 metabolism	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMC200029073	K05275	ko01100	Metabolic pathways	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMC200029074	K00100	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029074	K00100	ko00363	Bisphenol A degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029074	K00100	ko00591	Linoleic acid metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029074	K00100	ko00625	Tetrachloroethene degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029074	K00100	ko00650	Butanoate metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029074	K00100	ko01100	Metabolic pathways	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMC200029075	K00100	ko00051	Fructose and mannose metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029075	K00100	ko00363	Bisphenol A degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029075	K00100	ko00591	Linoleic acid metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029075	K00100	ko00625	Tetrachloroethene degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029075	K00100	ko00650	Butanoate metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029075	K00100	ko01100	Metabolic pathways	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMC200029076	K00100	ko00051	Fructose and mannose metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029076	K00100	ko00363	Bisphenol A degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029076	K00100	ko00591	Linoleic acid metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029076	K00100	ko00625	Tetrachloroethene degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029076	K00100	ko00650	Butanoate metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029076	K00100	ko01100	Metabolic pathways	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMC200029077	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMC200029077	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMC200029079	K02945	ko03010	Ribosome	381	3.5e-15	0.34	0.56	0.73
PGSC0003DMC200029080	K02945	ko03010	Ribosome	488	4.4e-21	0.34	0.51	0.70
PGSC0003DMC200029082	K03165	ko03440	Homologous recombination	3946	8.3e-212	0.81	0.90	1.00
PGSC0003DMC200029083	K03165	ko03440	Homologous recombination	2161	2.3e-113	0.83	0.91	0.99
PGSC0003DMC200029084	K03165	ko03440	Homologous recombination	5715	0.	0.81	0.89	1.00
PGSC0003DMC200029085	K03165	ko03440	Homologous recombination	6074	0.	0.81	0.89	0.99
PGSC0003DMC200029086	K03165	ko03440	Homologous recombination	2145	1.8e-112	0.77	0.88	0.90
PGSC0003DMC200009545	K01768	ko00230	Purine metabolism	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMC200009545	K01768	ko04113	Meiosis - yeast	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMC200009547	K00901	ko00561	Glycerolipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMC200009547	K00901	ko00564	Glycerophospholipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMC200009547	K00901	ko01100	Metabolic pathways	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMC200009547	K00901	ko04070	Phosphatidylinositol signaling system	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMC200009558	K04718	ko00600	Sphingolipid metabolism	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMC200009558	K04718	ko01100	Metabolic pathways	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMC200009558	K04718	ko04020	Calcium signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMC200009558	K04718	ko04370	VEGF signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMC200009558	K04718	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMC200009563	K05395	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.51	0.61	0.86
PGSC0003DMC200009564	K05395	ko00270	Cysteine and methionine metabolism	274	2.8e-09	0.58	0.66	0.94
PGSC0003DMC200009568	K09567	ko03040	Spliceosome	1464	6.5e-75	0.87	0.93	0.99
PGSC0003DMC200003691	K05862	ko04020	Calcium signaling pathway	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMC200003691	K05862	ko05012	Parkinson's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMC200003691	K05862	ko05016	Huntington's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMC200003703	K12669	ko00510	N-Glycan biosynthesis	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMC200003703	K12669	ko01100	Metabolic pathways	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMC200003705	K01051	ko00040	Pentose and glucuronate interconversions	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMC200003705	K01051	ko00500	Starch and sucrose metabolism	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMC200003705	K01051	ko01100	Metabolic pathways	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMC200003706	K01051	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMC200003706	K01051	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMC200003706	K01051	ko01100	Metabolic pathways	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMC200003711	K05350	ko00460	Cyanoamino acid metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMC200003711	K05350	ko00500	Starch and sucrose metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMC200003711	K05350	ko00940	Phenylpropanoid biosynthesis	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMC200003711	K05350	ko01110	Biosynthesis of secondary metabolites	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMC200003712	K05350	ko00460	Cyanoamino acid metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMC200003712	K05350	ko00500	Starch and sucrose metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMC200003712	K05350	ko00940	Phenylpropanoid biosynthesis	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMC200003712	K05350	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMC200003713	K05350	ko00460	Cyanoamino acid metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMC200003713	K05350	ko00500	Starch and sucrose metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMC200003713	K05350	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMC200003713	K05350	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMC200003714	K05350	ko00460	Cyanoamino acid metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMC200003714	K05350	ko00500	Starch and sucrose metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMC200003714	K05350	ko00940	Phenylpropanoid biosynthesis	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMC200003714	K05350	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMC200003715	K05350	ko00460	Cyanoamino acid metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMC200003715	K05350	ko00500	Starch and sucrose metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMC200003715	K05350	ko00940	Phenylpropanoid biosynthesis	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMC200003715	K05350	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMC200003716	K05350	ko00460	Cyanoamino acid metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMC200003716	K05350	ko00500	Starch and sucrose metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMC200003716	K05350	ko00940	Phenylpropanoid biosynthesis	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMC200003716	K05350	ko01110	Biosynthesis of secondary metabolites	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMC200003717	K05350	ko00460	Cyanoamino acid metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMC200003717	K05350	ko00500	Starch and sucrose metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMC200003717	K05350	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMC200003717	K05350	ko01110	Biosynthesis of secondary metabolites	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMC200003718	K05350	ko00460	Cyanoamino acid metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMC200003718	K05350	ko00500	Starch and sucrose metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMC200003718	K05350	ko00940	Phenylpropanoid biosynthesis	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMC200003718	K05350	ko01110	Biosynthesis of secondary metabolites	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMC200003719	K05350	ko00460	Cyanoamino acid metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMC200003719	K05350	ko00500	Starch and sucrose metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMC200003719	K05350	ko00940	Phenylpropanoid biosynthesis	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMC200003719	K05350	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMC200003720	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMC200003720	K00517	ko00626	Naphthalene and anthracene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMC200003720	K00517	ko00903	Limonene and pinene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMC200003720	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMC200003720	K00517	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMC200021061	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMC200021061	K01433	ko00670	One carbon pool by folate	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMC200021062	K01613	ko00564	Glycerophospholipid metabolism	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMC200021062	K01613	ko01100	Metabolic pathways	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMC200021063	K01613	ko00564	Glycerophospholipid metabolism	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMC200021063	K01613	ko01100	Metabolic pathways	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMC200021064	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMC200021064	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMC200021065	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMC200021065	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMC200026921	K00218	ko00860	Porphyrin and chlorophyll metabolism	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMC200026921	K00218	ko01100	Metabolic pathways	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMC200026921	K00218	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMC200026922	K00218	ko00860	Porphyrin and chlorophyll metabolism	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMC200026922	K00218	ko01100	Metabolic pathways	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMC200026922	K00218	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMC200026924	K12822	ko03040	Spliceosome	341	2.2e-12	0.29	0.47	0.88
PGSC0003DMC200026928	K10581	ko04120	Ubiquitin mediated proteolysis	459	3.6e-20	0.52	0.64	0.24
PGSC0003DMC200026929	K10581	ko04120	Ubiquitin mediated proteolysis	990	9.1e-49	0.56	0.71	0.90
PGSC0003DMC200026930	K10581	ko04120	Ubiquitin mediated proteolysis	1188	3.7e-61	0.52	0.67	0.42
PGSC0003DMC200026931	K02605	ko04110	Cell cycle	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMC200026931	K02605	ko04111	Cell cycle - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMC200026931	K02605	ko04113	Meiosis - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMC200026932	K02605	ko04110	Cell cycle	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMC200026932	K02605	ko04111	Cell cycle - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMC200026932	K02605	ko04113	Meiosis - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMC200026933	K02605	ko04110	Cell cycle	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMC200026933	K02605	ko04111	Cell cycle - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMC200026933	K02605	ko04113	Meiosis - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMC200026934	K02605	ko04110	Cell cycle	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMC200026934	K02605	ko04111	Cell cycle - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMC200026934	K02605	ko04113	Meiosis - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMC200026935	K02605	ko04110	Cell cycle	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMC200026935	K02605	ko04111	Cell cycle - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMC200026935	K02605	ko04113	Meiosis - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMC200026936	K02605	ko04110	Cell cycle	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMC200026936	K02605	ko04111	Cell cycle - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMC200026936	K02605	ko04113	Meiosis - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMC200055268	K12900	ko03040	Spliceosome	310	2.9e-11	0.44	0.60	0.56
PGSC0003DMC200055269	K12900	ko03040	Spliceosome	637	2.7e-29	0.44	0.56	0.83
PGSC0003DMC200055270	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.74
PGSC0003DMC200055271	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.66
PGSC0003DMC200055272	K01199	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.35	0.52	0.65
PGSC0003DMC200055278	K11594	ko04622	RIG-I-like receptor signaling pathway	2294	1.1e-120	0.76	0.85	0.92
PGSC0003DMC200055279	K11594	ko04622	RIG-I-like receptor signaling pathway	4135	3.1e-222	0.79	0.86	1.00
PGSC0003DMC200055281	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMC200055281	K07542	ko01100	Metabolic pathways	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMC200055282	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMC200055282	K07542	ko01100	Metabolic pathways	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMC200055283	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMC200055283	K07542	ko01100	Metabolic pathways	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMC200055284	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMC200055284	K07542	ko01100	Metabolic pathways	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMC200055285	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMC200055285	K07542	ko01100	Metabolic pathways	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMC200048889	K03110	ko03060	Protein export	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMC200048889	K03110	ko03070	Bacterial secretion system	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMC200048895	K10739	ko03030	DNA replication	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMC200048895	K10739	ko03420	Nucleotide excision repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMC200048895	K10739	ko03430	Mismatch repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMC200048895	K10739	ko03440	Homologous recombination	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMC200048896	K08064	ko04612	Antigen processing and presentation	365	2.7e-14	0.42	0.58	0.68
PGSC0003DMC200048897	K08064	ko04612	Antigen processing and presentation	363	3.5e-14	0.46	0.62	0.60
PGSC0003DMC200048898	K08064	ko04612	Antigen processing and presentation	356	8.4e-14	0.49	0.64	0.60
PGSC0003DMC200048899	K08486	ko04130	SNARE interactions in vesicular transport	1923	3.1e-100	0.75	0.89	1.00
PGSC0003DMC200030494	K11584	ko04113	Meiosis - yeast	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMC200030494	K11584	ko04114	Oocyte meiosis	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMC200030494	K11584	ko04310	Wnt signaling pathway	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMC200030495	K05666	ko02010	ABC transporters	2956	3.3e-157	0.36	0.56	0.94
PGSC0003DMC200030496	K02537	ko04110	Cell cycle	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMC200030496	K02537	ko04111	Cell cycle - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMC200030496	K02537	ko04113	Meiosis - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMC200030496	K02537	ko04114	Oocyte meiosis	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMC200030496	K02537	ko04914	Progesterone-mediated oocyte maturation	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMC200030497	K02537	ko04110	Cell cycle	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMC200030497	K02537	ko04111	Cell cycle - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMC200030497	K02537	ko04113	Meiosis - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMC200030497	K02537	ko04114	Oocyte meiosis	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMC200030497	K02537	ko04914	Progesterone-mediated oocyte maturation	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMC200030498	K02537	ko04110	Cell cycle	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMC200030498	K02537	ko04111	Cell cycle - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMC200030498	K02537	ko04113	Meiosis - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMC200030498	K02537	ko04114	Oocyte meiosis	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMC200030498	K02537	ko04914	Progesterone-mediated oocyte maturation	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMC200030500	K00059	ko00061	Fatty acid biosynthesis	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMC200030500	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMC200030500	K00059	ko01100	Metabolic pathways	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMC200030501	K00059	ko00061	Fatty acid biosynthesis	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMC200030501	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMC200030501	K00059	ko01100	Metabolic pathways	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMC200030509	K03165	ko03440	Homologous recombination	644	1.1e-29	0.77	0.90	0.71
PGSC0003DMC200030510	K03165	ko03440	Homologous recombination	1490	2.4e-76	0.86	0.93	0.82
PGSC0003DMC200067357	K00021	ko00900	Terpenoid backbone biosynthesis	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMC200067357	K00021	ko01100	Metabolic pathways	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMC200067357	K00021	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMC200067379	K11251	ko05322	Systemic lupus erythematosus	643	1.2e-29	0.66	0.79	0.91
PGSC0003DMC200002941	K01771	ko00562	Inositol phosphate metabolism	246	9.8e-08	0.30	0.43	0.74
PGSC0003DMC200002944	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMC200002944	K02433	ko01100	Metabolic pathways	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMC200002945	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMC200002945	K02433	ko01100	Metabolic pathways	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMC200002958	K00660	ko00941	Flavonoid biosynthesis	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMC200002958	K00660	ko01100	Metabolic pathways	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMC200002958	K00660	ko01110	Biosynthesis of secondary metabolites	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMC200002958	K00660	ko04712	Circadian rhythm - plant	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMC200002959	K01243	ko00270	Cysteine and methionine metabolism	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMC200002959	K01243	ko01100	Metabolic pathways	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMC200023924	K01179	ko00500	Starch and sucrose metabolism	4113	5.1e-221	0.75	0.86	1.00
PGSC0003DMC200023929	K04733	ko04210	Apoptosis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMC200023929	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMC200023929	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMC200023929	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMC200023929	K04733	ko05142	Chagas disease	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMC200023940	K10447	ko04120	Ubiquitin mediated proteolysis	358	6.5e-14	0.29	0.45	0.65
PGSC0003DMC200024061	K02912	ko03010	Ribosome	980	3.2e-48	0.89	0.96	0.33
PGSC0003DMC200024065	K12356	ko00940	Phenylpropanoid biosynthesis	658	1.9e-30	0.41	0.57	0.73
PGSC0003DMC200024068	K12356	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.39	0.55	0.88
PGSC0003DMC200020071	K10599	ko03040	Spliceosome	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMC200020071	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMC200020072	K10599	ko03040	Spliceosome	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMC200020072	K10599	ko04120	Ubiquitin mediated proteolysis	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMC200020073	K10599	ko03040	Spliceosome	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMC200020073	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMC200020075	K05580	ko00190	Oxidative phosphorylation	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMC200020075	K05580	ko01100	Metabolic pathways	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMC200020076	K05576	ko00190	Oxidative phosphorylation	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMC200020076	K05576	ko01100	Metabolic pathways	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMC200020077	K05575	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMC200020077	K05575	ko01100	Metabolic pathways	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMC200011444	K13067	ko00940	Phenylpropanoid biosynthesis	1112	1.7e-55	0.62	0.79	0.95
PGSC0003DMC200011445	K08967	ko00270	Cysteine and methionine metabolism	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMC200011445	K08967	ko01100	Metabolic pathways	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMC200011446	K08967	ko00270	Cysteine and methionine metabolism	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMC200011446	K08967	ko01100	Metabolic pathways	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMC200011447	K08967	ko00270	Cysteine and methionine metabolism	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMC200011447	K08967	ko01100	Metabolic pathways	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMC200011449	K08099	ko00860	Porphyrin and chlorophyll metabolism	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMC200011449	K08099	ko01100	Metabolic pathways	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMC200011449	K08099	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMC200011450	K08099	ko00860	Porphyrin and chlorophyll metabolism	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMC200011450	K08099	ko01100	Metabolic pathways	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMC200011450	K08099	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMC200025626	K00660	ko00941	Flavonoid biosynthesis	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMC200025626	K00660	ko01100	Metabolic pathways	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMC200025626	K00660	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMC200025626	K00660	ko04712	Circadian rhythm - plant	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMC200025627	K00660	ko00941	Flavonoid biosynthesis	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMC200025627	K00660	ko01100	Metabolic pathways	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMC200025627	K00660	ko01110	Biosynthesis of secondary metabolites	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMC200025627	K00660	ko04712	Circadian rhythm - plant	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMC200025631	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3172	4.1e-169	0.72	0.84	0.92
PGSC0003DMC200025636	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMC200025637	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMC200025638	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMC200025639	K01069	ko00620	Pyruvate metabolism	297	1.6e-10	0.28	0.45	0.56
PGSC0003DMC200018753	K02084	ko04115	p53 signaling pathway	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko04210	Apoptosis	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko05010	Alzheimer's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko05012	Parkinson's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko05016	Huntington's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018753	K02084	ko05222	Small cell lung cancer	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMC200018759	K08332	ko04140	Regulation of autophagy	381	3.5e-15	0.30	0.50	0.84
PGSC0003DMC200018767	K07195	ko04910	Insulin signaling pathway	739	6.3e-35	0.31	0.55	0.98
PGSC0003DMC200018772	K09756	ko00940	Phenylpropanoid biosynthesis	1804	1.2e-93	0.48	0.67	0.96
PGSC0003DMC200018775	K09756	ko00940	Phenylpropanoid biosynthesis	1392	6.1e-71	0.48	0.68	0.93
PGSC0003DMC200018776	K09756	ko00940	Phenylpropanoid biosynthesis	1144	2.9e-57	0.44	0.59	0.99
PGSC0003DMC200018777	K09756	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.48	0.65	1.00
PGSC0003DMC200018778	K09756	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.49	0.69	1.00
PGSC0003DMC200018779	K09756	ko00940	Phenylpropanoid biosynthesis	1235	2.8e-62	0.49	0.67	0.99
PGSC0003DMC200054421	K04733	ko04210	Apoptosis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMC200054421	K04733	ko04620	Toll-like receptor signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMC200054421	K04733	ko04722	Neurotrophin signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMC200054421	K04733	ko05140	Leishmaniasis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMC200054421	K04733	ko05142	Chagas disease	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMC200054443	K06688	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.89	0.91	0.97
PGSC0003DMC200054450	K10595	ko04120	Ubiquitin mediated proteolysis	861	4.7e-40	0.34	0.51	0.41
PGSC0003DMC200031217	K06268	ko04010	MAPK signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04020	Calcium signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04114	Oocyte meiosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04210	Apoptosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04310	Wnt signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04360	Axon guidance	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04370	VEGF signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04650	Natural killer cell mediated cytotoxicity	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04660	T cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04662	B cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko04720	Long-term potentiation	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko05010	Alzheimer's disease	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031217	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMC200031221	K08967	ko00270	Cysteine and methionine metabolism	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMC200031221	K08967	ko01100	Metabolic pathways	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMC200049953	K01051	ko00040	Pentose and glucuronate interconversions	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMC200049953	K01051	ko00500	Starch and sucrose metabolism	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMC200049953	K01051	ko01100	Metabolic pathways	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMC200049954	K01051	ko00040	Pentose and glucuronate interconversions	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMC200049954	K01051	ko00500	Starch and sucrose metabolism	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMC200049954	K01051	ko01100	Metabolic pathways	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMC200049960	K11717	ko00450	Selenoamino acid metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMC200049960	K11717	ko00730	Thiamine metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMC200049960	K11717	ko01100	Metabolic pathways	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMC200049964	K03938	ko00190	Oxidative phosphorylation	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMC200049964	K03938	ko01100	Metabolic pathways	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMC200049964	K03938	ko05010	Alzheimer's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMC200049964	K03938	ko05012	Parkinson's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMC200049964	K03938	ko05016	Huntington's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMC200041792	K01115	ko00564	Glycerophospholipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041792	K01115	ko00565	Ether lipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041792	K01115	ko01100	Metabolic pathways	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041792	K01115	ko04144	Endocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041792	K01115	ko04666	Fc gamma R-mediated phagocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041792	K01115	ko04912	GnRH signaling pathway	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMC200041793	K04508	ko04310	Wnt signaling pathway	262	6.4e-19	0.44	0.60	0.66
PGSC0003DMC200041798	K05349	ko00460	Cyanoamino acid metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMC200041798	K05349	ko00500	Starch and sucrose metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMC200041798	K05349	ko00940	Phenylpropanoid biosynthesis	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMC200041798	K05349	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMC200041809	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMC200041810	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMC200041811	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMC200041816	K00660	ko00941	Flavonoid biosynthesis	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMC200041816	K00660	ko01100	Metabolic pathways	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMC200041816	K00660	ko01110	Biosynthesis of secondary metabolites	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMC200041816	K00660	ko04712	Circadian rhythm - plant	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMC200041817	K00660	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMC200041817	K00660	ko01100	Metabolic pathways	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMC200041817	K00660	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMC200041817	K00660	ko04712	Circadian rhythm - plant	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMC200041818	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMC200041818	K01602	ko00710	Carbon fixation in photosynthetic organisms	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMC200041818	K01602	ko01100	Metabolic pathways	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMC200041819	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200041819	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200041820	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200041820	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200027752	K04733	ko04210	Apoptosis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMC200027752	K04733	ko04620	Toll-like receptor signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMC200027752	K04733	ko04722	Neurotrophin signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMC200027752	K04733	ko05140	Leishmaniasis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMC200027752	K04733	ko05142	Chagas disease	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMC200027780	K01066	ko00623	2,4-Dichlorobenzoate degradation	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMC200027780	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMC200017021	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMC200017022	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMC200017023	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMC200017024	K12796	ko04621	NOD-like receptor signaling pathway	450	1.5e-16	0.31	0.47	0.57
PGSC0003DMC200014376	K00942	ko00230	Purine metabolism	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMC200014376	K00942	ko01100	Metabolic pathways	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMC200014377	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMC200014377	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMC200014378	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMC200014378	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMC200014389	K12126	ko04712	Circadian rhythm - plant	287	8.8e-10	0.31	0.50	0.52
PGSC0003DMC200014391	K00801	ko00100	Steroid biosynthesis	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMC200014391	K00801	ko01100	Metabolic pathways	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMC200014391	K00801	ko01110	Biosynthesis of secondary metabolites	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMC200022622	K02183	ko04020	Calcium signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04070	Phosphatidylinositol signaling system	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04114	Oocyte meiosis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04270	Vascular smooth muscle contraction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04626	Plant-pathogen interaction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04720	Long-term potentiation	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04722	Neurotrophin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04740	Olfactory transduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04744	Phototransduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04745	Phototransduction - fly	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04910	Insulin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04912	GnRH signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04916	Melanogenesis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04970	Salivary secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko04971	Gastric acid secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko05010	Alzheimer's disease	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022622	K02183	ko05214	Glioma	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMC200022623	K02183	ko04020	Calcium signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04070	Phosphatidylinositol signaling system	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04114	Oocyte meiosis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04270	Vascular smooth muscle contraction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04626	Plant-pathogen interaction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04720	Long-term potentiation	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04722	Neurotrophin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04740	Olfactory transduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04744	Phototransduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04745	Phototransduction - fly	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04910	Insulin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04912	GnRH signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04916	Melanogenesis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04970	Salivary secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko04971	Gastric acid secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko05010	Alzheimer's disease	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022623	K02183	ko05214	Glioma	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMC200022626	K01955	ko00240	Pyrimidine metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMC200022626	K01955	ko00250	Alanine, aspartate and glutamate metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMC200022626	K01955	ko01100	Metabolic pathways	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMC200022636	K00908	ko01100	Metabolic pathways	338	1.2e-12	0.30	0.48	0.88
PGSC0003DMC200001594	K13230	ko00402	Benzoxazinoid biosynthesis	629	7.4e-29	0.33	0.49	0.46
PGSC0003DMC200001617	K02184	ko04320	Dorso-ventral axis formation	699	3.0e-32	0.33	0.51	0.88
PGSC0003DMC200001618	K13230	ko00402	Benzoxazinoid biosynthesis	892	2.3e-43	0.37	0.56	0.97
PGSC0003DMC200001619	K13230	ko00402	Benzoxazinoid biosynthesis	419	2.8e-17	0.41	0.68	0.99
PGSC0003DMC200045815	K01809	ko00051	Fructose and mannose metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMC200045815	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMC200045815	K01809	ko01100	Metabolic pathways	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMC200045815	K01809	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMC200045824	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMC200045824	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMC200045825	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMC200045825	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMC200045827	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMC200045828	K00227	ko00100	Steroid biosynthesis	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMC200045828	K00227	ko01100	Metabolic pathways	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMC200045828	K00227	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMC200045831	K00227	ko00100	Steroid biosynthesis	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMC200045831	K00227	ko01100	Metabolic pathways	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMC200045831	K00227	ko01110	Biosynthesis of secondary metabolites	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMC200045832	K00227	ko00100	Steroid biosynthesis	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMC200045832	K00227	ko01100	Metabolic pathways	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMC200045832	K00227	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMC200045834	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMC200045835	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMC200058955	K05765	ko04360	Axon guidance	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMC200058955	K05765	ko04666	Fc gamma R-mediated phagocytosis	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMC200058955	K05765	ko04810	Regulation of actin cytoskeleton	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMC200058978	K04728	ko04110	Cell cycle	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMC200058978	K04728	ko04115	p53 signaling pathway	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMC200058978	K04728	ko04210	Apoptosis	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMC200051421	K12478	ko04144	Endocytosis	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMC200051421	K12478	ko04145	Phagosome	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMC200051432	K02489	ko02020	Two-component system	966	1.9e-47	0.31	0.46	0.67
PGSC0003DMC200051438	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051438	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051438	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051439	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051439	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051439	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMC200051440	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMC200051440	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMC200051440	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMC200051440	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMC200051440	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMC200051441	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051441	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051441	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051442	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051442	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051442	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMC200051443	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMC200051443	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMC200051443	K00734	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMC200051445	K04420	ko04010	MAPK signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMC200051445	K04420	ko04540	Gap junction	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMC200051445	K04420	ko04912	GnRH signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMC200051446	K07195	ko04910	Insulin signaling pathway	3835	1.1e-205	0.69	0.83	1.00
PGSC0003DMC200051447	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4432	1.3e-238	0.78	0.87	0.99
PGSC0003DMC200051448	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200051449	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200051450	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200033934	K12042	ko04020	Calcium signaling pathway	227	1.1e-06	0.46	0.67	0.32
PGSC0003DMC200033947	K00799	ko00480	Glutathione metabolism	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMC200033947	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMC200033947	K00799	ko00982	Drug metabolism - cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMC200033948	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	287	5.4e-10	0.64	0.72	0.27
PGSC0003DMC200033949	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	227	1.1e-06	0.50	0.56	0.53
PGSC0003DMC200033952	K04422	ko04010	MAPK signaling pathway	292	2.9e-10	0.38	0.65	0.80
PGSC0003DMC200033958	K04043	ko03018	RNA degradation	703	6.1e-33	0.81	0.91	0.88
PGSC0003DMC200000392	K08008	ko04145	Phagosome	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMC200000392	K08008	ko04670	Leukocyte transendothelial migration	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMC200000394	K08008	ko04145	Phagosome	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMC200000394	K08008	ko04670	Leukocyte transendothelial migration	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMC200000395	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000395	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000396	K08008	ko04145	Phagosome	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMC200000396	K08008	ko04670	Leukocyte transendothelial migration	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMC200000397	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000397	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000398	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000398	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000399	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000399	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000400	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000400	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMC200000401	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000401	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMC200000402	K08008	ko04145	Phagosome	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMC200000402	K08008	ko04670	Leukocyte transendothelial migration	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMC200000403	K08008	ko04145	Phagosome	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMC200000403	K08008	ko04670	Leukocyte transendothelial migration	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMC200000404	K08008	ko04145	Phagosome	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMC200000404	K08008	ko04670	Leukocyte transendothelial migration	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMC200000405	K04733	ko04210	Apoptosis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMC200000405	K04733	ko04620	Toll-like receptor signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMC200000405	K04733	ko04722	Neurotrophin signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMC200000405	K04733	ko05140	Leishmaniasis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMC200000405	K04733	ko05142	Chagas disease	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMC200000406	K01213	ko00040	Pentose and glucuronate interconversions	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMC200000406	K01213	ko00500	Starch and sucrose metabolism	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMC200000406	K01213	ko01100	Metabolic pathways	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMC200000411	K12134	ko04712	Circadian rhythm - plant	474	2.6e-20	0.53	0.70	0.30
PGSC0003DMC200000412	K04496	ko04310	Wnt signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMC200000412	K04496	ko04330	Notch signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMC200000412	K04496	ko05200	Pathways in cancer	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMC200000412	K04496	ko05220	Chronic myeloid leukemia	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMC200000417	K01762	ko00270	Cysteine and methionine metabolism	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMC200000417	K01762	ko01110	Biosynthesis of secondary metabolites	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMC200028951	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMC200028951	K00891	ko01100	Metabolic pathways	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMC200028951	K00891	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMC200028952	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028952	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028952	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028953	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028953	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028953	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMC200028954	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMC200028954	K00891	ko01100	Metabolic pathways	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMC200028954	K00891	ko01110	Biosynthesis of secondary metabolites	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMC200028975	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMC200028975	K00517	ko00626	Naphthalene and anthracene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMC200028975	K00517	ko00903	Limonene and pinene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMC200028975	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMC200028975	K00517	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMC200015812	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMC200015813	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMC200015814	K10686	ko04120	Ubiquitin mediated proteolysis	659	1.6e-30	0.80	0.89	0.89
PGSC0003DMC200015818	K05592	ko03018	RNA degradation	440	2.0e-18	0.31	0.50	0.94
PGSC0003DMC200015819	K05592	ko03018	RNA degradation	448	7.1e-19	0.36	0.55	0.76
PGSC0003DMC200003935	K01369	ko04142	Lysosome	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMC200003935	K01369	ko04612	Antigen processing and presentation	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMC200003936	K01369	ko04142	Lysosome	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMC200003936	K01369	ko04612	Antigen processing and presentation	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMC200003937	K01369	ko04142	Lysosome	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMC200003937	K01369	ko04612	Antigen processing and presentation	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMC200003939	K02140	ko00190	Oxidative phosphorylation	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMC200003939	K02140	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMC200003943	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1890	2.1e-98	0.44	0.63	0.82
PGSC0003DMC200003944	K00128	ko00010	Glycolysis / Gluconeogenesis	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00053	Ascorbate and aldarate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00071	Fatty acid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00280	Valine, leucine and isoleucine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00310	Lysine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00330	Arginine and proline metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00340	Histidine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00380	Tryptophan metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00410	beta-Alanine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00561	Glycerolipid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00620	Pyruvate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00631	1,2-Dichloroethane degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00640	Propanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00641	3-Chloroacrylic acid degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00650	Butanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko00903	Limonene and pinene degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko01100	Metabolic pathways	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003944	K00128	ko01110	Biosynthesis of secondary metabolites	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMC200003951	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003951	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003952	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMC200003954	K01184	ko00040	Pentose and glucuronate interconversions	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMC200003954	K01184	ko00500	Starch and sucrose metabolism	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMC200003954	K01184	ko01100	Metabolic pathways	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMC200003956	K11294	ko05130	Pathogenic Escherichia coli infection	242	5.2e-07	0.30	0.50	0.55
PGSC0003DMC200003959	K04416	ko04010	MAPK signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMC200003959	K04416	ko04120	Ubiquitin mediated proteolysis	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMC200003959	K04416	ko04622	RIG-I-like receptor signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMC200003959	K04416	ko04722	Neurotrophin signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMC200003959	K04416	ko04912	GnRH signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMC200003960	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMC200021422	K01509	ko00230	Purine metabolism	1073	2.4e-53	0.45	0.61	0.91
PGSC0003DMC200021423	K12667	ko00510	N-Glycan biosynthesis	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMC200021423	K12667	ko01100	Metabolic pathways	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMC200021424	K12667	ko00510	N-Glycan biosynthesis	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMC200021424	K12667	ko01100	Metabolic pathways	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMC200021430	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMC200021430	K03857	ko01100	Metabolic pathways	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMC200021431	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMC200021431	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMC200021432	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMC200021432	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMC200021433	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMC200021433	K03857	ko01100	Metabolic pathways	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMC200021437	K01950	ko00760	Nicotinate and nicotinamide metabolism	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMC200021437	K01950	ko01100	Metabolic pathways	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMC200021438	K01950	ko00760	Nicotinate and nicotinamide metabolism	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMC200021438	K01950	ko01100	Metabolic pathways	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMC200021439	K01950	ko00760	Nicotinate and nicotinamide metabolism	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMC200021439	K01950	ko01100	Metabolic pathways	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMC200021440	K01950	ko00760	Nicotinate and nicotinamide metabolism	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMC200021440	K01950	ko01100	Metabolic pathways	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMC200021441	K01950	ko00760	Nicotinate and nicotinamide metabolism	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMC200021441	K01950	ko01100	Metabolic pathways	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMC200021442	K01177	ko00500	Starch and sucrose metabolism	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMC200021442	K01177	ko01100	Metabolic pathways	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMC200021443	K01177	ko00500	Starch and sucrose metabolism	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMC200021443	K01177	ko01100	Metabolic pathways	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMC200021449	K03105	ko03060	Protein export	927	2.7e-45	0.80	0.89	0.99
PGSC0003DMC200047014	K02350	ko01100	Metabolic pathways	359	2.2e-10	0.26	0.44	0.65
PGSC0003DMC200047017	K01728	ko00040	Pentose and glucuronate interconversions	2578	2.3e-136	0.74	0.85	0.98
PGSC0003DMC200047030	K01955	ko00240	Pyrimidine metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMC200047030	K01955	ko00250	Alanine, aspartate and glutamate metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMC200047030	K01955	ko01100	Metabolic pathways	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMC200057769	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMC200057769	K00517	ko00626	Naphthalene and anthracene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMC200057769	K00517	ko00903	Limonene and pinene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMC200057769	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMC200057769	K00517	ko01110	Biosynthesis of secondary metabolites	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMC200035131	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMC200035131	K05294	ko01100	Metabolic pathways	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMC200035132	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMC200035132	K05294	ko01100	Metabolic pathways	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMC200035133	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMC200035133	K05294	ko01100	Metabolic pathways	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMC200035134	K10652	ko04622	RIG-I-like receptor signaling pathway	280	1.0e-07	0.39	0.53	0.31
PGSC0003DMC200035136	K01895	ko00010	Glycolysis / Gluconeogenesis	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035136	K01895	ko00620	Pyruvate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035136	K01895	ko00640	Propanoate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035136	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035136	K01895	ko01100	Metabolic pathways	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035136	K01895	ko01110	Biosynthesis of secondary metabolites	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMC200035137	K01895	ko00010	Glycolysis / Gluconeogenesis	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035137	K01895	ko00620	Pyruvate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035137	K01895	ko00640	Propanoate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035137	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035137	K01895	ko01100	Metabolic pathways	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035137	K01895	ko01110	Biosynthesis of secondary metabolites	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMC200035144	K03723	ko03420	Nucleotide excision repair	1273	2.2e-64	0.42	0.60	0.97
PGSC0003DMC200035145	K03723	ko03420	Nucleotide excision repair	2362	1.9e-124	0.45	0.66	0.85
PGSC0003DMC200052645	K06685	ko04111	Cell cycle - yeast	342	1.0e-09	0.27	0.43	0.93
PGSC0003DMC200067475	K04508	ko04310	Wnt signaling pathway	298	4.4e-08	0.53	0.64	0.14
PGSC0003DMC200067490	K00850	ko00010	Glycolysis / Gluconeogenesis	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200067490	K00850	ko00030	Pentose phosphate pathway	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200067490	K00850	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200067490	K00850	ko00052	Galactose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200067490	K00850	ko01100	Metabolic pathways	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200067490	K00850	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMC200024421	K01369	ko04142	Lysosome	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMC200024421	K01369	ko04612	Antigen processing and presentation	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMC200024430	K12471	ko04144	Endocytosis	627	9.5e-29	0.31	0.47	0.81
PGSC0003DMC200024438	K05853	ko04020	Calcium signaling pathway	6444	0.	0.81	0.88	0.92
PGSC0003DMC200024438	K05853	ko05010	Alzheimer's disease	6444	0.	0.81	0.88	0.92
PGSC0003DMC200024440	K02132	ko00190	Oxidative phosphorylation	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMC200024440	K02132	ko01100	Metabolic pathways	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMC200024440	K02132	ko05010	Alzheimer's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMC200024440	K02132	ko05012	Parkinson's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMC200024440	K02132	ko05016	Huntington's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMC200024447	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMC200024447	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMC200024449	K00423	ko00053	Ascorbate and aldarate metabolism	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMC200024449	K00423	ko01100	Metabolic pathways	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMC200024450	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMC200024450	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMC200019951	K00228	ko00860	Porphyrin and chlorophyll metabolism	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMC200019951	K00228	ko01100	Metabolic pathways	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMC200019953	K13066	ko00940	Phenylpropanoid biosynthesis	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMC200019953	K13066	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMC200019978	K12742	ko00900	Terpenoid backbone biosynthesis	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMC200019978	K12742	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMC200011796	K00695	ko00500	Starch and sucrose metabolism	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMC200011796	K00695	ko01100	Metabolic pathways	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMC200011797	K00695	ko00500	Starch and sucrose metabolism	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMC200011797	K00695	ko01100	Metabolic pathways	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMC200011798	K00695	ko00500	Starch and sucrose metabolism	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMC200011798	K00695	ko01100	Metabolic pathways	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMC200011799	K00695	ko00500	Starch and sucrose metabolism	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMC200011799	K00695	ko01100	Metabolic pathways	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMC200011800	K00695	ko00500	Starch and sucrose metabolism	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMC200011800	K00695	ko01100	Metabolic pathways	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMC200011809	K01066	ko00623	2,4-Dichlorobenzoate degradation	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMC200011809	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMC200011810	K00813	ko00250	Alanine, aspartate and glutamate metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00270	Cysteine and methionine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00330	Arginine and proline metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00350	Tyrosine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00360	Phenylalanine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00401	Novobiocin biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00710	Carbon fixation in photosynthetic organisms	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00950	Isoquinoline alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko01100	Metabolic pathways	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011810	K00813	ko01110	Biosynthesis of secondary metabolites	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMC200011811	K00813	ko00250	Alanine, aspartate and glutamate metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00270	Cysteine and methionine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00330	Arginine and proline metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00350	Tyrosine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00360	Phenylalanine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00401	Novobiocin biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00710	Carbon fixation in photosynthetic organisms	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00950	Isoquinoline alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko01100	Metabolic pathways	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011811	K00813	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMC200011812	K00813	ko00250	Alanine, aspartate and glutamate metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00270	Cysteine and methionine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00330	Arginine and proline metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00350	Tyrosine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00360	Phenylalanine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00401	Novobiocin biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00710	Carbon fixation in photosynthetic organisms	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00950	Isoquinoline alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko01100	Metabolic pathways	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011812	K00813	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMC200011813	K00813	ko00250	Alanine, aspartate and glutamate metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00270	Cysteine and methionine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00330	Arginine and proline metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00350	Tyrosine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00360	Phenylalanine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00401	Novobiocin biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00710	Carbon fixation in photosynthetic organisms	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00950	Isoquinoline alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko01100	Metabolic pathways	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011813	K00813	ko01110	Biosynthesis of secondary metabolites	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMC200011814	K00430	ko00360	Phenylalanine metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMC200011814	K00430	ko00680	Methane metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMC200011814	K00430	ko00940	Phenylpropanoid biosynthesis	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMC200011814	K00430	ko01100	Metabolic pathways	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMC200011814	K00430	ko01110	Biosynthesis of secondary metabolites	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMC200011815	K00430	ko00360	Phenylalanine metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMC200011815	K00430	ko00680	Methane metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMC200011815	K00430	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMC200011815	K00430	ko01100	Metabolic pathways	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMC200011815	K00430	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMC200011816	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMC200011816	K00430	ko00680	Methane metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMC200011816	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMC200011816	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMC200011816	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMC200011818	K04567	ko00970	Aminoacyl-tRNA biosynthesis	602	2.3e-27	0.60	0.68	0.48
PGSC0003DMC200055621	K02735	ko03050	Proteasome	1599	2.3e-82	0.92	0.97	1.00
PGSC0003DMC200055627	K01358	ko04112	Cell cycle - Caulobacter	1672	2.2e-86	0.83	0.91	1.00
PGSC0003DMC200055635	K02864	ko03010	Ribosome	1290	2.6e-65	0.68	0.79	0.99
PGSC0003DMC200055644	K02084	ko04115	p53 signaling pathway	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko04210	Apoptosis	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko05010	Alzheimer's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko05012	Parkinson's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko05016	Huntington's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200055644	K02084	ko05222	Small cell lung cancer	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMC200048760	K04427	ko04010	MAPK signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04310	Wnt signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04520	Adherens junction	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04620	Toll-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04621	NOD-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04622	RIG-I-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko04660	T cell receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048760	K04427	ko05140	Leishmaniasis	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMC200048761	K04427	ko04010	MAPK signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04310	Wnt signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04520	Adherens junction	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04620	Toll-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04621	NOD-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04622	RIG-I-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko04660	T cell receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048761	K04427	ko05140	Leishmaniasis	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMC200048763	K04427	ko04010	MAPK signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04310	Wnt signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04520	Adherens junction	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04620	Toll-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04621	NOD-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04622	RIG-I-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko04660	T cell receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048763	K04427	ko05140	Leishmaniasis	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMC200048766	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMC200048766	K12449	ko01100	Metabolic pathways	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMC200048767	K11254	ko05322	Systemic lupus erythematosus	390	1.1e-15	0.55	0.58	0.99
PGSC0003DMC200048777	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	612	6.4e-28	0.34	0.50	0.95
PGSC0003DMC200048778	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	544	3.6e-24	0.33	0.49	0.94
PGSC0003DMC200048779	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	530	2.1e-23	0.37	0.53	0.85
PGSC0003DMC200030001	K13229	ko00402	Benzoxazinoid biosynthesis	820	2.2e-39	0.46	0.65	0.99
PGSC0003DMC200030002	K13229	ko00402	Benzoxazinoid biosynthesis	576	6.2e-26	0.49	0.66	0.95
PGSC0003DMC200030003	K13229	ko00402	Benzoxazinoid biosynthesis	459	1.8e-19	0.45	0.63	0.99
PGSC0003DMC200030008	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMC200030009	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMC200030010	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMC200030012	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMC200030013	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMC200030014	K13229	ko00402	Benzoxazinoid biosynthesis	834	3.6e-40	0.48	0.65	0.85
PGSC0003DMC200030015	K13229	ko00402	Benzoxazinoid biosynthesis	439	2.2e-18	0.51	0.69	0.91
PGSC0003DMC200030016	K13229	ko00402	Benzoxazinoid biosynthesis	876	1.8e-42	0.47	0.64	1.00
PGSC0003DMC200030017	K13229	ko00402	Benzoxazinoid biosynthesis	621	2.0e-28	0.49	0.68	0.94
PGSC0003DMC200030018	K13229	ko00402	Benzoxazinoid biosynthesis	267	6.8e-09	0.35	0.58	0.90
PGSC0003DMC200030019	K12356	ko00940	Phenylpropanoid biosynthesis	640	1.8e-29	0.34	0.51	0.97
PGSC0003DMC200030020	K12356	ko00940	Phenylpropanoid biosynthesis	730	2.0e-34	0.34	0.50	0.98
PGSC0003DMC200036789	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMC200036789	K05290	ko01100	Metabolic pathways	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMC200036792	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMC200036792	K02433	ko01100	Metabolic pathways	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMC200036793	K02433	ko00970	Aminoacyl-tRNA biosynthesis	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMC200036793	K02433	ko01100	Metabolic pathways	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMC200036794	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMC200036794	K02433	ko01100	Metabolic pathways	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMC200036795	K02433	ko00970	Aminoacyl-tRNA biosynthesis	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMC200036795	K02433	ko01100	Metabolic pathways	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMC200036807	K10595	ko04120	Ubiquitin mediated proteolysis	472	1.5e-18	0.31	0.47	0.97
PGSC0003DMC200036808	K10615	ko04120	Ubiquitin mediated proteolysis	366	1.5e-13	0.31	0.47	0.98
PGSC0003DMC200036810	K00799	ko00480	Glutathione metabolism	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMC200036810	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMC200036810	K00799	ko00982	Drug metabolism - cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMC200041974	K12845	ko03040	Spliceosome	995	4.8e-49	0.94	0.97	0.99
PGSC0003DMC200041975	K06700	ko03050	Proteasome	1359	4.0e-69	0.57	0.65	1.00
PGSC0003DMC200041976	K06700	ko03050	Proteasome	1396	3.7e-71	0.60	0.68	1.00
PGSC0003DMC200041977	K06700	ko03050	Proteasome	1406	1.0e-71	0.60	0.69	1.00
PGSC0003DMC200041978	K05863	ko04020	Calcium signaling pathway	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMC200041978	K05863	ko05012	Parkinson's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMC200041978	K05863	ko05016	Huntington's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMC200041985	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMC200041985	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMC200041985	K00771	ko01100	Metabolic pathways	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMC200041986	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMC200041986	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMC200041986	K00771	ko01100	Metabolic pathways	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMC200041993	K02084	ko04115	p53 signaling pathway	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko04210	Apoptosis	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko05010	Alzheimer's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko05012	Parkinson's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko05016	Huntington's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041993	K02084	ko05222	Small cell lung cancer	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMC200041994	K04123	ko00904	Diterpenoid biosynthesis	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMC200041994	K04123	ko01100	Metabolic pathways	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMC200041994	K04123	ko01110	Biosynthesis of secondary metabolites	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMC200023822	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMC200023822	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMC200023823	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMC200023823	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMC200023824	K04424	ko04010	MAPK signaling pathway	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMC200023824	K04424	ko04530	Tight junction	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMC200023835	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMC200023835	K00517	ko00626	Naphthalene and anthracene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMC200023835	K00517	ko00903	Limonene and pinene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMC200023835	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMC200023835	K00517	ko01110	Biosynthesis of secondary metabolites	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMC200023839	K01875	ko00970	Aminoacyl-tRNA biosynthesis	509	3.1e-22	0.80	0.93	0.34
PGSC0003DMC200023840	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.82	0.91	1.00
PGSC0003DMC200023845	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023845	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023845	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023845	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023845	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023845	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023846	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMC200023847	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023847	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023847	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023847	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023847	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023847	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMC200023850	K01648	ko00020	Citrate cycle (TCA cycle)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMC200023850	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMC200023850	K01648	ko01100	Metabolic pathways	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMC200023850	K01648	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMC200007983	K09561	ko04120	Ubiquitin mediated proteolysis	246	9.8e-08	0.36	0.51	0.37
PGSC0003DMC200007986	K00737	ko00510	N-Glycan biosynthesis	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMC200007986	K00737	ko01100	Metabolic pathways	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMC200007987	K00737	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMC200007987	K00737	ko01100	Metabolic pathways	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMC200007999	K12356	ko00940	Phenylpropanoid biosynthesis	682	8.8e-32	0.32	0.49	0.97
PGSC0003DMC200008000	K11866	ko04144	Endocytosis	544	1.4e-23	0.29	0.45	0.91
PGSC0003DMC200008007	K02639	ko00195	Photosynthesis	802	2.1e-38	0.66	0.83	0.99
PGSC0003DMC200008008	K01115	ko00564	Glycerophospholipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200008008	K01115	ko00565	Ether lipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200008008	K01115	ko01100	Metabolic pathways	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200008008	K01115	ko04144	Endocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200008008	K01115	ko04666	Fc gamma R-mediated phagocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200008008	K01115	ko04912	GnRH signaling pathway	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMC200013178	K00111	ko00564	Glycerophospholipid metabolism	4432	1.3e-238	0.86	0.93	0.52
PGSC0003DMC200013179	K08332	ko04140	Regulation of autophagy	328	2.5e-10	0.29	0.50	0.59
PGSC0003DMC200013180	K08332	ko04140	Regulation of autophagy	328	9.4e-10	0.29	0.50	0.46
PGSC0003DMC200013182	K03094	ko04110	Cell cycle	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04111	Cell cycle - yeast	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04114	Oocyte meiosis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04120	Ubiquitin mediated proteolysis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04310	Wnt signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04350	TGF-beta signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200013182	K03094	ko04710	Circadian rhythm - mammal	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMC200002800	K01177	ko00500	Starch and sucrose metabolism	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMC200002800	K01177	ko01100	Metabolic pathways	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMC200002808	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMC200002808	K01703	ko00660	C5-Branched dibasic acid metabolism	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMC200002808	K01703	ko01100	Metabolic pathways	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMC200002808	K01703	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMC200002809	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002809	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002809	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002809	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002810	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002810	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002810	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002810	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002811	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002811	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002811	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002811	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMC200002812	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMC200002812	K01703	ko00660	C5-Branched dibasic acid metabolism	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMC200002812	K01703	ko01100	Metabolic pathways	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMC200002812	K01703	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMC200002813	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002813	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002813	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002813	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002814	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002814	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002814	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002814	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMC200002817	K02434	ko00970	Aminoacyl-tRNA biosynthesis	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMC200002817	K02434	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMC200002818	K02434	ko00970	Aminoacyl-tRNA biosynthesis	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMC200002818	K02434	ko01100	Metabolic pathways	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMC200047161	K00382	ko00010	Glycolysis / Gluconeogenesis	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko00020	Citrate cycle (TCA cycle)	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko00260	Glycine, serine and threonine metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko00280	Valine, leucine and isoleucine degradation	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko00620	Pyruvate metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko01100	Metabolic pathways	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047161	K00382	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMC200047162	K00382	ko00010	Glycolysis / Gluconeogenesis	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko00020	Citrate cycle (TCA cycle)	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko00260	Glycine, serine and threonine metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko00280	Valine, leucine and isoleucine degradation	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko00620	Pyruvate metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko01100	Metabolic pathways	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047162	K00382	ko01110	Biosynthesis of secondary metabolites	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMC200047163	K00382	ko00010	Glycolysis / Gluconeogenesis	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko00020	Citrate cycle (TCA cycle)	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko00260	Glycine, serine and threonine metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko00280	Valine, leucine and isoleucine degradation	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko00620	Pyruvate metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko01100	Metabolic pathways	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047163	K00382	ko01110	Biosynthesis of secondary metabolites	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMC200047164	K00382	ko00010	Glycolysis / Gluconeogenesis	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko00020	Citrate cycle (TCA cycle)	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko00260	Glycine, serine and threonine metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko00280	Valine, leucine and isoleucine degradation	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko00620	Pyruvate metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko01100	Metabolic pathways	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047164	K00382	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMC200047173	K00660	ko00941	Flavonoid biosynthesis	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMC200047173	K00660	ko01100	Metabolic pathways	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMC200047173	K00660	ko01110	Biosynthesis of secondary metabolites	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMC200047173	K00660	ko04712	Circadian rhythm - plant	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMC200047189	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMC200047189	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMC200047189	K03877	ko01100	Metabolic pathways	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMC200047190	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMC200047190	K07819	ko01100	Metabolic pathways	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMC200040591	K10775	ko00360	Phenylalanine metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMC200040591	K10775	ko00910	Nitrogen metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMC200040591	K10775	ko00940	Phenylpropanoid biosynthesis	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMC200040591	K10775	ko01100	Metabolic pathways	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMC200040591	K10775	ko01110	Biosynthesis of secondary metabolites	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMC200040595	K08907	ko00196	Photosynthesis - antenna proteins	1812	4.2e-94	0.84	0.91	0.99
PGSC0003DMC200040600	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040600	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040600	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040600	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040600	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040600	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040601	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMC200040602	K01054	ko00561	Glycerolipid metabolism	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMC200040602	K01054	ko01100	Metabolic pathways	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMC200040603	K01054	ko00561	Glycerolipid metabolism	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMC200040603	K01054	ko01100	Metabolic pathways	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMC200040609	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040609	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040609	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040609	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040609	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040610	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040610	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040610	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040610	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200040610	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMC200032419	K00276	ko00260	Glycine, serine and threonine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko00350	Tyrosine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko00360	Phenylalanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko00410	beta-Alanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko01100	Metabolic pathways	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032419	K00276	ko01110	Biosynthesis of secondary metabolites	5714	0.	0.82	0.90	1.00
PGSC0003DMC200032423	K12393	ko04142	Lysosome	3390	3.8e-181	0.93	0.97	1.00
PGSC0003DMC200032425	K00737	ko00510	N-Glycan biosynthesis	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMC200032425	K00737	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMC200035049	K11420	ko00310	Lysine degradation	603	2.0e-27	0.36	0.48	0.50
PGSC0003DMC200035050	K11420	ko00310	Lysine degradation	606	1.4e-27	0.36	0.48	0.43
PGSC0003DMC200035056	K01834	ko00010	Glycolysis / Gluconeogenesis	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMC200035056	K01834	ko01100	Metabolic pathways	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMC200035056	K01834	ko01110	Biosynthesis of secondary metabolites	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMC200035069	K07195	ko04910	Insulin signaling pathway	2422	9.4e-128	0.47	0.64	0.97
PGSC0003DMC200015961	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMC200015961	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMC200015961	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMC200015962	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMC200015962	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMC200015962	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMC200015963	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMC200015963	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMC200015963	K00734	ko01100	Metabolic pathways	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMC200015967	K06689	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.99	1.00	0.99
PGSC0003DMC200015982	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMC200015983	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMC200015984	K00797	ko00270	Cysteine and methionine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMC200015984	K00797	ko00330	Arginine and proline metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMC200015984	K00797	ko00410	beta-Alanine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMC200015984	K00797	ko00480	Glutathione metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMC200015984	K00797	ko01100	Metabolic pathways	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMC200015986	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMC200015987	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMC200015988	K12827	ko03040	Spliceosome	1846	5.6e-96	0.85	0.92	1.00
PGSC0003DMC200015990	K01051	ko00040	Pentose and glucuronate interconversions	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMC200015990	K01051	ko00500	Starch and sucrose metabolism	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMC200015990	K01051	ko01100	Metabolic pathways	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMC200009398	K01358	ko04112	Cell cycle - Caulobacter	689	3.6e-32	0.79	0.94	0.92
PGSC0003DMC200009399	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMC200009400	K04382	ko04111	Cell cycle - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04113	Meiosis - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04114	Oocyte meiosis	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04310	Wnt signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04350	TGF-beta signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04530	Tight junction	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko04730	Long-term depression	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009400	K04382	ko05142	Chagas disease	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMC200009401	K04382	ko04111	Cell cycle - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04113	Meiosis - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04114	Oocyte meiosis	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04310	Wnt signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04350	TGF-beta signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04530	Tight junction	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko04730	Long-term depression	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009401	K04382	ko05142	Chagas disease	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMC200009402	K04382	ko04111	Cell cycle - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04113	Meiosis - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04114	Oocyte meiosis	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04310	Wnt signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04350	TGF-beta signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04530	Tight junction	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko04730	Long-term depression	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009402	K04382	ko05142	Chagas disease	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMC200009416	K02707	ko00195	Photosynthesis	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMC200009416	K02707	ko01100	Metabolic pathways	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMC200003841	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003841	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003841	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003842	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003842	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003842	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMC200003843	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003843	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003843	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003844	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003844	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003844	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMC200003845	K12593	ko03018	RNA degradation	270	4.7e-09	0.42	0.60	0.97
PGSC0003DMC200003846	K12593	ko03018	RNA degradation	726	3.3e-34	0.57	0.67	0.97
PGSC0003DMC200003856	K07750	ko00100	Steroid biosynthesis	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMC200003856	K07750	ko01100	Metabolic pathways	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMC200003857	K07750	ko00100	Steroid biosynthesis	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMC200003857	K07750	ko01100	Metabolic pathways	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMC200003865	K00799	ko00480	Glutathione metabolism	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMC200003865	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMC200003865	K00799	ko00982	Drug metabolism - cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMC200003866	K00799	ko00480	Glutathione metabolism	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMC200003866	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMC200003866	K00799	ko00982	Drug metabolism - cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMC200003867	K00799	ko00480	Glutathione metabolism	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMC200003867	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMC200003867	K00799	ko00982	Drug metabolism - cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMC200003869	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMC200003869	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMC200003869	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMC200003870	K00799	ko00480	Glutathione metabolism	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMC200003870	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMC200003870	K00799	ko00982	Drug metabolism - cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMC200026822	K05574	ko00190	Oxidative phosphorylation	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMC200026822	K05574	ko01100	Metabolic pathways	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMC200026849	K10143	ko04115	p53 signaling pathway	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMC200026849	K10143	ko04120	Ubiquitin mediated proteolysis	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMC200026850	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMC200026850	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMC200063142	K00558	ko00270	Cysteine and methionine metabolism	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMC200063142	K00558	ko01100	Metabolic pathways	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMC200039395	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039395	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039395	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039396	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039396	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039396	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMC200039397	K05732	ko04510	Focal adhesion	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMC200039397	K05732	ko04670	Leukocyte transendothelial migration	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMC200039397	K05732	ko04810	Regulation of actin cytoskeleton	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMC200039398	K05732	ko04510	Focal adhesion	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMC200039398	K05732	ko04670	Leukocyte transendothelial migration	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMC200039398	K05732	ko04810	Regulation of actin cytoskeleton	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMC200039399	K05732	ko04510	Focal adhesion	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMC200039399	K05732	ko04670	Leukocyte transendothelial migration	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMC200039399	K05732	ko04810	Regulation of actin cytoskeleton	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMC200039408	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039408	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039408	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039409	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039409	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039409	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMC200039410	K00100	ko00051	Fructose and mannose metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039410	K00100	ko00363	Bisphenol A degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039410	K00100	ko00591	Linoleic acid metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039410	K00100	ko00625	Tetrachloroethene degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039410	K00100	ko00650	Butanoate metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039410	K00100	ko01100	Metabolic pathways	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMC200039414	K03364	ko04110	Cell cycle	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMC200039414	K03364	ko04111	Cell cycle - yeast	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMC200039414	K03364	ko04120	Ubiquitin mediated proteolysis	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMC200039414	K03364	ko04914	Progesterone-mediated oocyte maturation	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMC200039418	K01115	ko00564	Glycerophospholipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039418	K01115	ko00565	Ether lipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039418	K01115	ko01100	Metabolic pathways	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039418	K01115	ko04144	Endocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039418	K01115	ko04666	Fc gamma R-mediated phagocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039418	K01115	ko04912	GnRH signaling pathway	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMC200039419	K01115	ko00564	Glycerophospholipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039419	K01115	ko00565	Ether lipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039419	K01115	ko01100	Metabolic pathways	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039419	K01115	ko04144	Endocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039419	K01115	ko04666	Fc gamma R-mediated phagocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039419	K01115	ko04912	GnRH signaling pathway	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMC200039420	K12451	ko00520	Amino sugar and nucleotide sugar metabolism	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMC200039420	K12451	ko00523	Polyketide sugar unit biosynthesis	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMC200045966	K10260	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.29	0.46	0.68
PGSC0003DMC200045972	K00852	ko00030	Pentose phosphate pathway	803	1.9e-38	0.37	0.55	0.67
PGSC0003DMC200045973	K00852	ko00030	Pentose phosphate pathway	382	3.1e-15	0.39	0.59	0.47
PGSC0003DMC200045974	K13056	ko04114	Oocyte meiosis	311	2.6e-11	0.29	0.44	0.58
PGSC0003DMC200045985	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6057	0.	0.73	0.83	0.98
PGSC0003DMC200045986	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6484	0.	0.77	0.88	0.98
PGSC0003DMC200045987	K01872	ko00970	Aminoacyl-tRNA biosynthesis	382	1.7e-14	0.95	0.95	0.66
PGSC0003DMC200033853	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMC200033853	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMC200033853	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMC200033853	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMC200033853	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMC200033855	K00430	ko00360	Phenylalanine metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMC200033855	K00430	ko00680	Methane metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMC200033855	K00430	ko00940	Phenylpropanoid biosynthesis	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMC200033855	K00430	ko01100	Metabolic pathways	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMC200033855	K00430	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMC200033856	K00430	ko00360	Phenylalanine metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMC200033856	K00430	ko00680	Methane metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMC200033856	K00430	ko00940	Phenylpropanoid biosynthesis	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMC200033856	K00430	ko01100	Metabolic pathways	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMC200033856	K00430	ko01110	Biosynthesis of secondary metabolites	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMC200033857	K00430	ko00360	Phenylalanine metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMC200033857	K00430	ko00680	Methane metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMC200033857	K00430	ko00940	Phenylpropanoid biosynthesis	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMC200033857	K00430	ko01100	Metabolic pathways	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMC200033857	K00430	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMC200033860	K05681	ko02010	ABC transporters	269	1.7e-08	0.33	0.51	0.69
PGSC0003DMC200056841	K04123	ko00904	Diterpenoid biosynthesis	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMC200056841	K04123	ko01100	Metabolic pathways	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMC200056841	K04123	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMC200064335	K03937	ko00190	Oxidative phosphorylation	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMC200064335	K03937	ko01100	Metabolic pathways	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMC200064335	K03937	ko05010	Alzheimer's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMC200064335	K03937	ko05012	Parkinson's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMC200064335	K03937	ko05016	Huntington's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMC200068682	K11816	ko00380	Tryptophan metabolism	1375	5.3e-70	0.45	0.67	0.96
PGSC0003DMC200068683	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200010610	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMC200010610	K08081	ko01100	Metabolic pathways	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMC200010610	K08081	ko01110	Biosynthesis of secondary metabolites	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMC200010611	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMC200010611	K08081	ko01100	Metabolic pathways	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMC200010611	K08081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMC200010612	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010612	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010612	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010612	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010612	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010613	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010613	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010613	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010613	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010613	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMC200010617	K12778	ko04113	Meiosis - yeast	432	6.2e-16	0.32	0.53	0.30
PGSC0003DMC200017165	K08241	ko00592	alpha-Linolenic acid metabolism	689	3.6e-32	0.34	0.52	0.98
PGSC0003DMC200017174	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017174	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMC200017175	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017175	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMC200017176	K08241	ko00592	alpha-Linolenic acid metabolism	673	2.8e-31	0.34	0.51	0.89
PGSC0003DMC200017177	K08241	ko00592	alpha-Linolenic acid metabolism	514	1.6e-22	0.32	0.47	0.89
PGSC0003DMC200017190	K03469	ko03030	DNA replication	255	3.1e-08	0.37	0.57	0.30
PGSC0003DMC200053835	K12338	ko00942	Anthocyanin biosynthesis	245	1.7e-07	0.47	0.68	0.53
PGSC0003DMC200053836	K12607	ko03018	RNA degradation	3943	1.2e-211	0.60	0.75	1.00
PGSC0003DMC200053846	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMC200053847	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMC200043182	K01528	ko04144	Endocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMC200043182	K01528	ko04666	Fc gamma R-mediated phagocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMC200043182	K01528	ko05100	Bacterial invasion of epithelial cells	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMC200043183	K01528	ko04144	Endocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMC200043183	K01528	ko04666	Fc gamma R-mediated phagocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMC200043183	K01528	ko05100	Bacterial invasion of epithelial cells	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMC200043196	K13034	ko00270	Cysteine and methionine metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMC200043196	K13034	ko00450	Selenoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMC200043196	K13034	ko00460	Cyanoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMC200043196	K13034	ko00920	Sulfur metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMC200043196	K13034	ko01100	Metabolic pathways	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMC200043198	K03024	ko00230	Purine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMC200043198	K03024	ko00240	Pyrimidine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMC200043198	K03024	ko01100	Metabolic pathways	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMC200043198	K03024	ko03020	RNA polymerase	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMC200043198	K03024	ko04623	Cytosolic DNA-sensing pathway	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMC200043199	K07904	ko04144	Endocytosis	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMC200043199	K07904	ko04962	Vasopressin-regulated water reabsorption	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMC200043200	K05894	ko00592	alpha-Linolenic acid metabolism	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMC200043200	K05894	ko01100	Metabolic pathways	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMC200037985	K02342	ko00230	Purine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037985	K02342	ko00240	Pyrimidine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037985	K02342	ko01100	Metabolic pathways	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037985	K02342	ko03030	DNA replication	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037985	K02342	ko03430	Mismatch repair	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037985	K02342	ko03440	Homologous recombination	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMC200037989	K05666	ko02010	ABC transporters	2410	4.3e-127	0.39	0.55	0.95
PGSC0003DMC200037990	K05666	ko02010	ABC transporters	2903	2.8e-154	0.46	0.63	0.94
PGSC0003DMC200037991	K05666	ko02010	ABC transporters	2867	2.7e-152	0.46	0.63	0.91
PGSC0003DMC200037992	K05666	ko02010	ABC transporters	3193	2.8e-170	0.40	0.59	0.96
PGSC0003DMC200037993	K05666	ko02010	ABC transporters	1598	2.6e-82	0.34	0.53	0.95
PGSC0003DMC200037994	K05666	ko02010	ABC transporters	3622	6.1e-194	0.43	0.62	0.96
PGSC0003DMC200037995	K05666	ko02010	ABC transporters	3509	1.0e-187	0.43	0.63	0.97
PGSC0003DMC200038006	K02084	ko04115	p53 signaling pathway	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko04210	Apoptosis	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko05010	Alzheimer's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko05012	Parkinson's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko05016	Huntington's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038006	K02084	ko05222	Small cell lung cancer	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMC200038010	K03097	ko04310	Wnt signaling pathway	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMC200038010	K03097	ko04520	Adherens junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMC200038010	K03097	ko04530	Tight junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMC200038010	K03097	ko04712	Circadian rhythm - plant	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMC200061079	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200061079	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200011984	K00680	ko00350	Tyrosine metabolism	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMC200011984	K00680	ko00624	1- and 2-Methylnaphthalene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMC200011984	K00680	ko00632	Benzoate degradation via CoA ligation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMC200011984	K00680	ko00642	Ethylbenzene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMC200011984	K00680	ko00903	Limonene and pinene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMC200011985	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMC200011985	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMC200011985	K00820	ko01100	Metabolic pathways	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMC200011986	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011986	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011986	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011987	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011987	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011987	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011988	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011988	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011988	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMC200011994	K03087	ko05111	Vibrio cholerae pathogenic cycle	571	1.2e-25	0.47	0.69	0.75
PGSC0003DMC200011999	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMC200011999	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMC200012000	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMC200012000	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMC200006781	K03679	ko03018	RNA degradation	1883	5.1e-98	0.70	0.83	1.00
PGSC0003DMC200006794	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMC200006802	K12741	ko03040	Spliceosome	872	2.9e-42	0.43	0.57	0.98
PGSC0003DMC200006803	K12741	ko03040	Spliceosome	1352	9.8e-69	0.46	0.59	0.99
PGSC0003DMC200016295	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMC200016295	K01850	ko01100	Metabolic pathways	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMC200016295	K01850	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMC200016296	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMC200016296	K01850	ko01100	Metabolic pathways	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMC200016296	K01850	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMC200016318	K03660	ko03410	Base excision repair	2101	4.8e-110	0.70	0.81	0.96
PGSC0003DMC200016320	K06627	ko04110	Cell cycle	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMC200016320	K06627	ko04914	Progesterone-mediated oocyte maturation	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMC200010863	K08496	ko04130	SNARE interactions in vesicular transport	1250	4.1e-63	0.62	0.82	0.94
PGSC0003DMC200010874	K12132	ko04712	Circadian rhythm - plant	1304	4.4e-66	0.59	0.73	0.95
PGSC0003DMC200010876	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMC200010877	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMC200010878	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMC200010886	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4416	9.9e-238	0.77	0.85	0.98
PGSC0003DMC200010887	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2681	4.9e-142	0.87	0.95	0.99
PGSC0003DMC200010888	K01868	ko00970	Aminoacyl-tRNA biosynthesis	574	8.0e-26	0.77	0.92	0.91
PGSC0003DMC200020701	K04122	ko00904	Diterpenoid biosynthesis	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMC200020701	K04122	ko01100	Metabolic pathways	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMC200020701	K04122	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMC200020703	K03100	ko03060	Protein export	1916	7.7e-100	0.63	0.76	1.00
PGSC0003DMC200020704	K03100	ko03060	Protein export	1701	5.5e-88	0.63	0.76	1.00
PGSC0003DMC200020708	K12356	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.29	0.46	0.93
PGSC0003DMC200020709	K12356	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.29	0.46	0.93
PGSC0003DMC200020710	K03911	ko04610	Complement and coagulation cascades	635	3.4e-29	0.32	0.50	0.94
PGSC0003DMC200020711	K03911	ko04610	Complement and coagulation cascades	705	4.8e-33	0.33	0.53	0.95
PGSC0003DMC200020712	K03911	ko04610	Complement and coagulation cascades	678	1.5e-31	0.32	0.51	0.92
PGSC0003DMC200020715	K03911	ko04610	Complement and coagulation cascades	698	1.2e-32	0.34	0.53	0.89
PGSC0003DMC200023345	K04733	ko04210	Apoptosis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMC200023345	K04733	ko04620	Toll-like receptor signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMC200023345	K04733	ko04722	Neurotrophin signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMC200023345	K04733	ko05140	Leishmaniasis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMC200023345	K04733	ko05142	Chagas disease	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMC200023349	K03935	ko00190	Oxidative phosphorylation	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMC200023349	K03935	ko01100	Metabolic pathways	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMC200023349	K03935	ko05010	Alzheimer's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMC200023349	K03935	ko05012	Parkinson's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMC200023349	K03935	ko05016	Huntington's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMC200023364	K02739	ko03050	Proteasome	1315	1.1e-66	0.87	0.95	0.99
PGSC0003DMC200023367	K06675	ko04111	Cell cycle - yeast	544	2.0e-38	0.44	0.61	0.97
PGSC0003DMC200023368	K06675	ko04111	Cell cycle - yeast	502	4.9e-21	0.60	0.64	0.94
PGSC0003DMC200023369	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMC200023370	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMC200065156	K10884	ko03450	Non-homologous end-joining	446	1.2e-17	0.47	0.66	0.83
PGSC0003DMC200002312	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002312	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002312	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002312	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002312	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002312	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002313	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002314	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMC200002316	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.41	0.58	0.95
PGSC0003DMC200002317	K05280	ko00941	Flavonoid biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMC200002317	K05280	ko00944	Flavone and flavonol biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMC200002317	K05280	ko01100	Metabolic pathways	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMC200002317	K05280	ko01110	Biosynthesis of secondary metabolites	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMC200002319	K03942	ko00190	Oxidative phosphorylation	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMC200002319	K03942	ko01100	Metabolic pathways	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMC200002319	K03942	ko05010	Alzheimer's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMC200002319	K03942	ko05012	Parkinson's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMC200002319	K03942	ko05016	Huntington's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMC200045097	K01046	ko00561	Glycerolipid metabolism	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMC200045097	K01046	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMC200045107	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMC200045107	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMC200045107	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMC200045108	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMC200045108	K00800	ko01100	Metabolic pathways	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMC200045108	K00800	ko01110	Biosynthesis of secondary metabolites	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMC200045109	K01480	ko00330	Arginine and proline metabolism	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMC200045109	K01480	ko01100	Metabolic pathways	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMC200045110	K01480	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMC200045110	K01480	ko01100	Metabolic pathways	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMC200045111	K01480	ko00330	Arginine and proline metabolism	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMC200045111	K01480	ko01100	Metabolic pathways	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMC200045112	K01480	ko00330	Arginine and proline metabolism	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMC200045112	K01480	ko01100	Metabolic pathways	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMC200045113	K01476	ko00330	Arginine and proline metabolism	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMC200045113	K01476	ko01100	Metabolic pathways	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMC200045113	K01476	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMC200045113	K01476	ko05146	Amoebiasis	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMC200045114	K01480	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMC200045114	K01480	ko01100	Metabolic pathways	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMC200039671	K00128	ko00010	Glycolysis / Gluconeogenesis	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00053	Ascorbate and aldarate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00071	Fatty acid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00280	Valine, leucine and isoleucine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00310	Lysine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00330	Arginine and proline metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00340	Histidine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00380	Tryptophan metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00410	beta-Alanine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00561	Glycerolipid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00620	Pyruvate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00631	1,2-Dichloroethane degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00640	Propanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00641	3-Chloroacrylic acid degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00650	Butanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko00903	Limonene and pinene degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko01100	Metabolic pathways	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039671	K00128	ko01110	Biosynthesis of secondary metabolites	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMC200039672	K00128	ko00010	Glycolysis / Gluconeogenesis	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00053	Ascorbate and aldarate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00071	Fatty acid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00280	Valine, leucine and isoleucine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00310	Lysine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00330	Arginine and proline metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00340	Histidine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00380	Tryptophan metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00410	beta-Alanine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00561	Glycerolipid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00620	Pyruvate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00631	1,2-Dichloroethane degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00640	Propanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00641	3-Chloroacrylic acid degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00650	Butanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko00903	Limonene and pinene degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko01100	Metabolic pathways	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039672	K00128	ko01110	Biosynthesis of secondary metabolites	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMC200039673	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039673	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039674	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMC200039675	K00128	ko00010	Glycolysis / Gluconeogenesis	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00053	Ascorbate and aldarate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00071	Fatty acid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00280	Valine, leucine and isoleucine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00310	Lysine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00330	Arginine and proline metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00340	Histidine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00380	Tryptophan metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00410	beta-Alanine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00561	Glycerolipid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00620	Pyruvate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00631	1,2-Dichloroethane degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00640	Propanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00641	3-Chloroacrylic acid degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00650	Butanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko00903	Limonene and pinene degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko01100	Metabolic pathways	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039675	K00128	ko01110	Biosynthesis of secondary metabolites	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMC200039676	K12620	ko03018	RNA degradation	833	4.1e-40	0.84	0.93	0.16
PGSC0003DMC200039683	K12620	ko03018	RNA degradation	983	2.2e-48	0.91	0.96	0.99
PGSC0003DMC200039684	K12620	ko03018	RNA degradation	789	1.1e-37	0.92	0.95	0.94
PGSC0003DMC200052146	K11229	ko04011	MAPK signaling pathway - yeast	298	1.6e-09	0.38	0.55	0.99
PGSC0003DMC200052154	K00283	ko00260	Glycine, serine and threonine metabolism	7770	0.	0.86	0.92	1.00
PGSC0003DMC200052154	K00283	ko01100	Metabolic pathways	7770	0.	0.86	0.92	1.00
PGSC0003DMC200052155	K04424	ko04010	MAPK signaling pathway	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMC200052155	K04424	ko04530	Tight junction	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMC200052156	K04424	ko04010	MAPK signaling pathway	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMC200052156	K04424	ko04530	Tight junction	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMC200052157	K04424	ko04010	MAPK signaling pathway	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMC200052157	K04424	ko04530	Tight junction	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMC200052158	K04424	ko04010	MAPK signaling pathway	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMC200052158	K04424	ko04530	Tight junction	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMC200052167	K06268	ko04010	MAPK signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04020	Calcium signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04114	Oocyte meiosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04210	Apoptosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04310	Wnt signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04360	Axon guidance	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04370	VEGF signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04650	Natural killer cell mediated cytotoxicity	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04660	T cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04662	B cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko04720	Long-term potentiation	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko05010	Alzheimer's disease	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052167	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMC200052168	K06268	ko04010	MAPK signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04020	Calcium signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04114	Oocyte meiosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04210	Apoptosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04310	Wnt signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04360	Axon guidance	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04370	VEGF signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04650	Natural killer cell mediated cytotoxicity	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04660	T cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04662	B cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko04720	Long-term potentiation	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko05010	Alzheimer's disease	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052168	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMC200052169	K06268	ko04010	MAPK signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04020	Calcium signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04114	Oocyte meiosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04210	Apoptosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04310	Wnt signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04360	Axon guidance	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04370	VEGF signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04650	Natural killer cell mediated cytotoxicity	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04660	T cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04662	B cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko04720	Long-term potentiation	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko05010	Alzheimer's disease	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052169	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMC200052170	K06268	ko04010	MAPK signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04020	Calcium signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04114	Oocyte meiosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04210	Apoptosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04310	Wnt signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04360	Axon guidance	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04370	VEGF signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04650	Natural killer cell mediated cytotoxicity	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04660	T cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04662	B cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko04720	Long-term potentiation	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko05010	Alzheimer's disease	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200052170	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMC200006278	K02732	ko03050	Proteasome	1781	2.1e-92	0.93	0.97	1.00
PGSC0003DMC200006285	K04371	ko04010	MAPK signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04012	ErbB signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04013	MAPK signaling pathway - fly	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04062	Chemokine signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04114	Oocyte meiosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04150	mTOR signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04270	Vascular smooth muscle contraction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04320	Dorso-ventral axis formation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04350	TGF-beta signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04360	Axon guidance	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04370	VEGF signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04510	Focal adhesion	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04520	Adherens junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04540	Gap junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04620	Toll-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04621	NOD-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04650	Natural killer cell mediated cytotoxicity	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04660	T cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04662	B cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04664	Fc epsilon RI signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04666	Fc gamma R-mediated phagocytosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04720	Long-term potentiation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04722	Neurotrophin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04730	Long-term depression	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04810	Regulation of actin cytoskeleton	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04910	Insulin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04912	GnRH signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04914	Progesterone-mediated oocyte maturation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04916	Melanogenesis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04930	Type II diabetes mellitus	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko04960	Aldosterone-regulated sodium reabsorption	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05010	Alzheimer's disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05020	Prion diseases	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05131	Shigellosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05140	Leishmaniasis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05142	Chagas disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05200	Pathways in cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05210	Colorectal cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05211	Renal cell carcinoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05212	Pancreatic cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05213	Endometrial cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05214	Glioma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05215	Prostate cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05216	Thyroid cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05218	Melanoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05219	Bladder cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05220	Chronic myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05221	Acute myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006285	K04371	ko05223	Non-small cell lung cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMC200006294	K00430	ko00360	Phenylalanine metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMC200006294	K00430	ko00680	Methane metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMC200006294	K00430	ko00940	Phenylpropanoid biosynthesis	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMC200006294	K00430	ko01100	Metabolic pathways	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMC200006294	K00430	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMC200006295	K00430	ko00360	Phenylalanine metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMC200006295	K00430	ko00680	Methane metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMC200006295	K00430	ko00940	Phenylpropanoid biosynthesis	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMC200006295	K00430	ko01100	Metabolic pathways	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMC200006295	K00430	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMC200006296	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMC200006296	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMC200006296	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMC200006296	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMC200006296	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMC200006297	K00430	ko00360	Phenylalanine metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMC200006297	K00430	ko00680	Methane metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMC200006297	K00430	ko00940	Phenylpropanoid biosynthesis	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMC200006297	K00430	ko01100	Metabolic pathways	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMC200006297	K00430	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMC200006298	K00430	ko00360	Phenylalanine metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMC200006298	K00430	ko00680	Methane metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMC200006298	K00430	ko00940	Phenylpropanoid biosynthesis	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMC200006298	K00430	ko01100	Metabolic pathways	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMC200006298	K00430	ko01110	Biosynthesis of secondary metabolites	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMC200006299	K00430	ko00360	Phenylalanine metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMC200006299	K00430	ko00680	Methane metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMC200006299	K00430	ko00940	Phenylpropanoid biosynthesis	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMC200006299	K00430	ko01100	Metabolic pathways	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMC200006299	K00430	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMC200006300	K00430	ko00360	Phenylalanine metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMC200006300	K00430	ko00680	Methane metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMC200006300	K00430	ko00940	Phenylpropanoid biosynthesis	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMC200006300	K00430	ko01100	Metabolic pathways	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMC200006300	K00430	ko01110	Biosynthesis of secondary metabolites	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMC200013093	K01528	ko04144	Endocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMC200013093	K01528	ko04666	Fc gamma R-mediated phagocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMC200013093	K01528	ko05100	Bacterial invasion of epithelial cells	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMC200013095	K05658	ko02010	ABC transporters	5892	0.	0.50	0.70	0.92
PGSC0003DMC200013096	K13065	ko00940	Phenylpropanoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMC200013096	K13065	ko00941	Flavonoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMC200013096	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMC200013096	K13065	ko01110	Biosynthesis of secondary metabolites	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMC200013102	K10798	ko03410	Base excision repair	1485	4.5e-76	0.32	0.52	0.97
PGSC0003DMC200013103	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMC200013104	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMC200013105	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMC200013106	K12196	ko04144	Endocytosis	3374	2.9e-180	0.91	0.96	1.00
PGSC0003DMC200013107	K12196	ko04144	Endocytosis	544	3.6e-24	1.00	1.00	0.59
PGSC0003DMC200013108	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMC200013109	K12196	ko04144	Endocytosis	352	1.4e-13	1.00	1.00	0.73
PGSC0003DMC200013110	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMC200026352	K03046	ko00230	Purine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMC200026352	K03046	ko00240	Pyrimidine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMC200026352	K03046	ko01100	Metabolic pathways	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMC200026352	K03046	ko03020	RNA polymerase	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMC200026360	K10875	ko03440	Homologous recombination	599	2.5e-29	0.29	0.49	0.43
PGSC0003DMC200029701	K04733	ko04210	Apoptosis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMC200029701	K04733	ko04620	Toll-like receptor signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMC200029701	K04733	ko04722	Neurotrophin signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMC200029701	K04733	ko05140	Leishmaniasis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMC200029701	K04733	ko05142	Chagas disease	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMC200029702	K04733	ko04210	Apoptosis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMC200029702	K04733	ko04620	Toll-like receptor signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMC200029702	K04733	ko04722	Neurotrophin signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMC200029702	K04733	ko05140	Leishmaniasis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMC200029702	K04733	ko05142	Chagas disease	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMC200029703	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029703	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029703	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029703	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029703	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029704	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029704	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029704	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029704	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029704	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMC200029705	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029705	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029705	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029705	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029705	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029706	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029706	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029706	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029706	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029706	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029707	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029707	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029707	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029707	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029707	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMC200029717	K00697	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.63	0.73	0.93
PGSC0003DMC200029718	K00697	ko00500	Starch and sucrose metabolism	4638	5.6e-250	0.65	0.76	0.98
PGSC0003DMC200029719	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMC200029720	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMC200029721	K00697	ko00500	Starch and sucrose metabolism	3181	1.3e-169	0.74	0.86	0.99
PGSC0003DMC200029726	K00128	ko00010	Glycolysis / Gluconeogenesis	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00053	Ascorbate and aldarate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00071	Fatty acid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00280	Valine, leucine and isoleucine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00310	Lysine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00330	Arginine and proline metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00340	Histidine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00380	Tryptophan metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00410	beta-Alanine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00561	Glycerolipid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00620	Pyruvate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00631	1,2-Dichloroethane degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00640	Propanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00641	3-Chloroacrylic acid degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00650	Butanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko00903	Limonene and pinene degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko01100	Metabolic pathways	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200029726	K00128	ko01110	Biosynthesis of secondary metabolites	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMC200035521	K02261	ko00190	Oxidative phosphorylation	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035521	K02261	ko01100	Metabolic pathways	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035521	K02261	ko04260	Cardiac muscle contraction	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035521	K02261	ko05010	Alzheimer's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035521	K02261	ko05012	Parkinson's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035521	K02261	ko05016	Huntington's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMC200035523	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMC200035523	K00517	ko00626	Naphthalene and anthracene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMC200035523	K00517	ko00903	Limonene and pinene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMC200035523	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMC200035523	K00517	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMC200035524	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMC200035524	K00517	ko00626	Naphthalene and anthracene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMC200035524	K00517	ko00903	Limonene and pinene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMC200035524	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMC200035524	K00517	ko01110	Biosynthesis of secondary metabolites	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMC200035525	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMC200035525	K00517	ko00626	Naphthalene and anthracene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMC200035525	K00517	ko00903	Limonene and pinene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMC200035525	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMC200035525	K00517	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMC200035526	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMC200035526	K00517	ko00626	Naphthalene and anthracene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMC200035526	K00517	ko00903	Limonene and pinene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMC200035526	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMC200035526	K00517	ko01110	Biosynthesis of secondary metabolites	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMC200035527	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMC200035527	K00517	ko00626	Naphthalene and anthracene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMC200035527	K00517	ko00903	Limonene and pinene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMC200035527	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMC200035527	K00517	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMC200035528	K11229	ko04011	MAPK signaling pathway - yeast	547	2.0e-23	0.34	0.51	0.88
PGSC0003DMC200035532	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMC200035532	K00224	ko00364	Fluorobenzoate degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMC200035532	K00224	ko00628	Fluorene degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMC200035532	K00224	ko00640	Propanoate metabolism	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMC200035533	K04420	ko04010	MAPK signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMC200035533	K04420	ko04540	Gap junction	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMC200035533	K04420	ko04912	GnRH signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMC200035535	K06228	ko04340	Hedgehog signaling pathway	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMC200035535	K06228	ko05200	Pathways in cancer	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMC200035535	K06228	ko05217	Basal cell carcinoma	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMC200055142	K03006	ko00230	Purine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMC200055142	K03006	ko00240	Pyrimidine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMC200055142	K03006	ko01100	Metabolic pathways	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMC200055142	K03006	ko03020	RNA polymerase	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMC200055142	K03006	ko05016	Huntington's disease	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMC200055143	K03006	ko00230	Purine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMC200055143	K03006	ko00240	Pyrimidine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMC200055143	K03006	ko01100	Metabolic pathways	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMC200055143	K03006	ko03020	RNA polymerase	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMC200055143	K03006	ko05016	Huntington's disease	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMC200055144	K05863	ko04020	Calcium signaling pathway	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMC200055144	K05863	ko05012	Parkinson's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMC200055144	K05863	ko05016	Huntington's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMC200055147	K08332	ko04140	Regulation of autophagy	388	1.7e-13	0.33	0.52	0.38
PGSC0003DMC200055148	K08332	ko04140	Regulation of autophagy	388	3.0e-13	0.33	0.52	0.32
PGSC0003DMC200055156	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055156	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055157	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055158	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200055159	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMC200037484	K12471	ko04144	Endocytosis	751	1.4e-35	0.32	0.45	0.71
PGSC0003DMC200037486	K01046	ko00561	Glycerolipid metabolism	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMC200037486	K01046	ko01100	Metabolic pathways	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMC200037488	K02153	ko00190	Oxidative phosphorylation	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200037488	K02153	ko01100	Metabolic pathways	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200037488	K02153	ko04145	Phagosome	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200037488	K02153	ko04966	Collecting duct acid secretion	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200037488	K02153	ko05110	Vibrio cholerae infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200037488	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMC200044282	K12356	ko00940	Phenylpropanoid biosynthesis	541	5.3e-24	0.47	0.59	0.39
PGSC0003DMC200044284	K00480	ko00624	1- and 2-Methylnaphthalene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMC200044284	K00480	ko00626	Naphthalene and anthracene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMC200044284	K00480	ko00628	Fluorene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMC200044284	K00480	ko01100	Metabolic pathways	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMC200044285	K00480	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMC200044285	K00480	ko00626	Naphthalene and anthracene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMC200044285	K00480	ko00628	Fluorene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMC200044285	K00480	ko01100	Metabolic pathways	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMC200044291	K11866	ko04144	Endocytosis	364	2.0e-13	0.34	0.53	0.83
PGSC0003DMC200044293	K11866	ko04144	Endocytosis	631	1.5e-28	0.31	0.49	0.93
PGSC0003DMC200044295	K12868	ko03040	Spliceosome	522	5.9e-23	0.95	0.97	0.98
PGSC0003DMC200044296	K03661	ko00190	Oxidative phosphorylation	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044296	K03661	ko01100	Metabolic pathways	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044296	K03661	ko04142	Lysosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044296	K03661	ko04145	Phagosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044296	K03661	ko05110	Vibrio cholerae infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044296	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMC200044310	K11097	ko03040	Spliceosome	684	6.8e-32	0.94	0.95	0.99
PGSC0003DMC200061210	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMC200061210	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMC200061210	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMC200061210	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMC200061210	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMC200005521	K12121	ko04712	Circadian rhythm - plant	483	4.7e-20	0.48	0.72	0.72
PGSC0003DMC200005528	K11247	ko04144	Endocytosis	1440	1.4e-73	0.52	0.68	0.99
PGSC0003DMC200005529	K11247	ko04144	Endocytosis	706	4.2e-33	0.55	0.72	0.90
PGSC0003DMC200005530	K05658	ko02010	ABC transporters	440	1.5e-17	0.88	0.95	0.92
PGSC0003DMC200005531	K05658	ko02010	ABC transporters	8020	0.	0.77	0.90	0.99
PGSC0003DMC200005532	K05278	ko00941	Flavonoid biosynthesis	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMC200005532	K05278	ko01100	Metabolic pathways	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMC200005532	K05278	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMC200005533	K05278	ko00941	Flavonoid biosynthesis	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMC200005533	K05278	ko01100	Metabolic pathways	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMC200005533	K05278	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMC200005534	K05277	ko00941	Flavonoid biosynthesis	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMC200005534	K05277	ko01100	Metabolic pathways	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMC200005534	K05277	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMC200005535	K05277	ko00941	Flavonoid biosynthesis	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMC200005535	K05277	ko01100	Metabolic pathways	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMC200005535	K05277	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMC200005544	K12130	ko04712	Circadian rhythm - plant	315	2.0e-11	0.35	0.58	0.91
PGSC0003DMC200014289	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMC200014289	K01904	ko00360	Phenylalanine metabolism	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMC200014289	K01904	ko00940	Phenylpropanoid biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMC200014289	K01904	ko01100	Metabolic pathways	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMC200014289	K01904	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMC200014290	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMC200014290	K01904	ko00360	Phenylalanine metabolism	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMC200014290	K01904	ko00940	Phenylpropanoid biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMC200014290	K01904	ko01100	Metabolic pathways	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMC200014290	K01904	ko01110	Biosynthesis of secondary metabolites	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMC200014297	K13230	ko00402	Benzoxazinoid biosynthesis	878	1.4e-42	0.36	0.53	0.99
PGSC0003DMC200014300	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMC200014300	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMC200014300	K00771	ko01100	Metabolic pathways	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMC200014301	K00225	ko00053	Ascorbate and aldarate metabolism	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMC200014301	K00225	ko01100	Metabolic pathways	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMC200014301	K00225	ko01110	Biosynthesis of secondary metabolites	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMC200014302	K00273	ko00260	Glycine, serine and threonine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014302	K00273	ko00311	Penicillin and cephalosporin biosynthesis	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014302	K00273	ko00330	Arginine and proline metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014302	K00273	ko00472	D-Arginine and D-ornithine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014302	K00273	ko01100	Metabolic pathways	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014302	K00273	ko04146	Peroxisome	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMC200014303	K00273	ko00260	Glycine, serine and threonine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014303	K00273	ko00311	Penicillin and cephalosporin biosynthesis	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014303	K00273	ko00330	Arginine and proline metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014303	K00273	ko00472	D-Arginine and D-ornithine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014303	K00273	ko01100	Metabolic pathways	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014303	K00273	ko04146	Peroxisome	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMC200014304	K00273	ko00260	Glycine, serine and threonine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014304	K00273	ko00311	Penicillin and cephalosporin biosynthesis	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014304	K00273	ko00330	Arginine and proline metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014304	K00273	ko00472	D-Arginine and D-ornithine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014304	K00273	ko01100	Metabolic pathways	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014304	K00273	ko04146	Peroxisome	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMC200014305	K05768	ko04666	Fc gamma R-mediated phagocytosis	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMC200014305	K05768	ko04810	Regulation of actin cytoskeleton	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMC200014306	K03124	ko03022	Basal transcription factors	2039	1.3e-106	0.77	0.88	0.99
PGSC0003DMC200014307	K03124	ko03022	Basal transcription factors	2028	5.1e-106	0.76	0.88	0.99
PGSC0003DMC200014308	K03124	ko03022	Basal transcription factors	1092	2.1e-54	0.76	0.87	0.93
PGSC0003DMC200014309	K03124	ko03022	Basal transcription factors	877	1.5e-42	0.85	0.93	0.87
PGSC0003DMC200014310	K03124	ko03022	Basal transcription factors	1296	1.2e-65	0.89	0.93	0.98
PGSC0003DMC200007474	K07203	ko04012	ErbB signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko04150	mTOR signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko04910	Insulin signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko04920	Adipocytokine signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko04930	Type II diabetes mellitus	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko05200	Pathways in cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko05214	Glioma	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko05215	Prostate cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007474	K07203	ko05221	Acute myeloid leukemia	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMC200007475	K07203	ko04012	ErbB signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko04150	mTOR signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko04910	Insulin signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko04920	Adipocytokine signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko04930	Type II diabetes mellitus	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko05200	Pathways in cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko05214	Glioma	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko05215	Prostate cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007475	K07203	ko05221	Acute myeloid leukemia	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMC200007482	K01681	ko00020	Citrate cycle (TCA cycle)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMC200007482	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMC200007482	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMC200007482	K01681	ko01100	Metabolic pathways	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMC200007482	K01681	ko01110	Biosynthesis of secondary metabolites	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMC200007498	K02901	ko03010	Ribosome	640	1.8e-29	0.75	0.84	0.48
PGSC0003DMC200007499	K02901	ko03010	Ribosome	359	5.8e-14	0.81	0.87	0.98
PGSC0003DMC200025141	K00215	ko00300	Lysine biosynthesis	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMC200025141	K00215	ko01100	Metabolic pathways	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMC200025141	K00215	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMC200025142	K00215	ko00300	Lysine biosynthesis	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMC200025142	K00215	ko01100	Metabolic pathways	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMC200025142	K00215	ko01110	Biosynthesis of secondary metabolites	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMC200025145	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMC200025145	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMC200025145	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMC200025145	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMC200025145	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMC200025146	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMC200025146	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMC200025146	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMC200025146	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMC200025146	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMC200025147	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMC200025147	K00517	ko00626	Naphthalene and anthracene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMC200025147	K00517	ko00903	Limonene and pinene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMC200025147	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMC200025147	K00517	ko01110	Biosynthesis of secondary metabolites	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMC200025148	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMC200025148	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMC200025148	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMC200025148	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMC200025148	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMC200025149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMC200025149	K00517	ko00626	Naphthalene and anthracene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMC200025149	K00517	ko00903	Limonene and pinene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMC200025149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMC200025149	K00517	ko01110	Biosynthesis of secondary metabolites	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMC200025150	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMC200025150	K00517	ko00626	Naphthalene and anthracene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMC200025150	K00517	ko00903	Limonene and pinene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMC200025150	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMC200025150	K00517	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMC200025151	K13083	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMC200025151	K13083	ko00944	Flavone and flavonol biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMC200025151	K13083	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMC200025152	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMC200025152	K00517	ko00626	Naphthalene and anthracene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMC200025152	K00517	ko00903	Limonene and pinene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMC200025152	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMC200025152	K00517	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMC200025153	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMC200025153	K00517	ko00626	Naphthalene and anthracene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMC200025153	K00517	ko00903	Limonene and pinene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMC200025153	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMC200025153	K00517	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMC200025154	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMC200025154	K00517	ko00626	Naphthalene and anthracene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMC200025154	K00517	ko00903	Limonene and pinene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMC200025154	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMC200025154	K00517	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMC200056346	K08488	ko04130	SNARE interactions in vesicular transport	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMC200056346	K08488	ko04145	Phagosome	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMC200056362	K00763	ko00760	Nicotinate and nicotinamide metabolism	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMC200056362	K00763	ko01100	Metabolic pathways	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMC200056363	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMC200056364	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMC200056365	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMC200056368	K12655	ko04622	RIG-I-like receptor signaling pathway	312	3.7e-11	0.31	0.49	0.72
PGSC0003DMC200056370	K12655	ko04622	RIG-I-like receptor signaling pathway	320	1.2e-11	0.26	0.47	0.81
PGSC0003DMC200043087	K03875	ko04110	Cell cycle	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMC200043087	K03875	ko04120	Ubiquitin mediated proteolysis	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMC200043087	K03875	ko05200	Pathways in cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMC200043087	K03875	ko05222	Small cell lung cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMC200043088	K03875	ko04110	Cell cycle	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMC200043088	K03875	ko04120	Ubiquitin mediated proteolysis	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMC200043088	K03875	ko05200	Pathways in cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMC200043088	K03875	ko05222	Small cell lung cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMC200043092	K00166	ko00280	Valine, leucine and isoleucine degradation	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMC200043092	K00166	ko01100	Metabolic pathways	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMC200043092	K00166	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMC200043096	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMC200043096	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMC200043096	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMC200043096	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMC200043096	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMC200043101	K00059	ko00061	Fatty acid biosynthesis	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMC200043101	K00059	ko01040	Biosynthesis of unsaturated fatty acids	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMC200043101	K00059	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMC200036273	K05692	ko04145	Phagosome	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04510	Focal adhesion	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04520	Adherens junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04530	Tight junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04670	Leukocyte transendothelial migration	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04745	Phototransduction - fly	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05110	Vibrio cholerae infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05131	Shigellosis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05414	Dilated cardiomyopathy	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036273	K05692	ko05416	Viral myocarditis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMC200036276	K05692	ko04145	Phagosome	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04510	Focal adhesion	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04520	Adherens junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04530	Tight junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04670	Leukocyte transendothelial migration	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04745	Phototransduction - fly	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko04810	Regulation of actin cytoskeleton	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05100	Bacterial invasion of epithelial cells	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05110	Vibrio cholerae infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05130	Pathogenic Escherichia coli infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05131	Shigellosis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05414	Dilated cardiomyopathy	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036276	K05692	ko05416	Viral myocarditis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMC200036280	K03936	ko00190	Oxidative phosphorylation	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMC200036280	K03936	ko01100	Metabolic pathways	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMC200036280	K03936	ko05010	Alzheimer's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMC200036280	K03936	ko05012	Parkinson's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMC200036280	K03936	ko05016	Huntington's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMC200036281	K03949	ko00190	Oxidative phosphorylation	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMC200036281	K03949	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMC200036281	K03949	ko05010	Alzheimer's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMC200036281	K03949	ko05012	Parkinson's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMC200036281	K03949	ko05016	Huntington's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMC200036282	K12795	ko04621	NOD-like receptor signaling pathway	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMC200036282	K12795	ko04626	Plant-pathogen interaction	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMC200036286	K12843	ko03040	Spliceosome	1138	6.2e-57	0.33	0.52	0.92
PGSC0003DMC200036296	K12356	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.31	0.48	0.96
PGSC0003DMC200036297	K12356	ko00940	Phenylpropanoid biosynthesis	581	3.3e-26	0.41	0.58	0.84
PGSC0003DMC200036298	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036298	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036298	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036298	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036298	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036299	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036299	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036299	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036299	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036299	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMC200036300	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMC200036300	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMC200036300	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMC200036300	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMC200036300	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMC200059709	K01674	ko00910	Nitrogen metabolism	1078	1.3e-53	0.57	0.74	0.65
PGSC0003DMC200059714	K10760	ko00908	Zeatin biosynthesis	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMC200059714	K10760	ko01100	Metabolic pathways	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMC200059714	K10760	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMC200059721	K10760	ko00908	Zeatin biosynthesis	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMC200059721	K10760	ko01100	Metabolic pathways	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMC200059721	K10760	ko01110	Biosynthesis of secondary metabolites	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMC200059729	K11816	ko00380	Tryptophan metabolism	1063	8.5e-53	0.42	0.66	0.98
PGSC0003DMC200001122	K00430	ko00360	Phenylalanine metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMC200001122	K00430	ko00680	Methane metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMC200001122	K00430	ko00940	Phenylpropanoid biosynthesis	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMC200001122	K00430	ko01100	Metabolic pathways	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMC200001122	K00430	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMC200001123	K13066	ko00940	Phenylpropanoid biosynthesis	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMC200001123	K13066	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMC200001124	K13066	ko00940	Phenylpropanoid biosynthesis	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMC200001124	K13066	ko01110	Biosynthesis of secondary metabolites	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMC200001128	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMC200001128	K00517	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMC200001128	K00517	ko00903	Limonene and pinene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMC200001128	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMC200001128	K00517	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMC200001129	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMC200001129	K00517	ko00626	Naphthalene and anthracene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMC200001129	K00517	ko00903	Limonene and pinene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMC200001129	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMC200001129	K00517	ko01110	Biosynthesis of secondary metabolites	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMC200001130	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMC200001130	K00517	ko00626	Naphthalene and anthracene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMC200001130	K00517	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMC200001130	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMC200001130	K00517	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMC200001136	K00356	ko00190	Oxidative phosphorylation	1068	4.5e-53	0.75	0.84	0.99
PGSC0003DMC200063958	K08243	ko00941	Flavonoid biosynthesis	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMC200063958	K08243	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMC200009670	K05658	ko02010	ABC transporters	3770	4.2e-202	0.43	0.64	0.99
PGSC0003DMC200009677	K12338	ko00942	Anthocyanin biosynthesis	539	6.8e-24	0.42	0.60	0.95
PGSC0003DMC200009679	K10775	ko00360	Phenylalanine metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMC200009679	K10775	ko00910	Nitrogen metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMC200009679	K10775	ko00940	Phenylpropanoid biosynthesis	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMC200009679	K10775	ko01100	Metabolic pathways	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMC200009679	K10775	ko01110	Biosynthesis of secondary metabolites	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMC200009681	K00103	ko00053	Ascorbate and aldarate metabolism	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMC200009681	K00103	ko01100	Metabolic pathways	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMC200009690	K10527	ko00592	alpha-Linolenic acid metabolism	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMC200009690	K10527	ko01100	Metabolic pathways	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMC200015092	K12185	ko04144	Endocytosis	1210	6.7e-61	0.67	0.81	0.97
PGSC0003DMC200015093	K05279	ko00944	Flavone and flavonol biosynthesis	984	1.9e-48	0.40	0.59	0.97
PGSC0003DMC200015094	K05279	ko00944	Flavone and flavonol biosynthesis	997	3.7e-49	0.41	0.60	0.97
PGSC0003DMC200015095	K05279	ko00944	Flavone and flavonol biosynthesis	1006	1.2e-49	0.42	0.60	0.96
PGSC0003DMC200015096	K05279	ko00944	Flavone and flavonol biosynthesis	240	2.1e-07	0.42	0.57	0.98
PGSC0003DMC200015097	K05279	ko00944	Flavone and flavonol biosynthesis	982	2.5e-48	0.41	0.59	0.96
PGSC0003DMC200015098	K05279	ko00944	Flavone and flavonol biosynthesis	264	1.0e-08	0.42	0.62	0.99
PGSC0003DMC200022158	K01641	ko00072	Synthesis and degradation of ketone bodies	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022158	K01641	ko00280	Valine, leucine and isoleucine degradation	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022158	K01641	ko00650	Butanoate metabolism	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022158	K01641	ko00900	Terpenoid backbone biosynthesis	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022158	K01641	ko01100	Metabolic pathways	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022158	K01641	ko01110	Biosynthesis of secondary metabolites	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMC200022159	K12307	ko04142	Lysosome	406	2.7e-16	0.26	0.46	0.61
PGSC0003DMC200040861	K12850	ko03040	Spliceosome	1538	5.4e-79	0.62	0.79	1.00
PGSC0003DMC200040862	K12850	ko03040	Spliceosome	2600	1.4e-137	0.70	0.84	0.99
PGSC0003DMC200040866	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMC200040866	K01915	ko00330	Arginine and proline metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMC200040866	K01915	ko00910	Nitrogen metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMC200040866	K01915	ko01100	Metabolic pathways	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMC200040866	K01915	ko02020	Two-component system	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMC200040870	K12881	ko03040	Spliceosome	1399	2.5e-71	0.65	0.78	0.99
PGSC0003DMC200040871	K12881	ko03040	Spliceosome	790	9.7e-38	0.65	0.77	0.99
PGSC0003DMC200040872	K03946	ko00190	Oxidative phosphorylation	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMC200040872	K03946	ko01100	Metabolic pathways	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMC200040872	K03946	ko05010	Alzheimer's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMC200040872	K03946	ko05012	Parkinson's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMC200040872	K03946	ko05016	Huntington's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMC200040873	K12478	ko04144	Endocytosis	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMC200040873	K12478	ko04145	Phagosome	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMC200040885	K00850	ko00010	Glycolysis / Gluconeogenesis	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040885	K00850	ko00030	Pentose phosphate pathway	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040885	K00850	ko00051	Fructose and mannose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040885	K00850	ko00052	Galactose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040885	K00850	ko01100	Metabolic pathways	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040885	K00850	ko01110	Biosynthesis of secondary metabolites	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMC200040889	K12818	ko03040	Spliceosome	1674	1.7e-86	0.35	0.56	0.44
PGSC0003DMC200046291	K08059	ko04612	Antigen processing and presentation	361	4.5e-14	0.56	0.74	0.65
PGSC0003DMC200046297	K12657	ko00330	Arginine and proline metabolism	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMC200046297	K12657	ko01100	Metabolic pathways	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMC200046298	K12657	ko00330	Arginine and proline metabolism	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMC200046298	K12657	ko01100	Metabolic pathways	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMC200046299	K12657	ko00330	Arginine and proline metabolism	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMC200046299	K12657	ko01100	Metabolic pathways	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMC200046303	K12486	ko04144	Endocytosis	509	3.1e-22	0.52	0.66	0.32
PGSC0003DMC200046304	K12486	ko04144	Endocytosis	511	2.4e-22	0.32	0.51	0.81
PGSC0003DMC200046319	K04733	ko04210	Apoptosis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMC200046319	K04733	ko04620	Toll-like receptor signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMC200046319	K04733	ko04722	Neurotrophin signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMC200046319	K04733	ko05140	Leishmaniasis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMC200046319	K04733	ko05142	Chagas disease	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMC200046320	K04733	ko04210	Apoptosis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMC200046320	K04733	ko04620	Toll-like receptor signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMC200046320	K04733	ko04722	Neurotrophin signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMC200046320	K04733	ko05140	Leishmaniasis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMC200046320	K04733	ko05142	Chagas disease	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMC200050712	K02706	ko00195	Photosynthesis	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMC200050712	K02706	ko01100	Metabolic pathways	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMC200050719	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050719	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050719	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050720	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050720	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050720	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMC200050725	K02894	ko03010	Ribosome	394	6.8e-16	0.72	0.74	0.95
PGSC0003DMC200050726	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050726	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050726	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050726	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050726	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050727	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050727	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050727	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050727	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050727	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMC200050729	K12356	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.32	0.50	0.98
PGSC0003DMC200050730	K12356	ko00940	Phenylpropanoid biosynthesis	588	1.3e-26	0.38	0.54	0.95
PGSC0003DMC200053341	K07374	ko04145	Phagosome	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMC200053341	K07374	ko04540	Gap junction	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMC200053341	K07374	ko05130	Pathogenic Escherichia coli infection	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMC200053342	K07374	ko04145	Phagosome	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMC200053342	K07374	ko04540	Gap junction	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMC200053342	K07374	ko05130	Pathogenic Escherichia coli infection	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMC200053343	K02266	ko00190	Oxidative phosphorylation	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053343	K02266	ko01100	Metabolic pathways	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053343	K02266	ko04260	Cardiac muscle contraction	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053343	K02266	ko05010	Alzheimer's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053343	K02266	ko05012	Parkinson's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053343	K02266	ko05016	Huntington's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMC200053344	K02266	ko00190	Oxidative phosphorylation	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053344	K02266	ko01100	Metabolic pathways	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053344	K02266	ko04260	Cardiac muscle contraction	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053344	K02266	ko05010	Alzheimer's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053344	K02266	ko05012	Parkinson's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053344	K02266	ko05016	Huntington's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMC200053345	K04487	ko00730	Thiamine metabolism	3187	6.0e-170	0.83	0.91	1.00
PGSC0003DMC200053350	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053350	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053351	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053351	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053353	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053353	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053354	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053354	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053355	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053355	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMC200053362	K10747	ko03030	DNA replication	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMC200053362	K10747	ko03410	Base excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMC200053362	K10747	ko03420	Nucleotide excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMC200053362	K10747	ko03430	Mismatch repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMC200053363	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053363	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053363	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053363	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053364	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053364	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053364	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053364	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053365	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053365	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053365	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053365	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053366	K10747	ko03030	DNA replication	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMC200053366	K10747	ko03410	Base excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMC200053366	K10747	ko03420	Nucleotide excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMC200053366	K10747	ko03430	Mismatch repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMC200053367	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053367	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053367	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053367	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053368	K10747	ko03030	DNA replication	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMC200053368	K10747	ko03410	Base excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMC200053368	K10747	ko03420	Nucleotide excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMC200053368	K10747	ko03430	Mismatch repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMC200053369	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053369	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053369	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053369	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053370	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053370	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053370	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200053370	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMC200041333	K07195	ko04910	Insulin signaling pathway	2729	1.1e-144	0.55	0.73	0.95
PGSC0003DMC200041334	K07195	ko04910	Insulin signaling pathway	2720	3.5e-144	0.55	0.73	0.95
PGSC0003DMC200038672	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMC200038672	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMC200038672	K00734	ko01100	Metabolic pathways	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMC200038685	K01076	ko00632	Benzoate degradation via CoA ligation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMC200038685	K01076	ko00903	Limonene and pinene degradation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMC200038685	K01076	ko01040	Biosynthesis of unsaturated fatty acids	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMC200038687	K10374	ko04260	Cardiac muscle contraction	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMC200038687	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMC200038687	K10374	ko05414	Dilated cardiomyopathy	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMC200038688	K10374	ko04260	Cardiac muscle contraction	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMC200038688	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMC200038688	K10374	ko05414	Dilated cardiomyopathy	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMC200052835	K12827	ko03040	Spliceosome	303	2.5e-10	0.52	0.65	0.47
PGSC0003DMC200052836	K00874	ko00030	Pentose phosphate pathway	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMC200052836	K00874	ko00040	Pentose and glucuronate interconversions	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMC200052836	K00874	ko01100	Metabolic pathways	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMC200052839	K06215	ko00750	Vitamin B6 metabolism	2427	5.0e-128	0.93	0.98	1.00
PGSC0003DMC200052840	K05857	ko00562	Inositol phosphate metabolism	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMC200052840	K05857	ko01100	Metabolic pathways	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMC200052840	K05857	ko04020	Calcium signaling pathway	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMC200052840	K05857	ko04070	Phosphatidylinositol signaling system	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMC200052843	K04124	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMC200052843	K04124	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMC200052851	K12854	ko03040	Spliceosome	16280	0.	0.88	0.95	1.00
PGSC0003DMC200052852	K12854	ko03040	Spliceosome	8666	0.	0.64	0.77	1.00
PGSC0003DMC200052853	K12854	ko03040	Spliceosome	847	8.1e-40	0.67	0.81	0.99
PGSC0003DMC200052856	K04103	ko00380	Tryptophan metabolism	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMC200052856	K04103	ko01100	Metabolic pathways	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMC200052857	K01103	ko00051	Fructose and mannose metabolism	5363	5.8e-290	0.85	0.91	1.00
PGSC0003DMC200052858	K01103	ko00051	Fructose and mannose metabolism	2762	1.7e-146	0.79	0.86	1.00
PGSC0003DMC200052859	K01103	ko00051	Fructose and mannose metabolism	5349	3.4e-289	0.85	0.90	1.00
PGSC0003DMC200034321	K00626	ko00071	Fatty acid metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00072	Synthesis and degradation of ketone bodies	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00280	Valine, leucine and isoleucine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00310	Lysine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00380	Tryptophan metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00620	Pyruvate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00632	Benzoate degradation via CoA ligation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00640	Propanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00650	Butanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko00900	Terpenoid backbone biosynthesis	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko01100	Metabolic pathways	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko01110	Biosynthesis of secondary metabolites	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034321	K00626	ko02020	Two-component system	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMC200034330	K01714	ko00300	Lysine biosynthesis	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMC200034330	K01714	ko01100	Metabolic pathways	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMC200034330	K01714	ko01110	Biosynthesis of secondary metabolites	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMC200034336	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	283	1.2e-19	0.35	0.51	0.74
PGSC0003DMC200034337	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMC200034338	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMC200034339	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMC200034340	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMC200034344	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.68
PGSC0003DMC200034346	K00430	ko00360	Phenylalanine metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMC200034346	K00430	ko00680	Methane metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMC200034346	K00430	ko00940	Phenylpropanoid biosynthesis	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMC200034346	K00430	ko01100	Metabolic pathways	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMC200034346	K00430	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMC200034350	K09755	ko00940	Phenylpropanoid biosynthesis	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMC200034350	K09755	ko01100	Metabolic pathways	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMC200034350	K09755	ko01110	Biosynthesis of secondary metabolites	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMC200010116	K12603	ko03018	RNA degradation	460	1.5e-19	0.30	0.47	0.77
PGSC0003DMC200010118	K12603	ko03018	RNA degradation	405	1.7e-16	0.30	0.48	0.63
PGSC0003DMC200010119	K12603	ko03018	RNA degradation	356	7.7e-15	0.31	0.51	0.65
PGSC0003DMC200010120	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.87
PGSC0003DMC200010121	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.85
PGSC0003DMC200010122	K12603	ko03018	RNA degradation	480	1.2e-20	0.30	0.46	0.72
PGSC0003DMC200010131	K04368	ko04010	MAPK signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04012	ErbB signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04013	MAPK signaling pathway - fly	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04062	Chemokine signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04114	Oocyte meiosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04270	Vascular smooth muscle contraction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04320	Dorso-ventral axis formation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04370	VEGF signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04510	Focal adhesion	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04540	Gap junction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04620	Toll-like receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04626	Plant-pathogen interaction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04650	Natural killer cell mediated cytotoxicity	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04660	T cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04662	B cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04664	Fc epsilon RI signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04666	Fc gamma R-mediated phagocytosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04720	Long-term potentiation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04722	Neurotrophin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04730	Long-term depression	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04810	Regulation of actin cytoskeleton	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04910	Insulin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04912	GnRH signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04914	Progesterone-mediated oocyte maturation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko04916	Melanogenesis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05020	Prion diseases	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05200	Pathways in cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05210	Colorectal cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05211	Renal cell carcinoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05212	Pancreatic cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05213	Endometrial cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05214	Glioma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05215	Prostate cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05216	Thyroid cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05218	Melanoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05219	Bladder cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05220	Chronic myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05221	Acute myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010131	K04368	ko05223	Non-small cell lung cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMC200010139	K03008	ko00230	Purine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMC200010139	K03008	ko00240	Pyrimidine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMC200010139	K03008	ko01100	Metabolic pathways	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMC200010139	K03008	ko03020	RNA polymerase	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMC200010139	K03008	ko05016	Huntington's disease	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMC200028504	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMC200028504	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMC200028504	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMC200028505	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028505	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028505	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028506	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028506	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028506	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMC200028508	K02183	ko04020	Calcium signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04070	Phosphatidylinositol signaling system	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04270	Vascular smooth muscle contraction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04626	Plant-pathogen interaction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04720	Long-term potentiation	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04722	Neurotrophin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04740	Olfactory transduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04744	Phototransduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04745	Phototransduction - fly	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04910	Insulin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04912	GnRH signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04916	Melanogenesis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04970	Salivary secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko04971	Gastric acid secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko05010	Alzheimer's disease	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028508	K02183	ko05214	Glioma	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMC200028509	K02183	ko04020	Calcium signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04070	Phosphatidylinositol signaling system	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04114	Oocyte meiosis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04270	Vascular smooth muscle contraction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04626	Plant-pathogen interaction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04720	Long-term potentiation	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04740	Olfactory transduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04744	Phototransduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04745	Phototransduction - fly	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04910	Insulin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04912	GnRH signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04916	Melanogenesis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04970	Salivary secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko04971	Gastric acid secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko05010	Alzheimer's disease	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028509	K02183	ko05214	Glioma	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMC200028511	K00660	ko00941	Flavonoid biosynthesis	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMC200028511	K00660	ko01100	Metabolic pathways	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMC200028511	K00660	ko01110	Biosynthesis of secondary metabolites	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMC200028511	K00660	ko04712	Circadian rhythm - plant	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMC200028516	K02958	ko03010	Ribosome	685	6.0e-32	0.94	0.99	0.96
PGSC0003DMC200028517	K02958	ko03010	Ribosome	1205	1.3e-60	0.92	0.97	0.99
PGSC0003DMC200028518	K02958	ko03010	Ribosome	521	6.7e-23	0.91	0.96	0.84
PGSC0003DMC200021632	K00001	ko00010	Glycolysis / Gluconeogenesis	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00071	Fatty acid metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00350	Tyrosine metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00641	3-Chloroacrylic acid degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00830	Retinol metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko00982	Drug metabolism - cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko01100	Metabolic pathways	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021632	K00001	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMC200021633	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021633	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021634	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMC200021635	K00001	ko00010	Glycolysis / Gluconeogenesis	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00071	Fatty acid metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00350	Tyrosine metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00641	3-Chloroacrylic acid degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00830	Retinol metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko00982	Drug metabolism - cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko01100	Metabolic pathways	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021635	K00001	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMC200021636	K00001	ko00010	Glycolysis / Gluconeogenesis	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00071	Fatty acid metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00350	Tyrosine metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00641	3-Chloroacrylic acid degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00830	Retinol metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko00982	Drug metabolism - cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko01100	Metabolic pathways	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021636	K00001	ko01110	Biosynthesis of secondary metabolites	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMC200021641	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMC200021641	K01078	ko00740	Riboflavin metabolism	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMC200021646	K01179	ko00500	Starch and sucrose metabolism	2068	3.2e-108	0.52	0.66	0.98
PGSC0003DMC200021647	K01179	ko00500	Starch and sucrose metabolism	2367	1.0e-124	0.58	0.73	0.99
PGSC0003DMC200021650	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMC200021651	K01761	ko00270	Cysteine and methionine metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMC200021651	K01761	ko00450	Selenoamino acid metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMC200003121	K07252	ko00510	N-Glycan biosynthesis	1344	2.7e-68	0.71	0.84	0.97
PGSC0003DMC200003126	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMC200003126	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMC200003127	K02706	ko00195	Photosynthesis	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMC200003127	K02706	ko01100	Metabolic pathways	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMC200003131	K02931	ko03010	Ribosome	1639	1.5e-84	0.74	0.86	1.00
PGSC0003DMC200003147	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMC200003148	K12478	ko04144	Endocytosis	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMC200003148	K12478	ko04145	Phagosome	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMC200063845	K11294	ko05130	Pathogenic Escherichia coli infection	219	3.3e-06	0.40	0.65	0.20
PGSC0003DMC200069402	K03869	ko04120	Ubiquitin mediated proteolysis	466	1.4e-19	0.43	0.62	0.84
PGSC0003DMC200069405	K11251	ko05322	Systemic lupus erythematosus	519	8.6e-23	0.68	0.83	0.72
PGSC0003DMC200000661	K01190	ko00052	Galactose metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMC200000661	K01190	ko00511	Other glycan degradation	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMC200000661	K01190	ko00600	Sphingolipid metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMC200000661	K01190	ko01100	Metabolic pathways	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMC200000662	K01190	ko00052	Galactose metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMC200000662	K01190	ko00511	Other glycan degradation	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMC200000662	K01190	ko00600	Sphingolipid metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMC200000662	K01190	ko01100	Metabolic pathways	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMC200000666	K00677	ko00540	Lipopolysaccharide biosynthesis	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMC200000666	K00677	ko01100	Metabolic pathways	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMC200000667	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMC200000667	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMC200000668	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMC200000668	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMC200000669	K00677	ko00540	Lipopolysaccharide biosynthesis	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMC200000669	K00677	ko01100	Metabolic pathways	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMC200000670	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMC200000670	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMC200000671	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMC200000671	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMC200000673	K05863	ko04020	Calcium signaling pathway	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMC200000673	K05863	ko05012	Parkinson's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMC200000673	K05863	ko05016	Huntington's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMC200000676	K12837	ko03040	Spliceosome	2859	7.5e-152	0.84	0.92	1.00
PGSC0003DMC200000677	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMC200000678	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMC200000679	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMC200000680	K12837	ko03040	Spliceosome	2672	1.5e-141	0.85	0.94	1.00
PGSC0003DMC200000681	K02910	ko03010	Ribosome	960	4.1e-47	0.95	0.98	0.99
PGSC0003DMC200055832	K00117	ko00030	Pentose phosphate pathway	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMC200055832	K00117	ko01100	Metabolic pathways	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMC200055832	K00117	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMC200055833	K00117	ko00030	Pentose phosphate pathway	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMC200055833	K00117	ko01100	Metabolic pathways	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMC200055833	K00117	ko01110	Biosynthesis of secondary metabolites	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMC200055834	K12866	ko03040	Spliceosome	745	3.0e-35	0.31	0.42	0.98
PGSC0003DMC200055840	K01728	ko00040	Pentose and glucuronate interconversions	1872	2.0e-97	0.58	0.72	0.88
PGSC0003DMC200055842	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMC200055842	K00294	ko00330	Arginine and proline metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMC200055842	K00294	ko01100	Metabolic pathways	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMC200055843	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMC200055843	K00294	ko00330	Arginine and proline metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMC200055843	K00294	ko01100	Metabolic pathways	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMC200055846	K05648	ko02010	ABC transporters	1174	8.5e-59	0.32	0.49	0.67
PGSC0003DMC200055847	K05648	ko02010	ABC transporters	1250	4.1e-63	0.32	0.51	0.68
PGSC0003DMC200055850	K02915	ko03010	Ribosome	764	2.6e-36	0.95	0.99	0.85
PGSC0003DMC200055858	K08910	ko00196	Photosynthesis - antenna proteins	1854	2.0e-96	0.85	0.93	0.99
PGSC0003DMC200031056	K13030	ko00460	Cyanoamino acid metabolism	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMC200031056	K13030	ko01110	Biosynthesis of secondary metabolites	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMC200031065	K00558	ko00270	Cysteine and methionine metabolism	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMC200031065	K00558	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMC200031066	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMC200031066	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMC200031067	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMC200031067	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMC200031070	K02933	ko03010	Ribosome	605	1.6e-27	0.84	0.95	0.92
PGSC0003DMC200031073	K00654	ko00600	Sphingolipid metabolism	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMC200031073	K00654	ko01100	Metabolic pathways	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMC200048301	K11821	ko00380	Tryptophan metabolism	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMC200048301	K11821	ko00966	Glucosinolate biosynthesis	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMC200048301	K11821	ko01110	Biosynthesis of secondary metabolites	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMC200048317	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048317	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048318	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048318	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048319	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048319	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMC200048320	K02690	ko00195	Photosynthesis	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMC200048320	K02690	ko01100	Metabolic pathways	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMC200048321	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048321	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048322	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048322	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048323	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048323	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048324	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048324	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMC200048325	K00859	ko00770	Pantothenate and CoA biosynthesis	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMC200048325	K00859	ko01100	Metabolic pathways	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMC200048326	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMC200048326	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMC200048326	K00734	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMC200024635	K05741	ko04810	Regulation of actin cytoskeleton	681	7.9e-30	0.29	0.44	0.54
PGSC0003DMC200024656	K01047	ko00564	Glycerophospholipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko00565	Ether lipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko00590	Arachidonic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko00591	Linoleic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko00592	alpha-Linolenic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko01100	Metabolic pathways	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04010	MAPK signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04370	VEGF signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04664	Fc epsilon RI signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04730	Long-term depression	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024656	K01047	ko04912	GnRH signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMC200024657	K01047	ko00564	Glycerophospholipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko00565	Ether lipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko00590	Arachidonic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko00591	Linoleic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko00592	alpha-Linolenic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko01100	Metabolic pathways	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04010	MAPK signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04270	Vascular smooth muscle contraction	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04370	VEGF signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04664	Fc epsilon RI signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04730	Long-term depression	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200024657	K01047	ko04912	GnRH signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMC200019501	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMC200019502	K02896	ko03010	Ribosome	1268	4.2e-64	0.91	0.95	0.99
PGSC0003DMC200019503	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMC200019503	K00517	ko00626	Naphthalene and anthracene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMC200019503	K00517	ko00903	Limonene and pinene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMC200019503	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMC200019503	K00517	ko01110	Biosynthesis of secondary metabolites	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMC200019504	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMC200019504	K00517	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMC200019504	K00517	ko00903	Limonene and pinene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMC200019504	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMC200019504	K00517	ko01110	Biosynthesis of secondary metabolites	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMC200019506	K01689	ko00010	Glycolysis / Gluconeogenesis	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMC200019506	K01689	ko01100	Metabolic pathways	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMC200019506	K01689	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMC200019506	K01689	ko03018	RNA degradation	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMC200019507	K01689	ko00010	Glycolysis / Gluconeogenesis	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMC200019507	K01689	ko01100	Metabolic pathways	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMC200019507	K01689	ko01110	Biosynthesis of secondary metabolites	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMC200019507	K01689	ko03018	RNA degradation	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMC200019515	K02930	ko03010	Ribosome	2846	3.9e-151	0.85	0.93	1.00
PGSC0003DMC200019518	K12134	ko04712	Circadian rhythm - plant	493	2.3e-21	0.35	0.51	0.88
PGSC0003DMC200019519	K12134	ko04712	Circadian rhythm - plant	293	6.2e-10	0.56	0.74	0.95
PGSC0003DMC200019521	K00799	ko00480	Glutathione metabolism	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMC200019521	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMC200019521	K00799	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMC200017506	K12666	ko00510	N-Glycan biosynthesis	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMC200017506	K12666	ko01100	Metabolic pathways	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMC200017515	K00100	ko00051	Fructose and mannose metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017515	K00100	ko00363	Bisphenol A degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017515	K00100	ko00591	Linoleic acid metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017515	K00100	ko00625	Tetrachloroethene degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017515	K00100	ko00650	Butanoate metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017515	K00100	ko01100	Metabolic pathways	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMC200017516	K00021	ko00900	Terpenoid backbone biosynthesis	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMC200017516	K00021	ko01100	Metabolic pathways	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMC200017516	K00021	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMC200067996	K01509	ko00230	Purine metabolism	276	1.1e-08	0.40	0.62	0.87
PGSC0003DMC200067999	K03469	ko03030	DNA replication	219	6.6e-06	0.31	0.48	0.26
PGSC0003DMC200054631	K10775	ko00360	Phenylalanine metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMC200054631	K10775	ko00910	Nitrogen metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMC200054631	K10775	ko00940	Phenylpropanoid biosynthesis	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMC200054631	K10775	ko01100	Metabolic pathways	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMC200054631	K10775	ko01110	Biosynthesis of secondary metabolites	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMC200054634	K00162	ko00010	Glycolysis / Gluconeogenesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko00020	Citrate cycle (TCA cycle)	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko00620	Pyruvate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko00650	Butanoate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko01100	Metabolic pathways	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054634	K00162	ko01110	Biosynthesis of secondary metabolites	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMC200054635	K00162	ko00010	Glycolysis / Gluconeogenesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko00020	Citrate cycle (TCA cycle)	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko00620	Pyruvate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko00650	Butanoate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko01100	Metabolic pathways	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054635	K00162	ko01110	Biosynthesis of secondary metabolites	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMC200054637	K04498	ko04110	Cell cycle	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04310	Wnt signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04330	Notch signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04350	TGF-beta signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04520	Adherens junction	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04630	Jak-STAT signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04720	Long-term potentiation	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko04916	Melanogenesis	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko05016	Huntington's disease	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko05200	Pathways in cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko05211	Renal cell carcinoma	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054637	K04498	ko05215	Prostate cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMC200054638	K04498	ko04110	Cell cycle	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04310	Wnt signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04330	Notch signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04350	TGF-beta signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04520	Adherens junction	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04630	Jak-STAT signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04720	Long-term potentiation	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko04916	Melanogenesis	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko05016	Huntington's disease	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko05200	Pathways in cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko05211	Renal cell carcinoma	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054638	K04498	ko05215	Prostate cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMC200054639	K04498	ko04110	Cell cycle	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04310	Wnt signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04330	Notch signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04350	TGF-beta signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04520	Adherens junction	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04630	Jak-STAT signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04720	Long-term potentiation	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko04916	Melanogenesis	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko05016	Huntington's disease	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko05200	Pathways in cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko05211	Renal cell carcinoma	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054639	K04498	ko05215	Prostate cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04110	Cell cycle	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04310	Wnt signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04330	Notch signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04350	TGF-beta signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04520	Adherens junction	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04630	Jak-STAT signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04720	Long-term potentiation	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko04916	Melanogenesis	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko05016	Huntington's disease	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko05200	Pathways in cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko05211	Renal cell carcinoma	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054640	K04498	ko05215	Prostate cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMC200054653	K09489	ko04612	Antigen processing and presentation	5215	8.4e-282	0.72	0.83	1.00
PGSC0003DMC200054654	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.74	0.85	1.00
PGSC0003DMC200054655	K09489	ko04612	Antigen processing and presentation	5268	1.0e-284	0.73	0.85	1.00
PGSC0003DMC200054656	K09489	ko04612	Antigen processing and presentation	5326	6.4e-288	0.74	0.85	1.00
PGSC0003DMC200054657	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.73	0.85	1.00
PGSC0003DMC200054658	K09489	ko04612	Antigen processing and presentation	5316	2.3e-287	0.74	0.85	1.00
PGSC0003DMC200054659	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMC200054660	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMC200049504	K04733	ko04210	Apoptosis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMC200049504	K04733	ko04620	Toll-like receptor signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMC200049504	K04733	ko04722	Neurotrophin signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMC200049504	K04733	ko05140	Leishmaniasis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMC200049504	K04733	ko05142	Chagas disease	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMC200049506	K04733	ko04210	Apoptosis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMC200049506	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMC200049506	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMC200049506	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMC200049506	K04733	ko05142	Chagas disease	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMC200049513	K00558	ko00270	Cysteine and methionine metabolism	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMC200049513	K00558	ko01100	Metabolic pathways	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMC200049516	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049516	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049516	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049516	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049516	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049517	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049517	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049517	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049517	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049517	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049520	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049520	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049520	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049520	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049520	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049523	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049523	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049523	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049523	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049523	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMC200049530	K04733	ko04210	Apoptosis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMC200049530	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMC200049530	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMC200049530	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMC200049530	K04733	ko05142	Chagas disease	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMC200032251	K01057	ko00030	Pentose phosphate pathway	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMC200032251	K01057	ko01100	Metabolic pathways	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMC200032251	K01057	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMC200032255	K01509	ko00230	Purine metabolism	740	5.6e-35	0.48	0.63	0.91
PGSC0003DMC200032256	K01509	ko00230	Purine metabolism	1083	6.7e-54	0.47	0.64	0.90
PGSC0003DMC200032257	K01509	ko00230	Purine metabolism	1097	1.1e-54	0.47	0.62	0.85
PGSC0003DMC200032258	K01509	ko00230	Purine metabolism	1055	2.4e-52	0.51	0.67	0.81
PGSC0003DMC200032279	K01199	ko00500	Starch and sucrose metabolism	747	2.3e-35	0.36	0.55	0.86
PGSC0003DMC200047492	K03707	ko00730	Thiamine metabolism	263	1.1e-08	0.28	0.47	0.91
PGSC0003DMC200047495	K02180	ko04110	Cell cycle	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMC200047495	K02180	ko04111	Cell cycle - yeast	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMC200047502	K01112	ko00051	Fructose and mannose metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMC200047502	K01112	ko00730	Thiamine metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMC200047502	K01112	ko00740	Riboflavin metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMC200047502	K01112	ko01100	Metabolic pathways	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMC200047503	K00873	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko00230	Purine metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko00620	Pyruvate metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko00710	Carbon fixation in photosynthetic organisms	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko01100	Metabolic pathways	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047503	K00873	ko04930	Type II diabetes mellitus	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMC200047515	K12662	ko03040	Spliceosome	296	2.3e-10	0.31	0.48	0.59
PGSC0003DMC200047516	K06685	ko04111	Cell cycle - yeast	404	4.4e-13	0.25	0.44	0.92
PGSC0003DMC200047519	K07199	ko04910	Insulin signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMC200047519	K07199	ko04920	Adipocytokine signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMC200047519	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMC200066797	K10760	ko00908	Zeatin biosynthesis	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMC200066797	K10760	ko01100	Metabolic pathways	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMC200066797	K10760	ko01110	Biosynthesis of secondary metabolites	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMC200066803	K01528	ko04144	Endocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMC200066803	K01528	ko04666	Fc gamma R-mediated phagocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMC200066803	K01528	ko05100	Bacterial invasion of epithelial cells	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMC200025831	K01885	ko00860	Porphyrin and chlorophyll metabolism	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMC200025831	K01885	ko00970	Aminoacyl-tRNA biosynthesis	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMC200025831	K01885	ko01100	Metabolic pathways	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMC200025831	K01885	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMC200025848	K00799	ko00480	Glutathione metabolism	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMC200025848	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMC200025848	K00799	ko00982	Drug metabolism - cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMC200025849	K00799	ko00480	Glutathione metabolism	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMC200025849	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMC200025849	K00799	ko00982	Drug metabolism - cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMC200025850	K00485	ko00982	Drug metabolism - cytochrome P450	644	1.1e-29	0.31	0.47	0.93
PGSC0003DMC200025851	K00485	ko00982	Drug metabolism - cytochrome P450	687	4.7e-32	0.31	0.47	0.97
PGSC0003DMC200025858	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.66
PGSC0003DMC200025859	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.67
PGSC0003DMC200018301	K10745	ko03030	DNA replication	676	1.9e-31	0.47	0.60	0.36
PGSC0003DMC200018304	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMC200018305	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMC200018307	K01363	ko04142	Lysosome	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMC200018307	K01363	ko04612	Antigen processing and presentation	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMC200018308	K01363	ko04142	Lysosome	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMC200018308	K01363	ko04612	Antigen processing and presentation	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMC200018326	K08139	ko04113	Meiosis - yeast	1002	2.0e-49	0.35	0.52	0.82
PGSC0003DMC200018329	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMC200058503	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMC200058503	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMC200058503	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMC200040123	K01738	ko00270	Cysteine and methionine metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMC200040123	K01738	ko00450	Selenoamino acid metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMC200040123	K01738	ko00920	Sulfur metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMC200040123	K01738	ko01100	Metabolic pathways	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMC200040125	K00276	ko00260	Glycine, serine and threonine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko00350	Tyrosine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko00360	Phenylalanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko00410	beta-Alanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko01100	Metabolic pathways	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040125	K00276	ko01110	Biosynthesis of secondary metabolites	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMC200040134	K12662	ko03040	Spliceosome	288	3.2e-08	0.28	0.45	0.63
PGSC0003DMC200040135	K01046	ko00561	Glycerolipid metabolism	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMC200040135	K01046	ko01100	Metabolic pathways	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMC200040137	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.41	0.57	0.89
PGSC0003DMC200040138	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.42	0.57	0.95
PGSC0003DMC200040140	K13030	ko00460	Cyanoamino acid metabolism	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMC200040140	K13030	ko01110	Biosynthesis of secondary metabolites	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMC200033134	K00696	ko00500	Starch and sucrose metabolism	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMC200033134	K00696	ko01100	Metabolic pathways	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMC200033135	K00696	ko00500	Starch and sucrose metabolism	6570	0.	0.75	0.85	1.00
PGSC0003DMC200033135	K00696	ko01100	Metabolic pathways	6570	0.	0.75	0.85	1.00
PGSC0003DMC200033136	K00696	ko00500	Starch and sucrose metabolism	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMC200033136	K00696	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMC200033137	K00696	ko00500	Starch and sucrose metabolism	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMC200033137	K00696	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMC200033138	K00696	ko00500	Starch and sucrose metabolism	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMC200033138	K00696	ko01100	Metabolic pathways	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMC200033144	K06118	ko00520	Amino sugar and nucleotide sugar metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMC200033144	K06118	ko00561	Glycerolipid metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMC200051639	K12596	ko03018	RNA degradation	246	3.4e-07	0.31	0.47	0.68
PGSC0003DMC200051648	K01728	ko00040	Pentose and glucuronate interconversions	2903	2.8e-154	0.77	0.86	0.94
PGSC0003DMC200051649	K06067	ko04110	Cell cycle	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMC200051649	K06067	ko04330	Notch signaling pathway	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMC200051649	K06067	ko05016	Huntington's disease	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMC200051649	K06067	ko05200	Pathways in cancer	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMC200051649	K06067	ko05220	Chronic myeloid leukemia	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMC200051650	K06067	ko04110	Cell cycle	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMC200051650	K06067	ko04330	Notch signaling pathway	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMC200051650	K06067	ko05016	Huntington's disease	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMC200051650	K06067	ko05200	Pathways in cancer	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMC200051650	K06067	ko05220	Chronic myeloid leukemia	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMC200051656	K12624	ko03018	RNA degradation	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMC200051656	K12624	ko03040	Spliceosome	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMC200001861	K03921	ko00061	Fatty acid biosynthesis	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMC200001861	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMC200001863	K00609	ko00240	Pyrimidine metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMC200001863	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMC200001863	K00609	ko01100	Metabolic pathways	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMC200001864	K00609	ko00240	Pyrimidine metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMC200001864	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMC200001864	K00609	ko01100	Metabolic pathways	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMC200001871	K10258	ko01040	Biosynthesis of unsaturated fatty acids	525	4.0e-23	0.33	0.53	0.95
PGSC0003DMC200001872	K10258	ko01040	Biosynthesis of unsaturated fatty acids	351	1.6e-13	0.37	0.56	0.94
PGSC0003DMC200001873	K10258	ko01040	Biosynthesis of unsaturated fatty acids	467	6.4e-20	0.36	0.51	0.91
PGSC0003DMC200001874	K10258	ko01040	Biosynthesis of unsaturated fatty acids	502	7.5e-22	0.35	0.54	0.88
PGSC0003DMC200001886	K11808	ko00230	Purine metabolism	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMC200001886	K11808	ko01100	Metabolic pathways	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMC200001886	K11808	ko01110	Biosynthesis of secondary metabolites	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMC200001887	K11808	ko00230	Purine metabolism	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMC200001887	K11808	ko01100	Metabolic pathways	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMC200001887	K11808	ko01110	Biosynthesis of secondary metabolites	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMC200065046	K02925	ko03010	Ribosome	214	6.9e-06	0.80	0.87	0.36
PGSC0003DMC200065047	K02738	ko03050	Proteasome	467	6.4e-20	0.37	0.55	0.80
PGSC0003DMC200065067	K12849	ko03040	Spliceosome	221	2.4e-06	0.30	0.49	0.90
PGSC0003DMC200062407	K00001	ko00010	Glycolysis / Gluconeogenesis	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00071	Fatty acid metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00350	Tyrosine metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00624	1- and 2-Methylnaphthalene degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00641	3-Chloroacrylic acid degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00830	Retinol metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko00982	Drug metabolism - cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko01100	Metabolic pathways	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062407	K00001	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMC200062421	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1396	3.7e-71	0.56	0.66	0.99
PGSC0003DMC200011311	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200011311	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200011311	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMC200011312	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMC200011312	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMC200011312	K10158	ko01100	Metabolic pathways	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMC200011315	K02492	ko00860	Porphyrin and chlorophyll metabolism	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMC200011315	K02492	ko01100	Metabolic pathways	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMC200011315	K02492	ko01110	Biosynthesis of secondary metabolites	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMC200011328	K00430	ko00360	Phenylalanine metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMC200011328	K00430	ko00680	Methane metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMC200011328	K00430	ko00940	Phenylpropanoid biosynthesis	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMC200011328	K00430	ko01100	Metabolic pathways	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMC200011328	K00430	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMC200011329	K12129	ko04712	Circadian rhythm - plant	248	3.4e-07	0.28	0.44	0.92
PGSC0003DMC200011334	K06100	ko04530	Tight junction	3487	1.7e-186	0.50	0.67	0.73
PGSC0003DMC200011335	K01610	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011335	K01610	ko00020	Citrate cycle (TCA cycle)	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011335	K01610	ko00620	Pyruvate metabolism	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011335	K01610	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011335	K01610	ko01100	Metabolic pathways	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011335	K01610	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMC200011336	K01610	ko00010	Glycolysis / Gluconeogenesis	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011336	K01610	ko00020	Citrate cycle (TCA cycle)	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011336	K01610	ko00620	Pyruvate metabolism	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011336	K01610	ko00710	Carbon fixation in photosynthetic organisms	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011336	K01610	ko01100	Metabolic pathways	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011336	K01610	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMC200011337	K01610	ko00010	Glycolysis / Gluconeogenesis	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200011337	K01610	ko00020	Citrate cycle (TCA cycle)	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200011337	K01610	ko00620	Pyruvate metabolism	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200011337	K01610	ko00710	Carbon fixation in photosynthetic organisms	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200011337	K01610	ko01100	Metabolic pathways	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200011337	K01610	ko01110	Biosynthesis of secondary metabolites	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMC200027307	K11820	ko00380	Tryptophan metabolism	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMC200027307	K11820	ko00966	Glucosinolate biosynthesis	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMC200027307	K11820	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMC200027310	K01199	ko00500	Starch and sucrose metabolism	767	1.8e-36	0.36	0.58	0.69
PGSC0003DMC200027312	K00430	ko00360	Phenylalanine metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMC200027312	K00430	ko00680	Methane metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMC200027312	K00430	ko00940	Phenylpropanoid biosynthesis	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMC200027312	K00430	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMC200027312	K00430	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMC200027313	K00430	ko00360	Phenylalanine metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMC200027313	K00430	ko00680	Methane metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMC200027313	K00430	ko00940	Phenylpropanoid biosynthesis	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMC200027313	K00430	ko01100	Metabolic pathways	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMC200027313	K00430	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMC200027327	K06627	ko04110	Cell cycle	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMC200027327	K06627	ko04914	Progesterone-mediated oocyte maturation	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMC200027330	K03512	ko03410	Base excision repair	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMC200027330	K03512	ko03450	Non-homologous end-joining	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMC200008676	K04354	ko04111	Cell cycle - yeast	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMC200008676	K04354	ko04530	Tight junction	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMC200008676	K04354	ko05142	Chagas disease	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMC200008677	K04354	ko04111	Cell cycle - yeast	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMC200008677	K04354	ko04530	Tight junction	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMC200008677	K04354	ko05142	Chagas disease	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMC200008679	K01955	ko00240	Pyrimidine metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMC200008679	K01955	ko00250	Alanine, aspartate and glutamate metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMC200008679	K01955	ko01100	Metabolic pathways	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMC200008680	K12309	ko00052	Galactose metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko00511	Other glycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko00531	Glycosaminoglycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko00600	Sphingolipid metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko01100	Metabolic pathways	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008680	K12309	ko04142	Lysosome	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMC200008681	K12309	ko00052	Galactose metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko00511	Other glycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko00531	Glycosaminoglycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko00600	Sphingolipid metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko01100	Metabolic pathways	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008681	K12309	ko04142	Lysosome	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMC200008682	K12309	ko00052	Galactose metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko00511	Other glycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko00531	Glycosaminoglycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko00600	Sphingolipid metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko01100	Metabolic pathways	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008682	K12309	ko04142	Lysosome	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMC200008683	K12309	ko00052	Galactose metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko00511	Other glycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko00531	Glycosaminoglycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko00600	Sphingolipid metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko01100	Metabolic pathways	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008683	K12309	ko04142	Lysosome	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMC200008693	K04733	ko04210	Apoptosis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMC200008693	K04733	ko04620	Toll-like receptor signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMC200008693	K04733	ko04722	Neurotrophin signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMC200008693	K04733	ko05140	Leishmaniasis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMC200008693	K04733	ko05142	Chagas disease	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMC200008694	K01733	ko00260	Glycine, serine and threonine metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMC200008694	K01733	ko00750	Vitamin B6 metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMC200008694	K01733	ko01100	Metabolic pathways	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMC200004330	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	246	9.8e-08	0.57	0.65	0.41
PGSC0003DMC200004346	K05350	ko00460	Cyanoamino acid metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMC200004346	K05350	ko00500	Starch and sucrose metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMC200004346	K05350	ko00940	Phenylpropanoid biosynthesis	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMC200004346	K05350	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMC200004347	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004347	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004347	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004347	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004348	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004348	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004348	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004348	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMC200004349	K05350	ko00460	Cyanoamino acid metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMC200004349	K05350	ko00500	Starch and sucrose metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMC200004349	K05350	ko00940	Phenylpropanoid biosynthesis	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMC200004349	K05350	ko01110	Biosynthesis of secondary metabolites	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMC200022845	K06630	ko04110	Cell cycle	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMC200022845	K06630	ko04114	Oocyte meiosis	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMC200022845	K06630	ko04722	Neurotrophin signaling pathway	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMC200022846	K06627	ko04110	Cell cycle	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMC200022846	K06627	ko04914	Progesterone-mediated oocyte maturation	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMC200022847	K06627	ko04110	Cell cycle	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMC200022847	K06627	ko04914	Progesterone-mediated oocyte maturation	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMC200022857	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMC200022858	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMC200015249	K04424	ko04010	MAPK signaling pathway	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMC200015249	K04424	ko04530	Tight junction	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMC200015250	K04424	ko04010	MAPK signaling pathway	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMC200015250	K04424	ko04530	Tight junction	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMC200015251	K04424	ko04010	MAPK signaling pathway	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMC200015251	K04424	ko04530	Tight junction	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMC200015253	K12897	ko03040	Spliceosome	847	7.0e-41	0.52	0.66	0.98
PGSC0003DMC200015254	K12897	ko03040	Spliceosome	252	4.6e-08	0.47	0.53	0.87
PGSC0003DMC200015255	K12897	ko03040	Spliceosome	638	2.4e-29	0.59	0.75	0.97
PGSC0003DMC200015256	K01115	ko00564	Glycerophospholipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015256	K01115	ko00565	Ether lipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015256	K01115	ko01100	Metabolic pathways	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015256	K01115	ko04144	Endocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015256	K01115	ko04666	Fc gamma R-mediated phagocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015256	K01115	ko04912	GnRH signaling pathway	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMC200015263	K12863	ko03040	Spliceosome	1674	1.7e-86	0.84	0.93	1.00
PGSC0003DMC200028381	K02988	ko03010	Ribosome	471	3.8e-20	0.39	0.62	0.31
PGSC0003DMC200028382	K03921	ko00061	Fatty acid biosynthesis	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMC200028382	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMC200028384	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMC200028384	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMC200028384	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMC200028384	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMC200028389	K00650	ko00564	Glycerophospholipid metabolism	423	1.7e-17	0.31	0.44	0.90
PGSC0003DMC200028390	K00650	ko00564	Glycerophospholipid metabolism	361	4.5e-14	0.34	0.48	0.89
PGSC0003DMC200022006	K00826	ko00280	Valine, leucine and isoleucine degradation	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMC200022006	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMC200022006	K00826	ko00770	Pantothenate and CoA biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMC200022006	K00826	ko01100	Metabolic pathways	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMC200022006	K00826	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMC200022007	K00826	ko00280	Valine, leucine and isoleucine degradation	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMC200022007	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMC200022007	K00826	ko00770	Pantothenate and CoA biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMC200022007	K00826	ko01100	Metabolic pathways	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMC200022007	K00826	ko01110	Biosynthesis of secondary metabolites	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMC200022013	K01528	ko04144	Endocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMC200022013	K01528	ko04666	Fc gamma R-mediated phagocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMC200022013	K01528	ko05100	Bacterial invasion of epithelial cells	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMC200022014	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMC200022015	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMC200022016	K10143	ko04115	p53 signaling pathway	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMC200022016	K10143	ko04120	Ubiquitin mediated proteolysis	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMC200022017	K10143	ko04115	p53 signaling pathway	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMC200022017	K10143	ko04120	Ubiquitin mediated proteolysis	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMC200022018	K10143	ko04115	p53 signaling pathway	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMC200022018	K10143	ko04120	Ubiquitin mediated proteolysis	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMC200003364	K01760	ko00270	Cysteine and methionine metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003364	K01760	ko00450	Selenoamino acid metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003364	K01760	ko00910	Nitrogen metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003364	K01760	ko00920	Sulfur metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003364	K01760	ko01100	Metabolic pathways	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003364	K01760	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMC200003367	K00680	ko00350	Tyrosine metabolism	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMC200003367	K00680	ko00624	1- and 2-Methylnaphthalene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMC200003367	K00680	ko00632	Benzoate degradation via CoA ligation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMC200003367	K00680	ko00642	Ethylbenzene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMC200003367	K00680	ko00903	Limonene and pinene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMC200003381	K05677	ko02010	ABC transporters	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMC200003381	K05677	ko04146	Peroxisome	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMC200069032	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMC200069032	K00517	ko00626	Naphthalene and anthracene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMC200069032	K00517	ko00903	Limonene and pinene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMC200069032	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMC200069032	K00517	ko01110	Biosynthesis of secondary metabolites	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMC200069053	K10592	ko04120	Ubiquitin mediated proteolysis	467	1.0e-15	0.29	0.48	0.64
PGSC0003DMC200001025	K00962	ko00230	Purine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMC200001025	K00962	ko00240	Pyrimidine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMC200001025	K00962	ko03018	RNA degradation	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMC200001026	K00962	ko00230	Purine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMC200001026	K00962	ko00240	Pyrimidine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMC200001026	K00962	ko03018	RNA degradation	6035	0.	0.74	0.85	1.00
PGSC0003DMC200001028	K12823	ko03040	Spliceosome	1968	1.0e-102	0.53	0.67	0.66
PGSC0003DMC200001029	K03083	ko04012	ErbB signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04062	Chemokine signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04110	Cell cycle	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04310	Wnt signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04340	Hedgehog signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04360	Axon guidance	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04510	Focal adhesion	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04660	T cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04662	B cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04711	Circadian rhythm - fly	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04722	Neurotrophin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04910	Insulin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko04916	Melanogenesis	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05010	Alzheimer's disease	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05200	Pathways in cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05210	Colorectal cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05213	Endometrial cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05215	Prostate cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001029	K03083	ko05217	Basal cell carcinoma	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMC200001031	K01199	ko00500	Starch and sucrose metabolism	1122	4.8e-56	0.47	0.66	1.00
PGSC0003DMC200001032	K01199	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.46	0.64	0.96
PGSC0003DMC200001034	K09753	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMC200001034	K09753	ko01100	Metabolic pathways	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMC200001034	K09753	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMC200001035	K09753	ko00940	Phenylpropanoid biosynthesis	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMC200001035	K09753	ko01100	Metabolic pathways	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMC200001035	K09753	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMC200046441	K03094	ko04110	Cell cycle	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04111	Cell cycle - yeast	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04114	Oocyte meiosis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04120	Ubiquitin mediated proteolysis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04310	Wnt signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04350	TGF-beta signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046441	K03094	ko04710	Circadian rhythm - mammal	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMC200046443	K05849	ko04020	Calcium signaling pathway	322	2.5e-11	0.33	0.52	0.92
PGSC0003DMC200046454	K13082	ko00941	Flavonoid biosynthesis	707	3.7e-33	0.39	0.61	0.85
PGSC0003DMC200046461	K03083	ko04012	ErbB signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04062	Chemokine signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04110	Cell cycle	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04310	Wnt signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04340	Hedgehog signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04360	Axon guidance	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04510	Focal adhesion	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04660	T cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04662	B cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04711	Circadian rhythm - fly	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04722	Neurotrophin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04910	Insulin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko04916	Melanogenesis	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05010	Alzheimer's disease	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05200	Pathways in cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05210	Colorectal cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05213	Endometrial cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05215	Prostate cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046461	K03083	ko05217	Basal cell carcinoma	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMC200046462	K03083	ko04012	ErbB signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04062	Chemokine signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04110	Cell cycle	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04310	Wnt signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04340	Hedgehog signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04360	Axon guidance	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04510	Focal adhesion	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04660	T cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04662	B cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04711	Circadian rhythm - fly	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04722	Neurotrophin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04910	Insulin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko04916	Melanogenesis	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05010	Alzheimer's disease	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05200	Pathways in cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05210	Colorectal cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05213	Endometrial cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05215	Prostate cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046462	K03083	ko05217	Basal cell carcinoma	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMC200046463	K03083	ko04012	ErbB signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04062	Chemokine signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04110	Cell cycle	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04310	Wnt signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04340	Hedgehog signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04360	Axon guidance	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04510	Focal adhesion	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04660	T cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04662	B cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04711	Circadian rhythm - fly	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04722	Neurotrophin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04910	Insulin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko04916	Melanogenesis	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05010	Alzheimer's disease	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05200	Pathways in cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05210	Colorectal cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05213	Endometrial cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05215	Prostate cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200046463	K03083	ko05217	Basal cell carcinoma	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMC200038560	K06611	ko00052	Galactose metabolism	228	5.2e-06	0.44	0.57	0.80
PGSC0003DMC200038561	K06611	ko00052	Galactose metabolism	505	6.9e-22	0.53	0.69	0.82
PGSC0003DMC200038562	K06611	ko00052	Galactose metabolism	2251	2.6e-118	0.42	0.60	0.96
PGSC0003DMC200038563	K12616	ko03018	RNA degradation	7528	0.	0.66	0.77	1.00
PGSC0003DMC200038565	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMC200038566	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMC200038567	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMC200038568	K03876	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.28	0.48	0.78
PGSC0003DMC200038571	K01623	ko00010	Glycolysis / Gluconeogenesis	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038571	K01623	ko00030	Pentose phosphate pathway	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038571	K01623	ko00051	Fructose and mannose metabolism	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038571	K01623	ko00710	Carbon fixation in photosynthetic organisms	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038571	K01623	ko01100	Metabolic pathways	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038571	K01623	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMC200038572	K01623	ko00010	Glycolysis / Gluconeogenesis	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038572	K01623	ko00030	Pentose phosphate pathway	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038572	K01623	ko00051	Fructose and mannose metabolism	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038572	K01623	ko00710	Carbon fixation in photosynthetic organisms	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038572	K01623	ko01100	Metabolic pathways	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038572	K01623	ko01110	Biosynthesis of secondary metabolites	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko00010	Glycolysis / Gluconeogenesis	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko00030	Pentose phosphate pathway	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko00051	Fructose and mannose metabolism	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko00710	Carbon fixation in photosynthetic organisms	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko01100	Metabolic pathways	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038573	K01623	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMC200038577	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038577	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038578	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMC200038579	K06268	ko04010	MAPK signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04020	Calcium signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04114	Oocyte meiosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04210	Apoptosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04310	Wnt signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04360	Axon guidance	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04370	VEGF signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04650	Natural killer cell mediated cytotoxicity	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04660	T cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04662	B cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko04720	Long-term potentiation	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko05010	Alzheimer's disease	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038579	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMC200038580	K06268	ko04010	MAPK signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04020	Calcium signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04114	Oocyte meiosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04210	Apoptosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04310	Wnt signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04360	Axon guidance	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04370	VEGF signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04650	Natural killer cell mediated cytotoxicity	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04660	T cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04662	B cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko04720	Long-term potentiation	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko05010	Alzheimer's disease	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200038580	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMC200053192	K12200	ko04144	Endocytosis	993	6.2e-49	0.64	0.75	0.99
PGSC0003DMC200053193	K12200	ko04144	Endocytosis	5898	0.	0.79	0.88	1.00
PGSC0003DMC200053194	K12200	ko04144	Endocytosis	4586	4.2e-247	0.83	0.92	0.96
PGSC0003DMC200053195	K12200	ko04144	Endocytosis	3967	5.8e-213	0.84	0.91	0.99
PGSC0003DMC200053196	K00523	ko00520	Amino sugar and nucleotide sugar metabolism	354	1.1e-13	0.31	0.49	0.74
PGSC0003DMC200053197	K02133	ko00190	Oxidative phosphorylation	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMC200053197	K02133	ko01100	Metabolic pathways	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMC200053197	K02133	ko05010	Alzheimer's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMC200053197	K02133	ko05012	Parkinson's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMC200053197	K02133	ko05016	Huntington's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMC200053200	K03118	ko03060	Protein export	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMC200053200	K03118	ko03070	Bacterial secretion system	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMC200053201	K03118	ko03060	Protein export	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMC200053201	K03118	ko03070	Bacterial secretion system	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMC200053202	K08730	ko00564	Glycerophospholipid metabolism	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMC200053202	K08730	ko01100	Metabolic pathways	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMC200053203	K08730	ko00564	Glycerophospholipid metabolism	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMC200053203	K08730	ko01100	Metabolic pathways	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMC200053204	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMC200053204	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMC200053205	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMC200053205	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMC200053206	K01623	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053206	K01623	ko00030	Pentose phosphate pathway	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053206	K01623	ko00051	Fructose and mannose metabolism	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053206	K01623	ko00710	Carbon fixation in photosynthetic organisms	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053206	K01623	ko01100	Metabolic pathways	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053206	K01623	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMC200053207	K01623	ko00010	Glycolysis / Gluconeogenesis	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053207	K01623	ko00030	Pentose phosphate pathway	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053207	K01623	ko00051	Fructose and mannose metabolism	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053207	K01623	ko00710	Carbon fixation in photosynthetic organisms	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053207	K01623	ko01100	Metabolic pathways	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053207	K01623	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMC200053216	K10352	ko04530	Tight junction	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMC200053216	K10352	ko05416	Viral myocarditis	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMC200053217	K10352	ko04530	Tight junction	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMC200053217	K10352	ko05416	Viral myocarditis	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMC200053220	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053220	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053220	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053220	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053220	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053220	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200034561	K00852	ko00030	Pentose phosphate pathway	315	1.5e-11	0.36	0.51	0.51
PGSC0003DMC200034563	K12886	ko03040	Spliceosome	276	2.2e-09	0.33	0.45	0.68
PGSC0003DMC200034573	K00799	ko00480	Glutathione metabolism	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMC200034573	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMC200034573	K00799	ko00982	Drug metabolism - cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMC200034579	K04424	ko04010	MAPK signaling pathway	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMC200034579	K04424	ko04530	Tight junction	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMC200005624	K02433	ko00970	Aminoacyl-tRNA biosynthesis	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMC200005624	K02433	ko01100	Metabolic pathways	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMC200005625	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMC200005625	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMC200005626	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMC200005626	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMC200005627	K02433	ko00970	Aminoacyl-tRNA biosynthesis	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMC200005627	K02433	ko01100	Metabolic pathways	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMC200005628	K02433	ko00970	Aminoacyl-tRNA biosynthesis	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMC200005628	K02433	ko01100	Metabolic pathways	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMC200005629	K01426	ko00330	Arginine and proline metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005629	K01426	ko00360	Phenylalanine metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005629	K01426	ko00380	Tryptophan metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005629	K01426	ko00460	Cyanoamino acid metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005629	K01426	ko00632	Benzoate degradation via CoA ligation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005629	K01426	ko00643	Styrene degradation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMC200005630	K02433	ko00970	Aminoacyl-tRNA biosynthesis	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMC200005630	K02433	ko01100	Metabolic pathways	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMC200005631	K01426	ko00330	Arginine and proline metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005631	K01426	ko00360	Phenylalanine metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005631	K01426	ko00380	Tryptophan metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005631	K01426	ko00460	Cyanoamino acid metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005631	K01426	ko00632	Benzoate degradation via CoA ligation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005631	K01426	ko00643	Styrene degradation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMC200005635	K04043	ko03018	RNA degradation	1261	1.0e-63	0.81	0.92	0.99
PGSC0003DMC200005636	K04043	ko03018	RNA degradation	4523	1.2e-243	0.89	0.96	1.00
PGSC0003DMC200005637	K04043	ko03018	RNA degradation	2075	1.3e-108	0.86	0.94	1.00
PGSC0003DMC200005638	K04043	ko03018	RNA degradation	4816	8.6e-260	0.86	0.93	1.00
PGSC0003DMC200005639	K01623	ko00010	Glycolysis / Gluconeogenesis	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005639	K01623	ko00030	Pentose phosphate pathway	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005639	K01623	ko00051	Fructose and mannose metabolism	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005639	K01623	ko00710	Carbon fixation in photosynthetic organisms	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005639	K01623	ko01100	Metabolic pathways	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005639	K01623	ko01110	Biosynthesis of secondary metabolites	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMC200005640	K01623	ko00010	Glycolysis / Gluconeogenesis	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200005640	K01623	ko00030	Pentose phosphate pathway	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200005640	K01623	ko00051	Fructose and mannose metabolism	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200005640	K01623	ko00710	Carbon fixation in photosynthetic organisms	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200005640	K01623	ko01100	Metabolic pathways	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200005640	K01623	ko01110	Biosynthesis of secondary metabolites	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMC200024991	K06268	ko04010	MAPK signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04020	Calcium signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04114	Oocyte meiosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04210	Apoptosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04310	Wnt signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04360	Axon guidance	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04370	VEGF signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04650	Natural killer cell mediated cytotoxicity	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04660	T cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04662	B cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko04720	Long-term potentiation	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko05010	Alzheimer's disease	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024991	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMC200024992	K06268	ko04010	MAPK signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04020	Calcium signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04114	Oocyte meiosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04210	Apoptosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04310	Wnt signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04360	Axon guidance	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04370	VEGF signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04650	Natural killer cell mediated cytotoxicity	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04660	T cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04662	B cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko04720	Long-term potentiation	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko05010	Alzheimer's disease	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024992	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMC200024993	K01507	ko00190	Oxidative phosphorylation	5947	0.	0.93	0.97	1.00
PGSC0003DMC200025001	K03283	ko03040	Spliceosome	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMC200025001	K03283	ko04010	MAPK signaling pathway	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMC200025001	K03283	ko04144	Endocytosis	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMC200025001	K03283	ko04612	Antigen processing and presentation	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMC200025002	K03283	ko03040	Spliceosome	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMC200025002	K03283	ko04010	MAPK signaling pathway	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMC200025002	K03283	ko04144	Endocytosis	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMC200025002	K03283	ko04612	Antigen processing and presentation	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMC200025003	K11229	ko04011	MAPK signaling pathway - yeast	583	1.9e-25	0.37	0.52	0.70
PGSC0003DMC200025009	K01213	ko00040	Pentose and glucuronate interconversions	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMC200025009	K01213	ko00500	Starch and sucrose metabolism	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMC200025009	K01213	ko01100	Metabolic pathways	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMC200025010	K01213	ko00040	Pentose and glucuronate interconversions	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMC200025010	K01213	ko00500	Starch and sucrose metabolism	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMC200025010	K01213	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMC200025011	K01213	ko00040	Pentose and glucuronate interconversions	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMC200025011	K01213	ko00500	Starch and sucrose metabolism	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMC200025011	K01213	ko01100	Metabolic pathways	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMC200025015	K10839	ko03420	Nucleotide excision repair	1111	1.9e-55	0.73	0.80	0.88
PGSC0003DMC200025016	K10839	ko03420	Nucleotide excision repair	2279	7.3e-120	0.70	0.79	1.00
PGSC0003DMC200019381	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMC200019390	K11423	ko00310	Lysine degradation	780	3.5e-37	0.41	0.55	0.64
PGSC0003DMC200019391	K11424	ko00310	Lysine degradation	685	6.0e-32	0.48	0.64	0.44
PGSC0003DMC200019393	K07253	ko00350	Tyrosine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMC200019393	K07253	ko00360	Phenylalanine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMC200019394	K02634	ko00195	Photosynthesis	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMC200019394	K02634	ko01100	Metabolic pathways	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMC200019400	K11424	ko00310	Lysine degradation	475	2.3e-20	0.49	0.65	0.56
PGSC0003DMC200019402	K11812	ko00380	Tryptophan metabolism	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMC200019402	K11812	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMC200017746	K02716	ko00195	Photosynthesis	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMC200017746	K02716	ko01100	Metabolic pathways	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMC200017750	K11419	ko00310	Lysine degradation	671	2.5e-30	0.35	0.50	0.17
PGSC0003DMC200017751	K11419	ko00310	Lysine degradation	242	1.9e-06	0.30	0.47	0.13
PGSC0003DMC200017760	K01784	ko00052	Galactose metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMC200017760	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMC200017760	K01784	ko01100	Metabolic pathways	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMC200068101	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200068101	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200068101	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200068101	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200068101	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200068128	K10747	ko03030	DNA replication	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMC200068128	K10747	ko03410	Base excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMC200068128	K10747	ko03420	Nucleotide excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMC200068128	K10747	ko03430	Mismatch repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMC200056194	K00207	ko00240	Pyrimidine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMC200056194	K00207	ko00410	beta-Alanine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMC200056194	K00207	ko00770	Pantothenate and CoA biosynthesis	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMC200056194	K00207	ko00983	Drug metabolism - other enzymes	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMC200056194	K00207	ko01100	Metabolic pathways	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMC200056195	K00207	ko00240	Pyrimidine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMC200056195	K00207	ko00410	beta-Alanine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMC200056195	K00207	ko00770	Pantothenate and CoA biosynthesis	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMC200056195	K00207	ko00983	Drug metabolism - other enzymes	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMC200056195	K00207	ko01100	Metabolic pathways	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMC200056196	K00207	ko00240	Pyrimidine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMC200056196	K00207	ko00410	beta-Alanine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMC200056196	K00207	ko00770	Pantothenate and CoA biosynthesis	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMC200056196	K00207	ko00983	Drug metabolism - other enzymes	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMC200056196	K00207	ko01100	Metabolic pathways	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMC200056197	K02984	ko03010	Ribosome	1960	2.9e-102	0.89	0.95	1.00
PGSC0003DMC200056198	K02183	ko04020	Calcium signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04070	Phosphatidylinositol signaling system	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04114	Oocyte meiosis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04270	Vascular smooth muscle contraction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04626	Plant-pathogen interaction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04720	Long-term potentiation	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04722	Neurotrophin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04740	Olfactory transduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04744	Phototransduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04745	Phototransduction - fly	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04910	Insulin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04912	GnRH signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04916	Melanogenesis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04970	Salivary secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko04971	Gastric acid secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko05010	Alzheimer's disease	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056198	K02183	ko05214	Glioma	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMC200056199	K01054	ko00561	Glycerolipid metabolism	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMC200056199	K01054	ko01100	Metabolic pathways	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMC200056201	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMC200056201	K01078	ko00740	Riboflavin metabolism	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMC200056206	K02904	ko03010	Ribosome	754	9.4e-36	0.78	0.88	0.72
PGSC0003DMC200056210	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMC200056211	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMC200056215	K04368	ko04010	MAPK signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04012	ErbB signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04013	MAPK signaling pathway - fly	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04062	Chemokine signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04114	Oocyte meiosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04270	Vascular smooth muscle contraction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04320	Dorso-ventral axis formation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04370	VEGF signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04510	Focal adhesion	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04540	Gap junction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04620	Toll-like receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04626	Plant-pathogen interaction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04650	Natural killer cell mediated cytotoxicity	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04660	T cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04662	B cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04664	Fc epsilon RI signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04666	Fc gamma R-mediated phagocytosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04720	Long-term potentiation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04722	Neurotrophin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04730	Long-term depression	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04810	Regulation of actin cytoskeleton	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04910	Insulin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04912	GnRH signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04914	Progesterone-mediated oocyte maturation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko04916	Melanogenesis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05020	Prion diseases	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05200	Pathways in cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05210	Colorectal cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05211	Renal cell carcinoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05212	Pancreatic cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05213	Endometrial cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05214	Glioma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05215	Prostate cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05216	Thyroid cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05218	Melanoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05219	Bladder cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05220	Chronic myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05221	Acute myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200056215	K04368	ko05223	Non-small cell lung cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMC200030572	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMC200030572	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMC200030573	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMC200030573	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMC200030574	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.29	0.48	0.93
PGSC0003DMC200030584	K01438	ko00330	Arginine and proline metabolism	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMC200030584	K01438	ko01100	Metabolic pathways	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMC200030584	K01438	ko01110	Biosynthesis of secondary metabolites	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMC200030585	K01438	ko00330	Arginine and proline metabolism	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMC200030585	K01438	ko01100	Metabolic pathways	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMC200030585	K01438	ko01110	Biosynthesis of secondary metabolites	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMC200030586	K01438	ko00330	Arginine and proline metabolism	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMC200030586	K01438	ko01100	Metabolic pathways	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMC200030586	K01438	ko01110	Biosynthesis of secondary metabolites	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMC200030587	K01438	ko00330	Arginine and proline metabolism	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMC200030587	K01438	ko01100	Metabolic pathways	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMC200030587	K01438	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMC200030589	K12493	ko04144	Endocytosis	2138	4.4e-112	0.66	0.76	1.00
PGSC0003DMC200030590	K12493	ko04144	Endocytosis	1297	1.1e-65	0.73	0.83	0.85
PGSC0003DMC200030591	K12493	ko04144	Endocytosis	2444	5.8e-129	0.72	0.84	1.00
PGSC0003DMC200030592	K12493	ko04144	Endocytosis	2439	1.1e-128	0.49	0.63	0.97
PGSC0003DMC200030598	K11294	ko05130	Pathogenic Escherichia coli infection	374	1.9e-14	0.31	0.51	0.76
PGSC0003DMC200048184	K03945	ko00190	Oxidative phosphorylation	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMC200048184	K03945	ko01100	Metabolic pathways	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMC200048184	K03945	ko05010	Alzheimer's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMC200048184	K03945	ko05012	Parkinson's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMC200048184	K03945	ko05016	Huntington's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMC200048190	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMC200048190	K00517	ko00626	Naphthalene and anthracene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMC200048190	K00517	ko00903	Limonene and pinene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMC200048190	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMC200048190	K00517	ko01110	Biosynthesis of secondary metabolites	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMC200048194	K04733	ko04210	Apoptosis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMC200048194	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMC200048194	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMC200048194	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMC200048194	K04733	ko05142	Chagas disease	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMC200048201	K13229	ko00402	Benzoxazinoid biosynthesis	986	1.5e-48	0.38	0.58	0.97
PGSC0003DMC200048204	K01955	ko00240	Pyrimidine metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMC200048204	K01955	ko00250	Alanine, aspartate and glutamate metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMC200048204	K01955	ko01100	Metabolic pathways	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMC200048206	K11188	ko00360	Phenylalanine metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMC200048206	K11188	ko00680	Methane metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMC200048206	K11188	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMC200048206	K11188	ko01100	Metabolic pathways	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMC200048206	K11188	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMC200066921	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMC200026195	K03469	ko03030	DNA replication	291	3.2e-10	0.37	0.54	0.82
PGSC0003DMC200026199	K00558	ko00270	Cysteine and methionine metabolism	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMC200026199	K00558	ko01100	Metabolic pathways	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMC200026200	K00558	ko00270	Cysteine and methionine metabolism	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMC200026200	K00558	ko01100	Metabolic pathways	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMC200026201	K11093	ko03040	Spliceosome	1256	1.9e-63	0.83	0.93	0.92
PGSC0003DMC200026202	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMC200026203	K11093	ko03040	Spliceosome	2893	9.9e-154	0.67	0.80	1.00
PGSC0003DMC200026204	K11093	ko03040	Spliceosome	2894	8.7e-154	0.67	0.80	1.00
PGSC0003DMC200026205	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMC200026214	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	393	1.5e-15	0.39	0.57	0.73
PGSC0003DMC200026215	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	473	3.0e-20	0.35	0.56	0.79
PGSC0003DMC200026219	K00234	ko00020	Citrate cycle (TCA cycle)	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko00190	Oxidative phosphorylation	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko01100	Metabolic pathways	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko01110	Biosynthesis of secondary metabolites	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko05010	Alzheimer's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko05012	Parkinson's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026219	K00234	ko05016	Huntington's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMC200026220	K09587	ko00905	Brassinosteroid biosynthesis	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMC200026220	K09587	ko01100	Metabolic pathways	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMC200026220	K09587	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMC200018181	K10841	ko03420	Nucleotide excision repair	6820	0.	0.69	0.80	1.00
PGSC0003DMC200018193	K05765	ko04360	Axon guidance	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMC200018193	K05765	ko04666	Fc gamma R-mediated phagocytosis	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMC200018193	K05765	ko04810	Regulation of actin cytoskeleton	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMC200018194	K05765	ko04360	Axon guidance	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMC200018194	K05765	ko04666	Fc gamma R-mediated phagocytosis	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMC200018194	K05765	ko04810	Regulation of actin cytoskeleton	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMC200018202	K00392	ko00450	Selenoamino acid metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMC200018202	K00392	ko00920	Sulfur metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMC200018202	K00392	ko01100	Metabolic pathways	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMC200018209	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMC200018209	K00517	ko00626	Naphthalene and anthracene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMC200018209	K00517	ko00903	Limonene and pinene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMC200018209	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMC200018209	K00517	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMC200035611	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035611	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035611	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035612	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035612	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035612	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMC200035613	K04123	ko00904	Diterpenoid biosynthesis	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMC200035613	K04123	ko01100	Metabolic pathways	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMC200035613	K04123	ko01110	Biosynthesis of secondary metabolites	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMC200035617	K11826	ko04144	Endocytosis	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMC200035617	K11826	ko05016	Huntington's disease	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMC200035620	K02698	ko00195	Photosynthesis	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMC200035620	K02698	ko01100	Metabolic pathways	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMC200035624	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMC200035625	K01177	ko00500	Starch and sucrose metabolism	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMC200035625	K01177	ko01100	Metabolic pathways	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMC200054991	K00688	ko00500	Starch and sucrose metabolism	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMC200054991	K00688	ko04910	Insulin signaling pathway	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMC200054992	K00688	ko00500	Starch and sucrose metabolism	5956	0.	0.83	0.92	0.81
PGSC0003DMC200054992	K00688	ko04910	Insulin signaling pathway	5956	0.	0.83	0.92	0.81
PGSC0003DMC200055002	K13230	ko00402	Benzoxazinoid biosynthesis	942	4.0e-46	0.38	0.55	0.98
PGSC0003DMC200055003	K13230	ko00402	Benzoxazinoid biosynthesis	924	4.0e-45	0.37	0.55	0.99
PGSC0003DMC200055008	K11821	ko00380	Tryptophan metabolism	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMC200055008	K11821	ko00966	Glucosinolate biosynthesis	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMC200055008	K11821	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMC200055010	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200055011	K03801	ko00785	Lipoic acid metabolism	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMC200055011	K03801	ko01100	Metabolic pathways	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMC200055014	K02891	ko03010	Ribosome	869	4.3e-42	0.83	0.91	0.99
PGSC0003DMC200055015	K02891	ko03010	Ribosome	514	1.6e-22	0.78	0.90	0.99
PGSC0003DMC200055016	K02891	ko03010	Ribosome	871	3.3e-42	0.83	0.93	0.99
PGSC0003DMC200055019	K02883	ko03010	Ribosome	1426	8.1e-73	0.90	0.95	0.99
PGSC0003DMC200049389	K01925	ko00471	D-Glutamine and D-glutamate metabolism	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMC200049389	K01925	ko00550	Peptidoglycan biosynthesis	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMC200049389	K01925	ko01100	Metabolic pathways	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMC200031771	K11866	ko04144	Endocytosis	626	3.0e-28	0.32	0.46	0.88
PGSC0003DMC200031772	K01136	ko00531	Glycosaminoglycan degradation	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMC200031772	K01136	ko01100	Metabolic pathways	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMC200031772	K01136	ko04142	Lysosome	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMC200031782	K12929	ko00904	Diterpenoid biosynthesis	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMC200031782	K12929	ko01110	Biosynthesis of secondary metabolites	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMC200031783	K12929	ko00904	Diterpenoid biosynthesis	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMC200031783	K12929	ko01110	Biosynthesis of secondary metabolites	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMC200031786	K10352	ko04530	Tight junction	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMC200031786	K10352	ko05416	Viral myocarditis	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMC200031788	K00558	ko00270	Cysteine and methionine metabolism	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMC200031788	K00558	ko01100	Metabolic pathways	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMC200047742	K00697	ko00500	Starch and sucrose metabolism	4624	3.3e-249	0.63	0.79	0.98
PGSC0003DMC200047743	K00697	ko00500	Starch and sucrose metabolism	4132	4.6e-222	0.64	0.79	0.96
PGSC0003DMC200047744	K00697	ko00500	Starch and sucrose metabolism	515	1.7e-22	0.64	0.73	0.83
PGSC0003DMC200047745	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMC200047746	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMC200047747	K01756	ko00230	Purine metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMC200047747	K01756	ko00250	Alanine, aspartate and glutamate metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMC200047747	K01756	ko01100	Metabolic pathways	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMC200047747	K01756	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMC200047754	K00901	ko00561	Glycerolipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMC200047754	K00901	ko00564	Glycerophospholipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMC200047754	K00901	ko01100	Metabolic pathways	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMC200047754	K00901	ko04070	Phosphatidylinositol signaling system	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMC200047755	K00901	ko00561	Glycerolipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMC200047755	K00901	ko00564	Glycerophospholipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMC200047755	K00901	ko01100	Metabolic pathways	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMC200047755	K00901	ko04070	Phosphatidylinositol signaling system	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMC200047758	K00558	ko00270	Cysteine and methionine metabolism	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMC200047758	K00558	ko01100	Metabolic pathways	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMC200002221	K04498	ko04110	Cell cycle	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04310	Wnt signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04330	Notch signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04350	TGF-beta signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04520	Adherens junction	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04630	Jak-STAT signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04720	Long-term potentiation	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko04916	Melanogenesis	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko05016	Huntington's disease	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko05200	Pathways in cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko05211	Renal cell carcinoma	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002221	K04498	ko05215	Prostate cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMC200002234	K02945	ko03010	Ribosome	2917	4.7e-155	0.84	0.93	1.00
PGSC0003DMC200016445	K00938	ko00900	Terpenoid backbone biosynthesis	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMC200016445	K00938	ko01100	Metabolic pathways	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMC200016445	K00938	ko01110	Biosynthesis of secondary metabolites	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMC200016446	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016446	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016446	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016447	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016447	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016447	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMC200016455	K04733	ko04210	Apoptosis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMC200016455	K04733	ko04620	Toll-like receptor signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMC200016455	K04733	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMC200016455	K04733	ko05140	Leishmaniasis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMC200016455	K04733	ko05142	Chagas disease	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMC200016465	K02084	ko04115	p53 signaling pathway	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko04210	Apoptosis	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko05010	Alzheimer's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko05012	Parkinson's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko05016	Huntington's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200016465	K02084	ko05222	Small cell lung cancer	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMC200027181	K02201	ko00770	Pantothenate and CoA biosynthesis	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMC200027181	K02201	ko01100	Metabolic pathways	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMC200027182	K02201	ko00770	Pantothenate and CoA biosynthesis	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMC200027182	K02201	ko01100	Metabolic pathways	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMC200027185	K07252	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.37	0.57	0.67
PGSC0003DMC200027186	K07252	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.38	0.56	0.67
PGSC0003DMC200027187	K07252	ko00510	N-Glycan biosynthesis	368	1.8e-14	0.35	0.53	0.70
PGSC0003DMC200027188	K07252	ko00510	N-Glycan biosynthesis	353	1.2e-13	0.37	0.56	0.68
PGSC0003DMC200027190	K00100	ko00051	Fructose and mannose metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027190	K00100	ko00363	Bisphenol A degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027190	K00100	ko00591	Linoleic acid metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027190	K00100	ko00625	Tetrachloroethene degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027190	K00100	ko00650	Butanoate metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027190	K00100	ko01100	Metabolic pathways	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMC200027191	K00102	ko00620	Pyruvate metabolism	838	2.2e-40	0.51	0.69	0.95
PGSC0003DMC200027192	K00102	ko00620	Pyruvate metabolism	836	2.8e-40	0.52	0.70	0.89
PGSC0003DMC200027202	K12127	ko04712	Circadian rhythm - plant	224	5.8e-06	0.32	0.50	0.93
PGSC0003DMC200027203	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200027204	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200027208	K12605	ko03018	RNA degradation	3598	1.3e-192	0.78	0.89	0.96
PGSC0003DMC200027209	K12605	ko03018	RNA degradation	4388	3.5e-236	0.77	0.88	1.00
PGSC0003DMC200027210	K12605	ko03018	RNA degradation	4152	3.6e-223	0.79	0.90	1.00
PGSC0003DMC200008551	K00010	ko00521	Streptomycin biosynthesis	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMC200008551	K00010	ko00562	Inositol phosphate metabolism	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMC200008551	K00010	ko01100	Metabolic pathways	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMC200008551	K00010	ko01110	Biosynthesis of secondary metabolites	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMC200008553	K12353	ko00600	Sphingolipid metabolism	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMC200008553	K12353	ko01100	Metabolic pathways	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMC200008554	K12353	ko00600	Sphingolipid metabolism	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMC200008554	K12353	ko01100	Metabolic pathways	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMC200008555	K12353	ko00600	Sphingolipid metabolism	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMC200008555	K12353	ko01100	Metabolic pathways	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMC200008556	K12353	ko00600	Sphingolipid metabolism	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMC200008556	K12353	ko01100	Metabolic pathways	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMC200008557	K12353	ko00600	Sphingolipid metabolism	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMC200008557	K12353	ko01100	Metabolic pathways	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMC200008559	K12353	ko00600	Sphingolipid metabolism	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMC200008559	K12353	ko01100	Metabolic pathways	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMC200008560	K05280	ko00941	Flavonoid biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMC200008560	K05280	ko00944	Flavone and flavonol biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMC200008560	K05280	ko01100	Metabolic pathways	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMC200008560	K05280	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMC200008561	K05280	ko00941	Flavonoid biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMC200008561	K05280	ko00944	Flavone and flavonol biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMC200008561	K05280	ko01100	Metabolic pathways	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMC200008561	K05280	ko01110	Biosynthesis of secondary metabolites	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMC200008565	K00232	ko00071	Fatty acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008565	K00232	ko00592	alpha-Linolenic acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008565	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008565	K00232	ko01100	Metabolic pathways	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008565	K00232	ko03320	PPAR signaling pathway	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008565	K00232	ko04146	Peroxisome	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMC200008566	K00232	ko00071	Fatty acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008566	K00232	ko00592	alpha-Linolenic acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008566	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008566	K00232	ko01100	Metabolic pathways	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008566	K00232	ko03320	PPAR signaling pathway	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008566	K00232	ko04146	Peroxisome	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMC200008572	K12125	ko04712	Circadian rhythm - plant	817	3.2e-39	0.31	0.45	0.96
PGSC0003DMC200008573	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMC200008574	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMC200008575	K12197	ko04144	Endocytosis	817	3.2e-39	0.87	0.94	0.99
PGSC0003DMC200008576	K12197	ko04144	Endocytosis	1478	1.1e-75	0.89	0.96	1.00
PGSC0003DMC200008577	K01112	ko00051	Fructose and mannose metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMC200008577	K01112	ko00730	Thiamine metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMC200008577	K01112	ko00740	Riboflavin metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMC200008577	K01112	ko01100	Metabolic pathways	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMC200008578	K01112	ko00051	Fructose and mannose metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMC200008578	K01112	ko00730	Thiamine metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMC200008578	K01112	ko00740	Riboflavin metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMC200008578	K01112	ko01100	Metabolic pathways	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMC200008580	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMC200008580	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMC200008580	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMC200008580	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMC200004561	K00812	ko00250	Alanine, aspartate and glutamate metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00270	Cysteine and methionine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00330	Arginine and proline metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00350	Tyrosine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00360	Phenylalanine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00401	Novobiocin biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00710	Carbon fixation in photosynthetic organisms	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00950	Isoquinoline alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko01100	Metabolic pathways	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004561	K00812	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMC200004562	K06627	ko04110	Cell cycle	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMC200004562	K06627	ko04914	Progesterone-mediated oocyte maturation	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMC200004563	K00865	ko00260	Glycine, serine and threonine metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMC200004563	K00865	ko00561	Glycerolipid metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMC200004563	K00865	ko00630	Glyoxylate and dicarboxylate metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMC200004563	K00865	ko01100	Metabolic pathways	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMC200004570	K03350	ko04110	Cell cycle	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004570	K03350	ko04111	Cell cycle - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004570	K03350	ko04113	Meiosis - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004570	K03350	ko04114	Oocyte meiosis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004570	K03350	ko04120	Ubiquitin mediated proteolysis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004570	K03350	ko04914	Progesterone-mediated oocyte maturation	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMC200004571	K03350	ko04110	Cell cycle	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004571	K03350	ko04111	Cell cycle - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004571	K03350	ko04113	Meiosis - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004571	K03350	ko04114	Oocyte meiosis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004571	K03350	ko04120	Ubiquitin mediated proteolysis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004571	K03350	ko04914	Progesterone-mediated oocyte maturation	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMC200004572	K03350	ko04110	Cell cycle	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004572	K03350	ko04111	Cell cycle - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004572	K03350	ko04113	Meiosis - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004572	K03350	ko04114	Oocyte meiosis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004572	K03350	ko04120	Ubiquitin mediated proteolysis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004572	K03350	ko04914	Progesterone-mediated oocyte maturation	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMC200004573	K03350	ko04110	Cell cycle	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004573	K03350	ko04111	Cell cycle - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004573	K03350	ko04113	Meiosis - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004573	K03350	ko04114	Oocyte meiosis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004573	K03350	ko04120	Ubiquitin mediated proteolysis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004573	K03350	ko04914	Progesterone-mediated oocyte maturation	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMC200004580	K03126	ko03022	Basal transcription factors	870	3.8e-42	0.35	0.50	0.97
PGSC0003DMC200004581	K03126	ko03022	Basal transcription factors	940	5.2e-46	0.32	0.47	0.97
PGSC0003DMC200004590	K00599	ko00340	Histidine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMC200004590	K00599	ko00350	Tyrosine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMC200004590	K00599	ko00450	Selenoamino acid metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMC200004590	K00599	ko00626	Naphthalene and anthracene degradation	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMC200023203	K08233	ko00901	Indole alkaloid biosynthesis	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMC200023203	K08233	ko01110	Biosynthesis of secondary metabolites	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMC200023204	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMC200023204	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMC200023205	K10802	ko03410	Base excision repair	459	1.8e-19	0.47	0.62	0.70
PGSC0003DMC200023206	K10802	ko03410	Base excision repair	398	4.1e-16	0.46	0.61	0.41
PGSC0003DMC200058384	K10760	ko00908	Zeatin biosynthesis	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMC200058384	K10760	ko01100	Metabolic pathways	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMC200058384	K10760	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMC200045249	K02888	ko03010	Ribosome	1021	1.8e-50	0.66	0.75	0.96
PGSC0003DMC200045250	K02888	ko03010	Ribosome	266	7.8e-09	0.48	0.59	0.83
PGSC0003DMC200045252	K09843	ko00906	Carotenoid biosynthesis	800	2.7e-38	0.40	0.62	0.97
PGSC0003DMC200045264	K11816	ko00380	Tryptophan metabolism	2048	4.0e-107	0.71	0.85	0.99
PGSC0003DMC200045265	K11816	ko00380	Tryptophan metabolism	1082	7.6e-54	0.71	0.86	0.94
PGSC0003DMC200045266	K06666	ko04111	Cell cycle - yeast	649	5.8e-30	0.26	0.41	0.92
PGSC0003DMC200045267	K06666	ko04111	Cell cycle - yeast	653	3.5e-30	0.26	0.41	0.92
PGSC0003DMC200033361	K05692	ko04145	Phagosome	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04510	Focal adhesion	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04520	Adherens junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04530	Tight junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04670	Leukocyte transendothelial migration	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04745	Phototransduction - fly	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko04810	Regulation of actin cytoskeleton	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05100	Bacterial invasion of epithelial cells	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05110	Vibrio cholerae infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05130	Pathogenic Escherichia coli infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05131	Shigellosis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05414	Dilated cardiomyopathy	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033361	K05692	ko05416	Viral myocarditis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMC200033362	K05692	ko04145	Phagosome	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04510	Focal adhesion	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04520	Adherens junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04530	Tight junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04670	Leukocyte transendothelial migration	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04745	Phototransduction - fly	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko04810	Regulation of actin cytoskeleton	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05100	Bacterial invasion of epithelial cells	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05110	Vibrio cholerae infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05130	Pathogenic Escherichia coli infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05131	Shigellosis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05414	Dilated cardiomyopathy	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033362	K05692	ko05416	Viral myocarditis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMC200033372	K03283	ko03040	Spliceosome	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMC200033372	K03283	ko04010	MAPK signaling pathway	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMC200033372	K03283	ko04144	Endocytosis	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMC200033372	K03283	ko04612	Antigen processing and presentation	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMC200033373	K12881	ko03040	Spliceosome	1021	1.8e-50	0.62	0.70	0.93
PGSC0003DMC200033374	K12881	ko03040	Spliceosome	304	6.2e-11	0.49	0.65	0.93
PGSC0003DMC200033375	K12881	ko03040	Spliceosome	1284	5.5e-65	0.66	0.74	1.00
PGSC0003DMC200033385	K02893	ko03010	Ribosome	1141	4.3e-57	0.89	0.93	0.99
PGSC0003DMC200051991	K12129	ko04712	Circadian rhythm - plant	283	3.9e-09	0.32	0.53	0.70
PGSC0003DMC200051992	K03415	ko02020	Two-component system	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMC200051992	K03415	ko02030	Bacterial chemotaxis	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMC200051998	K13228	ko00402	Benzoxazinoid biosynthesis	314	1.7e-11	0.29	0.44	0.88
PGSC0003DMC200052002	K00279	ko00908	Zeatin biosynthesis	1646	6.0e-85	0.67	0.84	0.90
PGSC0003DMC200052005	K01633	ko00790	Folate biosynthesis	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMC200052005	K01633	ko01100	Metabolic pathways	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMC200052006	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMC200052006	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMC200052007	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMC200052007	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMC200052016	K12129	ko04712	Circadian rhythm - plant	274	1.3e-08	0.32	0.53	0.70
PGSC0003DMC200045331	K04428	ko04010	MAPK signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMC200045331	K04428	ko04912	GnRH signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMC200045334	K00889	ko00562	Inositol phosphate metabolism	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045334	K00889	ko01100	Metabolic pathways	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045334	K00889	ko04070	Phosphatidylinositol signaling system	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045334	K00889	ko04144	Endocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045334	K00889	ko04666	Fc gamma R-mediated phagocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045334	K00889	ko04810	Regulation of actin cytoskeleton	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMC200045335	K00889	ko00562	Inositol phosphate metabolism	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045335	K00889	ko01100	Metabolic pathways	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045335	K00889	ko04070	Phosphatidylinositol signaling system	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045335	K00889	ko04144	Endocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045335	K00889	ko04666	Fc gamma R-mediated phagocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045335	K00889	ko04810	Regulation of actin cytoskeleton	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMC200045337	K00680	ko00350	Tyrosine metabolism	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMC200045337	K00680	ko00624	1- and 2-Methylnaphthalene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMC200045337	K00680	ko00632	Benzoate degradation via CoA ligation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMC200045337	K00680	ko00642	Ethylbenzene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMC200045337	K00680	ko00903	Limonene and pinene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMC200045338	K00876	ko00240	Pyrimidine metabolism	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMC200045338	K00876	ko00983	Drug metabolism - other enzymes	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMC200045338	K00876	ko01100	Metabolic pathways	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMC200045339	K02882	ko03010	Ribosome	1451	3.4e-74	0.93	0.98	0.99
PGSC0003DMC200045341	K11584	ko04113	Meiosis - yeast	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMC200045341	K11584	ko04114	Oocyte meiosis	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMC200045341	K11584	ko04310	Wnt signaling pathway	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMC200045351	K07192	ko04910	Insulin signaling pathway	1420	1.7e-72	0.42	0.62	1.00
PGSC0003DMC200045354	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMC200045355	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMC200045360	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMC200040035	K03966	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMC200040035	K03966	ko01100	Metabolic pathways	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMC200040035	K03966	ko05010	Alzheimer's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMC200040035	K03966	ko05012	Parkinson's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMC200040035	K03966	ko05016	Huntington's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMC200040039	K02976	ko03010	Ribosome	716	1.2e-33	0.78	0.87	0.99
PGSC0003DMC200040049	K09837	ko00906	Carotenoid biosynthesis	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMC200040049	K09837	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMC200040049	K09837	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMC200040050	K09837	ko00906	Carotenoid biosynthesis	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMC200040050	K09837	ko01100	Metabolic pathways	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMC200040050	K09837	ko01110	Biosynthesis of secondary metabolites	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMC200033220	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMC200033220	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMC200033220	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMC200033221	K05933	ko00270	Cysteine and methionine metabolism	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMC200033221	K05933	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMC200033225	K01051	ko00040	Pentose and glucuronate interconversions	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMC200033225	K01051	ko00500	Starch and sucrose metabolism	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMC200033225	K01051	ko01100	Metabolic pathways	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMC200033229	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMC200033229	K01988	ko01100	Metabolic pathways	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMC200033236	K07375	ko04145	Phagosome	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMC200033236	K07375	ko04540	Gap junction	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMC200033236	K07375	ko05130	Pathogenic Escherichia coli infection	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMC200033237	K07375	ko04145	Phagosome	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMC200033237	K07375	ko04540	Gap junction	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMC200033237	K07375	ko05130	Pathogenic Escherichia coli infection	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMC200000061	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000061	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000061	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000062	K00028	ko00620	Pyruvate metabolism	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMC200000062	K00028	ko00710	Carbon fixation in photosynthetic organisms	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMC200000062	K00028	ko01100	Metabolic pathways	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMC200000063	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000063	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000063	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMC200000065	K00079	ko00590	Arachidonic acid metabolism	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMC200000065	K00079	ko01100	Metabolic pathways	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMC200000066	K00079	ko00590	Arachidonic acid metabolism	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMC200000066	K00079	ko01100	Metabolic pathways	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMC200000068	K00079	ko00590	Arachidonic acid metabolism	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMC200000068	K00079	ko01100	Metabolic pathways	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMC200000069	K12844	ko03040	Spliceosome	2317	5.8e-122	0.64	0.75	1.00
PGSC0003DMC200000071	K01962	ko00061	Fatty acid biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000071	K01962	ko00253	Tetracycline biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000071	K01962	ko00620	Pyruvate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000071	K01962	ko00640	Propanoate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000071	K01962	ko01100	Metabolic pathways	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000071	K01962	ko01110	Biosynthesis of secondary metabolites	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMC200000072	K01962	ko00061	Fatty acid biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000072	K01962	ko00253	Tetracycline biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000072	K01962	ko00620	Pyruvate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000072	K01962	ko00640	Propanoate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000072	K01962	ko01100	Metabolic pathways	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000072	K01962	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMC200000073	K01962	ko00061	Fatty acid biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000073	K01962	ko00253	Tetracycline biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000073	K01962	ko00620	Pyruvate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000073	K01962	ko00640	Propanoate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000073	K01962	ko01100	Metabolic pathways	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000073	K01962	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko00061	Fatty acid biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko00253	Tetracycline biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko00620	Pyruvate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko00640	Propanoate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko01100	Metabolic pathways	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000074	K01962	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMC200000075	K12614	ko03018	RNA degradation	3635	1.2e-194	0.88	0.92	0.99
PGSC0003DMC200000079	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMC200000079	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMC200000081	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMC200000081	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMC200016545	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2806	6.2e-149	0.81	0.91	0.99
PGSC0003DMC200016546	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3490	1.2e-186	0.82	0.91	0.89
PGSC0003DMC200016547	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2684	3.3e-142	0.81	0.91	0.90
PGSC0003DMC200016548	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3022	7.6e-161	0.82	0.92	0.81
PGSC0003DMC200011230	K08737	ko03430	Mismatch repair	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMC200011230	K08737	ko05200	Pathways in cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMC200011230	K08737	ko05210	Colorectal cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMC200011232	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200011241	K07466	ko03030	DNA replication	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMC200011241	K07466	ko03420	Nucleotide excision repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMC200011241	K07466	ko03430	Mismatch repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMC200011241	K07466	ko03440	Homologous recombination	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMC200020591	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMC200020591	K12567	ko05414	Dilated cardiomyopathy	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMC200020593	K00059	ko00061	Fatty acid biosynthesis	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMC200020593	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMC200020593	K00059	ko01100	Metabolic pathways	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMC200020594	K00059	ko00061	Fatty acid biosynthesis	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMC200020594	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMC200020594	K00059	ko01100	Metabolic pathways	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMC200020596	K08336	ko04140	Regulation of autophagy	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMC200020596	K08336	ko04622	RIG-I-like receptor signaling pathway	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMC200020597	K08336	ko04140	Regulation of autophagy	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMC200020597	K08336	ko04622	RIG-I-like receptor signaling pathway	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMC200020609	K05658	ko02010	ABC transporters	2958	2.1e-163	0.42	0.60	0.99
PGSC0003DMC200020610	K05658	ko02010	ABC transporters	3859	5.2e-207	0.43	0.65	0.99
PGSC0003DMC200004426	K09589	ko00905	Brassinosteroid biosynthesis	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMC200004426	K09589	ko01100	Metabolic pathways	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMC200004426	K09589	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMC200004427	K09589	ko00905	Brassinosteroid biosynthesis	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMC200004427	K09589	ko01100	Metabolic pathways	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMC200004427	K09589	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMC200004434	K04354	ko04111	Cell cycle - yeast	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMC200004434	K04354	ko04530	Tight junction	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMC200004434	K04354	ko05142	Chagas disease	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMC200004439	K02957	ko03010	Ribosome	851	4.2e-41	0.75	0.91	0.69
PGSC0003DMC200035761	K06685	ko04111	Cell cycle - yeast	331	2.8e-10	0.27	0.45	0.63
PGSC0003DMC200035783	K08679	ko00500	Starch and sucrose metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMC200035783	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMC200035783	K08679	ko01100	Metabolic pathways	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMC200035789	K01897	ko00071	Fatty acid metabolism	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMC200035789	K01897	ko01100	Metabolic pathways	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMC200035789	K01897	ko03320	PPAR signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMC200035789	K01897	ko04146	Peroxisome	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMC200035789	K01897	ko04920	Adipocytokine signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMC200035790	K01897	ko00071	Fatty acid metabolism	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMC200035790	K01897	ko01100	Metabolic pathways	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMC200035790	K01897	ko03320	PPAR signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMC200035790	K01897	ko04146	Peroxisome	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMC200035790	K01897	ko04920	Adipocytokine signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMC200037351	K00856	ko00230	Purine metabolism	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMC200037351	K00856	ko01100	Metabolic pathways	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMC200037371	K13068	ko00940	Phenylpropanoid biosynthesis	883	7.2e-43	0.33	0.51	0.99
PGSC0003DMC200037372	K13068	ko00940	Phenylpropanoid biosynthesis	865	7.1e-42	0.32	0.51	0.96
PGSC0003DMC200037378	K12818	ko03040	Spliceosome	968	1.5e-47	0.52	0.65	0.93
PGSC0003DMC200043809	K05350	ko00460	Cyanoamino acid metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMC200043809	K05350	ko00500	Starch and sucrose metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMC200043809	K05350	ko00940	Phenylpropanoid biosynthesis	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMC200043809	K05350	ko01110	Biosynthesis of secondary metabolites	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMC200043810	K05350	ko00460	Cyanoamino acid metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMC200043810	K05350	ko00500	Starch and sucrose metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMC200043810	K05350	ko00940	Phenylpropanoid biosynthesis	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMC200043810	K05350	ko01110	Biosynthesis of secondary metabolites	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMC200043811	K05350	ko00460	Cyanoamino acid metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMC200043811	K05350	ko00500	Starch and sucrose metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMC200043811	K05350	ko00940	Phenylpropanoid biosynthesis	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMC200043811	K05350	ko01110	Biosynthesis of secondary metabolites	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMC200043815	K00799	ko00480	Glutathione metabolism	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMC200043815	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMC200043815	K00799	ko00982	Drug metabolism - cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMC200043817	K03002	ko00230	Purine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMC200043817	K03002	ko00240	Pyrimidine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMC200043817	K03002	ko01100	Metabolic pathways	7162	0.	0.76	0.87	1.00
PGSC0003DMC200043817	K03002	ko03020	RNA polymerase	7162	0.	0.76	0.87	1.00
PGSC0003DMC200043823	K11253	ko05322	Systemic lupus erythematosus	906	3.9e-44	0.83	0.88	0.89
PGSC0003DMC200043824	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200043826	K00600	ko00260	Glycine, serine and threonine metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200043826	K00600	ko00460	Cyanoamino acid metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200043826	K00600	ko00670	One carbon pool by folate	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200043826	K00600	ko00680	Methane metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200043826	K00600	ko01100	Metabolic pathways	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200043826	K00600	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMC200047642	K00475	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMC200047642	K00475	ko01100	Metabolic pathways	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMC200047642	K00475	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMC200047645	K00475	ko00941	Flavonoid biosynthesis	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMC200047645	K00475	ko01100	Metabolic pathways	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMC200047645	K00475	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMC200047652	K12524	ko00260	Glycine, serine and threonine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMC200047652	K12524	ko00270	Cysteine and methionine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMC200047652	K12524	ko00300	Lysine biosynthesis	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMC200047652	K12524	ko01100	Metabolic pathways	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMC200047652	K12524	ko01110	Biosynthesis of secondary metabolites	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMC200047658	K04532	ko05010	Alzheimer's disease	3133	5.7e-167	0.80	0.88	1.00
PGSC0003DMC200047659	K04532	ko05010	Alzheimer's disease	2944	1.5e-156	0.84	0.92	0.98
PGSC0003DMC200047660	K04532	ko05010	Alzheimer's disease	3680	3.9e-197	0.81	0.90	1.00
PGSC0003DMC200047661	K04532	ko05010	Alzheimer's disease	3711	7.6e-199	0.83	0.92	1.00
PGSC0003DMC200047662	K03133	ko03022	Basal transcription factors	1195	4.5e-60	0.76	0.90	0.99
PGSC0003DMC200047665	K05282	ko00904	Diterpenoid biosynthesis	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMC200047665	K05282	ko01100	Metabolic pathways	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMC200047665	K05282	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMC200047667	K05282	ko00904	Diterpenoid biosynthesis	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMC200047667	K05282	ko01100	Metabolic pathways	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMC200047667	K05282	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMC200047668	K05282	ko00904	Diterpenoid biosynthesis	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMC200047668	K05282	ko01100	Metabolic pathways	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMC200047668	K05282	ko01110	Biosynthesis of secondary metabolites	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMC200006151	K01051	ko00040	Pentose and glucuronate interconversions	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMC200006151	K01051	ko00500	Starch and sucrose metabolism	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMC200006151	K01051	ko01100	Metabolic pathways	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMC200006152	K06654	ko04111	Cell cycle - yeast	284	7.9e-10	0.33	0.55	0.70
PGSC0003DMC200006160	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.50
PGSC0003DMC200006161	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.43
PGSC0003DMC200006164	K00021	ko00900	Terpenoid backbone biosynthesis	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMC200006164	K00021	ko01100	Metabolic pathways	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMC200006164	K00021	ko01110	Biosynthesis of secondary metabolites	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMC200006167	K07407	ko00052	Galactose metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMC200006167	K07407	ko00561	Glycerolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMC200006167	K07407	ko00600	Sphingolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMC200006167	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMC200006168	K07407	ko00052	Galactose metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMC200006168	K07407	ko00561	Glycerolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMC200006168	K07407	ko00600	Sphingolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMC200006168	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMC200006170	K02936	ko03010	Ribosome	1872	2.0e-97	0.86	0.94	0.99
PGSC0003DMC200006171	K05765	ko04360	Axon guidance	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMC200006171	K05765	ko04666	Fc gamma R-mediated phagocytosis	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMC200006171	K05765	ko04810	Regulation of actin cytoskeleton	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMC200006172	K01834	ko00010	Glycolysis / Gluconeogenesis	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMC200006172	K01834	ko01100	Metabolic pathways	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMC200006172	K01834	ko01110	Biosynthesis of secondary metabolites	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMC200006173	K01834	ko00010	Glycolysis / Gluconeogenesis	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMC200006173	K01834	ko01100	Metabolic pathways	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMC200006173	K01834	ko01110	Biosynthesis of secondary metabolites	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMC200012603	K07424	ko00140	Steroid hormone biosynthesis	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00591	Linoleic acid metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00830	Retinol metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00982	Drug metabolism - cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko00983	Drug metabolism - other enzymes	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012603	K07424	ko01100	Metabolic pathways	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMC200012613	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMC200012613	K00517	ko00626	Naphthalene and anthracene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMC200012613	K00517	ko00903	Limonene and pinene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMC200012613	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMC200012613	K00517	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMC200012614	K02943	ko03010	Ribosome	814	4.6e-39	0.88	0.96	0.99
PGSC0003DMC200012615	K02943	ko03010	Ribosome	632	5.0e-29	0.87	0.96	0.72
PGSC0003DMC200012619	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMC200012619	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMC200012626	K00679	ko00561	Glycerolipid metabolism	1393	5.4e-71	0.37	0.55	0.84
PGSC0003DMC200029584	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.0e-12	0.31	0.47	0.65
PGSC0003DMC200029585	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.6e-13	0.31	0.47	0.75
PGSC0003DMC200029588	K02084	ko04115	p53 signaling pathway	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko04210	Apoptosis	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko05010	Alzheimer's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko05012	Parkinson's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko05016	Huntington's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029588	K02084	ko05222	Small cell lung cancer	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMC200029590	K02084	ko04115	p53 signaling pathway	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko04210	Apoptosis	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko05010	Alzheimer's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko05012	Parkinson's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko05016	Huntington's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029590	K02084	ko05222	Small cell lung cancer	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMC200029592	K02084	ko04115	p53 signaling pathway	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko04210	Apoptosis	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko05010	Alzheimer's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko05012	Parkinson's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko05016	Huntington's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029592	K02084	ko05222	Small cell lung cancer	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMC200029603	K02985	ko03010	Ribosome	293	2.5e-10	0.76	0.82	0.49
PGSC0003DMC200060493	K13065	ko00940	Phenylpropanoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMC200060493	K13065	ko00941	Flavonoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMC200060493	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMC200060493	K13065	ko01110	Biosynthesis of secondary metabolites	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMC200060495	K03094	ko04110	Cell cycle	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04111	Cell cycle - yeast	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04114	Oocyte meiosis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04120	Ubiquitin mediated proteolysis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04310	Wnt signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04350	TGF-beta signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060495	K03094	ko04710	Circadian rhythm - mammal	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMC200060503	K01051	ko00040	Pentose and glucuronate interconversions	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMC200060503	K01051	ko00500	Starch and sucrose metabolism	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMC200060503	K01051	ko01100	Metabolic pathways	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMC200042601	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMC200042601	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMC200042601	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMC200042602	K01757	ko00901	Indole alkaloid biosynthesis	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMC200042602	K01757	ko01100	Metabolic pathways	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMC200042602	K01757	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMC200042603	K01757	ko00901	Indole alkaloid biosynthesis	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMC200042603	K01757	ko01100	Metabolic pathways	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMC200042603	K01757	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMC200042604	K01757	ko00901	Indole alkaloid biosynthesis	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMC200042604	K01757	ko01100	Metabolic pathways	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMC200042604	K01757	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMC200042605	K00876	ko00240	Pyrimidine metabolism	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMC200042605	K00876	ko00983	Drug metabolism - other enzymes	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMC200042605	K00876	ko01100	Metabolic pathways	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMC200042624	K11821	ko00380	Tryptophan metabolism	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMC200042624	K11821	ko00966	Glucosinolate biosynthesis	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMC200042624	K11821	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMC200042625	K00754	ko00051	Fructose and mannose metabolism	1606	9.6e-83	0.40	0.60	0.95
PGSC0003DMC200036151	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036151	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036151	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036151	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036151	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036152	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036152	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036152	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036152	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036152	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036153	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036153	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036153	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036153	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036153	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMC200036154	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036154	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036154	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036154	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036154	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036156	K00430	ko00360	Phenylalanine metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMC200036156	K00430	ko00680	Methane metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMC200036156	K00430	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMC200036156	K00430	ko01100	Metabolic pathways	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMC200036156	K00430	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMC200036157	K00430	ko00360	Phenylalanine metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMC200036157	K00430	ko00680	Methane metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMC200036157	K00430	ko00940	Phenylpropanoid biosynthesis	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMC200036157	K00430	ko01100	Metabolic pathways	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMC200036157	K00430	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMC200036158	K00430	ko00360	Phenylalanine metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMC200036158	K00430	ko00680	Methane metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMC200036158	K00430	ko00940	Phenylpropanoid biosynthesis	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMC200036158	K00430	ko01100	Metabolic pathways	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMC200036158	K00430	ko01110	Biosynthesis of secondary metabolites	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMC200036159	K00430	ko00360	Phenylalanine metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMC200036159	K00430	ko00680	Methane metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMC200036159	K00430	ko00940	Phenylpropanoid biosynthesis	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMC200036159	K00430	ko01100	Metabolic pathways	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMC200036159	K00430	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMC200036166	K02995	ko03010	Ribosome	1669	3.2e-86	0.90	0.93	0.99
PGSC0003DMC200036170	K12126	ko04712	Circadian rhythm - plant	291	5.7e-08	0.30	0.54	0.38
PGSC0003DMC200036172	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMC200036172	K00517	ko00626	Naphthalene and anthracene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMC200036172	K00517	ko00903	Limonene and pinene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMC200036172	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMC200036172	K00517	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMC200036173	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMC200036173	K00517	ko00626	Naphthalene and anthracene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMC200036173	K00517	ko00903	Limonene and pinene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMC200036173	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMC200036173	K00517	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMC200036174	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMC200036174	K00517	ko00626	Naphthalene and anthracene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMC200036174	K00517	ko00903	Limonene and pinene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMC200036174	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMC200036174	K00517	ko01110	Biosynthesis of secondary metabolites	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMC200059584	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	439	2.2e-18	0.29	0.51	0.61
PGSC0003DMC200059595	K03006	ko00230	Purine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMC200059595	K03006	ko00240	Pyrimidine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMC200059595	K03006	ko01100	Metabolic pathways	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMC200059595	K03006	ko03020	RNA polymerase	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMC200059595	K03006	ko05016	Huntington's disease	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMC200061698	K08488	ko04130	SNARE interactions in vesicular transport	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMC200061698	K08488	ko04145	Phagosome	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMC200005764	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	568	1.7e-25	0.30	0.50	0.92
PGSC0003DMC200005768	K08516	ko04130	SNARE interactions in vesicular transport	1551	1.0e-79	0.90	0.94	0.99
PGSC0003DMC200005770	K12128	ko04712	Circadian rhythm - plant	405	4.5e-16	0.35	0.54	0.22
PGSC0003DMC200005771	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMC200005772	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMC200005773	K12128	ko04712	Circadian rhythm - plant	405	2.8e-16	0.35	0.54	0.25
PGSC0003DMC200005782	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	689	3.6e-32	0.32	0.54	0.86
PGSC0003DMC200005784	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	502	7.5e-22	0.37	0.57	0.97
PGSC0003DMC200013803	K12356	ko00940	Phenylpropanoid biosynthesis	677	1.7e-31	0.30	0.51	0.95
PGSC0003DMC200013804	K02706	ko00195	Photosynthesis	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMC200013804	K02706	ko01100	Metabolic pathways	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMC200013813	K03715	ko00561	Glycerolipid metabolism	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMC200013813	K03715	ko01100	Metabolic pathways	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMC200013814	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMC200013814	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMC200013815	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMC200013815	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMC200013816	K07432	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMC200013816	K07432	ko01100	Metabolic pathways	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMC200013826	K00799	ko00480	Glutathione metabolism	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMC200013826	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMC200013826	K00799	ko00982	Drug metabolism - cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMC200007353	K12391	ko04142	Lysosome	5879	0.	0.81	0.89	1.00
PGSC0003DMC200007354	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4661	3.0e-251	0.74	0.83	0.97
PGSC0003DMC200007355	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4731	4.2e-255	0.80	0.89	1.00
PGSC0003DMC200007366	K02952	ko03010	Ribosome	1117	9.0e-56	0.80	0.90	0.98
PGSC0003DMC200007371	K02960	ko03010	Ribosome	1134	1.0e-56	0.92	0.98	0.97
PGSC0003DMC200007372	K00128	ko00010	Glycolysis / Gluconeogenesis	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00053	Ascorbate and aldarate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00071	Fatty acid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00280	Valine, leucine and isoleucine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00310	Lysine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00330	Arginine and proline metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00340	Histidine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00380	Tryptophan metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00410	beta-Alanine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00561	Glycerolipid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00620	Pyruvate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00631	1,2-Dichloroethane degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00640	Propanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00641	3-Chloroacrylic acid degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00650	Butanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko00903	Limonene and pinene degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko01100	Metabolic pathways	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007372	K00128	ko01110	Biosynthesis of secondary metabolites	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMC200007373	K00128	ko00010	Glycolysis / Gluconeogenesis	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00053	Ascorbate and aldarate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00071	Fatty acid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00280	Valine, leucine and isoleucine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00310	Lysine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00330	Arginine and proline metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00340	Histidine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00380	Tryptophan metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00410	beta-Alanine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00561	Glycerolipid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00620	Pyruvate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00631	1,2-Dichloroethane degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00640	Propanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00641	3-Chloroacrylic acid degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00650	Butanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko00903	Limonene and pinene degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko01100	Metabolic pathways	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200007373	K00128	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMC200017648	K08852	ko05010	Alzheimer's disease	947	2.1e-46	0.74	0.87	0.92
PGSC0003DMC200017649	K08852	ko05010	Alzheimer's disease	3640	6.2e-195	0.53	0.67	1.00
PGSC0003DMC200017650	K08852	ko05010	Alzheimer's disease	3262	4.4e-174	0.56	0.69	0.99
PGSC0003DMC200017651	K08852	ko05010	Alzheimer's disease	1351	1.1e-68	0.43	0.58	0.97
PGSC0003DMC200017652	K05298	ko00710	Carbon fixation in photosynthetic organisms	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMC200017652	K05298	ko01100	Metabolic pathways	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMC200017669	K12741	ko03040	Spliceosome	341	5.7e-13	0.29	0.40	0.80
PGSC0003DMC200041221	K10256	ko01040	Biosynthesis of unsaturated fatty acids	776	5.8e-37	0.74	0.87	0.98
PGSC0003DMC200041222	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2416	2.0e-127	0.68	0.84	0.99
PGSC0003DMC200041223	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMC200041233	K09755	ko00940	Phenylpropanoid biosynthesis	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMC200041233	K09755	ko01100	Metabolic pathways	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMC200041233	K09755	ko01110	Biosynthesis of secondary metabolites	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMC200041234	K09755	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMC200041234	K09755	ko01100	Metabolic pathways	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMC200041234	K09755	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMC200041236	K07750	ko00100	Steroid biosynthesis	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMC200041236	K07750	ko01100	Metabolic pathways	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMC200041237	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2314	8.5e-122	0.67	0.80	1.00
PGSC0003DMC200041238	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMC200041239	K10256	ko01040	Biosynthesis of unsaturated fatty acids	802	2.1e-38	0.67	0.78	0.99
PGSC0003DMC200041240	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1081	8.7e-54	0.74	0.89	0.99
PGSC0003DMC200041241	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1658	1.3e-85	0.71	0.85	0.97
PGSC0003DMC200041242	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2390	5.5e-126	0.68	0.82	0.99
PGSC0003DMC200041243	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2393	3.8e-126	0.68	0.81	0.99
PGSC0003DMC200041244	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.82	0.98
PGSC0003DMC200041245	K00059	ko00061	Fatty acid biosynthesis	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMC200041245	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMC200041245	K00059	ko01100	Metabolic pathways	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMC200041246	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1377	4.1e-70	0.71	0.86	0.60
PGSC0003DMC200041248	K05282	ko00904	Diterpenoid biosynthesis	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMC200041248	K05282	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMC200041248	K05282	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMC200041249	K02933	ko03010	Ribosome	1507	2.8e-77	0.78	0.90	1.00
PGSC0003DMC200041250	K01955	ko00240	Pyrimidine metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMC200041250	K01955	ko00250	Alanine, aspartate and glutamate metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMC200041250	K01955	ko01100	Metabolic pathways	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMC200046541	K02084	ko04115	p53 signaling pathway	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko04210	Apoptosis	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko05010	Alzheimer's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko05012	Parkinson's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko05016	Huntington's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046541	K02084	ko05222	Small cell lung cancer	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMC200046545	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMC200046545	K00122	ko00680	Methane metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMC200046545	K00122	ko01100	Metabolic pathways	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMC200046546	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMC200046546	K00122	ko00680	Methane metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMC200046546	K00122	ko01100	Metabolic pathways	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMC200046547	K10760	ko00908	Zeatin biosynthesis	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMC200046547	K10760	ko01100	Metabolic pathways	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMC200046547	K10760	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMC200050582	K05749	ko04810	Regulation of actin cytoskeleton	5915	0.	0.83	0.93	1.00
PGSC0003DMC200050583	K05749	ko04810	Regulation of actin cytoskeleton	2319	4.5e-122	0.92	0.98	0.41
PGSC0003DMC200050584	K05749	ko04810	Regulation of actin cytoskeleton	2627	4.7e-139	0.90	0.96	0.98
PGSC0003DMC200050593	K01590	ko00340	Histidine metabolism	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMC200050593	K01590	ko01100	Metabolic pathways	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMC200050593	K01590	ko01110	Biosynthesis of secondary metabolites	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMC200050594	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMC200050594	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMC200050594	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMC200050595	K01590	ko00340	Histidine metabolism	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMC200050595	K01590	ko01100	Metabolic pathways	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMC200050595	K01590	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMC200050596	K01590	ko00340	Histidine metabolism	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMC200050596	K01590	ko01100	Metabolic pathways	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMC200050596	K01590	ko01110	Biosynthesis of secondary metabolites	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMC200050597	K01590	ko00340	Histidine metabolism	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMC200050597	K01590	ko01100	Metabolic pathways	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMC200050597	K01590	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMC200050598	K01590	ko00340	Histidine metabolism	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMC200050598	K01590	ko01100	Metabolic pathways	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMC200050598	K01590	ko01110	Biosynthesis of secondary metabolites	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMC200050599	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050599	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050599	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050600	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050600	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050600	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMC200050601	K01590	ko00340	Histidine metabolism	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMC200050601	K01590	ko01100	Metabolic pathways	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMC200050601	K01590	ko01110	Biosynthesis of secondary metabolites	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMC200050602	K01590	ko00340	Histidine metabolism	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMC200050602	K01590	ko01100	Metabolic pathways	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMC200050602	K01590	ko01110	Biosynthesis of secondary metabolites	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMC200050603	K01590	ko00340	Histidine metabolism	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMC200050603	K01590	ko01100	Metabolic pathways	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMC200050603	K01590	ko01110	Biosynthesis of secondary metabolites	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMC200050604	K01590	ko00340	Histidine metabolism	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMC200050604	K01590	ko01100	Metabolic pathways	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMC200050604	K01590	ko01110	Biosynthesis of secondary metabolites	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMC200050605	K01590	ko00340	Histidine metabolism	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMC200050605	K01590	ko01100	Metabolic pathways	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMC200050605	K01590	ko01110	Biosynthesis of secondary metabolites	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMC200050606	K01590	ko00340	Histidine metabolism	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMC200050606	K01590	ko01100	Metabolic pathways	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMC200050606	K01590	ko01110	Biosynthesis of secondary metabolites	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMC200034422	K01246	ko03410	Base excision repair	1833	2.9e-95	0.60	0.73	1.00
PGSC0003DMC200034423	K01246	ko03410	Base excision repair	605	1.6e-27	0.49	0.61	0.94
PGSC0003DMC200034425	K05391	ko04626	Plant-pathogen interaction	3983	7.5e-214	0.70	0.81	0.97
PGSC0003DMC200034431	K09753	ko00940	Phenylpropanoid biosynthesis	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMC200034431	K09753	ko01100	Metabolic pathways	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMC200034431	K09753	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMC200063696	K06631	ko04110	Cell cycle	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMC200063696	K06631	ko04114	Oocyte meiosis	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMC200063696	K06631	ko04914	Progesterone-mediated oocyte maturation	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMC200010021	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMC200010021	K00517	ko00626	Naphthalene and anthracene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMC200010021	K00517	ko00903	Limonene and pinene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMC200010021	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMC200010021	K00517	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMC200010022	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMC200010022	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMC200010022	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMC200010022	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMC200010022	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMC200010023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMC200010023	K00517	ko00626	Naphthalene and anthracene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMC200010023	K00517	ko00903	Limonene and pinene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMC200010023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMC200010023	K00517	ko01110	Biosynthesis of secondary metabolites	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMC200010024	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMC200010024	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMC200010024	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMC200010024	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMC200010024	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMC200010025	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMC200010025	K00517	ko00626	Naphthalene and anthracene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMC200010025	K00517	ko00903	Limonene and pinene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMC200010025	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMC200010025	K00517	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMC200010045	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMC200015334	K04077	ko03018	RNA degradation	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMC200015334	K04077	ko04940	Type I diabetes mellitus	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMC200015342	K00001	ko00010	Glycolysis / Gluconeogenesis	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00071	Fatty acid metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00350	Tyrosine metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00624	1- and 2-Methylnaphthalene degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00641	3-Chloroacrylic acid degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00830	Retinol metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko00982	Drug metabolism - cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko01100	Metabolic pathways	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015342	K00001	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMC200015343	K00001	ko00010	Glycolysis / Gluconeogenesis	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00071	Fatty acid metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00350	Tyrosine metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00641	3-Chloroacrylic acid degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00830	Retinol metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko00982	Drug metabolism - cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko01100	Metabolic pathways	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015343	K00001	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMC200015349	K01199	ko00500	Starch and sucrose metabolism	833	4.1e-40	0.34	0.59	0.74
PGSC0003DMC200015358	K04532	ko05010	Alzheimer's disease	1475	1.6e-75	0.91	0.95	0.94
PGSC0003DMC200015359	K04532	ko05010	Alzheimer's disease	1868	3.4e-97	0.76	0.87	1.00
PGSC0003DMC200015360	K04532	ko05010	Alzheimer's disease	1817	2.2e-94	0.88	0.94	0.87
PGSC0003DMC200003213	K01692	ko00071	Fatty acid metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00280	Valine, leucine and isoleucine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00281	Geraniol degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00310	Lysine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00380	Tryptophan metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00410	beta-Alanine metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00632	Benzoate degradation via CoA ligation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00640	Propanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00650	Butanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00903	Limonene and pinene degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko00930	Caprolactam degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko01100	Metabolic pathways	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003213	K01692	ko01110	Biosynthesis of secondary metabolites	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMC200003214	K01692	ko00071	Fatty acid metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00280	Valine, leucine and isoleucine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00281	Geraniol degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00310	Lysine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00380	Tryptophan metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00410	beta-Alanine metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00632	Benzoate degradation via CoA ligation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00640	Propanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00650	Butanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko00930	Caprolactam degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko01100	Metabolic pathways	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003214	K01692	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMC200003215	K01692	ko00071	Fatty acid metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00280	Valine, leucine and isoleucine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00281	Geraniol degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00310	Lysine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00380	Tryptophan metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00410	beta-Alanine metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00632	Benzoate degradation via CoA ligation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00640	Propanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00650	Butanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00903	Limonene and pinene degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko00930	Caprolactam degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko01100	Metabolic pathways	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003215	K01692	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMC200003219	K08241	ko00592	alpha-Linolenic acid metabolism	302	3.6e-16	0.39	0.53	0.90
PGSC0003DMC200003220	K00799	ko00480	Glutathione metabolism	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMC200003220	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMC200003220	K00799	ko00982	Drug metabolism - cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMC200003221	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMC200003221	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMC200003221	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMC200003222	K01923	ko00230	Purine metabolism	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMC200003222	K01923	ko01100	Metabolic pathways	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMC200003222	K01923	ko01110	Biosynthesis of secondary metabolites	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMC200003226	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMC200003226	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMC200003226	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMC200003227	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003227	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003227	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003228	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003228	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003228	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMC200003229	K00799	ko00480	Glutathione metabolism	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMC200003229	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMC200003229	K00799	ko00982	Drug metabolism - cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMC200003230	K00799	ko00480	Glutathione metabolism	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMC200003230	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMC200003230	K00799	ko00982	Drug metabolism - cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMC200003231	K00799	ko00480	Glutathione metabolism	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMC200003231	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMC200003231	K00799	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMC200032311	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.76
PGSC0003DMC200032316	K09490	ko03060	Protein export	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMC200032316	K09490	ko05020	Prion diseases	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMC200032317	K04461	ko04010	MAPK signaling pathway	474	2.6e-20	0.32	0.47	0.81
PGSC0003DMC200032318	K04461	ko04010	MAPK signaling pathway	548	2.2e-24	0.35	0.52	0.79
PGSC0003DMC200032323	K12478	ko04144	Endocytosis	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMC200032323	K12478	ko04145	Phagosome	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMC200032324	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMC200032324	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMC200032325	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMC200032325	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMC200032328	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMC200032328	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMC200032329	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMC200032329	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMC200032332	K12194	ko04144	Endocytosis	1608	7.4e-83	0.91	0.94	1.00
PGSC0003DMC200032333	K12194	ko04144	Endocytosis	971	1.0e-47	0.91	0.95	0.99
PGSC0003DMC200032334	K05759	ko04810	Regulation of actin cytoskeleton	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMC200032334	K05759	ko05131	Shigellosis	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMC200032335	K02087	ko04110	Cell cycle	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMC200032335	K02087	ko04114	Oocyte meiosis	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMC200032335	K02087	ko04115	p53 signaling pathway	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMC200032335	K02087	ko04540	Gap junction	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMC200032335	K02087	ko04914	Progesterone-mediated oocyte maturation	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMC200032336	K02087	ko04110	Cell cycle	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMC200032336	K02087	ko04114	Oocyte meiosis	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMC200032336	K02087	ko04115	p53 signaling pathway	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMC200032336	K02087	ko04540	Gap junction	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMC200032336	K02087	ko04914	Progesterone-mediated oocyte maturation	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMC200032340	K01051	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMC200032340	K01051	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMC200032340	K01051	ko01100	Metabolic pathways	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMC200037321	K00759	ko00230	Purine metabolism	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMC200037321	K00759	ko01100	Metabolic pathways	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMC200037322	K11866	ko04144	Endocytosis	271	7.3e-06	0.27	0.40	0.53
PGSC0003DMC200037327	K00599	ko00340	Histidine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMC200037327	K00599	ko00350	Tyrosine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMC200037327	K00599	ko00450	Selenoamino acid metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMC200037327	K00599	ko00626	Naphthalene and anthracene degradation	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMC200037328	K00599	ko00340	Histidine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMC200037328	K00599	ko00350	Tyrosine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMC200037328	K00599	ko00450	Selenoamino acid metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMC200037328	K00599	ko00626	Naphthalene and anthracene degradation	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMC200037329	K00599	ko00340	Histidine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMC200037329	K00599	ko00350	Tyrosine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMC200037329	K00599	ko00450	Selenoamino acid metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMC200037329	K00599	ko00626	Naphthalene and anthracene degradation	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMC200037337	K12347	ko04142	Lysosome	240	4.8e-07	0.51	0.63	0.97
PGSC0003DMC200037338	K12347	ko04142	Lysosome	3209	3.7e-171	0.76	0.86	0.94
PGSC0003DMC200037339	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMC200037339	K00517	ko00626	Naphthalene and anthracene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMC200037339	K00517	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMC200037339	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMC200037339	K00517	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMC200037340	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMC200037340	K00517	ko00626	Naphthalene and anthracene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMC200037340	K00517	ko00903	Limonene and pinene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMC200037340	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMC200037340	K00517	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMC200037341	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMC200037341	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMC200037341	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMC200037341	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMC200037341	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMC200037342	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMC200037342	K00517	ko00626	Naphthalene and anthracene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMC200037342	K00517	ko00903	Limonene and pinene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMC200037342	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMC200037342	K00517	ko01110	Biosynthesis of secondary metabolites	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMC200037343	K04508	ko04310	Wnt signaling pathway	3643	4.3e-195	0.71	0.84	1.00
PGSC0003DMC200037348	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037348	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037348	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037348	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037348	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037349	K10775	ko00360	Phenylalanine metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMC200037349	K10775	ko00910	Nitrogen metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMC200037349	K10775	ko00940	Phenylpropanoid biosynthesis	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMC200037349	K10775	ko01100	Metabolic pathways	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMC200037349	K10775	ko01110	Biosynthesis of secondary metabolites	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMC200037350	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037350	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037350	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037350	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200037350	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMC200043831	K00970	ko03018	RNA degradation	226	6.2e-06	0.30	0.50	0.71
PGSC0003DMC200043832	K02303	ko00860	Porphyrin and chlorophyll metabolism	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMC200043832	K02303	ko01100	Metabolic pathways	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMC200043832	K02303	ko01110	Biosynthesis of secondary metabolites	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMC200043833	K06670	ko04110	Cell cycle	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMC200043833	K06670	ko04111	Cell cycle - yeast	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMC200043842	K11253	ko05322	Systemic lupus erythematosus	443	1.3e-18	0.82	0.89	0.88
PGSC0003DMC200043843	K11253	ko05322	Systemic lupus erythematosus	449	6.3e-19	0.95	0.95	0.58
PGSC0003DMC200043844	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200043859	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMC200043859	K00517	ko00626	Naphthalene and anthracene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMC200043859	K00517	ko00903	Limonene and pinene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMC200043859	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMC200043859	K00517	ko01110	Biosynthesis of secondary metabolites	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMC200043860	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMC200043860	K00517	ko00626	Naphthalene and anthracene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMC200043860	K00517	ko00903	Limonene and pinene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMC200043860	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMC200043860	K00517	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMC200035685	K05577	ko00190	Oxidative phosphorylation	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMC200035685	K05577	ko01100	Metabolic pathways	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMC200035691	K05575	ko00190	Oxidative phosphorylation	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMC200035691	K05575	ko01100	Metabolic pathways	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMC200029491	K01404	ko05140	Leishmaniasis	5417	6.1e-293	0.75	0.85	0.96
PGSC0003DMC200029492	K01404	ko05140	Leishmaniasis	5219	5.1e-282	0.80	0.89	1.00
PGSC0003DMC200029494	K00754	ko00051	Fructose and mannose metabolism	293	4.9e-10	0.29	0.49	0.54
PGSC0003DMC200029502	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMC200029503	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMC200029507	K03801	ko00785	Lipoic acid metabolism	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMC200029507	K03801	ko01100	Metabolic pathways	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMC200029508	K03801	ko00785	Lipoic acid metabolism	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMC200029508	K03801	ko01100	Metabolic pathways	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMC200029509	K03801	ko00785	Lipoic acid metabolism	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMC200029509	K03801	ko01100	Metabolic pathways	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMC200029510	K03801	ko00785	Lipoic acid metabolism	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMC200029510	K03801	ko01100	Metabolic pathways	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMC200029511	K01723	ko00592	alpha-Linolenic acid metabolism	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMC200029511	K01723	ko01100	Metabolic pathways	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMC200029514	K00655	ko00561	Glycerolipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMC200029514	K00655	ko00564	Glycerophospholipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMC200029514	K00655	ko01100	Metabolic pathways	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMC200029519	K01099	ko00562	Inositol phosphate metabolism	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMC200029519	K01099	ko01100	Metabolic pathways	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMC200029519	K01099	ko04070	Phosphatidylinositol signaling system	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMC200006139	K01768	ko00230	Purine metabolism	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMC200006139	K01768	ko04113	Meiosis - yeast	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMC200006144	K11778	ko00900	Terpenoid backbone biosynthesis	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMC200006144	K11778	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMC200006145	K11778	ko00900	Terpenoid backbone biosynthesis	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMC200006145	K11778	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMC200006146	K11778	ko00900	Terpenoid backbone biosynthesis	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMC200006146	K11778	ko01110	Biosynthesis of secondary metabolites	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMC200012637	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMC200012638	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMC200012639	K10597	ko04120	Ubiquitin mediated proteolysis	6473	0.	0.77	0.86	1.00
PGSC0003DMC200012643	K12193	ko04144	Endocytosis	1571	8.2e-81	0.86	0.93	1.00
PGSC0003DMC200012660	K03368	ko00512	O-Glycan biosynthesis	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMC200012660	K03368	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMC200012660	K03368	ko00603	Glycosphingolipid biosynthesis - globo series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMC200012660	K03368	ko00604	Glycosphingolipid biosynthesis - ganglio series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMC200012660	K03368	ko01100	Metabolic pathways	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMC200060393	K06627	ko04110	Cell cycle	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMC200060393	K06627	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMC200045302	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMC200045302	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMC200045302	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMC200045307	K00939	ko00230	Purine metabolism	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMC200045307	K00939	ko01100	Metabolic pathways	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMC200045307	K00939	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMC200045308	K03800	ko00785	Lipoic acid metabolism	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMC200045308	K03800	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMC200045315	K09843	ko00906	Carotenoid biosynthesis	1011	6.3e-50	0.34	0.54	0.99
PGSC0003DMC200045324	K12876	ko03040	Spliceosome	1301	6.4e-66	0.77	0.87	0.99
PGSC0003DMC200040053	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMC200040053	K00517	ko00626	Naphthalene and anthracene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMC200040053	K00517	ko00903	Limonene and pinene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMC200040053	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMC200040053	K00517	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMC200040068	K01259	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.83	0.90	0.81
PGSC0003DMC200040069	K01259	ko00330	Arginine and proline metabolism	2374	4.2e-125	0.82	0.91	0.82
PGSC0003DMC200040074	K12821	ko03040	Spliceosome	665	8.5e-31	0.43	0.66	1.00
PGSC0003DMC200040075	K12821	ko03040	Spliceosome	3260	5.7e-174	0.53	0.68	0.96
PGSC0003DMC200020492	K10570	ko03420	Nucleotide excision repair	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMC200020492	K10570	ko04120	Ubiquitin mediated proteolysis	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMC200020493	K10570	ko03420	Nucleotide excision repair	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMC200020493	K10570	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMC200020494	K10570	ko03420	Nucleotide excision repair	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMC200020494	K10570	ko04120	Ubiquitin mediated proteolysis	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMC200020495	K08332	ko04140	Regulation of autophagy	363	3.9e-14	0.28	0.52	0.89
PGSC0003DMC200020506	K06627	ko04110	Cell cycle	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMC200020506	K06627	ko04914	Progesterone-mediated oocyte maturation	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMC200020510	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.0e-12	0.31	0.49	0.31
PGSC0003DMC200020513	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMC200020514	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMC200016503	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMC200016503	K01755	ko00330	Arginine and proline metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMC200016503	K01755	ko01100	Metabolic pathways	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMC200016503	K01755	ko01110	Biosynthesis of secondary metabolites	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMC200016504	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMC200016504	K01755	ko00330	Arginine and proline metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMC200016504	K01755	ko01100	Metabolic pathways	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMC200016504	K01755	ko01110	Biosynthesis of secondary metabolites	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMC200016513	K02893	ko03010	Ribosome	225	1.4e-06	0.29	0.45	0.85
PGSC0003DMC200016518	K12402	ko04142	Lysosome	1830	4.2e-95	0.88	0.96	1.00
PGSC0003DMC200016519	K12402	ko04142	Lysosome	2309	1.6e-121	0.86	0.94	1.00
PGSC0003DMC200016520	K12402	ko04142	Lysosome	3386	6.4e-181	0.87	0.95	1.00
PGSC0003DMC200016521	K12402	ko04142	Lysosome	3369	5.5e-180	0.87	0.94	1.00
PGSC0003DMC200016528	K03132	ko03022	Basal transcription factors	1018	2.6e-50	0.66	0.79	0.99
PGSC0003DMC200011259	K09755	ko00940	Phenylpropanoid biosynthesis	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMC200011259	K09755	ko01100	Metabolic pathways	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMC200011259	K09755	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMC200011260	K05280	ko00941	Flavonoid biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMC200011260	K05280	ko00944	Flavone and flavonol biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMC200011260	K05280	ko01100	Metabolic pathways	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMC200011260	K05280	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMC200011261	K11294	ko05130	Pathogenic Escherichia coli infection	244	2.1e-07	0.36	0.50	0.93
PGSC0003DMC200011263	K12741	ko03040	Spliceosome	647	7.5e-30	0.35	0.47	0.71
PGSC0003DMC200011272	K09755	ko00940	Phenylpropanoid biosynthesis	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMC200011272	K09755	ko01100	Metabolic pathways	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMC200011272	K09755	ko01110	Biosynthesis of secondary metabolites	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMC200011273	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMC200011273	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMC200011273	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMC200011273	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMC200011274	K05280	ko00941	Flavonoid biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMC200011274	K05280	ko00944	Flavone and flavonol biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMC200011274	K05280	ko01100	Metabolic pathways	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMC200011274	K05280	ko01110	Biosynthesis of secondary metabolites	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMC200011277	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMC200011279	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMC200064984	K01193	ko00052	Galactose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMC200064984	K01193	ko00500	Starch and sucrose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMC200064984	K01193	ko01100	Metabolic pathways	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMC200064989	K10760	ko00908	Zeatin biosynthesis	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMC200064989	K10760	ko01100	Metabolic pathways	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMC200064989	K10760	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMC200050495	K02149	ko00190	Oxidative phosphorylation	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050495	K02149	ko01100	Metabolic pathways	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050495	K02149	ko04145	Phagosome	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050495	K02149	ko04966	Collecting duct acid secretion	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050495	K02149	ko05110	Vibrio cholerae infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050495	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMC200050503	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050503	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050503	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050503	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050504	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050504	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050504	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050504	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMC200050514	K00939	ko00230	Purine metabolism	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMC200050514	K00939	ko01100	Metabolic pathways	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMC200050514	K00939	ko01110	Biosynthesis of secondary metabolites	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMC200050515	K00939	ko00230	Purine metabolism	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMC200050515	K00939	ko01100	Metabolic pathways	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMC200050515	K00939	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMC200050516	K12129	ko04712	Circadian rhythm - plant	3484	2.5e-186	0.58	0.72	0.99
PGSC0003DMC200050520	K01423	ko00310	Lysine degradation	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMC200050520	K01423	ko00780	Biotin metabolism	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMC200050520	K01423	ko01100	Metabolic pathways	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMC200041256	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMC200041256	K12567	ko05414	Dilated cardiomyopathy	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMC200041257	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMC200041257	K12567	ko05414	Dilated cardiomyopathy	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMC200041258	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMC200041258	K12567	ko05414	Dilated cardiomyopathy	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMC200041259	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMC200041259	K12567	ko05414	Dilated cardiomyopathy	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMC200041260	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMC200041260	K12567	ko05414	Dilated cardiomyopathy	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMC200041261	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	467	2.0e-19	0.31	0.44	0.99
PGSC0003DMC200041262	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMC200041262	K12567	ko05414	Dilated cardiomyopathy	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMC200041263	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	504	1.5e-21	0.31	0.44	0.90
PGSC0003DMC200041277	K01051	ko00040	Pentose and glucuronate interconversions	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMC200041277	K01051	ko00500	Starch and sucrose metabolism	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMC200041277	K01051	ko01100	Metabolic pathways	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMC200041278	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMC200041278	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMC200041279	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMC200041279	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMC200041280	K08507	ko04130	SNARE interactions in vesicular transport	263	1.1e-08	0.28	0.47	0.99
PGSC0003DMC200046501	K12657	ko00330	Arginine and proline metabolism	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMC200046501	K12657	ko01100	Metabolic pathways	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMC200046502	K12657	ko00330	Arginine and proline metabolism	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMC200046502	K12657	ko01100	Metabolic pathways	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMC200046503	K12657	ko00330	Arginine and proline metabolism	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMC200046503	K12657	ko01100	Metabolic pathways	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMC200046504	K12657	ko00330	Arginine and proline metabolism	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMC200046504	K12657	ko01100	Metabolic pathways	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMC200046507	K10760	ko00908	Zeatin biosynthesis	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMC200046507	K10760	ko01100	Metabolic pathways	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMC200046507	K10760	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMC200046509	K02704	ko00195	Photosynthesis	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMC200046509	K02704	ko01100	Metabolic pathways	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMC200046511	K11818	ko00380	Tryptophan metabolism	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMC200046511	K11818	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMC200046511	K11818	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMC200046512	K11818	ko00380	Tryptophan metabolism	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMC200046512	K11818	ko00966	Glucosinolate biosynthesis	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMC200046512	K11818	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMC200046519	K07199	ko04910	Insulin signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMC200046519	K07199	ko04920	Adipocytokine signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMC200046519	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMC200046528	K10843	ko03420	Nucleotide excision repair	4741	1.2e-255	0.75	0.84	1.00
PGSC0003DMC200046529	K01507	ko00190	Oxidative phosphorylation	2008	6.4e-105	0.78	0.86	1.00
PGSC0003DMC200010052	K07424	ko00140	Steroid hormone biosynthesis	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00591	Linoleic acid metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00830	Retinol metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00982	Drug metabolism - cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko00983	Drug metabolism - other enzymes	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010052	K07424	ko01100	Metabolic pathways	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMC200010053	K07424	ko00140	Steroid hormone biosynthesis	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00591	Linoleic acid metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00830	Retinol metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00982	Drug metabolism - cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko00983	Drug metabolism - other enzymes	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010053	K07424	ko01100	Metabolic pathways	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMC200010056	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMC200010057	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMC200010060	K04124	ko00904	Diterpenoid biosynthesis	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMC200010060	K04124	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMC200010061	K04124	ko00904	Diterpenoid biosynthesis	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMC200010061	K04124	ko01110	Biosynthesis of secondary metabolites	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMC200010071	K03136	ko03022	Basal transcription factors	2874	1.1e-152	0.73	0.85	1.00
PGSC0003DMC200010072	K03136	ko03022	Basal transcription factors	736	9.3e-35	0.61	0.75	0.99
PGSC0003DMC200010073	K03136	ko03022	Basal transcription factors	1268	4.2e-64	0.86	0.95	0.96
PGSC0003DMC200015309	K00549	ko00270	Cysteine and methionine metabolism	5723	0.	0.88	0.94	1.00
PGSC0003DMC200015309	K00549	ko01100	Metabolic pathways	5723	0.	0.88	0.94	1.00
PGSC0003DMC200015309	K00549	ko01110	Biosynthesis of secondary metabolites	5723	0.	0.88	0.94	1.00
PGSC0003DMC200015310	K00549	ko00270	Cysteine and methionine metabolism	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMC200015310	K00549	ko01100	Metabolic pathways	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMC200015310	K00549	ko01110	Biosynthesis of secondary metabolites	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMC200015312	K11817	ko00380	Tryptophan metabolism	6807	0.	0.61	0.78	0.99
PGSC0003DMC200015325	K02335	ko00230	Purine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko00240	Pyrimidine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko01100	Metabolic pathways	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko03030	DNA replication	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko03410	Base excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko03420	Nucleotide excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015325	K02335	ko03440	Homologous recombination	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMC200015326	K02335	ko00230	Purine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko00240	Pyrimidine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko01100	Metabolic pathways	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko03030	DNA replication	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko03410	Base excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko03420	Nucleotide excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015326	K02335	ko03440	Homologous recombination	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMC200015327	K02335	ko00230	Purine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko00240	Pyrimidine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko01100	Metabolic pathways	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko03030	DNA replication	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko03410	Base excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko03420	Nucleotide excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200015327	K02335	ko03440	Homologous recombination	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMC200031122	K10643	ko03018	RNA degradation	975	6.1e-48	0.65	0.79	0.99
PGSC0003DMC200031125	K02989	ko03010	Ribosome	1444	8.3e-74	0.84	0.90	0.99
PGSC0003DMC200031134	K07904	ko04144	Endocytosis	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMC200031134	K07904	ko04962	Vasopressin-regulated water reabsorption	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMC200031135	K07904	ko04144	Endocytosis	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMC200031135	K07904	ko04962	Vasopressin-regulated water reabsorption	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMC200031137	K04460	ko04010	MAPK signaling pathway	369	1.6e-14	0.36	0.54	0.36
PGSC0003DMC200031138	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMC200031138	K00517	ko00626	Naphthalene and anthracene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMC200031138	K00517	ko00903	Limonene and pinene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMC200031138	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMC200031138	K00517	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMC200059505	K13082	ko00941	Flavonoid biosynthesis	550	1.7e-24	0.39	0.64	0.98
PGSC0003DMC200042635	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMC200042635	K00517	ko00626	Naphthalene and anthracene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMC200042635	K00517	ko00903	Limonene and pinene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMC200042635	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMC200042635	K00517	ko01110	Biosynthesis of secondary metabolites	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMC200042640	K07466	ko03030	DNA replication	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMC200042640	K07466	ko03420	Nucleotide excision repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMC200042640	K07466	ko03430	Mismatch repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMC200042640	K07466	ko03440	Homologous recombination	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMC200042644	K06060	ko04330	Notch signaling pathway	827	8.9e-40	0.36	0.57	0.93
PGSC0003DMC200042645	K04505	ko04310	Wnt signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMC200042645	K04505	ko04330	Notch signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMC200042645	K04505	ko04722	Neurotrophin signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMC200042645	K04505	ko05010	Alzheimer's disease	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMC200042647	K02136	ko00190	Oxidative phosphorylation	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMC200042647	K02136	ko01100	Metabolic pathways	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMC200042647	K02136	ko05010	Alzheimer's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMC200042647	K02136	ko05012	Parkinson's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMC200042647	K02136	ko05016	Huntington's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMC200042654	K05280	ko00941	Flavonoid biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMC200042654	K05280	ko00944	Flavone and flavonol biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMC200042654	K05280	ko01100	Metabolic pathways	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMC200042654	K05280	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMC200042655	K05280	ko00941	Flavonoid biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMC200042655	K05280	ko00944	Flavone and flavonol biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMC200042655	K05280	ko01100	Metabolic pathways	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMC200042655	K05280	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMC200042656	K05280	ko00941	Flavonoid biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMC200042656	K05280	ko00944	Flavone and flavonol biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMC200042656	K05280	ko01100	Metabolic pathways	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMC200042656	K05280	ko01110	Biosynthesis of secondary metabolites	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMC200036145	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036145	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036145	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036145	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036145	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036146	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036146	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036146	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036146	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036146	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMC200036147	K00430	ko00360	Phenylalanine metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMC200036147	K00430	ko00680	Methane metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMC200036147	K00430	ko00940	Phenylpropanoid biosynthesis	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMC200036147	K00430	ko01100	Metabolic pathways	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMC200036147	K00430	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMC200036148	K00430	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMC200036148	K00430	ko00680	Methane metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMC200036148	K00430	ko00940	Phenylpropanoid biosynthesis	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMC200036148	K00430	ko01100	Metabolic pathways	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMC200036148	K00430	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMC200036149	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036149	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036149	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036149	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036149	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036150	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036150	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036150	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036150	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200036150	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMC200061609	K04508	ko04310	Wnt signaling pathway	470	3.8e-27	0.53	0.67	0.97
PGSC0003DMC200061614	K12493	ko04144	Endocytosis	760	7.9e-36	0.35	0.46	0.75
PGSC0003DMC200013832	K01115	ko00564	Glycerophospholipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013832	K01115	ko00565	Ether lipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013832	K01115	ko01100	Metabolic pathways	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013832	K01115	ko04144	Endocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013832	K01115	ko04666	Fc gamma R-mediated phagocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013832	K01115	ko04912	GnRH signaling pathway	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMC200013833	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013833	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013834	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMC200013835	K01692	ko00071	Fatty acid metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00280	Valine, leucine and isoleucine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00281	Geraniol degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00310	Lysine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00380	Tryptophan metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00410	beta-Alanine metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00632	Benzoate degradation via CoA ligation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00640	Propanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00650	Butanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko00930	Caprolactam degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko01100	Metabolic pathways	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013835	K01692	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMC200013843	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMC200013848	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMC200013848	K00053	ko00770	Pantothenate and CoA biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMC200013848	K00053	ko01100	Metabolic pathways	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMC200013848	K00053	ko01110	Biosynthesis of secondary metabolites	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMC200013856	K13066	ko00940	Phenylpropanoid biosynthesis	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMC200013856	K13066	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMC200013858	K08139	ko04113	Meiosis - yeast	1138	6.2e-57	0.36	0.61	0.86
PGSC0003DMC200007321	K02641	ko00195	Photosynthesis	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMC200007321	K02641	ko01100	Metabolic pathways	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMC200007322	K02641	ko00195	Photosynthesis	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMC200007322	K02641	ko01100	Metabolic pathways	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMC200007324	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMC200007324	K01602	ko00710	Carbon fixation in photosynthetic organisms	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMC200007324	K01602	ko01100	Metabolic pathways	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMC200007328	K01895	ko00010	Glycolysis / Gluconeogenesis	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007328	K01895	ko00620	Pyruvate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007328	K01895	ko00640	Propanoate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007328	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007328	K01895	ko01100	Metabolic pathways	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007328	K01895	ko01110	Biosynthesis of secondary metabolites	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMC200007329	K01895	ko00010	Glycolysis / Gluconeogenesis	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007329	K01895	ko00620	Pyruvate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007329	K01895	ko00640	Propanoate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007329	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007329	K01895	ko01100	Metabolic pathways	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007329	K01895	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMC200007330	K01895	ko00010	Glycolysis / Gluconeogenesis	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007330	K01895	ko00620	Pyruvate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007330	K01895	ko00640	Propanoate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007330	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007330	K01895	ko01100	Metabolic pathways	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007330	K01895	ko01110	Biosynthesis of secondary metabolites	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMC200007331	K01535	ko00190	Oxidative phosphorylation	7118	0.	0.89	0.95	0.99
PGSC0003DMC200007332	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMC200007332	K09833	ko01100	Metabolic pathways	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMC200007332	K09833	ko01110	Biosynthesis of secondary metabolites	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMC200007333	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMC200007333	K09833	ko01100	Metabolic pathways	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMC200007333	K09833	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMC200007334	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMC200007334	K09833	ko01100	Metabolic pathways	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMC200007334	K09833	ko01110	Biosynthesis of secondary metabolites	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMC200007337	K01423	ko00310	Lysine degradation	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMC200007337	K01423	ko00780	Biotin metabolism	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMC200007337	K01423	ko01100	Metabolic pathways	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMC200007338	K12115	ko04712	Circadian rhythm - plant	3939	2.0e-211	0.84	0.93	0.87
PGSC0003DMC200007339	K12115	ko04712	Circadian rhythm - plant	4455	7.0e-240	0.82	0.91	0.99
PGSC0003DMC200007340	K04733	ko04210	Apoptosis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMC200007340	K04733	ko04620	Toll-like receptor signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMC200007340	K04733	ko04722	Neurotrophin signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMC200007340	K04733	ko05140	Leishmaniasis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMC200007340	K04733	ko05142	Chagas disease	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMC200007344	K00797	ko00270	Cysteine and methionine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMC200007344	K00797	ko00330	Arginine and proline metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMC200007344	K00797	ko00410	beta-Alanine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMC200007344	K00797	ko00480	Glutathione metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMC200007344	K00797	ko01100	Metabolic pathways	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMC200007347	K00697	ko00500	Starch and sucrose metabolism	5607	0.	0.74	0.86	0.95
PGSC0003DMC200007348	K00697	ko00500	Starch and sucrose metabolism	4997	8.9e-270	0.76	0.90	0.95
PGSC0003DMC200007349	K00697	ko00500	Starch and sucrose metabolism	5058	3.8e-273	0.76	0.89	0.95
PGSC0003DMC200005676	K03939	ko00190	Oxidative phosphorylation	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMC200005676	K03939	ko01100	Metabolic pathways	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMC200005676	K03939	ko05010	Alzheimer's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMC200005676	K03939	ko05012	Parkinson's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMC200005676	K03939	ko05016	Huntington's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMC200005680	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005680	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005681	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMC200005695	K09753	ko00940	Phenylpropanoid biosynthesis	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMC200005695	K09753	ko01100	Metabolic pathways	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMC200005695	K09753	ko01110	Biosynthesis of secondary metabolites	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMC200005696	K09753	ko00940	Phenylpropanoid biosynthesis	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMC200005696	K09753	ko01100	Metabolic pathways	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMC200005696	K09753	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMC200017705	K00100	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017705	K00100	ko00363	Bisphenol A degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017705	K00100	ko00591	Linoleic acid metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017705	K00100	ko00625	Tetrachloroethene degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017705	K00100	ko00650	Butanoate metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017705	K00100	ko01100	Metabolic pathways	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMC200017706	K00100	ko00051	Fructose and mannose metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017706	K00100	ko00363	Bisphenol A degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017706	K00100	ko00591	Linoleic acid metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017706	K00100	ko00625	Tetrachloroethene degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017706	K00100	ko00650	Butanoate metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017706	K00100	ko01100	Metabolic pathways	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMC200017709	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMC200017709	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMC200017709	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMC200017717	K00423	ko00053	Ascorbate and aldarate metabolism	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMC200017717	K00423	ko01100	Metabolic pathways	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMC200017718	K00423	ko00053	Ascorbate and aldarate metabolism	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMC200017718	K00423	ko01100	Metabolic pathways	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMC200017719	K00423	ko00053	Ascorbate and aldarate metabolism	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMC200017719	K00423	ko01100	Metabolic pathways	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMC200017720	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMC200017720	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMC200017720	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMC200017720	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMC200017720	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMC200017721	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMC200017721	K00517	ko00626	Naphthalene and anthracene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMC200017721	K00517	ko00903	Limonene and pinene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMC200017721	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMC200017721	K00517	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMC200017722	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMC200017722	K00517	ko00626	Naphthalene and anthracene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMC200017722	K00517	ko00903	Limonene and pinene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMC200017722	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMC200017722	K00517	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMC200017723	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMC200017723	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMC200017723	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMC200017723	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMC200017723	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMC200017724	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMC200017724	K00517	ko00626	Naphthalene and anthracene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMC200017724	K00517	ko00903	Limonene and pinene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMC200017724	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMC200017724	K00517	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMC200017725	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMC200017725	K00517	ko00626	Naphthalene and anthracene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMC200017725	K00517	ko00903	Limonene and pinene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMC200017725	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMC200017725	K00517	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMC200019310	K03026	ko00230	Purine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMC200019310	K03026	ko00240	Pyrimidine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMC200019310	K03026	ko01100	Metabolic pathways	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMC200019310	K03026	ko03020	RNA polymerase	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMC200019310	K03026	ko04623	Cytosolic DNA-sensing pathway	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMC200019311	K03026	ko00230	Purine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMC200019311	K03026	ko00240	Pyrimidine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMC200019311	K03026	ko01100	Metabolic pathways	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMC200019311	K03026	ko03020	RNA polymerase	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMC200019311	K03026	ko04623	Cytosolic DNA-sensing pathway	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMC200019312	K03026	ko00230	Purine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMC200019312	K03026	ko00240	Pyrimidine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMC200019312	K03026	ko01100	Metabolic pathways	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMC200019312	K03026	ko03020	RNA polymerase	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMC200019312	K03026	ko04623	Cytosolic DNA-sensing pathway	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMC200014347	K13065	ko00940	Phenylpropanoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMC200014347	K13065	ko00941	Flavonoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMC200014347	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMC200014347	K13065	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMC200014350	K00088	ko00230	Purine metabolism	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMC200014350	K00088	ko00983	Drug metabolism - other enzymes	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMC200014350	K00088	ko01100	Metabolic pathways	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMC200014350	K00088	ko01110	Biosynthesis of secondary metabolites	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMC200014351	K06443	ko00906	Carotenoid biosynthesis	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMC200014351	K06443	ko01100	Metabolic pathways	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMC200014351	K06443	ko01110	Biosynthesis of secondary metabolites	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMC200014356	K02183	ko04020	Calcium signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04070	Phosphatidylinositol signaling system	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04114	Oocyte meiosis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04270	Vascular smooth muscle contraction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04626	Plant-pathogen interaction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04720	Long-term potentiation	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04722	Neurotrophin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04740	Olfactory transduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04744	Phototransduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04745	Phototransduction - fly	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04910	Insulin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04912	GnRH signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04916	Melanogenesis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04970	Salivary secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko04971	Gastric acid secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko05010	Alzheimer's disease	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014356	K02183	ko05214	Glioma	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMC200014369	K01674	ko00910	Nitrogen metabolism	1074	2.1e-53	0.49	0.68	0.98
PGSC0003DMC200025081	K03428	ko00860	Porphyrin and chlorophyll metabolism	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMC200025081	K03428	ko01100	Metabolic pathways	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMC200025081	K03428	ko01110	Biosynthesis of secondary metabolites	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMC200025082	K03428	ko00860	Porphyrin and chlorophyll metabolism	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMC200025082	K03428	ko01100	Metabolic pathways	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMC200025082	K03428	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMC200025096	K05766	ko04810	Regulation of actin cytoskeleton	403	9.3e-16	0.37	0.56	0.19
PGSC0003DMC200025097	K05766	ko04810	Regulation of actin cytoskeleton	403	3.3e-16	0.37	0.56	0.26
PGSC0003DMC200025098	K05766	ko04810	Regulation of actin cytoskeleton	403	2.2e-16	0.37	0.56	0.63
PGSC0003DMC200025099	K13289	ko04142	Lysosome	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMC200025099	K13289	ko04614	Renin-angiotensin system	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMC200025100	K13289	ko04142	Lysosome	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMC200025100	K13289	ko04614	Renin-angiotensin system	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMC200025101	K13289	ko04142	Lysosome	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMC200025101	K13289	ko04614	Renin-angiotensin system	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMC200025102	K13289	ko04142	Lysosome	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMC200025102	K13289	ko04614	Renin-angiotensin system	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMC200025103	K03015	ko00230	Purine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMC200025103	K03015	ko00240	Pyrimidine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMC200025103	K03015	ko01100	Metabolic pathways	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMC200025103	K03015	ko03020	RNA polymerase	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMC200025103	K03015	ko05016	Huntington's disease	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMC200030661	K03542	ko00195	Photosynthesis	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMC200030661	K03542	ko01100	Metabolic pathways	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMC200030674	K00889	ko00562	Inositol phosphate metabolism	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030674	K00889	ko01100	Metabolic pathways	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030674	K00889	ko04070	Phosphatidylinositol signaling system	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030674	K00889	ko04144	Endocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030674	K00889	ko04666	Fc gamma R-mediated phagocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030674	K00889	ko04810	Regulation of actin cytoskeleton	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMC200030675	K00889	ko00562	Inositol phosphate metabolism	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030675	K00889	ko01100	Metabolic pathways	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030675	K00889	ko04070	Phosphatidylinositol signaling system	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030675	K00889	ko04144	Endocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030675	K00889	ko04666	Fc gamma R-mediated phagocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030675	K00889	ko04810	Regulation of actin cytoskeleton	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMC200030690	K00128	ko00010	Glycolysis / Gluconeogenesis	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00053	Ascorbate and aldarate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00071	Fatty acid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00280	Valine, leucine and isoleucine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00310	Lysine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00330	Arginine and proline metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00340	Histidine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00380	Tryptophan metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00410	beta-Alanine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00561	Glycerolipid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00620	Pyruvate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00631	1,2-Dichloroethane degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00640	Propanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00641	3-Chloroacrylic acid degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00650	Butanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko00903	Limonene and pinene degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko01100	Metabolic pathways	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200030690	K00128	ko01110	Biosynthesis of secondary metabolites	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMC200048099	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMC200048099	K11517	ko01100	Metabolic pathways	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMC200048099	K11517	ko04146	Peroxisome	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMC200048100	K01179	ko00500	Starch and sucrose metabolism	231	2.3e-06	0.42	0.50	0.70
PGSC0003DMC200048104	K10717	ko00908	Zeatin biosynthesis	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMC200048104	K10717	ko01100	Metabolic pathways	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMC200048104	K10717	ko01110	Biosynthesis of secondary metabolites	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMC200048105	K10717	ko00908	Zeatin biosynthesis	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMC200048105	K10717	ko01100	Metabolic pathways	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMC200048105	K10717	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMC200048106	K01955	ko00240	Pyrimidine metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMC200048106	K01955	ko00250	Alanine, aspartate and glutamate metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMC200048106	K01955	ko01100	Metabolic pathways	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMC200048111	K02932	ko03010	Ribosome	2233	2.5e-117	0.86	0.94	1.00
PGSC0003DMC200048115	K05740	ko04510	Focal adhesion	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMC200048115	K05740	ko04810	Regulation of actin cytoskeleton	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMC200048115	K05740	ko05131	Shigellosis	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMC200048116	K11422	ko00310	Lysine degradation	373	7.5e-12	0.27	0.38	0.84
PGSC0003DMC200048120	K02699	ko00195	Photosynthesis	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMC200048120	K02699	ko01100	Metabolic pathways	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMC200056303	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMC200056303	K00224	ko00364	Fluorobenzoate degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMC200056303	K00224	ko00628	Fluorene degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMC200056303	K00224	ko00640	Propanoate metabolism	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMC200056304	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMC200056304	K00224	ko00364	Fluorobenzoate degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMC200056304	K00224	ko00628	Fluorene degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMC200056304	K00224	ko00640	Propanoate metabolism	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMC200056305	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMC200056305	K00224	ko00364	Fluorobenzoate degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMC200056305	K00224	ko00628	Fluorene degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMC200056305	K00224	ko00640	Propanoate metabolism	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMC200056306	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMC200056306	K00224	ko00364	Fluorobenzoate degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMC200056306	K00224	ko00628	Fluorene degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMC200056306	K00224	ko00640	Propanoate metabolism	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMC200056307	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMC200056307	K00224	ko00364	Fluorobenzoate degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMC200056307	K00224	ko00628	Fluorene degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMC200056307	K00224	ko00640	Propanoate metabolism	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMC200043141	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043141	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043142	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMC200043143	K01945	ko00230	Purine metabolism	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMC200043143	K01945	ko01100	Metabolic pathways	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMC200043143	K01945	ko01110	Biosynthesis of secondary metabolites	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMC200043144	K03283	ko03040	Spliceosome	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMC200043144	K03283	ko04010	MAPK signaling pathway	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMC200043144	K03283	ko04144	Endocytosis	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMC200043144	K03283	ko04612	Antigen processing and presentation	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMC200022090	K09553	ko05020	Prion diseases	3288	1.6e-175	0.69	0.80	0.91
PGSC0003DMC200022091	K09553	ko05020	Prion diseases	2007	7.3e-105	0.74	0.84	0.96
PGSC0003DMC200022108	K03952	ko00190	Oxidative phosphorylation	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMC200022108	K03952	ko01100	Metabolic pathways	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMC200022108	K03952	ko05010	Alzheimer's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMC200022108	K03952	ko05012	Parkinson's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMC200022108	K03952	ko05016	Huntington's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMC200003284	K00889	ko00562	Inositol phosphate metabolism	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003284	K00889	ko01100	Metabolic pathways	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003284	K00889	ko04070	Phosphatidylinositol signaling system	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003284	K00889	ko04144	Endocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003284	K00889	ko04666	Fc gamma R-mediated phagocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003284	K00889	ko04810	Regulation of actin cytoskeleton	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMC200003289	K10875	ko03440	Homologous recombination	720	7.1e-34	0.30	0.49	0.57
PGSC0003DMC200003299	K01338	ko04112	Cell cycle - Caulobacter	6472	0.	0.87	0.95	1.00
PGSC0003DMC200028306	K00560	ko00240	Pyrimidine metabolism	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMC200028306	K00560	ko00670	One carbon pool by folate	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMC200028306	K00560	ko01100	Metabolic pathways	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMC200028307	K00560	ko00240	Pyrimidine metabolism	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMC200028307	K00560	ko00670	One carbon pool by folate	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMC200028307	K00560	ko01100	Metabolic pathways	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMC200028311	K06670	ko04110	Cell cycle	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMC200028311	K06670	ko04111	Cell cycle - yeast	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMC200028314	K06670	ko04110	Cell cycle	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMC200028314	K06670	ko04111	Cell cycle - yeast	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMC200028315	K00850	ko00010	Glycolysis / Gluconeogenesis	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028315	K00850	ko00030	Pentose phosphate pathway	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028315	K00850	ko00051	Fructose and mannose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028315	K00850	ko00052	Galactose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028315	K00850	ko01100	Metabolic pathways	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028315	K00850	ko01110	Biosynthesis of secondary metabolites	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMC200028316	K00850	ko00010	Glycolysis / Gluconeogenesis	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200028316	K00850	ko00030	Pentose phosphate pathway	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200028316	K00850	ko00051	Fructose and mannose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200028316	K00850	ko00052	Galactose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200028316	K00850	ko01100	Metabolic pathways	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200028316	K00850	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMC200069019	K01193	ko00052	Galactose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMC200069019	K01193	ko00500	Starch and sucrose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMC200069019	K01193	ko01100	Metabolic pathways	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMC200069021	K10760	ko00908	Zeatin biosynthesis	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMC200069021	K10760	ko01100	Metabolic pathways	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMC200069021	K10760	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMC200001059	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001059	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001060	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001061	K00128	ko00010	Glycolysis / Gluconeogenesis	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00053	Ascorbate and aldarate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00071	Fatty acid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00310	Lysine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00330	Arginine and proline metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00340	Histidine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00380	Tryptophan metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00410	beta-Alanine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00561	Glycerolipid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00620	Pyruvate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00631	1,2-Dichloroethane degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00640	Propanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00641	3-Chloroacrylic acid degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00650	Butanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko00903	Limonene and pinene degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko01100	Metabolic pathways	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001061	K00128	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMC200001062	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001062	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMC200001063	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001063	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMC200001064	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001064	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMC200001065	K05391	ko04626	Plant-pathogen interaction	1341	4.0e-68	0.67	0.77	0.99
PGSC0003DMC200001066	K05391	ko04626	Plant-pathogen interaction	3746	8.9e-201	0.67	0.80	0.95
PGSC0003DMC200001075	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMC200001075	K00517	ko00626	Naphthalene and anthracene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMC200001075	K00517	ko00903	Limonene and pinene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMC200001075	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMC200001075	K00517	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMC200001076	K10601	ko04120	Ubiquitin mediated proteolysis	3076	8.0e-164	0.72	0.80	0.36
PGSC0003DMC200001077	K10601	ko04120	Ubiquitin mediated proteolysis	2929	1.0e-155	0.72	0.80	0.98
PGSC0003DMC200001079	K00951	ko00230	Purine metabolism	990	9.1e-49	0.38	0.53	0.61
PGSC0003DMC200001080	K00951	ko00230	Purine metabolism	800	2.7e-38	0.35	0.51	0.76
PGSC0003DMC200053289	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMC200053289	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMC200053290	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMC200053290	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMC200053291	K00604	ko00670	One carbon pool by folate	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMC200053291	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMC200053292	K00604	ko00670	One carbon pool by folate	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMC200053292	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMC200053295	K13030	ko00460	Cyanoamino acid metabolism	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMC200053295	K13030	ko01110	Biosynthesis of secondary metabolites	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMC200053296	K13030	ko00460	Cyanoamino acid metabolism	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMC200053296	K13030	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMC200053297	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMC200053297	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMC200053298	K13030	ko00460	Cyanoamino acid metabolism	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMC200053298	K13030	ko01110	Biosynthesis of secondary metabolites	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMC200053299	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMC200053299	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMC200053305	K04733	ko04210	Apoptosis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMC200053305	K04733	ko04620	Toll-like receptor signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMC200053305	K04733	ko04722	Neurotrophin signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMC200053305	K04733	ko05140	Leishmaniasis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMC200053305	K04733	ko05142	Chagas disease	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMC200053306	K02183	ko04020	Calcium signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04070	Phosphatidylinositol signaling system	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04114	Oocyte meiosis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04270	Vascular smooth muscle contraction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04626	Plant-pathogen interaction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04720	Long-term potentiation	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04722	Neurotrophin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04740	Olfactory transduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04744	Phototransduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04745	Phototransduction - fly	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04910	Insulin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04912	GnRH signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04916	Melanogenesis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04970	Salivary secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko04971	Gastric acid secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko05010	Alzheimer's disease	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200053306	K02183	ko05214	Glioma	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMC200034481	K00780	ko00512	O-Glycan biosynthesis	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMC200034481	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMC200034481	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMC200034481	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMC200034481	K00780	ko01100	Metabolic pathways	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMC200034482	K00780	ko00512	O-Glycan biosynthesis	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMC200034482	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMC200034482	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMC200034482	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMC200034482	K00780	ko01100	Metabolic pathways	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMC200034483	K00780	ko00512	O-Glycan biosynthesis	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMC200034483	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMC200034483	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMC200034483	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMC200034483	K00780	ko01100	Metabolic pathways	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMC200034485	K12126	ko04712	Circadian rhythm - plant	312	2.9e-11	0.28	0.44	0.98
PGSC0003DMC200034499	K04371	ko04010	MAPK signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04012	ErbB signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04013	MAPK signaling pathway - fly	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04062	Chemokine signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04114	Oocyte meiosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04150	mTOR signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04270	Vascular smooth muscle contraction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04320	Dorso-ventral axis formation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04350	TGF-beta signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04360	Axon guidance	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04370	VEGF signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04510	Focal adhesion	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04520	Adherens junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04540	Gap junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04620	Toll-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04621	NOD-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04650	Natural killer cell mediated cytotoxicity	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04660	T cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04662	B cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04664	Fc epsilon RI signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04666	Fc gamma R-mediated phagocytosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04720	Long-term potentiation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04722	Neurotrophin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04730	Long-term depression	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04810	Regulation of actin cytoskeleton	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04910	Insulin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04912	GnRH signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04914	Progesterone-mediated oocyte maturation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04916	Melanogenesis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04930	Type II diabetes mellitus	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko04960	Aldosterone-regulated sodium reabsorption	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05010	Alzheimer's disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05020	Prion diseases	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05131	Shigellosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05140	Leishmaniasis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05142	Chagas disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05200	Pathways in cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05210	Colorectal cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05211	Renal cell carcinoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05212	Pancreatic cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05213	Endometrial cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05214	Glioma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05215	Prostate cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05216	Thyroid cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05218	Melanoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05219	Bladder cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05220	Chronic myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05221	Acute myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200034499	K04371	ko05223	Non-small cell lung cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMC200038524	K08770	ko03320	PPAR signaling pathway	887	4.4e-43	0.97	0.97	0.95
PGSC0003DMC200038525	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMC200038526	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMC200038527	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMC200038531	K08905	ko00195	Photosynthesis	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMC200038531	K08905	ko01100	Metabolic pathways	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMC200038532	K03130	ko03022	Basal transcription factors	247	1.1e-07	0.32	0.60	0.23
PGSC0003DMC200038533	K04538	ko04062	Chemokine signaling pathway	282	1.0e-09	0.27	0.42	0.79
PGSC0003DMC200038546	K06689	ko04120	Ubiquitin mediated proteolysis	1271	2.9e-64	0.96	0.99	0.99
PGSC0003DMC200057092	K03094	ko04110	Cell cycle	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04111	Cell cycle - yeast	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04114	Oocyte meiosis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04120	Ubiquitin mediated proteolysis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04310	Wnt signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04350	TGF-beta signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200057092	K03094	ko04710	Circadian rhythm - mammal	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMC200002256	K01427	ko00230	Purine metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMC200002256	K01427	ko00330	Arginine and proline metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMC200002256	K01427	ko00791	Atrazine degradation	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMC200002257	K01427	ko00230	Purine metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMC200002257	K01427	ko00330	Arginine and proline metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMC200002257	K01427	ko00791	Atrazine degradation	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMC200002258	K01427	ko00230	Purine metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMC200002258	K01427	ko00330	Arginine and proline metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMC200002258	K01427	ko00791	Atrazine degradation	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMC200002259	K01427	ko00230	Purine metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMC200002259	K01427	ko00330	Arginine and proline metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMC200002259	K01427	ko00791	Atrazine degradation	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMC200002260	K01427	ko00230	Purine metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMC200002260	K01427	ko00330	Arginine and proline metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMC200002260	K01427	ko00791	Atrazine degradation	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMC200002261	K01427	ko00230	Purine metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMC200002261	K01427	ko00330	Arginine and proline metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMC200002261	K01427	ko00791	Atrazine degradation	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMC200002262	K00939	ko00230	Purine metabolism	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMC200002262	K00939	ko01100	Metabolic pathways	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMC200002262	K00939	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMC200002265	K04124	ko00904	Diterpenoid biosynthesis	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMC200002265	K04124	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMC200002266	K04124	ko00904	Diterpenoid biosynthesis	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMC200002266	K04124	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMC200002267	K05282	ko00904	Diterpenoid biosynthesis	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMC200002267	K05282	ko01100	Metabolic pathways	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMC200002267	K05282	ko01110	Biosynthesis of secondary metabolites	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMC200002268	K09843	ko00906	Carotenoid biosynthesis	966	1.9e-47	0.36	0.54	0.98
PGSC0003DMC200004474	K02866	ko03010	Ribosome	271	8.0e-09	0.40	0.53	0.79
PGSC0003DMC200004475	K02866	ko03010	Ribosome	671	3.6e-31	0.43	0.57	0.89
PGSC0003DMC200004477	K00844	ko00010	Glycolysis / Gluconeogenesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00051	Fructose and mannose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00052	Galactose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00500	Starch and sucrose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00521	Streptomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko00524	Butirosin and neomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko01100	Metabolic pathways	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko01110	Biosynthesis of secondary metabolites	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko04910	Insulin signaling pathway	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004477	K00844	ko04930	Type II diabetes mellitus	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMC200004499	K04077	ko03018	RNA degradation	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMC200004499	K04077	ko04940	Type I diabetes mellitus	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMC200023290	K13034	ko00270	Cysteine and methionine metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMC200023290	K13034	ko00450	Selenoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMC200023290	K13034	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMC200023290	K13034	ko00920	Sulfur metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMC200023290	K13034	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMC200023306	K13065	ko00940	Phenylpropanoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMC200023306	K13065	ko00941	Flavonoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMC200023306	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMC200023306	K13065	ko01110	Biosynthesis of secondary metabolites	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMC200023310	K07678	ko02020	Two-component system	242	1.3e-06	0.39	0.64	0.80
PGSC0003DMC200008521	K06096	ko04530	Tight junction	337	9.4e-13	0.34	0.54	0.71
PGSC0003DMC200008529	K13034	ko00270	Cysteine and methionine metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMC200008529	K13034	ko00450	Selenoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMC200008529	K13034	ko00460	Cyanoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMC200008529	K13034	ko00920	Sulfur metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMC200008529	K13034	ko01100	Metabolic pathways	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMC200008547	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMC200008547	K01433	ko00670	One carbon pool by folate	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMC200008548	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMC200008548	K01433	ko00670	One carbon pool by folate	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMC200027096	K02725	ko03050	Proteasome	729	2.3e-34	0.83	0.90	0.84
PGSC0003DMC200027097	K02725	ko03050	Proteasome	1930	1.3e-100	0.82	0.88	1.00
PGSC0003DMC200027098	K00611	ko00330	Arginine and proline metabolism	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMC200027098	K00611	ko01100	Metabolic pathways	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMC200027098	K00611	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMC200027099	K00611	ko00330	Arginine and proline metabolism	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMC200027099	K00611	ko01100	Metabolic pathways	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMC200027099	K00611	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMC200027100	K00611	ko00330	Arginine and proline metabolism	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMC200027100	K00611	ko01100	Metabolic pathways	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMC200027100	K00611	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMC200033283	K11153	ko00830	Retinol metabolism	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMC200033283	K11153	ko01100	Metabolic pathways	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMC200033285	K00889	ko00562	Inositol phosphate metabolism	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033285	K00889	ko01100	Metabolic pathways	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033285	K00889	ko04070	Phosphatidylinositol signaling system	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033285	K00889	ko04144	Endocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033285	K00889	ko04666	Fc gamma R-mediated phagocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033285	K00889	ko04810	Regulation of actin cytoskeleton	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMC200033286	K00889	ko00562	Inositol phosphate metabolism	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033286	K00889	ko01100	Metabolic pathways	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033286	K00889	ko04070	Phosphatidylinositol signaling system	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033286	K00889	ko04144	Endocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033286	K00889	ko04666	Fc gamma R-mediated phagocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033286	K00889	ko04810	Regulation of actin cytoskeleton	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMC200033287	K00889	ko00562	Inositol phosphate metabolism	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033287	K00889	ko01100	Metabolic pathways	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033287	K00889	ko04070	Phosphatidylinositol signaling system	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033287	K00889	ko04144	Endocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033287	K00889	ko04666	Fc gamma R-mediated phagocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033287	K00889	ko04810	Regulation of actin cytoskeleton	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMC200033288	K00889	ko00562	Inositol phosphate metabolism	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033288	K00889	ko01100	Metabolic pathways	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033288	K00889	ko04070	Phosphatidylinositol signaling system	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033288	K00889	ko04144	Endocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033288	K00889	ko04666	Fc gamma R-mediated phagocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033288	K00889	ko04810	Regulation of actin cytoskeleton	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMC200033290	K09840	ko00906	Carotenoid biosynthesis	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMC200033290	K09840	ko01100	Metabolic pathways	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMC200033290	K09840	ko01110	Biosynthesis of secondary metabolites	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMC200033291	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMC200033291	K01687	ko00770	Pantothenate and CoA biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMC200033291	K01687	ko01100	Metabolic pathways	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMC200033291	K01687	ko01110	Biosynthesis of secondary metabolites	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMC200033292	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMC200033292	K01687	ko00770	Pantothenate and CoA biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMC200033292	K01687	ko01100	Metabolic pathways	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMC200033292	K01687	ko01110	Biosynthesis of secondary metabolites	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMC200052081	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052081	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMC200052089	K02956	ko03010	Ribosome	590	1.0e-26	0.82	0.91	0.99
PGSC0003DMC200052091	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200052091	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200052091	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200052091	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200052091	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMC200058301	K01199	ko00500	Starch and sucrose metabolism	1243	1.0e-62	0.52	0.67	1.00
PGSC0003DMC200018091	K01952	ko00230	Purine metabolism	9021	0.	0.86	0.94	1.00
PGSC0003DMC200018091	K01952	ko01100	Metabolic pathways	9021	0.	0.86	0.94	1.00
PGSC0003DMC200018091	K01952	ko01110	Biosynthesis of secondary metabolites	9021	0.	0.86	0.94	1.00
PGSC0003DMC200018092	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018092	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018092	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018093	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018093	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018093	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMC200018096	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMC200018096	K01817	ko01100	Metabolic pathways	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMC200018096	K01817	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMC200018097	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200018097	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200018097	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200018098	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMC200018098	K01817	ko01100	Metabolic pathways	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMC200018098	K01817	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMC200018099	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMC200018099	K01817	ko01100	Metabolic pathways	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMC200018099	K01817	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMC200018100	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200018100	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200018100	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMC200013143	K06111	ko04530	Tight junction	6165	0.	0.68	0.79	0.93
PGSC0003DMC200013144	K06111	ko04530	Tight junction	6388	0.	0.73	0.84	1.00
PGSC0003DMC200013145	K06111	ko04530	Tight junction	4654	7.4e-251	0.75	0.85	0.99
PGSC0003DMC200013146	K03094	ko04110	Cell cycle	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04111	Cell cycle - yeast	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04114	Oocyte meiosis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04120	Ubiquitin mediated proteolysis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04310	Wnt signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04350	TGF-beta signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013146	K03094	ko04710	Circadian rhythm - mammal	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMC200013154	K11984	ko03040	Spliceosome	4052	1.2e-217	0.62	0.78	0.95
PGSC0003DMC200013155	K11984	ko03040	Spliceosome	2439	1.1e-128	0.70	0.84	1.00
PGSC0003DMC200013156	K11984	ko03040	Spliceosome	4381	8.4e-236	0.63	0.78	0.98
PGSC0003DMC200013157	K11984	ko03040	Spliceosome	4284	1.9e-230	0.63	0.78	0.98
PGSC0003DMC200013158	K02717	ko00195	Photosynthesis	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMC200013158	K02717	ko01100	Metabolic pathways	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMC200013159	K02717	ko00195	Photosynthesis	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMC200013159	K02717	ko01100	Metabolic pathways	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMC200013162	K02717	ko00195	Photosynthesis	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMC200013162	K02717	ko01100	Metabolic pathways	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMC200013165	K05692	ko04145	Phagosome	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04510	Focal adhesion	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04520	Adherens junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04530	Tight junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04670	Leukocyte transendothelial migration	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04745	Phototransduction - fly	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko04810	Regulation of actin cytoskeleton	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05100	Bacterial invasion of epithelial cells	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05110	Vibrio cholerae infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05130	Pathogenic Escherichia coli infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05131	Shigellosis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05414	Dilated cardiomyopathy	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013165	K05692	ko05416	Viral myocarditis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMC200013166	K02923	ko03010	Ribosome	472	3.4e-20	0.92	0.97	0.48
PGSC0003DMC200013167	K02923	ko03010	Ribosome	535	1.1e-23	0.93	0.97	0.99
PGSC0003DMC200026284	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMC200026284	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMC200026286	K07748	ko00100	Steroid biosynthesis	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMC200026286	K07748	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMC200026287	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMC200026287	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMC200026305	K12338	ko00942	Anthocyanin biosynthesis	1014	4.3e-50	0.40	0.62	0.99
PGSC0003DMC200026307	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMC200026307	K00517	ko00626	Naphthalene and anthracene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMC200026307	K00517	ko00903	Limonene and pinene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMC200026307	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMC200026307	K00517	ko01110	Biosynthesis of secondary metabolites	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMC200026308	K01719	ko00860	Porphyrin and chlorophyll metabolism	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMC200026308	K01719	ko01100	Metabolic pathways	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMC200026308	K01719	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMC200026310	K13065	ko00940	Phenylpropanoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMC200026310	K13065	ko00941	Flavonoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMC200026310	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMC200026310	K13065	ko01110	Biosynthesis of secondary metabolites	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMC200047701	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMC200047703	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMC200047707	K01066	ko00623	2,4-Dichlorobenzoate degradation	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMC200047707	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMC200047722	K07376	ko04540	Gap junction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMC200047722	K07376	ko04730	Long-term depression	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMC200047722	K07376	ko04740	Olfactory transduction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMC200047722	K07376	ko04970	Salivary secretion	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMC200047729	K01692	ko00071	Fatty acid metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00280	Valine, leucine and isoleucine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00281	Geraniol degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00310	Lysine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00380	Tryptophan metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00410	beta-Alanine metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00632	Benzoate degradation via CoA ligation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00640	Propanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00650	Butanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00903	Limonene and pinene degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko00930	Caprolactam degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko01100	Metabolic pathways	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047729	K01692	ko01110	Biosynthesis of secondary metabolites	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMC200047730	K01692	ko00071	Fatty acid metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00281	Geraniol degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00310	Lysine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00380	Tryptophan metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00410	beta-Alanine metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00632	Benzoate degradation via CoA ligation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00640	Propanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00650	Butanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00903	Limonene and pinene degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko00930	Caprolactam degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko01100	Metabolic pathways	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200047730	K01692	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMC200049293	K08493	ko04130	SNARE interactions in vesicular transport	1306	3.4e-66	0.72	0.84	1.00
PGSC0003DMC200049294	K08493	ko04130	SNARE interactions in vesicular transport	628	8.4e-29	0.78	0.88	0.99
PGSC0003DMC200049303	K07424	ko00140	Steroid hormone biosynthesis	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00591	Linoleic acid metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00830	Retinol metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00982	Drug metabolism - cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko00983	Drug metabolism - other enzymes	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049303	K07424	ko01100	Metabolic pathways	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMC200049317	K00796	ko00790	Folate biosynthesis	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMC200049317	K00796	ko01100	Metabolic pathways	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMC200049318	K00796	ko00790	Folate biosynthesis	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMC200049318	K00796	ko01100	Metabolic pathways	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMC200049319	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049319	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049319	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMC200049320	K01057	ko00030	Pentose phosphate pathway	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMC200049320	K01057	ko01100	Metabolic pathways	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMC200049320	K01057	ko01110	Biosynthesis of secondary metabolites	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMC200031861	K12929	ko00904	Diterpenoid biosynthesis	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMC200031861	K12929	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMC200031862	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMC200031862	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMC200031863	K12929	ko00904	Diterpenoid biosynthesis	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMC200031863	K12929	ko01110	Biosynthesis of secondary metabolites	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMC200031864	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMC200031864	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMC200031865	K12929	ko00904	Diterpenoid biosynthesis	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMC200031865	K12929	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMC200031866	K12929	ko00904	Diterpenoid biosynthesis	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMC200031866	K12929	ko01110	Biosynthesis of secondary metabolites	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMC200031867	K12929	ko00904	Diterpenoid biosynthesis	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMC200031867	K12929	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMC200031868	K12929	ko00904	Diterpenoid biosynthesis	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMC200031868	K12929	ko01110	Biosynthesis of secondary metabolites	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMC200031869	K12929	ko00904	Diterpenoid biosynthesis	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMC200031869	K12929	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMC200031870	K12929	ko00904	Diterpenoid biosynthesis	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMC200031870	K12929	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMC200031871	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200031871	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMC200031872	K12929	ko00904	Diterpenoid biosynthesis	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMC200031872	K12929	ko01110	Biosynthesis of secondary metabolites	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMC200031873	K12929	ko00904	Diterpenoid biosynthesis	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMC200031873	K12929	ko01110	Biosynthesis of secondary metabolites	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMC200031874	K12467	ko00902	Monoterpenoid biosynthesis	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMC200031874	K12467	ko01110	Biosynthesis of secondary metabolites	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMC200031875	K12929	ko00904	Diterpenoid biosynthesis	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMC200031875	K12929	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMC200031881	K10955	ko05110	Vibrio cholerae infection	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMC200031881	K10955	ko05146	Amoebiasis	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMC200031887	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031887	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031887	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031887	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031888	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031888	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031888	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031888	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMC200031889	K00430	ko00360	Phenylalanine metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMC200031889	K00430	ko00680	Methane metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMC200031889	K00430	ko00940	Phenylpropanoid biosynthesis	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMC200031889	K00430	ko01100	Metabolic pathways	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMC200031889	K00430	ko01110	Biosynthesis of secondary metabolites	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMC200031890	K00430	ko00360	Phenylalanine metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMC200031890	K00430	ko00680	Methane metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMC200031890	K00430	ko00940	Phenylpropanoid biosynthesis	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMC200031890	K00430	ko01100	Metabolic pathways	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMC200031890	K00430	ko01110	Biosynthesis of secondary metabolites	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMC200055083	K01679	ko00020	Citrate cycle (TCA cycle)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055083	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055083	K01679	ko01100	Metabolic pathways	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055083	K01679	ko01110	Biosynthesis of secondary metabolites	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055083	K01679	ko05200	Pathways in cancer	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055083	K01679	ko05211	Renal cell carcinoma	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMC200055084	K01679	ko00020	Citrate cycle (TCA cycle)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055084	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055084	K01679	ko01100	Metabolic pathways	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055084	K01679	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055084	K01679	ko05200	Pathways in cancer	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055084	K01679	ko05211	Renal cell carcinoma	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMC200055085	K01679	ko00020	Citrate cycle (TCA cycle)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055085	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055085	K01679	ko01100	Metabolic pathways	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055085	K01679	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055085	K01679	ko05200	Pathways in cancer	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055085	K01679	ko05211	Renal cell carcinoma	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMC200055104	K08139	ko04113	Meiosis - yeast	982	2.5e-48	0.34	0.50	0.88
PGSC0003DMC200044352	K01648	ko00020	Citrate cycle (TCA cycle)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMC200044352	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMC200044352	K01648	ko01100	Metabolic pathways	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMC200044352	K01648	ko01110	Biosynthesis of secondary metabolites	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMC200044357	K04733	ko04210	Apoptosis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMC200044357	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMC200044357	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMC200044357	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMC200044357	K04733	ko05142	Chagas disease	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMC200044359	K04733	ko04210	Apoptosis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMC200044359	K04733	ko04620	Toll-like receptor signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMC200044359	K04733	ko04722	Neurotrophin signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMC200044359	K04733	ko05140	Leishmaniasis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMC200044359	K04733	ko05142	Chagas disease	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMC200044360	K04733	ko04210	Apoptosis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMC200044360	K04733	ko04620	Toll-like receptor signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMC200044360	K04733	ko04722	Neurotrophin signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMC200044360	K04733	ko05140	Leishmaniasis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMC200044360	K04733	ko05142	Chagas disease	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMC200044361	K04733	ko04210	Apoptosis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMC200044361	K04733	ko04620	Toll-like receptor signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMC200044361	K04733	ko04722	Neurotrophin signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMC200044361	K04733	ko05140	Leishmaniasis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMC200044361	K04733	ko05142	Chagas disease	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMC200044363	K04733	ko04210	Apoptosis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMC200044363	K04733	ko04620	Toll-like receptor signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMC200044363	K04733	ko04722	Neurotrophin signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMC200044363	K04733	ko05140	Leishmaniasis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMC200044363	K04733	ko05142	Chagas disease	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMC200031021	K13030	ko00460	Cyanoamino acid metabolism	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMC200031021	K13030	ko01110	Biosynthesis of secondary metabolites	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMC200031028	K06630	ko04110	Cell cycle	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMC200031028	K06630	ko04114	Oocyte meiosis	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMC200031028	K06630	ko04722	Neurotrophin signaling pathway	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMC200031029	K02267	ko00190	Oxidative phosphorylation	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200031029	K02267	ko01100	Metabolic pathways	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200031029	K02267	ko04260	Cardiac muscle contraction	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200031029	K02267	ko05010	Alzheimer's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200031029	K02267	ko05012	Parkinson's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200031029	K02267	ko05016	Huntington's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMC200048338	K12796	ko04621	NOD-like receptor signaling pathway	327	2.3e-08	0.29	0.47	0.42
PGSC0003DMC200048350	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048350	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048350	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048350	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048350	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048350	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200048351	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMC200059651	K09754	ko00360	Phenylalanine metabolism	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059651	K09754	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059651	K09754	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059651	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059651	K09754	ko01100	Metabolic pathways	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059651	K09754	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMC200059654	K00430	ko00360	Phenylalanine metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMC200059654	K00430	ko00680	Methane metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMC200059654	K00430	ko00940	Phenylpropanoid biosynthesis	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMC200059654	K00430	ko01100	Metabolic pathways	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMC200059654	K00430	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMC200059657	K10760	ko00908	Zeatin biosynthesis	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMC200059657	K10760	ko01100	Metabolic pathways	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMC200059657	K10760	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMC200055803	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMC200055804	K12127	ko04712	Circadian rhythm - plant	2744	1.6e-145	0.63	0.77	0.98
PGSC0003DMC200055805	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMC200055806	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMC200055811	K07964	ko00531	Glycosaminoglycan degradation	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMC200055811	K07964	ko01100	Metabolic pathways	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMC200055814	K02160	ko00061	Fatty acid biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055814	K02160	ko00253	Tetracycline biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055814	K02160	ko00620	Pyruvate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055814	K02160	ko00640	Propanoate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055814	K02160	ko01100	Metabolic pathways	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055814	K02160	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMC200055821	K10643	ko03018	RNA degradation	277	1.9e-09	0.56	0.72	0.14
PGSC0003DMC200055823	K01950	ko00760	Nicotinate and nicotinamide metabolism	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMC200055823	K01950	ko01100	Metabolic pathways	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMC200055824	K01950	ko00760	Nicotinate and nicotinamide metabolism	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMC200055824	K01950	ko01100	Metabolic pathways	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMC200055825	K04688	ko04012	ErbB signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055825	K04688	ko04150	mTOR signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055825	K04688	ko04350	TGF-beta signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055825	K04688	ko04666	Fc gamma R-mediated phagocytosis	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055825	K04688	ko04910	Insulin signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055825	K04688	ko05221	Acute myeloid leukemia	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMC200055826	K04688	ko04012	ErbB signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055826	K04688	ko04150	mTOR signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055826	K04688	ko04350	TGF-beta signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055826	K04688	ko04666	Fc gamma R-mediated phagocytosis	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055826	K04688	ko04910	Insulin signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055826	K04688	ko05221	Acute myeloid leukemia	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMC200055827	K04688	ko04012	ErbB signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055827	K04688	ko04150	mTOR signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055827	K04688	ko04350	TGF-beta signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055827	K04688	ko04666	Fc gamma R-mediated phagocytosis	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055827	K04688	ko04910	Insulin signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055827	K04688	ko05221	Acute myeloid leukemia	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMC200055830	K10418	ko04962	Vasopressin-regulated water reabsorption	328	3.0e-12	0.52	0.66	0.31
PGSC0003DMC200036212	K12587	ko03018	RNA degradation	568	1.7e-25	0.38	0.63	0.79
PGSC0003DMC200036219	K12599	ko03018	RNA degradation	2479	6.8e-131	0.80	0.91	0.99
PGSC0003DMC200036220	K12599	ko03018	RNA degradation	2973	3.8e-158	0.77	0.89	0.98
PGSC0003DMC200036221	K12599	ko03018	RNA degradation	2957	2.9e-157	0.77	0.88	0.99
PGSC0003DMC200036222	K12599	ko03018	RNA degradation	3795	1.8e-203	0.80	0.90	1.00
PGSC0003DMC200036224	K12599	ko03018	RNA degradation	483	6.5e-20	0.84	0.88	0.97
PGSC0003DMC200036225	K12599	ko03018	RNA degradation	545	8.0e-24	0.53	0.73	0.94
PGSC0003DMC200036226	K12599	ko03018	RNA degradation	844	2.7e-40	0.88	0.96	0.92
PGSC0003DMC200036236	K07375	ko04145	Phagosome	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMC200036236	K07375	ko04540	Gap junction	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMC200036236	K07375	ko05130	Pathogenic Escherichia coli infection	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMC200017584	K01581	ko00330	Arginine and proline metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMC200017584	K01581	ko00480	Glutathione metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMC200017584	K01581	ko01100	Metabolic pathways	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMC200017584	K01581	ko01110	Biosynthesis of secondary metabolites	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMC200017593	K00423	ko00053	Ascorbate and aldarate metabolism	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMC200017593	K00423	ko01100	Metabolic pathways	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMC200017594	K00423	ko00053	Ascorbate and aldarate metabolism	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMC200017594	K00423	ko01100	Metabolic pathways	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMC200017596	K12349	ko00600	Sphingolipid metabolism	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMC200017596	K12349	ko01100	Metabolic pathways	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMC200019534	K02965	ko03010	Ribosome	286	6.1e-10	0.41	0.62	0.74
PGSC0003DMC200019535	K10603	ko04120	Ubiquitin mediated proteolysis	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMC200019535	K10603	ko05340	Primary immunodeficiency	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMC200019551	K00368	ko00910	Nitrogen metabolism	421	2.2e-17	0.40	0.59	0.80
PGSC0003DMC200019552	K00368	ko00910	Nitrogen metabolism	285	1.4e-09	0.43	0.58	0.94
PGSC0003DMC200019558	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMC200019558	K01602	ko00710	Carbon fixation in photosynthetic organisms	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMC200019558	K01602	ko01100	Metabolic pathways	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMC200019559	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMC200019559	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMC200019559	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMC200019560	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200019560	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200019560	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMC200007423	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMC200007423	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMC200007424	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMC200007424	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMC200007426	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMC200007426	K01657	ko01100	Metabolic pathways	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMC200007426	K01657	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMC200007439	K05857	ko00562	Inositol phosphate metabolism	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMC200007439	K05857	ko01100	Metabolic pathways	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMC200007439	K05857	ko04020	Calcium signaling pathway	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMC200007439	K05857	ko04070	Phosphatidylinositol signaling system	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMC200007440	K05857	ko00562	Inositol phosphate metabolism	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMC200007440	K05857	ko01100	Metabolic pathways	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMC200007440	K05857	ko04020	Calcium signaling pathway	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMC200007440	K05857	ko04070	Phosphatidylinositol signaling system	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMC200024620	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	972	8.9e-48	0.41	0.54	0.98
PGSC0003DMC200067902	K10760	ko00908	Zeatin biosynthesis	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMC200067902	K10760	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMC200067902	K10760	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMC200067913	K03094	ko04110	Cell cycle	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04111	Cell cycle - yeast	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04114	Oocyte meiosis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04120	Ubiquitin mediated proteolysis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04310	Wnt signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04350	TGF-beta signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067913	K03094	ko04710	Circadian rhythm - mammal	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMC200067918	K12356	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.32	0.47	0.90
PGSC0003DMC200061747	K03094	ko04110	Cell cycle	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04111	Cell cycle - yeast	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04114	Oocyte meiosis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04120	Ubiquitin mediated proteolysis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04310	Wnt signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04350	TGF-beta signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061747	K03094	ko04710	Circadian rhythm - mammal	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMC200061748	K10760	ko00908	Zeatin biosynthesis	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMC200061748	K10760	ko01100	Metabolic pathways	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMC200061748	K10760	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMC200052803	K01079	ko00260	Glycine, serine and threonine metabolism	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMC200052803	K01079	ko01100	Metabolic pathways	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMC200052804	K01079	ko00260	Glycine, serine and threonine metabolism	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMC200052804	K01079	ko01100	Metabolic pathways	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMC200052805	K01079	ko00260	Glycine, serine and threonine metabolism	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMC200052805	K01079	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMC200052806	K13228	ko00402	Benzoxazinoid biosynthesis	680	1.1e-31	0.45	0.64	0.88
PGSC0003DMC200052814	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMC200052814	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMC200052814	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMC200052814	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMC200052815	K01689	ko00010	Glycolysis / Gluconeogenesis	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMC200052815	K01689	ko01100	Metabolic pathways	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMC200052815	K01689	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMC200052815	K01689	ko03018	RNA degradation	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMC200052816	K01689	ko00010	Glycolysis / Gluconeogenesis	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMC200052816	K01689	ko01100	Metabolic pathways	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMC200052816	K01689	ko01110	Biosynthesis of secondary metabolites	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMC200052816	K01689	ko03018	RNA degradation	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMC200052817	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMC200052817	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMC200052817	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMC200052817	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMC200052818	K01689	ko00010	Glycolysis / Gluconeogenesis	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMC200052818	K01689	ko01100	Metabolic pathways	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMC200052818	K01689	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMC200052818	K01689	ko03018	RNA degradation	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMC200052819	K01689	ko00010	Glycolysis / Gluconeogenesis	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMC200052819	K01689	ko01100	Metabolic pathways	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMC200052819	K01689	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMC200052819	K01689	ko03018	RNA degradation	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMC200052820	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.37
PGSC0003DMC200052821	K12897	ko03040	Spliceosome	446	9.2e-19	0.49	0.55	0.57
PGSC0003DMC200052822	K12897	ko03040	Spliceosome	871	3.3e-42	0.54	0.61	0.67
PGSC0003DMC200052823	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.39
PGSC0003DMC200052827	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMC200052827	K00517	ko00626	Naphthalene and anthracene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMC200052827	K00517	ko00903	Limonene and pinene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMC200052827	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMC200052827	K00517	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMC200052830	K02213	ko04110	Cell cycle	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMC200052830	K02213	ko04111	Cell cycle - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMC200052830	K02213	ko04113	Meiosis - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMC200034351	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMC200034351	K00517	ko00626	Naphthalene and anthracene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMC200034351	K00517	ko00903	Limonene and pinene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMC200034351	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMC200034351	K00517	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMC200034352	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMC200034352	K00517	ko00626	Naphthalene and anthracene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMC200034352	K00517	ko00903	Limonene and pinene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMC200034352	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMC200034352	K00517	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMC200034353	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMC200034353	K00517	ko00626	Naphthalene and anthracene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMC200034353	K00517	ko00903	Limonene and pinene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMC200034353	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMC200034353	K00517	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMC200034354	K11818	ko00380	Tryptophan metabolism	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMC200034354	K11818	ko00966	Glucosinolate biosynthesis	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMC200034354	K11818	ko01110	Biosynthesis of secondary metabolites	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMC200034355	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMC200034355	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMC200034355	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMC200034355	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMC200034355	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMC200034356	K11778	ko00900	Terpenoid backbone biosynthesis	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMC200034356	K11778	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMC200034357	K12929	ko00904	Diterpenoid biosynthesis	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMC200034357	K12929	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMC200034358	K12929	ko00904	Diterpenoid biosynthesis	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMC200034358	K12929	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMC200034359	K12929	ko00904	Diterpenoid biosynthesis	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMC200034359	K12929	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMC200034360	K12929	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMC200034360	K12929	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMC200034361	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMC200034361	K00517	ko00626	Naphthalene and anthracene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMC200034361	K00517	ko00903	Limonene and pinene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMC200034361	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMC200034361	K00517	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMC200034363	K11778	ko00900	Terpenoid backbone biosynthesis	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMC200034363	K11778	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMC200034364	K11423	ko00310	Lysine degradation	2592	4.0e-137	0.52	0.63	0.46
PGSC0003DMC200034368	K11423	ko00310	Lysine degradation	2652	1.9e-140	0.54	0.66	0.41
PGSC0003DMC200034377	K12929	ko00904	Diterpenoid biosynthesis	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMC200034377	K12929	ko01110	Biosynthesis of secondary metabolites	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMC200034378	K12929	ko00904	Diterpenoid biosynthesis	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMC200034378	K12929	ko01110	Biosynthesis of secondary metabolites	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMC200034379	K12929	ko00904	Diterpenoid biosynthesis	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMC200034379	K12929	ko01110	Biosynthesis of secondary metabolites	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMC200038764	K03885	ko00190	Oxidative phosphorylation	3498	4.2e-187	0.75	0.86	1.00
PGSC0003DMC200038769	K01082	ko00920	Sulfur metabolism	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMC200038769	K01082	ko01100	Metabolic pathways	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMC200038770	K01082	ko00920	Sulfur metabolism	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMC200038770	K01082	ko01100	Metabolic pathways	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMC200038771	K01082	ko00920	Sulfur metabolism	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMC200038771	K01082	ko01100	Metabolic pathways	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMC200038772	K01082	ko00920	Sulfur metabolism	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMC200038772	K01082	ko01100	Metabolic pathways	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMC200038775	K13289	ko04142	Lysosome	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMC200038775	K13289	ko04614	Renin-angiotensin system	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMC200038776	K13289	ko04142	Lysosome	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMC200038776	K13289	ko04614	Renin-angiotensin system	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMC200038779	K05747	ko04062	Chemokine signaling pathway	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko04520	Adherens junction	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko04666	Fc gamma R-mediated phagocytosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko04810	Regulation of actin cytoskeleton	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko05100	Bacterial invasion of epithelial cells	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko05130	Pathogenic Escherichia coli infection	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038779	K05747	ko05131	Shigellosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMC200038783	K08139	ko04113	Meiosis - yeast	1108	2.8e-55	0.36	0.61	0.88
PGSC0003DMC200038784	K08726	ko00590	Arachidonic acid metabolism	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMC200038784	K08726	ko00625	Tetrachloroethene degradation	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMC200038784	K08726	ko01100	Metabolic pathways	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMC200038784	K08726	ko04146	Peroxisome	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMC200038785	K08726	ko00590	Arachidonic acid metabolism	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMC200038785	K08726	ko00625	Tetrachloroethene degradation	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMC200038785	K08726	ko01100	Metabolic pathways	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMC200038785	K08726	ko04146	Peroxisome	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMC200050643	K01838	ko00500	Starch and sucrose metabolism	272	3.6e-09	0.34	0.49	0.57
PGSC0003DMC200050644	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMC200050645	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMC200050646	K01838	ko00500	Starch and sucrose metabolism	292	2.9e-10	0.33	0.48	0.56
PGSC0003DMC200050651	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMC200050651	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMC200050651	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMC200050652	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMC200050652	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMC200050652	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMC200050661	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMC200050661	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMC200050662	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMC200050662	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMC200050663	K01243	ko00270	Cysteine and methionine metabolism	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMC200050663	K01243	ko01100	Metabolic pathways	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMC200050664	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMC200050664	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMC200050665	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMC200050665	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMC200050667	K00417	ko00190	Oxidative phosphorylation	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200050667	K00417	ko01100	Metabolic pathways	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200050667	K00417	ko04260	Cardiac muscle contraction	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200050667	K00417	ko05010	Alzheimer's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200050667	K00417	ko05012	Parkinson's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200050667	K00417	ko05016	Huntington's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMC200021605	K00799	ko00480	Glutathione metabolism	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMC200021605	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMC200021605	K00799	ko00982	Drug metabolism - cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMC200021606	K00799	ko00480	Glutathione metabolism	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMC200021606	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMC200021606	K00799	ko00982	Drug metabolism - cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMC200021607	K00799	ko00480	Glutathione metabolism	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMC200021607	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMC200021607	K00799	ko00982	Drug metabolism - cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMC200021608	K00799	ko00480	Glutathione metabolism	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMC200021608	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMC200021608	K00799	ko00982	Drug metabolism - cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMC200021610	K00799	ko00480	Glutathione metabolism	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMC200021610	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMC200021610	K00799	ko00982	Drug metabolism - cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMC200021620	K01507	ko00190	Oxidative phosphorylation	1349	1.4e-68	0.79	0.86	0.97
PGSC0003DMC200021621	K01507	ko00190	Oxidative phosphorylation	1470	3.0e-75	0.80	0.89	0.97
PGSC0003DMC200021622	K01507	ko00190	Oxidative phosphorylation	1566	1.5e-80	0.89	0.97	0.98
PGSC0003DMC200021624	K02867	ko03010	Ribosome	1346	2.1e-68	0.77	0.86	0.98
PGSC0003DMC200003161	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMC200003161	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMC200003161	K10158	ko01100	Metabolic pathways	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMC200003169	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMC200003169	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMC200003169	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMC200003169	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMC200003169	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMC200003170	K00430	ko00360	Phenylalanine metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMC200003170	K00430	ko00680	Methane metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMC200003170	K00430	ko00940	Phenylpropanoid biosynthesis	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMC200003170	K00430	ko01100	Metabolic pathways	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMC200003170	K00430	ko01110	Biosynthesis of secondary metabolites	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMC200028541	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028541	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028541	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028541	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028541	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028541	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028542	K01962	ko00061	Fatty acid biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028542	K01962	ko00253	Tetracycline biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028542	K01962	ko00620	Pyruvate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028542	K01962	ko00640	Propanoate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028542	K01962	ko01100	Metabolic pathways	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028542	K01962	ko01110	Biosynthesis of secondary metabolites	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMC200028543	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028543	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028543	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028543	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028543	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028543	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMC200028545	K09291	ko04011	MAPK signaling pathway - yeast	7204	0.	0.48	0.68	1.00
PGSC0003DMC200028545	K09291	ko05200	Pathways in cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMC200028545	K09291	ko05216	Thyroid cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMC200028546	K00797	ko00270	Cysteine and methionine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMC200028546	K00797	ko00330	Arginine and proline metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMC200028546	K00797	ko00410	beta-Alanine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMC200028546	K00797	ko00480	Glutathione metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMC200028546	K00797	ko01100	Metabolic pathways	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMC200028547	K00797	ko00270	Cysteine and methionine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMC200028547	K00797	ko00330	Arginine and proline metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMC200028547	K00797	ko00410	beta-Alanine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMC200028547	K00797	ko00480	Glutathione metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMC200028547	K00797	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMC200028549	K03921	ko00061	Fatty acid biosynthesis	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMC200028549	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMC200028552	K00624	ko04146	Peroxisome	533	1.2e-22	0.38	0.58	0.28
PGSC0003DMC200028559	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMC200028559	K01649	ko00620	Pyruvate metabolism	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMC200028559	K01649	ko01100	Metabolic pathways	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMC200028559	K01649	ko01110	Biosynthesis of secondary metabolites	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMC200000571	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200000571	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200000571	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMC200000572	K01762	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMC200000572	K01762	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMC200000573	K02140	ko00190	Oxidative phosphorylation	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMC200000573	K02140	ko01100	Metabolic pathways	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMC200000574	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMC200000576	K00469	ko00053	Ascorbate and aldarate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMC200000576	K00469	ko00562	Inositol phosphate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMC200000577	K00469	ko00053	Ascorbate and aldarate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMC200000577	K00469	ko00562	Inositol phosphate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMC200000578	K00469	ko00053	Ascorbate and aldarate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMC200000578	K00469	ko00562	Inositol phosphate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMC200000580	K00681	ko00430	Taurine and hypotaurine metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000580	K00681	ko00450	Selenoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000580	K00681	ko00460	Cyanoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000580	K00681	ko00480	Glutathione metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000580	K00681	ko00590	Arachidonic acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000580	K00681	ko01100	Metabolic pathways	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMC200000583	K05759	ko04810	Regulation of actin cytoskeleton	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMC200000583	K05759	ko05131	Shigellosis	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMC200000585	K01051	ko00040	Pentose and glucuronate interconversions	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMC200000585	K01051	ko00500	Starch and sucrose metabolism	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMC200000585	K01051	ko01100	Metabolic pathways	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMC200000586	K01051	ko00040	Pentose and glucuronate interconversions	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMC200000586	K01051	ko00500	Starch and sucrose metabolism	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMC200000586	K01051	ko01100	Metabolic pathways	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMC200000588	K00844	ko00010	Glycolysis / Gluconeogenesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00051	Fructose and mannose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00052	Galactose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00500	Starch and sucrose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00521	Streptomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko00524	Butirosin and neomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko01100	Metabolic pathways	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko01110	Biosynthesis of secondary metabolites	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko04910	Insulin signaling pathway	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000588	K00844	ko04930	Type II diabetes mellitus	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMC200000589	K00844	ko00010	Glycolysis / Gluconeogenesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00051	Fructose and mannose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00052	Galactose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00521	Streptomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko00524	Butirosin and neomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko01100	Metabolic pathways	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko04910	Insulin signaling pathway	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000589	K00844	ko04930	Type II diabetes mellitus	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMC200000600	K07151	ko00510	N-Glycan biosynthesis	5760	0.	0.87	0.93	1.00
PGSC0003DMC200000600	K07151	ko01100	Metabolic pathways	5760	0.	0.87	0.93	1.00
PGSC0003DMC200033157	K00276	ko00260	Glycine, serine and threonine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko00350	Tyrosine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko00410	beta-Alanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko01100	Metabolic pathways	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033157	K00276	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMC200033159	K00939	ko00230	Purine metabolism	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMC200033159	K00939	ko01100	Metabolic pathways	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMC200033159	K00939	ko01110	Biosynthesis of secondary metabolites	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMC200033160	K00939	ko00230	Purine metabolism	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMC200033160	K00939	ko01100	Metabolic pathways	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMC200033160	K00939	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMC200033161	K00939	ko00230	Purine metabolism	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMC200033161	K00939	ko01100	Metabolic pathways	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMC200033161	K00939	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMC200033162	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200033162	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200033162	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200033163	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200033163	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200033163	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMC200051619	K03032	ko03050	Proteasome	4568	4.1e-246	0.86	0.91	0.97
PGSC0003DMC200051620	K03032	ko03050	Proteasome	5163	6.2e-279	0.87	0.92	0.99
PGSC0003DMC200051621	K03032	ko03050	Proteasome	7089	0.	0.86	0.91	1.00
PGSC0003DMC200058554	K04733	ko04210	Apoptosis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMC200058554	K04733	ko04620	Toll-like receptor signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMC200058554	K04733	ko04722	Neurotrophin signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMC200058554	K04733	ko05140	Leishmaniasis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMC200058554	K04733	ko05142	Chagas disease	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMC200001776	K01213	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMC200001776	K01213	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMC200001776	K01213	ko01100	Metabolic pathways	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMC200001777	K01213	ko00040	Pentose and glucuronate interconversions	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMC200001777	K01213	ko00500	Starch and sucrose metabolism	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMC200001777	K01213	ko01100	Metabolic pathways	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMC200001780	K01834	ko00010	Glycolysis / Gluconeogenesis	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMC200001780	K01834	ko01100	Metabolic pathways	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMC200001780	K01834	ko01110	Biosynthesis of secondary metabolites	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMC200062436	K02893	ko03010	Ribosome	566	2.2e-25	0.97	0.99	0.99
PGSC0003DMC200004351	K05350	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMC200004351	K05350	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMC200004351	K05350	ko00940	Phenylpropanoid biosynthesis	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMC200004351	K05350	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMC200004352	K05350	ko00460	Cyanoamino acid metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMC200004352	K05350	ko00500	Starch and sucrose metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMC200004352	K05350	ko00940	Phenylpropanoid biosynthesis	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMC200004352	K05350	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMC200004353	K05350	ko00460	Cyanoamino acid metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMC200004353	K05350	ko00500	Starch and sucrose metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMC200004353	K05350	ko00940	Phenylpropanoid biosynthesis	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMC200004353	K05350	ko01110	Biosynthesis of secondary metabolites	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMC200004361	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMC200004361	K00517	ko00626	Naphthalene and anthracene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMC200004361	K00517	ko00903	Limonene and pinene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMC200004361	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMC200004361	K00517	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMC200004362	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMC200004362	K00517	ko00626	Naphthalene and anthracene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMC200004362	K00517	ko00903	Limonene and pinene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMC200004362	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMC200004362	K00517	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMC200004363	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004363	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004363	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004363	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004363	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004364	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004364	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004364	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004364	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004364	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMC200004367	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMC200004367	K00517	ko00626	Naphthalene and anthracene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMC200004367	K00517	ko00903	Limonene and pinene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMC200004367	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMC200004367	K00517	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMC200004369	K03040	ko00230	Purine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMC200004369	K03040	ko00240	Pyrimidine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMC200004369	K03040	ko01100	Metabolic pathways	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMC200004369	K03040	ko03020	RNA polymerase	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMC200004370	K01580	ko00250	Alanine, aspartate and glutamate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004370	K01580	ko00410	beta-Alanine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004370	K01580	ko00430	Taurine and hypotaurine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004370	K01580	ko00650	Butanoate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004370	K01580	ko01100	Metabolic pathways	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004370	K01580	ko04940	Type I diabetes mellitus	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMC200004377	K00688	ko00500	Starch and sucrose metabolism	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMC200004377	K00688	ko04910	Insulin signaling pathway	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMC200004378	K00688	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMC200004378	K00688	ko04910	Insulin signaling pathway	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMC200022809	K04120	ko00904	Diterpenoid biosynthesis	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMC200022809	K04120	ko01100	Metabolic pathways	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMC200022809	K04120	ko01110	Biosynthesis of secondary metabolites	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMC200022811	K08332	ko04140	Regulation of autophagy	449	8.4e-19	0.33	0.53	0.41
PGSC0003DMC200022814	K00788	ko00730	Thiamine metabolism	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMC200022814	K00788	ko01100	Metabolic pathways	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMC200022815	K00788	ko00730	Thiamine metabolism	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMC200022815	K00788	ko01100	Metabolic pathways	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMC200022825	K06654	ko04111	Cell cycle - yeast	311	2.6e-11	0.36	0.55	0.73
PGSC0003DMC200022826	K01784	ko00052	Galactose metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMC200022826	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMC200022826	K01784	ko01100	Metabolic pathways	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMC200008775	K12886	ko03040	Spliceosome	398	6.9e-16	0.28	0.41	0.56
PGSC0003DMC200008776	K00854	ko00040	Pentose and glucuronate interconversions	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMC200008776	K00854	ko01100	Metabolic pathways	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMC200008777	K00854	ko00040	Pentose and glucuronate interconversions	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMC200008777	K00854	ko01100	Metabolic pathways	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMC200008778	K00854	ko00040	Pentose and glucuronate interconversions	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMC200008778	K00854	ko01100	Metabolic pathways	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMC200008779	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMC200008779	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMC200008780	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMC200008780	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMC200008781	K00854	ko00040	Pentose and glucuronate interconversions	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMC200008781	K00854	ko01100	Metabolic pathways	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMC200008782	K00854	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMC200008782	K00854	ko01100	Metabolic pathways	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMC200008783	K00854	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMC200008783	K00854	ko01100	Metabolic pathways	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMC200008784	K00854	ko00040	Pentose and glucuronate interconversions	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMC200008784	K00854	ko01100	Metabolic pathways	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMC200008785	K09756	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.46	0.62	0.85
PGSC0003DMC200008786	K09756	ko00940	Phenylpropanoid biosynthesis	1448	5.0e-74	0.47	0.63	0.84
PGSC0003DMC200008787	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMC200008788	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMC200008789	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMC200008790	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMC200020651	K02134	ko00190	Oxidative phosphorylation	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMC200020651	K02134	ko01100	Metabolic pathways	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMC200020651	K02134	ko05010	Alzheimer's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMC200020651	K02134	ko05012	Parkinson's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMC200020651	K02134	ko05016	Huntington's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMC200020652	K02134	ko00190	Oxidative phosphorylation	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMC200020652	K02134	ko01100	Metabolic pathways	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMC200020652	K02134	ko05010	Alzheimer's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMC200020652	K02134	ko05012	Parkinson's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMC200020652	K02134	ko05016	Huntington's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMC200020653	K02134	ko00190	Oxidative phosphorylation	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMC200020653	K02134	ko01100	Metabolic pathways	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMC200020653	K02134	ko05010	Alzheimer's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMC200020653	K02134	ko05012	Parkinson's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMC200020653	K02134	ko05016	Huntington's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMC200020654	K01051	ko00040	Pentose and glucuronate interconversions	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMC200020654	K01051	ko00500	Starch and sucrose metabolism	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMC200020654	K01051	ko01100	Metabolic pathways	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMC200020659	K03006	ko00230	Purine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMC200020659	K03006	ko00240	Pyrimidine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMC200020659	K03006	ko01100	Metabolic pathways	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMC200020659	K03006	ko03020	RNA polymerase	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMC200020659	K03006	ko05016	Huntington's disease	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMC200020660	K00985	ko00230	Purine metabolism	534	1.3e-23	0.47	0.61	0.88
PGSC0003DMC200020663	K01859	ko00941	Flavonoid biosynthesis	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMC200020663	K01859	ko01100	Metabolic pathways	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMC200020663	K01859	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMC200027331	K03512	ko03410	Base excision repair	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMC200027331	K03512	ko03450	Non-homologous end-joining	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMC200027332	K03512	ko03410	Base excision repair	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMC200027332	K03512	ko03450	Non-homologous end-joining	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMC200027333	K11820	ko00380	Tryptophan metabolism	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMC200027333	K11820	ko00966	Glucosinolate biosynthesis	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMC200027333	K11820	ko01110	Biosynthesis of secondary metabolites	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMC200027334	K11820	ko00380	Tryptophan metabolism	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMC200027334	K11820	ko00966	Glucosinolate biosynthesis	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMC200027334	K11820	ko01110	Biosynthesis of secondary metabolites	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMC200027336	K08727	ko04621	NOD-like receptor signaling pathway	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMC200027336	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMC200027336	K08727	ko05131	Shigellosis	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMC200027337	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMC200027337	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMC200027337	K08727	ko05131	Shigellosis	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMC200027338	K12800	ko04621	NOD-like receptor signaling pathway	253	3.1e-07	0.31	0.47	0.74
PGSC0003DMC200027339	K08727	ko04621	NOD-like receptor signaling pathway	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMC200027339	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMC200027339	K08727	ko05131	Shigellosis	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMC200027340	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMC200027340	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMC200027340	K08727	ko05131	Shigellosis	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMC200027341	K04498	ko04110	Cell cycle	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04310	Wnt signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04330	Notch signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04350	TGF-beta signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04520	Adherens junction	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04630	Jak-STAT signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04720	Long-term potentiation	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko04916	Melanogenesis	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko05016	Huntington's disease	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko05200	Pathways in cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko05211	Renal cell carcinoma	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027341	K04498	ko05215	Prostate cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMC200027342	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMC200027342	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMC200027342	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMC200027342	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMC200027342	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMC200027343	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027343	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027343	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027343	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027344	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027344	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027344	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027344	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMC200027358	K10260	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.33	0.53	0.96
PGSC0003DMC200027359	K10260	ko04120	Ubiquitin mediated proteolysis	485	6.5e-21	0.28	0.47	0.68
PGSC0003DMC200047581	K11252	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.95	0.96	0.99
PGSC0003DMC200047582	K11252	ko05322	Systemic lupus erythematosus	1044	9.5e-52	0.88	0.91	0.99
PGSC0003DMC200047599	K01955	ko00240	Pyrimidine metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMC200047599	K01955	ko00250	Alanine, aspartate and glutamate metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMC200047599	K01955	ko01100	Metabolic pathways	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMC200047601	K02138	ko00190	Oxidative phosphorylation	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMC200047601	K02138	ko01100	Metabolic pathways	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMC200047601	K02138	ko05010	Alzheimer's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMC200047601	K02138	ko05012	Parkinson's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMC200047601	K02138	ko05016	Huntington's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMC200047610	K06685	ko04111	Cell cycle - yeast	343	2.0e-09	0.26	0.43	0.89
PGSC0003DMC200049537	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMC200049537	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMC200049537	K00771	ko01100	Metabolic pathways	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMC200049551	K02343	ko00230	Purine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049551	K02343	ko00240	Pyrimidine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049551	K02343	ko01100	Metabolic pathways	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049551	K02343	ko03030	DNA replication	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049551	K02343	ko03430	Mismatch repair	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049551	K02343	ko03440	Homologous recombination	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMC200049553	K10949	ko05110	Vibrio cholerae infection	1377	4.1e-70	0.82	0.92	0.76
PGSC0003DMC200049554	K10949	ko05110	Vibrio cholerae infection	1601	1.8e-82	0.86	0.94	1.00
PGSC0003DMC200049555	K01087	ko00500	Starch and sucrose metabolism	428	2.9e-17	0.69	0.80	0.88
PGSC0003DMC200049556	K01087	ko00500	Starch and sucrose metabolism	5572	1.7e-301	0.76	0.89	0.99
PGSC0003DMC200032222	K03363	ko04110	Cell cycle	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMC200032222	K03363	ko04111	Cell cycle - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMC200032222	K03363	ko04113	Meiosis - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMC200032222	K03363	ko04114	Oocyte meiosis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMC200032222	K03363	ko04120	Ubiquitin mediated proteolysis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMC200032223	K00558	ko00270	Cysteine and methionine metabolism	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMC200032223	K00558	ko01100	Metabolic pathways	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMC200032224	K00558	ko00270	Cysteine and methionine metabolism	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMC200032224	K00558	ko01100	Metabolic pathways	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMC200032225	K00558	ko00270	Cysteine and methionine metabolism	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMC200032225	K00558	ko01100	Metabolic pathways	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMC200032237	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.60
PGSC0003DMC200032238	K04631	ko04744	Phototransduction	692	2.5e-32	0.35	0.56	0.84
PGSC0003DMC200032239	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.45
PGSC0003DMC200032243	K12668	ko00510	N-Glycan biosynthesis	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMC200032243	K12668	ko01100	Metabolic pathways	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMC200032244	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMC200032244	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMC200032245	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMC200032245	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMC200054606	K13065	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMC200054606	K13065	ko00941	Flavonoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMC200054606	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMC200054606	K13065	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMC200054607	K01051	ko00040	Pentose and glucuronate interconversions	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMC200054607	K01051	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMC200054607	K01051	ko01100	Metabolic pathways	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMC200054608	K09903	ko00240	Pyrimidine metabolism	1915	8.7e-100	0.73	0.81	0.98
PGSC0003DMC200054609	K09903	ko00240	Pyrimidine metabolism	1987	9.3e-104	0.75	0.84	0.98
PGSC0003DMC200054617	K13068	ko00940	Phenylpropanoid biosynthesis	854	2.9e-41	0.32	0.51	0.95
PGSC0003DMC200054618	K05894	ko00592	alpha-Linolenic acid metabolism	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMC200054618	K05894	ko01100	Metabolic pathways	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMC200054619	K05894	ko00592	alpha-Linolenic acid metabolism	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMC200054619	K05894	ko01100	Metabolic pathways	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMC200054620	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054620	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054621	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054621	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054622	K05894	ko00592	alpha-Linolenic acid metabolism	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMC200054622	K05894	ko01100	Metabolic pathways	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMC200054623	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054623	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054624	K05894	ko00592	alpha-Linolenic acid metabolism	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMC200054624	K05894	ko01100	Metabolic pathways	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMC200054625	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054625	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMC200054627	K05894	ko00592	alpha-Linolenic acid metabolism	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMC200054627	K05894	ko01100	Metabolic pathways	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMC200054628	K05894	ko00592	alpha-Linolenic acid metabolism	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMC200054628	K05894	ko01100	Metabolic pathways	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMC200054630	K00856	ko00230	Purine metabolism	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMC200054630	K00856	ko01100	Metabolic pathways	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMC200037414	K00652	ko00780	Biotin metabolism	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMC200037414	K00652	ko01100	Metabolic pathways	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMC200037415	K00652	ko00780	Biotin metabolism	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMC200037415	K00652	ko01100	Metabolic pathways	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMC200037416	K00652	ko00780	Biotin metabolism	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMC200037416	K00652	ko01100	Metabolic pathways	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMC200037431	K06096	ko04530	Tight junction	381	3.5e-15	0.34	0.53	0.96
PGSC0003DMC200037434	K06096	ko04530	Tight junction	378	5.2e-15	0.34	0.53	0.96
PGSC0003DMC200037435	K06096	ko04530	Tight junction	359	5.8e-14	0.37	0.53	0.82
PGSC0003DMC200037438	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMC200037439	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMC200060542	K12356	ko00940	Phenylpropanoid biosynthesis	599	3.3e-27	0.38	0.57	0.67
PGSC0003DMC200060555	K04103	ko00380	Tryptophan metabolism	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMC200060555	K04103	ko01100	Metabolic pathways	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMC200060560	K13065	ko00940	Phenylpropanoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMC200060560	K13065	ko00941	Flavonoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMC200060560	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMC200060560	K13065	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMC200060562	K11251	ko05322	Systemic lupus erythematosus	503	6.6e-22	0.69	0.84	0.75
PGSC0003DMC200018331	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMC200018332	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMC200018334	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMC200029644	K03110	ko03060	Protein export	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMC200029644	K03110	ko03070	Bacterial secretion system	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMC200029646	K03110	ko03060	Protein export	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMC200029646	K03110	ko03070	Bacterial secretion system	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMC200029647	K03110	ko03060	Protein export	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMC200029647	K03110	ko03070	Bacterial secretion system	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMC200029648	K02739	ko03050	Proteasome	1821	1.3e-94	0.69	0.76	1.00
PGSC0003DMC200029649	K02739	ko03050	Proteasome	1956	4.8e-102	0.85	0.94	1.00
PGSC0003DMC200029655	K10260	ko04120	Ubiquitin mediated proteolysis	436	3.3e-18	0.29	0.48	0.62
PGSC0003DMC200029656	K03469	ko03030	DNA replication	249	6.7e-08	0.39	0.52	0.37
PGSC0003DMC200029664	K12796	ko04621	NOD-like receptor signaling pathway	419	1.2e-13	0.32	0.49	0.39
PGSC0003DMC200029665	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.88
PGSC0003DMC200029666	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.70
PGSC0003DMC200006211	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMC200006229	K02933	ko03010	Ribosome	847	7.0e-41	0.96	0.99	0.99
PGSC0003DMC200006231	K02292	ko00906	Carotenoid biosynthesis	1904	3.5e-99	0.51	0.67	0.95
PGSC0003DMC200006232	K02292	ko00906	Carotenoid biosynthesis	1617	2.4e-83	0.50	0.66	0.93
PGSC0003DMC200006233	K02292	ko00906	Carotenoid biosynthesis	260	4.4e-08	0.72	0.78	0.71
PGSC0003DMC200006234	K02292	ko00906	Carotenoid biosynthesis	1185	1.6e-59	0.52	0.67	0.99
PGSC0003DMC200006235	K02292	ko00906	Carotenoid biosynthesis	2151	8.4e-113	0.52	0.67	0.96
PGSC0003DMC200025804	K00454	ko00591	Linoleic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMC200025804	K00454	ko00592	alpha-Linolenic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMC200025804	K00454	ko01100	Metabolic pathways	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMC200025808	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMC200025808	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMC200025808	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMC200025809	K00799	ko00480	Glutathione metabolism	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMC200025809	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMC200025809	K00799	ko00982	Drug metabolism - cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMC200025810	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMC200025810	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMC200025810	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMC200025811	K00799	ko00480	Glutathione metabolism	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMC200025811	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMC200025811	K00799	ko00982	Drug metabolism - cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMC200025812	K00799	ko00480	Glutathione metabolism	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMC200025812	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMC200025812	K00799	ko00982	Drug metabolism - cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMC200025815	K01834	ko00010	Glycolysis / Gluconeogenesis	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMC200025815	K01834	ko01100	Metabolic pathways	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMC200025815	K01834	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMC200025816	K01834	ko00010	Glycolysis / Gluconeogenesis	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMC200025816	K01834	ko01100	Metabolic pathways	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMC200025816	K01834	ko01110	Biosynthesis of secondary metabolites	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMC200025822	K08139	ko04113	Meiosis - yeast	596	4.9e-27	0.40	0.62	0.87
PGSC0003DMC200018254	K01092	ko00521	Streptomycin biosynthesis	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMC200018254	K01092	ko00562	Inositol phosphate metabolism	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMC200018254	K01092	ko01100	Metabolic pathways	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMC200018254	K01092	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMC200018254	K01092	ko04070	Phosphatidylinositol signaling system	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMC200018255	K01092	ko00521	Streptomycin biosynthesis	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMC200018255	K01092	ko00562	Inositol phosphate metabolism	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMC200018255	K01092	ko01100	Metabolic pathways	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMC200018255	K01092	ko01110	Biosynthesis of secondary metabolites	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMC200018255	K01092	ko04070	Phosphatidylinositol signaling system	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMC200018256	K01092	ko00521	Streptomycin biosynthesis	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMC200018256	K01092	ko00562	Inositol phosphate metabolism	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMC200018256	K01092	ko01100	Metabolic pathways	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMC200018256	K01092	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMC200018256	K01092	ko04070	Phosphatidylinositol signaling system	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMC200018259	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMC200018259	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMC200029737	K00029	ko00620	Pyruvate metabolism	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMC200029737	K00029	ko00710	Carbon fixation in photosynthetic organisms	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMC200029737	K00029	ko01100	Metabolic pathways	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMC200029752	K10802	ko03410	Base excision repair	362	3.9e-14	0.44	0.62	0.81
PGSC0003DMC200029753	K10802	ko03410	Base excision repair	357	7.4e-14	0.44	0.64	0.81
PGSC0003DMC200029757	K12879	ko03040	Spliceosome	1115	5.4e-55	0.60	0.74	0.84
PGSC0003DMC200029758	K06671	ko04110	Cell cycle	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMC200029758	K06671	ko04111	Cell cycle - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMC200029758	K06671	ko04113	Meiosis - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMC200029759	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029759	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029759	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029760	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029760	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200029760	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMC200006361	K00908	ko01100	Metabolic pathways	3402	8.4e-182	0.80	0.89	0.89
PGSC0003DMC200006362	K00908	ko01100	Metabolic pathways	2377	2.9e-125	0.82	0.89	0.85
PGSC0003DMC200006364	K00908	ko01100	Metabolic pathways	807	1.1e-38	0.74	0.87	0.97
PGSC0003DMC200006368	K02641	ko00195	Photosynthesis	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMC200006368	K02641	ko01100	Metabolic pathways	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMC200006369	K02641	ko00195	Photosynthesis	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMC200006369	K02641	ko01100	Metabolic pathways	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMC200006383	K03029	ko03050	Proteasome	2477	8.7e-131	0.73	0.81	1.00
PGSC0003DMC200006384	K03029	ko03050	Proteasome	2807	5.5e-149	0.84	0.92	0.99
PGSC0003DMC200006385	K12311	ko00511	Other glycan degradation	6430	0.	0.74	0.85	1.00
PGSC0003DMC200006385	K12311	ko04142	Lysosome	6430	0.	0.74	0.85	1.00
PGSC0003DMC200012991	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012991	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012991	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012992	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012992	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012992	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMC200012993	K02958	ko03010	Ribosome	1208	8.6e-61	0.93	0.97	0.99
PGSC0003DMC200012996	K12275	ko03060	Protein export	2116	7.1e-111	0.72	0.80	0.99
PGSC0003DMC200012997	K12275	ko03060	Protein export	2216	2.2e-116	0.75	0.84	0.99
PGSC0003DMC200012998	K05666	ko02010	ABC transporters	2779	1.9e-147	0.35	0.56	0.89
PGSC0003DMC200013001	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMC200013001	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMC200013001	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMC200013001	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMC200013001	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMC200013002	K06685	ko04111	Cell cycle - yeast	490	1.3e-17	0.26	0.41	0.86
PGSC0003DMC200013007	K00655	ko00561	Glycerolipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMC200013007	K00655	ko00564	Glycerophospholipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMC200013007	K00655	ko01100	Metabolic pathways	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMC200013008	K00655	ko00561	Glycerolipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMC200013008	K00655	ko00564	Glycerophospholipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMC200013008	K00655	ko01100	Metabolic pathways	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMC200013009	K00655	ko00561	Glycerolipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMC200013009	K00655	ko00564	Glycerophospholipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMC200013009	K00655	ko01100	Metabolic pathways	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMC200013010	K00655	ko00561	Glycerolipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMC200013010	K00655	ko00564	Glycerophospholipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMC200013010	K00655	ko01100	Metabolic pathways	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMC200013011	K00655	ko00561	Glycerolipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMC200013011	K00655	ko00564	Glycerophospholipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMC200013011	K00655	ko01100	Metabolic pathways	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMC200013015	K01582	ko00310	Lysine degradation	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMC200013015	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMC200013015	K01582	ko01100	Metabolic pathways	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMC200013015	K01582	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMC200013016	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMC200013017	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMC200013018	K08064	ko04612	Antigen processing and presentation	375	7.6e-15	0.59	0.75	0.54
PGSC0003DMC200013019	K05666	ko02010	ABC transporters	2307	2.1e-121	0.34	0.55	0.88
PGSC0003DMC200013020	K05666	ko02010	ABC transporters	1627	6.7e-84	0.41	0.66	0.96
PGSC0003DMC200060037	K00657	ko00330	Arginine and proline metabolism	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMC200060037	K00657	ko01100	Metabolic pathways	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMC200049441	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200049441	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMC200049442	K10956	ko03060	Protein export	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMC200049442	K10956	ko04145	Phagosome	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMC200049442	K10956	ko05110	Vibrio cholerae infection	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMC200049443	K06636	ko04110	Cell cycle	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMC200049443	K06636	ko04111	Cell cycle - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMC200049443	K06636	ko04113	Meiosis - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMC200049443	K06636	ko04114	Oocyte meiosis	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMC200049453	K12857	ko03040	Spliceosome	254	6.1e-07	0.29	0.47	0.50
PGSC0003DMC200049461	K03083	ko04012	ErbB signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04062	Chemokine signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04110	Cell cycle	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04310	Wnt signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04340	Hedgehog signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04360	Axon guidance	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04510	Focal adhesion	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04660	T cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04662	B cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04711	Circadian rhythm - fly	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04722	Neurotrophin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04910	Insulin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko04916	Melanogenesis	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05010	Alzheimer's disease	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05200	Pathways in cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05210	Colorectal cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05213	Endometrial cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05215	Prostate cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049461	K03083	ko05217	Basal cell carcinoma	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMC200049465	K03015	ko00230	Purine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMC200049465	K03015	ko00240	Pyrimidine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMC200049465	K03015	ko01100	Metabolic pathways	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMC200049465	K03015	ko03020	RNA polymerase	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMC200049465	K03015	ko05016	Huntington's disease	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMC200037565	K08726	ko00590	Arachidonic acid metabolism	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMC200037565	K08726	ko00625	Tetrachloroethene degradation	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMC200037565	K08726	ko01100	Metabolic pathways	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMC200037565	K08726	ko04146	Peroxisome	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMC200037566	K08726	ko00590	Arachidonic acid metabolism	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMC200037566	K08726	ko00625	Tetrachloroethene degradation	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMC200037566	K08726	ko01100	Metabolic pathways	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMC200037566	K08726	ko04146	Peroxisome	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMC200037572	K03885	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.71	0.84	0.94
PGSC0003DMC200037573	K03885	ko00190	Oxidative phosphorylation	864	8.1e-42	0.82	0.89	0.98
PGSC0003DMC200037574	K03885	ko00190	Oxidative phosphorylation	3718	3.1e-199	0.75	0.87	0.99
PGSC0003DMC200037575	K03885	ko00190	Oxidative phosphorylation	585	2.0e-26	0.79	0.85	0.86
PGSC0003DMC200044193	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMC200044193	K01637	ko01100	Metabolic pathways	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMC200044194	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMC200044194	K01637	ko01100	Metabolic pathways	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMC200044197	K00430	ko00360	Phenylalanine metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMC200044197	K00430	ko00680	Methane metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMC200044197	K00430	ko00940	Phenylpropanoid biosynthesis	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMC200044197	K00430	ko01100	Metabolic pathways	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMC200044197	K00430	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMC200044198	K00430	ko00360	Phenylalanine metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMC200044198	K00430	ko00680	Methane metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMC200044198	K00430	ko00940	Phenylpropanoid biosynthesis	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMC200044198	K00430	ko01100	Metabolic pathways	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMC200044198	K00430	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMC200044199	K00430	ko00360	Phenylalanine metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMC200044199	K00430	ko00680	Methane metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMC200044199	K00430	ko00940	Phenylpropanoid biosynthesis	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMC200044199	K00430	ko01100	Metabolic pathways	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMC200044199	K00430	ko01110	Biosynthesis of secondary metabolites	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMC200044200	K08486	ko04130	SNARE interactions in vesicular transport	1880	7.4e-98	0.73	0.85	1.00
PGSC0003DMC200044201	K08486	ko04130	SNARE interactions in vesicular transport	1541	3.7e-79	0.81	0.92	0.99
PGSC0003DMC200035552	K02109	ko00190	Oxidative phosphorylation	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMC200035552	K02109	ko00195	Photosynthesis	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMC200035552	K02109	ko01100	Metabolic pathways	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMC200035553	K09755	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMC200035553	K09755	ko01100	Metabolic pathways	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMC200035553	K09755	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMC200035554	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMC200035554	K00517	ko00626	Naphthalene and anthracene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMC200035554	K00517	ko00903	Limonene and pinene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMC200035554	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMC200035554	K00517	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMC200035555	K11229	ko04011	MAPK signaling pathway - yeast	556	6.3e-24	0.34	0.51	0.88
PGSC0003DMC200035557	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMC200035557	K00224	ko00364	Fluorobenzoate degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMC200035557	K00224	ko00628	Fluorene degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMC200035557	K00224	ko00640	Propanoate metabolism	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMC200035559	K01179	ko00500	Starch and sucrose metabolism	2709	1.4e-143	0.69	0.80	0.93
PGSC0003DMC200035567	K12812	ko03040	Spliceosome	3442	5.2e-184	0.94	0.98	1.00
PGSC0003DMC200035568	K12812	ko03040	Spliceosome	2787	7.0e-148	0.96	0.98	1.00
PGSC0003DMC200035579	K02109	ko00190	Oxidative phosphorylation	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMC200035579	K02109	ko00195	Photosynthesis	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMC200035579	K02109	ko01100	Metabolic pathways	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMC200035580	K01046	ko00561	Glycerolipid metabolism	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMC200035580	K01046	ko01100	Metabolic pathways	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMC200008615	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMC200008616	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMC200008617	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMC200008619	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMC200008620	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMC200008628	K03868	ko03420	Nucleotide excision repair	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04110	Cell cycle	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04111	Cell cycle - yeast	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04114	Oocyte meiosis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04120	Ubiquitin mediated proteolysis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04310	Wnt signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04350	TGF-beta signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko04710	Circadian rhythm - mammal	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko05200	Pathways in cancer	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008628	K03868	ko05211	Renal cell carcinoma	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMC200008631	K12620	ko03018	RNA degradation	665	7.6e-31	0.80	0.88	0.22
PGSC0003DMC200008632	K12620	ko03018	RNA degradation	969	1.3e-47	0.91	0.96	0.99
PGSC0003DMC200008638	K04554	ko04120	Ubiquitin mediated proteolysis	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMC200008638	K04554	ko05012	Parkinson's disease	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMC200008639	K04554	ko04120	Ubiquitin mediated proteolysis	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMC200008639	K04554	ko05012	Parkinson's disease	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMC200008640	K04554	ko04120	Ubiquitin mediated proteolysis	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMC200008640	K04554	ko05012	Parkinson's disease	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMC200020734	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMC200020735	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMC200020746	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMC200020747	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMC200020748	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMC200016385	K10526	ko00592	alpha-Linolenic acid metabolism	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMC200016385	K10526	ko01100	Metabolic pathways	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMC200016386	K10526	ko00592	alpha-Linolenic acid metabolism	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMC200016386	K10526	ko01100	Metabolic pathways	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMC200016388	K05339	ko02020	Two-component system	297	1.5e-10	0.34	0.54	0.39
PGSC0003DMC200016390	K04428	ko04010	MAPK signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMC200016390	K04428	ko04912	GnRH signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMC200016391	K08866	ko04110	Cell cycle	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMC200016391	K08866	ko04111	Cell cycle - yeast	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMC200016394	K12189	ko04144	Endocytosis	1374	6.0e-70	0.88	0.96	0.99
PGSC0003DMC200016395	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMC200016396	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMC200016397	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMC200016398	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMC200016403	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMC200016404	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMC200010772	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMC200010772	K00517	ko00626	Naphthalene and anthracene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMC200010772	K00517	ko00903	Limonene and pinene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMC200010772	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMC200010772	K00517	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMC200010773	K05280	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMC200010773	K05280	ko00944	Flavone and flavonol biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMC200010773	K05280	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMC200010773	K05280	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMC200010774	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMC200010774	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMC200010774	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMC200010774	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMC200010774	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMC200010775	K05280	ko00941	Flavonoid biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMC200010775	K05280	ko00944	Flavone and flavonol biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMC200010775	K05280	ko01100	Metabolic pathways	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMC200010775	K05280	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMC200010776	K07424	ko00140	Steroid hormone biosynthesis	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00591	Linoleic acid metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00830	Retinol metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00982	Drug metabolism - cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko00983	Drug metabolism - other enzymes	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010776	K07424	ko01100	Metabolic pathways	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMC200010777	K07424	ko00140	Steroid hormone biosynthesis	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00591	Linoleic acid metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00830	Retinol metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00982	Drug metabolism - cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko00983	Drug metabolism - other enzymes	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010777	K07424	ko01100	Metabolic pathways	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMC200010778	K07424	ko00140	Steroid hormone biosynthesis	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00591	Linoleic acid metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00830	Retinol metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00982	Drug metabolism - cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko00983	Drug metabolism - other enzymes	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010778	K07424	ko01100	Metabolic pathways	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMC200010779	K07424	ko00140	Steroid hormone biosynthesis	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00591	Linoleic acid metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00830	Retinol metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00982	Drug metabolism - cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko00983	Drug metabolism - other enzymes	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010779	K07424	ko01100	Metabolic pathways	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMC200010786	K00873	ko00010	Glycolysis / Gluconeogenesis	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko00230	Purine metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko00620	Pyruvate metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko00710	Carbon fixation in photosynthetic organisms	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko01100	Metabolic pathways	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010786	K00873	ko04930	Type II diabetes mellitus	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMC200010794	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMC200010794	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMC200010795	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMC200010795	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMC200027246	K08008	ko04145	Phagosome	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMC200027246	K08008	ko04670	Leukocyte transendothelial migration	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMC200027247	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMC200027247	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMC200027248	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMC200027248	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMC200027251	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200027254	K04733	ko04210	Apoptosis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMC200027254	K04733	ko04620	Toll-like receptor signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMC200027254	K04733	ko04722	Neurotrophin signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMC200027254	K04733	ko05140	Leishmaniasis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMC200027254	K04733	ko05142	Chagas disease	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMC200027255	K00430	ko00360	Phenylalanine metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMC200027255	K00430	ko00680	Methane metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMC200027255	K00430	ko00940	Phenylpropanoid biosynthesis	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMC200027255	K00430	ko01100	Metabolic pathways	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMC200027255	K00430	ko01110	Biosynthesis of secondary metabolites	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMC200027265	K00660	ko00941	Flavonoid biosynthesis	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMC200027265	K00660	ko01100	Metabolic pathways	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMC200027265	K00660	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMC200027265	K00660	ko04712	Circadian rhythm - plant	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMC200027266	K07195	ko04910	Insulin signaling pathway	2046	5.2e-107	0.47	0.64	0.99
PGSC0003DMC200027267	K07195	ko04910	Insulin signaling pathway	1905	3.1e-99	0.51	0.67	0.88
PGSC0003DMC200062943	K01366	ko04142	Lysosome	418	3.2e-17	0.35	0.51	0.80
PGSC0003DMC200062946	K10760	ko00908	Zeatin biosynthesis	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMC200062946	K10760	ko01100	Metabolic pathways	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMC200062946	K10760	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMC200062969	K11433	ko00310	Lysine degradation	227	1.1e-06	0.30	0.44	0.69
PGSC0003DMC200065124	K08506	ko04130	SNARE interactions in vesicular transport	261	1.5e-08	0.38	0.44	0.99
PGSC0003DMC200058445	K03094	ko04110	Cell cycle	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04111	Cell cycle - yeast	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04114	Oocyte meiosis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04120	Ubiquitin mediated proteolysis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04310	Wnt signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04350	TGF-beta signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058445	K03094	ko04710	Circadian rhythm - mammal	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMC200058467	K06544	ko04514	Cell adhesion molecules (CAMs)	302	8.0e-11	0.27	0.55	0.96
PGSC0003DMC200045183	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045183	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045185	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMC200045186	K01074	ko00062	Fatty acid elongation in mitochondria	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMC200045186	K01074	ko01100	Metabolic pathways	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMC200045186	K01074	ko04142	Lysosome	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMC200045187	K01074	ko00062	Fatty acid elongation in mitochondria	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMC200045187	K01074	ko01100	Metabolic pathways	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMC200045187	K01074	ko04142	Lysosome	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMC200045188	K01074	ko00062	Fatty acid elongation in mitochondria	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMC200045188	K01074	ko01100	Metabolic pathways	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMC200045188	K01074	ko04142	Lysosome	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMC200045189	K01074	ko00062	Fatty acid elongation in mitochondria	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMC200045189	K01074	ko01100	Metabolic pathways	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMC200045189	K01074	ko04142	Lysosome	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMC200045190	K01074	ko00062	Fatty acid elongation in mitochondria	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMC200045190	K01074	ko01100	Metabolic pathways	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMC200045190	K01074	ko04142	Lysosome	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMC200039578	K12132	ko04712	Circadian rhythm - plant	1034	3.4e-51	0.48	0.67	0.85
PGSC0003DMC200039580	K04712	ko00600	Sphingolipid metabolism	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMC200039580	K04712	ko01100	Metabolic pathways	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMC200039596	K10352	ko04530	Tight junction	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMC200039596	K10352	ko05416	Viral myocarditis	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMC200039599	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200009573	K05395	ko00270	Cysteine and methionine metabolism	491	3.0e-21	0.46	0.59	0.86
PGSC0003DMC200009574	K05395	ko00270	Cysteine and methionine metabolism	486	5.7e-21	0.47	0.61	0.92
PGSC0003DMC200009596	K06671	ko04110	Cell cycle	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMC200009596	K06671	ko04111	Cell cycle - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMC200009596	K06671	ko04113	Meiosis - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMC200009597	K07203	ko04012	ErbB signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko04150	mTOR signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko04910	Insulin signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko04920	Adipocytokine signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko04930	Type II diabetes mellitus	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko05200	Pathways in cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko05214	Glioma	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko05215	Prostate cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200009597	K07203	ko05221	Acute myeloid leukemia	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMC200015187	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2405	8.2e-127	0.75	0.84	1.00
PGSC0003DMC200015193	K01955	ko00240	Pyrimidine metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMC200015193	K01955	ko00250	Alanine, aspartate and glutamate metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMC200015193	K01955	ko01100	Metabolic pathways	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMC200015194	K05278	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMC200015194	K05278	ko01100	Metabolic pathways	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMC200015194	K05278	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMC200015200	K04392	ko04010	MAPK signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04062	Chemokine signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04145	Phagosome	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04310	Wnt signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04360	Axon guidance	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04370	VEGF signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04510	Focal adhesion	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04520	Adherens junction	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04620	Toll-like receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04650	Natural killer cell mediated cytotoxicity	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04662	B cell receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04664	Fc epsilon RI signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04666	Fc gamma R-mediated phagocytosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04670	Leukocyte transendothelial migration	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04722	Neurotrophin signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko04810	Regulation of actin cytoskeleton	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05100	Bacterial invasion of epithelial cells	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05131	Shigellosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05200	Pathways in cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05210	Colorectal cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05211	Renal cell carcinoma	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05212	Pancreatic cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015200	K04392	ko05416	Viral myocarditis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMC200015201	K04392	ko04010	MAPK signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04062	Chemokine signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04145	Phagosome	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04310	Wnt signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04360	Axon guidance	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04370	VEGF signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04510	Focal adhesion	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04520	Adherens junction	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04620	Toll-like receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04650	Natural killer cell mediated cytotoxicity	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04662	B cell receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04664	Fc epsilon RI signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04666	Fc gamma R-mediated phagocytosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04670	Leukocyte transendothelial migration	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04722	Neurotrophin signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko04810	Regulation of actin cytoskeleton	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05100	Bacterial invasion of epithelial cells	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05131	Shigellosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05200	Pathways in cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05210	Colorectal cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05211	Renal cell carcinoma	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05212	Pancreatic cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015201	K04392	ko05416	Viral myocarditis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMC200015202	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015202	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015202	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015203	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015203	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015203	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015204	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015204	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015204	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015205	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015205	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015205	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015206	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015206	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015206	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMC200015208	K07191	ko04910	Insulin signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMC200015208	K07191	ko04920	Adipocytokine signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMC200015208	K07191	ko04930	Type II diabetes mellitus	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMC200015209	K07191	ko04910	Insulin signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMC200015209	K07191	ko04920	Adipocytokine signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMC200015209	K07191	ko04930	Type II diabetes mellitus	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMC200028448	K10886	ko03450	Non-homologous end-joining	522	5.9e-23	0.51	0.71	0.98
PGSC0003DMC200028449	K10886	ko03450	Non-homologous end-joining	1258	1.5e-63	0.65	0.77	0.90
PGSC0003DMC200028450	K08486	ko04130	SNARE interactions in vesicular transport	2053	2.1e-107	0.81	0.90	1.00
PGSC0003DMC200028455	K13229	ko00402	Benzoxazinoid biosynthesis	1147	2.0e-57	0.43	0.62	0.99
PGSC0003DMC200028456	K13229	ko00402	Benzoxazinoid biosynthesis	1224	1.1e-61	0.44	0.65	0.99
PGSC0003DMC200028457	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.20
PGSC0003DMC200028458	K13229	ko00402	Benzoxazinoid biosynthesis	800	2.7e-38	0.51	0.71	0.85
PGSC0003DMC200028459	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028459	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMC200028460	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028460	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMC200028461	K06269	ko04113	Meiosis - yeast	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04114	Oocyte meiosis	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04270	Vascular smooth muscle contraction	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04510	Focal adhesion	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04720	Long-term potentiation	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04810	Regulation of actin cytoskeleton	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200028461	K06269	ko04910	Insulin signaling pathway	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMC200038612	K01051	ko00040	Pentose and glucuronate interconversions	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMC200038612	K01051	ko00500	Starch and sucrose metabolism	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMC200038612	K01051	ko01100	Metabolic pathways	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMC200038623	K01126	ko00564	Glycerophospholipid metabolism	455	5.1e-19	0.29	0.51	0.43
PGSC0003DMC200038625	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMC200038626	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMC200038627	K03131	ko03022	Basal transcription factors	3141	2.1e-167	0.68	0.80	1.00
PGSC0003DMC200038628	K08503	ko04130	SNARE interactions in vesicular transport	1360	3.5e-69	0.70	0.85	1.00
PGSC0003DMC200038629	K12199	ko04144	Endocytosis	2502	3.7e-132	0.71	0.80	1.00
PGSC0003DMC200038630	K12199	ko04144	Endocytosis	1213	4.5e-61	0.65	0.76	0.98
PGSC0003DMC200038640	K12477	ko04144	Endocytosis	655	2.7e-30	0.50	0.69	0.95
PGSC0003DMC200050734	K03935	ko00190	Oxidative phosphorylation	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMC200050734	K03935	ko01100	Metabolic pathways	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMC200050734	K03935	ko05010	Alzheimer's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMC200050734	K03935	ko05012	Parkinson's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMC200050734	K03935	ko05016	Huntington's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMC200050735	K03935	ko00190	Oxidative phosphorylation	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMC200050735	K03935	ko01100	Metabolic pathways	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMC200050735	K03935	ko05010	Alzheimer's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMC200050735	K03935	ko05012	Parkinson's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMC200050735	K03935	ko05016	Huntington's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMC200050736	K01696	ko00260	Glycine, serine and threonine metabolism	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMC200050736	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMC200050736	K01696	ko01100	Metabolic pathways	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMC200050736	K01696	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMC200050741	K02866	ko03010	Ribosome	806	1.3e-38	0.47	0.64	0.79
PGSC0003DMC200057250	K12881	ko03040	Spliceosome	1114	1.3e-55	0.72	0.79	0.87
PGSC0003DMC200040772	K12741	ko03040	Spliceosome	1187	1.2e-59	0.40	0.56	0.98
PGSC0003DMC200040773	K12462	ko04722	Neurotrophin signaling pathway	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMC200040773	K12462	ko04962	Vasopressin-regulated water reabsorption	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMC200040796	K00558	ko00270	Cysteine and methionine metabolism	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMC200040796	K00558	ko01100	Metabolic pathways	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMC200046387	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMC200046389	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMC200046390	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMC200046391	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMC200046397	K01640	ko00072	Synthesis and degradation of ketone bodies	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko00280	Valine, leucine and isoleucine degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko00281	Geraniol degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko00650	Butanoate metabolism	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko01100	Metabolic pathways	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046397	K01640	ko04146	Peroxisome	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMC200046398	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMC200046399	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMC200046400	K01640	ko00072	Synthesis and degradation of ketone bodies	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko00280	Valine, leucine and isoleucine degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko00281	Geraniol degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko00650	Butanoate metabolism	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko01100	Metabolic pathways	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046400	K01640	ko04146	Peroxisome	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMC200046401	K01640	ko00072	Synthesis and degradation of ketone bodies	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko00280	Valine, leucine and isoleucine degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko00281	Geraniol degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko00650	Butanoate metabolism	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko01100	Metabolic pathways	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046401	K01640	ko04146	Peroxisome	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMC200046402	K01640	ko00072	Synthesis and degradation of ketone bodies	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko00280	Valine, leucine and isoleucine degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko00281	Geraniol degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko00650	Butanoate metabolism	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko01100	Metabolic pathways	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046402	K01640	ko04146	Peroxisome	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMC200046403	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMC200046408	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.72
PGSC0003DMC200046409	K09866	ko04962	Vasopressin-regulated water reabsorption	456	2.6e-19	0.35	0.54	0.87
PGSC0003DMC200046410	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.71
PGSC0003DMC200061238	K03133	ko03022	Basal transcription factors	335	1.2e-12	0.62	0.74	0.72
PGSC0003DMC200019448	K08269	ko04140	Regulation of autophagy	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMC200019448	K08269	ko04150	mTOR signaling pathway	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMC200019449	K08269	ko04140	Regulation of autophagy	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMC200019449	K08269	ko04150	mTOR signaling pathway	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMC200019450	K08269	ko04140	Regulation of autophagy	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMC200019450	K08269	ko04150	mTOR signaling pathway	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMC200019451	K00799	ko00480	Glutathione metabolism	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMC200019451	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMC200019451	K00799	ko00982	Drug metabolism - cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMC200019452	K00799	ko00480	Glutathione metabolism	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMC200019452	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMC200019452	K00799	ko00982	Drug metabolism - cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMC200019454	K04714	ko00600	Sphingolipid metabolism	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMC200019454	K04714	ko01100	Metabolic pathways	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMC200019462	K00368	ko00910	Nitrogen metabolism	1703	4.3e-88	0.45	0.60	0.89
PGSC0003DMC200019470	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200019470	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200019470	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200019470	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200019470	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200019470	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMC200014198	K02736	ko03050	Proteasome	1888	2.7e-98	0.89	0.96	1.00
PGSC0003DMC200014199	K02736	ko03050	Proteasome	495	1.8e-21	0.92	1.00	0.77
PGSC0003DMC200014208	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMC200014208	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMC200014209	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMC200014209	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMC200014216	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMC200007565	K01641	ko00072	Synthesis and degradation of ketone bodies	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007565	K01641	ko00280	Valine, leucine and isoleucine degradation	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007565	K01641	ko00650	Butanoate metabolism	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007565	K01641	ko00900	Terpenoid backbone biosynthesis	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007565	K01641	ko01100	Metabolic pathways	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007565	K01641	ko01110	Biosynthesis of secondary metabolites	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMC200007570	K12307	ko04142	Lysosome	349	2.3e-11	0.25	0.46	0.60
PGSC0003DMC200007571	K12307	ko04142	Lysosome	351	1.6e-11	0.25	0.46	0.60
PGSC0003DMC200007572	K12307	ko04142	Lysosome	351	2.4e-12	0.25	0.46	0.84
PGSC0003DMC200007573	K12307	ko04142	Lysosome	347	3.1e-11	0.24	0.45	0.60
PGSC0003DMC200007574	K12307	ko04142	Lysosome	349	3.7e-12	0.25	0.46	0.84
PGSC0003DMC200005553	K05933	ko00270	Cysteine and methionine metabolism	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMC200005553	K05933	ko01110	Biosynthesis of secondary metabolites	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMC200005555	K05277	ko00941	Flavonoid biosynthesis	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMC200005555	K05277	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMC200005555	K05277	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMC200005556	K05278	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMC200005556	K05278	ko01100	Metabolic pathways	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMC200005556	K05278	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMC200005557	K05278	ko00941	Flavonoid biosynthesis	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMC200005557	K05278	ko01100	Metabolic pathways	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMC200005557	K05278	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMC200005560	K05278	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMC200005560	K05278	ko01100	Metabolic pathways	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMC200005560	K05278	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMC200005561	K05278	ko00941	Flavonoid biosynthesis	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMC200005561	K05278	ko01100	Metabolic pathways	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMC200005561	K05278	ko01110	Biosynthesis of secondary metabolites	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMC200005562	K05278	ko00941	Flavonoid biosynthesis	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMC200005562	K05278	ko01100	Metabolic pathways	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMC200005562	K05278	ko01110	Biosynthesis of secondary metabolites	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMC200005563	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMC200005563	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMC200005563	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMC200005565	K05277	ko00941	Flavonoid biosynthesis	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMC200005565	K05277	ko01100	Metabolic pathways	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMC200005565	K05277	ko01110	Biosynthesis of secondary metabolites	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMC200005566	K05278	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMC200005566	K05278	ko01100	Metabolic pathways	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMC200005566	K05278	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMC200005567	K05278	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMC200005567	K05278	ko01100	Metabolic pathways	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMC200005567	K05278	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMC200005568	K05278	ko00941	Flavonoid biosynthesis	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMC200005568	K05278	ko01100	Metabolic pathways	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMC200005568	K05278	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMC200005569	K05278	ko00941	Flavonoid biosynthesis	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMC200005569	K05278	ko01100	Metabolic pathways	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMC200005569	K05278	ko01110	Biosynthesis of secondary metabolites	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMC200005570	K04124	ko00904	Diterpenoid biosynthesis	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMC200005570	K04124	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMC200005572	K04124	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMC200005572	K04124	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMC200005574	K04124	ko00904	Diterpenoid biosynthesis	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMC200005574	K04124	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMC200005578	K00064	ko00053	Ascorbate and aldarate metabolism	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMC200005578	K00064	ko01100	Metabolic pathways	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMC200005578	K00064	ko01110	Biosynthesis of secondary metabolites	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMC200005579	K00064	ko00053	Ascorbate and aldarate metabolism	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMC200005579	K00064	ko01100	Metabolic pathways	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMC200005579	K00064	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMC200005580	K01507	ko00190	Oxidative phosphorylation	796	4.5e-38	0.69	0.75	0.67
PGSC0003DMC200048247	K01803	ko00010	Glycolysis / Gluconeogenesis	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048247	K01803	ko00051	Fructose and mannose metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048247	K01803	ko00562	Inositol phosphate metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048247	K01803	ko00710	Carbon fixation in photosynthetic organisms	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048247	K01803	ko01100	Metabolic pathways	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048247	K01803	ko01110	Biosynthesis of secondary metabolites	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMC200048248	K05692	ko04145	Phagosome	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04510	Focal adhesion	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04520	Adherens junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04530	Tight junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04670	Leukocyte transendothelial migration	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04745	Phototransduction - fly	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko04810	Regulation of actin cytoskeleton	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05100	Bacterial invasion of epithelial cells	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05110	Vibrio cholerae infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05130	Pathogenic Escherichia coli infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05131	Shigellosis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05414	Dilated cardiomyopathy	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048248	K05692	ko05416	Viral myocarditis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMC200048253	K03283	ko03040	Spliceosome	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMC200048253	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMC200048253	K03283	ko04144	Endocytosis	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMC200048253	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMC200048254	K05765	ko04360	Axon guidance	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMC200048254	K05765	ko04666	Fc gamma R-mediated phagocytosis	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMC200048254	K05765	ko04810	Regulation of actin cytoskeleton	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMC200048256	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMC200048256	K00517	ko00626	Naphthalene and anthracene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMC200048256	K00517	ko00903	Limonene and pinene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMC200048256	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMC200048256	K00517	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMC200048270	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMC200059738	K07424	ko00140	Steroid hormone biosynthesis	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00591	Linoleic acid metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00830	Retinol metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00982	Drug metabolism - cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko00983	Drug metabolism - other enzymes	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059738	K07424	ko01100	Metabolic pathways	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMC200059754	K03094	ko04110	Cell cycle	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04111	Cell cycle - yeast	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04114	Oocyte meiosis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04120	Ubiquitin mediated proteolysis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04310	Wnt signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04350	TGF-beta signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059754	K03094	ko04710	Circadian rhythm - mammal	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMC200059759	K12493	ko04144	Endocytosis	658	6.1e-30	0.41	0.59	0.69
PGSC0003DMC200042999	K00430	ko00360	Phenylalanine metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMC200042999	K00430	ko00680	Methane metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMC200042999	K00430	ko00940	Phenylpropanoid biosynthesis	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMC200042999	K00430	ko01100	Metabolic pathways	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMC200042999	K00430	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMC200043002	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMC200043002	K02367	ko01100	Metabolic pathways	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMC200043019	K04420	ko04010	MAPK signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMC200043019	K04420	ko04540	Gap junction	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMC200043019	K04420	ko04912	GnRH signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMC200043020	K04421	ko04010	MAPK signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMC200043020	K04421	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMC200043020	K04421	ko04912	GnRH signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMC200036361	K12338	ko00942	Anthocyanin biosynthesis	280	1.3e-09	0.55	0.76	0.91
PGSC0003DMC200036373	K00679	ko00561	Glycerolipid metabolism	1118	7.9e-56	0.35	0.50	0.96
PGSC0003DMC200036374	K00679	ko00561	Glycerolipid metabolism	1285	4.9e-65	0.37	0.52	0.87
PGSC0003DMC200036382	K01199	ko00500	Starch and sucrose metabolism	280	1.3e-09	0.36	0.63	0.44
PGSC0003DMC200044911	K01966	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMC200044911	K01966	ko00640	Propanoate metabolism	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMC200044911	K01966	ko01100	Metabolic pathways	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMC200044912	K01966	ko00280	Valine, leucine and isoleucine degradation	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMC200044912	K01966	ko00640	Propanoate metabolism	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMC200044912	K01966	ko01100	Metabolic pathways	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMC200044913	K09054	ko05010	Alzheimer's disease	259	4.8e-06	0.34	0.50	0.41
PGSC0003DMC200044918	K02183	ko04020	Calcium signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04070	Phosphatidylinositol signaling system	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04114	Oocyte meiosis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04270	Vascular smooth muscle contraction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04626	Plant-pathogen interaction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04720	Long-term potentiation	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04722	Neurotrophin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04740	Olfactory transduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04744	Phototransduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04745	Phototransduction - fly	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04910	Insulin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04912	GnRH signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04916	Melanogenesis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04970	Salivary secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko04971	Gastric acid secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko05010	Alzheimer's disease	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044918	K02183	ko05214	Glioma	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMC200044927	K13289	ko04142	Lysosome	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMC200044927	K13289	ko04614	Renin-angiotensin system	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMC200044928	K13289	ko04142	Lysosome	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMC200044928	K13289	ko04614	Renin-angiotensin system	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMC200044929	K13289	ko04142	Lysosome	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMC200044929	K13289	ko04614	Renin-angiotensin system	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMC200044930	K13289	ko04142	Lysosome	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMC200044930	K13289	ko04614	Renin-angiotensin system	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMC200044931	K13289	ko04142	Lysosome	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMC200044931	K13289	ko04614	Renin-angiotensin system	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMC200044932	K13289	ko04142	Lysosome	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMC200044932	K13289	ko04614	Renin-angiotensin system	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMC200044933	K13289	ko04142	Lysosome	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMC200044933	K13289	ko04614	Renin-angiotensin system	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMC200044934	K13289	ko04142	Lysosome	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMC200044934	K13289	ko04614	Renin-angiotensin system	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMC200044935	K13289	ko04142	Lysosome	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMC200044935	K13289	ko04614	Renin-angiotensin system	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMC200044937	K13289	ko04142	Lysosome	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMC200044937	K13289	ko04614	Renin-angiotensin system	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMC200032447	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMC200032447	K00814	ko00710	Carbon fixation in photosynthetic organisms	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMC200032447	K00814	ko01100	Metabolic pathways	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMC200032448	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMC200032448	K00814	ko00710	Carbon fixation in photosynthetic organisms	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMC200032448	K00814	ko01100	Metabolic pathways	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMC200032450	K00430	ko00360	Phenylalanine metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMC200032450	K00430	ko00680	Methane metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMC200032450	K00430	ko00940	Phenylpropanoid biosynthesis	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMC200032450	K00430	ko01100	Metabolic pathways	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMC200032450	K00430	ko01110	Biosynthesis of secondary metabolites	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMC200032452	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMC200032460	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMC200032460	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMC200032460	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMC200032460	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMC200032460	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMC200047075	K10881	ko03050	Proteasome	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMC200047075	K10881	ko03440	Homologous recombination	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMC200047083	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047083	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047083	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047083	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047083	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047083	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047084	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMC200047097	K00368	ko00910	Nitrogen metabolism	1918	5.9e-100	0.47	0.60	0.89
PGSC0003DMC200047098	K00368	ko00910	Nitrogen metabolism	1945	1.9e-101	0.48	0.60	0.89
PGSC0003DMC200047099	K00368	ko00910	Nitrogen metabolism	1928	1.7e-100	0.47	0.60	0.91
PGSC0003DMC200040686	K12896	ko03040	Spliceosome	1927	1.9e-100	0.75	0.81	0.96
PGSC0003DMC200040687	K12896	ko03040	Spliceosome	1601	1.8e-82	0.72	0.78	0.95
PGSC0003DMC200040689	K12843	ko03040	Spliceosome	4858	4.1e-262	0.80	0.90	1.00
PGSC0003DMC200040690	K12843	ko03040	Spliceosome	3203	7.9e-171	0.72	0.87	0.93
PGSC0003DMC200040691	K12843	ko03040	Spliceosome	3292	9.8e-176	0.53	0.66	1.00
PGSC0003DMC200040692	K04733	ko04210	Apoptosis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMC200040692	K04733	ko04620	Toll-like receptor signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMC200040692	K04733	ko04722	Neurotrophin signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMC200040692	K04733	ko05140	Leishmaniasis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMC200040692	K04733	ko05142	Chagas disease	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMC200040693	K04733	ko04210	Apoptosis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMC200040693	K04733	ko04620	Toll-like receptor signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMC200040693	K04733	ko04722	Neurotrophin signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMC200040693	K04733	ko05140	Leishmaniasis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMC200040693	K04733	ko05142	Chagas disease	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMC200040695	K12460	ko04722	Neurotrophin signaling pathway	337	1.3e-11	0.40	0.56	0.39
PGSC0003DMC200040696	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.63
PGSC0003DMC200040697	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.57
PGSC0003DMC200040698	K07195	ko04910	Insulin signaling pathway	2335	5.9e-123	0.49	0.67	0.99
PGSC0003DMC200040699	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.96	0.99
PGSC0003DMC200026851	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMC200026851	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMC200026856	K00908	ko01100	Metabolic pathways	429	3.0e-17	0.31	0.50	0.46
PGSC0003DMC200026859	K04424	ko04010	MAPK signaling pathway	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMC200026859	K04424	ko04530	Tight junction	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMC200026860	K04424	ko04010	MAPK signaling pathway	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMC200026860	K04424	ko04530	Tight junction	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMC200026861	K04424	ko04010	MAPK signaling pathway	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMC200026861	K04424	ko04530	Tight junction	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMC200026862	K04424	ko04010	MAPK signaling pathway	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMC200026862	K04424	ko04530	Tight junction	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMC200026863	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMC200026863	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMC200026864	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMC200026864	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMC200026865	K02863	ko03010	Ribosome	736	9.3e-35	0.47	0.60	0.58
PGSC0003DMC200026866	K02863	ko03010	Ribosome	745	3.0e-35	0.47	0.62	0.56
PGSC0003DMC200026875	K00451	ko00350	Tyrosine metabolism	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMC200026875	K00451	ko00643	Styrene degradation	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMC200026875	K00451	ko01100	Metabolic pathways	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMC200026876	K00451	ko00350	Tyrosine metabolism	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMC200026876	K00451	ko00643	Styrene degradation	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMC200026876	K00451	ko01100	Metabolic pathways	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMC200026877	K00451	ko00350	Tyrosine metabolism	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMC200026877	K00451	ko00643	Styrene degradation	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMC200026877	K00451	ko01100	Metabolic pathways	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMC200015875	K00975	ko00500	Starch and sucrose metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMC200015875	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMC200015875	K00975	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMC200015876	K00975	ko00500	Starch and sucrose metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMC200015876	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMC200015876	K00975	ko01100	Metabolic pathways	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMC200015883	K01937	ko00240	Pyrimidine metabolism	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMC200015883	K01937	ko01100	Metabolic pathways	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMC200015884	K01937	ko00240	Pyrimidine metabolism	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMC200015884	K01937	ko01100	Metabolic pathways	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMC200015895	K05349	ko00460	Cyanoamino acid metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMC200015895	K05349	ko00500	Starch and sucrose metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMC200015895	K05349	ko00940	Phenylpropanoid biosynthesis	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMC200015895	K05349	ko01110	Biosynthesis of secondary metabolites	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMC200015898	K08737	ko03430	Mismatch repair	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMC200015898	K08737	ko05200	Pathways in cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMC200015898	K08737	ko05210	Colorectal cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMC200015899	K08737	ko03430	Mismatch repair	7323	0.	0.69	0.81	1.00
PGSC0003DMC200015899	K08737	ko05200	Pathways in cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMC200015899	K08737	ko05210	Colorectal cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMC200009482	K05546	ko00510	N-Glycan biosynthesis	6249	0.	0.77	0.87	1.00
PGSC0003DMC200009482	K05546	ko01100	Metabolic pathways	6249	0.	0.77	0.87	1.00
PGSC0003DMC200009484	K12619	ko03018	RNA degradation	2575	3.4e-136	0.53	0.60	0.98
PGSC0003DMC200009485	K12619	ko03018	RNA degradation	4234	1.1e-227	0.52	0.62	1.00
PGSC0003DMC200009486	K06065	ko04330	Notch signaling pathway	438	4.9e-14	0.25	0.41	0.71
PGSC0003DMC200009487	K06065	ko04330	Notch signaling pathway	438	5.8e-14	0.25	0.41	0.63
PGSC0003DMC200009493	K08057	ko04145	Phagosome	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMC200009493	K08057	ko04612	Antigen processing and presentation	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMC200009493	K08057	ko05142	Chagas disease	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMC200009494	K08057	ko04145	Phagosome	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMC200009494	K08057	ko04612	Antigen processing and presentation	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMC200009494	K08057	ko05142	Chagas disease	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMC200009495	K11866	ko04144	Endocytosis	445	5.6e-18	0.28	0.41	0.92
PGSC0003DMC200009496	K04371	ko04010	MAPK signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04012	ErbB signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04013	MAPK signaling pathway - fly	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04062	Chemokine signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04114	Oocyte meiosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04150	mTOR signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04270	Vascular smooth muscle contraction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04320	Dorso-ventral axis formation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04350	TGF-beta signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04360	Axon guidance	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04370	VEGF signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04510	Focal adhesion	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04520	Adherens junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04540	Gap junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04620	Toll-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04621	NOD-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04650	Natural killer cell mediated cytotoxicity	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04660	T cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04662	B cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04664	Fc epsilon RI signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04666	Fc gamma R-mediated phagocytosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04720	Long-term potentiation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04722	Neurotrophin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04730	Long-term depression	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04810	Regulation of actin cytoskeleton	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04910	Insulin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04912	GnRH signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04914	Progesterone-mediated oocyte maturation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04916	Melanogenesis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04930	Type II diabetes mellitus	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko04960	Aldosterone-regulated sodium reabsorption	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05010	Alzheimer's disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05020	Prion diseases	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05131	Shigellosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05140	Leishmaniasis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05142	Chagas disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05200	Pathways in cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05210	Colorectal cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05211	Renal cell carcinoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05212	Pancreatic cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05213	Endometrial cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05214	Glioma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05215	Prostate cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05216	Thyroid cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05218	Melanoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05219	Bladder cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05220	Chronic myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05221	Acute myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009496	K04371	ko05223	Non-small cell lung cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMC200009497	K05740	ko04510	Focal adhesion	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMC200009497	K05740	ko04810	Regulation of actin cytoskeleton	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMC200009497	K05740	ko05131	Shigellosis	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMC200009498	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMC200009498	K00517	ko00626	Naphthalene and anthracene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMC200009498	K00517	ko00903	Limonene and pinene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMC200009498	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMC200009498	K00517	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMC200009507	K01076	ko00632	Benzoate degradation via CoA ligation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMC200009507	K01076	ko00903	Limonene and pinene degradation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMC200009507	K01076	ko01040	Biosynthesis of unsaturated fatty acids	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMC200009508	K02689	ko00195	Photosynthesis	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMC200009508	K02689	ko01100	Metabolic pathways	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMC200063169	K03094	ko04110	Cell cycle	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04111	Cell cycle - yeast	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04114	Oocyte meiosis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04120	Ubiquitin mediated proteolysis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04310	Wnt signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04350	TGF-beta signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063169	K03094	ko04710	Circadian rhythm - mammal	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMC200063175	K04733	ko04210	Apoptosis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMC200063175	K04733	ko04620	Toll-like receptor signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMC200063175	K04733	ko04722	Neurotrophin signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMC200063175	K04733	ko05140	Leishmaniasis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMC200063175	K04733	ko05142	Chagas disease	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMC200063178	K10760	ko00908	Zeatin biosynthesis	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMC200063178	K10760	ko01100	Metabolic pathways	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMC200063178	K10760	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMC200030547	K12472	ko04144	Endocytosis	437	6.5e-15	0.23	0.39	0.91
PGSC0003DMC200030548	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMC200030548	K03858	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMC200030549	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMC200030549	K03858	ko01100	Metabolic pathways	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMC200030554	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMC200030554	K05291	ko01100	Metabolic pathways	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMC200030555	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMC200030555	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMC200030556	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMC200030556	K05291	ko01100	Metabolic pathways	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMC200030557	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMC200030557	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMC200036692	K01230	ko00510	N-Glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMC200036692	K01230	ko00513	High-mannose type N-glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMC200036692	K01230	ko01100	Metabolic pathways	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMC200036693	K02729	ko03050	Proteasome	1922	3.6e-100	0.97	1.00	1.00
PGSC0003DMC200036699	K10609	ko03420	Nucleotide excision repair	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMC200036699	K10609	ko04120	Ubiquitin mediated proteolysis	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMC200036700	K10609	ko03420	Nucleotide excision repair	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMC200036700	K10609	ko04120	Ubiquitin mediated proteolysis	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMC200036705	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMC200036706	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMC200036707	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMC200036708	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMC200036709	K02987	ko03010	Ribosome	2095	1.0e-109	0.92	0.99	0.98
PGSC0003DMC200042065	K01674	ko00910	Nitrogen metabolism	515	1.4e-22	0.53	0.76	0.63
PGSC0003DMC200042078	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042078	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042079	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042079	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042080	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042080	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042081	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200042081	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMC200007896	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMC200007897	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMC200007898	K01052	ko00100	Steroid biosynthesis	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMC200007898	K01052	ko04142	Lysosome	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMC200007899	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMC200007899	K12567	ko05414	Dilated cardiomyopathy	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMC200007900	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMC200007900	K12567	ko05414	Dilated cardiomyopathy	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMC200007901	K13065	ko00940	Phenylpropanoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMC200007901	K13065	ko00941	Flavonoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMC200007901	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMC200007901	K13065	ko01110	Biosynthesis of secondary metabolites	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMC200013261	K00162	ko00010	Glycolysis / Gluconeogenesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko00020	Citrate cycle (TCA cycle)	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko00620	Pyruvate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko00650	Butanoate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko01100	Metabolic pathways	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013261	K00162	ko01110	Biosynthesis of secondary metabolites	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMC200013262	K01590	ko00340	Histidine metabolism	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMC200013262	K01590	ko01100	Metabolic pathways	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMC200013262	K01590	ko01110	Biosynthesis of secondary metabolites	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMC200013268	K03133	ko03022	Basal transcription factors	1023	1.4e-50	0.66	0.80	0.99
PGSC0003DMC200013269	K03133	ko03022	Basal transcription factors	737	8.2e-35	0.72	0.83	0.85
PGSC0003DMC200013270	K03133	ko03022	Basal transcription factors	1044	9.5e-52	0.68	0.82	0.99
PGSC0003DMC200013272	K02154	ko00190	Oxidative phosphorylation	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko01100	Metabolic pathways	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko04142	Lysosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko04145	Phagosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko04966	Collecting duct acid secretion	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko05110	Vibrio cholerae infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013272	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMC200013273	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013273	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko00190	Oxidative phosphorylation	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko01100	Metabolic pathways	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko04142	Lysosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko04145	Phagosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko04966	Collecting duct acid secretion	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko05110	Vibrio cholerae infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013274	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013275	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMC200013276	K02154	ko00190	Oxidative phosphorylation	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko01100	Metabolic pathways	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko04142	Lysosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko04145	Phagosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko04966	Collecting duct acid secretion	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko05110	Vibrio cholerae infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013276	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko00190	Oxidative phosphorylation	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko01100	Metabolic pathways	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko04142	Lysosome	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko04145	Phagosome	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko04966	Collecting duct acid secretion	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko05110	Vibrio cholerae infection	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013277	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5946	0.	0.85	0.92	1.00
PGSC0003DMC200013278	K02154	ko00190	Oxidative phosphorylation	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko01100	Metabolic pathways	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko04142	Lysosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko04145	Phagosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko04966	Collecting duct acid secretion	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko05110	Vibrio cholerae infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013278	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMC200013279	K02154	ko00190	Oxidative phosphorylation	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko01100	Metabolic pathways	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko04142	Lysosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko04145	Phagosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko04966	Collecting duct acid secretion	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko05110	Vibrio cholerae infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013279	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMC200013280	K02154	ko00190	Oxidative phosphorylation	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko01100	Metabolic pathways	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko04142	Lysosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko04145	Phagosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko04966	Collecting duct acid secretion	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko05110	Vibrio cholerae infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013280	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMC200013288	K01955	ko00240	Pyrimidine metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMC200013288	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMC200013288	K01955	ko01100	Metabolic pathways	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMC200013289	K01955	ko00240	Pyrimidine metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMC200013289	K01955	ko00250	Alanine, aspartate and glutamate metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMC200013289	K01955	ko01100	Metabolic pathways	7779	0.	0.73	0.83	1.00
PGSC0003DMC200013290	K01955	ko00240	Pyrimidine metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMC200013290	K01955	ko00250	Alanine, aspartate and glutamate metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMC200013290	K01955	ko01100	Metabolic pathways	8293	0.	0.83	0.90	1.00
PGSC0003DMC200023865	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023865	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023865	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023865	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023865	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023866	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023866	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023866	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023866	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023866	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMC200023868	K01184	ko00040	Pentose and glucuronate interconversions	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMC200023868	K01184	ko00500	Starch and sucrose metabolism	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMC200023868	K01184	ko01100	Metabolic pathways	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMC200023869	K04733	ko04210	Apoptosis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMC200023869	K04733	ko04620	Toll-like receptor signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMC200023869	K04733	ko04722	Neurotrophin signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMC200023869	K04733	ko05140	Leishmaniasis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMC200023869	K04733	ko05142	Chagas disease	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMC200023870	K04733	ko04210	Apoptosis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMC200023870	K04733	ko04620	Toll-like receptor signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMC200023870	K04733	ko04722	Neurotrophin signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMC200023870	K04733	ko05140	Leishmaniasis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMC200023870	K04733	ko05142	Chagas disease	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMC200023871	K03660	ko03410	Base excision repair	593	7.1e-27	0.35	0.52	0.96
PGSC0003DMC200023872	K08065	ko04612	Antigen processing and presentation	512	2.1e-22	0.44	0.60	0.82
PGSC0003DMC200023873	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMC200023874	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMC200023875	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMC200023876	K08065	ko04612	Antigen processing and presentation	508	3.5e-22	0.57	0.78	0.59
PGSC0003DMC200023877	K08065	ko04612	Antigen processing and presentation	308	3.7e-11	0.38	0.58	0.70
PGSC0003DMC200023879	K08065	ko04612	Antigen processing and presentation	382	3.1e-15	0.44	0.62	0.56
PGSC0003DMC200002888	K01803	ko00010	Glycolysis / Gluconeogenesis	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002888	K01803	ko00051	Fructose and mannose metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002888	K01803	ko00562	Inositol phosphate metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002888	K01803	ko00710	Carbon fixation in photosynthetic organisms	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002888	K01803	ko01100	Metabolic pathways	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002888	K01803	ko01110	Biosynthesis of secondary metabolites	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMC200002889	K01803	ko00010	Glycolysis / Gluconeogenesis	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002889	K01803	ko00051	Fructose and mannose metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002889	K01803	ko00562	Inositol phosphate metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002889	K01803	ko00710	Carbon fixation in photosynthetic organisms	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002889	K01803	ko01100	Metabolic pathways	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002889	K01803	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMC200002890	K01193	ko00052	Galactose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMC200002890	K01193	ko00500	Starch and sucrose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMC200002890	K01193	ko01100	Metabolic pathways	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMC200002891	K10949	ko05110	Vibrio cholerae infection	478	1.6e-20	0.39	0.62	0.79
PGSC0003DMC200002892	K10949	ko05110	Vibrio cholerae infection	550	1.7e-24	0.38	0.59	0.82
PGSC0003DMC200067419	K10760	ko00908	Zeatin biosynthesis	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMC200067419	K10760	ko01100	Metabolic pathways	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMC200067419	K10760	ko01110	Biosynthesis of secondary metabolites	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMC200067431	K12338	ko00942	Anthocyanin biosynthesis	350	1.8e-13	0.39	0.52	0.66
PGSC0003DMC200062238	K12828	ko03040	Spliceosome	630	7.4e-29	0.54	0.70	0.81
PGSC0003DMC200062243	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	275	2.5e-09	0.53	0.72	0.70
PGSC0003DMC200062250	K04428	ko04010	MAPK signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMC200062250	K04428	ko04912	GnRH signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMC200031746	K08008	ko04145	Phagosome	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMC200031746	K08008	ko04670	Leukocyte transendothelial migration	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMC200031747	K08008	ko04145	Phagosome	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMC200031747	K08008	ko04670	Leukocyte transendothelial migration	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMC200031750	K01179	ko00500	Starch and sucrose metabolism	4121	1.8e-221	0.75	0.85	1.00
PGSC0003DMC200031766	K01885	ko00860	Porphyrin and chlorophyll metabolism	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMC200031766	K01885	ko00970	Aminoacyl-tRNA biosynthesis	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMC200031766	K01885	ko01100	Metabolic pathways	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMC200031766	K01885	ko01110	Biosynthesis of secondary metabolites	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMC200031767	K01885	ko00860	Porphyrin and chlorophyll metabolism	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMC200031767	K01885	ko00970	Aminoacyl-tRNA biosynthesis	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMC200031767	K01885	ko01100	Metabolic pathways	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMC200031767	K01885	ko01110	Biosynthesis of secondary metabolites	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMC200031769	K11866	ko04144	Endocytosis	629	2.0e-28	0.32	0.46	0.88
PGSC0003DMC200031770	K11866	ko04144	Endocytosis	604	5.4e-27	0.33	0.46	0.85
PGSC0003DMC200043268	K03097	ko04310	Wnt signaling pathway	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMC200043268	K03097	ko04520	Adherens junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMC200043268	K03097	ko04530	Tight junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMC200043268	K03097	ko04712	Circadian rhythm - plant	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMC200043271	K00472	ko00330	Arginine and proline metabolism	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMC200043271	K00472	ko01100	Metabolic pathways	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMC200043272	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMC200043272	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMC200043273	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMC200043273	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMC200043274	K00472	ko00330	Arginine and proline metabolism	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMC200043274	K00472	ko01100	Metabolic pathways	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMC200043275	K00472	ko00330	Arginine and proline metabolism	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMC200043275	K00472	ko01100	Metabolic pathways	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMC200043281	K01066	ko00623	2,4-Dichlorobenzoate degradation	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMC200043281	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMC200043282	K01066	ko00623	2,4-Dichlorobenzoate degradation	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMC200043282	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMC200043283	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMC200043284	K00908	ko01100	Metabolic pathways	396	4.1e-13	0.27	0.47	0.40
PGSC0003DMC200043285	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMC200043286	K00658	ko00020	Citrate cycle (TCA cycle)	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMC200043286	K00658	ko00310	Lysine degradation	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMC200043286	K00658	ko01100	Metabolic pathways	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMC200043286	K00658	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMC200043288	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMC200043288	K00517	ko00626	Naphthalene and anthracene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMC200043288	K00517	ko00903	Limonene and pinene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMC200043288	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMC200043288	K00517	ko01110	Biosynthesis of secondary metabolites	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMC200043289	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMC200043289	K00517	ko00626	Naphthalene and anthracene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMC200043289	K00517	ko00903	Limonene and pinene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMC200043289	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMC200043289	K00517	ko01110	Biosynthesis of secondary metabolites	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMC200043290	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMC200043290	K00517	ko00626	Naphthalene and anthracene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMC200043290	K00517	ko00903	Limonene and pinene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMC200043290	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMC200043290	K00517	ko01110	Biosynthesis of secondary metabolites	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMC200037892	K11818	ko00380	Tryptophan metabolism	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMC200037892	K11818	ko00966	Glucosinolate biosynthesis	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMC200037892	K11818	ko01110	Biosynthesis of secondary metabolites	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMC200037896	K11818	ko00380	Tryptophan metabolism	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMC200037896	K11818	ko00966	Glucosinolate biosynthesis	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMC200037896	K11818	ko01110	Biosynthesis of secondary metabolites	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMC200037915	K01057	ko00030	Pentose phosphate pathway	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMC200037915	K01057	ko01100	Metabolic pathways	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMC200037915	K01057	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMC200037916	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200037916	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200037916	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200037917	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200037917	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200037917	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMC200053867	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.88
PGSC0003DMC200053868	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.93
PGSC0003DMC200053869	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.92
PGSC0003DMC200053870	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.89
PGSC0003DMC200066228	K01952	ko00230	Purine metabolism	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMC200066228	K01952	ko01100	Metabolic pathways	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMC200066228	K01952	ko01110	Biosynthesis of secondary metabolites	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMC200066237	K01213	ko00040	Pentose and glucuronate interconversions	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMC200066237	K01213	ko00500	Starch and sucrose metabolism	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMC200066237	K01213	ko01100	Metabolic pathways	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMC200061047	K00764	ko00230	Purine metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMC200061047	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMC200061047	K00764	ko01100	Metabolic pathways	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMC200061047	K00764	ko01110	Biosynthesis of secondary metabolites	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMC200012078	K00262	ko00250	Alanine, aspartate and glutamate metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMC200012078	K00262	ko00330	Arginine and proline metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMC200012078	K00262	ko00910	Nitrogen metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMC200012078	K00262	ko01100	Metabolic pathways	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMC200012079	K00262	ko00250	Alanine, aspartate and glutamate metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMC200012079	K00262	ko00330	Arginine and proline metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMC200012079	K00262	ko00910	Nitrogen metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMC200012079	K00262	ko01100	Metabolic pathways	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMC200012084	K10960	ko00860	Porphyrin and chlorophyll metabolism	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMC200012084	K10960	ko00900	Terpenoid backbone biosynthesis	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMC200012084	K10960	ko01100	Metabolic pathways	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMC200012084	K10960	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMC200012089	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMC200012090	K09842	ko00906	Carotenoid biosynthesis	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMC200012090	K09842	ko01100	Metabolic pathways	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMC200012090	K09842	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMC200006691	K00430	ko00360	Phenylalanine metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMC200006691	K00430	ko00680	Methane metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMC200006691	K00430	ko00940	Phenylpropanoid biosynthesis	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMC200006691	K00430	ko01100	Metabolic pathways	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMC200006691	K00430	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMC200006704	K10688	ko04120	Ubiquitin mediated proteolysis	445	1.0e-18	0.98	1.00	0.98
PGSC0003DMC200006705	K10688	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.94	0.97	0.99
PGSC0003DMC200006706	K00279	ko00908	Zeatin biosynthesis	3146	1.1e-167	0.71	0.82	0.99
PGSC0003DMC200006707	K00279	ko00908	Zeatin biosynthesis	2539	3.3e-134	0.73	0.84	0.99
PGSC0003DMC200006717	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200006717	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200006718	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200006718	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200006719	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200006719	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMC200056873	K02943	ko03010	Ribosome	461	1.4e-19	0.60	0.69	0.99
PGSC0003DMC200039489	K00697	ko00500	Starch and sucrose metabolism	4377	1.4e-235	0.67	0.81	0.99
PGSC0003DMC200039490	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMC200039491	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMC200039493	K08241	ko00592	alpha-Linolenic acid metabolism	453	3.8e-19	0.41	0.55	0.74
PGSC0003DMC200039495	K08241	ko00592	alpha-Linolenic acid metabolism	684	6.8e-32	0.34	0.51	0.88
PGSC0003DMC200039497	K00928	ko00260	Glycine, serine and threonine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMC200039497	K00928	ko00270	Cysteine and methionine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMC200039497	K00928	ko00300	Lysine biosynthesis	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMC200039497	K00928	ko01100	Metabolic pathways	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMC200039497	K00928	ko01110	Biosynthesis of secondary metabolites	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMC200039498	K00928	ko00260	Glycine, serine and threonine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMC200039498	K00928	ko00270	Cysteine and methionine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMC200039498	K00928	ko00300	Lysine biosynthesis	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMC200039498	K00928	ko01100	Metabolic pathways	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMC200039498	K00928	ko01110	Biosynthesis of secondary metabolites	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMC200039499	K00928	ko00260	Glycine, serine and threonine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMC200039499	K00928	ko00270	Cysteine and methionine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMC200039499	K00928	ko00300	Lysine biosynthesis	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMC200039499	K00928	ko01100	Metabolic pathways	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMC200039499	K00928	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMC200039503	K02084	ko04115	p53 signaling pathway	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko04210	Apoptosis	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko05010	Alzheimer's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko05012	Parkinson's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko05016	Huntington's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200039503	K02084	ko05222	Small cell lung cancer	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMC200045880	K13229	ko00402	Benzoxazinoid biosynthesis	1097	1.1e-54	0.44	0.61	0.98
PGSC0003DMC200045888	K04711	ko00600	Sphingolipid metabolism	983	2.2e-48	0.77	0.85	0.99
PGSC0003DMC200045889	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMC200045890	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMC200045891	K00696	ko00500	Starch and sucrose metabolism	7278	0.	0.80	0.89	1.00
PGSC0003DMC200045891	K00696	ko01100	Metabolic pathways	7278	0.	0.80	0.89	1.00
PGSC0003DMC200045893	K01190	ko00052	Galactose metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMC200045893	K01190	ko00511	Other glycan degradation	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMC200045893	K01190	ko00600	Sphingolipid metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMC200045893	K01190	ko01100	Metabolic pathways	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMC200045894	K01190	ko00052	Galactose metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMC200045894	K01190	ko00511	Other glycan degradation	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMC200045894	K01190	ko00600	Sphingolipid metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMC200045894	K01190	ko01100	Metabolic pathways	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMC200045895	K01190	ko00052	Galactose metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMC200045895	K01190	ko00511	Other glycan degradation	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMC200045895	K01190	ko00600	Sphingolipid metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMC200045895	K01190	ko01100	Metabolic pathways	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMC200045896	K01190	ko00052	Galactose metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMC200045896	K01190	ko00511	Other glycan degradation	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMC200045896	K01190	ko00600	Sphingolipid metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMC200045896	K01190	ko01100	Metabolic pathways	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMC200068768	K11245	ko04011	MAPK signaling pathway - yeast	269	5.3e-09	0.44	0.62	0.44
PGSC0003DMC200068785	K10760	ko00908	Zeatin biosynthesis	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMC200068785	K10760	ko01100	Metabolic pathways	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMC200068785	K10760	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMC200064363	K00071	ko00140	Steroid hormone biosynthesis	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMC200064363	K00071	ko01100	Metabolic pathways	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMC200064363	K00071	ko04960	Aldosterone-regulated sodium reabsorption	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMC200064377	K05915	ko00363	Bisphenol A degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMC200064377	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMC200064377	K05915	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMC200014915	K01490	ko00230	Purine metabolism	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMC200014915	K01490	ko01100	Metabolic pathways	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMC200014915	K01490	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMC200014916	K01490	ko00230	Purine metabolism	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMC200014916	K01490	ko01100	Metabolic pathways	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMC200014916	K01490	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMC200014917	K01490	ko00230	Purine metabolism	5987	0.	0.82	0.89	0.99
PGSC0003DMC200014917	K01490	ko01100	Metabolic pathways	5987	0.	0.82	0.89	0.99
PGSC0003DMC200014917	K01490	ko01110	Biosynthesis of secondary metabolites	5987	0.	0.82	0.89	0.99
PGSC0003DMC200014922	K10802	ko03410	Base excision repair	665	7.6e-31	0.79	0.87	0.85
PGSC0003DMC200014923	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMC200014924	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMC200014925	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMC200010681	K10760	ko00908	Zeatin biosynthesis	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMC200010681	K10760	ko01100	Metabolic pathways	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMC200010681	K10760	ko01110	Biosynthesis of secondary metabolites	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMC200010689	K06627	ko04110	Cell cycle	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMC200010689	K06627	ko04914	Progesterone-mediated oocyte maturation	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMC200010693	K04733	ko04210	Apoptosis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMC200010693	K04733	ko04620	Toll-like receptor signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMC200010693	K04733	ko04722	Neurotrophin signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMC200010693	K04733	ko05140	Leishmaniasis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMC200010693	K04733	ko05142	Chagas disease	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMC200010694	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMC200010694	K00517	ko00626	Naphthalene and anthracene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMC200010694	K00517	ko00903	Limonene and pinene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMC200010694	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMC200010694	K00517	ko01110	Biosynthesis of secondary metabolites	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMC200010695	K11818	ko00380	Tryptophan metabolism	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMC200010695	K11818	ko00966	Glucosinolate biosynthesis	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMC200010695	K11818	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMC200010696	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMC200010696	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMC200010709	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMC200010709	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMC200010710	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMC200010710	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMC200017078	K12471	ko04144	Endocytosis	270	1.1e-08	0.26	0.43	0.97
PGSC0003DMC200017089	K01803	ko00010	Glycolysis / Gluconeogenesis	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017089	K01803	ko00051	Fructose and mannose metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017089	K01803	ko00562	Inositol phosphate metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017089	K01803	ko00710	Carbon fixation in photosynthetic organisms	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017089	K01803	ko01100	Metabolic pathways	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017089	K01803	ko01110	Biosynthesis of secondary metabolites	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMC200017090	K00854	ko00040	Pentose and glucuronate interconversions	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMC200017090	K00854	ko01100	Metabolic pathways	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMC200022651	K09292	ko05200	Pathways in cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMC200022651	K09292	ko05216	Thyroid cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMC200022653	K12929	ko00904	Diterpenoid biosynthesis	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMC200022653	K12929	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMC200022654	K10601	ko04120	Ubiquitin mediated proteolysis	245	1.7e-07	0.31	0.50	0.81
PGSC0003DMC200022656	K05280	ko00941	Flavonoid biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMC200022656	K05280	ko00944	Flavone and flavonol biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMC200022656	K05280	ko01100	Metabolic pathways	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMC200022656	K05280	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMC200022657	K05280	ko00941	Flavonoid biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMC200022657	K05280	ko00944	Flavone and flavonol biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMC200022657	K05280	ko01100	Metabolic pathways	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMC200022657	K05280	ko01110	Biosynthesis of secondary metabolites	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMC200022658	K09755	ko00940	Phenylpropanoid biosynthesis	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMC200022658	K09755	ko01100	Metabolic pathways	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMC200022658	K09755	ko01110	Biosynthesis of secondary metabolites	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMC200022659	K09755	ko00940	Phenylpropanoid biosynthesis	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMC200022659	K09755	ko01100	Metabolic pathways	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMC200022659	K09755	ko01110	Biosynthesis of secondary metabolites	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMC200022660	K09755	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMC200022660	K09755	ko01100	Metabolic pathways	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMC200022660	K09755	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMC200022661	K09755	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMC200022661	K09755	ko01100	Metabolic pathways	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMC200022661	K09755	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMC200022662	K01509	ko00230	Purine metabolism	343	1.9e-12	0.39	0.61	0.92
PGSC0003DMC200022663	K06123	ko00564	Glycerophospholipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMC200022663	K06123	ko00565	Ether lipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMC200022663	K06123	ko01100	Metabolic pathways	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMC200022667	K00827	ko00250	Alanine, aspartate and glutamate metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMC200022667	K00827	ko00260	Glycine, serine and threonine metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMC200022668	K00827	ko00250	Alanine, aspartate and glutamate metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMC200022668	K00827	ko00260	Glycine, serine and threonine metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMC200022671	K09755	ko00940	Phenylpropanoid biosynthesis	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMC200022671	K09755	ko01100	Metabolic pathways	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMC200022671	K09755	ko01110	Biosynthesis of secondary metabolites	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMC200022672	K09755	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMC200022672	K09755	ko01100	Metabolic pathways	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMC200022672	K09755	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMC200022673	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMC200022673	K00517	ko00626	Naphthalene and anthracene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMC200022673	K00517	ko00903	Limonene and pinene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMC200022673	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMC200022673	K00517	ko01110	Biosynthesis of secondary metabolites	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMC200005116	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMC200005117	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMC200005128	K04618	ko00052	Galactose metabolism	387	2.6e-13	0.28	0.43	0.77
PGSC0003DMC200014462	K05863	ko04020	Calcium signaling pathway	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMC200014462	K05863	ko05012	Parkinson's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMC200014462	K05863	ko05016	Huntington's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMC200014463	K05863	ko04020	Calcium signaling pathway	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMC200014463	K05863	ko05012	Parkinson's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMC200014463	K05863	ko05016	Huntington's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMC200014468	K01423	ko00310	Lysine degradation	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMC200014468	K01423	ko00780	Biotin metabolism	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMC200014468	K01423	ko01100	Metabolic pathways	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMC200014469	K01423	ko00310	Lysine degradation	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMC200014469	K01423	ko00780	Biotin metabolism	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMC200014469	K01423	ko01100	Metabolic pathways	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMC200014470	K01423	ko00310	Lysine degradation	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMC200014470	K01423	ko00780	Biotin metabolism	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMC200014470	K01423	ko01100	Metabolic pathways	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMC200014471	K01423	ko00310	Lysine degradation	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMC200014471	K01423	ko00780	Biotin metabolism	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMC200014471	K01423	ko01100	Metabolic pathways	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMC200014472	K01423	ko00310	Lysine degradation	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMC200014472	K01423	ko00780	Biotin metabolism	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMC200014472	K01423	ko01100	Metabolic pathways	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMC200014481	K03133	ko03022	Basal transcription factors	364	3.1e-14	0.62	0.78	0.94
PGSC0003DMC200014484	K02920	ko03010	Ribosome	816	3.6e-39	0.91	0.95	0.99
PGSC0003DMC200014486	K10955	ko05110	Vibrio cholerae infection	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMC200014486	K10955	ko05146	Amoebiasis	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMC200014487	K00964	ko00052	Galactose metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMC200014487	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMC200014487	K00964	ko01100	Metabolic pathways	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMC200014488	K00964	ko00052	Galactose metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMC200014488	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMC200014488	K00964	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMC200014489	K00964	ko00052	Galactose metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMC200014489	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMC200014489	K00964	ko01100	Metabolic pathways	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMC200014490	K00964	ko00052	Galactose metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMC200014490	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMC200014490	K00964	ko01100	Metabolic pathways	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMC200027721	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027721	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMC200027722	K00430	ko00360	Phenylalanine metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMC200027722	K00430	ko00680	Methane metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMC200027722	K00430	ko00940	Phenylpropanoid biosynthesis	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMC200027722	K00430	ko01100	Metabolic pathways	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMC200027722	K00430	ko01110	Biosynthesis of secondary metabolites	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMC200027723	K11229	ko04011	MAPK signaling pathway - yeast	1028	2.2e-50	0.32	0.47	0.71
PGSC0003DMC200027726	K03062	ko03050	Proteasome	3617	1.2e-193	0.97	0.99	1.00
PGSC0003DMC200027729	K04424	ko04010	MAPK signaling pathway	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMC200027729	K04424	ko04530	Tight junction	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMC200027730	K00632	ko00071	Fatty acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko00280	Valine, leucine and isoleucine degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko00281	Geraniol degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko00362	Benzoate degradation via hydroxylation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko00592	alpha-Linolenic acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko00642	Ethylbenzene degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko01100	Metabolic pathways	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027730	K00632	ko01110	Biosynthesis of secondary metabolites	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMC200027737	K01728	ko00040	Pentose and glucuronate interconversions	2930	9.0e-156	0.76	0.86	1.00
PGSC0003DMC200027747	K04424	ko04010	MAPK signaling pathway	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMC200027747	K04424	ko04530	Tight junction	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMC200027750	K04733	ko04210	Apoptosis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMC200027750	K04733	ko04620	Toll-like receptor signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMC200027750	K04733	ko04722	Neurotrophin signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMC200027750	K04733	ko05140	Leishmaniasis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMC200027750	K04733	ko05142	Chagas disease	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMC200068619	K05280	ko00941	Flavonoid biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMC200068619	K05280	ko00944	Flavone and flavonol biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMC200068619	K05280	ko01100	Metabolic pathways	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMC200068619	K05280	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMC200001681	K03876	ko04120	Ubiquitin mediated proteolysis	291	3.2e-10	0.37	0.57	0.71
PGSC0003DMC200001685	K12796	ko04621	NOD-like receptor signaling pathway	407	5.4e-13	0.31	0.47	0.30
PGSC0003DMC200001691	K01897	ko00071	Fatty acid metabolism	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMC200001691	K01897	ko01100	Metabolic pathways	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMC200001691	K01897	ko03320	PPAR signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMC200001691	K01897	ko04146	Peroxisome	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMC200001691	K01897	ko04920	Adipocytokine signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMC200001692	K01897	ko00071	Fatty acid metabolism	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMC200001692	K01897	ko01100	Metabolic pathways	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMC200001692	K01897	ko03320	PPAR signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMC200001692	K01897	ko04146	Peroxisome	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMC200001692	K01897	ko04920	Adipocytokine signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMC200001693	K02897	ko03010	Ribosome	1380	2.8e-70	0.72	0.84	0.90
PGSC0003DMC200001694	K00434	ko00053	Ascorbate and aldarate metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMC200001694	K00434	ko00480	Glutathione metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMC200001696	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.75
PGSC0003DMC200001697	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.68
PGSC0003DMC200001698	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.53
PGSC0003DMC200001699	K09291	ko04011	MAPK signaling pathway - yeast	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMC200001699	K09291	ko05200	Pathways in cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMC200001699	K09291	ko05216	Thyroid cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMC200001701	K09291	ko04011	MAPK signaling pathway - yeast	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMC200001701	K09291	ko05200	Pathways in cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMC200001701	K09291	ko05216	Thyroid cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMC200051451	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200051452	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200051453	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMC200051454	K05391	ko04626	Plant-pathogen interaction	4363	8.3e-235	0.72	0.82	1.00
PGSC0003DMC200051465	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	7028	0.	0.83	0.92	0.99
PGSC0003DMC200051465	K12446	ko01100	Metabolic pathways	7028	0.	0.83	0.92	0.99
PGSC0003DMC200051466	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMC200051466	K12446	ko01100	Metabolic pathways	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMC200051467	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	5740	0.	0.84	0.92	0.99
PGSC0003DMC200051467	K12446	ko01100	Metabolic pathways	5740	0.	0.84	0.92	0.99
PGSC0003DMC200051471	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMC200051471	K12446	ko01100	Metabolic pathways	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMC200051475	K02991	ko03010	Ribosome	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMC200051475	K02991	ko04150	mTOR signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMC200051475	K02991	ko04910	Insulin signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMC200051476	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051476	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051476	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051477	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051477	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051477	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051478	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051478	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051478	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMC200051479	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMC200051479	K00517	ko00626	Naphthalene and anthracene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMC200051479	K00517	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMC200051479	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMC200051479	K00517	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMC200033906	K08910	ko00196	Photosynthesis - antenna proteins	1890	2.1e-98	0.86	0.93	0.99
PGSC0003DMC200033908	K10960	ko00860	Porphyrin and chlorophyll metabolism	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMC200033908	K10960	ko00900	Terpenoid backbone biosynthesis	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMC200033908	K10960	ko01100	Metabolic pathways	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMC200033908	K10960	ko01110	Biosynthesis of secondary metabolites	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMC200033909	K00026	ko00020	Citrate cycle (TCA cycle)	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033909	K00026	ko00620	Pyruvate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033909	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033909	K00026	ko00710	Carbon fixation in photosynthetic organisms	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033909	K00026	ko01100	Metabolic pathways	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033909	K00026	ko01110	Biosynthesis of secondary metabolites	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMC200033916	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	195	5.2e-09	0.40	0.49	0.79
PGSC0003DMC200033917	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	197	4.0e-09	0.39	0.48	0.38
PGSC0003DMC200033919	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	218	3.4e-06	0.53	0.64	0.26
PGSC0003DMC200033920	K12127	ko04712	Circadian rhythm - plant	1436	2.3e-73	0.61	0.75	0.98
PGSC0003DMC200033921	K12127	ko04712	Circadian rhythm - plant	2920	3.2e-155	0.67	0.78	0.98
PGSC0003DMC200033922	K02342	ko00230	Purine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033922	K02342	ko00240	Pyrimidine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033922	K02342	ko01100	Metabolic pathways	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033922	K02342	ko03030	DNA replication	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033922	K02342	ko03430	Mismatch repair	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033922	K02342	ko03440	Homologous recombination	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMC200033924	K01783	ko00030	Pentose phosphate pathway	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMC200033924	K01783	ko00040	Pentose and glucuronate interconversions	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMC200033924	K01783	ko00710	Carbon fixation in photosynthetic organisms	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMC200033924	K01783	ko01100	Metabolic pathways	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMC200033924	K01783	ko01110	Biosynthesis of secondary metabolites	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMC200033925	K01783	ko00030	Pentose phosphate pathway	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMC200033925	K01783	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMC200033925	K01783	ko00710	Carbon fixation in photosynthetic organisms	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMC200033925	K01783	ko01100	Metabolic pathways	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMC200033925	K01783	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMC200058931	K00600	ko00260	Glycine, serine and threonine metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200058931	K00600	ko00460	Cyanoamino acid metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200058931	K00600	ko00670	One carbon pool by folate	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200058931	K00600	ko00680	Methane metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200058931	K00600	ko01100	Metabolic pathways	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200058931	K00600	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMC200018722	K12929	ko00904	Diterpenoid biosynthesis	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMC200018722	K12929	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMC200018723	K12929	ko00904	Diterpenoid biosynthesis	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMC200018723	K12929	ko01110	Biosynthesis of secondary metabolites	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMC200018734	K07424	ko00140	Steroid hormone biosynthesis	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00591	Linoleic acid metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00830	Retinol metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko00983	Drug metabolism - other enzymes	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018734	K07424	ko01100	Metabolic pathways	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMC200018735	K07424	ko00140	Steroid hormone biosynthesis	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00591	Linoleic acid metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00830	Retinol metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00982	Drug metabolism - cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko00983	Drug metabolism - other enzymes	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018735	K07424	ko01100	Metabolic pathways	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMC200018736	K07424	ko00140	Steroid hormone biosynthesis	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00591	Linoleic acid metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00830	Retinol metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00982	Drug metabolism - cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko00983	Drug metabolism - other enzymes	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018736	K07424	ko01100	Metabolic pathways	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMC200018737	K12817	ko03040	Spliceosome	1669	3.2e-86	0.57	0.69	0.98
PGSC0003DMC200018739	K12817	ko03040	Spliceosome	1762	2.4e-91	0.57	0.71	0.98
PGSC0003DMC200018740	K01509	ko00230	Purine metabolism	380	5.5e-39	0.42	0.60	0.63
PGSC0003DMC200025655	K10760	ko00908	Zeatin biosynthesis	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMC200025655	K10760	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMC200025655	K10760	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMC200025657	K10760	ko00908	Zeatin biosynthesis	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMC200025657	K10760	ko01100	Metabolic pathways	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMC200025657	K10760	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMC200025661	K12127	ko04712	Circadian rhythm - plant	225	3.9e-06	0.55	0.76	0.70
PGSC0003DMC200025662	K12135	ko04712	Circadian rhythm - plant	239	3.6e-07	0.38	0.52	0.32
PGSC0003DMC200025666	K11294	ko05130	Pathogenic Escherichia coli infection	283	1.0e-07	0.31	0.42	0.82
PGSC0003DMC200025668	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMC200025668	K01886	ko01100	Metabolic pathways	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMC200025669	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5679	0.	0.82	0.92	1.00
PGSC0003DMC200025669	K01886	ko01100	Metabolic pathways	5679	0.	0.82	0.92	1.00
PGSC0003DMC200025676	K10144	ko04115	p53 signaling pathway	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMC200025676	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMC200025677	K10144	ko04115	p53 signaling pathway	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMC200025677	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMC200012511	K07424	ko00140	Steroid hormone biosynthesis	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00591	Linoleic acid metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00830	Retinol metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00982	Drug metabolism - cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko00983	Drug metabolism - other enzymes	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012511	K07424	ko01100	Metabolic pathways	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMC200012512	K01859	ko00941	Flavonoid biosynthesis	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMC200012512	K01859	ko01100	Metabolic pathways	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMC200012512	K01859	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMC200012513	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMC200012514	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMC200012515	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMC200012520	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4771	2.6e-257	0.83	0.89	1.00
PGSC0003DMC200012521	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5055	5.6e-273	0.86	0.94	1.00
PGSC0003DMC200012522	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	3970	3.9e-213	0.86	0.94	0.99
PGSC0003DMC200012523	K00858	ko00760	Nicotinate and nicotinamide metabolism	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMC200012523	K00858	ko01100	Metabolic pathways	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMC200012524	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.95
PGSC0003DMC200012525	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.67
PGSC0003DMC200012526	K02871	ko03010	Ribosome	1545	2.2e-79	0.76	0.86	1.00
PGSC0003DMC200012527	K01710	ko00521	Streptomycin biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMC200012527	K01710	ko00523	Polyketide sugar unit biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMC200012527	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMC200012527	K01710	ko01100	Metabolic pathways	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMC200012527	K01710	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMC200012530	K01307	ko00790	Folate biosynthesis	1771	7.6e-92	0.67	0.80	0.98
PGSC0003DMC200012531	K01307	ko00790	Folate biosynthesis	2051	2.7e-107	0.71	0.83	0.97
PGSC0003DMC200012532	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012532	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012532	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012532	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012533	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012533	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012533	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200012533	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMC200066364	K10760	ko00908	Zeatin biosynthesis	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMC200066364	K10760	ko01100	Metabolic pathways	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMC200066364	K10760	ko01110	Biosynthesis of secondary metabolites	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMC200041887	K12130	ko04712	Circadian rhythm - plant	278	6.0e-07	0.24	0.50	0.56
PGSC0003DMC200041891	K01099	ko00562	Inositol phosphate metabolism	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMC200041891	K01099	ko01100	Metabolic pathways	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMC200041891	K01099	ko04070	Phosphatidylinositol signaling system	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMC200041892	K00873	ko00010	Glycolysis / Gluconeogenesis	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko00230	Purine metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko00620	Pyruvate metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko00710	Carbon fixation in photosynthetic organisms	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko01100	Metabolic pathways	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko01110	Biosynthesis of secondary metabolites	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200041892	K00873	ko04930	Type II diabetes mellitus	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMC200031233	K12823	ko03040	Spliceosome	1880	7.4e-98	0.53	0.66	0.69
PGSC0003DMC200031234	K12823	ko03040	Spliceosome	1986	1.1e-103	0.52	0.65	0.44
PGSC0003DMC200031236	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.85
PGSC0003DMC200031237	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.84
PGSC0003DMC200031250	K02266	ko00190	Oxidative phosphorylation	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031250	K02266	ko01100	Metabolic pathways	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031250	K02266	ko04260	Cardiac muscle contraction	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031250	K02266	ko05010	Alzheimer's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031250	K02266	ko05012	Parkinson's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031250	K02266	ko05016	Huntington's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMC200031251	K07374	ko04145	Phagosome	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMC200031251	K07374	ko04540	Gap junction	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMC200031251	K07374	ko05130	Pathogenic Escherichia coli infection	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMC200031252	K03006	ko00230	Purine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMC200031252	K03006	ko00240	Pyrimidine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMC200031252	K03006	ko01100	Metabolic pathways	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMC200031252	K03006	ko03020	RNA polymerase	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMC200031252	K03006	ko05016	Huntington's disease	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMC200031253	K03006	ko00230	Purine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMC200031253	K03006	ko00240	Pyrimidine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMC200031253	K03006	ko01100	Metabolic pathways	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMC200031253	K03006	ko03020	RNA polymerase	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMC200031253	K03006	ko05016	Huntington's disease	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMC200049921	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMC200049921	K00517	ko00626	Naphthalene and anthracene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMC200049921	K00517	ko00903	Limonene and pinene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMC200049921	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMC200049921	K00517	ko01110	Biosynthesis of secondary metabolites	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMC200049930	K11717	ko00450	Selenoamino acid metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMC200049930	K11717	ko00730	Thiamine metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMC200049930	K11717	ko01100	Metabolic pathways	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMC200049931	K11717	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMC200049931	K11717	ko00730	Thiamine metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMC200049931	K11717	ko01100	Metabolic pathways	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMC200049933	K11717	ko00450	Selenoamino acid metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMC200049933	K11717	ko00730	Thiamine metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMC200049933	K11717	ko01100	Metabolic pathways	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMC200049934	K00888	ko00562	Inositol phosphate metabolism	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMC200049934	K00888	ko01100	Metabolic pathways	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMC200049934	K00888	ko04070	Phosphatidylinositol signaling system	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMC200049935	K00888	ko00562	Inositol phosphate metabolism	6496	0.	0.73	0.83	0.99
PGSC0003DMC200049935	K00888	ko01100	Metabolic pathways	6496	0.	0.73	0.83	0.99
PGSC0003DMC200049935	K00888	ko04070	Phosphatidylinositol signaling system	6496	0.	0.73	0.83	0.99
PGSC0003DMC200049936	K00888	ko00562	Inositol phosphate metabolism	6998	0.	0.74	0.84	1.00
PGSC0003DMC200049936	K00888	ko01100	Metabolic pathways	6998	0.	0.74	0.84	1.00
PGSC0003DMC200049936	K00888	ko04070	Phosphatidylinositol signaling system	6998	0.	0.74	0.84	1.00
PGSC0003DMC200049944	K04420	ko04010	MAPK signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMC200049944	K04420	ko04540	Gap junction	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMC200049944	K04420	ko04912	GnRH signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMC200049948	K13068	ko00940	Phenylpropanoid biosynthesis	873	2.6e-42	0.33	0.51	0.99
PGSC0003DMC200049949	K13068	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.32	0.52	0.98
PGSC0003DMC200043732	K12670	ko00510	N-Glycan biosynthesis	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMC200043732	K12670	ko01100	Metabolic pathways	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMC200043733	K12670	ko00510	N-Glycan biosynthesis	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMC200043733	K12670	ko01100	Metabolic pathways	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMC200054453	K05666	ko02010	ABC transporters	1395	4.2e-71	0.44	0.64	0.98
PGSC0003DMC200054454	K05665	ko02010	ABC transporters	3070	1.7e-163	0.35	0.55	0.97
PGSC0003DMC200054459	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054459	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054460	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMC200054467	K04127	ko00311	Penicillin and cephalosporin biosynthesis	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMC200054467	K04127	ko01100	Metabolic pathways	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMC200054467	K04127	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMC200054471	K02915	ko03010	Ribosome	972	8.9e-48	0.96	0.98	0.99
PGSC0003DMC200065555	K01426	ko00330	Arginine and proline metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200065555	K01426	ko00360	Phenylalanine metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200065555	K01426	ko00380	Tryptophan metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200065555	K01426	ko00460	Cyanoamino acid metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200065555	K01426	ko00632	Benzoate degradation via CoA ligation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200065555	K01426	ko00643	Styrene degradation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMC200011893	K05391	ko04626	Plant-pathogen interaction	3648	2.3e-195	0.66	0.74	0.99
PGSC0003DMC200011894	K05391	ko04626	Plant-pathogen interaction	4219	7.3e-227	0.72	0.82	0.99
PGSC0003DMC200011897	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMC200011897	K01649	ko00620	Pyruvate metabolism	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMC200011897	K01649	ko01100	Metabolic pathways	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMC200011897	K01649	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMC200011898	K01590	ko00340	Histidine metabolism	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMC200011898	K01590	ko01100	Metabolic pathways	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMC200011898	K01590	ko01110	Biosynthesis of secondary metabolites	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMC200011903	K12859	ko03040	Spliceosome	1211	5.9e-61	0.97	1.00	0.99
PGSC0003DMC200011904	K12859	ko03040	Spliceosome	858	1.7e-41	0.97	1.00	0.99
PGSC0003DMC200011906	K12338	ko00942	Anthocyanin biosynthesis	1481	7.5e-76	0.36	0.48	0.99
PGSC0003DMC200011908	K06269	ko04113	Meiosis - yeast	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04114	Oocyte meiosis	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04270	Vascular smooth muscle contraction	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04510	Focal adhesion	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04720	Long-term potentiation	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04810	Regulation of actin cytoskeleton	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011908	K06269	ko04910	Insulin signaling pathway	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMC200011909	K06269	ko04113	Meiosis - yeast	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04114	Oocyte meiosis	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04270	Vascular smooth muscle contraction	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04510	Focal adhesion	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04720	Long-term potentiation	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04810	Regulation of actin cytoskeleton	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200011909	K06269	ko04910	Insulin signaling pathway	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMC200019922	K05282	ko00904	Diterpenoid biosynthesis	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMC200019922	K05282	ko01100	Metabolic pathways	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMC200019922	K05282	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMC200019931	K01488	ko00230	Purine metabolism	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMC200019931	K01488	ko01100	Metabolic pathways	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMC200019931	K01488	ko05340	Primary immunodeficiency	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMC200019932	K01488	ko00230	Purine metabolism	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMC200019932	K01488	ko01100	Metabolic pathways	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMC200019932	K01488	ko05340	Primary immunodeficiency	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMC200019933	K00995	ko00564	Glycerophospholipid metabolism	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMC200019933	K00995	ko01100	Metabolic pathways	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMC200019934	K08744	ko00564	Glycerophospholipid metabolism	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMC200019934	K08744	ko01100	Metabolic pathways	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMC200024451	K01193	ko00052	Galactose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMC200024451	K01193	ko00500	Starch and sucrose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMC200024451	K01193	ko01100	Metabolic pathways	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMC200024452	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMC200024453	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMC200024454	K01087	ko00500	Starch and sucrose metabolism	1364	2.1e-69	0.62	0.75	0.80
PGSC0003DMC200024459	K02261	ko00190	Oxidative phosphorylation	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024459	K02261	ko01100	Metabolic pathways	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024459	K02261	ko04260	Cardiac muscle contraction	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024459	K02261	ko05010	Alzheimer's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024459	K02261	ko05012	Parkinson's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024459	K02261	ko05016	Huntington's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMC200024462	K02261	ko00190	Oxidative phosphorylation	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024462	K02261	ko01100	Metabolic pathways	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024462	K02261	ko04260	Cardiac muscle contraction	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024462	K02261	ko05010	Alzheimer's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024462	K02261	ko05012	Parkinson's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024462	K02261	ko05016	Huntington's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMC200024463	K02878	ko03010	Ribosome	253	4.0e-08	0.63	0.75	0.94
PGSC0003DMC200024466	K12124	ko04712	Circadian rhythm - plant	453	2.4e-18	0.59	0.75	0.97
PGSC0003DMC200024467	K08241	ko00592	alpha-Linolenic acid metabolism	381	3.5e-15	0.40	0.61	0.86
PGSC0003DMC200013721	K00454	ko00591	Linoleic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMC200013721	K00454	ko00592	alpha-Linolenic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMC200013721	K00454	ko01100	Metabolic pathways	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMC200013726	K03260	ko05416	Viral myocarditis	1183	9.0e-59	0.34	0.49	0.79
PGSC0003DMC200013728	K01647	ko00020	Citrate cycle (TCA cycle)	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMC200013728	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMC200013728	K01647	ko01100	Metabolic pathways	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMC200013728	K01647	ko01110	Biosynthesis of secondary metabolites	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMC200048721	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMC200048721	K01649	ko00620	Pyruvate metabolism	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMC200048721	K01649	ko01100	Metabolic pathways	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMC200048721	K01649	ko01110	Biosynthesis of secondary metabolites	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMC200048722	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMC200048722	K01649	ko00620	Pyruvate metabolism	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMC200048722	K01649	ko01100	Metabolic pathways	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMC200048722	K01649	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMC200048723	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMC200048723	K01649	ko00620	Pyruvate metabolism	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMC200048723	K01649	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMC200048723	K01649	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMC200048731	K01179	ko00500	Starch and sucrose metabolism	1751	9.6e-91	0.47	0.61	0.97
PGSC0003DMC200048733	K09841	ko00906	Carotenoid biosynthesis	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMC200048733	K09841	ko01100	Metabolic pathways	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMC200048733	K09841	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMC200048737	K05280	ko00941	Flavonoid biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMC200048737	K05280	ko00944	Flavone and flavonol biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMC200048737	K05280	ko01100	Metabolic pathways	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMC200048737	K05280	ko01110	Biosynthesis of secondary metabolites	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMC200048738	K05280	ko00941	Flavonoid biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMC200048738	K05280	ko00944	Flavone and flavonol biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMC200048738	K05280	ko01100	Metabolic pathways	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMC200048738	K05280	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMC200048739	K05280	ko00941	Flavonoid biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMC200048739	K05280	ko00944	Flavone and flavonol biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMC200048739	K05280	ko01100	Metabolic pathways	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMC200048739	K05280	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMC200048740	K05280	ko00941	Flavonoid biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMC200048740	K05280	ko00944	Flavone and flavonol biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMC200048740	K05280	ko01100	Metabolic pathways	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMC200048740	K05280	ko01110	Biosynthesis of secondary metabolites	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMC200048741	K05280	ko00941	Flavonoid biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMC200048741	K05280	ko00944	Flavone and flavonol biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMC200048741	K05280	ko01100	Metabolic pathways	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMC200048741	K05280	ko01110	Biosynthesis of secondary metabolites	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMC200048742	K05280	ko00941	Flavonoid biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMC200048742	K05280	ko00944	Flavone and flavonol biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMC200048742	K05280	ko01100	Metabolic pathways	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMC200048742	K05280	ko01110	Biosynthesis of secondary metabolites	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMC200030035	K10599	ko03040	Spliceosome	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMC200030035	K10599	ko04120	Ubiquitin mediated proteolysis	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMC200030038	K05758	ko04666	Fc gamma R-mediated phagocytosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMC200030038	K05758	ko04810	Regulation of actin cytoskeleton	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMC200030038	K05758	ko05100	Bacterial invasion of epithelial cells	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMC200030038	K05758	ko05130	Pathogenic Escherichia coli infection	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMC200030038	K05758	ko05131	Shigellosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMC200030039	K05758	ko04666	Fc gamma R-mediated phagocytosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMC200030039	K05758	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMC200030039	K05758	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMC200030039	K05758	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMC200030039	K05758	ko05131	Shigellosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMC200030040	K05758	ko04666	Fc gamma R-mediated phagocytosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMC200030040	K05758	ko04810	Regulation of actin cytoskeleton	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMC200030040	K05758	ko05100	Bacterial invasion of epithelial cells	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMC200030040	K05758	ko05130	Pathogenic Escherichia coli infection	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMC200030040	K05758	ko05131	Shigellosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMC200030041	K05758	ko04666	Fc gamma R-mediated phagocytosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMC200030041	K05758	ko04810	Regulation of actin cytoskeleton	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMC200030041	K05758	ko05100	Bacterial invasion of epithelial cells	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMC200030041	K05758	ko05130	Pathogenic Escherichia coli infection	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMC200030041	K05758	ko05131	Shigellosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMC200030049	K00276	ko00260	Glycine, serine and threonine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko00350	Tyrosine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko00360	Phenylalanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko00410	beta-Alanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko00950	Isoquinoline alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko01100	Metabolic pathways	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030049	K00276	ko01110	Biosynthesis of secondary metabolites	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMC200030050	K00276	ko00260	Glycine, serine and threonine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko00350	Tyrosine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko00360	Phenylalanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko00410	beta-Alanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko01100	Metabolic pathways	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030050	K00276	ko01110	Biosynthesis of secondary metabolites	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMC200030051	K00276	ko00260	Glycine, serine and threonine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko00350	Tyrosine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko00360	Phenylalanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko00410	beta-Alanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko01100	Metabolic pathways	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200030051	K00276	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMC200042521	K01934	ko00670	One carbon pool by folate	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMC200042521	K01934	ko01100	Metabolic pathways	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMC200042522	K01934	ko00670	One carbon pool by folate	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMC200042522	K01934	ko01100	Metabolic pathways	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMC200042523	K01934	ko00670	One carbon pool by folate	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMC200042523	K01934	ko01100	Metabolic pathways	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMC200042537	K05740	ko04510	Focal adhesion	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMC200042537	K05740	ko04810	Regulation of actin cytoskeleton	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMC200042537	K05740	ko05131	Shigellosis	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMC200042538	K03413	ko02020	Two-component system	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMC200042538	K03413	ko02030	Bacterial chemotaxis	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMC200042539	K03415	ko02020	Two-component system	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMC200042539	K03415	ko02030	Bacterial chemotaxis	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMC200042540	K03355	ko04110	Cell cycle	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200042540	K03355	ko04111	Cell cycle - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200042540	K03355	ko04113	Meiosis - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200042540	K03355	ko04114	Oocyte meiosis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200042540	K03355	ko04120	Ubiquitin mediated proteolysis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200042540	K03355	ko04914	Progesterone-mediated oocyte maturation	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMC200055663	K00434	ko00053	Ascorbate and aldarate metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMC200055663	K00434	ko00480	Glutathione metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMC200055664	K00434	ko00053	Ascorbate and aldarate metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMC200055664	K00434	ko00480	Glutathione metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMC200055665	K00434	ko00053	Ascorbate and aldarate metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMC200055665	K00434	ko00480	Glutathione metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMC200055666	K00434	ko00053	Ascorbate and aldarate metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMC200055666	K00434	ko00480	Glutathione metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMC200000481	K01528	ko04144	Endocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMC200000481	K01528	ko04666	Fc gamma R-mediated phagocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMC200000481	K01528	ko05100	Bacterial invasion of epithelial cells	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMC200000482	K01528	ko04144	Endocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMC200000482	K01528	ko04666	Fc gamma R-mediated phagocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMC200000482	K01528	ko05100	Bacterial invasion of epithelial cells	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMC200000483	K01528	ko04144	Endocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMC200000483	K01528	ko04666	Fc gamma R-mediated phagocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMC200000483	K01528	ko05100	Bacterial invasion of epithelial cells	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMC200000485	K04506	ko04115	p53 signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMC200000485	K04506	ko04120	Ubiquitin mediated proteolysis	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMC200000485	K04506	ko04310	Wnt signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMC200000486	K04506	ko04115	p53 signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMC200000486	K04506	ko04120	Ubiquitin mediated proteolysis	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMC200000486	K04506	ko04310	Wnt signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMC200000497	K12667	ko00510	N-Glycan biosynthesis	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMC200000497	K12667	ko01100	Metabolic pathways	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMC200000500	K05305	ko00051	Fructose and mannose metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMC200000500	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMC200000500	K05305	ko01100	Metabolic pathways	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMC200000501	K05305	ko00051	Fructose and mannose metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMC200000501	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMC200000501	K05305	ko01100	Metabolic pathways	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMC200000502	K05305	ko00051	Fructose and mannose metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMC200000502	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMC200000502	K05305	ko01100	Metabolic pathways	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMC200000504	K12891	ko03040	Spliceosome	226	1.2e-06	0.39	0.50	0.89
PGSC0003DMC200000505	K12890	ko03040	Spliceosome	305	5.5e-11	0.33	0.45	0.91
PGSC0003DMC200000506	K12890	ko03040	Spliceosome	297	2.5e-16	0.43	0.54	0.64
PGSC0003DMC200000510	K09561	ko04120	Ubiquitin mediated proteolysis	254	2.6e-07	0.31	0.48	0.18
PGSC0003DMC200003909	K02540	ko03030	DNA replication	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMC200003909	K02540	ko04110	Cell cycle	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMC200003909	K02540	ko04111	Cell cycle - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMC200003909	K02540	ko04113	Meiosis - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMC200003910	K02540	ko03030	DNA replication	6932	0.	0.85	0.93	1.00
PGSC0003DMC200003910	K02540	ko04110	Cell cycle	6932	0.	0.85	0.93	1.00
PGSC0003DMC200003910	K02540	ko04111	Cell cycle - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMC200003910	K02540	ko04113	Meiosis - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMC200003916	K00705	ko00500	Starch and sucrose metabolism	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMC200003916	K00705	ko01100	Metabolic pathways	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMC200003917	K00705	ko00500	Starch and sucrose metabolism	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMC200003917	K00705	ko01100	Metabolic pathways	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMC200003918	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMC200003918	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMC200003919	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMC200003919	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMC200003921	K00030	ko00020	Citrate cycle (TCA cycle)	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMC200003921	K00030	ko01100	Metabolic pathways	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMC200003921	K00030	ko01110	Biosynthesis of secondary metabolites	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMC200003924	K00600	ko00260	Glycine, serine and threonine metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003924	K00600	ko00460	Cyanoamino acid metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003924	K00600	ko00670	One carbon pool by folate	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003924	K00600	ko00680	Methane metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003924	K00600	ko01100	Metabolic pathways	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003924	K00600	ko01110	Biosynthesis of secondary metabolites	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMC200003925	K00600	ko00260	Glycine, serine and threonine metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003925	K00600	ko00460	Cyanoamino acid metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003925	K00600	ko00670	One carbon pool by folate	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003925	K00600	ko00680	Methane metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003925	K00600	ko01100	Metabolic pathways	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003925	K00600	ko01110	Biosynthesis of secondary metabolites	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMC200003926	K01772	ko00860	Porphyrin and chlorophyll metabolism	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMC200003926	K01772	ko01100	Metabolic pathways	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMC200003926	K01772	ko01110	Biosynthesis of secondary metabolites	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMC200003927	K01772	ko00860	Porphyrin and chlorophyll metabolism	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMC200003927	K01772	ko01100	Metabolic pathways	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMC200003927	K01772	ko01110	Biosynthesis of secondary metabolites	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMC200003928	K02128	ko00190	Oxidative phosphorylation	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMC200003928	K02128	ko01100	Metabolic pathways	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMC200003928	K02128	ko05010	Alzheimer's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMC200003928	K02128	ko05012	Parkinson's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMC200003928	K02128	ko05016	Huntington's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMC200021455	K02990	ko03010	Ribosome	221	2.4e-06	0.40	0.55	0.50
PGSC0003DMC200021457	K10601	ko04120	Ubiquitin mediated proteolysis	246	2.1e-07	0.29	0.50	0.80
PGSC0003DMC200021474	K03217	ko03060	Protein export	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMC200021474	K03217	ko03070	Bacterial secretion system	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMC200021475	K03217	ko03060	Protein export	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMC200021475	K03217	ko03070	Bacterial secretion system	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMC200021476	K01897	ko00071	Fatty acid metabolism	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMC200021476	K01897	ko01100	Metabolic pathways	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMC200021476	K01897	ko03320	PPAR signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMC200021476	K01897	ko04146	Peroxisome	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMC200021476	K01897	ko04920	Adipocytokine signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMC200021477	K01897	ko00071	Fatty acid metabolism	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMC200021477	K01897	ko01100	Metabolic pathways	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMC200021477	K01897	ko03320	PPAR signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMC200021477	K01897	ko04146	Peroxisome	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMC200021477	K01897	ko04920	Adipocytokine signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMC200021480	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200021480	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200021480	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMC200028923	K02922	ko03010	Ribosome	700	9.0e-33	0.96	0.99	0.75
PGSC0003DMC200028924	K02922	ko03010	Ribosome	775	6.5e-37	0.93	0.98	0.99
PGSC0003DMC200028928	K05282	ko00904	Diterpenoid biosynthesis	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMC200028928	K05282	ko01100	Metabolic pathways	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMC200028928	K05282	ko01110	Biosynthesis of secondary metabolites	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMC200035108	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMC200035108	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMC200035110	K06670	ko04110	Cell cycle	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMC200035110	K06670	ko04111	Cell cycle - yeast	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMC200035111	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMC200035111	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMC200035115	K00413	ko00190	Oxidative phosphorylation	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035115	K00413	ko01100	Metabolic pathways	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035115	K00413	ko04260	Cardiac muscle contraction	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035115	K00413	ko05010	Alzheimer's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035115	K00413	ko05012	Parkinson's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035115	K00413	ko05016	Huntington's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMC200035120	K11584	ko04113	Meiosis - yeast	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMC200035120	K11584	ko04114	Oocyte meiosis	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMC200035120	K11584	ko04310	Wnt signaling pathway	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMC200035121	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035121	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035121	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035122	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035122	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035122	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMC200035123	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMC200035123	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMC200035124	K01066	ko00623	2,4-Dichlorobenzoate degradation	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMC200035124	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMC200035126	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMC200035126	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMC200035127	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMC200035127	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMC200052665	K08241	ko00592	alpha-Linolenic acid metabolism	517	1.1e-22	0.36	0.55	0.93
PGSC0003DMC200052666	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.37	0.53	0.96
PGSC0003DMC200052667	K08241	ko00592	alpha-Linolenic acid metabolism	705	4.8e-33	0.33	0.53	0.98
PGSC0003DMC200052668	K08241	ko00592	alpha-Linolenic acid metabolism	707	3.7e-33	0.33	0.53	0.99
PGSC0003DMC200052669	K08241	ko00592	alpha-Linolenic acid metabolism	711	2.2e-33	0.33	0.53	0.99
PGSC0003DMC200052672	K01719	ko00860	Porphyrin and chlorophyll metabolism	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMC200052672	K01719	ko01100	Metabolic pathways	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMC200052672	K01719	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMC200052675	K07374	ko04145	Phagosome	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMC200052675	K07374	ko04540	Gap junction	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMC200052675	K07374	ko05130	Pathogenic Escherichia coli infection	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMC200052676	K02266	ko00190	Oxidative phosphorylation	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200052676	K02266	ko01100	Metabolic pathways	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200052676	K02266	ko04260	Cardiac muscle contraction	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200052676	K02266	ko05010	Alzheimer's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200052676	K02266	ko05012	Parkinson's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200052676	K02266	ko05016	Huntington's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMC200044461	K12600	ko03018	RNA degradation	5837	0.	0.61	0.78	0.98
PGSC0003DMC200044462	K12600	ko03018	RNA degradation	4120	2.1e-221	0.58	0.75	0.95
PGSC0003DMC200044463	K03132	ko03022	Basal transcription factors	1058	1.6e-52	0.84	0.97	0.92
PGSC0003DMC200044464	K03132	ko03022	Basal transcription factors	651	4.5e-30	0.70	0.80	0.99
PGSC0003DMC200044465	K03132	ko03022	Basal transcription factors	1236	2.5e-62	0.75	0.88	0.99
PGSC0003DMC200044468	K10352	ko04530	Tight junction	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMC200044468	K10352	ko05416	Viral myocarditis	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMC200044479	K10591	ko04120	Ubiquitin mediated proteolysis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMC200044479	K10591	ko04144	Endocytosis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMC200044480	K10591	ko04120	Ubiquitin mediated proteolysis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMC200044480	K10591	ko04144	Endocytosis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMC200044488	K09756	ko00940	Phenylpropanoid biosynthesis	1262	9.0e-64	0.41	0.57	0.80
PGSC0003DMC200044489	K09756	ko00940	Phenylpropanoid biosynthesis	1607	8.4e-83	0.45	0.62	0.99
PGSC0003DMC200032941	K10527	ko00592	alpha-Linolenic acid metabolism	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMC200032941	K10527	ko01100	Metabolic pathways	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMC200032942	K10527	ko00592	alpha-Linolenic acid metabolism	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMC200032942	K10527	ko01100	Metabolic pathways	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMC200032948	K00422	ko00350	Tyrosine metabolism	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMC200032948	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMC200032948	K00422	ko01100	Metabolic pathways	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMC200032948	K00422	ko01110	Biosynthesis of secondary metabolites	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMC200032949	K00422	ko00350	Tyrosine metabolism	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMC200032949	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMC200032949	K00422	ko01100	Metabolic pathways	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMC200032949	K00422	ko01110	Biosynthesis of secondary metabolites	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMC200032951	K00422	ko00350	Tyrosine metabolism	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMC200032951	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMC200032951	K00422	ko01100	Metabolic pathways	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMC200032951	K00422	ko01110	Biosynthesis of secondary metabolites	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMC200032952	K00422	ko00350	Tyrosine metabolism	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMC200032952	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMC200032952	K00422	ko01100	Metabolic pathways	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMC200032952	K00422	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMC200032954	K00422	ko00350	Tyrosine metabolism	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMC200032954	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMC200032954	K00422	ko01100	Metabolic pathways	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMC200032954	K00422	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMC200032955	K00422	ko00350	Tyrosine metabolism	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMC200032955	K00422	ko00950	Isoquinoline alkaloid biosynthesis	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMC200032955	K00422	ko01100	Metabolic pathways	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMC200032955	K00422	ko01110	Biosynthesis of secondary metabolites	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMC200032961	K00422	ko00350	Tyrosine metabolism	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMC200032961	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMC200032961	K00422	ko01100	Metabolic pathways	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMC200032961	K00422	ko01110	Biosynthesis of secondary metabolites	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMC200032962	K00422	ko00350	Tyrosine metabolism	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMC200032962	K00422	ko00950	Isoquinoline alkaloid biosynthesis	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMC200032962	K00422	ko01100	Metabolic pathways	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMC200032962	K00422	ko01110	Biosynthesis of secondary metabolites	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMC200057735	K11294	ko05130	Pathogenic Escherichia coli infection	315	2.3e-11	0.28	0.49	0.56
PGSC0003DMC200057742	K02951	ko03010	Ribosome	328	3.0e-12	0.49	0.60	0.58
PGSC0003DMC200050971	K07195	ko04910	Insulin signaling pathway	3992	2.4e-214	0.70	0.85	1.00
PGSC0003DMC200050977	K02991	ko03010	Ribosome	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMC200050977	K02991	ko04150	mTOR signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMC200050977	K02991	ko04910	Insulin signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMC200033807	K01807	ko00030	Pentose phosphate pathway	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMC200033807	K01807	ko00710	Carbon fixation in photosynthetic organisms	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMC200033807	K01807	ko01100	Metabolic pathways	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMC200033807	K01807	ko01110	Biosynthesis of secondary metabolites	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMC200022174	K13065	ko00940	Phenylpropanoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMC200022174	K13065	ko00941	Flavonoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMC200022174	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMC200022174	K13065	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMC200022175	K13065	ko00940	Phenylpropanoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMC200022175	K13065	ko00941	Flavonoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMC200022175	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMC200022175	K13065	ko01110	Biosynthesis of secondary metabolites	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMC200022176	K13065	ko00940	Phenylpropanoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMC200022176	K13065	ko00941	Flavonoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMC200022176	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMC200022176	K13065	ko01110	Biosynthesis of secondary metabolites	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMC200022177	K13065	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMC200022177	K13065	ko00941	Flavonoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMC200022177	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMC200022177	K13065	ko01110	Biosynthesis of secondary metabolites	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMC200022178	K13065	ko00940	Phenylpropanoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMC200022178	K13065	ko00941	Flavonoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMC200022178	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMC200022178	K13065	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMC200022186	K13065	ko00940	Phenylpropanoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMC200022186	K13065	ko00941	Flavonoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMC200022186	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMC200022186	K13065	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMC200022195	K05849	ko04020	Calcium signaling pathway	240	1.1e-06	0.37	0.54	0.39
PGSC0003DMC200022199	K05681	ko02010	ABC transporters	1176	5.0e-59	0.36	0.53	0.90
PGSC0003DMC200004981	K01507	ko00190	Oxidative phosphorylation	5592	0.	0.89	0.95	1.00
PGSC0003DMC200004982	K08057	ko04145	Phagosome	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMC200004982	K08057	ko04612	Antigen processing and presentation	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMC200004982	K08057	ko05142	Chagas disease	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMC200004984	K00382	ko00010	Glycolysis / Gluconeogenesis	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko00020	Citrate cycle (TCA cycle)	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko00260	Glycine, serine and threonine metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko00280	Valine, leucine and isoleucine degradation	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko00620	Pyruvate metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko01100	Metabolic pathways	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004984	K00382	ko01110	Biosynthesis of secondary metabolites	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMC200004990	K02716	ko00195	Photosynthesis	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMC200004990	K02716	ko01100	Metabolic pathways	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMC200014821	K00963	ko00040	Pentose and glucuronate interconversions	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014821	K00963	ko00052	Galactose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014821	K00963	ko00500	Starch and sucrose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014821	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014821	K00963	ko01100	Metabolic pathways	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014821	K00963	ko01110	Biosynthesis of secondary metabolites	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMC200014822	K02934	ko03010	Ribosome	1575	4.9e-81	0.79	0.89	1.00
PGSC0003DMC200014823	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014823	K01580	ko00410	beta-Alanine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014823	K01580	ko00430	Taurine and hypotaurine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014823	K01580	ko00650	Butanoate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014823	K01580	ko01100	Metabolic pathways	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014823	K01580	ko04940	Type I diabetes mellitus	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMC200014824	K01580	ko00250	Alanine, aspartate and glutamate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014824	K01580	ko00410	beta-Alanine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014824	K01580	ko00430	Taurine and hypotaurine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014824	K01580	ko00650	Butanoate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014824	K01580	ko01100	Metabolic pathways	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014824	K01580	ko04940	Type I diabetes mellitus	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMC200014825	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014825	K01580	ko00410	beta-Alanine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014825	K01580	ko00430	Taurine and hypotaurine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014825	K01580	ko00650	Butanoate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014825	K01580	ko01100	Metabolic pathways	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014825	K01580	ko04940	Type I diabetes mellitus	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMC200014841	K03004	ko00230	Purine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMC200014841	K03004	ko00240	Pyrimidine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMC200014841	K03004	ko01100	Metabolic pathways	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMC200014841	K03004	ko03020	RNA polymerase	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMC200014842	K03004	ko00230	Purine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMC200014842	K03004	ko00240	Pyrimidine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMC200014842	K03004	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMC200014842	K03004	ko03020	RNA polymerase	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMC200014843	K08272	ko04150	mTOR signaling pathway	2402	1.2e-126	0.85	0.94	0.99
PGSC0003DMC200014845	K12462	ko04722	Neurotrophin signaling pathway	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMC200014845	K12462	ko04962	Vasopressin-regulated water reabsorption	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMC200014846	K10591	ko04120	Ubiquitin mediated proteolysis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMC200014846	K10591	ko04144	Endocytosis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMC200014847	K10591	ko04120	Ubiquitin mediated proteolysis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMC200014847	K10591	ko04144	Endocytosis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMC200027961	K02990	ko03010	Ribosome	352	1.4e-13	0.34	0.55	0.48
PGSC0003DMC200027970	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMC200027970	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMC200027970	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMC200027970	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMC200027971	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMC200027971	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMC200027971	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMC200027971	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMC200027972	K05350	ko00460	Cyanoamino acid metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMC200027972	K05350	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMC200027972	K05350	ko00940	Phenylpropanoid biosynthesis	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMC200027972	K05350	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMC200027973	K05350	ko00460	Cyanoamino acid metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMC200027973	K05350	ko00500	Starch and sucrose metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMC200027973	K05350	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMC200027973	K05350	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMC200027974	K05350	ko00460	Cyanoamino acid metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMC200027974	K05350	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMC200027974	K05350	ko00940	Phenylpropanoid biosynthesis	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMC200027974	K05350	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMC200027975	K05350	ko00460	Cyanoamino acid metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMC200027975	K05350	ko00500	Starch and sucrose metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMC200027975	K05350	ko00940	Phenylpropanoid biosynthesis	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMC200027975	K05350	ko01110	Biosynthesis of secondary metabolites	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMC200027982	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMC200027982	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMC200001208	K10595	ko04120	Ubiquitin mediated proteolysis	300	4.6e-08	0.43	0.58	0.27
PGSC0003DMC200001218	K01184	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMC200001218	K01184	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMC200001218	K01184	ko01100	Metabolic pathways	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMC200001219	K01184	ko00040	Pentose and glucuronate interconversions	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMC200001219	K01184	ko00500	Starch and sucrose metabolism	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMC200001219	K01184	ko01100	Metabolic pathways	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMC200001227	K01115	ko00564	Glycerophospholipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001227	K01115	ko00565	Ether lipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001227	K01115	ko01100	Metabolic pathways	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001227	K01115	ko04144	Endocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001227	K01115	ko04666	Fc gamma R-mediated phagocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001227	K01115	ko04912	GnRH signaling pathway	5605	0.	0.77	0.90	1.00
PGSC0003DMC200001228	K01115	ko00564	Glycerophospholipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200001228	K01115	ko00565	Ether lipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200001228	K01115	ko01100	Metabolic pathways	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200001228	K01115	ko04144	Endocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200001228	K01115	ko04666	Fc gamma R-mediated phagocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200001228	K01115	ko04912	GnRH signaling pathway	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMC200041403	K10875	ko03440	Homologous recombination	630	6.5e-29	0.29	0.48	0.83
PGSC0003DMC200041404	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMC200041405	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMC200041407	K00368	ko00910	Nitrogen metabolism	1965	1.5e-102	0.47	0.61	0.92
PGSC0003DMC200041411	K02160	ko00061	Fatty acid biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041411	K02160	ko00253	Tetracycline biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041411	K02160	ko00620	Pyruvate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041411	K02160	ko00640	Propanoate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041411	K02160	ko01100	Metabolic pathways	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041411	K02160	ko01110	Biosynthesis of secondary metabolites	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMC200041416	K12586	ko03018	RNA degradation	534	1.1e-22	0.52	0.69	0.95
PGSC0003DMC200041417	K12586	ko03018	RNA degradation	828	3.6e-39	0.43	0.59	0.95
PGSC0003DMC200041430	K10743	ko03030	DNA replication	2030	3.9e-106	0.81	0.90	1.00
PGSC0003DMC200031593	K00058	ko00260	Glycine, serine and threonine metabolism	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMC200031593	K00058	ko01100	Metabolic pathways	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMC200031594	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMC200031594	K00517	ko00626	Naphthalene and anthracene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMC200031594	K00517	ko00903	Limonene and pinene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMC200031594	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMC200031594	K00517	ko01110	Biosynthesis of secondary metabolites	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMC200031595	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMC200031595	K00517	ko00626	Naphthalene and anthracene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMC200031595	K00517	ko00903	Limonene and pinene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMC200031595	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMC200031595	K00517	ko01110	Biosynthesis of secondary metabolites	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMC200031596	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMC200031596	K00517	ko00626	Naphthalene and anthracene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMC200031596	K00517	ko00903	Limonene and pinene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMC200031596	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMC200031596	K00517	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMC200031597	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMC200031597	K00517	ko00626	Naphthalene and anthracene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMC200031597	K00517	ko00903	Limonene and pinene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMC200031597	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMC200031597	K00517	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMC200031598	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMC200031598	K00517	ko00626	Naphthalene and anthracene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMC200031598	K00517	ko00903	Limonene and pinene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMC200031598	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMC200031598	K00517	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMC200031599	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMC200031599	K00517	ko00626	Naphthalene and anthracene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMC200031599	K00517	ko00903	Limonene and pinene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMC200031599	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMC200031599	K00517	ko01110	Biosynthesis of secondary metabolites	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMC200031600	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMC200031600	K00517	ko00626	Naphthalene and anthracene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMC200031600	K00517	ko00903	Limonene and pinene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMC200031600	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMC200031600	K00517	ko01110	Biosynthesis of secondary metabolites	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMC200031601	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMC200031601	K00517	ko00626	Naphthalene and anthracene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMC200031601	K00517	ko00903	Limonene and pinene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMC200031601	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMC200031601	K00517	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMC200031602	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMC200031602	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMC200031602	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMC200031602	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMC200031602	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMC200031603	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMC200031603	K00517	ko00626	Naphthalene and anthracene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMC200031603	K00517	ko00903	Limonene and pinene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMC200031603	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMC200031603	K00517	ko01110	Biosynthesis of secondary metabolites	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMC200031604	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMC200031604	K00517	ko00626	Naphthalene and anthracene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMC200031604	K00517	ko00903	Limonene and pinene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMC200031604	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMC200031604	K00517	ko01110	Biosynthesis of secondary metabolites	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMC200031605	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMC200031605	K00517	ko00626	Naphthalene and anthracene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMC200031605	K00517	ko00903	Limonene and pinene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMC200031605	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMC200031605	K00517	ko01110	Biosynthesis of secondary metabolites	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMC200031606	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMC200031606	K00517	ko00626	Naphthalene and anthracene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMC200031606	K00517	ko00903	Limonene and pinene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMC200031606	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMC200031606	K00517	ko01110	Biosynthesis of secondary metabolites	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMC200031607	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMC200031607	K00517	ko00626	Naphthalene and anthracene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMC200031607	K00517	ko00903	Limonene and pinene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMC200031607	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMC200031607	K00517	ko01110	Biosynthesis of secondary metabolites	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMC200031608	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMC200031608	K00517	ko00626	Naphthalene and anthracene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMC200031608	K00517	ko00903	Limonene and pinene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMC200031608	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMC200031608	K00517	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMC200031609	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMC200031609	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMC200031609	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMC200031609	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMC200031609	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMC200031610	K01728	ko00040	Pentose and glucuronate interconversions	1843	8.1e-96	0.56	0.71	0.90
PGSC0003DMC200031611	K05648	ko02010	ABC transporters	1155	7.9e-58	0.32	0.49	0.63
PGSC0003DMC200031614	K05648	ko02010	ABC transporters	1267	4.8e-64	0.32	0.50	0.73
PGSC0003DMC200031618	K04728	ko04110	Cell cycle	14735	0.	0.61	0.75	0.96
PGSC0003DMC200031618	K04728	ko04115	p53 signaling pathway	14735	0.	0.61	0.75	0.96
PGSC0003DMC200031618	K04728	ko04210	Apoptosis	14735	0.	0.61	0.75	0.96
PGSC0003DMC200031620	K09680	ko00770	Pantothenate and CoA biosynthesis	6275	0.	0.84	0.90	0.98
PGSC0003DMC200031620	K09680	ko01100	Metabolic pathways	6275	0.	0.84	0.90	0.98
PGSC0003DMC200050162	K02183	ko04020	Calcium signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04070	Phosphatidylinositol signaling system	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04114	Oocyte meiosis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04270	Vascular smooth muscle contraction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04626	Plant-pathogen interaction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04720	Long-term potentiation	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04722	Neurotrophin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04740	Olfactory transduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04744	Phototransduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04745	Phototransduction - fly	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04910	Insulin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04912	GnRH signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04916	Melanogenesis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04970	Salivary secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko04971	Gastric acid secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko05010	Alzheimer's disease	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050162	K02183	ko05214	Glioma	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMC200050163	K05929	ko00564	Glycerophospholipid metabolism	767	1.8e-36	0.41	0.60	0.51
PGSC0003DMC200050164	K01613	ko00564	Glycerophospholipid metabolism	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMC200050164	K01613	ko01100	Metabolic pathways	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMC200050170	K12311	ko00511	Other glycan degradation	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMC200050170	K12311	ko04142	Lysosome	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMC200050171	K12311	ko00511	Other glycan degradation	6314	0.	0.73	0.84	0.98
PGSC0003DMC200050171	K12311	ko04142	Lysosome	6314	0.	0.73	0.84	0.98
PGSC0003DMC200050174	K10757	ko00944	Flavone and flavonol biosynthesis	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMC200050174	K10757	ko01100	Metabolic pathways	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMC200050174	K10757	ko01110	Biosynthesis of secondary metabolites	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMC200050176	K12617	ko03018	RNA degradation	4534	3.1e-244	0.68	0.79	1.00
PGSC0003DMC200050180	K13229	ko00402	Benzoxazinoid biosynthesis	988	1.2e-48	0.48	0.66	1.00
PGSC0003DMC200050181	K13229	ko00402	Benzoxazinoid biosynthesis	1238	1.9e-62	0.44	0.62	0.99
PGSC0003DMC200050182	K13229	ko00402	Benzoxazinoid biosynthesis	535	1.1e-23	0.41	0.62	0.96
PGSC0003DMC200038041	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMC200038042	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMC200038047	K02084	ko04115	p53 signaling pathway	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko04210	Apoptosis	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko05010	Alzheimer's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko05012	Parkinson's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko05016	Huntington's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038047	K02084	ko05222	Small cell lung cancer	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMC200038057	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMC200038057	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMC200038058	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMC200038058	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMC200038064	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMC200038065	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMC200053971	K04733	ko04210	Apoptosis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMC200053971	K04733	ko04620	Toll-like receptor signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMC200053971	K04733	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMC200053971	K04733	ko05140	Leishmaniasis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMC200053971	K04733	ko05142	Chagas disease	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMC200053977	K04424	ko04010	MAPK signaling pathway	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMC200053977	K04424	ko04530	Tight junction	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMC200053991	K07466	ko03030	DNA replication	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMC200053991	K07466	ko03420	Nucleotide excision repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMC200053991	K07466	ko03430	Mismatch repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMC200053991	K07466	ko03440	Homologous recombination	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMC200053992	K00001	ko00010	Glycolysis / Gluconeogenesis	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00071	Fatty acid metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00350	Tyrosine metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00624	1- and 2-Methylnaphthalene degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00641	3-Chloroacrylic acid degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00830	Retinol metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko00982	Drug metabolism - cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko01100	Metabolic pathways	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053992	K00001	ko01110	Biosynthesis of secondary metabolites	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMC200053996	K08766	ko00071	Fatty acid metabolism	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMC200053996	K08766	ko03320	PPAR signaling pathway	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMC200018964	K04392	ko04010	MAPK signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04062	Chemokine signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04145	Phagosome	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04310	Wnt signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04360	Axon guidance	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04370	VEGF signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04510	Focal adhesion	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04520	Adherens junction	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04620	Toll-like receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04650	Natural killer cell mediated cytotoxicity	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04662	B cell receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04664	Fc epsilon RI signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04666	Fc gamma R-mediated phagocytosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04670	Leukocyte transendothelial migration	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04722	Neurotrophin signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko04810	Regulation of actin cytoskeleton	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05100	Bacterial invasion of epithelial cells	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05131	Shigellosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05200	Pathways in cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05210	Colorectal cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05211	Renal cell carcinoma	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05212	Pancreatic cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018964	K04392	ko05416	Viral myocarditis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMC200018965	K04392	ko04010	MAPK signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04062	Chemokine signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04145	Phagosome	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04310	Wnt signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04360	Axon guidance	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04370	VEGF signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04510	Focal adhesion	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04520	Adherens junction	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04620	Toll-like receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04650	Natural killer cell mediated cytotoxicity	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04662	B cell receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04664	Fc epsilon RI signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04666	Fc gamma R-mediated phagocytosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04670	Leukocyte transendothelial migration	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04722	Neurotrophin signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko04810	Regulation of actin cytoskeleton	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05100	Bacterial invasion of epithelial cells	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05131	Shigellosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05200	Pathways in cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05210	Colorectal cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05211	Renal cell carcinoma	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05212	Pancreatic cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018965	K04392	ko05416	Viral myocarditis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMC200018969	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMC200018969	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMC200018970	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMC200018970	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMC200018971	K07203	ko04012	ErbB signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko04150	mTOR signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko04910	Insulin signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko04920	Adipocytokine signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko04930	Type II diabetes mellitus	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko05200	Pathways in cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko05214	Glioma	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko05215	Prostate cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018971	K07203	ko05221	Acute myeloid leukemia	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMC200018972	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018972	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018973	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018973	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018974	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018974	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018975	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018975	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMC200018977	K07203	ko04012	ErbB signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko04150	mTOR signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko04910	Insulin signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko04920	Adipocytokine signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko04930	Type II diabetes mellitus	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko05200	Pathways in cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko05214	Glioma	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko05215	Prostate cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018977	K07203	ko05221	Acute myeloid leukemia	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMC200018979	K06677	ko04111	Cell cycle - yeast	329	2.6e-11	0.41	0.61	0.84
PGSC0003DMC200018980	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018980	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMC200018981	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200018981	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMC200025173	K12614	ko03018	RNA degradation	797	2.2e-37	0.30	0.51	0.92
PGSC0003DMC200025174	K01553	ko00230	Purine metabolism	439	1.2e-17	0.29	0.49	0.90
PGSC0003DMC200025176	K10846	ko03420	Nucleotide excision repair	543	8.7e-32	0.33	0.47	0.76
PGSC0003DMC200025181	K12478	ko04144	Endocytosis	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMC200025181	K12478	ko04145	Phagosome	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMC200025182	K12478	ko04144	Endocytosis	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMC200025182	K12478	ko04145	Phagosome	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMC200025186	K07375	ko04145	Phagosome	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMC200025186	K07375	ko04540	Gap junction	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMC200025186	K07375	ko05130	Pathogenic Escherichia coli infection	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMC200025187	K07375	ko04145	Phagosome	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMC200025187	K07375	ko04540	Gap junction	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMC200025187	K07375	ko05130	Pathogenic Escherichia coli infection	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMC200025188	K07375	ko04145	Phagosome	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMC200025188	K07375	ko04540	Gap junction	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMC200025188	K07375	ko05130	Pathogenic Escherichia coli infection	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMC200025192	K02957	ko03010	Ribosome	898	1.1e-43	0.86	0.87	0.99
PGSC0003DMC200025195	K10717	ko00908	Zeatin biosynthesis	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMC200025195	K10717	ko01100	Metabolic pathways	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMC200025195	K10717	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMC200006843	K01046	ko00561	Glycerolipid metabolism	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMC200006843	K01046	ko01100	Metabolic pathways	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMC200006852	K12818	ko03040	Spliceosome	1259	1.3e-63	0.43	0.58	0.99
PGSC0003DMC200006853	K12818	ko03040	Spliceosome	1537	6.1e-79	0.52	0.70	0.99
PGSC0003DMC200066128	K07466	ko03030	DNA replication	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMC200066128	K07466	ko03420	Nucleotide excision repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMC200066128	K07466	ko03430	Mismatch repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMC200066128	K07466	ko03440	Homologous recombination	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMC200061136	K03094	ko04110	Cell cycle	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04111	Cell cycle - yeast	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04114	Oocyte meiosis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04120	Ubiquitin mediated proteolysis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04310	Wnt signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04350	TGF-beta signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200061136	K03094	ko04710	Circadian rhythm - mammal	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMC200048961	K00873	ko00010	Glycolysis / Gluconeogenesis	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko00230	Purine metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko00620	Pyruvate metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko00710	Carbon fixation in photosynthetic organisms	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko01100	Metabolic pathways	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048961	K00873	ko04930	Type II diabetes mellitus	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMC200048965	K12185	ko04144	Endocytosis	992	7.0e-49	0.48	0.57	0.99
PGSC0003DMC200048966	K12185	ko04144	Endocytosis	452	4.3e-19	0.55	0.68	0.74
PGSC0003DMC200048967	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMC200048968	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMC200048969	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMC200048970	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMC200048971	K09837	ko00906	Carotenoid biosynthesis	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMC200048971	K09837	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMC200048971	K09837	ko01110	Biosynthesis of secondary metabolites	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMC200048972	K09837	ko00906	Carotenoid biosynthesis	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMC200048972	K09837	ko01100	Metabolic pathways	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMC200048972	K09837	ko01110	Biosynthesis of secondary metabolites	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMC200048973	K09837	ko00906	Carotenoid biosynthesis	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMC200048973	K09837	ko01100	Metabolic pathways	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMC200048973	K09837	ko01110	Biosynthesis of secondary metabolites	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMC200048974	K10603	ko04120	Ubiquitin mediated proteolysis	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMC200048974	K10603	ko05340	Primary immunodeficiency	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMC200048975	K10603	ko04120	Ubiquitin mediated proteolysis	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMC200048975	K10603	ko05340	Primary immunodeficiency	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMC200048976	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMC200048976	K10603	ko05340	Primary immunodeficiency	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMC200048977	K10603	ko04120	Ubiquitin mediated proteolysis	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMC200048977	K10603	ko05340	Primary immunodeficiency	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMC200048978	K10603	ko04120	Ubiquitin mediated proteolysis	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMC200048978	K10603	ko05340	Primary immunodeficiency	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMC200048980	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMC200048980	K10603	ko05340	Primary immunodeficiency	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMC200048983	K00953	ko00740	Riboflavin metabolism	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMC200048983	K00953	ko01100	Metabolic pathways	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMC200048984	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMC200048984	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMC200048985	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMC200048985	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMC200048986	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMC200048986	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMC200048987	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMC200048987	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMC200048988	K00953	ko00740	Riboflavin metabolism	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMC200048988	K00953	ko01100	Metabolic pathways	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMC200030394	K02881	ko03010	Ribosome	728	2.6e-34	0.73	0.88	0.99
PGSC0003DMC200030413	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030413	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030413	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030413	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030413	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030414	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030414	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030414	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030414	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030414	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMC200030416	K12741	ko03040	Spliceosome	618	3.0e-28	0.44	0.51	0.99
PGSC0003DMC200030418	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMC200030419	K12741	ko03040	Spliceosome	1586	1.2e-81	0.54	0.67	0.76
PGSC0003DMC200030420	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMC200036852	K01599	ko00860	Porphyrin and chlorophyll metabolism	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMC200036852	K01599	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMC200036853	K01599	ko00860	Porphyrin and chlorophyll metabolism	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMC200036853	K01599	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMC200036854	K01595	ko00620	Pyruvate metabolism	7497	0.	0.91	0.96	1.00
PGSC0003DMC200036854	K01595	ko00710	Carbon fixation in photosynthetic organisms	7497	0.	0.91	0.96	1.00
PGSC0003DMC200036854	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7497	0.	0.91	0.96	1.00
PGSC0003DMC200036854	K01595	ko01100	Metabolic pathways	7497	0.	0.91	0.96	1.00
PGSC0003DMC200036858	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMC200036865	K06236	ko04510	Focal adhesion	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMC200036865	K06236	ko04512	ECM-receptor interaction	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMC200036865	K06236	ko05146	Amoebiasis	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMC200036869	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMC200036869	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMC200036870	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMC200036870	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMC200055175	K12153	ko00966	Glucosinolate biosynthesis	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMC200055175	K12153	ko01110	Biosynthesis of secondary metabolites	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMC200055189	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMC200055189	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMC200055194	K01239	ko00230	Purine metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMC200055194	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMC200055194	K01239	ko01100	Metabolic pathways	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMC200055195	K01239	ko00230	Purine metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMC200055195	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMC200055195	K01239	ko01100	Metabolic pathways	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMC200055196	K01239	ko00230	Purine metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMC200055196	K01239	ko00760	Nicotinate and nicotinamide metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMC200055196	K01239	ko01100	Metabolic pathways	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMC200065679	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.58	0.66	0.84
PGSC0003DMC200062328	K04428	ko04010	MAPK signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMC200062328	K04428	ko04912	GnRH signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMC200011414	K00100	ko00051	Fructose and mannose metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011414	K00100	ko00363	Bisphenol A degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011414	K00100	ko00591	Linoleic acid metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011414	K00100	ko00625	Tetrachloroethene degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011414	K00100	ko00650	Butanoate metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011414	K00100	ko01100	Metabolic pathways	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMC200011415	K00100	ko00051	Fructose and mannose metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011415	K00100	ko00363	Bisphenol A degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011415	K00100	ko00591	Linoleic acid metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011415	K00100	ko00625	Tetrachloroethene degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011415	K00100	ko00650	Butanoate metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011415	K00100	ko01100	Metabolic pathways	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMC200011418	K05275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMC200011418	K05275	ko01100	Metabolic pathways	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMC200011419	K00100	ko00051	Fructose and mannose metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011419	K00100	ko00363	Bisphenol A degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011419	K00100	ko00591	Linoleic acid metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011419	K00100	ko00625	Tetrachloroethene degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011419	K00100	ko00650	Butanoate metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011419	K00100	ko01100	Metabolic pathways	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMC200011420	K00100	ko00051	Fructose and mannose metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011420	K00100	ko00363	Bisphenol A degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011420	K00100	ko00591	Linoleic acid metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011420	K00100	ko00625	Tetrachloroethene degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011420	K00100	ko00650	Butanoate metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011420	K00100	ko01100	Metabolic pathways	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMC200011421	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011421	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011421	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011421	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011421	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011421	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMC200011422	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011422	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011422	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011422	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011422	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011422	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMC200011423	K00100	ko00051	Fructose and mannose metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011423	K00100	ko00363	Bisphenol A degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011423	K00100	ko00591	Linoleic acid metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011423	K00100	ko00625	Tetrachloroethene degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011423	K00100	ko00650	Butanoate metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011423	K00100	ko01100	Metabolic pathways	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko00051	Fructose and mannose metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko00363	Bisphenol A degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko00591	Linoleic acid metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko00625	Tetrachloroethene degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko00650	Butanoate metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011424	K00100	ko01100	Metabolic pathways	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMC200011425	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011425	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011425	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011425	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011425	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011425	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMC200011427	K00100	ko00051	Fructose and mannose metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011427	K00100	ko00363	Bisphenol A degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011427	K00100	ko00591	Linoleic acid metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011427	K00100	ko00625	Tetrachloroethene degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011427	K00100	ko00650	Butanoate metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011427	K00100	ko01100	Metabolic pathways	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMC200011428	K11251	ko05322	Systemic lupus erythematosus	521	6.7e-23	0.88	0.92	0.96
PGSC0003DMC200011429	K11251	ko05322	Systemic lupus erythematosus	1042	1.2e-51	0.91	0.92	0.99
PGSC0003DMC200020162	K03869	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.36	0.56	0.98
PGSC0003DMC200020163	K08065	ko04612	Antigen processing and presentation	564	2.8e-25	0.57	0.74	0.85
PGSC0003DMC200020168	K06632	ko04110	Cell cycle	843	5.6e-50	0.76	0.86	0.90
PGSC0003DMC200020169	K06632	ko04110	Cell cycle	2330	1.1e-122	0.79	0.89	0.94
PGSC0003DMC200020170	K06632	ko04110	Cell cycle	2132	9.3e-112	0.79	0.89	0.92
PGSC0003DMC200020171	K00416	ko00190	Oxidative phosphorylation	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020171	K00416	ko01100	Metabolic pathways	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020171	K00416	ko04260	Cardiac muscle contraction	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020171	K00416	ko05010	Alzheimer's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020171	K00416	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020171	K00416	ko05016	Huntington's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMC200020172	K00416	ko00190	Oxidative phosphorylation	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020172	K00416	ko01100	Metabolic pathways	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020172	K00416	ko04260	Cardiac muscle contraction	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020172	K00416	ko05010	Alzheimer's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020172	K00416	ko05012	Parkinson's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020172	K00416	ko05016	Huntington's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMC200020173	K00416	ko00190	Oxidative phosphorylation	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020173	K00416	ko01100	Metabolic pathways	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020173	K00416	ko04260	Cardiac muscle contraction	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020173	K00416	ko05010	Alzheimer's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020173	K00416	ko05012	Parkinson's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020173	K00416	ko05016	Huntington's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMC200020174	K00416	ko00190	Oxidative phosphorylation	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020174	K00416	ko01100	Metabolic pathways	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020174	K00416	ko04260	Cardiac muscle contraction	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020174	K00416	ko05010	Alzheimer's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020174	K00416	ko05012	Parkinson's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020174	K00416	ko05016	Huntington's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMC200020175	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMC200020175	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMC200020176	K03845	ko00510	N-Glycan biosynthesis	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMC200020176	K03845	ko01100	Metabolic pathways	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMC200020177	K03845	ko00510	N-Glycan biosynthesis	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMC200020177	K03845	ko01100	Metabolic pathways	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMC200020178	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMC200020178	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMC200020179	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMC200020179	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMC200020180	K03845	ko00510	N-Glycan biosynthesis	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMC200020180	K03845	ko01100	Metabolic pathways	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMC200020181	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMC200020181	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMC200023973	K01853	ko00100	Steroid biosynthesis	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMC200023973	K01853	ko01100	Metabolic pathways	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMC200023973	K01853	ko01110	Biosynthesis of secondary metabolites	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMC200023978	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMC200023978	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMC200023979	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMC200023979	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMC200023980	K00695	ko00500	Starch and sucrose metabolism	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMC200023980	K00695	ko01100	Metabolic pathways	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMC200023981	K00695	ko00500	Starch and sucrose metabolism	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMC200023981	K00695	ko01100	Metabolic pathways	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMC200023982	K00695	ko00500	Starch and sucrose metabolism	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMC200023982	K00695	ko01100	Metabolic pathways	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMC200023985	K08008	ko04145	Phagosome	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMC200023985	K08008	ko04670	Leukocyte transendothelial migration	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMC200023986	K08008	ko04145	Phagosome	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMC200023986	K08008	ko04670	Leukocyte transendothelial migration	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMC200023987	K08008	ko04145	Phagosome	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMC200023987	K08008	ko04670	Leukocyte transendothelial migration	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMC200023990	K01051	ko00040	Pentose and glucuronate interconversions	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMC200023990	K01051	ko00500	Starch and sucrose metabolism	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMC200023990	K01051	ko01100	Metabolic pathways	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMC200023994	K12356	ko00940	Phenylpropanoid biosynthesis	461	1.4e-19	0.47	0.65	0.93
PGSC0003DMC200023997	K10595	ko04120	Ubiquitin mediated proteolysis	731	1.5e-34	0.35	0.51	0.97
PGSC0003DMC200024000	K00161	ko00010	Glycolysis / Gluconeogenesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko00620	Pyruvate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko00650	Butanoate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko01100	Metabolic pathways	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200024000	K00161	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMC200008042	K08490	ko04130	SNARE interactions in vesicular transport	1791	6.0e-93	0.75	0.83	0.99
PGSC0003DMC200008043	K08490	ko04130	SNARE interactions in vesicular transport	465	8.2e-20	0.71	0.83	0.67
PGSC0003DMC200008044	K08490	ko04130	SNARE interactions in vesicular transport	2178	2.7e-114	0.76	0.85	1.00
PGSC0003DMC200008045	K02877	ko03010	Ribosome	337	9.4e-13	0.65	0.75	0.83
PGSC0003DMC200008062	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008062	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008062	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008063	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMC200008063	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMC200008063	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMC200008064	K11755	ko00340	Histidine metabolism	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMC200008064	K11755	ko01100	Metabolic pathways	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMC200008064	K11755	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMC200008065	K11755	ko00340	Histidine metabolism	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMC200008065	K11755	ko01100	Metabolic pathways	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMC200008065	K11755	ko01110	Biosynthesis of secondary metabolites	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMC200008066	K11755	ko00340	Histidine metabolism	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMC200008066	K11755	ko01100	Metabolic pathways	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMC200008066	K11755	ko01110	Biosynthesis of secondary metabolites	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMC200008067	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008067	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008067	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMC200008069	K11755	ko00340	Histidine metabolism	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMC200008069	K11755	ko01100	Metabolic pathways	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMC200008069	K11755	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMC200034981	K01728	ko00040	Pentose and glucuronate interconversions	2893	9.9e-154	0.78	0.87	0.97
PGSC0003DMC200034982	K12859	ko03040	Spliceosome	403	2.2e-16	0.41	0.58	0.89
PGSC0003DMC200034992	K10782	ko00061	Fatty acid biosynthesis	2144	2.0e-112	0.76	0.87	0.90
PGSC0003DMC200034994	K03007	ko00230	Purine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMC200034994	K03007	ko00240	Pyrimidine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMC200034994	K03007	ko01100	Metabolic pathways	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMC200034994	K03007	ko03020	RNA polymerase	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMC200034994	K03007	ko05016	Huntington's disease	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMC200034995	K03007	ko00230	Purine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMC200034995	K03007	ko00240	Pyrimidine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMC200034995	K03007	ko01100	Metabolic pathways	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMC200034995	K03007	ko03020	RNA polymerase	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMC200034995	K03007	ko05016	Huntington's disease	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMC200035002	K10949	ko05110	Vibrio cholerae infection	489	3.9e-21	0.33	0.55	0.82
PGSC0003DMC200035003	K10949	ko05110	Vibrio cholerae infection	512	2.1e-22	0.35	0.57	0.82
PGSC0003DMC200035004	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMC200035004	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMC200035004	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMC200035004	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMC200035004	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMC200035005	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMC200035005	K00517	ko00626	Naphthalene and anthracene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMC200035005	K00517	ko00903	Limonene and pinene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMC200035005	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMC200035005	K00517	ko01110	Biosynthesis of secondary metabolites	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMC200035006	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMC200035006	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMC200035006	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMC200035006	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMC200035006	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMC200052192	K01184	ko00040	Pentose and glucuronate interconversions	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMC200052192	K01184	ko00500	Starch and sucrose metabolism	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMC200052192	K01184	ko01100	Metabolic pathways	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMC200052199	K12667	ko00510	N-Glycan biosynthesis	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMC200052199	K12667	ko01100	Metabolic pathways	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMC200052200	K12667	ko00510	N-Glycan biosynthesis	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMC200052200	K12667	ko01100	Metabolic pathways	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMC200044830	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044830	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044830	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044830	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044831	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044831	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044831	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044831	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044832	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044832	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044832	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044832	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMC200044833	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044833	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044833	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044833	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMC200044834	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMC200044834	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMC200044834	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMC200044834	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMC200044835	K13065	ko00940	Phenylpropanoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMC200044835	K13065	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMC200044835	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMC200044835	K13065	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMC200044843	K10352	ko04530	Tight junction	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMC200044843	K10352	ko05416	Viral myocarditis	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMC200044845	K01952	ko00230	Purine metabolism	6579	0.	0.84	0.92	1.00
PGSC0003DMC200044845	K01952	ko01100	Metabolic pathways	6579	0.	0.84	0.92	1.00
PGSC0003DMC200044845	K01952	ko01110	Biosynthesis of secondary metabolites	6579	0.	0.84	0.92	1.00
PGSC0003DMC200057982	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2276	1.1e-119	0.64	0.79	1.00
PGSC0003DMC200057985	K10760	ko00908	Zeatin biosynthesis	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMC200057985	K10760	ko01100	Metabolic pathways	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMC200057985	K10760	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMC200003786	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMC200003786	K00517	ko00626	Naphthalene and anthracene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMC200003786	K00517	ko00903	Limonene and pinene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMC200003786	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMC200003786	K00517	ko01110	Biosynthesis of secondary metabolites	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMC200003793	K08505	ko04130	SNARE interactions in vesicular transport	764	2.6e-36	0.68	0.82	0.99
PGSC0003DMC200003795	K02971	ko03010	Ribosome	658	1.9e-30	0.91	0.98	0.99
PGSC0003DMC200003796	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMC200003797	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMC200003798	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMC200003808	K01507	ko00190	Oxidative phosphorylation	812	6.0e-39	0.86	0.93	0.76
PGSC0003DMC200020972	K12356	ko00940	Phenylpropanoid biosynthesis	221	5.5e-06	0.35	0.47	0.52
PGSC0003DMC200020988	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	785	1.8e-37	0.36	0.53	0.87
PGSC0003DMC200020989	K02209	ko03030	DNA replication	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMC200020989	K02209	ko04110	Cell cycle	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMC200020989	K02209	ko04111	Cell cycle - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMC200020989	K02209	ko04113	Meiosis - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMC200020995	K01535	ko00190	Oxidative phosphorylation	6718	0.	0.84	0.92	1.00
PGSC0003DMC200020996	K01535	ko00190	Oxidative phosphorylation	6702	0.	0.84	0.92	1.00
PGSC0003DMC200020997	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMC200020998	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMC200020999	K01535	ko00190	Oxidative phosphorylation	6693	0.	0.84	0.92	1.00
PGSC0003DMC200021000	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMC200029169	K10802	ko03410	Base excision repair	533	1.5e-23	0.48	0.64	0.93
PGSC0003DMC200029178	K03885	ko00190	Oxidative phosphorylation	2389	6.2e-126	0.75	0.86	0.84
PGSC0003DMC200029179	K03885	ko00190	Oxidative phosphorylation	2660	7.0e-141	0.75	0.86	0.98
PGSC0003DMC200029180	K03885	ko00190	Oxidative phosphorylation	2915	6.1e-155	0.75	0.87	1.00
PGSC0003DMC200029181	K03885	ko00190	Oxidative phosphorylation	1087	4.1e-54	0.75	0.87	0.73
PGSC0003DMC200029182	K03885	ko00190	Oxidative phosphorylation	2984	9.5e-159	0.74	0.86	0.89
PGSC0003DMC200029183	K03885	ko00190	Oxidative phosphorylation	453	3.8e-19	0.77	0.88	0.99
PGSC0003DMC200029184	K05752	ko04810	Regulation of actin cytoskeleton	618	3.0e-28	0.90	0.99	0.97
PGSC0003DMC200026383	K05743	ko04360	Axon guidance	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMC200026383	K05743	ko04666	Fc gamma R-mediated phagocytosis	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMC200026383	K05743	ko04810	Regulation of actin cytoskeleton	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMC200026389	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026389	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026390	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMC200026399	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.64
PGSC0003DMC200026400	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.61
PGSC0003DMC200029014	K02084	ko04115	p53 signaling pathway	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko04210	Apoptosis	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko05010	Alzheimer's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko05012	Parkinson's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko05016	Huntington's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029014	K02084	ko05222	Small cell lung cancer	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMC200029023	K12126	ko04712	Circadian rhythm - plant	322	4.3e-11	0.29	0.47	0.68
PGSC0003DMC200029024	K12126	ko04712	Circadian rhythm - plant	322	1.4e-10	0.29	0.47	0.66
PGSC0003DMC200029025	K05275	ko00750	Vitamin B6 metabolism	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMC200029025	K05275	ko01100	Metabolic pathways	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMC200029026	K00100	ko00051	Fructose and mannose metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029026	K00100	ko00363	Bisphenol A degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029026	K00100	ko00591	Linoleic acid metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029026	K00100	ko00625	Tetrachloroethene degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029026	K00100	ko00650	Butanoate metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029026	K00100	ko01100	Metabolic pathways	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMC200029027	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029027	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029027	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029027	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029027	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029027	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029028	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029029	K05275	ko00750	Vitamin B6 metabolism	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMC200029029	K05275	ko01100	Metabolic pathways	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMC200029030	K00100	ko00051	Fructose and mannose metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029030	K00100	ko00363	Bisphenol A degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029030	K00100	ko00591	Linoleic acid metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029030	K00100	ko00625	Tetrachloroethene degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029030	K00100	ko00650	Butanoate metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029030	K00100	ko01100	Metabolic pathways	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko00051	Fructose and mannose metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko00363	Bisphenol A degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko00591	Linoleic acid metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko00625	Tetrachloroethene degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko00650	Butanoate metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029031	K00100	ko01100	Metabolic pathways	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMC200029032	K00100	ko00051	Fructose and mannose metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029032	K00100	ko00363	Bisphenol A degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029032	K00100	ko00591	Linoleic acid metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029032	K00100	ko00625	Tetrachloroethene degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029032	K00100	ko00650	Butanoate metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029032	K00100	ko01100	Metabolic pathways	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMC200029033	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029033	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029033	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029033	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029033	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029033	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMC200029034	K00100	ko00051	Fructose and mannose metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029034	K00100	ko00363	Bisphenol A degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029034	K00100	ko00591	Linoleic acid metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029034	K00100	ko00625	Tetrachloroethene degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029034	K00100	ko00650	Butanoate metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029034	K00100	ko01100	Metabolic pathways	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMC200029035	K12356	ko00940	Phenylpropanoid biosynthesis	642	1.4e-29	0.41	0.59	0.90
PGSC0003DMC200029038	K01007	ko00620	Pyruvate metabolism	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMC200029038	K01007	ko00720	Reductive carboxylate cycle (CO2 fixation)	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMC200029038	K01007	ko01100	Metabolic pathways	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMC200015756	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMC200015757	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMC200015758	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMC200015762	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMC200015763	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMC200015765	K10575	ko04120	Ubiquitin mediated proteolysis	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMC200015765	K10575	ko05012	Parkinson's disease	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMC200015770	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMC200015770	K00517	ko00626	Naphthalene and anthracene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMC200015770	K00517	ko00903	Limonene and pinene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMC200015770	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMC200015770	K00517	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMC200015771	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMC200015771	K00517	ko00626	Naphthalene and anthracene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMC200015771	K00517	ko00903	Limonene and pinene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMC200015771	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMC200015771	K00517	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMC200015774	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMC200015774	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMC200015774	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMC200015775	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMC200015775	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMC200015775	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMC200015776	K03126	ko03022	Basal transcription factors	2276	1.1e-119	0.55	0.66	1.00
PGSC0003DMC200009005	K01509	ko00230	Purine metabolism	1248	5.3e-63	0.32	0.45	0.62
PGSC0003DMC200009006	K01509	ko00230	Purine metabolism	1292	2.0e-65	0.32	0.46	0.63
PGSC0003DMC200009008	K04718	ko00600	Sphingolipid metabolism	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMC200009008	K04718	ko01100	Metabolic pathways	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMC200009008	K04718	ko04020	Calcium signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMC200009008	K04718	ko04370	VEGF signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMC200009008	K04718	ko04666	Fc gamma R-mediated phagocytosis	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMC200009009	K04718	ko00600	Sphingolipid metabolism	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMC200009009	K04718	ko01100	Metabolic pathways	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMC200009009	K04718	ko04020	Calcium signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMC200009009	K04718	ko04370	VEGF signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMC200009009	K04718	ko04666	Fc gamma R-mediated phagocytosis	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMC200009010	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009010	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009010	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009010	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009010	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009011	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009011	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009011	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009011	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009011	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMC200009012	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009012	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009012	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009012	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009012	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009013	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009013	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009013	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009013	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009013	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMC200009017	K13065	ko00940	Phenylpropanoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMC200009017	K13065	ko00941	Flavonoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMC200009017	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMC200009017	K13065	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMC200009020	K13065	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMC200009020	K13065	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMC200009020	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMC200009020	K13065	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMC200009021	K00430	ko00360	Phenylalanine metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMC200009021	K00430	ko00680	Methane metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMC200009021	K00430	ko00940	Phenylpropanoid biosynthesis	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMC200009021	K00430	ko01100	Metabolic pathways	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMC200009021	K00430	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMC200009024	K08695	ko00941	Flavonoid biosynthesis	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMC200009024	K08695	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMC200032801	K00558	ko00270	Cysteine and methionine metabolism	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMC200032801	K00558	ko01100	Metabolic pathways	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMC200032819	K02219	ko04111	Cell cycle - yeast	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMC200032819	K02219	ko05200	Pathways in cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMC200032819	K02219	ko05222	Small cell lung cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMC200046952	K10352	ko04530	Tight junction	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMC200046952	K10352	ko05416	Viral myocarditis	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMC200046964	K04649	ko04120	Ubiquitin mediated proteolysis	1368	1.3e-69	0.82	0.92	0.99
PGSC0003DMC200046965	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.62
PGSC0003DMC200046966	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMC200046967	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMC200046969	K00680	ko00350	Tyrosine metabolism	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMC200046969	K00680	ko00624	1- and 2-Methylnaphthalene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMC200046969	K00680	ko00632	Benzoate degradation via CoA ligation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMC200046969	K00680	ko00642	Ethylbenzene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMC200046969	K00680	ko00903	Limonene and pinene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMC200046971	K02984	ko03010	Ribosome	1973	5.5e-103	0.90	0.95	1.00
PGSC0003DMC200046977	K11097	ko03040	Spliceosome	698	1.2e-32	0.95	0.98	0.99
PGSC0003DMC200046978	K00599	ko00340	Histidine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMC200046978	K00599	ko00350	Tyrosine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMC200046978	K00599	ko00450	Selenoamino acid metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMC200046978	K00599	ko00626	Naphthalene and anthracene degradation	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMC200046979	K00599	ko00340	Histidine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMC200046979	K00599	ko00350	Tyrosine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMC200046979	K00599	ko00450	Selenoamino acid metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMC200046979	K00599	ko00626	Naphthalene and anthracene degradation	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMC200040207	K12874	ko03040	Spliceosome	2349	3.1e-125	0.78	0.83	0.90
PGSC0003DMC200040208	K12874	ko03040	Spliceosome	1236	2.5e-62	0.89	0.94	0.84
PGSC0003DMC200040212	K02138	ko00190	Oxidative phosphorylation	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMC200040212	K02138	ko01100	Metabolic pathways	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMC200040212	K02138	ko05010	Alzheimer's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMC200040212	K02138	ko05012	Parkinson's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMC200040212	K02138	ko05016	Huntington's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMC200040213	K02138	ko00190	Oxidative phosphorylation	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMC200040213	K02138	ko01100	Metabolic pathways	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMC200040213	K02138	ko05010	Alzheimer's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMC200040213	K02138	ko05012	Parkinson's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMC200040213	K02138	ko05016	Huntington's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMC200040214	K02138	ko00190	Oxidative phosphorylation	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMC200040214	K02138	ko01100	Metabolic pathways	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMC200040214	K02138	ko05010	Alzheimer's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMC200040214	K02138	ko05012	Parkinson's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMC200040214	K02138	ko05016	Huntington's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMC200040216	K02084	ko04115	p53 signaling pathway	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko04210	Apoptosis	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko05010	Alzheimer's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko05012	Parkinson's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko05016	Huntington's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040216	K02084	ko05222	Small cell lung cancer	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMC200040220	K10591	ko04120	Ubiquitin mediated proteolysis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMC200040220	K10591	ko04144	Endocytosis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMC200040222	K10591	ko04120	Ubiquitin mediated proteolysis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMC200040222	K10591	ko04144	Endocytosis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMC200057814	K04124	ko00904	Diterpenoid biosynthesis	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMC200057814	K04124	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMC200057815	K02639	ko00195	Photosynthesis	845	9.0e-41	0.71	0.81	0.99
PGSC0003DMC200020011	K12133	ko04712	Circadian rhythm - plant	2050	3.1e-107	0.44	0.55	1.00
PGSC0003DMC200020015	K12130	ko04712	Circadian rhythm - plant	1396	3.7e-71	0.40	0.53	0.96
PGSC0003DMC200020017	K00558	ko00270	Cysteine and methionine metabolism	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMC200020017	K00558	ko01100	Metabolic pathways	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMC200020032	K10527	ko00592	alpha-Linolenic acid metabolism	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMC200020032	K10527	ko01100	Metabolic pathways	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMC200020040	K02971	ko03010	Ribosome	645	9.7e-30	0.89	0.95	0.99
PGSC0003DMC200008134	K01275	ko04142	Lysosome	283	9.9e-10	0.34	0.46	0.77
PGSC0003DMC200008135	K01365	ko04142	Lysosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMC200008135	K01365	ko04145	Phagosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMC200008135	K01365	ko04612	Antigen processing and presentation	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMC200008150	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMC200008151	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMC200008155	K00382	ko00010	Glycolysis / Gluconeogenesis	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko00020	Citrate cycle (TCA cycle)	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko00260	Glycine, serine and threonine metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko00280	Valine, leucine and isoleucine degradation	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko00620	Pyruvate metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko01100	Metabolic pathways	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008155	K00382	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMC200008156	K02945	ko03010	Ribosome	2753	5.2e-146	0.80	0.90	1.00
PGSC0003DMC200013623	K00121	ko00010	Glycolysis / Gluconeogenesis	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00071	Fatty acid metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00350	Tyrosine metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00624	1- and 2-Methylnaphthalene degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00641	3-Chloroacrylic acid degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00680	Methane metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00830	Retinol metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko00982	Drug metabolism - cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko01100	Metabolic pathways	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013623	K00121	ko01110	Biosynthesis of secondary metabolites	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMC200013626	K09553	ko05020	Prion diseases	286	1.4e-09	0.36	0.51	0.65
PGSC0003DMC200013627	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMC200013628	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMC200013629	K06061	ko04330	Notch signaling pathway	337	2.0e-09	0.28	0.42	0.49
PGSC0003DMC200013643	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMC200013644	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMC200013645	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMC200013645	K05288	ko01100	Metabolic pathways	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMC200013648	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMC200013648	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMC200013649	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMC200013649	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMC200023371	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMC200023372	K06675	ko04111	Cell cycle - yeast	329	3.3e-11	0.87	0.89	0.81
PGSC0003DMC200023382	K13065	ko00940	Phenylpropanoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMC200023382	K13065	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMC200023382	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMC200023382	K13065	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMC200023384	K13065	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMC200023384	K13065	ko00941	Flavonoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMC200023384	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMC200023384	K13065	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMC200023389	K12929	ko00904	Diterpenoid biosynthesis	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMC200023389	K12929	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMC200023391	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMC200023391	K00517	ko00626	Naphthalene and anthracene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMC200023391	K00517	ko00903	Limonene and pinene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMC200023391	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMC200023391	K00517	ko01110	Biosynthesis of secondary metabolites	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMC200023392	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMC200023392	K00517	ko00626	Naphthalene and anthracene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMC200023392	K00517	ko00903	Limonene and pinene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMC200023392	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMC200023392	K00517	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMC200023400	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMC200023400	K01915	ko00330	Arginine and proline metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMC200023400	K01915	ko00910	Nitrogen metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMC200023400	K01915	ko01100	Metabolic pathways	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMC200023400	K01915	ko02020	Two-component system	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMC200061868	K02940	ko03010	Ribosome	293	2.5e-10	0.62	0.72	0.65
PGSC0003DMC200061873	K05282	ko00904	Diterpenoid biosynthesis	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMC200061873	K05282	ko01100	Metabolic pathways	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMC200061873	K05282	ko01110	Biosynthesis of secondary metabolites	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMC200048811	K00059	ko00061	Fatty acid biosynthesis	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMC200048811	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMC200048811	K00059	ko01100	Metabolic pathways	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMC200048812	K00059	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMC200048812	K00059	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMC200048812	K00059	ko01100	Metabolic pathways	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMC200048813	K00059	ko00061	Fatty acid biosynthesis	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMC200048813	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMC200048813	K00059	ko01100	Metabolic pathways	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMC200048816	K05868	ko04110	Cell cycle	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMC200048816	K05868	ko04115	p53 signaling pathway	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMC200048816	K05868	ko04914	Progesterone-mediated oocyte maturation	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMC200048817	K05868	ko04110	Cell cycle	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMC200048817	K05868	ko04115	p53 signaling pathway	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMC200048817	K05868	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMC200048819	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMC200048819	K01491	ko00670	One carbon pool by folate	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMC200048819	K01491	ko01100	Metabolic pathways	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMC200048820	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMC200048820	K01491	ko00670	One carbon pool by folate	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMC200048820	K01491	ko01100	Metabolic pathways	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMC200048821	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMC200048821	K01491	ko00670	One carbon pool by folate	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMC200048821	K01491	ko01100	Metabolic pathways	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMC200048827	K08503	ko04130	SNARE interactions in vesicular transport	1180	3.0e-59	0.62	0.81	1.00
PGSC0003DMC200048828	K12828	ko03040	Spliceosome	7426	0.	0.72	0.80	0.98
PGSC0003DMC200048830	K02727	ko03050	Proteasome	2013	3.4e-105	0.95	0.98	1.00
PGSC0003DMC200048832	K10583	ko04120	Ubiquitin mediated proteolysis	632	5.0e-29	0.85	0.93	0.92
PGSC0003DMC200048833	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMC200048834	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMC200048835	K10583	ko04120	Ubiquitin mediated proteolysis	792	7.6e-38	0.67	0.77	0.99
PGSC0003DMC200036947	K10591	ko04120	Ubiquitin mediated proteolysis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMC200036947	K10591	ko04144	Endocytosis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMC200036954	K09480	ko00561	Glycerolipid metabolism	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMC200036954	K09480	ko01100	Metabolic pathways	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMC200036955	K09480	ko00561	Glycerolipid metabolism	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMC200036955	K09480	ko01100	Metabolic pathways	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMC200042440	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMC200042440	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMC200042441	K02717	ko00195	Photosynthesis	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMC200042441	K02717	ko01100	Metabolic pathways	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMC200042442	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMC200042442	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMC200042443	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMC200042444	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMC200042445	K05657	ko02010	ABC transporters	916	1.1e-44	0.38	0.56	0.95
PGSC0003DMC200042448	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMC200060684	K07385	ko00902	Monoterpenoid biosynthesis	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMC200060684	K07385	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMC200018813	K06096	ko04530	Tight junction	288	4.8e-10	0.26	0.45	0.80
PGSC0003DMC200018815	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMC200018816	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMC200018834	K07200	ko04910	Insulin signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMC200018834	K07200	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMC200018834	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMC200018835	K07200	ko04910	Insulin signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMC200018835	K07200	ko04920	Adipocytokine signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMC200018835	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMC200018836	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018836	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018836	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018837	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018837	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018837	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMC200018840	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMC200018840	K03785	ko01100	Metabolic pathways	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMC200018840	K03785	ko01110	Biosynthesis of secondary metabolites	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMC200012421	K04506	ko04115	p53 signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMC200012421	K04506	ko04120	Ubiquitin mediated proteolysis	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMC200012421	K04506	ko04310	Wnt signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMC200012422	K01528	ko04144	Endocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMC200012422	K01528	ko04666	Fc gamma R-mediated phagocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMC200012422	K01528	ko05100	Bacterial invasion of epithelial cells	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMC200012423	K01528	ko04144	Endocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMC200012423	K01528	ko04666	Fc gamma R-mediated phagocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMC200012423	K01528	ko05100	Bacterial invasion of epithelial cells	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMC200012427	K13082	ko00941	Flavonoid biosynthesis	1058	1.6e-52	0.44	0.63	0.97
PGSC0003DMC200012428	K08679	ko00500	Starch and sucrose metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMC200012428	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMC200012428	K08679	ko01100	Metabolic pathways	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMC200012429	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMC200012429	K00800	ko01100	Metabolic pathways	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMC200012429	K00800	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMC200012430	K00615	ko00030	Pentose phosphate pathway	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMC200012430	K00615	ko00710	Carbon fixation in photosynthetic organisms	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMC200012430	K00615	ko01051	Biosynthesis of ansamycins	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMC200012430	K00615	ko01100	Metabolic pathways	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMC200012430	K00615	ko01110	Biosynthesis of secondary metabolites	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMC200012431	K10870	ko03440	Homologous recombination	1117	9.0e-56	0.46	0.66	0.91
PGSC0003DMC200012437	K06636	ko04110	Cell cycle	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMC200012437	K06636	ko04111	Cell cycle - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMC200012437	K06636	ko04113	Meiosis - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMC200012437	K06636	ko04114	Oocyte meiosis	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMC200012444	K01178	ko00500	Starch and sucrose metabolism	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMC200012444	K01178	ko01100	Metabolic pathways	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMC200006931	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006931	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006932	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006932	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006933	K10144	ko04115	p53 signaling pathway	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMC200006933	K10144	ko04120	Ubiquitin mediated proteolysis	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMC200006934	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006934	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMC200006936	K00889	ko00562	Inositol phosphate metabolism	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006936	K00889	ko01100	Metabolic pathways	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006936	K00889	ko04070	Phosphatidylinositol signaling system	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006936	K00889	ko04144	Endocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006936	K00889	ko04666	Fc gamma R-mediated phagocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006936	K00889	ko04810	Regulation of actin cytoskeleton	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMC200006937	K00889	ko00562	Inositol phosphate metabolism	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006937	K00889	ko01100	Metabolic pathways	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006937	K00889	ko04070	Phosphatidylinositol signaling system	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006937	K00889	ko04144	Endocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006937	K00889	ko04666	Fc gamma R-mediated phagocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006937	K00889	ko04810	Regulation of actin cytoskeleton	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMC200006938	K00889	ko00562	Inositol phosphate metabolism	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006938	K00889	ko01100	Metabolic pathways	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006938	K00889	ko04070	Phosphatidylinositol signaling system	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006938	K00889	ko04144	Endocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006938	K00889	ko04666	Fc gamma R-mediated phagocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006938	K00889	ko04810	Regulation of actin cytoskeleton	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMC200006939	K00889	ko00562	Inositol phosphate metabolism	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006939	K00889	ko01100	Metabolic pathways	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006939	K00889	ko04070	Phosphatidylinositol signaling system	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006939	K00889	ko04144	Endocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006939	K00889	ko04666	Fc gamma R-mediated phagocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006939	K00889	ko04810	Regulation of actin cytoskeleton	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMC200006948	K10603	ko04120	Ubiquitin mediated proteolysis	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMC200006948	K10603	ko05340	Primary immunodeficiency	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMC200006950	K10603	ko04120	Ubiquitin mediated proteolysis	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMC200006950	K10603	ko05340	Primary immunodeficiency	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMC200006952	K10603	ko04120	Ubiquitin mediated proteolysis	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMC200006952	K10603	ko05340	Primary immunodeficiency	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMC200006954	K10352	ko04530	Tight junction	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMC200006954	K10352	ko05416	Viral myocarditis	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMC200006957	K10527	ko00592	alpha-Linolenic acid metabolism	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMC200006957	K10527	ko01100	Metabolic pathways	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMC200006958	K10527	ko00592	alpha-Linolenic acid metabolism	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMC200006958	K10527	ko01100	Metabolic pathways	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMC200006959	K10527	ko00592	alpha-Linolenic acid metabolism	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMC200006959	K10527	ko01100	Metabolic pathways	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMC200050032	K03707	ko00730	Thiamine metabolism	342	5.0e-13	0.40	0.55	0.30
PGSC0003DMC200050033	K03707	ko00730	Thiamine metabolism	473	3.0e-20	0.38	0.52	0.37
PGSC0003DMC200050039	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMC200050040	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMC200043624	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043624	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043624	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043624	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043624	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043624	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043625	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMC200043627	K00754	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.34	0.52	0.81
PGSC0003DMC200043628	K00754	ko00051	Fructose and mannose metabolism	1418	2.2e-72	0.41	0.59	0.88
PGSC0003DMC200043629	K00754	ko00051	Fructose and mannose metabolism	377	5.9e-15	0.48	0.67	0.95
PGSC0003DMC200043630	K07198	ko04140	Regulation of autophagy	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMC200043630	K07198	ko04150	mTOR signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMC200043630	K07198	ko04910	Insulin signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMC200043630	K07198	ko04920	Adipocytokine signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMC200043630	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMC200043637	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMC200043639	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMC200043642	K12741	ko03040	Spliceosome	336	1.1e-12	0.35	0.41	0.85
PGSC0003DMC200038137	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3012	2.7e-160	0.59	0.79	1.00
PGSC0003DMC200038138	K03660	ko03410	Base excision repair	880	1.1e-42	0.47	0.63	0.76
PGSC0003DMC200038142	K09843	ko00906	Carotenoid biosynthesis	442	1.5e-18	0.33	0.49	0.97
PGSC0003DMC200038152	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMC200038152	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMC200038153	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMC200038153	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMC200038154	K04103	ko00380	Tryptophan metabolism	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMC200038154	K04103	ko01100	Metabolic pathways	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMC200038155	K04103	ko00380	Tryptophan metabolism	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMC200038155	K04103	ko01100	Metabolic pathways	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMC200053371	K08241	ko00592	alpha-Linolenic acid metabolism	751	1.4e-35	0.35	0.52	0.89
PGSC0003DMC200053372	K08241	ko00592	alpha-Linolenic acid metabolism	390	1.1e-15	0.35	0.52	0.84
PGSC0003DMC200053377	K01358	ko04112	Cell cycle - Caulobacter	451	4.9e-19	0.63	0.74	0.99
PGSC0003DMC200053378	K01358	ko04112	Cell cycle - Caulobacter	467	6.4e-20	0.91	0.98	0.82
PGSC0003DMC200053379	K01358	ko04112	Cell cycle - Caulobacter	1776	4.0e-92	0.66	0.80	1.00
PGSC0003DMC200053382	K00868	ko00750	Vitamin B6 metabolism	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMC200053382	K00868	ko01100	Metabolic pathways	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMC200053383	K00868	ko00750	Vitamin B6 metabolism	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMC200053383	K00868	ko01100	Metabolic pathways	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMC200053392	K08332	ko04140	Regulation of autophagy	322	9.7e-12	0.27	0.47	0.96
PGSC0003DMC200053395	K02183	ko04020	Calcium signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04070	Phosphatidylinositol signaling system	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04114	Oocyte meiosis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04626	Plant-pathogen interaction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04720	Long-term potentiation	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04722	Neurotrophin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04740	Olfactory transduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04744	Phototransduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04745	Phototransduction - fly	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04910	Insulin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04912	GnRH signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04916	Melanogenesis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04970	Salivary secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko04971	Gastric acid secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko05010	Alzheimer's disease	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053395	K02183	ko05214	Glioma	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMC200053396	K00847	ko00051	Fructose and mannose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMC200053396	K00847	ko00500	Starch and sucrose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMC200053396	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMC200053396	K00847	ko01100	Metabolic pathways	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMC200053397	K00847	ko00051	Fructose and mannose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMC200053397	K00847	ko00500	Starch and sucrose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMC200053397	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMC200053397	K00847	ko01100	Metabolic pathways	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMC200068530	K03469	ko03030	DNA replication	253	4.0e-08	0.39	0.58	0.60
PGSC0003DMC200068538	K03006	ko00230	Purine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMC200068538	K03006	ko00240	Pyrimidine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMC200068538	K03006	ko01100	Metabolic pathways	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMC200068538	K03006	ko03020	RNA polymerase	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMC200068538	K03006	ko05016	Huntington's disease	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMC200064489	K06678	ko04111	Cell cycle - yeast	310	1.3e-07	0.26	0.47	0.40
PGSC0003DMC200027815	K10839	ko03420	Nucleotide excision repair	2574	3.9e-136	0.75	0.85	1.00
PGSC0003DMC200027819	K03456	ko04111	Cell cycle - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04113	Meiosis - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04114	Oocyte meiosis	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04310	Wnt signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04350	TGF-beta signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04530	Tight junction	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko04730	Long-term depression	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027819	K03456	ko05142	Chagas disease	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMC200027820	K03456	ko04111	Cell cycle - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04113	Meiosis - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04114	Oocyte meiosis	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04310	Wnt signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04350	TGF-beta signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04530	Tight junction	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko04730	Long-term depression	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027820	K03456	ko05142	Chagas disease	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMC200027821	K03456	ko04111	Cell cycle - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04113	Meiosis - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04114	Oocyte meiosis	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04310	Wnt signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04350	TGF-beta signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04530	Tight junction	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko04730	Long-term depression	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027821	K03456	ko05142	Chagas disease	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMC200027822	K03456	ko04111	Cell cycle - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04113	Meiosis - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04114	Oocyte meiosis	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04310	Wnt signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04350	TGF-beta signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04530	Tight junction	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko04730	Long-term depression	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027822	K03456	ko05142	Chagas disease	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMC200027823	K03456	ko04111	Cell cycle - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04113	Meiosis - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04114	Oocyte meiosis	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04310	Wnt signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04350	TGF-beta signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04530	Tight junction	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko04730	Long-term depression	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027823	K03456	ko05142	Chagas disease	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMC200027824	K03456	ko04111	Cell cycle - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04113	Meiosis - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04114	Oocyte meiosis	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04310	Wnt signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04350	TGF-beta signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04530	Tight junction	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko04730	Long-term depression	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027824	K03456	ko05142	Chagas disease	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMC200027836	K01187	ko00052	Galactose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMC200027836	K01187	ko00500	Starch and sucrose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMC200027836	K01187	ko01100	Metabolic pathways	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMC200010205	K02183	ko04020	Calcium signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04070	Phosphatidylinositol signaling system	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04114	Oocyte meiosis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04626	Plant-pathogen interaction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04720	Long-term potentiation	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04740	Olfactory transduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04744	Phototransduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04745	Phototransduction - fly	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04910	Insulin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04912	GnRH signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04916	Melanogenesis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04970	Salivary secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko04971	Gastric acid secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko05010	Alzheimer's disease	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010205	K02183	ko05214	Glioma	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMC200010206	K12831	ko03040	Spliceosome	1407	9.1e-72	0.69	0.77	0.99
PGSC0003DMC200010207	K12831	ko03040	Spliceosome	2591	4.5e-137	0.79	0.85	0.99
PGSC0003DMC200010210	K05929	ko00564	Glycerophospholipid metabolism	611	7.3e-28	0.41	0.57	0.99
PGSC0003DMC200010211	K05929	ko00564	Glycerophospholipid metabolism	741	4.9e-35	0.41	0.59	0.51
PGSC0003DMC200010212	K00599	ko00340	Histidine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMC200010212	K00599	ko00350	Tyrosine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMC200010212	K00599	ko00450	Selenoamino acid metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMC200010212	K00599	ko00626	Naphthalene and anthracene degradation	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMC200010215	K01613	ko00564	Glycerophospholipid metabolism	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMC200010215	K01613	ko01100	Metabolic pathways	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMC200010218	K01426	ko00330	Arginine and proline metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010218	K01426	ko00360	Phenylalanine metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010218	K01426	ko00380	Tryptophan metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010218	K01426	ko00460	Cyanoamino acid metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010218	K01426	ko00632	Benzoate degradation via CoA ligation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010218	K01426	ko00643	Styrene degradation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMC200010221	K01785	ko00010	Glycolysis / Gluconeogenesis	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMC200010221	K01785	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMC200010222	K01785	ko00010	Glycolysis / Gluconeogenesis	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMC200010222	K01785	ko01110	Biosynthesis of secondary metabolites	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMC200010223	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko00363	Bisphenol A degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko00624	1- and 2-Methylnaphthalene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko00626	Naphthalene and anthracene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko00632	Benzoate degradation via CoA ligation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko00903	Limonene and pinene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko01100	Metabolic pathways	7384	0.	0.66	0.78	0.99
PGSC0003DMC200010223	K00120	ko01110	Biosynthesis of secondary metabolites	7384	0.	0.66	0.78	0.99
PGSC0003DMC200016954	K01915	ko00250	Alanine, aspartate and glutamate metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMC200016954	K01915	ko00330	Arginine and proline metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMC200016954	K01915	ko00910	Nitrogen metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMC200016954	K01915	ko01100	Metabolic pathways	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMC200016954	K01915	ko02020	Two-component system	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMC200016957	K01115	ko00564	Glycerophospholipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016957	K01115	ko00565	Ether lipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016957	K01115	ko01100	Metabolic pathways	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016957	K01115	ko04144	Endocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016957	K01115	ko04666	Fc gamma R-mediated phagocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016957	K01115	ko04912	GnRH signaling pathway	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMC200016958	K01115	ko00564	Glycerophospholipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016958	K01115	ko00565	Ether lipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016958	K01115	ko01100	Metabolic pathways	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016958	K01115	ko04144	Endocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016958	K01115	ko04666	Fc gamma R-mediated phagocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016958	K01115	ko04912	GnRH signaling pathway	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko00564	Glycerophospholipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko00565	Ether lipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko01100	Metabolic pathways	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko04144	Endocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko04666	Fc gamma R-mediated phagocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016959	K01115	ko04912	GnRH signaling pathway	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMC200016960	K01115	ko00564	Glycerophospholipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016960	K01115	ko00565	Ether lipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016960	K01115	ko01100	Metabolic pathways	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016960	K01115	ko04144	Endocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016960	K01115	ko04666	Fc gamma R-mediated phagocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016960	K01115	ko04912	GnRH signaling pathway	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMC200016961	K10260	ko04120	Ubiquitin mediated proteolysis	327	3.4e-12	0.28	0.43	0.72
PGSC0003DMC200016962	K01759	ko00620	Pyruvate metabolism	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMC200016962	K01759	ko04011	MAPK signaling pathway - yeast	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMC200016965	K01179	ko00500	Starch and sucrose metabolism	306	3.0e-08	0.25	0.42	0.65
PGSC0003DMC200016966	K00894	ko00564	Glycerophospholipid metabolism	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMC200016966	K00894	ko01100	Metabolic pathways	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMC200016967	K00894	ko00564	Glycerophospholipid metabolism	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMC200016967	K00894	ko01100	Metabolic pathways	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMC200016968	K00894	ko00564	Glycerophospholipid metabolism	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMC200016968	K00894	ko01100	Metabolic pathways	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMC200016969	K00894	ko00564	Glycerophospholipid metabolism	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMC200016969	K00894	ko01100	Metabolic pathways	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMC200056372	K12655	ko04622	RIG-I-like receptor signaling pathway	292	5.5e-10	0.33	0.55	0.49
PGSC0003DMC200056375	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056375	K01652	ko00650	Butanoate metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056375	K01652	ko00660	C5-Branched dibasic acid metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056375	K01652	ko00770	Pantothenate and CoA biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056375	K01652	ko01100	Metabolic pathways	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056375	K01652	ko01110	Biosynthesis of secondary metabolites	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMC200056381	K12467	ko00902	Monoterpenoid biosynthesis	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMC200056381	K12467	ko01110	Biosynthesis of secondary metabolites	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMC200056382	K12929	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMC200056382	K12929	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMC200056384	K02112	ko00190	Oxidative phosphorylation	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMC200056384	K02112	ko00195	Photosynthesis	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMC200056384	K02112	ko01100	Metabolic pathways	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMC200056389	K07385	ko00902	Monoterpenoid biosynthesis	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMC200056389	K07385	ko01100	Metabolic pathways	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMC200056390	K03064	ko03050	Proteasome	306	4.8e-11	0.82	0.95	0.60
PGSC0003DMC200056392	K03064	ko03050	Proteasome	324	4.9e-12	0.87	0.91	0.74
PGSC0003DMC200039009	K04424	ko04010	MAPK signaling pathway	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMC200039009	K04424	ko04530	Tight junction	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMC200039010	K01520	ko00240	Pyrimidine metabolism	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMC200039010	K01520	ko01100	Metabolic pathways	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMC200039011	K01738	ko00270	Cysteine and methionine metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMC200039011	K01738	ko00450	Selenoamino acid metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMC200039011	K01738	ko00920	Sulfur metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMC200039011	K01738	ko01100	Metabolic pathways	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMC200039012	K01738	ko00270	Cysteine and methionine metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMC200039012	K01738	ko00450	Selenoamino acid metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMC200039012	K01738	ko00920	Sulfur metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMC200039012	K01738	ko01100	Metabolic pathways	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMC200039013	K01738	ko00270	Cysteine and methionine metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMC200039013	K01738	ko00450	Selenoamino acid metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMC200039013	K01738	ko00920	Sulfur metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMC200039013	K01738	ko01100	Metabolic pathways	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMC200039014	K01738	ko00270	Cysteine and methionine metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMC200039014	K01738	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMC200039014	K01738	ko00920	Sulfur metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMC200039014	K01738	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMC200039015	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039015	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039015	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039015	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039016	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039016	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039016	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039016	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMC200039017	K01738	ko00270	Cysteine and methionine metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMC200039017	K01738	ko00450	Selenoamino acid metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMC200039017	K01738	ko00920	Sulfur metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMC200039017	K01738	ko01100	Metabolic pathways	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMC200039018	K01738	ko00270	Cysteine and methionine metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMC200039018	K01738	ko00450	Selenoamino acid metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMC200039018	K01738	ko00920	Sulfur metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMC200039018	K01738	ko01100	Metabolic pathways	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMC200039023	K02974	ko03010	Ribosome	883	7.2e-43	0.88	0.90	0.37
PGSC0003DMC200039024	K01487	ko00230	Purine metabolism	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMC200039024	K01487	ko01100	Metabolic pathways	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMC200039025	K12132	ko04712	Circadian rhythm - plant	911	2.1e-44	0.42	0.59	1.00
PGSC0003DMC200039026	K12132	ko04712	Circadian rhythm - plant	3753	3.7e-201	0.63	0.75	1.00
PGSC0003DMC200039027	K12132	ko04712	Circadian rhythm - plant	2200	1.7e-115	0.53	0.68	1.00
PGSC0003DMC200039029	K01808	ko00030	Pentose phosphate pathway	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMC200039029	K01808	ko00710	Carbon fixation in photosynthetic organisms	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMC200039029	K01808	ko01100	Metabolic pathways	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMC200039029	K01808	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMC200039030	K01092	ko00521	Streptomycin biosynthesis	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMC200039030	K01092	ko00562	Inositol phosphate metabolism	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMC200039030	K01092	ko01100	Metabolic pathways	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMC200039030	K01092	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMC200039030	K01092	ko04070	Phosphatidylinositol signaling system	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMC200045753	K02326	ko00230	Purine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045753	K02326	ko00240	Pyrimidine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045753	K02326	ko01100	Metabolic pathways	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045753	K02326	ko03030	DNA replication	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045753	K02326	ko03410	Base excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045753	K02326	ko03420	Nucleotide excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMC200045755	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.34	0.55	0.79
PGSC0003DMC200045756	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.55	0.88
PGSC0003DMC200045757	K01199	ko00500	Starch and sucrose metabolism	620	2.3e-28	0.35	0.54	0.87
PGSC0003DMC200045758	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMC200045759	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMC200045760	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMC200045761	K02865	ko03010	Ribosome	1581	2.3e-81	0.88	0.94	1.00
PGSC0003DMC200045762	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMC200045763	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMC200045773	K13065	ko00940	Phenylpropanoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMC200045773	K13065	ko00941	Flavonoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMC200045773	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMC200045773	K13065	ko01110	Biosynthesis of secondary metabolites	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMC200045774	K13065	ko00940	Phenylpropanoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMC200045774	K13065	ko00941	Flavonoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMC200045774	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMC200045774	K13065	ko01110	Biosynthesis of secondary metabolites	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMC200059016	K10591	ko04120	Ubiquitin mediated proteolysis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMC200059016	K10591	ko04144	Endocytosis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMC200059039	K11251	ko05322	Systemic lupus erythematosus	629	7.4e-29	0.63	0.77	0.92
PGSC0003DMC200047763	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMC200047763	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMC200047763	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMC200047763	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMC200047765	K10757	ko00944	Flavone and flavonol biosynthesis	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMC200047765	K10757	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMC200047765	K10757	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMC200047771	K03660	ko03410	Base excision repair	586	1.7e-26	0.34	0.52	0.91
PGSC0003DMC200047772	K04733	ko04210	Apoptosis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMC200047772	K04733	ko04620	Toll-like receptor signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMC200047772	K04733	ko04722	Neurotrophin signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMC200047772	K04733	ko05140	Leishmaniasis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMC200047772	K04733	ko05142	Chagas disease	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMC200047774	K03660	ko03410	Base excision repair	309	1.6e-10	0.39	0.51	0.58
PGSC0003DMC200047775	K10956	ko03060	Protein export	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMC200047775	K10956	ko04145	Phagosome	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMC200047775	K10956	ko05110	Vibrio cholerae infection	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMC200047776	K10956	ko03060	Protein export	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMC200047776	K10956	ko04145	Phagosome	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMC200047776	K10956	ko05110	Vibrio cholerae infection	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMC200047781	K12135	ko04712	Circadian rhythm - plant	450	5.5e-19	0.31	0.49	0.59
PGSC0003DMC200047783	K01805	ko00040	Pentose and glucuronate interconversions	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMC200047783	K01805	ko00051	Fructose and mannose metabolism	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMC200047783	K01805	ko01100	Metabolic pathways	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMC200031812	K02343	ko00230	Purine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031812	K02343	ko00240	Pyrimidine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031812	K02343	ko01100	Metabolic pathways	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031812	K02343	ko03030	DNA replication	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031812	K02343	ko03430	Mismatch repair	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031812	K02343	ko03440	Homologous recombination	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMC200031813	K01892	ko00970	Aminoacyl-tRNA biosynthesis	3949	5.7e-212	0.59	0.74	0.99
PGSC0003DMC200031816	K04733	ko04210	Apoptosis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMC200031816	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMC200031816	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMC200031816	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMC200031816	K04733	ko05142	Chagas disease	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMC200031826	K01800	ko00350	Tyrosine metabolism	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMC200031826	K01800	ko00643	Styrene degradation	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMC200031826	K01800	ko01100	Metabolic pathways	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMC200049354	K06630	ko04110	Cell cycle	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMC200049354	K06630	ko04114	Oocyte meiosis	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMC200049354	K06630	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMC200049355	K06630	ko04110	Cell cycle	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMC200049355	K06630	ko04114	Oocyte meiosis	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMC200049355	K06630	ko04722	Neurotrophin signaling pathway	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMC200049363	K12605	ko03018	RNA degradation	925	3.5e-45	0.40	0.60	0.90
PGSC0003DMC200049364	K12605	ko03018	RNA degradation	683	7.8e-32	0.47	0.66	0.96
PGSC0003DMC200049369	K00688	ko00500	Starch and sucrose metabolism	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMC200049369	K00688	ko04910	Insulin signaling pathway	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMC200049370	K00688	ko00500	Starch and sucrose metabolism	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMC200049370	K00688	ko04910	Insulin signaling pathway	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMC200049371	K00688	ko00500	Starch and sucrose metabolism	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMC200049371	K00688	ko04910	Insulin signaling pathway	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMC200049372	K00688	ko00500	Starch and sucrose metabolism	6170	0.	0.75	0.87	0.99
PGSC0003DMC200049372	K00688	ko04910	Insulin signaling pathway	6170	0.	0.75	0.87	0.99
PGSC0003DMC200055021	K01051	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMC200055021	K01051	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMC200055021	K01051	ko01100	Metabolic pathways	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMC200055022	K01179	ko00500	Starch and sucrose metabolism	2420	1.2e-127	0.60	0.74	0.95
PGSC0003DMC200055028	K02885	ko03010	Ribosome	1619	1.8e-83	0.90	0.93	1.00
PGSC0003DMC200055029	K01213	ko00040	Pentose and glucuronate interconversions	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMC200055029	K01213	ko00500	Starch and sucrose metabolism	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMC200055029	K01213	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMC200055030	K01213	ko00040	Pentose and glucuronate interconversions	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMC200055030	K01213	ko00500	Starch and sucrose metabolism	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMC200055030	K01213	ko01100	Metabolic pathways	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMC200055031	K01213	ko00040	Pentose and glucuronate interconversions	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMC200055031	K01213	ko00500	Starch and sucrose metabolism	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMC200055031	K01213	ko01100	Metabolic pathways	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMC200055035	K08489	ko04130	SNARE interactions in vesicular transport	1549	1.3e-79	0.67	0.80	0.88
PGSC0003DMC200055036	K08489	ko04130	SNARE interactions in vesicular transport	1783	1.7e-92	0.69	0.82	1.00
PGSC0003DMC200055045	K01897	ko00071	Fatty acid metabolism	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMC200055045	K01897	ko01100	Metabolic pathways	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMC200055045	K01897	ko03320	PPAR signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMC200055045	K01897	ko04146	Peroxisome	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMC200055045	K01897	ko04920	Adipocytokine signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMC200055046	K01897	ko00071	Fatty acid metabolism	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMC200055046	K01897	ko01100	Metabolic pathways	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMC200055046	K01897	ko03320	PPAR signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMC200055046	K01897	ko04146	Peroxisome	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMC200055046	K01897	ko04920	Adipocytokine signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMC200035667	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.97
PGSC0003DMC200035669	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.93
PGSC0003DMC200066892	K12338	ko00942	Anthocyanin biosynthesis	641	1.6e-29	0.35	0.51	0.96
PGSC0003DMC200018154	K01115	ko00564	Glycerophospholipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018154	K01115	ko00565	Ether lipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018154	K01115	ko01100	Metabolic pathways	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018154	K01115	ko04144	Endocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018154	K01115	ko04666	Fc gamma R-mediated phagocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018154	K01115	ko04912	GnRH signaling pathway	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMC200018155	K00847	ko00051	Fructose and mannose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMC200018155	K00847	ko00500	Starch and sucrose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMC200018155	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMC200018155	K00847	ko01100	Metabolic pathways	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMC200018156	K00847	ko00051	Fructose and mannose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMC200018156	K00847	ko00500	Starch and sucrose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMC200018156	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMC200018156	K00847	ko01100	Metabolic pathways	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMC200018158	K09480	ko00561	Glycerolipid metabolism	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMC200018158	K09480	ko01100	Metabolic pathways	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMC200018159	K09480	ko00561	Glycerolipid metabolism	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMC200018159	K09480	ko01100	Metabolic pathways	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMC200018160	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMC200018161	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMC200018164	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018164	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018165	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMC200018166	K04424	ko04010	MAPK signaling pathway	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMC200018166	K04424	ko04530	Tight junction	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMC200018167	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMC200018167	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMC200018168	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMC200018168	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMC200018169	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMC200018169	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMC200018169	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMC200018170	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.60	0.73	0.97
PGSC0003DMC200018180	K02875	ko03010	Ribosome	1015	3.8e-50	0.89	0.95	0.99
PGSC0003DMC200026221	K09587	ko00905	Brassinosteroid biosynthesis	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMC200026221	K09587	ko01100	Metabolic pathways	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMC200026221	K09587	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMC200026222	K09587	ko00905	Brassinosteroid biosynthesis	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMC200026222	K09587	ko01100	Metabolic pathways	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMC200026222	K09587	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMC200026223	K09587	ko00905	Brassinosteroid biosynthesis	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMC200026223	K09587	ko01100	Metabolic pathways	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMC200026223	K09587	ko01110	Biosynthesis of secondary metabolites	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMC200026224	K09587	ko00905	Brassinosteroid biosynthesis	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMC200026224	K09587	ko01100	Metabolic pathways	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMC200026224	K09587	ko01110	Biosynthesis of secondary metabolites	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMC200026227	K03124	ko03022	Basal transcription factors	2146	1.6e-112	0.78	0.87	0.77
PGSC0003DMC200026231	K01228	ko00510	N-Glycan biosynthesis	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMC200026231	K01228	ko01100	Metabolic pathways	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMC200026232	K01228	ko00510	N-Glycan biosynthesis	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMC200026232	K01228	ko01100	Metabolic pathways	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMC200026233	K01228	ko00510	N-Glycan biosynthesis	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMC200026233	K01228	ko01100	Metabolic pathways	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMC200026234	K01228	ko00510	N-Glycan biosynthesis	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMC200026234	K01228	ko01100	Metabolic pathways	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMC200026235	K01199	ko00500	Starch and sucrose metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMC200026236	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMC200026237	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMC200026238	K01199	ko00500	Starch and sucrose metabolism	629	7.4e-29	0.32	0.53	0.71
PGSC0003DMC200052023	K01757	ko00901	Indole alkaloid biosynthesis	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMC200052023	K01757	ko01100	Metabolic pathways	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMC200052023	K01757	ko01110	Biosynthesis of secondary metabolites	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMC200052037	K11086	ko03040	Spliceosome	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMC200052037	K11086	ko05322	Systemic lupus erythematosus	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMC200052038	K00819	ko00330	Arginine and proline metabolism	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMC200052038	K00819	ko01100	Metabolic pathways	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMC200052038	K00819	ko01110	Biosynthesis of secondary metabolites	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMC200052039	K00819	ko00330	Arginine and proline metabolism	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMC200052039	K00819	ko01100	Metabolic pathways	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMC200052039	K00819	ko01110	Biosynthesis of secondary metabolites	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMC200033331	K00368	ko00910	Nitrogen metabolism	1661	8.9e-86	0.44	0.59	0.89
PGSC0003DMC200033332	K05278	ko00941	Flavonoid biosynthesis	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMC200033332	K05278	ko01100	Metabolic pathways	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMC200033332	K05278	ko01110	Biosynthesis of secondary metabolites	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMC200033333	K02728	ko03050	Proteasome	1859	1.1e-96	0.88	0.96	1.00
PGSC0003DMC200033335	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033335	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033335	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033336	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033336	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033336	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033337	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033337	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033337	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMC200033338	K03841	ko00010	Glycolysis / Gluconeogenesis	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko00030	Pentose phosphate pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko00051	Fructose and mannose metabolism	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko00710	Carbon fixation in photosynthetic organisms	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko01100	Metabolic pathways	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko01110	Biosynthesis of secondary metabolites	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033338	K03841	ko04910	Insulin signaling pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMC200033339	K03841	ko00010	Glycolysis / Gluconeogenesis	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko00030	Pentose phosphate pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko00051	Fructose and mannose metabolism	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko00710	Carbon fixation in photosynthetic organisms	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko01100	Metabolic pathways	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko01110	Biosynthesis of secondary metabolites	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033339	K03841	ko04910	Insulin signaling pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMC200033340	K04714	ko00600	Sphingolipid metabolism	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMC200033340	K04714	ko01100	Metabolic pathways	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMC200033341	K04714	ko00600	Sphingolipid metabolism	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMC200033341	K04714	ko01100	Metabolic pathways	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMC200033351	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMC200033351	K08081	ko01100	Metabolic pathways	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMC200033351	K08081	ko01110	Biosynthesis of secondary metabolites	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMC200033352	K01051	ko00040	Pentose and glucuronate interconversions	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMC200033352	K01051	ko00500	Starch and sucrose metabolism	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMC200033352	K01051	ko01100	Metabolic pathways	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMC200033353	K01051	ko00040	Pentose and glucuronate interconversions	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMC200033353	K01051	ko00500	Starch and sucrose metabolism	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMC200033353	K01051	ko01100	Metabolic pathways	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMC200033356	K12343	ko00140	Steroid hormone biosynthesis	1319	6.5e-67	0.64	0.78	1.00
PGSC0003DMC200033357	K11866	ko04144	Endocytosis	429	4.4e-17	0.37	0.54	0.76
PGSC0003DMC200033358	K11866	ko04144	Endocytosis	653	8.3e-30	0.31	0.47	0.84
PGSC0003DMC200033359	K11866	ko04144	Endocytosis	541	2.1e-23	0.31	0.47	0.94
PGSC0003DMC200058356	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMC200058356	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMC200058356	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMC200058370	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMC200058370	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMC200058370	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMC200058370	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMC200058370	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMC200045215	K01879	ko00970	Aminoacyl-tRNA biosynthesis	5673	0.	0.71	0.84	0.98
PGSC0003DMC200045216	K01879	ko00970	Aminoacyl-tRNA biosynthesis	4120	2.1e-221	0.67	0.83	1.00
PGSC0003DMC200045217	K01879	ko00970	Aminoacyl-tRNA biosynthesis	6292	0.	0.70	0.83	1.00
PGSC0003DMC200045219	K05278	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMC200045219	K05278	ko01100	Metabolic pathways	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMC200045219	K05278	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMC200045226	K06685	ko04111	Cell cycle - yeast	356	8.6e-11	0.31	0.47	0.52
PGSC0003DMC200045227	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMC200045228	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMC200045229	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMC200045230	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMC200045236	K00680	ko00350	Tyrosine metabolism	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMC200045236	K00680	ko00624	1- and 2-Methylnaphthalene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMC200045236	K00680	ko00632	Benzoate degradation via CoA ligation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMC200045236	K00680	ko00642	Ethylbenzene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMC200045236	K00680	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMC200062859	K06627	ko04110	Cell cycle	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMC200062859	K06627	ko04914	Progesterone-mediated oocyte maturation	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMC200062861	K11251	ko05322	Systemic lupus erythematosus	694	1.9e-32	0.69	0.80	0.94
PGSC0003DMC200062864	K05681	ko02010	ABC transporters	301	2.6e-10	0.59	0.73	0.78
PGSC0003DMC200062880	K05282	ko00904	Diterpenoid biosynthesis	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMC200062880	K05282	ko01100	Metabolic pathways	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMC200062880	K05282	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMC200002199	K01692	ko00071	Fatty acid metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00280	Valine, leucine and isoleucine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00281	Geraniol degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00310	Lysine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00380	Tryptophan metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00410	beta-Alanine metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00632	Benzoate degradation via CoA ligation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00640	Propanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00650	Butanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00903	Limonene and pinene degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko00930	Caprolactam degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko01100	Metabolic pathways	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002199	K01692	ko01110	Biosynthesis of secondary metabolites	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMC200002202	K05350	ko00460	Cyanoamino acid metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMC200002202	K05350	ko00500	Starch and sucrose metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMC200002202	K05350	ko00940	Phenylpropanoid biosynthesis	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMC200002202	K05350	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMC200002203	K05350	ko00460	Cyanoamino acid metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMC200002203	K05350	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMC200002203	K05350	ko00940	Phenylpropanoid biosynthesis	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMC200002203	K05350	ko01110	Biosynthesis of secondary metabolites	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMC200002207	K06630	ko04110	Cell cycle	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMC200002207	K06630	ko04114	Oocyte meiosis	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMC200002207	K06630	ko04722	Neurotrophin signaling pathway	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMC200023239	K00889	ko00562	Inositol phosphate metabolism	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023239	K00889	ko01100	Metabolic pathways	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023239	K00889	ko04070	Phosphatidylinositol signaling system	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023239	K00889	ko04144	Endocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023239	K00889	ko04666	Fc gamma R-mediated phagocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023239	K00889	ko04810	Regulation of actin cytoskeleton	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMC200023240	K00889	ko00562	Inositol phosphate metabolism	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023240	K00889	ko01100	Metabolic pathways	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023240	K00889	ko04070	Phosphatidylinositol signaling system	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023240	K00889	ko04144	Endocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023240	K00889	ko04666	Fc gamma R-mediated phagocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023240	K00889	ko04810	Regulation of actin cytoskeleton	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMC200023242	K02921	ko03010	Ribosome	551	1.5e-24	1.00	1.00	0.98
PGSC0003DMC200023243	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMC200004560	K00812	ko00250	Alanine, aspartate and glutamate metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00270	Cysteine and methionine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00330	Arginine and proline metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00350	Tyrosine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00360	Phenylalanine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00401	Novobiocin biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00710	Carbon fixation in photosynthetic organisms	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00950	Isoquinoline alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko01100	Metabolic pathways	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200004560	K00812	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMC200008581	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMC200008581	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMC200008581	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMC200008581	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMC200008582	K01112	ko00051	Fructose and mannose metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMC200008582	K01112	ko00730	Thiamine metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMC200008582	K01112	ko00740	Riboflavin metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMC200008582	K01112	ko01100	Metabolic pathways	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMC200008583	K01112	ko00051	Fructose and mannose metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMC200008583	K01112	ko00730	Thiamine metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMC200008583	K01112	ko00740	Riboflavin metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMC200008583	K01112	ko01100	Metabolic pathways	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMC200008584	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008584	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008584	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008584	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008585	K01112	ko00051	Fructose and mannose metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMC200008585	K01112	ko00730	Thiamine metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMC200008585	K01112	ko00740	Riboflavin metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMC200008585	K01112	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMC200008586	K01112	ko00051	Fructose and mannose metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMC200008586	K01112	ko00730	Thiamine metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMC200008586	K01112	ko00740	Riboflavin metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMC200008586	K01112	ko01100	Metabolic pathways	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMC200008587	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008587	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008587	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008587	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMC200008589	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008589	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008589	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008589	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008590	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008590	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008590	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008590	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMC200008591	K01190	ko00052	Galactose metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMC200008591	K01190	ko00511	Other glycan degradation	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMC200008591	K01190	ko00600	Sphingolipid metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMC200008591	K01190	ko01100	Metabolic pathways	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMC200008592	K01190	ko00052	Galactose metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMC200008592	K01190	ko00511	Other glycan degradation	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMC200008592	K01190	ko00600	Sphingolipid metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMC200008592	K01190	ko01100	Metabolic pathways	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMC200008594	K08248	ko00460	Cyanoamino acid metabolism	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMC200008594	K08248	ko01100	Metabolic pathways	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMC200008599	K12741	ko03040	Spliceosome	1268	4.2e-64	0.46	0.61	0.86
PGSC0003DMC200008600	K12741	ko03040	Spliceosome	934	1.1e-45	0.46	0.63	0.99
PGSC0003DMC200008602	K03787	ko00230	Purine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMC200008602	K03787	ko00240	Pyrimidine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMC200008602	K03787	ko00760	Nicotinate and nicotinamide metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMC200008602	K03787	ko01100	Metabolic pathways	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMC200008602	K03787	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMC200008603	K03787	ko00230	Purine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMC200008603	K03787	ko00240	Pyrimidine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMC200008603	K03787	ko00760	Nicotinate and nicotinamide metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMC200008603	K03787	ko01100	Metabolic pathways	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMC200008603	K03787	ko01110	Biosynthesis of secondary metabolites	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMC200008604	K03787	ko00230	Purine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMC200008604	K03787	ko00240	Pyrimidine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMC200008604	K03787	ko00760	Nicotinate and nicotinamide metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMC200008604	K03787	ko01100	Metabolic pathways	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMC200008604	K03787	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMC200008605	K02914	ko03010	Ribosome	263	1.1e-08	0.70	0.91	0.29
PGSC0003DMC200008609	K02218	ko04340	Hedgehog signaling pathway	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMC200008609	K02218	ko04711	Circadian rhythm - fly	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMC200016420	K02084	ko04115	p53 signaling pathway	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko04210	Apoptosis	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko05010	Alzheimer's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko05012	Parkinson's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko05016	Huntington's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016420	K02084	ko05222	Small cell lung cancer	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMC200016427	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMC200016427	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMC200016427	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMC200016427	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMC200016427	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMC200016428	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMC200016428	K00517	ko00626	Naphthalene and anthracene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMC200016428	K00517	ko00903	Limonene and pinene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMC200016428	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMC200016428	K00517	ko01110	Biosynthesis of secondary metabolites	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMC200016430	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMC200016430	K00517	ko00626	Naphthalene and anthracene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMC200016430	K00517	ko00903	Limonene and pinene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMC200016430	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMC200016430	K00517	ko01110	Biosynthesis of secondary metabolites	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMC200016431	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMC200016431	K00517	ko00626	Naphthalene and anthracene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMC200016431	K00517	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMC200016431	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMC200016431	K00517	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMC200016432	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMC200016432	K00517	ko00626	Naphthalene and anthracene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMC200016432	K00517	ko00903	Limonene and pinene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMC200016432	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMC200016432	K00517	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMC200016433	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMC200016433	K00517	ko00626	Naphthalene and anthracene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMC200016433	K00517	ko00903	Limonene and pinene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMC200016433	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMC200016433	K00517	ko01110	Biosynthesis of secondary metabolites	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMC200016434	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMC200016434	K00517	ko00626	Naphthalene and anthracene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMC200016434	K00517	ko00903	Limonene and pinene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMC200016434	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMC200016434	K00517	ko01110	Biosynthesis of secondary metabolites	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMC200016435	K00855	ko00710	Carbon fixation in photosynthetic organisms	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMC200016435	K00855	ko01100	Metabolic pathways	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMC200027154	K04371	ko04010	MAPK signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04012	ErbB signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04013	MAPK signaling pathway - fly	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04062	Chemokine signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04114	Oocyte meiosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04150	mTOR signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04270	Vascular smooth muscle contraction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04320	Dorso-ventral axis formation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04350	TGF-beta signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04360	Axon guidance	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04370	VEGF signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04510	Focal adhesion	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04520	Adherens junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04540	Gap junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04620	Toll-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04621	NOD-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04650	Natural killer cell mediated cytotoxicity	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04660	T cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04662	B cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04664	Fc epsilon RI signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04666	Fc gamma R-mediated phagocytosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04720	Long-term potentiation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04722	Neurotrophin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04730	Long-term depression	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04810	Regulation of actin cytoskeleton	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04910	Insulin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04912	GnRH signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04914	Progesterone-mediated oocyte maturation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04916	Melanogenesis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04930	Type II diabetes mellitus	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko04960	Aldosterone-regulated sodium reabsorption	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05010	Alzheimer's disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05020	Prion diseases	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05131	Shigellosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05140	Leishmaniasis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05142	Chagas disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05200	Pathways in cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05210	Colorectal cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05211	Renal cell carcinoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05212	Pancreatic cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05213	Endometrial cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05214	Glioma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05215	Prostate cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05216	Thyroid cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05218	Melanoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05219	Bladder cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05220	Chronic myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05221	Acute myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027154	K04371	ko05223	Non-small cell lung cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMC200027157	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMC200027158	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMC200027159	K01718	ko00240	Pyrimidine metabolism	432	5.4e-18	0.42	0.54	0.92
PGSC0003DMC200027160	K00430	ko00360	Phenylalanine metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMC200027160	K00430	ko00680	Methane metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMC200027160	K00430	ko00940	Phenylpropanoid biosynthesis	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMC200027160	K00430	ko01100	Metabolic pathways	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMC200027160	K00430	ko01110	Biosynthesis of secondary metabolites	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMC200027165	K12837	ko03040	Spliceosome	3943	1.2e-211	0.81	0.89	1.00
PGSC0003DMC200027166	K12837	ko03040	Spliceosome	2717	5.1e-144	0.88	0.93	1.00
PGSC0003DMC200027167	K12837	ko03040	Spliceosome	2321	3.5e-122	0.88	0.93	1.00
PGSC0003DMC200027168	K03107	ko03060	Protein export	3934	3.8e-211	0.78	0.88	0.98
PGSC0003DMC200027169	K03107	ko03060	Protein export	3338	2.8e-178	0.80	0.91	1.00
PGSC0003DMC200027170	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMC200027171	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMC200027174	K00558	ko00270	Cysteine and methionine metabolism	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMC200027174	K00558	ko01100	Metabolic pathways	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMC200027176	K13065	ko00940	Phenylpropanoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMC200027176	K13065	ko00941	Flavonoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMC200027176	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMC200027176	K13065	ko01110	Biosynthesis of secondary metabolites	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMC200034531	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200034531	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200034531	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMC200034532	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMC200034532	K01904	ko00360	Phenylalanine metabolism	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMC200034532	K01904	ko00940	Phenylpropanoid biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMC200034532	K01904	ko01100	Metabolic pathways	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMC200034532	K01904	ko01110	Biosynthesis of secondary metabolites	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMC200034533	K02937	ko03010	Ribosome	1756	5.1e-91	0.84	0.93	1.00
PGSC0003DMC200034540	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMC200034541	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMC200034547	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.74
PGSC0003DMC200034548	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.73
PGSC0003DMC200034549	K11818	ko00380	Tryptophan metabolism	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMC200034549	K11818	ko00966	Glucosinolate biosynthesis	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMC200034549	K11818	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMC200034550	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMC200034550	K00517	ko00626	Naphthalene and anthracene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMC200034550	K00517	ko00903	Limonene and pinene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMC200034550	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMC200034550	K00517	ko01110	Biosynthesis of secondary metabolites	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMC200034560	K00847	ko00051	Fructose and mannose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMC200034560	K00847	ko00500	Starch and sucrose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMC200034560	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMC200034560	K00847	ko01100	Metabolic pathways	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMC200053221	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053221	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053221	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053221	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053221	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053221	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMC200053222	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053222	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053222	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053222	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053222	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053222	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053223	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053224	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053225	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMC200053238	K00052	ko00290	Valine, leucine and isoleucine biosynthesis	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMC200053238	K00052	ko01100	Metabolic pathways	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMC200053238	K00052	ko01110	Biosynthesis of secondary metabolites	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMC200053250	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200053250	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200053250	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200053250	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200053250	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200053250	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMC200038590	K10592	ko04120	Ubiquitin mediated proteolysis	591	2.9e-25	0.92	0.99	0.75
PGSC0003DMC200038591	K10592	ko04120	Ubiquitin mediated proteolysis	1984	1.6e-102	0.68	0.79	0.97
PGSC0003DMC200038592	K10592	ko04120	Ubiquitin mediated proteolysis	18212	0.	0.62	0.75	1.00
PGSC0003DMC200038596	K08065	ko04612	Antigen processing and presentation	311	2.6e-11	0.49	0.70	0.48
PGSC0003DMC200038602	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	651	8.3e-30	0.32	0.46	0.86
PGSC0003DMC200038603	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	691	3.6e-32	0.31	0.44	0.87
PGSC0003DMC200038604	K01738	ko00270	Cysteine and methionine metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMC200038604	K01738	ko00450	Selenoamino acid metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMC200038604	K01738	ko00920	Sulfur metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMC200038604	K01738	ko01100	Metabolic pathways	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMC200038605	K01738	ko00270	Cysteine and methionine metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMC200038605	K01738	ko00450	Selenoamino acid metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMC200038605	K01738	ko00920	Sulfur metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMC200038605	K01738	ko01100	Metabolic pathways	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMC200057164	K08066	ko04612	Antigen processing and presentation	313	2.0e-11	0.51	0.77	0.73
PGSC0003DMC200057171	K01593	ko00340	Histidine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00350	Tyrosine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00360	Phenylalanine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00380	Tryptophan metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00901	Indole alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00950	Isoquinoline alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko00965	Betalain biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko01100	Metabolic pathways	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200057171	K01593	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMC200046414	K01066	ko00623	2,4-Dichlorobenzoate degradation	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMC200046414	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMC200046420	K05576	ko00190	Oxidative phosphorylation	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMC200046420	K05576	ko01100	Metabolic pathways	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMC200046421	K12868	ko03040	Spliceosome	1982	1.8e-103	0.74	0.82	1.00
PGSC0003DMC200046422	K02147	ko00190	Oxidative phosphorylation	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046422	K02147	ko01100	Metabolic pathways	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046422	K02147	ko04145	Phagosome	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046422	K02147	ko04966	Collecting duct acid secretion	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046422	K02147	ko05110	Vibrio cholerae infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046422	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMC200046429	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046429	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046429	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046430	K03094	ko04110	Cell cycle	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04111	Cell cycle - yeast	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04114	Oocyte meiosis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04120	Ubiquitin mediated proteolysis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04310	Wnt signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04350	TGF-beta signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046430	K03094	ko04710	Circadian rhythm - mammal	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMC200046431	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046431	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046431	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046432	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046432	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046432	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMC200046433	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046433	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046433	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMC200046434	K03094	ko04110	Cell cycle	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04111	Cell cycle - yeast	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04114	Oocyte meiosis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04120	Ubiquitin mediated proteolysis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04310	Wnt signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04350	TGF-beta signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046434	K03094	ko04710	Circadian rhythm - mammal	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMC200046438	K03094	ko04110	Cell cycle	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04111	Cell cycle - yeast	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04114	Oocyte meiosis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04120	Ubiquitin mediated proteolysis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04310	Wnt signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04350	TGF-beta signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046438	K03094	ko04710	Circadian rhythm - mammal	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMC200046439	K03094	ko04110	Cell cycle	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04111	Cell cycle - yeast	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04114	Oocyte meiosis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04120	Ubiquitin mediated proteolysis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04310	Wnt signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04350	TGF-beta signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200046439	K03094	ko04710	Circadian rhythm - mammal	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMC200003340	K01838	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.40	0.60	0.90
PGSC0003DMC200003341	K01838	ko00500	Starch and sucrose metabolism	256	2.8e-08	0.39	0.66	0.76
PGSC0003DMC200003342	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMC200003343	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMC200003354	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMC200003354	K01953	ko00910	Nitrogen metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMC200003354	K01953	ko01100	Metabolic pathways	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMC200003354	K01953	ko01110	Biosynthesis of secondary metabolites	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMC200003355	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMC200003355	K01953	ko00910	Nitrogen metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMC200003355	K01953	ko01100	Metabolic pathways	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMC200003355	K01953	ko01110	Biosynthesis of secondary metabolites	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMC200022023	K10418	ko04962	Vasopressin-regulated water reabsorption	314	1.7e-11	0.42	0.61	0.72
PGSC0003DMC200022046	K06685	ko04111	Cell cycle - yeast	295	1.0e-06	0.27	0.45	0.46
PGSC0003DMC200022047	K06685	ko04111	Cell cycle - yeast	295	5.0e-07	0.27	0.45	0.67
PGSC0003DMC200015212	K00004	ko00650	Butanoate metabolism	888	3.8e-43	0.58	0.70	0.98
PGSC0003DMC200015213	K00004	ko00650	Butanoate metabolism	644	1.1e-29	0.89	0.98	0.59
PGSC0003DMC200015214	K00004	ko00650	Butanoate metabolism	416	4.1e-17	0.89	0.94	0.61
PGSC0003DMC200015215	K00004	ko00650	Butanoate metabolism	2749	8.7e-146	0.86	0.94	1.00
PGSC0003DMC200015216	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMC200015217	K00004	ko00650	Butanoate metabolism	2544	1.8e-134	0.73	0.83	0.95
PGSC0003DMC200015218	K00004	ko00650	Butanoate metabolism	3605	5.3e-193	0.76	0.85	1.00
PGSC0003DMC200015219	K00004	ko00650	Butanoate metabolism	1364	2.1e-69	0.66	0.76	0.99
PGSC0003DMC200015220	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMC200015221	K00004	ko00650	Butanoate metabolism	1688	2.9e-87	0.86	0.94	0.92
PGSC0003DMC200015223	K01046	ko00561	Glycerolipid metabolism	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMC200015223	K01046	ko01100	Metabolic pathways	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMC200015225	K01046	ko00561	Glycerolipid metabolism	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMC200015225	K01046	ko01100	Metabolic pathways	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMC200015232	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1613	3.9e-83	0.72	0.85	0.91
PGSC0003DMC200028359	K00423	ko00053	Ascorbate and aldarate metabolism	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMC200028359	K00423	ko01100	Metabolic pathways	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMC200028363	K12373	ko00511	Other glycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko00531	Glycosaminoglycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko01100	Metabolic pathways	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028363	K12373	ko04142	Lysosome	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMC200028368	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028368	K01653	ko00650	Butanoate metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028368	K01653	ko00660	C5-Branched dibasic acid metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028368	K01653	ko00770	Pantothenate and CoA biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028368	K01653	ko01100	Metabolic pathways	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028368	K01653	ko01110	Biosynthesis of secondary metabolites	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMC200028378	K05350	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMC200028378	K05350	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMC200028378	K05350	ko00940	Phenylpropanoid biosynthesis	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMC200028378	K05350	ko01110	Biosynthesis of secondary metabolites	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMC200028379	K05350	ko00460	Cyanoamino acid metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMC200028379	K05350	ko00500	Starch and sucrose metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMC200028379	K05350	ko00940	Phenylpropanoid biosynthesis	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMC200028379	K05350	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMC200028380	K05350	ko00460	Cyanoamino acid metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMC200028380	K05350	ko00500	Starch and sucrose metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMC200028380	K05350	ko00940	Phenylpropanoid biosynthesis	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMC200028380	K05350	ko01110	Biosynthesis of secondary metabolites	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMC200000994	K10529	ko00592	alpha-Linolenic acid metabolism	4061	3.8e-218	0.74	0.86	0.99
PGSC0003DMC200000995	K10529	ko00592	alpha-Linolenic acid metabolism	3756	2.5e-201	0.70	0.81	0.99
PGSC0003DMC200000996	K10529	ko00592	alpha-Linolenic acid metabolism	3989	3.5e-214	0.73	0.85	0.99
PGSC0003DMC200000997	K10529	ko00592	alpha-Linolenic acid metabolism	3951	4.4e-212	0.72	0.85	0.99
PGSC0003DMC200000998	K10529	ko00592	alpha-Linolenic acid metabolism	410	1.0e-16	0.77	0.89	0.86
PGSC0003DMC200000999	K10529	ko00592	alpha-Linolenic acid metabolism	1884	4.5e-98	0.67	0.81	0.96
PGSC0003DMC200001000	K10529	ko00592	alpha-Linolenic acid metabolism	3810	2.6e-204	0.71	0.83	0.99
PGSC0003DMC200001001	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMC200001002	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMC200001003	K03469	ko03030	DNA replication	365	2.7e-14	0.42	0.61	0.42
PGSC0003DMC200001004	K03469	ko03030	DNA replication	364	3.1e-14	0.43	0.61	0.43
PGSC0003DMC200001005	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.42
PGSC0003DMC200001006	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.82
PGSC0003DMC200001007	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMC200001010	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMC200001010	K05285	ko01100	Metabolic pathways	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMC200001011	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	6030	0.	0.72	0.85	0.99
PGSC0003DMC200001011	K05285	ko01100	Metabolic pathways	6030	0.	0.72	0.85	0.99
PGSC0003DMC200001012	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMC200001012	K05285	ko01100	Metabolic pathways	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMC200001014	K00430	ko00360	Phenylalanine metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMC200001014	K00430	ko00680	Methane metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMC200001014	K00430	ko00940	Phenylpropanoid biosynthesis	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMC200001014	K00430	ko01100	Metabolic pathways	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMC200001014	K00430	ko01110	Biosynthesis of secondary metabolites	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMC200001015	K00430	ko00360	Phenylalanine metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMC200001015	K00430	ko00680	Methane metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMC200001015	K00430	ko00940	Phenylpropanoid biosynthesis	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMC200001015	K00430	ko01100	Metabolic pathways	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMC200001015	K00430	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMC200001018	K06611	ko00052	Galactose metabolism	4630	1.6e-249	0.68	0.81	1.00
PGSC0003DMC200069082	K13065	ko00940	Phenylpropanoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMC200069082	K13065	ko00941	Flavonoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMC200069082	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMC200069082	K13065	ko01110	Biosynthesis of secondary metabolites	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMC200069088	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMC200048151	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048151	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048152	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048152	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048153	K13289	ko04142	Lysosome	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMC200048153	K13289	ko04614	Renin-angiotensin system	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMC200048154	K13289	ko04142	Lysosome	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMC200048154	K13289	ko04614	Renin-angiotensin system	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMC200048155	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048155	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMC200048156	K13289	ko04142	Lysosome	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMC200048156	K13289	ko04614	Renin-angiotensin system	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMC200048157	K00967	ko00440	Phosphonate and phosphinate metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMC200048157	K00967	ko00564	Glycerophospholipid metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMC200048157	K00967	ko01100	Metabolic pathways	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMC200048158	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048158	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048158	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048159	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048159	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048159	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMC200048164	K02183	ko04020	Calcium signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04070	Phosphatidylinositol signaling system	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04114	Oocyte meiosis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04270	Vascular smooth muscle contraction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04626	Plant-pathogen interaction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04720	Long-term potentiation	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04722	Neurotrophin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04740	Olfactory transduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04744	Phototransduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04745	Phototransduction - fly	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04910	Insulin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04912	GnRH signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04916	Melanogenesis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04970	Salivary secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko04971	Gastric acid secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko05010	Alzheimer's disease	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200048164	K02183	ko05214	Glioma	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMC200030605	K05658	ko02010	ABC transporters	262	1.3e-07	0.38	0.55	0.82
PGSC0003DMC200030606	K05658	ko02010	ABC transporters	4433	1.1e-238	0.46	0.66	0.98
PGSC0003DMC200030607	K05658	ko02010	ABC transporters	2008	6.4e-105	0.72	0.89	0.99
PGSC0003DMC200030608	K05658	ko02010	ABC transporters	1260	1.2e-63	0.74	0.87	0.88
PGSC0003DMC200030612	K02882	ko03010	Ribosome	517	1.1e-22	0.84	0.87	0.94
PGSC0003DMC200030622	K02639	ko00195	Photosynthesis	1138	6.2e-57	0.72	0.82	0.99
PGSC0003DMC200030623	K02639	ko00195	Photosynthesis	1319	6.5e-67	0.80	0.90	0.99
PGSC0003DMC200056248	K00029	ko00620	Pyruvate metabolism	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMC200056248	K00029	ko00710	Carbon fixation in photosynthetic organisms	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMC200056248	K00029	ko01100	Metabolic pathways	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMC200017761	K04072	ko00010	Glycolysis / Gluconeogenesis	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00071	Fatty acid metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00350	Tyrosine metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00620	Pyruvate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00641	3-Chloroacrylic acid degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko00650	Butanoate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko01100	Metabolic pathways	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017761	K04072	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMC200017771	K11599	ko03050	Proteasome	946	2.4e-46	0.77	0.90	0.99
PGSC0003DMC200017784	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200017784	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200017784	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200017785	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200017785	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200017785	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMC200019355	K05577	ko00190	Oxidative phosphorylation	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMC200019355	K05577	ko01100	Metabolic pathways	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMC200019359	K06666	ko04111	Cell cycle - yeast	338	1.2e-09	0.26	0.42	0.43
PGSC0003DMC200019364	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMC200019365	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMC200019369	K06666	ko04111	Cell cycle - yeast	326	1.3e-08	0.26	0.41	0.48
PGSC0003DMC200019370	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMC200019371	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMC200019373	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMC200019377	K04733	ko04210	Apoptosis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMC200019377	K04733	ko04620	Toll-like receptor signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMC200019377	K04733	ko04722	Neurotrophin signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMC200019377	K04733	ko05140	Leishmaniasis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMC200019377	K04733	ko05142	Chagas disease	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMC200019380	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMC200025022	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025022	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025022	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025023	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025023	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025023	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025024	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMC200025024	K01602	ko00710	Carbon fixation in photosynthetic organisms	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMC200025024	K01602	ko01100	Metabolic pathways	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMC200025025	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025025	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025025	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMC200025029	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMC200025029	K01904	ko00360	Phenylalanine metabolism	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMC200025029	K01904	ko00940	Phenylpropanoid biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMC200025029	K01904	ko01100	Metabolic pathways	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMC200025029	K01904	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMC200025030	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMC200025030	K01904	ko00360	Phenylalanine metabolism	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMC200025030	K01904	ko00940	Phenylpropanoid biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMC200025030	K01904	ko01100	Metabolic pathways	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMC200025030	K01904	ko01110	Biosynthesis of secondary metabolites	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMC200025041	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMC200025042	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMC200005641	K01179	ko00500	Starch and sucrose metabolism	1271	2.9e-64	0.69	0.87	0.98
PGSC0003DMC200005642	K01179	ko00500	Starch and sucrose metabolism	3084	2.9e-164	0.73	0.88	0.94
PGSC0003DMC200005643	K01179	ko00500	Starch and sucrose metabolism	1165	2.0e-58	0.71	0.87	0.98
PGSC0003DMC200005649	K00801	ko00100	Steroid biosynthesis	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMC200005649	K00801	ko01100	Metabolic pathways	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMC200005649	K00801	ko01110	Biosynthesis of secondary metabolites	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMC200005661	K12489	ko04144	Endocytosis	684	6.8e-32	0.69	0.82	0.53
PGSC0003DMC200005662	K08737	ko03430	Mismatch repair	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMC200005662	K08737	ko05200	Pathways in cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMC200005662	K08737	ko05210	Colorectal cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMC200005663	K08737	ko03430	Mismatch repair	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMC200005663	K08737	ko05200	Pathways in cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMC200005663	K08737	ko05210	Colorectal cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMC200005667	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMC200005667	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMC200005667	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMC200005667	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMC200005667	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMC200005668	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMC200005668	K00517	ko00626	Naphthalene and anthracene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMC200005668	K00517	ko00903	Limonene and pinene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMC200005668	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMC200005668	K00517	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMC200005669	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005669	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005669	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005669	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005669	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005670	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005670	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005670	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005670	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200005670	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMC200068071	K11252	ko05322	Systemic lupus erythematosus	414	5.3e-17	0.43	0.67	0.95
PGSC0003DMC200068080	K10760	ko00908	Zeatin biosynthesis	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMC200068080	K10760	ko01100	Metabolic pathways	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMC200068080	K10760	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMC200068095	K12493	ko04144	Endocytosis	300	8.7e-10	0.49	0.70	0.49
PGSC0003DMC200061663	K12581	ko03018	RNA degradation	904	5.0e-44	0.50	0.65	0.94
PGSC0003DMC200017619	K00162	ko00010	Glycolysis / Gluconeogenesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko00020	Citrate cycle (TCA cycle)	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko00620	Pyruvate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko00650	Butanoate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko01100	Metabolic pathways	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017619	K00162	ko01110	Biosynthesis of secondary metabolites	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMC200017622	K01300	ko04610	Complement and coagulation cascades	259	1.9e-08	0.35	0.50	0.47
PGSC0003DMC200017623	K00721	ko00510	N-Glycan biosynthesis	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMC200017623	K00721	ko01100	Metabolic pathways	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMC200017624	K00721	ko00510	N-Glycan biosynthesis	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMC200017624	K00721	ko01100	Metabolic pathways	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMC200017626	K00700	ko00500	Starch and sucrose metabolism	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMC200017626	K00700	ko01100	Metabolic pathways	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMC200017627	K00700	ko00500	Starch and sucrose metabolism	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMC200017627	K00700	ko01100	Metabolic pathways	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMC200017632	K05868	ko04110	Cell cycle	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMC200017632	K05868	ko04115	p53 signaling pathway	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMC200017632	K05868	ko04914	Progesterone-mediated oocyte maturation	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMC200017633	K05868	ko04110	Cell cycle	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMC200017633	K05868	ko04115	p53 signaling pathway	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMC200017633	K05868	ko04914	Progesterone-mediated oocyte maturation	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMC200017634	K12385	ko04142	Lysosome	8598	0.	0.82	0.90	0.95
PGSC0003DMC200017635	K12385	ko04142	Lysosome	2386	9.1e-126	0.82	0.91	0.99
PGSC0003DMC200017636	K12385	ko04142	Lysosome	4213	1.6e-226	0.85	0.93	1.00
PGSC0003DMC200017637	K12385	ko04142	Lysosome	963	2.8e-47	0.91	0.95	0.98
PGSC0003DMC200017638	K12385	ko04142	Lysosome	694	6.9e-32	0.88	0.95	0.96
PGSC0003DMC200007386	K00134	ko00010	Glycolysis / Gluconeogenesis	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMC200007386	K00134	ko01100	Metabolic pathways	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMC200007386	K00134	ko01110	Biosynthesis of secondary metabolites	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMC200007386	K00134	ko05010	Alzheimer's disease	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMC200007398	K01955	ko00240	Pyrimidine metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMC200007398	K01955	ko00250	Alanine, aspartate and glutamate metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMC200007398	K01955	ko01100	Metabolic pathways	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMC200013781	K08679	ko00500	Starch and sucrose metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMC200013781	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMC200013781	K08679	ko01100	Metabolic pathways	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMC200013783	K07297	ko04920	Adipocytokine signaling pathway	1700	6.3e-88	0.54	0.70	0.95
PGSC0003DMC200013784	K07297	ko04920	Adipocytokine signaling pathway	1744	2.3e-90	0.58	0.74	0.95
PGSC0003DMC200013789	K00939	ko00230	Purine metabolism	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMC200013789	K00939	ko01100	Metabolic pathways	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMC200013789	K00939	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMC200013790	K12128	ko04712	Circadian rhythm - plant	413	9.8e-17	0.34	0.51	0.29
PGSC0003DMC200013791	K12128	ko04712	Circadian rhythm - plant	413	1.1e-16	0.34	0.51	0.28
PGSC0003DMC200013795	K01658	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMC200013795	K01658	ko01100	Metabolic pathways	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMC200013795	K01658	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMC200013796	K12126	ko04712	Circadian rhythm - plant	326	4.1e-12	0.51	0.81	0.19
PGSC0003DMC200013800	K01255	ko00480	Glutathione metabolism	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMC200013800	K01255	ko01100	Metabolic pathways	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMC200005745	K00754	ko00051	Fructose and mannose metabolism	1312	1.6e-66	0.37	0.53	0.84
PGSC0003DMC200005746	K00754	ko00051	Fructose and mannose metabolism	1283	6.3e-65	0.44	0.61	0.97
PGSC0003DMC200005748	K01199	ko00500	Starch and sucrose metabolism	668	5.2e-31	0.35	0.52	0.71
PGSC0003DMC200059558	K12478	ko04144	Endocytosis	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMC200059558	K12478	ko04145	Phagosome	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMC200059564	K04733	ko04210	Apoptosis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMC200059564	K04733	ko04620	Toll-like receptor signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMC200059564	K04733	ko04722	Neurotrophin signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMC200059564	K04733	ko05140	Leishmaniasis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMC200059564	K04733	ko05142	Chagas disease	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMC200036181	K02937	ko03010	Ribosome	1768	1.1e-91	0.86	0.94	0.99
PGSC0003DMC200036191	K00602	ko00230	Purine metabolism	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMC200036191	K00602	ko00670	One carbon pool by folate	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMC200036191	K00602	ko01100	Metabolic pathways	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMC200036191	K00602	ko01110	Biosynthesis of secondary metabolites	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMC200036196	K11866	ko04144	Endocytosis	301	6.8e-10	0.45	0.60	0.94
PGSC0003DMC200036202	K03020	ko00230	Purine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMC200036202	K03020	ko00240	Pyrimidine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMC200036202	K03020	ko01100	Metabolic pathways	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMC200036202	K03020	ko03020	RNA polymerase	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMC200036202	K03020	ko04623	Cytosolic DNA-sensing pathway	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMC200036203	K03015	ko00230	Purine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMC200036203	K03015	ko00240	Pyrimidine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMC200036203	K03015	ko01100	Metabolic pathways	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMC200036203	K03015	ko03020	RNA polymerase	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMC200036203	K03015	ko05016	Huntington's disease	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMC200036204	K06269	ko04113	Meiosis - yeast	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04114	Oocyte meiosis	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04270	Vascular smooth muscle contraction	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04510	Focal adhesion	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04720	Long-term potentiation	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04810	Regulation of actin cytoskeleton	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036204	K06269	ko04910	Insulin signaling pathway	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMC200036205	K06269	ko04113	Meiosis - yeast	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04114	Oocyte meiosis	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04270	Vascular smooth muscle contraction	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04510	Focal adhesion	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04720	Long-term potentiation	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04810	Regulation of actin cytoskeleton	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200036205	K06269	ko04910	Insulin signaling pathway	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMC200042573	K04424	ko04010	MAPK signaling pathway	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMC200042573	K04424	ko04530	Tight junction	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMC200042588	K02183	ko04020	Calcium signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04070	Phosphatidylinositol signaling system	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04114	Oocyte meiosis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04270	Vascular smooth muscle contraction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04626	Plant-pathogen interaction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04720	Long-term potentiation	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04722	Neurotrophin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04740	Olfactory transduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04744	Phototransduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04745	Phototransduction - fly	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04910	Insulin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04912	GnRH signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04916	Melanogenesis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04970	Salivary secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko04971	Gastric acid secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko05010	Alzheimer's disease	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042588	K02183	ko05214	Glioma	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMC200042598	K10712	ko00430	Taurine and hypotaurine metabolism	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMC200042598	K10712	ko01100	Metabolic pathways	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMC200042599	K01757	ko00901	Indole alkaloid biosynthesis	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMC200042599	K01757	ko01100	Metabolic pathways	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMC200042599	K01757	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMC200042600	K01757	ko00901	Indole alkaloid biosynthesis	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMC200042600	K01757	ko01100	Metabolic pathways	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMC200042600	K01757	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMC200063724	K02638	ko00195	Photosynthesis	945	2.8e-46	0.69	0.82	0.99
PGSC0003DMC200063735	K13065	ko00940	Phenylpropanoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMC200063735	K13065	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMC200063735	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMC200063735	K13065	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMC200003244	K00142	ko00300	Lysine biosynthesis	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMC200003244	K00142	ko00310	Lysine degradation	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMC200003244	K00142	ko01100	Metabolic pathways	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMC200003247	K04780	ko01053	Biosynthesis of siderophore group nonribosomal peptides	849	7.6e-40	0.30	0.48	0.83
PGSC0003DMC200003249	K10601	ko04120	Ubiquitin mediated proteolysis	249	6.7e-08	0.40	0.58	0.24
PGSC0003DMC200003250	K08241	ko00592	alpha-Linolenic acid metabolism	535	2.4e-28	0.38	0.63	0.97
PGSC0003DMC200003251	K01692	ko00071	Fatty acid metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00280	Valine, leucine and isoleucine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00281	Geraniol degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00310	Lysine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00380	Tryptophan metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00410	beta-Alanine metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00632	Benzoate degradation via CoA ligation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00640	Propanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00650	Butanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00903	Limonene and pinene degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko00930	Caprolactam degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko01100	Metabolic pathways	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003251	K01692	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMC200003252	K08241	ko00592	alpha-Linolenic acid metabolism	605	1.6e-27	0.49	0.65	0.69
PGSC0003DMC200003253	K08241	ko00592	alpha-Linolenic acid metabolism	683	7.8e-32	0.32	0.47	0.88
PGSC0003DMC200003254	K08241	ko00592	alpha-Linolenic acid metabolism	1012	5.5e-50	0.42	0.62	0.99
PGSC0003DMC200003255	K08241	ko00592	alpha-Linolenic acid metabolism	1018	2.6e-50	0.39	0.60	0.97
PGSC0003DMC200003256	K08241	ko00592	alpha-Linolenic acid metabolism	612	6.4e-28	0.49	0.65	0.82
PGSC0003DMC200003257	K08241	ko00592	alpha-Linolenic acid metabolism	326	3.8e-12	0.30	0.59	0.97
PGSC0003DMC200003258	K08241	ko00592	alpha-Linolenic acid metabolism	841	1.5e-40	0.45	0.61	0.90
PGSC0003DMC200003259	K08241	ko00592	alpha-Linolenic acid metabolism	989	1.0e-48	0.44	0.62	0.93
PGSC0003DMC200003260	K08241	ko00592	alpha-Linolenic acid metabolism	1142	3.7e-57	0.44	0.63	0.92
PGSC0003DMC200003261	K01692	ko00071	Fatty acid metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00280	Valine, leucine and isoleucine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00281	Geraniol degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00310	Lysine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00380	Tryptophan metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00410	beta-Alanine metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00632	Benzoate degradation via CoA ligation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00640	Propanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00650	Butanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00903	Limonene and pinene degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko00930	Caprolactam degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko01100	Metabolic pathways	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003261	K01692	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMC200003263	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMC200003263	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMC200003264	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMC200003264	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMC200003265	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMC200003265	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMC200003266	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMC200003266	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMC200003269	K04123	ko00904	Diterpenoid biosynthesis	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMC200003269	K04123	ko01100	Metabolic pathways	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMC200003269	K04123	ko01110	Biosynthesis of secondary metabolites	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMC200003270	K04123	ko00904	Diterpenoid biosynthesis	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMC200003270	K04123	ko01100	Metabolic pathways	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMC200003270	K04123	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMC200015361	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMC200015362	K04532	ko05010	Alzheimer's disease	3743	1.3e-200	0.83	0.93	1.00
PGSC0003DMC200015363	K04532	ko05010	Alzheimer's disease	1487	3.5e-76	0.91	0.96	0.91
PGSC0003DMC200015364	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMC200015365	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015365	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015365	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015366	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015366	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015366	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMC200015374	K01681	ko00020	Citrate cycle (TCA cycle)	7220	0.	0.87	0.93	1.00
PGSC0003DMC200015374	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7220	0.	0.87	0.93	1.00
PGSC0003DMC200015374	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7220	0.	0.87	0.93	1.00
PGSC0003DMC200015374	K01681	ko01100	Metabolic pathways	7220	0.	0.87	0.93	1.00
PGSC0003DMC200015374	K01681	ko01110	Biosynthesis of secondary metabolites	7220	0.	0.87	0.93	1.00
PGSC0003DMC200015375	K01681	ko00020	Citrate cycle (TCA cycle)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMC200015375	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMC200015375	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMC200015375	K01681	ko01100	Metabolic pathways	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMC200015375	K01681	ko01110	Biosynthesis of secondary metabolites	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMC200015376	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMC200015376	K00517	ko00626	Naphthalene and anthracene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMC200015376	K00517	ko00903	Limonene and pinene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMC200015376	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMC200015376	K00517	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMC200015378	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMC200015378	K00122	ko00680	Methane metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMC200015378	K00122	ko01100	Metabolic pathways	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMC200015380	K07466	ko03030	DNA replication	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMC200015380	K07466	ko03420	Nucleotide excision repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMC200015380	K07466	ko03430	Mismatch repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMC200015380	K07466	ko03440	Homologous recombination	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMC200015382	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMC200015382	K00517	ko00626	Naphthalene and anthracene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMC200015382	K00517	ko00903	Limonene and pinene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMC200015382	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMC200015382	K00517	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMC200015385	K07374	ko04145	Phagosome	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMC200015385	K07374	ko04540	Gap junction	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMC200015385	K07374	ko05130	Pathogenic Escherichia coli infection	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMC200015386	K05666	ko02010	ABC transporters	3353	2.3e-184	0.35	0.55	0.76
PGSC0003DMC200015387	K05666	ko02010	ABC transporters	3778	1.5e-202	0.34	0.54	0.85
PGSC0003DMC200015388	K05667	ko02010	ABC transporters	2276	1.1e-119	0.35	0.54	0.94
PGSC0003DMC200015389	K02912	ko03010	Ribosome	1051	3.9e-52	0.91	0.96	0.99
PGSC0003DMC200009992	K07375	ko04145	Phagosome	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMC200009992	K07375	ko04540	Gap junction	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMC200009992	K07375	ko05130	Pathogenic Escherichia coli infection	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMC200010008	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMC200010010	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMC200010011	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMC200010020	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMC200010020	K00517	ko00626	Naphthalene and anthracene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMC200010020	K00517	ko00903	Limonene and pinene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMC200010020	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMC200010020	K00517	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMC200034445	K09481	ko03060	Protein export	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMC200034445	K09481	ko04145	Phagosome	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMC200034445	K09481	ko05110	Vibrio cholerae infection	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMC200034446	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMC200034446	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMC200034447	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMC200034447	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMC200034448	K03648	ko03410	Base excision repair	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMC200034448	K03648	ko05340	Primary immunodeficiency	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMC200034460	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034460	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034461	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034461	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034462	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034462	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034463	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034463	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMC200034464	K08139	ko04113	Meiosis - yeast	389	1.3e-15	0.36	0.53	0.86
PGSC0003DMC200034470	K02148	ko00190	Oxidative phosphorylation	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200034470	K02148	ko01100	Metabolic pathways	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200034470	K02148	ko04145	Phagosome	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200034470	K02148	ko04966	Collecting duct acid secretion	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200034470	K02148	ko05110	Vibrio cholerae infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200034470	K02148	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMC200050554	K12128	ko04712	Circadian rhythm - plant	270	5.9e-09	0.38	0.56	0.38
PGSC0003DMC200050555	K00927	ko00010	Glycolysis / Gluconeogenesis	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMC200050555	K00927	ko00710	Carbon fixation in photosynthetic organisms	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMC200050555	K00927	ko01100	Metabolic pathways	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMC200050555	K00927	ko01110	Biosynthesis of secondary metabolites	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMC200050556	K01431	ko00240	Pyrimidine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMC200050556	K01431	ko00410	beta-Alanine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMC200050556	K01431	ko00770	Pantothenate and CoA biosynthesis	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMC200050556	K01431	ko00983	Drug metabolism - other enzymes	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMC200050556	K01431	ko01100	Metabolic pathways	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMC200050557	K01431	ko00240	Pyrimidine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMC200050557	K01431	ko00410	beta-Alanine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMC200050557	K01431	ko00770	Pantothenate and CoA biosynthesis	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMC200050557	K01431	ko00983	Drug metabolism - other enzymes	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMC200050557	K01431	ko01100	Metabolic pathways	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMC200050558	K01431	ko00240	Pyrimidine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMC200050558	K01431	ko00410	beta-Alanine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMC200050558	K01431	ko00770	Pantothenate and CoA biosynthesis	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMC200050558	K01431	ko00983	Drug metabolism - other enzymes	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMC200050558	K01431	ko01100	Metabolic pathways	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMC200050561	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMC200050561	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMC200050561	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMC200050565	K05278	ko00941	Flavonoid biosynthesis	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMC200050565	K05278	ko01100	Metabolic pathways	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMC200050565	K05278	ko01110	Biosynthesis of secondary metabolites	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMC200050566	K05282	ko00904	Diterpenoid biosynthesis	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMC200050566	K05282	ko01100	Metabolic pathways	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMC200050566	K05282	ko01110	Biosynthesis of secondary metabolites	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMC200050567	K00889	ko00562	Inositol phosphate metabolism	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050567	K00889	ko01100	Metabolic pathways	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050567	K00889	ko04070	Phosphatidylinositol signaling system	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050567	K00889	ko04144	Endocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050567	K00889	ko04666	Fc gamma R-mediated phagocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050567	K00889	ko04810	Regulation of actin cytoskeleton	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMC200050571	K01942	ko00780	Biotin metabolism	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMC200050571	K01942	ko01100	Metabolic pathways	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMC200050572	K01942	ko00780	Biotin metabolism	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMC200050572	K01942	ko01100	Metabolic pathways	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMC200050573	K08866	ko04110	Cell cycle	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMC200050573	K08866	ko04111	Cell cycle - yeast	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMC200050574	K08866	ko04110	Cell cycle	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMC200050574	K08866	ko04111	Cell cycle - yeast	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMC200050575	K08866	ko04110	Cell cycle	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMC200050575	K08866	ko04111	Cell cycle - yeast	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMC200050576	K08866	ko04110	Cell cycle	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMC200050576	K08866	ko04111	Cell cycle - yeast	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMC200050577	K08866	ko04110	Cell cycle	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMC200050577	K08866	ko04111	Cell cycle - yeast	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMC200046565	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00270	Cysteine and methionine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00350	Tyrosine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00401	Novobiocin biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko01100	Metabolic pathways	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046565	K00815	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMC200046566	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00270	Cysteine and methionine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00350	Tyrosine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00360	Phenylalanine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00401	Novobiocin biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00950	Isoquinoline alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko01100	Metabolic pathways	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046566	K00815	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMC200046567	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046567	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046568	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046569	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMC200046570	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00350	Tyrosine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00360	Phenylalanine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00401	Novobiocin biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko01100	Metabolic pathways	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200046570	K00815	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMC200041193	K10246	ko01040	Biosynthesis of unsaturated fatty acids	397	4.6e-16	0.38	0.52	0.95
PGSC0003DMC200041202	K09588	ko01100	Metabolic pathways	1826	7.0e-95	0.72	0.82	0.98
PGSC0003DMC200041203	K09588	ko01100	Metabolic pathways	2484	3.6e-131	0.74	0.83	0.82
PGSC0003DMC200041211	K00970	ko03018	RNA degradation	339	7.4e-12	0.37	0.54	0.58
PGSC0003DMC200004448	K00599	ko00340	Histidine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMC200004448	K00599	ko00350	Tyrosine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMC200004448	K00599	ko00450	Selenoamino acid metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMC200004448	K00599	ko00626	Naphthalene and anthracene degradation	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMC200004449	K00599	ko00340	Histidine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMC200004449	K00599	ko00350	Tyrosine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMC200004449	K00599	ko00450	Selenoamino acid metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMC200004449	K00599	ko00626	Naphthalene and anthracene degradation	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMC200004450	K00599	ko00340	Histidine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMC200004450	K00599	ko00350	Tyrosine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMC200004450	K00599	ko00450	Selenoamino acid metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMC200004450	K00599	ko00626	Naphthalene and anthracene degradation	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMC200020557	K04077	ko03018	RNA degradation	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMC200020557	K04077	ko04940	Type I diabetes mellitus	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMC200020562	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMC200020562	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMC200020562	K00771	ko01100	Metabolic pathways	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMC200020568	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMC200020568	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMC200020569	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMC200020569	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMC200020574	K00441	ko00790	Folate biosynthesis	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMC200020574	K00441	ko01100	Metabolic pathways	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMC200020575	K00441	ko00790	Folate biosynthesis	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMC200020575	K00441	ko01100	Metabolic pathways	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMC200020579	K00356	ko00190	Oxidative phosphorylation	1097	1.1e-54	0.87	0.92	0.99
PGSC0003DMC200011206	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMC200011212	K05350	ko00460	Cyanoamino acid metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMC200011212	K05350	ko00500	Starch and sucrose metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMC200011212	K05350	ko00940	Phenylpropanoid biosynthesis	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMC200011212	K05350	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMC200011213	K05350	ko00460	Cyanoamino acid metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMC200011213	K05350	ko00500	Starch and sucrose metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMC200011213	K05350	ko00940	Phenylpropanoid biosynthesis	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMC200011213	K05350	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMC200016570	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00270	Cysteine and methionine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00350	Tyrosine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00360	Phenylalanine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00401	Novobiocin biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko01100	Metabolic pathways	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016570	K00815	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMC200016572	K07466	ko03030	DNA replication	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMC200016572	K07466	ko03420	Nucleotide excision repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMC200016572	K07466	ko03430	Mismatch repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMC200016572	K07466	ko03440	Homologous recombination	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMC200016574	K12826	ko03040	Spliceosome	346	3.0e-13	0.29	0.41	0.78
PGSC0003DMC200016575	K12826	ko03040	Spliceosome	342	5.0e-13	0.33	0.44	0.85
PGSC0003DMC200016587	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMC200016587	K00517	ko00626	Naphthalene and anthracene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMC200016587	K00517	ko00903	Limonene and pinene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMC200016587	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMC200016587	K00517	ko01110	Biosynthesis of secondary metabolites	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMC200000032	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.67
PGSC0003DMC200000033	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.65
PGSC0003DMC200000034	K05282	ko00904	Diterpenoid biosynthesis	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMC200000034	K05282	ko01100	Metabolic pathways	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMC200000034	K05282	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMC200000035	K05282	ko00904	Diterpenoid biosynthesis	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMC200000035	K05282	ko01100	Metabolic pathways	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMC200000035	K05282	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMC200000040	K01692	ko00071	Fatty acid metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00280	Valine, leucine and isoleucine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00281	Geraniol degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00310	Lysine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00380	Tryptophan metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00410	beta-Alanine metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00632	Benzoate degradation via CoA ligation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00640	Propanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00650	Butanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00903	Limonene and pinene degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko00930	Caprolactam degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000040	K01692	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMC200000041	K01692	ko00071	Fatty acid metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00280	Valine, leucine and isoleucine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00281	Geraniol degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00310	Lysine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00380	Tryptophan metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00410	beta-Alanine metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00632	Benzoate degradation via CoA ligation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00640	Propanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00650	Butanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00903	Limonene and pinene degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko00930	Caprolactam degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko01100	Metabolic pathways	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000041	K01692	ko01110	Biosynthesis of secondary metabolites	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMC200000043	K01692	ko00071	Fatty acid metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00280	Valine, leucine and isoleucine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00281	Geraniol degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00310	Lysine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00380	Tryptophan metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00410	beta-Alanine metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00632	Benzoate degradation via CoA ligation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00640	Propanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00650	Butanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00903	Limonene and pinene degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko00930	Caprolactam degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko01100	Metabolic pathways	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000043	K01692	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMC200000046	K01692	ko00071	Fatty acid metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00280	Valine, leucine and isoleucine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00281	Geraniol degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00310	Lysine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00410	beta-Alanine metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00632	Benzoate degradation via CoA ligation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00640	Propanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00650	Butanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00903	Limonene and pinene degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko00930	Caprolactam degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko01100	Metabolic pathways	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000046	K01692	ko01110	Biosynthesis of secondary metabolites	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMC200000047	K01692	ko00071	Fatty acid metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00280	Valine, leucine and isoleucine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00281	Geraniol degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00310	Lysine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00380	Tryptophan metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00410	beta-Alanine metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00632	Benzoate degradation via CoA ligation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00640	Propanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00650	Butanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00903	Limonene and pinene degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko00930	Caprolactam degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko01100	Metabolic pathways	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000047	K01692	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMC200000048	K01692	ko00071	Fatty acid metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00280	Valine, leucine and isoleucine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00281	Geraniol degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00310	Lysine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00380	Tryptophan metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00410	beta-Alanine metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00632	Benzoate degradation via CoA ligation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00640	Propanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00650	Butanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00903	Limonene and pinene degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko00930	Caprolactam degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko01100	Metabolic pathways	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000048	K01692	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMC200000056	K00067	ko00521	Streptomycin biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMC200000056	K00067	ko00523	Polyketide sugar unit biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMC200000056	K00067	ko01100	Metabolic pathways	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMC200000056	K00067	ko01110	Biosynthesis of secondary metabolites	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMC200000057	K00067	ko00521	Streptomycin biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMC200000057	K00067	ko00523	Polyketide sugar unit biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMC200000057	K00067	ko01100	Metabolic pathways	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMC200000057	K00067	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMC200000058	K00028	ko00620	Pyruvate metabolism	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMC200000058	K00028	ko00710	Carbon fixation in photosynthetic organisms	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMC200000058	K00028	ko01100	Metabolic pathways	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMC200000059	K00079	ko00590	Arachidonic acid metabolism	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMC200000059	K00079	ko01100	Metabolic pathways	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMC200000060	K00079	ko00590	Arachidonic acid metabolism	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMC200000060	K00079	ko01100	Metabolic pathways	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMC200064933	K12356	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.30	0.44	0.88
PGSC0003DMC200033252	K04618	ko00052	Galactose metabolism	526	1.0e-22	0.29	0.41	0.95
PGSC0003DMC200033265	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMC200033265	K01602	ko00710	Carbon fixation in photosynthetic organisms	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMC200033265	K01602	ko01100	Metabolic pathways	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMC200039993	K04565	ko04146	Peroxisome	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMC200039993	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMC200039993	K04565	ko05016	Huntington's disease	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMC200039993	K04565	ko05020	Prion diseases	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMC200039996	K01515	ko00230	Purine metabolism	243	1.4e-07	0.35	0.57	0.81
PGSC0003DMC200040007	K01110	ko00562	Inositol phosphate metabolism	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko04070	Phosphatidylinositol signaling system	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko04115	p53 signaling pathway	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko04510	Focal adhesion	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko04530	Tight junction	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05200	Pathways in cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05213	Endometrial cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05214	Glioma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05215	Prostate cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05218	Melanoma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040007	K01110	ko05222	Small cell lung cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMC200040012	K07466	ko03030	DNA replication	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMC200040012	K07466	ko03420	Nucleotide excision repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMC200040012	K07466	ko03430	Mismatch repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMC200040012	K07466	ko03440	Homologous recombination	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMC200040014	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMC200040014	K05292	ko01100	Metabolic pathways	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMC200040014	K05292	ko01110	Biosynthesis of secondary metabolites	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMC200040015	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMC200040015	K05292	ko01100	Metabolic pathways	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMC200040015	K05292	ko01110	Biosynthesis of secondary metabolites	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMC200045362	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045362	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045362	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045363	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045363	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045363	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045366	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMC200045368	K04428	ko04010	MAPK signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMC200045368	K04428	ko04912	GnRH signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMC200045369	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045369	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045369	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMC200045370	K01057	ko00030	Pentose phosphate pathway	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMC200045370	K01057	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMC200045370	K01057	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMC200045371	K01057	ko00030	Pentose phosphate pathway	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMC200045371	K01057	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMC200045371	K01057	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMC200045372	K01057	ko00030	Pentose phosphate pathway	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMC200045372	K01057	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMC200045372	K01057	ko01110	Biosynthesis of secondary metabolites	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMC200045373	K01057	ko00030	Pentose phosphate pathway	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMC200045373	K01057	ko01100	Metabolic pathways	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMC200045373	K01057	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMC200045387	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMC200045387	K01078	ko00740	Riboflavin metabolism	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMC200029551	K06276	ko03320	PPAR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029551	K06276	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMC200029552	K06276	ko03320	PPAR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko04150	mTOR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko04510	Focal adhesion	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko04910	Insulin signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko05213	Endometrial cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko05215	Prostate cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029552	K06276	ko05223	Non-small cell lung cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMC200029555	K01728	ko00040	Pentose and glucuronate interconversions	2088	2.5e-109	0.63	0.77	0.76
PGSC0003DMC200029566	K11252	ko05322	Systemic lupus erythematosus	1101	6.8e-55	0.93	0.94	0.99
PGSC0003DMC200029568	K12897	ko03040	Spliceosome	376	6.7e-15	0.37	0.46	0.93
PGSC0003DMC200029569	K12885	ko03040	Spliceosome	469	4.9e-20	0.34	0.45	0.97
PGSC0003DMC200012571	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMC200012572	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMC200012573	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMC200012574	K00697	ko00500	Starch and sucrose metabolism	1792	5.3e-93	0.79	0.86	0.99
PGSC0003DMC200012575	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMC200012586	K03006	ko00230	Purine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMC200012586	K03006	ko00240	Pyrimidine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMC200012586	K03006	ko01100	Metabolic pathways	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMC200012586	K03006	ko03020	RNA polymerase	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMC200012586	K03006	ko05016	Huntington's disease	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMC200006188	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.92
PGSC0003DMC200006189	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.93
PGSC0003DMC200006193	K09658	ko00510	N-Glycan biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMC200006193	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMC200006193	K09658	ko01100	Metabolic pathways	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMC200006194	K01184	ko00040	Pentose and glucuronate interconversions	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMC200006194	K01184	ko00500	Starch and sucrose metabolism	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMC200006194	K01184	ko01100	Metabolic pathways	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMC200006195	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006195	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006195	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006196	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006196	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006196	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMC200006200	K12885	ko03040	Spliceosome	424	1.5e-17	0.30	0.39	0.90
PGSC0003DMC200006205	K00688	ko00500	Starch and sucrose metabolism	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMC200006205	K00688	ko04910	Insulin signaling pathway	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMC200006207	K02982	ko03010	Ribosome	576	6.2e-26	0.91	0.97	0.99
PGSC0003DMC200006208	K02982	ko03010	Ribosome	487	5.0e-21	0.90	0.98	0.91
PGSC0003DMC200006209	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMC200006210	K12189	ko04144	Endocytosis	1357	5.2e-69	0.87	0.96	0.99
PGSC0003DMC200047617	K02183	ko04020	Calcium signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04070	Phosphatidylinositol signaling system	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04114	Oocyte meiosis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04270	Vascular smooth muscle contraction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04626	Plant-pathogen interaction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04720	Long-term potentiation	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04722	Neurotrophin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04740	Olfactory transduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04744	Phototransduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04745	Phototransduction - fly	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04910	Insulin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04912	GnRH signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04916	Melanogenesis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04970	Salivary secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko04971	Gastric acid secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko05010	Alzheimer's disease	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047617	K02183	ko05214	Glioma	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMC200047618	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMC200047620	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047620	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200047621	K02183	ko04020	Calcium signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04070	Phosphatidylinositol signaling system	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04114	Oocyte meiosis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04270	Vascular smooth muscle contraction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04626	Plant-pathogen interaction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04720	Long-term potentiation	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04722	Neurotrophin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04740	Olfactory transduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04744	Phototransduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04745	Phototransduction - fly	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04910	Insulin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04912	GnRH signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04916	Melanogenesis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04970	Salivary secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko04971	Gastric acid secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko05010	Alzheimer's disease	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047621	K02183	ko05214	Glioma	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMC200047622	K02183	ko04020	Calcium signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04070	Phosphatidylinositol signaling system	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04114	Oocyte meiosis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04270	Vascular smooth muscle contraction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04626	Plant-pathogen interaction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04720	Long-term potentiation	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04722	Neurotrophin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04740	Olfactory transduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04744	Phototransduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04745	Phototransduction - fly	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04910	Insulin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04912	GnRH signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04916	Melanogenesis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04970	Salivary secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko04971	Gastric acid secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko05010	Alzheimer's disease	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047622	K02183	ko05214	Glioma	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMC200047623	K01199	ko00500	Starch and sucrose metabolism	621	2.0e-28	0.32	0.51	0.92
PGSC0003DMC200047632	K00475	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMC200047632	K00475	ko01100	Metabolic pathways	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMC200047632	K00475	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMC200047634	K00475	ko00941	Flavonoid biosynthesis	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMC200047634	K00475	ko01100	Metabolic pathways	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMC200047634	K00475	ko01110	Biosynthesis of secondary metabolites	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMC200047636	K05278	ko00941	Flavonoid biosynthesis	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMC200047636	K05278	ko01100	Metabolic pathways	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMC200047636	K05278	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMC200047637	K05277	ko00941	Flavonoid biosynthesis	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMC200047637	K05277	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMC200047637	K05277	ko01110	Biosynthesis of secondary metabolites	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMC200047639	K05277	ko00941	Flavonoid biosynthesis	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMC200047639	K05277	ko01100	Metabolic pathways	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMC200047639	K05277	ko01110	Biosynthesis of secondary metabolites	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMC200047640	K00475	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMC200047640	K00475	ko01100	Metabolic pathways	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMC200047640	K00475	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMC200043773	K11090	ko05322	Systemic lupus erythematosus	318	1.1e-11	0.36	0.55	0.50
PGSC0003DMC200043774	K11090	ko05322	Systemic lupus erythematosus	331	2.0e-12	0.29	0.45	0.59
PGSC0003DMC200043775	K00794	ko00740	Riboflavin metabolism	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMC200043775	K00794	ko01100	Metabolic pathways	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMC200043776	K00794	ko00740	Riboflavin metabolism	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMC200043776	K00794	ko01100	Metabolic pathways	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMC200043777	K00975	ko00500	Starch and sucrose metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMC200043777	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMC200043777	K00975	ko01100	Metabolic pathways	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMC200043778	K13065	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMC200043778	K13065	ko00941	Flavonoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMC200043778	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMC200043778	K13065	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMC200043779	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMC200043779	K00517	ko00626	Naphthalene and anthracene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMC200043779	K00517	ko00903	Limonene and pinene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMC200043779	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMC200043779	K00517	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMC200043780	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMC200043780	K00517	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMC200043780	K00517	ko00903	Limonene and pinene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMC200043780	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMC200043780	K00517	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMC200043781	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMC200043781	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMC200043782	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMC200043782	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMC200043783	K04424	ko04010	MAPK signaling pathway	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMC200043783	K04424	ko04530	Tight junction	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMC200043786	K01190	ko00052	Galactose metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMC200043786	K01190	ko00511	Other glycan degradation	6612	0.	0.67	0.80	1.00
PGSC0003DMC200043786	K01190	ko00600	Sphingolipid metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMC200043786	K01190	ko01100	Metabolic pathways	6612	0.	0.67	0.80	1.00
PGSC0003DMC200043787	K01190	ko00052	Galactose metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMC200043787	K01190	ko00511	Other glycan degradation	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMC200043787	K01190	ko00600	Sphingolipid metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMC200043787	K01190	ko01100	Metabolic pathways	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMC200043788	K01190	ko00052	Galactose metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMC200043788	K01190	ko00511	Other glycan degradation	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMC200043788	K01190	ko00600	Sphingolipid metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMC200043788	K01190	ko01100	Metabolic pathways	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMC200043791	K01099	ko00562	Inositol phosphate metabolism	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMC200043791	K01099	ko01100	Metabolic pathways	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMC200043791	K01099	ko04070	Phosphatidylinositol signaling system	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMC200043795	K00599	ko00340	Histidine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMC200043795	K00599	ko00350	Tyrosine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMC200043795	K00599	ko00450	Selenoamino acid metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMC200043795	K00599	ko00626	Naphthalene and anthracene degradation	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMC200043797	K00599	ko00340	Histidine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMC200043797	K00599	ko00350	Tyrosine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMC200043797	K00599	ko00450	Selenoamino acid metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMC200043797	K00599	ko00626	Naphthalene and anthracene degradation	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMC200037385	K11294	ko05130	Pathogenic Escherichia coli infection	478	1.6e-20	0.35	0.52	0.84
PGSC0003DMC200037387	K10775	ko00360	Phenylalanine metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMC200037387	K10775	ko00910	Nitrogen metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMC200037387	K10775	ko00940	Phenylpropanoid biosynthesis	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMC200037387	K10775	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMC200037387	K10775	ko01110	Biosynthesis of secondary metabolites	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMC200037388	K10775	ko00360	Phenylalanine metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMC200037388	K10775	ko00910	Nitrogen metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMC200037388	K10775	ko00940	Phenylpropanoid biosynthesis	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMC200037388	K10775	ko01100	Metabolic pathways	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMC200037388	K10775	ko01110	Biosynthesis of secondary metabolites	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMC200037391	K05681	ko02010	ABC transporters	905	8.0e-44	0.30	0.49	0.44
PGSC0003DMC200037395	K05681	ko02010	ABC transporters	921	5.8e-45	0.30	0.49	0.56
PGSC0003DMC200037396	K12356	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.92
PGSC0003DMC200037398	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMC200037399	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMC200037403	K01358	ko04112	Cell cycle - Caulobacter	489	3.9e-21	0.80	0.94	0.94
PGSC0003DMC200037406	K01051	ko00040	Pentose and glucuronate interconversions	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMC200037406	K01051	ko00500	Starch and sucrose metabolism	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMC200037406	K01051	ko01100	Metabolic pathways	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMC200037407	K01051	ko00040	Pentose and glucuronate interconversions	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMC200037407	K01051	ko00500	Starch and sucrose metabolism	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMC200037407	K01051	ko01100	Metabolic pathways	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMC200037410	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMC200037410	K00517	ko00626	Naphthalene and anthracene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMC200037410	K00517	ko00903	Limonene and pinene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMC200037410	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMC200037410	K00517	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMC200035733	K01955	ko00240	Pyrimidine metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMC200035733	K01955	ko00250	Alanine, aspartate and glutamate metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMC200035733	K01955	ko01100	Metabolic pathways	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMC200035737	K02976	ko03010	Ribosome	981	2.8e-48	0.88	0.91	0.99
PGSC0003DMC200035740	K10579	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.71	0.81	0.97
PGSC0003DMC200035741	K06689	ko04120	Ubiquitin mediated proteolysis	1231	4.6e-62	0.83	0.83	0.99
PGSC0003DMC200035742	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMC200035743	K03063	ko03050	Proteasome	3209	3.7e-171	0.93	0.96	1.00
PGSC0003DMC200035744	K03063	ko03050	Proteasome	573	9.1e-26	0.95	0.97	0.94
PGSC0003DMC200035747	K01251	ko00270	Cysteine and methionine metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMC200035747	K01251	ko00450	Selenoamino acid metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMC200035747	K01251	ko01100	Metabolic pathways	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMC200035748	K01251	ko00270	Cysteine and methionine metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMC200035748	K01251	ko00450	Selenoamino acid metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMC200035748	K01251	ko01100	Metabolic pathways	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMC200035749	K01251	ko00270	Cysteine and methionine metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMC200035749	K01251	ko00450	Selenoamino acid metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMC200035749	K01251	ko01100	Metabolic pathways	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMC200035750	K01516	ko00230	Purine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMC200035750	K01516	ko00730	Thiamine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMC200035750	K01516	ko01100	Metabolic pathways	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMC200035753	K06685	ko04111	Cell cycle - yeast	331	2.1e-10	0.27	0.45	0.69
PGSC0003DMC200059682	K09590	ko00905	Brassinosteroid biosynthesis	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMC200059682	K09590	ko01100	Metabolic pathways	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMC200059682	K09590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMC200059691	K05933	ko00270	Cysteine and methionine metabolism	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMC200059691	K05933	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMC200059692	K01199	ko00500	Starch and sucrose metabolism	480	1.2e-20	0.56	0.81	0.99
PGSC0003DMC200056311	K01358	ko04112	Cell cycle - Caulobacter	1652	2.8e-85	0.73	0.82	1.00
PGSC0003DMC200056313	K03941	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMC200056313	K03941	ko01100	Metabolic pathways	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMC200056313	K03941	ko05010	Alzheimer's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMC200056313	K03941	ko05012	Parkinson's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMC200056313	K03941	ko05016	Huntington's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMC200056324	K12879	ko03040	Spliceosome	11430	0.	0.74	0.83	1.00
PGSC0003DMC200056325	K12879	ko03040	Spliceosome	6858	0.	0.71	0.80	1.00
PGSC0003DMC200056326	K12879	ko03040	Spliceosome	3449	2.1e-184	0.61	0.73	1.00
PGSC0003DMC200056327	K12879	ko03040	Spliceosome	5317	2.0e-287	0.69	0.78	1.00
PGSC0003DMC200056336	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMC200056336	K00517	ko00626	Naphthalene and anthracene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMC200056336	K00517	ko00903	Limonene and pinene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMC200056336	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMC200056336	K00517	ko01110	Biosynthesis of secondary metabolites	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMC200036301	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMC200036301	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMC200036301	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMC200036301	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMC200036301	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMC200036302	K04733	ko04210	Apoptosis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMC200036302	K04733	ko04620	Toll-like receptor signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMC200036302	K04733	ko04722	Neurotrophin signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMC200036302	K04733	ko05140	Leishmaniasis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMC200036302	K04733	ko05142	Chagas disease	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMC200036303	K12356	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.32	0.50	0.89
PGSC0003DMC200036304	K12356	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.48	0.97
PGSC0003DMC200036306	K12356	ko00940	Phenylpropanoid biosynthesis	672	3.1e-31	0.32	0.49	0.92
PGSC0003DMC200043068	K12479	ko04144	Endocytosis	1614	3.5e-83	0.49	0.72	0.96
PGSC0003DMC200043069	K12479	ko04144	Endocytosis	2125	2.3e-111	0.47	0.71	1.00
PGSC0003DMC200043071	K00001	ko00010	Glycolysis / Gluconeogenesis	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00071	Fatty acid metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00350	Tyrosine metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00641	3-Chloroacrylic acid degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00830	Retinol metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko00982	Drug metabolism - cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko01100	Metabolic pathways	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043071	K00001	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMC200043072	K00001	ko00010	Glycolysis / Gluconeogenesis	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00071	Fatty acid metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00350	Tyrosine metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00641	3-Chloroacrylic acid degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00830	Retinol metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko00982	Drug metabolism - cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko01100	Metabolic pathways	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200043072	K00001	ko01110	Biosynthesis of secondary metabolites	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMC200007506	K02703	ko00195	Photosynthesis	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMC200007506	K02703	ko01100	Metabolic pathways	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMC200007516	K01046	ko00561	Glycerolipid metabolism	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMC200007516	K01046	ko01100	Metabolic pathways	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMC200007520	K04708	ko00600	Sphingolipid metabolism	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMC200007520	K04708	ko01100	Metabolic pathways	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMC200007521	K04708	ko00600	Sphingolipid metabolism	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMC200007521	K04708	ko01100	Metabolic pathways	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMC200014252	K04499	ko04310	Wnt signaling pathway	3459	6.0e-185	0.92	0.96	1.00
PGSC0003DMC200014253	K04499	ko04310	Wnt signaling pathway	2089	2.2e-109	0.91	0.97	1.00
PGSC0003DMC200014262	K07359	ko04920	Adipocytokine signaling pathway	2192	4.6e-115	0.65	0.78	1.00
PGSC0003DMC200014263	K07359	ko04920	Adipocytokine signaling pathway	2505	2.5e-132	0.74	0.85	0.98
PGSC0003DMC200014264	K01190	ko00052	Galactose metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMC200014264	K01190	ko00511	Other glycan degradation	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMC200014264	K01190	ko00600	Sphingolipid metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMC200014264	K01190	ko01100	Metabolic pathways	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMC200014265	K01190	ko00052	Galactose metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMC200014265	K01190	ko00511	Other glycan degradation	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMC200014265	K01190	ko00600	Sphingolipid metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMC200014265	K01190	ko01100	Metabolic pathways	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMC200014266	K01190	ko00052	Galactose metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMC200014266	K01190	ko00511	Other glycan degradation	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMC200014266	K01190	ko00600	Sphingolipid metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMC200014266	K01190	ko01100	Metabolic pathways	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMC200014267	K01190	ko00052	Galactose metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMC200014267	K01190	ko00511	Other glycan degradation	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMC200014267	K01190	ko00600	Sphingolipid metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMC200014267	K01190	ko01100	Metabolic pathways	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMC200014269	K08506	ko04130	SNARE interactions in vesicular transport	460	1.5e-19	0.78	0.94	0.99
PGSC0003DMC200014270	K08506	ko04130	SNARE interactions in vesicular transport	828	7.8e-40	0.59	0.77	0.99
PGSC0003DMC200014271	K08506	ko04130	SNARE interactions in vesicular transport	1385	1.5e-70	0.64	0.81	1.00
PGSC0003DMC200014273	K00253	ko00280	Valine, leucine and isoleucine degradation	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMC200014273	K00253	ko01100	Metabolic pathways	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMC200014274	K00253	ko00280	Valine, leucine and isoleucine degradation	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMC200014274	K00253	ko01100	Metabolic pathways	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMC200014275	K00253	ko00280	Valine, leucine and isoleucine degradation	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMC200014275	K00253	ko01100	Metabolic pathways	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMC200014277	K04706	ko04120	Ubiquitin mediated proteolysis	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMC200014277	K04706	ko04630	Jak-STAT signaling pathway	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMC200014277	K04706	ko05200	Pathways in cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMC200014277	K04706	ko05222	Small cell lung cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMC200014278	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014278	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014278	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014278	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014279	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014279	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014279	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014279	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMC200014280	K04706	ko04120	Ubiquitin mediated proteolysis	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMC200014280	K04706	ko04630	Jak-STAT signaling pathway	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMC200014280	K04706	ko05200	Pathways in cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMC200014280	K04706	ko05222	Small cell lung cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMC200025115	K08967	ko00270	Cysteine and methionine metabolism	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMC200025115	K08967	ko01100	Metabolic pathways	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMC200025132	K11329	ko02020	Two-component system	300	2.7e-10	0.32	0.51	0.35
PGSC0003DMC200025133	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMC200025135	K12893	ko03040	Spliceosome	492	2.7e-21	0.30	0.45	1.00
PGSC0003DMC200025136	K12891	ko03040	Spliceosome	457	2.3e-19	0.35	0.45	0.83
PGSC0003DMC200025137	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMC200025139	K00215	ko00300	Lysine biosynthesis	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMC200025139	K00215	ko01100	Metabolic pathways	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMC200025139	K00215	ko01110	Biosynthesis of secondary metabolites	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMC200025140	K00215	ko00300	Lysine biosynthesis	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMC200025140	K00215	ko01100	Metabolic pathways	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMC200025140	K00215	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMC200005518	K12123	ko04712	Circadian rhythm - plant	3877	4.5e-210	0.68	0.80	0.94
PGSC0003DMC200005519	K12123	ko04712	Circadian rhythm - plant	5792	0.	0.63	0.78	0.96
PGSC0003DMC200005520	K12123	ko04712	Circadian rhythm - plant	5781	0.	0.63	0.78	0.96
PGSC0003DMC200053311	K00600	ko00260	Glycine, serine and threonine metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053311	K00600	ko00460	Cyanoamino acid metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053311	K00600	ko00670	One carbon pool by folate	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053311	K00600	ko00680	Methane metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053311	K00600	ko01100	Metabolic pathways	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053311	K00600	ko01110	Biosynthesis of secondary metabolites	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMC200053323	K00703	ko00500	Starch and sucrose metabolism	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMC200053323	K00703	ko01100	Metabolic pathways	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMC200053324	K00703	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMC200053324	K00703	ko01100	Metabolic pathways	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMC200053329	K12126	ko04712	Circadian rhythm - plant	255	9.2e-07	0.28	0.49	0.65
PGSC0003DMC200053330	K12126	ko04712	Circadian rhythm - plant	218	9.1e-06	0.40	0.68	0.48
PGSC0003DMC200053331	K12126	ko04712	Circadian rhythm - plant	220	6.9e-06	0.29	0.46	0.88
PGSC0003DMC200053334	K00844	ko00010	Glycolysis / Gluconeogenesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00051	Fructose and mannose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00052	Galactose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00500	Starch and sucrose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00521	Streptomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko00524	Butirosin and neomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko01100	Metabolic pathways	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko01110	Biosynthesis of secondary metabolites	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko04910	Insulin signaling pathway	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053334	K00844	ko04930	Type II diabetes mellitus	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMC200053335	K00844	ko00010	Glycolysis / Gluconeogenesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00051	Fructose and mannose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00052	Galactose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00500	Starch and sucrose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00521	Streptomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko00524	Butirosin and neomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko01100	Metabolic pathways	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko01110	Biosynthesis of secondary metabolites	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko04910	Insulin signaling pathway	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053335	K00844	ko04930	Type II diabetes mellitus	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMC200053336	K00844	ko00010	Glycolysis / Gluconeogenesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00051	Fructose and mannose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00052	Galactose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00500	Starch and sucrose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00521	Streptomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko00524	Butirosin and neomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko01100	Metabolic pathways	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko04910	Insulin signaling pathway	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200053336	K00844	ko04930	Type II diabetes mellitus	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMC200050673	K06573	ko04966	Collecting duct acid secretion	323	3.1e-11	0.33	0.49	0.47
PGSC0003DMC200050674	K06573	ko04966	Collecting duct acid secretion	636	3.3e-29	0.26	0.43	0.92
PGSC0003DMC200050675	K01662	ko00900	Terpenoid backbone biosynthesis	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMC200050675	K01662	ko01100	Metabolic pathways	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMC200050675	K01662	ko01110	Biosynthesis of secondary metabolites	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMC200050676	K01662	ko00900	Terpenoid backbone biosynthesis	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMC200050676	K01662	ko01100	Metabolic pathways	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMC200050676	K01662	ko01110	Biosynthesis of secondary metabolites	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMC200050688	K08066	ko04612	Antigen processing and presentation	234	4.5e-07	0.33	0.61	0.75
PGSC0003DMC200050690	K12778	ko04113	Meiosis - yeast	343	8.2e-11	0.34	0.56	0.32
PGSC0003DMC200050691	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMC200050693	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMC200050694	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMC200050694	K00517	ko00626	Naphthalene and anthracene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMC200050694	K00517	ko00903	Limonene and pinene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMC200050694	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMC200050694	K00517	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMC200046321	K01623	ko00010	Glycolysis / Gluconeogenesis	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046321	K01623	ko00030	Pentose phosphate pathway	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046321	K01623	ko00051	Fructose and mannose metabolism	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046321	K01623	ko00710	Carbon fixation in photosynthetic organisms	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046321	K01623	ko01100	Metabolic pathways	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046321	K01623	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMC200046327	K01623	ko00010	Glycolysis / Gluconeogenesis	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046327	K01623	ko00030	Pentose phosphate pathway	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046327	K01623	ko00051	Fructose and mannose metabolism	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046327	K01623	ko00710	Carbon fixation in photosynthetic organisms	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046327	K01623	ko01100	Metabolic pathways	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046327	K01623	ko01110	Biosynthesis of secondary metabolites	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMC200046329	K01623	ko00010	Glycolysis / Gluconeogenesis	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046329	K01623	ko00030	Pentose phosphate pathway	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046329	K01623	ko00051	Fructose and mannose metabolism	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046329	K01623	ko00710	Carbon fixation in photosynthetic organisms	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046329	K01623	ko01100	Metabolic pathways	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046329	K01623	ko01110	Biosynthesis of secondary metabolites	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMC200046330	K01623	ko00010	Glycolysis / Gluconeogenesis	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046330	K01623	ko00030	Pentose phosphate pathway	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046330	K01623	ko00051	Fructose and mannose metabolism	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046330	K01623	ko00710	Carbon fixation in photosynthetic organisms	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046330	K01623	ko01100	Metabolic pathways	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046330	K01623	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMC200046331	K01623	ko00010	Glycolysis / Gluconeogenesis	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046331	K01623	ko00030	Pentose phosphate pathway	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046331	K01623	ko00051	Fructose and mannose metabolism	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046331	K01623	ko00710	Carbon fixation in photosynthetic organisms	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046331	K01623	ko01100	Metabolic pathways	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046331	K01623	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMC200046332	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMC200046332	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMC200046333	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMC200046333	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMC200046334	K02717	ko00195	Photosynthesis	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMC200046334	K02717	ko01100	Metabolic pathways	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMC200040831	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMC200040831	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMC200040831	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMC200040831	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMC200040831	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMC200040832	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMC200040832	K00517	ko00626	Naphthalene and anthracene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMC200040832	K00517	ko00903	Limonene and pinene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMC200040832	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMC200040832	K00517	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMC200040840	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040840	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040840	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040840	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040840	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040841	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040841	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040841	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040841	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040841	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040842	K01092	ko00521	Streptomycin biosynthesis	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMC200040842	K01092	ko00562	Inositol phosphate metabolism	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMC200040842	K01092	ko01100	Metabolic pathways	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMC200040842	K01092	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMC200040842	K01092	ko04070	Phosphatidylinositol signaling system	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMC200040843	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040843	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040843	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040843	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040843	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMC200040849	K01555	ko00350	Tyrosine metabolism	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMC200040849	K01555	ko00643	Styrene degradation	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMC200040849	K01555	ko01100	Metabolic pathways	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMC200040850	K02934	ko03010	Ribosome	1580	2.6e-81	0.81	0.89	1.00
PGSC0003DMC200040851	K04424	ko04010	MAPK signaling pathway	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMC200040851	K04424	ko04530	Tight junction	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMC200040853	K11147	ko00830	Retinol metabolism	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMC200040853	K11147	ko01100	Metabolic pathways	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMC200040853	K11147	ko04146	Peroxisome	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMC200040854	K11147	ko00830	Retinol metabolism	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMC200040854	K11147	ko01100	Metabolic pathways	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMC200040854	K11147	ko04146	Peroxisome	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMC200040860	K12850	ko03040	Spliceosome	1292	2.0e-65	0.60	0.78	1.00
PGSC0003DMC200063963	K10760	ko00908	Zeatin biosynthesis	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMC200063963	K10760	ko01100	Metabolic pathways	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMC200063963	K10760	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMC200063974	K03094	ko04110	Cell cycle	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04111	Cell cycle - yeast	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04114	Oocyte meiosis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04120	Ubiquitin mediated proteolysis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04310	Wnt signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04350	TGF-beta signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200063974	K03094	ko04710	Circadian rhythm - mammal	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMC200001141	K05743	ko04360	Axon guidance	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMC200001141	K05743	ko04666	Fc gamma R-mediated phagocytosis	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMC200001141	K05743	ko04810	Regulation of actin cytoskeleton	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMC200001142	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMC200001144	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMC200001146	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMC200001147	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMC200001148	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMC200001155	K07456	ko03430	Mismatch repair	1498	8.7e-77	0.34	0.52	0.93
PGSC0003DMC200001156	K07456	ko03430	Mismatch repair	1016	1.8e-53	0.54	0.72	0.73
PGSC0003DMC200001158	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMC200001159	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMC200001160	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMC200001161	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMC200001162	K07456	ko03430	Mismatch repair	1101	6.8e-55	0.35	0.54	0.88
PGSC0003DMC200001163	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.99
PGSC0003DMC200001164	K07456	ko03430	Mismatch repair	1562	2.6e-80	0.35	0.54	0.93
PGSC0003DMC200001165	K09880	ko00270	Cysteine and methionine metabolism	266	3.2e-08	0.42	0.52	0.97
PGSC0003DMC200022111	K06685	ko04111	Cell cycle - yeast	439	2.7e-14	0.25	0.41	0.40
PGSC0003DMC200022112	K06685	ko04111	Cell cycle - yeast	344	7.5e-10	0.25	0.41	0.93
PGSC0003DMC200022113	K06685	ko04111	Cell cycle - yeast	444	2.6e-15	0.25	0.42	0.89
PGSC0003DMC200022116	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMC200022116	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMC200022117	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMC200022117	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMC200022129	K02291	ko00906	Carotenoid biosynthesis	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMC200022129	K02291	ko01100	Metabolic pathways	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMC200022129	K02291	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMC200022135	K12589	ko03018	RNA degradation	1840	1.2e-95	0.78	0.90	0.99
PGSC0003DMC200015125	K01136	ko00531	Glycosaminoglycan degradation	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMC200015125	K01136	ko01100	Metabolic pathways	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMC200015125	K01136	ko04142	Lysosome	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMC200015132	K11253	ko05322	Systemic lupus erythematosus	920	6.6e-45	0.96	0.99	0.98
PGSC0003DMC200015135	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.31
PGSC0003DMC200015136	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.27
PGSC0003DMC200009636	K10147	ko04115	p53 signaling pathway	271	9.6e-09	0.37	0.51	0.59
PGSC0003DMC200009638	K01358	ko04112	Cell cycle - Caulobacter	702	7.0e-33	0.47	0.63	0.53
PGSC0003DMC200009646	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMC200009650	K01509	ko00230	Purine metabolism	1106	3.6e-55	0.46	0.62	0.85
PGSC0003DMC200009653	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009653	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009653	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009654	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009654	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009654	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMC200009657	K04371	ko04010	MAPK signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04012	ErbB signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04013	MAPK signaling pathway - fly	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04062	Chemokine signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04114	Oocyte meiosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04150	mTOR signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04270	Vascular smooth muscle contraction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04320	Dorso-ventral axis formation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04350	TGF-beta signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04360	Axon guidance	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04370	VEGF signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04510	Focal adhesion	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04520	Adherens junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04540	Gap junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04620	Toll-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04621	NOD-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04650	Natural killer cell mediated cytotoxicity	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04660	T cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04662	B cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04664	Fc epsilon RI signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04666	Fc gamma R-mediated phagocytosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04720	Long-term potentiation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04722	Neurotrophin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04730	Long-term depression	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04810	Regulation of actin cytoskeleton	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04910	Insulin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04912	GnRH signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04914	Progesterone-mediated oocyte maturation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04916	Melanogenesis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04930	Type II diabetes mellitus	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko04960	Aldosterone-regulated sodium reabsorption	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05010	Alzheimer's disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05020	Prion diseases	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05131	Shigellosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05140	Leishmaniasis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05142	Chagas disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05200	Pathways in cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05210	Colorectal cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05211	Renal cell carcinoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05212	Pancreatic cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05213	Endometrial cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05214	Glioma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05215	Prostate cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05216	Thyroid cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05218	Melanoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05219	Bladder cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05220	Chronic myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05221	Acute myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009657	K04371	ko05223	Non-small cell lung cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMC200009660	K01762	ko00270	Cysteine and methionine metabolism	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMC200009660	K01762	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMC200052111	K05765	ko04360	Axon guidance	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMC200052111	K05765	ko04666	Fc gamma R-mediated phagocytosis	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMC200052111	K05765	ko04810	Regulation of actin cytoskeleton	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMC200052112	K03023	ko00230	Purine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMC200052112	K03023	ko00240	Pyrimidine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMC200052112	K03023	ko01100	Metabolic pathways	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMC200052112	K03023	ko03020	RNA polymerase	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMC200052112	K03023	ko04623	Cytosolic DNA-sensing pathway	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMC200052113	K03023	ko00230	Purine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMC200052113	K03023	ko00240	Pyrimidine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMC200052113	K03023	ko01100	Metabolic pathways	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMC200052113	K03023	ko03020	RNA polymerase	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMC200052113	K03023	ko04623	Cytosolic DNA-sensing pathway	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMC200052129	K00287	ko00670	One carbon pool by folate	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMC200052129	K00287	ko00790	Folate biosynthesis	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMC200052129	K00287	ko01100	Metabolic pathways	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMC200052131	K07375	ko04145	Phagosome	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMC200052131	K07375	ko04540	Gap junction	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMC200052131	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMC200052133	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMC200052134	K03094	ko04110	Cell cycle	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04111	Cell cycle - yeast	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04114	Oocyte meiosis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04120	Ubiquitin mediated proteolysis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04310	Wnt signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04350	TGF-beta signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052134	K03094	ko04710	Circadian rhythm - mammal	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMC200052135	K03094	ko04110	Cell cycle	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04111	Cell cycle - yeast	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04114	Oocyte meiosis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04120	Ubiquitin mediated proteolysis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04310	Wnt signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04350	TGF-beta signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052135	K03094	ko04710	Circadian rhythm - mammal	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMC200052137	K11229	ko04011	MAPK signaling pathway - yeast	1058	4.1e-52	0.31	0.47	0.75
PGSC0003DMC200052138	K11229	ko04011	MAPK signaling pathway - yeast	897	5.9e-43	0.30	0.46	0.97
PGSC0003DMC200039631	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMC200039632	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMC200039651	K00475	ko00941	Flavonoid biosynthesis	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMC200039651	K00475	ko01100	Metabolic pathways	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMC200039651	K00475	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMC200039657	K11927	ko03018	RNA degradation	757	6.4e-36	0.34	0.54	0.61
PGSC0003DMC200045124	K00981	ko00564	Glycerophospholipid metabolism	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMC200045124	K00981	ko01100	Metabolic pathways	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMC200045124	K00981	ko04070	Phosphatidylinositol signaling system	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMC200045125	K00981	ko00564	Glycerophospholipid metabolism	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMC200045125	K00981	ko01100	Metabolic pathways	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMC200045125	K00981	ko04070	Phosphatidylinositol signaling system	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMC200045126	K06096	ko04530	Tight junction	342	5.0e-13	0.35	0.54	0.69
PGSC0003DMC200045127	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMC200045128	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMC200045130	K06653	ko04111	Cell cycle - yeast	330	1.4e-11	0.30	0.55	0.70
PGSC0003DMC200045132	K03514	ko03018	RNA degradation	567	1.5e-24	0.31	0.49	0.26
PGSC0003DMC200045133	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMC200045134	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMC200045136	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMC200045138	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMC200045139	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMC200045148	K06654	ko04111	Cell cycle - yeast	290	3.7e-10	0.38	0.57	0.61
PGSC0003DMC200045149	K12604	ko03018	RNA degradation	5926	0.	0.64	0.79	0.99
PGSC0003DMC200045150	K12604	ko03018	RNA degradation	12708	0.	0.66	0.79	1.00
PGSC0003DMC200023322	K01955	ko00240	Pyrimidine metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMC200023322	K01955	ko00250	Alanine, aspartate and glutamate metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMC200023322	K01955	ko01100	Metabolic pathways	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMC200023324	K10144	ko04115	p53 signaling pathway	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMC200023324	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMC200023325	K10144	ko04115	p53 signaling pathway	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMC200023325	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMC200023328	K00844	ko00010	Glycolysis / Gluconeogenesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00051	Fructose and mannose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00052	Galactose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00500	Starch and sucrose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00521	Streptomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko00524	Butirosin and neomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko01100	Metabolic pathways	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko01110	Biosynthesis of secondary metabolites	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko04910	Insulin signaling pathway	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023328	K00844	ko04930	Type II diabetes mellitus	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMC200023329	K10756	ko03030	DNA replication	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMC200023329	K10756	ko03420	Nucleotide excision repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMC200023329	K10756	ko03430	Mismatch repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMC200023332	K01952	ko00230	Purine metabolism	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMC200023332	K01952	ko01100	Metabolic pathways	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMC200023332	K01952	ko01110	Biosynthesis of secondary metabolites	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMC200020674	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMC200020674	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMC200020674	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMC200020680	K11294	ko05130	Pathogenic Escherichia coli infection	331	2.9e-09	0.28	0.45	0.38
PGSC0003DMC200020681	K11294	ko05130	Pathogenic Escherichia coli infection	296	6.0e-10	0.27	0.44	0.89
PGSC0003DMC200020696	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020696	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020696	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020697	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020697	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020697	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020698	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020698	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020698	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMC200020699	K04122	ko00904	Diterpenoid biosynthesis	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMC200020699	K04122	ko01100	Metabolic pathways	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMC200020699	K04122	ko01110	Biosynthesis of secondary metabolites	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMC200020700	K04122	ko00904	Diterpenoid biosynthesis	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMC200020700	K04122	ko01100	Metabolic pathways	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMC200020700	K04122	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMC200010831	K00660	ko00941	Flavonoid biosynthesis	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMC200010831	K00660	ko01100	Metabolic pathways	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMC200010831	K00660	ko01110	Biosynthesis of secondary metabolites	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMC200010831	K00660	ko04712	Circadian rhythm - plant	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMC200010847	K00981	ko00564	Glycerophospholipid metabolism	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMC200010847	K00981	ko01100	Metabolic pathways	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMC200010847	K00981	ko04070	Phosphatidylinositol signaling system	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMC200010848	K07424	ko00140	Steroid hormone biosynthesis	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00591	Linoleic acid metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00830	Retinol metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00982	Drug metabolism - cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko00983	Drug metabolism - other enzymes	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200010848	K07424	ko01100	Metabolic pathways	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMC200016329	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016329	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016329	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016330	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016330	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016330	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016331	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016331	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016331	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMC200016338	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMC200002349	K01728	ko00040	Pentose and glucuronate interconversions	1763	2.1e-91	0.53	0.69	0.89
PGSC0003DMC200002350	K10570	ko03420	Nucleotide excision repair	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMC200002350	K10570	ko04120	Ubiquitin mediated proteolysis	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMC200002353	K10712	ko00430	Taurine and hypotaurine metabolism	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMC200002353	K10712	ko01100	Metabolic pathways	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMC200002354	K10712	ko00430	Taurine and hypotaurine metabolism	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMC200002354	K10712	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMC200002356	K10573	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.98	1.00	0.76
PGSC0003DMC200002359	K01785	ko00010	Glycolysis / Gluconeogenesis	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMC200002359	K01785	ko01110	Biosynthesis of secondary metabolites	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMC200002360	K01785	ko00010	Glycolysis / Gluconeogenesis	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMC200002360	K01785	ko01110	Biosynthesis of secondary metabolites	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMC200002361	K01785	ko00010	Glycolysis / Gluconeogenesis	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMC200002361	K01785	ko01110	Biosynthesis of secondary metabolites	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMC200002362	K01785	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMC200002362	K01785	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMC200002363	K01785	ko00010	Glycolysis / Gluconeogenesis	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMC200002363	K01785	ko01110	Biosynthesis of secondary metabolites	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMC200002364	K01785	ko00010	Glycolysis / Gluconeogenesis	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMC200002364	K01785	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMC200002365	K01785	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMC200002365	K01785	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMC200002366	K01785	ko00010	Glycolysis / Gluconeogenesis	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMC200002366	K01785	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMC200002369	K07374	ko04145	Phagosome	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMC200002369	K07374	ko04540	Gap junction	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMC200002369	K07374	ko05130	Pathogenic Escherichia coli infection	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMC200002370	K03869	ko04120	Ubiquitin mediated proteolysis	450	8.8e-19	0.86	0.89	0.85
PGSC0003DMC200065166	K10760	ko00908	Zeatin biosynthesis	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMC200065166	K10760	ko01100	Metabolic pathways	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMC200065166	K10760	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMC200055111	K00797	ko00270	Cysteine and methionine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMC200055111	K00797	ko00330	Arginine and proline metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMC200055111	K00797	ko00410	beta-Alanine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMC200055111	K00797	ko00480	Glutathione metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMC200055111	K00797	ko01100	Metabolic pathways	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMC200055112	K00276	ko00260	Glycine, serine and threonine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko00350	Tyrosine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko00360	Phenylalanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko00410	beta-Alanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko00950	Isoquinoline alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko01100	Metabolic pathways	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055112	K00276	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMC200055113	K00276	ko00260	Glycine, serine and threonine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko00360	Phenylalanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko00410	beta-Alanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko00950	Isoquinoline alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko01100	Metabolic pathways	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055113	K00276	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMC200055114	K00276	ko00260	Glycine, serine and threonine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko00350	Tyrosine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko00360	Phenylalanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko00410	beta-Alanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko01100	Metabolic pathways	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055114	K00276	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMC200055118	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.27	0.43	0.78
PGSC0003DMC200055123	K01066	ko00623	2,4-Dichlorobenzoate degradation	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMC200055123	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMC200055124	K01046	ko00561	Glycerolipid metabolism	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMC200055124	K01046	ko01100	Metabolic pathways	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMC200055132	K00454	ko00591	Linoleic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMC200055132	K00454	ko00592	alpha-Linolenic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMC200055132	K00454	ko01100	Metabolic pathways	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMC200044252	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044252	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044253	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMC200044254	K02084	ko04115	p53 signaling pathway	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko04210	Apoptosis	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko05010	Alzheimer's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko05012	Parkinson's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko05016	Huntington's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044254	K02084	ko05222	Small cell lung cancer	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMC200044263	K12125	ko04712	Circadian rhythm - plant	1390	7.9e-71	0.38	0.50	1.00
PGSC0003DMC200044264	K12125	ko04712	Circadian rhythm - plant	539	6.8e-24	0.34	0.50	0.98
PGSC0003DMC200044265	K12125	ko04712	Circadian rhythm - plant	1316	9.5e-67	0.37	0.51	0.99
PGSC0003DMC200044268	K03940	ko00190	Oxidative phosphorylation	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMC200044268	K03940	ko01100	Metabolic pathways	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMC200044268	K03940	ko05010	Alzheimer's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMC200044268	K03940	ko05012	Parkinson's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMC200044268	K03940	ko05016	Huntington's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMC200044269	K01528	ko04144	Endocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMC200044269	K01528	ko04666	Fc gamma R-mediated phagocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMC200044269	K01528	ko05100	Bacterial invasion of epithelial cells	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMC200044275	K00558	ko00270	Cysteine and methionine metabolism	9363	0.	0.72	0.83	0.99
PGSC0003DMC200044275	K00558	ko01100	Metabolic pathways	9363	0.	0.72	0.83	0.99
PGSC0003DMC200037504	K05894	ko00592	alpha-Linolenic acid metabolism	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMC200037504	K05894	ko01100	Metabolic pathways	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMC200037505	K05894	ko00592	alpha-Linolenic acid metabolism	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMC200037505	K05894	ko01100	Metabolic pathways	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMC200037509	K01184	ko00040	Pentose and glucuronate interconversions	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMC200037509	K01184	ko00500	Starch and sucrose metabolism	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMC200037509	K01184	ko01100	Metabolic pathways	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMC200037511	K08770	ko03320	PPAR signaling pathway	418	3.2e-17	0.71	0.85	0.94
PGSC0003DMC200037513	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMC200037513	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMC200037513	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMC200037513	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMC200037514	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037514	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037514	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037514	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037515	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037515	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037515	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200037515	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMC200035495	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMC200035498	K00430	ko00360	Phenylalanine metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMC200035498	K00430	ko00680	Methane metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMC200035498	K00430	ko00940	Phenylpropanoid biosynthesis	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMC200035498	K00430	ko01100	Metabolic pathways	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMC200035498	K00430	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMC200035499	K00430	ko00360	Phenylalanine metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMC200035499	K00430	ko00680	Methane metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMC200035499	K00430	ko00940	Phenylpropanoid biosynthesis	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMC200035499	K00430	ko01100	Metabolic pathways	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMC200035499	K00430	ko01110	Biosynthesis of secondary metabolites	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMC200035501	K10880	ko03440	Homologous recombination	1172	8.3e-59	0.51	0.71	0.98
PGSC0003DMC200035505	K02726	ko03050	Proteasome	1634	2.7e-84	0.86	0.89	1.00
PGSC0003DMC200035506	K02726	ko03050	Proteasome	1851	2.9e-96	0.95	0.97	1.00
PGSC0003DMC200035517	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMC200035517	K00053	ko00770	Pantothenate and CoA biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMC200035517	K00053	ko01100	Metabolic pathways	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMC200035517	K00053	ko01110	Biosynthesis of secondary metabolites	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMC200035518	K12843	ko03040	Spliceosome	1344	2.7e-68	0.35	0.55	0.94
PGSC0003DMC200029677	K06685	ko04111	Cell cycle - yeast	330	1.3e-08	0.32	0.45	0.29
PGSC0003DMC200029687	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029687	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029687	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029687	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029687	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029688	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029688	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029688	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029688	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029688	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029689	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029689	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029689	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029689	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029689	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMC200029696	K07195	ko04910	Insulin signaling pathway	3587	5.2e-192	0.82	0.89	0.93
PGSC0003DMC200029697	K04733	ko04210	Apoptosis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMC200029697	K04733	ko04620	Toll-like receptor signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMC200029697	K04733	ko04722	Neurotrophin signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMC200029697	K04733	ko05140	Leishmaniasis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMC200029697	K04733	ko05142	Chagas disease	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMC200029698	K04733	ko04210	Apoptosis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMC200029698	K04733	ko04620	Toll-like receptor signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMC200029698	K04733	ko04722	Neurotrophin signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMC200029698	K04733	ko05140	Leishmaniasis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMC200029698	K04733	ko05142	Chagas disease	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMC200029700	K04733	ko04210	Apoptosis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMC200029700	K04733	ko04620	Toll-like receptor signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMC200029700	K04733	ko04722	Neurotrophin signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMC200029700	K04733	ko05140	Leishmaniasis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMC200029700	K04733	ko05142	Chagas disease	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMC200013051	K12603	ko03018	RNA degradation	345	6.8e-13	0.31	0.44	0.31
PGSC0003DMC200013052	K00660	ko00941	Flavonoid biosynthesis	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMC200013052	K00660	ko01100	Metabolic pathways	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMC200013052	K00660	ko01110	Biosynthesis of secondary metabolites	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMC200013052	K00660	ko04712	Circadian rhythm - plant	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMC200013055	K08912	ko00196	Photosynthesis - antenna proteins	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMC200013055	K08912	ko01100	Metabolic pathways	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMC200013064	K03352	ko04110	Cell cycle	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013064	K03352	ko04111	Cell cycle - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013064	K03352	ko04113	Meiosis - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013064	K03352	ko04114	Oocyte meiosis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013064	K03352	ko04120	Ubiquitin mediated proteolysis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013064	K03352	ko04914	Progesterone-mediated oocyte maturation	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMC200013065	K03352	ko04110	Cell cycle	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013065	K03352	ko04111	Cell cycle - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013065	K03352	ko04113	Meiosis - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013065	K03352	ko04114	Oocyte meiosis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013065	K03352	ko04120	Ubiquitin mediated proteolysis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013065	K03352	ko04914	Progesterone-mediated oocyte maturation	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMC200013075	K02084	ko04115	p53 signaling pathway	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko04210	Apoptosis	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko05010	Alzheimer's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko05012	Parkinson's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko05016	Huntington's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200013075	K02084	ko05222	Small cell lung cancer	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMC200006301	K00430	ko00360	Phenylalanine metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMC200006301	K00430	ko00680	Methane metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMC200006301	K00430	ko00940	Phenylpropanoid biosynthesis	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMC200006301	K00430	ko01100	Metabolic pathways	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMC200006301	K00430	ko01110	Biosynthesis of secondary metabolites	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMC200006302	K00430	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMC200006302	K00430	ko00680	Methane metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMC200006302	K00430	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMC200006302	K00430	ko01100	Metabolic pathways	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMC200006302	K00430	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMC200006303	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006303	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006303	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006303	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006303	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006304	K00430	ko00360	Phenylalanine metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMC200006304	K00430	ko00680	Methane metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMC200006304	K00430	ko00940	Phenylpropanoid biosynthesis	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMC200006304	K00430	ko01100	Metabolic pathways	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMC200006304	K00430	ko01110	Biosynthesis of secondary metabolites	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMC200006305	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006305	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006305	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006305	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006305	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMC200006306	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMC200006306	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMC200006306	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMC200006306	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMC200006306	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMC200006310	K12637	ko00905	Brassinosteroid biosynthesis	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMC200006310	K12637	ko01100	Metabolic pathways	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMC200006310	K12637	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMC200006311	K12637	ko00905	Brassinosteroid biosynthesis	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMC200006311	K12637	ko01100	Metabolic pathways	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMC200006311	K12637	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMC200006312	K01190	ko00052	Galactose metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMC200006312	K01190	ko00511	Other glycan degradation	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMC200006312	K01190	ko00600	Sphingolipid metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMC200006312	K01190	ko01100	Metabolic pathways	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMC200006328	K09755	ko00940	Phenylpropanoid biosynthesis	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMC200006328	K09755	ko01100	Metabolic pathways	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMC200006328	K09755	ko01110	Biosynthesis of secondary metabolites	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMC200006329	K09755	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMC200006329	K09755	ko01100	Metabolic pathways	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMC200006329	K09755	ko01110	Biosynthesis of secondary metabolites	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMC200026311	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	260	9.3e-08	0.42	0.58	0.97
PGSC0003DMC200026315	K03066	ko03050	Proteasome	2770	6.0e-147	0.81	0.86	1.00
PGSC0003DMC200026316	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMC200026317	K03066	ko03050	Proteasome	1292	2.0e-65	0.98	0.99	0.99
PGSC0003DMC200026323	K10615	ko04120	Ubiquitin mediated proteolysis	814	4.6e-39	0.35	0.53	0.89
PGSC0003DMC200026329	K00655	ko00561	Glycerolipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMC200026329	K00655	ko00564	Glycerophospholipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMC200026329	K00655	ko01100	Metabolic pathways	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMC200026330	K00655	ko00561	Glycerolipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMC200026330	K00655	ko00564	Glycerophospholipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMC200026330	K00655	ko01100	Metabolic pathways	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMC200026331	K02737	ko03050	Proteasome	827	8.9e-40	0.82	0.89	0.98
PGSC0003DMC200026332	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMC200026333	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMC200026335	K02328	ko00230	Purine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko00240	Pyrimidine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko01100	Metabolic pathways	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko03030	DNA replication	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko03410	Base excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko03420	Nucleotide excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko03430	Mismatch repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026335	K02328	ko03440	Homologous recombination	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMC200026336	K02328	ko00230	Purine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko00240	Pyrimidine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko01100	Metabolic pathways	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko03030	DNA replication	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko03410	Base excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko03420	Nucleotide excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko03430	Mismatch repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200026336	K02328	ko03440	Homologous recombination	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMC200059995	K10760	ko00908	Zeatin biosynthesis	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMC200059995	K10760	ko01100	Metabolic pathways	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMC200059995	K10760	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMC200066769	K13229	ko00402	Benzoxazinoid biosynthesis	228	9.7e-07	0.40	0.57	0.52
PGSC0003DMC200018289	K00650	ko00564	Glycerophospholipid metabolism	358	6.5e-14	0.29	0.43	0.68
PGSC0003DMC200018290	K00650	ko00564	Glycerophospholipid metabolism	353	1.2e-13	0.31	0.47	0.74
PGSC0003DMC200018291	K08906	ko00195	Photosynthesis	901	7.4e-44	0.72	0.81	0.81
PGSC0003DMC200025863	K00726	ko00510	N-Glycan biosynthesis	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMC200025863	K00726	ko01100	Metabolic pathways	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMC200025864	K00726	ko00510	N-Glycan biosynthesis	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMC200025864	K00726	ko01100	Metabolic pathways	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMC200025865	K00726	ko00510	N-Glycan biosynthesis	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMC200025865	K00726	ko01100	Metabolic pathways	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMC200025866	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMC200025866	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMC200025867	K00726	ko00510	N-Glycan biosynthesis	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMC200025867	K00726	ko01100	Metabolic pathways	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMC200025868	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMC200025868	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMC200025869	K00726	ko00510	N-Glycan biosynthesis	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMC200025869	K00726	ko01100	Metabolic pathways	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMC200025870	K00726	ko00510	N-Glycan biosynthesis	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMC200025870	K00726	ko01100	Metabolic pathways	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMC200025871	K00726	ko00510	N-Glycan biosynthesis	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMC200025871	K00726	ko01100	Metabolic pathways	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMC200025872	K09680	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMC200025872	K09680	ko01100	Metabolic pathways	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMC200025873	K09680	ko00770	Pantothenate and CoA biosynthesis	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMC200025873	K09680	ko01100	Metabolic pathways	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMC200025874	K01436	ko00330	Arginine and proline metabolism	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMC200025874	K01436	ko01100	Metabolic pathways	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMC200025874	K01436	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMC200025875	K01436	ko00330	Arginine and proline metabolism	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMC200025875	K01436	ko01100	Metabolic pathways	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMC200025875	K01436	ko01110	Biosynthesis of secondary metabolites	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMC200025882	K05279	ko00944	Flavone and flavonol biosynthesis	1346	2.1e-68	0.49	0.67	0.99
PGSC0003DMC200025884	K06236	ko04510	Focal adhesion	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMC200025884	K06236	ko04512	ECM-receptor interaction	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMC200025884	K06236	ko05146	Amoebiasis	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMC200047526	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMC200047526	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMC200047526	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMC200047533	K12929	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMC200047533	K12929	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMC200047534	K12929	ko00904	Diterpenoid biosynthesis	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMC200047534	K12929	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMC200047535	K12356	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.36	0.53	0.71
PGSC0003DMC200047537	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMC200047537	K00517	ko00626	Naphthalene and anthracene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMC200047537	K00517	ko00903	Limonene and pinene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMC200047537	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMC200047537	K00517	ko01110	Biosynthesis of secondary metabolites	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMC200047538	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMC200047538	K00517	ko00626	Naphthalene and anthracene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMC200047538	K00517	ko00903	Limonene and pinene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMC200047538	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMC200047538	K00517	ko01110	Biosynthesis of secondary metabolites	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMC200047541	K10773	ko03410	Base excision repair	2638	1.5e-148	0.38	0.51	0.69
PGSC0003DMC200047544	K05592	ko03018	RNA degradation	245	4.1e-06	0.31	0.53	0.45
PGSC0003DMC200047546	K00873	ko00010	Glycolysis / Gluconeogenesis	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko00230	Purine metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko00620	Pyruvate metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko00710	Carbon fixation in photosynthetic organisms	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko01100	Metabolic pathways	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047546	K00873	ko04930	Type II diabetes mellitus	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMC200047547	K00873	ko00010	Glycolysis / Gluconeogenesis	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko00230	Purine metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko00620	Pyruvate metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko00710	Carbon fixation in photosynthetic organisms	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko01100	Metabolic pathways	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200047547	K00873	ko04930	Type II diabetes mellitus	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMC200032298	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMC200032308	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.58
PGSC0003DMC200032310	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.49
PGSC0003DMC200049486	K04424	ko04010	MAPK signaling pathway	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMC200049486	K04424	ko04530	Tight junction	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMC200049487	K04424	ko04010	MAPK signaling pathway	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMC200049487	K04424	ko04530	Tight junction	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMC200054661	K09489	ko04612	Antigen processing and presentation	5305	9.2e-287	0.74	0.85	1.00
PGSC0003DMC200054669	K02690	ko00195	Photosynthesis	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMC200054669	K02690	ko01100	Metabolic pathways	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMC200054670	K11866	ko04144	Endocytosis	594	2.0e-26	0.33	0.43	0.69
PGSC0003DMC200054671	K11866	ko04144	Endocytosis	361	2.9e-13	0.33	0.43	0.96
PGSC0003DMC200054672	K11866	ko04144	Endocytosis	645	2.4e-29	0.34	0.46	0.86
PGSC0003DMC200054674	K03083	ko04012	ErbB signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04062	Chemokine signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04110	Cell cycle	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04310	Wnt signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04340	Hedgehog signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04360	Axon guidance	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04510	Focal adhesion	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04660	T cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04662	B cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04711	Circadian rhythm - fly	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04722	Neurotrophin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04910	Insulin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko04916	Melanogenesis	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05010	Alzheimer's disease	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05200	Pathways in cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05210	Colorectal cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05213	Endometrial cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05215	Prostate cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054674	K03083	ko05217	Basal cell carcinoma	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMC200054677	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMC200054678	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMC200054679	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMC200054679	K00766	ko01100	Metabolic pathways	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMC200054679	K00766	ko01110	Biosynthesis of secondary metabolites	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMC200054680	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMC200054680	K00766	ko01100	Metabolic pathways	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMC200054680	K00766	ko01110	Biosynthesis of secondary metabolites	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMC200054681	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMC200054681	K00766	ko01100	Metabolic pathways	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMC200054681	K00766	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMC200054683	K02717	ko00195	Photosynthesis	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMC200054683	K02717	ko01100	Metabolic pathways	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMC200054684	K02149	ko00190	Oxidative phosphorylation	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054684	K02149	ko01100	Metabolic pathways	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054684	K02149	ko04145	Phagosome	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054684	K02149	ko04966	Collecting duct acid secretion	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054684	K02149	ko05110	Vibrio cholerae infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054684	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMC200054688	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMC200054688	K12448	ko01100	Metabolic pathways	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMC200054689	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMC200054689	K12448	ko01100	Metabolic pathways	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMC200054690	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMC200054690	K12448	ko01100	Metabolic pathways	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMC200062388	K03094	ko04110	Cell cycle	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04111	Cell cycle - yeast	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04114	Oocyte meiosis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04120	Ubiquitin mediated proteolysis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04310	Wnt signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04350	TGF-beta signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200062388	K03094	ko04710	Circadian rhythm - mammal	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMC200065013	K03094	ko04110	Cell cycle	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04111	Cell cycle - yeast	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04114	Oocyte meiosis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04310	Wnt signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04350	TGF-beta signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065013	K03094	ko04710	Circadian rhythm - mammal	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMC200065017	K13065	ko00940	Phenylpropanoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMC200065017	K13065	ko00941	Flavonoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMC200065017	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMC200065017	K13065	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMC200065036	K10760	ko00908	Zeatin biosynthesis	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMC200065036	K10760	ko01100	Metabolic pathways	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMC200065036	K10760	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMC200001846	K02969	ko03010	Ribosome	999	2.9e-49	0.97	0.99	0.99
PGSC0003DMC200001856	K01955	ko00240	Pyrimidine metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMC200001856	K01955	ko00250	Alanine, aspartate and glutamate metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMC200001856	K01955	ko01100	Metabolic pathways	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMC200001860	K00423	ko00053	Ascorbate and aldarate metabolism	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMC200001860	K00423	ko01100	Metabolic pathways	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMC200022862	K09756	ko00940	Phenylpropanoid biosynthesis	1534	9.0e-79	0.45	0.59	0.88
PGSC0003DMC200022863	K09756	ko00940	Phenylpropanoid biosynthesis	1685	4.2e-87	0.49	0.62	0.99
PGSC0003DMC200022865	K01810	ko00010	Glycolysis / Gluconeogenesis	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022865	K01810	ko00030	Pentose phosphate pathway	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022865	K01810	ko00500	Starch and sucrose metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022865	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022865	K01810	ko01100	Metabolic pathways	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022865	K01810	ko01110	Biosynthesis of secondary metabolites	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMC200022866	K01810	ko00010	Glycolysis / Gluconeogenesis	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200022866	K01810	ko00030	Pentose phosphate pathway	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200022866	K01810	ko00500	Starch and sucrose metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200022866	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200022866	K01810	ko01100	Metabolic pathways	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200022866	K01810	ko01110	Biosynthesis of secondary metabolites	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMC200004298	K10246	ko01040	Biosynthesis of unsaturated fatty acids	450	5.5e-19	0.32	0.52	0.97
PGSC0003DMC200004303	K00002	ko00010	Glycolysis / Gluconeogenesis	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMC200004303	K00002	ko00561	Glycerolipid metabolism	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMC200004303	K00002	ko00930	Caprolactam degradation	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMC200004303	K00002	ko01100	Metabolic pathways	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMC200004303	K00002	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMC200004318	K03005	ko00230	Purine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMC200004318	K03005	ko00240	Pyrimidine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMC200004318	K03005	ko01100	Metabolic pathways	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMC200004318	K03005	ko03020	RNA polymerase	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMC200008703	K00679	ko00561	Glycerolipid metabolism	376	1.0e-14	0.41	0.59	0.97
PGSC0003DMC200008707	K07195	ko04910	Insulin signaling pathway	3473	1.0e-185	0.69	0.80	1.00
PGSC0003DMC200008709	K08517	ko04130	SNARE interactions in vesicular transport	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMC200008709	K08517	ko04145	Phagosome	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMC200008710	K08517	ko04130	SNARE interactions in vesicular transport	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMC200008710	K08517	ko04145	Phagosome	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMC200008711	K08517	ko04130	SNARE interactions in vesicular transport	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMC200008711	K08517	ko04145	Phagosome	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMC200008716	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMC200008716	K00814	ko00710	Carbon fixation in photosynthetic organisms	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMC200008716	K00814	ko01100	Metabolic pathways	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMC200008718	K03061	ko03050	Proteasome	518	9.8e-23	0.92	0.97	0.94
PGSC0003DMC200011345	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011345	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011345	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011345	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011345	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011345	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011346	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMC200011352	K08139	ko04113	Meiosis - yeast	853	3.3e-41	0.33	0.51	0.99
PGSC0003DMC200011353	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.55	0.89
PGSC0003DMC200011366	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMC200011367	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMC200027280	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMC200027281	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMC200027282	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMC200027297	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMC200027298	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMC200027299	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMC200027300	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMC200051666	K01051	ko00040	Pentose and glucuronate interconversions	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMC200051666	K01051	ko00500	Starch and sucrose metabolism	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMC200051666	K01051	ko01100	Metabolic pathways	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMC200051667	K02872	ko03010	Ribosome	1598	2.6e-82	0.90	0.97	1.00
PGSC0003DMC200051673	K00383	ko00480	Glutathione metabolism	2512	3.6e-142	0.83	0.90	1.00
PGSC0003DMC200051674	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMC200051675	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMC200033101	K01366	ko04142	Lysosome	2191	5.2e-115	0.73	0.84	1.00
PGSC0003DMC200033103	K00866	ko00564	Glycerophospholipid metabolism	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMC200033103	K00866	ko01100	Metabolic pathways	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMC200033105	K04125	ko00904	Diterpenoid biosynthesis	1465	5.7e-75	0.56	0.72	0.89
PGSC0003DMC200033120	K03004	ko00230	Purine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMC200033120	K03004	ko00240	Pyrimidine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMC200033120	K03004	ko01100	Metabolic pathways	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMC200033120	K03004	ko03020	RNA polymerase	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMC200058496	K02942	ko03010	Ribosome	532	1.7e-23	0.60	0.77	0.99
PGSC0003DMC200040141	K13030	ko00460	Cyanoamino acid metabolism	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMC200040141	K13030	ko01110	Biosynthesis of secondary metabolites	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMC200040142	K13030	ko00460	Cyanoamino acid metabolism	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMC200040142	K13030	ko01110	Biosynthesis of secondary metabolites	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMC200040149	K09841	ko00906	Carotenoid biosynthesis	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMC200040149	K09841	ko01100	Metabolic pathways	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMC200040149	K09841	ko01110	Biosynthesis of secondary metabolites	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMC200040151	K11927	ko03018	RNA degradation	921	5.8e-45	0.36	0.55	0.71
PGSC0003DMC200040152	K11927	ko03018	RNA degradation	428	9.0e-18	0.34	0.52	0.86
PGSC0003DMC200003092	K03849	ko00510	N-Glycan biosynthesis	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMC200003092	K03849	ko01100	Metabolic pathways	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMC200003093	K03849	ko00510	N-Glycan biosynthesis	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMC200003093	K03849	ko01100	Metabolic pathways	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMC200003095	K03260	ko05416	Viral myocarditis	6741	0.	0.53	0.65	1.00
PGSC0003DMC200003096	K03260	ko05416	Viral myocarditis	7201	0.	0.52	0.64	1.00
PGSC0003DMC200003102	K03115	ko04310	Wnt signaling pathway	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMC200003102	K03115	ko04520	Adherens junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMC200003102	K03115	ko04530	Tight junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMC200003102	K03115	ko04712	Circadian rhythm - plant	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMC200003112	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMC200003113	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMC200003114	K10590	ko04120	Ubiquitin mediated proteolysis	6966	0.	0.57	0.73	1.00
PGSC0003DMC200003115	K10590	ko04120	Ubiquitin mediated proteolysis	6297	0.	0.55	0.72	1.00
PGSC0003DMC200021667	K12132	ko04712	Circadian rhythm - plant	1614	3.5e-83	0.54	0.69	0.66
PGSC0003DMC200021668	K12132	ko04712	Circadian rhythm - plant	1738	5.0e-90	0.54	0.68	0.68
PGSC0003DMC200021676	K00599	ko00340	Histidine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMC200021676	K00599	ko00350	Tyrosine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMC200021676	K00599	ko00450	Selenoamino acid metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMC200021676	K00599	ko00626	Naphthalene and anthracene degradation	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMC200021678	K00599	ko00340	Histidine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMC200021678	K00599	ko00350	Tyrosine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMC200021678	K00599	ko00450	Selenoamino acid metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMC200021678	K00599	ko00626	Naphthalene and anthracene degradation	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMC200021679	K00599	ko00340	Histidine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMC200021679	K00599	ko00350	Tyrosine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMC200021679	K00599	ko00450	Selenoamino acid metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMC200021679	K00599	ko00626	Naphthalene and anthracene degradation	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMC200021682	K01194	ko00500	Starch and sucrose metabolism	2228	4.7e-117	0.67	0.82	1.00
PGSC0003DMC200021684	K09490	ko03060	Protein export	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMC200021684	K09490	ko05020	Prion diseases	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMC200010146	K12126	ko04712	Circadian rhythm - plant	300	1.5e-10	0.34	0.54	0.59
PGSC0003DMC200010159	K10144	ko04115	p53 signaling pathway	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMC200010159	K10144	ko04120	Ubiquitin mediated proteolysis	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMC200010160	K10144	ko04115	p53 signaling pathway	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMC200010160	K10144	ko04120	Ubiquitin mediated proteolysis	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMC200010166	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010166	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010166	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010166	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010166	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010167	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010167	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010167	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010167	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010167	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMC200010168	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010168	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010168	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010168	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010168	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010169	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010169	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010169	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010169	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200010169	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMC200028481	K03104	ko03060	Protein export	689	3.6e-32	0.70	0.83	0.94
PGSC0003DMC200028482	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1331	1.4e-67	0.58	0.69	0.91
PGSC0003DMC200028483	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	799	3.1e-38	0.63	0.79	0.99
PGSC0003DMC200028485	K03005	ko00230	Purine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMC200028485	K03005	ko00240	Pyrimidine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMC200028485	K03005	ko01100	Metabolic pathways	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMC200028485	K03005	ko03020	RNA polymerase	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMC200000631	K12355	ko00940	Phenylpropanoid biosynthesis	3144	1.4e-167	0.75	0.86	0.99
PGSC0003DMC200000632	K12486	ko04144	Endocytosis	488	4.4e-21	0.26	0.40	0.94
PGSC0003DMC200000640	K12191	ko04144	Endocytosis	1731	1.2e-89	0.95	0.98	1.00
PGSC0003DMC200000641	K01897	ko00071	Fatty acid metabolism	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMC200000641	K01897	ko01100	Metabolic pathways	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMC200000641	K01897	ko03320	PPAR signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMC200000641	K01897	ko04146	Peroxisome	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMC200000641	K01897	ko04920	Adipocytokine signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMC200000642	K12602	ko03018	RNA degradation	1970	8.0e-103	0.71	0.84	1.00
PGSC0003DMC200000647	K06444	ko00906	Carotenoid biosynthesis	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMC200000647	K06444	ko01100	Metabolic pathways	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMC200000647	K06444	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMC200000648	K06444	ko00906	Carotenoid biosynthesis	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMC200000648	K06444	ko01100	Metabolic pathways	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMC200000648	K06444	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMC200000649	K06444	ko00906	Carotenoid biosynthesis	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMC200000649	K06444	ko01100	Metabolic pathways	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMC200000649	K06444	ko01110	Biosynthesis of secondary metabolites	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMC200000652	K00279	ko00908	Zeatin biosynthesis	1858	1.2e-96	0.56	0.76	0.57
PGSC0003DMC200000655	K01956	ko00240	Pyrimidine metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMC200000655	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMC200000655	K01956	ko01100	Metabolic pathways	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMC200000656	K01956	ko00240	Pyrimidine metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMC200000656	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMC200000656	K01956	ko01100	Metabolic pathways	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMC200000658	K01190	ko00052	Galactose metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMC200000658	K01190	ko00511	Other glycan degradation	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMC200000658	K01190	ko00600	Sphingolipid metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMC200000658	K01190	ko01100	Metabolic pathways	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMC200000659	K01190	ko00052	Galactose metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMC200000659	K01190	ko00511	Other glycan degradation	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMC200000659	K01190	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMC200000659	K01190	ko01100	Metabolic pathways	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMC200000660	K01190	ko00052	Galactose metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMC200000660	K01190	ko00511	Other glycan degradation	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMC200000660	K01190	ko00600	Sphingolipid metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMC200000660	K01190	ko01100	Metabolic pathways	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMC200069432	K01199	ko00500	Starch and sucrose metabolism	873	2.6e-42	0.37	0.58	0.99
PGSC0003DMC200063834	K07466	ko03030	DNA replication	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMC200063834	K07466	ko03420	Nucleotide excision repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMC200063834	K07466	ko03430	Mismatch repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMC200063834	K07466	ko03440	Homologous recombination	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMC200034299	K00850	ko00010	Glycolysis / Gluconeogenesis	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034299	K00850	ko00030	Pentose phosphate pathway	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034299	K00850	ko00051	Fructose and mannose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034299	K00850	ko00052	Galactose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034299	K00850	ko01100	Metabolic pathways	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034299	K00850	ko01110	Biosynthesis of secondary metabolites	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMC200034300	K01199	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.38	0.56	0.65
PGSC0003DMC200034301	K01199	ko00500	Starch and sucrose metabolism	543	4.1e-24	0.38	0.56	0.60
PGSC0003DMC200034302	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	1951	9.0e-102	0.75	0.89	0.99
PGSC0003DMC200034307	K02084	ko04115	p53 signaling pathway	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko04210	Apoptosis	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko05010	Alzheimer's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko05012	Parkinson's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko05016	Huntington's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034307	K02084	ko05222	Small cell lung cancer	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMC200034311	K03012	ko00230	Purine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMC200034311	K03012	ko00240	Pyrimidine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMC200034311	K03012	ko01100	Metabolic pathways	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMC200034311	K03012	ko03020	RNA polymerase	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMC200034311	K03012	ko05016	Huntington's disease	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMC200034312	K03012	ko00230	Purine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMC200034312	K03012	ko00240	Pyrimidine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMC200034312	K03012	ko01100	Metabolic pathways	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMC200034312	K03012	ko03020	RNA polymerase	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMC200034312	K03012	ko05016	Huntington's disease	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMC200034319	K10352	ko04530	Tight junction	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMC200034319	K10352	ko05416	Viral myocarditis	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMC200034320	K00626	ko00071	Fatty acid metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00072	Synthesis and degradation of ketone bodies	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00280	Valine, leucine and isoleucine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00310	Lysine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00380	Tryptophan metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00620	Pyruvate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00632	Benzoate degradation via CoA ligation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00640	Propanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00650	Butanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko00900	Terpenoid backbone biosynthesis	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko01100	Metabolic pathways	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200034320	K00626	ko02020	Two-component system	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMC200052875	K12741	ko03040	Spliceosome	358	6.5e-14	0.41	0.44	0.63
PGSC0003DMC200052877	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMC200052878	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMC200052890	K00430	ko00360	Phenylalanine metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMC200052890	K00430	ko00680	Methane metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMC200052890	K00430	ko00940	Phenylpropanoid biosynthesis	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMC200052890	K00430	ko01100	Metabolic pathways	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMC200052890	K00430	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMC200038710	K00430	ko00360	Phenylalanine metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMC200038710	K00430	ko00680	Methane metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMC200038710	K00430	ko00940	Phenylpropanoid biosynthesis	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMC200038710	K00430	ko01100	Metabolic pathways	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMC200038710	K00430	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMC200038711	K00430	ko00360	Phenylalanine metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMC200038711	K00430	ko00680	Methane metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMC200038711	K00430	ko00940	Phenylpropanoid biosynthesis	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMC200038711	K00430	ko01100	Metabolic pathways	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMC200038711	K00430	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMC200057285	K02966	ko03010	Ribosome	341	5.7e-13	0.66	0.75	0.71
PGSC0003DMC200057289	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200057289	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200057289	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200041348	K12843	ko03040	Spliceosome	4209	2.6e-226	0.70	0.83	0.97
PGSC0003DMC200041349	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMC200041350	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMC200041351	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMC200041352	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMC200041353	K12896	ko03040	Spliceosome	1740	3.9e-90	0.71	0.78	0.95
PGSC0003DMC200041359	K01099	ko00562	Inositol phosphate metabolism	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMC200041359	K01099	ko01100	Metabolic pathways	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMC200041359	K01099	ko04070	Phosphatidylinositol signaling system	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMC200041360	K01099	ko00562	Inositol phosphate metabolism	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMC200041360	K01099	ko01100	Metabolic pathways	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMC200041360	K01099	ko04070	Phosphatidylinositol signaling system	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMC200041361	K01778	ko00300	Lysine biosynthesis	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMC200041361	K01778	ko01100	Metabolic pathways	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMC200041361	K01778	ko01110	Biosynthesis of secondary metabolites	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMC200041362	K02893	ko03010	Ribosome	1134	1.0e-56	0.88	0.95	0.99
PGSC0003DMC200041363	K13229	ko00402	Benzoxazinoid biosynthesis	312	2.3e-11	0.43	0.61	0.97
PGSC0003DMC200041364	K13229	ko00402	Benzoxazinoid biosynthesis	370	1.4e-14	0.36	0.53	0.86
PGSC0003DMC200041366	K01710	ko00521	Streptomycin biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMC200041366	K01710	ko00523	Polyketide sugar unit biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMC200041366	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMC200041366	K01710	ko01100	Metabolic pathways	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMC200041366	K01710	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMC200041367	K01710	ko00521	Streptomycin biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMC200041367	K01710	ko00523	Polyketide sugar unit biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMC200041367	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMC200041367	K01710	ko01100	Metabolic pathways	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMC200041367	K01710	ko01110	Biosynthesis of secondary metabolites	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMC200041368	K01710	ko00521	Streptomycin biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMC200041368	K01710	ko00523	Polyketide sugar unit biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMC200041368	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMC200041368	K01710	ko01100	Metabolic pathways	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMC200041368	K01710	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMC200041369	K07195	ko04910	Insulin signaling pathway	2668	2.6e-141	0.54	0.72	0.97
PGSC0003DMC200041370	K01728	ko00040	Pentose and glucuronate interconversions	2056	1.5e-107	0.73	0.86	0.90
PGSC0003DMC200017527	K08913	ko00196	Photosynthesis - antenna proteins	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMC200017527	K08913	ko01100	Metabolic pathways	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMC200017528	K08913	ko00196	Photosynthesis - antenna proteins	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMC200017528	K08913	ko01100	Metabolic pathways	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMC200017529	K08913	ko00196	Photosynthesis - antenna proteins	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMC200017529	K08913	ko01100	Metabolic pathways	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMC200017548	K01193	ko00052	Galactose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMC200017548	K01193	ko00500	Starch and sucrose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMC200017548	K01193	ko01100	Metabolic pathways	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMC200019471	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019471	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019471	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019471	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019471	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019471	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMC200019475	K07964	ko00531	Glycosaminoglycan degradation	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMC200019475	K07964	ko01100	Metabolic pathways	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMC200019476	K07964	ko00531	Glycosaminoglycan degradation	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMC200019476	K07964	ko01100	Metabolic pathways	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMC200019477	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.39	0.59	0.88
PGSC0003DMC200019478	K13228	ko00402	Benzoxazinoid biosynthesis	783	2.4e-37	0.46	0.65	0.88
PGSC0003DMC200019479	K13228	ko00402	Benzoxazinoid biosynthesis	804	1.6e-38	0.34	0.55	0.93
PGSC0003DMC200019480	K13228	ko00402	Benzoxazinoid biosynthesis	613	5.6e-28	0.41	0.59	0.87
PGSC0003DMC200019481	K13228	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.34	0.55	0.91
PGSC0003DMC200019482	K13228	ko00402	Benzoxazinoid biosynthesis	805	1.4e-38	0.46	0.67	0.88
PGSC0003DMC200019483	K13228	ko00402	Benzoxazinoid biosynthesis	1033	3.9e-51	0.39	0.58	0.88
PGSC0003DMC200019484	K02184	ko04320	Dorso-ventral axis formation	502	4.3e-21	0.41	0.46	0.44
PGSC0003DMC200019494	K01193	ko00052	Galactose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMC200019494	K01193	ko00500	Starch and sucrose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMC200019494	K01193	ko01100	Metabolic pathways	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMC200019495	K09841	ko00906	Carotenoid biosynthesis	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMC200019495	K09841	ko01100	Metabolic pathways	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMC200019495	K09841	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMC200019498	K12382	ko04142	Lysosome	267	8.7e-09	0.28	0.49	0.71
PGSC0003DMC200019499	K12382	ko04142	Lysosome	270	5.8e-09	0.29	0.50	0.76
PGSC0003DMC200019500	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMC200024663	K13065	ko00940	Phenylpropanoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMC200024663	K13065	ko00941	Flavonoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMC200024663	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMC200024663	K13065	ko01110	Biosynthesis of secondary metabolites	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMC200024665	K13065	ko00940	Phenylpropanoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMC200024665	K13065	ko00941	Flavonoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMC200024665	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMC200024665	K13065	ko01110	Biosynthesis of secondary metabolites	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMC200024669	K03469	ko03030	DNA replication	239	1.6e-06	0.38	0.54	0.13
PGSC0003DMC200024671	K13065	ko00940	Phenylpropanoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMC200024671	K13065	ko00941	Flavonoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMC200024671	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMC200024671	K13065	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMC200024676	K01772	ko00860	Porphyrin and chlorophyll metabolism	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMC200024676	K01772	ko01100	Metabolic pathways	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMC200024676	K01772	ko01110	Biosynthesis of secondary metabolites	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMC200024677	K05280	ko00941	Flavonoid biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMC200024677	K05280	ko00944	Flavone and flavonol biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMC200024677	K05280	ko01100	Metabolic pathways	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMC200024677	K05280	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMC200024678	K05280	ko00941	Flavonoid biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMC200024678	K05280	ko00944	Flavone and flavonol biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMC200024678	K05280	ko01100	Metabolic pathways	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMC200024678	K05280	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMC200024679	K05280	ko00941	Flavonoid biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMC200024679	K05280	ko00944	Flavone and flavonol biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMC200024679	K05280	ko01100	Metabolic pathways	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMC200024679	K05280	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMC200024680	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024680	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024680	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024680	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024680	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024681	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024681	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024681	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024681	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024681	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMC200024682	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMC200024682	K00517	ko00626	Naphthalene and anthracene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMC200024682	K00517	ko00903	Limonene and pinene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMC200024682	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMC200024682	K00517	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMC200024683	K11868	ko00380	Tryptophan metabolism	512	2.1e-22	0.34	0.59	0.99
PGSC0003DMC200024684	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMC200024684	K00517	ko00626	Naphthalene and anthracene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMC200024684	K00517	ko00903	Limonene and pinene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMC200024684	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMC200024684	K00517	ko01110	Biosynthesis of secondary metabolites	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMC200024685	K09755	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMC200024685	K09755	ko01100	Metabolic pathways	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMC200024685	K09755	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMC200024686	K05280	ko00941	Flavonoid biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMC200024686	K05280	ko00944	Flavone and flavonol biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMC200024686	K05280	ko01100	Metabolic pathways	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMC200024686	K05280	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMC200024687	K05280	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMC200024687	K05280	ko00944	Flavone and flavonol biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMC200024687	K05280	ko01100	Metabolic pathways	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMC200024687	K05280	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMC200067972	K01051	ko00040	Pentose and glucuronate interconversions	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMC200067972	K01051	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMC200067972	K01051	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMC200048271	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMC200048285	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMC200048285	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMC200048286	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048286	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048287	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048287	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048288	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMC200048288	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMC200048289	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048289	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMC200048290	K03110	ko03060	Protein export	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMC200048290	K03110	ko03070	Bacterial secretion system	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMC200031088	K01509	ko00230	Purine metabolism	1249	4.7e-63	0.32	0.47	0.76
PGSC0003DMC200031089	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.79
PGSC0003DMC200031090	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMC200031091	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMC200055864	K12126	ko04712	Circadian rhythm - plant	395	6.0e-16	0.47	0.64	0.29
PGSC0003DMC200055865	K08509	ko04130	SNARE interactions in vesicular transport	581	3.3e-26	0.67	0.80	0.95
PGSC0003DMC200055866	K08509	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.62	0.75	1.00
PGSC0003DMC200055874	K00059	ko00061	Fatty acid biosynthesis	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMC200055874	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMC200055874	K00059	ko01100	Metabolic pathways	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMC200055875	K00059	ko00061	Fatty acid biosynthesis	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMC200055875	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMC200055875	K00059	ko01100	Metabolic pathways	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMC200055879	K00012	ko00040	Pentose and glucuronate interconversions	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055879	K00012	ko00053	Ascorbate and aldarate metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055879	K00012	ko00500	Starch and sucrose metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055879	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055879	K00012	ko01100	Metabolic pathways	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055879	K00012	ko01110	Biosynthesis of secondary metabolites	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMC200055884	K10604	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.40	0.57	0.69
PGSC0003DMC200055888	K01640	ko00072	Synthesis and degradation of ketone bodies	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko00280	Valine, leucine and isoleucine degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko00281	Geraniol degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko00650	Butanoate metabolism	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko01100	Metabolic pathways	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055888	K01640	ko04146	Peroxisome	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMC200055889	K01640	ko00072	Synthesis and degradation of ketone bodies	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko00280	Valine, leucine and isoleucine degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko00281	Geraniol degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko00650	Butanoate metabolism	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko01100	Metabolic pathways	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055889	K01640	ko04146	Peroxisome	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMC200055890	K01640	ko00072	Synthesis and degradation of ketone bodies	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko00280	Valine, leucine and isoleucine degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko00281	Geraniol degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko00650	Butanoate metabolism	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko01100	Metabolic pathways	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko01110	Biosynthesis of secondary metabolites	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200055890	K01640	ko04146	Peroxisome	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMC200052591	K00360	ko00910	Nitrogen metabolism	2956	3.3e-157	0.78	0.89	1.00
PGSC0003DMC200052592	K00360	ko00910	Nitrogen metabolism	3072	1.3e-163	0.78	0.90	1.00
PGSC0003DMC200052593	K00360	ko00910	Nitrogen metabolism	6070	0.	0.76	0.86	1.00
PGSC0003DMC200052605	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMC200052605	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMC200052605	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMC200052606	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMC200052606	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMC200052606	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMC200052615	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.37	0.60	0.53
PGSC0003DMC200035162	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035162	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035162	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035163	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMC200035163	K00891	ko01100	Metabolic pathways	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMC200035163	K00891	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMC200035164	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035164	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035164	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035165	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035165	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035165	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035166	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035166	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035166	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMC200035167	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMC200035167	K00891	ko01100	Metabolic pathways	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMC200035167	K00891	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMC200035168	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMC200035168	K00891	ko01100	Metabolic pathways	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMC200035168	K00891	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMC200044406	K12128	ko04712	Circadian rhythm - plant	428	1.2e-17	0.29	0.46	0.60
PGSC0003DMC200044412	K01581	ko00330	Arginine and proline metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMC200044412	K01581	ko00480	Glutathione metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMC200044412	K01581	ko01100	Metabolic pathways	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMC200044412	K01581	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMC200044419	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.83
PGSC0003DMC200044420	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.85
PGSC0003DMC200044427	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMC200044427	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMC200044428	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMC200044428	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMC200047042	K04354	ko04111	Cell cycle - yeast	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMC200047042	K04354	ko04530	Tight junction	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMC200047042	K04354	ko05142	Chagas disease	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMC200047043	K04354	ko04111	Cell cycle - yeast	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMC200047043	K04354	ko04530	Tight junction	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMC200047043	K04354	ko05142	Chagas disease	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMC200047044	K04354	ko04111	Cell cycle - yeast	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMC200047044	K04354	ko04530	Tight junction	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMC200047044	K04354	ko05142	Chagas disease	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMC200047045	K04354	ko04111	Cell cycle - yeast	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMC200047045	K04354	ko04530	Tight junction	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMC200047045	K04354	ko05142	Chagas disease	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMC200047046	K04354	ko04111	Cell cycle - yeast	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMC200047046	K04354	ko04530	Tight junction	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMC200047046	K04354	ko05142	Chagas disease	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMC200047047	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMC200047047	K00766	ko01100	Metabolic pathways	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMC200047047	K00766	ko01110	Biosynthesis of secondary metabolites	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMC200047050	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMC200047053	K06573	ko04966	Collecting duct acid secretion	491	9.7e-21	0.29	0.48	0.72
PGSC0003DMC200047055	K06573	ko04966	Collecting duct acid secretion	307	2.5e-10	0.38	0.57	0.80
PGSC0003DMC200047056	K06573	ko04966	Collecting duct acid secretion	752	1.2e-35	0.29	0.46	0.84
PGSC0003DMC200047057	K06573	ko04966	Collecting duct acid secretion	228	6.7e-06	0.26	0.47	0.88
PGSC0003DMC200047064	K03681	ko03018	RNA degradation	1546	2.0e-79	0.81	0.90	0.97
PGSC0003DMC200057789	K08271	ko04150	mTOR signaling pathway	346	3.0e-13	0.30	0.45	0.63
PGSC0003DMC200057806	K12581	ko03018	RNA degradation	982	2.5e-48	0.52	0.68	0.94
PGSC0003DMC200000431	K01068	ko01040	Biosynthesis of unsaturated fatty acids	792	7.6e-38	0.57	0.66	0.99
PGSC0003DMC200000432	K12604	ko03018	RNA degradation	2187	8.6e-115	0.59	0.77	0.97
PGSC0003DMC200000433	K12604	ko03018	RNA degradation	571	1.6e-24	0.45	0.63	0.83
PGSC0003DMC200000434	K12604	ko03018	RNA degradation	2739	3.1e-145	0.57	0.75	0.99
PGSC0003DMC200000435	K12604	ko03018	RNA degradation	555	1.6e-23	0.48	0.65	0.95
PGSC0003DMC200000436	K12604	ko03018	RNA degradation	760	6.5e-35	0.50	0.65	0.95
PGSC0003DMC200000437	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMC200000438	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMC200000439	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMC200000440	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMC200000441	K12604	ko03018	RNA degradation	2339	3.6e-123	0.58	0.76	0.99
PGSC0003DMC200000447	K11600	ko03018	RNA degradation	1787	1.0e-92	0.90	0.95	0.98
PGSC0003DMC200021398	K00703	ko00500	Starch and sucrose metabolism	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMC200021398	K00703	ko01100	Metabolic pathways	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMC200021399	K00703	ko00500	Starch and sucrose metabolism	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMC200021399	K00703	ko01100	Metabolic pathways	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMC200021400	K01199	ko00500	Starch and sucrose metabolism	744	3.4e-35	0.35	0.54	0.80
PGSC0003DMC200003961	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMC200003967	K00975	ko00500	Starch and sucrose metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMC200003967	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMC200003967	K00975	ko01100	Metabolic pathways	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMC200003969	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003969	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003969	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003970	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003970	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003970	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMC200003971	K00975	ko00500	Starch and sucrose metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMC200003971	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMC200003971	K00975	ko01100	Metabolic pathways	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMC200003972	K12842	ko03040	Spliceosome	4915	3.0e-265	0.71	0.79	0.97
PGSC0003DMC200003973	K12842	ko03040	Spliceosome	1543	2.9e-79	0.84	0.93	0.96
PGSC0003DMC200003974	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMC200003975	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMC200003976	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMC200003987	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMC200003987	K02367	ko01100	Metabolic pathways	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMC200003988	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMC200003988	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMC200003989	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMC200003989	K02367	ko01100	Metabolic pathways	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMC200003990	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMC200003990	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMC200028998	K00705	ko00500	Starch and sucrose metabolism	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMC200028998	K00705	ko01100	Metabolic pathways	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMC200028999	K00705	ko00500	Starch and sucrose metabolism	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMC200028999	K00705	ko01100	Metabolic pathways	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMC200029000	K00705	ko00500	Starch and sucrose metabolism	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMC200029000	K00705	ko01100	Metabolic pathways	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMC200015854	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMC200015855	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMC200015857	K06611	ko00052	Galactose metabolism	2939	2.9e-156	0.44	0.60	1.00
PGSC0003DMC200015858	K10581	ko04120	Ubiquitin mediated proteolysis	591	1.8e-26	0.36	0.54	0.82
PGSC0003DMC200015859	K12820	ko03040	Spliceosome	3968	5.1e-213	0.89	0.95	0.99
PGSC0003DMC200015860	K12820	ko03040	Spliceosome	5626	0.	0.90	0.94	1.00
PGSC0003DMC200015861	K12820	ko03040	Spliceosome	3975	2.1e-213	0.89	0.95	0.93
PGSC0003DMC200015864	K04125	ko00904	Diterpenoid biosynthesis	869	4.3e-42	0.47	0.63	0.89
PGSC0003DMC200015865	K04125	ko00904	Diterpenoid biosynthesis	1117	9.0e-56	0.47	0.63	0.93
PGSC0003DMC200029971	K12837	ko03040	Spliceosome	780	1.0e-41	0.35	0.51	0.45
PGSC0003DMC200029972	K02902	ko03010	Ribosome	431	6.2e-18	0.68	0.85	0.50
PGSC0003DMC200029983	K00026	ko00020	Citrate cycle (TCA cycle)	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029983	K00026	ko00620	Pyruvate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029983	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029983	K00026	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029983	K00026	ko01100	Metabolic pathways	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029983	K00026	ko01110	Biosynthesis of secondary metabolites	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMC200029984	K05765	ko04360	Axon guidance	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMC200029984	K05765	ko04666	Fc gamma R-mediated phagocytosis	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMC200029984	K05765	ko04810	Regulation of actin cytoskeleton	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMC200029985	K12119	ko04712	Circadian rhythm - plant	3751	4.7e-201	0.69	0.82	0.98
PGSC0003DMC200029986	K12119	ko04712	Circadian rhythm - plant	2548	1.1e-134	0.66	0.79	0.99
PGSC0003DMC200029999	K13229	ko00402	Benzoxazinoid biosynthesis	1093	1.9e-54	0.45	0.59	0.98
PGSC0003DMC200030000	K13229	ko00402	Benzoxazinoid biosynthesis	413	6.1e-17	0.50	0.68	0.95
PGSC0003DMC200048785	K02084	ko04115	p53 signaling pathway	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko04210	Apoptosis	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko05010	Alzheimer's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko05012	Parkinson's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko05016	Huntington's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048785	K02084	ko05222	Small cell lung cancer	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMC200048808	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMC200048808	K00517	ko00626	Naphthalene and anthracene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMC200048808	K00517	ko00903	Limonene and pinene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMC200048808	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMC200048808	K00517	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMC200048809	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMC200048809	K00517	ko00626	Naphthalene and anthracene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMC200048809	K00517	ko00903	Limonene and pinene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMC200048809	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMC200048809	K00517	ko01110	Biosynthesis of secondary metabolites	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMC200048810	K00059	ko00061	Fatty acid biosynthesis	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMC200048810	K00059	ko01040	Biosynthesis of unsaturated fatty acids	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMC200048810	K00059	ko01100	Metabolic pathways	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMC200055591	K12859	ko03040	Spliceosome	861	1.2e-41	0.97	1.00	0.99
PGSC0003DMC200055595	K01845	ko00860	Porphyrin and chlorophyll metabolism	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMC200055595	K01845	ko01100	Metabolic pathways	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMC200055595	K01845	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMC200055596	K01845	ko00860	Porphyrin and chlorophyll metabolism	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMC200055596	K01845	ko01100	Metabolic pathways	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMC200055596	K01845	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMC200055597	K01845	ko00860	Porphyrin and chlorophyll metabolism	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMC200055597	K01845	ko01100	Metabolic pathways	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMC200055597	K01845	ko01110	Biosynthesis of secondary metabolites	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMC200055601	K02084	ko04115	p53 signaling pathway	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko04210	Apoptosis	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko05010	Alzheimer's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko05012	Parkinson's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko05016	Huntington's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055601	K02084	ko05222	Small cell lung cancer	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMC200055606	K00995	ko00564	Glycerophospholipid metabolism	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMC200055606	K00995	ko01100	Metabolic pathways	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMC200055607	K00995	ko00564	Glycerophospholipid metabolism	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMC200055607	K00995	ko01100	Metabolic pathways	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMC200055611	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMC200055612	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMC200055613	K10643	ko03018	RNA degradation	941	4.6e-46	0.32	0.49	0.92
PGSC0003DMC200055614	K10643	ko03018	RNA degradation	2311	1.3e-121	0.37	0.52	1.00
PGSC0003DMC200065504	K02084	ko04115	p53 signaling pathway	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko04210	Apoptosis	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko05010	Alzheimer's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko05012	Parkinson's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko05016	Huntington's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065504	K02084	ko05222	Small cell lung cancer	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMC200065520	K12833	ko03040	Spliceosome	421	2.2e-17	0.75	0.81	0.99
PGSC0003DMC200011836	K02685	ko00230	Purine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMC200011836	K02685	ko00240	Pyrimidine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMC200011836	K02685	ko01100	Metabolic pathways	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMC200011836	K02685	ko03030	DNA replication	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMC200011838	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMC200011838	K00517	ko00626	Naphthalene and anthracene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMC200011838	K00517	ko00903	Limonene and pinene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMC200011838	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMC200011838	K00517	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMC200011840	K12467	ko00902	Monoterpenoid biosynthesis	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMC200011840	K12467	ko01110	Biosynthesis of secondary metabolites	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMC200011841	K13066	ko00940	Phenylpropanoid biosynthesis	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMC200011841	K13066	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMC200011843	K12182	ko04144	Endocytosis	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMC200011843	K12182	ko04145	Phagosome	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMC200011849	K08905	ko00195	Photosynthesis	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMC200011849	K08905	ko01100	Metabolic pathways	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMC200019982	K01696	ko00260	Glycine, serine and threonine metabolism	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMC200019982	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMC200019982	K01696	ko01100	Metabolic pathways	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMC200019982	K01696	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMC200019983	K12184	ko04144	Endocytosis	748	2.0e-35	0.58	0.70	0.75
PGSC0003DMC200019988	K01246	ko03410	Base excision repair	865	7.1e-42	0.53	0.66	1.00
PGSC0003DMC200019989	K01246	ko03410	Base excision repair	578	4.8e-26	0.69	0.92	0.96
PGSC0003DMC200019990	K01246	ko03410	Base excision repair	1680	8.0e-87	0.59	0.73	0.99
PGSC0003DMC200020001	K05277	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMC200020001	K05277	ko01100	Metabolic pathways	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMC200020001	K05277	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMC200020004	K05277	ko00941	Flavonoid biosynthesis	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMC200020004	K05277	ko01100	Metabolic pathways	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMC200020004	K05277	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMC200020008	K12134	ko04712	Circadian rhythm - plant	480	1.2e-20	0.90	0.98	0.86
PGSC0003DMC200020009	K12133	ko04712	Circadian rhythm - plant	1266	5.4e-64	0.43	0.56	0.85
PGSC0003DMC200020010	K12133	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.44	0.55	0.98
PGSC0003DMC200024398	K06063	ko03040	Spliceosome	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMC200024398	K06063	ko04330	Notch signaling pathway	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMC200024400	K01369	ko04142	Lysosome	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMC200024400	K01369	ko04612	Antigen processing and presentation	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMC200024401	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMC200024401	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMC200024402	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMC200024402	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMC200024403	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMC200024403	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMC200024404	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMC200024404	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMC200024407	K12125	ko04712	Circadian rhythm - plant	664	8.7e-31	0.41	0.51	0.98
PGSC0003DMC200024408	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.37	0.53	0.99
PGSC0003DMC200024409	K12125	ko04712	Circadian rhythm - plant	859	1.5e-41	0.40	0.56	0.98
PGSC0003DMC200024410	K12125	ko04712	Circadian rhythm - plant	1636	2.1e-84	0.40	0.54	0.99
PGSC0003DMC200024412	K12194	ko04144	Endocytosis	1410	6.2e-72	0.84	0.87	0.56
PGSC0003DMC200024413	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMC200024414	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMC200024415	K01369	ko04142	Lysosome	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMC200024415	K01369	ko04612	Antigen processing and presentation	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMC200024416	K01369	ko04142	Lysosome	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMC200024416	K01369	ko04612	Antigen processing and presentation	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMC200024417	K01369	ko04142	Lysosome	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMC200024417	K01369	ko04612	Antigen processing and presentation	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMC200041821	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200041821	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMC200041832	K06630	ko04110	Cell cycle	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMC200041832	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMC200041832	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMC200041834	K03715	ko00561	Glycerolipid metabolism	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMC200041834	K03715	ko01100	Metabolic pathways	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMC200041835	K10839	ko03420	Nucleotide excision repair	2475	1.1e-130	0.76	0.84	1.00
PGSC0003DMC200041837	K00075	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMC200041837	K00075	ko00550	Peptidoglycan biosynthesis	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMC200041837	K00075	ko01100	Metabolic pathways	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMC200041844	K01915	ko00250	Alanine, aspartate and glutamate metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMC200041844	K01915	ko00330	Arginine and proline metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMC200041844	K01915	ko00910	Nitrogen metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMC200041844	K01915	ko01100	Metabolic pathways	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMC200041844	K01915	ko02020	Two-component system	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMC200041847	K02084	ko04115	p53 signaling pathway	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko04210	Apoptosis	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko05010	Alzheimer's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko05012	Parkinson's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko05016	Huntington's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041847	K02084	ko05222	Small cell lung cancer	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMC200041850	K00949	ko00730	Thiamine metabolism	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMC200041850	K00949	ko01100	Metabolic pathways	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMC200049981	K00599	ko00340	Histidine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMC200049981	K00599	ko00350	Tyrosine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMC200049981	K00599	ko00450	Selenoamino acid metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMC200049981	K00599	ko00626	Naphthalene and anthracene degradation	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMC200049992	K01853	ko00100	Steroid biosynthesis	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMC200049992	K01853	ko01100	Metabolic pathways	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMC200049992	K01853	ko01110	Biosynthesis of secondary metabolites	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMC200049993	K01853	ko00100	Steroid biosynthesis	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMC200049993	K01853	ko01100	Metabolic pathways	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMC200049993	K01853	ko01110	Biosynthesis of secondary metabolites	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMC200050006	K07573	ko03018	RNA degradation	1318	7.4e-67	0.84	0.90	0.96
PGSC0003DMC200031174	K12493	ko04144	Endocytosis	1499	7.6e-77	0.41	0.57	0.93
PGSC0003DMC200031175	K12493	ko04144	Endocytosis	412	4.7e-16	0.32	0.51	0.99
PGSC0003DMC200031179	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMC200031179	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMC200031179	K00771	ko01100	Metabolic pathways	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMC200031185	K04424	ko04010	MAPK signaling pathway	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMC200031185	K04424	ko04530	Tight junction	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMC200054399	K05863	ko04020	Calcium signaling pathway	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMC200054399	K05863	ko05012	Parkinson's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMC200054399	K05863	ko05016	Huntington's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMC200018793	K02183	ko04020	Calcium signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04070	Phosphatidylinositol signaling system	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04114	Oocyte meiosis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04270	Vascular smooth muscle contraction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04626	Plant-pathogen interaction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04720	Long-term potentiation	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04722	Neurotrophin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04740	Olfactory transduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04744	Phototransduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04745	Phototransduction - fly	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04910	Insulin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04912	GnRH signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04916	Melanogenesis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04970	Salivary secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko04971	Gastric acid secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko05010	Alzheimer's disease	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018793	K02183	ko05214	Glioma	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMC200018798	K06443	ko00906	Carotenoid biosynthesis	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMC200018798	K06443	ko01100	Metabolic pathways	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMC200018798	K06443	ko01110	Biosynthesis of secondary metabolites	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMC200018799	K00599	ko00340	Histidine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMC200018799	K00599	ko00350	Tyrosine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMC200018799	K00599	ko00450	Selenoamino acid metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMC200018799	K00599	ko00626	Naphthalene and anthracene degradation	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMC200018809	K03013	ko00230	Purine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMC200018809	K03013	ko00240	Pyrimidine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMC200018809	K03013	ko01100	Metabolic pathways	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMC200018809	K03013	ko03020	RNA polymerase	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMC200018809	K03013	ko05016	Huntington's disease	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMC200025612	K01187	ko00052	Galactose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMC200025612	K01187	ko00500	Starch and sucrose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMC200025612	K01187	ko01100	Metabolic pathways	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMC200025618	K01054	ko00561	Glycerolipid metabolism	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMC200025618	K01054	ko01100	Metabolic pathways	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMC200025619	K02876	ko03010	Ribosome	1568	1.2e-80	0.77	0.85	0.92
PGSC0003DMC200033968	K06671	ko04110	Cell cycle	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMC200033968	K06671	ko04111	Cell cycle - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMC200033968	K06671	ko04113	Meiosis - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMC200033969	K06671	ko04110	Cell cycle	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMC200033969	K06671	ko04111	Cell cycle - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMC200033969	K06671	ko04113	Meiosis - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMC200033970	K06671	ko04110	Cell cycle	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMC200033970	K06671	ko04111	Cell cycle - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMC200033970	K06671	ko04113	Meiosis - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMC200033971	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.39	0.53	0.69
PGSC0003DMC200033972	K10352	ko04530	Tight junction	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMC200033972	K10352	ko05416	Viral myocarditis	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMC200033973	K10352	ko04530	Tight junction	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMC200033973	K10352	ko05416	Viral myocarditis	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMC200033974	K02985	ko03010	Ribosome	1782	1.9e-92	0.93	0.96	0.95
PGSC0003DMC200033975	K00797	ko00270	Cysteine and methionine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMC200033975	K00797	ko00330	Arginine and proline metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMC200033975	K00797	ko00410	beta-Alanine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMC200033975	K00797	ko00480	Glutathione metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMC200033975	K00797	ko01100	Metabolic pathways	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMC200033980	K04733	ko04210	Apoptosis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMC200033980	K04733	ko04620	Toll-like receptor signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMC200033980	K04733	ko04722	Neurotrophin signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMC200033980	K04733	ko05140	Leishmaniasis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMC200033980	K04733	ko05142	Chagas disease	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMC200033981	K07424	ko00140	Steroid hormone biosynthesis	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00591	Linoleic acid metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00830	Retinol metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00982	Drug metabolism - cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko00983	Drug metabolism - other enzymes	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033981	K07424	ko01100	Metabolic pathways	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMC200033989	K01501	ko00380	Tryptophan metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033989	K01501	ko00460	Cyanoamino acid metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033989	K01501	ko00632	Benzoate degradation via CoA ligation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033989	K01501	ko00643	Styrene degradation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033989	K01501	ko00910	Nitrogen metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033989	K01501	ko01100	Metabolic pathways	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMC200033990	K01501	ko00380	Tryptophan metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200033990	K01501	ko00460	Cyanoamino acid metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200033990	K01501	ko00632	Benzoate degradation via CoA ligation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200033990	K01501	ko00643	Styrene degradation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200033990	K01501	ko00910	Nitrogen metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200033990	K01501	ko01100	Metabolic pathways	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMC200051405	K05868	ko04110	Cell cycle	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMC200051405	K05868	ko04115	p53 signaling pathway	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMC200051405	K05868	ko04914	Progesterone-mediated oocyte maturation	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMC200051406	K12128	ko04712	Circadian rhythm - plant	406	1.5e-16	0.35	0.55	0.67
PGSC0003DMC200051407	K12128	ko04712	Circadian rhythm - plant	406	2.0e-16	0.35	0.55	0.27
PGSC0003DMC200051408	K12128	ko04712	Circadian rhythm - plant	406	1.9e-16	0.35	0.55	0.27
PGSC0003DMC200051409	K10352	ko04530	Tight junction	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMC200051409	K10352	ko05416	Viral myocarditis	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMC200051410	K10866	ko03440	Homologous recombination	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMC200051410	K10866	ko03450	Non-homologous end-joining	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMC200051412	K10352	ko04530	Tight junction	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMC200051412	K10352	ko05416	Viral myocarditis	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMC200051414	K13229	ko00402	Benzoxazinoid biosynthesis	1103	5.3e-55	0.41	0.60	0.95
PGSC0003DMC200051420	K12478	ko04144	Endocytosis	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMC200051420	K12478	ko04145	Phagosome	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMC200045849	K01054	ko00561	Glycerolipid metabolism	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMC200045849	K01054	ko01100	Metabolic pathways	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMC200045850	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMC200045850	K01602	ko00710	Carbon fixation in photosynthetic organisms	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMC200045850	K01602	ko01100	Metabolic pathways	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMC200045851	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045851	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045851	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045852	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045852	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045852	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045853	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045853	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045853	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMC200045860	K12845	ko03040	Spliceosome	989	1.0e-48	0.93	0.97	0.99
PGSC0003DMC200045861	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.63
PGSC0003DMC200045862	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMC200045863	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMC200045864	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMC200045868	K12831	ko03040	Spliceosome	231	7.1e-07	0.37	0.43	0.57
PGSC0003DMC200005169	K02997	ko03010	Ribosome	1585	1.4e-81	0.94	0.99	0.99
PGSC0003DMC200005190	K07297	ko04920	Adipocytokine signaling pathway	534	1.3e-23	0.59	0.77	0.63
PGSC0003DMC200022592	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMC200022592	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMC200022598	K01046	ko00561	Glycerolipid metabolism	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMC200022598	K01046	ko01100	Metabolic pathways	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMC200022599	K01955	ko00240	Pyrimidine metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMC200022599	K01955	ko00250	Alanine, aspartate and glutamate metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMC200022599	K01955	ko01100	Metabolic pathways	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMC200022606	K10885	ko03450	Non-homologous end-joining	4138	2.1e-222	0.70	0.85	0.97
PGSC0003DMC200022607	K01800	ko00350	Tyrosine metabolism	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMC200022607	K01800	ko00643	Styrene degradation	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMC200022607	K01800	ko01100	Metabolic pathways	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMC200022608	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMC200022608	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMC200022608	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMC200022609	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMC200022609	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMC200022609	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMC200022610	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022610	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022610	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022611	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022611	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022611	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMC200022612	K07750	ko00100	Steroid biosynthesis	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMC200022612	K07750	ko01100	Metabolic pathways	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMC200022613	K08272	ko04150	mTOR signaling pathway	1897	8.5e-99	0.80	0.88	0.98
PGSC0003DMC200022614	K08272	ko04150	mTOR signaling pathway	2273	1.6e-119	0.80	0.89	0.99
PGSC0003DMC200022615	K08272	ko04150	mTOR signaling pathway	1998	2.3e-104	0.80	0.89	0.99
PGSC0003DMC200022616	K08272	ko04150	mTOR signaling pathway	1279	1.0e-64	0.79	0.88	0.94
PGSC0003DMC200014409	K00599	ko00340	Histidine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMC200014409	K00599	ko00350	Tyrosine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMC200014409	K00599	ko00450	Selenoamino acid metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMC200014409	K00599	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMC200014410	K00599	ko00340	Histidine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMC200014410	K00599	ko00350	Tyrosine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMC200014410	K00599	ko00450	Selenoamino acid metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMC200014410	K00599	ko00626	Naphthalene and anthracene degradation	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMC200027781	K12194	ko04144	Endocytosis	424	7.9e-17	0.46	0.66	0.13
PGSC0003DMC200027782	K12194	ko04144	Endocytosis	424	3.7e-17	0.46	0.66	0.17
PGSC0003DMC200027788	K00655	ko00561	Glycerolipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMC200027788	K00655	ko00564	Glycerophospholipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMC200027788	K00655	ko01100	Metabolic pathways	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMC200027801	K02703	ko00195	Photosynthesis	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMC200027801	K02703	ko01100	Metabolic pathways	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMC200027810	K01179	ko00500	Starch and sucrose metabolism	224	3.4e-06	0.53	0.69	0.57
PGSC0003DMC200017046	K02729	ko03050	Proteasome	1652	2.8e-85	0.96	1.00	0.95
PGSC0003DMC200017047	K02729	ko03050	Proteasome	1923	3.1e-100	0.97	1.00	1.00
PGSC0003DMC200017052	K12812	ko03040	Spliceosome	541	5.3e-24	0.73	0.88	0.56
PGSC0003DMC200017053	K12812	ko03040	Spliceosome	2689	1.8e-142	0.89	0.92	0.59
PGSC0003DMC200017054	K12812	ko03040	Spliceosome	2806	6.2e-149	0.96	0.99	1.00
PGSC0003DMC200017055	K12812	ko03040	Spliceosome	3452	1.5e-184	0.94	0.99	1.00
PGSC0003DMC200017061	K11821	ko00380	Tryptophan metabolism	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMC200017061	K11821	ko00966	Glucosinolate biosynthesis	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMC200017061	K11821	ko01110	Biosynthesis of secondary metabolites	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMC200017063	K02471	ko02010	ABC transporters	766	2.1e-36	0.43	0.64	0.74
PGSC0003DMC200017064	K02471	ko02010	ABC transporters	1473	2.1e-75	0.41	0.58	0.98
PGSC0003DMC200017065	K02471	ko02010	ABC transporters	309	7.7e-11	0.43	0.66	0.97
PGSC0003DMC200017068	K02471	ko02010	ABC transporters	338	1.0e-12	0.60	0.73	0.86
PGSC0003DMC200001631	K03129	ko03022	Basal transcription factors	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMC200001631	K03129	ko05016	Huntington's disease	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMC200001633	K01728	ko00040	Pentose and glucuronate interconversions	1820	1.5e-94	0.53	0.69	0.92
PGSC0003DMC200001634	K13289	ko04142	Lysosome	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMC200001634	K13289	ko04614	Renin-angiotensin system	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMC200001635	K13289	ko04142	Lysosome	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMC200001635	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMC200001636	K13289	ko04142	Lysosome	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMC200001636	K13289	ko04614	Renin-angiotensin system	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMC200001637	K13289	ko04142	Lysosome	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMC200001637	K13289	ko04614	Renin-angiotensin system	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMC200001638	K13289	ko04142	Lysosome	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMC200001638	K13289	ko04614	Renin-angiotensin system	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMC200001639	K13289	ko04142	Lysosome	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMC200001639	K13289	ko04614	Renin-angiotensin system	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMC200001640	K13289	ko04142	Lysosome	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMC200001640	K13289	ko04614	Renin-angiotensin system	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMC200001641	K13289	ko04142	Lysosome	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMC200001641	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMC200001642	K13289	ko04142	Lysosome	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMC200001642	K13289	ko04614	Renin-angiotensin system	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMC200001650	K05862	ko04020	Calcium signaling pathway	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMC200001650	K05862	ko05012	Parkinson's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMC200001650	K05862	ko05016	Huntington's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMC200068706	K08241	ko00592	alpha-Linolenic acid metabolism	625	1.2e-28	0.33	0.53	0.88
PGSC0003DMC200068727	K10352	ko04530	Tight junction	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMC200068727	K10352	ko05416	Viral myocarditis	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMC200064292	K11816	ko00380	Tryptophan metabolism	497	1.4e-21	0.47	0.66	0.98
PGSC0003DMC200064300	K12586	ko03018	RNA degradation	244	4.5e-11	0.53	0.72	0.48
PGSC0003DMC200005012	K12608	ko03018	RNA degradation	551	1.5e-24	0.80	0.84	0.78
PGSC0003DMC200005013	K12608	ko03018	RNA degradation	631	5.7e-29	0.80	0.86	0.99
PGSC0003DMC200005014	K12608	ko03018	RNA degradation	2391	4.8e-126	0.87	0.92	1.00
PGSC0003DMC200017145	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMC200017145	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMC200017146	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMC200017146	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMC200017147	K01114	ko00562	Inositol phosphate metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMC200017147	K01114	ko00564	Glycerophospholipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMC200017147	K01114	ko00565	Ether lipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMC200017147	K01114	ko01100	Metabolic pathways	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMC200017148	K01955	ko00240	Pyrimidine metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMC200017148	K01955	ko00250	Alanine, aspartate and glutamate metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMC200017148	K01955	ko01100	Metabolic pathways	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMC200017151	K05278	ko00941	Flavonoid biosynthesis	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMC200017151	K05278	ko01100	Metabolic pathways	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMC200017151	K05278	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMC200017152	K01955	ko00240	Pyrimidine metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMC200017152	K01955	ko00250	Alanine, aspartate and glutamate metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMC200017152	K01955	ko01100	Metabolic pathways	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMC200017158	K05278	ko00941	Flavonoid biosynthesis	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMC200017158	K05278	ko01100	Metabolic pathways	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMC200017158	K05278	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMC200017159	K05278	ko00941	Flavonoid biosynthesis	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMC200017159	K05278	ko01100	Metabolic pathways	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMC200017159	K05278	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMC200010632	K08332	ko04140	Regulation of autophagy	388	1.6e-13	0.30	0.51	0.49
PGSC0003DMC200010641	K12200	ko04144	Endocytosis	5739	0.	0.75	0.86	1.00
PGSC0003DMC200010642	K12200	ko04144	Endocytosis	5413	1.0e-292	0.75	0.85	1.00
PGSC0003DMC200010643	K02133	ko00190	Oxidative phosphorylation	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMC200010643	K02133	ko01100	Metabolic pathways	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMC200010643	K02133	ko05010	Alzheimer's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMC200010643	K02133	ko05012	Parkinson's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMC200010643	K02133	ko05016	Huntington's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMC200010644	K08730	ko00564	Glycerophospholipid metabolism	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMC200010644	K08730	ko01100	Metabolic pathways	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMC200010647	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.21
PGSC0003DMC200010649	K12135	ko04712	Circadian rhythm - plant	296	1.9e-10	0.45	0.62	0.17
PGSC0003DMC200010650	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.27
PGSC0003DMC200056792	K07374	ko04145	Phagosome	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMC200056792	K07374	ko04540	Gap junction	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMC200056792	K07374	ko05130	Pathogenic Escherichia coli infection	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMC200033812	K00100	ko00051	Fructose and mannose metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033812	K00100	ko00363	Bisphenol A degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033812	K00100	ko00591	Linoleic acid metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033812	K00100	ko00625	Tetrachloroethene degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033812	K00100	ko00650	Butanoate metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033812	K00100	ko01100	Metabolic pathways	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMC200033813	K00100	ko00051	Fructose and mannose metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033813	K00100	ko00363	Bisphenol A degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033813	K00100	ko00591	Linoleic acid metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033813	K00100	ko00625	Tetrachloroethene degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033813	K00100	ko00650	Butanoate metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033813	K00100	ko01100	Metabolic pathways	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMC200033814	K00100	ko00051	Fructose and mannose metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033814	K00100	ko00363	Bisphenol A degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033814	K00100	ko00591	Linoleic acid metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033814	K00100	ko00625	Tetrachloroethene degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033814	K00100	ko00650	Butanoate metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033814	K00100	ko01100	Metabolic pathways	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMC200033815	K00100	ko00051	Fructose and mannose metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033815	K00100	ko00363	Bisphenol A degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033815	K00100	ko00591	Linoleic acid metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033815	K00100	ko00625	Tetrachloroethene degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033815	K00100	ko00650	Butanoate metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033815	K00100	ko01100	Metabolic pathways	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMC200033816	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033816	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033816	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033816	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033816	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033816	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMC200033817	K00100	ko00051	Fructose and mannose metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033817	K00100	ko00363	Bisphenol A degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033817	K00100	ko00591	Linoleic acid metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033817	K00100	ko00625	Tetrachloroethene degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033817	K00100	ko00650	Butanoate metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033817	K00100	ko01100	Metabolic pathways	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMC200033818	K00100	ko00051	Fructose and mannose metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033818	K00100	ko00363	Bisphenol A degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033818	K00100	ko00591	Linoleic acid metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033818	K00100	ko00625	Tetrachloroethene degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033818	K00100	ko00650	Butanoate metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033818	K00100	ko01100	Metabolic pathways	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko00051	Fructose and mannose metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko00363	Bisphenol A degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko00591	Linoleic acid metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko00625	Tetrachloroethene degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko00650	Butanoate metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033819	K00100	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMC200033820	K00100	ko00051	Fructose and mannose metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033820	K00100	ko00363	Bisphenol A degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033820	K00100	ko00591	Linoleic acid metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033820	K00100	ko00625	Tetrachloroethene degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033820	K00100	ko00650	Butanoate metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033820	K00100	ko01100	Metabolic pathways	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMC200033822	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033822	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033822	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033822	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033823	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033823	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033823	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033823	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMC200033825	K04371	ko04010	MAPK signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04012	ErbB signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04013	MAPK signaling pathway - fly	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04062	Chemokine signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04114	Oocyte meiosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04150	mTOR signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04270	Vascular smooth muscle contraction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04320	Dorso-ventral axis formation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04350	TGF-beta signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04360	Axon guidance	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04370	VEGF signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04510	Focal adhesion	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04520	Adherens junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04540	Gap junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04620	Toll-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04621	NOD-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04650	Natural killer cell mediated cytotoxicity	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04660	T cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04662	B cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04664	Fc epsilon RI signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04666	Fc gamma R-mediated phagocytosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04720	Long-term potentiation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04722	Neurotrophin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04730	Long-term depression	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04810	Regulation of actin cytoskeleton	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04910	Insulin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04912	GnRH signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04914	Progesterone-mediated oocyte maturation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04916	Melanogenesis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04930	Type II diabetes mellitus	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko04960	Aldosterone-regulated sodium reabsorption	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05010	Alzheimer's disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05020	Prion diseases	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05131	Shigellosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05140	Leishmaniasis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05142	Chagas disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05200	Pathways in cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05210	Colorectal cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05211	Renal cell carcinoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05212	Pancreatic cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05213	Endometrial cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05214	Glioma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05215	Prostate cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05216	Thyroid cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05218	Melanoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05219	Bladder cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05220	Chronic myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05221	Acute myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033825	K04371	ko05223	Non-small cell lung cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMC200033826	K03116	ko03060	Protein export	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMC200033826	K03116	ko03070	Bacterial secretion system	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMC200033827	K03116	ko03060	Protein export	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMC200033827	K03116	ko03070	Bacterial secretion system	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMC200033831	K08803	ko05200	Pathways in cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMC200033831	K08803	ko05219	Bladder cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMC200033833	K09553	ko05020	Prion diseases	313	3.4e-11	0.40	0.52	0.39
PGSC0003DMC200033835	K08769	ko03320	PPAR signaling pathway	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMC200033835	K08769	ko05016	Huntington's disease	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMC200045932	K01889	ko00970	Aminoacyl-tRNA biosynthesis	425	3.7e-26	0.85	0.95	0.83
PGSC0003DMC200045947	K00029	ko00620	Pyruvate metabolism	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMC200045947	K00029	ko00710	Carbon fixation in photosynthetic organisms	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMC200045947	K00029	ko01100	Metabolic pathways	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMC200039422	K03952	ko00190	Oxidative phosphorylation	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMC200039422	K03952	ko01100	Metabolic pathways	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMC200039422	K03952	ko05010	Alzheimer's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMC200039422	K03952	ko05012	Parkinson's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMC200039422	K03952	ko05016	Huntington's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMC200039423	K03952	ko00190	Oxidative phosphorylation	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMC200039423	K03952	ko01100	Metabolic pathways	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMC200039423	K03952	ko05010	Alzheimer's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMC200039423	K03952	ko05012	Parkinson's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMC200039423	K03952	ko05016	Huntington's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMC200039427	K00818	ko00330	Arginine and proline metabolism	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMC200039427	K00818	ko01100	Metabolic pathways	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMC200039427	K00818	ko01110	Biosynthesis of secondary metabolites	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMC200039428	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMC200039428	K00517	ko00626	Naphthalene and anthracene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMC200039428	K00517	ko00903	Limonene and pinene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMC200039428	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMC200039428	K00517	ko01110	Biosynthesis of secondary metabolites	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMC200039429	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMC200039429	K00517	ko00626	Naphthalene and anthracene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMC200039429	K00517	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMC200039429	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMC200039429	K00517	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMC200039430	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMC200039430	K00517	ko00626	Naphthalene and anthracene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMC200039430	K00517	ko00903	Limonene and pinene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMC200039430	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMC200039430	K00517	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMC200039432	K05277	ko00941	Flavonoid biosynthesis	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMC200039432	K05277	ko01100	Metabolic pathways	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMC200039432	K05277	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMC200039439	K01641	ko00072	Synthesis and degradation of ketone bodies	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039439	K01641	ko00280	Valine, leucine and isoleucine degradation	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039439	K01641	ko00650	Butanoate metabolism	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039439	K01641	ko00900	Terpenoid backbone biosynthesis	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039439	K01641	ko01100	Metabolic pathways	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039439	K01641	ko01110	Biosynthesis of secondary metabolites	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMC200039440	K01641	ko00072	Synthesis and degradation of ketone bodies	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039440	K01641	ko00280	Valine, leucine and isoleucine degradation	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039440	K01641	ko00650	Butanoate metabolism	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039440	K01641	ko00900	Terpenoid backbone biosynthesis	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039440	K01641	ko01100	Metabolic pathways	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039440	K01641	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMC200039442	K08248	ko00460	Cyanoamino acid metabolism	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMC200039442	K08248	ko01100	Metabolic pathways	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMC200039443	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMC200039444	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMC200039445	K12307	ko04142	Lysosome	360	3.4e-12	0.24	0.45	0.61
PGSC0003DMC200039446	K12307	ko04142	Lysosome	358	4.9e-12	0.24	0.45	0.61
PGSC0003DMC200039447	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMC200039449	K03006	ko00230	Purine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMC200039449	K03006	ko00240	Pyrimidine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMC200039449	K03006	ko01100	Metabolic pathways	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMC200039449	K03006	ko03020	RNA polymerase	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMC200039449	K03006	ko05016	Huntington's disease	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMC200061082	K05280	ko00941	Flavonoid biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMC200061082	K05280	ko00944	Flavone and flavonol biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMC200061082	K05280	ko01100	Metabolic pathways	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMC200061082	K05280	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMC200061093	K12356	ko00940	Phenylpropanoid biosynthesis	637	2.7e-29	0.29	0.48	0.94
PGSC0003DMC200061109	K00801	ko00100	Steroid biosynthesis	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMC200061109	K00801	ko01100	Metabolic pathways	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMC200061109	K00801	ko01110	Biosynthesis of secondary metabolites	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMC200006762	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMC200006762	K01061	ko00364	Fluorobenzoate degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMC200006762	K01061	ko00627	1,4-Dichlorobenzene degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMC200006762	K01061	ko01100	Metabolic pathways	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMC200012001	K09753	ko00940	Phenylpropanoid biosynthesis	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMC200012001	K09753	ko01100	Metabolic pathways	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMC200012001	K09753	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMC200012002	K09753	ko00940	Phenylpropanoid biosynthesis	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMC200012002	K09753	ko01100	Metabolic pathways	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMC200012002	K09753	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMC200012003	K09753	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMC200012003	K09753	ko01100	Metabolic pathways	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMC200012003	K09753	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMC200012004	K09753	ko00940	Phenylpropanoid biosynthesis	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMC200012004	K09753	ko01100	Metabolic pathways	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMC200012004	K09753	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMC200012005	K09753	ko00940	Phenylpropanoid biosynthesis	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMC200012005	K09753	ko01100	Metabolic pathways	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMC200012005	K09753	ko01110	Biosynthesis of secondary metabolites	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMC200012006	K01205	ko00531	Glycosaminoglycan degradation	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMC200012006	K01205	ko01100	Metabolic pathways	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMC200012006	K01205	ko04142	Lysosome	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMC200012007	K01205	ko00531	Glycosaminoglycan degradation	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMC200012007	K01205	ko01100	Metabolic pathways	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMC200012007	K01205	ko04142	Lysosome	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMC200012008	K01205	ko00531	Glycosaminoglycan degradation	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMC200012008	K01205	ko01100	Metabolic pathways	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMC200012008	K01205	ko04142	Lysosome	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMC200012009	K01205	ko00531	Glycosaminoglycan degradation	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMC200012009	K01205	ko01100	Metabolic pathways	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMC200012009	K01205	ko04142	Lysosome	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMC200012013	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	301	1.3e-10	0.40	0.63	0.34
PGSC0003DMC200012014	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	437	2.9e-18	0.45	0.69	0.52
PGSC0003DMC200037958	K00948	ko00030	Pentose phosphate pathway	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMC200037958	K00948	ko00230	Purine metabolism	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMC200037958	K00948	ko01100	Metabolic pathways	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMC200037958	K00948	ko01110	Biosynthesis of secondary metabolites	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMC200037960	K00948	ko00030	Pentose phosphate pathway	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMC200037960	K00948	ko00230	Purine metabolism	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMC200037960	K00948	ko01100	Metabolic pathways	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMC200037960	K00948	ko01110	Biosynthesis of secondary metabolites	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMC200037961	K00948	ko00030	Pentose phosphate pathway	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMC200037961	K00948	ko00230	Purine metabolism	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMC200037961	K00948	ko01100	Metabolic pathways	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMC200037961	K00948	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMC200037962	K05665	ko02010	ABC transporters	2752	5.9e-146	0.31	0.50	0.93
PGSC0003DMC200037967	K02291	ko00906	Carotenoid biosynthesis	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMC200037967	K02291	ko01100	Metabolic pathways	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMC200037967	K02291	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMC200037968	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.98
PGSC0003DMC200037969	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.83
PGSC0003DMC200037976	K05768	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMC200037976	K05768	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMC200037977	K05768	ko04666	Fc gamma R-mediated phagocytosis	5694	0.	0.67	0.83	1.00
PGSC0003DMC200037977	K05768	ko04810	Regulation of actin cytoskeleton	5694	0.	0.67	0.83	1.00
PGSC0003DMC200043209	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMC200043210	K02925	ko03010	Ribosome	2597	2.1e-137	0.91	0.98	0.94
PGSC0003DMC200043211	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMC200053803	K05894	ko00592	alpha-Linolenic acid metabolism	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMC200053803	K05894	ko01100	Metabolic pathways	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMC200053804	K06611	ko00052	Galactose metabolism	2157	3.9e-113	0.39	0.57	0.86
PGSC0003DMC200053805	K06611	ko00052	Galactose metabolism	273	1.5e-08	0.30	0.47	0.87
PGSC0003DMC200053806	K02183	ko04020	Calcium signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04070	Phosphatidylinositol signaling system	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04114	Oocyte meiosis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04270	Vascular smooth muscle contraction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04626	Plant-pathogen interaction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04720	Long-term potentiation	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04722	Neurotrophin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04740	Olfactory transduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04744	Phototransduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04745	Phototransduction - fly	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04910	Insulin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04912	GnRH signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04916	Melanogenesis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04970	Salivary secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko04971	Gastric acid secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko05010	Alzheimer's disease	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053806	K02183	ko05214	Glioma	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMC200053820	K00737	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMC200053820	K00737	ko01100	Metabolic pathways	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMC200013208	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013208	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013209	K07203	ko04012	ErbB signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko04150	mTOR signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko04910	Insulin signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko04920	Adipocytokine signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko04930	Type II diabetes mellitus	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko05200	Pathways in cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko05214	Glioma	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko05215	Prostate cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013209	K07203	ko05221	Acute myeloid leukemia	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMC200013210	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013210	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013211	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013212	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013213	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMC200013214	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013214	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013215	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMC200013216	K07203	ko04012	ErbB signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko04150	mTOR signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko04910	Insulin signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko04920	Adipocytokine signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko04930	Type II diabetes mellitus	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko05200	Pathways in cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko05214	Glioma	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko05215	Prostate cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013216	K07203	ko05221	Acute myeloid leukemia	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMC200013217	K07203	ko04012	ErbB signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko04150	mTOR signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko04910	Insulin signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko04920	Adipocytokine signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko04930	Type II diabetes mellitus	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko05200	Pathways in cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko05214	Glioma	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko05215	Prostate cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013217	K07203	ko05221	Acute myeloid leukemia	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMC200013218	K00558	ko00270	Cysteine and methionine metabolism	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMC200013218	K00558	ko01100	Metabolic pathways	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMC200013219	K02183	ko04020	Calcium signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04070	Phosphatidylinositol signaling system	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04114	Oocyte meiosis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04270	Vascular smooth muscle contraction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04626	Plant-pathogen interaction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04720	Long-term potentiation	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04722	Neurotrophin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04740	Olfactory transduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04744	Phototransduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04745	Phototransduction - fly	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04910	Insulin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04912	GnRH signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04916	Melanogenesis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04970	Salivary secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko04971	Gastric acid secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko05010	Alzheimer's disease	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200013219	K02183	ko05214	Glioma	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMC200007951	K01054	ko00561	Glycerolipid metabolism	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMC200007951	K01054	ko01100	Metabolic pathways	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMC200007952	K01054	ko00561	Glycerolipid metabolism	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMC200007952	K01054	ko01100	Metabolic pathways	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMC200007957	K05768	ko04666	Fc gamma R-mediated phagocytosis	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMC200007957	K05768	ko04810	Regulation of actin cytoskeleton	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMC200007962	K01190	ko00052	Galactose metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMC200007962	K01190	ko00511	Other glycan degradation	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMC200007962	K01190	ko00600	Sphingolipid metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMC200007962	K01190	ko01100	Metabolic pathways	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMC200007964	K01190	ko00052	Galactose metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMC200007964	K01190	ko00511	Other glycan degradation	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMC200007964	K01190	ko00600	Sphingolipid metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMC200007964	K01190	ko01100	Metabolic pathways	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMC200007969	K12356	ko00940	Phenylpropanoid biosynthesis	2032	3.1e-106	0.54	0.72	0.99
PGSC0003DMC200007970	K12356	ko00940	Phenylpropanoid biosynthesis	2029	4.5e-106	0.53	0.73	0.99
PGSC0003DMC200007971	K12356	ko00940	Phenylpropanoid biosynthesis	1927	1.9e-100	0.53	0.73	0.97
PGSC0003DMC200007972	K03006	ko00230	Purine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMC200007972	K03006	ko00240	Pyrimidine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMC200007972	K03006	ko01100	Metabolic pathways	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMC200007972	K03006	ko03020	RNA polymerase	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMC200007972	K03006	ko05016	Huntington's disease	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMC200007979	K07203	ko04012	ErbB signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko04150	mTOR signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko04910	Insulin signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko04920	Adipocytokine signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko04930	Type II diabetes mellitus	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko05200	Pathways in cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko05214	Glioma	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko05215	Prostate cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200007979	K07203	ko05221	Acute myeloid leukemia	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMC200023794	K00981	ko00564	Glycerophospholipid metabolism	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMC200023794	K00981	ko01100	Metabolic pathways	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMC200023794	K00981	ko04070	Phosphatidylinositol signaling system	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMC200023803	K10594	ko04120	Ubiquitin mediated proteolysis	793	2.8e-36	0.31	0.49	0.62
PGSC0003DMC200023807	K12741	ko03040	Spliceosome	2738	3.5e-145	0.69	0.79	1.00
PGSC0003DMC200023810	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMC200023810	K01703	ko00660	C5-Branched dibasic acid metabolism	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMC200023810	K01703	ko01100	Metabolic pathways	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMC200023810	K01703	ko01110	Biosynthesis of secondary metabolites	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMC200023811	K08912	ko00196	Photosynthesis - antenna proteins	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMC200023811	K08912	ko01100	Metabolic pathways	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMC200023812	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200023812	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200023813	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200023813	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMC200062284	K03094	ko04110	Cell cycle	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04111	Cell cycle - yeast	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04114	Oocyte meiosis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04310	Wnt signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04350	TGF-beta signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200062284	K03094	ko04710	Circadian rhythm - mammal	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMC200002821	K11420	ko00310	Lysine degradation	490	3.4e-21	0.32	0.47	0.38
PGSC0003DMC200002824	K01091	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMC200002824	K01091	ko01100	Metabolic pathways	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMC200002842	K10802	ko03410	Base excision repair	837	2.5e-40	0.69	0.79	0.99
PGSC0003DMC200002845	K03781	ko00380	Tryptophan metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMC200002845	K03781	ko00680	Methane metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMC200002845	K03781	ko01100	Metabolic pathways	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMC200002845	K03781	ko04146	Peroxisome	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMC200002845	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMC200002848	K06267	ko04512	ECM-receptor interaction	594	5.6e-25	0.26	0.49	0.88
PGSC0003DMC200002849	K00640	ko00270	Cysteine and methionine metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMC200002849	K00640	ko00920	Sulfur metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMC200002849	K00640	ko01100	Metabolic pathways	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMC200002850	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMC200002850	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMC200002850	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMC200042002	K01852	ko00100	Steroid biosynthesis	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMC200042002	K01852	ko01100	Metabolic pathways	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMC200042002	K01852	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMC200042004	K01593	ko00340	Histidine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00350	Tyrosine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00360	Phenylalanine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00380	Tryptophan metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00901	Indole alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko00965	Betalain biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko01100	Metabolic pathways	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042004	K01593	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMC200042010	K00679	ko00561	Glycerolipid metabolism	413	6.1e-17	0.34	0.48	0.48
PGSC0003DMC200042011	K00679	ko00561	Glycerolipid metabolism	293	6.6e-10	0.36	0.52	0.79
PGSC0003DMC200042012	K00679	ko00561	Glycerolipid metabolism	531	1.9e-23	0.29	0.43	0.75
PGSC0003DMC200042013	K00679	ko00561	Glycerolipid metabolism	516	1.3e-22	0.30	0.46	0.88
PGSC0003DMC200042015	K00430	ko00360	Phenylalanine metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMC200042015	K00430	ko00680	Methane metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMC200042015	K00430	ko00940	Phenylpropanoid biosynthesis	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMC200042015	K00430	ko01100	Metabolic pathways	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMC200042015	K00430	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMC200042016	K00430	ko00360	Phenylalanine metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMC200042016	K00430	ko00680	Methane metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMC200042016	K00430	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMC200042016	K00430	ko01100	Metabolic pathways	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMC200042016	K00430	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMC200042021	K13065	ko00940	Phenylpropanoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMC200042021	K13065	ko00941	Flavonoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMC200042021	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMC200042021	K13065	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMC200042023	K12462	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMC200042023	K12462	ko04962	Vasopressin-regulated water reabsorption	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMC200042028	K00119	ko00362	Benzoate degradation via hydroxylation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMC200042028	K00119	ko00440	Phosphonate and phosphinate metabolism	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMC200042028	K00119	ko00903	Limonene and pinene degradation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMC200042028	K00119	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMC200036757	K01955	ko00240	Pyrimidine metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMC200036757	K01955	ko00250	Alanine, aspartate and glutamate metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMC200036757	K01955	ko01100	Metabolic pathways	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMC200026792	K09587	ko00905	Brassinosteroid biosynthesis	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMC200026792	K09587	ko01100	Metabolic pathways	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMC200026792	K09587	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMC200026804	K03126	ko03022	Basal transcription factors	395	1.1e-14	0.30	0.41	0.16
PGSC0003DMC200026817	K05573	ko00190	Oxidative phosphorylation	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMC200026817	K05573	ko01100	Metabolic pathways	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMC200003811	K00287	ko00670	One carbon pool by folate	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMC200003811	K00287	ko00790	Folate biosynthesis	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMC200003811	K00287	ko01100	Metabolic pathways	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMC200003812	K00287	ko00670	One carbon pool by folate	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMC200003812	K00287	ko00790	Folate biosynthesis	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMC200003812	K00287	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMC200003813	K00287	ko00670	One carbon pool by folate	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMC200003813	K00287	ko00790	Folate biosynthesis	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMC200003813	K00287	ko01100	Metabolic pathways	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMC200003814	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMC200003814	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMC200003814	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMC200009422	K05746	ko04810	Regulation of actin cytoskeleton	224	9.0e-06	0.40	0.55	0.34
PGSC0003DMC200009425	K01509	ko00230	Purine metabolism	724	1.6e-61	0.41	0.61	0.82
PGSC0003DMC200009428	K02939	ko03010	Ribosome	716	1.2e-33	0.51	0.64	0.96
PGSC0003DMC200009429	K02939	ko03010	Ribosome	1023	1.4e-50	0.58	0.72	1.00
PGSC0003DMC200009430	K12135	ko04712	Circadian rhythm - plant	263	1.1e-08	0.37	0.52	0.24
PGSC0003DMC200009443	K10609	ko03420	Nucleotide excision repair	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMC200009443	K10609	ko04120	Ubiquitin mediated proteolysis	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMC200009444	K08852	ko05010	Alzheimer's disease	244	3.7e-06	0.40	0.55	0.24
PGSC0003DMC200015931	K01897	ko00071	Fatty acid metabolism	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMC200015931	K01897	ko01100	Metabolic pathways	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMC200015931	K01897	ko03320	PPAR signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMC200015931	K01897	ko04146	Peroxisome	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMC200015931	K01897	ko04920	Adipocytokine signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMC200015932	K01897	ko00071	Fatty acid metabolism	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMC200015932	K01897	ko01100	Metabolic pathways	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMC200015932	K01897	ko03320	PPAR signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMC200015932	K01897	ko04146	Peroxisome	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMC200015932	K01897	ko04920	Adipocytokine signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMC200015933	K01897	ko00071	Fatty acid metabolism	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMC200015933	K01897	ko01100	Metabolic pathways	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMC200015933	K01897	ko03320	PPAR signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMC200015933	K01897	ko04146	Peroxisome	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMC200015933	K01897	ko04920	Adipocytokine signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMC200015945	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMC200015945	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMC200015945	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMC200015946	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMC200015946	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMC200015946	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMC200015947	K00619	ko00330	Arginine and proline metabolism	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMC200015947	K00619	ko01100	Metabolic pathways	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMC200015947	K00619	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMC200015948	K00619	ko00330	Arginine and proline metabolism	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMC200015948	K00619	ko01100	Metabolic pathways	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMC200015948	K00619	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMC200015949	K00619	ko00330	Arginine and proline metabolism	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMC200015949	K00619	ko01100	Metabolic pathways	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMC200015949	K00619	ko01110	Biosynthesis of secondary metabolites	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMC200015950	K00619	ko00330	Arginine and proline metabolism	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMC200015950	K00619	ko01100	Metabolic pathways	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMC200015950	K00619	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMC200015955	K02898	ko03010	Ribosome	1137	7.1e-57	0.90	0.99	0.99
PGSC0003DMC200015956	K12867	ko03040	Spliceosome	532	4.0e-23	0.64	0.75	0.96
PGSC0003DMC200015960	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMC200015960	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMC200015960	K00734	ko01100	Metabolic pathways	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMC200063097	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.45	0.63	0.89
PGSC0003DMC200063111	K01148	ko03018	RNA degradation	378	5.2e-15	0.50	0.66	0.59
PGSC0003DMC200035017	K12126	ko04712	Circadian rhythm - plant	308	3.2e-09	0.28	0.50	0.51
PGSC0003DMC200035018	K09561	ko04120	Ubiquitin mediated proteolysis	388	1.4e-15	0.77	0.89	0.67
PGSC0003DMC200035020	K09561	ko04120	Ubiquitin mediated proteolysis	1780	2.4e-92	0.77	0.86	0.98
PGSC0003DMC200035022	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMC200035023	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	487	5.0e-21	0.88	0.90	0.99
PGSC0003DMC200035024	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMC200032376	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMC200032376	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMC200032376	K10158	ko01100	Metabolic pathways	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMC200032377	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMC200032377	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMC200032377	K10157	ko01100	Metabolic pathways	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMC200032381	K00826	ko00280	Valine, leucine and isoleucine degradation	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMC200032381	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMC200032381	K00826	ko00770	Pantothenate and CoA biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMC200032381	K00826	ko01100	Metabolic pathways	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMC200032381	K00826	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMC200032382	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032382	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032382	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032382	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032382	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032383	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032383	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032383	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032383	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032383	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMC200032384	K00826	ko00280	Valine, leucine and isoleucine degradation	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMC200032384	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMC200032384	K00826	ko00770	Pantothenate and CoA biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMC200032384	K00826	ko01100	Metabolic pathways	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMC200032384	K00826	ko01110	Biosynthesis of secondary metabolites	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMC200032385	K00826	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMC200032385	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMC200032385	K00826	ko00770	Pantothenate and CoA biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMC200032385	K00826	ko01100	Metabolic pathways	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMC200032385	K00826	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMC200032386	K00826	ko00280	Valine, leucine and isoleucine degradation	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMC200032386	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMC200032386	K00826	ko00770	Pantothenate and CoA biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMC200032386	K00826	ko01100	Metabolic pathways	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMC200032386	K00826	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMC200032391	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200032391	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200032392	K00079	ko00590	Arachidonic acid metabolism	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMC200032392	K00079	ko01100	Metabolic pathways	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMC200032393	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200032393	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200032394	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200032394	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMC200040628	K00423	ko00053	Ascorbate and aldarate metabolism	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMC200040628	K00423	ko01100	Metabolic pathways	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMC200040629	K02923	ko03010	Ribosome	524	4.6e-23	0.90	0.97	0.22
PGSC0003DMC200040630	K02923	ko03010	Ribosome	491	3.0e-21	0.91	0.97	0.84
PGSC0003DMC200040641	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMC200040641	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMC200040641	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMC200040641	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMC200040642	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.63	0.80	0.46
PGSC0003DMC200040644	K01728	ko00040	Pentose and glucuronate interconversions	1752	8.5e-91	0.64	0.80	0.93
PGSC0003DMC200040645	K01728	ko00040	Pentose and glucuronate interconversions	1274	2.0e-64	0.60	0.78	0.88
PGSC0003DMC200040646	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.60	0.76	0.81
PGSC0003DMC200047136	K13030	ko00460	Cyanoamino acid metabolism	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMC200047136	K13030	ko01110	Biosynthesis of secondary metabolites	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMC200047137	K13030	ko00460	Cyanoamino acid metabolism	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMC200047137	K13030	ko01110	Biosynthesis of secondary metabolites	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMC200047138	K12356	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.38	0.57	0.94
PGSC0003DMC200047139	K13030	ko00460	Cyanoamino acid metabolism	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMC200047139	K13030	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMC200047141	K12356	ko00940	Phenylpropanoid biosynthesis	464	9.3e-20	0.39	0.55	0.97
PGSC0003DMC200056432	K01834	ko00010	Glycolysis / Gluconeogenesis	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMC200056432	K01834	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMC200056432	K01834	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMC200051541	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMC200051541	K03434	ko01100	Metabolic pathways	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMC200051543	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.36	0.56	0.67
PGSC0003DMC200051551	K01509	ko00230	Purine metabolism	3627	3.3e-194	0.38	0.56	1.00
PGSC0003DMC200051552	K01509	ko00230	Purine metabolism	300	1.7e-09	0.52	0.68	0.57
PGSC0003DMC200045693	K11820	ko00380	Tryptophan metabolism	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMC200045693	K11820	ko00966	Glucosinolate biosynthesis	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMC200045693	K11820	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMC200045694	K11820	ko00380	Tryptophan metabolism	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMC200045694	K11820	ko00966	Glucosinolate biosynthesis	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMC200045694	K11820	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMC200045695	K11820	ko00380	Tryptophan metabolism	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMC200045695	K11820	ko00966	Glucosinolate biosynthesis	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMC200045695	K11820	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMC200045696	K04733	ko04210	Apoptosis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMC200045696	K04733	ko04620	Toll-like receptor signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMC200045696	K04733	ko04722	Neurotrophin signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMC200045696	K04733	ko05140	Leishmaniasis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMC200045696	K04733	ko05142	Chagas disease	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMC200045697	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045697	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045697	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045697	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045697	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045698	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045698	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045698	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045698	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045698	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMC200045702	K12857	ko03040	Spliceosome	2641	7.9e-140	0.88	0.94	1.00
PGSC0003DMC200045703	K13035	ko00460	Cyanoamino acid metabolism	2637	1.3e-139	0.87	0.93	1.00
PGSC0003DMC200045714	K12251	ko00330	Arginine and proline metabolism	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMC200045714	K12251	ko01100	Metabolic pathways	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMC200039071	K11424	ko00310	Lysine degradation	328	1.3e-08	0.44	0.53	0.12
PGSC0003DMC200039079	K00430	ko00360	Phenylalanine metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMC200039079	K00430	ko00680	Methane metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMC200039079	K00430	ko00940	Phenylpropanoid biosynthesis	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMC200039079	K00430	ko01100	Metabolic pathways	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMC200039079	K00430	ko01110	Biosynthesis of secondary metabolites	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMC200039090	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMC200039090	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMC200068598	K12356	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.31	0.45	0.97
PGSC0003DMC200068602	K05282	ko00904	Diterpenoid biosynthesis	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMC200068602	K05282	ko01100	Metabolic pathways	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMC200068602	K05282	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMC200064535	K05282	ko00904	Diterpenoid biosynthesis	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMC200064535	K05282	ko01100	Metabolic pathways	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMC200064535	K05282	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMC200001715	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.81
PGSC0003DMC200001716	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.79
PGSC0003DMC200001717	K12585	ko03018	RNA degradation	1536	1.9e-81	0.35	0.51	0.75
PGSC0003DMC200001721	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001721	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001721	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001722	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001722	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001722	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMC200001728	K05366	ko00550	Peptidoglycan biosynthesis	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMC200001728	K05366	ko01100	Metabolic pathways	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMC200001729	K05366	ko00550	Peptidoglycan biosynthesis	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMC200001729	K05366	ko01100	Metabolic pathways	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMC200001731	K05366	ko00550	Peptidoglycan biosynthesis	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMC200001731	K05366	ko01100	Metabolic pathways	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMC200001734	K03217	ko03060	Protein export	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMC200001734	K03217	ko03070	Bacterial secretion system	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMC200001737	K03217	ko03060	Protein export	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMC200001737	K03217	ko03070	Bacterial secretion system	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMC200022741	K03531	ko04112	Cell cycle - Caulobacter	1193	5.8e-60	0.75	0.83	0.92
PGSC0003DMC200022742	K03531	ko04112	Cell cycle - Caulobacter	2656	1.2e-140	0.79	0.86	1.00
PGSC0003DMC200022749	K00278	ko00250	Alanine, aspartate and glutamate metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMC200022749	K00278	ko00760	Nicotinate and nicotinamide metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMC200022749	K00278	ko01100	Metabolic pathways	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMC200022750	K00278	ko00250	Alanine, aspartate and glutamate metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMC200022750	K00278	ko00760	Nicotinate and nicotinamide metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMC200022750	K00278	ko01100	Metabolic pathways	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMC200022751	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022751	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022751	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022752	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022752	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022752	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022753	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022753	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022753	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMC200022754	K08241	ko00592	alpha-Linolenic acid metabolism	799	3.1e-38	0.36	0.52	0.96
PGSC0003DMC200022767	K01126	ko00564	Glycerophospholipid metabolism	224	1.6e-06	0.38	0.50	0.42
PGSC0003DMC200022768	K01126	ko00564	Glycerophospholipid metabolism	448	1.3e-18	0.31	0.47	0.79
PGSC0003DMC200022769	K08503	ko04130	SNARE interactions in vesicular transport	943	3.5e-46	0.62	0.76	0.72
PGSC0003DMC200022770	K08503	ko04130	SNARE interactions in vesicular transport	1190	8.4e-60	0.63	0.82	1.00
PGSC0003DMC200010267	K00940	ko00230	Purine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMC200010267	K00940	ko00240	Pyrimidine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMC200010267	K00940	ko01100	Metabolic pathways	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMC200010267	K00940	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMC200010268	K00940	ko00230	Purine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMC200010268	K00940	ko00240	Pyrimidine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMC200010268	K00940	ko01100	Metabolic pathways	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMC200010268	K00940	ko01110	Biosynthesis of secondary metabolites	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMC200041911	K00558	ko00270	Cysteine and methionine metabolism	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMC200041911	K00558	ko01100	Metabolic pathways	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMC200041913	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	1739	4.4e-90	0.76	0.87	0.95
PGSC0003DMC200041914	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	2578	2.3e-136	0.76	0.87	0.98
PGSC0003DMC200041915	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	3071	1.5e-163	0.76	0.87	1.00
PGSC0003DMC200041917	K00948	ko00030	Pentose phosphate pathway	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMC200041917	K00948	ko00230	Purine metabolism	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMC200041917	K00948	ko01100	Metabolic pathways	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMC200041917	K00948	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMC200041918	K00948	ko00030	Pentose phosphate pathway	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMC200041918	K00948	ko00230	Purine metabolism	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMC200041918	K00948	ko01100	Metabolic pathways	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMC200041918	K00948	ko01110	Biosynthesis of secondary metabolites	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMC200041925	K02084	ko04115	p53 signaling pathway	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko04210	Apoptosis	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko05010	Alzheimer's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko05012	Parkinson's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko05016	Huntington's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041925	K02084	ko05222	Small cell lung cancer	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMC200041926	K00797	ko00270	Cysteine and methionine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMC200041926	K00797	ko00330	Arginine and proline metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMC200041926	K00797	ko00410	beta-Alanine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMC200041926	K00797	ko00480	Glutathione metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMC200041926	K00797	ko01100	Metabolic pathways	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMC200041938	K13065	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMC200041938	K13065	ko00941	Flavonoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMC200041938	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMC200041938	K13065	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMC200038083	K06627	ko04110	Cell cycle	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMC200038083	K06627	ko04914	Progesterone-mediated oocyte maturation	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMC200038088	K02693	ko00195	Photosynthesis	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMC200038088	K02693	ko01100	Metabolic pathways	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMC200038089	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMC200038089	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMC200038089	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMC200038090	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMC200038090	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMC200038090	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMC200038092	K11816	ko00380	Tryptophan metabolism	2608	5.2e-138	0.72	0.86	0.99
PGSC0003DMC200038093	K11816	ko00380	Tryptophan metabolism	999	2.9e-49	0.41	0.51	0.94
PGSC0003DMC200043681	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043681	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043681	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043681	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043681	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043682	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043682	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043682	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043682	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043682	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMC200043698	K01897	ko00071	Fatty acid metabolism	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMC200043698	K01897	ko01100	Metabolic pathways	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMC200043698	K01897	ko03320	PPAR signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMC200043698	K01897	ko04146	Peroxisome	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMC200043698	K01897	ko04920	Adipocytokine signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMC200043699	K01897	ko00071	Fatty acid metabolism	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMC200043699	K01897	ko01100	Metabolic pathways	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMC200043699	K01897	ko03320	PPAR signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMC200043699	K01897	ko04146	Peroxisome	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMC200043699	K01897	ko04920	Adipocytokine signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMC200043700	K01897	ko00071	Fatty acid metabolism	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMC200043700	K01897	ko01100	Metabolic pathways	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMC200043700	K01897	ko03320	PPAR signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMC200043700	K01897	ko04146	Peroxisome	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMC200043700	K01897	ko04920	Adipocytokine signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMC200043701	K01897	ko00071	Fatty acid metabolism	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMC200043701	K01897	ko01100	Metabolic pathways	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMC200043701	K01897	ko03320	PPAR signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMC200043701	K01897	ko04146	Peroxisome	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMC200043701	K01897	ko04920	Adipocytokine signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMC200043702	K01897	ko00071	Fatty acid metabolism	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMC200043702	K01897	ko01100	Metabolic pathways	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMC200043702	K01897	ko03320	PPAR signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMC200043702	K01897	ko04146	Peroxisome	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMC200043702	K01897	ko04920	Adipocytokine signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMC200043703	K01897	ko00071	Fatty acid metabolism	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMC200043703	K01897	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMC200043703	K01897	ko03320	PPAR signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMC200043703	K01897	ko04146	Peroxisome	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMC200043703	K01897	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMC200054542	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMC200054543	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMC200054544	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMC200054547	K06654	ko04111	Cell cycle - yeast	332	1.8e-12	0.35	0.53	0.74
PGSC0003DMC200054564	K06685	ko04111	Cell cycle - yeast	312	4.7e-09	0.31	0.49	0.65
PGSC0003DMC200053433	K01613	ko00564	Glycerophospholipid metabolism	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMC200053433	K01613	ko01100	Metabolic pathways	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMC200053435	K01507	ko00190	Oxidative phosphorylation	5771	0.	0.91	0.95	1.00
PGSC0003DMC200053436	K12586	ko03018	RNA degradation	923	1.4e-44	0.42	0.57	0.86
PGSC0003DMC200060608	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMC200060608	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMC200060625	K10760	ko00908	Zeatin biosynthesis	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMC200060625	K10760	ko01100	Metabolic pathways	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMC200060625	K10760	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMC200025747	K13068	ko00940	Phenylpropanoid biosynthesis	1919	5.2e-100	0.51	0.69	0.94
PGSC0003DMC200025751	K12235	ko00260	Glycine, serine and threonine metabolism	1973	5.5e-103	0.72	0.84	0.99
PGSC0003DMC200025752	K12235	ko00260	Glycine, serine and threonine metabolism	340	6.4e-13	0.67	0.80	0.95
PGSC0003DMC200025757	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMC200025757	K01649	ko00620	Pyruvate metabolism	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMC200025757	K01649	ko01100	Metabolic pathways	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMC200025757	K01649	ko01110	Biosynthesis of secondary metabolites	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMC200025759	K02358	ko04626	Plant-pathogen interaction	2244	6.2e-118	0.88	0.92	0.94
PGSC0003DMC200025760	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMC200025761	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMC200025769	K00799	ko00480	Glutathione metabolism	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMC200025769	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMC200025769	K00799	ko00982	Drug metabolism - cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMC200006877	K01728	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.65	0.77	0.83
PGSC0003DMC200006880	K12826	ko03040	Spliceosome	2641	7.9e-140	0.84	0.89	1.00
PGSC0003DMC200012483	K08770	ko03320	PPAR signaling pathway	289	8.8e-10	0.30	0.51	0.37
PGSC0003DMC200012499	K02926	ko03010	Ribosome	1383	1.9e-70	0.73	0.84	0.66
PGSC0003DMC200012509	K12831	ko03040	Spliceosome	247	9.6e-08	0.43	0.54	0.39
PGSC0003DMC200042481	K08509	ko04130	SNARE interactions in vesicular transport	1532	1.2e-78	0.63	0.77	1.00
PGSC0003DMC200042484	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.65
PGSC0003DMC200042485	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.61
PGSC0003DMC200042486	K00485	ko00982	Drug metabolism - cytochrome P450	1382	2.2e-70	0.53	0.70	0.97
PGSC0003DMC200042487	K00485	ko00982	Drug metabolism - cytochrome P450	1611	5.1e-83	0.52	0.69	0.96
PGSC0003DMC200042488	K00485	ko00982	Drug metabolism - cytochrome P450	1737	5.7e-90	0.50	0.67	0.95
PGSC0003DMC200042489	K00485	ko00982	Drug metabolism - cytochrome P450	688	4.1e-32	0.50	0.65	0.92
PGSC0003DMC200042491	K01956	ko00240	Pyrimidine metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMC200042491	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMC200042491	K01956	ko01100	Metabolic pathways	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMC200042498	K02184	ko04320	Dorso-ventral axis formation	1938	4.7e-101	0.31	0.44	0.76
PGSC0003DMC200042499	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMC200042500	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMC200042502	K02184	ko04320	Dorso-ventral axis formation	1912	1.3e-99	0.31	0.44	0.76
PGSC0003DMC200042503	K02184	ko04320	Dorso-ventral axis formation	1928	1.7e-100	0.31	0.44	0.76
PGSC0003DMC200042504	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMC200042505	K02184	ko04320	Dorso-ventral axis formation	1922	3.6e-100	0.31	0.44	0.76
PGSC0003DMC200042506	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMC200042507	K07198	ko04140	Regulation of autophagy	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMC200042507	K07198	ko04150	mTOR signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMC200042507	K07198	ko04910	Insulin signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMC200042507	K07198	ko04920	Adipocytokine signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMC200042507	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMC200042508	K07198	ko04140	Regulation of autophagy	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMC200042508	K07198	ko04150	mTOR signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMC200042508	K07198	ko04910	Insulin signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMC200042508	K07198	ko04920	Adipocytokine signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMC200042508	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMC200042509	K07198	ko04140	Regulation of autophagy	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMC200042509	K07198	ko04150	mTOR signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMC200042509	K07198	ko04910	Insulin signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMC200042509	K07198	ko04920	Adipocytokine signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMC200042509	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMC200042510	K07198	ko04140	Regulation of autophagy	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMC200042510	K07198	ko04150	mTOR signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMC200042510	K07198	ko04910	Insulin signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMC200042510	K07198	ko04920	Adipocytokine signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMC200042510	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMC200036871	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00270	Cysteine and methionine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00350	Tyrosine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00360	Phenylalanine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00401	Novobiocin biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko01100	Metabolic pathways	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036871	K00815	ko01110	Biosynthesis of secondary metabolites	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMC200036872	K07466	ko03030	DNA replication	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMC200036872	K07466	ko03420	Nucleotide excision repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMC200036872	K07466	ko03430	Mismatch repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMC200036872	K07466	ko03440	Homologous recombination	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMC200036875	K10955	ko05110	Vibrio cholerae infection	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMC200036875	K10955	ko05146	Amoebiasis	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMC200036879	K00948	ko00030	Pentose phosphate pathway	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMC200036879	K00948	ko00230	Purine metabolism	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMC200036879	K00948	ko01100	Metabolic pathways	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMC200036879	K00948	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMC200036880	K00948	ko00030	Pentose phosphate pathway	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMC200036880	K00948	ko00230	Purine metabolism	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMC200036880	K00948	ko01100	Metabolic pathways	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMC200036880	K00948	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMC200036884	K08909	ko00196	Photosynthesis - antenna proteins	2026	6.6e-106	0.86	0.94	1.00
PGSC0003DMC200036886	K03009	ko00230	Purine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMC200036886	K03009	ko00240	Pyrimidine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMC200036886	K03009	ko01100	Metabolic pathways	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMC200036886	K03009	ko03020	RNA polymerase	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMC200036886	K03009	ko05016	Huntington's disease	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMC200036887	K03009	ko00230	Purine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMC200036887	K03009	ko00240	Pyrimidine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMC200036887	K03009	ko01100	Metabolic pathways	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMC200036887	K03009	ko03020	RNA polymerase	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMC200036887	K03009	ko05016	Huntington's disease	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMC200036894	K04125	ko00904	Diterpenoid biosynthesis	1547	1.7e-79	0.59	0.74	0.99
PGSC0003DMC200055749	K12741	ko03040	Spliceosome	322	6.3e-12	0.52	0.87	0.60
PGSC0003DMC200055759	K00130	ko00260	Glycine, serine and threonine metabolism	3163	1.3e-168	0.72	0.87	0.99
PGSC0003DMC200055767	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMC200055767	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMC200055767	K03877	ko01100	Metabolic pathways	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMC200055768	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMC200055768	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMC200055768	K03877	ko01100	Metabolic pathways	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMC200011911	K04354	ko04111	Cell cycle - yeast	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMC200011911	K04354	ko04530	Tight junction	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMC200011911	K04354	ko05142	Chagas disease	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMC200011912	K04354	ko04111	Cell cycle - yeast	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMC200011912	K04354	ko04530	Tight junction	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMC200011912	K04354	ko05142	Chagas disease	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMC200011918	K10875	ko03440	Homologous recombination	610	8.3e-28	0.29	0.47	0.75
PGSC0003DMC200011920	K10875	ko03440	Homologous recombination	678	1.1e-36	0.31	0.51	0.42
PGSC0003DMC200011924	K10841	ko03420	Nucleotide excision repair	1469	3.5e-75	0.31	0.47	0.85
PGSC0003DMC200011929	K10260	ko04120	Ubiquitin mediated proteolysis	335	1.2e-12	0.29	0.46	0.80
PGSC0003DMC200024542	K02335	ko00230	Purine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko00240	Pyrimidine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko01100	Metabolic pathways	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko03030	DNA replication	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko03410	Base excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko03420	Nucleotide excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024542	K02335	ko03440	Homologous recombination	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMC200024544	K02335	ko00230	Purine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko00240	Pyrimidine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko01100	Metabolic pathways	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko03030	DNA replication	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko03410	Base excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko03420	Nucleotide excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024544	K02335	ko03440	Homologous recombination	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMC200024559	K08769	ko03320	PPAR signaling pathway	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMC200024559	K08769	ko05016	Huntington's disease	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMC200024560	K08769	ko03320	PPAR signaling pathway	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMC200024560	K08769	ko05016	Huntington's disease	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMC200024561	K08769	ko03320	PPAR signaling pathway	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMC200024561	K08769	ko05016	Huntington's disease	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMC200024563	K05280	ko00941	Flavonoid biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMC200024563	K05280	ko00944	Flavone and flavonol biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMC200024563	K05280	ko01100	Metabolic pathways	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMC200024563	K05280	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMC200024566	K00939	ko00230	Purine metabolism	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMC200024566	K00939	ko01100	Metabolic pathways	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMC200024566	K00939	ko01110	Biosynthesis of secondary metabolites	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMC200024567	K00939	ko00230	Purine metabolism	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMC200024567	K00939	ko01100	Metabolic pathways	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMC200024567	K00939	ko01110	Biosynthesis of secondary metabolites	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMC200024569	K01239	ko00230	Purine metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMC200024569	K01239	ko00760	Nicotinate and nicotinamide metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMC200024569	K01239	ko01100	Metabolic pathways	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMC200013693	K12197	ko04144	Endocytosis	1314	1.2e-66	0.79	0.90	1.00
PGSC0003DMC200013702	K00688	ko00500	Starch and sucrose metabolism	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMC200013702	K00688	ko04910	Insulin signaling pathway	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMC200013705	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMC200013705	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMC200013705	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMC200013706	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMC200013706	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMC200013706	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMC200013707	K08909	ko00196	Photosynthesis - antenna proteins	2011	4.4e-105	0.84	0.91	1.00
PGSC0003DMC200008071	K05755	ko04666	Fc gamma R-mediated phagocytosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMC200008071	K05755	ko04810	Regulation of actin cytoskeleton	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMC200008071	K05755	ko05100	Bacterial invasion of epithelial cells	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMC200008071	K05755	ko05130	Pathogenic Escherichia coli infection	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMC200008071	K05755	ko05131	Shigellosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMC200008072	K05755	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMC200008072	K05755	ko04810	Regulation of actin cytoskeleton	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMC200008072	K05755	ko05100	Bacterial invasion of epithelial cells	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMC200008072	K05755	ko05130	Pathogenic Escherichia coli infection	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMC200008072	K05755	ko05131	Shigellosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMC200008075	K01251	ko00270	Cysteine and methionine metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMC200008075	K01251	ko00450	Selenoamino acid metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMC200008075	K01251	ko01100	Metabolic pathways	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMC200008076	K01251	ko00270	Cysteine and methionine metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMC200008076	K01251	ko00450	Selenoamino acid metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMC200008076	K01251	ko01100	Metabolic pathways	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMC200008077	K01251	ko00270	Cysteine and methionine metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMC200008077	K01251	ko00450	Selenoamino acid metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMC200008077	K01251	ko01100	Metabolic pathways	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMC200008078	K12338	ko00942	Anthocyanin biosynthesis	451	4.9e-19	0.46	0.66	0.85
PGSC0003DMC200008079	K12338	ko00942	Anthocyanin biosynthesis	1669	3.2e-86	0.47	0.65	0.98
PGSC0003DMC200008080	K12338	ko00942	Anthocyanin biosynthesis	1225	9.9e-62	0.48	0.64	0.97
PGSC0003DMC200008081	K12338	ko00942	Anthocyanin biosynthesis	937	7.6e-46	0.46	0.65	0.98
PGSC0003DMC200008082	K12338	ko00942	Anthocyanin biosynthesis	1408	8.0e-72	0.41	0.62	0.97
PGSC0003DMC200008095	K12126	ko04712	Circadian rhythm - plant	314	2.2e-11	0.29	0.47	0.72
PGSC0003DMC200008096	K12126	ko04712	Circadian rhythm - plant	314	6.5e-11	0.29	0.47	0.66
PGSC0003DMC200008097	K12462	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMC200008097	K12462	ko04962	Vasopressin-regulated water reabsorption	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMC200023433	K00454	ko00591	Linoleic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMC200023433	K00454	ko00592	alpha-Linolenic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMC200023433	K00454	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMC200023434	K00454	ko00591	Linoleic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMC200023434	K00454	ko00592	alpha-Linolenic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMC200023434	K00454	ko01100	Metabolic pathways	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMC200023435	K00454	ko00591	Linoleic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMC200023435	K00454	ko00592	alpha-Linolenic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMC200023435	K00454	ko01100	Metabolic pathways	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMC200023436	K00454	ko00591	Linoleic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMC200023436	K00454	ko00592	alpha-Linolenic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMC200023436	K00454	ko01100	Metabolic pathways	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMC200065641	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200065641	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200065641	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMC200065648	K05868	ko04110	Cell cycle	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMC200065648	K05868	ko04115	p53 signaling pathway	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMC200065648	K05868	ko04914	Progesterone-mediated oocyte maturation	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMC200061806	K03006	ko00230	Purine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMC200061806	K03006	ko00240	Pyrimidine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMC200061806	K03006	ko01100	Metabolic pathways	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMC200061806	K03006	ko03020	RNA polymerase	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMC200061806	K03006	ko05016	Huntington's disease	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMC200002464	K04733	ko04210	Apoptosis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMC200002464	K04733	ko04620	Toll-like receptor signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMC200002464	K04733	ko04722	Neurotrophin signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMC200002464	K04733	ko05140	Leishmaniasis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMC200002464	K04733	ko05142	Chagas disease	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMC200002465	K04733	ko04210	Apoptosis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMC200002465	K04733	ko04620	Toll-like receptor signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMC200002465	K04733	ko04722	Neurotrophin signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMC200002465	K04733	ko05140	Leishmaniasis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMC200002465	K04733	ko05142	Chagas disease	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMC200002466	K04733	ko04210	Apoptosis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMC200002466	K04733	ko04620	Toll-like receptor signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMC200002466	K04733	ko04722	Neurotrophin signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMC200002466	K04733	ko05140	Leishmaniasis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMC200002466	K04733	ko05142	Chagas disease	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMC200002467	K04733	ko04210	Apoptosis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMC200002467	K04733	ko04620	Toll-like receptor signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMC200002467	K04733	ko04722	Neurotrophin signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMC200002467	K04733	ko05140	Leishmaniasis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMC200002467	K04733	ko05142	Chagas disease	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMC200002468	K04733	ko04210	Apoptosis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMC200002468	K04733	ko04620	Toll-like receptor signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMC200002468	K04733	ko04722	Neurotrophin signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMC200002468	K04733	ko05140	Leishmaniasis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMC200002468	K04733	ko05142	Chagas disease	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMC200002478	K12640	ko00905	Brassinosteroid biosynthesis	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMC200002478	K12640	ko01100	Metabolic pathways	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMC200002478	K12640	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMC200002485	K05746	ko04810	Regulation of actin cytoskeleton	461	2.7e-19	0.38	0.44	0.59
PGSC0003DMC200052741	K12605	ko03018	RNA degradation	2418	1.6e-127	0.79	0.90	0.98
PGSC0003DMC200052742	K12605	ko03018	RNA degradation	4346	7.2e-234	0.78	0.86	1.00
PGSC0003DMC200052743	K12605	ko03018	RNA degradation	4598	9.1e-248	0.80	0.88	1.00
PGSC0003DMC200052744	K12605	ko03018	RNA degradation	482	9.5e-21	0.81	0.91	0.72
PGSC0003DMC200052757	K11252	ko05322	Systemic lupus erythematosus	1138	6.2e-57	0.95	0.97	0.99
PGSC0003DMC200052758	K01227	ko00511	Other glycan degradation	414	5.0e-16	0.29	0.47	0.73
PGSC0003DMC200052766	K05692	ko04145	Phagosome	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04510	Focal adhesion	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04520	Adherens junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04530	Tight junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04670	Leukocyte transendothelial migration	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04745	Phototransduction - fly	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko04810	Regulation of actin cytoskeleton	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05100	Bacterial invasion of epithelial cells	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05110	Vibrio cholerae infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05130	Pathogenic Escherichia coli infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05131	Shigellosis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05414	Dilated cardiomyopathy	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052766	K05692	ko05416	Viral myocarditis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04145	Phagosome	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04510	Focal adhesion	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04520	Adherens junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04530	Tight junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04670	Leukocyte transendothelial migration	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04745	Phototransduction - fly	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko04810	Regulation of actin cytoskeleton	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05100	Bacterial invasion of epithelial cells	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05110	Vibrio cholerae infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05130	Pathogenic Escherichia coli infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05131	Shigellosis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05414	Dilated cardiomyopathy	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200052767	K05692	ko05416	Viral myocarditis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMC200032859	K01444	ko00511	Other glycan degradation	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMC200032859	K01444	ko04142	Lysosome	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMC200032860	K01444	ko00511	Other glycan degradation	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMC200032860	K01444	ko04142	Lysosome	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMC200032861	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMC200032861	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMC200032862	K01444	ko00511	Other glycan degradation	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMC200032862	K01444	ko04142	Lysosome	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMC200032863	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMC200032863	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMC200032864	K01444	ko00511	Other glycan degradation	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMC200032864	K01444	ko04142	Lysosome	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMC200032865	K05732	ko04510	Focal adhesion	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMC200032865	K05732	ko04670	Leukocyte transendothelial migration	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMC200032865	K05732	ko04810	Regulation of actin cytoskeleton	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMC200032869	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMC200032878	K01066	ko00623	2,4-Dichlorobenzoate degradation	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMC200032878	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMC200040278	K01190	ko00052	Galactose metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMC200040278	K01190	ko00511	Other glycan degradation	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMC200040278	K01190	ko00600	Sphingolipid metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMC200040278	K01190	ko01100	Metabolic pathways	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMC200040281	K06611	ko00052	Galactose metabolism	426	2.9e-17	0.37	0.55	0.91
PGSC0003DMC200040287	K12796	ko04621	NOD-like receptor signaling pathway	396	5.0e-15	0.31	0.47	0.95
PGSC0003DMC200046892	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMC200046895	K06172	ko04330	Notch signaling pathway	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMC200046895	K06172	ko05010	Alzheimer's disease	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMC200046896	K06172	ko04330	Notch signaling pathway	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMC200046896	K06172	ko05010	Alzheimer's disease	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMC200046899	K02964	ko03010	Ribosome	1223	1.3e-61	0.93	0.98	0.66
PGSC0003DMC200046905	K10206	ko00300	Lysine biosynthesis	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMC200046905	K10206	ko01110	Biosynthesis of secondary metabolites	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMC200046906	K10206	ko00300	Lysine biosynthesis	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMC200046906	K10206	ko01110	Biosynthesis of secondary metabolites	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMC200046915	K12135	ko04712	Circadian rhythm - plant	318	1.1e-11	0.31	0.49	0.83
PGSC0003DMC200026437	K08734	ko03430	Mismatch repair	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMC200026437	K08734	ko05200	Pathways in cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMC200026437	K08734	ko05210	Colorectal cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMC200026437	K08734	ko05213	Endometrial cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMC200026438	K08734	ko03430	Mismatch repair	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMC200026438	K08734	ko05200	Pathways in cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMC200026438	K08734	ko05210	Colorectal cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMC200026438	K08734	ko05213	Endometrial cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMC200026439	K08734	ko03430	Mismatch repair	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMC200026439	K08734	ko05200	Pathways in cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMC200026439	K08734	ko05210	Colorectal cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMC200026439	K08734	ko05213	Endometrial cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMC200026440	K08734	ko03430	Mismatch repair	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMC200026440	K08734	ko05200	Pathways in cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMC200026440	K08734	ko05210	Colorectal cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMC200026440	K08734	ko05213	Endometrial cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMC200026441	K08734	ko03430	Mismatch repair	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMC200026441	K08734	ko05200	Pathways in cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMC200026441	K08734	ko05210	Colorectal cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMC200026441	K08734	ko05213	Endometrial cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMC200026444	K11821	ko00380	Tryptophan metabolism	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMC200026444	K11821	ko00966	Glucosinolate biosynthesis	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMC200026444	K11821	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMC200026445	K11821	ko00380	Tryptophan metabolism	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMC200026445	K11821	ko00966	Glucosinolate biosynthesis	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMC200026445	K11821	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMC200026457	K02948	ko03010	Ribosome	569	1.5e-25	0.87	0.90	0.57
PGSC0003DMC200026459	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMC200026459	K00517	ko00626	Naphthalene and anthracene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMC200026459	K00517	ko00903	Limonene and pinene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMC200026459	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMC200026459	K00517	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMC200026460	K02704	ko00195	Photosynthesis	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMC200026460	K02704	ko01100	Metabolic pathways	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMC200021542	K04371	ko04010	MAPK signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04012	ErbB signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04013	MAPK signaling pathway - fly	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04062	Chemokine signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04114	Oocyte meiosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04150	mTOR signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04270	Vascular smooth muscle contraction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04320	Dorso-ventral axis formation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04350	TGF-beta signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04360	Axon guidance	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04370	VEGF signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04510	Focal adhesion	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04520	Adherens junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04540	Gap junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04620	Toll-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04621	NOD-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04650	Natural killer cell mediated cytotoxicity	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04660	T cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04662	B cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04664	Fc epsilon RI signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04666	Fc gamma R-mediated phagocytosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04720	Long-term potentiation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04722	Neurotrophin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04730	Long-term depression	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04810	Regulation of actin cytoskeleton	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04910	Insulin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04912	GnRH signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04914	Progesterone-mediated oocyte maturation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04916	Melanogenesis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04930	Type II diabetes mellitus	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05010	Alzheimer's disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05020	Prion diseases	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05131	Shigellosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05140	Leishmaniasis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05142	Chagas disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05200	Pathways in cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05210	Colorectal cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05211	Renal cell carcinoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05212	Pancreatic cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05213	Endometrial cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05214	Glioma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05215	Prostate cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05216	Thyroid cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05218	Melanoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05219	Bladder cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05220	Chronic myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05221	Acute myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021542	K04371	ko05223	Non-small cell lung cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMC200021545	K01834	ko00010	Glycolysis / Gluconeogenesis	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMC200021545	K01834	ko01100	Metabolic pathways	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMC200021545	K01834	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMC200021546	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMC200021546	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMC200021546	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMC200021547	K01834	ko00010	Glycolysis / Gluconeogenesis	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMC200021547	K01834	ko01100	Metabolic pathways	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMC200021547	K01834	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMC200021552	K12392	ko04142	Lysosome	6726	0.	0.90	0.94	1.00
PGSC0003DMC200021561	K10576	ko04120	Ubiquitin mediated proteolysis	1429	5.6e-73	0.89	0.94	0.99
PGSC0003DMC200021562	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMC200021562	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMC200021563	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMC200021563	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMC200021564	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMC200021564	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMC200021565	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMC200021565	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMC200021566	K03006	ko00230	Purine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMC200021566	K03006	ko00240	Pyrimidine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMC200021566	K03006	ko01100	Metabolic pathways	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMC200021566	K03006	ko03020	RNA polymerase	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMC200021566	K03006	ko05016	Huntington's disease	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMC200021567	K03006	ko00230	Purine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMC200021567	K03006	ko00240	Pyrimidine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMC200021567	K03006	ko01100	Metabolic pathways	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMC200021567	K03006	ko03020	RNA polymerase	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMC200021567	K03006	ko05016	Huntington's disease	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMC200021569	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMC200021569	K00517	ko00626	Naphthalene and anthracene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMC200021569	K00517	ko00903	Limonene and pinene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMC200021569	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMC200021569	K00517	ko01110	Biosynthesis of secondary metabolites	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMC200021570	K04421	ko04010	MAPK signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMC200021570	K04421	ko04722	Neurotrophin signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMC200021570	K04421	ko04912	GnRH signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMC200009067	K08775	ko03440	Homologous recombination	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMC200009067	K08775	ko05200	Pathways in cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMC200009067	K08775	ko05212	Pancreatic cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMC200009075	K00511	ko00100	Steroid biosynthesis	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMC200009075	K00511	ko01100	Metabolic pathways	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMC200009075	K00511	ko01110	Biosynthesis of secondary metabolites	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMC200009076	K00511	ko00100	Steroid biosynthesis	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMC200009076	K00511	ko01100	Metabolic pathways	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMC200009076	K00511	ko01110	Biosynthesis of secondary metabolites	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMC200015691	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMC200015691	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMC200015692	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMC200015692	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMC200015692	K00771	ko01100	Metabolic pathways	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMC200015694	K03283	ko03040	Spliceosome	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMC200015694	K03283	ko04010	MAPK signaling pathway	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMC200015694	K03283	ko04144	Endocytosis	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMC200015694	K03283	ko04612	Antigen processing and presentation	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMC200015695	K12862	ko03040	Spliceosome	2006	8.3e-105	0.76	0.85	0.98
PGSC0003DMC200015697	K12492	ko04144	Endocytosis	2778	2.2e-147	0.71	0.80	1.00
PGSC0003DMC200015698	K03014	ko00230	Purine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMC200015698	K03014	ko00240	Pyrimidine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMC200015698	K03014	ko01100	Metabolic pathways	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMC200015698	K03014	ko03020	RNA polymerase	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMC200015698	K03014	ko05016	Huntington's disease	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMC200015699	K03014	ko00230	Purine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMC200015699	K03014	ko00240	Pyrimidine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMC200015699	K03014	ko01100	Metabolic pathways	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMC200015699	K03014	ko03020	RNA polymerase	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMC200015699	K03014	ko05016	Huntington's disease	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMC200015706	K05765	ko04360	Axon guidance	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMC200015706	K05765	ko04666	Fc gamma R-mediated phagocytosis	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMC200015706	K05765	ko04810	Regulation of actin cytoskeleton	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMC200015707	K05765	ko04360	Axon guidance	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMC200015707	K05765	ko04666	Fc gamma R-mediated phagocytosis	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMC200015707	K05765	ko04810	Regulation of actin cytoskeleton	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMC200015710	K11251	ko05322	Systemic lupus erythematosus	1112	1.7e-55	0.95	0.97	0.97
PGSC0003DMC200015713	K01507	ko00190	Oxidative phosphorylation	288	4.8e-10	0.85	0.93	0.78
PGSC0003DMC200015714	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMC200015715	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMC200015719	K12831	ko03040	Spliceosome	2631	2.8e-139	0.80	0.87	1.00
PGSC0003DMC200000511	K09561	ko04120	Ubiquitin mediated proteolysis	254	1.3e-07	0.31	0.48	0.26
PGSC0003DMC200000514	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMC200000514	K00517	ko00626	Naphthalene and anthracene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMC200000514	K00517	ko00903	Limonene and pinene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMC200000514	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMC200000514	K00517	ko01110	Biosynthesis of secondary metabolites	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMC200000516	K00697	ko00500	Starch and sucrose metabolism	1672	2.2e-86	0.65	0.81	0.46
PGSC0003DMC200000520	K02942	ko03010	Ribosome	400	3.2e-16	0.74	0.84	0.97
PGSC0003DMC200000537	K05279	ko00944	Flavone and flavonol biosynthesis	505	5.1e-22	0.36	0.54	0.84
PGSC0003DMC200000538	K05279	ko00944	Flavone and flavonol biosynthesis	764	2.6e-36	0.37	0.56	0.84
PGSC0003DMC200000539	K05279	ko00944	Flavone and flavonol biosynthesis	699	1.0e-32	0.41	0.59	0.92
PGSC0003DMC200000540	K05279	ko00944	Flavone and flavonol biosynthesis	687	4.7e-32	0.38	0.56	0.75
PGSC0003DMC200063332	K03094	ko04110	Cell cycle	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04111	Cell cycle - yeast	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04114	Oocyte meiosis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04120	Ubiquitin mediated proteolysis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04310	Wnt signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04350	TGF-beta signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063332	K03094	ko04710	Circadian rhythm - mammal	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMC200063339	K13229	ko00402	Benzoxazinoid biosynthesis	521	6.7e-23	0.49	0.67	0.84
PGSC0003DMC200063265	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	343	3.1e-12	0.33	0.44	0.78
PGSC0003DMC200026964	K00026	ko00020	Citrate cycle (TCA cycle)	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026964	K00026	ko00620	Pyruvate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026964	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026964	K00026	ko00710	Carbon fixation in photosynthetic organisms	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026964	K00026	ko01100	Metabolic pathways	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026964	K00026	ko01110	Biosynthesis of secondary metabolites	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMC200026966	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMC200026966	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMC200026966	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMC200026967	K00791	ko00908	Zeatin biosynthesis	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMC200026967	K00791	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMC200026967	K00791	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMC200026968	K00791	ko00908	Zeatin biosynthesis	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMC200026968	K00791	ko01100	Metabolic pathways	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMC200026968	K00791	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMC200026969	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMC200026969	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMC200026969	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMC200026970	K00791	ko00908	Zeatin biosynthesis	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMC200026970	K00791	ko01100	Metabolic pathways	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMC200026970	K00791	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMC200021036	K07204	ko04150	mTOR signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMC200021036	K07204	ko04910	Insulin signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMC200021037	K07204	ko04150	mTOR signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMC200021037	K07204	ko04910	Insulin signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMC200021038	K07204	ko04150	mTOR signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMC200021038	K07204	ko04910	Insulin signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMC200021039	K07204	ko04150	mTOR signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMC200021039	K07204	ko04910	Insulin signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMC200021040	K07204	ko04150	mTOR signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMC200021040	K07204	ko04910	Insulin signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMC200021041	K00827	ko00250	Alanine, aspartate and glutamate metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMC200021041	K00827	ko00260	Glycine, serine and threonine metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMC200021060	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMC200021060	K01433	ko00670	One carbon pool by folate	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMC200003721	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMC200003721	K00517	ko00626	Naphthalene and anthracene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMC200003721	K00517	ko00903	Limonene and pinene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMC200003721	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMC200003721	K00517	ko01110	Biosynthesis of secondary metabolites	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMC200003722	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMC200003722	K00517	ko00626	Naphthalene and anthracene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMC200003722	K00517	ko00903	Limonene and pinene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMC200003722	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMC200003722	K00517	ko01110	Biosynthesis of secondary metabolites	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMC200003724	K00558	ko00270	Cysteine and methionine metabolism	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMC200003724	K00558	ko01100	Metabolic pathways	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMC200003743	K01051	ko00040	Pentose and glucuronate interconversions	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMC200003743	K01051	ko00500	Starch and sucrose metabolism	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMC200003743	K01051	ko01100	Metabolic pathways	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMC200003744	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMC200003745	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMC200029106	K03413	ko02020	Two-component system	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMC200029106	K03413	ko02030	Bacterial chemotaxis	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMC200029107	K03413	ko02020	Two-component system	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMC200029107	K03413	ko02030	Bacterial chemotaxis	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMC200029108	K00057	ko00564	Glycerophospholipid metabolism	405	1.7e-16	0.41	0.57	0.59
PGSC0003DMC200029109	K00057	ko00564	Glycerophospholipid metabolism	677	1.7e-31	0.43	0.67	0.62
PGSC0003DMC200029110	K00057	ko00564	Glycerophospholipid metabolism	854	2.9e-41	0.43	0.66	0.74
PGSC0003DMC200029111	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.68
PGSC0003DMC200029112	K00057	ko00564	Glycerophospholipid metabolism	920	6.6e-45	0.45	0.62	0.96
PGSC0003DMC200029113	K00057	ko00564	Glycerophospholipid metabolism	1002	2.0e-49	0.45	0.62	0.78
PGSC0003DMC200029114	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.67
PGSC0003DMC200029115	K00057	ko00564	Glycerophospholipid metabolism	421	2.2e-17	0.47	0.70	0.93
PGSC0003DMC200029118	K04564	ko04146	Peroxisome	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMC200029118	K04564	ko05016	Huntington's disease	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMC200009523	K02993	ko03010	Ribosome	696	1.5e-32	0.89	0.99	0.91
PGSC0003DMC200009524	K02993	ko03010	Ribosome	1111	1.9e-55	0.84	0.96	0.91
PGSC0003DMC200009525	K02993	ko03010	Ribosome	1419	2.0e-72	0.87	0.97	0.99
PGSC0003DMC200009531	K12126	ko04712	Circadian rhythm - plant	267	1.3e-08	0.30	0.47	0.96
PGSC0003DMC200009532	K12126	ko04712	Circadian rhythm - plant	297	2.2e-10	0.31	0.47	0.77
PGSC0003DMC200009535	K02183	ko04020	Calcium signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04070	Phosphatidylinositol signaling system	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04114	Oocyte meiosis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04270	Vascular smooth muscle contraction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04626	Plant-pathogen interaction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04720	Long-term potentiation	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04722	Neurotrophin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04740	Olfactory transduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04744	Phototransduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04745	Phototransduction - fly	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04910	Insulin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04912	GnRH signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04916	Melanogenesis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04970	Salivary secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko04971	Gastric acid secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko05010	Alzheimer's disease	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009535	K02183	ko05214	Glioma	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMC200009538	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.28	0.41	0.75
PGSC0003DMC200052231	K01354	ko05142	Chagas disease	1919	5.2e-100	0.87	0.94	0.70
PGSC0003DMC200052232	K01354	ko05142	Chagas disease	2818	1.4e-149	0.74	0.86	0.99
PGSC0003DMC200052233	K01354	ko05142	Chagas disease	4837	6.0e-261	0.78	0.88	1.00
PGSC0003DMC200052245	K01199	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.46	0.62	0.96
PGSC0003DMC200052246	K05681	ko02010	ABC transporters	978	4.2e-48	0.38	0.60	0.88
PGSC0003DMC200052247	K05681	ko02010	ABC transporters	1116	1.0e-55	0.36	0.58	0.89
PGSC0003DMC200052248	K05681	ko02010	ABC transporters	1163	2.6e-58	0.36	0.56	0.86
PGSC0003DMC200052250	K05681	ko02010	ABC transporters	1147	2.0e-57	0.34	0.52	0.89
PGSC0003DMC200052260	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMC200052260	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMC200034924	K08332	ko04140	Regulation of autophagy	465	9.2e-20	0.34	0.53	0.41
PGSC0003DMC200034925	K08332	ko04140	Regulation of autophagy	465	8.2e-20	0.34	0.53	0.51
PGSC0003DMC200034926	K08332	ko04140	Regulation of autophagy	390	1.1e-15	0.34	0.55	0.60
PGSC0003DMC200034940	K11087	ko03040	Spliceosome	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMC200034940	K11087	ko05322	Systemic lupus erythematosus	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMC200034945	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMC200034946	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMC200034947	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMC200034948	K00648	ko00061	Fatty acid biosynthesis	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMC200034948	K00648	ko01100	Metabolic pathways	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMC200044881	K12356	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.36	0.51	0.65
PGSC0003DMC200044882	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMC200044883	K12356	ko00940	Phenylpropanoid biosynthesis	765	2.3e-36	0.33	0.48	0.98
PGSC0003DMC200044885	K12356	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.33	0.51	0.97
PGSC0003DMC200044886	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.45	0.59	0.90
PGSC0003DMC200044889	K12356	ko00940	Phenylpropanoid biosynthesis	783	2.4e-37	0.32	0.51	0.99
PGSC0003DMC200044894	K00635	ko00561	Glycerolipid metabolism	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMC200044894	K00635	ko01100	Metabolic pathways	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMC200044895	K00588	ko00360	Phenylalanine metabolism	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044895	K00588	ko00940	Phenylpropanoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044895	K00588	ko00941	Flavonoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044895	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044895	K00588	ko01100	Metabolic pathways	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044895	K00588	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMC200044896	K00588	ko00360	Phenylalanine metabolism	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044896	K00588	ko00940	Phenylpropanoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044896	K00588	ko00941	Flavonoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044896	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044896	K00588	ko01100	Metabolic pathways	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044896	K00588	ko01110	Biosynthesis of secondary metabolites	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMC200044907	K01966	ko00280	Valine, leucine and isoleucine degradation	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMC200044907	K01966	ko00640	Propanoate metabolism	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMC200044907	K01966	ko01100	Metabolic pathways	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMC200044908	K01966	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMC200044908	K01966	ko00640	Propanoate metabolism	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMC200044908	K01966	ko01100	Metabolic pathways	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMC200044909	K01966	ko00280	Valine, leucine and isoleucine degradation	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMC200044909	K01966	ko00640	Propanoate metabolism	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMC200044909	K01966	ko01100	Metabolic pathways	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMC200044910	K01966	ko00280	Valine, leucine and isoleucine degradation	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMC200044910	K01966	ko00640	Propanoate metabolism	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMC200044910	K01966	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMC200040713	K03128	ko03022	Basal transcription factors	660	3.4e-29	0.52	0.68	0.59
PGSC0003DMC200040714	K00164	ko00020	Citrate cycle (TCA cycle)	7847	0.	0.88	0.95	1.00
PGSC0003DMC200040714	K00164	ko00310	Lysine degradation	7847	0.	0.88	0.95	1.00
PGSC0003DMC200040714	K00164	ko00380	Tryptophan metabolism	7847	0.	0.88	0.95	1.00
PGSC0003DMC200040714	K00164	ko01100	Metabolic pathways	7847	0.	0.88	0.95	1.00
PGSC0003DMC200040714	K00164	ko01110	Biosynthesis of secondary metabolites	7847	0.	0.88	0.95	1.00
PGSC0003DMC200040719	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200040720	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200040721	K01710	ko00521	Streptomycin biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMC200040721	K01710	ko00523	Polyketide sugar unit biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMC200040721	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMC200040721	K01710	ko01100	Metabolic pathways	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMC200040721	K01710	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMC200040725	K10575	ko04120	Ubiquitin mediated proteolysis	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMC200040725	K10575	ko05012	Parkinson's disease	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMC200040726	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040726	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040727	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040727	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040728	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040728	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040729	K10575	ko04120	Ubiquitin mediated proteolysis	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMC200040729	K10575	ko05012	Parkinson's disease	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMC200040730	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040730	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMC200040737	K00729	ko00510	N-Glycan biosynthesis	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMC200040737	K00729	ko01100	Metabolic pathways	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMC200040738	K00729	ko00510	N-Glycan biosynthesis	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMC200040738	K00729	ko01100	Metabolic pathways	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMC200040739	K00729	ko00510	N-Glycan biosynthesis	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMC200040739	K00729	ko01100	Metabolic pathways	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMC200057904	K03094	ko04110	Cell cycle	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04111	Cell cycle - yeast	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04114	Oocyte meiosis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04120	Ubiquitin mediated proteolysis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04310	Wnt signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04350	TGF-beta signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057904	K03094	ko04710	Circadian rhythm - mammal	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMC200057920	K04733	ko04210	Apoptosis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMC200057920	K04733	ko04620	Toll-like receptor signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMC200057920	K04733	ko04722	Neurotrophin signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMC200057920	K04733	ko05140	Leishmaniasis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMC200057920	K04733	ko05142	Chagas disease	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMC200002916	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMC200002916	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMC200002920	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMC200002920	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMC200002932	K09578	ko04622	RIG-I-like receptor signaling pathway	839	1.9e-40	0.80	0.92	0.99
PGSC0003DMC200002933	K00764	ko00230	Purine metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMC200002933	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMC200002933	K00764	ko01100	Metabolic pathways	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMC200002933	K00764	ko01110	Biosynthesis of secondary metabolites	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMC200002934	K12345	ko00140	Steroid hormone biosynthesis	1455	2.0e-74	0.55	0.66	1.00
PGSC0003DMC200002935	K12345	ko00140	Steroid hormone biosynthesis	1692	1.7e-87	0.63	0.75	0.96
PGSC0003DMC200002936	K12345	ko00140	Steroid hormone biosynthesis	1554	7.1e-80	0.65	0.77	0.80
PGSC0003DMC200002937	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMC200002938	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMC200002940	K01771	ko00562	Inositol phosphate metabolism	232	2.4e-06	0.29	0.44	0.70
PGSC0003DMC200065745	K12828	ko03040	Spliceosome	1823	1.0e-94	0.92	0.95	0.82
PGSC0003DMC200065755	K10591	ko04120	Ubiquitin mediated proteolysis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMC200065755	K10591	ko04144	Endocytosis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMC200067391	K01051	ko00040	Pentose and glucuronate interconversions	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMC200067391	K01051	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMC200067391	K01051	ko01100	Metabolic pathways	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMC200067400	K00660	ko00941	Flavonoid biosynthesis	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMC200067400	K00660	ko01100	Metabolic pathways	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMC200067400	K00660	ko01110	Biosynthesis of secondary metabolites	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMC200067400	K00660	ko04712	Circadian rhythm - plant	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMC200011472	K12194	ko04144	Endocytosis	415	4.7e-17	0.48	0.68	0.24
PGSC0003DMC200011484	K02704	ko00195	Photosynthesis	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMC200011484	K02704	ko01100	Metabolic pathways	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMC200011490	K10577	ko04120	Ubiquitin mediated proteolysis	1204	1.4e-60	0.93	0.98	0.83
PGSC0003DMC200020122	K00799	ko00480	Glutathione metabolism	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMC200020122	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMC200020122	K00799	ko00982	Drug metabolism - cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMC200020123	K00799	ko00480	Glutathione metabolism	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMC200020123	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMC200020123	K00799	ko00982	Drug metabolism - cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMC200020124	K00799	ko00480	Glutathione metabolism	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMC200020124	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMC200020124	K00799	ko00982	Drug metabolism - cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMC200024032	K00485	ko00982	Drug metabolism - cytochrome P450	652	4.0e-30	0.29	0.47	0.99
PGSC0003DMC200024038	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMC200024038	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMC200024039	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMC200024039	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMC200024060	K05863	ko04020	Calcium signaling pathway	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMC200024060	K05863	ko05012	Parkinson's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMC200024060	K05863	ko05016	Huntington's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMC200023947	K00703	ko00500	Starch and sucrose metabolism	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMC200023947	K00703	ko01100	Metabolic pathways	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMC200023948	K00703	ko00500	Starch and sucrose metabolism	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMC200023948	K00703	ko01100	Metabolic pathways	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMC200023949	K00703	ko00500	Starch and sucrose metabolism	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMC200023949	K00703	ko01100	Metabolic pathways	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMC200023950	K00703	ko00500	Starch and sucrose metabolism	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMC200023950	K00703	ko01100	Metabolic pathways	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMC200030454	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMC200030454	K00457	ko00350	Tyrosine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMC200030454	K00457	ko00360	Phenylalanine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMC200030454	K00457	ko01100	Metabolic pathways	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMC200030455	K05278	ko00941	Flavonoid biosynthesis	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMC200030455	K05278	ko01100	Metabolic pathways	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMC200030455	K05278	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMC200030461	K13065	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMC200030461	K13065	ko00941	Flavonoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMC200030461	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMC200030461	K13065	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMC200030462	K05666	ko02010	ABC transporters	2942	2.0e-156	0.33	0.53	0.94
PGSC0003DMC200030463	K00134	ko00010	Glycolysis / Gluconeogenesis	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMC200030463	K00134	ko01100	Metabolic pathways	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMC200030463	K00134	ko01110	Biosynthesis of secondary metabolites	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMC200030463	K00134	ko05010	Alzheimer's disease	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMC200030464	K00134	ko00010	Glycolysis / Gluconeogenesis	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMC200030464	K00134	ko01100	Metabolic pathways	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMC200030464	K00134	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMC200030464	K00134	ko05010	Alzheimer's disease	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMC200030466	K05665	ko02010	ABC transporters	322	5.8e-11	0.62	0.73	0.70
PGSC0003DMC200030469	K02321	ko00230	Purine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMC200030469	K02321	ko00240	Pyrimidine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMC200030469	K02321	ko01100	Metabolic pathways	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMC200030469	K02321	ko03030	DNA replication	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMC200030470	K02321	ko00230	Purine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMC200030470	K02321	ko00240	Pyrimidine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMC200030470	K02321	ko01100	Metabolic pathways	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMC200030470	K02321	ko03030	DNA replication	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMC200030472	K06688	ko04120	Ubiquitin mediated proteolysis	279	1.5e-09	0.94	0.97	0.18
PGSC0003DMC200048904	K07195	ko04910	Insulin signaling pathway	3637	9.1e-195	0.68	0.83	0.99
PGSC0003DMC200048907	K08488	ko04130	SNARE interactions in vesicular transport	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMC200048907	K08488	ko04145	Phagosome	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMC200048908	K08488	ko04130	SNARE interactions in vesicular transport	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMC200048908	K08488	ko04145	Phagosome	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMC200048925	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMC200055235	K00031	ko00020	Citrate cycle (TCA cycle)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200055235	K00031	ko00480	Glutathione metabolism	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200055235	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200055235	K00031	ko01100	Metabolic pathways	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200055235	K00031	ko01110	Biosynthesis of secondary metabolites	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200055235	K00031	ko04146	Peroxisome	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMC200018909	K09839	ko00906	Carotenoid biosynthesis	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMC200018909	K09839	ko01100	Metabolic pathways	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMC200018909	K09839	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMC200018910	K09839	ko00906	Carotenoid biosynthesis	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMC200018910	K09839	ko01100	Metabolic pathways	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMC200018910	K09839	ko01110	Biosynthesis of secondary metabolites	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMC200018911	K09839	ko00906	Carotenoid biosynthesis	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMC200018911	K09839	ko01100	Metabolic pathways	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMC200018911	K09839	ko01110	Biosynthesis of secondary metabolites	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMC200018912	K09839	ko00906	Carotenoid biosynthesis	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMC200018912	K09839	ko01100	Metabolic pathways	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMC200018912	K09839	ko01110	Biosynthesis of secondary metabolites	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMC200018913	K04733	ko04210	Apoptosis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMC200018913	K04733	ko04620	Toll-like receptor signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMC200018913	K04733	ko04722	Neurotrophin signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMC200018913	K04733	ko05140	Leishmaniasis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMC200018913	K04733	ko05142	Chagas disease	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMC200018923	K08064	ko04612	Antigen processing and presentation	519	8.6e-23	0.40	0.54	0.73
PGSC0003DMC200018928	K04733	ko04210	Apoptosis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMC200018928	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMC200018928	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMC200018928	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMC200018928	K04733	ko05142	Chagas disease	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMC200018930	K12275	ko03060	Protein export	2035	2.1e-106	0.79	0.88	0.92
PGSC0003DMC200025259	K05747	ko04062	Chemokine signaling pathway	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko04520	Adherens junction	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko04666	Fc gamma R-mediated phagocytosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko04810	Regulation of actin cytoskeleton	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko05100	Bacterial invasion of epithelial cells	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko05130	Pathogenic Escherichia coli infection	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200025259	K05747	ko05131	Shigellosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMC200041461	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMC200041461	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMC200041461	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMC200041463	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMC200041463	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMC200041463	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMC200041482	K00697	ko00500	Starch and sucrose metabolism	5633	0.	0.76	0.88	0.99
PGSC0003DMC200041483	K12391	ko04142	Lysosome	2536	4.9e-134	0.71	0.82	0.97
PGSC0003DMC200041484	K12391	ko04142	Lysosome	4771	2.6e-257	0.85	0.93	0.95
PGSC0003DMC200041485	K12391	ko04142	Lysosome	5866	0.	0.80	0.90	1.00
PGSC0003DMC200041489	K00480	ko00624	1- and 2-Methylnaphthalene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMC200041489	K00480	ko00626	Naphthalene and anthracene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMC200041489	K00480	ko00628	Fluorene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMC200041489	K00480	ko01100	Metabolic pathways	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMC200041490	K00480	ko00624	1- and 2-Methylnaphthalene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMC200041490	K00480	ko00626	Naphthalene and anthracene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMC200041490	K00480	ko00628	Fluorene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMC200041490	K00480	ko01100	Metabolic pathways	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMC200050105	K11252	ko05322	Systemic lupus erythematosus	714	1.5e-33	0.61	0.72	0.42
PGSC0003DMC200050106	K11252	ko05322	Systemic lupus erythematosus	830	6.1e-40	0.80	0.87	0.96
PGSC0003DMC200050108	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMC200050108	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMC200050108	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMC200050108	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMC200050120	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMC200050120	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMC200050125	K02993	ko03010	Ribosome	1454	2.3e-74	0.88	0.97	0.99
PGSC0003DMC200050126	K00799	ko00480	Glutathione metabolism	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMC200050126	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMC200050126	K00799	ko00982	Drug metabolism - cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMC200050127	K00799	ko00480	Glutathione metabolism	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMC200050127	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMC200050127	K00799	ko00982	Drug metabolism - cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMC200050128	K04424	ko04010	MAPK signaling pathway	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMC200050128	K04424	ko04530	Tight junction	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMC200050129	K04424	ko04010	MAPK signaling pathway	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMC200050129	K04424	ko04530	Tight junction	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMC200050130	K04424	ko04010	MAPK signaling pathway	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMC200050130	K04424	ko04530	Tight junction	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMC200031652	K10577	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.75	0.86	0.99
PGSC0003DMC200031653	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.44
PGSC0003DMC200031654	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.39
PGSC0003DMC200031658	K12609	ko03018	RNA degradation	414	4.4e-13	0.26	0.40	0.47
PGSC0003DMC200031659	K12831	ko03040	Spliceosome	324	4.8e-11	0.37	0.42	0.12
PGSC0003DMC200031676	K11152	ko00830	Retinol metabolism	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMC200031676	K11152	ko01100	Metabolic pathways	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMC200054039	K01762	ko00270	Cysteine and methionine metabolism	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMC200054039	K01762	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMC200054044	K01206	ko00511	Other glycan degradation	657	2.1e-30	0.68	0.84	0.99
PGSC0003DMC200054045	K01206	ko00511	Other glycan degradation	3091	1.2e-164	0.74	0.86	0.98
PGSC0003DMC200054049	K08243	ko00941	Flavonoid biosynthesis	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMC200054049	K08243	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMC200054050	K00100	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054050	K00100	ko00363	Bisphenol A degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054050	K00100	ko00591	Linoleic acid metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054050	K00100	ko00625	Tetrachloroethene degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054050	K00100	ko00650	Butanoate metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054050	K00100	ko01100	Metabolic pathways	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMC200054051	K00100	ko00051	Fructose and mannose metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054051	K00100	ko00363	Bisphenol A degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054051	K00100	ko00591	Linoleic acid metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054051	K00100	ko00625	Tetrachloroethene degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054051	K00100	ko00650	Butanoate metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054051	K00100	ko01100	Metabolic pathways	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMC200054052	K00100	ko00051	Fructose and mannose metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054052	K00100	ko00363	Bisphenol A degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054052	K00100	ko00591	Linoleic acid metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054052	K00100	ko00625	Tetrachloroethene degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054052	K00100	ko00650	Butanoate metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054052	K00100	ko01100	Metabolic pathways	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMC200054058	K01199	ko00500	Starch and sucrose metabolism	501	8.5e-22	0.33	0.50	0.95
PGSC0003DMC200054059	K01505	ko00640	Propanoate metabolism	1109	2.5e-55	0.41	0.57	0.89
PGSC0003DMC200054060	K01505	ko00640	Propanoate metabolism	1278	1.2e-64	0.44	0.62	0.94
PGSC0003DMC200053946	K07432	ko00510	N-Glycan biosynthesis	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMC200053946	K07432	ko01100	Metabolic pathways	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMC200053947	K07432	ko00510	N-Glycan biosynthesis	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMC200053947	K07432	ko01100	Metabolic pathways	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMC200053948	K07432	ko00510	N-Glycan biosynthesis	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMC200053948	K07432	ko01100	Metabolic pathways	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMC200053949	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMC200053950	K12822	ko03040	Spliceosome	4410	2.1e-237	0.58	0.73	0.99
PGSC0003DMC200053951	K12822	ko03040	Spliceosome	4433	1.1e-238	0.59	0.73	0.99
PGSC0003DMC200053952	K12822	ko03040	Spliceosome	476	7.5e-20	0.41	0.50	0.91
PGSC0003DMC200053953	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMC200053955	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMC200053956	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMC200053957	K12619	ko03018	RNA degradation	280	2.9e-06	0.24	0.40	0.62
PGSC0003DMC200053965	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMC200053966	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMC200053969	K08065	ko04612	Antigen processing and presentation	314	1.7e-11	0.49	0.66	0.60
PGSC0003DMC200004923	K01184	ko00040	Pentose and glucuronate interconversions	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMC200004923	K01184	ko00500	Starch and sucrose metabolism	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMC200004923	K01184	ko01100	Metabolic pathways	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMC200004924	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004924	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004924	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004924	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004925	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004925	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004925	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004925	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004926	K00036	ko00030	Pentose phosphate pathway	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMC200004926	K00036	ko00480	Glutathione metabolism	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMC200004926	K00036	ko01100	Metabolic pathways	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMC200004926	K00036	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMC200004927	K00036	ko00030	Pentose phosphate pathway	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMC200004927	K00036	ko00480	Glutathione metabolism	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMC200004927	K00036	ko01100	Metabolic pathways	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMC200004927	K00036	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMC200004928	K00036	ko00030	Pentose phosphate pathway	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMC200004928	K00036	ko00480	Glutathione metabolism	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMC200004928	K00036	ko01100	Metabolic pathways	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMC200004928	K00036	ko01110	Biosynthesis of secondary metabolites	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMC200004929	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004929	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004929	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004929	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMC200004939	K12398	ko04142	Lysosome	2911	1.0e-154	0.83	0.94	1.00
PGSC0003DMC200004940	K12398	ko04142	Lysosome	2169	8.5e-114	0.83	0.94	1.00
PGSC0003DMC200004941	K12398	ko04142	Lysosome	1612	4.5e-83	0.83	0.95	0.90
PGSC0003DMC200004942	K01193	ko00052	Galactose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMC200004942	K01193	ko00500	Starch and sucrose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMC200004942	K01193	ko01100	Metabolic pathways	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMC200022238	K02372	ko00061	Fatty acid biosynthesis	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMC200022238	K02372	ko01100	Metabolic pathways	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMC200022254	K02858	ko00740	Riboflavin metabolism	2143	2.3e-112	0.68	0.79	0.93
PGSC0003DMC200022255	K02858	ko00740	Riboflavin metabolism	2374	4.2e-125	0.82	0.90	0.97
PGSC0003DMC200022256	K02858	ko00740	Riboflavin metabolism	3357	2.5e-179	0.74	0.84	0.99
PGSC0003DMC200014882	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMC200014882	K03857	ko01100	Metabolic pathways	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMC200014884	K04040	ko00860	Porphyrin and chlorophyll metabolism	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMC200014884	K04040	ko01100	Metabolic pathways	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMC200014884	K04040	ko01110	Biosynthesis of secondary metabolites	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMC200014894	K08915	ko00196	Photosynthesis - antenna proteins	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMC200014894	K08915	ko01100	Metabolic pathways	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMC200014895	K09648	ko03060	Protein export	498	1.2e-21	0.75	0.83	0.82
PGSC0003DMC200014896	K09648	ko03060	Protein export	434	4.2e-18	0.65	0.79	0.99
PGSC0003DMC200014897	K09648	ko03060	Protein export	965	2.2e-47	0.68	0.80	0.96
PGSC0003DMC200014898	K09648	ko03060	Protein export	799	3.1e-38	0.69	0.80	0.89
PGSC0003DMC200014903	K02085	ko04310	Wnt signaling pathway	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014903	K02085	ko04810	Regulation of actin cytoskeleton	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014903	K02085	ko05200	Pathways in cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014903	K02085	ko05210	Colorectal cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014903	K02085	ko05213	Endometrial cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014903	K02085	ko05217	Basal cell carcinoma	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMC200014904	K02085	ko04310	Wnt signaling pathway	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200014904	K02085	ko04810	Regulation of actin cytoskeleton	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200014904	K02085	ko05200	Pathways in cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200014904	K02085	ko05210	Colorectal cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200014904	K02085	ko05213	Endometrial cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200014904	K02085	ko05217	Basal cell carcinoma	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMC200027901	K12617	ko03018	RNA degradation	470	9.4e-20	0.50	0.59	0.79
PGSC0003DMC200027902	K12617	ko03018	RNA degradation	847	7.0e-41	0.73	0.84	0.99
PGSC0003DMC200027903	K12617	ko03018	RNA degradation	247	4.4e-07	0.51	0.63	0.81
PGSC0003DMC200027911	K00889	ko00562	Inositol phosphate metabolism	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027911	K00889	ko01100	Metabolic pathways	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027911	K00889	ko04070	Phosphatidylinositol signaling system	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027911	K00889	ko04144	Endocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027911	K00889	ko04666	Fc gamma R-mediated phagocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027911	K00889	ko04810	Regulation of actin cytoskeleton	7079	0.	0.53	0.64	1.00
PGSC0003DMC200027912	K00889	ko00562	Inositol phosphate metabolism	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027912	K00889	ko01100	Metabolic pathways	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027912	K00889	ko04070	Phosphatidylinositol signaling system	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027912	K00889	ko04144	Endocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027912	K00889	ko04666	Fc gamma R-mediated phagocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027912	K00889	ko04810	Regulation of actin cytoskeleton	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMC200027913	K00889	ko00562	Inositol phosphate metabolism	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027913	K00889	ko01100	Metabolic pathways	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027913	K00889	ko04070	Phosphatidylinositol signaling system	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027913	K00889	ko04144	Endocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027913	K00889	ko04666	Fc gamma R-mediated phagocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027913	K00889	ko04810	Regulation of actin cytoskeleton	8889	0.	0.61	0.74	1.00
PGSC0003DMC200027914	K01051	ko00040	Pentose and glucuronate interconversions	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMC200027914	K01051	ko00500	Starch and sucrose metabolism	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMC200027914	K01051	ko01100	Metabolic pathways	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMC200027916	K00290	ko00300	Lysine biosynthesis	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMC200027916	K00290	ko00310	Lysine degradation	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMC200027916	K00290	ko01100	Metabolic pathways	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMC200027916	K00290	ko01110	Biosynthesis of secondary metabolites	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMC200027917	K00292	ko00310	Lysine degradation	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMC200027917	K00292	ko01100	Metabolic pathways	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMC200027917	K00292	ko01110	Biosynthesis of secondary metabolites	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMC200027918	K00292	ko00310	Lysine degradation	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMC200027918	K00292	ko01100	Metabolic pathways	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMC200027918	K00292	ko01110	Biosynthesis of secondary metabolites	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMC200027919	K00292	ko00310	Lysine degradation	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMC200027919	K00292	ko01100	Metabolic pathways	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMC200027919	K00292	ko01110	Biosynthesis of secondary metabolites	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMC200027923	K01051	ko00040	Pentose and glucuronate interconversions	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMC200027923	K01051	ko00500	Starch and sucrose metabolism	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMC200027923	K01051	ko01100	Metabolic pathways	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMC200027925	K10134	ko04115	p53 signaling pathway	242	1.6e-07	0.32	0.44	0.69
PGSC0003DMC200010711	K01509	ko00230	Purine metabolism	2089	2.2e-109	0.41	0.57	0.98
PGSC0003DMC200010712	K12394	ko04142	Lysosome	723	4.8e-34	0.66	0.82	0.86
PGSC0003DMC200010713	K12394	ko04142	Lysosome	219	3.0e-06	0.68	0.85	0.47
PGSC0003DMC200010714	K12394	ko04142	Lysosome	936	8.6e-46	0.73	0.88	0.90
PGSC0003DMC200010729	K10755	ko03030	DNA replication	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMC200010729	K10755	ko03420	Nucleotide excision repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMC200010729	K10755	ko03430	Mismatch repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMC200010735	K03070	ko03060	Protein export	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMC200010735	K03070	ko03070	Bacterial secretion system	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMC200010736	K03070	ko03060	Protein export	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMC200010736	K03070	ko03070	Bacterial secretion system	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMC200010737	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMC200010737	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMC200010738	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMC200010738	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMC200010739	K03070	ko03060	Protein export	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMC200010739	K03070	ko03070	Bacterial secretion system	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMC200010740	K03070	ko03060	Protein export	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMC200010740	K03070	ko03070	Bacterial secretion system	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMC200001266	K00507	ko01040	Biosynthesis of unsaturated fatty acids	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMC200001266	K00507	ko03320	PPAR signaling pathway	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMC200001269	K06666	ko04111	Cell cycle - yeast	318	9.8e-09	0.27	0.42	0.52
PGSC0003DMC200001286	K01757	ko00901	Indole alkaloid biosynthesis	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMC200001286	K01757	ko01100	Metabolic pathways	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMC200001286	K01757	ko01110	Biosynthesis of secondary metabolites	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMC200001287	K05280	ko00941	Flavonoid biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMC200001287	K05280	ko00944	Flavone and flavonol biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMC200001287	K05280	ko01100	Metabolic pathways	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMC200001287	K05280	ko01110	Biosynthesis of secondary metabolites	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMC200001290	K10536	ko00330	Arginine and proline metabolism	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMC200001290	K10536	ko01100	Metabolic pathways	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMC200064447	K12356	ko00940	Phenylpropanoid biosynthesis	596	4.9e-27	0.33	0.49	0.95
PGSC0003DMC200064453	K11816	ko00380	Tryptophan metabolism	1143	3.3e-57	0.42	0.60	0.98
PGSC0003DMC200064468	K03681	ko03018	RNA degradation	503	6.6e-22	0.67	0.80	0.59
PGSC0003DMC200056949	K04705	ko04144	Endocytosis	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMC200056949	K04705	ko04630	Jak-STAT signaling pathway	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMC200056956	K11294	ko05130	Pathogenic Escherichia coli infection	245	4.7e-07	0.53	0.59	0.81
PGSC0003DMC200056963	K04733	ko04210	Apoptosis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMC200056963	K04733	ko04620	Toll-like receptor signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMC200056963	K04733	ko04722	Neurotrophin signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMC200056963	K04733	ko05140	Leishmaniasis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMC200056963	K04733	ko05142	Chagas disease	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMC200033724	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033724	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMC200033725	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033725	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMC200033726	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033726	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMC200033737	K04733	ko04210	Apoptosis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMC200033737	K04733	ko04620	Toll-like receptor signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMC200033737	K04733	ko04722	Neurotrophin signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMC200033737	K04733	ko05140	Leishmaniasis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMC200033737	K04733	ko05142	Chagas disease	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMC200033743	K02635	ko00195	Photosynthesis	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMC200033743	K02635	ko01100	Metabolic pathways	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMC200051034	K00895	ko00051	Fructose and mannose metabolism	4420	6.0e-238	0.83	0.92	1.00
PGSC0003DMC200051044	K05868	ko04110	Cell cycle	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMC200051044	K05868	ko04115	p53 signaling pathway	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMC200051044	K05868	ko04914	Progesterone-mediated oocyte maturation	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMC200051051	K10591	ko04120	Ubiquitin mediated proteolysis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMC200051051	K10591	ko04144	Endocytosis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMC200051055	K10526	ko00592	alpha-Linolenic acid metabolism	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMC200051055	K10526	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMC200051059	K00423	ko00053	Ascorbate and aldarate metabolism	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMC200051059	K00423	ko01100	Metabolic pathways	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMC200051060	K00423	ko00053	Ascorbate and aldarate metabolism	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMC200051060	K00423	ko01100	Metabolic pathways	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMC200039512	K01099	ko00562	Inositol phosphate metabolism	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMC200039512	K01099	ko01100	Metabolic pathways	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMC200039512	K01099	ko04070	Phosphatidylinositol signaling system	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMC200039524	K08241	ko00592	alpha-Linolenic acid metabolism	529	2.4e-23	0.36	0.51	0.83
PGSC0003DMC200039525	K00133	ko00260	Glycine, serine and threonine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMC200039525	K00133	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMC200039525	K00133	ko00300	Lysine biosynthesis	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMC200039525	K00133	ko01100	Metabolic pathways	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMC200039525	K00133	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMC200059130	K00797	ko00270	Cysteine and methionine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMC200059130	K00797	ko00330	Arginine and proline metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMC200059130	K00797	ko00410	beta-Alanine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMC200059130	K00797	ko00480	Glutathione metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMC200059130	K00797	ko01100	Metabolic pathways	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMC200017915	K13065	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMC200017915	K13065	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMC200017915	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMC200017915	K13065	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMC200017916	K13065	ko00940	Phenylpropanoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMC200017916	K13065	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMC200017916	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMC200017916	K13065	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMC200017929	K08008	ko04145	Phagosome	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMC200017929	K08008	ko04670	Leukocyte transendothelial migration	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMC200017930	K08008	ko04145	Phagosome	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMC200017930	K08008	ko04670	Leukocyte transendothelial migration	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMC200005431	K08008	ko04145	Phagosome	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMC200005431	K08008	ko04670	Leukocyte transendothelial migration	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMC200005432	K08008	ko04145	Phagosome	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMC200005432	K08008	ko04670	Leukocyte transendothelial migration	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMC200005435	K02084	ko04115	p53 signaling pathway	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko04210	Apoptosis	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko05010	Alzheimer's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko05012	Parkinson's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko05016	Huntington's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005435	K02084	ko05222	Small cell lung cancer	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMC200005449	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMC200005449	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMC200005449	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMC200005449	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMC200005449	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMC200005450	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMC200005450	K00517	ko00626	Naphthalene and anthracene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMC200005450	K00517	ko00903	Limonene and pinene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMC200005450	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMC200005450	K00517	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMC200005451	K05293	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMC200005451	K05293	ko01100	Metabolic pathways	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMC200005452	K09843	ko00906	Carotenoid biosynthesis	385	2.1e-15	0.34	0.58	0.82
PGSC0003DMC200005453	K09587	ko00905	Brassinosteroid biosynthesis	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMC200005453	K09587	ko01100	Metabolic pathways	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMC200005453	K09587	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMC200005454	K04424	ko04010	MAPK signaling pathway	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMC200005454	K04424	ko04530	Tight junction	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMC200014076	K00759	ko00230	Purine metabolism	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMC200014076	K00759	ko01100	Metabolic pathways	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMC200014086	K09054	ko05010	Alzheimer's disease	288	9.7e-08	0.31	0.47	0.48
PGSC0003DMC200014087	K09054	ko05010	Alzheimer's disease	280	3.0e-07	0.31	0.47	0.46
PGSC0003DMC200014099	K09756	ko00940	Phenylpropanoid biosynthesis	694	1.8e-40	0.45	0.67	0.88
PGSC0003DMC200014100	K09756	ko00940	Phenylpropanoid biosynthesis	1585	1.4e-81	0.45	0.62	0.99
PGSC0003DMC200007689	K01728	ko00040	Pentose and glucuronate interconversions	1359	4.0e-69	0.61	0.77	0.85
PGSC0003DMC200007690	K02704	ko00195	Photosynthesis	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMC200007690	K02704	ko01100	Metabolic pathways	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMC200007704	K00162	ko00010	Glycolysis / Gluconeogenesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko00020	Citrate cycle (TCA cycle)	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko00620	Pyruvate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko00650	Butanoate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko01100	Metabolic pathways	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007704	K00162	ko01110	Biosynthesis of secondary metabolites	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMC200007705	K00162	ko00010	Glycolysis / Gluconeogenesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko00020	Citrate cycle (TCA cycle)	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko00620	Pyruvate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko00650	Butanoate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko01100	Metabolic pathways	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200007705	K00162	ko01110	Biosynthesis of secondary metabolites	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMC200061378	K05282	ko00904	Diterpenoid biosynthesis	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMC200061378	K05282	ko01100	Metabolic pathways	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMC200061378	K05282	ko01110	Biosynthesis of secondary metabolites	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMC200059879	K00901	ko00561	Glycerolipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMC200059879	K00901	ko00564	Glycerophospholipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMC200059879	K00901	ko01100	Metabolic pathways	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMC200059879	K00901	ko04070	Phosphatidylinositol signaling system	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMC200042874	K08065	ko04612	Antigen processing and presentation	470	4.3e-20	0.53	0.76	0.76
PGSC0003DMC200042875	K11984	ko03040	Spliceosome	1080	9.9e-54	0.51	0.64	0.93
PGSC0003DMC200042876	K11984	ko03040	Spliceosome	869	4.3e-42	0.52	0.64	0.93
PGSC0003DMC200042879	K11251	ko05322	Systemic lupus erythematosus	999	2.9e-49	0.79	0.86	0.99
PGSC0003DMC200042885	K00799	ko00480	Glutathione metabolism	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMC200042885	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMC200042885	K00799	ko00982	Drug metabolism - cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMC200042887	K08008	ko04145	Phagosome	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMC200042887	K08008	ko04670	Leukocyte transendothelial migration	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMC200042895	K02947	ko03010	Ribosome	1488	3.1e-76	0.92	0.96	0.98
PGSC0003DMC200042898	K12890	ko03040	Spliceosome	1333	1.1e-67	0.85	0.91	0.54
PGSC0003DMC200042899	K12890	ko03040	Spliceosome	1629	5.2e-84	0.73	0.79	0.98
PGSC0003DMC200042900	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMC200036493	K02965	ko03010	Ribosome	520	7.6e-23	0.68	0.80	0.96
PGSC0003DMC200003546	K02703	ko00195	Photosynthesis	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMC200003546	K02703	ko01100	Metabolic pathways	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMC200003549	K00469	ko00053	Ascorbate and aldarate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMC200003549	K00469	ko00562	Inositol phosphate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMC200003550	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.68
PGSC0003DMC200003551	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.96
PGSC0003DMC200003552	K02183	ko04020	Calcium signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04070	Phosphatidylinositol signaling system	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04114	Oocyte meiosis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04270	Vascular smooth muscle contraction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04626	Plant-pathogen interaction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04720	Long-term potentiation	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04740	Olfactory transduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04744	Phototransduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04745	Phototransduction - fly	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04910	Insulin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04912	GnRH signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04916	Melanogenesis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04970	Salivary secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko04971	Gastric acid secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko05010	Alzheimer's disease	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003552	K02183	ko05214	Glioma	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMC200003553	K00365	ko00230	Purine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMC200003553	K00365	ko00232	Caffeine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMC200003553	K00365	ko01100	Metabolic pathways	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMC200003554	K03885	ko00190	Oxidative phosphorylation	474	3.4e-20	0.33	0.45	0.90
PGSC0003DMC200003556	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko04210	Apoptosis	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko05016	Huntington's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003556	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMC200003559	K02084	ko04115	p53 signaling pathway	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko04210	Apoptosis	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko05010	Alzheimer's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko05012	Parkinson's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko05016	Huntington's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003559	K02084	ko05222	Small cell lung cancer	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMC200003560	K02084	ko04115	p53 signaling pathway	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko04210	Apoptosis	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko05010	Alzheimer's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko05012	Parkinson's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko05016	Huntington's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003560	K02084	ko05222	Small cell lung cancer	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMC200003561	K02084	ko04115	p53 signaling pathway	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko04210	Apoptosis	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko05010	Alzheimer's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko05012	Parkinson's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko05016	Huntington's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003561	K02084	ko05222	Small cell lung cancer	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMC200003562	K02084	ko04115	p53 signaling pathway	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko04210	Apoptosis	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko05010	Alzheimer's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko05012	Parkinson's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko05016	Huntington's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003562	K02084	ko05222	Small cell lung cancer	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMC200003563	K12198	ko04144	Endocytosis	1692	1.7e-87	0.86	0.94	1.00
PGSC0003DMC200003570	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003570	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003570	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003570	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200003570	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMC200009691	K10527	ko00592	alpha-Linolenic acid metabolism	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMC200009691	K10527	ko01100	Metabolic pathways	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMC200009692	K10527	ko00592	alpha-Linolenic acid metabolism	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMC200009692	K10527	ko01100	Metabolic pathways	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMC200009693	K10527	ko00592	alpha-Linolenic acid metabolism	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMC200009693	K10527	ko01100	Metabolic pathways	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMC200009694	K10527	ko00592	alpha-Linolenic acid metabolism	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMC200009694	K10527	ko01100	Metabolic pathways	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMC200009695	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009695	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009695	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009696	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009696	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009696	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009697	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009697	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009697	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMC200009709	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMC200009710	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMC200009711	K01199	ko00500	Starch and sucrose metabolism	707	3.7e-33	0.34	0.54	0.67
PGSC0003DMC200009719	K00423	ko00053	Ascorbate and aldarate metabolism	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMC200009719	K00423	ko01100	Metabolic pathways	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMC200009720	K00423	ko00053	Ascorbate and aldarate metabolism	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMC200009720	K00423	ko01100	Metabolic pathways	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMC200015063	K01593	ko00340	Histidine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00350	Tyrosine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00360	Phenylalanine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00380	Tryptophan metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00901	Indole alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko00965	Betalain biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko01100	Metabolic pathways	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015063	K01593	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMC200015064	K01593	ko00340	Histidine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00350	Tyrosine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00360	Phenylalanine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00380	Tryptophan metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00901	Indole alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00950	Isoquinoline alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko00965	Betalain biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko01100	Metabolic pathways	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015064	K01593	ko01110	Biosynthesis of secondary metabolites	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMC200015065	K01593	ko00340	Histidine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00350	Tyrosine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00360	Phenylalanine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00380	Tryptophan metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00901	Indole alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko00965	Betalain biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko01100	Metabolic pathways	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015065	K01593	ko01110	Biosynthesis of secondary metabolites	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMC200015066	K05666	ko02010	ABC transporters	3248	2.6e-173	0.37	0.56	0.89
PGSC0003DMC200015067	K05666	ko02010	ABC transporters	3310	9.9e-177	0.36	0.55	0.91
PGSC0003DMC200015068	K05673	ko02010	ABC transporters	1972	6.2e-103	0.36	0.54	0.78
PGSC0003DMC200015069	K05666	ko02010	ABC transporters	484	7.4e-20	0.35	0.52	0.94
PGSC0003DMC200015070	K05666	ko02010	ABC transporters	1473	2.1e-75	0.47	0.70	0.96
PGSC0003DMC200015071	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015071	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015071	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015071	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015071	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015072	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015072	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015072	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015072	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015072	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMC200015075	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.50
PGSC0003DMC200015076	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.40
PGSC0003DMC200015078	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	465	2.5e-19	0.37	0.49	0.85
PGSC0003DMC200015087	K08903	ko00195	Photosynthesis	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMC200015087	K08903	ko01100	Metabolic pathways	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMC200015090	K01768	ko00230	Purine metabolism	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMC200015090	K01768	ko04113	Meiosis - yeast	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMC200069214	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069214	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMC200069225	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMC200069225	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMC200069225	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMC200069225	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMC200069225	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMC200069232	K01754	ko00260	Glycine, serine and threonine metabolism	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMC200069232	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMC200069232	K01754	ko01100	Metabolic pathways	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMC200069232	K01754	ko01110	Biosynthesis of secondary metabolites	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMC200069237	K10760	ko00908	Zeatin biosynthesis	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMC200069237	K10760	ko01100	Metabolic pathways	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMC200069237	K10760	ko01110	Biosynthesis of secondary metabolites	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMC200064027	K12836	ko03040	Spliceosome	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMC200064027	K12836	ko05131	Shigellosis	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMC200064039	K01051	ko00040	Pentose and glucuronate interconversions	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMC200064039	K01051	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMC200064039	K01051	ko01100	Metabolic pathways	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMC200034741	K01853	ko00100	Steroid biosynthesis	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMC200034741	K01853	ko01100	Metabolic pathways	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMC200034741	K01853	ko01110	Biosynthesis of secondary metabolites	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMC200034742	K01853	ko00100	Steroid biosynthesis	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMC200034742	K01853	ko01100	Metabolic pathways	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMC200034742	K01853	ko01110	Biosynthesis of secondary metabolites	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMC200034743	K01590	ko00340	Histidine metabolism	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMC200034743	K01590	ko01100	Metabolic pathways	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMC200034743	K01590	ko01110	Biosynthesis of secondary metabolites	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMC200034755	K12621	ko03018	RNA degradation	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMC200034755	K12621	ko03040	Spliceosome	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMC200034756	K12621	ko03018	RNA degradation	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMC200034756	K12621	ko03040	Spliceosome	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMC200034762	K04120	ko00904	Diterpenoid biosynthesis	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMC200034762	K04120	ko01100	Metabolic pathways	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMC200034762	K04120	ko01110	Biosynthesis of secondary metabolites	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMC200034764	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMC200040900	K04733	ko04210	Apoptosis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMC200040900	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMC200040900	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMC200040900	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMC200040900	K04733	ko05142	Chagas disease	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMC200040907	K03035	ko03050	Proteasome	3171	4.6e-169	0.86	0.94	1.00
PGSC0003DMC200040909	K02084	ko04115	p53 signaling pathway	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko04210	Apoptosis	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko05010	Alzheimer's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko05012	Parkinson's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko05016	Huntington's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200040909	K02084	ko05222	Small cell lung cancer	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMC200046266	K03405	ko00860	Porphyrin and chlorophyll metabolism	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMC200046266	K03405	ko01100	Metabolic pathways	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMC200046266	K03405	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMC200046267	K03405	ko00860	Porphyrin and chlorophyll metabolism	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMC200046267	K03405	ko01100	Metabolic pathways	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMC200046267	K03405	ko01110	Biosynthesis of secondary metabolites	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMC200046269	K13065	ko00940	Phenylpropanoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMC200046269	K13065	ko00941	Flavonoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMC200046269	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMC200046269	K13065	ko01110	Biosynthesis of secondary metabolites	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMC200046272	K13065	ko00940	Phenylpropanoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMC200046272	K13065	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMC200046272	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMC200046272	K13065	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMC200046288	K03178	ko04120	Ubiquitin mediated proteolysis	7544	0.	0.80	0.90	1.00
PGSC0003DMC200046288	K03178	ko05012	Parkinson's disease	7544	0.	0.80	0.90	1.00
PGSC0003DMC200046289	K08059	ko04612	Antigen processing and presentation	802	2.1e-38	0.48	0.67	0.84
PGSC0003DMC200046290	K08059	ko04612	Antigen processing and presentation	442	1.5e-18	0.43	0.63	0.90
PGSC0003DMC200050859	K04382	ko04111	Cell cycle - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04113	Meiosis - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04114	Oocyte meiosis	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04310	Wnt signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04350	TGF-beta signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04530	Tight junction	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko04730	Long-term depression	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050859	K04382	ko05142	Chagas disease	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMC200050865	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMC200050865	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMC200050865	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMC200050865	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMC200050865	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMC200050869	K01728	ko00040	Pentose and glucuronate interconversions	1586	1.2e-81	0.67	0.83	0.82
PGSC0003DMC200050870	K09755	ko00940	Phenylpropanoid biosynthesis	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMC200050870	K09755	ko01100	Metabolic pathways	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMC200050870	K09755	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMC200050872	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMC200050872	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMC200050873	K07748	ko00100	Steroid biosynthesis	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMC200050873	K07748	ko01100	Metabolic pathways	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMC200050874	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMC200050874	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMC200050875	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMC200050875	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMC200065229	K02155	ko00190	Oxidative phosphorylation	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko01100	Metabolic pathways	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko04142	Lysosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko04145	Phagosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko04966	Collecting duct acid secretion	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko05110	Vibrio cholerae infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065229	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMC200065248	K03094	ko04110	Cell cycle	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04111	Cell cycle - yeast	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04114	Oocyte meiosis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04120	Ubiquitin mediated proteolysis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04310	Wnt signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04350	TGF-beta signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200065248	K03094	ko04710	Circadian rhythm - mammal	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMC200004746	K05581	ko00190	Oxidative phosphorylation	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMC200004746	K05581	ko01100	Metabolic pathways	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMC200004764	K09054	ko05010	Alzheimer's disease	276	5.5e-07	0.30	0.44	0.65
PGSC0003DMC200004765	K03531	ko04112	Cell cycle - Caulobacter	2227	5.4e-117	0.79	0.88	0.97
PGSC0003DMC200004766	K03531	ko04112	Cell cycle - Caulobacter	1025	1.1e-50	0.89	0.94	0.99
PGSC0003DMC200004767	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMC200004768	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMC200016265	K00627	ko00010	Glycolysis / Gluconeogenesis	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMC200016265	K00627	ko00020	Citrate cycle (TCA cycle)	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMC200016265	K00627	ko00620	Pyruvate metabolism	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMC200016265	K00627	ko01100	Metabolic pathways	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMC200016265	K00627	ko01110	Biosynthesis of secondary metabolites	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMC200016273	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMC200016273	K03434	ko01100	Metabolic pathways	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMC200016274	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMC200016274	K03434	ko01100	Metabolic pathways	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMC200016279	K01190	ko00052	Galactose metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMC200016279	K01190	ko00511	Other glycan degradation	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMC200016279	K01190	ko00600	Sphingolipid metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMC200016279	K01190	ko01100	Metabolic pathways	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMC200016280	K01190	ko00052	Galactose metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMC200016280	K01190	ko00511	Other glycan degradation	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMC200016280	K01190	ko00600	Sphingolipid metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMC200016280	K01190	ko01100	Metabolic pathways	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMC200016281	K01190	ko00052	Galactose metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMC200016281	K01190	ko00511	Other glycan degradation	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMC200016281	K01190	ko00600	Sphingolipid metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMC200016281	K01190	ko01100	Metabolic pathways	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMC200016282	K01190	ko00052	Galactose metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMC200016282	K01190	ko00511	Other glycan degradation	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMC200016282	K01190	ko00600	Sphingolipid metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMC200016282	K01190	ko01100	Metabolic pathways	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMC200016283	K01190	ko00052	Galactose metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMC200016283	K01190	ko00511	Other glycan degradation	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMC200016283	K01190	ko00600	Sphingolipid metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMC200016283	K01190	ko01100	Metabolic pathways	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMC200010895	K11644	ko05016	Huntington's disease	236	3.8e-06	0.27	0.47	0.65
PGSC0003DMC200010903	K04079	ko04612	Antigen processing and presentation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010903	K04079	ko04621	NOD-like receptor signaling pathway	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010903	K04079	ko04626	Plant-pathogen interaction	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010903	K04079	ko04914	Progesterone-mediated oocyte maturation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010903	K04079	ko05200	Pathways in cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010903	K04079	ko05215	Prostate cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMC200010904	K04079	ko04612	Antigen processing and presentation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010904	K04079	ko04621	NOD-like receptor signaling pathway	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010904	K04079	ko04626	Plant-pathogen interaction	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010904	K04079	ko04914	Progesterone-mediated oocyte maturation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010904	K04079	ko05200	Pathways in cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010904	K04079	ko05215	Prostate cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMC200010905	K00059	ko00061	Fatty acid biosynthesis	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMC200010905	K00059	ko01040	Biosynthesis of unsaturated fatty acids	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMC200010905	K00059	ko01100	Metabolic pathways	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMC200010908	K08913	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMC200010908	K08913	ko01100	Metabolic pathways	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMC200020855	K01213	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMC200020855	K01213	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMC200020855	K01213	ko01100	Metabolic pathways	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMC200020856	K01213	ko00040	Pentose and glucuronate interconversions	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMC200020856	K01213	ko00500	Starch and sucrose metabolism	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMC200020856	K01213	ko01100	Metabolic pathways	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMC200020866	K01809	ko00051	Fructose and mannose metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMC200020866	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMC200020866	K01809	ko01100	Metabolic pathways	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMC200020866	K01809	ko01110	Biosynthesis of secondary metabolites	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMC200020867	K12929	ko00904	Diterpenoid biosynthesis	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMC200020867	K12929	ko01110	Biosynthesis of secondary metabolites	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMC200020868	K12929	ko00904	Diterpenoid biosynthesis	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMC200020868	K12929	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMC200020869	K12929	ko00904	Diterpenoid biosynthesis	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMC200020869	K12929	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMC200020870	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMC200020870	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMC200020871	K12929	ko00904	Diterpenoid biosynthesis	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMC200020871	K12929	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMC200020872	K12929	ko00904	Diterpenoid biosynthesis	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMC200020872	K12929	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMC200020873	K12929	ko00904	Diterpenoid biosynthesis	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMC200020873	K12929	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMC200020874	K12929	ko00904	Diterpenoid biosynthesis	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMC200020874	K12929	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMC200020875	K12929	ko00904	Diterpenoid biosynthesis	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMC200020875	K12929	ko01110	Biosynthesis of secondary metabolites	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMC200020876	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMC200020876	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMC200020877	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMC200020877	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMC200020878	K12929	ko00904	Diterpenoid biosynthesis	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMC200020878	K12929	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMC200020879	K10756	ko03030	DNA replication	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMC200020879	K10756	ko03420	Nucleotide excision repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMC200020879	K10756	ko03430	Mismatch repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMC200033559	K00547	ko00270	Cysteine and methionine metabolism	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMC200033559	K00547	ko01100	Metabolic pathways	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMC200033559	K00547	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMC200033560	K00547	ko00270	Cysteine and methionine metabolism	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMC200033560	K00547	ko01100	Metabolic pathways	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMC200033560	K00547	ko01110	Biosynthesis of secondary metabolites	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMC200033561	K00547	ko00270	Cysteine and methionine metabolism	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMC200033561	K00547	ko01100	Metabolic pathways	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMC200033561	K00547	ko01110	Biosynthesis of secondary metabolites	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMC200033564	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033564	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033564	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033565	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033565	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033565	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMC200033566	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMC200033566	K00517	ko00626	Naphthalene and anthracene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMC200033566	K00517	ko00903	Limonene and pinene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMC200033566	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMC200033566	K00517	ko01110	Biosynthesis of secondary metabolites	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMC200045061	K01509	ko00230	Purine metabolism	1308	2.6e-66	0.42	0.58	0.91
PGSC0003DMC200045079	K08332	ko04140	Regulation of autophagy	376	5.2e-12	0.30	0.46	0.47
PGSC0003DMC200045083	K12585	ko03018	RNA degradation	239	1.6e-06	0.54	0.62	0.82
PGSC0003DMC200039691	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMC200039691	K11517	ko01100	Metabolic pathways	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMC200039691	K11517	ko04146	Peroxisome	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMC200039692	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMC200039692	K11517	ko01100	Metabolic pathways	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMC200039692	K11517	ko04146	Peroxisome	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMC200039693	K09458	ko00061	Fatty acid biosynthesis	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMC200039693	K09458	ko01100	Metabolic pathways	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMC200039694	K09458	ko00061	Fatty acid biosynthesis	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMC200039694	K09458	ko01100	Metabolic pathways	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMC200039695	K09458	ko00061	Fatty acid biosynthesis	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMC200039695	K09458	ko01100	Metabolic pathways	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMC200039697	K05280	ko00941	Flavonoid biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMC200039697	K05280	ko00944	Flavone and flavonol biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMC200039697	K05280	ko01100	Metabolic pathways	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMC200039697	K05280	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMC200039698	K05280	ko00941	Flavonoid biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMC200039698	K05280	ko00944	Flavone and flavonol biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMC200039698	K05280	ko01100	Metabolic pathways	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMC200039698	K05280	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMC200039699	K05280	ko00941	Flavonoid biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMC200039699	K05280	ko00944	Flavone and flavonol biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMC200039699	K05280	ko01100	Metabolic pathways	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMC200039699	K05280	ko01110	Biosynthesis of secondary metabolites	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMC200039700	K00454	ko00591	Linoleic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMC200039700	K00454	ko00592	alpha-Linolenic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMC200039700	K00454	ko01100	Metabolic pathways	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMC200039701	K00454	ko00591	Linoleic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMC200039701	K00454	ko00592	alpha-Linolenic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMC200039701	K00454	ko01100	Metabolic pathways	5702	0.	0.72	0.84	1.00
PGSC0003DMC200039702	K00454	ko00591	Linoleic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMC200039702	K00454	ko00592	alpha-Linolenic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMC200039702	K00454	ko01100	Metabolic pathways	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMC200039712	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMC200039713	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMC200039715	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMC200039715	K11517	ko01100	Metabolic pathways	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMC200039715	K11517	ko04146	Peroxisome	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMC200039716	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMC200039716	K11517	ko01100	Metabolic pathways	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMC200039716	K11517	ko04146	Peroxisome	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMC200039717	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMC200039717	K11517	ko01100	Metabolic pathways	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMC200039717	K11517	ko04146	Peroxisome	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMC200039718	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMC200039718	K11517	ko01100	Metabolic pathways	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMC200039718	K11517	ko04146	Peroxisome	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMC200039719	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMC200039719	K11517	ko01100	Metabolic pathways	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMC200039719	K11517	ko04146	Peroxisome	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMC200039720	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMC200039720	K11517	ko01100	Metabolic pathways	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMC200039720	K11517	ko04146	Peroxisome	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMC200060168	K05350	ko00460	Cyanoamino acid metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMC200060168	K05350	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMC200060168	K05350	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMC200060168	K05350	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMC200029864	K08269	ko04140	Regulation of autophagy	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMC200029864	K08269	ko04150	mTOR signaling pathway	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMC200029865	K08269	ko04140	Regulation of autophagy	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMC200029865	K08269	ko04150	mTOR signaling pathway	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMC200029866	K02183	ko04020	Calcium signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04070	Phosphatidylinositol signaling system	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04114	Oocyte meiosis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04270	Vascular smooth muscle contraction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04626	Plant-pathogen interaction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04720	Long-term potentiation	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04722	Neurotrophin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04740	Olfactory transduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04744	Phototransduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04745	Phototransduction - fly	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04910	Insulin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04912	GnRH signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04916	Melanogenesis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04970	Salivary secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko04971	Gastric acid secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko05010	Alzheimer's disease	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029866	K02183	ko05214	Glioma	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMC200029872	K03456	ko04111	Cell cycle - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04113	Meiosis - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04114	Oocyte meiosis	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04310	Wnt signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04350	TGF-beta signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04530	Tight junction	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko04730	Long-term depression	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029872	K03456	ko05142	Chagas disease	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMC200029879	K00849	ko00052	Galactose metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMC200029879	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMC200029879	K00849	ko01100	Metabolic pathways	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMC200029880	K00001	ko00010	Glycolysis / Gluconeogenesis	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00071	Fatty acid metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00350	Tyrosine metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00624	1- and 2-Methylnaphthalene degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00641	3-Chloroacrylic acid degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00830	Retinol metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko00982	Drug metabolism - cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko01100	Metabolic pathways	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200029880	K00001	ko01110	Biosynthesis of secondary metabolites	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMC200006484	K03544	ko04112	Cell cycle - Caulobacter	299	1.5e-14	0.48	0.67	0.88
PGSC0003DMC200006487	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006487	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMC200006492	K01711	ko00051	Fructose and mannose metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMC200006492	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMC200006492	K01711	ko01100	Metabolic pathways	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMC200006499	K01179	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.47	0.72	0.88
PGSC0003DMC200006500	K01179	ko00500	Starch and sucrose metabolism	1027	8.3e-51	0.46	0.63	0.96
PGSC0003DMC200006501	K01179	ko00500	Starch and sucrose metabolism	674	2.4e-31	0.44	0.60	0.90
PGSC0003DMC200006502	K01179	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.44	0.62	0.95
PGSC0003DMC200006503	K01179	ko00500	Starch and sucrose metabolism	1001	2.2e-49	0.47	0.64	0.89
PGSC0003DMC200012872	K10875	ko03440	Homologous recombination	4786	3.9e-258	0.69	0.79	0.91
PGSC0003DMC200012873	K10875	ko03440	Homologous recombination	5464	1.6e-295	0.74	0.84	0.92
PGSC0003DMC200012883	K01823	ko00900	Terpenoid backbone biosynthesis	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMC200012883	K01823	ko01100	Metabolic pathways	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMC200012883	K01823	ko01110	Biosynthesis of secondary metabolites	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMC200012894	K04751	ko02020	Two-component system	512	2.1e-22	0.59	0.78	0.55
PGSC0003DMC200035431	K01184	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMC200035431	K01184	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMC200035431	K01184	ko01100	Metabolic pathways	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMC200035432	K01184	ko00040	Pentose and glucuronate interconversions	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMC200035432	K01184	ko00500	Starch and sucrose metabolism	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMC200035432	K01184	ko01100	Metabolic pathways	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMC200035433	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMC200035433	K01873	ko00970	Aminoacyl-tRNA biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMC200035434	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMC200035434	K01873	ko00970	Aminoacyl-tRNA biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMC200035435	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMC200035435	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMC200035436	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMC200035436	K01873	ko00970	Aminoacyl-tRNA biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMC200035439	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMC200035439	K02367	ko01100	Metabolic pathways	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMC200035441	K01239	ko00230	Purine metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMC200035441	K01239	ko00760	Nicotinate and nicotinamide metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMC200035441	K01239	ko01100	Metabolic pathways	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMC200035442	K01239	ko00230	Purine metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMC200035442	K01239	ko00760	Nicotinate and nicotinamide metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMC200035442	K01239	ko01100	Metabolic pathways	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMC200035458	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00270	Cysteine and methionine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00330	Arginine and proline metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00350	Tyrosine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00360	Phenylalanine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00401	Novobiocin biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00710	Carbon fixation in photosynthetic organisms	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko01100	Metabolic pathways	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035458	K00813	ko01110	Biosynthesis of secondary metabolites	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMC200035460	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMC200035460	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMC200037681	K11820	ko00380	Tryptophan metabolism	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMC200037681	K11820	ko00966	Glucosinolate biosynthesis	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMC200037681	K11820	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMC200037682	K01501	ko00380	Tryptophan metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037682	K01501	ko00460	Cyanoamino acid metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037682	K01501	ko00632	Benzoate degradation via CoA ligation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037682	K01501	ko00643	Styrene degradation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037682	K01501	ko00910	Nitrogen metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037682	K01501	ko01100	Metabolic pathways	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMC200037683	K01501	ko00380	Tryptophan metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037683	K01501	ko00460	Cyanoamino acid metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037683	K01501	ko00632	Benzoate degradation via CoA ligation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037683	K01501	ko00643	Styrene degradation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037683	K01501	ko00910	Nitrogen metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037683	K01501	ko01100	Metabolic pathways	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMC200037684	K01501	ko00380	Tryptophan metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037684	K01501	ko00460	Cyanoamino acid metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037684	K01501	ko00632	Benzoate degradation via CoA ligation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037684	K01501	ko00643	Styrene degradation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037684	K01501	ko00910	Nitrogen metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037684	K01501	ko01100	Metabolic pathways	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMC200037686	K04424	ko04010	MAPK signaling pathway	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMC200037686	K04424	ko04530	Tight junction	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMC200037689	K02950	ko03010	Ribosome	639	2.1e-29	0.64	0.81	0.78
PGSC0003DMC200037693	K08803	ko05200	Pathways in cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMC200037693	K08803	ko05219	Bladder cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMC200037694	K08064	ko04612	Antigen processing and presentation	557	6.9e-25	0.61	0.79	0.53
PGSC0003DMC200037695	K08064	ko04612	Antigen processing and presentation	669	4.6e-31	0.45	0.65	0.70
PGSC0003DMC200037701	K00797	ko00270	Cysteine and methionine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMC200037701	K00797	ko00330	Arginine and proline metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMC200037701	K00797	ko00410	beta-Alanine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMC200037701	K00797	ko00480	Glutathione metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMC200037701	K00797	ko01100	Metabolic pathways	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMC200037702	K00797	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMC200037702	K00797	ko00330	Arginine and proline metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMC200037702	K00797	ko00410	beta-Alanine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMC200037702	K00797	ko00480	Glutathione metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMC200037702	K00797	ko01100	Metabolic pathways	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMC200037703	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMC200037704	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMC200037705	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMC200037706	K02985	ko03010	Ribosome	1798	2.5e-93	0.92	0.95	1.00
PGSC0003DMC200044076	K00162	ko00010	Glycolysis / Gluconeogenesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko00020	Citrate cycle (TCA cycle)	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko00620	Pyruvate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko00650	Butanoate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko01100	Metabolic pathways	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044076	K00162	ko01110	Biosynthesis of secondary metabolites	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMC200044077	K00162	ko00010	Glycolysis / Gluconeogenesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko00020	Citrate cycle (TCA cycle)	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko00620	Pyruvate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko00650	Butanoate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko01100	Metabolic pathways	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044077	K00162	ko01110	Biosynthesis of secondary metabolites	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMC200044078	K00162	ko00010	Glycolysis / Gluconeogenesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko00020	Citrate cycle (TCA cycle)	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko00620	Pyruvate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko00650	Butanoate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko01100	Metabolic pathways	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044078	K00162	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMC200044082	K01692	ko00071	Fatty acid metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00280	Valine, leucine and isoleucine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00281	Geraniol degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00310	Lysine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00380	Tryptophan metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00410	beta-Alanine metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00632	Benzoate degradation via CoA ligation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00640	Propanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00650	Butanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00903	Limonene and pinene degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko00930	Caprolactam degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko01100	Metabolic pathways	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044082	K01692	ko01110	Biosynthesis of secondary metabolites	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMC200044086	K12135	ko04712	Circadian rhythm - plant	316	1.4e-11	0.38	0.57	0.21
PGSC0003DMC200044093	K03654	ko03018	RNA degradation	2345	1.7e-123	0.63	0.76	0.94
PGSC0003DMC200044094	K03654	ko03018	RNA degradation	4503	1.6e-242	0.60	0.76	1.00
PGSC0003DMC200044095	K03654	ko03018	RNA degradation	1799	2.2e-93	0.48	0.64	0.94
PGSC0003DMC200044096	K03654	ko03018	RNA degradation	3061	5.4e-163	0.74	0.88	0.99
PGSC0003DMC200044097	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMC200044098	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMC200044099	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMC200049653	K05933	ko00270	Cysteine and methionine metabolism	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMC200049653	K05933	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMC200049657	K09753	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMC200049657	K09753	ko01100	Metabolic pathways	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMC200049657	K09753	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMC200049658	K09753	ko00940	Phenylpropanoid biosynthesis	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMC200049658	K09753	ko01100	Metabolic pathways	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMC200049658	K09753	ko01110	Biosynthesis of secondary metabolites	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMC200049659	K09753	ko00940	Phenylpropanoid biosynthesis	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMC200049659	K09753	ko01100	Metabolic pathways	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMC200049659	K09753	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMC200049679	K02937	ko03010	Ribosome	1389	8.9e-71	0.67	0.83	1.00
PGSC0003DMC200032104	K12796	ko04621	NOD-like receptor signaling pathway	369	8.8e-11	0.31	0.46	0.40
PGSC0003DMC200032116	K08901	ko00195	Photosynthesis	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMC200032116	K08901	ko01100	Metabolic pathways	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMC200032117	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMC200032117	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMC200032118	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMC200032118	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMC200032123	K03349	ko04110	Cell cycle	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032123	K03349	ko04111	Cell cycle - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032123	K03349	ko04113	Meiosis - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032123	K03349	ko04114	Oocyte meiosis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032123	K03349	ko04120	Ubiquitin mediated proteolysis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032123	K03349	ko04914	Progesterone-mediated oocyte maturation	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMC200032129	K13030	ko00460	Cyanoamino acid metabolism	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMC200032129	K13030	ko01110	Biosynthesis of secondary metabolites	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMC200032130	K13030	ko00460	Cyanoamino acid metabolism	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMC200032130	K13030	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMC200047472	K12356	ko00940	Phenylpropanoid biosynthesis	732	1.5e-34	0.32	0.51	0.95
PGSC0003DMC200047473	K12356	ko00940	Phenylpropanoid biosynthesis	647	7.5e-30	0.41	0.62	0.69
PGSC0003DMC200047475	K12356	ko00940	Phenylpropanoid biosynthesis	755	8.3e-36	0.36	0.52	0.84
PGSC0003DMC200047480	K13066	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMC200047480	K13066	ko01110	Biosynthesis of secondary metabolites	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMC200047481	K05849	ko04020	Calcium signaling pathway	422	4.9e-17	0.34	0.55	0.50
PGSC0003DMC200047485	K03006	ko00230	Purine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMC200047485	K03006	ko00240	Pyrimidine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMC200047485	K03006	ko01100	Metabolic pathways	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMC200047485	K03006	ko03020	RNA polymerase	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMC200047485	K03006	ko05016	Huntington's disease	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMC200035945	K10418	ko04962	Vasopressin-regulated water reabsorption	327	3.4e-12	0.54	0.69	0.34
PGSC0003DMC200035946	K12929	ko00904	Diterpenoid biosynthesis	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMC200035946	K12929	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMC200035963	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035963	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035963	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035964	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035964	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035964	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMC200035965	K00967	ko00440	Phosphonate and phosphinate metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMC200035965	K00967	ko00564	Glycerophospholipid metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMC200035965	K00967	ko01100	Metabolic pathways	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMC200035966	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	302	8.0e-11	0.59	0.69	0.66
PGSC0003DMC200035967	K10352	ko04530	Tight junction	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMC200035967	K10352	ko05416	Viral myocarditis	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMC200054725	K08504	ko04130	SNARE interactions in vesicular transport	784	2.1e-37	0.81	0.93	0.62
PGSC0003DMC200054730	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054730	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054730	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054730	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054730	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054730	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054731	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMC200054735	K01184	ko00040	Pentose and glucuronate interconversions	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMC200054735	K01184	ko00500	Starch and sucrose metabolism	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMC200054735	K01184	ko01100	Metabolic pathways	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMC200054736	K11778	ko00900	Terpenoid backbone biosynthesis	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMC200054736	K11778	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMC200054737	K00806	ko00900	Terpenoid backbone biosynthesis	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMC200054737	K00806	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMC200054741	K12929	ko00904	Diterpenoid biosynthesis	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMC200054741	K12929	ko01110	Biosynthesis of secondary metabolites	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMC200054745	K12192	ko04144	Endocytosis	1021	1.8e-50	0.77	0.92	0.89
PGSC0003DMC200054746	K12192	ko04144	Endocytosis	1275	1.7e-64	0.75	0.91	0.99
PGSC0003DMC200018452	K01937	ko00240	Pyrimidine metabolism	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMC200018452	K01937	ko01100	Metabolic pathways	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMC200018453	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMC200018454	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMC200018461	K00286	ko00330	Arginine and proline metabolism	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMC200018461	K00286	ko01100	Metabolic pathways	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMC200018461	K00286	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMC200018462	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018462	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018462	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018463	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018463	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018463	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMC200018464	K00286	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMC200018464	K00286	ko01100	Metabolic pathways	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMC200018464	K00286	ko01110	Biosynthesis of secondary metabolites	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMC200018472	K04424	ko04010	MAPK signaling pathway	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMC200018472	K04424	ko04530	Tight junction	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMC200018475	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMC200018475	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMC200018476	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMC200018476	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMC200025940	K00213	ko00100	Steroid biosynthesis	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMC200025940	K00213	ko01100	Metabolic pathways	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMC200025940	K00213	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMC200025944	K00430	ko00360	Phenylalanine metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMC200025944	K00430	ko00680	Methane metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMC200025944	K00430	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMC200025944	K00430	ko01100	Metabolic pathways	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMC200025944	K00430	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMC200025945	K00430	ko00360	Phenylalanine metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMC200025945	K00430	ko00680	Methane metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMC200025945	K00430	ko00940	Phenylpropanoid biosynthesis	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMC200025945	K00430	ko01100	Metabolic pathways	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMC200025945	K00430	ko01110	Biosynthesis of secondary metabolites	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMC200025946	K00430	ko00360	Phenylalanine metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMC200025946	K00430	ko00680	Methane metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMC200025946	K00430	ko00940	Phenylpropanoid biosynthesis	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMC200025946	K00430	ko01100	Metabolic pathways	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMC200025946	K00430	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMC200025947	K00430	ko00360	Phenylalanine metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMC200025947	K00430	ko00680	Methane metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMC200025947	K00430	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMC200025947	K00430	ko01100	Metabolic pathways	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMC200025947	K00430	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMC200025950	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200025950	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200025950	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMC200066587	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMC200066587	K00517	ko00626	Naphthalene and anthracene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMC200066587	K00517	ko00903	Limonene and pinene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMC200066587	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMC200066587	K00517	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMC200066598	K11816	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.64	0.95
PGSC0003DMC200033039	K03936	ko00190	Oxidative phosphorylation	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMC200033039	K03936	ko01100	Metabolic pathways	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMC200033039	K03936	ko05010	Alzheimer's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMC200033039	K03936	ko05012	Parkinson's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMC200033039	K03936	ko05016	Huntington's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMC200033049	K01051	ko00040	Pentose and glucuronate interconversions	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMC200033049	K01051	ko00500	Starch and sucrose metabolism	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMC200033049	K01051	ko01100	Metabolic pathways	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMC200051722	K02152	ko00190	Oxidative phosphorylation	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051722	K02152	ko01100	Metabolic pathways	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051722	K02152	ko04145	Phagosome	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051722	K02152	ko04966	Collecting duct acid secretion	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051722	K02152	ko05110	Vibrio cholerae infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051722	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMC200051723	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMC200051723	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMC200051724	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMC200051724	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMC200051735	K12821	ko03040	Spliceosome	247	4.8e-07	0.31	0.40	0.79
PGSC0003DMC200051740	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMC200051741	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMC200051744	K02988	ko03010	Ribosome	1806	8.9e-94	0.72	0.83	1.00
PGSC0003DMC200058661	K12854	ko03040	Spliceosome	440	2.7e-17	0.84	0.90	0.95
PGSC0003DMC200058663	K00588	ko00360	Phenylalanine metabolism	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058663	K00588	ko00940	Phenylpropanoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058663	K00588	ko00941	Flavonoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058663	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058663	K00588	ko01100	Metabolic pathways	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058663	K00588	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMC200058673	K10760	ko00908	Zeatin biosynthesis	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMC200058673	K10760	ko01100	Metabolic pathways	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMC200058673	K10760	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMC200045518	K00492	ko00340	Histidine metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00363	Bisphenol A degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00622	Toluene and xylene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00624	1- and 2-Methylnaphthalene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00626	Naphthalene and anthracene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00627	1,4-Dichlorobenzene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00680	Methane metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko00903	Limonene and pinene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko01100	Metabolic pathways	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045518	K00492	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMC200045521	K01692	ko00071	Fatty acid metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00280	Valine, leucine and isoleucine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00281	Geraniol degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00310	Lysine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00380	Tryptophan metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00410	beta-Alanine metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00632	Benzoate degradation via CoA ligation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00640	Propanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00650	Butanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00903	Limonene and pinene degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko00930	Caprolactam degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko01100	Metabolic pathways	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045521	K01692	ko01110	Biosynthesis of secondary metabolites	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMC200045522	K01692	ko00071	Fatty acid metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00280	Valine, leucine and isoleucine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00281	Geraniol degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00310	Lysine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00380	Tryptophan metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00410	beta-Alanine metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00632	Benzoate degradation via CoA ligation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00640	Propanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00650	Butanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00903	Limonene and pinene degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko00930	Caprolactam degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko01100	Metabolic pathways	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045522	K01692	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMC200045523	K01692	ko00071	Fatty acid metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00280	Valine, leucine and isoleucine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00281	Geraniol degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00310	Lysine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00380	Tryptophan metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00410	beta-Alanine metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00632	Benzoate degradation via CoA ligation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00640	Propanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00650	Butanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko00930	Caprolactam degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko01100	Metabolic pathways	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045523	K01692	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMC200045524	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00310	Lysine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045524	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMC200045537	K01074	ko00062	Fatty acid elongation in mitochondria	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMC200045537	K01074	ko01100	Metabolic pathways	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMC200045537	K01074	ko04142	Lysosome	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMC200008883	K09841	ko00906	Carotenoid biosynthesis	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMC200008883	K09841	ko01100	Metabolic pathways	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMC200008883	K09841	ko01110	Biosynthesis of secondary metabolites	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMC200008891	K06689	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.86	0.88	0.99
PGSC0003DMC200008892	K06689	ko04120	Ubiquitin mediated proteolysis	1290	2.6e-65	0.98	0.99	0.99
PGSC0003DMC200008896	K01178	ko00500	Starch and sucrose metabolism	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMC200008896	K01178	ko01100	Metabolic pathways	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMC200008898	K01179	ko00500	Starch and sucrose metabolism	1397	3.2e-71	0.41	0.57	0.75
PGSC0003DMC200008899	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMC200008899	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMC200008899	K00771	ko01100	Metabolic pathways	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMC200008907	K01784	ko00052	Galactose metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMC200008907	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMC200008907	K01784	ko01100	Metabolic pathways	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMC200008908	K01784	ko00052	Galactose metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMC200008908	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMC200008908	K01784	ko01100	Metabolic pathways	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMC200008909	K01784	ko00052	Galactose metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMC200008909	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMC200008909	K01784	ko01100	Metabolic pathways	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMC200008910	K01784	ko00052	Galactose metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMC200008910	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMC200008910	K01784	ko01100	Metabolic pathways	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMC200004235	K01918	ko00410	beta-Alanine metabolism	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMC200004235	K01918	ko00770	Pantothenate and CoA biosynthesis	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMC200004235	K01918	ko01100	Metabolic pathways	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMC200004235	K01918	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMC200004236	K12843	ko03040	Spliceosome	3543	1.4e-189	0.76	0.84	0.69
PGSC0003DMC200004248	K00588	ko00360	Phenylalanine metabolism	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004248	K00588	ko00940	Phenylpropanoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004248	K00588	ko00941	Flavonoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004248	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004248	K00588	ko01100	Metabolic pathways	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004248	K00588	ko01110	Biosynthesis of secondary metabolites	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMC200004249	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004249	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004249	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004249	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004249	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004249	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMC200004250	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004250	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004250	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004250	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004250	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004250	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMC200004251	K00588	ko00360	Phenylalanine metabolism	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200004251	K00588	ko00940	Phenylpropanoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200004251	K00588	ko00941	Flavonoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200004251	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200004251	K00588	ko01100	Metabolic pathways	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200004251	K00588	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMC200022924	K12580	ko03018	RNA degradation	5263	1.9e-284	0.71	0.82	1.00
PGSC0003DMC200022925	K12580	ko03018	RNA degradation	5252	7.7e-284	0.71	0.81	1.00
PGSC0003DMC200022927	K05280	ko00941	Flavonoid biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMC200022927	K05280	ko00944	Flavone and flavonol biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMC200022927	K05280	ko01100	Metabolic pathways	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMC200022927	K05280	ko01110	Biosynthesis of secondary metabolites	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMC200022938	K09755	ko00940	Phenylpropanoid biosynthesis	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMC200022938	K09755	ko01100	Metabolic pathways	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMC200022938	K09755	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMC200022939	K09755	ko00940	Phenylpropanoid biosynthesis	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMC200022939	K09755	ko01100	Metabolic pathways	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMC200022939	K09755	ko01110	Biosynthesis of secondary metabolites	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMC200022950	K02974	ko03010	Ribosome	378	5.2e-15	0.83	0.93	0.96
PGSC0003DMC200016722	K01464	ko00240	Pyrimidine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMC200016722	K01464	ko00410	beta-Alanine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMC200016722	K01464	ko00770	Pantothenate and CoA biosynthesis	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMC200016722	K01464	ko00983	Drug metabolism - other enzymes	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMC200016722	K01464	ko01100	Metabolic pathways	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMC200016723	K01464	ko00240	Pyrimidine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMC200016723	K01464	ko00410	beta-Alanine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMC200016723	K01464	ko00770	Pantothenate and CoA biosynthesis	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMC200016723	K01464	ko00983	Drug metabolism - other enzymes	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMC200016723	K01464	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMC200027454	K01199	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.38	0.58	0.53
PGSC0003DMC200027455	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMC200027456	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMC200027461	K10838	ko03420	Nucleotide excision repair	3553	3.9e-190	0.52	0.68	0.97
PGSC0003DMC200027464	K00795	ko00900	Terpenoid backbone biosynthesis	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMC200027464	K00795	ko01100	Metabolic pathways	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMC200027464	K00795	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMC200000246	K00635	ko00561	Glycerolipid metabolism	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMC200000246	K00635	ko01100	Metabolic pathways	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMC200000254	K08770	ko03320	PPAR signaling pathway	324	8.0e-12	0.30	0.49	0.52
PGSC0003DMC200000255	K08770	ko03320	PPAR signaling pathway	324	4.9e-12	0.30	0.49	0.64
PGSC0003DMC200000268	K12132	ko04712	Circadian rhythm - plant	1860	9.4e-97	0.54	0.70	0.62
PGSC0003DMC200001898	K08738	ko04115	p53 signaling pathway	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko04210	Apoptosis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05010	Alzheimer's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05012	Parkinson's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05016	Huntington's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05200	Pathways in cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05210	Colorectal cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05222	Small cell lung cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001898	K08738	ko05416	Viral myocarditis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMC200001910	K01066	ko00623	2,4-Dichlorobenzoate degradation	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMC200001910	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMC200001911	K01066	ko00623	2,4-Dichlorobenzoate degradation	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMC200001911	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMC200062565	K10591	ko04120	Ubiquitin mediated proteolysis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMC200062565	K10591	ko04144	Endocytosis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMC200062571	K03260	ko05416	Viral myocarditis	316	1.0e-08	0.25	0.41	0.93
PGSC0003DMC200062574	K12183	ko04144	Endocytosis	254	9.6e-08	0.37	0.45	0.61
PGSC0003DMC200038895	K00422	ko00350	Tyrosine metabolism	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMC200038895	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMC200038895	K00422	ko01100	Metabolic pathways	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMC200038895	K00422	ko01110	Biosynthesis of secondary metabolites	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMC200038897	K12829	ko03040	Spliceosome	4163	8.9e-224	0.84	0.91	0.98
PGSC0003DMC200038898	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMC200038898	K01988	ko01100	Metabolic pathways	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMC200038908	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMC200038909	K12837	ko03040	Spliceosome	1395	4.2e-71	0.61	0.76	0.97
PGSC0003DMC200038910	K12837	ko03040	Spliceosome	2403	1.1e-126	0.57	0.70	0.99
PGSC0003DMC200052921	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMC200052922	K08332	ko04140	Regulation of autophagy	310	8.7e-09	0.30	0.52	0.46
PGSC0003DMC200052923	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMC200052932	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMC200052932	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMC200052932	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMC200052932	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMC200052932	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMC200052933	K01199	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.35	0.57	0.70
PGSC0003DMC200052935	K03006	ko00230	Purine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMC200052935	K03006	ko00240	Pyrimidine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMC200052935	K03006	ko01100	Metabolic pathways	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMC200052935	K03006	ko03020	RNA polymerase	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMC200052935	K03006	ko05016	Huntington's disease	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMC200052939	K00368	ko00910	Nitrogen metabolism	1682	6.2e-87	0.43	0.58	0.94
PGSC0003DMC200052942	K03122	ko03022	Basal transcription factors	2033	2.7e-106	0.65	0.73	0.83
PGSC0003DMC200052943	K03122	ko03022	Basal transcription factors	2369	7.9e-125	0.70	0.79	1.00
PGSC0003DMC200052944	K07750	ko00100	Steroid biosynthesis	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMC200052944	K07750	ko01100	Metabolic pathways	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMC200052945	K07750	ko00100	Steroid biosynthesis	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMC200052945	K07750	ko01100	Metabolic pathways	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMC200052946	K03006	ko00230	Purine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMC200052946	K03006	ko00240	Pyrimidine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMC200052946	K03006	ko01100	Metabolic pathways	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMC200052946	K03006	ko03020	RNA polymerase	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMC200052946	K03006	ko05016	Huntington's disease	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMC200052947	K06269	ko04113	Meiosis - yeast	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04114	Oocyte meiosis	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04270	Vascular smooth muscle contraction	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04510	Focal adhesion	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04720	Long-term potentiation	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04810	Regulation of actin cytoskeleton	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200052947	K06269	ko04910	Insulin signaling pathway	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMC200034241	K03035	ko03050	Proteasome	3109	1.2e-165	0.81	0.88	1.00
PGSC0003DMC200034242	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMC200034243	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMC200034249	K00454	ko00591	Linoleic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMC200034249	K00454	ko00592	alpha-Linolenic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMC200034249	K00454	ko01100	Metabolic pathways	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMC200034252	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034252	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034252	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034252	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034252	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034253	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034253	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034253	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034253	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200034253	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMC200057469	K08233	ko00901	Indole alkaloid biosynthesis	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMC200057469	K08233	ko01110	Biosynthesis of secondary metabolites	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMC200057474	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.32	0.50	0.95
PGSC0003DMC200046711	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3734	4.1e-200	0.79	0.87	0.97
PGSC0003DMC200046712	K04567	ko00970	Aminoacyl-tRNA biosynthesis	402	2.4e-16	0.90	0.98	0.77
PGSC0003DMC200046713	K02940	ko03010	Ribosome	1358	4.6e-69	0.88	0.93	0.99
PGSC0003DMC200046714	K02901	ko03010	Ribosome	1053	3.0e-52	0.90	0.98	0.99
PGSC0003DMC200046718	K01784	ko00052	Galactose metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMC200046718	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMC200046718	K01784	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMC200046720	K01784	ko00052	Galactose metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMC200046720	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMC200046720	K01784	ko01100	Metabolic pathways	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMC200046722	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04744	Phototransduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04916	Melanogenesis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04970	Salivary secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046722	K02183	ko05214	Glioma	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMC200046723	K02183	ko04020	Calcium signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04070	Phosphatidylinositol signaling system	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04114	Oocyte meiosis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04270	Vascular smooth muscle contraction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04626	Plant-pathogen interaction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04720	Long-term potentiation	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04722	Neurotrophin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04740	Olfactory transduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04744	Phototransduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04745	Phototransduction - fly	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04910	Insulin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04912	GnRH signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04916	Melanogenesis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04970	Salivary secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko04971	Gastric acid secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko05010	Alzheimer's disease	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046723	K02183	ko05214	Glioma	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMC200046726	K00847	ko00051	Fructose and mannose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMC200046726	K00847	ko00500	Starch and sucrose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMC200046726	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMC200046726	K00847	ko01100	Metabolic pathways	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMC200046739	K00475	ko00941	Flavonoid biosynthesis	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMC200046739	K00475	ko01100	Metabolic pathways	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMC200046739	K00475	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMC200046740	K00475	ko00941	Flavonoid biosynthesis	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMC200046740	K00475	ko01100	Metabolic pathways	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMC200046740	K00475	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMC200069371	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200069371	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200069371	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMC200000696	K02111	ko00190	Oxidative phosphorylation	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMC200000696	K02111	ko00195	Photosynthesis	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMC200000696	K02111	ko01100	Metabolic pathways	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMC200000698	K01199	ko00500	Starch and sucrose metabolism	962	3.2e-47	0.39	0.61	0.67
PGSC0003DMC200000699	K01887	ko00970	Aminoacyl-tRNA biosynthesis	2133	8.2e-112	0.82	0.93	0.99
PGSC0003DMC200000700	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMC200000701	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMC200000702	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMC200000711	K00029	ko00620	Pyruvate metabolism	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMC200000711	K00029	ko00710	Carbon fixation in photosynthetic organisms	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMC200000711	K00029	ko01100	Metabolic pathways	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMC200021728	K01784	ko00052	Galactose metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMC200021728	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMC200021728	K01784	ko01100	Metabolic pathways	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMC200021729	K01784	ko00052	Galactose metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMC200021729	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMC200021729	K01784	ko01100	Metabolic pathways	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMC200021731	K00940	ko00230	Purine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMC200021731	K00940	ko00240	Pyrimidine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMC200021731	K00940	ko01100	Metabolic pathways	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMC200021731	K00940	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMC200021742	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021742	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021742	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021743	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021743	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021743	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMC200021750	K01179	ko00500	Starch and sucrose metabolism	1878	9.5e-98	0.48	0.64	0.79
PGSC0003DMC200003033	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMC200003039	K10717	ko00908	Zeatin biosynthesis	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMC200003039	K10717	ko01100	Metabolic pathways	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMC200003039	K10717	ko01110	Biosynthesis of secondary metabolites	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMC200003040	K10717	ko00908	Zeatin biosynthesis	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMC200003040	K10717	ko01100	Metabolic pathways	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMC200003040	K10717	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMC200003041	K10717	ko00908	Zeatin biosynthesis	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMC200003041	K10717	ko01100	Metabolic pathways	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMC200003041	K10717	ko01110	Biosynthesis of secondary metabolites	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMC200003044	K11294	ko05130	Pathogenic Escherichia coli infection	320	1.4e-11	0.28	0.45	0.97
PGSC0003DMC200003059	K10742	ko03030	DNA replication	5770	0.	0.60	0.74	0.84
PGSC0003DMC200003060	K10742	ko03030	DNA replication	3296	5.9e-176	0.69	0.81	0.99
PGSC0003DMC200015527	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMC200015528	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMC200015534	K11153	ko00830	Retinol metabolism	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMC200015534	K11153	ko01100	Metabolic pathways	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMC200015535	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015535	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015535	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015535	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015535	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015535	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015536	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMC200015537	K11153	ko00830	Retinol metabolism	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMC200015537	K11153	ko01100	Metabolic pathways	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMC200015540	K00620	ko00330	Arginine and proline metabolism	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMC200015540	K00620	ko01100	Metabolic pathways	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMC200015540	K00620	ko01110	Biosynthesis of secondary metabolites	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMC200028658	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028658	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028658	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028659	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028659	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028659	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMC200028661	K03469	ko03030	DNA replication	296	6.8e-10	0.35	0.51	0.21
PGSC0003DMC200028664	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.61
PGSC0003DMC200028665	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMC200028666	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMC200028667	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.52
PGSC0003DMC200028668	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMC200028669	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.48
PGSC0003DMC200030911	K00599	ko00340	Histidine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMC200030911	K00599	ko00350	Tyrosine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMC200030911	K00599	ko00450	Selenoamino acid metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMC200030911	K00599	ko00626	Naphthalene and anthracene degradation	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMC200030912	K00599	ko00340	Histidine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMC200030912	K00599	ko00350	Tyrosine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMC200030912	K00599	ko00450	Selenoamino acid metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMC200030912	K00599	ko00626	Naphthalene and anthracene degradation	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMC200030928	K02183	ko04020	Calcium signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04070	Phosphatidylinositol signaling system	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04114	Oocyte meiosis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04270	Vascular smooth muscle contraction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04626	Plant-pathogen interaction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04720	Long-term potentiation	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04722	Neurotrophin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04740	Olfactory transduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04744	Phototransduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04745	Phototransduction - fly	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04910	Insulin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04912	GnRH signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04916	Melanogenesis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04970	Salivary secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko04971	Gastric acid secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko05010	Alzheimer's disease	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030928	K02183	ko05214	Glioma	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMC200030930	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMC200030930	K01491	ko00670	One carbon pool by folate	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMC200030930	K01491	ko01100	Metabolic pathways	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMC200048468	K00658	ko00020	Citrate cycle (TCA cycle)	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMC200048468	K00658	ko00310	Lysine degradation	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMC200048468	K00658	ko01100	Metabolic pathways	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMC200048468	K00658	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMC200048469	K00658	ko00020	Citrate cycle (TCA cycle)	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMC200048469	K00658	ko00310	Lysine degradation	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMC200048469	K00658	ko01100	Metabolic pathways	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMC200048469	K00658	ko01110	Biosynthesis of secondary metabolites	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMC200048470	K00658	ko00020	Citrate cycle (TCA cycle)	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMC200048470	K00658	ko00310	Lysine degradation	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMC200048470	K00658	ko01100	Metabolic pathways	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMC200048470	K00658	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMC200048471	K00658	ko00020	Citrate cycle (TCA cycle)	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMC200048471	K00658	ko00310	Lysine degradation	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMC200048471	K00658	ko01100	Metabolic pathways	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMC200048471	K00658	ko01110	Biosynthesis of secondary metabolites	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMC200048472	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMC200048472	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMC200048472	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMC200048474	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMC200048474	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMC200048474	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMC200048475	K02115	ko00190	Oxidative phosphorylation	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMC200048475	K02115	ko00195	Photosynthesis	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMC200048475	K02115	ko01100	Metabolic pathways	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMC200048480	K10373	ko04260	Cardiac muscle contraction	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMC200048480	K10373	ko05410	Hypertrophic cardiomyopathy (HCM)	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMC200048480	K10373	ko05414	Dilated cardiomyopathy	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMC200055921	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMC200055921	K02367	ko01100	Metabolic pathways	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMC200055922	K13230	ko00402	Benzoxazinoid biosynthesis	895	1.6e-43	0.36	0.57	0.97
PGSC0003DMC200055928	K01193	ko00052	Galactose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMC200055928	K01193	ko00500	Starch and sucrose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMC200055928	K01193	ko01100	Metabolic pathways	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMC200055929	K01193	ko00052	Galactose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMC200055929	K01193	ko00500	Starch and sucrose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMC200055929	K01193	ko01100	Metabolic pathways	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMC200055930	K01193	ko00052	Galactose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMC200055930	K01193	ko00500	Starch and sucrose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMC200055930	K01193	ko01100	Metabolic pathways	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMC200055931	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMC200055935	K13230	ko00402	Benzoxazinoid biosynthesis	496	1.6e-21	0.33	0.51	0.94
PGSC0003DMC200055939	K02084	ko04115	p53 signaling pathway	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko04210	Apoptosis	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko05010	Alzheimer's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko05012	Parkinson's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko05016	Huntington's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200055939	K02084	ko05222	Small cell lung cancer	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMC200067771	K13065	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMC200067771	K13065	ko00941	Flavonoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMC200067771	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMC200067771	K13065	ko01110	Biosynthesis of secondary metabolites	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMC200067800	K07424	ko00140	Steroid hormone biosynthesis	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00591	Linoleic acid metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00830	Retinol metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00982	Drug metabolism - cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko00983	Drug metabolism - other enzymes	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200067800	K07424	ko01100	Metabolic pathways	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMC200019654	K00131	ko00010	Glycolysis / Gluconeogenesis	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMC200019654	K00131	ko01100	Metabolic pathways	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMC200019655	K12126	ko04712	Circadian rhythm - plant	338	2.2e-12	0.51	0.76	0.18
PGSC0003DMC200019659	K10255	ko01040	Biosynthesis of unsaturated fatty acids	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMC200019659	K10255	ko02020	Two-component system	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMC200019663	K00655	ko00561	Glycerolipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMC200019663	K00655	ko00564	Glycerophospholipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMC200019663	K00655	ko01100	Metabolic pathways	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMC200019664	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019664	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019664	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019665	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019665	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019665	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMC200019667	K05391	ko04626	Plant-pathogen interaction	4777	1.2e-257	0.79	0.87	0.98
PGSC0003DMC200017478	K09561	ko04120	Ubiquitin mediated proteolysis	253	1.4e-07	0.35	0.51	0.25
PGSC0003DMC200017481	K03781	ko00380	Tryptophan metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMC200017481	K03781	ko00680	Methane metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMC200017481	K03781	ko01100	Metabolic pathways	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMC200017481	K03781	ko04146	Peroxisome	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMC200017481	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMC200005947	K01136	ko00531	Glycosaminoglycan degradation	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMC200005947	K01136	ko01100	Metabolic pathways	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMC200005947	K01136	ko04142	Lysosome	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMC200005950	K01199	ko00500	Starch and sucrose metabolism	738	7.2e-35	0.35	0.56	0.69
PGSC0003DMC200005951	K00860	ko00230	Purine metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMC200005951	K00860	ko00450	Selenoamino acid metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMC200005951	K00860	ko00920	Sulfur metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMC200005951	K00860	ko01100	Metabolic pathways	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMC200005952	K00860	ko00230	Purine metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMC200005952	K00860	ko00450	Selenoamino acid metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMC200005952	K00860	ko00920	Sulfur metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMC200005952	K00860	ko01100	Metabolic pathways	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMC200005956	K01684	ko00052	Galactose metabolism	273	3.2e-09	0.31	0.45	0.83
PGSC0003DMC200005957	K12741	ko03040	Spliceosome	667	5.9e-31	0.46	0.67	0.31
PGSC0003DMC200005958	K00511	ko00100	Steroid biosynthesis	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMC200005958	K00511	ko01100	Metabolic pathways	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMC200005958	K00511	ko01110	Biosynthesis of secondary metabolites	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMC200005959	K00511	ko00100	Steroid biosynthesis	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMC200005959	K00511	ko01100	Metabolic pathways	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMC200005959	K00511	ko01110	Biosynthesis of secondary metabolites	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMC200005960	K01762	ko00270	Cysteine and methionine metabolism	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMC200005960	K01762	ko01110	Biosynthesis of secondary metabolites	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMC200005962	K02918	ko03010	Ribosome	553	1.1e-24	0.89	0.91	0.86
PGSC0003DMC200024738	K01593	ko00340	Histidine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00350	Tyrosine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00360	Phenylalanine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00380	Tryptophan metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00901	Indole alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko00965	Betalain biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko01100	Metabolic pathways	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024738	K01593	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMC200024741	K00430	ko00360	Phenylalanine metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMC200024741	K00430	ko00680	Methane metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMC200024741	K00430	ko00940	Phenylpropanoid biosynthesis	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMC200024741	K00430	ko01100	Metabolic pathways	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMC200024741	K00430	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMC200017976	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMC200017976	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMC200017977	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017977	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017978	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017978	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017979	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017979	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMC200017980	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMC200017980	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMC200017981	K12842	ko03040	Spliceosome	6229	0.	0.77	0.88	1.00
PGSC0003DMC200017982	K12842	ko03040	Spliceosome	5627	0.	0.77	0.88	1.00
PGSC0003DMC200017983	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMC200017984	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMC200026166	K01593	ko00340	Histidine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00350	Tyrosine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00360	Phenylalanine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00380	Tryptophan metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00901	Indole alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko00965	Betalain biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko01100	Metabolic pathways	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026166	K01593	ko01110	Biosynthesis of secondary metabolites	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMC200026173	K00430	ko00360	Phenylalanine metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMC200026173	K00430	ko00680	Methane metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMC200026173	K00430	ko00940	Phenylpropanoid biosynthesis	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMC200026173	K00430	ko01100	Metabolic pathways	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMC200026173	K00430	ko01110	Biosynthesis of secondary metabolites	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMC200026177	K05741	ko04810	Regulation of actin cytoskeleton	653	1.9e-28	0.29	0.43	0.60
PGSC0003DMC200026179	K00001	ko00010	Glycolysis / Gluconeogenesis	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00071	Fatty acid metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00350	Tyrosine metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00624	1- and 2-Methylnaphthalene degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00641	3-Chloroacrylic acid degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00830	Retinol metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko00982	Drug metabolism - cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko01100	Metabolic pathways	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026179	K00001	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMC200026180	K00121	ko00010	Glycolysis / Gluconeogenesis	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00071	Fatty acid metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00350	Tyrosine metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00641	3-Chloroacrylic acid degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00680	Methane metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00830	Retinol metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko00982	Drug metabolism - cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko01100	Metabolic pathways	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026180	K00121	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMC200026181	K00121	ko00010	Glycolysis / Gluconeogenesis	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00071	Fatty acid metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00350	Tyrosine metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00641	3-Chloroacrylic acid degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00680	Methane metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00830	Retinol metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko00982	Drug metabolism - cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko01100	Metabolic pathways	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026181	K00121	ko01110	Biosynthesis of secondary metabolites	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMC200026182	K00121	ko00010	Glycolysis / Gluconeogenesis	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00071	Fatty acid metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00350	Tyrosine metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00641	3-Chloroacrylic acid degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00680	Methane metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00830	Retinol metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko00982	Drug metabolism - cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko01100	Metabolic pathways	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026182	K00121	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMC200026183	K00121	ko00010	Glycolysis / Gluconeogenesis	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00071	Fatty acid metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00350	Tyrosine metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00641	3-Chloroacrylic acid degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00680	Methane metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00830	Retinol metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko00982	Drug metabolism - cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko01100	Metabolic pathways	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026183	K00121	ko01110	Biosynthesis of secondary metabolites	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMC200026184	K00121	ko00010	Glycolysis / Gluconeogenesis	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00071	Fatty acid metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00350	Tyrosine metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00641	3-Chloroacrylic acid degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00680	Methane metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00830	Retinol metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko00982	Drug metabolism - cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko01100	Metabolic pathways	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026184	K00121	ko01110	Biosynthesis of secondary metabolites	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMC200026185	K12846	ko03040	Spliceosome	792	7.6e-38	0.33	0.51	0.97
PGSC0003DMC200026187	K04733	ko04210	Apoptosis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMC200026187	K04733	ko04620	Toll-like receptor signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMC200026187	K04733	ko04722	Neurotrophin signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMC200026187	K04733	ko05140	Leishmaniasis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMC200026187	K04733	ko05142	Chagas disease	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMC200026188	K04733	ko04210	Apoptosis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMC200026188	K04733	ko04620	Toll-like receptor signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMC200026188	K04733	ko04722	Neurotrophin signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMC200026188	K04733	ko05140	Leishmaniasis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMC200026188	K04733	ko05142	Chagas disease	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMC200026189	K03097	ko04310	Wnt signaling pathway	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMC200026189	K03097	ko04520	Adherens junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMC200026189	K03097	ko04530	Tight junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMC200026189	K03097	ko04712	Circadian rhythm - plant	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMC200067060	K10760	ko00908	Zeatin biosynthesis	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMC200067060	K10760	ko01100	Metabolic pathways	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMC200067060	K10760	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMC200049173	K11584	ko04113	Meiosis - yeast	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMC200049173	K11584	ko04114	Oocyte meiosis	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMC200049173	K11584	ko04310	Wnt signaling pathway	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMC200049183	K00789	ko00270	Cysteine and methionine metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMC200049183	K00789	ko00450	Selenoamino acid metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMC200049183	K00789	ko01100	Metabolic pathways	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMC200049183	K00789	ko01110	Biosynthesis of secondary metabolites	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMC200031981	K00793	ko00740	Riboflavin metabolism	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMC200031981	K00793	ko01100	Metabolic pathways	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMC200031982	K00218	ko00860	Porphyrin and chlorophyll metabolism	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMC200031982	K00218	ko01100	Metabolic pathways	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMC200031982	K00218	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMC200031983	K00218	ko00860	Porphyrin and chlorophyll metabolism	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMC200031983	K00218	ko01100	Metabolic pathways	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMC200031983	K00218	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMC200031994	K01593	ko00340	Histidine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00350	Tyrosine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00360	Phenylalanine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00380	Tryptophan metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00901	Indole alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko00965	Betalain biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko01100	Metabolic pathways	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031994	K01593	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00340	Histidine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00350	Tyrosine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00360	Phenylalanine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00380	Tryptophan metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00901	Indole alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko00965	Betalain biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko01100	Metabolic pathways	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031995	K01593	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMC200031996	K01593	ko00340	Histidine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00350	Tyrosine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00360	Phenylalanine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00380	Tryptophan metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00901	Indole alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko00965	Betalain biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko01100	Metabolic pathways	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031996	K01593	ko01110	Biosynthesis of secondary metabolites	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMC200031997	K08902	ko00195	Photosynthesis	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMC200031997	K08902	ko01100	Metabolic pathways	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMC200032000	K10352	ko04530	Tight junction	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMC200032000	K10352	ko05416	Viral myocarditis	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMC200032001	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMC200032001	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMC200032001	K00771	ko01100	Metabolic pathways	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMC200032002	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMC200032002	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMC200032002	K00771	ko01100	Metabolic pathways	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMC200047841	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	380	2.6e-14	0.29	0.43	0.97
PGSC0003DMC200047842	K10569	ko03410	Base excision repair	412	6.9e-17	0.42	0.56	0.42
PGSC0003DMC200047847	K01188	ko00460	Cyanoamino acid metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMC200047847	K01188	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMC200047847	K01188	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMC200047847	K01188	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMC200047848	K01188	ko00460	Cyanoamino acid metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMC200047848	K01188	ko00500	Starch and sucrose metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMC200047848	K01188	ko00940	Phenylpropanoid biosynthesis	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMC200047848	K01188	ko01110	Biosynthesis of secondary metabolites	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMC200054968	K03801	ko00785	Lipoic acid metabolism	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMC200054968	K03801	ko01100	Metabolic pathways	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMC200054972	K01066	ko00623	2,4-Dichlorobenzoate degradation	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMC200054972	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMC200054973	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMC200054973	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMC200054974	K01066	ko00623	2,4-Dichlorobenzoate degradation	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMC200054974	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMC200054975	K01066	ko00623	2,4-Dichlorobenzoate degradation	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMC200054975	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMC200054976	K01066	ko00623	2,4-Dichlorobenzoate degradation	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMC200054976	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMC200054977	K01066	ko00623	2,4-Dichlorobenzoate degradation	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMC200054977	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMC200054979	K01066	ko00623	2,4-Dichlorobenzoate degradation	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMC200054979	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMC200054990	K00688	ko00500	Starch and sucrose metabolism	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMC200054990	K00688	ko04910	Insulin signaling pathway	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMC200008405	K00759	ko00230	Purine metabolism	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMC200008405	K00759	ko01100	Metabolic pathways	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMC200008406	K00759	ko00230	Purine metabolism	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMC200008406	K00759	ko01100	Metabolic pathways	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMC200004591	K00599	ko00340	Histidine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMC200004591	K00599	ko00350	Tyrosine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMC200004591	K00599	ko00450	Selenoamino acid metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMC200004591	K00599	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMC200004592	K00599	ko00340	Histidine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMC200004592	K00599	ko00350	Tyrosine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMC200004592	K00599	ko00450	Selenoamino acid metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMC200004592	K00599	ko00626	Naphthalene and anthracene degradation	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMC200004593	K00599	ko00340	Histidine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMC200004593	K00599	ko00350	Tyrosine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMC200004593	K00599	ko00450	Selenoamino acid metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMC200004593	K00599	ko00626	Naphthalene and anthracene degradation	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMC200004598	K08959	ko04340	Hedgehog signaling pathway	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMC200004598	K08959	ko04540	Gap junction	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMC200004598	K08959	ko04710	Circadian rhythm - mammal	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMC200004599	K02218	ko04340	Hedgehog signaling pathway	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMC200004599	K02218	ko04711	Circadian rhythm - fly	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMC200004600	K02218	ko04340	Hedgehog signaling pathway	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMC200004600	K02218	ko04711	Circadian rhythm - fly	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMC200004603	K03787	ko00230	Purine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMC200004603	K03787	ko00240	Pyrimidine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMC200004603	K03787	ko00760	Nicotinate and nicotinamide metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMC200004603	K03787	ko01100	Metabolic pathways	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMC200004603	K03787	ko01110	Biosynthesis of secondary metabolites	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMC200004604	K00020	ko00280	Valine, leucine and isoleucine degradation	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMC200004604	K00020	ko01100	Metabolic pathways	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMC200004605	K00020	ko00280	Valine, leucine and isoleucine degradation	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMC200004605	K00020	ko01100	Metabolic pathways	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMC200004606	K12741	ko03040	Spliceosome	1112	1.7e-55	0.49	0.64	0.97
PGSC0003DMC200004607	K12741	ko03040	Spliceosome	1331	1.4e-67	0.51	0.66	0.99
PGSC0003DMC200004608	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMC200004609	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMC200004610	K01193	ko00052	Galactose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMC200004610	K01193	ko00500	Starch and sucrose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMC200004610	K01193	ko01100	Metabolic pathways	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMC200004613	K04077	ko03018	RNA degradation	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMC200004613	K04077	ko04940	Type I diabetes mellitus	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMC200004615	K08248	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMC200004615	K08248	ko01100	Metabolic pathways	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMC200004616	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMC200004616	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMC200004617	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMC200004617	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMC200004620	K01190	ko00052	Galactose metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMC200004620	K01190	ko00511	Other glycan degradation	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMC200004620	K01190	ko00600	Sphingolipid metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMC200004620	K01190	ko01100	Metabolic pathways	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMC200023169	K01193	ko00052	Galactose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMC200023169	K01193	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMC200023169	K01193	ko01100	Metabolic pathways	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMC200023170	K01193	ko00052	Galactose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMC200023170	K01193	ko00500	Starch and sucrose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMC200023170	K01193	ko01100	Metabolic pathways	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMC200023171	K01193	ko00052	Galactose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMC200023171	K01193	ko00500	Starch and sucrose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMC200023171	K01193	ko01100	Metabolic pathways	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMC200023174	K04125	ko00904	Diterpenoid biosynthesis	689	3.6e-32	0.51	0.66	0.93
PGSC0003DMC200023190	K06260	ko04512	ECM-receptor interaction	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMC200023190	K06260	ko04640	Hematopoietic cell lineage	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMC200011046	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMC200011046	K12567	ko05414	Dilated cardiomyopathy	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMC200011048	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMC200011048	K12567	ko05414	Dilated cardiomyopathy	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMC200011049	K03110	ko03060	Protein export	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMC200011049	K03110	ko03070	Bacterial secretion system	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMC200011050	K03110	ko03060	Protein export	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMC200011050	K03110	ko03070	Bacterial secretion system	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMC200011051	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMC200011051	K12567	ko05414	Dilated cardiomyopathy	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMC200011052	K03110	ko03060	Protein export	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMC200011052	K03110	ko03070	Bacterial secretion system	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMC200011053	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.86
PGSC0003DMC200011054	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMC200011055	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMC200011056	K01115	ko00564	Glycerophospholipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011056	K01115	ko00565	Ether lipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011056	K01115	ko01100	Metabolic pathways	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011056	K01115	ko04144	Endocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011056	K01115	ko04666	Fc gamma R-mediated phagocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011056	K01115	ko04912	GnRH signaling pathway	6722	0.	0.79	0.90	0.97
PGSC0003DMC200011057	K01115	ko00564	Glycerophospholipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011057	K01115	ko00565	Ether lipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011057	K01115	ko01100	Metabolic pathways	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011057	K01115	ko04144	Endocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011057	K01115	ko04666	Fc gamma R-mediated phagocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011057	K01115	ko04912	GnRH signaling pathway	7548	0.	0.78	0.88	1.00
PGSC0003DMC200011064	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.71
PGSC0003DMC200011065	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.72
PGSC0003DMC200026973	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMC200026974	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMC200026975	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.68
PGSC0003DMC200026976	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.40
PGSC0003DMC200026978	K01595	ko00620	Pyruvate metabolism	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMC200026978	K01595	ko00710	Carbon fixation in photosynthetic organisms	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMC200026978	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMC200026978	K01595	ko01100	Metabolic pathways	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMC200026979	K01595	ko00620	Pyruvate metabolism	5747	0.	0.91	0.96	1.00
PGSC0003DMC200026979	K01595	ko00710	Carbon fixation in photosynthetic organisms	5747	0.	0.91	0.96	1.00
PGSC0003DMC200026979	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5747	0.	0.91	0.96	1.00
PGSC0003DMC200026979	K01595	ko01100	Metabolic pathways	5747	0.	0.91	0.96	1.00
PGSC0003DMC200026980	K01595	ko00620	Pyruvate metabolism	7521	0.	0.91	0.96	1.00
PGSC0003DMC200026980	K01595	ko00710	Carbon fixation in photosynthetic organisms	7521	0.	0.91	0.96	1.00
PGSC0003DMC200026980	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7521	0.	0.91	0.96	1.00
PGSC0003DMC200026980	K01595	ko01100	Metabolic pathways	7521	0.	0.91	0.96	1.00
PGSC0003DMC200026981	K01595	ko00620	Pyruvate metabolism	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMC200026981	K01595	ko00710	Carbon fixation in photosynthetic organisms	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMC200026981	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMC200026981	K01595	ko01100	Metabolic pathways	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMC200026985	K03353	ko04110	Cell cycle	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026985	K03353	ko04111	Cell cycle - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026985	K03353	ko04113	Meiosis - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026985	K03353	ko04114	Oocyte meiosis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026985	K03353	ko04120	Ubiquitin mediated proteolysis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026985	K03353	ko04914	Progesterone-mediated oocyte maturation	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMC200026986	K06636	ko04110	Cell cycle	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMC200026986	K06636	ko04111	Cell cycle - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMC200026986	K06636	ko04113	Meiosis - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMC200026986	K06636	ko04114	Oocyte meiosis	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMC200026990	K02871	ko03010	Ribosome	1513	1.3e-77	0.74	0.85	1.00
PGSC0003DMC200026993	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMC200026993	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMC200026993	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMC200026993	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMC200026993	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMC200026994	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMC200026994	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMC200026994	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMC200026994	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMC200026994	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMC200026995	K06627	ko04110	Cell cycle	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMC200026995	K06627	ko04914	Progesterone-mediated oocyte maturation	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMC200026996	K06627	ko04110	Cell cycle	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMC200026996	K06627	ko04914	Progesterone-mediated oocyte maturation	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMC200026997	K06627	ko04110	Cell cycle	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMC200026997	K06627	ko04914	Progesterone-mediated oocyte maturation	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMC200026998	K06627	ko04110	Cell cycle	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMC200026998	K06627	ko04914	Progesterone-mediated oocyte maturation	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMC200026999	K10577	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.86	0.96	0.99
PGSC0003DMC200002131	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMC200002132	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMC200002136	K12493	ko04144	Endocytosis	2515	7.0e-133	0.74	0.87	1.00
PGSC0003DMC200002159	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMC200002159	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMC200002160	K01066	ko00623	2,4-Dichlorobenzoate degradation	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMC200002160	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMC200065337	K08242	ko00100	Steroid biosynthesis	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMC200065337	K08242	ko01110	Biosynthesis of secondary metabolites	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMC200033391	K03469	ko03030	DNA replication	253	4.0e-08	0.42	0.61	0.41
PGSC0003DMC200033395	K05581	ko00190	Oxidative phosphorylation	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMC200033395	K05581	ko01100	Metabolic pathways	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMC200033406	K00754	ko00051	Fructose and mannose metabolism	1372	7.7e-70	0.41	0.59	0.81
PGSC0003DMC200033407	K05740	ko04510	Focal adhesion	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMC200033407	K05740	ko04810	Regulation of actin cytoskeleton	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMC200033407	K05740	ko05131	Shigellosis	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMC200033415	K05350	ko00460	Cyanoamino acid metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMC200033415	K05350	ko00500	Starch and sucrose metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMC200033415	K05350	ko00940	Phenylpropanoid biosynthesis	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMC200033415	K05350	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMC200033416	K01188	ko00460	Cyanoamino acid metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMC200033416	K01188	ko00500	Starch and sucrose metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMC200033416	K01188	ko00940	Phenylpropanoid biosynthesis	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMC200033416	K01188	ko01110	Biosynthesis of secondary metabolites	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMC200051967	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.45	0.63	0.98
PGSC0003DMC200051968	K12356	ko00940	Phenylpropanoid biosynthesis	216	9.7e-06	0.37	0.58	0.87
PGSC0003DMC200051969	K12356	ko00940	Phenylpropanoid biosynthesis	584	2.2e-26	0.42	0.60	0.96
PGSC0003DMC200051976	K01199	ko00500	Starch and sucrose metabolism	1489	2.7e-76	0.57	0.74	0.96
PGSC0003DMC200051980	K02183	ko04020	Calcium signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04070	Phosphatidylinositol signaling system	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04114	Oocyte meiosis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04270	Vascular smooth muscle contraction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04626	Plant-pathogen interaction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04720	Long-term potentiation	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04722	Neurotrophin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04740	Olfactory transduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04744	Phototransduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04745	Phototransduction - fly	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04910	Insulin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04912	GnRH signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04916	Melanogenesis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04970	Salivary secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko04971	Gastric acid secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko05010	Alzheimer's disease	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051980	K02183	ko05214	Glioma	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMC200051983	K06677	ko04111	Cell cycle - yeast	8161	0.	0.76	0.85	0.98
PGSC0003DMC200051984	K01760	ko00270	Cysteine and methionine metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051984	K01760	ko00450	Selenoamino acid metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051984	K01760	ko00910	Nitrogen metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051984	K01760	ko00920	Sulfur metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051984	K01760	ko01100	Metabolic pathways	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051984	K01760	ko01110	Biosynthesis of secondary metabolites	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMC200051987	K01760	ko00270	Cysteine and methionine metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200051987	K01760	ko00450	Selenoamino acid metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200051987	K01760	ko00910	Nitrogen metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200051987	K01760	ko00920	Sulfur metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200051987	K01760	ko01100	Metabolic pathways	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200051987	K01760	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMC200058171	K02992	ko03010	Ribosome	636	3.0e-29	0.99	0.99	0.22
PGSC0003DMC200058179	K05282	ko00904	Diterpenoid biosynthesis	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMC200058179	K05282	ko01100	Metabolic pathways	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMC200058179	K05282	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMC200058186	K02995	ko03010	Ribosome	1268	4.2e-64	0.74	0.80	0.97
PGSC0003DMC200058190	K03094	ko04110	Cell cycle	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04111	Cell cycle - yeast	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04114	Oocyte meiosis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04120	Ubiquitin mediated proteolysis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04310	Wnt signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04350	TGF-beta signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058190	K03094	ko04710	Circadian rhythm - mammal	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMC200058195	K13230	ko00402	Benzoxazinoid biosynthesis	381	3.5e-15	0.35	0.49	0.99
PGSC0003DMC200039845	K11423	ko00310	Lysine degradation	770	1.2e-36	0.39	0.56	0.89
PGSC0003DMC200039850	K02959	ko03010	Ribosome	429	7.9e-18	0.55	0.78	0.78
PGSC0003DMC200039863	K01866	ko00970	Aminoacyl-tRNA biosynthesis	1800	1.9e-93	0.76	0.88	1.00
PGSC0003DMC200039864	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2707	1.8e-143	0.66	0.79	1.00
PGSC0003DMC200039867	K11423	ko00310	Lysine degradation	735	1.1e-34	0.36	0.53	0.95
PGSC0003DMC200069148	K00795	ko00900	Terpenoid backbone biosynthesis	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMC200069148	K00795	ko01100	Metabolic pathways	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMC200069148	K00795	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMC200064130	K02947	ko03010	Ribosome	315	1.5e-11	0.74	0.79	0.56
PGSC0003DMC200064137	K02866	ko03010	Ribosome	243	3.4e-07	0.59	0.78	0.54
PGSC0003DMC200000939	K00031	ko00020	Citrate cycle (TCA cycle)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000939	K00031	ko00480	Glutathione metabolism	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000939	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000939	K00031	ko01100	Metabolic pathways	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000939	K00031	ko01110	Biosynthesis of secondary metabolites	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000939	K00031	ko04146	Peroxisome	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMC200000940	K00031	ko00020	Citrate cycle (TCA cycle)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000940	K00031	ko00480	Glutathione metabolism	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000940	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000940	K00031	ko01100	Metabolic pathways	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000940	K00031	ko01110	Biosynthesis of secondary metabolites	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000940	K00031	ko04146	Peroxisome	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMC200000948	K08232	ko00053	Ascorbate and aldarate metabolism	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMC200000948	K08232	ko01100	Metabolic pathways	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMC200000949	K08232	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMC200000949	K08232	ko01100	Metabolic pathways	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMC200000950	K08232	ko00053	Ascorbate and aldarate metabolism	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMC200000950	K08232	ko01100	Metabolic pathways	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMC200000951	K02935	ko03010	Ribosome	1061	1.1e-52	0.72	0.85	0.99
PGSC0003DMC200000952	K02935	ko03010	Ribosome	1059	1.4e-52	0.73	0.87	0.99
PGSC0003DMC200000953	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200000953	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200000953	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200000954	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200000954	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200000954	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMC200021962	K00979	ko00540	Lipopolysaccharide biosynthesis	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMC200021962	K00979	ko01100	Metabolic pathways	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMC200021972	K10615	ko04120	Ubiquitin mediated proteolysis	609	1.0e-27	0.32	0.49	0.76
PGSC0003DMC200021973	K10614	ko04120	Ubiquitin mediated proteolysis	290	2.7e-09	0.39	0.58	0.94
PGSC0003DMC200021979	K00790	ko00520	Amino sugar and nucleotide sugar metabolism	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMC200021979	K00790	ko00550	Peptidoglycan biosynthesis	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMC200021979	K00790	ko01100	Metabolic pathways	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMC200021983	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMC200021983	K07819	ko01100	Metabolic pathways	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMC200021985	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMC200021985	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMC200021985	K00734	ko01100	Metabolic pathways	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMC200021987	K10603	ko04120	Ubiquitin mediated proteolysis	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMC200021987	K10603	ko05340	Primary immunodeficiency	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMC200021988	K10603	ko04120	Ubiquitin mediated proteolysis	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMC200021988	K10603	ko05340	Primary immunodeficiency	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMC200021989	K12843	ko03040	Spliceosome	1511	1.7e-77	0.36	0.55	0.96
PGSC0003DMC200003393	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMC200003393	K00517	ko00626	Naphthalene and anthracene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMC200003393	K00517	ko00903	Limonene and pinene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMC200003393	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMC200003393	K00517	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMC200003394	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMC200003394	K00517	ko00626	Naphthalene and anthracene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMC200003394	K00517	ko00903	Limonene and pinene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMC200003394	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMC200003394	K00517	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMC200003395	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMC200003395	K00517	ko00626	Naphthalene and anthracene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMC200003395	K00517	ko00903	Limonene and pinene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMC200003395	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMC200003395	K00517	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMC200003401	K04424	ko04010	MAPK signaling pathway	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMC200003401	K04424	ko04530	Tight junction	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMC200003402	K04424	ko04010	MAPK signaling pathway	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMC200003402	K04424	ko04530	Tight junction	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMC200003405	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMC200003405	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMC200003405	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMC200003405	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMC200003406	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMC200003406	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMC200003406	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMC200003406	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMC200003407	K01835	ko00010	Glycolysis / Gluconeogenesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00030	Pentose phosphate pathway	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00052	Galactose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00230	Purine metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00500	Starch and sucrose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko00521	Streptomycin biosynthesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko01100	Metabolic pathways	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003407	K01835	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMC200003409	K12929	ko00904	Diterpenoid biosynthesis	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMC200003409	K12929	ko01110	Biosynthesis of secondary metabolites	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMC200003411	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMC200003411	K00517	ko00626	Naphthalene and anthracene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMC200003411	K00517	ko00903	Limonene and pinene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMC200003411	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMC200003411	K00517	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMC200003412	K04371	ko04010	MAPK signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04012	ErbB signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04013	MAPK signaling pathway - fly	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04062	Chemokine signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04114	Oocyte meiosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04150	mTOR signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04270	Vascular smooth muscle contraction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04320	Dorso-ventral axis formation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04350	TGF-beta signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04360	Axon guidance	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04370	VEGF signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04510	Focal adhesion	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04520	Adherens junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04540	Gap junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04620	Toll-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04621	NOD-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04650	Natural killer cell mediated cytotoxicity	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04660	T cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04662	B cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04664	Fc epsilon RI signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04666	Fc gamma R-mediated phagocytosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04720	Long-term potentiation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04722	Neurotrophin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04730	Long-term depression	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04810	Regulation of actin cytoskeleton	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04910	Insulin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04912	GnRH signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04914	Progesterone-mediated oocyte maturation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04916	Melanogenesis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04930	Type II diabetes mellitus	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko04960	Aldosterone-regulated sodium reabsorption	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05010	Alzheimer's disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05020	Prion diseases	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05131	Shigellosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05140	Leishmaniasis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05142	Chagas disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05200	Pathways in cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05210	Colorectal cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05211	Renal cell carcinoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05212	Pancreatic cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05213	Endometrial cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05214	Glioma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05215	Prostate cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05216	Thyroid cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05218	Melanoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05219	Bladder cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05220	Chronic myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05221	Acute myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003412	K04371	ko05223	Non-small cell lung cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMC200003413	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMC200003413	K02551	ko01100	Metabolic pathways	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMC200003413	K02551	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMC200003414	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMC200003414	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMC200003414	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMC200003415	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMC200003415	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMC200003415	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMC200003416	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMC200003416	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMC200003416	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMC200003417	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMC200003417	K08680	ko01100	Metabolic pathways	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMC200003417	K08680	ko01110	Biosynthesis of secondary metabolites	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMC200003420	K12126	ko04712	Circadian rhythm - plant	341	5.7e-13	0.25	0.41	0.89
PGSC0003DMC200009841	K12929	ko00904	Diterpenoid biosynthesis	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMC200009841	K12929	ko01110	Biosynthesis of secondary metabolites	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMC200009845	K00059	ko00061	Fatty acid biosynthesis	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMC200009845	K00059	ko01040	Biosynthesis of unsaturated fatty acids	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMC200009845	K00059	ko01100	Metabolic pathways	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMC200009850	K10577	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.98	1.00	0.53
PGSC0003DMC200009851	K12929	ko00904	Diterpenoid biosynthesis	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMC200009851	K12929	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMC200009855	K12929	ko00904	Diterpenoid biosynthesis	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMC200009855	K12929	ko01110	Biosynthesis of secondary metabolites	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMC200009868	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMC200028178	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMC200028179	K11644	ko05016	Huntington's disease	284	2.5e-06	0.28	0.43	0.46
PGSC0003DMC200028180	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMC200028182	K10703	ko01040	Biosynthesis of unsaturated fatty acids	715	1.3e-33	0.56	0.61	0.94
PGSC0003DMC200028185	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1515	1.0e-77	0.33	0.49	0.95
PGSC0003DMC200028186	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	584	5.2e-26	0.42	0.62	0.93
PGSC0003DMC200028189	K06630	ko04110	Cell cycle	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMC200028189	K06630	ko04114	Oocyte meiosis	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMC200028189	K06630	ko04722	Neurotrophin signaling pathway	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMC200028192	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMC200028192	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMC200028192	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMC200028193	K04503	ko04110	Cell cycle	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko04115	p53 signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko04310	Wnt signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko04510	Focal adhesion	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko04630	Jak-STAT signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05200	Pathways in cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05210	Colorectal cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05212	Pancreatic cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05213	Endometrial cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05214	Glioma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05215	Prostate cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05216	Thyroid cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05218	Melanoma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05219	Bladder cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05220	Chronic myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05221	Acute myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05222	Small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05223	Non-small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028193	K04503	ko05416	Viral myocarditis	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMC200028194	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMC200028194	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMC200028194	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMC200038402	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.93
PGSC0003DMC200038403	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.94
PGSC0003DMC200038404	K12132	ko04712	Circadian rhythm - plant	862	1.0e-41	0.64	0.80	0.94
PGSC0003DMC200038405	K12132	ko04712	Circadian rhythm - plant	531	1.9e-23	0.66	0.82	0.84
PGSC0003DMC200038410	K02995	ko03010	Ribosome	1666	4.7e-86	0.90	0.95	0.99
PGSC0003DMC200038414	K03714	ko00510	N-Glycan biosynthesis	2686	2.6e-142	0.60	0.72	1.00
PGSC0003DMC200038415	K08272	ko04150	mTOR signaling pathway	1325	3.0e-67	0.81	0.92	0.85
PGSC0003DMC200038416	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMC200038417	K08272	ko04150	mTOR signaling pathway	1997	2.6e-104	0.71	0.84	0.82
PGSC0003DMC200038418	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMC200038429	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMC200038429	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMC200038429	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMC200038429	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMC200038429	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMC200038430	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMC200038430	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMC200038430	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMC200038430	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMC200038430	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMC200053167	K08332	ko04140	Regulation of autophagy	297	3.1e-10	0.26	0.51	1.00
PGSC0003DMC200053168	K08332	ko04140	Regulation of autophagy	308	1.8e-08	0.28	0.49	0.48
PGSC0003DMC200053185	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMC200053185	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMC200053185	K00771	ko01100	Metabolic pathways	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMC200034596	K09578	ko04622	RIG-I-like receptor signaling pathway	782	2.7e-37	0.77	0.91	0.93
PGSC0003DMC200034598	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.72
PGSC0003DMC200034599	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.73
PGSC0003DMC200034605	K11088	ko03040	Spliceosome	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMC200034605	K11088	ko05322	Systemic lupus erythematosus	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMC200034615	K13082	ko00941	Flavonoid biosynthesis	1125	3.2e-56	0.46	0.66	0.95
PGSC0003DMC200034616	K13082	ko00941	Flavonoid biosynthesis	973	7.9e-48	0.45	0.68	0.95
PGSC0003DMC200041051	K12586	ko03018	RNA degradation	1683	5.4e-87	0.83	0.91	0.76
PGSC0003DMC200041052	K12586	ko03018	RNA degradation	2015	2.7e-105	0.82	0.90	1.00
PGSC0003DMC200041068	K12356	ko00940	Phenylpropanoid biosynthesis	645	9.7e-30	0.37	0.55	0.95
PGSC0003DMC200019187	K00454	ko00591	Linoleic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMC200019187	K00454	ko00592	alpha-Linolenic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMC200019187	K00454	ko01100	Metabolic pathways	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMC200019188	K00454	ko00591	Linoleic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMC200019188	K00454	ko00592	alpha-Linolenic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMC200019188	K00454	ko01100	Metabolic pathways	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMC200017840	K05280	ko00941	Flavonoid biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMC200017840	K05280	ko00944	Flavone and flavonol biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMC200017840	K05280	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMC200017840	K05280	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMC200017841	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMC200017841	K00517	ko00626	Naphthalene and anthracene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMC200017841	K00517	ko00903	Limonene and pinene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMC200017841	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMC200017841	K00517	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMC200017842	K05280	ko00941	Flavonoid biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMC200017842	K05280	ko00944	Flavone and flavonol biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMC200017842	K05280	ko01100	Metabolic pathways	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMC200017842	K05280	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMC200017843	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMC200017843	K00517	ko00626	Naphthalene and anthracene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMC200017843	K00517	ko00903	Limonene and pinene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMC200017843	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMC200017843	K00517	ko01110	Biosynthesis of secondary metabolites	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMC200017844	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMC200017844	K00517	ko00626	Naphthalene and anthracene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMC200017844	K00517	ko00903	Limonene and pinene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMC200017844	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMC200017844	K00517	ko01110	Biosynthesis of secondary metabolites	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMC200017845	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMC200017845	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMC200017845	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMC200017845	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMC200017845	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMC200024962	K02937	ko03010	Ribosome	1363	2.4e-69	0.65	0.83	1.00
PGSC0003DMC200024980	K07192	ko04910	Insulin signaling pathway	1395	4.2e-71	0.41	0.61	0.98
PGSC0003DMC200024981	K07192	ko04910	Insulin signaling pathway	1399	2.5e-71	0.41	0.61	0.98
PGSC0003DMC200024983	K02906	ko03010	Ribosome	1559	3.8e-80	0.71	0.84	0.81
PGSC0003DMC200030783	K01176	ko00500	Starch and sucrose metabolism	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMC200030783	K01176	ko01100	Metabolic pathways	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMC200030784	K01176	ko00500	Starch and sucrose metabolism	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMC200030784	K01176	ko01100	Metabolic pathways	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMC200030786	K01728	ko00040	Pentose and glucuronate interconversions	1759	3.5e-91	0.57	0.73	0.77
PGSC0003DMC200030787	K01728	ko00040	Pentose and glucuronate interconversions	604	1.8e-27	0.53	0.72	0.95
PGSC0003DMC200030788	K01728	ko00040	Pentose and glucuronate interconversions	1291	2.3e-65	0.55	0.71	1.00
PGSC0003DMC200030804	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030804	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030804	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030805	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030805	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030805	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMC200030806	K01490	ko00230	Purine metabolism	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMC200030806	K01490	ko01100	Metabolic pathways	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMC200030806	K01490	ko01110	Biosynthesis of secondary metabolites	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMC200030808	K10615	ko04120	Ubiquitin mediated proteolysis	610	2.3e-27	0.32	0.47	0.93
PGSC0003DMC200030809	K10615	ko04120	Ubiquitin mediated proteolysis	615	1.2e-27	0.32	0.48	0.94
PGSC0003DMC200047979	K03015	ko00230	Purine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMC200047979	K03015	ko00240	Pyrimidine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMC200047979	K03015	ko01100	Metabolic pathways	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMC200047979	K03015	ko03020	RNA polymerase	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMC200047979	K03015	ko05016	Huntington's disease	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMC200047980	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047980	K00261	ko00330	Arginine and proline metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047980	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047980	K00261	ko00910	Nitrogen metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047980	K00261	ko01100	Metabolic pathways	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047980	K00261	ko04964	Proximal tubule bicarbonate reclamation	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMC200047981	K02134	ko00190	Oxidative phosphorylation	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMC200047981	K02134	ko01100	Metabolic pathways	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMC200047981	K02134	ko05010	Alzheimer's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMC200047981	K02134	ko05012	Parkinson's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMC200047981	K02134	ko05016	Huntington's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMC200047989	K01069	ko00620	Pyruvate metabolism	1683	5.4e-87	0.75	0.85	0.99
PGSC0003DMC200047991	K08233	ko00901	Indole alkaloid biosynthesis	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMC200047991	K08233	ko01110	Biosynthesis of secondary metabolites	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMC200047992	K03413	ko02020	Two-component system	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMC200047992	K03413	ko02030	Bacterial chemotaxis	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMC200047993	K01874	ko00450	Selenoamino acid metabolism	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMC200047993	K01874	ko00970	Aminoacyl-tRNA biosynthesis	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMC200047994	K01874	ko00450	Selenoamino acid metabolism	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMC200047994	K01874	ko00970	Aminoacyl-tRNA biosynthesis	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMC200047995	K01874	ko00450	Selenoamino acid metabolism	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMC200047995	K01874	ko00970	Aminoacyl-tRNA biosynthesis	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMC200048000	K01599	ko00860	Porphyrin and chlorophyll metabolism	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMC200048000	K01599	ko01110	Biosynthesis of secondary metabolites	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMC200056162	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMC200056162	K01061	ko00364	Fluorobenzoate degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMC200056162	K01061	ko00627	1,4-Dichlorobenzene degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMC200056162	K01061	ko01100	Metabolic pathways	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMC200056167	K01509	ko00230	Purine metabolism	1626	1.0e-117	0.40	0.57	0.80
PGSC0003DMC200056168	K04421	ko04010	MAPK signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMC200056168	K04421	ko04722	Neurotrophin signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMC200056168	K04421	ko04912	GnRH signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMC200056190	K04631	ko04744	Phototransduction	745	3.0e-35	0.33	0.55	0.45
PGSC0003DMC200059390	K02639	ko00195	Photosynthesis	517	1.1e-22	0.58	0.81	0.97
PGSC0003DMC200056028	K02183	ko04020	Calcium signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04070	Phosphatidylinositol signaling system	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04114	Oocyte meiosis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04270	Vascular smooth muscle contraction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04626	Plant-pathogen interaction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04720	Long-term potentiation	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04722	Neurotrophin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04740	Olfactory transduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04744	Phototransduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04745	Phototransduction - fly	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04910	Insulin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04912	GnRH signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04916	Melanogenesis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04970	Salivary secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko04971	Gastric acid secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko05010	Alzheimer's disease	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056028	K02183	ko05214	Glioma	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMC200056030	K05933	ko00270	Cysteine and methionine metabolism	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMC200056030	K05933	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMC200056031	K00475	ko00941	Flavonoid biosynthesis	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMC200056031	K00475	ko01100	Metabolic pathways	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMC200056031	K00475	ko01110	Biosynthesis of secondary metabolites	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMC200056032	K05277	ko00941	Flavonoid biosynthesis	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMC200056032	K05277	ko01100	Metabolic pathways	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMC200056032	K05277	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMC200056033	K05277	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMC200056033	K05277	ko01100	Metabolic pathways	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMC200056033	K05277	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMC200056034	K05277	ko00941	Flavonoid biosynthesis	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMC200056034	K05277	ko01100	Metabolic pathways	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMC200056034	K05277	ko01110	Biosynthesis of secondary metabolites	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMC200042755	K10901	ko03440	Homologous recombination	707	1.9e-32	0.32	0.44	0.91
PGSC0003DMC200042756	K03654	ko03018	RNA degradation	763	3.0e-36	0.34	0.47	0.95
PGSC0003DMC200042757	K03654	ko03018	RNA degradation	1044	9.5e-52	0.32	0.46	0.73
PGSC0003DMC200042765	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMC200042772	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMC200042778	K05745	ko04810	Regulation of actin cytoskeleton	432	3.7e-17	0.30	0.48	0.83
PGSC0003DMC200042779	K05740	ko04510	Focal adhesion	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMC200042779	K05740	ko04810	Regulation of actin cytoskeleton	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMC200042779	K05740	ko05131	Shigellosis	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMC200042780	K09490	ko03060	Protein export	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMC200042780	K09490	ko05020	Prion diseases	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMC200036001	K12598	ko03018	RNA degradation	6767	0.	0.81	0.90	1.00
PGSC0003DMC200036002	K12598	ko03018	RNA degradation	6959	0.	0.83	0.92	1.00
PGSC0003DMC200036003	K06638	ko04110	Cell cycle	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMC200036003	K06638	ko04914	Progesterone-mediated oocyte maturation	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMC200036004	K06638	ko04110	Cell cycle	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMC200036004	K06638	ko04914	Progesterone-mediated oocyte maturation	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMC200036013	K12839	ko03040	Spliceosome	1797	2.8e-93	0.74	0.85	0.99
PGSC0003DMC200036014	K12839	ko03040	Spliceosome	582	2.9e-26	0.69	0.79	0.98
PGSC0003DMC200036015	K12839	ko03040	Spliceosome	1413	4.2e-72	0.74	0.85	0.98
PGSC0003DMC200036018	K03544	ko04112	Cell cycle - Caulobacter	499	1.1e-21	0.55	0.69	0.99
PGSC0003DMC200036019	K03544	ko04112	Cell cycle - Caulobacter	233	1.1e-06	0.42	0.55	0.88
PGSC0003DMC200036020	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMC200036021	K03544	ko04112	Cell cycle - Caulobacter	2945	1.3e-156	0.62	0.74	0.91
PGSC0003DMC200036022	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMC200036023	K03544	ko04112	Cell cycle - Caulobacter	1134	1.0e-56	0.53	0.63	0.77
PGSC0003DMC200036025	K11294	ko05130	Pathogenic Escherichia coli infection	285	4.8e-07	0.30	0.48	0.24
PGSC0003DMC200036026	K11294	ko05130	Pathogenic Escherichia coli infection	285	1.7e-08	0.30	0.48	0.54
PGSC0003DMC200005806	K02112	ko00190	Oxidative phosphorylation	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMC200005806	K02112	ko00195	Photosynthesis	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMC200005806	K02112	ko01100	Metabolic pathways	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMC200005809	K12890	ko03040	Spliceosome	1651	3.2e-85	0.87	0.94	0.66
PGSC0003DMC200005810	K12890	ko03040	Spliceosome	1850	3.3e-96	0.80	0.88	0.98
PGSC0003DMC200005811	K12890	ko03040	Spliceosome	1847	4.9e-96	0.81	0.89	0.98
PGSC0003DMC200013951	K02144	ko00190	Oxidative phosphorylation	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013951	K02144	ko01100	Metabolic pathways	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013951	K02144	ko04142	Lysosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013951	K02144	ko04145	Phagosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013951	K02144	ko05110	Vibrio cholerae infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013951	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMC200013953	K01507	ko00190	Oxidative phosphorylation	5827	0.	0.91	0.96	1.00
PGSC0003DMC200013954	K01613	ko00564	Glycerophospholipid metabolism	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMC200013954	K01613	ko01100	Metabolic pathways	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMC200013955	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMC200013955	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMC200013956	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMC200013956	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMC200007222	K11423	ko00310	Lysine degradation	451	7.8e-18	0.29	0.47	0.83
PGSC0003DMC200007227	K02150	ko00190	Oxidative phosphorylation	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007227	K02150	ko01100	Metabolic pathways	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007227	K02150	ko04145	Phagosome	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007227	K02150	ko04966	Collecting duct acid secretion	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007227	K02150	ko05110	Vibrio cholerae infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007227	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMC200007228	K02866	ko03010	Ribosome	292	4.7e-10	0.70	0.85	0.87
PGSC0003DMC200007230	K03902	ko04610	Complement and coagulation cascades	373	1.8e-13	0.38	0.46	0.97
PGSC0003DMC200024811	K01081	ko00230	Purine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMC200024811	K01081	ko00240	Pyrimidine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMC200024811	K01081	ko00760	Nicotinate and nicotinamide metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMC200024811	K01081	ko01100	Metabolic pathways	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMC200024811	K01081	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMC200024812	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024812	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024812	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024812	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024812	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024814	K00430	ko00360	Phenylalanine metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMC200024814	K00430	ko00680	Methane metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMC200024814	K00430	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMC200024814	K00430	ko01100	Metabolic pathways	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMC200024814	K00430	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMC200024818	K01915	ko00250	Alanine, aspartate and glutamate metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMC200024818	K01915	ko00330	Arginine and proline metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMC200024818	K01915	ko00910	Nitrogen metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMC200024818	K01915	ko01100	Metabolic pathways	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMC200024818	K01915	ko02020	Two-component system	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMC200024826	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMC200024827	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMC200024836	K01535	ko00190	Oxidative phosphorylation	4939	1.4e-266	0.85	0.92	1.00
PGSC0003DMC200053011	K03843	ko00510	N-Glycan biosynthesis	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMC200053011	K03843	ko01100	Metabolic pathways	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMC200053023	K00487	ko00360	Phenylalanine metabolism	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053023	K00487	ko00940	Phenylpropanoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053023	K00487	ko00941	Flavonoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053023	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053023	K00487	ko01100	Metabolic pathways	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053023	K00487	ko01110	Biosynthesis of secondary metabolites	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMC200053024	K00487	ko00360	Phenylalanine metabolism	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053024	K00487	ko00940	Phenylpropanoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053024	K00487	ko00941	Flavonoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053024	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053024	K00487	ko01100	Metabolic pathways	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053024	K00487	ko01110	Biosynthesis of secondary metabolites	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMC200053025	K00487	ko00360	Phenylalanine metabolism	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053025	K00487	ko00940	Phenylpropanoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053025	K00487	ko00941	Flavonoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053025	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053025	K00487	ko01100	Metabolic pathways	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053025	K00487	ko01110	Biosynthesis of secondary metabolites	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko00360	Phenylalanine metabolism	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko00940	Phenylpropanoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko00941	Flavonoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko01100	Metabolic pathways	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053026	K00487	ko01110	Biosynthesis of secondary metabolites	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMC200053031	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMC200053032	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMC200053036	K03063	ko03050	Proteasome	3214	2.0e-171	0.93	0.95	0.99
PGSC0003DMC200041141	K00941	ko00730	Thiamine metabolism	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMC200041141	K00941	ko01100	Metabolic pathways	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMC200041142	K00941	ko00730	Thiamine metabolism	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMC200041142	K00941	ko01100	Metabolic pathways	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMC200041143	K00941	ko00730	Thiamine metabolism	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMC200041143	K00941	ko01100	Metabolic pathways	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMC200041146	K00941	ko00730	Thiamine metabolism	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMC200041146	K00941	ko01100	Metabolic pathways	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMC200041149	K02365	ko04110	Cell cycle	7297	0.	0.46	0.63	1.00
PGSC0003DMC200041149	K02365	ko04111	Cell cycle - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMC200041149	K02365	ko04113	Meiosis - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMC200041149	K02365	ko04114	Oocyte meiosis	7297	0.	0.46	0.63	1.00
PGSC0003DMC200046621	K02873	ko03010	Ribosome	954	8.8e-47	0.81	0.91	0.99
PGSC0003DMC200046622	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1802	1.5e-93	0.70	0.80	0.91
PGSC0003DMC200046623	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.82	0.98
PGSC0003DMC200046624	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.80	0.98
PGSC0003DMC200046625	K00012	ko00040	Pentose and glucuronate interconversions	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046625	K00012	ko00053	Ascorbate and aldarate metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046625	K00012	ko00500	Starch and sucrose metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046625	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046625	K00012	ko01100	Metabolic pathways	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046625	K00012	ko01110	Biosynthesis of secondary metabolites	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMC200046626	K12829	ko03040	Spliceosome	3879	4.1e-208	0.80	0.88	1.00
PGSC0003DMC200046627	K12829	ko03040	Spliceosome	2509	1.5e-132	0.90	0.97	1.00
PGSC0003DMC200046628	K12829	ko03040	Spliceosome	4097	3.9e-220	0.83	0.91	1.00
PGSC0003DMC200046629	K02184	ko04320	Dorso-ventral axis formation	490	8.6e-19	0.30	0.43	0.56
PGSC0003DMC200046630	K05740	ko04510	Focal adhesion	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMC200046630	K05740	ko04810	Regulation of actin cytoskeleton	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMC200046630	K05740	ko05131	Shigellosis	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMC200046637	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.61
PGSC0003DMC200046638	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.43
PGSC0003DMC200046640	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMC200046641	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.85
PGSC0003DMC200046642	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMC200046643	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMC200046644	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMC200046649	K04733	ko04210	Apoptosis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMC200046649	K04733	ko04620	Toll-like receptor signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMC200046649	K04733	ko04722	Neurotrophin signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMC200046649	K04733	ko05140	Leishmaniasis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMC200046649	K04733	ko05142	Chagas disease	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMC200046650	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMC200046650	K01657	ko01100	Metabolic pathways	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMC200046650	K01657	ko01110	Biosynthesis of secondary metabolites	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMC200050372	K04079	ko04612	Antigen processing and presentation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050372	K04079	ko04621	NOD-like receptor signaling pathway	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050372	K04079	ko04626	Plant-pathogen interaction	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050372	K04079	ko04914	Progesterone-mediated oocyte maturation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050372	K04079	ko05200	Pathways in cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050372	K04079	ko05215	Prostate cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMC200050373	K04079	ko04612	Antigen processing and presentation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050373	K04079	ko04621	NOD-like receptor signaling pathway	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050373	K04079	ko04626	Plant-pathogen interaction	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050373	K04079	ko04914	Progesterone-mediated oocyte maturation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050373	K04079	ko05200	Pathways in cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050373	K04079	ko05215	Prostate cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMC200050374	K04079	ko04612	Antigen processing and presentation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050374	K04079	ko04621	NOD-like receptor signaling pathway	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050374	K04079	ko04626	Plant-pathogen interaction	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050374	K04079	ko04914	Progesterone-mediated oocyte maturation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050374	K04079	ko05200	Pathways in cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050374	K04079	ko05215	Prostate cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMC200050375	K04079	ko04612	Antigen processing and presentation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050375	K04079	ko04621	NOD-like receptor signaling pathway	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050375	K04079	ko04626	Plant-pathogen interaction	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050375	K04079	ko04914	Progesterone-mediated oocyte maturation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050375	K04079	ko05200	Pathways in cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050375	K04079	ko05215	Prostate cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMC200050397	K08008	ko04145	Phagosome	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMC200050397	K08008	ko04670	Leukocyte transendothelial migration	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMC200050399	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMC200050399	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMC200050400	K08008	ko04145	Phagosome	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMC200050400	K08008	ko04670	Leukocyte transendothelial migration	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMC200021828	K10843	ko03420	Nucleotide excision repair	5489	6.5e-297	0.89	0.93	0.98
PGSC0003DMC200021829	K10843	ko03420	Nucleotide excision repair	5851	0.	0.90	0.94	0.99
PGSC0003DMC200021833	K02202	ko03420	Nucleotide excision repair	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMC200021833	K02202	ko04110	Cell cycle	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMC200021835	K11153	ko00830	Retinol metabolism	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMC200021835	K11153	ko01100	Metabolic pathways	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMC200021840	K01928	ko00300	Lysine biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMC200021840	K01928	ko00550	Peptidoglycan biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMC200009931	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMC200009932	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMC200009933	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMC200009934	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMC200009937	K02993	ko03010	Ribosome	1467	4.5e-75	0.90	0.97	0.99
PGSC0003DMC200009938	K11866	ko04144	Endocytosis	365	2.7e-14	0.76	0.88	0.94
PGSC0003DMC200009939	K11866	ko04144	Endocytosis	1417	2.5e-72	0.55	0.69	0.92
PGSC0003DMC200009940	K11866	ko04144	Endocytosis	2742	2.1e-145	0.65	0.78	0.99
PGSC0003DMC200009941	K11866	ko04144	Endocytosis	2432	2.7e-128	0.65	0.77	1.00
PGSC0003DMC200009944	K01892	ko00970	Aminoacyl-tRNA biosynthesis	2067	3.6e-108	0.83	0.95	1.00
PGSC0003DMC200009945	K12396	ko04142	Lysosome	4696	3.6e-253	0.63	0.76	1.00
PGSC0003DMC200009947	K02183	ko04020	Calcium signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04070	Phosphatidylinositol signaling system	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04114	Oocyte meiosis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04270	Vascular smooth muscle contraction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04626	Plant-pathogen interaction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04720	Long-term potentiation	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04722	Neurotrophin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04740	Olfactory transduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04744	Phototransduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04745	Phototransduction - fly	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04910	Insulin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04912	GnRH signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04916	Melanogenesis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04970	Salivary secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko04971	Gastric acid secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko05010	Alzheimer's disease	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009947	K02183	ko05214	Glioma	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMC200009948	K02183	ko04020	Calcium signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04070	Phosphatidylinositol signaling system	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04114	Oocyte meiosis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04270	Vascular smooth muscle contraction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04626	Plant-pathogen interaction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04720	Long-term potentiation	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04722	Neurotrophin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04740	Olfactory transduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04744	Phototransduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04745	Phototransduction - fly	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04910	Insulin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04912	GnRH signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04916	Melanogenesis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04970	Salivary secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko04971	Gastric acid secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko05010	Alzheimer's disease	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009948	K02183	ko05214	Glioma	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMC200009955	K05350	ko00460	Cyanoamino acid metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMC200009955	K05350	ko00500	Starch and sucrose metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMC200009955	K05350	ko00940	Phenylpropanoid biosynthesis	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMC200009955	K05350	ko01110	Biosynthesis of secondary metabolites	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMC200009956	K05350	ko00460	Cyanoamino acid metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMC200009956	K05350	ko00500	Starch and sucrose metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMC200009956	K05350	ko00940	Phenylpropanoid biosynthesis	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMC200009956	K05350	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMC200015425	K00368	ko00910	Nitrogen metabolism	1216	3.1e-61	0.45	0.57	0.86
PGSC0003DMC200015430	K05579	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMC200015430	K05579	ko01100	Metabolic pathways	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMC200015431	K05572	ko00190	Oxidative phosphorylation	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMC200015431	K05572	ko01100	Metabolic pathways	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMC200015434	K09841	ko00906	Carotenoid biosynthesis	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMC200015434	K09841	ko01100	Metabolic pathways	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMC200015434	K09841	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMC200015436	K09841	ko00906	Carotenoid biosynthesis	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMC200015436	K09841	ko01100	Metabolic pathways	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMC200015436	K09841	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMC200015437	K09841	ko00906	Carotenoid biosynthesis	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMC200015437	K09841	ko01100	Metabolic pathways	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMC200015437	K09841	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMC200015440	K00522	ko00860	Porphyrin and chlorophyll metabolism	817	3.2e-39	0.59	0.74	0.67
PGSC0003DMC200015442	K13065	ko00940	Phenylpropanoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMC200015442	K13065	ko00941	Flavonoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMC200015442	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMC200015442	K13065	ko01110	Biosynthesis of secondary metabolites	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMC200015445	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMC200015447	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMC200000852	K13065	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMC200000852	K13065	ko00941	Flavonoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMC200000852	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMC200000852	K13065	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMC200000854	K12356	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.33	0.50	0.94
PGSC0003DMC200000855	K12356	ko00940	Phenylpropanoid biosynthesis	751	1.4e-35	0.32	0.49	0.93
PGSC0003DMC200000856	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMC200000856	K12449	ko01100	Metabolic pathways	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMC200000857	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMC200000857	K12449	ko01100	Metabolic pathways	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMC200000861	K11824	ko04144	Endocytosis	7361	0.	0.85	0.90	1.00
PGSC0003DMC200000861	K11824	ko05016	Huntington's disease	7361	0.	0.85	0.90	1.00
PGSC0003DMC200000862	K11824	ko04144	Endocytosis	7394	0.	0.87	0.92	1.00
PGSC0003DMC200000862	K11824	ko05016	Huntington's disease	7394	0.	0.87	0.92	1.00
PGSC0003DMC200000863	K11824	ko04144	Endocytosis	7426	0.	0.87	0.92	1.00
PGSC0003DMC200000863	K11824	ko05016	Huntington's disease	7426	0.	0.87	0.92	1.00
PGSC0003DMC200000868	K05692	ko04145	Phagosome	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04510	Focal adhesion	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04520	Adherens junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04530	Tight junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04670	Leukocyte transendothelial migration	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04745	Phototransduction - fly	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko04810	Regulation of actin cytoskeleton	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05100	Bacterial invasion of epithelial cells	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05110	Vibrio cholerae infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05130	Pathogenic Escherichia coli infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05131	Shigellosis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05414	Dilated cardiomyopathy	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200000868	K05692	ko05416	Viral myocarditis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMC200063684	K10532	ko00531	Glycosaminoglycan degradation	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMC200063684	K10532	ko01100	Metabolic pathways	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMC200063684	K10532	ko04142	Lysosome	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMC200051814	K01613	ko00564	Glycerophospholipid metabolism	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMC200051814	K01613	ko01100	Metabolic pathways	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMC200051815	K01613	ko00564	Glycerophospholipid metabolism	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMC200051815	K01613	ko01100	Metabolic pathways	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMC200045428	K01768	ko00230	Purine metabolism	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMC200045428	K01768	ko04113	Meiosis - yeast	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMC200045429	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMC200045429	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMC200045430	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMC200045430	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMC200045431	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.85
PGSC0003DMC200045432	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.54
PGSC0003DMC200039951	K02997	ko03010	Ribosome	1579	3.0e-81	0.93	0.99	0.99
PGSC0003DMC200039952	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039952	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039952	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039952	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039952	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039953	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039953	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039953	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039953	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039953	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMC200039958	K10594	ko04120	Ubiquitin mediated proteolysis	766	2.7e-33	0.32	0.48	0.51
PGSC0003DMC200064862	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMC200064862	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMC200064890	K03062	ko03050	Proteasome	235	1.8e-06	0.33	0.54	0.83
PGSC0003DMC200002041	K13027	ko00460	Cyanoamino acid metabolism	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMC200002041	K13027	ko00966	Glucosinolate biosynthesis	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMC200002041	K13027	ko01100	Metabolic pathways	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMC200002041	K13027	ko01110	Biosynthesis of secondary metabolites	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMC200002047	K11594	ko04622	RIG-I-like receptor signaling pathway	4180	1.0e-224	0.78	0.87	1.00
PGSC0003DMC200002048	K04717	ko00600	Sphingolipid metabolism	484	7.3e-21	0.30	0.46	0.91
PGSC0003DMC200002057	K12124	ko04712	Circadian rhythm - plant	367	1.6e-13	0.49	0.68	0.84
PGSC0003DMC200000092	K12862	ko03040	Spliceosome	3273	1.1e-174	0.78	0.87	1.00
PGSC0003DMC200000094	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2537	4.3e-134	0.69	0.84	0.99
PGSC0003DMC200000095	K01068	ko01040	Biosynthesis of unsaturated fatty acids	417	3.6e-17	0.66	0.85	0.95
PGSC0003DMC200000116	K13034	ko00270	Cysteine and methionine metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMC200000116	K13034	ko00450	Selenoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMC200000116	K13034	ko00460	Cyanoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMC200000116	K13034	ko00920	Sulfur metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMC200000116	K13034	ko01100	Metabolic pathways	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMC200000117	K13034	ko00270	Cysteine and methionine metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMC200000117	K13034	ko00450	Selenoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMC200000117	K13034	ko00460	Cyanoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMC200000117	K13034	ko00920	Sulfur metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMC200000117	K13034	ko01100	Metabolic pathways	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMC200000118	K13034	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMC200000118	K13034	ko00450	Selenoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMC200000118	K13034	ko00460	Cyanoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMC200000118	K13034	ko00920	Sulfur metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMC200000118	K13034	ko01100	Metabolic pathways	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMC200000119	K12604	ko03018	RNA degradation	1434	3.7e-73	0.45	0.61	0.97
PGSC0003DMC200000120	K12604	ko03018	RNA degradation	365	4.5e-13	0.54	0.79	0.86
PGSC0003DMC200023019	K05714	ko00360	Phenylalanine metabolism	214	5.7e-06	0.36	0.54	0.45
PGSC0003DMC200023020	K10702	ko00642	Ethylbenzene degradation	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMC200023020	K10702	ko01100	Metabolic pathways	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMC200016630	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMC200016631	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMC200016633	K13068	ko00940	Phenylpropanoid biosynthesis	673	2.8e-31	0.29	0.49	0.99
PGSC0003DMC200016635	K13068	ko00940	Phenylpropanoid biosynthesis	750	1.6e-35	0.30	0.51	0.97
PGSC0003DMC200016636	K13068	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.28	0.49	0.98
PGSC0003DMC200016637	K13068	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.30	0.49	0.97
PGSC0003DMC200016643	K00558	ko00270	Cysteine and methionine metabolism	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMC200016643	K00558	ko01100	Metabolic pathways	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMC200011133	K05666	ko02010	ABC transporters	2647	3.7e-140	0.34	0.53	0.86
PGSC0003DMC200011134	K05666	ko02010	ABC transporters	3378	1.8e-180	0.39	0.61	0.88
PGSC0003DMC200011135	K05666	ko02010	ABC transporters	1802	5.5e-97	0.31	0.53	0.87
PGSC0003DMC200011147	K01239	ko00230	Purine metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMC200011147	K01239	ko00760	Nicotinate and nicotinamide metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMC200011147	K01239	ko01100	Metabolic pathways	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMC200011148	K01239	ko00230	Purine metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMC200011148	K01239	ko00760	Nicotinate and nicotinamide metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMC200011148	K01239	ko01100	Metabolic pathways	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMC200011150	K02084	ko04115	p53 signaling pathway	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko04210	Apoptosis	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko05010	Alzheimer's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko05012	Parkinson's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko05016	Huntington's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011150	K02084	ko05222	Small cell lung cancer	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMC200011151	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMC200011151	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMC200011152	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMC200011152	K01870	ko00970	Aminoacyl-tRNA biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMC200011153	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMC200011153	K01870	ko00970	Aminoacyl-tRNA biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMC200011155	K02706	ko00195	Photosynthesis	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMC200011155	K02706	ko01100	Metabolic pathways	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMC200020374	K00817	ko00340	Histidine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko00350	Tyrosine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko00360	Phenylalanine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko00401	Novobiocin biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko01100	Metabolic pathways	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020374	K00817	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMC200020375	K00817	ko00340	Histidine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko00350	Tyrosine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko00360	Phenylalanine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko00401	Novobiocin biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko01100	Metabolic pathways	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020375	K00817	ko01110	Biosynthesis of secondary metabolites	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMC200020390	K11753	ko00740	Riboflavin metabolism	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMC200020390	K11753	ko01100	Metabolic pathways	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMC200020391	K11753	ko00740	Riboflavin metabolism	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMC200020391	K11753	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMC200020395	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020395	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020396	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMC200020397	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020397	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020397	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020397	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020397	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020397	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMC200020398	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020398	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020398	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020398	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020398	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020398	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMC200020400	K02084	ko04115	p53 signaling pathway	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko04210	Apoptosis	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko05010	Alzheimer's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko05012	Parkinson's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko05016	Huntington's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200020400	K02084	ko05222	Small cell lung cancer	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMC200035791	K01897	ko00071	Fatty acid metabolism	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMC200035791	K01897	ko01100	Metabolic pathways	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMC200035791	K01897	ko03320	PPAR signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMC200035791	K01897	ko04146	Peroxisome	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMC200035791	K01897	ko04920	Adipocytokine signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMC200035793	K12929	ko00904	Diterpenoid biosynthesis	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMC200035793	K12929	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMC200035805	K01176	ko00500	Starch and sucrose metabolism	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMC200035805	K01176	ko01100	Metabolic pathways	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMC200035806	K01176	ko00500	Starch and sucrose metabolism	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMC200035806	K01176	ko01100	Metabolic pathways	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMC200035807	K01176	ko00500	Starch and sucrose metabolism	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMC200035807	K01176	ko01100	Metabolic pathways	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMC200035808	K01176	ko00500	Starch and sucrose metabolism	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMC200035808	K01176	ko01100	Metabolic pathways	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMC200035809	K01176	ko00500	Starch and sucrose metabolism	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMC200035809	K01176	ko01100	Metabolic pathways	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMC200054827	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.33	0.51	0.89
PGSC0003DMC200054829	K01590	ko00340	Histidine metabolism	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMC200054829	K01590	ko01100	Metabolic pathways	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMC200054829	K01590	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMC200037214	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037214	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037214	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037215	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037215	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037215	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037220	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037220	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037220	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037222	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037222	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037222	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037223	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037223	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037223	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037224	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037224	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037224	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037226	K02602	ko04114	Oocyte meiosis	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMC200037226	K02602	ko04320	Dorso-ventral axis formation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMC200037226	K02602	ko04914	Progesterone-mediated oocyte maturation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMC200037227	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037227	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200037227	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMC200043968	K05862	ko04020	Calcium signaling pathway	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMC200043968	K05862	ko05012	Parkinson's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMC200043968	K05862	ko05016	Huntington's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMC200043969	K05862	ko04020	Calcium signaling pathway	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMC200043969	K05862	ko05012	Parkinson's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMC200043969	K05862	ko05016	Huntington's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMC200043970	K05862	ko04020	Calcium signaling pathway	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMC200043970	K05862	ko05012	Parkinson's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMC200043970	K05862	ko05016	Huntington's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMC200043971	K05862	ko04020	Calcium signaling pathway	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMC200043971	K05862	ko05012	Parkinson's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMC200043971	K05862	ko05016	Huntington's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMC200043973	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043973	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043974	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043974	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043975	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043975	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMC200043976	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMC200043977	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMC200060273	K11644	ko05016	Huntington's disease	461	1.2e-18	0.35	0.50	0.73
PGSC0003DMC200060295	K03660	ko03410	Base excision repair	463	2.9e-19	0.31	0.50	0.97
PGSC0003DMC200060296	K03094	ko04110	Cell cycle	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04111	Cell cycle - yeast	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04114	Oocyte meiosis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04120	Ubiquitin mediated proteolysis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04310	Wnt signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04350	TGF-beta signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060296	K03094	ko04710	Circadian rhythm - mammal	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMC200060299	K02738	ko03050	Proteasome	456	2.6e-19	0.38	0.58	0.85
PGSC0003DMC200029375	K02923	ko03010	Ribosome	521	6.7e-23	0.90	0.96	0.99
PGSC0003DMC200029376	K06236	ko04510	Focal adhesion	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMC200029376	K06236	ko04512	ECM-receptor interaction	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMC200029376	K06236	ko05146	Amoebiasis	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMC200029377	K01213	ko00040	Pentose and glucuronate interconversions	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMC200029377	K01213	ko00500	Starch and sucrose metabolism	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMC200029377	K01213	ko01100	Metabolic pathways	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMC200029393	K00030	ko00020	Citrate cycle (TCA cycle)	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMC200029393	K00030	ko01100	Metabolic pathways	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMC200029393	K00030	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMC200029399	K09680	ko00770	Pantothenate and CoA biosynthesis	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMC200029399	K09680	ko01100	Metabolic pathways	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMC200029400	K09680	ko00770	Pantothenate and CoA biosynthesis	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMC200029400	K09680	ko01100	Metabolic pathways	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMC200006008	K01509	ko00230	Purine metabolism	264	8.2e-26	0.47	0.67	0.62
PGSC0003DMC200006010	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMC200006011	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMC200006012	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMC200006013	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMC200006015	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMC200006015	K02367	ko01100	Metabolic pathways	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMC200006029	K02870	ko03010	Ribosome	1326	2.7e-67	0.95	0.99	0.99
PGSC0003DMC200012751	K12815	ko03040	Spliceosome	8555	0.	0.81	0.88	0.99
PGSC0003DMC200012752	K12815	ko03040	Spliceosome	427	8.0e-17	0.96	0.98	0.95
PGSC0003DMC200012753	K12815	ko03040	Spliceosome	363	3.0e-13	0.90	0.98	0.80
PGSC0003DMC200012759	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMC200012759	K00517	ko00626	Naphthalene and anthracene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMC200012759	K00517	ko00903	Limonene and pinene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMC200012759	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMC200012759	K00517	ko01110	Biosynthesis of secondary metabolites	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMC200012760	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMC200012760	K00517	ko00626	Naphthalene and anthracene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMC200012760	K00517	ko00903	Limonene and pinene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMC200012760	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMC200012760	K00517	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMC200012761	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMC200012761	K00517	ko00626	Naphthalene and anthracene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMC200012761	K00517	ko00903	Limonene and pinene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMC200012761	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMC200012761	K00517	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMC200012769	K02723	ko00195	Photosynthesis	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMC200012769	K02723	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMC200012775	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1380	2.8e-70	0.38	0.55	0.96
PGSC0003DMC200012777	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012777	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMC200012778	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	368	4.4e-14	0.30	0.47	0.93
PGSC0003DMC200012779	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	380	8.8e-15	0.29	0.46	0.92
PGSC0003DMC200012780	K12486	ko04144	Endocytosis	285	5.8e-07	0.26	0.39	0.60
PGSC0003DMC200026025	K02218	ko04340	Hedgehog signaling pathway	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMC200026025	K02218	ko04711	Circadian rhythm - fly	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMC200026026	K02218	ko04340	Hedgehog signaling pathway	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMC200026026	K02218	ko04711	Circadian rhythm - fly	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMC200026027	K02218	ko04340	Hedgehog signaling pathway	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMC200026027	K02218	ko04711	Circadian rhythm - fly	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMC200026038	K12668	ko00510	N-Glycan biosynthesis	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMC200026038	K12668	ko01100	Metabolic pathways	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMC200026040	K00630	ko00561	Glycerolipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMC200026040	K00630	ko00564	Glycerophospholipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMC200026040	K00630	ko01100	Metabolic pathways	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMC200005322	K05894	ko00592	alpha-Linolenic acid metabolism	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMC200005322	K05894	ko01100	Metabolic pathways	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMC200005324	K05894	ko00592	alpha-Linolenic acid metabolism	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMC200005324	K05894	ko01100	Metabolic pathways	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMC200005330	K01757	ko00901	Indole alkaloid biosynthesis	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMC200005330	K01757	ko01100	Metabolic pathways	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMC200005330	K01757	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMC200005337	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMC200005340	K02256	ko00190	Oxidative phosphorylation	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200005340	K02256	ko01100	Metabolic pathways	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200005340	K02256	ko04260	Cardiac muscle contraction	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200005340	K02256	ko05010	Alzheimer's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200005340	K02256	ko05012	Parkinson's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200005340	K02256	ko05016	Huntington's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMC200010321	K12235	ko00260	Glycine, serine and threonine metabolism	1160	3.8e-58	0.73	0.85	0.98
PGSC0003DMC200010322	K12235	ko00260	Glycine, serine and threonine metabolism	1966	1.3e-102	0.71	0.84	0.99
PGSC0003DMC200010323	K12235	ko00260	Glycine, serine and threonine metabolism	2007	7.3e-105	0.73	0.86	0.99
PGSC0003DMC200010324	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMC200010333	K01762	ko00270	Cysteine and methionine metabolism	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMC200010333	K01762	ko01110	Biosynthesis of secondary metabolites	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMC200010336	K04706	ko04120	Ubiquitin mediated proteolysis	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMC200010336	K04706	ko04630	Jak-STAT signaling pathway	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMC200010336	K04706	ko05200	Pathways in cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMC200010336	K04706	ko05222	Small cell lung cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMC200010337	K04706	ko04120	Ubiquitin mediated proteolysis	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMC200010337	K04706	ko04630	Jak-STAT signaling pathway	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMC200010337	K04706	ko05200	Pathways in cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMC200010337	K04706	ko05222	Small cell lung cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMC200010344	K02150	ko00190	Oxidative phosphorylation	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200010344	K02150	ko01100	Metabolic pathways	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200010344	K02150	ko04145	Phagosome	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200010344	K02150	ko04966	Collecting duct acid secretion	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200010344	K02150	ko05110	Vibrio cholerae infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200010344	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMC200016831	K11820	ko00380	Tryptophan metabolism	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMC200016831	K11820	ko00966	Glucosinolate biosynthesis	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMC200016831	K11820	ko01110	Biosynthesis of secondary metabolites	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMC200016832	K11820	ko00380	Tryptophan metabolism	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMC200016832	K11820	ko00966	Glucosinolate biosynthesis	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMC200016832	K11820	ko01110	Biosynthesis of secondary metabolites	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMC200016833	K11820	ko00380	Tryptophan metabolism	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMC200016833	K11820	ko00966	Glucosinolate biosynthesis	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMC200016833	K11820	ko01110	Biosynthesis of secondary metabolites	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMC200016834	K11820	ko00380	Tryptophan metabolism	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMC200016834	K11820	ko00966	Glucosinolate biosynthesis	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMC200016834	K11820	ko01110	Biosynthesis of secondary metabolites	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMC200016835	K11820	ko00380	Tryptophan metabolism	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMC200016835	K11820	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMC200016835	K11820	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMC200016840	K00658	ko00020	Citrate cycle (TCA cycle)	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMC200016840	K00658	ko00310	Lysine degradation	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMC200016840	K00658	ko01100	Metabolic pathways	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMC200016840	K00658	ko01110	Biosynthesis of secondary metabolites	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMC200016844	K11820	ko00380	Tryptophan metabolism	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMC200016844	K11820	ko00966	Glucosinolate biosynthesis	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMC200016844	K11820	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMC200064602	K08912	ko00196	Photosynthesis - antenna proteins	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMC200064602	K08912	ko01100	Metabolic pathways	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMC200064610	K00368	ko00910	Nitrogen metabolism	699	1.0e-32	0.36	0.54	0.83
PGSC0003DMC200068407	K02704	ko00195	Photosynthesis	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMC200068407	K02704	ko01100	Metabolic pathways	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMC200034112	K08337	ko04140	Regulation of autophagy	423	3.0e-17	0.77	0.81	0.97
PGSC0003DMC200034113	K08337	ko04140	Regulation of autophagy	4693	5.2e-253	0.77	0.87	1.00
PGSC0003DMC200034121	K01206	ko00511	Other glycan degradation	2801	1.2e-148	0.74	0.86	0.93
PGSC0003DMC200034122	K01206	ko00511	Other glycan degradation	1713	1.2e-88	0.66	0.82	0.95
PGSC0003DMC200034124	K01354	ko05142	Chagas disease	600	2.9e-27	0.37	0.59	0.80
PGSC0003DMC200034125	K01354	ko05142	Chagas disease	679	1.3e-31	0.48	0.67	0.98
PGSC0003DMC200034126	K01354	ko05142	Chagas disease	269	2.0e-08	0.56	0.69	0.91
PGSC0003DMC200034131	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.34	0.48	0.95
PGSC0003DMC200034132	K12356	ko00940	Phenylpropanoid biosynthesis	698	1.2e-32	0.33	0.48	0.97
PGSC0003DMC200034134	K04079	ko04612	Antigen processing and presentation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200034134	K04079	ko04621	NOD-like receptor signaling pathway	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200034134	K04079	ko04626	Plant-pathogen interaction	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200034134	K04079	ko04914	Progesterone-mediated oocyte maturation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200034134	K04079	ko05200	Pathways in cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200034134	K04079	ko05215	Prostate cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMC200039121	K10772	ko03410	Base excision repair	1846	5.6e-96	0.55	0.66	0.99
PGSC0003DMC200039122	K10772	ko03410	Base excision repair	2985	8.4e-159	0.61	0.72	0.99
PGSC0003DMC200039123	K00908	ko01100	Metabolic pathways	3426	4.0e-183	0.83	0.92	0.85
PGSC0003DMC200039124	K00908	ko01100	Metabolic pathways	2034	2.4e-106	0.84	0.93	0.87
PGSC0003DMC200039126	K11088	ko03040	Spliceosome	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMC200039126	K11088	ko05322	Systemic lupus erythematosus	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMC200039128	K00430	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMC200039128	K00430	ko00680	Methane metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMC200039128	K00430	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMC200039128	K00430	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMC200039128	K00430	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMC200039130	K02732	ko03050	Proteasome	1743	2.7e-90	0.91	0.96	1.00
PGSC0003DMC200039139	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMC200039139	K00224	ko00364	Fluorobenzoate degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMC200039139	K00224	ko00628	Fluorene degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMC200039139	K00224	ko00640	Propanoate metabolism	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMC200039140	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.46
PGSC0003DMC200039142	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.44
PGSC0003DMC200039149	K04371	ko04010	MAPK signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04012	ErbB signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04013	MAPK signaling pathway - fly	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04062	Chemokine signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04114	Oocyte meiosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04150	mTOR signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04270	Vascular smooth muscle contraction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04320	Dorso-ventral axis formation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04350	TGF-beta signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04360	Axon guidance	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04370	VEGF signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04510	Focal adhesion	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04520	Adherens junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04540	Gap junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04620	Toll-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04621	NOD-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04650	Natural killer cell mediated cytotoxicity	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04660	T cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04662	B cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04664	Fc epsilon RI signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04666	Fc gamma R-mediated phagocytosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04720	Long-term potentiation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04722	Neurotrophin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04730	Long-term depression	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04810	Regulation of actin cytoskeleton	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04910	Insulin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04912	GnRH signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04914	Progesterone-mediated oocyte maturation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04916	Melanogenesis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04930	Type II diabetes mellitus	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko04960	Aldosterone-regulated sodium reabsorption	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05010	Alzheimer's disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05020	Prion diseases	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05131	Shigellosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05140	Leishmaniasis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05142	Chagas disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05200	Pathways in cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05210	Colorectal cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05211	Renal cell carcinoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05212	Pancreatic cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05213	Endometrial cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05214	Glioma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05215	Prostate cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05216	Thyroid cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05218	Melanoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05219	Bladder cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05220	Chronic myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05221	Acute myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200039149	K04371	ko05223	Non-small cell lung cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMC200045631	K03715	ko00561	Glycerolipid metabolism	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMC200045631	K03715	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMC200045633	K01528	ko04144	Endocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMC200045633	K01528	ko04666	Fc gamma R-mediated phagocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMC200045633	K01528	ko05100	Bacterial invasion of epithelial cells	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMC200045634	K01528	ko04144	Endocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMC200045634	K01528	ko04666	Fc gamma R-mediated phagocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMC200045634	K01528	ko05100	Bacterial invasion of epithelial cells	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMC200045635	K01528	ko04144	Endocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMC200045635	K01528	ko04666	Fc gamma R-mediated phagocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMC200045635	K01528	ko05100	Bacterial invasion of epithelial cells	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMC200045636	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045636	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045636	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045637	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045637	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045637	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMC200045648	K02956	ko03010	Ribosome	293	2.5e-10	0.30	0.46	0.84
PGSC0003DMC200045649	K02956	ko03010	Ribosome	774	7.4e-37	0.38	0.54	0.87
PGSC0003DMC200045650	K02956	ko03010	Ribosome	1118	7.9e-56	0.45	0.59	0.88
PGSC0003DMC200045653	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMC200045653	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMC200045653	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMC200012321	K01673	ko00910	Nitrogen metabolism	865	7.1e-42	0.72	0.85	0.97
PGSC0003DMC200012322	K01673	ko00910	Nitrogen metabolism	592	8.1e-27	0.72	0.84	0.96
PGSC0003DMC200012323	K01673	ko00910	Nitrogen metabolism	217	3.9e-06	0.55	0.71	0.81
PGSC0003DMC200012324	K01673	ko00910	Nitrogen metabolism	301	9.1e-11	0.54	0.71	0.88
PGSC0003DMC200012325	K01673	ko00910	Nitrogen metabolism	292	2.9e-10	0.60	0.72	0.98
PGSC0003DMC200012327	K05289	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMC200012327	K05289	ko01100	Metabolic pathways	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMC200012330	K00876	ko00240	Pyrimidine metabolism	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMC200012330	K00876	ko00983	Drug metabolism - other enzymes	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMC200012330	K00876	ko01100	Metabolic pathways	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMC200007058	K12182	ko04144	Endocytosis	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMC200007058	K12182	ko04145	Phagosome	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMC200060805	K11294	ko05130	Pathogenic Escherichia coli infection	283	2.6e-09	0.32	0.50	0.92
PGSC0003DMC200053492	K05756	ko04666	Fc gamma R-mediated phagocytosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMC200053492	K05756	ko04810	Regulation of actin cytoskeleton	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMC200053492	K05756	ko05100	Bacterial invasion of epithelial cells	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMC200053492	K05756	ko05130	Pathogenic Escherichia coli infection	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMC200053492	K05756	ko05131	Shigellosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMC200053493	K03715	ko00561	Glycerolipid metabolism	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMC200053493	K03715	ko01100	Metabolic pathways	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMC200053494	K03715	ko00561	Glycerolipid metabolism	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMC200053494	K03715	ko01100	Metabolic pathways	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMC200053497	K07964	ko00531	Glycosaminoglycan degradation	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMC200053497	K07964	ko01100	Metabolic pathways	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMC200053498	K07964	ko00531	Glycosaminoglycan degradation	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMC200053498	K07964	ko01100	Metabolic pathways	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMC200053506	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMC200053506	K00517	ko00626	Naphthalene and anthracene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMC200053506	K00517	ko00903	Limonene and pinene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMC200053506	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMC200053506	K00517	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMC200053509	K05864	ko04020	Calcium signaling pathway	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMC200053509	K05864	ko05012	Parkinson's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMC200053509	K05864	ko05016	Huntington's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMC200053510	K05864	ko04020	Calcium signaling pathway	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMC200053510	K05864	ko05012	Parkinson's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMC200053510	K05864	ko05016	Huntington's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMC200053519	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200053519	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200053519	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200053520	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200053520	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200053520	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMC200043507	K02945	ko03010	Ribosome	321	7.2e-12	0.72	0.87	0.90
PGSC0003DMC200043508	K02945	ko03010	Ribosome	1241	1.3e-62	0.59	0.68	0.99
PGSC0003DMC200043509	K02945	ko03010	Ribosome	2631	2.8e-139	0.66	0.77	0.99
PGSC0003DMC200043512	K01528	ko04144	Endocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMC200043512	K01528	ko04666	Fc gamma R-mediated phagocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMC200043512	K01528	ko05100	Bacterial invasion of epithelial cells	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMC200043513	K01528	ko04144	Endocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMC200043513	K01528	ko04666	Fc gamma R-mediated phagocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMC200043513	K01528	ko05100	Bacterial invasion of epithelial cells	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMC200043514	K00866	ko00564	Glycerophospholipid metabolism	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMC200043514	K00866	ko01100	Metabolic pathways	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMC200043515	K00866	ko00564	Glycerophospholipid metabolism	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMC200043515	K00866	ko01100	Metabolic pathways	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMC200043519	K00430	ko00360	Phenylalanine metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMC200043519	K00430	ko00680	Methane metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMC200043519	K00430	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMC200043519	K00430	ko01100	Metabolic pathways	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMC200043519	K00430	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMC200043520	K00430	ko00360	Phenylalanine metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMC200043520	K00430	ko00680	Methane metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMC200043520	K00430	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMC200043520	K00430	ko01100	Metabolic pathways	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMC200043520	K00430	ko01110	Biosynthesis of secondary metabolites	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMC200043521	K00430	ko00360	Phenylalanine metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMC200043521	K00430	ko00680	Methane metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMC200043521	K00430	ko00940	Phenylpropanoid biosynthesis	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMC200043521	K00430	ko01100	Metabolic pathways	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMC200043521	K00430	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMC200043522	K00430	ko00360	Phenylalanine metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMC200043522	K00430	ko00680	Methane metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMC200043522	K00430	ko00940	Phenylpropanoid biosynthesis	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMC200043522	K00430	ko01100	Metabolic pathways	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMC200043522	K00430	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMC200043523	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMC200043523	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMC200043523	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMC200043523	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMC200043523	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMC200043524	K01507	ko00190	Oxidative phosphorylation	6009	0.	0.90	0.95	1.00
PGSC0003DMC200043525	K01507	ko00190	Oxidative phosphorylation	5748	0.	0.89	0.95	1.00
PGSC0003DMC200043530	K05280	ko00941	Flavonoid biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMC200043530	K05280	ko00944	Flavone and flavonol biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMC200043530	K05280	ko01100	Metabolic pathways	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMC200043530	K05280	ko01110	Biosynthesis of secondary metabolites	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMC200038257	K12831	ko03040	Spliceosome	214	9.1e-06	0.40	0.51	0.80
PGSC0003DMC200038264	K03553	ko03440	Homologous recombination	2643	6.1e-140	0.81	0.90	0.94
PGSC0003DMC200002523	K01231	ko00510	N-Glycan biosynthesis	7172	0.	0.71	0.83	1.00
PGSC0003DMC200002523	K01231	ko01100	Metabolic pathways	7172	0.	0.71	0.83	1.00
PGSC0003DMC200002525	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.28	0.46	0.79
PGSC0003DMC200002526	K11644	ko05016	Huntington's disease	6729	0.	0.61	0.74	0.99
PGSC0003DMC200002527	K11644	ko05016	Huntington's disease	6993	0.	0.62	0.75	1.00
PGSC0003DMC200002528	K11644	ko05016	Huntington's disease	847	2.3e-40	0.38	0.54	0.96
PGSC0003DMC200002529	K11644	ko05016	Huntington's disease	1210	6.7e-61	0.46	0.58	0.96
PGSC0003DMC200002530	K11644	ko05016	Huntington's disease	1265	6.2e-64	0.47	0.60	0.96
PGSC0003DMC200002531	K05658	ko02010	ABC transporters	4157	1.9e-223	0.45	0.66	0.99
PGSC0003DMC200002532	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMC200002532	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMC200002532	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMC200002533	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMC200002533	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMC200002533	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMC200002536	K00472	ko00330	Arginine and proline metabolism	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMC200002536	K00472	ko01100	Metabolic pathways	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMC200002541	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMC200002541	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMC200002541	K00771	ko01100	Metabolic pathways	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMC200061986	K01213	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMC200061986	K01213	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMC200061986	K01213	ko01100	Metabolic pathways	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMC200061993	K10760	ko00908	Zeatin biosynthesis	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMC200061993	K10760	ko01100	Metabolic pathways	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMC200061993	K10760	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMC200023491	K08272	ko04150	mTOR signaling pathway	2462	5.9e-130	0.88	0.94	0.99
PGSC0003DMC200023492	K08272	ko04150	mTOR signaling pathway	344	3.9e-13	0.80	0.87	0.95
PGSC0003DMC200023494	K01092	ko00521	Streptomycin biosynthesis	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMC200023494	K01092	ko00562	Inositol phosphate metabolism	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMC200023494	K01092	ko01100	Metabolic pathways	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMC200023494	K01092	ko01110	Biosynthesis of secondary metabolites	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMC200023494	K01092	ko04070	Phosphatidylinositol signaling system	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMC200023495	K01092	ko00521	Streptomycin biosynthesis	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMC200023495	K01092	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMC200023495	K01092	ko01100	Metabolic pathways	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMC200023495	K01092	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMC200023495	K01092	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMC200023496	K08332	ko04140	Regulation of autophagy	288	1.2e-07	0.30	0.45	0.76
PGSC0003DMC200023497	K08332	ko04140	Regulation of autophagy	288	9.6e-08	0.30	0.46	0.75
PGSC0003DMC200023501	K00857	ko00240	Pyrimidine metabolism	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMC200023501	K00857	ko00983	Drug metabolism - other enzymes	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMC200023501	K00857	ko01100	Metabolic pathways	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMC200023502	K00857	ko00240	Pyrimidine metabolism	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMC200023502	K00857	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMC200023502	K00857	ko01100	Metabolic pathways	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMC200008256	K01516	ko00230	Purine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMC200008256	K01516	ko00730	Thiamine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMC200008256	K01516	ko01100	Metabolic pathways	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMC200008257	K01516	ko00230	Purine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMC200008257	K01516	ko00730	Thiamine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMC200008257	K01516	ko01100	Metabolic pathways	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMC200008258	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008258	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008258	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008259	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008259	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008259	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008260	K01516	ko00230	Purine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMC200008260	K01516	ko00730	Thiamine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMC200008260	K01516	ko01100	Metabolic pathways	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMC200008261	K01516	ko00230	Purine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMC200008261	K01516	ko00730	Thiamine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMC200008261	K01516	ko01100	Metabolic pathways	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMC200008262	K01516	ko00230	Purine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMC200008262	K01516	ko00730	Thiamine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMC200008262	K01516	ko01100	Metabolic pathways	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMC200008263	K01516	ko00230	Purine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMC200008263	K01516	ko00730	Thiamine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMC200008263	K01516	ko01100	Metabolic pathways	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMC200008264	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008264	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008264	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008265	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008265	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008265	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008266	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008266	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008266	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMC200008269	K12338	ko00942	Anthocyanin biosynthesis	548	2.2e-24	0.57	0.75	0.96
PGSC0003DMC200008270	K12338	ko00942	Anthocyanin biosynthesis	716	1.2e-33	0.40	0.60	0.96
PGSC0003DMC200008277	K08246	ko00100	Steroid biosynthesis	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMC200008277	K08246	ko01100	Metabolic pathways	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMC200008277	K08246	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMC200008278	K08246	ko00100	Steroid biosynthesis	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMC200008278	K08246	ko01100	Metabolic pathways	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMC200008278	K08246	ko01110	Biosynthesis of secondary metabolites	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMC200013502	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.74
PGSC0003DMC200013503	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.69
PGSC0003DMC200013504	K00970	ko03018	RNA degradation	2726	1.6e-144	0.68	0.81	0.72
PGSC0003DMC200013505	K01590	ko00340	Histidine metabolism	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMC200013505	K01590	ko01100	Metabolic pathways	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMC200013505	K01590	ko01110	Biosynthesis of secondary metabolites	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMC200013506	K01590	ko00340	Histidine metabolism	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMC200013506	K01590	ko01100	Metabolic pathways	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMC200013506	K01590	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMC200013517	K09755	ko00940	Phenylpropanoid biosynthesis	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMC200013517	K09755	ko01100	Metabolic pathways	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMC200013517	K09755	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMC200013518	K09755	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMC200013518	K09755	ko01100	Metabolic pathways	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMC200013518	K09755	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMC200013519	K13083	ko00941	Flavonoid biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMC200013519	K13083	ko00944	Flavone and flavonol biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMC200013519	K13083	ko01110	Biosynthesis of secondary metabolites	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMC200013520	K05280	ko00941	Flavonoid biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMC200013520	K05280	ko00944	Flavone and flavonol biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMC200013520	K05280	ko01100	Metabolic pathways	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMC200013520	K05280	ko01110	Biosynthesis of secondary metabolites	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMC200013521	K05280	ko00941	Flavonoid biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMC200013521	K05280	ko00944	Flavone and flavonol biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMC200013521	K05280	ko01100	Metabolic pathways	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMC200013521	K05280	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMC200013523	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMC200013523	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMC200013523	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMC200013523	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMC200013523	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMC200013524	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200013524	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200013524	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200013524	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMC200013526	K13025	ko03040	Spliceosome	3032	2.1e-161	0.89	0.93	1.00
PGSC0003DMC200013527	K13025	ko03040	Spliceosome	3163	1.3e-168	0.92	0.96	1.00
PGSC0003DMC200037077	K00343	ko00190	Oxidative phosphorylation	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMC200037077	K00343	ko01100	Metabolic pathways	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMC200042309	K08332	ko04140	Regulation of autophagy	266	3.5e-06	0.32	0.47	0.40
PGSC0003DMC200042310	K10773	ko03410	Base excision repair	1417	2.5e-72	0.61	0.78	0.89
PGSC0003DMC200042323	K02183	ko04020	Calcium signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04070	Phosphatidylinositol signaling system	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04114	Oocyte meiosis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04270	Vascular smooth muscle contraction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04626	Plant-pathogen interaction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04720	Long-term potentiation	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04722	Neurotrophin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04740	Olfactory transduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04744	Phototransduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04745	Phototransduction - fly	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04910	Insulin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04912	GnRH signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04916	Melanogenesis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04970	Salivary secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko04971	Gastric acid secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko05010	Alzheimer's disease	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042323	K02183	ko05214	Glioma	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMC200042324	K02183	ko04020	Calcium signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04070	Phosphatidylinositol signaling system	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04114	Oocyte meiosis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04270	Vascular smooth muscle contraction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04626	Plant-pathogen interaction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04720	Long-term potentiation	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04722	Neurotrophin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04740	Olfactory transduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04744	Phototransduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04745	Phototransduction - fly	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04910	Insulin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04912	GnRH signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04916	Melanogenesis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04970	Salivary secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko04971	Gastric acid secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko05010	Alzheimer's disease	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042324	K02183	ko05214	Glioma	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMC200042325	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042325	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042326	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMC200042328	K02183	ko04020	Calcium signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04070	Phosphatidylinositol signaling system	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04114	Oocyte meiosis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04270	Vascular smooth muscle contraction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04626	Plant-pathogen interaction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04720	Long-term potentiation	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04722	Neurotrophin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04740	Olfactory transduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04744	Phototransduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04745	Phototransduction - fly	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04910	Insulin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04912	GnRH signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04916	Melanogenesis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04970	Salivary secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko04971	Gastric acid secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko05010	Alzheimer's disease	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042328	K02183	ko05214	Glioma	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMC200042330	K02183	ko04020	Calcium signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04114	Oocyte meiosis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04270	Vascular smooth muscle contraction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04626	Plant-pathogen interaction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04720	Long-term potentiation	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04722	Neurotrophin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04740	Olfactory transduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04744	Phototransduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04745	Phototransduction - fly	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04910	Insulin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04912	GnRH signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04916	Melanogenesis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04970	Salivary secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko04971	Gastric acid secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko05010	Alzheimer's disease	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200042330	K02183	ko05214	Glioma	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMC200063410	K00002	ko00010	Glycolysis / Gluconeogenesis	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMC200063410	K00002	ko00561	Glycerolipid metabolism	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMC200063410	K00002	ko00930	Caprolactam degradation	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMC200063410	K00002	ko01100	Metabolic pathways	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMC200063410	K00002	ko01110	Biosynthesis of secondary metabolites	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMC200004111	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004111	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004111	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004112	K00292	ko00310	Lysine degradation	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMC200004112	K00292	ko01100	Metabolic pathways	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMC200004112	K00292	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMC200004113	K01199	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.37	0.58	0.65
PGSC0003DMC200004120	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMC200004121	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMC200004122	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMC200004129	K03541	ko00195	Photosynthesis	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMC200004129	K03541	ko01100	Metabolic pathways	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMC200004130	K03541	ko00195	Photosynthesis	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMC200004130	K03541	ko01100	Metabolic pathways	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMC200004136	K10955	ko05110	Vibrio cholerae infection	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMC200004136	K10955	ko05146	Amoebiasis	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMC200004139	K05933	ko00270	Cysteine and methionine metabolism	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMC200004139	K05933	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMC200004140	K05933	ko00270	Cysteine and methionine metabolism	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMC200004140	K05933	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMC200026495	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMC200026496	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMC200026497	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1914	9.9e-100	0.68	0.79	0.99
PGSC0003DMC200026498	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1948	1.3e-101	0.69	0.79	0.99
PGSC0003DMC200026499	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	361	2.2e-13	0.37	0.52	0.91
PGSC0003DMC200026500	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	546	2.8e-24	0.74	0.79	0.97
PGSC0003DMC200026502	K04503	ko04110	Cell cycle	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko04115	p53 signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko04310	Wnt signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko04510	Focal adhesion	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko04630	Jak-STAT signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05200	Pathways in cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05210	Colorectal cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05212	Pancreatic cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05213	Endometrial cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05214	Glioma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05215	Prostate cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05216	Thyroid cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05218	Melanoma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05219	Bladder cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05220	Chronic myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05221	Acute myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05222	Small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05223	Non-small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026502	K04503	ko05416	Viral myocarditis	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMC200026514	K00971	ko00051	Fructose and mannose metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMC200026514	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMC200026514	K00971	ko01100	Metabolic pathways	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMC200026514	K00971	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMC200026516	K09840	ko00906	Carotenoid biosynthesis	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMC200026516	K09840	ko01100	Metabolic pathways	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMC200026516	K09840	ko01110	Biosynthesis of secondary metabolites	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMC200015631	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015631	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015631	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015631	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015631	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMC200015632	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015632	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015632	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015632	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015632	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015633	K00002	ko00010	Glycolysis / Gluconeogenesis	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMC200015633	K00002	ko00561	Glycerolipid metabolism	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMC200015633	K00002	ko00930	Caprolactam degradation	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMC200015633	K00002	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMC200015633	K00002	ko01110	Biosynthesis of secondary metabolites	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMC200015634	K00002	ko00010	Glycolysis / Gluconeogenesis	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMC200015634	K00002	ko00561	Glycerolipid metabolism	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMC200015634	K00002	ko00930	Caprolactam degradation	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMC200015634	K00002	ko01100	Metabolic pathways	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMC200015634	K00002	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMC200015635	K00002	ko00010	Glycolysis / Gluconeogenesis	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMC200015635	K00002	ko00561	Glycerolipid metabolism	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMC200015635	K00002	ko00930	Caprolactam degradation	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMC200015635	K00002	ko01100	Metabolic pathways	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMC200015635	K00002	ko01110	Biosynthesis of secondary metabolites	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMC200015636	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015636	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015636	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015636	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015636	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMC200015637	K00002	ko00010	Glycolysis / Gluconeogenesis	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMC200015637	K00002	ko00561	Glycerolipid metabolism	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMC200015637	K00002	ko00930	Caprolactam degradation	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMC200015637	K00002	ko01100	Metabolic pathways	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMC200015637	K00002	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMC200015638	K00002	ko00010	Glycolysis / Gluconeogenesis	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMC200015638	K00002	ko00561	Glycerolipid metabolism	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMC200015638	K00002	ko00930	Caprolactam degradation	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMC200015638	K00002	ko01100	Metabolic pathways	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMC200015638	K00002	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMC200015639	K00971	ko00051	Fructose and mannose metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMC200015639	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMC200015639	K00971	ko01100	Metabolic pathways	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMC200015639	K00971	ko01110	Biosynthesis of secondary metabolites	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMC200015640	K00971	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMC200015640	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMC200015640	K00971	ko01100	Metabolic pathways	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMC200015640	K00971	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMC200015642	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMC200015643	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMC200015645	K10594	ko04120	Ubiquitin mediated proteolysis	460	6.4e-23	0.33	0.49	0.67
PGSC0003DMC200015646	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMC200015647	K10594	ko04120	Ubiquitin mediated proteolysis	460	1.7e-22	0.32	0.49	0.67
PGSC0003DMC200015648	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMC200015648	K08081	ko01100	Metabolic pathways	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMC200015648	K08081	ko01110	Biosynthesis of secondary metabolites	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMC200015649	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMC200015649	K08081	ko01100	Metabolic pathways	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMC200015649	K08081	ko01110	Biosynthesis of secondary metabolites	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMC200015652	K00368	ko00910	Nitrogen metabolism	1587	1.1e-81	0.42	0.57	0.91
PGSC0003DMC200015657	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.91
PGSC0003DMC200015658	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.98
PGSC0003DMC200015659	K00368	ko00910	Nitrogen metabolism	812	6.0e-39	0.40	0.54	0.88
PGSC0003DMC200009136	K10717	ko00908	Zeatin biosynthesis	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMC200009136	K10717	ko01100	Metabolic pathways	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMC200009136	K10717	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMC200009137	K07424	ko00140	Steroid hormone biosynthesis	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00591	Linoleic acid metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00830	Retinol metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00982	Drug metabolism - cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko00983	Drug metabolism - other enzymes	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009137	K07424	ko01100	Metabolic pathways	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMC200009146	K00430	ko00360	Phenylalanine metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMC200009146	K00430	ko00680	Methane metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMC200009146	K00430	ko00940	Phenylpropanoid biosynthesis	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMC200009146	K00430	ko01100	Metabolic pathways	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMC200009146	K00430	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMC200035312	K12586	ko03018	RNA degradation	901	2.6e-43	0.45	0.62	0.68
PGSC0003DMC200035336	K13065	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMC200035336	K13065	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMC200035336	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMC200035336	K13065	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMC200035339	K00368	ko00910	Nitrogen metabolism	1706	2.9e-88	0.45	0.59	0.90
PGSC0003DMC200046835	K00059	ko00061	Fatty acid biosynthesis	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMC200046835	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMC200046835	K00059	ko01100	Metabolic pathways	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMC200046842	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMC200046843	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMC200046844	K02880	ko03010	Ribosome	1341	4.0e-68	0.90	0.94	0.99
PGSC0003DMC200046845	K02880	ko03010	Ribosome	526	3.5e-23	0.90	0.96	0.93
PGSC0003DMC200046846	K02880	ko03010	Ribosome	534	1.3e-23	0.91	0.97	0.93
PGSC0003DMC200046847	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMC200046847	K00517	ko00626	Naphthalene and anthracene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMC200046847	K00517	ko00903	Limonene and pinene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMC200046847	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMC200046847	K00517	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMC200046848	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMC200046848	K00517	ko00626	Naphthalene and anthracene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMC200046848	K00517	ko00903	Limonene and pinene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMC200046848	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMC200046848	K00517	ko01110	Biosynthesis of secondary metabolites	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMC200046849	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMC200046849	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMC200046849	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMC200046849	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMC200046849	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMC200046850	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMC200046850	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMC200046850	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMC200046850	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMC200046850	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMC200046851	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMC200046851	K00517	ko00626	Naphthalene and anthracene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMC200046851	K00517	ko00903	Limonene and pinene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMC200046851	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMC200046851	K00517	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMC200046852	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMC200046852	K00517	ko00626	Naphthalene and anthracene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMC200046852	K00517	ko00903	Limonene and pinene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMC200046852	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMC200046852	K00517	ko01110	Biosynthesis of secondary metabolites	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMC200046853	K12132	ko04712	Circadian rhythm - plant	1960	2.9e-102	0.53	0.63	0.67
PGSC0003DMC200046854	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMC200046855	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMC200046856	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMC200046858	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMC200046859	K12132	ko04712	Circadian rhythm - plant	437	4.2e-18	0.57	0.80	0.27
PGSC0003DMC200040331	K01889	ko00970	Aminoacyl-tRNA biosynthesis	1792	5.3e-93	0.89	0.96	1.00
PGSC0003DMC200040332	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3057	8.9e-163	0.80	0.89	1.00
PGSC0003DMC200040333	K08057	ko04145	Phagosome	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMC200040333	K08057	ko04612	Antigen processing and presentation	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMC200040333	K08057	ko05142	Chagas disease	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMC200040334	K08057	ko04145	Phagosome	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMC200040334	K08057	ko04612	Antigen processing and presentation	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMC200040334	K08057	ko05142	Chagas disease	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMC200040343	K02737	ko03050	Proteasome	2029	4.5e-106	0.89	0.93	0.99
PGSC0003DMC200040344	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040344	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040344	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040345	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040345	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040345	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040346	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040346	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040346	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMC200040347	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040347	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040347	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMC200040349	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMC200040349	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMC200040350	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMC200040350	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMC200032675	K04424	ko04010	MAPK signaling pathway	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMC200032675	K04424	ko04530	Tight junction	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMC200032678	K00875	ko00040	Pentose and glucuronate interconversions	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMC200032678	K00875	ko01100	Metabolic pathways	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMC200032680	K00875	ko00040	Pentose and glucuronate interconversions	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMC200032680	K00875	ko01100	Metabolic pathways	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMC200032681	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.36	0.55	0.70
PGSC0003DMC200032692	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.52	0.94
PGSC0003DMC200032693	K08139	ko04113	Meiosis - yeast	886	4.9e-43	0.34	0.52	0.90
PGSC0003DMC200044714	K09843	ko00906	Carotenoid biosynthesis	2395	2.9e-126	0.70	0.85	0.93
PGSC0003DMC200044715	K09843	ko00906	Carotenoid biosynthesis	2807	5.5e-149	0.71	0.85	0.96
PGSC0003DMC200044716	K09843	ko00906	Carotenoid biosynthesis	973	7.9e-48	0.69	0.85	0.98
PGSC0003DMC200044728	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMC200044728	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMC200044728	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMC200044728	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMC200044728	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMC200034861	K06666	ko04111	Cell cycle - yeast	508	4.3e-22	0.26	0.41	0.65
PGSC0003DMC200034862	K05279	ko00944	Flavone and flavonol biosynthesis	1379	3.2e-70	0.51	0.71	0.97
PGSC0003DMC200034863	K05279	ko00944	Flavone and flavonol biosynthesis	646	8.5e-30	0.47	0.66	0.99
PGSC0003DMC200034864	K05279	ko00944	Flavone and flavonol biosynthesis	1389	8.9e-71	0.51	0.71	0.96
PGSC0003DMC200034865	K05279	ko00944	Flavone and flavonol biosynthesis	1413	4.2e-72	0.51	0.71	0.97
PGSC0003DMC200034871	K00754	ko00051	Fructose and mannose metabolism	3078	6.2e-164	0.65	0.79	1.00
PGSC0003DMC200034874	K01495	ko00790	Folate biosynthesis	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMC200034874	K01495	ko01100	Metabolic pathways	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMC200034875	K01495	ko00790	Folate biosynthesis	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMC200034875	K01495	ko01100	Metabolic pathways	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMC200034882	K02995	ko03010	Ribosome	1432	3.8e-73	0.88	0.91	0.98
PGSC0003DMC200034883	K02995	ko03010	Ribosome	1653	2.5e-85	0.89	0.92	1.00
PGSC0003DMC200052305	K08332	ko04140	Regulation of autophagy	311	1.3e-08	0.35	0.51	0.36
PGSC0003DMC200052307	K02178	ko04110	Cell cycle	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMC200052307	K02178	ko04111	Cell cycle - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMC200052307	K02178	ko04113	Meiosis - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMC200052307	K02178	ko04114	Oocyte meiosis	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMC200052307	K02178	ko04914	Progesterone-mediated oocyte maturation	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMC200047341	K01188	ko00460	Cyanoamino acid metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMC200047341	K01188	ko00500	Starch and sucrose metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMC200047341	K01188	ko00940	Phenylpropanoid biosynthesis	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMC200047341	K01188	ko01110	Biosynthesis of secondary metabolites	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMC200047342	K01188	ko00460	Cyanoamino acid metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMC200047342	K01188	ko00500	Starch and sucrose metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMC200047342	K01188	ko00940	Phenylpropanoid biosynthesis	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMC200047342	K01188	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMC200047353	K08695	ko00941	Flavonoid biosynthesis	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMC200047353	K08695	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMC200047354	K08695	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMC200047354	K08695	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMC200047355	K08695	ko00941	Flavonoid biosynthesis	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMC200047355	K08695	ko01110	Biosynthesis of secondary metabolites	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMC200047356	K08695	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMC200047356	K08695	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMC200047358	K08695	ko00941	Flavonoid biosynthesis	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMC200047358	K08695	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMC200047363	K01408	ko05010	Alzheimer's disease	3765	8.0e-202	0.77	0.88	0.98
PGSC0003DMC200047364	K01408	ko05010	Alzheimer's disease	6332	0.	0.76	0.88	0.99
PGSC0003DMC200047365	K01408	ko05010	Alzheimer's disease	2736	4.5e-145	0.73	0.85	0.99
PGSC0003DMC200047366	K01408	ko05010	Alzheimer's disease	3203	7.9e-171	0.64	0.80	0.98
PGSC0003DMC200047367	K01408	ko05010	Alzheimer's disease	5464	1.6e-295	0.67	0.81	0.99
PGSC0003DMC200047368	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMC200047369	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMC200047370	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMC200058107	K05282	ko00904	Diterpenoid biosynthesis	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMC200058107	K05282	ko01100	Metabolic pathways	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMC200058107	K05282	ko01110	Biosynthesis of secondary metabolites	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMC200058108	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2260	8.1e-119	0.65	0.80	0.99
PGSC0003DMC200003662	K04446	ko04310	Wnt signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003662	K04446	ko04360	Axon guidance	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003662	K04446	ko04370	VEGF signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003662	K04446	ko04650	Natural killer cell mediated cytotoxicity	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003662	K04446	ko04660	T cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003662	K04446	ko04662	B cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMC200003663	K04498	ko04110	Cell cycle	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04310	Wnt signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04330	Notch signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04350	TGF-beta signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04520	Adherens junction	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04630	Jak-STAT signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04720	Long-term potentiation	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko04916	Melanogenesis	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko05016	Huntington's disease	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko05200	Pathways in cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko05211	Renal cell carcinoma	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003663	K04498	ko05215	Prostate cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMC200003668	K03123	ko03022	Basal transcription factors	810	7.7e-39	0.92	0.94	0.99
PGSC0003DMC200003685	K06611	ko00052	Galactose metabolism	1731	1.2e-89	0.41	0.58	0.97
PGSC0003DMC200003686	K06611	ko00052	Galactose metabolism	2118	5.5e-111	0.40	0.57	0.97
PGSC0003DMC200003687	K12603	ko03018	RNA degradation	3577	1.9e-191	0.53	0.59	1.00
PGSC0003DMC200003688	K12603	ko03018	RNA degradation	4248	1.8e-228	0.82	0.91	1.00
PGSC0003DMC200003689	K12603	ko03018	RNA degradation	3263	3.9e-174	0.81	0.91	0.96
PGSC0003DMC200021091	K02084	ko04115	p53 signaling pathway	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko04210	Apoptosis	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko05010	Alzheimer's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko05012	Parkinson's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko05016	Huntington's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021091	K02084	ko05222	Small cell lung cancer	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMC200021107	K06130	ko00564	Glycerophospholipid metabolism	382	3.1e-15	0.36	0.50	0.79
PGSC0003DMC200021113	K12524	ko00260	Glycine, serine and threonine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMC200021113	K12524	ko00270	Cysteine and methionine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMC200021113	K12524	ko00300	Lysine biosynthesis	6121	0.	0.80	0.89	1.00
PGSC0003DMC200021113	K12524	ko01100	Metabolic pathways	6121	0.	0.80	0.89	1.00
PGSC0003DMC200021113	K12524	ko01110	Biosynthesis of secondary metabolites	6121	0.	0.80	0.89	1.00
PGSC0003DMC200021116	K01597	ko00900	Terpenoid backbone biosynthesis	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMC200021116	K01597	ko01100	Metabolic pathways	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMC200021116	K01597	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMC200021117	K02084	ko04115	p53 signaling pathway	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko04210	Apoptosis	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko05010	Alzheimer's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko05012	Parkinson's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko05016	Huntington's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021117	K02084	ko05222	Small cell lung cancer	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMC200021120	K01597	ko00900	Terpenoid backbone biosynthesis	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMC200021120	K01597	ko01100	Metabolic pathways	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMC200021120	K01597	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMC200029281	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMC200029281	K08081	ko01100	Metabolic pathways	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMC200029281	K08081	ko01110	Biosynthesis of secondary metabolites	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMC200029288	K08065	ko04612	Antigen processing and presentation	578	4.8e-26	0.62	0.81	0.58
PGSC0003DMC200029292	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMC200029292	K00517	ko00626	Naphthalene and anthracene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMC200029292	K00517	ko00903	Limonene and pinene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMC200029292	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMC200029292	K00517	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMC200029293	K09754	ko00360	Phenylalanine metabolism	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029293	K09754	ko00940	Phenylpropanoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029293	K09754	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029293	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029293	K09754	ko01100	Metabolic pathways	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029293	K09754	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMC200029308	K08488	ko04130	SNARE interactions in vesicular transport	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMC200029308	K08488	ko04145	Phagosome	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMC200029309	K08488	ko04130	SNARE interactions in vesicular transport	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMC200029309	K08488	ko04145	Phagosome	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMC200029310	K08488	ko04130	SNARE interactions in vesicular transport	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMC200029310	K08488	ko04145	Phagosome	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMC200016141	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200016141	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200016141	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMC200016142	K02293	ko00906	Carotenoid biosynthesis	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMC200016142	K02293	ko01100	Metabolic pathways	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMC200016142	K02293	ko01110	Biosynthesis of secondary metabolites	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMC200016143	K02293	ko00906	Carotenoid biosynthesis	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMC200016143	K02293	ko01100	Metabolic pathways	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMC200016143	K02293	ko01110	Biosynthesis of secondary metabolites	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMC200016145	K08248	ko00460	Cyanoamino acid metabolism	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMC200016145	K08248	ko01100	Metabolic pathways	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMC200016146	K00058	ko00260	Glycine, serine and threonine metabolism	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMC200016146	K00058	ko01100	Metabolic pathways	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMC200016147	K00058	ko00260	Glycine, serine and threonine metabolism	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMC200016147	K00058	ko01100	Metabolic pathways	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMC200049083	K08488	ko04130	SNARE interactions in vesicular transport	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMC200049083	K08488	ko04145	Phagosome	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMC200049088	K01714	ko00300	Lysine biosynthesis	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMC200049088	K01714	ko01100	Metabolic pathways	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMC200049088	K01714	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMC200049089	K01714	ko00300	Lysine biosynthesis	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMC200049089	K01714	ko01100	Metabolic pathways	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMC200049089	K01714	ko01110	Biosynthesis of secondary metabolites	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMC200049096	K02962	ko03010	Ribosome	971	1.0e-47	0.82	0.89	0.97
PGSC0003DMC200049101	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMC200049102	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMC200049103	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMC200049104	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMC200049107	K11294	ko05130	Pathogenic Escherichia coli infection	255	3.1e-08	0.50	0.76	0.67
PGSC0003DMC200030271	K07424	ko00140	Steroid hormone biosynthesis	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00591	Linoleic acid metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00830	Retinol metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00982	Drug metabolism - cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko00983	Drug metabolism - other enzymes	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030271	K07424	ko01100	Metabolic pathways	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMC200030272	K07424	ko00140	Steroid hormone biosynthesis	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00591	Linoleic acid metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00830	Retinol metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00982	Drug metabolism - cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko00983	Drug metabolism - other enzymes	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030272	K07424	ko01100	Metabolic pathways	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMC200030273	K07424	ko00140	Steroid hormone biosynthesis	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00591	Linoleic acid metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00830	Retinol metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00982	Drug metabolism - cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko00983	Drug metabolism - other enzymes	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030273	K07424	ko01100	Metabolic pathways	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMC200030274	K07424	ko00140	Steroid hormone biosynthesis	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00591	Linoleic acid metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00830	Retinol metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00982	Drug metabolism - cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko00983	Drug metabolism - other enzymes	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030274	K07424	ko01100	Metabolic pathways	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMC200030275	K07424	ko00140	Steroid hormone biosynthesis	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00591	Linoleic acid metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00830	Retinol metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00982	Drug metabolism - cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko00983	Drug metabolism - other enzymes	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030275	K07424	ko01100	Metabolic pathways	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMC200030276	K07424	ko00140	Steroid hormone biosynthesis	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00591	Linoleic acid metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00830	Retinol metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00982	Drug metabolism - cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko00983	Drug metabolism - other enzymes	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030276	K07424	ko01100	Metabolic pathways	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMC200030277	K11251	ko05322	Systemic lupus erythematosus	241	1.9e-07	0.48	0.58	0.93
PGSC0003DMC200030291	K01757	ko00901	Indole alkaloid biosynthesis	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMC200030291	K01757	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMC200030291	K01757	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMC200030292	K01757	ko00901	Indole alkaloid biosynthesis	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMC200030292	K01757	ko01100	Metabolic pathways	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMC200030292	K01757	ko01110	Biosynthesis of secondary metabolites	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMC200030294	K01647	ko00020	Citrate cycle (TCA cycle)	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMC200030294	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMC200030294	K01647	ko01100	Metabolic pathways	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMC200030294	K01647	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMC200030295	K01647	ko00020	Citrate cycle (TCA cycle)	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMC200030295	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMC200030295	K01647	ko01100	Metabolic pathways	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMC200030295	K01647	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMC200030296	K01647	ko00020	Citrate cycle (TCA cycle)	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMC200030296	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMC200030296	K01647	ko01100	Metabolic pathways	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMC200030296	K01647	ko01110	Biosynthesis of secondary metabolites	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMC200030297	K01647	ko00020	Citrate cycle (TCA cycle)	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMC200030297	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMC200030297	K01647	ko01100	Metabolic pathways	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMC200030297	K01647	ko01110	Biosynthesis of secondary metabolites	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMC200030298	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMC200030298	K00591	ko01100	Metabolic pathways	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMC200030298	K00591	ko01110	Biosynthesis of secondary metabolites	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMC200030299	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMC200030299	K00591	ko01100	Metabolic pathways	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMC200030299	K00591	ko01110	Biosynthesis of secondary metabolites	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMC200030300	K04460	ko04010	MAPK signaling pathway	3754	3.2e-201	0.81	0.87	1.00
PGSC0003DMC200055298	K08342	ko04140	Regulation of autophagy	1608	7.4e-83	0.66	0.79	0.98
PGSC0003DMC200055299	K08342	ko04140	Regulation of autophagy	650	5.1e-30	0.50	0.62	0.85
PGSC0003DMC200055300	K08342	ko04140	Regulation of autophagy	2369	7.9e-125	0.61	0.73	0.98
PGSC0003DMC200055301	K08342	ko04140	Regulation of autophagy	2304	3.0e-121	0.57	0.69	0.98
PGSC0003DMC200055303	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMC200055303	K01938	ko00670	One carbon pool by folate	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMC200055303	K01938	ko01100	Metabolic pathways	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMC200055304	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMC200055304	K01938	ko00670	One carbon pool by folate	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMC200055304	K01938	ko01100	Metabolic pathways	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMC200055305	K00430	ko00360	Phenylalanine metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMC200055305	K00430	ko00680	Methane metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMC200055305	K00430	ko00940	Phenylpropanoid biosynthesis	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMC200055305	K00430	ko01100	Metabolic pathways	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMC200055305	K00430	ko01110	Biosynthesis of secondary metabolites	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMC200055314	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMC200055315	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMC200055320	K00208	ko00061	Fatty acid biosynthesis	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMC200055320	K00208	ko01100	Metabolic pathways	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMC200020292	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMC200020292	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMC200020292	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMC200020292	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMC200020292	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMC200020293	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMC200020293	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMC200020293	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMC200020293	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMC200020293	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMC200020296	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMC200020296	K05290	ko01100	Metabolic pathways	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMC200020297	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMC200020297	K05290	ko01100	Metabolic pathways	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMC200020301	K12843	ko03040	Spliceosome	4379	1.1e-235	0.75	0.85	0.99
PGSC0003DMC200020306	K02913	ko03010	Ribosome	332	1.8e-12	0.70	0.78	0.98
PGSC0003DMC200020308	K10581	ko04120	Ubiquitin mediated proteolysis	477	9.4e-20	0.28	0.39	0.63
PGSC0003DMC200011528	K13034	ko00270	Cysteine and methionine metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMC200011528	K13034	ko00450	Selenoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMC200011528	K13034	ko00460	Cyanoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMC200011528	K13034	ko00920	Sulfur metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMC200011528	K13034	ko01100	Metabolic pathways	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMC200011539	K00228	ko00860	Porphyrin and chlorophyll metabolism	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMC200011539	K00228	ko01100	Metabolic pathways	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMC200011542	K00423	ko00053	Ascorbate and aldarate metabolism	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMC200011542	K00423	ko01100	Metabolic pathways	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMC200011543	K01692	ko00071	Fatty acid metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00280	Valine, leucine and isoleucine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00281	Geraniol degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00310	Lysine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00380	Tryptophan metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00410	beta-Alanine metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00632	Benzoate degradation via CoA ligation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00640	Propanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00650	Butanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00903	Limonene and pinene degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko00930	Caprolactam degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko01100	Metabolic pathways	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011543	K01692	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMC200011544	K01692	ko00071	Fatty acid metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00281	Geraniol degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00310	Lysine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00380	Tryptophan metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00410	beta-Alanine metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00632	Benzoate degradation via CoA ligation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00640	Propanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00650	Butanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko00930	Caprolactam degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko01100	Metabolic pathways	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011544	K01692	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMC200011545	K01692	ko00071	Fatty acid metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00280	Valine, leucine and isoleucine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00281	Geraniol degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00310	Lysine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00380	Tryptophan metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00410	beta-Alanine metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00632	Benzoate degradation via CoA ligation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00640	Propanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00650	Butanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00903	Limonene and pinene degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko00930	Caprolactam degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko01100	Metabolic pathways	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200011545	K01692	ko01110	Biosynthesis of secondary metabolites	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMC200024101	K05849	ko04020	Calcium signaling pathway	409	2.7e-16	0.35	0.51	0.51
PGSC0003DMC200024105	K06685	ko04111	Cell cycle - yeast	372	6.5e-11	0.29	0.46	0.39
PGSC0003DMC200024107	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMC200024107	K00517	ko00626	Naphthalene and anthracene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMC200024107	K00517	ko00903	Limonene and pinene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMC200024107	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMC200024107	K00517	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMC200024110	K01246	ko03410	Base excision repair	2203	1.1e-115	0.67	0.78	1.00
PGSC0003DMC200024111	K01246	ko03410	Base excision repair	928	2.4e-45	0.58	0.68	0.88
PGSC0003DMC200024113	K02542	ko03030	DNA replication	5593	0.	0.77	0.86	1.00
PGSC0003DMC200024113	K02542	ko04110	Cell cycle	5593	0.	0.77	0.86	1.00
PGSC0003DMC200024113	K02542	ko04111	Cell cycle - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMC200024113	K02542	ko04113	Meiosis - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMC200024114	K02542	ko03030	DNA replication	5664	0.	0.80	0.89	1.00
PGSC0003DMC200024114	K02542	ko04110	Cell cycle	5664	0.	0.80	0.89	1.00
PGSC0003DMC200024114	K02542	ko04111	Cell cycle - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMC200024114	K02542	ko04113	Meiosis - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMC200024115	K01937	ko00240	Pyrimidine metabolism	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMC200024115	K01937	ko01100	Metabolic pathways	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMC200024116	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMC200024116	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMC200024117	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMC200024117	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMC200067217	K00412	ko00190	Oxidative phosphorylation	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067217	K00412	ko01100	Metabolic pathways	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067217	K00412	ko04260	Cardiac muscle contraction	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067217	K00412	ko05010	Alzheimer's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067217	K00412	ko05012	Parkinson's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067217	K00412	ko05016	Huntington's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMC200067221	K00797	ko00270	Cysteine and methionine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMC200067221	K00797	ko00330	Arginine and proline metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMC200067221	K00797	ko00410	beta-Alanine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMC200067221	K00797	ko00480	Glutathione metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMC200067221	K00797	ko01100	Metabolic pathways	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMC200031472	K11812	ko00380	Tryptophan metabolism	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMC200031472	K11812	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMC200031473	K13027	ko00460	Cyanoamino acid metabolism	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMC200031473	K13027	ko00966	Glucosinolate biosynthesis	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMC200031473	K13027	ko01100	Metabolic pathways	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMC200031473	K13027	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMC200031474	K12153	ko00966	Glucosinolate biosynthesis	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMC200031474	K12153	ko01110	Biosynthesis of secondary metabolites	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMC200031480	K13030	ko00460	Cyanoamino acid metabolism	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMC200031480	K13030	ko01110	Biosynthesis of secondary metabolites	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMC200031481	K13030	ko00460	Cyanoamino acid metabolism	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMC200031481	K13030	ko01110	Biosynthesis of secondary metabolites	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMC200031482	K05280	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMC200031482	K05280	ko00944	Flavone and flavonol biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMC200031482	K05280	ko01100	Metabolic pathways	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMC200031482	K05280	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMC200031483	K05280	ko00941	Flavonoid biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMC200031483	K05280	ko00944	Flavone and flavonol biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMC200031483	K05280	ko01100	Metabolic pathways	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMC200031483	K05280	ko01110	Biosynthesis of secondary metabolites	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMC200031484	K12929	ko00904	Diterpenoid biosynthesis	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMC200031484	K12929	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMC200031489	K02917	ko03010	Ribosome	430	7.0e-18	0.77	0.83	0.58
PGSC0003DMC200031500	K10712	ko00430	Taurine and hypotaurine metabolism	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMC200031500	K10712	ko01100	Metabolic pathways	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMC200050290	K00889	ko00562	Inositol phosphate metabolism	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050290	K00889	ko01100	Metabolic pathways	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050290	K00889	ko04070	Phosphatidylinositol signaling system	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050290	K00889	ko04144	Endocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050290	K00889	ko04666	Fc gamma R-mediated phagocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050290	K00889	ko04810	Regulation of actin cytoskeleton	9812	0.	0.65	0.75	1.00
PGSC0003DMC200050291	K00889	ko00562	Inositol phosphate metabolism	9925	0.	0.67	0.78	1.00
PGSC0003DMC200050291	K00889	ko01100	Metabolic pathways	9925	0.	0.67	0.78	1.00
PGSC0003DMC200050291	K00889	ko04070	Phosphatidylinositol signaling system	9925	0.	0.67	0.78	1.00
PGSC0003DMC200050291	K00889	ko04144	Endocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMC200050291	K00889	ko04666	Fc gamma R-mediated phagocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMC200050291	K00889	ko04810	Regulation of actin cytoskeleton	9925	0.	0.67	0.78	1.00
PGSC0003DMC200041521	K04077	ko03018	RNA degradation	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMC200041521	K04077	ko04940	Type I diabetes mellitus	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMC200041522	K04077	ko03018	RNA degradation	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMC200041522	K04077	ko04940	Type I diabetes mellitus	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMC200041529	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041529	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041529	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041529	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041530	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041530	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041530	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041530	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMC200041531	K12121	ko04712	Circadian rhythm - plant	8059	0.	0.84	0.92	0.99
PGSC0003DMC200041532	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMC200041532	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMC200041533	K04424	ko04010	MAPK signaling pathway	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMC200041533	K04424	ko04530	Tight junction	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMC200041534	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMC200041534	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMC200041535	K00430	ko00360	Phenylalanine metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMC200041535	K00430	ko00680	Methane metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMC200041535	K00430	ko00940	Phenylpropanoid biosynthesis	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMC200041535	K00430	ko01100	Metabolic pathways	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMC200041535	K00430	ko01110	Biosynthesis of secondary metabolites	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMC200041545	K11251	ko05322	Systemic lupus erythematosus	945	2.8e-46	0.85	0.88	0.99
PGSC0003DMC200041546	K08773	ko05200	Pathways in cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMC200041546	K08773	ko05212	Pancreatic cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMC200041547	K08773	ko05200	Pathways in cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMC200041547	K08773	ko05212	Pancreatic cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMC200054094	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMC200054095	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMC200054096	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMC200054097	K00654	ko00600	Sphingolipid metabolism	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMC200054097	K00654	ko01100	Metabolic pathways	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMC200054098	K00654	ko00600	Sphingolipid metabolism	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMC200054098	K00654	ko01100	Metabolic pathways	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMC200054101	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMC200054101	K00517	ko00626	Naphthalene and anthracene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMC200054101	K00517	ko00903	Limonene and pinene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMC200054101	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMC200054101	K00517	ko01110	Biosynthesis of secondary metabolites	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMC200054102	K00026	ko00020	Citrate cycle (TCA cycle)	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054102	K00026	ko00620	Pyruvate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054102	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054102	K00026	ko00710	Carbon fixation in photosynthetic organisms	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054102	K00026	ko01100	Metabolic pathways	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054102	K00026	ko01110	Biosynthesis of secondary metabolites	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMC200054103	K00026	ko00020	Citrate cycle (TCA cycle)	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054103	K00026	ko00620	Pyruvate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054103	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054103	K00026	ko00710	Carbon fixation in photosynthetic organisms	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054103	K00026	ko01100	Metabolic pathways	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054103	K00026	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMC200054104	K00423	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMC200054104	K00423	ko01100	Metabolic pathways	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMC200054108	K01728	ko00040	Pentose and glucuronate interconversions	2086	3.2e-109	0.65	0.80	0.93
PGSC0003DMC200054109	K01728	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.63	0.79	0.78
PGSC0003DMC200054110	K01373	ko04142	Lysosome	2119	4.9e-111	0.74	0.86	0.84
PGSC0003DMC200054115	K12929	ko00904	Diterpenoid biosynthesis	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMC200054115	K12929	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMC200054116	K12929	ko00904	Diterpenoid biosynthesis	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMC200054116	K12929	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMC200066004	K10760	ko00908	Zeatin biosynthesis	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMC200066004	K10760	ko01100	Metabolic pathways	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMC200066004	K10760	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMC200019088	K00036	ko00030	Pentose phosphate pathway	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMC200019088	K00036	ko00480	Glutathione metabolism	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMC200019088	K00036	ko01100	Metabolic pathways	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMC200019088	K00036	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMC200019089	K00036	ko00030	Pentose phosphate pathway	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMC200019089	K00036	ko00480	Glutathione metabolism	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMC200019089	K00036	ko01100	Metabolic pathways	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMC200019089	K00036	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMC200019090	K00036	ko00030	Pentose phosphate pathway	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMC200019090	K00036	ko00480	Glutathione metabolism	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMC200019090	K00036	ko01100	Metabolic pathways	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMC200019090	K00036	ko01110	Biosynthesis of secondary metabolites	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMC200019091	K00036	ko00030	Pentose phosphate pathway	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMC200019091	K00036	ko00480	Glutathione metabolism	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMC200019091	K00036	ko01100	Metabolic pathways	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMC200019091	K00036	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMC200019092	K00071	ko00140	Steroid hormone biosynthesis	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMC200019092	K00071	ko01100	Metabolic pathways	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMC200019092	K00071	ko04960	Aldosterone-regulated sodium reabsorption	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMC200019093	K00071	ko00140	Steroid hormone biosynthesis	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMC200019093	K00071	ko01100	Metabolic pathways	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMC200019093	K00071	ko04960	Aldosterone-regulated sodium reabsorption	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMC200019098	K01962	ko00061	Fatty acid biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019098	K01962	ko00253	Tetracycline biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019098	K01962	ko00620	Pyruvate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019098	K01962	ko00640	Propanoate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019098	K01962	ko01100	Metabolic pathways	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019098	K01962	ko01110	Biosynthesis of secondary metabolites	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMC200019101	K01051	ko00040	Pentose and glucuronate interconversions	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMC200019101	K01051	ko00500	Starch and sucrose metabolism	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMC200019101	K01051	ko01100	Metabolic pathways	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMC200019106	K13030	ko00460	Cyanoamino acid metabolism	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMC200019106	K13030	ko01110	Biosynthesis of secondary metabolites	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMC200019107	K01051	ko00040	Pentose and glucuronate interconversions	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMC200019107	K01051	ko00500	Starch and sucrose metabolism	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMC200019107	K01051	ko01100	Metabolic pathways	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMC200025294	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025294	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025294	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025297	K00795	ko00900	Terpenoid backbone biosynthesis	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMC200025297	K00795	ko01100	Metabolic pathways	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMC200025297	K00795	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMC200025298	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025298	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025298	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMC200025300	K06268	ko04010	MAPK signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04020	Calcium signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04114	Oocyte meiosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04210	Apoptosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04310	Wnt signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04360	Axon guidance	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04370	VEGF signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04650	Natural killer cell mediated cytotoxicity	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04660	T cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04662	B cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko04720	Long-term potentiation	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko05010	Alzheimer's disease	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025300	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMC200025301	K06268	ko04010	MAPK signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04020	Calcium signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04114	Oocyte meiosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04210	Apoptosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04310	Wnt signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04360	Axon guidance	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04370	VEGF signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04650	Natural killer cell mediated cytotoxicity	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04660	T cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04662	B cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko04720	Long-term potentiation	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko05010	Alzheimer's disease	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025301	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMC200025302	K06268	ko04010	MAPK signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04020	Calcium signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04114	Oocyte meiosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04210	Apoptosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04310	Wnt signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04360	Axon guidance	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04370	VEGF signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04650	Natural killer cell mediated cytotoxicity	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04660	T cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04662	B cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko04720	Long-term potentiation	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko05010	Alzheimer's disease	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025302	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMC200025307	K00876	ko00240	Pyrimidine metabolism	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMC200025307	K00876	ko00983	Drug metabolism - other enzymes	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMC200025307	K00876	ko01100	Metabolic pathways	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMC200025308	K00876	ko00240	Pyrimidine metabolism	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMC200025308	K00876	ko00983	Drug metabolism - other enzymes	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMC200025308	K00876	ko01100	Metabolic pathways	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMC200025309	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025309	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025309	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025310	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025310	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025310	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMC200025311	K03141	ko03022	Basal transcription factors	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMC200025311	K03141	ko03420	Nucleotide excision repair	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMC200025312	K03141	ko03022	Basal transcription factors	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMC200025312	K03141	ko03420	Nucleotide excision repair	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMC200025313	K03141	ko03022	Basal transcription factors	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMC200025313	K03141	ko03420	Nucleotide excision repair	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMC200025314	K03141	ko03022	Basal transcription factors	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMC200025314	K03141	ko03420	Nucleotide excision repair	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMC200025315	K12616	ko03018	RNA degradation	7363	0.	0.64	0.77	1.00
PGSC0003DMC200025319	K02946	ko03010	Ribosome	1035	3.0e-51	0.67	0.78	0.99
PGSC0003DMC200025320	K00640	ko00270	Cysteine and methionine metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMC200025320	K00640	ko00920	Sulfur metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMC200025320	K00640	ko01100	Metabolic pathways	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMC200051103	K13068	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.49	0.70	0.95
PGSC0003DMC200051104	K13068	ko00940	Phenylpropanoid biosynthesis	1770	8.6e-92	0.48	0.69	0.95
PGSC0003DMC200051105	K01076	ko00632	Benzoate degradation via CoA ligation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMC200051105	K01076	ko00903	Limonene and pinene degradation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMC200051105	K01076	ko01040	Biosynthesis of unsaturated fatty acids	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMC200051106	K11820	ko00380	Tryptophan metabolism	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMC200051106	K11820	ko00966	Glucosinolate biosynthesis	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMC200051106	K11820	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMC200051107	K11820	ko00380	Tryptophan metabolism	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMC200051107	K11820	ko00966	Glucosinolate biosynthesis	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMC200051107	K11820	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMC200051108	K13068	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.55	0.73	0.79
PGSC0003DMC200051109	K11820	ko00380	Tryptophan metabolism	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMC200051109	K11820	ko00966	Glucosinolate biosynthesis	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMC200051109	K11820	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMC200051110	K11820	ko00380	Tryptophan metabolism	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMC200051110	K11820	ko00966	Glucosinolate biosynthesis	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMC200051110	K11820	ko01110	Biosynthesis of secondary metabolites	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMC200051111	K11820	ko00380	Tryptophan metabolism	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMC200051111	K11820	ko00966	Glucosinolate biosynthesis	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMC200051111	K11820	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMC200051115	K07512	ko00062	Fatty acid elongation in mitochondria	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMC200051115	K07512	ko01100	Metabolic pathways	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMC200051117	K07512	ko00062	Fatty acid elongation in mitochondria	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMC200051117	K07512	ko01100	Metabolic pathways	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMC200051118	K07512	ko00062	Fatty acid elongation in mitochondria	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMC200051118	K07512	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMC200051120	K01184	ko00040	Pentose and glucuronate interconversions	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMC200051120	K01184	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMC200051120	K01184	ko01100	Metabolic pathways	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMC200033663	K10143	ko04115	p53 signaling pathway	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMC200033663	K10143	ko04120	Ubiquitin mediated proteolysis	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMC200033664	K10143	ko04115	p53 signaling pathway	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMC200033664	K10143	ko04120	Ubiquitin mediated proteolysis	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMC200033672	K10775	ko00360	Phenylalanine metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMC200033672	K10775	ko00910	Nitrogen metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMC200033672	K10775	ko00940	Phenylpropanoid biosynthesis	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMC200033672	K10775	ko01100	Metabolic pathways	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMC200033672	K10775	ko01110	Biosynthesis of secondary metabolites	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMC200059308	K03130	ko03022	Basal transcription factors	235	7.4e-07	0.26	0.49	0.37
PGSC0003DMC200001345	K00368	ko00910	Nitrogen metabolism	2161	2.3e-113	0.51	0.66	0.92
PGSC0003DMC200001350	K02942	ko03010	Ribosome	504	5.8e-22	0.60	0.74	0.96
PGSC0003DMC200014706	K10352	ko04530	Tight junction	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMC200014706	K10352	ko05416	Viral myocarditis	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMC200014714	K04424	ko04010	MAPK signaling pathway	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMC200014714	K04424	ko04530	Tight junction	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMC200014715	K04424	ko04010	MAPK signaling pathway	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMC200014715	K04424	ko04530	Tight junction	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMC200014716	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMC200014716	K04424	ko04530	Tight junction	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMC200014717	K04424	ko04010	MAPK signaling pathway	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMC200014717	K04424	ko04530	Tight junction	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMC200014719	K12183	ko04144	Endocytosis	2365	1.3e-124	0.69	0.81	0.99
PGSC0003DMC200014720	K01692	ko00071	Fatty acid metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00280	Valine, leucine and isoleucine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00281	Geraniol degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00310	Lysine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00380	Tryptophan metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00410	beta-Alanine metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00632	Benzoate degradation via CoA ligation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00640	Propanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00650	Butanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00903	Limonene and pinene degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko00930	Caprolactam degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko01100	Metabolic pathways	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014720	K01692	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMC200014721	K01193	ko00052	Galactose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMC200014721	K01193	ko00500	Starch and sucrose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMC200014721	K01193	ko01100	Metabolic pathways	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMC200022299	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMC200022299	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMC200022299	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMC200022299	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMC200022299	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMC200022300	K08917	ko00196	Photosynthesis - antenna proteins	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMC200022300	K08917	ko01100	Metabolic pathways	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMC200022301	K08917	ko00196	Photosynthesis - antenna proteins	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMC200022301	K08917	ko01100	Metabolic pathways	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMC200022318	K12741	ko03040	Spliceosome	1347	1.8e-68	0.50	0.57	0.94
PGSC0003DMC200022319	K12741	ko03040	Spliceosome	2122	3.3e-111	0.67	0.78	0.95
PGSC0003DMC200004866	K00700	ko00500	Starch and sucrose metabolism	5670	0.	0.75	0.84	0.98
PGSC0003DMC200004866	K00700	ko01100	Metabolic pathways	5670	0.	0.75	0.84	0.98
PGSC0003DMC200004880	K04424	ko04010	MAPK signaling pathway	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMC200004880	K04424	ko04530	Tight junction	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMC200004881	K04424	ko04010	MAPK signaling pathway	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMC200004881	K04424	ko04530	Tight junction	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMC200004883	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.68
PGSC0003DMC200004885	K10773	ko03410	Base excision repair	2136	5.6e-112	0.43	0.57	0.77
PGSC0003DMC200004886	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.70
PGSC0003DMC200004887	K00222	ko00100	Steroid biosynthesis	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMC200004887	K00222	ko01100	Metabolic pathways	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMC200004887	K00222	ko01110	Biosynthesis of secondary metabolites	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMC200004888	K00222	ko00100	Steroid biosynthesis	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMC200004888	K00222	ko01100	Metabolic pathways	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMC200004888	K00222	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMC200004889	K00222	ko00100	Steroid biosynthesis	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMC200004889	K00222	ko01100	Metabolic pathways	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMC200004889	K00222	ko01110	Biosynthesis of secondary metabolites	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMC200004890	K00222	ko00100	Steroid biosynthesis	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMC200004890	K00222	ko01100	Metabolic pathways	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMC200004890	K00222	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMC200028086	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMC200028086	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMC200028087	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMC200028087	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMC200028097	K02894	ko03010	Ribosome	499	1.1e-21	0.91	0.94	0.98
PGSC0003DMC200028102	K12602	ko03018	RNA degradation	1946	1.7e-101	0.70	0.84	1.00
PGSC0003DMC200028104	K02861	ko04210	Apoptosis	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMC200028104	K02861	ko04620	Toll-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMC200028104	K02861	ko04622	RIG-I-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMC200028104	K02861	ko04623	Cytosolic DNA-sensing pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMC200017341	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMC200017342	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMC200017350	K12929	ko00904	Diterpenoid biosynthesis	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMC200017350	K12929	ko01110	Biosynthesis of secondary metabolites	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMC200017351	K12929	ko00904	Diterpenoid biosynthesis	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMC200017351	K12929	ko01110	Biosynthesis of secondary metabolites	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMC200017352	K11813	ko00380	Tryptophan metabolism	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMC200017352	K11813	ko00966	Glucosinolate biosynthesis	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMC200017353	K12153	ko00966	Glucosinolate biosynthesis	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMC200017353	K12153	ko01110	Biosynthesis of secondary metabolites	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMC200017354	K12153	ko00966	Glucosinolate biosynthesis	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMC200017354	K12153	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMC200017356	K02908	ko03010	Ribosome	878	1.4e-42	0.90	0.98	0.99
PGSC0003DMC200017357	K02908	ko03010	Ribosome	886	4.9e-43	0.91	0.98	0.99
PGSC0003DMC200017359	K01835	ko00010	Glycolysis / Gluconeogenesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00030	Pentose phosphate pathway	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00052	Galactose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00230	Purine metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00500	Starch and sucrose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko00521	Streptomycin biosynthesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko01100	Metabolic pathways	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017359	K01835	ko01110	Biosynthesis of secondary metabolites	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMC200017361	K10577	ko04120	Ubiquitin mediated proteolysis	905	4.4e-44	0.88	0.94	0.97
PGSC0003DMC200017362	K10577	ko04120	Ubiquitin mediated proteolysis	449	6.3e-19	0.94	0.98	0.50
PGSC0003DMC200017363	K10577	ko04120	Ubiquitin mediated proteolysis	901	7.4e-44	0.90	0.95	0.78
PGSC0003DMC200017367	K01810	ko00010	Glycolysis / Gluconeogenesis	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200017367	K01810	ko00030	Pentose phosphate pathway	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200017367	K01810	ko00500	Starch and sucrose metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200017367	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200017367	K01810	ko01100	Metabolic pathways	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200017367	K01810	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMC200004021	K12489	ko04144	Endocytosis	5562	6.1e-301	0.80	0.89	1.00
PGSC0003DMC200004023	K04733	ko04210	Apoptosis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMC200004023	K04733	ko04620	Toll-like receptor signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMC200004023	K04733	ko04722	Neurotrophin signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMC200004023	K04733	ko05140	Leishmaniasis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMC200004023	K04733	ko05142	Chagas disease	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMC200021335	K12824	ko03040	Spliceosome	483	2.5e-18	0.30	0.39	0.57
PGSC0003DMC200021338	K03260	ko05416	Viral myocarditis	313	2.4e-08	0.27	0.43	0.92
PGSC0003DMC200021343	K13030	ko00460	Cyanoamino acid metabolism	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMC200021343	K13030	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMC200021348	K06199	ko01100	Metabolic pathways	220	2.7e-06	0.35	0.51	0.42
PGSC0003DMC200021351	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMC200021352	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMC200021353	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMC200021354	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMC200026642	K01493	ko00240	Pyrimidine metabolism	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMC200026642	K01493	ko01100	Metabolic pathways	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMC200026643	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMC200026643	K00517	ko00626	Naphthalene and anthracene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMC200026643	K00517	ko00903	Limonene and pinene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMC200026643	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMC200026643	K00517	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMC200026644	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMC200026644	K00517	ko00626	Naphthalene and anthracene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMC200026644	K00517	ko00903	Limonene and pinene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMC200026644	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMC200026644	K00517	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMC200026645	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMC200026645	K00517	ko00626	Naphthalene and anthracene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMC200026645	K00517	ko00903	Limonene and pinene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMC200026645	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMC200026645	K00517	ko01110	Biosynthesis of secondary metabolites	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMC200026647	K00939	ko00230	Purine metabolism	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMC200026647	K00939	ko01100	Metabolic pathways	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMC200026647	K00939	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMC200026651	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMC200026651	K01904	ko00360	Phenylalanine metabolism	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMC200026651	K01904	ko00940	Phenylpropanoid biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMC200026651	K01904	ko01100	Metabolic pathways	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMC200026651	K01904	ko01110	Biosynthesis of secondary metabolites	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMC200026653	K01638	ko00620	Pyruvate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMC200026653	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMC200026653	K01638	ko01100	Metabolic pathways	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMC200026654	K01638	ko00620	Pyruvate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMC200026654	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMC200026654	K01638	ko01100	Metabolic pathways	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMC200026655	K01638	ko00620	Pyruvate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMC200026655	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMC200026655	K01638	ko01100	Metabolic pathways	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMC200026656	K01638	ko00620	Pyruvate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMC200026656	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMC200026656	K01638	ko01100	Metabolic pathways	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMC200026669	K07342	ko03060	Protein export	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMC200026669	K07342	ko04145	Phagosome	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMC200026669	K07342	ko05110	Vibrio cholerae infection	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMC200028814	K00423	ko00053	Ascorbate and aldarate metabolism	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMC200028814	K00423	ko01100	Metabolic pathways	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMC200028815	K00423	ko00053	Ascorbate and aldarate metabolism	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMC200028815	K00423	ko01100	Metabolic pathways	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMC200028816	K01199	ko00500	Starch and sucrose metabolism	699	1.0e-32	0.31	0.52	0.67
PGSC0003DMC200028820	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMC200028820	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMC200028821	K08341	ko04140	Regulation of autophagy	927	2.7e-45	0.91	0.98	0.94
PGSC0003DMC200028823	K00703	ko00500	Starch and sucrose metabolism	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMC200028823	K00703	ko01100	Metabolic pathways	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMC200028824	K00703	ko00500	Starch and sucrose metabolism	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMC200028824	K00703	ko01100	Metabolic pathways	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMC200028825	K02115	ko00190	Oxidative phosphorylation	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMC200028825	K02115	ko00195	Photosynthesis	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMC200028825	K02115	ko01100	Metabolic pathways	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMC200028826	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMC200028827	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMC200009211	K03137	ko03022	Basal transcription factors	1921	4.1e-100	0.83	0.90	0.99
PGSC0003DMC200009215	K03110	ko03060	Protein export	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMC200009215	K03110	ko03070	Bacterial secretion system	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMC200009220	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMC200009227	K09753	ko00940	Phenylpropanoid biosynthesis	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMC200009227	K09753	ko01100	Metabolic pathways	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMC200009227	K09753	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMC200009228	K09753	ko00940	Phenylpropanoid biosynthesis	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMC200009228	K09753	ko01100	Metabolic pathways	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMC200009228	K09753	ko01110	Biosynthesis of secondary metabolites	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMC200009229	K08341	ko04140	Regulation of autophagy	582	2.9e-26	0.59	0.77	0.97
PGSC0003DMC200009230	K02977	ko03010	Ribosome	1314	1.2e-66	0.99	0.99	0.99
PGSC0003DMC200000362	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2576	3.0e-136	0.70	0.85	1.00
PGSC0003DMC200000363	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2469	2.4e-130	0.70	0.86	0.99
PGSC0003DMC200000365	K11086	ko03040	Spliceosome	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMC200000365	K11086	ko05322	Systemic lupus erythematosus	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMC200000366	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMC200000367	K01177	ko00500	Starch and sucrose metabolism	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMC200000367	K01177	ko01100	Metabolic pathways	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMC200000368	K01177	ko00500	Starch and sucrose metabolism	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMC200000368	K01177	ko01100	Metabolic pathways	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMC200000377	K02607	ko04110	Cell cycle	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMC200000377	K02607	ko04111	Cell cycle - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMC200000377	K02607	ko04113	Meiosis - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMC200000381	K10576	ko04120	Ubiquitin mediated proteolysis	286	6.1e-10	0.78	0.89	0.81
PGSC0003DMC200000382	K10576	ko04120	Ubiquitin mediated proteolysis	1478	1.1e-75	0.91	0.96	0.99
PGSC0003DMC200000383	K10576	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.90	0.96	0.99
PGSC0003DMC200063562	K12796	ko04621	NOD-like receptor signaling pathway	353	2.7e-10	0.33	0.51	0.32
PGSC0003DMC200044593	K02180	ko04110	Cell cycle	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMC200044593	K02180	ko04111	Cell cycle - yeast	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMC200044607	K11422	ko00310	Lysine degradation	413	7.8e-16	0.33	0.43	0.92
PGSC0003DMC200035225	K00036	ko00030	Pentose phosphate pathway	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMC200035225	K00036	ko00480	Glutathione metabolism	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMC200035225	K00036	ko01100	Metabolic pathways	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMC200035225	K00036	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMC200035243	K03575	ko03410	Base excision repair	2302	3.9e-121	0.65	0.79	0.92
PGSC0003DMC200052538	K10872	ko04113	Meiosis - yeast	2474	1.3e-130	0.95	0.98	0.92
PGSC0003DMC200052554	K01728	ko00040	Pentose and glucuronate interconversions	2407	6.3e-127	0.83	0.92	0.97
PGSC0003DMC200052555	K01728	ko00040	Pentose and glucuronate interconversions	338	8.3e-13	0.64	0.82	0.84
PGSC0003DMC200052556	K01054	ko00561	Glycerolipid metabolism	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMC200052556	K01054	ko01100	Metabolic pathways	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMC200052557	K01054	ko00561	Glycerolipid metabolism	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMC200052557	K01054	ko01100	Metabolic pathways	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMC200052558	K03075	ko03060	Protein export	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMC200052558	K03075	ko03070	Bacterial secretion system	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMC200052559	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMC200052559	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMC200052559	K00771	ko01100	Metabolic pathways	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMC200040415	K11584	ko04113	Meiosis - yeast	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMC200040415	K11584	ko04114	Oocyte meiosis	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMC200040415	K11584	ko04310	Wnt signaling pathway	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMC200040423	K11252	ko05322	Systemic lupus erythematosus	1143	3.3e-57	0.95	0.97	0.99
PGSC0003DMC200040426	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMC200040426	K02367	ko01100	Metabolic pathways	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMC200040433	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMC200040433	K00517	ko00626	Naphthalene and anthracene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMC200040433	K00517	ko00903	Limonene and pinene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMC200040433	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMC200040433	K00517	ko01110	Biosynthesis of secondary metabolites	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMC200019801	K03260	ko05416	Viral myocarditis	2361	2.2e-124	0.48	0.63	0.88
PGSC0003DMC200019802	K03283	ko03040	Spliceosome	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMC200019802	K03283	ko04010	MAPK signaling pathway	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMC200019802	K03283	ko04144	Endocytosis	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMC200019802	K03283	ko04612	Antigen processing and presentation	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMC200019817	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMC200019817	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMC200019817	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMC200019818	K10754	ko03030	DNA replication	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMC200019818	K10754	ko03420	Nucleotide excision repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMC200019818	K10754	ko03430	Mismatch repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMC200019819	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMC200019819	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMC200019819	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMC200019820	K10754	ko03030	DNA replication	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMC200019820	K10754	ko03420	Nucleotide excision repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMC200019820	K10754	ko03430	Mismatch repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMC200019827	K02144	ko00190	Oxidative phosphorylation	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019827	K02144	ko01100	Metabolic pathways	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019827	K02144	ko04142	Lysosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019827	K02144	ko04145	Phagosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019827	K02144	ko05110	Vibrio cholerae infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019827	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMC200019828	K02144	ko00190	Oxidative phosphorylation	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019828	K02144	ko01100	Metabolic pathways	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019828	K02144	ko04142	Lysosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019828	K02144	ko04145	Phagosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019828	K02144	ko05110	Vibrio cholerae infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019828	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMC200019829	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019829	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019829	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019829	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019829	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019829	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200019830	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMC200011779	K01126	ko00564	Glycerophospholipid metabolism	446	9.2e-19	0.29	0.53	0.88
PGSC0003DMC200011780	K01126	ko00564	Glycerophospholipid metabolism	302	1.8e-10	0.29	0.52	0.89
PGSC0003DMC200011781	K01126	ko00564	Glycerophospholipid metabolism	269	1.4e-08	0.27	0.54	0.90
PGSC0003DMC200023641	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.97
PGSC0003DMC200023642	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.98
PGSC0003DMC200024332	K12130	ko04712	Circadian rhythm - plant	266	2.3e-08	0.31	0.49	0.79
PGSC0003DMC200024333	K12130	ko04712	Circadian rhythm - plant	282	2.0e-07	0.27	0.47	0.77
PGSC0003DMC200024340	K10739	ko03030	DNA replication	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMC200024340	K10739	ko03420	Nucleotide excision repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMC200024340	K10739	ko03430	Mismatch repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMC200024340	K10739	ko03440	Homologous recombination	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMC200024345	K06085	ko04520	Adherens junction	527	3.1e-23	0.29	0.52	0.92
PGSC0003DMC200024360	K04733	ko04210	Apoptosis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMC200024360	K04733	ko04620	Toll-like receptor signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMC200024360	K04733	ko04722	Neurotrophin signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMC200024360	K04733	ko05140	Leishmaniasis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMC200024360	K04733	ko05142	Chagas disease	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMC200067689	K07466	ko03030	DNA replication	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMC200067689	K07466	ko03420	Nucleotide excision repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMC200067689	K07466	ko03430	Mismatch repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMC200067689	K07466	ko03440	Homologous recombination	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMC200067707	K02183	ko04020	Calcium signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04070	Phosphatidylinositol signaling system	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04114	Oocyte meiosis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04270	Vascular smooth muscle contraction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04626	Plant-pathogen interaction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04720	Long-term potentiation	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04722	Neurotrophin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04740	Olfactory transduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04744	Phototransduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04745	Phototransduction - fly	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04910	Insulin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04912	GnRH signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04916	Melanogenesis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04970	Salivary secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko04971	Gastric acid secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko05010	Alzheimer's disease	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200067707	K02183	ko05214	Glioma	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMC200065445	K10760	ko00908	Zeatin biosynthesis	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMC200065445	K10760	ko01100	Metabolic pathways	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMC200065445	K10760	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMC200065460	K00650	ko00564	Glycerophospholipid metabolism	266	9.1e-09	0.27	0.45	0.88
PGSC0003DMC200002613	K00754	ko00051	Fructose and mannose metabolism	674	2.4e-31	0.51	0.67	0.95
PGSC0003DMC200002614	K00754	ko00051	Fructose and mannose metabolism	1413	4.2e-72	0.42	0.59	0.83
PGSC0003DMC200002620	K00012	ko00040	Pentose and glucuronate interconversions	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002620	K00012	ko00053	Ascorbate and aldarate metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002620	K00012	ko00500	Starch and sucrose metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002620	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002620	K00012	ko01100	Metabolic pathways	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002620	K00012	ko01110	Biosynthesis of secondary metabolites	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMC200002624	K13068	ko00940	Phenylpropanoid biosynthesis	833	4.1e-40	0.31	0.53	0.98
PGSC0003DMC200002625	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.35
PGSC0003DMC200002626	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.67
PGSC0003DMC200002636	K12741	ko03040	Spliceosome	659	1.6e-30	0.41	0.56	0.86
PGSC0003DMC200002637	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMC200002638	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMC200048606	K01066	ko00623	2,4-Dichlorobenzoate degradation	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMC200048606	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMC200048609	K05282	ko00904	Diterpenoid biosynthesis	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMC200048609	K05282	ko01100	Metabolic pathways	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMC200048609	K05282	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMC200048615	K03660	ko03410	Base excision repair	951	1.3e-46	0.55	0.71	0.72
PGSC0003DMC200048624	K03876	ko04120	Ubiquitin mediated proteolysis	254	3.6e-08	0.31	0.56	0.74
PGSC0003DMC200048628	K02085	ko04310	Wnt signaling pathway	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048628	K02085	ko04810	Regulation of actin cytoskeleton	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048628	K02085	ko05200	Pathways in cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048628	K02085	ko05210	Colorectal cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048628	K02085	ko05213	Endometrial cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048628	K02085	ko05217	Basal cell carcinoma	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMC200048629	K02085	ko04310	Wnt signaling pathway	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200048629	K02085	ko04810	Regulation of actin cytoskeleton	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200048629	K02085	ko05200	Pathways in cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200048629	K02085	ko05210	Colorectal cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200048629	K02085	ko05213	Endometrial cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200048629	K02085	ko05217	Basal cell carcinoma	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMC200030151	K12356	ko00940	Phenylpropanoid biosynthesis	615	4.4e-28	0.33	0.50	0.96
PGSC0003DMC200030152	K12356	ko00940	Phenylpropanoid biosynthesis	357	7.4e-14	0.42	0.65	0.91
PGSC0003DMC200030155	K08504	ko04130	SNARE interactions in vesicular transport	530	2.1e-23	0.65	0.88	0.80
PGSC0003DMC200030156	K08504	ko04130	SNARE interactions in vesicular transport	741	4.9e-35	0.65	0.86	0.96
PGSC0003DMC200030162	K02706	ko00195	Photosynthesis	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMC200030162	K02706	ko01100	Metabolic pathways	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMC200055532	K12842	ko03040	Spliceosome	383	1.4e-14	0.55	0.65	0.69
PGSC0003DMC200055552	K00423	ko00053	Ascorbate and aldarate metabolism	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMC200055552	K00423	ko01100	Metabolic pathways	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMC200055553	K12356	ko00940	Phenylpropanoid biosynthesis	646	8.5e-30	0.34	0.53	0.93
PGSC0003DMC200055554	K12356	ko00940	Phenylpropanoid biosynthesis	653	3.5e-30	0.32	0.52	0.74
PGSC0003DMC200018602	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMC200018603	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMC200018604	K11752	ko00740	Riboflavin metabolism	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMC200018604	K11752	ko01100	Metabolic pathways	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMC200018605	K11752	ko00740	Riboflavin metabolism	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMC200018605	K11752	ko01100	Metabolic pathways	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMC200018606	K11752	ko00740	Riboflavin metabolism	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMC200018606	K11752	ko01100	Metabolic pathways	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMC200018616	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMC200018616	K00517	ko00626	Naphthalene and anthracene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMC200018616	K00517	ko00903	Limonene and pinene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMC200018616	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMC200018616	K00517	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMC200018617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMC200018617	K00517	ko00626	Naphthalene and anthracene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMC200018617	K00517	ko00903	Limonene and pinene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMC200018617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMC200018617	K00517	ko01110	Biosynthesis of secondary metabolites	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMC200018619	K06685	ko04111	Cell cycle - yeast	291	1.4e-06	0.33	0.55	0.19
PGSC0003DMC200025531	K10144	ko04115	p53 signaling pathway	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMC200025531	K10144	ko04120	Ubiquitin mediated proteolysis	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMC200025532	K10144	ko04115	p53 signaling pathway	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMC200025532	K10144	ko04120	Ubiquitin mediated proteolysis	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMC200025542	K00128	ko00010	Glycolysis / Gluconeogenesis	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00053	Ascorbate and aldarate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00071	Fatty acid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00280	Valine, leucine and isoleucine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00310	Lysine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00330	Arginine and proline metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00340	Histidine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00380	Tryptophan metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00410	beta-Alanine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00561	Glycerolipid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00620	Pyruvate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00631	1,2-Dichloroethane degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00640	Propanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00641	3-Chloroacrylic acid degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00650	Butanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko00903	Limonene and pinene degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko01100	Metabolic pathways	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025542	K00128	ko01110	Biosynthesis of secondary metabolites	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMC200025543	K12401	ko04142	Lysosome	1726	2.3e-89	0.39	0.60	0.79
PGSC0003DMC200025546	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.97
PGSC0003DMC200025547	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.76
PGSC0003DMC200025548	K02899	ko03010	Ribosome	584	2.2e-26	0.86	0.91	0.95
PGSC0003DMC200025549	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMC200025549	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMC200025549	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMC200025549	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMC200025549	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMC200025551	K11294	ko05130	Pathogenic Escherichia coli infection	246	2.3e-07	0.27	0.43	0.86
PGSC0003DMC200025554	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.5e-08	0.29	0.47	0.92
PGSC0003DMC200025555	K08490	ko04130	SNARE interactions in vesicular transport	2314	8.5e-122	0.82	0.90	1.00
PGSC0003DMC200031354	K13065	ko00940	Phenylpropanoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMC200031354	K13065	ko00941	Flavonoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMC200031354	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMC200031354	K13065	ko01110	Biosynthesis of secondary metabolites	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMC200031355	K13065	ko00940	Phenylpropanoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMC200031355	K13065	ko00941	Flavonoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMC200031355	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMC200031355	K13065	ko01110	Biosynthesis of secondary metabolites	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMC200031356	K02895	ko03010	Ribosome	396	5.2e-16	0.52	0.71	0.61
PGSC0003DMC200031357	K13065	ko00940	Phenylpropanoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMC200031357	K13065	ko00941	Flavonoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMC200031357	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMC200031357	K13065	ko01110	Biosynthesis of secondary metabolites	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMC200031358	K08334	ko04140	Regulation of autophagy	2565	1.2e-135	0.80	0.90	0.99
PGSC0003DMC200031359	K08334	ko04140	Regulation of autophagy	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMC200031360	K08334	ko04140	Regulation of autophagy	3625	4.2e-194	0.81	0.90	1.00
PGSC0003DMC200031361	K05391	ko04626	Plant-pathogen interaction	2665	3.7e-141	0.64	0.79	0.99
PGSC0003DMC200031362	K05391	ko04626	Plant-pathogen interaction	3638	8.1e-195	0.61	0.77	0.99
PGSC0003DMC200031363	K05391	ko04626	Plant-pathogen interaction	3182	1.1e-169	0.56	0.71	0.99
PGSC0003DMC200031364	K05391	ko04626	Plant-pathogen interaction	2241	9.1e-118	0.66	0.82	0.99
PGSC0003DMC200031365	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMC200031366	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMC200031367	K05391	ko04626	Plant-pathogen interaction	1919	5.2e-100	0.61	0.79	0.85
PGSC0003DMC200031368	K05391	ko04626	Plant-pathogen interaction	513	1.8e-22	0.42	0.57	0.93
PGSC0003DMC200031369	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMC200031370	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMC200031371	K05391	ko04626	Plant-pathogen interaction	2823	7.2e-150	0.66	0.81	0.99
PGSC0003DMC200031372	K05391	ko04626	Plant-pathogen interaction	1819	1.7e-94	0.69	0.87	0.99
PGSC0003DMC200031373	K05391	ko04626	Plant-pathogen interaction	1670	2.8e-86	0.60	0.78	0.99
PGSC0003DMC200031374	K05391	ko04626	Plant-pathogen interaction	557	6.9e-25	0.42	0.59	0.97
PGSC0003DMC200031376	K03108	ko03060	Protein export	1014	4.3e-50	0.60	0.76	0.95
PGSC0003DMC200031377	K05277	ko00941	Flavonoid biosynthesis	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMC200031377	K05277	ko01100	Metabolic pathways	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMC200031377	K05277	ko01110	Biosynthesis of secondary metabolites	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMC200031379	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMC200031379	K00517	ko00626	Naphthalene and anthracene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMC200031379	K00517	ko00903	Limonene and pinene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMC200031379	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMC200031379	K00517	ko01110	Biosynthesis of secondary metabolites	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMC200031380	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMC200031380	K00517	ko00626	Naphthalene and anthracene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMC200031380	K00517	ko00903	Limonene and pinene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMC200031380	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMC200031380	K00517	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMC200049803	K00215	ko00300	Lysine biosynthesis	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMC200049803	K00215	ko01100	Metabolic pathways	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMC200049803	K00215	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMC200049804	K00215	ko00300	Lysine biosynthesis	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMC200049804	K00215	ko01100	Metabolic pathways	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMC200049804	K00215	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMC200049806	K11232	ko04011	MAPK signaling pathway - yeast	210	9.5e-06	0.33	0.52	0.79
PGSC0003DMC200049816	K01937	ko00240	Pyrimidine metabolism	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMC200049816	K01937	ko01100	Metabolic pathways	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMC200049818	K08739	ko03430	Mismatch repair	281	1.0e-08	0.65	0.87	0.74
PGSC0003DMC200049819	K01920	ko00480	Glutathione metabolism	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMC200049819	K01920	ko01100	Metabolic pathways	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMC200049820	K01920	ko00480	Glutathione metabolism	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMC200049820	K01920	ko01100	Metabolic pathways	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMC200049821	K01920	ko00480	Glutathione metabolism	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMC200049821	K01920	ko01100	Metabolic pathways	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMC200041767	K01704	ko00290	Valine, leucine and isoleucine biosynthesis	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMC200041767	K01704	ko00660	C5-Branched dibasic acid metabolism	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMC200041767	K01704	ko01100	Metabolic pathways	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMC200041767	K01704	ko01110	Biosynthesis of secondary metabolites	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMC200041780	K00492	ko00340	Histidine metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00363	Bisphenol A degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00622	Toluene and xylene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00624	1- and 2-Methylnaphthalene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00626	Naphthalene and anthracene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00627	1,4-Dichlorobenzene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00680	Methane metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko00903	Limonene and pinene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko01100	Metabolic pathways	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041780	K00492	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMC200041781	K00480	ko00624	1- and 2-Methylnaphthalene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMC200041781	K00480	ko00626	Naphthalene and anthracene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMC200041781	K00480	ko00628	Fluorene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMC200041781	K00480	ko01100	Metabolic pathways	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMC200041790	K04952	ko04740	Olfactory transduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMC200041790	K04952	ko04744	Phototransduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMC200053650	K02981	ko03010	Ribosome	1791	6.0e-93	0.80	0.84	1.00
PGSC0003DMC200053651	K02981	ko03010	Ribosome	1285	4.9e-65	0.90	0.93	0.84
PGSC0003DMC200053654	K13030	ko00460	Cyanoamino acid metabolism	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMC200053654	K13030	ko01110	Biosynthesis of secondary metabolites	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMC200053655	K13030	ko00460	Cyanoamino acid metabolism	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMC200053655	K13030	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMC200053656	K13068	ko00940	Phenylpropanoid biosynthesis	426	1.2e-17	0.46	0.60	0.83
PGSC0003DMC200053657	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMC200053658	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMC200053659	K13030	ko00460	Cyanoamino acid metabolism	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMC200053659	K13030	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMC200053664	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMC200053664	K01626	ko01100	Metabolic pathways	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMC200053664	K01626	ko01110	Biosynthesis of secondary metabolites	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMC200053669	K06630	ko04110	Cell cycle	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMC200053669	K06630	ko04114	Oocyte meiosis	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMC200053669	K06630	ko04722	Neurotrophin signaling pathway	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMC200053670	K00121	ko00010	Glycolysis / Gluconeogenesis	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00071	Fatty acid metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00350	Tyrosine metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00641	3-Chloroacrylic acid degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00680	Methane metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00830	Retinol metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko00982	Drug metabolism - cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko01100	Metabolic pathways	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200053670	K00121	ko01110	Biosynthesis of secondary metabolites	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMC200054334	K08233	ko00901	Indole alkaloid biosynthesis	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMC200054334	K08233	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMC200054335	K08233	ko00901	Indole alkaloid biosynthesis	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMC200054335	K08233	ko01110	Biosynthesis of secondary metabolites	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMC200054337	K01199	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.35	0.58	0.59
PGSC0003DMC200054338	K01199	ko00500	Starch and sucrose metabolism	289	4.2e-10	0.37	0.64	0.54
PGSC0003DMC200064744	K02878	ko03010	Ribosome	379	4.5e-15	0.51	0.76	0.74
PGSC0003DMC200001572	K13081	ko00941	Flavonoid biosynthesis	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMC200001572	K13081	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMC200001574	K00754	ko00051	Fructose and mannose metabolism	423	1.7e-17	0.27	0.47	0.81
PGSC0003DMC200001587	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMC200001588	K12874	ko03040	Spliceosome	2078	8.9e-109	0.66	0.74	1.00
PGSC0003DMC200001589	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMC200014585	K09647	ko03060	Protein export	837	2.5e-40	0.64	0.80	0.94
PGSC0003DMC200014586	K09647	ko03060	Protein export	863	9.2e-42	0.59	0.77	0.99
PGSC0003DMC200014590	K00703	ko00500	Starch and sucrose metabolism	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMC200014590	K00703	ko01100	Metabolic pathways	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMC200014600	K03107	ko03060	Protein export	3995	1.6e-214	0.80	0.91	0.98
PGSC0003DMC200022531	K00279	ko00908	Zeatin biosynthesis	2036	1.8e-106	0.67	0.82	0.91
PGSC0003DMC200022539	K01001	ko00510	N-Glycan biosynthesis	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMC200022539	K01001	ko01100	Metabolic pathways	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMC200022541	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMC200022542	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMC200022543	K01142	ko03410	Base excision repair	808	9.9e-39	0.42	0.60	0.96
PGSC0003DMC200022547	K01930	ko00790	Folate biosynthesis	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMC200022547	K01930	ko01100	Metabolic pathways	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMC200022548	K01930	ko00790	Folate biosynthesis	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMC200022548	K01930	ko01100	Metabolic pathways	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMC200022549	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMC200022549	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMC200022550	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMC200022550	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMC200022551	K01930	ko00790	Folate biosynthesis	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMC200022551	K01930	ko01100	Metabolic pathways	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMC200022552	K01930	ko00790	Folate biosynthesis	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMC200022552	K01930	ko01100	Metabolic pathways	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMC200022553	K13030	ko00460	Cyanoamino acid metabolism	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMC200022553	K13030	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMC200005223	K01051	ko00040	Pentose and glucuronate interconversions	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMC200005223	K01051	ko00500	Starch and sucrose metabolism	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMC200005223	K01051	ko01100	Metabolic pathways	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMC200005227	K08908	ko00196	Photosynthesis - antenna proteins	1717	7.2e-89	0.75	0.82	1.00
PGSC0003DMC200005228	K08908	ko00196	Photosynthesis - antenna proteins	1130	1.7e-56	0.81	0.88	0.99
PGSC0003DMC200005232	K02730	ko03050	Proteasome	1922	3.6e-100	0.91	0.98	1.00
PGSC0003DMC200005233	K02634	ko00195	Photosynthesis	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMC200005233	K02634	ko01100	Metabolic pathways	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMC200005244	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	464	5.4e-19	0.30	0.47	1.00
PGSC0003DMC200027607	K12338	ko00942	Anthocyanin biosynthesis	1378	3.6e-70	0.41	0.62	0.98
PGSC0003DMC200027608	K00600	ko00260	Glycine, serine and threonine metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027608	K00600	ko00460	Cyanoamino acid metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027608	K00600	ko00670	One carbon pool by folate	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027608	K00600	ko00680	Methane metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027608	K00600	ko01100	Metabolic pathways	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027608	K00600	ko01110	Biosynthesis of secondary metabolites	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMC200027609	K08679	ko00500	Starch and sucrose metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMC200027609	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMC200027609	K08679	ko01100	Metabolic pathways	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMC200027610	K11984	ko03040	Spliceosome	509	1.5e-21	0.28	0.48	0.83
PGSC0003DMC200027611	K11984	ko03040	Spliceosome	508	1.7e-21	0.30	0.51	0.78
PGSC0003DMC200027612	K04711	ko00600	Sphingolipid metabolism	1519	6.0e-78	0.69	0.78	1.00
PGSC0003DMC200027613	K04711	ko00600	Sphingolipid metabolism	1728	1.8e-89	0.76	0.87	1.00
PGSC0003DMC200027629	K10866	ko03440	Homologous recombination	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMC200027629	K10866	ko03450	Non-homologous end-joining	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMC200027630	K10866	ko03440	Homologous recombination	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMC200027630	K10866	ko03450	Non-homologous end-joining	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMC200010417	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMC200010418	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMC200010419	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMC200010420	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMC200010424	K08515	ko04130	SNARE interactions in vesicular transport	1384	1.7e-70	0.83	0.92	0.86
PGSC0003DMC200010425	K08515	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.86	0.94	1.00
PGSC0003DMC200010427	K06443	ko00906	Carotenoid biosynthesis	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMC200010427	K06443	ko01100	Metabolic pathways	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMC200010427	K06443	ko01110	Biosynthesis of secondary metabolites	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMC200010430	K12655	ko04622	RIG-I-like receptor signaling pathway	820	2.2e-39	0.39	0.57	0.61
PGSC0003DMC200010431	K12655	ko04622	RIG-I-like receptor signaling pathway	914	1.4e-44	0.36	0.55	0.64
PGSC0003DMC200010432	K12655	ko04622	RIG-I-like receptor signaling pathway	842	1.3e-40	0.39	0.57	0.62
PGSC0003DMC200010433	K12655	ko04622	RIG-I-like receptor signaling pathway	456	2.6e-19	0.34	0.50	0.57
PGSC0003DMC200010434	K12611	ko03018	RNA degradation	577	5.5e-26	0.29	0.51	0.95
PGSC0003DMC200010436	K10352	ko04530	Tight junction	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMC200010436	K10352	ko05416	Viral myocarditis	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMC200051340	K02183	ko04020	Calcium signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04070	Phosphatidylinositol signaling system	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04114	Oocyte meiosis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04270	Vascular smooth muscle contraction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04626	Plant-pathogen interaction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04720	Long-term potentiation	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04722	Neurotrophin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04740	Olfactory transduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04744	Phototransduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04745	Phototransduction - fly	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04910	Insulin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04912	GnRH signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04916	Melanogenesis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04970	Salivary secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko04971	Gastric acid secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko05010	Alzheimer's disease	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051340	K02183	ko05214	Glioma	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMC200051352	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMC200051352	K00517	ko00626	Naphthalene and anthracene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMC200051352	K00517	ko00903	Limonene and pinene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMC200051352	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMC200051352	K00517	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMC200051353	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMC200051353	K00517	ko00626	Naphthalene and anthracene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMC200051353	K00517	ko00903	Limonene and pinene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMC200051353	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMC200051353	K00517	ko01110	Biosynthesis of secondary metabolites	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMC200051354	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMC200051354	K00517	ko00626	Naphthalene and anthracene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMC200051354	K00517	ko00903	Limonene and pinene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMC200051354	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMC200051354	K00517	ko01110	Biosynthesis of secondary metabolites	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMC200051356	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.35	0.55	0.66
PGSC0003DMC200034022	K02894	ko03010	Ribosome	573	9.1e-26	0.93	0.96	0.97
PGSC0003DMC200034039	K04506	ko04115	p53 signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMC200034039	K04506	ko04120	Ubiquitin mediated proteolysis	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMC200034039	K04506	ko04310	Wnt signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMC200034040	K06268	ko04010	MAPK signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04020	Calcium signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04114	Oocyte meiosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04210	Apoptosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04310	Wnt signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04360	Axon guidance	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04370	VEGF signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04650	Natural killer cell mediated cytotoxicity	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04660	T cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04662	B cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko04720	Long-term potentiation	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko05010	Alzheimer's disease	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034040	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMC200034041	K06268	ko04010	MAPK signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04020	Calcium signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04114	Oocyte meiosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04210	Apoptosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04310	Wnt signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04360	Axon guidance	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04370	VEGF signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04650	Natural killer cell mediated cytotoxicity	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04660	T cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04662	B cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko04720	Long-term potentiation	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko05010	Alzheimer's disease	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034041	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMC200034042	K06268	ko04010	MAPK signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04020	Calcium signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04114	Oocyte meiosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04210	Apoptosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04310	Wnt signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04360	Axon guidance	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04370	VEGF signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04650	Natural killer cell mediated cytotoxicity	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04660	T cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04662	B cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko04720	Long-term potentiation	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko05010	Alzheimer's disease	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034042	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMC200034043	K06268	ko04010	MAPK signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04020	Calcium signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04114	Oocyte meiosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04210	Apoptosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04310	Wnt signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04360	Axon guidance	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04370	VEGF signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04650	Natural killer cell mediated cytotoxicity	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04660	T cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04662	B cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko04720	Long-term potentiation	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko05010	Alzheimer's disease	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034043	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMC200034045	K07466	ko03030	DNA replication	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMC200034045	K07466	ko03420	Nucleotide excision repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMC200034045	K07466	ko03430	Mismatch repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMC200034045	K07466	ko03440	Homologous recombination	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMC200034046	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034046	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034046	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034046	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034047	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034047	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034047	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200034047	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMC200039213	K00799	ko00480	Glutathione metabolism	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMC200039213	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMC200039213	K00799	ko00982	Drug metabolism - cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMC200039214	K00799	ko00480	Glutathione metabolism	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMC200039214	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMC200039214	K00799	ko00982	Drug metabolism - cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMC200039215	K00799	ko00480	Glutathione metabolism	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMC200039215	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMC200039215	K00799	ko00982	Drug metabolism - cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMC200039216	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMC200039216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMC200039216	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMC200058812	K03065	ko03050	Proteasome	528	2.8e-23	0.62	0.65	0.75
PGSC0003DMC200058817	K05298	ko00710	Carbon fixation in photosynthetic organisms	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMC200058817	K05298	ko01100	Metabolic pathways	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMC200058818	K12126	ko04712	Circadian rhythm - plant	303	1.0e-10	0.27	0.44	0.95
PGSC0003DMC200051242	K01186	ko00511	Other glycan degradation	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMC200051242	K01186	ko00600	Sphingolipid metabolism	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMC200051242	K01186	ko04142	Lysosome	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMC200051254	K03963	ko00190	Oxidative phosphorylation	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMC200051254	K03963	ko01100	Metabolic pathways	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMC200051254	K03963	ko05010	Alzheimer's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMC200051254	K03963	ko05012	Parkinson's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMC200051254	K03963	ko05016	Huntington's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMC200039363	K00919	ko00900	Terpenoid backbone biosynthesis	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMC200039363	K00919	ko01100	Metabolic pathways	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMC200039363	K00919	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMC200039364	K00919	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMC200039364	K00919	ko01100	Metabolic pathways	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMC200039364	K00919	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMC200039365	K00919	ko00900	Terpenoid backbone biosynthesis	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMC200039365	K00919	ko01100	Metabolic pathways	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMC200039365	K00919	ko01110	Biosynthesis of secondary metabolites	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMC200039379	K05396	ko00270	Cysteine and methionine metabolism	362	3.9e-14	0.29	0.49	0.73
PGSC0003DMC200039386	K00423	ko00053	Ascorbate and aldarate metabolism	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMC200039386	K00423	ko01100	Metabolic pathways	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMC200039387	K00423	ko00053	Ascorbate and aldarate metabolism	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMC200039387	K00423	ko01100	Metabolic pathways	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMC200039390	K01114	ko00562	Inositol phosphate metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMC200039390	K01114	ko00564	Glycerophospholipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMC200039390	K01114	ko00565	Ether lipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMC200039390	K01114	ko01100	Metabolic pathways	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMC200046001	K00071	ko00140	Steroid hormone biosynthesis	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMC200046001	K00071	ko01100	Metabolic pathways	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMC200046001	K00071	ko04960	Aldosterone-regulated sodium reabsorption	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMC200046012	K03087	ko05111	Vibrio cholerae pathogenic cycle	687	4.7e-32	0.40	0.64	0.95
PGSC0003DMC200022441	K10717	ko00908	Zeatin biosynthesis	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMC200022441	K10717	ko01100	Metabolic pathways	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMC200022441	K10717	ko01110	Biosynthesis of secondary metabolites	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMC200022442	K10717	ko00908	Zeatin biosynthesis	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMC200022442	K10717	ko01100	Metabolic pathways	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMC200022442	K10717	ko01110	Biosynthesis of secondary metabolites	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMC200022443	K10717	ko00908	Zeatin biosynthesis	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMC200022443	K10717	ko01100	Metabolic pathways	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMC200022443	K10717	ko01110	Biosynthesis of secondary metabolites	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMC200022444	K10717	ko00908	Zeatin biosynthesis	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMC200022444	K10717	ko01100	Metabolic pathways	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMC200022444	K10717	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMC200022446	K00660	ko00941	Flavonoid biosynthesis	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMC200022446	K00660	ko01100	Metabolic pathways	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMC200022446	K00660	ko01110	Biosynthesis of secondary metabolites	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMC200022446	K00660	ko04712	Circadian rhythm - plant	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMC200022447	K03848	ko00510	N-Glycan biosynthesis	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMC200022447	K03848	ko01100	Metabolic pathways	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMC200022448	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMC200022448	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMC200022449	K03848	ko00510	N-Glycan biosynthesis	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMC200022449	K03848	ko01100	Metabolic pathways	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMC200022450	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMC200022450	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMC200022460	K01066	ko00623	2,4-Dichlorobenzoate degradation	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMC200022460	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMC200010576	K00889	ko00562	Inositol phosphate metabolism	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010576	K00889	ko01100	Metabolic pathways	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010576	K00889	ko04070	Phosphatidylinositol signaling system	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010576	K00889	ko04144	Endocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010576	K00889	ko04666	Fc gamma R-mediated phagocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010576	K00889	ko04810	Regulation of actin cytoskeleton	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMC200010577	K00889	ko00562	Inositol phosphate metabolism	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010577	K00889	ko01100	Metabolic pathways	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010577	K00889	ko04070	Phosphatidylinositol signaling system	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010577	K00889	ko04144	Endocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010577	K00889	ko04666	Fc gamma R-mediated phagocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010577	K00889	ko04810	Regulation of actin cytoskeleton	7831	0.	0.60	0.72	0.99
PGSC0003DMC200010582	K01807	ko00030	Pentose phosphate pathway	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMC200010582	K01807	ko00710	Carbon fixation in photosynthetic organisms	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMC200010582	K01807	ko01100	Metabolic pathways	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMC200010582	K01807	ko01110	Biosynthesis of secondary metabolites	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMC200017191	K11866	ko04144	Endocytosis	1149	1.5e-57	0.62	0.76	0.94
PGSC0003DMC200017192	K11866	ko04144	Endocytosis	935	9.8e-46	0.54	0.65	0.93
PGSC0003DMC200017193	K11866	ko04144	Endocytosis	432	5.4e-18	0.69	0.78	0.99
PGSC0003DMC200017196	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMC200017196	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMC200017197	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017197	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017198	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017198	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017199	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017199	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMC200017200	K00846	ko00051	Fructose and mannose metabolism	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMC200017200	K00846	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMC200017201	K00847	ko00051	Fructose and mannose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMC200017201	K00847	ko00500	Starch and sucrose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMC200017201	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMC200017201	K00847	ko01100	Metabolic pathways	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMC200017212	K05849	ko04020	Calcium signaling pathway	312	9.2e-11	0.36	0.54	0.60
PGSC0003DMC200001412	K03941	ko00190	Oxidative phosphorylation	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMC200001412	K03941	ko01100	Metabolic pathways	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMC200001412	K03941	ko05010	Alzheimer's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMC200001412	K03941	ko05012	Parkinson's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMC200001412	K03941	ko05016	Huntington's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMC200001426	K01055	ko00362	Benzoate degradation via hydroxylation	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMC200001426	K01055	ko01100	Metabolic pathways	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMC200001427	K08486	ko04130	SNARE interactions in vesicular transport	1400	2.2e-71	0.59	0.79	0.99
PGSC0003DMC200001429	K00975	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMC200001429	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMC200001429	K00975	ko01100	Metabolic pathways	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMC200001430	K00975	ko00500	Starch and sucrose metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMC200001430	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMC200001430	K00975	ko01100	Metabolic pathways	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMC200001431	K00560	ko00240	Pyrimidine metabolism	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMC200001431	K00560	ko00670	One carbon pool by folate	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMC200001431	K00560	ko01100	Metabolic pathways	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMC200001432	K00560	ko00240	Pyrimidine metabolism	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMC200001432	K00560	ko00670	One carbon pool by folate	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMC200001432	K00560	ko01100	Metabolic pathways	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMC200001433	K01586	ko00300	Lysine biosynthesis	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMC200001433	K01586	ko01100	Metabolic pathways	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMC200001433	K01586	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMC200001438	K05391	ko04626	Plant-pathogen interaction	1253	2.8e-63	0.83	0.89	0.92
PGSC0003DMC200001439	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMC200001440	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMC200001440	K00517	ko00626	Naphthalene and anthracene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMC200001440	K00517	ko00903	Limonene and pinene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMC200001440	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMC200001440	K00517	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMC200064251	K10760	ko00908	Zeatin biosynthesis	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMC200064251	K10760	ko01100	Metabolic pathways	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMC200064251	K10760	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMC200068900	K04427	ko04010	MAPK signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04310	Wnt signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04520	Adherens junction	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04620	Toll-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04621	NOD-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04622	RIG-I-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko04660	T cell receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068900	K04427	ko05140	Leishmaniasis	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMC200068909	K05282	ko00904	Diterpenoid biosynthesis	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMC200068909	K05282	ko01100	Metabolic pathways	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMC200068909	K05282	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMC200041612	K00430	ko00360	Phenylalanine metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMC200041612	K00430	ko00680	Methane metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMC200041612	K00430	ko00940	Phenylpropanoid biosynthesis	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMC200041612	K00430	ko01100	Metabolic pathways	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMC200041612	K00430	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMC200041623	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMC200041624	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMC200041628	K02291	ko00906	Carotenoid biosynthesis	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMC200041628	K02291	ko01100	Metabolic pathways	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMC200041628	K02291	ko01110	Biosynthesis of secondary metabolites	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMC200041629	K02291	ko00906	Carotenoid biosynthesis	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMC200041629	K02291	ko01100	Metabolic pathways	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMC200041629	K02291	ko01110	Biosynthesis of secondary metabolites	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMC200053744	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMC200053745	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMC200053755	K07466	ko03030	DNA replication	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMC200053755	K07466	ko03420	Nucleotide excision repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMC200053755	K07466	ko03430	Mismatch repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMC200053755	K07466	ko03440	Homologous recombination	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMC200053756	K07466	ko03030	DNA replication	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMC200053756	K07466	ko03420	Nucleotide excision repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMC200053756	K07466	ko03430	Mismatch repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMC200053756	K07466	ko03440	Homologous recombination	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMC200043397	K00059	ko00061	Fatty acid biosynthesis	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMC200043397	K00059	ko01040	Biosynthesis of unsaturated fatty acids	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMC200043397	K00059	ko01100	Metabolic pathways	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMC200043401	K00218	ko00860	Porphyrin and chlorophyll metabolism	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMC200043401	K00218	ko01100	Metabolic pathways	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMC200043401	K00218	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMC200043404	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.76	0.84	0.98
PGSC0003DMC200043405	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3534	4.4e-189	0.83	0.92	0.98
PGSC0003DMC200043407	K11251	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.98	0.98	0.99
PGSC0003DMC200043408	K02895	ko03010	Ribosome	1088	3.6e-54	0.57	0.65	1.00
PGSC0003DMC200043409	K02895	ko03010	Ribosome	1223	1.3e-61	0.77	0.88	0.99
PGSC0003DMC200037776	K13082	ko00941	Flavonoid biosynthesis	827	8.9e-40	0.41	0.61	0.97
PGSC0003DMC200037777	K11251	ko05322	Systemic lupus erythematosus	505	5.1e-22	0.98	0.98	0.78
PGSC0003DMC200037778	K11251	ko05322	Systemic lupus erythematosus	1026	9.4e-51	0.96	0.97	0.99
PGSC0003DMC200037781	K11228	ko04011	MAPK signaling pathway - yeast	317	5.7e-11	0.30	0.47	0.77
PGSC0003DMC200037782	K13082	ko00941	Flavonoid biosynthesis	823	1.5e-39	0.41	0.61	0.97
PGSC0003DMC200037783	K03083	ko04012	ErbB signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04062	Chemokine signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04110	Cell cycle	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04310	Wnt signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04340	Hedgehog signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04360	Axon guidance	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04510	Focal adhesion	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04660	T cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04662	B cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04711	Circadian rhythm - fly	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04722	Neurotrophin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko04916	Melanogenesis	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05010	Alzheimer's disease	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05200	Pathways in cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05210	Colorectal cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05213	Endometrial cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05215	Prostate cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037783	K03083	ko05217	Basal cell carcinoma	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMC200037784	K13082	ko00941	Flavonoid biosynthesis	1017	2.9e-50	0.42	0.62	0.97
PGSC0003DMC200037787	K11294	ko05130	Pathogenic Escherichia coli infection	239	3.5e-07	0.36	0.55	0.68
PGSC0003DMC200037788	K02938	ko03010	Ribosome	2196	2.8e-115	0.96	0.99	0.99
PGSC0003DMC200037789	K11866	ko04144	Endocytosis	459	9.1e-19	0.28	0.43	0.85
PGSC0003DMC200037790	K11866	ko04144	Endocytosis	481	5.2e-20	0.29	0.43	0.90
PGSC0003DMC200037791	K08099	ko00860	Porphyrin and chlorophyll metabolism	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMC200037791	K08099	ko01100	Metabolic pathways	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMC200037791	K08099	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMC200054251	K04713	ko00600	Sphingolipid metabolism	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMC200054251	K04713	ko01100	Metabolic pathways	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMC200054264	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	460	1.5e-19	0.32	0.47	0.94
PGSC0003DMC200025441	K09755	ko00940	Phenylpropanoid biosynthesis	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMC200025441	K09755	ko01100	Metabolic pathways	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMC200025441	K09755	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMC200025442	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMC200025442	K00517	ko00626	Naphthalene and anthracene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMC200025442	K00517	ko00903	Limonene and pinene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMC200025442	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMC200025442	K00517	ko01110	Biosynthesis of secondary metabolites	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMC200025449	K12489	ko04144	Endocytosis	3346	1.0e-178	0.56	0.67	0.96
PGSC0003DMC200025450	K12489	ko04144	Endocytosis	1727	2.0e-89	0.62	0.72	0.99
PGSC0003DMC200025451	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMC200025452	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMC200025453	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMC200025454	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMC200025455	K02949	ko03010	Ribosome	970	1.2e-47	0.76	0.82	0.99
PGSC0003DMC200025456	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200025457	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200025458	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200025459	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200025460	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMC200025464	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMC200025464	K01915	ko00330	Arginine and proline metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMC200025464	K01915	ko00910	Nitrogen metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMC200025464	K01915	ko01100	Metabolic pathways	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMC200025464	K01915	ko02020	Two-component system	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMC200012181	K01136	ko00531	Glycosaminoglycan degradation	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMC200012181	K01136	ko01100	Metabolic pathways	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMC200012181	K01136	ko04142	Lysosome	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMC200012182	K12867	ko03040	Spliceosome	6303	0.	0.81	0.89	1.00
PGSC0003DMC200012204	K05862	ko04020	Calcium signaling pathway	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMC200012204	K05862	ko05012	Parkinson's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMC200012204	K05862	ko05016	Huntington's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMC200012209	K00472	ko00330	Arginine and proline metabolism	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMC200012209	K00472	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMC200012210	K00472	ko00330	Arginine and proline metabolism	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMC200012210	K00472	ko01100	Metabolic pathways	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMC200006573	K10955	ko05110	Vibrio cholerae infection	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMC200006573	K10955	ko05146	Amoebiasis	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMC200006574	K01051	ko00040	Pentose and glucuronate interconversions	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMC200006574	K01051	ko00500	Starch and sucrose metabolism	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMC200006574	K01051	ko01100	Metabolic pathways	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMC200006577	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMC200006577	K00224	ko00364	Fluorobenzoate degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMC200006577	K00224	ko00628	Fluorene degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMC200006577	K00224	ko00640	Propanoate metabolism	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMC200006578	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMC200006578	K00224	ko00364	Fluorobenzoate degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMC200006578	K00224	ko00628	Fluorene degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMC200006578	K00224	ko00640	Propanoate metabolism	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMC200006579	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMC200006579	K00224	ko00364	Fluorobenzoate degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMC200006579	K00224	ko00628	Fluorene degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMC200006579	K00224	ko00640	Propanoate metabolism	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMC200006580	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMC200006580	K00224	ko00364	Fluorobenzoate degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMC200006580	K00224	ko00628	Fluorene degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMC200006580	K00224	ko00640	Propanoate metabolism	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMC200006581	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMC200006581	K00224	ko00364	Fluorobenzoate degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMC200006581	K00224	ko00628	Fluorene degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMC200006581	K00224	ko00640	Propanoate metabolism	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMC200006582	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMC200006582	K00224	ko00364	Fluorobenzoate degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMC200006582	K00224	ko00628	Fluorene degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMC200006582	K00224	ko00640	Propanoate metabolism	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMC200006583	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMC200006583	K00224	ko00364	Fluorobenzoate degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMC200006583	K00224	ko00628	Fluorene degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMC200006583	K00224	ko00640	Propanoate metabolism	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMC200006584	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMC200006584	K00224	ko00364	Fluorobenzoate degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMC200006584	K00224	ko00628	Fluorene degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMC200006584	K00224	ko00640	Propanoate metabolism	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMC200006585	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMC200006585	K00224	ko00364	Fluorobenzoate degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMC200006585	K00224	ko00628	Fluorene degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMC200006585	K00224	ko00640	Propanoate metabolism	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMC200006586	K00680	ko00350	Tyrosine metabolism	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMC200006586	K00680	ko00624	1- and 2-Methylnaphthalene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMC200006586	K00680	ko00632	Benzoate degradation via CoA ligation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMC200006586	K00680	ko00642	Ethylbenzene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMC200006586	K00680	ko00903	Limonene and pinene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMC200006588	K00847	ko00051	Fructose and mannose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMC200006588	K00847	ko00500	Starch and sucrose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMC200006588	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMC200006588	K00847	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMC200006591	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.72
PGSC0003DMC200006592	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.87
PGSC0003DMC200006594	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006594	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006594	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006595	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMC200006595	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMC200006595	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMC200006596	K10572	ko00562	Inositol phosphate metabolism	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMC200006596	K10572	ko01100	Metabolic pathways	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMC200006596	K10572	ko04070	Phosphatidylinositol signaling system	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMC200006597	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006597	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006597	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMC200006598	K10572	ko00562	Inositol phosphate metabolism	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMC200006598	K10572	ko01100	Metabolic pathways	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMC200006598	K10572	ko04070	Phosphatidylinositol signaling system	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMC200006600	K04371	ko04010	MAPK signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04012	ErbB signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04013	MAPK signaling pathway - fly	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04062	Chemokine signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04114	Oocyte meiosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04150	mTOR signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04270	Vascular smooth muscle contraction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04320	Dorso-ventral axis formation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04350	TGF-beta signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04360	Axon guidance	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04370	VEGF signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04510	Focal adhesion	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04520	Adherens junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04540	Gap junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04620	Toll-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04621	NOD-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04650	Natural killer cell mediated cytotoxicity	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04660	T cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04662	B cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04664	Fc epsilon RI signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04666	Fc gamma R-mediated phagocytosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04720	Long-term potentiation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04722	Neurotrophin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04730	Long-term depression	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04810	Regulation of actin cytoskeleton	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04910	Insulin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04912	GnRH signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04914	Progesterone-mediated oocyte maturation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04916	Melanogenesis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04930	Type II diabetes mellitus	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05010	Alzheimer's disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05020	Prion diseases	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05131	Shigellosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05140	Leishmaniasis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05142	Chagas disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05200	Pathways in cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05210	Colorectal cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05211	Renal cell carcinoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05212	Pancreatic cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05213	Endometrial cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05214	Glioma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05215	Prostate cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05216	Thyroid cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05218	Melanoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05219	Bladder cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05220	Chronic myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05221	Acute myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200006600	K04371	ko05223	Non-small cell lung cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMC200060928	K10773	ko03410	Base excision repair	1542	3.2e-79	0.32	0.46	0.82
PGSC0003DMC200036576	K06093	ko04144	Endocytosis	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMC200036576	K06093	ko04530	Tight junction	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMC200042192	K02152	ko00190	Oxidative phosphorylation	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042192	K02152	ko01100	Metabolic pathways	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042192	K02152	ko04145	Phagosome	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042192	K02152	ko04966	Collecting duct acid secretion	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042192	K02152	ko05110	Vibrio cholerae infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042192	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMC200042200	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMC200042200	K01736	ko01100	Metabolic pathways	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMC200042200	K01736	ko01110	Biosynthesis of secondary metabolites	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMC200055442	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055442	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055442	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055443	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055443	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055443	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055444	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055444	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055444	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMC200055446	K02734	ko03050	Proteasome	1533	1.0e-78	0.87	0.94	0.99
PGSC0003DMC200055462	K01371	ko04142	Lysosome	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMC200055462	K01371	ko04620	Toll-like receptor signaling pathway	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMC200002766	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1479	9.7e-76	0.67	0.80	0.91
PGSC0003DMC200062124	K01087	ko00500	Starch and sucrose metabolism	1190	8.4e-60	0.54	0.70	0.98
PGSC0003DMC200062125	K12338	ko00942	Anthocyanin biosynthesis	910	2.3e-44	0.46	0.65	0.96
PGSC0003DMC200011625	K00100	ko00051	Fructose and mannose metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011625	K00100	ko00363	Bisphenol A degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011625	K00100	ko00591	Linoleic acid metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011625	K00100	ko00625	Tetrachloroethene degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011625	K00100	ko00650	Butanoate metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011625	K00100	ko01100	Metabolic pathways	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMC200011626	K05275	ko00750	Vitamin B6 metabolism	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMC200011626	K05275	ko01100	Metabolic pathways	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMC200011627	K05275	ko00750	Vitamin B6 metabolism	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMC200011627	K05275	ko01100	Metabolic pathways	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMC200011628	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011628	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011628	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011628	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011628	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011628	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMC200011629	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011629	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011629	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011629	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011629	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011629	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011630	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011631	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011632	K05275	ko00750	Vitamin B6 metabolism	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMC200011632	K05275	ko01100	Metabolic pathways	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMC200011633	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011633	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011633	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011633	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011633	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011633	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMC200011634	K05275	ko00750	Vitamin B6 metabolism	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMC200011634	K05275	ko01100	Metabolic pathways	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMC200023738	K08912	ko00196	Photosynthesis - antenna proteins	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMC200023738	K08912	ko01100	Metabolic pathways	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMC200023739	K08912	ko00196	Photosynthesis - antenna proteins	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMC200023739	K08912	ko01100	Metabolic pathways	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMC200023740	K08912	ko00196	Photosynthesis - antenna proteins	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMC200023740	K08912	ko01100	Metabolic pathways	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMC200023741	K08912	ko00196	Photosynthesis - antenna proteins	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMC200023741	K08912	ko01100	Metabolic pathways	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMC200023742	K08912	ko00196	Photosynthesis - antenna proteins	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMC200023742	K08912	ko01100	Metabolic pathways	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMC200023743	K08912	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMC200023743	K08912	ko01100	Metabolic pathways	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMC200023744	K08912	ko00196	Photosynthesis - antenna proteins	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMC200023744	K08912	ko01100	Metabolic pathways	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMC200023745	K08912	ko00196	Photosynthesis - antenna proteins	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMC200023745	K08912	ko01100	Metabolic pathways	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMC200023746	K08912	ko00196	Photosynthesis - antenna proteins	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMC200023746	K08912	ko01100	Metabolic pathways	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMC200023747	K08912	ko00196	Photosynthesis - antenna proteins	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMC200023747	K08912	ko01100	Metabolic pathways	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMC200023748	K08912	ko00196	Photosynthesis - antenna proteins	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMC200023748	K08912	ko01100	Metabolic pathways	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMC200023749	K07441	ko00510	N-Glycan biosynthesis	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMC200023749	K07441	ko01100	Metabolic pathways	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMC200023750	K07441	ko00510	N-Glycan biosynthesis	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMC200023750	K07441	ko01100	Metabolic pathways	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMC200023751	K07441	ko00510	N-Glycan biosynthesis	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMC200023751	K07441	ko01100	Metabolic pathways	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMC200023752	K07441	ko00510	N-Glycan biosynthesis	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMC200023752	K07441	ko01100	Metabolic pathways	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMC200023753	K05658	ko02010	ABC transporters	6882	0.	0.67	0.83	1.00
PGSC0003DMC200023754	K03259	ko04150	mTOR signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMC200023754	K03259	ko04910	Insulin signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMC200023755	K03259	ko04150	mTOR signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMC200023755	K03259	ko04910	Insulin signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMC200023759	K00599	ko00340	Histidine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMC200023759	K00599	ko00350	Tyrosine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMC200023759	K00599	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMC200023759	K00599	ko00626	Naphthalene and anthracene degradation	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMC200023760	K00599	ko00340	Histidine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMC200023760	K00599	ko00350	Tyrosine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMC200023760	K00599	ko00450	Selenoamino acid metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMC200023760	K00599	ko00626	Naphthalene and anthracene degradation	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMC200024260	K06685	ko04111	Cell cycle - yeast	536	3.5e-20	0.25	0.42	0.82
PGSC0003DMC200024261	K02140	ko00190	Oxidative phosphorylation	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMC200024261	K02140	ko01100	Metabolic pathways	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMC200024265	K11247	ko04144	Endocytosis	1697	9.2e-88	0.58	0.76	0.99
PGSC0003DMC200024266	K11247	ko04144	Endocytosis	1070	3.5e-53	0.59	0.76	0.98
PGSC0003DMC200024267	K11247	ko04144	Endocytosis	578	4.8e-26	0.53	0.74	0.81
PGSC0003DMC200024269	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024269	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024269	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024269	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024269	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024270	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024270	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024270	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024270	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024270	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200007773	K08517	ko04130	SNARE interactions in vesicular transport	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMC200007773	K08517	ko04145	Phagosome	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMC200007774	K08517	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMC200007774	K08517	ko04145	Phagosome	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMC200007784	K12349	ko00600	Sphingolipid metabolism	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMC200007784	K12349	ko01100	Metabolic pathways	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMC200007793	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	541	5.3e-24	0.63	0.74	0.80
PGSC0003DMC200007794	K05033	ko02010	ABC transporters	684	4.7e-31	0.54	0.75	0.89
PGSC0003DMC200007795	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMC200007796	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMC200013391	K02695	ko00195	Photosynthesis	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMC200013391	K02695	ko01100	Metabolic pathways	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMC200013392	K00058	ko00260	Glycine, serine and threonine metabolism	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMC200013392	K00058	ko01100	Metabolic pathways	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMC200013393	K00100	ko00051	Fructose and mannose metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013393	K00100	ko00363	Bisphenol A degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013393	K00100	ko00591	Linoleic acid metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013393	K00100	ko00625	Tetrachloroethene degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013393	K00100	ko00650	Butanoate metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013393	K00100	ko01100	Metabolic pathways	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMC200013394	K00058	ko00260	Glycine, serine and threonine metabolism	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMC200013394	K00058	ko01100	Metabolic pathways	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMC200013400	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013400	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013401	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013402	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013403	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013404	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013405	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013406	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200013407	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMC200052447	K01590	ko00340	Histidine metabolism	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMC200052447	K01590	ko01100	Metabolic pathways	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMC200052447	K01590	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMC200052454	K02087	ko04110	Cell cycle	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMC200052454	K02087	ko04114	Oocyte meiosis	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMC200052454	K02087	ko04115	p53 signaling pathway	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMC200052454	K02087	ko04540	Gap junction	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMC200052454	K02087	ko04914	Progesterone-mediated oocyte maturation	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMC200052455	K02087	ko04110	Cell cycle	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMC200052455	K02087	ko04114	Oocyte meiosis	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMC200052455	K02087	ko04115	p53 signaling pathway	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMC200052455	K02087	ko04540	Gap junction	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMC200052455	K02087	ko04914	Progesterone-mediated oocyte maturation	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMC200052470	K00029	ko00620	Pyruvate metabolism	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMC200052470	K00029	ko00710	Carbon fixation in photosynthetic organisms	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMC200052470	K00029	ko01100	Metabolic pathways	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMC200047193	K00382	ko00010	Glycolysis / Gluconeogenesis	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko00020	Citrate cycle (TCA cycle)	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko00260	Glycine, serine and threonine metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko00280	Valine, leucine and isoleucine degradation	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko00620	Pyruvate metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko01100	Metabolic pathways	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047193	K00382	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMC200047198	K02905	ko03010	Ribosome	469	4.9e-20	0.87	0.95	0.98
PGSC0003DMC200047200	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.60	0.91
PGSC0003DMC200047202	K04077	ko03018	RNA degradation	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMC200047202	K04077	ko04940	Type I diabetes mellitus	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMC200047203	K00878	ko00730	Thiamine metabolism	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMC200047203	K00878	ko01100	Metabolic pathways	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMC200047204	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMC200047204	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMC200047204	K00771	ko01100	Metabolic pathways	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMC200047205	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMC200047205	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMC200047205	K00771	ko01100	Metabolic pathways	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMC200047209	K00368	ko00910	Nitrogen metabolism	1934	7.8e-101	0.48	0.62	0.89
PGSC0003DMC200047215	K01510	ko00230	Purine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMC200047215	K01510	ko00240	Pyrimidine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMC200047216	K04646	ko04142	Lysosome	10939	0.	0.79	0.82	1.00
PGSC0003DMC200047216	K04646	ko04144	Endocytosis	10939	0.	0.79	0.82	1.00
PGSC0003DMC200047216	K04646	ko05016	Huntington's disease	10939	0.	0.79	0.82	1.00
PGSC0003DMC200047216	K04646	ko05100	Bacterial invasion of epithelial cells	10939	0.	0.79	0.82	1.00
PGSC0003DMC200047217	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMC200047217	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMC200047217	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMC200047217	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMC200047220	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.97
PGSC0003DMC200040566	K00166	ko00280	Valine, leucine and isoleucine degradation	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMC200040566	K00166	ko01100	Metabolic pathways	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMC200040566	K00166	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMC200040567	K00166	ko00280	Valine, leucine and isoleucine degradation	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMC200040567	K00166	ko01100	Metabolic pathways	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMC200040567	K00166	ko01110	Biosynthesis of secondary metabolites	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMC200040582	K02160	ko00061	Fatty acid biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040582	K02160	ko00253	Tetracycline biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040582	K02160	ko00620	Pyruvate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040582	K02160	ko00640	Propanoate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040582	K02160	ko01100	Metabolic pathways	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040582	K02160	ko01110	Biosynthesis of secondary metabolites	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMC200040588	K03955	ko00190	Oxidative phosphorylation	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMC200040588	K03955	ko01100	Metabolic pathways	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMC200040588	K03955	ko05010	Alzheimer's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMC200040588	K03955	ko05012	Parkinson's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMC200040588	K03955	ko05016	Huntington's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMC200040589	K03955	ko00190	Oxidative phosphorylation	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMC200040589	K03955	ko01100	Metabolic pathways	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMC200040589	K03955	ko05010	Alzheimer's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMC200040589	K03955	ko05012	Parkinson's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMC200040589	K03955	ko05016	Huntington's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMC200032551	K05868	ko04110	Cell cycle	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMC200032551	K05868	ko04115	p53 signaling pathway	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMC200032551	K05868	ko04914	Progesterone-mediated oocyte maturation	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMC200032562	K00021	ko00900	Terpenoid backbone biosynthesis	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMC200032562	K00021	ko01100	Metabolic pathways	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMC200032562	K00021	ko01110	Biosynthesis of secondary metabolites	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMC200032574	K10802	ko03410	Base excision repair	684	6.8e-32	0.72	0.82	0.68
PGSC0003DMC200032575	K10802	ko03410	Base excision repair	819	2.5e-39	0.70	0.79	0.99
PGSC0003DMC200032578	K00588	ko00360	Phenylalanine metabolism	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032578	K00588	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032578	K00588	ko00941	Flavonoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032578	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032578	K00588	ko01100	Metabolic pathways	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032578	K00588	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMC200032579	K00588	ko00360	Phenylalanine metabolism	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200032579	K00588	ko00940	Phenylpropanoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200032579	K00588	ko00941	Flavonoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200032579	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200032579	K00588	ko01100	Metabolic pathways	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200032579	K00588	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMC200063055	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	273	3.2e-09	0.53	0.72	0.70
PGSC0003DMC200021241	K05681	ko02010	ABC transporters	888	1.0e-44	0.34	0.53	0.48
PGSC0003DMC200021242	K00634	ko00650	Butanoate metabolism	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMC200021242	K00634	ko01100	Metabolic pathways	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMC200021247	K06626	ko04110	Cell cycle	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021247	K06626	ko04114	Oocyte meiosis	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021247	K06626	ko04115	p53 signaling pathway	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021247	K06626	ko05200	Pathways in cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021247	K06626	ko05215	Prostate cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021247	K06626	ko05222	Small cell lung cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMC200021248	K02220	ko04111	Cell cycle - yeast	291	3.9e-10	0.34	0.55	0.47
PGSC0003DMC200021251	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMC200021252	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMC200021253	K01178	ko00500	Starch and sucrose metabolism	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMC200021253	K01178	ko01100	Metabolic pathways	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMC200021255	K01623	ko00010	Glycolysis / Gluconeogenesis	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021255	K01623	ko00030	Pentose phosphate pathway	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021255	K01623	ko00051	Fructose and mannose metabolism	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021255	K01623	ko00710	Carbon fixation in photosynthetic organisms	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021255	K01623	ko01100	Metabolic pathways	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021255	K01623	ko01110	Biosynthesis of secondary metabolites	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMC200021266	K08332	ko04140	Regulation of autophagy	294	8.3e-08	0.25	0.48	0.62
PGSC0003DMC200021268	K13230	ko00402	Benzoxazinoid biosynthesis	702	7.0e-33	0.34	0.52	0.96
PGSC0003DMC200021269	K13230	ko00402	Benzoxazinoid biosynthesis	645	9.7e-30	0.38	0.54	0.96
PGSC0003DMC200021270	K13230	ko00402	Benzoxazinoid biosynthesis	668	5.2e-31	0.39	0.55	0.96
PGSC0003DMC200026732	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMC200026732	K00517	ko00626	Naphthalene and anthracene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMC200026732	K00517	ko00903	Limonene and pinene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMC200026732	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMC200026732	K00517	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMC200026740	K02880	ko03010	Ribosome	1347	1.8e-68	0.91	0.95	0.99
PGSC0003DMC200026741	K07199	ko04910	Insulin signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMC200026741	K07199	ko04920	Adipocytokine signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMC200026741	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMC200026742	K07199	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMC200026742	K07199	ko04920	Adipocytokine signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMC200026742	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMC200026745	K00059	ko00061	Fatty acid biosynthesis	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMC200026745	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMC200026745	K00059	ko01100	Metabolic pathways	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMC200026753	K00134	ko00010	Glycolysis / Gluconeogenesis	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMC200026753	K00134	ko01100	Metabolic pathways	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMC200026753	K00134	ko01110	Biosynthesis of secondary metabolites	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMC200026753	K00134	ko05010	Alzheimer's disease	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMC200026754	K00940	ko00230	Purine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMC200026754	K00940	ko00240	Pyrimidine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMC200026754	K00940	ko01100	Metabolic pathways	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMC200026754	K00940	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMC200026759	K02970	ko03010	Ribosome	215	5.0e-06	0.51	0.70	0.22
PGSC0003DMC200026760	K02970	ko03010	Ribosome	219	3.0e-06	0.51	0.69	0.33
PGSC0003DMC200015991	K01051	ko00040	Pentose and glucuronate interconversions	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMC200015991	K01051	ko00500	Starch and sucrose metabolism	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMC200015991	K01051	ko01100	Metabolic pathways	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMC200015992	K01051	ko00040	Pentose and glucuronate interconversions	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMC200015992	K01051	ko00500	Starch and sucrose metabolism	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMC200015992	K01051	ko01100	Metabolic pathways	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMC200016005	K01228	ko00510	N-Glycan biosynthesis	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMC200016005	K01228	ko01100	Metabolic pathways	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMC200016006	K07297	ko04920	Adipocytokine signaling pathway	1096	1.3e-54	0.75	0.87	0.99
PGSC0003DMC200016007	K07297	ko04920	Adipocytokine signaling pathway	2314	8.5e-122	0.66	0.80	0.97
PGSC0003DMC200016010	K05862	ko04020	Calcium signaling pathway	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMC200016010	K05862	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMC200016010	K05862	ko05016	Huntington's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMC200016011	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMC200016011	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMC200016011	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMC200016013	K05033	ko02010	ABC transporters	415	5.2e-16	0.51	0.67	0.84
PGSC0003DMC200016014	K05666	ko02010	ABC transporters	3162	1.4e-168	0.38	0.59	0.82
PGSC0003DMC200016015	K05666	ko02010	ABC transporters	1344	2.7e-68	0.44	0.66	0.97
PGSC0003DMC200009361	K01509	ko00230	Purine metabolism	194	1.1e-09	0.50	0.71	0.40
PGSC0003DMC200009373	K00430	ko00360	Phenylalanine metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMC200009373	K00430	ko00680	Methane metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMC200009373	K00430	ko00940	Phenylpropanoid biosynthesis	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMC200009373	K00430	ko01100	Metabolic pathways	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMC200009373	K00430	ko01110	Biosynthesis of secondary metabolites	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMC200009376	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMC200009376	K03785	ko01100	Metabolic pathways	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMC200009376	K03785	ko01110	Biosynthesis of secondary metabolites	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMC200009377	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMC200009377	K03785	ko01100	Metabolic pathways	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMC200009377	K03785	ko01110	Biosynthesis of secondary metabolites	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMC200019592	K11778	ko00900	Terpenoid backbone biosynthesis	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMC200019592	K11778	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMC200019593	K11778	ko00900	Terpenoid backbone biosynthesis	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMC200019593	K11778	ko01110	Biosynthesis of secondary metabolites	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMC200019594	K11778	ko00900	Terpenoid backbone biosynthesis	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMC200019594	K11778	ko01110	Biosynthesis of secondary metabolites	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMC200019595	K11778	ko00900	Terpenoid backbone biosynthesis	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMC200019595	K11778	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMC200019596	K11778	ko00900	Terpenoid backbone biosynthesis	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMC200019596	K11778	ko01110	Biosynthesis of secondary metabolites	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMC200019597	K11778	ko00900	Terpenoid backbone biosynthesis	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMC200019597	K11778	ko01110	Biosynthesis of secondary metabolites	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMC200019598	K11778	ko00900	Terpenoid backbone biosynthesis	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMC200019598	K11778	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMC200019601	K05933	ko00270	Cysteine and methionine metabolism	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMC200019601	K05933	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMC200019602	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMC200019602	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMC200019602	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMC200019610	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMC200019610	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMC200019610	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMC200019611	K01921	ko00473	D-Alanine metabolism	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMC200019611	K01921	ko00550	Peptidoglycan biosynthesis	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMC200019611	K01921	ko01100	Metabolic pathways	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMC200019612	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMC200019612	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMC200019612	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMC200017411	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMC200017411	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMC200017412	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMC200017412	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMC200017424	K08766	ko00071	Fatty acid metabolism	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMC200017424	K08766	ko03320	PPAR signaling pathway	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMC200017425	K08766	ko00071	Fatty acid metabolism	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMC200017425	K08766	ko03320	PPAR signaling pathway	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMC200014047	K00510	ko00860	Porphyrin and chlorophyll metabolism	981	2.8e-48	0.49	0.68	0.58
PGSC0003DMC200014049	K13289	ko04142	Lysosome	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMC200014049	K13289	ko04614	Renin-angiotensin system	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMC200014050	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014050	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014050	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014051	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014051	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014051	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMC200014058	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMC200014059	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMC200014063	K02084	ko04115	p53 signaling pathway	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko04210	Apoptosis	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko05010	Alzheimer's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko05012	Parkinson's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko05016	Huntington's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014063	K02084	ko05222	Small cell lung cancer	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMC200014064	K02084	ko04115	p53 signaling pathway	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko04210	Apoptosis	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko05010	Alzheimer's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko05012	Parkinson's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko05016	Huntington's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014064	K02084	ko05222	Small cell lung cancer	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMC200014067	K06627	ko04110	Cell cycle	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMC200014067	K06627	ko04914	Progesterone-mediated oocyte maturation	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMC200014070	K01136	ko00531	Glycosaminoglycan degradation	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMC200014070	K01136	ko01100	Metabolic pathways	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMC200014070	K01136	ko04142	Lysosome	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMC200024792	K05278	ko00941	Flavonoid biosynthesis	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMC200024792	K05278	ko01100	Metabolic pathways	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMC200024792	K05278	ko01110	Biosynthesis of secondary metabolites	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMC200024793	K00059	ko00061	Fatty acid biosynthesis	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMC200024793	K00059	ko01040	Biosynthesis of unsaturated fatty acids	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMC200024793	K00059	ko01100	Metabolic pathways	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMC200024794	K00059	ko00061	Fatty acid biosynthesis	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMC200024794	K00059	ko01040	Biosynthesis of unsaturated fatty acids	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMC200024794	K00059	ko01100	Metabolic pathways	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMC200024795	K00059	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMC200024795	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMC200024795	K00059	ko01100	Metabolic pathways	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMC200024798	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024798	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024798	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024799	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024799	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024799	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMC200024801	K04725	ko04120	Ubiquitin mediated proteolysis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024801	K04725	ko04210	Apoptosis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024801	K04725	ko04510	Focal adhesion	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024801	K04725	ko04621	NOD-like receptor signaling pathway	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024801	K04725	ko05200	Pathways in cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024801	K04725	ko05222	Small cell lung cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMC200024809	K01081	ko00230	Purine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMC200024809	K01081	ko00240	Pyrimidine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMC200024809	K01081	ko00760	Nicotinate and nicotinamide metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMC200024809	K01081	ko01100	Metabolic pathways	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMC200024809	K01081	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMC200024810	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024810	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024810	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024810	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200024810	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMC200048399	K00249	ko00071	Fatty acid metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko00280	Valine, leucine and isoleucine degradation	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko00410	beta-Alanine metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko00640	Propanoate metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko01100	Metabolic pathways	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko01110	Biosynthesis of secondary metabolites	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048399	K00249	ko03320	PPAR signaling pathway	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMC200048400	K00249	ko00071	Fatty acid metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko00280	Valine, leucine and isoleucine degradation	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko00410	beta-Alanine metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko00640	Propanoate metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko01100	Metabolic pathways	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko01110	Biosynthesis of secondary metabolites	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048400	K00249	ko03320	PPAR signaling pathway	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMC200048402	K01051	ko00040	Pentose and glucuronate interconversions	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMC200048402	K01051	ko00500	Starch and sucrose metabolism	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMC200048402	K01051	ko01100	Metabolic pathways	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMC200048404	K11253	ko05322	Systemic lupus erythematosus	282	1.0e-09	0.97	0.97	0.67
PGSC0003DMC200048416	K01051	ko00040	Pentose and glucuronate interconversions	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMC200048416	K01051	ko00500	Starch and sucrose metabolism	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMC200048416	K01051	ko01100	Metabolic pathways	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMC200048419	K11253	ko05322	Systemic lupus erythematosus	787	1.4e-37	0.92	0.94	0.95
PGSC0003DMC200030969	K01507	ko00190	Oxidative phosphorylation	489	3.9e-21	0.59	0.66	0.73
PGSC0003DMC200030972	K04733	ko04210	Apoptosis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMC200030972	K04733	ko04620	Toll-like receptor signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMC200030972	K04733	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMC200030972	K04733	ko05140	Leishmaniasis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMC200030972	K04733	ko05142	Chagas disease	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMC200055987	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMC200055995	K11090	ko05322	Systemic lupus erythematosus	260	1.7e-08	0.31	0.50	0.39
PGSC0003DMC200042841	K01514	ko00230	Purine metabolism	827	8.9e-40	0.35	0.54	0.93
PGSC0003DMC200042842	K01514	ko00230	Purine metabolism	903	5.7e-44	0.35	0.54	0.87
PGSC0003DMC200042843	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMC200042846	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMC200042846	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMC200042849	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMC200042849	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMC200042850	K01192	ko00511	Other glycan degradation	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMC200042850	K01192	ko04142	Lysosome	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMC200042858	K00454	ko00591	Linoleic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMC200042858	K00454	ko00592	alpha-Linolenic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMC200042858	K00454	ko01100	Metabolic pathways	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMC200042863	K07200	ko04910	Insulin signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMC200042863	K07200	ko04920	Adipocytokine signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMC200042863	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMC200042866	K10609	ko03420	Nucleotide excision repair	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMC200042866	K10609	ko04120	Ubiquitin mediated proteolysis	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMC200000751	K10527	ko00592	alpha-Linolenic acid metabolism	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMC200000751	K10527	ko01100	Metabolic pathways	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMC200000754	K03100	ko03060	Protein export	1729	1.6e-89	0.67	0.76	0.98
PGSC0003DMC200000755	K00558	ko00270	Cysteine and methionine metabolism	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMC200000755	K00558	ko01100	Metabolic pathways	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMC200000762	K02184	ko04320	Dorso-ventral axis formation	1261	1.0e-63	0.42	0.46	0.48
PGSC0003DMC200000768	K12471	ko04144	Endocytosis	344	3.9e-13	0.33	0.57	0.63
PGSC0003DMC200000769	K12471	ko04144	Endocytosis	226	3.4e-06	0.33	0.56	0.87
PGSC0003DMC200000776	K08332	ko04140	Regulation of autophagy	304	3.3e-08	0.29	0.52	0.45
PGSC0003DMC200000777	K08332	ko04140	Regulation of autophagy	304	1.2e-10	0.29	0.52	0.96
PGSC0003DMC200002973	K10352	ko04530	Tight junction	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMC200002973	K10352	ko05416	Viral myocarditis	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMC200002989	K01583	ko00330	Arginine and proline metabolism	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMC200002989	K01583	ko01100	Metabolic pathways	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMC200002996	K02257	ko00190	Oxidative phosphorylation	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMC200002996	K02257	ko00860	Porphyrin and chlorophyll metabolism	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMC200002996	K02257	ko01100	Metabolic pathways	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMC200002996	K02257	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMC200002997	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMC200002997	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMC200002997	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMC200002997	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMC200002998	K02257	ko00190	Oxidative phosphorylation	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMC200002998	K02257	ko00860	Porphyrin and chlorophyll metabolism	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMC200002998	K02257	ko01100	Metabolic pathways	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMC200002998	K02257	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMC200002999	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMC200002999	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMC200002999	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMC200002999	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMC200021782	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMC200021782	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMC200021782	K00734	ko01100	Metabolic pathways	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMC200021788	K10456	ko04120	Ubiquitin mediated proteolysis	301	3.5e-08	0.30	0.47	0.42
PGSC0003DMC200021789	K10456	ko04120	Ubiquitin mediated proteolysis	301	1.5e-08	0.30	0.47	0.50
PGSC0003DMC200021795	K08008	ko04145	Phagosome	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMC200021795	K08008	ko04670	Leukocyte transendothelial migration	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMC200021796	K08008	ko04145	Phagosome	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMC200021796	K08008	ko04670	Leukocyte transendothelial migration	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMC200021802	K01762	ko00270	Cysteine and methionine metabolism	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMC200021802	K01762	ko01110	Biosynthesis of secondary metabolites	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMC200021803	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMC200021803	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMC200021804	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMC200021804	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMC200021808	K01213	ko00040	Pentose and glucuronate interconversions	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMC200021808	K01213	ko00500	Starch and sucrose metabolism	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMC200021808	K01213	ko01100	Metabolic pathways	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMC200021809	K01213	ko00040	Pentose and glucuronate interconversions	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMC200021809	K01213	ko00500	Starch and sucrose metabolism	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMC200021809	K01213	ko01100	Metabolic pathways	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMC200028597	K04498	ko04110	Cell cycle	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04310	Wnt signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04330	Notch signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04350	TGF-beta signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04520	Adherens junction	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04630	Jak-STAT signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04720	Long-term potentiation	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko04916	Melanogenesis	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko05016	Huntington's disease	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko05200	Pathways in cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko05211	Renal cell carcinoma	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028597	K04498	ko05215	Prostate cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04110	Cell cycle	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04310	Wnt signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04330	Notch signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04350	TGF-beta signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04520	Adherens junction	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04630	Jak-STAT signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04720	Long-term potentiation	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko04916	Melanogenesis	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko05016	Huntington's disease	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko05200	Pathways in cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko05211	Renal cell carcinoma	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028598	K04498	ko05215	Prostate cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04110	Cell cycle	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04310	Wnt signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04330	Notch signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04350	TGF-beta signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04520	Adherens junction	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04630	Jak-STAT signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04720	Long-term potentiation	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko04916	Melanogenesis	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko05016	Huntington's disease	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko05200	Pathways in cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko05211	Renal cell carcinoma	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028599	K04498	ko05215	Prostate cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04110	Cell cycle	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04310	Wnt signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04330	Notch signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04350	TGF-beta signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04520	Adherens junction	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04630	Jak-STAT signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04720	Long-term potentiation	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko04916	Melanogenesis	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko05016	Huntington's disease	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko05200	Pathways in cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko05211	Renal cell carcinoma	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028600	K04498	ko05215	Prostate cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMC200028601	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMC200028602	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMC200028603	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMC200028604	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMC200028607	K01046	ko00561	Glycerolipid metabolism	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMC200028607	K01046	ko01100	Metabolic pathways	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMC200028608	K01046	ko00561	Glycerolipid metabolism	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMC200028608	K01046	ko01100	Metabolic pathways	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMC200028610	K00430	ko00360	Phenylalanine metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMC200028610	K00430	ko00680	Methane metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMC200028610	K00430	ko00940	Phenylpropanoid biosynthesis	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMC200028610	K00430	ko01100	Metabolic pathways	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMC200028610	K00430	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMC200028611	K02084	ko04115	p53 signaling pathway	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko04210	Apoptosis	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko05010	Alzheimer's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko05012	Parkinson's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko05016	Huntington's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028611	K02084	ko05222	Small cell lung cancer	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMC200028612	K00814	ko00250	Alanine, aspartate and glutamate metabolism	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMC200028612	K00814	ko00710	Carbon fixation in photosynthetic organisms	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMC200028612	K00814	ko01100	Metabolic pathways	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMC200028614	K13065	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMC200028614	K13065	ko00941	Flavonoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMC200028614	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMC200028614	K13065	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMC200028618	K03531	ko04112	Cell cycle - Caulobacter	308	1.5e-10	0.28	0.48	0.32
PGSC0003DMC200028619	K03531	ko04112	Cell cycle - Caulobacter	304	2.6e-10	0.27	0.49	0.32
PGSC0003DMC200038824	K01082	ko00920	Sulfur metabolism	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMC200038824	K01082	ko01100	Metabolic pathways	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMC200038825	K01107	ko00562	Inositol phosphate metabolism	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMC200038825	K01107	ko01100	Metabolic pathways	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMC200038825	K01107	ko04070	Phosphatidylinositol signaling system	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMC200038826	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038826	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038826	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038827	K01107	ko00562	Inositol phosphate metabolism	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMC200038827	K01107	ko01100	Metabolic pathways	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMC200038827	K01107	ko04070	Phosphatidylinositol signaling system	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMC200038828	K01082	ko00920	Sulfur metabolism	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMC200038828	K01082	ko01100	Metabolic pathways	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMC200038829	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038829	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038829	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMC200038830	K01107	ko00562	Inositol phosphate metabolism	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMC200038830	K01107	ko01100	Metabolic pathways	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMC200038830	K01107	ko04070	Phosphatidylinositol signaling system	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMC200038831	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038831	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038832	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038832	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038833	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038833	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMC200038834	K01082	ko00920	Sulfur metabolism	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMC200038834	K01082	ko01100	Metabolic pathways	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMC200038835	K01082	ko00920	Sulfur metabolism	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMC200038835	K01082	ko01100	Metabolic pathways	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMC200038836	K01082	ko00920	Sulfur metabolism	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMC200038836	K01082	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMC200038840	K08139	ko04113	Meiosis - yeast	994	5.5e-49	0.37	0.56	0.87
PGSC0003DMC200038843	K03885	ko00190	Oxidative phosphorylation	3993	2.1e-214	0.79	0.90	1.00
PGSC0003DMC200038847	K00861	ko00740	Riboflavin metabolism	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMC200038847	K00861	ko01100	Metabolic pathways	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMC200038848	K00861	ko00740	Riboflavin metabolism	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMC200038848	K00861	ko01100	Metabolic pathways	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMC200038849	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMC200038849	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMC200038850	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMC200038850	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMC200034176	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034177	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034178	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034179	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034181	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034184	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMC200034192	K01528	ko04144	Endocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMC200034192	K01528	ko04666	Fc gamma R-mediated phagocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMC200034192	K01528	ko05100	Bacterial invasion of epithelial cells	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMC200034198	K04663	ko04340	Hedgehog signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMC200034198	K04663	ko04350	TGF-beta signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMC200052986	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMC200052986	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMC200052986	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMC200052987	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMC200052987	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMC200052987	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMC200052990	K01188	ko00460	Cyanoamino acid metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMC200052990	K01188	ko00500	Starch and sucrose metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMC200052990	K01188	ko00940	Phenylpropanoid biosynthesis	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMC200052990	K01188	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMC200052992	K13030	ko00460	Cyanoamino acid metabolism	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMC200052992	K13030	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMC200052993	K13068	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.27	0.50	0.98
PGSC0003DMC200052994	K13068	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.27	0.50	0.98
PGSC0003DMC200052995	K01955	ko00240	Pyrimidine metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMC200052995	K01955	ko00250	Alanine, aspartate and glutamate metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMC200052995	K01955	ko01100	Metabolic pathways	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMC200052998	K11094	ko03040	Spliceosome	435	3.7e-18	0.77	0.97	0.98
PGSC0003DMC200052999	K11094	ko03040	Spliceosome	1491	2.1e-76	0.73	0.87	0.99
PGSC0003DMC200053001	K01955	ko00240	Pyrimidine metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMC200053001	K01955	ko00250	Alanine, aspartate and glutamate metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMC200053001	K01955	ko01100	Metabolic pathways	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMC200053002	K01955	ko00240	Pyrimidine metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMC200053002	K01955	ko00250	Alanine, aspartate and glutamate metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMC200053002	K01955	ko01100	Metabolic pathways	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMC200053004	K12132	ko04712	Circadian rhythm - plant	1349	1.4e-68	0.41	0.55	0.93
PGSC0003DMC200053005	K12132	ko04712	Circadian rhythm - plant	1826	7.0e-95	0.58	0.70	0.84
PGSC0003DMC200053006	K12132	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.46	0.60	0.93
PGSC0003DMC200053008	K03843	ko00510	N-Glycan biosynthesis	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMC200053008	K03843	ko01100	Metabolic pathways	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMC200053009	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMC200053009	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMC200053010	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMC200053010	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMC200008823	K00826	ko00280	Valine, leucine and isoleucine degradation	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMC200008823	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMC200008823	K00826	ko00770	Pantothenate and CoA biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMC200008823	K00826	ko01100	Metabolic pathways	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMC200008823	K00826	ko01110	Biosynthesis of secondary metabolites	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMC200008825	K00826	ko00280	Valine, leucine and isoleucine degradation	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMC200008825	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMC200008825	K00826	ko00770	Pantothenate and CoA biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMC200008825	K00826	ko01100	Metabolic pathways	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMC200008825	K00826	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMC200008842	K07374	ko04145	Phagosome	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMC200008842	K07374	ko04540	Gap junction	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMC200008842	K07374	ko05130	Pathogenic Escherichia coli infection	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMC200008843	K07374	ko04145	Phagosome	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMC200008843	K07374	ko04540	Gap junction	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMC200008843	K07374	ko05130	Pathogenic Escherichia coli infection	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMC200022986	K10588	ko04120	Ubiquitin mediated proteolysis	1646	6.0e-85	0.31	0.48	0.98
PGSC0003DMC200022987	K10588	ko04120	Ubiquitin mediated proteolysis	1613	3.9e-83	0.42	0.59	0.67
PGSC0003DMC200022988	K10588	ko04120	Ubiquitin mediated proteolysis	1693	1.5e-87	0.32	0.48	0.98
PGSC0003DMC200023002	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMC200023002	K02366	ko01100	Metabolic pathways	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMC200023003	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMC200023003	K02366	ko01100	Metabolic pathways	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMC200023006	K01754	ko00260	Glycine, serine and threonine metabolism	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMC200023006	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMC200023006	K01754	ko01100	Metabolic pathways	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMC200023006	K01754	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMC200004171	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.52	0.68	0.92
PGSC0003DMC200004172	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMC200004173	K01199	ko00500	Starch and sucrose metabolism	718	9.1e-34	0.48	0.62	0.99
PGSC0003DMC200004174	K01199	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.50	0.64	0.94
PGSC0003DMC200004175	K01199	ko00500	Starch and sucrose metabolism	1296	1.2e-65	0.50	0.66	1.00
PGSC0003DMC200004176	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMC200004177	K01199	ko00500	Starch and sucrose metabolism	939	5.9e-46	0.51	0.66	0.93
PGSC0003DMC200004178	K01199	ko00500	Starch and sucrose metabolism	701	7.9e-33	0.49	0.65	0.98
PGSC0003DMC200004179	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMC200004180	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMC200004180	K00517	ko00626	Naphthalene and anthracene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMC200004180	K00517	ko00903	Limonene and pinene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMC200004180	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMC200004180	K00517	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMC200004181	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMC200004181	K00517	ko00626	Naphthalene and anthracene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMC200004181	K00517	ko00903	Limonene and pinene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMC200004181	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMC200004181	K00517	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMC200004182	K01199	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.46	0.67	0.97
PGSC0003DMC200004183	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.45	0.67	0.94
PGSC0003DMC200004184	K01199	ko00500	Starch and sucrose metabolism	1155	7.2e-58	0.47	0.68	0.96
PGSC0003DMC200004187	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMC200004187	K00517	ko00626	Naphthalene and anthracene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMC200004187	K00517	ko00903	Limonene and pinene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMC200004187	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMC200004187	K00517	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMC200004188	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMC200004188	K00517	ko00626	Naphthalene and anthracene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMC200004188	K00517	ko00903	Limonene and pinene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMC200004188	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMC200004188	K00517	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMC200004194	K07424	ko00140	Steroid hormone biosynthesis	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00591	Linoleic acid metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00830	Retinol metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00982	Drug metabolism - cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko00983	Drug metabolism - other enzymes	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004194	K07424	ko01100	Metabolic pathways	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMC200004195	K07424	ko00140	Steroid hormone biosynthesis	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00591	Linoleic acid metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00830	Retinol metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00982	Drug metabolism - cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko00983	Drug metabolism - other enzymes	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004195	K07424	ko01100	Metabolic pathways	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMC200004196	K07424	ko00140	Steroid hormone biosynthesis	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00591	Linoleic acid metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00830	Retinol metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00982	Drug metabolism - cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko00983	Drug metabolism - other enzymes	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004196	K07424	ko01100	Metabolic pathways	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMC200004197	K07424	ko00140	Steroid hormone biosynthesis	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00591	Linoleic acid metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00830	Retinol metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko00983	Drug metabolism - other enzymes	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004197	K07424	ko01100	Metabolic pathways	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMC200004198	K01930	ko00790	Folate biosynthesis	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMC200004198	K01930	ko01100	Metabolic pathways	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMC200004199	K01930	ko00790	Folate biosynthesis	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMC200004199	K01930	ko01100	Metabolic pathways	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMC200004200	K01930	ko00790	Folate biosynthesis	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMC200004200	K01930	ko01100	Metabolic pathways	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMC200027394	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00270	Cysteine and methionine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00330	Arginine and proline metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00350	Tyrosine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00360	Phenylalanine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00401	Novobiocin biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00710	Carbon fixation in photosynthetic organisms	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko01100	Metabolic pathways	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027394	K00813	ko01110	Biosynthesis of secondary metabolites	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMC200027398	K02906	ko03010	Ribosome	1689	2.5e-87	0.73	0.83	1.00
PGSC0003DMC200027407	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027407	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027407	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027407	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027408	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027408	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027408	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027408	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027409	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027409	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027409	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027409	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027410	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027410	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027410	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027410	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMC200027411	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027411	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027411	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027411	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMC200027412	K00971	ko00051	Fructose and mannose metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMC200027412	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMC200027412	K00971	ko01100	Metabolic pathways	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMC200027412	K00971	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMC200027416	K04646	ko04142	Lysosome	11637	0.	0.83	0.87	1.00
PGSC0003DMC200027416	K04646	ko04144	Endocytosis	11637	0.	0.83	0.87	1.00
PGSC0003DMC200027416	K04646	ko05016	Huntington's disease	11637	0.	0.83	0.87	1.00
PGSC0003DMC200027416	K04646	ko05100	Bacterial invasion of epithelial cells	11637	0.	0.83	0.87	1.00
PGSC0003DMC200027417	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMC200027417	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMC200027417	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMC200027417	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMC200027418	K04646	ko04142	Lysosome	12750	0.	0.94	0.97	1.00
PGSC0003DMC200027418	K04646	ko04144	Endocytosis	12750	0.	0.94	0.97	1.00
PGSC0003DMC200027418	K04646	ko05016	Huntington's disease	12750	0.	0.94	0.97	1.00
PGSC0003DMC200027418	K04646	ko05100	Bacterial invasion of epithelial cells	12750	0.	0.94	0.97	1.00
PGSC0003DMC200027420	K13065	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMC200027420	K13065	ko00941	Flavonoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMC200027420	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMC200027420	K13065	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMC200062512	K03094	ko04110	Cell cycle	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04111	Cell cycle - yeast	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04114	Oocyte meiosis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04310	Wnt signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04350	TGF-beta signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200062512	K03094	ko04710	Circadian rhythm - mammal	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMC200001966	K01696	ko00260	Glycine, serine and threonine metabolism	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMC200001966	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMC200001966	K01696	ko01100	Metabolic pathways	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMC200001966	K01696	ko01110	Biosynthesis of secondary metabolites	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMC200001967	K01696	ko00260	Glycine, serine and threonine metabolism	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMC200001967	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMC200001967	K01696	ko01100	Metabolic pathways	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMC200001967	K01696	ko01110	Biosynthesis of secondary metabolites	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMC200001973	K07203	ko04012	ErbB signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko04150	mTOR signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko04910	Insulin signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko04920	Adipocytokine signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko04930	Type II diabetes mellitus	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko05200	Pathways in cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko05214	Glioma	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko05215	Prostate cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001973	K07203	ko05221	Acute myeloid leukemia	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMC200001975	K00660	ko00941	Flavonoid biosynthesis	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMC200001975	K00660	ko01100	Metabolic pathways	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMC200001975	K00660	ko01110	Biosynthesis of secondary metabolites	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMC200001975	K00660	ko04712	Circadian rhythm - plant	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMC200001978	K07424	ko00140	Steroid hormone biosynthesis	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00591	Linoleic acid metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00830	Retinol metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00982	Drug metabolism - cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko00983	Drug metabolism - other enzymes	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001978	K07424	ko01100	Metabolic pathways	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMC200001979	K06130	ko00564	Glycerophospholipid metabolism	587	1.5e-26	0.38	0.55	0.87
PGSC0003DMC200051781	K02888	ko03010	Ribosome	520	7.6e-23	0.41	0.57	0.81
PGSC0003DMC200051805	K05349	ko00460	Cyanoamino acid metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMC200051805	K05349	ko00500	Starch and sucrose metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMC200051805	K05349	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMC200051805	K05349	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMC200051806	K05349	ko00460	Cyanoamino acid metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMC200051806	K05349	ko00500	Starch and sucrose metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMC200051806	K05349	ko00940	Phenylpropanoid biosynthesis	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMC200051806	K05349	ko01110	Biosynthesis of secondary metabolites	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMC200051807	K05349	ko00460	Cyanoamino acid metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMC200051807	K05349	ko00500	Starch and sucrose metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMC200051807	K05349	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMC200051807	K05349	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMC200051808	K06027	ko04962	Vasopressin-regulated water reabsorption	895	1.6e-43	0.49	0.59	0.93
PGSC0003DMC200051809	K06027	ko04962	Vasopressin-regulated water reabsorption	4721	1.5e-254	0.73	0.84	1.00
PGSC0003DMC200051810	K06027	ko04962	Vasopressin-regulated water reabsorption	4994	1.3e-269	0.80	0.91	1.00
PGSC0003DMC200032972	K13065	ko00940	Phenylpropanoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMC200032972	K13065	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMC200032972	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMC200032972	K13065	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMC200032975	K08242	ko00100	Steroid biosynthesis	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMC200032975	K08242	ko01110	Biosynthesis of secondary metabolites	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMC200032978	K04424	ko04010	MAPK signaling pathway	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMC200032978	K04424	ko04530	Tight junction	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMC200032980	K00958	ko00230	Purine metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMC200032980	K00958	ko00450	Selenoamino acid metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMC200032980	K00958	ko00920	Sulfur metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMC200032980	K00958	ko01100	Metabolic pathways	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMC200032981	K02950	ko03010	Ribosome	280	1.3e-09	0.65	0.87	0.65
PGSC0003DMC200032984	K03144	ko03022	Basal transcription factors	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMC200032984	K03144	ko03420	Nucleotide excision repair	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMC200032985	K03144	ko03022	Basal transcription factors	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMC200032985	K03144	ko03420	Nucleotide excision repair	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMC200032987	K12126	ko04712	Circadian rhythm - plant	768	1.6e-36	0.35	0.48	0.85
PGSC0003DMC200032988	K12126	ko04712	Circadian rhythm - plant	301	1.3e-10	0.28	0.42	0.97
PGSC0003DMC200032989	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.76
PGSC0003DMC200032990	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.80
PGSC0003DMC200058618	K00235	ko00020	Citrate cycle (TCA cycle)	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko00190	Oxidative phosphorylation	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko01100	Metabolic pathways	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko05010	Alzheimer's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko05012	Parkinson's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200058618	K00235	ko05016	Huntington's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMC200018398	K12343	ko00140	Steroid hormone biosynthesis	384	2.4e-15	0.29	0.49	0.82
PGSC0003DMC200018400	K02183	ko04020	Calcium signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04070	Phosphatidylinositol signaling system	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04114	Oocyte meiosis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04270	Vascular smooth muscle contraction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04626	Plant-pathogen interaction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04720	Long-term potentiation	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04722	Neurotrophin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04740	Olfactory transduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04744	Phototransduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04745	Phototransduction - fly	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04910	Insulin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04912	GnRH signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04916	Melanogenesis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04970	Salivary secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko04971	Gastric acid secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko05010	Alzheimer's disease	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018400	K02183	ko05214	Glioma	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMC200018401	K04733	ko04210	Apoptosis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMC200018401	K04733	ko04620	Toll-like receptor signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMC200018401	K04733	ko04722	Neurotrophin signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMC200018401	K04733	ko05140	Leishmaniasis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMC200018401	K04733	ko05142	Chagas disease	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMC200018403	K04733	ko04210	Apoptosis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMC200018403	K04733	ko04620	Toll-like receptor signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMC200018403	K04733	ko04722	Neurotrophin signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMC200018403	K04733	ko05140	Leishmaniasis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMC200018403	K04733	ko05142	Chagas disease	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMC200018407	K00227	ko00100	Steroid biosynthesis	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMC200018407	K00227	ko01100	Metabolic pathways	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMC200018407	K00227	ko01110	Biosynthesis of secondary metabolites	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMC200018409	K01054	ko00561	Glycerolipid metabolism	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMC200018409	K01054	ko01100	Metabolic pathways	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMC200018410	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMC200018410	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMC200018411	K01054	ko00561	Glycerolipid metabolism	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMC200018411	K01054	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMC200018412	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMC200018412	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMC200012846	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMC200012847	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMC200012848	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMC200012859	K10746	ko03430	Mismatch repair	2508	1.7e-132	0.47	0.62	1.00
PGSC0003DMC200025997	K00680	ko00350	Tyrosine metabolism	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMC200025997	K00680	ko00624	1- and 2-Methylnaphthalene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMC200025997	K00680	ko00632	Benzoate degradation via CoA ligation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMC200025997	K00680	ko00642	Ethylbenzene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMC200025997	K00680	ko00903	Limonene and pinene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMC200025998	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMC200025998	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMC200025998	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMC200025998	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMC200025998	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMC200025999	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMC200025999	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMC200025999	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMC200025999	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMC200025999	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMC200026001	K00680	ko00350	Tyrosine metabolism	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMC200026001	K00680	ko00624	1- and 2-Methylnaphthalene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMC200026001	K00680	ko00632	Benzoate degradation via CoA ligation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMC200026001	K00680	ko00642	Ethylbenzene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMC200026001	K00680	ko00903	Limonene and pinene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMC200026003	K00680	ko00350	Tyrosine metabolism	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMC200026003	K00680	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMC200026003	K00680	ko00632	Benzoate degradation via CoA ligation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMC200026003	K00680	ko00642	Ethylbenzene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMC200026003	K00680	ko00903	Limonene and pinene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMC200026005	K00680	ko00350	Tyrosine metabolism	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMC200026005	K00680	ko00624	1- and 2-Methylnaphthalene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMC200026005	K00680	ko00632	Benzoate degradation via CoA ligation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMC200026005	K00680	ko00642	Ethylbenzene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMC200026005	K00680	ko00903	Limonene and pinene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMC200026006	K01590	ko00340	Histidine metabolism	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMC200026006	K01590	ko01100	Metabolic pathways	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMC200026006	K01590	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMC200026007	K01590	ko00340	Histidine metabolism	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMC200026007	K01590	ko01100	Metabolic pathways	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMC200026007	K01590	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMC200026008	K01590	ko00340	Histidine metabolism	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMC200026008	K01590	ko01100	Metabolic pathways	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMC200026008	K01590	ko01110	Biosynthesis of secondary metabolites	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMC200066650	K07188	ko04910	Insulin signaling pathway	306	1.9e-10	0.28	0.47	0.91
PGSC0003DMC200032161	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032161	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMC200032162	K02084	ko04115	p53 signaling pathway	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko04210	Apoptosis	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko05010	Alzheimer's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko05012	Parkinson's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko05016	Huntington's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032162	K02084	ko05222	Small cell lung cancer	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMC200032164	K02084	ko04115	p53 signaling pathway	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko04210	Apoptosis	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko05010	Alzheimer's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko05012	Parkinson's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko05016	Huntington's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032164	K02084	ko05222	Small cell lung cancer	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMC200032165	K02084	ko04115	p53 signaling pathway	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko04210	Apoptosis	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko05010	Alzheimer's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko05012	Parkinson's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko05016	Huntington's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032165	K02084	ko05222	Small cell lung cancer	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMC200032166	K02084	ko04115	p53 signaling pathway	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko04210	Apoptosis	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko05010	Alzheimer's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko05012	Parkinson's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko05016	Huntington's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032166	K02084	ko05222	Small cell lung cancer	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMC200032167	K02084	ko04115	p53 signaling pathway	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko04210	Apoptosis	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko05010	Alzheimer's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko05012	Parkinson's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko05016	Huntington's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032167	K02084	ko05222	Small cell lung cancer	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMC200032185	K04121	ko00904	Diterpenoid biosynthesis	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMC200032185	K04121	ko01100	Metabolic pathways	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMC200032185	K04121	ko01110	Biosynthesis of secondary metabolites	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMC200032188	K09843	ko00906	Carotenoid biosynthesis	2995	2.3e-159	0.76	0.87	0.99
PGSC0003DMC200032189	K09843	ko00906	Carotenoid biosynthesis	2598	1.9e-137	0.80	0.90	0.99
PGSC0003DMC200049603	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMC200049604	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMC200049611	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3834	1.2e-205	0.87	0.95	0.96
PGSC0003DMC200049613	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.49
PGSC0003DMC200049616	K05278	ko00941	Flavonoid biosynthesis	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMC200049616	K05278	ko01100	Metabolic pathways	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMC200049616	K05278	ko01110	Biosynthesis of secondary metabolites	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMC200049617	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMC200049617	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMC200049617	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMC200049618	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049618	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049618	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMC200049619	K05277	ko00941	Flavonoid biosynthesis	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMC200049619	K05277	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMC200049619	K05277	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMC200049620	K05278	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMC200049620	K05278	ko01100	Metabolic pathways	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMC200049620	K05278	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMC200047404	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.43	0.63	0.89
PGSC0003DMC200047407	K12356	ko00940	Phenylpropanoid biosynthesis	711	2.2e-33	0.33	0.51	0.88
PGSC0003DMC200047409	K08249	ko00460	Cyanoamino acid metabolism	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMC200047409	K08249	ko01100	Metabolic pathways	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMC200047410	K08249	ko00460	Cyanoamino acid metabolism	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMC200047410	K08249	ko01100	Metabolic pathways	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMC200047414	K03955	ko00190	Oxidative phosphorylation	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMC200047414	K03955	ko01100	Metabolic pathways	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMC200047414	K03955	ko05010	Alzheimer's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMC200047414	K03955	ko05012	Parkinson's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMC200047414	K03955	ko05016	Huntington's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMC200054802	K10879	ko03440	Homologous recombination	332	1.8e-12	0.35	0.43	0.93
PGSC0003DMC200054803	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.76
PGSC0003DMC200054804	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.92
PGSC0003DMC200054805	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.80
PGSC0003DMC200054807	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMC200054807	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMC200054807	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMC200054807	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMC200054807	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMC200044041	K10869	ko03440	Homologous recombination	1059	1.4e-52	0.67	0.83	0.96
PGSC0003DMC200044042	K10869	ko03440	Homologous recombination	537	8.8e-24	0.61	0.75	0.70
PGSC0003DMC200044043	K10869	ko03440	Homologous recombination	323	5.6e-12	0.65	0.86	0.75
PGSC0003DMC200044044	K10869	ko03440	Homologous recombination	349	2.1e-13	0.65	0.78	0.97
PGSC0003DMC200044046	K10955	ko05110	Vibrio cholerae infection	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMC200044046	K10955	ko05146	Amoebiasis	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMC200044057	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMC200044063	K01955	ko00240	Pyrimidine metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMC200044063	K01955	ko00250	Alanine, aspartate and glutamate metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMC200044063	K01955	ko01100	Metabolic pathways	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMC200044064	K01955	ko00240	Pyrimidine metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMC200044064	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMC200044064	K01955	ko01100	Metabolic pathways	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMC200032014	K11423	ko00310	Lysine degradation	273	8.3e-06	0.26	0.44	0.76
PGSC0003DMC200032026	K00901	ko00561	Glycerolipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMC200032026	K00901	ko00564	Glycerophospholipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMC200032026	K00901	ko01100	Metabolic pathways	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMC200032026	K00901	ko04070	Phosphatidylinositol signaling system	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMC200032027	K00901	ko00561	Glycerolipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMC200032027	K00901	ko00564	Glycerophospholipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMC200032027	K00901	ko01100	Metabolic pathways	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMC200032027	K00901	ko04070	Phosphatidylinositol signaling system	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMC200032028	K00901	ko00561	Glycerolipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMC200032028	K00901	ko00564	Glycerophospholipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMC200032028	K00901	ko01100	Metabolic pathways	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMC200032028	K00901	ko04070	Phosphatidylinositol signaling system	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMC200032031	K00889	ko00562	Inositol phosphate metabolism	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032031	K00889	ko01100	Metabolic pathways	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032031	K00889	ko04070	Phosphatidylinositol signaling system	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032031	K00889	ko04144	Endocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032031	K00889	ko04666	Fc gamma R-mediated phagocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032031	K00889	ko04810	Regulation of actin cytoskeleton	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMC200032032	K00889	ko00562	Inositol phosphate metabolism	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032032	K00889	ko01100	Metabolic pathways	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032032	K00889	ko04070	Phosphatidylinositol signaling system	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032032	K00889	ko04144	Endocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032032	K00889	ko04666	Fc gamma R-mediated phagocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032032	K00889	ko04810	Regulation of actin cytoskeleton	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMC200032033	K00889	ko00562	Inositol phosphate metabolism	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032033	K00889	ko01100	Metabolic pathways	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032033	K00889	ko04070	Phosphatidylinositol signaling system	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032033	K00889	ko04144	Endocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032033	K00889	ko04666	Fc gamma R-mediated phagocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032033	K00889	ko04810	Regulation of actin cytoskeleton	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMC200032036	K08490	ko04130	SNARE interactions in vesicular transport	1723	3.4e-89	0.64	0.77	0.99
PGSC0003DMC200035375	K04714	ko00600	Sphingolipid metabolism	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMC200035375	K04714	ko01100	Metabolic pathways	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMC200035384	K01425	ko00250	Alanine, aspartate and glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035384	K01425	ko00330	Arginine and proline metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035384	K01425	ko00471	D-Glutamine and D-glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035384	K01425	ko00910	Nitrogen metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035384	K01425	ko01100	Metabolic pathways	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035384	K01425	ko04964	Proximal tubule bicarbonate reclamation	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMC200035385	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMC200035385	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMC200035386	K04424	ko04010	MAPK signaling pathway	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMC200035386	K04424	ko04530	Tight junction	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMC200035387	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMC200035387	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMC200035388	K04424	ko04010	MAPK signaling pathway	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMC200035388	K04424	ko04530	Tight junction	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMC200035389	K04424	ko04010	MAPK signaling pathway	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMC200035389	K04424	ko04530	Tight junction	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMC200035390	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035390	K01653	ko00650	Butanoate metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035390	K01653	ko00660	C5-Branched dibasic acid metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035390	K01653	ko00770	Pantothenate and CoA biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035390	K01653	ko01100	Metabolic pathways	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035390	K01653	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMC200035391	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035391	K01653	ko00650	Butanoate metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035391	K01653	ko00660	C5-Branched dibasic acid metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035391	K01653	ko00770	Pantothenate and CoA biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035391	K01653	ko01100	Metabolic pathways	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035391	K01653	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMC200035392	K01184	ko00040	Pentose and glucuronate interconversions	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMC200035392	K01184	ko00500	Starch and sucrose metabolism	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMC200035392	K01184	ko01100	Metabolic pathways	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMC200035393	K01184	ko00040	Pentose and glucuronate interconversions	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMC200035393	K01184	ko00500	Starch and sucrose metabolism	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMC200035393	K01184	ko01100	Metabolic pathways	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMC200035394	K01184	ko00040	Pentose and glucuronate interconversions	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMC200035394	K01184	ko00500	Starch and sucrose metabolism	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMC200035394	K01184	ko01100	Metabolic pathways	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMC200035395	K01099	ko00562	Inositol phosphate metabolism	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMC200035395	K01099	ko01100	Metabolic pathways	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMC200035395	K01099	ko04070	Phosphatidylinositol signaling system	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMC200044138	K12831	ko03040	Spliceosome	350	1.8e-13	0.45	0.53	0.73
PGSC0003DMC200044143	K00850	ko00010	Glycolysis / Gluconeogenesis	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044143	K00850	ko00030	Pentose phosphate pathway	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044143	K00850	ko00051	Fructose and mannose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044143	K00850	ko00052	Galactose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044143	K00850	ko01100	Metabolic pathways	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044143	K00850	ko01110	Biosynthesis of secondary metabolites	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMC200044144	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044144	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044144	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044144	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044144	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044144	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044145	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMC200044146	K00850	ko00010	Glycolysis / Gluconeogenesis	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044146	K00850	ko00030	Pentose phosphate pathway	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044146	K00850	ko00051	Fructose and mannose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044146	K00850	ko00052	Galactose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044146	K00850	ko01100	Metabolic pathways	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044146	K00850	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMC200044147	K00850	ko00010	Glycolysis / Gluconeogenesis	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044147	K00850	ko00030	Pentose phosphate pathway	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044147	K00850	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044147	K00850	ko00052	Galactose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044147	K00850	ko01100	Metabolic pathways	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044147	K00850	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMC200044148	K07195	ko04910	Insulin signaling pathway	2559	2.6e-135	0.53	0.69	0.99
PGSC0003DMC200044149	K00654	ko00600	Sphingolipid metabolism	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMC200044149	K00654	ko01100	Metabolic pathways	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMC200044150	K00654	ko00600	Sphingolipid metabolism	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMC200044150	K00654	ko01100	Metabolic pathways	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMC200044153	K05759	ko04810	Regulation of actin cytoskeleton	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMC200044153	K05759	ko05131	Shigellosis	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMC200044154	K11481	ko04114	Oocyte meiosis	2035	2.1e-106	0.88	0.93	0.99
PGSC0003DMC200044155	K11481	ko04114	Oocyte meiosis	1409	7.0e-72	0.86	0.90	0.98
PGSC0003DMC200044157	K11481	ko04114	Oocyte meiosis	2258	1.0e-118	0.87	0.93	0.99
PGSC0003DMC200037622	K13228	ko00402	Benzoxazinoid biosynthesis	602	2.3e-27	0.35	0.53	0.85
PGSC0003DMC200037633	K06236	ko04510	Focal adhesion	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMC200037633	K06236	ko04512	ECM-receptor interaction	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMC200037633	K06236	ko05146	Amoebiasis	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMC200037640	K07385	ko00902	Monoterpenoid biosynthesis	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMC200037640	K07385	ko01100	Metabolic pathways	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMC200037641	K07385	ko00902	Monoterpenoid biosynthesis	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMC200037641	K07385	ko01100	Metabolic pathways	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMC200067149	K01087	ko00500	Starch and sucrose metabolism	739	6.3e-35	0.43	0.53	0.93
PGSC0003DMC200060108	K12338	ko00942	Anthocyanin biosynthesis	415	4.7e-17	0.38	0.61	0.99
PGSC0003DMC200029792	K10846	ko03420	Nucleotide excision repair	395	1.8e-26	0.43	0.55	0.96
PGSC0003DMC200029796	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMC200029797	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMC200029798	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMC200029799	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMC200029800	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMC200029801	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	0.93
PGSC0003DMC200029802	K12897	ko03040	Spliceosome	287	5.4e-10	0.35	0.48	0.90
PGSC0003DMC200029813	K06677	ko04111	Cell cycle - yeast	291	6.7e-11	0.49	0.58	0.63
PGSC0003DMC200029814	K06671	ko04110	Cell cycle	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMC200029814	K06671	ko04111	Cell cycle - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMC200029814	K06671	ko04113	Meiosis - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMC200029816	K02084	ko04115	p53 signaling pathway	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko04210	Apoptosis	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko05010	Alzheimer's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko05012	Parkinson's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko05016	Huntington's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200029816	K02084	ko05222	Small cell lung cancer	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMC200012937	K01213	ko00040	Pentose and glucuronate interconversions	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMC200012937	K01213	ko00500	Starch and sucrose metabolism	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMC200012937	K01213	ko01100	Metabolic pathways	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMC200012938	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012938	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012938	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012939	K01213	ko00040	Pentose and glucuronate interconversions	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMC200012939	K01213	ko00500	Starch and sucrose metabolism	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMC200012939	K01213	ko01100	Metabolic pathways	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMC200012940	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012940	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012940	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMC200012941	K04733	ko04210	Apoptosis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMC200012941	K04733	ko04620	Toll-like receptor signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMC200012941	K04733	ko04722	Neurotrophin signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMC200012941	K04733	ko05140	Leishmaniasis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMC200012941	K04733	ko05142	Chagas disease	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMC200012942	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMC200012943	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMC200012944	K07748	ko00100	Steroid biosynthesis	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMC200012944	K07748	ko01100	Metabolic pathways	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMC200012945	K13065	ko00940	Phenylpropanoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMC200012945	K13065	ko00941	Flavonoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMC200012945	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMC200012945	K13065	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMC200012947	K13065	ko00940	Phenylpropanoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMC200012947	K13065	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMC200012947	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMC200012947	K13065	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMC200012950	K13065	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMC200012950	K13065	ko00941	Flavonoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMC200012950	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMC200012950	K13065	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMC200006422	K04424	ko04010	MAPK signaling pathway	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMC200006422	K04424	ko04530	Tight junction	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMC200006424	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMC200006425	K12399	ko04142	Lysosome	739	6.3e-35	0.60	0.74	0.99
PGSC0003DMC200006426	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMC200006427	K12399	ko04142	Lysosome	895	1.6e-43	0.74	0.89	0.89
PGSC0003DMC200006428	K12399	ko04142	Lysosome	939	5.9e-46	0.70	0.86	0.98
PGSC0003DMC200006438	K08486	ko04130	SNARE interactions in vesicular transport	1591	6.4e-82	0.64	0.84	1.00
PGSC0003DMC200006441	K13082	ko00941	Flavonoid biosynthesis	2077	1.0e-108	0.73	0.87	0.85
PGSC0003DMC200006443	K07252	ko00510	N-Glycan biosynthesis	327	3.4e-12	0.40	0.57	0.69
PGSC0003DMC200006444	K07252	ko00510	N-Glycan biosynthesis	332	1.8e-12	0.37	0.54	0.66
PGSC0003DMC200006445	K07252	ko00510	N-Glycan biosynthesis	310	2.9e-11	0.38	0.54	0.74
PGSC0003DMC200006446	K07252	ko00510	N-Glycan biosynthesis	325	4.3e-12	0.36	0.53	0.54
PGSC0003DMC200006447	K07252	ko00510	N-Glycan biosynthesis	323	5.6e-12	0.36	0.53	0.47
PGSC0003DMC200006448	K08241	ko00592	alpha-Linolenic acid metabolism	614	5.0e-28	0.48	0.67	0.85
PGSC0003DMC200006449	K08241	ko00592	alpha-Linolenic acid metabolism	1032	4.4e-51	0.40	0.60	0.95
PGSC0003DMC200006450	K04123	ko00904	Diterpenoid biosynthesis	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMC200006450	K04123	ko01100	Metabolic pathways	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMC200006450	K04123	ko01110	Biosynthesis of secondary metabolites	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMC200039751	K08233	ko00901	Indole alkaloid biosynthesis	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMC200039751	K08233	ko01110	Biosynthesis of secondary metabolites	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMC200039752	K08233	ko00901	Indole alkaloid biosynthesis	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMC200039752	K08233	ko01110	Biosynthesis of secondary metabolites	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMC200039753	K08233	ko00901	Indole alkaloid biosynthesis	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMC200039753	K08233	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMC200039754	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMC200039754	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMC200039755	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMC200039755	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMC200039758	K02183	ko04020	Calcium signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04070	Phosphatidylinositol signaling system	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04114	Oocyte meiosis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04270	Vascular smooth muscle contraction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04626	Plant-pathogen interaction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04720	Long-term potentiation	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04722	Neurotrophin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04740	Olfactory transduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04744	Phototransduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04745	Phototransduction - fly	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04910	Insulin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04912	GnRH signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04916	Melanogenesis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04970	Salivary secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko04971	Gastric acid secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko05010	Alzheimer's disease	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039758	K02183	ko05214	Glioma	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMC200039759	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039759	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039759	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039759	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039759	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039760	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039760	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039760	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039760	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039760	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMC200039762	K10206	ko00300	Lysine biosynthesis	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMC200039762	K10206	ko01110	Biosynthesis of secondary metabolites	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMC200039767	K09054	ko05010	Alzheimer's disease	246	4.8e-06	0.34	0.48	0.52
PGSC0003DMC200039768	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMC200039769	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMC200039773	K05349	ko00460	Cyanoamino acid metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMC200039773	K05349	ko00500	Starch and sucrose metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMC200039773	K05349	ko00940	Phenylpropanoid biosynthesis	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMC200039773	K05349	ko01110	Biosynthesis of secondary metabolites	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMC200039774	K05349	ko00460	Cyanoamino acid metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMC200039774	K05349	ko00500	Starch and sucrose metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMC200039774	K05349	ko00940	Phenylpropanoid biosynthesis	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMC200039774	K05349	ko01110	Biosynthesis of secondary metabolites	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMC200039775	K03514	ko03018	RNA degradation	257	2.4e-08	0.31	0.48	0.85
PGSC0003DMC200045001	K03006	ko00230	Purine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMC200045001	K03006	ko00240	Pyrimidine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMC200045001	K03006	ko01100	Metabolic pathways	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMC200045001	K03006	ko03020	RNA polymerase	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMC200045001	K03006	ko05016	Huntington's disease	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMC200045022	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMC200045026	K06636	ko04110	Cell cycle	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMC200045026	K06636	ko04111	Cell cycle - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMC200045026	K06636	ko04113	Meiosis - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMC200045026	K06636	ko04114	Oocyte meiosis	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMC200065294	K05282	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMC200065294	K05282	ko01100	Metabolic pathways	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMC200065294	K05282	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMC200065303	K04508	ko04310	Wnt signaling pathway	2067	3.6e-108	0.65	0.79	1.00
PGSC0003DMC200010955	K00434	ko00053	Ascorbate and aldarate metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMC200010955	K00434	ko00480	Glutathione metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMC200010959	K02731	ko03050	Proteasome	1362	2.8e-69	0.85	0.90	0.99
PGSC0003DMC200010969	K03094	ko04110	Cell cycle	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04111	Cell cycle - yeast	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04114	Oocyte meiosis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04120	Ubiquitin mediated proteolysis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04310	Wnt signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04350	TGF-beta signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010969	K03094	ko04710	Circadian rhythm - mammal	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMC200010970	K03094	ko04110	Cell cycle	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04111	Cell cycle - yeast	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04114	Oocyte meiosis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04120	Ubiquitin mediated proteolysis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04310	Wnt signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04350	TGF-beta signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010970	K03094	ko04710	Circadian rhythm - mammal	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMC200010971	K03094	ko04110	Cell cycle	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04111	Cell cycle - yeast	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04114	Oocyte meiosis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04120	Ubiquitin mediated proteolysis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04310	Wnt signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04350	TGF-beta signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010971	K03094	ko04710	Circadian rhythm - mammal	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMC200010972	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMC200010972	K00015	ko01100	Metabolic pathways	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMC200010977	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010977	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010978	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMC200010980	K01190	ko00052	Galactose metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMC200010980	K01190	ko00511	Other glycan degradation	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMC200010980	K01190	ko00600	Sphingolipid metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMC200010980	K01190	ko01100	Metabolic pathways	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMC200016201	K02135	ko00190	Oxidative phosphorylation	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMC200016201	K02135	ko01100	Metabolic pathways	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMC200016201	K02135	ko05010	Alzheimer's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMC200016201	K02135	ko05012	Parkinson's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMC200016201	K02135	ko05016	Huntington's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMC200016204	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016204	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016204	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016205	K01230	ko00510	N-Glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMC200016205	K01230	ko00513	High-mannose type N-glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMC200016205	K01230	ko01100	Metabolic pathways	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMC200016206	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016206	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016206	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMC200016224	K12828	ko03040	Spliceosome	1790	6.8e-93	0.76	0.82	0.85
PGSC0003DMC200020791	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMC200020791	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMC200020791	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMC200020791	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMC200020792	K03517	ko00760	Nicotinate and nicotinamide metabolism	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMC200020792	K03517	ko01100	Metabolic pathways	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMC200020793	K03517	ko00760	Nicotinate and nicotinamide metabolism	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMC200020793	K03517	ko01100	Metabolic pathways	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMC200020794	K03517	ko00760	Nicotinate and nicotinamide metabolism	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMC200020794	K03517	ko01100	Metabolic pathways	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMC200020800	K00799	ko00480	Glutathione metabolism	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMC200020800	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMC200020800	K00799	ko00982	Drug metabolism - cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMC200020809	K11099	ko03040	Spliceosome	444	1.2e-18	0.88	0.94	0.79
PGSC0003DMC200020814	K02901	ko03010	Ribosome	1046	7.4e-52	0.90	0.96	0.99
PGSC0003DMC200046202	K07424	ko00140	Steroid hormone biosynthesis	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00591	Linoleic acid metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00830	Retinol metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00982	Drug metabolism - cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko00983	Drug metabolism - other enzymes	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046202	K07424	ko01100	Metabolic pathways	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00140	Steroid hormone biosynthesis	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00591	Linoleic acid metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00830	Retinol metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00982	Drug metabolism - cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko00983	Drug metabolism - other enzymes	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046213	K07424	ko01100	Metabolic pathways	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMC200046214	K00948	ko00030	Pentose phosphate pathway	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMC200046214	K00948	ko00230	Purine metabolism	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMC200046214	K00948	ko01100	Metabolic pathways	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMC200046214	K00948	ko01110	Biosynthesis of secondary metabolites	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMC200046215	K00948	ko00030	Pentose phosphate pathway	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMC200046215	K00948	ko00230	Purine metabolism	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMC200046215	K00948	ko01100	Metabolic pathways	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMC200046215	K00948	ko01110	Biosynthesis of secondary metabolites	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMC200046227	K02132	ko00190	Oxidative phosphorylation	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMC200046227	K02132	ko01100	Metabolic pathways	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMC200046227	K02132	ko05010	Alzheimer's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMC200046227	K02132	ko05012	Parkinson's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMC200046227	K02132	ko05016	Huntington's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMC200040972	K01939	ko00230	Purine metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMC200040972	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMC200040972	K01939	ko01100	Metabolic pathways	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMC200040977	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMC200040978	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMC200040979	K00559	ko00100	Steroid biosynthesis	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMC200040979	K00559	ko01100	Metabolic pathways	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMC200040979	K00559	ko01110	Biosynthesis of secondary metabolites	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMC200040980	K02996	ko03010	Ribosome	1992	4.9e-104	0.63	0.74	1.00
PGSC0003DMC200050803	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMC200050803	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMC200050803	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMC200050803	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMC200050803	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMC200050804	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMC200050804	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMC200050804	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMC200050804	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMC200050804	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMC200050816	K01648	ko00020	Citrate cycle (TCA cycle)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMC200050816	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMC200050816	K01648	ko01100	Metabolic pathways	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMC200050816	K01648	ko01110	Biosynthesis of secondary metabolites	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMC200050817	K08233	ko00901	Indole alkaloid biosynthesis	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMC200050817	K08233	ko01110	Biosynthesis of secondary metabolites	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMC200015007	K12118	ko04712	Circadian rhythm - plant	3105	2.0e-165	0.85	0.94	0.91
PGSC0003DMC200015008	K12118	ko04712	Circadian rhythm - plant	4157	1.9e-223	0.83	0.91	0.99
PGSC0003DMC200015009	K12118	ko04712	Circadian rhythm - plant	502	7.5e-22	0.68	0.77	0.95
PGSC0003DMC200015018	K11262	ko00061	Fatty acid biosynthesis	14832	0.	0.80	0.87	1.00
PGSC0003DMC200015018	K11262	ko00620	Pyruvate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMC200015018	K11262	ko00640	Propanoate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMC200015018	K11262	ko01100	Metabolic pathways	14832	0.	0.80	0.87	1.00
PGSC0003DMC200015018	K11262	ko04910	Insulin signaling pathway	14832	0.	0.80	0.87	1.00
PGSC0003DMC200015019	K11262	ko00061	Fatty acid biosynthesis	16040	0.	0.84	0.92	0.99
PGSC0003DMC200015019	K11262	ko00620	Pyruvate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMC200015019	K11262	ko00640	Propanoate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMC200015019	K11262	ko01100	Metabolic pathways	16040	0.	0.84	0.92	0.99
PGSC0003DMC200015019	K11262	ko04910	Insulin signaling pathway	16040	0.	0.84	0.92	0.99
PGSC0003DMC200015021	K01210	ko00500	Starch and sucrose metabolism	2599	1.6e-137	0.64	0.77	0.92
PGSC0003DMC200015027	K13030	ko00460	Cyanoamino acid metabolism	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMC200015027	K13030	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMC200009761	K02183	ko04020	Calcium signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04070	Phosphatidylinositol signaling system	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04114	Oocyte meiosis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04270	Vascular smooth muscle contraction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04626	Plant-pathogen interaction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04720	Long-term potentiation	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04722	Neurotrophin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04740	Olfactory transduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04744	Phototransduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04745	Phototransduction - fly	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04910	Insulin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04912	GnRH signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04916	Melanogenesis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04970	Salivary secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko04971	Gastric acid secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko05010	Alzheimer's disease	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009761	K02183	ko05214	Glioma	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMC200009764	K07199	ko04910	Insulin signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMC200009764	K07199	ko04920	Adipocytokine signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMC200009764	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMC200009772	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMC200009772	K00517	ko00626	Naphthalene and anthracene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMC200009772	K00517	ko00903	Limonene and pinene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMC200009772	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMC200009772	K00517	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMC200009773	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMC200009773	K00517	ko00626	Naphthalene and anthracene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMC200009773	K00517	ko00903	Limonene and pinene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMC200009773	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMC200009773	K00517	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMC200009774	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMC200009774	K00517	ko00626	Naphthalene and anthracene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMC200009774	K00517	ko00903	Limonene and pinene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMC200009774	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMC200009774	K00517	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMC200009775	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMC200009775	K00517	ko00626	Naphthalene and anthracene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMC200009775	K00517	ko00903	Limonene and pinene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMC200009775	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMC200009775	K00517	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMC200009776	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMC200009776	K00517	ko00626	Naphthalene and anthracene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMC200009776	K00517	ko00903	Limonene and pinene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMC200009776	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMC200009776	K00517	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMC200009777	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMC200009777	K00517	ko00626	Naphthalene and anthracene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMC200009777	K00517	ko00903	Limonene and pinene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMC200009777	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMC200009777	K00517	ko01110	Biosynthesis of secondary metabolites	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMC200009780	K01178	ko00500	Starch and sucrose metabolism	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMC200009780	K01178	ko01100	Metabolic pathways	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMC200064081	K11229	ko04011	MAPK signaling pathway - yeast	572	7.9e-25	0.35	0.57	0.79
PGSC0003DMC200064087	K00799	ko00480	Glutathione metabolism	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMC200064087	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMC200064087	K00799	ko00982	Drug metabolism - cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMC200064109	K00059	ko00061	Fatty acid biosynthesis	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMC200064109	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMC200064109	K00059	ko01100	Metabolic pathways	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMC200059797	K10781	ko00061	Fatty acid biosynthesis	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMC200059797	K10781	ko01100	Metabolic pathways	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMC200059802	K12338	ko00942	Anthocyanin biosynthesis	489	3.9e-21	0.49	0.63	0.83
PGSC0003DMC200030813	K04618	ko00052	Galactose metabolism	474	9.6e-20	0.28	0.43	1.00
PGSC0003DMC200030837	K06666	ko04111	Cell cycle - yeast	459	2.0e-19	0.25	0.39	0.89
PGSC0003DMC200030838	K06666	ko04111	Cell cycle - yeast	496	2.1e-21	0.27	0.43	0.68
PGSC0003DMC200036443	K09839	ko00906	Carotenoid biosynthesis	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMC200036443	K09839	ko01100	Metabolic pathways	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMC200036443	K09839	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMC200042951	K02342	ko00230	Purine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042951	K02342	ko00240	Pyrimidine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042951	K02342	ko01100	Metabolic pathways	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042951	K02342	ko03030	DNA replication	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042951	K02342	ko03430	Mismatch repair	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042951	K02342	ko03440	Homologous recombination	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMC200042952	K02342	ko00230	Purine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042952	K02342	ko00240	Pyrimidine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042952	K02342	ko01100	Metabolic pathways	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042952	K02342	ko03030	DNA replication	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042952	K02342	ko03430	Mismatch repair	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042952	K02342	ko03440	Homologous recombination	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMC200042955	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.29	0.47	0.74
PGSC0003DMC200005372	K02183	ko04020	Calcium signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04070	Phosphatidylinositol signaling system	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04114	Oocyte meiosis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04270	Vascular smooth muscle contraction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04626	Plant-pathogen interaction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04720	Long-term potentiation	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04722	Neurotrophin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04740	Olfactory transduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04744	Phototransduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04745	Phototransduction - fly	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04910	Insulin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04912	GnRH signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04916	Melanogenesis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04970	Salivary secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko04971	Gastric acid secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko05010	Alzheimer's disease	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005372	K02183	ko05214	Glioma	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMC200005373	K02183	ko04020	Calcium signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04070	Phosphatidylinositol signaling system	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04114	Oocyte meiosis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04270	Vascular smooth muscle contraction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04626	Plant-pathogen interaction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04720	Long-term potentiation	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04722	Neurotrophin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04740	Olfactory transduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04744	Phototransduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04745	Phototransduction - fly	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04910	Insulin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04912	GnRH signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04916	Melanogenesis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04970	Salivary secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko04971	Gastric acid secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko05010	Alzheimer's disease	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200005373	K02183	ko05214	Glioma	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMC200007622	K13065	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMC200007622	K13065	ko00941	Flavonoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMC200007622	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMC200007622	K13065	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMC200007625	K00558	ko00270	Cysteine and methionine metabolism	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMC200007625	K00558	ko01100	Metabolic pathways	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMC200007630	K04506	ko04115	p53 signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMC200007630	K04506	ko04120	Ubiquitin mediated proteolysis	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMC200007630	K04506	ko04310	Wnt signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMC200007631	K11424	ko00310	Lysine degradation	854	2.9e-41	0.55	0.68	0.88
PGSC0003DMC200007632	K11424	ko00310	Lysine degradation	819	2.5e-39	0.49	0.62	0.95
PGSC0003DMC200007633	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMC200007634	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMC200007635	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMC200007636	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMC200007650	K08065	ko04612	Antigen processing and presentation	639	2.1e-29	0.62	0.78	0.79
PGSC0003DMC200014144	K11228	ko04011	MAPK signaling pathway - yeast	967	1.7e-47	0.36	0.50	0.73
PGSC0003DMC200014145	K11228	ko04011	MAPK signaling pathway - yeast	893	2.0e-43	0.34	0.48	0.73
PGSC0003DMC200014146	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMC200014146	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMC200014147	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMC200014147	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMC200014148	K04420	ko04010	MAPK signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMC200014148	K04420	ko04540	Gap junction	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMC200014148	K04420	ko04912	GnRH signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMC200014157	K05681	ko02010	ABC transporters	905	4.4e-44	0.31	0.51	0.55
PGSC0003DMC200068358	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMC200068358	K00224	ko00364	Fluorobenzoate degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMC200068358	K00224	ko00628	Fluorene degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMC200068358	K00224	ko00640	Propanoate metabolism	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMC200061303	K08243	ko00941	Flavonoid biosynthesis	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMC200061303	K08243	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMC200061315	K10760	ko00908	Zeatin biosynthesis	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMC200061315	K10760	ko01100	Metabolic pathways	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMC200061315	K10760	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMC200060331	K10591	ko04120	Ubiquitin mediated proteolysis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMC200060331	K10591	ko04144	Endocytosis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMC200060334	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMC200060334	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMC200060338	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMC200060342	K06268	ko04010	MAPK signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04020	Calcium signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04114	Oocyte meiosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04210	Apoptosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04310	Wnt signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04360	Axon guidance	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04370	VEGF signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04650	Natural killer cell mediated cytotoxicity	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04660	T cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04662	B cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko04720	Long-term potentiation	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko05010	Alzheimer's disease	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060342	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMC200060353	K12338	ko00942	Anthocyanin biosynthesis	303	7.1e-11	0.33	0.62	0.87
PGSC0003DMC200029451	K09841	ko00906	Carotenoid biosynthesis	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMC200029451	K09841	ko01100	Metabolic pathways	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMC200029451	K09841	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMC200018542	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018542	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018542	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018542	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018542	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMC200018543	K00858	ko00760	Nicotinate and nicotinamide metabolism	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMC200018543	K00858	ko01100	Metabolic pathways	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMC200018544	K00858	ko00760	Nicotinate and nicotinamide metabolism	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMC200018544	K00858	ko01100	Metabolic pathways	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMC200018545	K00858	ko00760	Nicotinate and nicotinamide metabolism	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMC200018545	K00858	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMC200018546	K00858	ko00760	Nicotinate and nicotinamide metabolism	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMC200018546	K00858	ko01100	Metabolic pathways	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMC200018547	K09753	ko00940	Phenylpropanoid biosynthesis	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMC200018547	K09753	ko01100	Metabolic pathways	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMC200018547	K09753	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMC200018548	K09753	ko00940	Phenylpropanoid biosynthesis	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMC200018548	K09753	ko01100	Metabolic pathways	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMC200018548	K09753	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMC200018549	K09753	ko00940	Phenylpropanoid biosynthesis	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMC200018549	K09753	ko01100	Metabolic pathways	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMC200018549	K09753	ko01110	Biosynthesis of secondary metabolites	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMC200018550	K09753	ko00940	Phenylpropanoid biosynthesis	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMC200018550	K09753	ko01100	Metabolic pathways	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMC200018550	K09753	ko01110	Biosynthesis of secondary metabolites	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMC200018551	K09753	ko00940	Phenylpropanoid biosynthesis	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMC200018551	K09753	ko01100	Metabolic pathways	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMC200018551	K09753	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMC200018552	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018552	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018552	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018553	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018553	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018553	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMC200018554	K09753	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMC200018554	K09753	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMC200018554	K09753	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMC200018555	K09753	ko00940	Phenylpropanoid biosynthesis	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMC200018555	K09753	ko01100	Metabolic pathways	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMC200018555	K09753	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMC200018556	K09753	ko00940	Phenylpropanoid biosynthesis	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMC200018556	K09753	ko01100	Metabolic pathways	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMC200018556	K09753	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMC200018557	K09753	ko00940	Phenylpropanoid biosynthesis	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMC200018557	K09753	ko01100	Metabolic pathways	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMC200018557	K09753	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMC200018558	K03066	ko03050	Proteasome	3166	8.7e-169	0.90	0.92	1.00
PGSC0003DMC200018559	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMC200018562	K01199	ko00500	Starch and sucrose metabolism	449	6.3e-19	0.54	0.78	0.99
PGSC0003DMC200018563	K01199	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.55	0.79	0.99
PGSC0003DMC200018564	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMC200018565	K01199	ko00500	Starch and sucrose metabolism	1335	8.5e-68	0.51	0.70	0.98
PGSC0003DMC200018566	K01199	ko00500	Starch and sucrose metabolism	1342	3.5e-68	0.51	0.68	1.00
PGSC0003DMC200018567	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMC200012693	K13065	ko00940	Phenylpropanoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMC200012693	K13065	ko00941	Flavonoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMC200012693	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMC200012693	K13065	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMC200012698	K11252	ko05322	Systemic lupus erythematosus	1039	1.8e-51	0.89	0.92	0.99
PGSC0003DMC200012699	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.94	0.99
PGSC0003DMC200012705	K00902	ko00510	N-Glycan biosynthesis	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMC200012705	K00902	ko01100	Metabolic pathways	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMC200012706	K00902	ko00510	N-Glycan biosynthesis	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMC200012706	K00902	ko01100	Metabolic pathways	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMC200012707	K00902	ko00510	N-Glycan biosynthesis	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMC200012707	K00902	ko01100	Metabolic pathways	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMC200012709	K00059	ko00061	Fatty acid biosynthesis	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMC200012709	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMC200012709	K00059	ko01100	Metabolic pathways	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMC200012710	K00059	ko00061	Fatty acid biosynthesis	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMC200012710	K00059	ko01040	Biosynthesis of unsaturated fatty acids	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMC200012710	K00059	ko01100	Metabolic pathways	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMC200012711	K00059	ko00061	Fatty acid biosynthesis	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMC200012711	K00059	ko01040	Biosynthesis of unsaturated fatty acids	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMC200012711	K00059	ko01100	Metabolic pathways	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMC200012715	K13065	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMC200012715	K13065	ko00941	Flavonoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMC200012715	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMC200012715	K13065	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMC200012716	K05868	ko04110	Cell cycle	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMC200012716	K05868	ko04115	p53 signaling pathway	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMC200012716	K05868	ko04914	Progesterone-mediated oocyte maturation	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMC200012717	K06027	ko04962	Vasopressin-regulated water reabsorption	2042	8.6e-107	0.46	0.64	0.77
PGSC0003DMC200012718	K06027	ko04962	Vasopressin-regulated water reabsorption	2109	1.7e-110	0.44	0.61	0.79
PGSC0003DMC200012719	K06027	ko04962	Vasopressin-regulated water reabsorption	1386	1.3e-70	0.45	0.63	0.98
PGSC0003DMC200006061	K03950	ko00190	Oxidative phosphorylation	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMC200006061	K03950	ko01100	Metabolic pathways	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMC200006061	K03950	ko05010	Alzheimer's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMC200006061	K03950	ko05012	Parkinson's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMC200006061	K03950	ko05016	Huntington's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMC200006076	K04733	ko04210	Apoptosis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMC200006076	K04733	ko04620	Toll-like receptor signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMC200006076	K04733	ko04722	Neurotrophin signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMC200006076	K04733	ko05140	Leishmaniasis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMC200006076	K04733	ko05142	Chagas disease	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMC200006078	K00801	ko00100	Steroid biosynthesis	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMC200006078	K00801	ko01100	Metabolic pathways	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMC200006078	K00801	ko01110	Biosynthesis of secondary metabolites	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMC200006079	K00801	ko00100	Steroid biosynthesis	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMC200006079	K00801	ko01100	Metabolic pathways	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMC200006079	K00801	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMC200006080	K00801	ko00100	Steroid biosynthesis	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMC200006080	K00801	ko01100	Metabolic pathways	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMC200006080	K00801	ko01110	Biosynthesis of secondary metabolites	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMC200006090	K10643	ko03018	RNA degradation	1666	4.7e-86	0.39	0.53	0.98
PGSC0003DMC200049753	K01695	ko00260	Glycine, serine and threonine metabolism	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMC200049753	K01695	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMC200049753	K01695	ko01100	Metabolic pathways	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMC200049753	K01695	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMC200049759	K01834	ko00010	Glycolysis / Gluconeogenesis	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMC200049759	K01834	ko01100	Metabolic pathways	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMC200049759	K01834	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMC200049761	K01834	ko00010	Glycolysis / Gluconeogenesis	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMC200049761	K01834	ko01100	Metabolic pathways	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMC200049761	K01834	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMC200049763	K01834	ko00010	Glycolysis / Gluconeogenesis	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMC200049763	K01834	ko01100	Metabolic pathways	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMC200049763	K01834	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMC200049764	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049764	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049764	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049765	K01834	ko00010	Glycolysis / Gluconeogenesis	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMC200049765	K01834	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMC200049765	K01834	ko01110	Biosynthesis of secondary metabolites	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMC200049766	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049766	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049766	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMC200049769	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMC200049769	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMC200049769	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMC200035854	K02866	ko03010	Ribosome	638	2.4e-29	0.44	0.57	0.91
PGSC0003DMC200035855	K02866	ko03010	Ribosome	1447	5.6e-74	0.92	0.95	0.99
PGSC0003DMC200035856	K02995	ko03010	Ribosome	1676	1.3e-86	0.89	0.94	0.99
PGSC0003DMC200035859	K11820	ko00380	Tryptophan metabolism	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMC200035859	K11820	ko00966	Glucosinolate biosynthesis	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMC200035859	K11820	ko01110	Biosynthesis of secondary metabolites	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMC200035862	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMC200035863	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMC200035864	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2306	2.4e-121	0.85	0.92	1.00
PGSC0003DMC200035873	K10949	ko05110	Vibrio cholerae infection	466	7.2e-20	0.31	0.54	0.82
PGSC0003DMC200035874	K10949	ko05110	Vibrio cholerae infection	511	2.4e-22	0.34	0.58	0.81
PGSC0003DMC200043891	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043891	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043892	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMC200043893	K07407	ko00052	Galactose metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMC200043893	K07407	ko00561	Glycerolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMC200043893	K07407	ko00600	Sphingolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMC200043893	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMC200043895	K12832	ko03040	Spliceosome	617	3.4e-28	0.97	1.00	0.92
PGSC0003DMC200043896	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMC200043897	K01929	ko00300	Lysine biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMC200043897	K01929	ko00550	Peptidoglycan biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMC200043897	K01929	ko01100	Metabolic pathways	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMC200043898	K01929	ko00300	Lysine biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMC200043898	K01929	ko00550	Peptidoglycan biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMC200043898	K01929	ko01100	Metabolic pathways	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMC200043900	K10802	ko03410	Base excision repair	493	2.3e-21	0.43	0.61	0.73
PGSC0003DMC200043901	K10802	ko03410	Base excision repair	507	4.0e-22	0.45	0.69	0.66
PGSC0003DMC200043902	K02976	ko03010	Ribosome	989	1.0e-48	0.88	0.91	0.99
PGSC0003DMC200043904	K13082	ko00941	Flavonoid biosynthesis	1070	3.5e-53	0.45	0.64	0.94
PGSC0003DMC200043907	K00872	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMC200043907	K00872	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMC200043911	K12824	ko03040	Spliceosome	4375	1.8e-235	0.65	0.78	1.00
PGSC0003DMC200043912	K12824	ko03040	Spliceosome	4842	3.2e-261	0.58	0.71	1.00
PGSC0003DMC200043913	K12824	ko03040	Spliceosome	4853	7.8e-262	0.58	0.71	1.00
PGSC0003DMC200043915	K11423	ko00310	Lysine degradation	2609	4.6e-138	0.54	0.67	0.47
PGSC0003DMC200037266	K08486	ko04130	SNARE interactions in vesicular transport	293	2.5e-10	0.62	0.75	0.76
PGSC0003DMC200037267	K08486	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.88	0.94	0.50
PGSC0003DMC200037268	K08486	ko04130	SNARE interactions in vesicular transport	2079	7.8e-109	0.82	0.90	1.00
PGSC0003DMC200037269	K01937	ko00240	Pyrimidine metabolism	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMC200037269	K01937	ko01100	Metabolic pathways	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMC200037270	K01937	ko00240	Pyrimidine metabolism	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMC200037270	K01937	ko01100	Metabolic pathways	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMC200037271	K01937	ko00240	Pyrimidine metabolism	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMC200037271	K01937	ko01100	Metabolic pathways	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMC200037272	K01937	ko00240	Pyrimidine metabolism	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMC200037272	K01937	ko01100	Metabolic pathways	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMC200037284	K03129	ko03022	Basal transcription factors	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMC200037284	K03129	ko05016	Huntington's disease	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMC200037285	K04446	ko04310	Wnt signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200037285	K04446	ko04360	Axon guidance	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200037285	K04446	ko04370	VEGF signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200037285	K04446	ko04650	Natural killer cell mediated cytotoxicity	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200037285	K04446	ko04660	T cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200037285	K04446	ko04662	B cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMC200062642	K02183	ko04020	Calcium signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04070	Phosphatidylinositol signaling system	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04114	Oocyte meiosis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04270	Vascular smooth muscle contraction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04626	Plant-pathogen interaction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04720	Long-term potentiation	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04722	Neurotrophin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04740	Olfactory transduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04744	Phototransduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04745	Phototransduction - fly	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04910	Insulin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04912	GnRH signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04916	Melanogenesis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04970	Salivary secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko04971	Gastric acid secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko05010	Alzheimer's disease	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062642	K02183	ko05214	Glioma	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMC200062645	K11251	ko05322	Systemic lupus erythematosus	594	6.3e-27	0.59	0.71	0.94
PGSC0003DMC200062667	K10875	ko03440	Homologous recombination	290	1.6e-09	0.30	0.49	0.78
PGSC0003DMC200008911	K00166	ko00280	Valine, leucine and isoleucine degradation	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMC200008911	K00166	ko01100	Metabolic pathways	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMC200008911	K00166	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMC200008912	K00166	ko00280	Valine, leucine and isoleucine degradation	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMC200008912	K00166	ko01100	Metabolic pathways	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMC200008912	K00166	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMC200008913	K00166	ko00280	Valine, leucine and isoleucine degradation	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMC200008913	K00166	ko01100	Metabolic pathways	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMC200008913	K00166	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMC200008914	K00166	ko00280	Valine, leucine and isoleucine degradation	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMC200008914	K00166	ko01100	Metabolic pathways	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMC200008914	K00166	ko01110	Biosynthesis of secondary metabolites	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMC200008915	K00166	ko00280	Valine, leucine and isoleucine degradation	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMC200008915	K00166	ko01100	Metabolic pathways	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMC200008915	K00166	ko01110	Biosynthesis of secondary metabolites	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMC200008916	K00166	ko00280	Valine, leucine and isoleucine degradation	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMC200008916	K00166	ko01100	Metabolic pathways	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMC200008916	K00166	ko01110	Biosynthesis of secondary metabolites	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMC200008917	K01507	ko00190	Oxidative phosphorylation	1594	4.4e-82	0.86	0.94	1.00
PGSC0003DMC200008932	K01762	ko00270	Cysteine and methionine metabolism	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMC200008932	K01762	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMC200008937	K10852	ko00311	Penicillin and cephalosporin biosynthesis	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMC200008937	K10852	ko01100	Metabolic pathways	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMC200008937	K10852	ko01110	Biosynthesis of secondary metabolites	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMC200008939	K12869	ko03040	Spliceosome	4306	1.2e-231	0.51	0.64	1.00
PGSC0003DMC200008940	K12869	ko03040	Spliceosome	5274	4.7e-285	0.86	0.93	1.00
PGSC0003DMC200011091	K07385	ko00902	Monoterpenoid biosynthesis	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMC200011091	K07385	ko01100	Metabolic pathways	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMC200011092	K07385	ko00902	Monoterpenoid biosynthesis	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMC200011092	K07385	ko01100	Metabolic pathways	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMC200016685	K00968	ko00440	Phosphonate and phosphinate metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMC200016685	K00968	ko00564	Glycerophospholipid metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMC200016685	K00968	ko01100	Metabolic pathways	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMC200016688	K12847	ko03040	Spliceosome	3713	5.9e-199	0.78	0.86	1.00
PGSC0003DMC200016689	K12847	ko03040	Spliceosome	738	7.2e-35	0.98	0.99	0.93
PGSC0003DMC200027550	K11866	ko04144	Endocytosis	329	1.8e-11	0.37	0.55	0.77
PGSC0003DMC200027551	K11866	ko04144	Endocytosis	601	8.0e-27	0.31	0.48	0.89
PGSC0003DMC200027552	K11866	ko04144	Endocytosis	435	2.0e-17	0.38	0.55	0.68
PGSC0003DMC200027561	K12603	ko03018	RNA degradation	388	1.4e-15	0.34	0.45	0.94
PGSC0003DMC200027562	K12603	ko03018	RNA degradation	629	7.4e-29	0.33	0.47	0.98
PGSC0003DMC200027565	K11866	ko04144	Endocytosis	380	7.6e-16	0.33	0.49	0.66
PGSC0003DMC200027566	K11866	ko04144	Endocytosis	427	5.7e-17	0.34	0.50	0.90
PGSC0003DMC200027567	K11866	ko04144	Endocytosis	545	1.2e-23	0.32	0.48	0.97
PGSC0003DMC200000158	K01259	ko00330	Arginine and proline metabolism	946	2.4e-46	0.47	0.65	0.79
PGSC0003DMC200000159	K01259	ko00330	Arginine and proline metabolism	1607	8.4e-83	0.48	0.67	0.85
PGSC0003DMC200000160	K01259	ko00330	Arginine and proline metabolism	1128	2.2e-56	0.46	0.65	0.81
PGSC0003DMC200000173	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1635	2.4e-84	0.64	0.76	0.99
PGSC0003DMC200000174	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1642	9.9e-85	0.64	0.76	0.99
PGSC0003DMC200058757	K05765	ko04360	Axon guidance	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMC200058757	K05765	ko04666	Fc gamma R-mediated phagocytosis	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMC200058757	K05765	ko04810	Regulation of actin cytoskeleton	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMC200058760	K10760	ko00908	Zeatin biosynthesis	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMC200058760	K10760	ko01100	Metabolic pathways	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMC200058760	K10760	ko01110	Biosynthesis of secondary metabolites	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMC200039878	K08679	ko00500	Starch and sucrose metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMC200039878	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMC200039878	K08679	ko01100	Metabolic pathways	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMC200039879	K08679	ko00500	Starch and sucrose metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMC200039879	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMC200039879	K08679	ko01100	Metabolic pathways	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMC200039892	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMC200039893	K02183	ko04020	Calcium signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04070	Phosphatidylinositol signaling system	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04114	Oocyte meiosis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04270	Vascular smooth muscle contraction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04626	Plant-pathogen interaction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04720	Long-term potentiation	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04722	Neurotrophin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04740	Olfactory transduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04744	Phototransduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04745	Phototransduction - fly	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04910	Insulin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04912	GnRH signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04916	Melanogenesis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04970	Salivary secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko04971	Gastric acid secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko05010	Alzheimer's disease	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039893	K02183	ko05214	Glioma	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMC200039898	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.94
PGSC0003DMC200039899	K01509	ko00230	Purine metabolism	1516	8.8e-78	0.43	0.57	0.94
PGSC0003DMC200039900	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.96
PGSC0003DMC200045493	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMC200045494	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMC200045495	K10848	ko03420	Nucleotide excision repair	5254	6.0e-284	0.67	0.79	1.00
PGSC0003DMC200045496	K10848	ko03420	Nucleotide excision repair	3551	5.1e-190	0.69	0.80	0.95
PGSC0003DMC200045507	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMC200045508	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMC200045509	K01358	ko04112	Cell cycle - Caulobacter	1399	2.5e-71	0.71	0.80	0.94
PGSC0003DMC200015484	K00901	ko00561	Glycerolipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMC200015484	K00901	ko00564	Glycerophospholipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMC200015484	K00901	ko01100	Metabolic pathways	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMC200015484	K00901	ko04070	Phosphatidylinositol signaling system	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMC200015494	K12813	ko03040	Spliceosome	860	1.3e-41	0.60	0.64	0.99
PGSC0003DMC200015498	K00368	ko00910	Nitrogen metabolism	1576	4.3e-81	0.42	0.57	0.91
PGSC0003DMC200015499	K01673	ko00910	Nitrogen metabolism	1395	4.2e-71	0.60	0.71	0.99
PGSC0003DMC200015500	K01673	ko00910	Nitrogen metabolism	509	3.1e-22	0.66	0.83	0.87
PGSC0003DMC200015501	K01673	ko00910	Nitrogen metabolism	1342	3.5e-68	0.67	0.80	0.98
PGSC0003DMC200015502	K01673	ko00910	Nitrogen metabolism	618	3.0e-28	0.68	0.76	0.98
PGSC0003DMC200009874	K01054	ko00561	Glycerolipid metabolism	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMC200009874	K01054	ko01100	Metabolic pathways	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMC200009888	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMC200009889	K03128	ko03022	Basal transcription factors	2277	9.4e-120	0.47	0.60	0.99
PGSC0003DMC200009890	K03128	ko03022	Basal transcription factors	6464	0.	0.62	0.73	1.00
PGSC0003DMC200009891	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMC200009893	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009893	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009893	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009893	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009893	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009893	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200009894	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMC200028751	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMC200028751	K01869	ko00970	Aminoacyl-tRNA biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMC200028752	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMC200028752	K01869	ko00970	Aminoacyl-tRNA biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMC200028753	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMC200028753	K01869	ko00970	Aminoacyl-tRNA biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMC200028759	K01728	ko00040	Pentose and glucuronate interconversions	1981	2.0e-103	0.64	0.74	0.98
PGSC0003DMC200028760	K01728	ko00040	Pentose and glucuronate interconversions	1811	4.7e-94	0.57	0.72	0.96
PGSC0003DMC200028766	K00605	ko00260	Glycine, serine and threonine metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMC200028766	K00605	ko00670	One carbon pool by folate	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMC200028766	K00605	ko00910	Nitrogen metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMC200028766	K00605	ko01100	Metabolic pathways	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMC200063612	K00804	ko00900	Terpenoid backbone biosynthesis	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMC200063612	K00804	ko01100	Metabolic pathways	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMC200063612	K00804	ko01110	Biosynthesis of secondary metabolites	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMC200038911	K12837	ko03040	Spliceosome	2004	1.1e-104	0.69	0.83	0.99
PGSC0003DMC200038912	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMC200038915	K03144	ko03022	Basal transcription factors	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMC200038915	K03144	ko03420	Nucleotide excision repair	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMC200038916	K03144	ko03022	Basal transcription factors	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMC200038916	K03144	ko03420	Nucleotide excision repair	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMC200038917	K03144	ko03022	Basal transcription factors	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMC200038917	K03144	ko03420	Nucleotide excision repair	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMC200038918	K03144	ko03022	Basal transcription factors	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMC200038918	K03144	ko03420	Nucleotide excision repair	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMC200038919	K03144	ko03022	Basal transcription factors	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMC200038919	K03144	ko03420	Nucleotide excision repair	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMC200038920	K03144	ko03022	Basal transcription factors	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMC200038920	K03144	ko03420	Nucleotide excision repair	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMC200038921	K03144	ko03022	Basal transcription factors	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMC200038921	K03144	ko03420	Nucleotide excision repair	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMC200038922	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMC200038922	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMC200038923	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMC200038923	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMC200038936	K01955	ko00240	Pyrimidine metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMC200038936	K01955	ko00250	Alanine, aspartate and glutamate metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMC200038936	K01955	ko01100	Metabolic pathways	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMC200038939	K06096	ko04530	Tight junction	350	1.8e-13	0.27	0.44	0.98
PGSC0003DMC200057544	K10760	ko00908	Zeatin biosynthesis	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMC200057544	K10760	ko01100	Metabolic pathways	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMC200057544	K10760	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMC200057563	K03347	ko04110	Cell cycle	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04111	Cell cycle - yeast	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04114	Oocyte meiosis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04120	Ubiquitin mediated proteolysis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04310	Wnt signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04350	TGF-beta signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200057563	K03347	ko04710	Circadian rhythm - mammal	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMC200046682	K12356	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.48	0.60	0.87
PGSC0003DMC200046684	K11294	ko05130	Pathogenic Escherichia coli infection	403	2.2e-16	0.36	0.50	0.70
PGSC0003DMC200046689	K01692	ko00071	Fatty acid metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00280	Valine, leucine and isoleucine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00281	Geraniol degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00310	Lysine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00380	Tryptophan metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00410	beta-Alanine metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00632	Benzoate degradation via CoA ligation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00640	Propanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00650	Butanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00903	Limonene and pinene degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko00930	Caprolactam degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko01100	Metabolic pathways	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046689	K01692	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMC200046694	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMC200046694	K00517	ko00626	Naphthalene and anthracene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMC200046694	K00517	ko00903	Limonene and pinene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMC200046694	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMC200046694	K00517	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMC200046695	K00253	ko00280	Valine, leucine and isoleucine degradation	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMC200046695	K00253	ko01100	Metabolic pathways	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMC200046701	K01012	ko00780	Biotin metabolism	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMC200046701	K01012	ko01100	Metabolic pathways	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMC200046702	K00432	ko00480	Glutathione metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMC200046702	K00432	ko00590	Arachidonic acid metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMC200046703	K10773	ko03410	Base excision repair	840	1.7e-40	0.90	0.91	0.99
PGSC0003DMC200046704	K10773	ko03410	Base excision repair	242	1.6e-07	0.42	0.64	0.77
PGSC0003DMC200046705	K10773	ko03410	Base excision repair	665	7.6e-31	0.53	0.66	0.98
PGSC0003DMC200046710	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3866	2.1e-207	0.78	0.87	0.96
PGSC0003DMC200041077	K11229	ko04011	MAPK signaling pathway - yeast	867	3.0e-43	0.43	0.59	0.97
PGSC0003DMC200041078	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMC200041079	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMC200041098	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMC200041099	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMC200050432	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMC200050433	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMC200050441	K12194	ko04144	Endocytosis	1453	2.6e-74	0.93	0.97	0.99
PGSC0003DMC200050442	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMC200050443	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMC200050446	K12868	ko03040	Spliceosome	585	2.0e-26	0.86	0.95	0.72
PGSC0003DMC200050450	K12591	ko03018	RNA degradation	899	9.5e-44	0.37	0.51	0.49
PGSC0003DMC200050451	K01681	ko00020	Citrate cycle (TCA cycle)	7302	0.	0.86	0.92	1.00
PGSC0003DMC200050451	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7302	0.	0.86	0.92	1.00
PGSC0003DMC200050451	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7302	0.	0.86	0.92	1.00
PGSC0003DMC200050451	K01681	ko01100	Metabolic pathways	7302	0.	0.86	0.92	1.00
PGSC0003DMC200050451	K01681	ko01110	Biosynthesis of secondary metabolites	7302	0.	0.86	0.92	1.00
PGSC0003DMC200050453	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMC200050453	K00517	ko00626	Naphthalene and anthracene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMC200050453	K00517	ko00903	Limonene and pinene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMC200050453	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMC200050453	K00517	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMC200019762	K05745	ko04810	Regulation of actin cytoskeleton	545	1.7e-23	0.30	0.57	0.99
PGSC0003DMC200019763	K04512	ko04310	Wnt signaling pathway	545	1.4e-23	0.31	0.58	0.96
PGSC0003DMC200019764	K02184	ko04320	Dorso-ventral axis formation	1304	6.8e-66	0.30	0.42	0.76
PGSC0003DMC200019765	K02184	ko04320	Dorso-ventral axis formation	1051	2.0e-51	0.31	0.41	0.69
PGSC0003DMC200005853	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMC200005853	K00224	ko00364	Fluorobenzoate degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMC200005853	K00224	ko00628	Fluorene degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMC200005853	K00224	ko00640	Propanoate metabolism	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMC200005854	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMC200005854	K00224	ko00364	Fluorobenzoate degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMC200005854	K00224	ko00628	Fluorene degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMC200005854	K00224	ko00640	Propanoate metabolism	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMC200005857	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMC200005857	K00517	ko00626	Naphthalene and anthracene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMC200005857	K00517	ko00903	Limonene and pinene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMC200005857	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMC200005857	K00517	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMC200005858	K09843	ko00906	Carotenoid biosynthesis	344	3.9e-13	0.49	0.62	0.81
PGSC0003DMC200005875	K05756	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMC200005875	K05756	ko04810	Regulation of actin cytoskeleton	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMC200005875	K05756	ko05100	Bacterial invasion of epithelial cells	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMC200005875	K05756	ko05130	Pathogenic Escherichia coli infection	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMC200005875	K05756	ko05131	Shigellosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMC200005876	K01126	ko00564	Glycerophospholipid metabolism	400	8.6e-16	0.30	0.47	0.40
PGSC0003DMC200005879	K01126	ko00564	Glycerophospholipid metabolism	455	4.6e-19	0.32	0.50	0.60
PGSC0003DMC200005880	K01126	ko00564	Glycerophospholipid metabolism	455	4.4e-19	0.32	0.50	0.61
PGSC0003DMC200007268	K01379	ko04142	Lysosome	288	1.3e-08	0.26	0.42	0.86
PGSC0003DMC200007269	K01379	ko04142	Lysosome	273	3.2e-09	0.28	0.43	0.94
PGSC0003DMC200007270	K08735	ko03430	Mismatch repair	6438	0.	0.80	0.92	0.99
PGSC0003DMC200007270	K08735	ko05200	Pathways in cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMC200007270	K08735	ko05210	Colorectal cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMC200013893	K04460	ko04010	MAPK signaling pathway	433	3.0e-22	0.36	0.51	0.73
PGSC0003DMC200013900	K01535	ko00190	Oxidative phosphorylation	6457	0.	0.83	0.91	0.99
PGSC0003DMC200013901	K12834	ko03040	Spliceosome	1004	1.5e-49	1.00	1.00	0.99
PGSC0003DMC200013915	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMC200013916	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMC200013917	K00754	ko00051	Fructose and mannose metabolism	982	2.5e-48	0.35	0.55	0.94
PGSC0003DMC200013918	K00754	ko00051	Fructose and mannose metabolism	1378	3.6e-70	0.38	0.56	0.86
PGSC0003DMC200013919	K00754	ko00051	Fructose and mannose metabolism	1376	4.7e-70	0.38	0.57	0.96
PGSC0003DMC200013920	K00754	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.42	0.60	0.91
PGSC0003DMC200061557	K12356	ko00940	Phenylpropanoid biosynthesis	737	8.2e-35	0.43	0.58	1.00
PGSC0003DMC200059442	K04454	ko04010	MAPK signaling pathway	230	1.1e-06	0.32	0.52	0.91
PGSC0003DMC200059448	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMC200059448	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMC200059448	K00771	ko01100	Metabolic pathways	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMC200059459	K13065	ko00940	Phenylpropanoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMC200059459	K13065	ko00941	Flavonoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMC200059459	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMC200059459	K13065	ko01110	Biosynthesis of secondary metabolites	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMC200048541	K00423	ko00053	Ascorbate and aldarate metabolism	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMC200048541	K00423	ko01100	Metabolic pathways	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMC200048542	K00423	ko00053	Ascorbate and aldarate metabolism	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMC200048542	K00423	ko01100	Metabolic pathways	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMC200048544	K01858	ko00521	Streptomycin biosynthesis	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMC200048544	K01858	ko00562	Inositol phosphate metabolism	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMC200048544	K01858	ko01100	Metabolic pathways	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMC200048544	K01858	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMC200048548	K02342	ko00230	Purine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048548	K02342	ko00240	Pyrimidine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048548	K02342	ko01100	Metabolic pathways	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048548	K02342	ko03030	DNA replication	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048548	K02342	ko03430	Mismatch repair	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048548	K02342	ko03440	Homologous recombination	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMC200048550	K00812	ko00250	Alanine, aspartate and glutamate metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00270	Cysteine and methionine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00330	Arginine and proline metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00350	Tyrosine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00360	Phenylalanine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00401	Novobiocin biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00710	Carbon fixation in photosynthetic organisms	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00950	Isoquinoline alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko01100	Metabolic pathways	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048550	K00812	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMC200048555	K01193	ko00052	Galactose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMC200048555	K01193	ko00500	Starch and sucrose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMC200048555	K01193	ko01100	Metabolic pathways	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMC200048567	K00696	ko00500	Starch and sucrose metabolism	7380	0.	0.81	0.91	1.00
PGSC0003DMC200048567	K00696	ko01100	Metabolic pathways	7380	0.	0.81	0.91	1.00
PGSC0003DMC200048568	K07297	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.68	0.87	0.98
PGSC0003DMC200048569	K07297	ko04920	Adipocytokine signaling pathway	1944	2.2e-101	0.60	0.74	0.98
PGSC0003DMC200036062	K02084	ko04115	p53 signaling pathway	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko04210	Apoptosis	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko05010	Alzheimer's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko05012	Parkinson's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko05016	Huntington's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200036062	K02084	ko05222	Small cell lung cancer	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMC200042692	K10352	ko04530	Tight junction	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMC200042692	K10352	ko05416	Viral myocarditis	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMC200042695	K04733	ko04210	Apoptosis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMC200042695	K04733	ko04620	Toll-like receptor signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMC200042695	K04733	ko04722	Neurotrophin signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMC200042695	K04733	ko05140	Leishmaniasis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMC200042695	K04733	ko05142	Chagas disease	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMC200042709	K08901	ko00195	Photosynthesis	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMC200042709	K08901	ko01100	Metabolic pathways	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMC200042713	K01897	ko00071	Fatty acid metabolism	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMC200042713	K01897	ko01100	Metabolic pathways	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMC200042713	K01897	ko03320	PPAR signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMC200042713	K01897	ko04146	Peroxisome	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMC200042713	K01897	ko04920	Adipocytokine signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMC200042714	K01897	ko00071	Fatty acid metabolism	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMC200042714	K01897	ko01100	Metabolic pathways	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMC200042714	K01897	ko03320	PPAR signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMC200042714	K01897	ko04146	Peroxisome	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMC200042714	K01897	ko04920	Adipocytokine signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMC200042717	K00454	ko00591	Linoleic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMC200042717	K00454	ko00592	alpha-Linolenic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMC200042717	K00454	ko01100	Metabolic pathways	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMC200042718	K00454	ko00591	Linoleic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMC200042718	K00454	ko00592	alpha-Linolenic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMC200042718	K00454	ko01100	Metabolic pathways	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMC200042719	K00454	ko00591	Linoleic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMC200042719	K00454	ko00592	alpha-Linolenic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMC200042719	K00454	ko01100	Metabolic pathways	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMC200042720	K00454	ko00591	Linoleic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMC200042720	K00454	ko00592	alpha-Linolenic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMC200042720	K00454	ko01100	Metabolic pathways	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMC200059944	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.50	0.63	0.91
PGSC0003DMC200059948	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMC200059948	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMC200059948	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMC200059948	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMC200059948	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMC200059968	K06611	ko00052	Galactose metabolism	311	1.1e-10	0.48	0.66	0.83
PGSC0003DMC200048036	K04125	ko00904	Diterpenoid biosynthesis	480	1.2e-20	0.51	0.64	0.99
PGSC0003DMC200048037	K04125	ko00904	Diterpenoid biosynthesis	1094	1.7e-54	0.56	0.70	0.92
PGSC0003DMC200048038	K04125	ko00904	Diterpenoid biosynthesis	1001	2.2e-49	0.65	0.79	0.98
PGSC0003DMC200048039	K04125	ko00904	Diterpenoid biosynthesis	1516	8.8e-78	0.59	0.73	0.99
PGSC0003DMC200048040	K04125	ko00904	Diterpenoid biosynthesis	1076	1.6e-53	0.54	0.71	0.90
PGSC0003DMC200048041	K04125	ko00904	Diterpenoid biosynthesis	1521	4.7e-78	0.57	0.73	0.98
PGSC0003DMC200048042	K04125	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.48	0.65	0.99
PGSC0003DMC200048043	K04125	ko00904	Diterpenoid biosynthesis	1036	2.6e-51	0.65	0.78	0.97
PGSC0003DMC200048044	K09840	ko00906	Carotenoid biosynthesis	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMC200048044	K09840	ko01100	Metabolic pathways	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMC200048044	K09840	ko01110	Biosynthesis of secondary metabolites	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMC200048050	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMC200048050	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMC200048050	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMC200048051	K00799	ko00480	Glutathione metabolism	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMC200048051	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMC200048051	K00799	ko00982	Drug metabolism - cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMC200030721	K10352	ko04530	Tight junction	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMC200030721	K10352	ko05416	Viral myocarditis	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMC200030722	K10352	ko04530	Tight junction	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMC200030722	K10352	ko05416	Viral myocarditis	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMC200030723	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMC200030727	K12129	ko04712	Circadian rhythm - plant	1893	1.4e-98	0.43	0.59	0.98
PGSC0003DMC200030728	K12129	ko04712	Circadian rhythm - plant	2125	2.3e-111	0.45	0.62	0.98
PGSC0003DMC200030739	K01710	ko00521	Streptomycin biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMC200030739	K01710	ko00523	Polyketide sugar unit biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMC200030739	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMC200030739	K01710	ko01100	Metabolic pathways	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMC200030739	K01710	ko01110	Biosynthesis of secondary metabolites	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMC200030740	K01710	ko00521	Streptomycin biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMC200030740	K01710	ko00523	Polyketide sugar unit biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMC200030740	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMC200030740	K01710	ko01100	Metabolic pathways	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMC200030740	K01710	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMC200030745	K01754	ko00260	Glycine, serine and threonine metabolism	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMC200030745	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMC200030745	K01754	ko01100	Metabolic pathways	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMC200030745	K01754	ko01110	Biosynthesis of secondary metabolites	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMC200030749	K02930	ko03010	Ribosome	2911	1.0e-154	0.84	0.92	1.00
PGSC0003DMC200056120	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2432	2.7e-128	0.69	0.84	0.99
PGSC0003DMC200056122	K09755	ko00940	Phenylpropanoid biosynthesis	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMC200056122	K09755	ko01100	Metabolic pathways	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMC200056122	K09755	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMC200056127	K12823	ko03040	Spliceosome	2249	3.3e-118	0.91	0.95	0.91
PGSC0003DMC200056128	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMC200056129	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMC200056130	K12823	ko03040	Spliceosome	3780	1.2e-202	0.87	0.93	1.00
PGSC0003DMC200036513	K11818	ko00380	Tryptophan metabolism	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMC200036513	K11818	ko00966	Glucosinolate biosynthesis	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMC200036513	K11818	ko01110	Biosynthesis of secondary metabolites	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMC200036514	K11818	ko00380	Tryptophan metabolism	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMC200036514	K11818	ko00966	Glucosinolate biosynthesis	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMC200036514	K11818	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMC200036515	K11818	ko00380	Tryptophan metabolism	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMC200036515	K11818	ko00966	Glucosinolate biosynthesis	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMC200036515	K11818	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMC200036516	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMC200036516	K00517	ko00626	Naphthalene and anthracene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMC200036516	K00517	ko00903	Limonene and pinene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMC200036516	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMC200036516	K00517	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMC200036526	K02183	ko04020	Calcium signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04070	Phosphatidylinositol signaling system	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04114	Oocyte meiosis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04270	Vascular smooth muscle contraction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04626	Plant-pathogen interaction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04720	Long-term potentiation	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04722	Neurotrophin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04740	Olfactory transduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04744	Phototransduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04745	Phototransduction - fly	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04910	Insulin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04912	GnRH signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04916	Melanogenesis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04970	Salivary secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko04971	Gastric acid secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko05010	Alzheimer's disease	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036526	K02183	ko05214	Glioma	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMC200036527	K09658	ko00510	N-Glycan biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMC200036527	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMC200036527	K09658	ko01100	Metabolic pathways	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMC200036533	K01692	ko00071	Fatty acid metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00280	Valine, leucine and isoleucine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00281	Geraniol degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00310	Lysine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00380	Tryptophan metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00410	beta-Alanine metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00632	Benzoate degradation via CoA ligation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00640	Propanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00650	Butanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00903	Limonene and pinene degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko00930	Caprolactam degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko01100	Metabolic pathways	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036533	K01692	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMC200036538	K09755	ko00940	Phenylpropanoid biosynthesis	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMC200036538	K09755	ko01100	Metabolic pathways	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMC200036538	K09755	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMC200068199	K10760	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMC200068199	K10760	ko01100	Metabolic pathways	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMC200068199	K10760	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMC200068209	K03012	ko00230	Purine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMC200068209	K03012	ko00240	Pyrimidine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMC200068209	K03012	ko01100	Metabolic pathways	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMC200068209	K03012	ko03020	RNA polymerase	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMC200068209	K03012	ko05016	Huntington's disease	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMC200068210	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMC200068210	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMC200068210	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMC200068210	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMC200068210	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMC200068211	K00059	ko00061	Fatty acid biosynthesis	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMC200068211	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMC200068211	K00059	ko01100	Metabolic pathways	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMC200068216	K03122	ko03022	Basal transcription factors	335	1.2e-12	0.35	0.52	0.90
PGSC0003DMC200061453	K01051	ko00040	Pentose and glucuronate interconversions	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMC200061453	K01051	ko00500	Starch and sucrose metabolism	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMC200061453	K01051	ko01100	Metabolic pathways	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMC200061468	K03094	ko04110	Cell cycle	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04111	Cell cycle - yeast	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04114	Oocyte meiosis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04120	Ubiquitin mediated proteolysis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04310	Wnt signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04350	TGF-beta signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200061468	K03094	ko04710	Circadian rhythm - mammal	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMC200019235	K02084	ko04115	p53 signaling pathway	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko04210	Apoptosis	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko05010	Alzheimer's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko05012	Parkinson's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko05016	Huntington's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019235	K02084	ko05222	Small cell lung cancer	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMC200019236	K02084	ko04115	p53 signaling pathway	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko04210	Apoptosis	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko05010	Alzheimer's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko05012	Parkinson's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko05016	Huntington's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019236	K02084	ko05222	Small cell lung cancer	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMC200019245	K08504	ko04130	SNARE interactions in vesicular transport	815	4.1e-39	0.85	0.92	0.99
PGSC0003DMC200019246	K08504	ko04130	SNARE interactions in vesicular transport	835	3.2e-40	0.83	0.92	0.99
PGSC0003DMC200019250	K02084	ko04115	p53 signaling pathway	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko04210	Apoptosis	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko05010	Alzheimer's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko05012	Parkinson's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko05016	Huntington's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019250	K02084	ko05222	Small cell lung cancer	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMC200019257	K01553	ko00230	Purine metabolism	529	1.3e-20	0.25	0.43	0.95
PGSC0003DMC200019258	K08065	ko04612	Antigen processing and presentation	395	6.0e-16	0.55	0.75	0.84
PGSC0003DMC200019259	K01528	ko04144	Endocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMC200019259	K01528	ko04666	Fc gamma R-mediated phagocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMC200019259	K01528	ko05100	Bacterial invasion of epithelial cells	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMC200019260	K01528	ko04144	Endocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMC200019260	K01528	ko04666	Fc gamma R-mediated phagocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMC200019260	K01528	ko05100	Bacterial invasion of epithelial cells	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMC200017881	K00754	ko00051	Fructose and mannose metabolism	300	1.9e-10	0.30	0.48	0.56
PGSC0003DMC200017886	K04498	ko04110	Cell cycle	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04310	Wnt signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04330	Notch signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04350	TGF-beta signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04520	Adherens junction	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04630	Jak-STAT signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04720	Long-term potentiation	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko04916	Melanogenesis	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko05016	Huntington's disease	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko05200	Pathways in cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko05211	Renal cell carcinoma	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017886	K04498	ko05215	Prostate cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMC200017890	K09753	ko00940	Phenylpropanoid biosynthesis	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMC200017890	K09753	ko01100	Metabolic pathways	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMC200017890	K09753	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMC200017891	K09753	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMC200017891	K09753	ko01100	Metabolic pathways	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMC200017891	K09753	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMC200017892	K09753	ko00940	Phenylpropanoid biosynthesis	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMC200017892	K09753	ko01100	Metabolic pathways	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMC200017892	K09753	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMC200017893	K00558	ko00270	Cysteine and methionine metabolism	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMC200017893	K00558	ko01100	Metabolic pathways	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMC200017902	K10872	ko04113	Meiosis - yeast	245	4.1e-07	0.32	0.50	0.55
PGSC0003DMC200007719	K13230	ko00402	Benzoxazinoid biosynthesis	687	4.7e-32	0.38	0.54	0.99
PGSC0003DMC200007720	K13230	ko00402	Benzoxazinoid biosynthesis	410	8.9e-17	0.45	0.62	0.95
PGSC0003DMC200007721	K13230	ko00402	Benzoxazinoid biosynthesis	683	7.8e-32	0.47	0.64	0.97
PGSC0003DMC200007722	K13230	ko00402	Benzoxazinoid biosynthesis	640	1.8e-29	0.48	0.63	0.93
PGSC0003DMC200007723	K13230	ko00402	Benzoxazinoid biosynthesis	382	3.1e-15	0.53	0.70	0.76
PGSC0003DMC200007724	K13230	ko00402	Benzoxazinoid biosynthesis	380	4.0e-15	0.56	0.71	0.98
PGSC0003DMC200007733	K00526	ko00230	Purine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMC200007733	K00526	ko00240	Pyrimidine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMC200007733	K00526	ko01100	Metabolic pathways	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMC200007734	K00526	ko00230	Purine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMC200007734	K00526	ko00240	Pyrimidine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMC200007734	K00526	ko01100	Metabolic pathways	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMC200024902	K07750	ko00100	Steroid biosynthesis	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMC200024902	K07750	ko01100	Metabolic pathways	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMC200024911	K11092	ko03040	Spliceosome	1739	4.4e-90	0.75	0.84	1.00
PGSC0003DMC200024912	K10798	ko03410	Base excision repair	6008	0.	0.71	0.84	1.00
PGSC0003DMC200024913	K08008	ko04145	Phagosome	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMC200024913	K08008	ko04670	Leukocyte transendothelial migration	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMC200024915	K07200	ko04910	Insulin signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMC200024915	K07200	ko04920	Adipocytokine signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMC200024915	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMC200024916	K07200	ko04910	Insulin signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMC200024916	K07200	ko04920	Adipocytokine signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMC200024916	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMC200024927	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMC200024928	K12489	ko04144	Endocytosis	1744	2.3e-90	0.73	0.85	0.96
PGSC0003DMC200024929	K12489	ko04144	Endocytosis	3901	2.5e-209	0.70	0.81	0.97
PGSC0003DMC200024930	K12489	ko04144	Endocytosis	4336	2.6e-233	0.66	0.77	0.99
PGSC0003DMC200038462	K01681	ko00020	Citrate cycle (TCA cycle)	6607	0.	0.78	0.87	1.00
PGSC0003DMC200038462	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	6607	0.	0.78	0.87	1.00
PGSC0003DMC200038462	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	6607	0.	0.78	0.87	1.00
PGSC0003DMC200038462	K01681	ko01100	Metabolic pathways	6607	0.	0.78	0.87	1.00
PGSC0003DMC200038462	K01681	ko01110	Biosynthesis of secondary metabolites	6607	0.	0.78	0.87	1.00
PGSC0003DMC200038463	K01681	ko00020	Citrate cycle (TCA cycle)	5900	0.	0.78	0.87	0.99
PGSC0003DMC200038463	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5900	0.	0.78	0.87	0.99
PGSC0003DMC200038463	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5900	0.	0.78	0.87	0.99
PGSC0003DMC200038463	K01681	ko01100	Metabolic pathways	5900	0.	0.78	0.87	0.99
PGSC0003DMC200038463	K01681	ko01110	Biosynthesis of secondary metabolites	5900	0.	0.78	0.87	0.99
PGSC0003DMC200038464	K01681	ko00020	Citrate cycle (TCA cycle)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMC200038464	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMC200038464	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMC200038464	K01681	ko01100	Metabolic pathways	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMC200038464	K01681	ko01110	Biosynthesis of secondary metabolites	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMC200038465	K01681	ko00020	Citrate cycle (TCA cycle)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMC200038465	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMC200038465	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMC200038465	K01681	ko01100	Metabolic pathways	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMC200038465	K01681	ko01110	Biosynthesis of secondary metabolites	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMC200038477	K09843	ko00906	Carotenoid biosynthesis	806	1.3e-38	0.41	0.61	0.98
PGSC0003DMC200038478	K09588	ko01100	Metabolic pathways	325	4.3e-12	0.35	0.53	0.77
PGSC0003DMC200038479	K09843	ko00906	Carotenoid biosynthesis	1028	7.3e-51	0.35	0.55	1.00
PGSC0003DMC200038485	K02978	ko03010	Ribosome	534	1.3e-23	0.78	0.84	0.85
PGSC0003DMC200038486	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMC200038486	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMC200038486	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMC200038487	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038487	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038487	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038488	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038488	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038488	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMC200038489	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMC200038489	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMC200038489	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMC200038490	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMC200038490	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMC200038490	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMC200034656	K01408	ko05010	Alzheimer's disease	2201	2.1e-120	0.37	0.57	0.93
PGSC0003DMC200034658	K12116	ko04712	Circadian rhythm - plant	4269	1.3e-229	0.85	0.91	0.91
PGSC0003DMC200034659	K01528	ko04144	Endocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMC200034659	K01528	ko04666	Fc gamma R-mediated phagocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMC200034659	K01528	ko05100	Bacterial invasion of epithelial cells	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMC200034661	K12343	ko00140	Steroid hormone biosynthesis	232	5.8e-07	0.34	0.49	0.89
PGSC0003DMC200034662	K12343	ko00140	Steroid hormone biosynthesis	356	8.4e-14	0.32	0.52	0.85
PGSC0003DMC200034663	K12343	ko00140	Steroid hormone biosynthesis	372	1.1e-14	0.29	0.50	0.81
PGSC0003DMC200034664	K10352	ko04530	Tight junction	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMC200034664	K10352	ko05416	Viral myocarditis	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMC200034674	K11866	ko04144	Endocytosis	350	1.2e-12	0.50	0.59	0.77
PGSC0003DMC200034675	K11866	ko04144	Endocytosis	479	6.7e-20	0.31	0.44	0.96
PGSC0003DMC200034676	K11866	ko04144	Endocytosis	414	3.1e-16	0.40	0.52	0.79
PGSC0003DMC200034677	K11866	ko04144	Endocytosis	366	1.5e-13	0.30	0.44	0.96
PGSC0003DMC200053104	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMC200053105	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMC200053108	K00970	ko03018	RNA degradation	3056	1.0e-162	0.71	0.81	0.72
PGSC0003DMC200053109	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.72
PGSC0003DMC200053110	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.71
PGSC0003DMC200053119	K04715	ko00600	Sphingolipid metabolism	405	1.7e-16	0.43	0.63	0.47
PGSC0003DMC200053120	K04715	ko00600	Sphingolipid metabolism	932	1.4e-45	0.32	0.47	0.79
PGSC0003DMC200053121	K04715	ko00600	Sphingolipid metabolism	504	5.8e-22	0.34	0.48	0.91
PGSC0003DMC200053123	K01080	ko00561	Glycerolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053123	K01080	ko00564	Glycerophospholipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053123	K01080	ko00565	Ether lipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053123	K01080	ko00600	Sphingolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053123	K01080	ko01100	Metabolic pathways	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053123	K01080	ko04666	Fc gamma R-mediated phagocytosis	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMC200053124	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053124	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053124	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053124	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053124	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053124	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMC200053125	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053125	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053125	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053125	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053125	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053125	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMC200053128	K12816	ko03040	Spliceosome	2118	5.5e-111	0.84	0.92	0.98
PGSC0003DMC200057051	K00021	ko00900	Terpenoid backbone biosynthesis	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMC200057051	K00021	ko01100	Metabolic pathways	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMC200057051	K00021	ko01110	Biosynthesis of secondary metabolites	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMC200050945	K01184	ko00040	Pentose and glucuronate interconversions	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMC200050945	K01184	ko00500	Starch and sucrose metabolism	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMC200050945	K01184	ko01100	Metabolic pathways	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMC200050946	K02940	ko03010	Ribosome	1401	1.9e-71	0.90	0.96	0.99
PGSC0003DMC200050958	K11090	ko05322	Systemic lupus erythematosus	338	8.3e-13	0.35	0.56	0.32
PGSC0003DMC200050961	K00794	ko00740	Riboflavin metabolism	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMC200050961	K00794	ko01100	Metabolic pathways	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMC200050964	K02947	ko03010	Ribosome	1482	6.6e-76	0.92	0.95	0.98
PGSC0003DMC200050968	K03134	ko03022	Basal transcription factors	979	3.7e-48	0.79	0.91	0.99
PGSC0003DMC200050970	K12811	ko03040	Spliceosome	335	2.4e-11	0.27	0.45	0.97
PGSC0003DMC200000877	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000877	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000877	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000877	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000878	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000878	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000878	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000878	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMC200000879	K03283	ko03040	Spliceosome	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMC200000879	K03283	ko04010	MAPK signaling pathway	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMC200000879	K03283	ko04144	Endocytosis	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMC200000879	K03283	ko04612	Antigen processing and presentation	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMC200000886	K12193	ko04144	Endocytosis	1587	1.1e-81	0.87	0.93	1.00
PGSC0003DMC200000887	K12193	ko04144	Endocytosis	747	2.3e-35	0.83	0.91	0.99
PGSC0003DMC200000892	K12272	ko03060	Protein export	944	3.1e-46	0.71	0.86	0.97
PGSC0003DMC200000893	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMC200000894	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMC200000895	K10747	ko03030	DNA replication	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMC200000895	K10747	ko03410	Base excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMC200000895	K10747	ko03420	Nucleotide excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMC200000895	K10747	ko03430	Mismatch repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMC200000896	K10747	ko03030	DNA replication	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMC200000896	K10747	ko03410	Base excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMC200000896	K10747	ko03420	Nucleotide excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMC200000896	K10747	ko03430	Mismatch repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMC200000897	K10747	ko03030	DNA replication	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMC200000897	K10747	ko03410	Base excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMC200000897	K10747	ko03420	Nucleotide excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMC200000897	K10747	ko03430	Mismatch repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMC200000900	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMC200069210	K10760	ko00908	Zeatin biosynthesis	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMC200069210	K10760	ko01100	Metabolic pathways	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMC200069210	K10760	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMC200003460	K09564	ko03040	Spliceosome	465	8.2e-20	0.58	0.74	0.47
PGSC0003DMC200003461	K09564	ko03040	Spliceosome	520	7.6e-23	0.48	0.65	0.80
PGSC0003DMC200003462	K12153	ko00966	Glucosinolate biosynthesis	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMC200003462	K12153	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMC200003463	K11812	ko00380	Tryptophan metabolism	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMC200003463	K11812	ko00966	Glucosinolate biosynthesis	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMC200003464	K11812	ko00380	Tryptophan metabolism	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMC200003464	K11812	ko00966	Glucosinolate biosynthesis	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMC200003465	K12153	ko00966	Glucosinolate biosynthesis	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMC200003465	K12153	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMC200003466	K12153	ko00966	Glucosinolate biosynthesis	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMC200003466	K12153	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMC200003467	K12153	ko00966	Glucosinolate biosynthesis	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMC200003467	K12153	ko01110	Biosynthesis of secondary metabolites	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMC200003468	K13027	ko00460	Cyanoamino acid metabolism	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMC200003468	K13027	ko00966	Glucosinolate biosynthesis	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMC200003468	K13027	ko01100	Metabolic pathways	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMC200003468	K13027	ko01110	Biosynthesis of secondary metabolites	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMC200003470	K01246	ko03410	Base excision repair	529	2.4e-23	0.73	0.92	0.99
PGSC0003DMC200003471	K04120	ko00904	Diterpenoid biosynthesis	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMC200003471	K04120	ko01100	Metabolic pathways	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMC200003471	K04120	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMC200003472	K04120	ko00904	Diterpenoid biosynthesis	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMC200003472	K04120	ko01100	Metabolic pathways	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMC200003472	K04120	ko01110	Biosynthesis of secondary metabolites	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMC200003473	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMC200003473	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMC200003473	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMC200003474	K04120	ko00904	Diterpenoid biosynthesis	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMC200003474	K04120	ko01100	Metabolic pathways	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMC200003474	K04120	ko01110	Biosynthesis of secondary metabolites	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMC200003475	K04120	ko00904	Diterpenoid biosynthesis	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMC200003475	K04120	ko01100	Metabolic pathways	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMC200003475	K04120	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMC200003476	K04120	ko00904	Diterpenoid biosynthesis	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMC200003476	K04120	ko01100	Metabolic pathways	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMC200003476	K04120	ko01110	Biosynthesis of secondary metabolites	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMC200003477	K04120	ko00904	Diterpenoid biosynthesis	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMC200003477	K04120	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMC200003477	K04120	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMC200003478	K04120	ko00904	Diterpenoid biosynthesis	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMC200003478	K04120	ko01100	Metabolic pathways	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMC200003478	K04120	ko01110	Biosynthesis of secondary metabolites	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMC200003479	K04120	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMC200003479	K04120	ko01100	Metabolic pathways	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMC200003479	K04120	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMC200003480	K04120	ko00904	Diterpenoid biosynthesis	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMC200003480	K04120	ko01100	Metabolic pathways	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMC200003480	K04120	ko01110	Biosynthesis of secondary metabolites	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMC200021901	K03846	ko00510	N-Glycan biosynthesis	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMC200021901	K03846	ko01100	Metabolic pathways	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMC200021902	K03846	ko00510	N-Glycan biosynthesis	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMC200021902	K03846	ko01100	Metabolic pathways	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMC200021904	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMC200021908	K12741	ko03040	Spliceosome	337	9.4e-13	0.29	0.47	0.85
PGSC0003DMC200021915	K00026	ko00020	Citrate cycle (TCA cycle)	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021915	K00026	ko00620	Pyruvate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021915	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021915	K00026	ko00710	Carbon fixation in photosynthetic organisms	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021915	K00026	ko01100	Metabolic pathways	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021915	K00026	ko01110	Biosynthesis of secondary metabolites	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMC200021919	K01681	ko00020	Citrate cycle (TCA cycle)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMC200021919	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMC200021919	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMC200021919	K01681	ko01100	Metabolic pathways	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMC200021919	K01681	ko01110	Biosynthesis of secondary metabolites	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMC200021923	K06027	ko04962	Vasopressin-regulated water reabsorption	939	4.0e-45	0.45	0.63	0.16
PGSC0003DMC200021930	K02968	ko03010	Ribosome	310	2.9e-11	0.53	0.66	0.46
PGSC0003DMC200028235	K01838	ko00500	Starch and sucrose metabolism	306	1.8e-13	0.39	0.54	0.52
PGSC0003DMC200028236	K01838	ko00500	Starch and sucrose metabolism	266	2.6e-11	0.39	0.58	0.45
PGSC0003DMC200028247	K00297	ko00670	One carbon pool by folate	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMC200028247	K00297	ko00680	Methane metabolism	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMC200028247	K00297	ko01100	Metabolic pathways	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMC200028248	K01179	ko00500	Starch and sucrose metabolism	1024	1.2e-50	0.54	0.69	0.94
PGSC0003DMC200028249	K01179	ko00500	Starch and sucrose metabolism	3033	1.9e-161	0.57	0.72	0.99
PGSC0003DMC200028250	K01179	ko00500	Starch and sucrose metabolism	2257	1.2e-118	0.55	0.71	0.95
PGSC0003DMC200028251	K01099	ko00562	Inositol phosphate metabolism	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMC200028251	K01099	ko01100	Metabolic pathways	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMC200028251	K01099	ko04070	Phosphatidylinositol signaling system	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMC200028252	K01099	ko00562	Inositol phosphate metabolism	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMC200028252	K01099	ko01100	Metabolic pathways	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMC200028252	K01099	ko04070	Phosphatidylinositol signaling system	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMC200028253	K01099	ko00562	Inositol phosphate metabolism	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMC200028253	K01099	ko01100	Metabolic pathways	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMC200028253	K01099	ko04070	Phosphatidylinositol signaling system	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMC200028260	K06670	ko04110	Cell cycle	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMC200028260	K06670	ko04111	Cell cycle - yeast	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMC200051927	K12741	ko03040	Spliceosome	1428	6.3e-73	0.46	0.59	0.99
PGSC0003DMC200033454	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200033454	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200033454	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200033454	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200033454	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200033455	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMC200033456	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMC200033458	K01051	ko00040	Pentose and glucuronate interconversions	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMC200033458	K01051	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMC200033458	K01051	ko01100	Metabolic pathways	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMC200033459	K01051	ko00040	Pentose and glucuronate interconversions	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMC200033459	K01051	ko00500	Starch and sucrose metabolism	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMC200033459	K01051	ko01100	Metabolic pathways	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMC200033460	K01051	ko00040	Pentose and glucuronate interconversions	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMC200033460	K01051	ko00500	Starch and sucrose metabolism	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMC200033460	K01051	ko01100	Metabolic pathways	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMC200033463	K05658	ko02010	ABC transporters	3935	3.3e-211	0.42	0.62	0.99
PGSC0003DMC200033470	K12844	ko03040	Spliceosome	2375	3.7e-125	0.65	0.77	0.98
PGSC0003DMC200033477	K02895	ko03010	Ribosome	1113	1.5e-55	0.74	0.83	0.99
PGSC0003DMC200033478	K02895	ko03010	Ribosome	1190	8.4e-60	0.76	0.86	0.99
PGSC0003DMC200058233	K13065	ko00940	Phenylpropanoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMC200058233	K13065	ko00941	Flavonoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMC200058233	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMC200058233	K13065	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMC200058235	K00797	ko00270	Cysteine and methionine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMC200058235	K00797	ko00330	Arginine and proline metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMC200058235	K00797	ko00410	beta-Alanine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMC200058235	K00797	ko00480	Glutathione metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMC200058235	K00797	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMC200058236	K10760	ko00908	Zeatin biosynthesis	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMC200058236	K10760	ko01100	Metabolic pathways	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMC200058236	K10760	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMC200058254	K01509	ko00230	Purine metabolism	688	4.1e-32	0.35	0.55	0.89
PGSC0003DMC200008463	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMC200008463	K02366	ko01100	Metabolic pathways	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMC200008464	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMC200008464	K02366	ko01100	Metabolic pathways	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMC200008466	K12844	ko03040	Spliceosome	3586	5.9e-192	0.89	0.96	1.00
PGSC0003DMC200008467	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMC200008468	K00852	ko00030	Pentose phosphate pathway	248	7.6e-08	0.31	0.52	0.97
PGSC0003DMC200008469	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMC200008471	K05280	ko00941	Flavonoid biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMC200008471	K05280	ko00944	Flavone and flavonol biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMC200008471	K05280	ko01100	Metabolic pathways	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMC200008471	K05280	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMC200008472	K05280	ko00941	Flavonoid biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMC200008472	K05280	ko00944	Flavone and flavonol biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMC200008472	K05280	ko01100	Metabolic pathways	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMC200008472	K05280	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMC200008473	K05280	ko00941	Flavonoid biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMC200008473	K05280	ko00944	Flavone and flavonol biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMC200008473	K05280	ko01100	Metabolic pathways	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMC200008473	K05280	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMC200008474	K05280	ko00941	Flavonoid biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMC200008474	K05280	ko00944	Flavone and flavonol biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMC200008474	K05280	ko01100	Metabolic pathways	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMC200008474	K05280	ko01110	Biosynthesis of secondary metabolites	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMC200008475	K05280	ko00941	Flavonoid biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMC200008475	K05280	ko00944	Flavone and flavonol biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMC200008475	K05280	ko01100	Metabolic pathways	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMC200008475	K05280	ko01110	Biosynthesis of secondary metabolites	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMC200008476	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMC200008476	K00517	ko00626	Naphthalene and anthracene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMC200008476	K00517	ko00903	Limonene and pinene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMC200008476	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMC200008476	K00517	ko01110	Biosynthesis of secondary metabolites	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMC200008477	K05280	ko00941	Flavonoid biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMC200008477	K05280	ko00944	Flavone and flavonol biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMC200008477	K05280	ko01100	Metabolic pathways	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMC200008477	K05280	ko01110	Biosynthesis of secondary metabolites	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMC200008478	K05280	ko00941	Flavonoid biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMC200008478	K05280	ko00944	Flavone and flavonol biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMC200008478	K05280	ko01100	Metabolic pathways	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMC200008478	K05280	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMC200008479	K05280	ko00941	Flavonoid biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMC200008479	K05280	ko00944	Flavone and flavonol biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMC200008479	K05280	ko01100	Metabolic pathways	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMC200008479	K05280	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMC200008485	K09553	ko05020	Prion diseases	3875	6.8e-208	0.78	0.88	1.00
PGSC0003DMC200023104	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.66
PGSC0003DMC200023105	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.69
PGSC0003DMC200004669	K00029	ko00620	Pyruvate metabolism	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMC200004669	K00029	ko00710	Carbon fixation in photosynthetic organisms	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMC200004669	K00029	ko01100	Metabolic pathways	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMC200004670	K00029	ko00620	Pyruvate metabolism	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMC200004670	K00029	ko00710	Carbon fixation in photosynthetic organisms	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMC200004670	K00029	ko01100	Metabolic pathways	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMC200004671	K00029	ko00620	Pyruvate metabolism	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMC200004671	K00029	ko00710	Carbon fixation in photosynthetic organisms	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMC200004671	K00029	ko01100	Metabolic pathways	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMC200004672	K00029	ko00620	Pyruvate metabolism	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMC200004672	K00029	ko00710	Carbon fixation in photosynthetic organisms	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMC200004672	K00029	ko01100	Metabolic pathways	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMC200004673	K00029	ko00620	Pyruvate metabolism	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMC200004673	K00029	ko00710	Carbon fixation in photosynthetic organisms	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMC200004673	K00029	ko01100	Metabolic pathways	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMC200027032	K04508	ko04310	Wnt signaling pathway	394	6.8e-16	0.74	0.88	0.98
PGSC0003DMC200027033	K04508	ko04310	Wnt signaling pathway	2724	2.1e-144	0.63	0.79	0.67
PGSC0003DMC200027034	K04508	ko04310	Wnt signaling pathway	2907	1.7e-154	0.66	0.80	0.94
PGSC0003DMC200027035	K01136	ko00531	Glycosaminoglycan degradation	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMC200027035	K01136	ko01100	Metabolic pathways	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMC200027035	K01136	ko04142	Lysosome	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMC200027038	K04503	ko04110	Cell cycle	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko04115	p53 signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko04310	Wnt signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko04510	Focal adhesion	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko04630	Jak-STAT signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05200	Pathways in cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05210	Colorectal cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05212	Pancreatic cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05213	Endometrial cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05214	Glioma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05215	Prostate cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05216	Thyroid cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05218	Melanoma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05219	Bladder cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05220	Chronic myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05221	Acute myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05222	Small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05223	Non-small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027038	K04503	ko05416	Viral myocarditis	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMC200027057	K00091	ko00941	Flavonoid biosynthesis	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMC200027057	K00091	ko01100	Metabolic pathways	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMC200027057	K00091	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMC200020941	K02641	ko00195	Photosynthesis	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMC200020941	K02641	ko01100	Metabolic pathways	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMC200020943	K04708	ko00600	Sphingolipid metabolism	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMC200020943	K04708	ko01100	Metabolic pathways	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMC200020944	K04708	ko00600	Sphingolipid metabolism	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMC200020944	K04708	ko01100	Metabolic pathways	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMC200020945	K12420	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.42	0.59	0.75
PGSC0003DMC200020951	K02692	ko00195	Photosynthesis	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMC200020951	K02692	ko01100	Metabolic pathways	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMC200020958	K02992	ko03010	Ribosome	1163	2.6e-58	0.97	0.99	0.99
PGSC0003DMC200020961	K03787	ko00230	Purine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMC200020961	K03787	ko00240	Pyrimidine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMC200020961	K03787	ko00760	Nicotinate and nicotinamide metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMC200020961	K03787	ko01100	Metabolic pathways	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMC200020961	K03787	ko01110	Biosynthesis of secondary metabolites	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMC200020962	K03787	ko00230	Purine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMC200020962	K03787	ko00240	Pyrimidine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMC200020962	K03787	ko00760	Nicotinate and nicotinamide metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMC200020962	K03787	ko01100	Metabolic pathways	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMC200020962	K03787	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMC200020963	K03787	ko00230	Purine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMC200020963	K03787	ko00240	Pyrimidine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMC200020963	K03787	ko00760	Nicotinate and nicotinamide metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMC200020963	K03787	ko01100	Metabolic pathways	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMC200020963	K03787	ko01110	Biosynthesis of secondary metabolites	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMC200020964	K03787	ko00230	Purine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMC200020964	K03787	ko00240	Pyrimidine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMC200020964	K03787	ko00760	Nicotinate and nicotinamide metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMC200020964	K03787	ko01100	Metabolic pathways	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMC200020964	K03787	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMC200020965	K03787	ko00230	Purine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMC200020965	K03787	ko00240	Pyrimidine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMC200020965	K03787	ko00760	Nicotinate and nicotinamide metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMC200020965	K03787	ko01100	Metabolic pathways	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMC200020965	K03787	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMC200062740	K00799	ko00480	Glutathione metabolism	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMC200062740	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMC200062740	K00799	ko00982	Drug metabolism - cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMC200062752	K03026	ko00230	Purine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMC200062752	K03026	ko00240	Pyrimidine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMC200062752	K03026	ko01100	Metabolic pathways	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMC200062752	K03026	ko03020	RNA polymerase	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMC200062752	K03026	ko04623	Cytosolic DNA-sensing pathway	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMC200002072	K00231	ko00860	Porphyrin and chlorophyll metabolism	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMC200002072	K00231	ko01100	Metabolic pathways	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMC200002072	K00231	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMC200002073	K00231	ko00860	Porphyrin and chlorophyll metabolism	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMC200002073	K00231	ko01100	Metabolic pathways	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMC200002073	K00231	ko01110	Biosynthesis of secondary metabolites	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMC200002074	K00231	ko00860	Porphyrin and chlorophyll metabolism	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMC200002074	K00231	ko01100	Metabolic pathways	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMC200002074	K00231	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMC200002075	K00231	ko00860	Porphyrin and chlorophyll metabolism	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMC200002075	K00231	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMC200002075	K00231	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMC200002076	K00680	ko00350	Tyrosine metabolism	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMC200002076	K00680	ko00624	1- and 2-Methylnaphthalene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMC200002076	K00680	ko00632	Benzoate degradation via CoA ligation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMC200002076	K00680	ko00642	Ethylbenzene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMC200002076	K00680	ko00903	Limonene and pinene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMC200002077	K11253	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.99	1.00	0.99
PGSC0003DMC200002080	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002080	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002080	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002081	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002081	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002081	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMC200002084	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMC200002084	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMC200002085	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMC200002085	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMC200002094	K02958	ko03010	Ribosome	514	1.6e-22	0.88	0.94	0.95
PGSC0003DMC200002095	K02958	ko03010	Ribosome	1198	3.1e-60	0.91	0.97	0.99
PGSC0003DMC200002096	K03015	ko00230	Purine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMC200002096	K03015	ko00240	Pyrimidine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMC200002096	K03015	ko01100	Metabolic pathways	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMC200002096	K03015	ko03020	RNA polymerase	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMC200002096	K03015	ko05016	Huntington's disease	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMC200002097	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200002097	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200002097	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200002098	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200002098	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200002098	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMC200031926	K00603	ko00340	Histidine metabolism	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMC200031926	K00603	ko00670	One carbon pool by folate	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMC200031926	K00603	ko01100	Metabolic pathways	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMC200031927	K00603	ko00340	Histidine metabolism	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMC200031927	K00603	ko00670	One carbon pool by folate	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMC200031927	K00603	ko01100	Metabolic pathways	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMC200031929	K00603	ko00340	Histidine metabolism	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMC200031929	K00603	ko00670	One carbon pool by folate	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMC200031929	K00603	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMC200031935	K03644	ko00785	Lipoic acid metabolism	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMC200031935	K03644	ko01100	Metabolic pathways	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMC200031937	K03885	ko00190	Oxidative phosphorylation	1973	5.5e-103	0.73	0.87	0.99
PGSC0003DMC200031945	K03006	ko00230	Purine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMC200031945	K03006	ko00240	Pyrimidine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMC200031945	K03006	ko01100	Metabolic pathways	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMC200031945	K03006	ko03020	RNA polymerase	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMC200031945	K03006	ko05016	Huntington's disease	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMC200049242	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMC200049242	K00517	ko00626	Naphthalene and anthracene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMC200049242	K00517	ko00903	Limonene and pinene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMC200049242	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMC200049242	K00517	ko01110	Biosynthesis of secondary metabolites	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMC200049244	K08509	ko04130	SNARE interactions in vesicular transport	1215	3.5e-61	0.59	0.73	1.00
PGSC0003DMC200049245	K08509	ko04130	SNARE interactions in vesicular transport	1240	1.5e-62	0.60	0.73	1.00
PGSC0003DMC200049246	K07964	ko00531	Glycosaminoglycan degradation	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMC200049246	K07964	ko01100	Metabolic pathways	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMC200049247	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	349	1.0e-12	0.32	0.46	0.85
PGSC0003DMC200049248	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	360	3.7e-13	0.27	0.44	0.95
PGSC0003DMC200047881	K02975	ko03010	Ribosome	614	5.0e-28	0.91	0.97	0.98
PGSC0003DMC200047890	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047890	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047892	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047892	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047893	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047893	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMC200047894	K01922	ko00770	Pantothenate and CoA biosynthesis	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMC200047894	K01922	ko01100	Metabolic pathways	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMC200047910	K00850	ko00010	Glycolysis / Gluconeogenesis	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200047910	K00850	ko00030	Pentose phosphate pathway	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200047910	K00850	ko00051	Fructose and mannose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200047910	K00850	ko00052	Galactose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200047910	K00850	ko01100	Metabolic pathways	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200047910	K00850	ko01110	Biosynthesis of secondary metabolites	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMC200054906	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMC200054906	K00517	ko00626	Naphthalene and anthracene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMC200054906	K00517	ko00903	Limonene and pinene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMC200054906	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMC200054906	K00517	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMC200054912	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMC200054919	K03064	ko03050	Proteasome	941	4.6e-46	0.93	0.97	0.99
PGSC0003DMC200054923	K10747	ko03030	DNA replication	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMC200054923	K10747	ko03410	Base excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMC200054923	K10747	ko03420	Nucleotide excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMC200054923	K10747	ko03430	Mismatch repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMC200054924	K10747	ko03030	DNA replication	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMC200054924	K10747	ko03410	Base excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMC200054924	K10747	ko03420	Nucleotide excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMC200054924	K10747	ko03430	Mismatch repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMC200054925	K10747	ko03030	DNA replication	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMC200054925	K10747	ko03410	Base excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMC200054925	K10747	ko03420	Nucleotide excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMC200054925	K10747	ko03430	Mismatch repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMC200054926	K13065	ko00940	Phenylpropanoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMC200054926	K13065	ko00941	Flavonoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMC200054926	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMC200054926	K13065	ko01110	Biosynthesis of secondary metabolites	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMC200054927	K13065	ko00940	Phenylpropanoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMC200054927	K13065	ko00941	Flavonoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMC200054927	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMC200054927	K13065	ko01110	Biosynthesis of secondary metabolites	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMC200037737	K06102	ko04530	Tight junction	355	1.0e-10	0.26	0.45	0.99
PGSC0003DMC200037738	K06102	ko04530	Tight junction	328	2.6e-09	0.26	0.46	0.97
PGSC0003DMC200029941	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMC200029941	K00135	ko00350	Tyrosine metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMC200029941	K00135	ko00650	Butanoate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMC200029941	K00135	ko01100	Metabolic pathways	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMC200029942	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029942	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029942	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029942	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029943	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029943	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029943	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029943	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMC200029945	K00797	ko00270	Cysteine and methionine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMC200029945	K00797	ko00330	Arginine and proline metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMC200029945	K00797	ko00410	beta-Alanine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMC200029945	K00797	ko00480	Glutathione metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMC200029945	K00797	ko01100	Metabolic pathways	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMC200029949	K12587	ko03018	RNA degradation	330	2.6e-11	0.35	0.54	0.45
PGSC0003DMC200029950	K12127	ko04712	Circadian rhythm - plant	223	7.5e-08	0.34	0.50	0.63
PGSC0003DMC200029956	K11420	ko00310	Lysine degradation	610	4.0e-27	0.35	0.47	0.48
PGSC0003DMC200029957	K02894	ko03010	Ribosome	1184	1.8e-59	0.99	1.00	0.99
PGSC0003DMC200029958	K02866	ko03010	Ribosome	609	9.4e-28	0.40	0.59	0.83
PGSC0003DMC200029959	K03259	ko04150	mTOR signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMC200029959	K03259	ko04910	Insulin signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMC200029960	K03259	ko04150	mTOR signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMC200029960	K03259	ko04910	Insulin signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMC200029964	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMC200029965	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMC200029966	K00276	ko00260	Glycine, serine and threonine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko00350	Tyrosine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko00360	Phenylalanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko00410	beta-Alanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko00950	Isoquinoline alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko01100	Metabolic pathways	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029966	K00276	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMC200029967	K00276	ko00260	Glycine, serine and threonine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko00350	Tyrosine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko00360	Phenylalanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko00410	beta-Alanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko01100	Metabolic pathways	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029967	K00276	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMC200029970	K01725	ko00910	Nitrogen metabolism	1087	4.1e-54	0.82	0.92	0.97
PGSC0003DMC200018037	K04424	ko04010	MAPK signaling pathway	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMC200018037	K04424	ko04530	Tight junction	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMC200018038	K04424	ko04010	MAPK signaling pathway	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMC200018038	K04424	ko04530	Tight junction	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMC200018039	K04424	ko04010	MAPK signaling pathway	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMC200018039	K04424	ko04530	Tight junction	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMC200006516	K00434	ko00053	Ascorbate and aldarate metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMC200006516	K00434	ko00480	Glutathione metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMC200006517	K00434	ko00053	Ascorbate and aldarate metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMC200006517	K00434	ko00480	Glutathione metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMC200006519	K00434	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMC200006519	K00434	ko00480	Glutathione metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMC200006520	K06662	ko04111	Cell cycle - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMC200006520	K06662	ko04113	Meiosis - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMC200006521	K06662	ko04111	Cell cycle - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMC200006521	K06662	ko04113	Meiosis - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMC200006522	K06662	ko04111	Cell cycle - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMC200006522	K06662	ko04113	Meiosis - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMC200006523	K06662	ko04111	Cell cycle - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMC200006523	K06662	ko04113	Meiosis - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMC200006533	K00430	ko00360	Phenylalanine metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMC200006533	K00430	ko00680	Methane metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMC200006533	K00430	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMC200006533	K00430	ko01100	Metabolic pathways	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMC200006533	K00430	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMC200006534	K00430	ko00360	Phenylalanine metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMC200006534	K00430	ko00680	Methane metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMC200006534	K00430	ko00940	Phenylpropanoid biosynthesis	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMC200006534	K00430	ko01100	Metabolic pathways	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMC200006534	K00430	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMC200006535	K00430	ko00360	Phenylalanine metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMC200006535	K00430	ko00680	Methane metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMC200006535	K00430	ko00940	Phenylpropanoid biosynthesis	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMC200006535	K00430	ko01100	Metabolic pathways	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMC200006535	K00430	ko01110	Biosynthesis of secondary metabolites	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMC200006536	K00430	ko00360	Phenylalanine metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMC200006536	K00430	ko00680	Methane metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMC200006536	K00430	ko00940	Phenylpropanoid biosynthesis	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMC200006536	K00430	ko01100	Metabolic pathways	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMC200006536	K00430	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMC200006537	K00430	ko00360	Phenylalanine metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMC200006537	K00430	ko00680	Methane metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMC200006537	K00430	ko00940	Phenylpropanoid biosynthesis	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMC200006537	K00430	ko01100	Metabolic pathways	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMC200006537	K00430	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMC200026111	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMC200026111	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMC200026111	K00734	ko01100	Metabolic pathways	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMC200060260	K01535	ko00190	Oxidative phosphorylation	6228	0.	0.78	0.88	0.99
PGSC0003DMC200060262	K05391	ko04626	Plant-pathogen interaction	3510	9.2e-188	0.64	0.78	0.99
PGSC0003DMC200060266	K00599	ko00340	Histidine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMC200060266	K00599	ko00350	Tyrosine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMC200060266	K00599	ko00450	Selenoamino acid metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMC200060266	K00599	ko00626	Naphthalene and anthracene degradation	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMC200001381	K12399	ko04142	Lysosome	704	5.4e-33	0.57	0.72	0.99
PGSC0003DMC200001382	K12399	ko04142	Lysosome	999	2.9e-49	0.73	0.87	0.98
PGSC0003DMC200001383	K12399	ko04142	Lysosome	411	7.8e-17	0.69	0.89	0.99
PGSC0003DMC200001386	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMC200001386	K08680	ko01100	Metabolic pathways	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMC200001386	K08680	ko01110	Biosynthesis of secondary metabolites	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMC200001387	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMC200001387	K08680	ko01100	Metabolic pathways	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMC200001387	K08680	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMC200001388	K12126	ko04712	Circadian rhythm - plant	319	1.9e-10	0.30	0.46	0.62
PGSC0003DMC200001390	K12126	ko04712	Circadian rhythm - plant	319	2.8e-10	0.30	0.46	0.60
PGSC0003DMC200001391	K01051	ko00040	Pentose and glucuronate interconversions	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMC200001391	K01051	ko00500	Starch and sucrose metabolism	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMC200001391	K01051	ko01100	Metabolic pathways	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMC200001403	K07897	ko04144	Endocytosis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMC200001403	K07897	ko04145	Phagosome	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMC200001403	K07897	ko05146	Amoebiasis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMC200001405	K04536	ko04062	Chemokine signaling pathway	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMC200001405	K04536	ko04742	Taste transduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMC200001405	K04536	ko04744	Phototransduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMC200001406	K01199	ko00500	Starch and sucrose metabolism	869	4.3e-42	0.38	0.57	0.71
PGSC0003DMC200068914	K03094	ko04110	Cell cycle	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04111	Cell cycle - yeast	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04114	Oocyte meiosis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04310	Wnt signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068914	K03094	ko04710	Circadian rhythm - mammal	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMC200068917	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMC200068917	K00517	ko00626	Naphthalene and anthracene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMC200068917	K00517	ko00903	Limonene and pinene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMC200068917	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMC200068917	K00517	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMC200068933	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	350	7.7e-11	0.26	0.44	0.69
PGSC0003DMC200014769	K01179	ko00500	Starch and sucrose metabolism	1467	4.5e-75	0.60	0.73	0.93
PGSC0003DMC200014770	K01179	ko00500	Starch and sucrose metabolism	2482	4.6e-131	0.62	0.77	0.95
PGSC0003DMC200014771	K01179	ko00500	Starch and sucrose metabolism	1060	1.2e-52	0.56	0.70	0.99
PGSC0003DMC200014775	K00817	ko00340	Histidine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko00350	Tyrosine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko00360	Phenylalanine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko00401	Novobiocin biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko01100	Metabolic pathways	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014775	K00817	ko01110	Biosynthesis of secondary metabolites	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMC200014776	K08735	ko03430	Mismatch repair	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMC200014776	K08735	ko05200	Pathways in cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMC200014776	K08735	ko05210	Colorectal cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMC200014777	K08735	ko03430	Mismatch repair	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMC200014777	K08735	ko05200	Pathways in cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMC200014777	K08735	ko05210	Colorectal cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMC200014783	K02929	ko03010	Ribosome	840	1.7e-40	0.92	0.95	0.36
PGSC0003DMC200004815	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004815	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004815	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004816	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004816	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004816	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004817	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004817	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004817	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMC200004818	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMC200004818	K00517	ko00626	Naphthalene and anthracene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMC200004818	K00517	ko00903	Limonene and pinene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMC200004818	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMC200004818	K00517	ko01110	Biosynthesis of secondary metabolites	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMC200004819	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMC200004819	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMC200004819	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMC200004819	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMC200004822	K00873	ko00010	Glycolysis / Gluconeogenesis	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko00230	Purine metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko00620	Pyruvate metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko00710	Carbon fixation in photosynthetic organisms	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko01100	Metabolic pathways	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko01110	Biosynthesis of secondary metabolites	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004822	K00873	ko04930	Type II diabetes mellitus	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMC200004828	K12626	ko03018	RNA degradation	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMC200004828	K12626	ko03040	Spliceosome	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMC200022361	K00235	ko00020	Citrate cycle (TCA cycle)	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko00190	Oxidative phosphorylation	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko01100	Metabolic pathways	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko05010	Alzheimer's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko05012	Parkinson's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022361	K00235	ko05016	Huntington's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMC200022362	K12386	ko04142	Lysosome	807	1.1e-38	0.82	0.88	0.88
PGSC0003DMC200022363	K12386	ko04142	Lysosome	1685	4.2e-87	0.76	0.84	0.97
PGSC0003DMC200022371	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022371	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022371	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022372	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022372	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022372	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMC200022375	K06665	ko04111	Cell cycle - yeast	295	1.6e-09	0.27	0.44	0.87
PGSC0003DMC200028023	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMC200028023	K01736	ko01100	Metabolic pathways	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMC200028023	K01736	ko01110	Biosynthesis of secondary metabolites	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMC200028024	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMC200028024	K01736	ko01100	Metabolic pathways	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMC200028024	K01736	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMC200028026	K01187	ko00052	Galactose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMC200028026	K01187	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMC200028026	K01187	ko01100	Metabolic pathways	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMC200028027	K01187	ko00052	Galactose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMC200028027	K01187	ko00500	Starch and sucrose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMC200028027	K01187	ko01100	Metabolic pathways	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMC200028028	K01187	ko00052	Galactose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMC200028028	K01187	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMC200028028	K01187	ko01100	Metabolic pathways	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMC200028029	K01187	ko00052	Galactose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMC200028029	K01187	ko00500	Starch and sucrose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMC200028029	K01187	ko01100	Metabolic pathways	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMC200028030	K01187	ko00052	Galactose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMC200028030	K01187	ko00500	Starch and sucrose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMC200028030	K01187	ko01100	Metabolic pathways	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMC200028032	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1759	3.5e-91	0.50	0.67	0.91
PGSC0003DMC200028049	K01213	ko00040	Pentose and glucuronate interconversions	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMC200028049	K01213	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMC200028049	K01213	ko01100	Metabolic pathways	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMC200033622	K08099	ko00860	Porphyrin and chlorophyll metabolism	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMC200033622	K08099	ko01100	Metabolic pathways	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMC200033622	K08099	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMC200033628	K01968	ko00280	Valine, leucine and isoleucine degradation	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMC200033628	K01968	ko01100	Metabolic pathways	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMC200033629	K01968	ko00280	Valine, leucine and isoleucine degradation	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMC200033629	K01968	ko01100	Metabolic pathways	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMC200033630	K01968	ko00280	Valine, leucine and isoleucine degradation	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMC200033630	K01968	ko01100	Metabolic pathways	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMC200051165	K02937	ko03010	Ribosome	1803	1.3e-93	0.87	0.94	1.00
PGSC0003DMC200051168	K06001	ko00260	Glycine, serine and threonine metabolism	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMC200051168	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMC200051168	K06001	ko01100	Metabolic pathways	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMC200051168	K06001	ko01110	Biosynthesis of secondary metabolites	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMC200051169	K06001	ko00260	Glycine, serine and threonine metabolism	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMC200051169	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMC200051169	K06001	ko01100	Metabolic pathways	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMC200051169	K06001	ko01110	Biosynthesis of secondary metabolites	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMC200051170	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMC200051171	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMC200051179	K00600	ko00260	Glycine, serine and threonine metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051179	K00600	ko00460	Cyanoamino acid metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051179	K00600	ko00670	One carbon pool by folate	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051179	K00600	ko00680	Methane metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051179	K00600	ko01100	Metabolic pathways	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051179	K00600	ko01110	Biosynthesis of secondary metabolites	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMC200051180	K00600	ko00260	Glycine, serine and threonine metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200051180	K00600	ko00460	Cyanoamino acid metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200051180	K00600	ko00670	One carbon pool by folate	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200051180	K00600	ko00680	Methane metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200051180	K00600	ko01100	Metabolic pathways	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200051180	K00600	ko01110	Biosynthesis of secondary metabolites	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMC200066066	K01051	ko00040	Pentose and glucuronate interconversions	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMC200066066	K01051	ko00500	Starch and sucrose metabolism	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMC200066066	K01051	ko01100	Metabolic pathways	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMC200066081	K01178	ko00500	Starch and sucrose metabolism	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMC200066081	K01178	ko01100	Metabolic pathways	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMC200066088	K01051	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMC200066088	K01051	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMC200066088	K01051	ko01100	Metabolic pathways	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMC200019023	K04733	ko04210	Apoptosis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMC200019023	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMC200019023	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMC200019023	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMC200019023	K04733	ko05142	Chagas disease	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMC200019028	K00850	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019028	K00850	ko00030	Pentose phosphate pathway	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019028	K00850	ko00051	Fructose and mannose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019028	K00850	ko00052	Galactose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019028	K00850	ko01100	Metabolic pathways	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019028	K00850	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMC200019029	K00850	ko00010	Glycolysis / Gluconeogenesis	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019029	K00850	ko00030	Pentose phosphate pathway	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019029	K00850	ko00051	Fructose and mannose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019029	K00850	ko00052	Galactose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019029	K00850	ko01100	Metabolic pathways	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019029	K00850	ko01110	Biosynthesis of secondary metabolites	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMC200019050	K01728	ko00040	Pentose and glucuronate interconversions	2645	4.7e-140	0.74	0.86	0.99
PGSC0003DMC200025359	K00754	ko00051	Fructose and mannose metabolism	1386	1.3e-70	0.39	0.59	0.98
PGSC0003DMC200025360	K00754	ko00051	Fructose and mannose metabolism	1383	1.9e-70	0.42	0.60	0.83
PGSC0003DMC200025362	K08901	ko00195	Photosynthesis	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMC200025362	K08901	ko01100	Metabolic pathways	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMC200025363	K08901	ko00195	Photosynthesis	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMC200025363	K08901	ko01100	Metabolic pathways	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMC200025364	K08901	ko00195	Photosynthesis	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMC200025364	K08901	ko01100	Metabolic pathways	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMC200025365	K11238	ko04011	MAPK signaling pathway - yeast	498	1.6e-20	0.38	0.44	0.38
PGSC0003DMC200025373	K04079	ko04612	Antigen processing and presentation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025373	K04079	ko04621	NOD-like receptor signaling pathway	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025373	K04079	ko04626	Plant-pathogen interaction	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025373	K04079	ko04914	Progesterone-mediated oocyte maturation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025373	K04079	ko05200	Pathways in cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025373	K04079	ko05215	Prostate cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMC200025374	K04079	ko04612	Antigen processing and presentation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200025374	K04079	ko04621	NOD-like receptor signaling pathway	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200025374	K04079	ko04626	Plant-pathogen interaction	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200025374	K04079	ko04914	Progesterone-mediated oocyte maturation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200025374	K04079	ko05200	Pathways in cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200025374	K04079	ko05215	Prostate cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMC200012211	K00472	ko00330	Arginine and proline metabolism	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMC200012211	K00472	ko01100	Metabolic pathways	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMC200012212	K00599	ko00340	Histidine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMC200012212	K00599	ko00350	Tyrosine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMC200012212	K00599	ko00450	Selenoamino acid metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMC200012212	K00599	ko00626	Naphthalene and anthracene degradation	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMC200012214	K00599	ko00340	Histidine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMC200012214	K00599	ko00350	Tyrosine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMC200012214	K00599	ko00450	Selenoamino acid metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMC200012214	K00599	ko00626	Naphthalene and anthracene degradation	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMC200012217	K11644	ko05016	Huntington's disease	6353	0.	0.60	0.73	0.95
PGSC0003DMC200012218	K11644	ko05016	Huntington's disease	7395	0.	0.64	0.78	1.00
PGSC0003DMC200012219	K11644	ko05016	Huntington's disease	7378	0.	0.64	0.77	1.00
PGSC0003DMC200012220	K11644	ko05016	Huntington's disease	7304	0.	0.64	0.77	1.00
PGSC0003DMC200012227	K01184	ko00040	Pentose and glucuronate interconversions	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMC200012227	K01184	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMC200012227	K01184	ko01100	Metabolic pathways	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMC200012228	K01184	ko00040	Pentose and glucuronate interconversions	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMC200012228	K01184	ko00500	Starch and sucrose metabolism	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMC200012228	K01184	ko01100	Metabolic pathways	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMC200012229	K01184	ko00040	Pentose and glucuronate interconversions	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMC200012229	K01184	ko00500	Starch and sucrose metabolism	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMC200012229	K01184	ko01100	Metabolic pathways	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMC200012231	K10846	ko03420	Nucleotide excision repair	5547	4.1e-300	0.50	0.64	1.00
PGSC0003DMC200012237	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200012237	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200012237	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200012238	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200012238	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200012238	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMC200050224	K01213	ko00040	Pentose and glucuronate interconversions	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMC200050224	K01213	ko00500	Starch and sucrose metabolism	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMC200050224	K01213	ko01100	Metabolic pathways	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMC200050225	K01213	ko00040	Pentose and glucuronate interconversions	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMC200050225	K01213	ko00500	Starch and sucrose metabolism	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMC200050225	K01213	ko01100	Metabolic pathways	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMC200050226	K01213	ko00040	Pentose and glucuronate interconversions	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMC200050226	K01213	ko00500	Starch and sucrose metabolism	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMC200050226	K01213	ko01100	Metabolic pathways	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMC200050227	K01213	ko00040	Pentose and glucuronate interconversions	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMC200050227	K01213	ko00500	Starch and sucrose metabolism	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMC200050227	K01213	ko01100	Metabolic pathways	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMC200050228	K01213	ko00040	Pentose and glucuronate interconversions	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMC200050228	K01213	ko00500	Starch and sucrose metabolism	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMC200050228	K01213	ko01100	Metabolic pathways	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMC200050235	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMC200050236	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMC200050240	K02145	ko00190	Oxidative phosphorylation	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050240	K02145	ko01100	Metabolic pathways	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050240	K02145	ko04145	Phagosome	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050240	K02145	ko04966	Collecting duct acid secretion	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050240	K02145	ko05110	Vibrio cholerae infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050240	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMC200050242	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.43	0.64	0.97
PGSC0003DMC200050243	K02135	ko00190	Oxidative phosphorylation	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMC200050243	K02135	ko01100	Metabolic pathways	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMC200050243	K02135	ko05010	Alzheimer's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMC200050243	K02135	ko05012	Parkinson's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMC200050243	K02135	ko05016	Huntington's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMC200031533	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMC200031533	K00766	ko01100	Metabolic pathways	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMC200031533	K00766	ko01110	Biosynthesis of secondary metabolites	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMC200031539	K04733	ko04210	Apoptosis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMC200031539	K04733	ko04620	Toll-like receptor signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMC200031539	K04733	ko04722	Neurotrophin signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMC200031539	K04733	ko05140	Leishmaniasis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMC200031539	K04733	ko05142	Chagas disease	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMC200031549	K06611	ko00052	Galactose metabolism	3566	7.5e-191	0.68	0.82	0.97
PGSC0003DMC200031551	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMC200031552	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMC200031553	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMC200031554	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMC200031555	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMC200031556	K01955	ko00240	Pyrimidine metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMC200031556	K01955	ko00250	Alanine, aspartate and glutamate metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMC200031556	K01955	ko01100	Metabolic pathways	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMC200031558	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMC200031558	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMC200031559	K08008	ko04145	Phagosome	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMC200031559	K08008	ko04670	Leukocyte transendothelial migration	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMC200031560	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMC200031560	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMC200041582	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041582	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041582	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041583	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041583	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041583	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMC200041584	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMC200041584	K03785	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMC200041584	K03785	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMC200041585	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMC200041585	K03785	ko01100	Metabolic pathways	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMC200041585	K03785	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMC200041586	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMC200041586	K03785	ko01100	Metabolic pathways	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMC200041586	K03785	ko01110	Biosynthesis of secondary metabolites	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMC200041591	K10144	ko04115	p53 signaling pathway	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMC200041591	K10144	ko04120	Ubiquitin mediated proteolysis	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMC200041592	K10144	ko04115	p53 signaling pathway	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMC200041592	K10144	ko04120	Ubiquitin mediated proteolysis	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMC200041593	K03869	ko04120	Ubiquitin mediated proteolysis	1769	9.8e-92	0.36	0.56	0.99
PGSC0003DMC200041594	K03869	ko04120	Ubiquitin mediated proteolysis	1809	6.1e-94	0.36	0.57	0.99
PGSC0003DMC200041608	K01051	ko00040	Pentose and glucuronate interconversions	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMC200041608	K01051	ko00500	Starch and sucrose metabolism	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMC200041608	K01051	ko01100	Metabolic pathways	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMC200041610	K06672	ko04111	Cell cycle - yeast	236	6.6e-06	0.46	0.59	0.80
PGSC0003DMC200043412	K02938	ko03010	Ribosome	836	2.8e-40	0.99	1.00	0.99
PGSC0003DMC200043413	K02938	ko03010	Ribosome	2210	4.7e-116	0.96	0.99	1.00
PGSC0003DMC200043431	K05391	ko04626	Plant-pathogen interaction	1999	2.0e-104	0.79	0.89	1.00
PGSC0003DMC200043432	K05391	ko04626	Plant-pathogen interaction	3466	2.5e-185	0.65	0.77	0.90
PGSC0003DMC200043436	K12486	ko04144	Endocytosis	434	4.2e-18	0.61	0.75	0.93
PGSC0003DMC200043437	K12486	ko04144	Endocytosis	2301	4.5e-121	0.60	0.73	1.00
PGSC0003DMC200043438	K04733	ko04210	Apoptosis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMC200043438	K04733	ko04620	Toll-like receptor signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMC200043438	K04733	ko04722	Neurotrophin signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMC200043438	K04733	ko05140	Leishmaniasis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMC200043438	K04733	ko05142	Chagas disease	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMC200043439	K04733	ko04210	Apoptosis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMC200043439	K04733	ko04620	Toll-like receptor signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMC200043439	K04733	ko04722	Neurotrophin signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMC200043439	K04733	ko05140	Leishmaniasis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMC200043439	K04733	ko05142	Chagas disease	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMC200054154	K00799	ko00480	Glutathione metabolism	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMC200054154	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMC200054154	K00799	ko00982	Drug metabolism - cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMC200054155	K00799	ko00480	Glutathione metabolism	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMC200054155	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMC200054155	K00799	ko00982	Drug metabolism - cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMC200054156	K00799	ko00480	Glutathione metabolism	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMC200054156	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMC200054156	K00799	ko00982	Drug metabolism - cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMC200054157	K00799	ko00480	Glutathione metabolism	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMC200054157	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMC200054157	K00799	ko00982	Drug metabolism - cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMC200020240	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020240	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020241	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMC200020242	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020242	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020243	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200020244	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMC200011586	K03869	ko04120	Ubiquitin mediated proteolysis	5531	3.1e-299	0.89	0.95	1.00
PGSC0003DMC200011587	K04713	ko00600	Sphingolipid metabolism	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMC200011587	K04713	ko01100	Metabolic pathways	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMC200011600	K04733	ko04210	Apoptosis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMC200011600	K04733	ko04620	Toll-like receptor signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMC200011600	K04733	ko04722	Neurotrophin signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMC200011600	K04733	ko05140	Leishmaniasis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMC200011600	K04733	ko05142	Chagas disease	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMC200011602	K04733	ko04210	Apoptosis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMC200011602	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMC200011602	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMC200011602	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMC200011602	K04733	ko05142	Chagas disease	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMC200011603	K04733	ko04210	Apoptosis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMC200011603	K04733	ko04620	Toll-like receptor signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMC200011603	K04733	ko04722	Neurotrophin signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMC200011603	K04733	ko05140	Leishmaniasis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMC200011603	K04733	ko05142	Chagas disease	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMC200024154	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMC200024154	K00517	ko00626	Naphthalene and anthracene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMC200024154	K00517	ko00903	Limonene and pinene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMC200024154	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMC200024154	K00517	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMC200024156	K00430	ko00360	Phenylalanine metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMC200024156	K00430	ko00680	Methane metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMC200024156	K00430	ko00940	Phenylpropanoid biosynthesis	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMC200024156	K00430	ko01100	Metabolic pathways	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMC200024156	K00430	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMC200024165	K04460	ko04010	MAPK signaling pathway	790	9.7e-38	0.40	0.55	0.73
PGSC0003DMC200024173	K00021	ko00900	Terpenoid backbone biosynthesis	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMC200024173	K00021	ko01100	Metabolic pathways	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMC200024173	K00021	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMC200024174	K00021	ko00900	Terpenoid backbone biosynthesis	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMC200024174	K00021	ko01100	Metabolic pathways	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMC200024174	K00021	ko01110	Biosynthesis of secondary metabolites	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMC200024176	K11594	ko04622	RIG-I-like receptor signaling pathway	244	1.3e-07	0.36	0.47	0.82
PGSC0003DMC200024180	K12585	ko03018	RNA degradation	6391	0.	0.80	0.89	1.00
PGSC0003DMC200013411	K10418	ko04962	Vasopressin-regulated water reabsorption	332	1.8e-12	0.49	0.67	0.94
PGSC0003DMC200013421	K07424	ko00140	Steroid hormone biosynthesis	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00591	Linoleic acid metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00830	Retinol metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00982	Drug metabolism - cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko00983	Drug metabolism - other enzymes	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013421	K07424	ko01100	Metabolic pathways	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMC200013423	K01528	ko04144	Endocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMC200013423	K01528	ko04666	Fc gamma R-mediated phagocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMC200013423	K01528	ko05100	Bacterial invasion of epithelial cells	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMC200013424	K01528	ko04144	Endocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMC200013424	K01528	ko04666	Fc gamma R-mediated phagocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMC200013424	K01528	ko05100	Bacterial invasion of epithelial cells	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMC200067273	K10591	ko04120	Ubiquitin mediated proteolysis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMC200067273	K10591	ko04144	Endocytosis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMC200030331	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030331	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030332	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMC200030342	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMC200030343	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMC200030353	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030353	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200030354	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMC200049021	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049021	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMC200049023	K04505	ko04310	Wnt signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMC200049023	K04505	ko04330	Notch signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMC200049023	K04505	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMC200049023	K04505	ko05010	Alzheimer's disease	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMC200049030	K11294	ko05130	Pathogenic Escherichia coli infection	383	2.7e-15	0.31	0.49	0.62
PGSC0003DMC200049040	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMC200049041	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMC200049046	K02146	ko00190	Oxidative phosphorylation	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049046	K02146	ko01100	Metabolic pathways	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049046	K02146	ko04142	Lysosome	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049046	K02146	ko04966	Collecting duct acid secretion	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049046	K02146	ko05110	Vibrio cholerae infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049046	K02146	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMC200049048	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMC200049048	K00517	ko00626	Naphthalene and anthracene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMC200049048	K00517	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMC200049048	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMC200049048	K00517	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMC200049049	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMC200049049	K08081	ko01100	Metabolic pathways	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMC200049049	K08081	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMC200049050	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMC200049050	K08081	ko01100	Metabolic pathways	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMC200049050	K08081	ko01110	Biosynthesis of secondary metabolites	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMC200042213	K07424	ko00140	Steroid hormone biosynthesis	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00591	Linoleic acid metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00830	Retinol metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00982	Drug metabolism - cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko00983	Drug metabolism - other enzymes	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042213	K07424	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMC200042214	K07424	ko00140	Steroid hormone biosynthesis	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00591	Linoleic acid metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00830	Retinol metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko00983	Drug metabolism - other enzymes	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042214	K07424	ko01100	Metabolic pathways	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMC200042228	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042228	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042229	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042229	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042230	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042230	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMC200042234	K02976	ko03010	Ribosome	564	2.8e-25	0.73	0.83	0.86
PGSC0003DMC200042238	K12929	ko00904	Diterpenoid biosynthesis	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMC200042238	K12929	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMC200042239	K12929	ko00904	Diterpenoid biosynthesis	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMC200042239	K12929	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMC200055353	K04567	ko00970	Aminoacyl-tRNA biosynthesis	674	2.4e-31	0.79	0.90	0.99
PGSC0003DMC200055354	K04567	ko00970	Aminoacyl-tRNA biosynthesis	2006	8.3e-105	0.82	0.91	1.00
PGSC0003DMC200055355	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3907	1.2e-209	0.80	0.89	0.99
PGSC0003DMC200055379	K04382	ko04111	Cell cycle - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04113	Meiosis - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04114	Oocyte meiosis	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04310	Wnt signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04350	TGF-beta signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04530	Tight junction	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko04730	Long-term depression	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200055379	K04382	ko05142	Chagas disease	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMC200021153	K04392	ko04010	MAPK signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04062	Chemokine signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04145	Phagosome	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04310	Wnt signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04360	Axon guidance	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04370	VEGF signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04510	Focal adhesion	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04520	Adherens junction	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04620	Toll-like receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04650	Natural killer cell mediated cytotoxicity	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04662	B cell receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04664	Fc epsilon RI signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04666	Fc gamma R-mediated phagocytosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04670	Leukocyte transendothelial migration	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko04810	Regulation of actin cytoskeleton	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05100	Bacterial invasion of epithelial cells	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05131	Shigellosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05200	Pathways in cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05210	Colorectal cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05211	Renal cell carcinoma	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05212	Pancreatic cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021153	K04392	ko05416	Viral myocarditis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMC200021154	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021154	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021155	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMC200021156	K04392	ko04010	MAPK signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04062	Chemokine signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04145	Phagosome	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04310	Wnt signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04360	Axon guidance	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04370	VEGF signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04510	Focal adhesion	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04520	Adherens junction	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04620	Toll-like receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04664	Fc epsilon RI signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04666	Fc gamma R-mediated phagocytosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04670	Leukocyte transendothelial migration	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko04810	Regulation of actin cytoskeleton	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05100	Bacterial invasion of epithelial cells	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05131	Shigellosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05200	Pathways in cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05210	Colorectal cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05211	Renal cell carcinoma	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05212	Pancreatic cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021156	K04392	ko05416	Viral myocarditis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMC200021157	K10590	ko04120	Ubiquitin mediated proteolysis	6211	0.	0.73	0.83	0.99
PGSC0003DMC200021158	K10590	ko04120	Ubiquitin mediated proteolysis	5226	2.1e-282	0.77	0.86	0.97
PGSC0003DMC200021159	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMC200021160	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMC200021162	K00430	ko00360	Phenylalanine metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMC200021162	K00430	ko00680	Methane metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMC200021162	K00430	ko00940	Phenylpropanoid biosynthesis	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMC200021162	K00430	ko01100	Metabolic pathways	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMC200021162	K00430	ko01110	Biosynthesis of secondary metabolites	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMC200021165	K02639	ko00195	Photosynthesis	859	1.5e-41	0.70	0.86	0.98
PGSC0003DMC200003602	K00606	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMC200003602	K00606	ko01100	Metabolic pathways	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMC200003602	K00606	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMC200003603	K00606	ko00770	Pantothenate and CoA biosynthesis	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMC200003603	K00606	ko01100	Metabolic pathways	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMC200003603	K00606	ko01110	Biosynthesis of secondary metabolites	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMC200003604	K00606	ko00770	Pantothenate and CoA biosynthesis	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMC200003604	K00606	ko01100	Metabolic pathways	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMC200003604	K00606	ko01110	Biosynthesis of secondary metabolites	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMC200003613	K00799	ko00480	Glutathione metabolism	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMC200003613	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMC200003613	K00799	ko00982	Drug metabolism - cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMC200003614	K00799	ko00480	Glutathione metabolism	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMC200003614	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMC200003614	K00799	ko00982	Drug metabolism - cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMC200003615	K01426	ko00330	Arginine and proline metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003615	K01426	ko00360	Phenylalanine metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003615	K01426	ko00380	Tryptophan metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003615	K01426	ko00460	Cyanoamino acid metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003615	K01426	ko00632	Benzoate degradation via CoA ligation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003615	K01426	ko00643	Styrene degradation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMC200003617	K02433	ko00970	Aminoacyl-tRNA biosynthesis	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMC200003617	K02433	ko01100	Metabolic pathways	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMC200029229	K05933	ko00270	Cysteine and methionine metabolism	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMC200029229	K05933	ko01110	Biosynthesis of secondary metabolites	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMC200029230	K05933	ko00270	Cysteine and methionine metabolism	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMC200029230	K05933	ko01110	Biosynthesis of secondary metabolites	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMC200029231	K05933	ko00270	Cysteine and methionine metabolism	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMC200029231	K05933	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMC200029234	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-34	0.31	0.49	0.54
PGSC0003DMC200029235	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-32	0.31	0.49	0.47
PGSC0003DMC200029237	K02016	ko02010	ABC transporters	326	3.8e-12	0.26	0.44	0.92
PGSC0003DMC200029238	K02016	ko02010	ABC transporters	310	2.9e-11	0.28	0.45	0.86
PGSC0003DMC200029239	K12858	ko03040	Spliceosome	5141	1.0e-277	0.86	0.92	1.00
PGSC0003DMC200029240	K02291	ko00906	Carotenoid biosynthesis	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMC200029240	K02291	ko01100	Metabolic pathways	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMC200029240	K02291	ko01110	Biosynthesis of secondary metabolites	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMC200029241	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029241	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029241	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029242	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029242	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029242	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMC200029243	K00799	ko00480	Glutathione metabolism	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMC200029243	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMC200029243	K00799	ko00982	Drug metabolism - cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMC200029247	K00895	ko00051	Fructose and mannose metabolism	3888	1.3e-208	0.82	0.90	0.99
PGSC0003DMC200044761	K00366	ko00910	Nitrogen metabolism	4199	9.2e-226	0.82	0.92	1.00
PGSC0003DMC200044764	K08233	ko00901	Indole alkaloid biosynthesis	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMC200044764	K08233	ko01110	Biosynthesis of secondary metabolites	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMC200044765	K08233	ko00901	Indole alkaloid biosynthesis	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMC200044765	K08233	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMC200044766	K08233	ko00901	Indole alkaloid biosynthesis	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMC200044766	K08233	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMC200044767	K08233	ko00901	Indole alkaloid biosynthesis	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMC200044767	K08233	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMC200044768	K01692	ko00071	Fatty acid metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00280	Valine, leucine and isoleucine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00281	Geraniol degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00310	Lysine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00380	Tryptophan metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00410	beta-Alanine metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00640	Propanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00650	Butanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00903	Limonene and pinene degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko00930	Caprolactam degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko01100	Metabolic pathways	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044768	K01692	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMC200044770	K01692	ko00071	Fatty acid metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00280	Valine, leucine and isoleucine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00281	Geraniol degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00310	Lysine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00380	Tryptophan metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00410	beta-Alanine metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00632	Benzoate degradation via CoA ligation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00640	Propanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00650	Butanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00903	Limonene and pinene degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko00930	Caprolactam degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko01100	Metabolic pathways	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044770	K01692	ko01110	Biosynthesis of secondary metabolites	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMC200044771	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00310	Lysine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044771	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMC200044772	K01692	ko00071	Fatty acid metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00280	Valine, leucine and isoleucine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00281	Geraniol degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00310	Lysine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00380	Tryptophan metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00410	beta-Alanine metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00632	Benzoate degradation via CoA ligation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00640	Propanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00650	Butanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00903	Limonene and pinene degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko00930	Caprolactam degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko01100	Metabolic pathways	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044772	K01692	ko01110	Biosynthesis of secondary metabolites	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMC200044773	K01692	ko00071	Fatty acid metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00280	Valine, leucine and isoleucine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00281	Geraniol degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00310	Lysine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00380	Tryptophan metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00410	beta-Alanine metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00632	Benzoate degradation via CoA ligation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00640	Propanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00650	Butanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00903	Limonene and pinene degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko00930	Caprolactam degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko01100	Metabolic pathways	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044773	K01692	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMC200044774	K01692	ko00071	Fatty acid metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00280	Valine, leucine and isoleucine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00281	Geraniol degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00310	Lysine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00380	Tryptophan metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00410	beta-Alanine metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00632	Benzoate degradation via CoA ligation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00640	Propanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00650	Butanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00903	Limonene and pinene degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko00930	Caprolactam degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko01100	Metabolic pathways	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044774	K01692	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMC200044775	K01692	ko00071	Fatty acid metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00281	Geraniol degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00310	Lysine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00380	Tryptophan metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00410	beta-Alanine metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00632	Benzoate degradation via CoA ligation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00640	Propanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00650	Butanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00903	Limonene and pinene degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko00930	Caprolactam degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko01100	Metabolic pathways	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044775	K01692	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMC200044776	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044776	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044778	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMC200044779	K01692	ko00071	Fatty acid metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00280	Valine, leucine and isoleucine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00281	Geraniol degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00310	Lysine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00380	Tryptophan metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00410	beta-Alanine metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00632	Benzoate degradation via CoA ligation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00640	Propanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00650	Butanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00903	Limonene and pinene degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko00930	Caprolactam degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko01100	Metabolic pathways	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044779	K01692	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMC200044780	K01692	ko00071	Fatty acid metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00280	Valine, leucine and isoleucine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00281	Geraniol degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00310	Lysine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00380	Tryptophan metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00410	beta-Alanine metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00632	Benzoate degradation via CoA ligation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00640	Propanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00650	Butanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00903	Limonene and pinene degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko00930	Caprolactam degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko01100	Metabolic pathways	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200044780	K01692	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMC200052355	K00434	ko00053	Ascorbate and aldarate metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMC200052355	K00434	ko00480	Glutathione metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMC200052356	K00434	ko00053	Ascorbate and aldarate metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMC200052356	K00434	ko00480	Glutathione metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMC200052358	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMC200052359	K11247	ko04144	Endocytosis	653	3.5e-30	0.59	0.79	0.71
PGSC0003DMC200052360	K11247	ko04144	Endocytosis	1121	5.4e-56	0.59	0.77	1.00
PGSC0003DMC200052361	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMC200052362	K11247	ko04144	Endocytosis	1744	2.3e-90	0.59	0.76	0.99
PGSC0003DMC200052366	K10798	ko03410	Base excision repair	3038	1.2e-167	0.54	0.70	0.98
PGSC0003DMC200052367	K10798	ko03410	Base excision repair	2868	2.4e-152	0.61	0.72	0.99
PGSC0003DMC200052380	K11419	ko00310	Lysine degradation	634	3.9e-29	0.37	0.51	0.38
PGSC0003DMC200034801	K12819	ko03040	Spliceosome	4030	1.9e-216	0.86	0.93	1.00
PGSC0003DMC200034802	K12819	ko03040	Spliceosome	3478	5.4e-186	0.88	0.94	0.97
PGSC0003DMC200034803	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMC200034817	K11816	ko00380	Tryptophan metabolism	2650	2.5e-140	0.73	0.86	0.99
PGSC0003DMC200034818	K00384	ko00240	Pyrimidine metabolism	222	9.6e-13	0.45	0.58	0.48
PGSC0003DMC200058049	K01760	ko00270	Cysteine and methionine metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200058049	K01760	ko00450	Selenoamino acid metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200058049	K01760	ko00910	Nitrogen metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200058049	K01760	ko00920	Sulfur metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200058049	K01760	ko01100	Metabolic pathways	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200058049	K01760	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMC200032650	K00627	ko00010	Glycolysis / Gluconeogenesis	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMC200032650	K00627	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMC200032650	K00627	ko00620	Pyruvate metabolism	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMC200032650	K00627	ko01100	Metabolic pathways	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMC200032650	K00627	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMC200032651	K00833	ko00780	Biotin metabolism	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMC200032651	K00833	ko01100	Metabolic pathways	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMC200032652	K00833	ko00780	Biotin metabolism	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMC200032652	K00833	ko01100	Metabolic pathways	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMC200032653	K00833	ko00780	Biotin metabolism	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMC200032653	K00833	ko01100	Metabolic pathways	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMC200032654	K03125	ko03022	Basal transcription factors	7537	0.	0.53	0.67	1.00
PGSC0003DMC200032655	K03125	ko03022	Basal transcription factors	6049	0.	0.58	0.73	0.98
PGSC0003DMC200032656	K03125	ko03022	Basal transcription factors	5968	0.	0.59	0.74	0.99
PGSC0003DMC200032657	K03125	ko03022	Basal transcription factors	7634	0.	0.54	0.69	1.00
PGSC0003DMC200032658	K03125	ko03022	Basal transcription factors	7627	0.	0.54	0.69	1.00
PGSC0003DMC200032659	K02183	ko04020	Calcium signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04070	Phosphatidylinositol signaling system	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04114	Oocyte meiosis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04270	Vascular smooth muscle contraction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04626	Plant-pathogen interaction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04720	Long-term potentiation	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04722	Neurotrophin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04740	Olfactory transduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04744	Phototransduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04745	Phototransduction - fly	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04910	Insulin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04912	GnRH signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04916	Melanogenesis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04970	Salivary secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko04971	Gastric acid secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko05010	Alzheimer's disease	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032659	K02183	ko05214	Glioma	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMC200032660	K02183	ko04020	Calcium signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04070	Phosphatidylinositol signaling system	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04114	Oocyte meiosis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04270	Vascular smooth muscle contraction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04626	Plant-pathogen interaction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04720	Long-term potentiation	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04722	Neurotrophin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04740	Olfactory transduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04744	Phototransduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04745	Phototransduction - fly	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04910	Insulin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04912	GnRH signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04916	Melanogenesis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04970	Salivary secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko04971	Gastric acid secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko05010	Alzheimer's disease	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032660	K02183	ko05214	Glioma	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMC200032667	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMC200032667	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMC200032667	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMC200032667	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMC200032667	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMC200044639	K00083	ko00940	Phenylpropanoid biosynthesis	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMC200044639	K00083	ko01100	Metabolic pathways	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMC200044639	K00083	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMC200040386	K03553	ko03440	Homologous recombination	2528	1.3e-133	0.69	0.77	1.00
PGSC0003DMC200040387	K03553	ko03440	Homologous recombination	2623	7.7e-139	0.76	0.85	1.00
PGSC0003DMC200040388	K01823	ko00900	Terpenoid backbone biosynthesis	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMC200040388	K01823	ko01100	Metabolic pathways	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMC200040388	K01823	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMC200040391	K00297	ko00670	One carbon pool by folate	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMC200040391	K00297	ko00680	Methane metabolism	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMC200040391	K00297	ko01100	Metabolic pathways	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMC200040392	K00297	ko00670	One carbon pool by folate	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMC200040392	K00297	ko00680	Methane metabolism	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMC200040392	K00297	ko01100	Metabolic pathways	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMC200040393	K00297	ko00670	One carbon pool by folate	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMC200040393	K00297	ko00680	Methane metabolism	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMC200040393	K00297	ko01100	Metabolic pathways	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMC200040407	K00599	ko00340	Histidine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMC200040407	K00599	ko00350	Tyrosine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMC200040407	K00599	ko00450	Selenoamino acid metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMC200040407	K00599	ko00626	Naphthalene and anthracene degradation	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMC200040408	K00599	ko00340	Histidine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMC200040408	K00599	ko00350	Tyrosine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMC200040408	K00599	ko00450	Selenoamino acid metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMC200040408	K00599	ko00626	Naphthalene and anthracene degradation	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMC200046771	K00162	ko00010	Glycolysis / Gluconeogenesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko00020	Citrate cycle (TCA cycle)	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko00620	Pyruvate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko00650	Butanoate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko01100	Metabolic pathways	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046771	K00162	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMC200046774	K02904	ko03010	Ribosome	761	3.9e-36	0.80	0.91	0.69
PGSC0003DMC200046777	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMC200046777	K01078	ko00740	Riboflavin metabolism	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMC200046786	K01099	ko00562	Inositol phosphate metabolism	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMC200046786	K01099	ko01100	Metabolic pathways	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMC200046786	K01099	ko04070	Phosphatidylinositol signaling system	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMC200046787	K01099	ko00562	Inositol phosphate metabolism	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMC200046787	K01099	ko01100	Metabolic pathways	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMC200046787	K01099	ko04070	Phosphatidylinositol signaling system	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMC200046788	K00863	ko00561	Glycerolipid metabolism	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMC200046788	K00863	ko01100	Metabolic pathways	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMC200046788	K00863	ko04622	RIG-I-like receptor signaling pathway	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMC200046789	K00863	ko00561	Glycerolipid metabolism	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMC200046789	K00863	ko01100	Metabolic pathways	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMC200046789	K00863	ko04622	RIG-I-like receptor signaling pathway	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMC200046790	K00863	ko00561	Glycerolipid metabolism	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMC200046790	K00863	ko01100	Metabolic pathways	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMC200046790	K00863	ko04622	RIG-I-like receptor signaling pathway	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMC200046798	K00654	ko00600	Sphingolipid metabolism	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMC200046798	K00654	ko01100	Metabolic pathways	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMC200032733	K02132	ko00190	Oxidative phosphorylation	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMC200032733	K02132	ko01100	Metabolic pathways	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMC200032733	K02132	ko05010	Alzheimer's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMC200032733	K02132	ko05012	Parkinson's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMC200032733	K02132	ko05016	Huntington's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMC200032734	K05894	ko00592	alpha-Linolenic acid metabolism	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMC200032734	K05894	ko01100	Metabolic pathways	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMC200032735	K05894	ko00592	alpha-Linolenic acid metabolism	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMC200032735	K05894	ko01100	Metabolic pathways	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMC200032737	K01046	ko00561	Glycerolipid metabolism	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMC200032737	K01046	ko01100	Metabolic pathways	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMC200032738	K01046	ko00561	Glycerolipid metabolism	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMC200032738	K01046	ko01100	Metabolic pathways	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMC200032745	K01066	ko00623	2,4-Dichlorobenzoate degradation	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMC200032745	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMC200032749	K12124	ko04712	Circadian rhythm - plant	6214	0.	0.77	0.87	1.00
PGSC0003DMC200032750	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMC200032751	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMC200032753	K12124	ko04712	Circadian rhythm - plant	5479	2.3e-296	0.75	0.85	1.00
PGSC0003DMC200032754	K12124	ko04712	Circadian rhythm - plant	536	5.1e-23	0.86	0.89	0.53
PGSC0003DMC200032760	K05658	ko02010	ABC transporters	3664	3.0e-196	0.45	0.65	1.00
PGSC0003DMC200063451	K12639	ko00905	Brassinosteroid biosynthesis	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMC200063451	K12639	ko01100	Metabolic pathways	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMC200063451	K12639	ko01110	Biosynthesis of secondary metabolites	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMC200063479	K04428	ko04010	MAPK signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMC200063479	K04428	ko04912	GnRH signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMC200026552	K01522	ko00230	Purine metabolism	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMC200026552	K01522	ko05222	Small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMC200026552	K01522	ko05223	Non-small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMC200026553	K01522	ko00230	Purine metabolism	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMC200026553	K01522	ko05222	Small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMC200026553	K01522	ko05223	Non-small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMC200026564	K10756	ko03030	DNA replication	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMC200026564	K10756	ko03420	Nucleotide excision repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMC200026564	K10756	ko03430	Mismatch repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMC200026567	K00901	ko00561	Glycerolipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMC200026567	K00901	ko00564	Glycerophospholipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMC200026567	K00901	ko01100	Metabolic pathways	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMC200026567	K00901	ko04070	Phosphatidylinositol signaling system	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMC200026578	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMC200026578	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMC200026578	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMC200026578	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMC200026578	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMC200026579	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMC200026579	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMC200026579	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMC200026579	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMC200026579	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMC200026580	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMC200026580	K00517	ko00626	Naphthalene and anthracene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMC200026580	K00517	ko00903	Limonene and pinene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMC200026580	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMC200026580	K00517	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMC200009181	K02084	ko04115	p53 signaling pathway	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko04210	Apoptosis	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko05010	Alzheimer's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko05012	Parkinson's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko05016	Huntington's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009181	K02084	ko05222	Small cell lung cancer	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMC200009188	K08233	ko00901	Indole alkaloid biosynthesis	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMC200009188	K08233	ko01110	Biosynthesis of secondary metabolites	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMC200009189	K08233	ko00901	Indole alkaloid biosynthesis	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMC200009189	K08233	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMC200009190	K08233	ko00901	Indole alkaloid biosynthesis	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMC200009190	K08233	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMC200009192	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009192	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009192	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009192	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009192	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009192	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009193	K01501	ko00380	Tryptophan metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009193	K01501	ko00460	Cyanoamino acid metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009193	K01501	ko00632	Benzoate degradation via CoA ligation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009193	K01501	ko00643	Styrene degradation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009193	K01501	ko00910	Nitrogen metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009193	K01501	ko01100	Metabolic pathways	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMC200009194	K01501	ko00380	Tryptophan metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009194	K01501	ko00460	Cyanoamino acid metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009194	K01501	ko00632	Benzoate degradation via CoA ligation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009194	K01501	ko00643	Styrene degradation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009194	K01501	ko00910	Nitrogen metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009194	K01501	ko01100	Metabolic pathways	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMC200009195	K01501	ko00380	Tryptophan metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009195	K01501	ko00460	Cyanoamino acid metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009195	K01501	ko00632	Benzoate degradation via CoA ligation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009195	K01501	ko00643	Styrene degradation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009195	K01501	ko00910	Nitrogen metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009195	K01501	ko01100	Metabolic pathways	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMC200009197	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009197	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009197	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009197	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009197	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200009197	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMC200015574	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMC200015575	K10609	ko03420	Nucleotide excision repair	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMC200015575	K10609	ko04120	Ubiquitin mediated proteolysis	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMC200015576	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMC200015577	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMC200015578	K13229	ko00402	Benzoxazinoid biosynthesis	951	1.3e-46	0.44	0.61	0.95
PGSC0003DMC200015586	K03106	ko03060	Protein export	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMC200015586	K03106	ko03070	Bacterial secretion system	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMC200015587	K03106	ko03060	Protein export	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMC200015587	K03106	ko03070	Bacterial secretion system	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMC200030254	K07424	ko00140	Steroid hormone biosynthesis	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00591	Linoleic acid metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00830	Retinol metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00982	Drug metabolism - cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko00983	Drug metabolism - other enzymes	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030254	K07424	ko01100	Metabolic pathways	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMC200030257	K06685	ko04111	Cell cycle - yeast	417	1.6e-13	0.29	0.47	0.36
PGSC0003DMC200030259	K07424	ko00140	Steroid hormone biosynthesis	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00591	Linoleic acid metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00830	Retinol metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00982	Drug metabolism - cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko00983	Drug metabolism - other enzymes	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030259	K07424	ko01100	Metabolic pathways	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMC200030260	K07424	ko00140	Steroid hormone biosynthesis	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00591	Linoleic acid metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00830	Retinol metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00982	Drug metabolism - cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko00983	Drug metabolism - other enzymes	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030260	K07424	ko01100	Metabolic pathways	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMC200030261	K07424	ko00140	Steroid hormone biosynthesis	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00591	Linoleic acid metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00830	Retinol metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00982	Drug metabolism - cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko00983	Drug metabolism - other enzymes	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030261	K07424	ko01100	Metabolic pathways	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMC200030262	K07424	ko00140	Steroid hormone biosynthesis	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00591	Linoleic acid metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00830	Retinol metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00982	Drug metabolism - cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko00983	Drug metabolism - other enzymes	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030262	K07424	ko01100	Metabolic pathways	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMC200030263	K07424	ko00140	Steroid hormone biosynthesis	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00591	Linoleic acid metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00830	Retinol metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00982	Drug metabolism - cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko00983	Drug metabolism - other enzymes	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030263	K07424	ko01100	Metabolic pathways	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMC200030264	K07424	ko00140	Steroid hormone biosynthesis	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00591	Linoleic acid metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00830	Retinol metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00982	Drug metabolism - cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko00983	Drug metabolism - other enzymes	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030264	K07424	ko01100	Metabolic pathways	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMC200030265	K07424	ko00140	Steroid hormone biosynthesis	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00591	Linoleic acid metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00830	Retinol metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00982	Drug metabolism - cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko00983	Drug metabolism - other enzymes	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030265	K07424	ko01100	Metabolic pathways	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMC200030266	K07424	ko00140	Steroid hormone biosynthesis	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00591	Linoleic acid metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00830	Retinol metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00982	Drug metabolism - cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko00983	Drug metabolism - other enzymes	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030266	K07424	ko01100	Metabolic pathways	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00140	Steroid hormone biosynthesis	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00591	Linoleic acid metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00830	Retinol metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00982	Drug metabolism - cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko00983	Drug metabolism - other enzymes	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030267	K07424	ko01100	Metabolic pathways	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMC200030268	K07424	ko00140	Steroid hormone biosynthesis	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00591	Linoleic acid metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00830	Retinol metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00982	Drug metabolism - cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko00983	Drug metabolism - other enzymes	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030268	K07424	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMC200030269	K07424	ko00140	Steroid hormone biosynthesis	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00591	Linoleic acid metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00830	Retinol metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00982	Drug metabolism - cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko00983	Drug metabolism - other enzymes	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030269	K07424	ko01100	Metabolic pathways	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMC200030270	K07424	ko00140	Steroid hormone biosynthesis	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00591	Linoleic acid metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00830	Retinol metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00982	Drug metabolism - cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko00983	Drug metabolism - other enzymes	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200030270	K07424	ko01100	Metabolic pathways	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMC200042370	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042370	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042370	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042371	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042371	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042371	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMC200042372	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMC200042372	K06125	ko01100	Metabolic pathways	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMC200042372	K06125	ko01110	Biosynthesis of secondary metabolites	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMC200042373	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMC200042373	K06125	ko01100	Metabolic pathways	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMC200042373	K06125	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMC200042374	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMC200042374	K06125	ko01100	Metabolic pathways	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMC200042374	K06125	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMC200042375	K04424	ko04010	MAPK signaling pathway	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMC200042375	K04424	ko04530	Tight junction	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMC200042381	K00099	ko00900	Terpenoid backbone biosynthesis	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMC200042381	K00099	ko01100	Metabolic pathways	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMC200042381	K00099	ko01110	Biosynthesis of secondary metabolites	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMC200042382	K00099	ko00900	Terpenoid backbone biosynthesis	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMC200042382	K00099	ko01100	Metabolic pathways	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMC200042382	K00099	ko01110	Biosynthesis of secondary metabolites	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMC200042383	K00099	ko00900	Terpenoid backbone biosynthesis	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMC200042383	K00099	ko01100	Metabolic pathways	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMC200042383	K00099	ko01110	Biosynthesis of secondary metabolites	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMC200037003	K12356	ko00940	Phenylpropanoid biosynthesis	824	1.3e-39	0.33	0.49	0.92
PGSC0003DMC200067712	K10760	ko00908	Zeatin biosynthesis	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMC200067712	K10760	ko01100	Metabolic pathways	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMC200067712	K10760	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMC200067719	K08233	ko00901	Indole alkaloid biosynthesis	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMC200067719	K08233	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMC200061925	K06063	ko03040	Spliceosome	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMC200061925	K06063	ko04330	Notch signaling pathway	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMC200002602	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMC200002602	K01850	ko01100	Metabolic pathways	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMC200002602	K01850	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMC200002603	K12356	ko00940	Phenylpropanoid biosynthesis	494	2.1e-21	0.31	0.52	0.92
PGSC0003DMC200002604	K10597	ko04120	Ubiquitin mediated proteolysis	1181	2.6e-59	0.80	0.93	0.94
PGSC0003DMC200002605	K10597	ko04120	Ubiquitin mediated proteolysis	3905	1.5e-209	0.88	0.95	0.98
PGSC0003DMC200002606	K10597	ko04120	Ubiquitin mediated proteolysis	6972	0.	0.81	0.89	0.99
PGSC0003DMC200002607	K10597	ko04120	Ubiquitin mediated proteolysis	5800	0.	0.80	0.88	1.00
PGSC0003DMC200002608	K05391	ko04626	Plant-pathogen interaction	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMC200002609	K05391	ko04626	Plant-pathogen interaction	4645	2.3e-250	0.75	0.84	1.00
PGSC0003DMC200023551	K06171	ko04330	Notch signaling pathway	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMC200023551	K06171	ko05010	Alzheimer's disease	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMC200023552	K06171	ko04330	Notch signaling pathway	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMC200023552	K06171	ko05010	Alzheimer's disease	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMC200023553	K06171	ko04330	Notch signaling pathway	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMC200023553	K06171	ko05010	Alzheimer's disease	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMC200023573	K00735	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMC200023573	K00735	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMC200023573	K00735	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMC200013570	K01046	ko00561	Glycerolipid metabolism	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMC200013570	K01046	ko01100	Metabolic pathways	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMC200013571	K01046	ko00561	Glycerolipid metabolism	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMC200013571	K01046	ko01100	Metabolic pathways	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMC200013572	K01046	ko00561	Glycerolipid metabolism	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMC200013572	K01046	ko01100	Metabolic pathways	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMC200013573	K01046	ko00561	Glycerolipid metabolism	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMC200013573	K01046	ko01100	Metabolic pathways	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMC200013580	K02984	ko03010	Ribosome	1934	7.8e-101	0.88	0.94	1.00
PGSC0003DMC200013582	K09553	ko05020	Prion diseases	265	1.3e-08	0.28	0.50	0.63
PGSC0003DMC200013583	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.38
PGSC0003DMC200013584	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.73
PGSC0003DMC200008192	K10527	ko00592	alpha-Linolenic acid metabolism	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMC200008192	K10527	ko01100	Metabolic pathways	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMC200008194	K01710	ko00521	Streptomycin biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMC200008194	K01710	ko00523	Polyketide sugar unit biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMC200008194	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMC200008194	K01710	ko01100	Metabolic pathways	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMC200008194	K01710	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMC200008212	K03644	ko00785	Lipoic acid metabolism	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMC200008212	K03644	ko01100	Metabolic pathways	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMC200008219	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMC200008219	K00517	ko00626	Naphthalene and anthracene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMC200008219	K00517	ko00903	Limonene and pinene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMC200008219	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMC200008219	K00517	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMC200008220	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMC200008220	K00517	ko00626	Naphthalene and anthracene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMC200008220	K00517	ko00903	Limonene and pinene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMC200008220	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMC200008220	K00517	ko01110	Biosynthesis of secondary metabolites	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMC200031441	K01051	ko00040	Pentose and glucuronate interconversions	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMC200031441	K01051	ko00500	Starch and sucrose metabolism	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMC200031441	K01051	ko01100	Metabolic pathways	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMC200031442	K01051	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMC200031442	K01051	ko00500	Starch and sucrose metabolism	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMC200031442	K01051	ko01100	Metabolic pathways	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMC200031446	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031446	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031446	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031447	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031447	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031447	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031448	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031448	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031448	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMC200031449	K01939	ko00230	Purine metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMC200031449	K01939	ko00250	Alanine, aspartate and glutamate metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMC200031449	K01939	ko01100	Metabolic pathways	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMC200031460	K02084	ko04115	p53 signaling pathway	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko04210	Apoptosis	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko05010	Alzheimer's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko05012	Parkinson's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko05016	Huntington's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031460	K02084	ko05222	Small cell lung cancer	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMC200031462	K07195	ko04910	Insulin signaling pathway	576	6.2e-26	0.88	0.97	0.61
PGSC0003DMC200031463	K07195	ko04910	Insulin signaling pathway	424	1.5e-17	0.83	0.92	0.97
PGSC0003DMC200053561	K02343	ko00230	Purine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053561	K02343	ko00240	Pyrimidine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053561	K02343	ko01100	Metabolic pathways	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053561	K02343	ko03030	DNA replication	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053561	K02343	ko03430	Mismatch repair	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053561	K02343	ko03440	Homologous recombination	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMC200053565	K01046	ko00561	Glycerolipid metabolism	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMC200053565	K01046	ko01100	Metabolic pathways	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMC200053566	K01046	ko00561	Glycerolipid metabolism	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMC200053566	K01046	ko01100	Metabolic pathways	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMC200053568	K10144	ko04115	p53 signaling pathway	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMC200053568	K10144	ko04120	Ubiquitin mediated proteolysis	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMC200053569	K10144	ko04115	p53 signaling pathway	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMC200053569	K10144	ko04120	Ubiquitin mediated proteolysis	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMC200053571	K00430	ko00360	Phenylalanine metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMC200053571	K00430	ko00680	Methane metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMC200053571	K00430	ko00940	Phenylpropanoid biosynthesis	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMC200053571	K00430	ko01100	Metabolic pathways	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMC200053571	K00430	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMC200053573	K01611	ko00270	Cysteine and methionine metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMC200053573	K01611	ko00330	Arginine and proline metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMC200053573	K01611	ko01100	Metabolic pathways	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMC200038199	K03364	ko04110	Cell cycle	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMC200038199	K03364	ko04111	Cell cycle - yeast	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMC200038199	K03364	ko04120	Ubiquitin mediated proteolysis	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMC200038199	K03364	ko04914	Progesterone-mediated oocyte maturation	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMC200038200	K03469	ko03030	DNA replication	245	1.1e-07	0.36	0.53	0.52
PGSC0003DMC200038204	K09756	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.42	0.59	0.99
PGSC0003DMC200038205	K01184	ko00040	Pentose and glucuronate interconversions	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMC200038205	K01184	ko00500	Starch and sucrose metabolism	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMC200038205	K01184	ko01100	Metabolic pathways	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMC200038206	K01184	ko00040	Pentose and glucuronate interconversions	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMC200038206	K01184	ko00500	Starch and sucrose metabolism	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMC200038206	K01184	ko01100	Metabolic pathways	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMC200038210	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMC200038210	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMC200038210	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMC200038219	K04121	ko00904	Diterpenoid biosynthesis	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMC200038219	K04121	ko01100	Metabolic pathways	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMC200038219	K04121	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMC200038220	K04121	ko00904	Diterpenoid biosynthesis	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMC200038220	K04121	ko01100	Metabolic pathways	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMC200038220	K04121	ko01110	Biosynthesis of secondary metabolites	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMC200043561	K02114	ko00190	Oxidative phosphorylation	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMC200043561	K02114	ko00195	Photosynthesis	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMC200043561	K02114	ko01100	Metabolic pathways	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMC200043585	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMC200043585	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMC200043585	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMC200043586	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMC200043586	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMC200043586	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMC200043587	K03011	ko00230	Purine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMC200043587	K03011	ko00240	Pyrimidine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMC200043587	K03011	ko01100	Metabolic pathways	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMC200043587	K03011	ko03020	RNA polymerase	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMC200043587	K03011	ko05016	Huntington's disease	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMC200043588	K01859	ko00941	Flavonoid biosynthesis	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMC200043588	K01859	ko01100	Metabolic pathways	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMC200043588	K01859	ko01110	Biosynthesis of secondary metabolites	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMC200043589	K00430	ko00360	Phenylalanine metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMC200043589	K00430	ko00680	Methane metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMC200043589	K00430	ko00940	Phenylpropanoid biosynthesis	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMC200043589	K00430	ko01100	Metabolic pathways	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMC200043589	K00430	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMC200007005	K00276	ko00260	Glycine, serine and threonine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko00350	Tyrosine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko00360	Phenylalanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko00410	beta-Alanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko01100	Metabolic pathways	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007005	K00276	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMC200007006	K00276	ko00260	Glycine, serine and threonine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko00350	Tyrosine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko00360	Phenylalanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko00410	beta-Alanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko00950	Isoquinoline alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko01100	Metabolic pathways	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007006	K00276	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMC200007012	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.60
PGSC0003DMC200007013	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.46
PGSC0003DMC200007014	K01515	ko00230	Purine metabolism	253	4.0e-08	0.41	0.54	0.50
PGSC0003DMC200012365	K02970	ko03010	Ribosome	228	9.7e-07	0.51	0.71	0.32
PGSC0003DMC200012373	K05582	ko00190	Oxidative phosphorylation	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMC200012373	K05582	ko01100	Metabolic pathways	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMC200012374	K12870	ko03040	Spliceosome	2149	1.1e-112	0.85	0.92	1.00
PGSC0003DMC200012382	K02953	ko03010	Ribosome	1220	1.9e-61	0.95	0.99	0.99
PGSC0003DMC200012383	K00485	ko00982	Drug metabolism - cytochrome P450	845	9.0e-41	0.35	0.46	0.95
PGSC0003DMC200012384	K00485	ko00982	Drug metabolism - cytochrome P450	1606	9.6e-83	0.49	0.65	0.98
PGSC0003DMC200012385	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200012386	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200012387	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200012388	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200012389	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200012390	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMC200066521	K11251	ko05322	Systemic lupus erythematosus	713	1.7e-33	0.68	0.81	0.94
PGSC0003DMC200066524	K07466	ko03030	DNA replication	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMC200066524	K07466	ko03420	Nucleotide excision repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMC200066524	K07466	ko03430	Mismatch repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMC200066524	K07466	ko03440	Homologous recombination	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMC200066536	K12581	ko03018	RNA degradation	470	4.3e-20	0.54	0.70	0.68
PGSC0003DMC200056551	K12843	ko03040	Spliceosome	1707	2.6e-88	0.39	0.55	0.94
PGSC0003DMC200056577	K10760	ko00908	Zeatin biosynthesis	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMC200056577	K10760	ko01100	Metabolic pathways	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMC200056577	K10760	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMC200045582	K00846	ko00051	Fructose and mannose metabolism	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMC200045582	K00846	ko01100	Metabolic pathways	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMC200045583	K00847	ko00051	Fructose and mannose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMC200045583	K00847	ko00500	Starch and sucrose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMC200045583	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMC200045583	K00847	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMC200045585	K00852	ko00030	Pentose phosphate pathway	336	1.1e-12	0.30	0.45	0.85
PGSC0003DMC200045587	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMC200045588	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMC200045592	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.94
PGSC0003DMC200045595	K00846	ko00051	Fructose and mannose metabolism	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMC200045595	K00846	ko01100	Metabolic pathways	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMC200045596	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.85
PGSC0003DMC200045597	K00852	ko00030	Pentose phosphate pathway	346	3.0e-13	0.31	0.45	0.94
PGSC0003DMC200039197	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMC200039198	K01358	ko04112	Cell cycle - Caulobacter	422	1.9e-17	0.77	0.90	0.94
PGSC0003DMC200039200	K10676	ko00627	1,4-Dichlorobenzene degradation	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMC200039200	K10676	ko01100	Metabolic pathways	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMC200039201	K10676	ko00627	1,4-Dichlorobenzene degradation	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMC200039201	K10676	ko01100	Metabolic pathways	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMC200039202	K10676	ko00627	1,4-Dichlorobenzene degradation	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMC200039202	K10676	ko01100	Metabolic pathways	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMC200039203	K10676	ko00627	1,4-Dichlorobenzene degradation	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMC200039203	K10676	ko01100	Metabolic pathways	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMC200039204	K10676	ko00627	1,4-Dichlorobenzene degradation	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMC200039204	K10676	ko01100	Metabolic pathways	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMC200014621	K00236	ko00020	Citrate cycle (TCA cycle)	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko00190	Oxidative phosphorylation	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko01100	Metabolic pathways	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko05010	Alzheimer's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko05012	Parkinson's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014621	K00236	ko05016	Huntington's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMC200014623	K03657	ko03420	Nucleotide excision repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMC200014623	K03657	ko03430	Mismatch repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMC200014624	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMC200014624	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMC200014625	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMC200014625	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMC200014632	K02354	ko04310	Wnt signaling pathway	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMC200014632	K02354	ko04916	Melanogenesis	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMC200014632	K02354	ko05200	Pathways in cancer	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMC200014632	K02354	ko05217	Basal cell carcinoma	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMC200014634	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014634	K00261	ko00330	Arginine and proline metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014634	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014634	K00261	ko00910	Nitrogen metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014634	K00261	ko01100	Metabolic pathways	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014634	K00261	ko04964	Proximal tubule bicarbonate reclamation	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMC200014635	K00261	ko00250	Alanine, aspartate and glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200014635	K00261	ko00330	Arginine and proline metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200014635	K00261	ko00471	D-Glutamine and D-glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200014635	K00261	ko00910	Nitrogen metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200014635	K00261	ko01100	Metabolic pathways	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200014635	K00261	ko04964	Proximal tubule bicarbonate reclamation	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMC200016772	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMC200016773	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMC200016778	K05349	ko00460	Cyanoamino acid metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMC200016778	K05349	ko00500	Starch and sucrose metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMC200016778	K05349	ko00940	Phenylpropanoid biosynthesis	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMC200016778	K05349	ko01110	Biosynthesis of secondary metabolites	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMC200016779	K05349	ko00460	Cyanoamino acid metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMC200016779	K05349	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMC200016779	K05349	ko00940	Phenylpropanoid biosynthesis	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMC200016779	K05349	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMC200016780	K05349	ko00460	Cyanoamino acid metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMC200016780	K05349	ko00500	Starch and sucrose metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMC200016780	K05349	ko00940	Phenylpropanoid biosynthesis	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMC200016780	K05349	ko01110	Biosynthesis of secondary metabolites	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMC200016785	K05349	ko00460	Cyanoamino acid metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMC200016785	K05349	ko00500	Starch and sucrose metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMC200016785	K05349	ko00940	Phenylpropanoid biosynthesis	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMC200016785	K05349	ko01110	Biosynthesis of secondary metabolites	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMC200016795	K08008	ko04145	Phagosome	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMC200016795	K08008	ko04670	Leukocyte transendothelial migration	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMC200016796	K09540	ko03060	Protein export	2534	6.3e-134	0.72	0.86	0.97
PGSC0003DMC200016797	K09540	ko03060	Protein export	2272	1.8e-119	0.64	0.78	0.99
PGSC0003DMC200010385	K01507	ko00190	Oxidative phosphorylation	1477	1.3e-75	0.90	0.95	0.98
PGSC0003DMC200010392	K02927	ko03010	Ribosome	1015	3.8e-50	0.99	1.00	0.92
PGSC0003DMC200010393	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMC200010394	K01761	ko00270	Cysteine and methionine metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMC200010394	K01761	ko00450	Selenoamino acid metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMC200010403	K00028	ko00620	Pyruvate metabolism	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMC200010403	K00028	ko00710	Carbon fixation in photosynthetic organisms	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMC200010403	K00028	ko01100	Metabolic pathways	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMC200010404	K00028	ko00620	Pyruvate metabolism	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMC200010404	K00028	ko00710	Carbon fixation in photosynthetic organisms	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMC200010404	K00028	ko01100	Metabolic pathways	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMC200010407	K00430	ko00360	Phenylalanine metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMC200010407	K00430	ko00680	Methane metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMC200010407	K00430	ko00940	Phenylpropanoid biosynthesis	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMC200010407	K00430	ko01100	Metabolic pathways	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMC200010407	K00430	ko01110	Biosynthesis of secondary metabolites	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMC200010409	K13228	ko00402	Benzoxazinoid biosynthesis	309	3.3e-11	0.44	0.69	0.95
PGSC0003DMC200064673	K13230	ko00402	Benzoxazinoid biosynthesis	220	2.9e-06	0.45	0.62	0.86
PGSC0003DMC200068478	K02489	ko02020	Two-component system	264	5.4e-08	0.42	0.58	0.83
PGSC0003DMC200062998	K10760	ko00908	Zeatin biosynthesis	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMC200062998	K10760	ko01100	Metabolic pathways	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMC200062998	K10760	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMC200026673	K00680	ko00350	Tyrosine metabolism	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMC200026673	K00680	ko00624	1- and 2-Methylnaphthalene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMC200026673	K00680	ko00632	Benzoate degradation via CoA ligation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMC200026673	K00680	ko00642	Ethylbenzene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMC200026673	K00680	ko00903	Limonene and pinene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMC200026683	K04368	ko04010	MAPK signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04012	ErbB signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04013	MAPK signaling pathway - fly	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04062	Chemokine signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04114	Oocyte meiosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04270	Vascular smooth muscle contraction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04320	Dorso-ventral axis formation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04370	VEGF signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04510	Focal adhesion	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04540	Gap junction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04620	Toll-like receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04626	Plant-pathogen interaction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04650	Natural killer cell mediated cytotoxicity	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04660	T cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04662	B cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04664	Fc epsilon RI signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04666	Fc gamma R-mediated phagocytosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04720	Long-term potentiation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04722	Neurotrophin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04730	Long-term depression	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04810	Regulation of actin cytoskeleton	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04910	Insulin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04912	GnRH signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04914	Progesterone-mediated oocyte maturation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko04916	Melanogenesis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05020	Prion diseases	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05200	Pathways in cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05210	Colorectal cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05211	Renal cell carcinoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05212	Pancreatic cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05213	Endometrial cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05214	Glioma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05215	Prostate cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05216	Thyroid cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05218	Melanoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05219	Bladder cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05220	Chronic myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05221	Acute myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026683	K04368	ko05223	Non-small cell lung cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMC200026684	K04368	ko04010	MAPK signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04012	ErbB signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04013	MAPK signaling pathway - fly	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04062	Chemokine signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04114	Oocyte meiosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04270	Vascular smooth muscle contraction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04320	Dorso-ventral axis formation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04370	VEGF signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04510	Focal adhesion	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04540	Gap junction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04620	Toll-like receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04626	Plant-pathogen interaction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04650	Natural killer cell mediated cytotoxicity	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04660	T cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04662	B cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04664	Fc epsilon RI signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04666	Fc gamma R-mediated phagocytosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04720	Long-term potentiation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04722	Neurotrophin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04730	Long-term depression	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04810	Regulation of actin cytoskeleton	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04910	Insulin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04912	GnRH signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04914	Progesterone-mediated oocyte maturation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko04916	Melanogenesis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05020	Prion diseases	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05200	Pathways in cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05210	Colorectal cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05211	Renal cell carcinoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05212	Pancreatic cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05213	Endometrial cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05214	Glioma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05215	Prostate cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05216	Thyroid cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05218	Melanoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05219	Bladder cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05220	Chronic myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05221	Acute myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026684	K04368	ko05223	Non-small cell lung cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMC200026685	K04368	ko04010	MAPK signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04012	ErbB signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04013	MAPK signaling pathway - fly	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04062	Chemokine signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04114	Oocyte meiosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04270	Vascular smooth muscle contraction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04320	Dorso-ventral axis formation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04370	VEGF signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04510	Focal adhesion	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04540	Gap junction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04620	Toll-like receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04626	Plant-pathogen interaction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04650	Natural killer cell mediated cytotoxicity	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04660	T cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04662	B cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04664	Fc epsilon RI signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04666	Fc gamma R-mediated phagocytosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04720	Long-term potentiation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04722	Neurotrophin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04730	Long-term depression	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04810	Regulation of actin cytoskeleton	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04910	Insulin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04912	GnRH signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04914	Progesterone-mediated oocyte maturation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko04916	Melanogenesis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05020	Prion diseases	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05200	Pathways in cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05210	Colorectal cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05211	Renal cell carcinoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05212	Pancreatic cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05213	Endometrial cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05214	Glioma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05215	Prostate cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05216	Thyroid cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05218	Melanoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05219	Bladder cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05220	Chronic myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05221	Acute myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026685	K04368	ko05223	Non-small cell lung cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMC200026686	K04368	ko04010	MAPK signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04012	ErbB signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04013	MAPK signaling pathway - fly	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04062	Chemokine signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04114	Oocyte meiosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04270	Vascular smooth muscle contraction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04320	Dorso-ventral axis formation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04370	VEGF signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04510	Focal adhesion	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04540	Gap junction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04620	Toll-like receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04626	Plant-pathogen interaction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04650	Natural killer cell mediated cytotoxicity	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04660	T cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04662	B cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04664	Fc epsilon RI signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04666	Fc gamma R-mediated phagocytosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04720	Long-term potentiation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04722	Neurotrophin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04730	Long-term depression	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04810	Regulation of actin cytoskeleton	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04910	Insulin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04912	GnRH signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04914	Progesterone-mediated oocyte maturation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko04916	Melanogenesis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05020	Prion diseases	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05200	Pathways in cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05210	Colorectal cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05211	Renal cell carcinoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05212	Pancreatic cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05213	Endometrial cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05214	Glioma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05215	Prostate cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05216	Thyroid cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05218	Melanoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05219	Bladder cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05220	Chronic myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05221	Acute myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026686	K04368	ko05223	Non-small cell lung cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMC200026688	K01190	ko00052	Galactose metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMC200026688	K01190	ko00511	Other glycan degradation	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMC200026688	K01190	ko00600	Sphingolipid metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMC200026688	K01190	ko01100	Metabolic pathways	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMC200026689	K01190	ko00052	Galactose metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMC200026689	K01190	ko00511	Other glycan degradation	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMC200026689	K01190	ko00600	Sphingolipid metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMC200026689	K01190	ko01100	Metabolic pathways	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMC200026694	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3843	4.0e-206	0.78	0.88	1.00
PGSC0003DMC200026695	K01893	ko00970	Aminoacyl-tRNA biosynthesis	2285	3.4e-120	0.72	0.82	0.97
PGSC0003DMC200026700	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMC200026700	K00517	ko00626	Naphthalene and anthracene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMC200026700	K00517	ko00903	Limonene and pinene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMC200026700	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMC200026700	K00517	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMC200029311	K04499	ko04310	Wnt signaling pathway	3478	5.4e-186	0.92	0.96	1.00
PGSC0003DMC200029312	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.31	0.48	0.94
PGSC0003DMC200029314	K05282	ko00904	Diterpenoid biosynthesis	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMC200029314	K05282	ko01100	Metabolic pathways	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMC200029314	K05282	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMC200029315	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMC200029315	K00517	ko00626	Naphthalene and anthracene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMC200029315	K00517	ko00903	Limonene and pinene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMC200029315	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMC200029315	K00517	ko01110	Biosynthesis of secondary metabolites	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMC200029316	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMC200029316	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMC200029316	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMC200029316	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMC200029316	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMC200029317	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMC200029317	K00517	ko00626	Naphthalene and anthracene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMC200029317	K00517	ko00903	Limonene and pinene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMC200029317	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMC200029317	K00517	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMC200029318	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMC200029318	K00517	ko00626	Naphthalene and anthracene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMC200029318	K00517	ko00903	Limonene and pinene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMC200029318	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMC200029318	K00517	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMC200029319	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMC200029319	K00517	ko00626	Naphthalene and anthracene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMC200029319	K00517	ko00903	Limonene and pinene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMC200029319	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMC200029319	K00517	ko01110	Biosynthesis of secondary metabolites	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMC200029322	K00938	ko00900	Terpenoid backbone biosynthesis	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMC200029322	K00938	ko01100	Metabolic pathways	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMC200029322	K00938	ko01110	Biosynthesis of secondary metabolites	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMC200029325	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMC200029325	K00224	ko00364	Fluorobenzoate degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMC200029325	K00224	ko00628	Fluorene degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMC200029325	K00224	ko00640	Propanoate metabolism	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMC200029326	K09658	ko00510	N-Glycan biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMC200029326	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMC200029326	K09658	ko01100	Metabolic pathways	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMC200029327	K00485	ko00982	Drug metabolism - cytochrome P450	1703	4.3e-88	0.60	0.75	0.96
PGSC0003DMC200029328	K00485	ko00982	Drug metabolism - cytochrome P450	2268	2.9e-119	0.59	0.75	0.97
PGSC0003DMC200029329	K00485	ko00982	Drug metabolism - cytochrome P450	1006	1.2e-49	0.58	0.72	0.91
PGSC0003DMC200029337	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMC200009304	K07195	ko04910	Insulin signaling pathway	2471	1.9e-130	0.50	0.67	0.99
PGSC0003DMC200009317	K04564	ko04146	Peroxisome	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMC200009317	K04564	ko05016	Huntington's disease	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMC200009318	K04564	ko04146	Peroxisome	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMC200009318	K04564	ko05016	Huntington's disease	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMC200009325	K01046	ko00561	Glycerolipid metabolism	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMC200009325	K01046	ko01100	Metabolic pathways	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMC200009326	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko00903	Limonene and pinene degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko00930	Caprolactam degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko01100	Metabolic pathways	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009326	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko00903	Limonene and pinene degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko00930	Caprolactam degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko01100	Metabolic pathways	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200009327	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMC200016052	K00264	ko00250	Alanine, aspartate and glutamate metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMC200016052	K00264	ko00910	Nitrogen metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMC200016052	K00264	ko01100	Metabolic pathways	16388	0.	0.87	0.94	1.00
PGSC0003DMC200016052	K00264	ko01110	Biosynthesis of secondary metabolites	16388	0.	0.87	0.94	1.00
PGSC0003DMC200016059	K11422	ko00310	Lysine degradation	644	1.0e-28	0.39	0.54	0.92
PGSC0003DMC200016061	K11422	ko00310	Lysine degradation	605	5.0e-27	0.51	0.67	0.14
PGSC0003DMC200016068	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMC200016069	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMC200016072	K06268	ko04010	MAPK signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04020	Calcium signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04114	Oocyte meiosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04210	Apoptosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04310	Wnt signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04360	Axon guidance	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04370	VEGF signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04650	Natural killer cell mediated cytotoxicity	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04660	T cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04662	B cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko04720	Long-term potentiation	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko05010	Alzheimer's disease	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016072	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMC200016074	K06268	ko04010	MAPK signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04020	Calcium signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04114	Oocyte meiosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04210	Apoptosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04310	Wnt signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04360	Axon guidance	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04370	VEGF signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04650	Natural killer cell mediated cytotoxicity	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04660	T cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04662	B cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko04720	Long-term potentiation	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko05010	Alzheimer's disease	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016074	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMC200016075	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMC200016076	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMC200016077	K04506	ko04115	p53 signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMC200016077	K04506	ko04120	Ubiquitin mediated proteolysis	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMC200016077	K04506	ko04310	Wnt signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMC200016078	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMC200016079	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMC200040505	K12373	ko00511	Other glycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko00531	Glycosaminoglycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko01100	Metabolic pathways	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040505	K12373	ko04142	Lysosome	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMC200040508	K04733	ko04210	Apoptosis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMC200040508	K04733	ko04620	Toll-like receptor signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMC200040508	K04733	ko04722	Neurotrophin signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMC200040508	K04733	ko05140	Leishmaniasis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMC200040508	K04733	ko05142	Chagas disease	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMC200040511	K01874	ko00450	Selenoamino acid metabolism	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMC200040511	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMC200040512	K01874	ko00450	Selenoamino acid metabolism	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMC200040512	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMC200040513	K01874	ko00450	Selenoamino acid metabolism	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMC200040513	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMC200040514	K02941	ko03010	Ribosome	2342	2.4e-123	0.88	0.95	1.00
PGSC0003DMC200040522	K10258	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.85	0.95	1.00
PGSC0003DMC200040523	K05692	ko04145	Phagosome	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04510	Focal adhesion	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04520	Adherens junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04530	Tight junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04670	Leukocyte transendothelial migration	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04745	Phototransduction - fly	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko04810	Regulation of actin cytoskeleton	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05100	Bacterial invasion of epithelial cells	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05110	Vibrio cholerae infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05130	Pathogenic Escherichia coli infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05131	Shigellosis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05414	Dilated cardiomyopathy	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200040523	K05692	ko05416	Viral myocarditis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMC200047259	K01930	ko00790	Folate biosynthesis	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMC200047259	K01930	ko01100	Metabolic pathways	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMC200047260	K01930	ko00790	Folate biosynthesis	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMC200047260	K01930	ko01100	Metabolic pathways	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMC200047265	K10594	ko04120	Ubiquitin mediated proteolysis	487	3.1e-28	0.33	0.50	0.88
PGSC0003DMC200047278	K12356	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.47	0.62	0.83
PGSC0003DMC200047279	K03039	ko03050	Proteasome	2840	8.3e-151	0.88	0.95	1.00
PGSC0003DMC200058113	K12338	ko00942	Anthocyanin biosynthesis	259	2.4e-08	0.48	0.62	0.47
PGSC0003DMC200058127	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMC200058127	K00517	ko00626	Naphthalene and anthracene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMC200058127	K00517	ko00903	Limonene and pinene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMC200058127	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMC200058127	K00517	ko01110	Biosynthesis of secondary metabolites	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMC200032491	K05279	ko00944	Flavone and flavonol biosynthesis	795	5.2e-38	0.40	0.56	0.85
PGSC0003DMC200032492	K05279	ko00944	Flavone and flavonol biosynthesis	668	5.2e-31	0.37	0.53	0.86
PGSC0003DMC200032499	K00423	ko00053	Ascorbate and aldarate metabolism	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMC200032499	K00423	ko01100	Metabolic pathways	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMC200032511	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.57
PGSC0003DMC200032512	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.55
PGSC0003DMC200032515	K00485	ko00982	Drug metabolism - cytochrome P450	703	6.1e-33	0.33	0.47	0.85
PGSC0003DMC200032517	K00485	ko00982	Drug metabolism - cytochrome P450	743	3.8e-35	0.31	0.49	0.98
PGSC0003DMC200032518	K00485	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.38	0.52	0.91
PGSC0003DMC200032519	K00485	ko00982	Drug metabolism - cytochrome P450	517	1.1e-22	0.38	0.52	0.87
PGSC0003DMC200032520	K00485	ko00982	Drug metabolism - cytochrome P450	680	1.1e-31	0.29	0.47	0.94
PGSC0003DMC200062168	K10760	ko00908	Zeatin biosynthesis	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMC200062168	K10760	ko01100	Metabolic pathways	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMC200062168	K10760	ko01110	Biosynthesis of secondary metabolites	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMC200062170	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200062170	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200062170	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200062170	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200062170	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMC200062185	K00600	ko00260	Glycine, serine and threonine metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200062185	K00600	ko00460	Cyanoamino acid metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200062185	K00600	ko00670	One carbon pool by folate	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200062185	K00600	ko00680	Methane metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200062185	K00600	ko01100	Metabolic pathways	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200062185	K00600	ko01110	Biosynthesis of secondary metabolites	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMC200002701	K08737	ko03430	Mismatch repair	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMC200002701	K08737	ko05200	Pathways in cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMC200002701	K08737	ko05210	Colorectal cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMC200002702	K08497	ko04130	SNARE interactions in vesicular transport	1337	6.6e-68	0.52	0.61	1.00
PGSC0003DMC200002703	K08497	ko04130	SNARE interactions in vesicular transport	1252	3.2e-63	0.73	0.83	0.99
PGSC0003DMC200002704	K08497	ko04130	SNARE interactions in vesicular transport	1523	3.6e-78	0.67	0.79	1.00
PGSC0003DMC200002713	K08852	ko05010	Alzheimer's disease	2230	3.7e-117	0.50	0.64	0.92
PGSC0003DMC200002714	K08852	ko05010	Alzheimer's disease	2813	2.6e-149	0.53	0.67	0.94
PGSC0003DMC200002715	K08852	ko05010	Alzheimer's disease	3432	1.9e-183	0.57	0.71	0.99
PGSC0003DMC200002716	K08852	ko05010	Alzheimer's disease	3789	3.8e-203	0.57	0.70	0.94
PGSC0003DMC200002721	K10615	ko04120	Ubiquitin mediated proteolysis	644	1.1e-29	0.33	0.50	0.94
PGSC0003DMC200002722	K02867	ko03010	Ribosome	516	1.3e-22	0.46	0.66	0.90
PGSC0003DMC200002727	K08739	ko03430	Mismatch repair	2798	1.7e-148	0.39	0.53	1.00
PGSC0003DMC200002728	K08739	ko03430	Mismatch repair	845	9.0e-41	0.31	0.45	0.98
PGSC0003DMC200002729	K08739	ko03430	Mismatch repair	761	6.8e-36	0.31	0.44	0.98
PGSC0003DMC200002730	K08739	ko03430	Mismatch repair	399	4.0e-13	0.28	0.40	0.95
PGSC0003DMC200020324	K12843	ko03040	Spliceosome	4554	2.4e-245	0.75	0.85	0.99
PGSC0003DMC200020335	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.46	0.68
PGSC0003DMC200020336	K12356	ko00940	Phenylpropanoid biosynthesis	479	1.4e-20	0.29	0.47	0.92
PGSC0003DMC200020337	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMC200020338	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMC200020339	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMC200023677	K00939	ko00230	Purine metabolism	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMC200023677	K00939	ko01100	Metabolic pathways	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMC200023677	K00939	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMC200023678	K00939	ko00230	Purine metabolism	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMC200023678	K00939	ko01100	Metabolic pathways	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMC200023678	K00939	ko01110	Biosynthesis of secondary metabolites	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMC200023679	K11584	ko04113	Meiosis - yeast	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMC200023679	K11584	ko04114	Oocyte meiosis	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMC200023679	K11584	ko04310	Wnt signaling pathway	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMC200023690	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	251	7.6e-08	0.36	0.54	0.86
PGSC0003DMC200023691	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMC200023691	K12502	ko01100	Metabolic pathways	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMC200023691	K12502	ko01110	Biosynthesis of secondary metabolites	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMC200023692	K02183	ko04020	Calcium signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04070	Phosphatidylinositol signaling system	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04114	Oocyte meiosis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04270	Vascular smooth muscle contraction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04626	Plant-pathogen interaction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04720	Long-term potentiation	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04722	Neurotrophin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04740	Olfactory transduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04744	Phototransduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04745	Phototransduction - fly	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04910	Insulin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04912	GnRH signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04916	Melanogenesis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04970	Salivary secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko04971	Gastric acid secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko05010	Alzheimer's disease	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023692	K02183	ko05214	Glioma	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMC200023696	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMC200023697	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMC200023698	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMC200023700	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.33
PGSC0003DMC200013327	K04371	ko04010	MAPK signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04012	ErbB signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04013	MAPK signaling pathway - fly	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04062	Chemokine signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04114	Oocyte meiosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04150	mTOR signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04270	Vascular smooth muscle contraction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04320	Dorso-ventral axis formation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04350	TGF-beta signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04360	Axon guidance	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04370	VEGF signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04510	Focal adhesion	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04520	Adherens junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04540	Gap junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04620	Toll-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04621	NOD-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04650	Natural killer cell mediated cytotoxicity	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04660	T cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04662	B cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04664	Fc epsilon RI signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04666	Fc gamma R-mediated phagocytosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04720	Long-term potentiation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04722	Neurotrophin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04730	Long-term depression	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04810	Regulation of actin cytoskeleton	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04910	Insulin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04912	GnRH signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04914	Progesterone-mediated oocyte maturation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04916	Melanogenesis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04930	Type II diabetes mellitus	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko04960	Aldosterone-regulated sodium reabsorption	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05010	Alzheimer's disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05020	Prion diseases	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05131	Shigellosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05140	Leishmaniasis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05142	Chagas disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05200	Pathways in cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05210	Colorectal cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05211	Renal cell carcinoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05212	Pancreatic cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05213	Endometrial cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05214	Glioma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05215	Prostate cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05216	Thyroid cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05218	Melanoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05219	Bladder cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05220	Chronic myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05221	Acute myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013327	K04371	ko05223	Non-small cell lung cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMC200013342	K02721	ko00195	Photosynthesis	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMC200013342	K02721	ko01100	Metabolic pathways	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMC200013343	K00383	ko00480	Glutathione metabolism	3788	4.3e-203	0.82	0.90	1.00
PGSC0003DMC200013344	K10532	ko00531	Glycosaminoglycan degradation	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMC200013344	K10532	ko01100	Metabolic pathways	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMC200013344	K10532	ko04142	Lysosome	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMC200013345	K10532	ko00531	Glycosaminoglycan degradation	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMC200013345	K10532	ko01100	Metabolic pathways	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMC200013345	K10532	ko04142	Lysosome	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMC200013346	K12623	ko03018	RNA degradation	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMC200013346	K12623	ko03040	Spliceosome	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMC200013347	K12623	ko03018	RNA degradation	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMC200013347	K12623	ko03040	Spliceosome	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMC200007836	K00799	ko00480	Glutathione metabolism	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMC200007836	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMC200007836	K00799	ko00982	Drug metabolism - cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMC200007837	K12132	ko04712	Circadian rhythm - plant	895	1.6e-43	0.36	0.53	0.99
PGSC0003DMC200007838	K12132	ko04712	Circadian rhythm - plant	1964	1.7e-102	0.46	0.61	0.97
PGSC0003DMC200007844	K08139	ko04113	Meiosis - yeast	986	1.5e-48	0.35	0.56	0.95
PGSC0003DMC200007848	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007848	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMC200007856	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMC200007857	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMC200049111	K01528	ko04144	Endocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMC200049111	K01528	ko04666	Fc gamma R-mediated phagocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMC200049111	K01528	ko05100	Bacterial invasion of epithelial cells	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMC200049112	K01193	ko00052	Galactose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMC200049112	K01193	ko00500	Starch and sucrose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMC200049112	K01193	ko01100	Metabolic pathways	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMC200049113	K01193	ko00052	Galactose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMC200049113	K01193	ko00500	Starch and sucrose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMC200049113	K01193	ko01100	Metabolic pathways	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMC200049114	K01193	ko00052	Galactose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMC200049114	K01193	ko00500	Starch and sucrose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMC200049114	K01193	ko01100	Metabolic pathways	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMC200049122	K10591	ko04120	Ubiquitin mediated proteolysis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMC200049122	K10591	ko04144	Endocytosis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMC200049123	K10591	ko04120	Ubiquitin mediated proteolysis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMC200049123	K10591	ko04144	Endocytosis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMC200049124	K10591	ko04120	Ubiquitin mediated proteolysis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMC200049124	K10591	ko04144	Endocytosis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMC200049130	K01623	ko00010	Glycolysis / Gluconeogenesis	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049130	K01623	ko00030	Pentose phosphate pathway	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049130	K01623	ko00051	Fructose and mannose metabolism	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049130	K01623	ko00710	Carbon fixation in photosynthetic organisms	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049130	K01623	ko01100	Metabolic pathways	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049130	K01623	ko01110	Biosynthesis of secondary metabolites	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMC200049131	K01623	ko00010	Glycolysis / Gluconeogenesis	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049131	K01623	ko00030	Pentose phosphate pathway	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049131	K01623	ko00051	Fructose and mannose metabolism	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049131	K01623	ko00710	Carbon fixation in photosynthetic organisms	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049131	K01623	ko01100	Metabolic pathways	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049131	K01623	ko01110	Biosynthesis of secondary metabolites	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMC200049133	K04424	ko04010	MAPK signaling pathway	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMC200049133	K04424	ko04530	Tight junction	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMC200049134	K10773	ko03410	Base excision repair	2266	1.1e-125	0.33	0.47	0.85
PGSC0003DMC200049135	K10773	ko03410	Base excision repair	2728	4.4e-151	0.34	0.48	0.80
PGSC0003DMC200049137	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200049137	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200049138	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200049138	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200049139	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200049139	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMC200042121	K00490	ko00590	Arachidonic acid metabolism	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMC200042121	K00490	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMC200042122	K00490	ko00590	Arachidonic acid metabolism	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMC200042122	K00490	ko01100	Metabolic pathways	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMC200042125	K00001	ko00010	Glycolysis / Gluconeogenesis	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00071	Fatty acid metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00350	Tyrosine metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00641	3-Chloroacrylic acid degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00830	Retinol metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko00982	Drug metabolism - cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko01100	Metabolic pathways	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042125	K00001	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMC200042135	K00826	ko00280	Valine, leucine and isoleucine degradation	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMC200042135	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMC200042135	K00826	ko00770	Pantothenate and CoA biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMC200042135	K00826	ko01100	Metabolic pathways	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMC200042135	K00826	ko01110	Biosynthesis of secondary metabolites	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMC200042136	K00826	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMC200042136	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMC200042136	K00826	ko00770	Pantothenate and CoA biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMC200042136	K00826	ko01100	Metabolic pathways	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMC200042136	K00826	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMC200042137	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042137	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042137	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042137	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042137	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042138	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042138	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042138	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042138	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042138	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMC200042139	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMC200042144	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMC200042145	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMC200042148	K11093	ko03040	Spliceosome	273	4.5e-09	0.30	0.45	0.96
PGSC0003DMC200036632	K01187	ko00052	Galactose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMC200036632	K01187	ko00500	Starch and sucrose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMC200036632	K01187	ko01100	Metabolic pathways	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMC200036633	K01187	ko00052	Galactose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMC200036633	K01187	ko00500	Starch and sucrose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMC200036633	K01187	ko01100	Metabolic pathways	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMC200036639	K01807	ko00030	Pentose phosphate pathway	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMC200036639	K01807	ko00710	Carbon fixation in photosynthetic organisms	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMC200036639	K01807	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMC200036639	K01807	ko01110	Biosynthesis of secondary metabolites	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMC200036640	K01807	ko00030	Pentose phosphate pathway	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMC200036640	K01807	ko00710	Carbon fixation in photosynthetic organisms	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMC200036640	K01807	ko01100	Metabolic pathways	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMC200036640	K01807	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMC200036641	K01807	ko00030	Pentose phosphate pathway	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMC200036641	K01807	ko00710	Carbon fixation in photosynthetic organisms	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMC200036641	K01807	ko01100	Metabolic pathways	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMC200036641	K01807	ko01110	Biosynthesis of secondary metabolites	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMC200036642	K09843	ko00906	Carotenoid biosynthesis	777	5.1e-37	0.32	0.51	0.99
PGSC0003DMC200036644	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMC200036644	K12448	ko01100	Metabolic pathways	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMC200036646	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMC200036646	K12448	ko01100	Metabolic pathways	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMC200036647	K01514	ko00230	Purine metabolism	378	5.7e-14	0.36	0.54	0.13
PGSC0003DMC200036651	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036651	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036651	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036652	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036652	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036652	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMC200036653	K09828	ko00100	Steroid biosynthesis	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMC200036653	K09828	ko01100	Metabolic pathways	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMC200036653	K09828	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMC200036655	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMC200036655	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMC200036656	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMC200036656	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMC200036657	K02694	ko00195	Photosynthesis	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMC200036657	K02694	ko01100	Metabolic pathways	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMC200019117	K00660	ko00941	Flavonoid biosynthesis	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMC200019117	K00660	ko01100	Metabolic pathways	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMC200019117	K00660	ko01110	Biosynthesis of secondary metabolites	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMC200019117	K00660	ko04712	Circadian rhythm - plant	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMC200019135	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019135	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019136	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019137	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMC200019138	K02183	ko04020	Calcium signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04070	Phosphatidylinositol signaling system	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04114	Oocyte meiosis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04270	Vascular smooth muscle contraction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04626	Plant-pathogen interaction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04720	Long-term potentiation	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04722	Neurotrophin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04740	Olfactory transduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04744	Phototransduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04745	Phototransduction - fly	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04910	Insulin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04912	GnRH signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04916	Melanogenesis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04970	Salivary secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko04971	Gastric acid secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko05010	Alzheimer's disease	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200019138	K02183	ko05214	Glioma	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMC200006643	K10352	ko04530	Tight junction	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMC200006643	K10352	ko05416	Viral myocarditis	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMC200006644	K10352	ko04530	Tight junction	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMC200006644	K10352	ko05416	Viral myocarditis	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMC200006645	K12619	ko03018	RNA degradation	6361	0.	0.68	0.78	1.00
PGSC0003DMC200012128	K02863	ko03010	Ribosome	1169	1.2e-58	0.59	0.79	0.69
PGSC0003DMC200012142	K00559	ko00100	Steroid biosynthesis	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMC200012142	K00559	ko01100	Metabolic pathways	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMC200012142	K00559	ko01110	Biosynthesis of secondary metabolites	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMC200012149	K12900	ko03040	Spliceosome	258	1.6e-07	0.37	0.53	0.16
PGSC0003DMC200012150	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMC200060984	K12606	ko03018	RNA degradation	422	1.9e-17	0.33	0.49	0.66
PGSC0003DMC200060986	K13065	ko00940	Phenylpropanoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMC200060986	K13065	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMC200060986	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMC200060986	K13065	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMC200050322	K00423	ko00053	Ascorbate and aldarate metabolism	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMC200050322	K00423	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMC200050323	K00423	ko00053	Ascorbate and aldarate metabolism	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMC200050323	K00423	ko01100	Metabolic pathways	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMC200050324	K00423	ko00053	Ascorbate and aldarate metabolism	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMC200050324	K00423	ko01100	Metabolic pathways	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMC200050325	K00423	ko00053	Ascorbate and aldarate metabolism	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMC200050325	K00423	ko01100	Metabolic pathways	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMC200050326	K01148	ko03018	RNA degradation	494	2.1e-21	0.30	0.48	0.57
PGSC0003DMC200050328	K01148	ko03018	RNA degradation	528	2.8e-23	0.30	0.47	0.61
PGSC0003DMC200050329	K03153	ko00730	Thiamine metabolism	300	1.0e-10	0.32	0.50	0.78
PGSC0003DMC200050330	K00303	ko00260	Glycine, serine and threonine metabolism	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMC200050330	K00303	ko01100	Metabolic pathways	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMC200050332	K00454	ko00591	Linoleic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMC200050332	K00454	ko00592	alpha-Linolenic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMC200050332	K00454	ko01100	Metabolic pathways	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMC200050333	K00454	ko00591	Linoleic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMC200050333	K00454	ko00592	alpha-Linolenic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMC200050333	K00454	ko01100	Metabolic pathways	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMC200050334	K00454	ko00591	Linoleic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMC200050334	K00454	ko00592	alpha-Linolenic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMC200050334	K00454	ko01100	Metabolic pathways	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMC200053671	K00121	ko00010	Glycolysis / Gluconeogenesis	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00071	Fatty acid metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00350	Tyrosine metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00641	3-Chloroacrylic acid degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00680	Methane metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00830	Retinol metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko00982	Drug metabolism - cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko01100	Metabolic pathways	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053671	K00121	ko01110	Biosynthesis of secondary metabolites	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMC200053672	K00121	ko00010	Glycolysis / Gluconeogenesis	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00071	Fatty acid metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00350	Tyrosine metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00641	3-Chloroacrylic acid degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00680	Methane metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00830	Retinol metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko00982	Drug metabolism - cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko01100	Metabolic pathways	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053672	K00121	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMC200053673	K02267	ko00190	Oxidative phosphorylation	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053673	K02267	ko01100	Metabolic pathways	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053673	K02267	ko04260	Cardiac muscle contraction	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053673	K02267	ko05010	Alzheimer's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053673	K02267	ko05012	Parkinson's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053673	K02267	ko05016	Huntington's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMC200053675	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2152	7.4e-113	0.73	0.83	0.89
PGSC0003DMC200053676	K01875	ko00970	Aminoacyl-tRNA biosynthesis	1108	2.8e-55	0.84	0.92	0.97
PGSC0003DMC200053677	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2726	1.6e-144	0.85	0.92	0.99
PGSC0003DMC200053678	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3338	2.8e-178	0.78	0.87	0.99
PGSC0003DMC200053688	K13030	ko00460	Cyanoamino acid metabolism	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMC200053688	K13030	ko01110	Biosynthesis of secondary metabolites	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMC200053689	K13030	ko00460	Cyanoamino acid metabolism	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMC200053689	K13030	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMC200053690	K13030	ko00460	Cyanoamino acid metabolism	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMC200053690	K13030	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMC200053691	K13030	ko00460	Cyanoamino acid metabolism	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMC200053691	K13030	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMC200053692	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMC200053692	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMC200053693	K13030	ko00460	Cyanoamino acid metabolism	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMC200053693	K13030	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMC200053694	K13030	ko00460	Cyanoamino acid metabolism	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMC200053694	K13030	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMC200037841	K04733	ko04210	Apoptosis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMC200037841	K04733	ko04620	Toll-like receptor signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMC200037841	K04733	ko04722	Neurotrophin signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMC200037841	K04733	ko05140	Leishmaniasis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMC200037841	K04733	ko05142	Chagas disease	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMC200037849	K01199	ko00500	Starch and sucrose metabolism	916	1.1e-44	0.44	0.59	0.93
PGSC0003DMC200037853	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037853	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037853	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037853	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037853	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037853	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037854	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMC200037855	K00232	ko00071	Fatty acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037855	K00232	ko00592	alpha-Linolenic acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037855	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037855	K00232	ko01100	Metabolic pathways	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037855	K00232	ko03320	PPAR signaling pathway	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037855	K00232	ko04146	Peroxisome	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMC200037856	K13230	ko00402	Benzoxazinoid biosynthesis	973	7.9e-48	0.39	0.56	0.97
PGSC0003DMC200043326	K03955	ko00190	Oxidative phosphorylation	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMC200043326	K03955	ko01100	Metabolic pathways	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMC200043326	K03955	ko05010	Alzheimer's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMC200043326	K03955	ko05012	Parkinson's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMC200043326	K03955	ko05016	Huntington's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMC200043328	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMC200043328	K01455	ko00910	Nitrogen metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMC200043329	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMC200043329	K01455	ko00910	Nitrogen metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMC200043334	K00430	ko00360	Phenylalanine metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMC200043334	K00430	ko00680	Methane metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMC200043334	K00430	ko00940	Phenylpropanoid biosynthesis	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMC200043334	K00430	ko01100	Metabolic pathways	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMC200043334	K00430	ko01110	Biosynthesis of secondary metabolites	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMC200043335	K00430	ko00360	Phenylalanine metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMC200043335	K00430	ko00680	Methane metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMC200043335	K00430	ko00940	Phenylpropanoid biosynthesis	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMC200043335	K00430	ko01100	Metabolic pathways	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMC200043335	K00430	ko01110	Biosynthesis of secondary metabolites	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMC200043343	K00235	ko00020	Citrate cycle (TCA cycle)	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko00190	Oxidative phosphorylation	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko01100	Metabolic pathways	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko01110	Biosynthesis of secondary metabolites	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko05010	Alzheimer's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko05012	Parkinson's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043343	K00235	ko05016	Huntington's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMC200043347	K12347	ko04142	Lysosome	3012	2.7e-160	0.80	0.89	0.93
PGSC0003DMC200043348	K12347	ko04142	Lysosome	3273	1.1e-174	0.77	0.89	0.97
PGSC0003DMC200028117	K01610	ko00010	Glycolysis / Gluconeogenesis	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028117	K01610	ko00020	Citrate cycle (TCA cycle)	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028117	K01610	ko00620	Pyruvate metabolism	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028117	K01610	ko00710	Carbon fixation in photosynthetic organisms	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028117	K01610	ko01100	Metabolic pathways	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028117	K01610	ko01110	Biosynthesis of secondary metabolites	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMC200028119	K13065	ko00940	Phenylpropanoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMC200028119	K13065	ko00941	Flavonoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMC200028119	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMC200028119	K13065	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMC200028122	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMC200028124	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMC200028129	K13289	ko04142	Lysosome	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMC200028129	K13289	ko04614	Renin-angiotensin system	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMC200017251	K12606	ko03018	RNA degradation	236	3.5e-07	0.49	0.56	0.96
PGSC0003DMC200017256	K02738	ko03050	Proteasome	1695	1.2e-87	0.85	0.94	0.97
PGSC0003DMC200017258	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMC200017258	K12446	ko01100	Metabolic pathways	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMC200017259	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMC200017259	K12446	ko01100	Metabolic pathways	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMC200017260	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMC200017260	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMC200017261	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMC200017261	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMC200017262	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMC200017262	K12446	ko01100	Metabolic pathways	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMC200017264	K01665	ko00790	Folate biosynthesis	2272	1.8e-119	0.43	0.55	0.90
PGSC0003DMC200017265	K01665	ko00790	Folate biosynthesis	1635	2.4e-84	0.49	0.62	0.84
PGSC0003DMC200017266	K01665	ko00790	Folate biosynthesis	1156	6.3e-58	0.63	0.74	0.91
PGSC0003DMC200017267	K01665	ko00790	Folate biosynthesis	794	5.9e-38	0.65	0.76	0.96
PGSC0003DMC200010504	K00419	ko00190	Oxidative phosphorylation	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010504	K00419	ko01100	Metabolic pathways	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010504	K00419	ko04260	Cardiac muscle contraction	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010504	K00419	ko05010	Alzheimer's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010504	K00419	ko05012	Parkinson's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010504	K00419	ko05016	Huntington's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMC200010505	K00419	ko00190	Oxidative phosphorylation	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010505	K00419	ko01100	Metabolic pathways	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010505	K00419	ko04260	Cardiac muscle contraction	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010505	K00419	ko05010	Alzheimer's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010505	K00419	ko05012	Parkinson's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010505	K00419	ko05016	Huntington's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMC200010507	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMC200010507	K00517	ko00626	Naphthalene and anthracene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMC200010507	K00517	ko00903	Limonene and pinene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMC200010507	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMC200010507	K00517	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMC200010508	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMC200010508	K00517	ko00626	Naphthalene and anthracene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMC200010508	K00517	ko00903	Limonene and pinene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMC200010508	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMC200010508	K00517	ko01110	Biosynthesis of secondary metabolites	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMC200010519	K06620	ko04110	Cell cycle	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05200	Pathways in cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05212	Pancreatic cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05214	Glioma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05215	Prostate cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05218	Melanoma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05219	Bladder cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05220	Chronic myeloid leukemia	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05222	Small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010519	K06620	ko05223	Non-small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMC200010520	K06620	ko04110	Cell cycle	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05200	Pathways in cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05212	Pancreatic cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05214	Glioma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05215	Prostate cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05218	Melanoma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05219	Bladder cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05220	Chronic myeloid leukemia	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05222	Small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010520	K06620	ko05223	Non-small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMC200010526	K01757	ko00901	Indole alkaloid biosynthesis	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMC200010526	K01757	ko01100	Metabolic pathways	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMC200010526	K01757	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMC200010527	K01757	ko00901	Indole alkaloid biosynthesis	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMC200010527	K01757	ko01100	Metabolic pathways	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMC200010527	K01757	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMC200064183	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMC200064183	K00517	ko00626	Naphthalene and anthracene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMC200064183	K00517	ko00903	Limonene and pinene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMC200064183	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMC200064183	K00517	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMC200068847	K05692	ko04145	Phagosome	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04510	Focal adhesion	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04520	Adherens junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04530	Tight junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04670	Leukocyte transendothelial migration	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04745	Phototransduction - fly	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko04810	Regulation of actin cytoskeleton	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05100	Bacterial invasion of epithelial cells	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05110	Vibrio cholerae infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05130	Pathogenic Escherichia coli infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05131	Shigellosis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05414	Dilated cardiomyopathy	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068847	K05692	ko05416	Viral myocarditis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMC200068850	K12356	ko00940	Phenylpropanoid biosynthesis	1279	1.0e-64	0.58	0.74	0.97
PGSC0003DMC200056678	K05279	ko00944	Flavone and flavonol biosynthesis	410	8.9e-17	0.42	0.58	0.98
PGSC0003DMC200056689	K10760	ko00908	Zeatin biosynthesis	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMC200056689	K10760	ko01100	Metabolic pathways	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMC200056689	K10760	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMC200056695	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056695	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056695	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056695	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056695	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056695	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMC200056697	K10760	ko00908	Zeatin biosynthesis	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMC200056697	K10760	ko01100	Metabolic pathways	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMC200056697	K10760	ko01110	Biosynthesis of secondary metabolites	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMC200056698	K00430	ko00360	Phenylalanine metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMC200056698	K00430	ko00680	Methane metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMC200056698	K00430	ko00940	Phenylpropanoid biosynthesis	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMC200056698	K00430	ko01100	Metabolic pathways	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMC200056698	K00430	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMC200046056	K12117	ko04712	Circadian rhythm - plant	319	1.9e-11	0.34	0.50	0.93
PGSC0003DMC200046057	K12115	ko04712	Circadian rhythm - plant	622	1.8e-28	0.33	0.48	0.91
PGSC0003DMC200046063	K12135	ko04712	Circadian rhythm - plant	210	9.5e-06	0.35	0.53	0.30
PGSC0003DMC200039304	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	337	6.5e-12	0.33	0.49	0.94
PGSC0003DMC200039306	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMC200039307	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMC200039308	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMC200039309	K03869	ko04120	Ubiquitin mediated proteolysis	1307	3.0e-66	0.33	0.52	0.97
PGSC0003DMC200039311	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMC200039312	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMC200039313	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMC200039314	K03869	ko04120	Ubiquitin mediated proteolysis	1310	2.0e-66	0.33	0.53	0.97
PGSC0003DMC200039315	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMC200039316	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMC200039317	K10609	ko03420	Nucleotide excision repair	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMC200039317	K10609	ko04120	Ubiquitin mediated proteolysis	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMC200039318	K10609	ko03420	Nucleotide excision repair	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMC200039318	K10609	ko04120	Ubiquitin mediated proteolysis	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMC200039319	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMC200039320	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMC200039321	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMC200039322	K03869	ko04120	Ubiquitin mediated proteolysis	1601	1.8e-82	0.33	0.52	0.98
PGSC0003DMC200039323	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMC200039324	K03869	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.33	0.53	0.97
PGSC0003DMC200039325	K08065	ko04612	Antigen processing and presentation	547	2.5e-24	0.59	0.78	0.80
PGSC0003DMC200059318	K07466	ko03030	DNA replication	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMC200059318	K07466	ko03420	Nucleotide excision repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMC200059318	K07466	ko03430	Mismatch repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMC200059318	K07466	ko03440	Homologous recombination	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMC200059330	K00799	ko00480	Glutathione metabolism	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMC200059330	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMC200059330	K00799	ko00982	Drug metabolism - cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMC200059331	K01087	ko00500	Starch and sucrose metabolism	313	9.7e-11	0.80	0.90	0.63
PGSC0003DMC200059337	K07466	ko03030	DNA replication	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMC200059337	K07466	ko03420	Nucleotide excision repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMC200059337	K07466	ko03430	Mismatch repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMC200059337	K07466	ko03440	Homologous recombination	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMC200059339	K12356	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.41	0.59	0.66
PGSC0003DMC200034083	K12581	ko03018	RNA degradation	1200	2.4e-60	0.56	0.73	0.94
PGSC0003DMC200034086	K01591	ko00240	Pyrimidine metabolism	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMC200034086	K01591	ko01100	Metabolic pathways	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMC200034098	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034098	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034099	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMC200034101	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034101	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMC200034102	K06620	ko04110	Cell cycle	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05200	Pathways in cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05212	Pancreatic cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05214	Glioma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05215	Prostate cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05218	Melanoma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05219	Bladder cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05220	Chronic myeloid leukemia	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05222	Small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034102	K06620	ko05223	Non-small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMC200034103	K04682	ko04110	Cell cycle	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMC200034103	K04682	ko04350	TGF-beta signaling pathway	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMC200034104	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034104	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMC200034107	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMC200034108	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMC200051293	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.50	0.62	0.99
PGSC0003DMC200051298	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMC200051298	K01078	ko00740	Riboflavin metabolism	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMC200058864	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMC200058864	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMC200058872	K06237	ko04510	Focal adhesion	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMC200058872	K06237	ko04512	ECM-receptor interaction	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMC200058872	K06237	ko05146	Amoebiasis	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMC200058872	K06237	ko05200	Pathways in cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMC200058872	K06237	ko05222	Small cell lung cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMC200058877	K01509	ko00230	Purine metabolism	255	2.1e-07	0.74	0.83	0.70
PGSC0003DMC200001501	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMC200001501	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMC200001501	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMC200001502	K01590	ko00340	Histidine metabolism	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMC200001502	K01590	ko01100	Metabolic pathways	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMC200001502	K01590	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMC200001504	K05681	ko02010	ABC transporters	1191	7.4e-60	0.33	0.53	0.86
PGSC0003DMC200001515	K10595	ko04120	Ubiquitin mediated proteolysis	752	7.2e-32	0.34	0.51	0.43
PGSC0003DMC200001518	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMC200001518	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMC200001519	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMC200001519	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMC200001520	K04424	ko04010	MAPK signaling pathway	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMC200001520	K04424	ko04530	Tight junction	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMC200001522	K04424	ko04010	MAPK signaling pathway	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMC200001522	K04424	ko04530	Tight junction	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMC200001525	K09843	ko00906	Carotenoid biosynthesis	1068	4.5e-53	0.37	0.57	0.94
PGSC0003DMC200001526	K09843	ko00906	Carotenoid biosynthesis	260	2.9e-08	0.40	0.65	0.88
PGSC0003DMC200014534	K02882	ko03010	Ribosome	1469	3.5e-75	0.94	0.98	0.99
PGSC0003DMC200014543	K02084	ko04115	p53 signaling pathway	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko04210	Apoptosis	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko05010	Alzheimer's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko05012	Parkinson's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko05016	Huntington's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200014543	K02084	ko05222	Small cell lung cancer	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMC200005283	K01213	ko00040	Pentose and glucuronate interconversions	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMC200005283	K01213	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMC200005283	K01213	ko01100	Metabolic pathways	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMC200005284	K01213	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMC200005284	K01213	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMC200005284	K01213	ko01100	Metabolic pathways	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMC200005291	K03868	ko03420	Nucleotide excision repair	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04110	Cell cycle	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04111	Cell cycle - yeast	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04114	Oocyte meiosis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04120	Ubiquitin mediated proteolysis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04310	Wnt signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04350	TGF-beta signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko04710	Circadian rhythm - mammal	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko05200	Pathways in cancer	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005291	K03868	ko05211	Renal cell carcinoma	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMC200005292	K03868	ko03420	Nucleotide excision repair	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04110	Cell cycle	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04111	Cell cycle - yeast	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04114	Oocyte meiosis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04120	Ubiquitin mediated proteolysis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04310	Wnt signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04350	TGF-beta signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko04710	Circadian rhythm - mammal	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko05200	Pathways in cancer	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005292	K03868	ko05211	Renal cell carcinoma	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMC200005301	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2186	9.8e-115	0.63	0.78	0.99
PGSC0003DMC200005304	K12130	ko04712	Circadian rhythm - plant	267	1.4e-08	0.31	0.46	0.92
PGSC0003DMC200022472	K10525	ko00592	alpha-Linolenic acid metabolism	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMC200022472	K10525	ko01100	Metabolic pathways	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMC200022484	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMC200022485	K12837	ko03040	Spliceosome	3856	7.6e-207	0.80	0.89	0.99
PGSC0003DMC200022486	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMC200022492	K12356	ko00940	Phenylpropanoid biosynthesis	651	4.5e-30	0.47	0.63	0.93
PGSC0003DMC200022494	K12356	ko00940	Phenylpropanoid biosynthesis	769	1.4e-36	0.50	0.63	0.93
PGSC0003DMC200027667	K02897	ko03010	Ribosome	1284	5.5e-65	0.75	0.87	0.88
PGSC0003DMC200049862	K02295	ko04710	Circadian rhythm - mammal	3588	4.6e-192	0.76	0.86	0.99
PGSC0003DMC200049863	K02295	ko04710	Circadian rhythm - mammal	3802	7.3e-204	0.80	0.90	0.99
PGSC0003DMC200049864	K02295	ko04710	Circadian rhythm - mammal	1409	7.0e-72	0.76	0.90	0.98
PGSC0003DMC200049865	K02265	ko00190	Oxidative phosphorylation	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049865	K02265	ko01100	Metabolic pathways	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049865	K02265	ko04260	Cardiac muscle contraction	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049865	K02265	ko05010	Alzheimer's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049865	K02265	ko05012	Parkinson's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049865	K02265	ko05016	Huntington's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMC200049866	K06130	ko00564	Glycerophospholipid metabolism	567	1.9e-25	0.36	0.55	0.87
PGSC0003DMC200049876	K03106	ko03060	Protein export	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMC200049876	K03106	ko03070	Bacterial secretion system	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMC200049877	K03106	ko03060	Protein export	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMC200049877	K03106	ko03070	Bacterial secretion system	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMC200049878	K03106	ko03060	Protein export	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMC200049878	K03106	ko03070	Bacterial secretion system	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMC200049884	K02951	ko03010	Ribosome	1021	1.8e-50	0.86	0.92	0.99
PGSC0003DMC200049885	K12356	ko00940	Phenylpropanoid biosynthesis	779	3.9e-37	0.33	0.50	0.97
PGSC0003DMC200049887	K03283	ko03040	Spliceosome	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMC200049887	K03283	ko04010	MAPK signaling pathway	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMC200049887	K03283	ko04144	Endocytosis	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMC200049887	K03283	ko04612	Antigen processing and presentation	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMC200049888	K03283	ko03040	Spliceosome	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMC200049888	K03283	ko04010	MAPK signaling pathway	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMC200049888	K03283	ko04144	Endocytosis	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMC200049888	K03283	ko04612	Antigen processing and presentation	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMC200031303	K04564	ko04146	Peroxisome	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMC200031303	K04564	ko05016	Huntington's disease	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMC200031311	K08991	ko03440	Homologous recombination	3168	6.7e-169	0.60	0.74	1.00
PGSC0003DMC200031316	K01509	ko00230	Purine metabolism	2112	1.2e-110	0.42	0.60	0.88
PGSC0003DMC200031317	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMC200031318	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMC200041705	K03841	ko00010	Glycolysis / Gluconeogenesis	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko00030	Pentose phosphate pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko00051	Fructose and mannose metabolism	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko00710	Carbon fixation in photosynthetic organisms	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko01100	Metabolic pathways	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko01110	Biosynthesis of secondary metabolites	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041705	K03841	ko04910	Insulin signaling pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMC200041706	K03841	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko00030	Pentose phosphate pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko00051	Fructose and mannose metabolism	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko00710	Carbon fixation in photosynthetic organisms	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko01100	Metabolic pathways	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041706	K03841	ko04910	Insulin signaling pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMC200041707	K03841	ko00010	Glycolysis / Gluconeogenesis	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko00030	Pentose phosphate pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko00051	Fructose and mannose metabolism	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko00710	Carbon fixation in photosynthetic organisms	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko01100	Metabolic pathways	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko01110	Biosynthesis of secondary metabolites	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041707	K03841	ko04910	Insulin signaling pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMC200041708	K03841	ko00010	Glycolysis / Gluconeogenesis	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko00030	Pentose phosphate pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko00051	Fructose and mannose metabolism	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko00710	Carbon fixation in photosynthetic organisms	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko01100	Metabolic pathways	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041708	K03841	ko04910	Insulin signaling pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMC200041709	K03841	ko00010	Glycolysis / Gluconeogenesis	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko00030	Pentose phosphate pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko00051	Fructose and mannose metabolism	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko00710	Carbon fixation in photosynthetic organisms	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko01100	Metabolic pathways	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041709	K03841	ko04910	Insulin signaling pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMC200041712	K10842	ko03420	Nucleotide excision repair	1036	2.6e-51	0.66	0.78	0.99
PGSC0003DMC200041723	K03108	ko03060	Protein export	1275	1.7e-64	0.76	0.86	0.99
PGSC0003DMC200041724	K03108	ko03060	Protein export	2544	1.8e-134	0.75	0.88	1.00
PGSC0003DMC200041725	K03108	ko03060	Protein export	2075	1.3e-108	0.74	0.85	1.00
PGSC0003DMC200041727	K03108	ko03060	Protein export	1194	5.1e-60	0.68	0.84	0.99
PGSC0003DMC200041729	K03108	ko03060	Protein export	1140	4.8e-57	0.75	0.87	0.50
PGSC0003DMC200041730	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMC200041730	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMC200041730	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMC200038348	K01148	ko03018	RNA degradation	1654	2.2e-85	0.47	0.65	0.67
PGSC0003DMC200038349	K01148	ko03018	RNA degradation	909	2.7e-44	0.45	0.66	0.60
PGSC0003DMC200038350	K01148	ko03018	RNA degradation	1601	1.8e-82	0.48	0.65	0.86
PGSC0003DMC200038351	K01148	ko03018	RNA degradation	648	6.6e-30	0.49	0.63	0.75
PGSC0003DMC200038352	K01148	ko03018	RNA degradation	1231	4.6e-62	0.51	0.67	0.83
PGSC0003DMC200038353	K00952	ko00760	Nicotinate and nicotinamide metabolism	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMC200038353	K00952	ko01100	Metabolic pathways	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMC200038354	K00952	ko00760	Nicotinate and nicotinamide metabolism	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMC200038354	K00952	ko01100	Metabolic pathways	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMC200038355	K00952	ko00760	Nicotinate and nicotinamide metabolism	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMC200038355	K00952	ko01100	Metabolic pathways	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMC200038356	K00952	ko00760	Nicotinate and nicotinamide metabolism	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMC200038356	K00952	ko01100	Metabolic pathways	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMC200038360	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMC200038361	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMC200038364	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMC200038365	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMC200038368	K01692	ko00071	Fatty acid metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00280	Valine, leucine and isoleucine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00281	Geraniol degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00310	Lysine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00380	Tryptophan metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00410	beta-Alanine metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00632	Benzoate degradation via CoA ligation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00640	Propanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00650	Butanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00903	Limonene and pinene degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko00930	Caprolactam degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko01100	Metabolic pathways	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038368	K01692	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMC200038369	K01692	ko00071	Fatty acid metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00280	Valine, leucine and isoleucine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00281	Geraniol degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00310	Lysine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00380	Tryptophan metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00410	beta-Alanine metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00632	Benzoate degradation via CoA ligation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00640	Propanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00650	Butanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00903	Limonene and pinene degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko00930	Caprolactam degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko01100	Metabolic pathways	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038369	K01692	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMC200038370	K01692	ko00071	Fatty acid metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00280	Valine, leucine and isoleucine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00281	Geraniol degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00310	Lysine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00380	Tryptophan metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00632	Benzoate degradation via CoA ligation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00640	Propanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00650	Butanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00903	Limonene and pinene degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko00930	Caprolactam degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko01100	Metabolic pathways	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200038370	K01692	ko01110	Biosynthesis of secondary metabolites	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMC200054292	K02492	ko00860	Porphyrin and chlorophyll metabolism	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMC200054292	K02492	ko01100	Metabolic pathways	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMC200054292	K02492	ko01110	Biosynthesis of secondary metabolites	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMC200054296	K00940	ko00230	Purine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMC200054296	K00940	ko00240	Pyrimidine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMC200054296	K00940	ko01100	Metabolic pathways	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMC200054296	K00940	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMC200054298	K06654	ko04111	Cell cycle - yeast	344	3.9e-13	0.33	0.50	0.83
PGSC0003DMC200060824	K08770	ko03320	PPAR signaling pathway	3748	6.9e-201	1.00	1.00	1.00
PGSC0003DMC200018668	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018668	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018669	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00140	Steroid hormone biosynthesis	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00591	Linoleic acid metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00830	Retinol metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00982	Drug metabolism - cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko00983	Drug metabolism - other enzymes	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018670	K07424	ko01100	Metabolic pathways	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMC200018671	K01087	ko00500	Starch and sucrose metabolism	5434	7.0e-294	0.69	0.82	0.98
PGSC0003DMC200018672	K01087	ko00500	Starch and sucrose metabolism	5444	2.0e-294	0.75	0.89	0.98
PGSC0003DMC200018673	K01723	ko00592	alpha-Linolenic acid metabolism	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMC200018673	K01723	ko01100	Metabolic pathways	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMC200018675	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMC200025472	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.34	0.55	0.74
PGSC0003DMC200025473	K01613	ko00564	Glycerophospholipid metabolism	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMC200025473	K01613	ko01100	Metabolic pathways	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMC200025475	K01613	ko00564	Glycerophospholipid metabolism	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMC200025475	K01613	ko01100	Metabolic pathways	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMC200025476	K05929	ko00564	Glycerophospholipid metabolism	753	1.1e-35	0.39	0.58	0.53
PGSC0003DMC200025477	K00059	ko00061	Fatty acid biosynthesis	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMC200025477	K00059	ko01040	Biosynthesis of unsaturated fatty acids	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMC200025477	K00059	ko01100	Metabolic pathways	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMC200025478	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.83	0.99
PGSC0003DMC200025480	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMC200025480	K05287	ko01100	Metabolic pathways	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMC200025481	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMC200025481	K05287	ko01100	Metabolic pathways	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMC200025483	K08243	ko00941	Flavonoid biosynthesis	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMC200025483	K08243	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMC200025484	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMC200025484	K01904	ko00360	Phenylalanine metabolism	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMC200025484	K01904	ko00940	Phenylpropanoid biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMC200025484	K01904	ko01100	Metabolic pathways	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMC200025484	K01904	ko01110	Biosynthesis of secondary metabolites	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMC200025485	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMC200025485	K01904	ko00360	Phenylalanine metabolism	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMC200025485	K01904	ko00940	Phenylpropanoid biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMC200025485	K01904	ko01100	Metabolic pathways	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMC200025485	K01904	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMC200025486	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025486	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025486	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025486	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025486	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025487	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025487	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025487	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025487	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025487	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMC200025488	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMC200025488	K01904	ko00360	Phenylalanine metabolism	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMC200025488	K01904	ko00940	Phenylpropanoid biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMC200025488	K01904	ko01100	Metabolic pathways	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMC200025488	K01904	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMC200025489	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMC200025489	K01904	ko00360	Phenylalanine metabolism	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMC200025489	K01904	ko00940	Phenylpropanoid biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMC200025489	K01904	ko01100	Metabolic pathways	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMC200025489	K01904	ko01110	Biosynthesis of secondary metabolites	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMC200025490	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMC200025491	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMC200007151	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.61
PGSC0003DMC200007152	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.57
PGSC0003DMC200007153	K00763	ko00760	Nicotinate and nicotinamide metabolism	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMC200007153	K00763	ko01100	Metabolic pathways	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMC200007162	K01046	ko00561	Glycerolipid metabolism	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMC200007162	K01046	ko01100	Metabolic pathways	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMC200007163	K01046	ko00561	Glycerolipid metabolism	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMC200007163	K01046	ko01100	Metabolic pathways	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMC200007167	K12741	ko03040	Spliceosome	549	1.9e-24	0.32	0.45	0.96
PGSC0003DMC200007168	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMC200007169	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMC200030107	K06269	ko04113	Meiosis - yeast	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04114	Oocyte meiosis	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04270	Vascular smooth muscle contraction	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04510	Focal adhesion	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04720	Long-term potentiation	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04810	Regulation of actin cytoskeleton	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030107	K06269	ko04910	Insulin signaling pathway	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMC200030108	K05746	ko04810	Regulation of actin cytoskeleton	702	7.0e-33	0.34	0.43	0.76
PGSC0003DMC200030119	K13229	ko00402	Benzoxazinoid biosynthesis	798	3.5e-38	0.42	0.60	0.91
PGSC0003DMC200048675	K00558	ko00270	Cysteine and methionine metabolism	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMC200048675	K00558	ko01100	Metabolic pathways	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMC200048685	K04420	ko04010	MAPK signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMC200048685	K04420	ko04540	Gap junction	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMC200048685	K04420	ko04912	GnRH signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMC200048690	K05894	ko00592	alpha-Linolenic acid metabolism	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMC200048690	K05894	ko01100	Metabolic pathways	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMC200037143	K06123	ko00564	Glycerophospholipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMC200037143	K06123	ko00565	Ether lipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMC200037143	K06123	ko01100	Metabolic pathways	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMC200037144	K04371	ko04010	MAPK signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04012	ErbB signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04013	MAPK signaling pathway - fly	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04062	Chemokine signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04114	Oocyte meiosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04150	mTOR signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04270	Vascular smooth muscle contraction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04320	Dorso-ventral axis formation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04350	TGF-beta signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04360	Axon guidance	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04370	VEGF signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04510	Focal adhesion	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04520	Adherens junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04540	Gap junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04620	Toll-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04621	NOD-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04650	Natural killer cell mediated cytotoxicity	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04660	T cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04662	B cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04664	Fc epsilon RI signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04666	Fc gamma R-mediated phagocytosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04720	Long-term potentiation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04722	Neurotrophin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04730	Long-term depression	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04810	Regulation of actin cytoskeleton	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04910	Insulin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04912	GnRH signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04914	Progesterone-mediated oocyte maturation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04916	Melanogenesis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04930	Type II diabetes mellitus	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko04960	Aldosterone-regulated sodium reabsorption	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05010	Alzheimer's disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05020	Prion diseases	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05131	Shigellosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05140	Leishmaniasis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05142	Chagas disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05200	Pathways in cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05210	Colorectal cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05211	Renal cell carcinoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05212	Pancreatic cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05213	Endometrial cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05214	Glioma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05215	Prostate cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05216	Thyroid cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05218	Melanoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05219	Bladder cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05220	Chronic myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05221	Acute myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037144	K04371	ko05223	Non-small cell lung cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMC200037153	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMC200037154	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMC200037155	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMC200037155	K00517	ko00626	Naphthalene and anthracene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMC200037155	K00517	ko00903	Limonene and pinene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMC200037155	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMC200037155	K00517	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMC200037156	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037156	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037156	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037156	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037156	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037157	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037157	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037157	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037157	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037157	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMC200037158	K03937	ko00190	Oxidative phosphorylation	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMC200037158	K03937	ko01100	Metabolic pathways	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMC200037158	K03937	ko05010	Alzheimer's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMC200037158	K03937	ko05012	Parkinson's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMC200037158	K03937	ko05016	Huntington's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMC200037159	K02935	ko03010	Ribosome	364	3.1e-14	0.41	0.62	0.80
PGSC0003DMC200037168	K10598	ko04120	Ubiquitin mediated proteolysis	4215	1.2e-226	0.81	0.90	1.00
PGSC0003DMC200037169	K00860	ko00230	Purine metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMC200037169	K00860	ko00450	Selenoamino acid metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMC200037169	K00860	ko00920	Sulfur metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMC200037169	K00860	ko01100	Metabolic pathways	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMC200037170	K00860	ko00230	Purine metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMC200037170	K00860	ko00450	Selenoamino acid metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMC200037170	K00860	ko00920	Sulfur metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMC200037170	K00860	ko01100	Metabolic pathways	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMC200055473	K01738	ko00270	Cysteine and methionine metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMC200055473	K01738	ko00450	Selenoamino acid metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMC200055473	K01738	ko00920	Sulfur metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMC200055473	K01738	ko01100	Metabolic pathways	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMC200055474	K01738	ko00270	Cysteine and methionine metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMC200055474	K01738	ko00450	Selenoamino acid metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMC200055474	K01738	ko00920	Sulfur metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMC200055474	K01738	ko01100	Metabolic pathways	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMC200055475	K01738	ko00270	Cysteine and methionine metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMC200055475	K01738	ko00450	Selenoamino acid metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMC200055475	K01738	ko00920	Sulfur metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMC200055475	K01738	ko01100	Metabolic pathways	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMC200019861	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMC200019861	K05286	ko01100	Metabolic pathways	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMC200011711	K05857	ko00562	Inositol phosphate metabolism	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMC200011711	K05857	ko01100	Metabolic pathways	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMC200011711	K05857	ko04020	Calcium signaling pathway	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMC200011711	K05857	ko04070	Phosphatidylinositol signaling system	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMC200011712	K05857	ko00562	Inositol phosphate metabolism	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMC200011712	K05857	ko01100	Metabolic pathways	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMC200011712	K05857	ko04020	Calcium signaling pathway	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMC200011712	K05857	ko04070	Phosphatidylinositol signaling system	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMC200011713	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011713	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011713	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011713	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011714	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011714	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011714	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011714	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMC200011715	K05857	ko00562	Inositol phosphate metabolism	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMC200011715	K05857	ko01100	Metabolic pathways	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMC200011715	K05857	ko04020	Calcium signaling pathway	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMC200011715	K05857	ko04070	Phosphatidylinositol signaling system	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMC200011722	K06675	ko04111	Cell cycle - yeast	862	1.5e-41	0.52	0.61	0.93
PGSC0003DMC200024272	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMC200024272	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMC200024272	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMC200024272	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMC200024272	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMC200024273	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024273	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024273	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024273	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024273	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024274	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024274	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024274	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024274	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024274	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMC200024285	K01768	ko00230	Purine metabolism	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMC200024285	K01768	ko04113	Meiosis - yeast	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMC200008357	K10595	ko04120	Ubiquitin mediated proteolysis	857	7.9e-40	0.33	0.49	0.80
PGSC0003DMC200008361	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMC200008362	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMC200008368	K03109	ko03060	Protein export	775	6.5e-37	0.87	0.93	0.99
PGSC0003DMC200008369	K03109	ko03060	Protein export	780	3.5e-37	0.87	0.94	0.99
PGSC0003DMC200067628	K03094	ko04110	Cell cycle	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04111	Cell cycle - yeast	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04114	Oocyte meiosis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04120	Ubiquitin mediated proteolysis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04310	Wnt signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04350	TGF-beta signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067628	K03094	ko04710	Circadian rhythm - mammal	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMC200067631	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMC200067631	K00517	ko00626	Naphthalene and anthracene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMC200067631	K00517	ko00903	Limonene and pinene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMC200067631	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMC200067631	K00517	ko01110	Biosynthesis of secondary metabolites	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMC200065371	K00804	ko00900	Terpenoid backbone biosynthesis	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMC200065371	K00804	ko01100	Metabolic pathways	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMC200065371	K00804	ko01110	Biosynthesis of secondary metabolites	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMC200065376	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMC200065376	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMC200065376	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMC200065392	K06675	ko04111	Cell cycle - yeast	243	3.0e-16	0.46	0.62	0.95
PGSC0003DMC200062021	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.49	0.96
PGSC0003DMC200062023	K11821	ko00380	Tryptophan metabolism	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMC200062023	K11821	ko00966	Glucosinolate biosynthesis	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMC200062023	K11821	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMC200044521	K08008	ko04145	Phagosome	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMC200044521	K08008	ko04670	Leukocyte transendothelial migration	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMC200044544	K08233	ko00901	Indole alkaloid biosynthesis	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMC200044544	K08233	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMC200044545	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko00363	Bisphenol A degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko00624	1- and 2-Methylnaphthalene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko00632	Benzoate degradation via CoA ligation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko00903	Limonene and pinene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko01100	Metabolic pathways	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044545	K00120	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMC200044549	K07203	ko04012	ErbB signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko04150	mTOR signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko04910	Insulin signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko04920	Adipocytokine signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko04930	Type II diabetes mellitus	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko05200	Pathways in cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko05214	Glioma	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko05215	Prostate cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044549	K07203	ko05221	Acute myeloid leukemia	17462	0.	0.84	0.91	1.00
PGSC0003DMC200044550	K07203	ko04012	ErbB signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko04150	mTOR signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko04910	Insulin signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko04920	Adipocytokine signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko04930	Type II diabetes mellitus	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko05200	Pathways in cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko05214	Glioma	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko05215	Prostate cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMC200044550	K07203	ko05221	Acute myeloid leukemia	17695	0.	0.85	0.92	1.00
PGSC0003DMC200052472	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052472	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052472	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052472	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052472	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052472	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052473	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052473	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052473	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052473	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052473	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052473	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052474	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052474	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052474	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052474	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052474	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052474	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMC200052475	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052475	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052475	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052475	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052475	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052475	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMC200052476	K01513	ko00230	Purine metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052476	K01513	ko00500	Starch and sucrose metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052476	K01513	ko00740	Riboflavin metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052476	K01513	ko00760	Nicotinate and nicotinamide metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052476	K01513	ko00770	Pantothenate and CoA biosynthesis	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052476	K01513	ko01100	Metabolic pathways	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMC200052480	K01810	ko00010	Glycolysis / Gluconeogenesis	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052480	K01810	ko00030	Pentose phosphate pathway	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052480	K01810	ko00500	Starch and sucrose metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052480	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052480	K01810	ko01100	Metabolic pathways	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052480	K01810	ko01110	Biosynthesis of secondary metabolites	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMC200052481	K00588	ko00360	Phenylalanine metabolism	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052481	K00588	ko00940	Phenylpropanoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052481	K00588	ko00941	Flavonoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052481	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052481	K00588	ko01100	Metabolic pathways	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052481	K00588	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMC200052498	K03506	ko00230	Purine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052498	K03506	ko00240	Pyrimidine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052498	K03506	ko01100	Metabolic pathways	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052498	K03506	ko03030	DNA replication	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052498	K03506	ko03410	Base excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052498	K03506	ko03420	Nucleotide excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMC200052499	K06170	ko04330	Notch signaling pathway	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMC200052499	K06170	ko05010	Alzheimer's disease	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMC200035281	K06119	ko00561	Glycerolipid metabolism	1021	1.8e-50	0.76	0.87	0.96
PGSC0003DMC200035289	K02882	ko03010	Ribosome	1442	1.1e-73	0.92	0.97	0.99
PGSC0003DMC200035290	K02882	ko03010	Ribosome	705	4.8e-33	0.93	0.98	0.99
PGSC0003DMC200035296	K01962	ko00061	Fatty acid biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035296	K01962	ko00253	Tetracycline biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035296	K01962	ko00620	Pyruvate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035296	K01962	ko00640	Propanoate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035296	K01962	ko01100	Metabolic pathways	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035296	K01962	ko01110	Biosynthesis of secondary metabolites	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMC200035297	K01962	ko00061	Fatty acid biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200035297	K01962	ko00253	Tetracycline biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200035297	K01962	ko00620	Pyruvate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200035297	K01962	ko00640	Propanoate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200035297	K01962	ko01100	Metabolic pathways	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200035297	K01962	ko01110	Biosynthesis of secondary metabolites	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMC200057677	K12356	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.31	0.52	0.96
PGSC0003DMC200057682	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	408	4.5e-16	0.33	0.44	0.92
PGSC0003DMC200021275	K12338	ko00942	Anthocyanin biosynthesis	869	4.3e-42	0.38	0.58	0.97
PGSC0003DMC200021282	K03110	ko03060	Protein export	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMC200021282	K03110	ko03070	Bacterial secretion system	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMC200021283	K02689	ko00195	Photosynthesis	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMC200021283	K02689	ko01100	Metabolic pathways	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMC200021297	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMC200021297	K00517	ko00626	Naphthalene and anthracene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMC200021297	K00517	ko00903	Limonene and pinene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMC200021297	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMC200021297	K00517	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMC200004081	K01046	ko00561	Glycerolipid metabolism	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMC200004081	K01046	ko01100	Metabolic pathways	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMC200004088	K05355	ko00900	Terpenoid backbone biosynthesis	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMC200004088	K05355	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMC200004089	K05355	ko00900	Terpenoid backbone biosynthesis	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMC200004089	K05355	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMC200004103	K00290	ko00300	Lysine biosynthesis	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMC200004103	K00290	ko00310	Lysine degradation	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMC200004103	K00290	ko01100	Metabolic pathways	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMC200004103	K00290	ko01110	Biosynthesis of secondary metabolites	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMC200004104	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004104	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004104	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004104	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004105	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004105	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004105	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004105	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004106	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004106	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004106	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004106	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMC200004107	K00290	ko00300	Lysine biosynthesis	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMC200004107	K00290	ko00310	Lysine degradation	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMC200004107	K00290	ko01100	Metabolic pathways	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMC200004107	K00290	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMC200004108	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004108	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004108	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004109	K00291	ko00300	Lysine biosynthesis	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMC200004109	K00291	ko00310	Lysine degradation	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMC200004109	K00291	ko01100	Metabolic pathways	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMC200004109	K00291	ko01110	Biosynthesis of secondary metabolites	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMC200004110	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004110	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200004110	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMC200028862	K02695	ko00195	Photosynthesis	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMC200028862	K02695	ko01100	Metabolic pathways	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMC200028870	K10803	ko03410	Base excision repair	605	1.6e-27	0.60	0.69	0.88
PGSC0003DMC200028871	K10803	ko03410	Base excision repair	1008	9.2e-50	0.55	0.71	0.94
PGSC0003DMC200028872	K10803	ko03410	Base excision repair	1458	1.4e-74	0.53	0.68	0.95
PGSC0003DMC200028873	K10803	ko03410	Base excision repair	1129	2.0e-56	0.53	0.70	0.96
PGSC0003DMC200028884	K04124	ko00904	Diterpenoid biosynthesis	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMC200028884	K04124	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMC200000301	K00970	ko03018	RNA degradation	537	5.1e-22	0.32	0.50	0.48
PGSC0003DMC200000302	K01066	ko00623	2,4-Dichlorobenzoate degradation	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMC200000302	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMC200000303	K01046	ko00561	Glycerolipid metabolism	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMC200000303	K01046	ko01100	Metabolic pathways	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMC200000310	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMC200000310	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMC200000310	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMC200000310	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMC200000310	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMC200000312	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000312	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000312	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000312	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000312	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000313	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000313	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000313	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000313	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000313	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000314	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000314	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000314	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000314	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000314	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMC200000315	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMC200000315	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMC200000315	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMC200000315	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMC200000315	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMC200000316	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMC200000316	K00517	ko00626	Naphthalene and anthracene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMC200000316	K00517	ko00903	Limonene and pinene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMC200000316	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMC200000316	K00517	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMC200000317	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMC200000317	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMC200000317	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMC200000317	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMC200000317	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMC200000318	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMC200000318	K00517	ko00626	Naphthalene and anthracene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMC200000318	K00517	ko00903	Limonene and pinene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMC200000318	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMC200000318	K00517	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMC200000319	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMC200000319	K00517	ko00626	Naphthalene and anthracene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMC200000319	K00517	ko00903	Limonene and pinene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMC200000319	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMC200000319	K00517	ko01110	Biosynthesis of secondary metabolites	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMC200000323	K11821	ko00380	Tryptophan metabolism	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMC200000323	K11821	ko00966	Glucosinolate biosynthesis	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMC200000323	K11821	ko01110	Biosynthesis of secondary metabolites	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMC200000324	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000324	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000324	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000324	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000324	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000325	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMC200000325	K00517	ko00626	Naphthalene and anthracene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMC200000325	K00517	ko00903	Limonene and pinene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMC200000325	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMC200000325	K00517	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMC200000326	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000326	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000326	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000326	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000326	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMC200000327	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMC200000327	K00517	ko00626	Naphthalene and anthracene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMC200000327	K00517	ko00903	Limonene and pinene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMC200000327	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMC200000327	K00517	ko01110	Biosynthesis of secondary metabolites	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMC200000328	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMC200000328	K00517	ko00626	Naphthalene and anthracene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMC200000328	K00517	ko00903	Limonene and pinene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMC200000328	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMC200000328	K00517	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMC200000329	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000329	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000329	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000329	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000329	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMC200000330	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMC200000330	K00517	ko00626	Naphthalene and anthracene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMC200000330	K00517	ko00903	Limonene and pinene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMC200000330	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMC200000330	K00517	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.40	0.62	0.95
